( (S (NP (NP (NP (NN Resistance)) (PP (TO to) (NP (NP (NP (NN IL-10)) (NN inhibition)) (PP (IN of) (NP (NP (NN interferon) (NN gamma)) (NN production)))))) (CC and) (NP (NP (NN expression)) (PP (IN of) (NP (NP (NN suppressor)) (PP (IN of) (NP (NN cytokine) (NN signaling) (CD 1))))) (PP (IN in) (NP (NP (JJ CD4+) (NN T) (NNS cells)) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ rheumatoid) (NN arthritis)))))))))))
( (S (NP (NN Abstract))))
( (S (S (NP (NN IL-10)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB block) (NP (DT the) (JJ antigen-specific) (NN T-cell) (NN cytokine) (NN response)) (PP (IN by) (S (VP (VBG inhibiting) (NP (DT the) (NN CD28) (NN signaling) (NN pathway)))))))))))) (. .)))
( (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (JJ peripheral) (NN blood) (JJ CD4+) (NN T) (NNS cells)) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ active) (JJ rheumatoid) (NN arthritis)) (PRN (-LRB- -LRB-) (NP (NN RA)) (-RRB- -RRB-))))))) (VP (VBD were) (ADJP (JJ able) (S (VP (TO to) (VP (VB produce) (NP (NP (JJR greater) (NNS amounts)) (PP (IN of) (NP (NN interferon) (NN gamma)))) (PP (IN after) (NP (NP (NN CD3)) (CC and) (NP (NN CD28)) (NP (NN costimulation)))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (ADJP (CD 1) (NN ng/ml)) (NN IL-10) (SBAR (IN than) (SINV (VBD were) (NP (JJ normal) (NN control) (JJ CD4+) (NN T) (NNS cells)))))))))))) (, ,) (SBAR (IN although) (S (NP (NP (PRP$ their) (NN surface) (NN expression)) (PP (IN of) (NP (DT the) (NN type) (CD 1) (NN IL-10) (NN receptor)))) (VP (VBD was) (VP (VBN increased))))))))) (. .)))
( (S (S (S (NP (NP (DT The) (NN phosphorylation)) (PP (IN of) (NP (NP (NP (NN signal) (NN transducer)) (CC and) (NP (NN activator))) (PP (IN of) (NP (NN transcription) (CD 3)))))) (VP (VBD was) (VP (VBN sustained) (PP (IN in) (NP (NP (NP (CC both) (NP (NN blood)) (CC and) (NP (JJ synovial) (NN tissue))) (JJ CD4+) (NN T) (NNS cells)) (PP (IN of) (NP (NN RA)))))))) (, ,) (CC but) (S (NP (PRP it)) (VP (VBD was) (RB not) (VP (VBN augmented) (PP (IN by) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (ADJP (CD 1) (NN ng/ml)) (NN IL-10))))))))) (. .)))
( (S (S (NP (NP (NN Sera)) (PP (IN from) (NP (NN RA) (NNS patients)))) (VP (VBD induced) (NP (NP (NP (NP (NN signal) (NN transducer)) (CC and) (NP (NN activator))) (PP (IN of) (NP (NN transcription) (CD 3)))) (NN phosphorylation)) (PP (IN in) (NP (JJ normal) (JJ CD4+) (NN T) (NNS cells))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (ADVP (RB mostly)) (VP (VBN abolished) (PP (IN by) (S (VP (VBG neutralizing) (NP (JJ anti-IL-6) (NN antibody))))))))))) (. .)))
( (S (S (NP (NP (NN Preincubation)) (PP (IN of) (NP (JJ normal) (JJ CD4+) (NN T) (NNS cells))) (PP (IN with) (NP (NN IL-6)))) (VP (VBD reduced) (NP (NP (JJ IL-10-mediated) (NN inhibition)) (PP (IN of) (NP (NN interferon) (NN gamma) (NN production)))))) (. .)))
( (S (S (NP (NP (NN Blood) (JJ CD4+) (NN T) (NNS cells)) (PP (IN from) (NP (NN RA) (NNS patients)))) (VP (VBD contained) (NP (NP (NP (JJR higher) (NNS levels)) (PP (IN of) (NP (NP (NN suppressor)) (PP (IN of) (NP (NN cytokine) (NN signaling) (CD 1)))))) (CC but) (NP (NP (JJR lower) (NNS levels)) (PP (IN of) (NP (NP (NN suppressor)) (PP (IN of) (NP (NN cytokine) (NN signaling) (CD 3) (NN mRNA))))))) (PP (VBN compared) (PP (IN with) (NP (NN control) (JJ CD4+) (NN T) (NNS cells)))) (, ,) (SBAR (IN as) (S (VP (VBN determined) (PP (IN by) (NP (JJ real-time) (NN PCR)))))))) (. .)))
( (S (S (NP (DT These) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (S (NP (NN RA) (JJ CD4+) (NN T) (NNS cells)) (VP (VBP become) (ADJP (JJ resistant) (PP (TO to) (NP (NP (DT the) (JJ immunosuppressive) (NN effect)) (PP (IN of) (NP (NN IL-10)))))) (PP (IN before) (NP (NP (NN migration)) (PP (IN into) (NP (JJ synovial) (NN tissue))))))) (, ,) (CC and) (S (NP (DT this) (JJ impaired) (NN IL-10) (NN signaling)) (VP (MD may) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NP (NP (NP (NP (JJ sustained) (NN signal) (NN transducer)) (CC and) (NP (NN activator))) (PP (IN of) (NP (NN transcription) (CD 3)))) (NN activation)) (CC and) (NP (NP (NN suppressor)) (PP (IN of) (NP (NN cytokine) (NN signaling) (CD 1)))) (NP (NN induction)))))))))))) (. .)))
( (S (NP (NN Introduction))))
( (S (S (NP (NN IL-10)) (VP (VBZ is) (NP (DT a) (JJ key) (NN cytokine)) (PP (IN in) (S (VP (VBG regulating) (NP (JJ inflammatory) (NNS responses))))) (, ,) (PP (ADVP (RB mainly)) (IN by) (S (VP (VBG inhibiting) (NP (NP (DT the) (NP (NN production)) (CC and) (NP (NN function))) (PP (IN of) (NP (JJ proinflammatory) (NNS cytokines))))))))) (. .)))
( (S (S (NP (NN IL-10)) (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (NP (NP (NN IL-10) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN IL-10R)) (-RRB- -RRB-))) (NN complex)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN composed) (PP (IN of) (NP (NP (CD two) (NNS subunits)) (, ,) (NP (NP (NP (DT the) (JJ primary) (JJ ligand-binding) (NN component) (NN type) (CD 1) (NN IL-10R)) (PRN (-LRB- -LRB-) (NP (NN IL-10R1)) (-RRB- -RRB-))) (CC and) (NP (DT the) (NN accessory) (NN component) (NN type) (CD 2) (NN IL-10R) (CD -LSB-1) (-RRB- -RSB-))))))))))))) (. .)))
( (S (NP (NP (DT The) (NN interaction)) (PP (IN of) (NP (NP (NN IL-10)) (CC and) (NP (NN IL-10R))))) (VP (VBZ engages) (NP (NP (NP (DT the) (NN Janus) (NN kinase) (-LRB- -LRB-) (NN JAK) (-RRB- -RRB-) (NN family) (NN tyrosine) (NNS kinases)) (NP (NP (NN Jak1)) (CC and) (NP (NN Tyk2)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (ADVP (RB constitutively)) (VP (VBN associated) (PP (IN with) (NP (NP (NN IL-10R1)) (CC and) (NP (NN type) (CD 2) (NN IL-10R)) (, ,) (ADVP (RB respectively)) (NP (NN -LSB-2)))))))))) (-RRB- -RSB-) (. .)))
( (S (S (NP (NN IL-10)) (VP (VBZ induces) (NP (NP (NN tyrosine) (NN phosphorylation)) (CC and) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (JJ latent) (JJ transcriptional) (NNS factors) (NP (NP (NN signal) (NN transducer)) (CC and) (NP (NN activator))))) (PP (IN of) (NP (NP (NN transcription) (-LRB- -LRB-) (NN STAT) (-RRB- -RRB-) (CD 3)) (CC and) (NP (NN STAT1) (CD -LSB-3) (-RRB- -RSB-)))))))) (. .)))
( (S (S (PP (IN Upon) (NP (NN phosphorylation))) (, ,) (NP (NP (NP (NN STAT1)) (CC and) (NP (NN STAT3))) (NNS proteins)) (VP (VP (VBP form) (NP (NP (NNS homodimers)) (CC or) (NP (NNS heterodimers)))) (, ,) (VP (ADVP (RB rapidly)) (VBP translocate) (PP (IN into) (NP (DT the) (NN nucleus)))) (, ,) (CC and) (VP (VB modulate) (NP (NN gene) (NN transcription))))) (. .)))
( (S (S (ADVP (RB Intriguingly)) (, ,) (NP (NN STAT3)) (VP (VBZ is) (ADJP (JJ indispensable) (PP (IN for) (NP (CC both) (NP (JJ IL-10-derived) (JJ anti-inflammatory)) (CC and) (NP (JJ IL-6-derived) (JJ proinflammatory) (NNS responses)) (NP (NN -LSB-4)))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (NP (NNS Studies)) (PP (IN of) (NP (JJ cell-type-specific) (JJ STAT3-deficient) (NNS mice)))) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NN STAT3) (NN activation)) (VP (VP (VBZ is) (ADJP (JJ essential) (PP (IN for) (NP (NP (JJ IL-10-mediated) (JJ anti-inflammatory) (NNS reactions)) (PP (IN in) (NP (NP (NNS macrophages)) (CC and) (NP (NNS neutrophils) (CD -LSB-5) (-RRB- -RSB-)))))))) (, ,) (CC but) (VP (VBZ is) (ADJP (JJ responsible) (PP (IN for) (NP (NP (JJ IL-6-mediated) (NN prevention)) (PP (IN of) (NP (NN apoptosis))) (PP (IN in) (NP (NN T) (NNS cells) (CD -LSB-6) (-RRB- -RSB-))))))))))))) (. .)))
( (S (S (NP (NP (NP (DT The) (NN suppressor)) (PP (IN of) (NP (NN cytokine) (NN signaling) (-LRB- -LRB-) (NN SOCS) (-RRB- -RRB-)))) (NNS proteins)) (VP (VBP have) (VP (VBN been) (VP (VBN identified) (PP (IN as) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NP (JJ endogenous) (NN JAK) (NN kinase) (NNS inhibitors)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB act) (PP (IN in) (NP (JJ classic) (NN feedback) (NN inhibition) (NNS loops))))))))))))))) (, ,) (CC but) (S (NP (NP (PRP$ their) (NNS roles)) (PP (IN as) (NP (NP (DT the) (NNS mediators)) (PP (IN of) (NP (NP (NN crosstalk) (NN inhibition)) (PP (IN by) (NP (JJ opposing) (NN cytokine) (NN signaling) (NNS pathways)))))))) (VP (VBP have) (VP (VBN been) (VP (VBN clarified) (S (NP (NN -LSB-7)) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (JJ Recent) (NNS studies)) (VP (VBP indicate) (SBAR (SBAR (IN that) (S (NP (NN SOCS3)) (VP (VBZ plays) (NP (DT a) (JJ key) (NN role)) (PP (IN in) (S (VP (VBG regulating) (NP (NP (DT the) (JJ divergent) (NN action)) (PP (IN of) (NP (NP (NN IL-10)) (CC and) (NP (NN IL-6)))))))) (, ,) (PP (IN by) (S (ADVP (RB specifically)) (VP (VBG blocking) (NP (NP (NN STAT3) (NN activation)) (VP (VBN induced) (PP (IN by) (NP (NN IL-6))))))))))) (CONJP (CC but) (RB not)) (SBAR (IN that) (S (VP (VBN induced) (PP (IN by) (NP (NN IL-10) (NN -LSB-8,9) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ synovial) (NN membrane)) (PP (IN of) (NP (NP (JJ rheumatoid) (NN arthritis)) (PRN (-LRB- -LRB-) (NP (NN RA)) (-RRB- -RRB-))))) (VP (VBZ is) (VP (VBN characterized) (PP (IN by) (NP (NP (DT an) (NN infiltrate)) (PP (IN of) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (JJ inflammatory) (NNS cells)) (, ,) (PP (JJ such) (IN as) (NP (NP (NNS lymphocytes)) (, ,) (NP (NNS macrophages)) (, ,) (CC and) (NP (JJ dendritic) (NNS cells)))) (, ,))))) (PP (ADVP (RB together)) (IN with) (NP (NP (NN proliferation)) (PP (IN of) (NP (JJ synovial) (JJ fibroblast-like) (NNS cells)))))))))) (. .)))
( (S (S (S (NP (JJ Numerous) (NNS cytokines)) (VP (VBP are) (ADJP (JJ overproduced) (PP (IN in) (NP (DT the) (JJ inflamed) (NN joint)))))) (, ,) (CC and) (S (NP (NP (NNS macrophages)) (CC and) (NP (JJ synovial) (NNS fibroblasts))) (VP (VBP are) (NP (NP (DT an) (JJ important) (NN source)) (PP (IN of) (NP (JJ proinflammatory) (NNS cytokines))))))) (. .)))
( (S (S (S (NP (NP (NP (NN Tumor) (NN necrosis) (NN factor) (NN alpha)) (PRN (-LRB- -LRB-) (NP (NN TNF-α)) (-RRB- -RRB-))) (CC and) (NP (NP (NN IL-1)) (, ,) (NP (CD two) (JJ major) (NN macrophage) (NNS products)) (, ,))) (VP (VBP are) (ADJP (JJ crucial) (PP (IN in) (NP (NP (DT the) (NN process)) (PP (IN of) (NP (NP (JJ chronic) (NN inflammation)) (CC and) (NP (NN joint) (NN destruction))))))))) (, ,) (CC and) (S (NP (PRP they)) (VP (VBP give) (NP (NN rise)) (PP (TO to) (NP (NP (NN effector) (NNS components)) (, ,) (PP (VBG including) (NP (NP (JJ other) (JJ inflammatory) (NNS cytokines)) (, ,) (NP (NNS chemokines)) (, ,) (NP (NN growth) (NNS factors)) (, ,) (NP (NN matrix) (NNS proteases)) (, ,) (NP (JJ nitric) (NN oxide)) (, ,) (CC and) (NP (JJ reactive) (NN oxygen) (NNS species) (CD -LSB-10)) (-RRB- -RSB-)))))))) (. .)))
( (S (S (S (NP (NN IL-6)) (VP (VBZ is) (NP (NP (DT a) (JJ pleiotropic) (NN cytokine)) (VP (VBN produced) (ADVP (RB substantially)) (PP (IN by) (NP (VBN activated) (NNS fibroblasts))))))) (, ,) (CC and) (S (NP (PRP$ its) (JJ proinflammatory) (NNS actions)) (VP (VBP include) (S (VP (VBG simulating) (NP (NP (DT the) (JJ acute-phase) (NN response)) (, ,) (NP (NP (NN B-cell) (NN maturation)) (PP (IN into) (NP (NP (NN plasma) (NNS cells)) (, ,) (NP (NN T-cell) (NNS functions))))) (, ,) (CC and) (NP (JJ hematopoietic) (NN precursor) (NN cell) (NN differentiation) (CD -LSB-11)))) (-RRB- -RSB-))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NP (JJ anti-inflammatory) (NNS cytokines)) (CC and) (NP (NN cytokine) (NNS inhibitors))) (VP (VBP are) (ADVP (RB also)) (ADJP (JJ present) (PP (IN in) (NP (NP (JJ large) (NNS quantities)) (PP (IN in) (NP (NN RA) (NNS joints)))))))) (. .)))
( (S (S (S (NP (NP (NN IL-10)) (, ,) (VP (VBN produced) (PP (PP (IN by) (NP (NNS macrophages))) (CC and) (ADVP (RB partly)) (PP (IN by) (NP (NP (NN T) (NNS cells)) (PP (IN in) (NP (NP (DT the) (JJ synovial) (NN tissue)) (PRN (-LRB- -LRB-) (NP (JJ ST)) (-RRB- -RRB-)))))))) (, ,)) (VP (VBZ is) (ADVP (RB best)) (VP (VBN known) (PP (IN as) (NP (NP (DT a) (JJ negative) (NN regulator)) (PP (IN for) (NP (NN macrophage) (CC and) (NN Th1) (NNS cells)))))))) (, ,) (CC but) (S (NP (DT the) (NN expression) (NN level)) (VP (VBZ is) (ADJP (JJ insufficient) (S (VP (TO to) (VP (VB counterbalance) (NP (NP (DT the) (NN cascade)) (PP (IN of) (NP (JJ proinflammatory) (NNS events) (CD -LSB-12) (-RRB- -RSB-))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (DT the) (JJ anti-inflammatory) (NN action)) (PP (IN of) (NP (NN IL-10)))) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (VP (VBN modulated) (PP (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN signal) (NN transduction))))) (PP (IN during) (NP (JJ chronic) (NN inflammation))))))))) (. .)))
( (S (S (NP (NN IL-10) (NN signaling)) (VP (VBZ is) (VP (VBN impaired) (PP (IN in) (NP (NNS macrophages))) (PP (IN upon) (NP (NP (JJ chronic) (NN exposure)) (PP (TO to) (NP (NP (JJ proinflammatory) (NNS cytokines)) (PP (JJ such) (IN as) (NP (NP (NN TNF-α)) (CC and) (NP (NP (NP (NN IL-1)) (CC and) (NP (JJ immune) (NNS complexes))) (CD -LSB-13,14) (-RRB- -RSB-))))))))))) (. .)))
( (S (S (NP (NP (NN Cell) (NN surface) (NN expression)) (PP (IN of) (NP (NN IL-10R1)))) (VP (VBZ is) (VP (VBN decreased) (PP (IN in) (NP (NP (JJ synovial) (NN fluid) (JJ dendritic) (NNS cells)) (ADJP (JJ due) (PP (TO to) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (NN TNF-α)) (, ,) (NP (NN IL-1)) (, ,) (CC and) (NP (NN granulocyte–macrophage) (JJ colony-stimulating) (NN factor) (CD -LSB-15)) (-RRB- -RSB-))))))))))) (. .)))
( (S (S (NP (JJ CD4+) (NN T) (NNS cells)) (VP (MD may) (VP (VB be) (VP (VBN activated) (PP (IN by) (NP (JJ arthritogenic) (NNS antigens))) (, ,) (PP (IN in) (NP (NP (NN conjunction)) (PP (IN with) (NP (JJ CD28-mediated) (NN costimulatory) (NN signaling))))) (, ,) (PP (IN in) (NP (NN RA))))))) (. .)))
( (S (S (NP (NP (DT The) (NN significance)) (PP (IN of) (NP (DT this) (JJ autoimmune) (NN process)))) (VP (VBZ has) (VP (VBN been) (VP (VBN supported) (PP (PP (IN by) (NP (NP (DT the) (NN linkage)) (PP (IN of) (NP (NP (DT the) (NP (NN MHC) (NN class) (CD II)) (NNS antigens)) (NP (NP (NN HLA-DRB1) (NN *) (CD 0404)) (CC and) (NP (NN HLA-DRB1) (NN *) (CD 0401))))) (PP (IN with) (NP (NP (NN disease) (NN susceptibility)) (CC and) (NP (NN severity) (CD -LSB-16,17) (-RRB- -RSB-)))))) (, ,) (CC and) (PP (IN by) (NP (NP (NP (DT the) (JJ high-level) (NN expression)) (PP (IN of) (NP (NN MHC) (NN class) (CD II) (NNS molecules)))) (CC and) (NP (NP (DT both) (NN CD28) (NNS ligands)) (, ,) (NP (NP (NN CD80)) (CC and) (NP (NN CD86))) (, ,)))) (PP (IN in) (NP (DT the) (JJ inflamed) (JJ ST) (NN -LSB-18-20))) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (NP (DT The) (VBG continuing) (NN emergence)) (PP (IN of) (NP (VBN activated) (JJ CD4+) (NN T) (NNS cells)))) (, ,) (PP (ADVP (RB even)) (IN though) (NP (NP (JJ few)) (PP (IN in) (NP (NN number))))) (, ,) (VP (MD may) (VP (VB be) (ADJP (JJ crucial) (PP (IN in) (S (VP (VBG sustaining) (NP (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NP (NNS macrophages)) (CC and) (NP (JJ synovial) (NNS fibroblasts)))) (PP (IN through) (NP (NP (NN cell) (NN surface) (NN signaling)) (PP (IN by) (NP (NP (NNS means)) (PP (IN of) (NP (NP (NN cell) (NN surface) (NN CD69)) (CC and) (NP (NN CD11))))))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT the) (NN release)) (PP (IN of) (NP (NP (JJ proinflammatory) (NN Th1) (NNS cytokines)) (PP (JJ such) (IN as) (NP (NP (NP (NP (NN interferon) (NN gamma)) (PRN (-LRB- -LRB-) (NP (NN IFN)) (-RRB- -RRB-))) (NN -γ)) (CC and) (NP (NN IL-17) (NN -LSB-21,22))))))))) (-RRB- -RSB-))))))) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (JJ CD4+) (NN T) (NNS cells)) (VP (MD could) (VP (VB stimulate) (NP (NP (NN B-cell) (NN production)) (PP (IN of) (NP (NP (NNS autoantibodies)) (PP (JJ such) (IN as) (NP (NP (JJ rheumatoid) (NN factor)) (CC and) (NP (JJ osteoclast-mediated) (NN bone) (NN destruction)))))))))) (. .)))
( (S (NP (NP (PRP$ Their) (JJ obligatory) (NN role)) (PP (IN in) (NP (NN RA) (NN synovitis)))) (VP (VBD was) (ADVP (RB recently)) (VP (VBD proved) (PP (IN by) (NP (NP (JJ successful) (NN treatment)) (PP (IN of) (NP (JJ active) (NN disease))))) (PP (IN by) (NP (NP (JJ selective) (NN inhibition)) (PP (IN of) (NP (NN T-cell) (NN activation))) (PP (IN with) (NP (NP (NN fusion) (NN protein)) (PP (IN of) (NP (NP (JJ cytotoxic) (JJ T-cell-associated) (NN antigen)) (NP (CD 4) (-LRB- -LRB-) (CD CD152) (-RRB- -RRB-) (NN -IgG)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB block) (NP (NP (DT the) (NN engagement)) (PP (IN of) (NP (NN CD28))) (PP (IN on) (NP (NN T) (NNS cells)))) (PP (IN by) (S (VP (VBG binding) (PP (TO to) (NP (NP (NN CD80)) (CC and) (NP (NN CD86)))) (PP (IN with) (NP (JJ high) (NN avidity) (CD -LSB-23) (-RRB- -RSB-)))))))))))))))))) (. .)))
( (S (S (NP (NN IL-10)) (ADVP (RB efficiently)) (VP (VBZ blocks) (NP (DT the) (JJ antigen-specific) (NN T-cell) (NN cytokine) (NN response)) (PP (PP (IN by) (S (VP (VBG inhibiting) (NP (DT the) (NN CD28) (NN signaling) (NN pathway) (CD -LSB-24))) (-RRB- -RSB-))) (, ,) (CONJP (RB as) (RB well) (IN as)) (ADVP (RB indirectly)) (PP (IN by) (S (VP (VBG downregulating) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (JJ antigen-presenting) (NNS cells)))))))))) (. .)))
( (S (S (VP (TO To) (VP (VB elucidate) (NP (NP (DT the) (NN resistance)) (PP (IN of) (NP (JJ CD4+) (NN T) (NNS cells))) (PP (TO to) (NP (NP (DT this) (JJ direct) (NN inhibition)) (PP (IN in) (NP (NN RA))))))))) (, ,) (NP (PRP we)) (VP (VBD investigated) (NP (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NP (NN IFN-γ)) (PP (IN after) (NP (NP (NP (NN CD3)) (CC and) (NP (NN CD28))) (NN costimulation))))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN IL-10)))))) (, ,) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NP (NN STAT1)) (CC and) (NP (NN STAT3)) (NP (NN phosphorylation)))) (PP (IN by) (NP (NN IL-10)))) (, ,) (CC and) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NN SOCS1)) (CC and) (NP (NN SOCS3)) (NP (NN mRNA)))) (PP (IN in) (NP (NP (NP (NP (JJ peripheral) (NN blood)) (PRN (-LRB- -LRB-) (NP (NN PB)) (-RRB- -RRB-))) (JJ CD4+) (NN T) (NNS cells)) (PP (IN from) (NP (NN RA) (NNS patients)))))))) (. .)))
( (S (NP (NP (NNS Materials)) (CC and) (NP (NNS methods)))))
( (S (S (NP (DT The) (JJ total) (NN patient) (NN population)) (VP (VBD consisted) (PP (IN of) (NP (NP (CD 32) (NNS patients)) (PP (IN with) (NP (NN RA))) (PRN (-LRB- -LRB-) (NP (NP (CD 25) (NNS women)) (CC and) (NP (CD seven) (NNS men))) (: ;) (NP (NN mean) (NN ±) (JJ standard) (NN deviation) (NN age)) (, ,) (NP (CD 52.8) (NN ±) (CD 12.4) (NNS years)) (-RRB- -RRB-)) (VP (VBN diagnosed) (PP (VBG according) (PP (TO to) (NP (NP (DT the) (JJ revised) (CD 1987) (NNS criteria)) (PP (IN of) (NP (NP (DT the) (NNP American) (NNP College)) (PP (IN of) (NP (NN Rheumatology) (PRN (-LRB- -LRB-) (NP (NP (RB formally)) (, ,) (NP (DT the) (NP (NNP American)) (NN Rheumatism) (NN Association))) (-RRB- -RRB-)) (CD -LSB-25) (-RRB- -RSB-))))))))))))) (. .)))
( (S (S (NP (DT All) (NNS patients)) (VP (VBD were) (VP (VBG receiving) (NP (NP (NP (NN prednisolone)) (PRN (-LRB- -LRB-) (NP (NN ≤) (CD 7.5) (NN mg/day)) (-RRB- -RRB-))) (CC and) (NP (JJ disease-modifying) (NN antirheumatic) (NNS drugs)))))) (. .)))
( (S (S (NP (NP (JJ Clinical) (NNS parameters)) (PP (IN in) (NP (DT the) (NN study) (NNS patients)))) (VP (VBD were) (SBAR (IN as) (S (VP (VBZ follows) (-LRB- -LRB-) (NP (NN mean) (NN ±) (JJ standard) (NN deviation)) (-RRB- -RRB-)))))) (: :) (NP (NP (NN erythrocyte) (NN sedimentation) (NN rate)) (, ,) (NP (CD 55.9) (NN ±) (CD 35.4) (NN mm/hour)) (: ;) (NP (NP (NP (NP (NN serum) (JJ C-reactive) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN CRP)) (-RRB- -RRB-))) (NN level)) (, ,) (NP (QP (CD 32.0) (CD ±) (CD 32.0)) (NN mg/l))) (: ;) (CC and) (NP (NP (NN IgM) (NN class) (NN rheumatoid) (NN factor) (NN titer)) (, ,) (NP (CD 142) (NN ±) (CD 158) (NN U/ml)))) (. .)))
( (S (S (NP (NNS Patients)) (VP (VBD were) (VP (VBN divided) (PP (IN into) (NP (NP (CD two) (NNS groups)) (: :) (NP (NP (CD 24) (NNS patients)) (PP (IN with) (NP (JJ active) (NN disease))) (, ,) (SBAR (WHNP (WP who)) (S (VP (VP (VBD had) (NP (JJ multiple) (NN tender) (CC and/or) (JJ swollen) (NNS joints))) (CC and) (VP (VBD elevated) (NP (NP (NN serum) (NN CRP) (NN level)) (PRN (-LRB- -LRB-) (NP (NN ≥) (CD 10) (NN mg/l)) (-RRB- -RRB-)))))))) (: ;) (CC and) (NP (NP (CD eight) (NNS patients)) (PP (IN with) (NP (JJ inactive) (NN disease))) (, ,) (SBAR (WHNP (WP who)) (S (VP (VBD satisfied) (NP (NP (NP (NP (DT the) (NNP American) (NNP College)) (PP (IN of) (NP (NN Rheumatology)))) (JJ preliminary) (NNS criteria)) (PP (IN for) (NP (JJ clinical) (NN remission) (CD -LSB-26))))) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (NP (CD Sixteen) (JJ healthy) (NNS volunteers)) (PRN (-LRB- -LRB-) (NP (NP (CD 11) (NNS women)) (CC and) (NP (CD five) (NNS men))) (: ;) (NP (NN age)) (, ,) (NP (QP (CD 45.8) (CD ±) (CD 11.2)) (NNS years)) (-RRB- -RRB-))) (VP (VBD served) (PP (IN as) (NP (NNS controls))))) (. .)))
( (S (S (NP (JJ ST) (NNS samples)) (VP (VBD were) (VP (VBN obtained) (PP (IN from) (NP (NP (CD three) (NN RA) (NNS patients)) (VP (VBG undergoing) (NP (JJ total) (NN knee) (NN replacement)))))))) (. .)))
( (S (S (NP (DT All) (NNS patients)) (VP (VBD gave) (NP (VBN informed) (NN consent)))) (. .)))
( (S (S (NP (NP (JJ Peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN PBMC)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN prepared) (PP (IN from) (NP (JJ heparinized) (NN blood) (NNS samples))) (PP (IN by) (NP (NP (NN centrifugation)) (PP (IN over) (NP (NP (JJ Ficoll-Hypaque) (NN density) (NNS gradients)) (PRN (-LRB- -LRB-) (NP (NP (NNP Pharmacia)) (, ,) (NP (NNP Uppsala) (, ,) (NNP Sweden))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (JJ CD4+) (NN T) (NNS cells)) (VP (VBD were) (VP (VBN purified) (PP (IN from) (NP (NN PBMC))) (PP (IN by) (NP (NP (JJ positive) (NN selection)) (VP (VBG using) (NP (NP (JJ anti-CD4) (JJ mAb-coated) (JJ magnetic) (NNS beads)) (PRN (-LRB- -LRB-) (NP (NP (NNP Miltenyi) (NNP Biotec)) (, ,) (NP (NNP Gladbach) (, ,) (NNP Germany))) (-RRB- -RRB-)))))) (, ,) (PP (VBG according) (PP (TO to) (NP (NP (DT the) (NN manufacturer) (POS 's)) (NNS instructions))))))) (. .)))
( (S (S (NP (JJ CD4+) (NN T) (NNS cells)) (VP (VBD were) (VP (VBN isolated) (PP (IN from) (NP (JJ ST) (NNS samples))) (, ,) (PP (IN as) (NP (ADJP (RB previously) (VBN described)) (NN -LSB-27))) (-RRB- -RSB-)))) (. .)))
( (S (S (ADVP (RB Briefly)) (, ,) (NP (JJ fresh) (JJ ST) (NNS samples)) (VP (VBD were) (ADJP (ADJP (JJ fragmented)) (CC and) (ADJP (JJ digested)) (PP (IN with) (NP (NP (NN collagenase)) (CC and) (NP (NN DNase)))) (PP (IN for) (NP (NP (CD 1) (NN hour)) (PP (IN at) (NP (NN 37°C)))))))) (. .)))
( (S (S (PP (IN After) (NP (VBG removing) (NN tissue) (NN debris))) (, ,) (NP (NP (JJ ST) (NN cell) (NNS suspensions)) (PP (IN in) (NP (NP (NP (NN culture) (NN medium)) (PRN (-LRB- -LRB-) (NP (NP (NN RPMI) (CD 1640) (NN medium)) (: ;) (NP (NN Life) (NNS Technologies)) (, ,) (NP (NNP Gaithersburg) (, ,) (NNP MD) (, ,) (NNP USA))) (-RRB- -RRB-))) (VP (VBN supplemented) (PP (IN with) (NP (NP (CD 25) (NN mM) (NNS HEPES)) (PRN (-LRB- -LRB-) (NP (CD 2) (NN mM) (NN L-glutamine)) (, ,) (NP (NP (ADJP (CD 2) (NN %)) (JJ nonessential) (NN amino) (NNS acids)) (, ,) (NP (CD 100) (NN IU/ml) (NN penicillin)) (, ,) (CC and) (NP (CD 100) (NN mg/ml) (NN streptomycin))) (: ;) (NP (NN Life) (NNS Technologies)) (-RRB- -RRB-)))) (PP (IN with) (NP (NP (ADJP (CD 10) (NN %)) (JJ heat-inactivated) (NN FCS)) (PRN (-LRB- -LRB-) (NP (NN Life) (NNS Technologies)) (-RRB- -RRB-)))))))) (VP (VBD were) (VP (VBN incubated) (PP (IN at) (NP (NP (NN 37°C)) (PP (IN in) (NP (NP (JJ six-well) (NNS plates)) (PRN (-LRB- -LRB-) (NP (NNP Coster)) (, ,) (NP (NN Cambridge)) (, ,) (NP (NNP MA) (, ,) (NNP USA)) (-RRB- -RRB-)))))) (PP (IN for) (NP (CD 45) (NN min)))))) (. .)))
( (S (S (S (NP (JJ Non-adherent) (NNS cells)) (VP (VBD were) (VP (VBN harvested)))) (CC and) (S (NP (JJ CD4+) (NN T) (NNS cells)) (VP (VBD were) (VP (VBN purified) (PP (IN by) (NP (JJ positive) (NN selection)))) (SBAR (IN as) (S (ADVP (RB already)) (VP (VBN described))))))) (. .)))
( (S (S (NP (ADJP (NN PB) (JJ CD4+)) (NN T-cell) (NNS populations)) (VP (VBD were) (VP (VBN resuspended) (PP (IN at) (NP (NP (DT a) (NN density)) (PP (IN of) (NP (QP (CD 1) (CD ×) (CD 106)) (NNS cells/ml))))) (PP (IN in) (NP (NP (NN culture) (NN medium)) (PP (IN with) (NP (ADJP (CD 10) (NN %)) (NN FCS)))))))) (, ,) (CC and) (S (NP (ADJP (CD 0.5) (NN ml)) (NN cell) (NNS suspensions)) (VP (VBD were) (VP (VBN dispensed) (PP (IN into) (NP (NP (DT the) (NNS wells)) (PP (IN of) (NP (NP (NP (JJ 24-well) (NN microtiter) (NNS plates)) (PRN (-LRB- -LRB-) (NP (NNP Coster)) (-RRB- -RRB-))) (VP (VBN coated) (PP (IN with) (NP (NP (ADJP (CD 1) (NN μg/ml)) (JJ anti-CD3) (NN mAb)) (PRN (-LRB- -LRB-) (NP (NNP Immunotech) (, ,) (NNP Marseille) (, ,) (NNP France)) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (NP (DT The) (NNS cells)) (VP (VBD were) (VP (VBN incubated) (PP (IN with) (NP (CD 1) (NN μg/ml) (JJ anti-CD28) (NN mAb))) (PRN (-LRB- -LRB-) (NP (NNP Immunotech)) (-RRB- -RRB-)) (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC or) (NP (NN absence))) (PP (IN of) (NP (NP (DT the) (VBN indicated) (NNS concentrations)) (PP (IN of) (NP (NN IL-10))))))) (PRN (-LRB- -LRB-) (NP (NP (NNP Becton) (NNP Dickinson) (, ,) (NNP San) (NNP Jose)) (, ,) (NP (NN CA)) (, ,) (NP (NNP USA))) (-RRB- -RRB-)) (PP (IN at) (NP (NP (NN 37°C)) (PP (IN in) (NP (NP (DT a) (JJ humidified) (NN atmosphere)) (VP (VBG containing) (NP (ADJP (CD 5) (NN %)) (NN CO2) (CD -LSB-28) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (S (NP (NN Culture) (NNS supernatants)) (VP (VBD were) (VP (VBN collected) (ADVP (NP (CD 36) (NNS hours)) (RB later))))) (CC and) (S (NP (JJ cell-free) (NNS samples)) (VP (VBD were) (VP (VBN stored) (PP (IN at) (NP (NN -30°C))) (PP (IN until) (NP (NN cytokine) (NN assay))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB examine) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN IL-6))) (PP (IN on) (NP (NP (NN T-cell) (NN responsiveness)) (PP (TO to) (NP (NN IL-10))))))))) (, ,) (NP (NP (JJ CD4+) (NN T) (NNS cells)) (PP (IN from) (NP (JJ healthy) (NNS controls)))) (VP (VBD were) (VP (VBN incubated) (PP (IN in) (NP (NN culture) (NN medium))) (PP (IN with) (NP (NP (ADJP (CD 10) (NN %)) (NN FCS)) (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC or) (NP (NN absence))) (PP (IN of) (NP (ADJP (CD 10) (NN ng/ml)) (NN IL-6))))))) (PRN (-LRB- -LRB-) (NP (NNP Becton) (NNP Dickinson)) (-RRB- -RRB-)) (PP (IN for) (NP (CD 36) (NNS hours)))))) (. .)))
( (S (S (NP (NNS Cells)) (VP (VBD were) (ADVP (RB then)) (VP (VBN stimulated) (PP (IN for) (NP (NP (CD 36) (NNS hours)) (PP (IN with) (NP (NP (JJ anti-CD3) (NN mAb)) (CC and) (NP (JJ anti-CD28) (NN mAb)))))) (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC or) (NP (NN absence))) (PP (IN of) (NP (ADJP (CD 1) (NN ng/ml)) (NN IL-10)))))))) (. .)))
( (S (S (NP (NN Culture) (NNS supernatants)) (VP (VBD were) (VP (VBN measured) (PP (IN for) (NP (JJ IFN-γ) (NNS concentrations)))))) (. .)))
( (S (S (NP (NP (DT A) (NN sample)) (PP (IN of) (NP (NP (CD 5) (NN ×) (CD 105) (NNS cells)) (PP (IN of) (NP (NN PBMC)))))) (VP (VBD was) (VP (VBN resuspended) (PP (IN in) (NP (NP (NNS PBS)) (PP (IN with) (NP (ADJP (CD 1) (NN %)) (NN FCS)))))))) (. .)))
( (S (NP (NN PBMC)) (VP (VBD were) (VP (VBN incubated) (PP (PP (IN with) (NP (NP (JJ saturating) (NNS concentrations)) (PP (IN of) (NP (NP (JJ anti-IL-10R1) (NN mAb)) (PRN (-LRB- -LRB-) (NP (NN IgG1)) (: ;) (NP (NN R&D) (NNS systems)) (, ,) (NP (NP (NNP Minneapolis)) (, ,) (NP (NN MN)) (, ,) (NP (NNP USA))) (-RRB- -RRB-)))))) (CC or) (PP (IN with) (NP (NP (NP (JJ isotype-matched) (NN control) (NN mAb)) (PRN (-LRB- -LRB-) (NP (NN Immunotech)) (-RRB- -RRB-))) (, ,) (VP (VBN followed) (PP (IN by) (NP (NP (NN incubation)) (PP (IN with) (NP (NP (JJ FITC-conjugated) (NN goat) (JJ anti-mouse) (NN IgG1) (JJ polyclonal) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NNP Santa) (NNP Cruz) (NNP Biotechnologies) (, ,) (NNP Santa) (NNP Cruz) (, ,) (NP (NN CA)) (, ,) (NP (NNP USA))) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (NP (NNS Cells)) (VP (VBD were) (ADVP (RB then)) (VP (VBN incubated) (PP (IN with) (NP (NP (JJ phycoerythrin-conjugated) (JJ anti-CD4) (NN mAb)) (PRN (-LRB- -LRB-) (NP (NNP Becton) (NNP Dickinson)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NNS Cells)) (VP (VBD were) (VP (VBN washed) (ADVP (RB well)) (PP (IN with) (NP (NP (ADJP (CD 1) (NN %)) (NN FCS/PBS)) (PP (IN between) (NP (NNS incubations)))))))) (. .)))
( (S (S (NP (NN Analysis)) (VP (VBD was) (VP (VBN performed) (PP (IN on) (NP (NP (DT a) (NN FACScan) (NN flow) (NN cytometer)) (PRN (-LRB- -LRB-) (NP (NNP Becton) (NNP Dickinson)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (NNS Concentrations)) (PP (IN of) (NP (NP (NN IFN-γ)) (CC and) (NP (NN IL-2)))) (PP (IN in) (NP (NP (NN culture) (NNS supernatants)) (PP (IN of) (NP (JJ CD4+) (NN T) (NNS cells)))))) (VP (VBD were) (VP (VBN measured) (PP (IN in) (NP (NN duplicate))) (PP (IN by) (NP (NP (DT the) (JJ quantitative) (NN sandwich) (NN ELISA)) (VP (VBG using) (NP (JJ cytokine-specific) (NN capture))))) (PP (IN with) (NP (NP (VBN biotinylated) (NN detection) (NN mAb)) (CC and) (NP (NP (JJ recombinant) (NN cytokine) (NNS proteins)) (PRN (-LRB- -LRB-) (NP (NP (NN all)) (PP (IN from) (NP (NNP Becton) (NNP Dickinson)))) (-RRB- -RRB-))))) (, ,) (PP (VBG according) (PP (TO to) (NP (NP (DT the) (NN manufacturer) (POS 's)) (NN protocol))))))) (. .)))
( (S (S (NP (NP (DT The) (NN detection) (NNS limits)) (PP (IN for) (NP (NP (NN IFN-γ)) (CC and) (NP (NN IL-2))))) (VP (VBD were) (NP (CD 15) (NN pg/ml)))) (. .)))
( (S (S (NP (JJ Total) (JJ cellular) (NN RNA)) (VP (VBD was) (VP (VBN extracted) (PP (IN from) (NP (NP (NN PB) (JJ CD4+) (NN T) (NNS cells)) (VP (VBG using) (NP (NP (DT an) (NN RNA) (NN isolation) (NN kit)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP RNeasy) (NNP Mini)) (NP (NN kit))) (: ;) (NP (NN Qiagen)) (, ,) (NP (NNP Valencia)) (, ,) (NP (NN CA) (, ,) (NNP USA))) (-RRB- -RRB-)))))) (, ,) (PP (VBG according) (PP (TO to) (NP (NP (DT the) (NN manufacturer) (POS 's)) (NNS instructions))))))) (. .)))
( (S (S (NP (NN cDNA)) (VP (VBD was) (VP (VBN synthesized) (PP (IN from) (NP (NP (JJ total) (NN RNA)) (PP (IN with) (NP (NP (NP (NN Molony) (JJ murine) (NN leukemia) (NN virus) (JJ reverse) (NN transcriptase)) (-LRB- -LRB-) (NP (ADJP (NP (PRP US)) (JJ Biochemical)) (, ,) (NNP Cleveland) (, ,) (NN OH) (, ,) (NNP USA)) (-RRB- -RRB-) (CC and) (JJ oligo-) (-LRB- -LRB-) (NN dT) (-RRB- -RRB-) (CD 15) (NNS primers)) (PRN (-LRB- -LRB-) (NP (NP (NNP Promega) (, ,) (NNP Madison) (, ,) (NNP WI)) (, ,) (NP (NNP USA))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (JJ Real-time) (NN PCR)) (VP (VBD was) (VP (VBN performed) (PP (IN with) (NP (NP (NP (DT the) (NN LightCycler) (NN Instrument)) (PRN (-LRB- -LRB-) (NP (NP (NN Roche) (NN Diagnostics)) (, ,) (NP (NNP Penzberg) (, ,) (NNP Germany))) (-RRB- -RRB-))) (PP (IN in) (NP (NN glass) (NNS capillaries)))))))) (. .)))
( (S (S (NP (NP (DT The) (NN reaction) (NN mix)) (VP (VBG containing) (NP (NP (NP (NP (NN Taq) (NN DNA) (NN polymerase)) (CC and) (NP (NN DNA) (JJ double-strand-specific) (NN SYBR) (NN Green) (NN I) (CD dye))) (PRN (-LRB- -LRB-) (NP (NP (NN Lightcycler) (NN FastStart) (NN DNA) (NN Master) (NN SYBR) (NN Green) (NN I)) (: ;) (NP (NN Roche) (NN Diagnostics))) (-RRB- -RRB-))) (CC and) (NP (JJ specific) (NNS primers))))) (VP (VBD were) (VP (VBN added) (PP (TO to) (NP (NN cDNA) (NNS dilutions)))))) (. .)))
( (S (S (NP (DT The) (NN cDNA) (NNS samples)) (VP (VBD were) (VP (VBN denatured) (PP (IN at) (NP (NP (NN 95°) (NN C)) (PP (IN for) (NP (CD 10) (NN min)))))) (, ,) (CC and) (VP (VBD were) (ADVP (RB then)) (VP (VBN amplified) (PP (IN for) (NP (NP (CD 40–50) (NNS cycles)) (: :) (PP (PP (PP (IN at) (NP (NP (NP (NP (NP (NP (NN 95°) (NN C)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN s)) (-RRB- -RRB-))) (, ,) (PP (IN at) (NP (NP (NN 65°) (NN C)) (PRN (-LRB- -LRB-) (NP (CD 15) (NN s)) (-RRB- -RRB-)))) (, ,)) (CC and) (NP (NN 72°) (NN C))) (PRN (-LRB- -LRB-) (NP (CD 22) (NNS s)) (-RRB- -RRB-))) (PP (IN for) (NP (NP (NN β-actin) (: ;)) (PP (IN at) (NP (NP (NN 95°) (NN C)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN s)) (-RRB- -RRB-)))))))) (, ,) (PP (IN at) (NP (NP (NN 62°) (NN C)) (PRN (-LRB- -LRB-) (NP (CD 15) (NNS s)) (-RRB- -RRB-)))) (, ,) (CC and) (PP (IN at) (NP (NP (NP (NN 72°) (NN C)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN s)) (-RRB- -RRB-))) (PP (IN for) (NP (NN SOCS1))))) (: ;) (CC and) (PP (IN at) (NP (NP (NN 96°) (NN C)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN s)) (-RRB- -RRB-))))) (, ,) (PP (IN at) (NP (NP (NN 68°) (NN C)) (PRN (-LRB- -LRB-) (NP (CD 15) (NNS s)) (-RRB- -RRB-)))) (, ,) (CC and) (PP (IN at) (NP (NP (NP (NN 72°) (NN C)) (PRN (-LRB- -LRB-) (NP (CD 15) (NN s)) (-RRB- -RRB-))) (PP (IN for) (NP (NN SOCS3)))))))))))) (. .)))
( (S (S (S (NP (NP (NN Amplification) (NNS curves)) (PP (IN of) (NP (NP (DT the) (NN fluorescence) (NNS values)) (CC versus) (NP (NN cycle) (NN number))))) (VP (VBD were) (VP (VBN obtained)))) (, ,) (CC and) (S (NP (DT a) (NN melting) (NN curve) (NN analysis)) (VP (VBD was) (ADVP (RB then)) (VP (VBN performed))))) (. .)))
( (S (S (NP (NP (DT The) (NNS levels)) (PP (IN of) (NP (NP (NN SOCS1)) (CC and) (NP (NN SOCS3)) (NP (NN expression))))) (VP (VBD were) (VP (VBN determined) (PP (IN by) (S (VP (VBG normalizing) (PP (JJ relative) (TO to) (NP (NN β-actin) (NN expression))))))))) (. .)))
( (S (S (NP (DT The) (ADJP (ADJP (JJ forward)) (CC and) (ADJP (JJ reverse))) (NNS primers)) (VP (VBD were) (PP (IN as) (NP (NP (VBZ follows)) (: :) (PP (PP (IN for) (NP (NP (NN β-actin)) (, ,) (NP (NP (NN 5'-GTGGGGCGCCCCAGGCACCA-3) (POS ')) (CC and) (NP (NN 5'-CTCCTTAATGTCACGCACGATTTC-3) (POS '))))) (: ;) (PP (IN for) (NP (NP (NN SOCS1)) (, ,) (NP (NP (NN 5'-AGACCCCTTCTCACCTCTTG-3) (POS ')) (CC and) (NP (NN 5'-GCACAGCAGAAAAATAAAGC-3) (POS '))))) (: ;) (CC and) (PP (IN for) (NP (NP (NN SOCS3)) (, ,) (NP (NP (NN 5'-CCCGCCGGCACCTTTCTG-3) (POS ')) (CC and) (NP (NN 5'-AGGGGCCGGCTCAACACC-3) (POS ')))))))))) (. .)))
( (S (S (NP (JJ CD4+) (NN T) (NNS cells)) (VP (VBD were) (VP (VBN stimulated) (PP (IN for) (NP (CD 20) (NN min))) (PP (IN by) (NP (NP (DT the) (VBN indicated) (NNS concentrations)) (PP (IN of) (NP (NP (NN IL-10)) (CC and) (NP (NN IL-6)))))) (PP (IN at) (NP (NP (DT a) (NN density)) (PP (IN of) (NP (NP (CD 5) (NN ×) (CD 105) (NNS cells)) (PP (IN in) (NP (NP (ADJP (CD 0.5) (NN ml)) (NN culture) (NN medium)) (PP (IN with) (NP (ADJP (CD 10) (NN %)) (NN FCS)))))))))))) (. .)))
( (S (S (VP (TO To) (VP (VB examine) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN serum) (NN IL-6))) (PP (IN on) (NP (NN STAT) (NN phosphorylation))))))) (, ,) (NP (JJ normal) (JJ CD4+) (NN T) (NNS cells)) (VP (VBD were) (VP (VBN stimulated) (PP (IN for) (NP (CD 20) (NN min))) (PP (IN with) (NP (ADJP (CD 30) (NN %)) (JJ active) (NN RA) (NN serum))) (PP (IN in) (NP (NP (NN culture) (NN medium)) (PP (IN with) (NP (NP (CD 40) (NNS μg/ml)) (VP (VBG neutralizing) (NP (NP (NP (NN goat) (JJ anti-IL-6) (JJ polyclonal) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NP (NN IgG)) (: ;) (NP (NNP Techne) (, ,) (NNP Princeton) (, ,) (NNP NJ)) (, ,) (NP (NN USA))) (-RRB- -RRB-))) (CC or) (NP (NP (NN control) (NN goat) (NN IgG)) (PRN (-LRB- -LRB-) (NP (NN Techne)) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (NP (JJ Whole) (NN cell) (NNS lysates)) (VP (VBD were) (VP (VBN prepared) (PP (IN by) (S (VP (VBG placing) (NP (NNS cells)) (PP (IN in) (NP (NP (CD 100) (NN μl) (NN SDS) (VBG lysing) (NN buffer)) (PRN (-LRB- -LRB-) (NP (CD 62.5) (NN mM) (NN Tris–HCl) (NN -LSB-pH) (CD 6.8)) (-RRB- -RSB-)))) (PRN (, ,) (NP (NP (ADJP (CD 2) (NN %)) (NN SDS)) (, ,) (NP (ADJP (CD 10) (NN %)) (NN glycerol)) (, ,) (NP (ADJP (CD 50) (NN mM)) (NN dithiothreitol))) (, ,) (NP (NP (CD 0.1) (NN %)) (ADJP (NN bromphenol) (JJ blue))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (S (NP (QP (RB Then) (CD 20)) (JJ μl) (NN protein) (NNS samples)) (VP (VP (VBD were) (VP (VBN fractionated) (PP (IN on) (NP (ADJP (CD 10) (NN %)) (NN SDS-polyacrylamide) (NNS gels))))) (CC and) (VP (VBD were) (VP (VBN transferred) (PP (TO to) (NP (NN nitrocellulose) (NNS membranes))) (PRN (-LRB- -LRB-) (NP (NP (NNP Amersham) (, ,) (NNP Buckinghamshire)) (, ,) (NP (NNP UK))) (-RRB- -RRB-)))))) (, ,) (CC and) (S (NP (DT the) (NN membrane)) (VP (VBD was) (VP (VBN blocked) (PP (IN with) (NP (NP (ADJP (CD 5) (NN %)) (NN skim) (NN milk)) (PP (IN in) (NP (NP (JJ Tris-buffered) (NN saline)) (PP (IN with) (NP (ADJP (CD 0.1) (NN %)) (NNP Tween) (CD 20))))))))))) (. .)))
( (S (S (NP (NP (NN Tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (NN STAT1)) (CC and) (NP (NN STAT3))))) (VP (VBD was) (VP (VBN detected) (S (VP (VBG using) (NP (NP (NP (JJ commercial) (JJ available) (NNS kits)) (PRN (-LRB- -LRB-) (NP (NP (NN Cell) (NN Signaling) (NN Technology)) (, ,) (NP (NNP Beverly) (, ,) (NNP MA)) (, ,) (NP (NN USA))) (-RRB- -RRB-))) (VP (VBG according) (PP (TO to) (NP (NP (DT the) (NN manufacturer) (POS 's)) (NNS instructions)))))))))) (. .)))
( (S (ADVP (RB Briefly)) (, ,) (NP (DT the) (NN membrane)) (VP (VBD was) (VP (VBN incubated) (PP (IN with) (NP (NP (NP (NP (DT the) (NNS antibodies)) (PRN (-LRB- -LRB-) (NP (NN rabbit) (NN IgG)) (-RRB- -RRB-))) (NN anti-STAT1) (NN antibody)) (, ,) (NP (NP (NP (JJ anti-phosphorylated) (NN tyrosine) (CD 701)) (PP (IN of) (NP (NN STAT1)))) (NN antibody)) (, ,) (NP (JJ anti-STAT3) (NN antibody)) (, ,) (CC and) (NP (NP (JJ anti-phosphorylated) (NN tyrosine) (NN 705)) (PP (IN of) (NP (NN STAT3) (NN antibody)))))) (, ,) (S (VP (VBN diluted) (SBAR (IN as) (S (VP (VBN recommended) (PP (IN at) (NP (NP (NN 1/2000)) (PP (IN with) (NP (NP (JJ Tris-buffered) (NN saline)) (PP (IN with) (NP (ADJP (CD 0.1) (NN %)) (NNP Tween) (CD 20))) (PP (IN with) (NP (ADJP (CD 5) (NN %)) (NN BSA)))))))))))))) (. .)))
( (S (S (NP (NN Antibody) (NN binding)) (VP (VP (VBD was) (VP (VBN detected) (PP (IN by) (NP (NP (NN horseradish) (JJ peroxidase-conjugated) (JJ anti-rabbit) (NN IgG) (NN antibody)) (VP (VBN diluted) (PP (IN at) (NP (NP (NN 1/4000)) (PP (IN with) (NP (NP (JJ Tris-buffered) (NN saline)) (PP (IN with) (NP (ADJP (CD 0.1) (NN %)) (NNP Tween) (CD 20))) (PP (IN with) (NP (ADJP (CD 5) (NN %)) (NN BSA)))))))))))) (, ,) (CC and) (VP (VBD was) (VP (VBN revealed) (S (VP (VBG using) (NP (DT the) (NN chemiluminescence) (NN system)))))))) (. .)))
( (S (S (S (NP (NN Protein) (NNS bands)) (VP (VBD were) (VP (VBN quantified) (PP (IN by) (NP (NN densitometry))) (S (VP (VBG using) (NP (NN NIH-Image) (NN analysis))))))) (, ,) (CC and) (S (NP (NN STAT) (NN phosphorylation)) (VP (VBD was) (VP (VBN compared) (PP (IN with) (NP (NP (DT the) (JJ total) (NN amount)) (PP (IN of) (NP (NN STAT) (NN protein))))))))) (. .)))
( (S (S (NP (JJ IFN-γ-stimulated) (NN Hela) (NNS cells)) (VP (VBD were) (VP (VBN used) (PP (IN as) (NP (NP (DT a) (JJ positive) (NN control)) (PP (IN for) (NP (NN STAT1) (NN phosophorylation)))))))) (. .)))
( (S (S (NP (NNS Data)) (VP (VBP are) (VP (VBN expressed) (PP (IN as) (NP (NP (DT the) (NN mean) (NN value)) (VP (VBG ±) (NP (NP (JJ standard) (NN error)) (PP (IN of) (NP (DT the) (NN mean) (CC or) (NN box) (NNS plots)))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ statistical) (NN significance)) (PP (IN of) (NP (NP (NNS differences)) (PP (IN between) (NP (CD two) (NNS groups)))))) (VP (VBD was) (VP (VBN determined) (PP (IN by) (NP (NP (DT the) (NN Mann–Whitney) (NN U) (NN test)) (CC or) (NP (DT the) (NN Wilcoxon) (JJ signed) (NN rank) (NN test))))))) (. .)))
( (S (S (NP (NN P) (NN <) (CD 0.05)) (VP (VBD was) (VP (VBN considered) (ADJP (JJ significant))))) (. .)))
( (S (NP (NNS Results))))
( (S (S (S (NP (DT The) (NN CD28) (NN costimulatory) (NN pathway)) (VP (VBZ is) (ADJP (JJ crucial) (PP (IN for) (NP (JJ effective) (JJ antigen-specific) (NN T-cell) (NN cytokine) (NN production)))))) (, ,) (CC and) (S (NP (NN IL-10)) (VP (MD can) (ADVP (RB directly)) (VP (VB suppress) (NP (DT this) (NN response)) (PP (IN by) (S (VP (VBG inhibiting) (NP (NP (NN CD28) (NN tyrosine) (NN phosphorylation)) (CC and) (NP (NP (NN binding)) (PP (IN of) (NP (NN phosphatidylinositol) (NN 3-kinase) (CD -LSB-24)))))) (-RRB- -RSB-))))))) (. .)))
( (S (S (S (S (VP (TO To) (VP (VB evaluate) (NP (NP (DT the) (NN responsiveness)) (PP (IN of) (NP (NN RA) (JJ CD4+) (NN T) (NNS cells))) (PP (TO to) (NP (NN IL-10))))))) (, ,) (NP (NP (VBN purified) (NN PB) (JJ CD4+) (NN T) (NNS cells)) (PP (PP (IN from) (NP (NP (CD three) (NNS patients)) (PP (IN with) (NP (JJ active) (NN RA))))) (CC and) (PP (IN from) (NP (CD three) (JJ healthy) (NNS controls))))) (VP (VBD were) (VP (VBN stimulated) (PP (IN by) (NP (NP (VBN immobilized) (JJ anti-CD3) (NN antibody)) (CC and) (NP (JJ anti-CD28) (NN antibody)))) (PP (IN with) (CC or) (PP (IN without) (NP (NP (JJ diluted) (NNS concentrations)) (PP (IN of) (NP (NN IL-10)))))) (PP (IN for) (NP (CD 36) (NNS hours)))))) (, ,) (CC and) (S (NP (NN IFN-γ) (NN production)) (VP (VBD was) (VP (VBN measured) (PP (IN by) (NP (NN ELISA))))))) (. .)))
( (S (S (SBAR (IN As) (S (VP (VBN shown) (PP (IN in) (NP (NNP Fig.) (CD 1)))))) (, ,) (NP (NP (NN IFN-γ) (NN production)) (PP (IN by) (NP (VBN activated) (JJ normal) (JJ CD4+) (NN T) (NNS cells)))) (VP (VBD was) (ADVP (RB mostly)) (VP (VBN inhibited) (PP (IN at) (NP (NP (NNS concentrations)) (ADJP (RB as) (JJ low) (PP (IN as) (NP (ADJP (CD 1) (NN ng/ml)) (NN IL-10))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (S (NP (NN RA) (JJ CD4+) (NN T) (NNS cells)) (VP (VBD were) (ADJP (JJ able) (S (VP (TO to) (VP (VB produce) (NP (NP (JJ significant) (NNS amounts)) (PP (IN of) (NP (NN IFN-γ)))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (ADJP (CD 1) (NN ng/ml)) (NN IL-10))))))))))) (, ,) (CC and) (S (NP (NP (DT the) (ADJP (ADJP (JJ maximal)) (CONJP (CC but) (RB not)) (ADJP (JJ complete))) (NN inhibition)) (PP (IN by) (NP (NN IL-10)))) (VP (VBD was) (VP (VBN obtained) (PP (IN at) (NP (CD 10–100) (NN ng/ml))))))) (. .)))
( (S (NP (PRP We)) (ADVP (RB thus)) (VP (VBD compared) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NP (NN IFN-γ) (NN production)) (PP (IN by) (NP (JJ CD4+) (NN T) (NNS cells)))))) (PP (IN after) (NP (NP (NP (NN CD3)) (CC and) (NP (NN CD28))) (NN costimulation))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (ADJP (CD 1) (NN ng/ml)) (NN IL-10))) (PP (PP (IN in) (NP (NP (NN RA) (NNS patients)) (PP (IN with) (NP (NP (NP (JJ active) (NN disease)) (PRN (-LRB- -LRB-) (NP (NP (JJ multiple) (JJ inflammatory) (NNS joints)) (, ,) (NP (NN CRP) (NN level) (NN ≥) (CD 10) (NN mg/l))) (-RRB- -RRB-))) (CC and) (NP (NP (JJ inactive) (NN disease)) (PRN (-LRB- -LRB-) (PP (IN in) (NP (NN remission))) (, ,) (NP (NN CRP) (NN level) (NN <) (CD 10) (NN mg/l) (-RRB- -RRB-) (CD -LSB-26)) (-RRB- -RSB-))))))) (CC and) (PP (IN in) (NP (JJ healthy) (NNS controls))))))) (. .)))
( (S (S (S (NP (EX There)) (VP (VBD were) (NP (NP (DT no) (ADJP (RB statistically) (JJ significant)) (NNS differences)) (PP (IN in) (NP (NP (JJ IFN-γ) (NN production)) (PP (IN without) (NP (NN IL-10))) (PP (IN among) (NP (NP (DT these) (CD three) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 2a)) (-RRB- -RRB-))))))))) (, ,) (CC but) (S (NP (NP (DT the) (JJ inhibitory) (NN effect)) (PP (IN of) (NP (NN IL-10))) (PP (IN on) (NP (NN IFN-γ) (NN production)))) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN limited) (PP (IN in) (NP (DT the) (JJ active) (NN RA) (NN group))) (SBAR (IN as) (S (VP (VBN compared) (PP (IN with) (NP (NP (DT the) (JJ inactive) (NN RA) (NN group)) (CC and) (NP (NP (NP (JJ healthy) (NNS controls)) (PRN (-LRB- -LRB-) (NP (NN percentage) (NN decrease)) (: :) (NP (JJ active) (NN RA)) (, ,) (NP (CD 2.9) (NN ±) (CD 14.4) (NN %)) (: ;) (NP (JJ inactive) (NN RA)) (, ,) (NP (CD 45.6) (NN ±) (CD 14.4) (NN %)) (: ;) (NP (NNS controls)) (, ,) (NP (CD 65.8) (NN ±) (CD 7.9) (NN %)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 2b)) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (PP (IN As) (NP (DT a) (NN consequence))) (, ,) (NP (NP (JJ CD4+) (NN T) (NNS cells)) (PP (IN from) (NP (JJ active) (NN RA) (NNS patients)))) (VP (VBD produced) (NP (NP (JJR higher) (NNS levels)) (PP (IN of) (NP (NN IFN-γ)))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (ADJP (CD 1) (NN ng/ml)) (NN IL-10))))) (SBAR (IN than) (SINV (VBD did) (NP (NP (JJ normal) (JJ CD4+) (NN T) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 2a)) (-RRB- -RRB-))))))) (. .)))
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBD compared) (NP (NP (NN IL-2) (NN production)) (PP (IN by) (NP (JJ CD4+) (NN T) (NNS cells)))) (PP (IN after) (NP (NP (NN CD3)) (CC and) (NP (NN CD28)) (NP (NN costimulation)))) (PP (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN IL-10))) (PP (IN in) (NP (JJ active) (NN RA) (NNS patients))))) (CC and) (PP (IN in) (NP (JJ healthy) (NNS controls))))) (. .)))
( (S (ADVP (RB Similarly)) (, ,) (NP (NN IL-2) (NN production)) (VP (VBD was) (RB not) (VP (VBN affected) (PP (IN by) (NP (ADJP (CD 1) (NN ng/ml)) (NN IL-10))) (PP (IN in) (NP (NP (NN RA) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NN percentage) (NN decrease)) (, ,) (NP (QP (CD -2.1) (CD ±) (CD 13.8)) (NN %)) (-RRB- -RRB-))))) (, ,) (SBAR (IN while) (S (NP (PRP it)) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN reduced) (PP (IN in) (NP (NP (JJ healthy) (NNS controls)) (PRN (-LRB- -LRB-) (NP (CD 61.1) (NN ±) (CD 13.7) (NN %)) (: ;) (NP (NN P) (NN <) (CD 0.05)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (NP (DT these) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN RA) (JJ CD4+) (NN T) (NNS cells)) (VP (VBP become) (ADJP (RBR less) (JJ susceptible) (PP (TO to) (NP (NP (DT the) (JJ immunoregulatory) (NN effect)) (PP (IN of) (NP (NN IL-10)))))) (PP (IN during) (NP (DT the) (JJ active) (NN phase)))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ functional) (NN receptor) (NN complex)) (PP (IN of) (NP (NN IL-10)))) (VP (VBZ consists) (PP (IN of) (NP (NP (CD two) (NNS subunits)) (, ,) (NP (NP (DT the) (JJ primary) (JJ ligand-binding) (NN component) (NN IL-10R1)) (CC and) (NP (DT the) (JJ accessory) (NN component) (NN type) (CD 2) (NN IL-10R) (CD -LSB-1) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (NN IL-10R1) (NN expression)) (VP (VBZ plays) (NP (DT a) (JJ critical) (NN role)) (PP (IN in) (NP (NP (JJ cellular) (NNS responses)) (PP (TO to) (NP (NN IL-10) (CD -LSB-29)))))) (-RRB- -RSB-)) (. .)))
( (S (S (VP (TO To) (VP (VB examine) (SBAR (IN whether) (S (NP (NP (DT the) (NN resistance)) (PP (TO to) (NP (NN IL-10) (NN inhibition))) (PP (IN in) (NP (NN RA) (JJ CD4+) (NN T) (NNS cells)))) (VP (VBD was) (ADJP (JJ due) (PP (TO to) (NP (JJ limited) (NN receptor) (NN expression)))))))))) (, ,) (NP (NP (DT the) (NN cell) (NN surface) (NN expression)) (PP (IN of) (NP (NN IL-10R1))) (PP (IN on) (NP (NP (NN PB) (JJ CD4+) (NN T) (NNS cells)) (PP (PP (IN from) (NP (JJ active) (NN RA) (NNS patients))) (CC and) (PP (IN from) (NP (JJ healthy) (NNS controls))))))) (VP (VBD was) (VP (VBN determined) (PP (IN by) (NP (NN flow) (JJ cytometric) (NN analysis))))) (. .)))
( (S (SBAR (IN As) (S (VP (VBN shown) (PP (IN in) (NP (NNP Fig.) (CD 3a,3b)))))) (, ,) (NP (NP (DT the) (NN intensity)) (PP (IN of) (NP (NN IL-10R1) (NN expression))) (PP (IN on) (NP (JJ CD4+) (NN T) (NNS cells)))) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN increased) (PP (IN in) (NP (NN RA) (NNS patients))) (PP (VBN compared) (PP (IN with) (PP (IN in) (NP (JJ healthy) (NNS controls))))))) (. .)))
( (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (JJ intracellular) (NN signal) (NN transduction) (NN pathway)) (PP (IN of) (NP (NN IL-10)))) (VP (MD may) (VP (VB be) (VP (VBN impaired) (PP (IN in) (NP (NP (JJ CD4+) (NN T) (NNS cells)) (PP (IN of) (NP (JJ active) (NN RA)))))))))))) (. .)))
( (S (NP (NP (DT The) (NN interaction)) (PP (IN of) (NP (NN IL-10R))) (PP (IN with) (NP (NN IL-10)))) (VP (VBZ induces) (NP (NP (NN tyrosine) (NN phosphorylation)) (CC and) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (JJ latent) (NN transcription) (NNS factors) (NP (NP (NN STAT1)) (CC and) (NP (NN STAT3) (CD -LSB-3)))))))) (-RRB- -RSB-) (. .)))
( (S (S (NP (JJ Macrophage-specific) (JJ STAT3-deficient) (NNS mice)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NN STAT3)) (VP (VBZ plays) (NP (DT a) (JJ dominant) (NN role)) (PP (IN in) (NP (NP (NP (JJ IL-10-mediated) (JJ anti-inflammatory) (NNS responses)) (CD -LSB-5) (-RRB- -RSB-)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (ADVP (RB recently)) (VP (VBN been) (VP (VBN confirmed) (PP (IN in) (NP (JJ human) (NNS macrophages))) (PP (IN by) (NP (NP (NNS studies)) (PP (IN of) (NP (JJ dominant-negative) (NN STAT3) (NN overexpression) (CD -LSB-30) (-RRB- -RSB-))))))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN induction)) (PP (IN of) (NP (NP (NN STAT1)) (CC and) (NP (NN STAT3)) (NP (NN phosphorylation)))) (PP (IN by) (NP (NN IL-10))) (PP (IN in) (NP (NP (NN PB) (JJ CD4+) (NN T) (NNS cells)) (PP (PP (IN from) (NP (JJ active) (NN RA) (NNS patients))) (CC and) (PP (IN from) (NP (JJ healthy) (NNS controls))))))) (VP (VBD was) (VP (VBN examined) (S (VP (VBG using) (NP (NN western) (NN blotting))))))) (. .)))
( (S (S (NP (NN STAT3) (NN phosphorylation)) (VP (VBD was) (ADVP (RB dose-dependently)) (VP (VBN induced) (PP (IN after) (NP (NN IL-10) (NN activation))) (PP (IN for) (NP (NP (CD 20) (NN min)) (PP (IN in) (NP (JJ normal) (JJ CD4+) (NN T) (NNS cells))))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 4a,4b)) (-RRB- -RRB-))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (S (NP (NN STAT3)) (VP (VBD was) (VP (VBN phosphorylated) (PP (IN in) (NP (NP (ADJP (RB freshly) (VBN isolated)) (NN PB) (JJ CD4+) (NNS cells)) (PP (IN from) (NP (NN RA) (NNS patients)))))))) (CC and) (S (NP (DT this) (NN STAT3) (NN phosphorylation)) (VP (VBD was) (ADJP (JJ detectable) (PP (IN for) (NP (QP (RB up) (TO to) (CD 6)) (NNS hours))))))) (. .)))
( (S (S (NP (NN STAT3) (NN phosphorylation)) (VP (VBD was) (VP (VBN augmented) (SBAR (WHADVP (RB only) (WRB when)) (S (VP (VBN activated) (PP (IN by) (NP (ADJP (QP (RB as) (JJ much) (IN as) (CD 10)) (NN ng/ml)) (NN IL-10))))))))) (. .)))
( (S (S (NP (CC Both) (NP (JJ sustained) (NN STAT3) (NN phosphorylation)) (CC and) (NP (JJ defective) (JJ IL-10-induced) (NN STAT3) (NN phosphorylation))) (VP (VBD were) (VP (VBN found) (PP (IN in) (NP (NP (NN RA) (JJ ST) (JJ CD4+) (NN T) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 4c)) (-RRB- -RRB-))))))) (. .)))
( (S (S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP (JJ IL-10-induced) (NN STAT1) (NN phosphorylation)) (VP (VBD was) (RB not) (VP (VBN detected) (PP (IN in) (NP (CC either) (NP (NN RA) (JJ CD4+) (NN T) (NNS cells)) (CC or) (NP (NP (JJ normal) (JJ CD4+) (NN T) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 4a)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (DT These) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (S (NP (NN STAT3)) (VP (VBZ is) (NP (NP (DT the) (JJ major) (JJ IL-10-activated) (NN STAT)) (PP (IN in) (NP (JJ CD4+) (NN T) (NNS cells)))))) (, ,) (CC and) (S (NP (JJ IL-10-induced) (NN STAT3) (NN activation)) (VP (MD may) (VP (VB be) (VP (VBN diminished) (PP (IN in) (NP (JJ active) (NN RA))) (, ,) (PP (IN in) (NP (NP (NN association)) (PP (IN with) (NP (JJ sustained) (NN STAT3) (NN phosphorylation))))))))))))) (. .)))
( (S (S (NP (NN STAT3)) (VP (VBZ is) (VP (VBN activated) (PP (IN by) (NP (NP (NP (JJ many) (NNS cytokines)) (CC and) (NP (NN growth) (NNS factors))) (PP (JJ such) (IN as) (NP (NP (DT the) (NN IL-6) (NN family)) (PP (IN of) (NP (NP (NP (NNS cytokines)) (PRN (-LRB- -LRB-) (NP (NP (NN IL-6)) (, ,) (NP (NN IL-11)) (, ,) (NP (NN leukemia) (JJ inhibitory) (NN factor)) (, ,) (CC and) (NP (NN oncostatin) (NN M))) (-RRB- -RRB-))) (, ,) (NP (JJ platelet-derived) (NN growth) (NN factor)) (, ,) (CC and) (NP (JJ epidermal) (NN growth) (NN factor)))))))) (, ,) (PP (IN in) (NN addition) (TO to) (NP (NN IL-10) (NN -LSB-4) (-RRB- -RSB-)))))) (, ,) (CC but) (S (NP (JJ previous) (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NN IL-6)) (VP (VBZ is) (NP (NP (DT the) (JJ major) (NN factor)) (PP (IN in) (NP (NN RA) (JJ synovial) (NN fluid))) (SBAR (WHNP (WDT that)) (S (VP (VBZ induces) (NP (NP (JJ constitutive) (NN activation)) (PP (IN of) (NP (NN STAT3)))) (PP (IN in) (NP (NP (JJ mononuclear) (NNS cells)) (NP (CD -LSB-31) (-RRB- -RSB-)))))))))))))) (. .)))
( (S (SBAR (IN Since) (S (NP (NN IL-6)) (VP (VBZ is) (ADVP (RB also)) (ADJP (JJ abundant) (PP (IN in) (NP (NP (NN sera)) (PP (IN of) (NP (JJ active) (NN RA) (NNS patients)))))) (, ,) (ADVP (RB frequently)) (VP (VBN detected) (PP (IN at) (NP (NN >) (CD 1) (NN ng/ml) (CD -LSB-27) (-RRB- -RSB-))))))) (, ,) (NP (PRP we)) (VP (VBD examined) (SBAR (IN whether) (S (NP (NP (JJ persistent) (NN exposure)) (PP (IN of) (NP (JJ CD4+) (NN T) (NNS cells))) (PP (TO to) (NP (NP (JJ high) (NNS concentrations)) (PP (IN of) (NP (NP (NN IL-6)) (PP (IN in) (NP (DT the) (NN blood) (NN circulation)))))))) (VP (VBD was) (ADJP (JJ responsible) (PP (IN for) (NP (NP (PRP$ their) (JJ sustained) (NN STAT3) (NN activation)) (CC and) (NP (NP (NN resistance)) (PP (TO to) (NP (NN IL-10) (NN inhibition))) (PP (IN in) (NP (JJ active) (NN RA))))))))))) (. .)))
( (S (NP (CC Both) (NP (NN STAT1)) (CC and) (NP (NN STAT3)) (NP (NN phosphorylation))) (VP (VBD was) (VP (VBN activated) (PP (IN by) (NP (NN IL-6))) (PP (IN in) (NP (NP (JJ normal) (JJ CD4+) (NN T) (NNS cells)) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))) (, ,) (PP (IN in) (NP (NP (NN agreement)) (PP (IN with) (NP (NP (JJ previous) (NNS observations)) (CD -LSB-4) (-RRB- -RSB-))))))) (. .)))
( (S (S (S (NP (JJ Normal) (JJ CD4+) (NN T) (NNS cells)) (VP (VBD were) (ADVP (RB thus)) (VP (VBN incubated) (PP (IN for) (NP (CD 20) (NN min))) (PP (IN with) (NP (NP (NN culture) (NN medium)) (VP (VP (VBG containing) (NP (NP (ADJP (CD 30) (NN %)) (NN serum)) (PP (IN from) (NP (JJ active) (NN RA) (NNS patients))))) (CC and) (VP (VBG neutralizing) (NP (NP (JJ anti-IL-6) (NN antibody)) (CC or) (NP (NN control) (NN antibody)))))))))) (, ,) (CC and) (S (NP (NN STAT) (NN phosphorylation)) (VP (VBD was) (VP (VBN examined) (PP (IN by) (NP (NN western) (NN blot) (NN analysis))))))) (. .)))
( (S (S (S (NP (NN RA) (NN serum)) (VP (VBD was) (ADJP (JJ able) (S (VP (TO to) (VP (VB induce) (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (NN STAT3)) (CONJP (CC but) (RB not)) (NP (NN STAT1))))))))))) (, ,) (CC and) (S (NP (DT this) (NN STAT3) (NN activation)) (VP (VBD was) (ADVP (RB mostly)) (VP (VBN abolished) (PP (IN by) (NP (NP (NN neutralization)) (PP (IN of) (NP (NP (NN IL-6) (NN activity)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 5a)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (DT These) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN IL-6)) (VP (VBZ is) (NP (NP (DT the) (JJ dominant) (NN STAT3-activating) (NN factor)) (VP (VBN contained) (PP (IN in) (NP (NP (NN sera)) (PP (IN of) (NP (JJ active) (NN RA) (NNS patients)))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN lack)) (PP (IN of) (NP (NN STAT1) (NN activation))) (PP (IN by) (NP (NN RA) (NN serum)))) (VP (VBZ suggests) (SBAR (SBAR (IN that) (S (NP (NP (ADJP (RB much) (JJR higher)) (NNS concentrations)) (PP (IN of) (NP (NN IL-6)))) (VP (MD may) (VP (VB be) (VP (VBN required) (PP (IN for) (NP (NN STAT1) (NN activation))))) (SBAR (IN as) (S (VP (VBN compared) (PP (IN with) (NP (NN STAT3) (NN activation))))))))) (, ,) (CC or) (SBAR (IN that) (S (NP (NP (NNS inhibitors)) (PP (IN of) (NP (NN STAT1) (NN signaling)))) (VP (MD may) (VP (VB be) (ADJP (JJ present) (PP (IN in) (NP (NN RA) (NN serum))))))))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB next)) (VP (VBD examined) (SBAR (IN whether) (S (NP (NN IL-6)) (VP (MD could) (VP (VB suppress) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN IL-10))) (S (VP (TO to) (VP (VB inhibit) (NP (NP (NN IFN-γ) (NN production)) (PP (IN by) (NP (JJ CD4+) (NN T) (NNS cells)))))))))))))) (. .)))
( (S (PP (IN After) (NP (NP (NN preincubation)) (PP (PP (IN with)) (CC or) (PP (IN without) (NP (ADJP (CD 10) (NN ng/ml)) (NN IL-6)))) (PP (IN for) (NP (CD 36) (NNS hours))))) (, ,) (S (S (NP (JJ normal) (JJ CD4+) (NN T) (NNS cells)) (VP (VBD were) (VP (VBN stimulated) (PP (IN by) (NP (NP (NP (NN CD3)) (CC and) (NP (NN CD28))) (NN costimulation))) (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC or) (NP (NN absence))) (PP (IN of) (NP (ADJP (CD 1) (NN ng/ml)) (NN IL-10))) (PP (IN for) (NP (CD 36) (NNS hours)))))))) (, ,) (CC and) (S (NP (DT the) (JJ IFN-γ) (NN production)) (VP (VBD was) (VP (VBN measured) (PP (IN by) (NP (NN ELISA))))))) (. .)))
( (S (S (NP (NP (NN IL-6) (NN pretreatment)) (PP (IN of) (NP (JJ normal) (NNS cells)))) (VP (VBD reduced) (NP (NP (JJ IL-10-mediated) (NN inhibition)) (PP (IN of) (NP (NP (JJ IFN-γ) (NN production)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 5b)) (-RRB- -RRB-))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (JJ high) (NNS concentrations)) (PP (IN of) (NP (NN IL-6)))) (VP (MD could) (VP (VB modulate) (NP (NP (NN T-cell) (NN responsiveness)) (PP (TO to) (NP (NN IL-10)))))))))))) (. .)))
( (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (S (NP (DT these) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (JJ persistent) (NN exposure)) (PP (TO to) (NP (NN serum) (NN IL-6)))) (VP (MD may) (VP (VB have) (NP (DT a) (NN role)) (PP (IN in) (NP (CC both) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NN STAT3) (NN activation)))) (CC and) (NP (NP (DT the) (NN resistance)) (PP (TO to) (NP (NP (DT the) (JJ inhibitory) (NN effect)) (PP (IN of) (NP (NN IL-10))) (PP (IN in) (NP (NN RA) (JJ CD4+) (NN T) (NNS cells)))))))))))))) (. .)))
( (S (S (NP (NN IL-6)) (VP (VBZ induces) (NP (NP (CD two) (JJ potent) (NNS inhibitors)) (PP (IN of) (NP (NP (NP (NNS JAKs)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN SOCS1)) (CC and) (NP (NN SOCS3))) (NNS proteins)) (-RRB- -RRB-))) (SBAR (WHNP (WDT that)) (S (VP (CONJP (RB not) (RB only)) (VP (VBP act) (PP (IN as) (NP (NP (NNS mediators)) (PP (IN of) (NP (JJ negative) (NN feedback) (NN inhibition)))))) (, ,) (CONJP (CC but) (RB also)) (VP (VBP play) (NP (DT a) (JJ major) (NN role)) (PP (IN in) (NP (NN crosstalk) (NN inhibition)))))))))) (PP (IN by) (S (VP (VBG opposing) (NP (NP (JJ other) (JJ cytokine-signaling) (NNS pathways)) (CD -LSB-7) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (NN SOCS3)) (VP (VBZ has) (ADVP (RB recently)) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (ADVP (RB specifically)) (VP (VB inhibit) (NP (NP (NN STAT3) (NN activation)) (VP (VBN induced) (PP (PP (IN by) (NP (NN IL-6))) (CC but) (PP (RB not) (IN by) (NP (NN IL-10)))))) (, ,) (S (ADVP (RB thereby)) (VP (VBG regulating) (NP (NP (DT the) (JJ divergent) (NN action)) (PP (IN of) (NP (NP (NN IL-6)) (CC and) (NP (NN IL-10)) (NP (NN -LSB-8,9)))))) (-RRB- -RSB-))))))))) (. .)))
( (S (S (PP (IN On) (NP (DT the) (NN contrary))) (, ,) (NP (NN SOCS1)) (VP (VBZ is) (ADJP (JJ able) (S (VP (TO to) (ADVP (RB partially)) (VP (VB inhibit) (NP (NP (NP (JJ IL-10-mediated) (NN STAT3) (NN activation)) (CC and) (NP (JJ cellular) (NNS responses))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (JJ IFN-γ-mediated) (NN STAT1) (NN activation) (CD -LSB-32))))) (-RRB- -RSB-))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB determine) (SBAR (IN whether) (S (NP (NNS SOCSs)) (VP (VBD were) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (JJ defective) (JJ IL-10-induced) (NN STAT3) (NN activation)) (PP (IN of) (NP (NN RA) (JJ CD4+) (NN T) (NNS cells)))))))))))) (, ,) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NP (NN SOCS1)) (CC and) (NP (NN SOCS3)) (NP (NN mRNA) (NN expression)))) (PP (IN in) (NP (NP (NN PB) (JJ CD4+) (NN T) (NNS cells)) (PP (PP (IN from) (NP (JJ active) (NN RA) (NNS patients))) (CC and) (PP (IN from) (NP (JJ healthy) (NNS controls))))))) (VP (VBD were) (VP (VBN compared) (PP (IN by) (NP (JJ semiquantitative) (JJ real-time) (NN PCR)))))) (. .)))
( (S (S (NP (DT The) (NN RA) (JJ CD4+) (NN T) (NNS cells)) (VP (VBD contained) (NP (NP (NP (JJR higher) (NNS levels)) (PP (IN of) (NP (NN SOCS1)))) (CC but) (NP (NP (JJR lower) (NNS levels)) (PP (IN of) (NP (NN SOCS3) (NNS transcripts))))) (SBAR (IN than) (SINV (VBD did) (NP (NP (JJ control) (JJ CD4+) (NN T) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 6a)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (JJ Constitutive) (NN expression)) (PP (IN of) (NP (NN SOCS1) (NN mRNA))) (PP (IN in) (NP (NN RA) (JJ CD4+) (NN T) (NNS cells)))) (VP (VBD was) (ADJP (JJ comparable) (PP (IN with) (NP (NP (DT the) (NN expression)) (PP (IN in) (NP (NP (JJ normal) (JJ CD4+) (NN T) (NNS cells)) (VP (VBN stimulated) (PP (IN by) (NP (NP (ADJP (CD 10) (NN ng/ml)) (NN IL-6)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 6b)) (-RRB- -RRB-)))))))))) (, ,) (S (VP (VBG supporting) (NP (PRP$ its) (JJ functional) (NN significance)))))) (. .)))
( (S (S (NP (JJ Defective) (JJ IL-10-induced) (NN STAT3) (NN activation)) (ADVP (RB therefore)) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (ADJP (JJ due) (PP (ADVP (IN at) (JJS least)) (IN in) (NP (NN part))) (PP (TO to) (NP (NP (DT an) (NN abundance)) (PP (IN of) (NP (NN SOCS1))) (PP (IN in) (NP (NN RA) (JJ CD4+) (NN T) (NNS cells))))))))))) (. .)))
( (S (NP (NN Discussion))))
( (S (S (NP (JJ CD4+) (NN T) (NNS cells)) (VP (VBP orchestrate) (NP (DT the) (ADJP (NN Th1-type) (JJ cell-mediated)) (JJ immune) (NN response)) (PP (IN in) (NP (NN RA) (NN -LSB-22) (-RRB- -RSB-))))) (. .)))
( (S (S (NP (VBN Activated) (JJ CD4+) (NN T) (NNS cells)) (VP (VBP stimulate) (NP (NP (NNS macrophages)) (, ,) (NP (JJ synovial) (NNS fibroblasts)) (, ,) (NP (NN B) (NNS cells)) (, ,) (CC and) (NP (NNS osteoclasts))) (PP (IN through) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NN cell) (NN surface) (NNS molecules)) (CC and) (NP (NN Th1) (NNS cytokines)))))) (, ,) (S (ADVP (RB thereby)) (VP (VBG contributing) (PP (TO to) (NP (CC both) (NP (DT the) (JJ chronic) (NN inflammation)) (CC and) (NP (DT the) (NN joint) (NN destruction)))))))) (. .)))
( (S (S (NP (JJ CD4+) (NN T) (NNS cells)) (VP (VBP require) (NP (NP (NP (CD two) (NNS signals)) (S (VP (TO to) (VP (VB be) (VP (VBN activated)))))) (: ;) (NP (NP (NN antigen) (NN receptor) (NN occupancy)) (CC and) (NP (JJ CD28-mediated) (NN costimulation)))))) (. .)))
( (S (S (PP (IN In) (NP (DT the) (JJ ST) (NN lesion))) (, ,) (NP (NP (NP (DT the) (NN CD28) (NNS ligands)) (, ,) (NP (CC both) (NP (NN CD80)) (CC and) (NP (NN CD86)))) (, ,) (CONJP (RB together) (IN with)) (NP (NN MHC) (NN class) (CD II) (NNS antigens)) (, ,)) (VP (VBP are) (ADVP (RB substantially)) (VP (VBN expressed) (PP (IN by) (NP (NP (JJ antigen-presenting) (NNS cells)) (PP (JJ such) (IN as) (NP (NP (NNS macrophages)) (CC and) (NP (NP (JJ dendritic) (NNS cells)) (CD -LSB-18-20) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN significance)) (PP (IN of) (NP (NN CD28) (NN engagement))) (PP (IN in) (NP (DT the) (JJ T-cell-mediated) (NN disease) (NN process)))) (VP (VBZ has) (ADVP (RB recently)) (VP (VBN been) (VP (VBN proven) (PP (IN by) (NP (NP (DT the) (JJ clinical) (NN efficacy)) (PP (IN of) (NP (NP (PRP$ its) (NN blocker) (JJ cytotoxic) (JJ T-cell-associated) (NN antigen)) (NP (CD 4) (-LRB- -LRB-) (CD CD152) (-RRB- -RRB-) (NN -IgG)))) (PP (IN in) (NP (NN RA) (NNS patients) (CD -LSB-23) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (NN IL-10)) (VP (VBZ plays) (NP (DT a) (JJ predominant) (NN role)) (PP (IN in) (S (VP (VBG limiting) (NP (ADJP (ADJP (JJ immune)) (CC and) (ADJP (JJ inflammatory))) (NNS responses)) (PP (IN by) (S (VP (VBG regulating) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (CC both) (NP (NNS macrophages)) (CC and) (NP (NP (NN Th1) (NNS cells)) (PRN (NN -LSB-1) (-RRB- -RSB-)))))))))))))) (. .)))
( (S (S (NP (NN IL-10)) (VP (VP (VBZ inhibits) (NP (NP (NP (DT the) (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (DT the) (NN CD28) (NN molecule)))) (CC and) (NP (NP (NP (DT the) (JJ subsequent) (NN phosphatidylinositol) (NN 3-kinase)) (NN binding)) (PP (IN in) (NP (NN T) (NNS cells)))))) (, ,) (CC and) (ADVP (RB thereby)) (ADVP (RB directly)) (VP (VBZ acts) (PP (IN on) (NP (NN T) (NNS cells) (CD -LSB-24) (-RRB- -RSB-)))))) (. .)))
( (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (NN PB) (JJ CD4+) (NN T) (NNS cells)) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ active) (NN RA))))) (, ,) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN IL-10))))) (, ,)) (VP (VBP are) (ADJP (JJ able) (S (VP (TO to) (VP (VB produce) (NP (NP (JJR higher) (NNS levels)) (PP (IN of) (NP (NN IFN-γ)))) (PP (IN after) (NP (NP (NP (NP (NN CD3)) (CC and) (NP (NN CD28))) (NN costimulation)) (PP (IN than) (NP (JJ normal) (JJ CD4+) (NN T) (NNS cells))))))))))))) (. .)))
( (S (S (PP (IN Despite) (NP (NP (JJ high-level) (NN IL-10R1) (NN expression)) (CC and) (NP (JJ constitutive) (NN STAT3) (NN activation)))) (, ,) (NP (NP (JJ IL-10-induced) (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NN STAT3)))) (VP (VBZ is) (VP (VBN suppressed) (PP (IN in) (NP (NN RA) (JJ CD4+) (NN T) (NNS cells))) (, ,) (PP (IN in) (NN contrast) (TO to) (NP (NP (JJ normal) (JJ CD4+) (NN T) (NNS cells)) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (NN STAT3) (NN phosphorylation)) (VP (VBZ is) (ADJP (RB dose-dependently) (JJ inducible) (PP (IN by) (NP (NN IL-10)))))))))))) (. .)))
( (S (S (S (NP (NP (NN Serum) (NN IL-6)) (PP (IN from) (NP (NN RA) (NNS patients)))) (VP (VBZ induces) (NP (NP (NP (NP (NN STAT3)) (CONJP (CC but) (RB not)) (NP (NN STAT1))) (NN phosphorylation)) (PP (IN in) (NP (JJ normal) (JJ CD4+) (NN T) (NNS cells)))))) (, ,) (CC and) (S (NP (JJ exogenous) (NN IL-6)) (VP (VBZ induces) (NP (NP (DT the) (NN resistance)) (PP (TO to) (NP (NP (NP (NN IL-10)) (NN inhibition)) (PP (IN of) (NP (NN IFN-γ) (NN production))))))))) (. .)))
( (S (S (NP (NN RA) (JJ CD4+) (NN T) (NNS cells)) (VP (VP (VBP contain) (NP (NP (JJR higher) (NNS levels)) (PP (IN of) (NP (NN SOCS1))))) (CC but) (VP (VBP contain) (NP (NP (JJR lower) (NNS levels)) (PP (IN of) (NP (NN SOCS3) (NNS transcripts))) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (JJ normal) (JJ CD4+) (NN T) (NNS cells))))))))) (. .)))
( (S (S (NP (DT These) (NNS findings)) (VP (VP (VBP indicate) (SBAR (IN that) (S (NP (JJ CD4+) (NN T) (NNS cells)) (VP (VBP become) (ADJP (JJ resistant) (PP (TO to) (NP (NP (DT the) (JJ inhibitory) (NN effect)) (PP (IN of) (NP (NN IL-10)))))) (PP (IN before) (NP (NP (NN migration)) (PP (IN into) (NP (DT the) (JJ inflamed) (JJ ST))))))))) (, ,) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (DT this) (NN resistance)) (VP (MD may) (VP (VB be) (ADJP (JJ attributable) (PP (TO to) (NP (JJ impaired) (JJ IL-10-dependent) (NN STAT3) (NN activation)))) (, ,) (PP (IN in) (NP (NP (NN association)) (PP (IN with) (NP (NP (JJ sustained) (NN STAT3) (NN phosphorylation)) (CC and) (NP (NN SOCS1) (NN induction))))))))))))) (. .)))
( (S (S (NP (NP (JJ IL-10-mediated) (NN inhibition)) (PP (IN of) (NP (JJ CD4+) (NN T-cell) (NN cytokine) (NN production)))) (VP (VBZ is) (ADVP (RB principally)) (ADJP (JJ dependent) (PP (IN on) (NP (NP (PRP$ its) (NN inhibition)) (PP (IN of) (NP (NN macrophage) (JJ antigen-presenting) (NN cell) (NN function) (CD -LSB-1))))))) (-RRB- -RSB-)) (. .)))
( (S (ADVP (RB However)) (, ,) (NP (DT this) (JJ indirect) (JJ inhibitory) (NN effect)) (VP (VBZ is) (VP (VBN thought) (S (VP (TO to) (VP (VB be) (VP (VBN restricted) (PP (IN at) (NP (NP (DT the) (NN site)) (PP (IN of) (NP (NN T-cell) (NN activation))) (PP (IN in) (NP (NN RA))))))))) (, ,) (SBAR (IN because) (S (NP (NP (NNS macrophages)) (PP (IN in) (NP (DT the) (JJ ST)))) (VP (VBP express) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NP (NNS cytokines)) (, ,) (NP (NP (NP (NN CD80)) (CC and) (NP (NN CD86))) (NNS molecules)) (, ,) (CC and) (NP (NP (NN MHC) (NN class) (CD II)) (NNS antigens)) (NP (CD -LSB-10,18-20)))))) (-RRB- -RSB-))))) (. .)))
( (S (S (ADVP (RBR More) (RB recently)) (, ,) (NP (NN IL-10)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB induce) (NP (DT the) (JJ antigen-specific) (NN T-cell) (NN unresponsiveness)) (PP (IN by) (S (VP (VBG inhibiting) (NP (NN CD28) (NN tyrosine) (NN phosphorylation) (CD -LSB-33))))))))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (DT This) (JJ direct) (NN effect)) (VP (ADVP (RB also)) (MD may) (VP (VB be) (VP (VBN limited) (PP (IN in) (NP (JJ active) (NN RA) (NNS patients))) (, ,) (SBAR (IN because) (S (NP (PRP$ their) (NN PB) (JJ CD4+) (NN T) (NNS cells)) (VP (VBD showed) (NP (NP (NP (DT a) (JJ defective) (NN IL-10)) (NN inhibition)) (PP (IN of) (NP (NP (JJ CD28-costimulated) (NN production)) (PP (IN of) (NP (CC both) (NP (NN IFN-γ)) (CC and) (NP (NN IL-2)))))))))))))) (. .)))
( (S (S (S (NP (NP (JJ Numerous) (NNS cytokines)) (, ,) (ADJP (CC both) (ADJP (JJ proinflammatory)) (CC and) (ADJP (JJ anti-inflammatory))) (, ,)) (VP (VBP have) (VP (VBN been) (VP (VBN detected) (PP (IN in) (NP (NP (DT the) (JJ ST)) (PP (IN of) (NP (NN RA))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN balance)) (PP (IN between) (NP (DT these) (JJ opposing) (NN cytokine) (NNS activities)))) (VP (VBZ regulates) (NP (NN disease) (NN severity) (CD -LSB-10) (-RRB- -RSB-))))) (. .)))
( (S (S (NP (NP (JJ Endogenous) (NN IL-10)) (, ,) (VP (VBN produced) (ADVP (RB mainly)) (PP (IN by) (NP (NP (NNS macrophages)) (CC and) (NP (NN T) (NNS cells))))) (, ,)) (VP (VBZ inhibits) (NP (JJ proinflammatory) (NN cytokine) (NN production)) (PP (IN by) (NP (JJ ST) (NNS cells) (CD -LSB-12) (-RRB- -RSB-))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (DT this) (JJ regulatory) (NN activity)) (VP (VBZ seems) (S (VP (TO to) (VP (VB be) (VP (VBN restricted) (PP (IN during) (NP (JJ chronic) (NN inflammation))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN activation)) (PP (IN of) (NP (DT both) (NP (NP (DT the) (JJ extracellular) (JJ stimulus-regulated) (NN kinase)) (CC and) (NP (NN p38) (NN kinase))) (NNS pathways))) (, ,) (VP (VBN induced) (PP (IN by) (NP (NP (NN TNF-α)) (CC and) (NP (NN IL-1))))) (, ,)) (VP (VBZ inhibits) (NP (NP (DT the) (NN Jak1–STAT3) (NN signaling) (NN pathway)) (VP (VBN shared) (PP (IN by) (NP (NP (NN IL-10)) (CC and) (NP (NN IL-6)))))) (PP (IN in) (NP (JJ adhered) (NNS macrophages) (CD -LSB-13) (-RRB- -RSB-))))) (. .)))
( (S (S (ADVP (RBR More) (RB importantly)) (, ,) (NP (JJ IL-10-mediated) (NN STAT3) (NN activation)) (VP (VBZ is) (ADJP (RB mostly) (JJ undetectable) (PP (IN in) (NP (NN RA) (JJ synovial) (NNS macrophages)))))) (. .)))
( (S (S (NP (DT This) (JJ impaired) (NN IL-10) (NN signaling)) (VP (VBZ is) (ADVP (RB probably)) (VP (VBN induced) (PP (IN by) (NP (NP (JJ chronic) (NN exposure)) (PP (TO to) (NP (JJ immune) (NNS complexes))))) (ADVP (FW in) (FW vivo))) (, ,) (SBAR (IN because) (S (NP (CC both) (NP (NN cell) (NN surface) (NN IL-10R1) (NN expression)) (CC and) (NP (JJ IL-10-induced) (NN Jak1) (NN activation))) (VP (VBP are) (VP (VBN suppressed) (PP (IN in) (NP (JJ IFN-γ-primed) (NNS macrophages))) (PP (IN by) (NP (NP (DT a) (ADJP (NN protein) (NN kinase) (JJ C-dependent)) (NN pathway)) (PP (VBG following) (NP (NP (NN ligation)) (PP (IN of) (NP (DT the) (NN IgG) (NN Fc) (NN gamma) (NN receptor) (CD -LSB-14))))))))) (-RRB- -RSB-))))) (. .)))
( (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (JJ dendritic) (NNS cells)) (PP (IN from) (NP (NN RA) (JJ synovial) (NNS fluids)))) (VP (VBP are) (ADJP (JJ resistant) (PP (TO to) (NP (NP (DT the) (JJ immunoregulatory) (NN effect)) (PP (IN of) (NP (NN IL-10))) (ADJP (JJ due) (PP (TO to) (NP (NP (VBN decreased) (NN transport)) (PP (IN of) (NP (JJ intracellular) (NN IL-10R1))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (JJ proinflammatory) (NN cytokine) (NNS stimuli)) (PP (JJ such) (IN as) (NP (NP (NN TNF-α)) (, ,) (NP (NN IL-1)) (, ,) (CC and) (NP (NN granulocyte–macrophage) (JJ colony-stimulating) (NN factor) (CD -LSB-15))))))))))) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NP (DT the) (NN resistance)) (PP (IN of) (NP (NN RA) (JJ CD4+) (NN T) (NNS cells))) (PP (TO to) (NP (NN IL-10)))) (VP (MD may) (VP (VB be) (VP (VBN associated) (PP (PP (IN with) (NP (JJ defective) (JJ IL-10-dependent) (NN STAT3) (NN activation))) (, ,) (CC but) (PP (RB not) (IN with) (NP (NN IL-10R1) (NN expression)))))))))))) (. .)))
( (S (S (NP (NP (JJ Inhibitory) (NNS effects)) (PP (IN of) (NP (NN IL-10))) (PP (IN on) (NP (DT these) (JJ inflammatory) (NN cell) (NNS types)))) (VP (VBP are) (ADVP (RB therefore)) (ADVP (RB differentially)) (VP (VBN modulated) (PP (IN at) (NP (DT the) (NN signal) (NN transduction) (NN level))) (PP (IN under) (NP (NP (DT the) (JJ inflammatory) (NN environment)) (PP (IN in) (NP (NN RA)))))))) (. .)))
( (S (S (PP (IN In) (NP (NP (NN association)) (PP (IN with) (NP (JJ impaired) (JJ IL-10-mediated) (NN STAT3) (NN activation))))) (, ,) (NP (NN STAT3)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB be) (NP (NP (NN tyrosine)) (VP (VBN phosphorylated) (ADVP (RB persistently)) (PRN (-LRB- -LRB-) (NP (QP (RB up) (TO to) (CD 6)) (NNS hours)) (-RRB- -RRB-)) (PP (IN in) (NP (NP (ADJP (RB freshly) (VBN isolated)) (NN PB) (CC and) (JJ ST) (JJ CD4+) (NN T) (NNS cells)) (PP (IN from) (NP (NN RA) (NNS patients))))))))))))) (. .)))
( (S (NP (NN STAT3)) (VP (VBZ is) (VP (VBN activated) (PP (IN by) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NNS cytokines))))) (, ,) (ADVP (RB notably)) (NP (NP (DT the) (NN IL-6) (NN family)) (PP (IN of) (NP (NP (NNS cytokines)) (PRN (-LRB- -LRB-) (PP (FW e.g.))))))))))
( (S (NP (NP (NP (NP (NN IL-6)) (, ,) (NP (NN IL-11)) (, ,) (NP (NN leukemia) (JJ inhibitory) (NN factor)) (, ,) (CC and) (NP (NN oncostatin) (NN M)) (-RRB- -RRB-) (CC and) (NP (NN growth) (NNS factors))) (PRN (, ,) (PP (IN in) (NN addition) (TO to) (NP (NN IL-10) (NN -LSB-4))) (-RRB- -RSB-))) (. .))))
( (S (PP (IN Of) (NP (DT these) (NNS cytokines))) (, ,) (NP (NN IL-6)) (VP (VBZ plays) (NP (DT a) (JJ predominant) (NN role)) (PP (IN in) (S (VP (VBG eliciting) (NP (DT a) (JJ systemic) (NN reaction)) (PP (JJ such) (IN as) (NP (NP (DT the) (JJ acute) (NN phase) (NN response)) (PP (IN in) (NP (JJ active) (NN RA)))))))) (, ,) (PP (JJ due) (ADVP (RB mainly)) (TO to) (NP (NP (PRP$ its) (NN abundance)) (PP (IN in) (NP (DT the) (NN blood) (NN circulation) (CD -LSB-27) (-RRB- -RSB-)))))) (. .)))
( (S (S (S (S (ADJP (JJ Consistent) (PP (IN with) (NP (DT this) (NN notion))))) (, ,) (NP (NN IL-6)) (VP (VBD was) (NP (NP (DT the) (JJ major) (NN STAT3-activating) (NN factor)) (VP (VBN contained) (PP (IN in) (NP (NP (DT the) (NN serum)) (PP (IN of) (NP (JJ active) (NN RA) (NNS patients))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN responsiveness)) (PP (TO to) (NP (NN IL-10)))) (VP (VBD was) (VP (VBN suppressed) (PP (IN in) (NP (JJ normal) (JJ CD4+) (NN T) (NNS cells))) (PP (IN after) (NP (NP (CD 36) (NNS hours)) (PP (IN of) (NP (NP (NN incubation)) (PP (IN with) (NP (NN IL-6))))))))))) (. .)))
( (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (CC both) (NP (DT the) (JJ sustained) (NN STAT3) (NN activation)) (CC and) (NP (NP (DT the) (NN resistance)) (PP (TO to) (NP (NN IL-10) (NN inhibition))) (VP (VBN found) (PP (IN in) (NP (NN RA) (JJ CD4+) (NN T) (NNS cells)))))) (VP (MD may) (VP (VB be) (VP (VBN induced) (PP (IN after) (NP (JJ chronic) (NN exposure))) (ADVP (FW in) (FW vivo)) (PP (TO to) (NP (NP (JJ high) (NNS concentrations)) (PP (IN of) (NP (NN serum) (NN IL-6)))))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (PRP it)) (VP (VBZ is) (ADVP (RB also)) (ADJP (JJ possible)) (SBAR (IN that) (S (NP (NN STAT3) (NN activity)) (VP (MD could) (VP (VB be) (ADVP (RB constitutively)) (VP (VBN induced) (PP (IN in) (NP (JJ CD4+) (NN T) (NNS cells))) (PP (IN by) (NP (PRP$ their) (JJ own) (NN IL-10) (NN secretion))) (, ,) (S (VP (VBG leading) (PP (TO to) (NP (NP (DT the) (NN loss)) (PP (IN of) (NP (NP (NN sensitivity)) (PP (TO to) (NP (JJ exogenous) (NN IL-10)))))))))) (, ,) (SBAR (IN because) (S (NP (NP (NN RA) (JJ CD4+) (NN T) (NNS cells)) (PP (IN in) (NP (DT the) (JJ ST)))) (VP (VBP are) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG producing) (NP (NP (JJ significant) (NNS levels)) (PP (IN of) (NP (NN IL-10) (CD -LSB-34) (-RRB- -RSB-))))))))))))))))) (. .)))
( (S (S (NP (NP (JJ CD4+) (NN T) (NNS cells)) (VP (VBN isolated) (PP (IN from) (NP (NP (DT the) (JJ ST)) (PP (IN of) (NP (NN RA))))))) (ADVP (RB also)) (VP (VBD showed) (NP (NP (DT a) (NN defect)) (PP (IN in) (NP (DT the) (JJ IL-10-induced) (NN STAT3) (NN signaling) (NN pathway)))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (RBS most) (JJ probable) (SBAR (IN that) (S (NP (NP (DT the) (NN resistance)) (PP (IN of) (NP (JJ CD4+) (NN T) (NNS cells))) (PP (TO to) (NP (NN IL-10)))) (VP (MD can) (VP (VB be) (ADVP (RB even)) (VP (VBN augmented) (PP (IN after) (NP (NP (NN migration)) (PP (IN into) (NP (DT the) (JJ inflamed) (JJ ST))))))))))) (, ,) (SBAR (IN because) (S (NP (NN IL-6)) (VP (VBZ is) (ADVP (RB highly)) (VP (VBN concentrated) (PP (VBN compared) (PP (IN with) (NP (DT the) (NN blood) (NN level) (CD -LSB-27) (-RRB- -RSB-)))))))))) (. .)))
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (DT the) (NN involvement)) (PP (IN of) (NP (JJ other) (JJ essential) (JJ proinflammatory) (NNS cytokines))) (PP (IN in) (NP (DT this) (NN process)))) (VP (VBD was) (VP (VBN suggested) (PP (IN by) (NP (NP (PRP$ our) (JJ preliminary) (NNS experiments)) (VP (VBG demonstrating) (SBAR (IN that) (S (NP (NP (JJ IL-10-mediated) (JJ IFN-γ) (NN inhibition)) (PP (IN in) (NP (JJ CD4+) (NN T) (NNS cells)))) (VP (VBD was) (VP (VBN reduced) (PP (IN by) (NP (NP (NN pretreatment)) (PP (IN with) (NP (NP (NN IL-1β)) (CC and) (NP (NN TNF-α))))))) (, ,) (SBAR (IN although) (FRAG (ADVP (JJR less) (RB effectively)) (SBAR (IN than) (S (PP (IN by) (NP (NN IL-6))) (PRN (-LRB- -LRB-) (NP (NP (NN data)) (VP (ADVP (RB not)) (VBN shown))) (-RRB- -RRB-)))))))))))))) (. .)))
( (S (ADVP (RB Furthermore)) (, ,) (NP (NP (NP (NN IFN-γ)) (CC and) (NP (NN IL-10))) (VP (VBN produced) (PP (IN by) (NP (NP (JJ CD4+) (NN T) (NNS cells)) (NP (PRP themselves)))))) (VP (MD could) (VP (VB be) (ADJP (JJ responsible) (PP (IN for) (NP (NP (JJ impaired) (NN IL-10) (NN signaling)) (PP (IN in) (NP (DT the) (JJ ST)))))) (, ,) (SBAR (IN because) (S (NP (NN T-cell) (NNS infiltrates)) (VP (VBP produce) (NP (DT both) (NNS cytokines) (NP (CD -LSB-34,35)))) (-RRB- -RSB-))))) (. .)))
( (S (S (PP (IN In) (NP (DT an) (JJ autocrine) (NN fashion))) (, ,) (S (NP (NN IL-10)) (VP (MD may) (ADVP (RB persistently)) (VP (VB stimulate) (NP (NN STAT3) (NN activation))))) (CC and) (S (NP (NN IFN-γ)) (VP (MD can) (VP (VB induce) (NP (NN SOCS1) (NN protein)) (PP (IN as) (NP (NP (DT a) (NN crosstalk) (NN inhibitor)) (PP (IN of) (NP (NN IL-10) (NN signaling) (CD -LSB-32))))) (-RRB- -RSB-))))) (. .)))
( (S (S (NP (NP (DT The) (JJ T-cell-inhibitory) (NN effect)) (PP (IN of) (NP (NN IL-10)))) (VP (MD may) (ADVP (RB therefore)) (VP (VB be) (VP (VBN modulated) (ADVP (RB complicatedly)) (PP (IN upon) (NP (NP (NN exposure)) (PP (TO to) (NP (NP (DT an) (JJ inflammatory) (NN environment)) (PP (IN in) (NP (NN RA) (NNS joints))) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (JJ many) (NNS cytokines)) (VP (VBP are) (ADJP (JJ present) (PP (RB substantially) (NP (NN -LSB-10) (-RRB- -RSB-))))))))))))))) (. .)))
( (S (S (NP (NN STAT3) (NN activation)) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (NN RA))))))))) (. .)))
( (S (S (NP (JJ Active) (NN STAT3)) (VP (VBZ is) (ADVP (RB constitutively)) (VP (VBN expressed) (PP (IN in) (NP (NP (JJ synovial) (NN fluid) (JJ mononuclear) (NNS cells)) (PP (IN from) (NP (NN RA) (NNS patients) (CD -LSB-36) (-RRB- -RSB-)))))))) (. .)))
( (S (S (NP (NN IL-6)) (VP (VBZ is) (NP (NP (DT the) (JJ major) (JJ STAT3-activating) (NN factor)) (ADJP (JJ present) (PP (IN in) (NP (NP (JJ synovial) (NN fluid)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (NP (DT a) (JJ crucial) (NN role)) (PP (IN in) (NP (NP (DT the) (NN activation)) (PP (PP (IN of) (NP (NP (NN monocyte) (NNS functions)) (PP (JJ such) (IN as) (NP (NP (NN gene) (NN expression)) (PP (IN of) (NP (DT the) (NN Fc) (NN gamma) (NN receptor) (NP (NP (NN type) (CD I)) (CC and) (NP (NN type) (CD III))))))))) (CC and) (PP (IN of) (NP (NN HLA-DR) (CD -LSB-31) (-RRB- -RSB-))))))))))))))) (. .)))
( (S (ADVP (RBR More) (RB recently)) (, ,) (S (S (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (VBN activated) (NP (NN STAT3)) (, ,) (VP (VBN thought) (S (VP (TO to) (VP (VB be) (VP (VBN induced) (ADVP (RB mainly)) (PP (IN by) (NP (NN IL-6)))))))) (, ,)))) (VP (VBP have) (VP (VBN been) (VP (VBN detected) (PP (IN in) (NP (DT the) (JJ ST))))))) (, ,) (CC and) (S (NP (NN STAT3) (NN activation)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (VP (VBN involved) (PP (IN in) (NP (NP (JJ synovial) (NN fibroblast) (NN proliferation)) (CC and) (NP (NN IL-6) (NN production) (CD -LSB-37) (-RRB- -RSB-))))))))))))) (. .)))
( (S (S (PP (IN In) (NP (DT this) (NN regard))) (, ,) (NP (NN STAT3)) (VP (VBZ is) (ADJP (JJ critical) (PP (IN in) (NP (NP (DT the) (NP (NN survival)) (CC and) (NP (NN expansion))) (PP (IN of) (NP (NN growth) (JJ factor-dependent) (JJ synovial) (NNS fibroblasts) (NP (CD -LSB-38)))))))) (-RRB- -RSB-)) (. .)))
( (S (ADVP (RB Furthermore)) (, ,) (NP (NP (DT the) (NN significance)) (PP (IN of) (NP (JJ persistent) (NN STAT3) (NN signaling))) (PP (IN in) (NP (JJ Th1-cell-dominated) (JJ autoimmune) (NN arthritis)))) (VP (VBZ has) (VP (VBN been) (VP (VBN suggested) (PP (IN by) (NP (NP (NNS studies)) (PP (IN of) (NP (DT the) (CD gp130F759/F759) (NNS mice))) (, ,) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (DT the) (NN Src) (NN homology) (NN phosphatase-2) (NN binding) (NN site)) (PP (IN of) (NP (NP (NP (NN gp130)) (PRN (-LRB- -LRB-) (NP (NP (DT the) (JJ transmembrane) (NN glycoprotein) (NN β) (NN subunit)) (PP (IN of) (NP (DT the) (NN IL-6) (NN family) (NN cytokine) (NN receptor)))) (-RRB- -RRB-))) (, ,) (NP (NN tyrosine) (CD 759)) (, ,)))) (VP (VBD was) (VP (VBN mutated) (PP (TO to) (NP (NN phenylalanine) (CD -LSB-39) (-RRB- -RSB-)))))))))))) (. .)))
( (S (S (PP (IN In) (NP (DT the) (CD gp130F759/F759) (NNS mice))) (, ,) (NP (NP (NN T) (NNS cells)) (, ,) (NP (ADVP (RB particularly)) (NP (DT the) (JJ CD4+) (NN T-cell) (NN subset))) (, ,)) (VP (VBP are) (ADVP (RB chronically)) (VP (VP (VBN activated)) (CC and) (ADJP (JJ resistant) (PP (TO to) (NP (NP (JJ activation-induced) (NN cell) (NN death)) (PP (IN through) (NP (JJ gp130-mediated) (NN STAT3) (NN activation))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN longevity)) (PP (IN of) (NP (NP (NN cytokine) (NNS signals)) (VP (VBN transduced) (PP (IN by) (NP (DT the) (NN JAK–STAT) (NN pathway))))))) (VP (VBZ is) (VP (VBN regulated) (PP (IN by) (NP (DT the) (NN SOCS) (NN family) (NNS proteins) (NP (CD -LSB-7)) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (JJ CD4+) (NN T) (NNS cells)) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ active) (NN RA)))))) (VP (VBD expressed) (NP (NP (JJR higher) (NNS levels)) (PP (IN of) (NP (NN SOCS1)))) (, ,) (CC but) (NP (NP (JJR lower) (NNS levels)) (PP (IN of) (NP (NN SOCS3)))) (, ,) (PP (VBN compared) (PP (IN with) (NP (JJ normal) (JJ CD4+) (NN T) (NNS cells))))))))) (. .)))
( (S (S (S (NP (NN SOCS1)) (VP (VBZ prevents) (NP (NP (NN activation)) (PP (IN of) (NP (NN JAK)))) (PP (IN by) (S (ADVP (RB directly)) (VP (VBG binding) (PP (TO to) (NP (NN JAK)))))))) (, ,) (CC and) (S (NP (NN SOCS3)) (VP (VBZ inhibits) (NP (NP (DT the) (NN action)) (PP (IN of) (NP (NN JAK)))) (PP (IN by) (S (VP (VBG binding) (PP (TO to) (NP (NP (DT the) (NN Src) (NN homology) (NN phosphatase-2-binding) (NN domain)) (PP (IN of) (NP (NP (NNS receptors)) (PP (JJ such) (IN as) (NP (NN gp130) (NN -LSB-40) (-RRB- -RSB-))))))))))))) (. .)))
( (S (S (NP (NP (NN SOCS1)) (CC and) (NP (NN SOCS3))) (VP (VBP are) (VP (VBN induced) (PP (IN by) (NP (NP (JJ various) (NNS cytokines)) (, ,) (PP (VBG including) (NP (NP (NN IL-6)) (CC and) (NP (NN IL-10)))) (, ,))) (PP (IN as) (NP (NP (NNS mediators)) (PP (IN of) (NP (NP (JJ negative) (NN feedback)) (CC and) (NP (NN crosstalk) (NN inhibition) (CD -LSB-7) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (NP (JJ Recent) (NNS studies)) (PP (IN with) (NP (NP (NNS mice)) (VP (VBG lacking) (NP (NP (NN SOCS3)) (CC or) (NP (NN SOCS1))))))) (VP (VBD revealed) (SBAR (IN that) (S (NP (NN SOCS3)) (VP (VBZ is) (NP (NP (DT a) (JJ negative) (NN regulator)) (PP (PP (IN of) (NP (NN IL-6) (NN signaling))) (CC but) (PP (RB not) (IN of) (NP (NN IL-10) (NN signaling)))))))))) (. .)))
( (S (S (NP (NP (NNS Studies)) (PP (IN of) (NP (JJ conditional) (JJ SOCS3-deficient) (NNS mice)))) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (NN SOCS3) (NN deficiency)) (, ,) (CONJP (CC but) (RB not)) (NP (NN SOCS1) (NN deficiency)) (, ,)) (VP (VBZ results) (PP (IN in) (NP (NP (JJ sustained) (NN activation)) (PP (IN of) (NP (NN STAT3))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN IL-6) (CD -LSB-8,41)))))))) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (NP (DT The) (NN analysis)) (PP (IN of) (NP (JJ SOCS3-deficient) (NNS macrophages)))) (VP (VBZ has) (VP (VBN indicated) (SBAR (IN that) (S (NP (NN SOCS3)) (VP (VBZ is) (NP (NP (DT a) (JJ crucial) (NN inhibitor)) (PP (IN of) (NP (DT the) (JJ IL-6-induced) (JJ transcriptional) (NN response) (NN -LSB-42))))) (-RRB- -RSB-)))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NN SOCS3)) (VP (VBZ is) (ADJP (JJ dispensable) (PP (IN for) (NP (CC both) (NP (DT the) (JJ negative) (NN feedback) (NN inhibition)) (CC and) (NP (NP (DT the) (JJ immunoregulatory) (NN action)) (PP (IN of) (NP (NN IL-10))) (PP (IN in) (NP (NNS macrophages) (CD -LSB-41)))))))) (-RRB- -RSB-)) (. .)))
( (S (S (PP (IN On) (NP (DT the) (NN contrary))) (, ,) (NP (NN SOCS1)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (ADVP (RB directly)) (VP (VB inhibit) (NP (JJ IL-10-mediated) (NN signaling) (NN -LSB-43))))))) (-RRB- -RSB-)) (. .)))
( (S (S (S (NP (NP (VBN Increased) (NN SOCS1) (NN expression)) (PP (IN in) (NP (NN RA) (JJ CD4+) (NN T) (NNS cells)))) (VP (MD may) (ADVP (RB therefore)) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NP (PDT both) (DT the) (JJ impaired) (NN responsiveness)) (PP (PP (TO to) (NP (NN IL-10))) (CC and) (PP (TO to) (NP (JJ IL-10-mediated) (NN STAT3) (NN activation)))))))))) (, ,) (CC and) (S (NP (JJ defective) (NN SOCS3) (NN expression)) (VP (MD may) (VP (VB be) (ADJP (JJ responsible) (PP (IN for) (NP (NP (JJ persistent) (NN STAT3) (NN activation)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN serum) (NN IL-6)))))))))))) (. .)))
( (S (S (NP (EX There)) (VP (VBZ is) (NP (DT a) (NN possibility) (SBAR (IN that) (S (NP (NN SOCS1) (NN induction)) (VP (MD may) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (JJ CD4+) (NN T) (NNS cells))) (S (VP (TO to) (VP (VB produce) (NP (NN IFN-γ))))))))))))) (, ,) (SBAR (SBAR (IN because) (S (NP (NP (JJ CD4+) (NN T) (NNS cells)) (PP (IN from) (NP (JJ active) (NN RA)))) (VP (MD could) (VP (VB produce) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NN IFN-γ)))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN IL-10))))))))) (, ,) (CC and) (SBAR (IN because) (S (NP (NN IFN-γ)) (VP (VBZ has) (VP (VBN been) (VP (VBN known) (PP (IN as) (NP (NP (DT a) (JJ potent) (NN inducer)) (PP (IN of) (NP (NN SOCS1) (CD -LSB-32)))))))) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ is) (PP (IN of) (NP (NP (NN interest)) (PP (IN in) (NP (DT this) (NN regard))))) (S (VP (TO to) (VP (VB indicate) (SBAR (IN that) (S (NP (VBN polarized) (NP (NP (NN Th1)) (CC and) (NP (NN Th2))) (NNS cells)) (VP (VBP express) (NP (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NP (NN SOCS1)) (CC and) (NP (NN SOCS3)) (NP (NN mRNA))))) (, ,) (ADVP (RB respectively)) (NP (CD -LSB-44) (-RRB- -RSB-))))))))))) (. .)))
( (S (S (S (NP (JJ IL-12-induced) (NN STAT4) (NN activation)) (VP (VBZ is) (VP (VBN inhibited) (PP (IN by) (NP (NP (NN SOCS3) (NN induction)) (PP (IN in) (NP (NN Th2) (NNS cells)))))))) (, ,) (IN whereas) (S (NP (JJ IL-4-induced) (NN STAT6) (NN signaling)) (VP (VBZ is) (VP (VBN diminished) (PP (IN by) (NP (NP (NN SOCS1) (NN induction)) (PP (IN in) (NP (NN Th1) (NNS cells))))))))) (. .)))
( (S (S (NP (NP (NN SOCS1)) (CC and) (NP (NN SOCS3))) (VP (MD may) (ADVP (RB thus)) (VP (VB have) (NP (JJ important) (NNS roles)) (PP (IN as) (NP (NP (ADJP (ADJP (JJ Th1-specific)) (CC and) (ADJP (JJ Th2-specific))) (, ,) (ADJP (RB mutually) (JJ exclusive)) (, ,) (NP (NN cross-talk)) (NNS repressors)) (PP (IN of) (NP (DT the) (NP (NN IL-4–STAT6)) (CC and) (NP (DT the) (NN IL-12–STAT4) (NN signaling) (NNS pathways)) (, ,) (ADVP (RB respectively))))))))) (. .)))
( (S (S (S (S (ADJP (JJ Consistent) (PP (IN with) (NP (DT this) (NN notion))))) (, ,) (NP (NP (NN PB) (NN T) (NNS cells)) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ allergic) (NNS diseases)))))) (ADVP (RB significantly)) (VP (VBP express) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NN SOCS3) (NNS transcripts)))))) (, ,) (CC and) (S (NP (DT the) (NN SOCS3) (NN expression)) (VP (VBZ correlates) (ADVP (RB well)) (PP (IN with) (NP (NP (NN serum) (NN IgE) (NNS levels)) (CC and) (NP (NN disease) (NN pathology) (CD -LSB-45))))) (-RRB- -RSB-))) (. .)))
( (S (S (NP (NP (JJR Higher) (NN SOCS1) (NN expression)) (PP (IN with) (NP (NP (JJR lower) (NN SOCS3) (NN expression)) (PP (IN in) (NP (NP (NN PB) (JJ CD4+) (NN T) (NNS cells)) (PP (IN from) (NP (NN RA) (NNS patients))) (, ,) (PP (VBN compared) (PP (IN with) (NP (JJ healthy) (NNS controls)))) (, ,)))))) (VP (VBZ is) (ADVP (RB therefore)) (ADJP (RB probably) (JJ consistent) (PP (IN with) (NP (NP (PRP$ their) (JJ systemic) (NN bias)) (PP (IN towards) (NP (DT a) (NN Th1) (NN phenotype)))))) (, ,) (SBAR (IN as) (S (VP (VBZ has) (ADVP (RB previously)) (VP (VBN been) (VP (VBN demonstrated) (NP (CD -LSB-46-49) (-RRB- -RSB-))))))))) (. .)))
( (S (NP (NN Conclusion))))
( (S (S (NP (NP (JJ CD4+) (NN T) (NNS cells)) (PP (IN from) (NP (JJ active) (NN RA) (NNS patients)))) (VP (VBP are) (VP (VBN characterized) (PP (IN by) (NP (NP (PRP$ their) (NN resistance)) (PP (TO to) (NP (NP (NP (NN IL-10)) (NN inhibition)) (PP (IN of) (NP (NP (NN IFN-γ) (NN production)) (, ,) (ADJP (JJ due) (PP (TO to) (NP (NP (JJ constitutive) (NN STAT3) (NN phosphorylation)) (CC and) (NP (JJ impaired) (JJ IL-10-mediated) (NN STAT3) (NN activation)))))))))))))) (. .)))
( (S (S (NP (DT The) (JJ defective) (NN STAT3) (NN signaling)) (VP (VBZ is) (ADVP (RB possibly)) (VP (VBN associated) (PP (IN with) (NP (NP (NN SOCS1) (NN predominance)) (PP (IN over) (NP (NN SOCS3)))))))) (. .)))
( (S (S (NP (NP (DT These) (NNS abnormalities)) (PP (IN in) (NP (JJ active) (NN RA)))) (VP (VBP are) (VP (VBN thought) (S (VP (TO to) (VP (VB be) (VP (VBN induced) (ADVP (RB mainly)) (PP (IN after) (NP (NP (JJ chronic) (NN exposure)) (PP (TO to) (NP (NP (JJ high) (NNS concentrations)) (PP (IN of) (NP (NN IL-6)))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ limited) (NN efficacy)) (PP (IN of) (NP (NP (NN IL-10) (NN treatment)) (PP (IN of) (NP (NN RA) (NNS patients) (CD -LSB-50) (-RRB- -RSB-)))))) (VP (MD may) (VP (VB be) (VP (VBN explained) (PP (IN in) (NP (NN part))) (PP (IN by) (NP (NP (DT the) (NN unresponsiveness)) (PP (TO to) (NP (NP (NN IL-10)) (PP (IN of) (NP (NP (JJ inflammatory) (NNS cells)) (, ,) (PP (VBG including) (NP (NN T) (NNS cells))))))))))))) (. .)))
( (S (S (S (PP (IN On) (NP (DT the) (NN contrary))) (, ,) (NP (NP (DT the) (JJ therapeutic) (NN efficacy)) (PP (IN of) (NP (JJ anti-IL-6) (NN receptor) (NN antibody)))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NN RA) (NNS patients) (CD -LSB-51) (-RRB- -RSB-))))))) (, ,) (CC and) (S (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (DT this) (NN therapy)))))) (VP (MD may) (VP (VB be) (S (VP (TO to) (VP (VB normalize) (NP (NN T) (NNS cells)) (PP (IN through) (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (JJ IL-6-dependent) (NN STAT3) (NN activation)))))))))))) (. .)))
( (S (S (NP (NP (ADJP (RBR More) (JJ specific)) (NN therapy)) (VP (VBG targeting) (NP (NN STAT3) (NN activation)))) (VP (MD will) (VP (VB be) (VP (VBN awaited))))) (: ;) (S (PP (IN for) (NP (NP (NN example)) (, ,) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (DT the) (NN SOCS3) (NN gene)))))) (, ,) (NP (NP (DT the) (NN efficacy)) (PP (IN of) (NP (WDT which)))) (VP (VBZ has) (VP (VBN been) (VP (VBN demonstrated) (PP (IN in) (NP (NN animal) (NNS models) (CD -LSB-37) (-RRB- -RSB-))))))) (. .)))
( (S (NP (NNS Abbreviations))))
( (S (S (VP (NP (NP (NP (NP (NN BSA) (JJ =) (JJ bovine) (NN serum) (NN albumin)) (: ;) (NP (NP (NN CRP) (JJ =) (JJ C-reactive) (NN protein)) (: ;) (NP (NN ELISA) (JJ =) (JJ enzyme-linked) (JJ immunosorbent) (NN assay)) (: ;) (NP (NN Fc) (JJ =) (NN crystallazibe) (NN fragment)) (: ;) (NP (NN FCS) (JJ =) (JJ fetal) (NN calf) (NN serum)) (: ;) (NP (NN FITC) (JJ =) (NN fluorescein) (NN isothiocyanate))) (: ;) (CD IFN-γ)) (JJ =) (NN interferon) (NN gamma) (: ;) (NN IL) (JJ =) (NN interleukin)) (: ;) (NP (NN IL-10R) (JJ =) (NN interleukin-10) (NN receptor)) (: ;) (NP (NN IL-10R1) (JJ =) (NN type) (CD 1) (NN interleukin-10) (NN receptor) (: ;) (NN JAK) (JJ =) (NN Janus) (NN kinase)) (: ;) (NP (NN mAb) (JJ =) (JJ monoclonal) (NN antibody)) (: ;) (NP (NN MHC) (JJ =) (JJ major) (NN histocompatibility) (NN complex)) (: ;) (NP (NN PB) (JJ =) (JJ peripheral) (NN blood)) (: ;) (NP (NN PBMC) (JJ =) (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (: ;)) (NNS PBS) (NP (ADJP (JJ =) (NP (NP (JJ phosphate-buffered) (NN saline)) (: ;) (NP (NN PCR) (JJ =) (NN polymerase) (NN chain) (NN reaction)) (: ;) (NP (NN RA) (JJ =) (JJ rheumatoid) (NN arthritis)) (: ;) (NP (NP (NN SOXS) (JJ =) (NN suppressor)) (PP (IN of) (NP (NN cytokine) (NN signaling)))) (: ;) (NP (NP (NP (JJ ST) (JJ =) (JJ synovial) (NN tissue) (: ;) (NN STAT) (JJ =) (NN signal) (NN transducer)) (CC and) (NP (NN activator))) (PP (IN of) (NP (NN transcription)))) (: ;) (NP (NN Th) (JJ =) (NN T) (NN helper) (NNS cells)) (: ;) (CD TNF-α))) (JJ =) (NN tumor) (NN necrosis) (NN factor) (NN alpha)))) (. .)))
( (S (NP (VBG Competing) (NNS interests))))
( (S (S (NP (DT The) (NN author) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-)) (VP (VB declare) (SBAR (IN that) (S (NP (PRP they)) (VP (VBP have) (NP (DT no) (VBG competing) (NNS interests))))))) (. .)))
( (S (NP (NP (NNS Authors) (POS ')) (NNS contributions))))
( (S (S (NP (NN Jiro) (NN Yamana)) (VP (VP (VBD was) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (NNS experiments)) (CC and) (NP (NN data) (NN analysis)))))) (CC and) (VP (VBP wrote) (NP (DT the) (NN report))))) (. .)))
( (S (S (NP (NN Masahiro) (NN Yamamura)) (VP (VP (VBD was) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (NN planning)) (PP (IN of) (NP (DT the) (NN research))))))) (CC and) (VP (VBP wrote) (PP (IN up) (NP (DT the) (NN manuscript)))))) (. .)))
( (S (S (NP (NP (NNP Akira) (NNP Okamoto) (, ,) (NNP Tetsushi) (NNP Aita)) (, ,) (NP (NNP Mitsuhiro) (NNP Iwahashi)) (, ,) (CC and) (NP (NNP Katsue) (NNP Sunahori))) (VP (JJ assisted) (NP (DT the) (NNS experiments)))) (. .)))
( (S (S (NP (NN Hirofumi) (NN Makino)) (ADVP (RB critically)) (VP (VBN read) (NP (DT the) (NN manuscript)))) (. .)))
( (S (NP (NP (NN Figure)) (CC and) (NP (NN Table)) (NP (NNS captions)))))
( (S (NP (NP (NN Figure) (CD 1)) (: :) (NP (NP (NN Dose) (NN response)) (PP (IN of) (NP (NP (NN IL-10) (NN inhibition)) (PP (IN of) (NP (NP (NP (NP (NN interferon) (NN gamma)) (PRN (-LRB- -LRB-) (NP (NN IFN-γ)) (-RRB- -RRB-))) (NN production)) (PP (IN by) (NP (JJ CD4+) (NN T) (NNS cells))) (PP (IN after) (NP (NP (NP (NN CD3)) (CC and) (NP (NN CD28))) (NN costimulation))) (PP (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ rheumatoid) (NN arthritis)) (PRN (-LRB- -LRB-) (NP (NN RA)) (-RRB- -RRB-)))))) (CC and) (PP (IN in) (NP (NP (JJ healthy) (NNS controls)) (PRN (-LRB- -LRB-) (NP (NN HC)) (-RRB- -RRB-)))))))))) (. .))))
( (S (S (NP (JJ CD4+) (NN T) (NNS cells)) (VP (VBD were) (VP (VBN purified) (PP (IN from) (NP (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (PP (IN of) (NP (NP (CD three) (NN RA) (NNS patients)) (CC and) (NP (CD three) (NNS HC)))))) (PP (IN by) (NP (NP (JJ positive) (NN selection)) (PP (IN with) (NP (JJ anti-CD4) (NN antibody)))))))) (. .)))
( (S (S (NP (NP (JJ CD4+) (NN T) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NP (CD 5) (NN ×) (CD 105) (NNS cells)) (PP (IN in) (NP (ADJP (CD 0.5) (NN ml)) (NN culture) (NN medium))) (PP (IN with) (NP (ADJP (CD 10) (NN %)) (NN FCS)))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN stimulated) (PP (IN by) (NP (NP (VBN immobilized) (JJ anti-CD3) (NN antibody)) (CC and) (NP (JJ anti-CD28) (NN antibody)))) (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC or) (NP (NN absence))) (PP (IN of) (NP (NP (JJ diluted) (NN IL-10) (NNS concentrations)) (PP (IN for) (NP (CD 36) (NNS hours)))))))))) (. .)))
( (S (S (NP (NN Culture) (NNS supernatants)) (VP (VBD were) (VP (VBN measured) (PP (IN for) (NP (NP (NNS concentrations)) (PP (IN of) (NP (NN IFN-γ))))) (PP (IN by) (NP (NN ELISA)))))) (. .)))
( (S (S (NP (NP (NN IFN-γ) (NN production)) (PP (IN with) (NP (NN IL-10)))) (VP (VBD expressed) (PP (IN as) (NP (NP (NN %) (NN IFN-γ)) (NN production))) (PP (IN without) (NP (NN IL-10))))) (. .)))
( (S (S (NP (NNS Values)) (VP (VBP are) (NP (NP (DT the) (NN mean) (NN ±) (JJ standard) (NN error)) (PP (IN of) (NP (DT the) (NN mean)))))) (. .)))
( (S (S (NP (NP (NP (NP (NN Figure) (CD 2) (: :) (LST (-LRB- -LRB-) (LS a) (-RRB- -RRB-)) (NN Interferon) (NN gamma)) (PRN (-LRB- -LRB-) (NP (NN IFN-γ)) (-RRB- -RRB-))) (NN production)) (PP (IN by) (NP (NP (NN CD3)) (CC and) (NP (NN CD28))))) (VP (VBD costimulated) (NP (JJ CD4+) (NN T) (NNS cells)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN IL-10))))) (PP (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ rheumatoid) (NN arthritis)) (PRN (-LRB- -LRB-) (NP (NN RA)) (-RRB- -RRB-)))))) (CC and) (PP (IN in) (NP (NP (JJ healthy) (NNS controls)) (PRN (-LRB- -LRB-) (NP (NN HC)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (JJ CD4+) (NN T) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NP (CD 5) (NN ×) (CD 105) (NNS cells)) (PP (IN in) (NP (ADJP (CD 0.5) (NN ml)) (NN culture) (NN medium))) (PP (IN with) (NP (ADJP (CD 10) (NN %)) (NN FCS)))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN stimulated) (PP (IN by) (NP (NP (JJ anti-CD3) (NN antibody)) (CC and) (NP (JJ anti-CD28) (NN antibody)))) (PP (PP (IN with)) (CC or) (PP (IN without) (NP (ADJP (CD 1) (NN ng/ml)) (NN IL-10))))))) (. .)))
( (S (S (NP (NP (NNS Concentrations)) (PP (IN of) (NP (NN IFN-γ))) (PP (IN in) (NP (NN culture) (NNS supernatants)))) (VP (VBD were) (VP (VBN measured) (PP (IN in) (NP (NN duplicate))) (PP (IN by) (NP (NN ELISA)))))) (. .)))
( (S (S (NP (NN RA) (NNS patients)) (VP (VBD were) (VP (VBN divided) (PP (IN into) (NP (NP (DT those)) (PP (IN with) (NP (NP (NP (JJ active) (NN disease)) (PRN (-LRB- -LRB-) (NP (NP (NP (JJ multiple) (JJ inflammatory) (NNS joints)) (CC and) (NP (NN CRP) (NN level))) (NN ≥) (CD 10) (NN mg/l)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ inactive) (NN disease)) (PRN (-LRB- -LRB-) (PP (IN in) (NP (NP (NN remission)) (CC and) (NP (NN CRP) (NN level)))) (NP (NN ≤) (CD 4) (NN mg/l)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (DT The) (NNS results)) (VP (VBP are) (VP (VBN represented) (PP (IN as) (NP (DT a) (NN box) (NN plot)))) (PRN (: ;) (NP (ADJP (ADJP (JJ upper)) (CC and) (ADJP (JJR lower))) (NNS bars)) (, ,) (NP (NP (ADJP (ADJP (JJ 90th)) (CC and) (ADJP (JJ 10th))) (NNS percentiles)) (, ,) (ADVP (RB respectively))) (: ;) (NP (JJ upper)) (, ,) (NP (NP (NP (NP (NN center)) (CC and) (NP (JJR lower) (NNS lines))) (PP (IN of) (NP (NP (NN box)) (, ,) (NP (NN 75th)) (, ,) (NP (NN 50th)) (, ,) (CC and) (NP (NN 25th) (NNS percentiles))))) (, ,) (ADVP (RB respectively)))))) (. .)))
( (S (S (NP (NP (LST (-LRB- -LRB-) (LS b) (-RRB- -RRB-)) (NN Percentage)) (PP (IN of) (NP (NN IFN-γ) (NN production))))) (. .)))
( (S (S (NP (NP (NN IFN-γ) (NN production)) (PP (IN with) (NP (NN IL-10)))) (VP (VBD expressed) (PP (IN as) (NP (NP (NN %) (NN IFN-γ)) (NN production))) (PP (IN without) (NP (NN IL-10))))) (. .)))
( (S (S (NP (NNS Values)) (VP (VBP are) (NP (NP (DT the) (NN mean) (NN ±) (JJ standard) (NN error)) (PP (IN of) (NP (DT the) (NN mean)))))) (. .)))
( (S (S (NP (NN n)) (, ,) (NP (NP (NN number)) (PP (IN of) (NP (NP (NNS samples)) (VP (VBN tested)))))) (. .)))
( (S (NP (NP (NN Figure) (CD 3)) (: :) (NP (NP (LST (-LRB- -LRB-) (LS a) (-RRB- -RRB-)) (NN Cell) (NN surface) (NN expression)) (PP (IN of) (NP (NP (NN type) (CD 1) (NN interleukin-10) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN IL-10R1)) (-RRB- -RRB-)))) (PP (IN on) (NP (NP (JJ CD4+) (NN T) (NNS cells)) (PP (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ rheumatoid) (NN arthritis)) (PRN (-LRB- -LRB-) (NP (NN RA)) (-RRB- -RRB-)))))) (CC and) (PP (IN from) (NP (NP (JJ healthy) (NNS controls)) (PRN (-LRB- -LRB-) (NP (NN HC)) (-RRB- -RRB-)))))))) (. .))))
( (S (S (NP (JJ Peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (VP (VP (VBD were) (VP (VBN stained) (PP (PP (IN with) (NP (JJ anti-IL-10R1) (NN antibody))) (CC or) (PP (IN with) (NP (JJ isotype-matched) (JJ control) (NN antibody)))) (, ,) (S (VP (VBN followed) (PP (IN by) (NP (NP (NN incubation)) (PP (IN with) (NP (JJ FITC-conjugated) (NN goat) (JJ anti-mouse) (NN IgG1) (JJ polyclonal) (NN antibody))))))))) (, ,) (CC and) (VP (VBD were) (ADVP (RB then)) (VP (VBN stained) (PP (IN with) (NP (JJ phycoerythrin-conjugated) (JJ anti-CD4) (NN mAb))))))) (. .)))
( (S (S (NP (NP (DT The) (NN expression)) (PP (IN of) (NP (NP (NN CD4)) (CC and) (NP (NN IL-10R1))))) (VP (VBD was) (VP (VBN determined) (PP (IN by) (NP (NN flow) (JJ cytometric) (NN analysis)))))) (. .)))
( (S (S (NP (NP (JJ Representative) (JJ histographic) (NNS patterns)) (PP (IN of) (NP (NP (NN IL-10R1) (NN expression)) (PP (IN on) (NP (NP (JJ CD4+) (NN T) (NNS cells)) (PP (IN from) (NP (NP (NN RA) (NNS patients)) (CC and) (NP (NNS HC))))))))) (VP (VBP are) (VP (VBN shown)))) (. .)))
( (S (S (LST (-LRB- -LRB-) (LS b) (-RRB- -RRB-)) (NP (NP (DT The) (NN intensity)) (PP (IN of) (NP (NN IL-10R1))) (PP (IN on) (NP (JJ CD4+) (NN T) (NNS cells)))) (VP (VBD was) (VP (VBN expressed) (PP (IN as) (NP (NP (DT the) (NN ratio)) (PP (IN of) (NP (NP (NP (DT the) (JJ mean) (NN fluorescence) (NN intensity)) (-LRB- -LRB-) (NP (NN MFI)) (-RRB- -RRB-)) (PP (IN of) (S (VP (VBG staining) (PP (IN with) (NP (NP (NN anti-IL-10R1)) (PP (TO to) (NP (JJ control) (NN antibody))))))))))))))) (. .)))
( (S (S (NP (NNS Values)) (VP (VBP are) (NP (NP (DT the) (NN mean) (NN ±) (JJ standard) (NN error)) (PP (IN of) (NP (DT the) (NN mean)))))) (. .)))
( (S (S (NP (NN n)) (, ,) (NP (NP (NN number)) (PP (IN of) (NP (NP (NNS samples)) (VP (VBN tested)))))) (. .)))
( (S (NP (NP (NN Figure) (CD 4)) (: :) (NP (NP (LST (-LRB- -LRB-) (LS a) (-RRB- -RRB-)) (JJ IL-10-mediated) (NN phosphorylation)) (PP (IN of) (NP (NP (NP (NN signal) (NN transducer)) (CC and) (NP (NN activator))) (PP (IN of) (NP (NP (NN transcription) (-LRB- -LRB-) (NN STAT) (-RRB- -RRB-) (CD 1)) (CC and) (NP (NN STAT3)))))) (PP (IN in) (NP (NP (JJ CD4+) (NN T) (NNS cells)) (PP (IN from) (NP (NP (NNS patients)) (PP (PP (IN with) (NP (NP (JJ rheumatoid) (NN arthritis)) (PRN (-LRB- -LRB-) (NP (NN RA)) (-RRB- -RRB-)))) (CC and) (PP (IN from) (NP (NP (JJ healthy) (NNS controls)) (PRN (-LRB- -LRB-) (NP (NN HC)) (-RRB- -RRB-)))))))))) (. .))))
( (S (S (S (NP (NP (JJ CD4+) (NN T) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NP (CD 5) (NN ×) (CD 105) (NNS cells)) (PP (IN in) (NP (ADJP (CD 0.5) (NN ml)) (NN culture) (NN medium))) (PP (IN with) (NP (ADJP (CD 10) (NN %)) (NN FCS)))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN incubated) (PP (PP (IN with)) (CC or) (PP (IN without) (NP (NP (NN IL-10)) (PRN (-LRB- -LRB-) (NP (QP (CD 1) (CC and) (CD 10)) (NN ng/ml)) (-RRB- -RRB-)))))))) (CC and) (S (NP (NNS cells)) (VP (VBD were) (VP (VBN harvested) (ADVP (NP (CD 20) (NN min)) (RB later)))))) (. .)))
( (S (S (S (NP (JJ Whole) (NN cell) (NNS extracts)) (VP (VBD were) (VP (VBN prepared) (PP (IN by) (S (VP (VBG placing) (NP (NNS cells)) (PP (IN in) (NP (NN SDS) (NN buffer))))))))) (, ,) (CC and) (S (NP (NP (NP (NN tyrosine) (NN phosophorylation)) (PRN (-LRB- -LRB-) (NP (NN p-Tyr)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NN STAT1)) (CC and) (NP (NN STAT3))))) (VP (VBD was) (VP (VBN detected) (PP (IN by) (NP (NN western) (NN blot) (NN analysis))))))) (. .)))
( (S (S (NP (JJ IFN-γ-stimulated) (NN Hela) (NNS cells)) (VP (VBD were) (VP (VBN used) (PP (IN as) (NP (NP (DT a) (JJ positive) (NN control)) (PP (IN for) (NP (NN STAT1) (NN phosphorylation)))))))) (. .)))
( (S (NP (NP (-LRB- -LRB-) (NN b) (-RRB- -RRB-) (NN Percentage)) (PP (IN of) (NP (JJ IL-10-activated) (NN STAT3) (NN phosphorylation))) (PP (IN in) (NP (NP (JJ CD4+) (NN T) (NNS cells)) (PP (PP (IN from) (NP (NN RA) (NNS patients))) (CC and) (PP (IN from) (NP (NN HC)))))) (. .))))
( (S (S (S (NP (NN Protein) (NNS bands)) (VP (VBD were) (VP (VBN quantified) (PP (IN by) (NP (NN densitometry))) (S (VP (VBG using) (NP (NN NIH-Image) (NN analysis))))))) (, ,) (CC and) (S (NP (NN STAT3) (NN phosphorylation)) (VP (VBD was) (VP (VBN expressed) (PP (IN as) (NP (NN %) (JJ total) (NN STAT3) (NN protein))))))) (. .)))
( (S (S (LST (-LRB- -LRB-) (LS c) (-RRB- -RRB-)) (NP (NN STAT3)) (VP (NN phosphorylation) (PP (IN in) (NP (NP (JJ ST) (JJ CD4+) (NN T) (NNS cells)) (PP (IN from) (NP (NN RA) (NNS patients))))))) (. .)))
( (S (S (NP (NP (JJ Representative) (NNS results)) (PP (IN of) (NP (NN STAT3) (NN phosphorylation))) (PP (IN in) (NP (NP (JJ CD4+) (NN T) (NNS cells)) (PP (IN from) (NP (NP (NP (NP (CD three) (JJ synovial) (NN tissue) (NNS samples)) (PP (IN of) (NP (NN RA) (NNS patients)))) (CC and) (NP (CD three) (JJ peripheral) (NN blood) (NNS samples))) (PP (IN of) (NP (NN HC)))))))) (VP (VBP are) (VP (VBN shown)))) (. .)))
( (S (S (NP (NNS Values)) (VP (VBP are) (NP (NP (DT the) (NN mean) (NN ±) (JJ standard) (NN error)) (PP (IN of) (NP (DT the) (NN mean)))))) (. .)))
( (S (S (NP (NN n)) (, ,) (NP (NP (NN number)) (PP (IN of) (NP (NP (NNS samples)) (VP (VBN tested)))))) (. .)))
( (S (NP (NP (NN Figure) (CD 5)) (: :) (NP (NP (LST (-LRB- -LRB-) (LS a) (-RRB- -RRB-)) (NN Activation)) (PP (IN of) (NP (NP (NN signal) (NP (NP (NP (NN transducer)) (CC and) (NP (NN activator))) (PP (IN of) (NP (NN transcription) (-LRB- -LRB-) (NN STAT) (-RRB- -RRB-) (CD 3))))) (PP (IN in) (NP (JJ normal) (JJ CD4+) (NN T) (NNS cells))))) (PP (IN by) (NP (NP (NN serum) (NN IL-6)) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ rheumatoid) (NN arthritis)) (PRN (-LRB- -LRB-) (NP (NN RA)) (-RRB- -RRB-))))))))) (. .))))
( (S (S (NP (NP (JJ CD4+) (NN T) (NNS cells)) (PP (IN from) (NP (NP (JJ healthy) (NNS controls)) (PRN (-LRB- -LRB-) (NP (NP (CD 5) (NN ×) (CD 105) (NNS cells)) (PP (IN in) (NP (ADJP (CD 0.5) (NN ml)) (NN culture) (NN medium)))) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN stimulated) (PP (IN by) (NP (ADJP (CD 30) (NN %)) (NN RA) (NN serum))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (PP (IN of) (NP (VBG neutralizing) (NP (NP (NP (JJ anti-IL-6) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NN Ab)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (CD 40) (NN μg/ml)) (-RRB- -RRB-))))) (CC or) (PP (IN of) (NP (NP (NP (JJ control) (NN antibody)) (PRN (-LRB- -LRB-) (NP (CD 40) (NN μg/ml)) (-RRB- -RRB-))) (PP (IN for) (NP (CD 20) (NN min))))))))))) (. .)))
( (S (NP (NP (NN Phosophorylation)) (PP (IN of) (NP (NP (NN STAT1)) (CC and) (NP (NN STAT3))))) (VP (VBD was) (VP (VBN detected) (PP (IN by) (NP (NN western) (NN blot) (NN analysis.))))) (LST (-LRB- -LRB-) (LS b) (-RRB- -RRB-))))
( (S (NP (NP (NN Effect)) (PP (IN of) (NP (NN IL-6) (NN pretreatment))) (PP (IN on) (NP (NP (NN IL-10) (NN inhibition)) (PP (IN of) (NP (NN IFN-γ) (NN production))) (PP (IN by) (NP (JJ CD4+) (NN T) (NNS cells))))) (. .))))
( (S (S (NP (NP (JJ CD4+) (NN T) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NP (CD 5) (NN ×) (CD 105) (NNS cells)) (PP (IN in) (NP (ADJP (CD 0.5) (NN ml)) (NN culture) (NN medium))) (PP (IN with) (NP (ADJP (CD 10) (NN %)) (NN FCS)))) (-RRB- -RRB-))) (VP (VP (VBD were) (VP (VBN incubated) (PP (PP (IN with)) (CC or) (PP (IN without) (NP (NP (NN IL-6)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN ng/ml)) (-RRB- -RRB-))))) (PP (IN for) (NP (CD 36) (NNS hours))))) (, ,) (CC and) (VP (VBD were) (ADVP (RB then)) (VP (VBN stimulated) (PP (IN by) (NP (NP (JJ anti-CD3) (NN antibody)) (CC and) (NP (JJ anti-CD28) (NN antibody)))) (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC or) (NP (NN absence))) (PP (IN of) (NP (NP (NP (NN IL-10)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN ng/ml)) (-RRB- -RRB-))) (PP (IN for) (NP (CD 36) (NNS hours))))))))))) (. .)))
( (S (S (NP (NP (NNS Concentrations)) (PP (IN of) (NP (NN IFN-γ))) (PP (IN in) (NP (NN culture) (NNS supernatants)))) (VP (VBD were) (VP (VBN measured) (PP (IN in) (NP (NN duplicate))) (PP (IN by) (NP (NN ELISA)))))) (. .)))
( (S (S (NP (NP (NN IFN-γ) (NN production)) (PP (IN with) (NP (NN IL-10)))) (VP (VBD was) (VP (VBN expressed) (PP (IN as) (NP (NP (NN %) (NN IFN-γ) (NN production)) (PP (IN without) (NP (NN IL-10)))))))) (. .)))
( (S (S (NP (NNS Values)) (VP (VBP are) (NP (NP (DT the) (NN mean) (NN ±) (JJ standard) (NN error)) (PP (IN of) (NP (DT the) (NN mean)))))) (. .)))
( (S (S (NP (NN n)) (, ,) (NP (NP (NN number)) (PP (IN of) (NP (NP (NNS samples)) (VP (VBN tested)))))) (. .)))
( (S (NP (NP (NN P-Tyr)) (, ,) (NP (NN tyrosine) (NN phosophorylation)) (. .))))
( (S (NP (NP (NN Figure) (CD 6)) (: :) (NP (LST (-LRB- -LRB-) (LS a) (-RRB- -RRB-)) (NP (DT The) (NN mRNA) (NN expression)) (PP (IN of) (NP (NP (NN SOCS1)) (CC and) (NP (NN SOCS3)))) (PP (IN in) (NP (NP (JJ CD4+) (NN T) (NNS cells)) (PP (IN from) (NP (NP (NP (NNS patients)) (PP (IN with) (NP (NN RA)))) (CC and) (NP (NP (JJ healthy) (NNS controls)) (PRN (-LRB- -LRB-) (NP (NN HC)) (-RRB- -RRB-)))))))) (. .))))
( (S (S (S (NP (JJ Total) (JJ cellular) (NN RNA)) (VP (VBD was) (VP (VBN extracted) (PP (IN from) (NP (ADJP (RB freshly) (VBN isolated)) (JJ CD4+) (NN T) (NNS cells)))))) (CC and) (S (NP (NP (NN mRNA) (NN expression)) (PP (IN of) (NP (NP (NN SOCS1)) (CC and) (NP (NN SOCS3))))) (VP (VBD was) (VP (VBN analyzed) (PP (IN by) (NP (JJ real) (NN time-PCR))) (SBAR (IN as) (S (VP (VBN described) (PP (IN in) (NP (NP (NNS Patients)) (CC and) (NP (NNS Methods))))))))))) (. .)))
( (S (S (NP (NP (NNS Levels)) (PP (IN of) (NP (NP (NN SOCS1)) (CC and) (NP (NN SOCS3)) (NP (NNS mRNAs))))) (VP (VBD were) (VP (VBN normalized) (PP (JJ relative) (TO to) (NP (NN β-actin) (NN expression)))))) (. .)))
( (S (S (NP (NNS Values)) (VP (VBP are) (NP (NP (DT the) (ADJP (NN mean) (NN ±) (NN SEM.) (NN n) (JJ =)) (NN number)) (PP (IN of) (NP (NP (NNS samples)) (VP (VBN tested))))))) (. .)))
( (S (NP (NP (-LRB- -LRB-) (NN b) (-RRB- -RRB-) (NN Kinetics)) (PP (IN of) (NP (JJ IL-6-induced) (NN SOCS1) (NN mRNA) (NN expression))) (PP (IN in) (NP (JJ normal) (JJ CD4+) (NN T) (NNS cells))) (. .))))
( (S (S (S (NP (NP (NP (JJ CD4+) (NN T) (NNS cells)) (PP (IN from) (NP (NN HC)))) (PRN (-LRB- -LRB-) (NP (NP (CD 5) (NN ×) (CD 105) (NNS cells)) (PP (IN in) (NP (NP (CD 0.5) (NN ml)) (PP (IN of) (NP (NN culture) (NN medium))))) (PP (IN with) (NP (ADJP (CD 10) (NN %)) (NN FCS)))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN stimulated) (PP (IN with) (NP (NP (NN IL-6)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN ng/ml)) (-RRB- -RRB-))))))) (CC and) (S (NP (NN SOCS1) (NN mRNA) (NN expression)) (VP (VBD was) (VP (VBN determined) (PP (IN at) (NP (NP (DT the) (VBN indicated) (NN time)) (PP (IN after) (NP (NN stimulation))))))))) (. .)))
( (S (NP (NP (VBN Increased) (NN interleukin-17) (NN production)) (PP (IN via) (NP (DT a) (NP (NP (NN phosphoinositide) (NN 3-kinase/Akt)) (CC and) (NP (JJ nuclear) (NN factor))) (NN κB-dependent) (NN pathway))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ rheumatoid) (NN arthritis))))))))
( (S (NP (NN Abstract))))
( (S (S (NP (JJ Inflammatory) (NNS mediators)) (VP (VBP have) (VP (VBN been) (VP (VBN recognized) (PP (IN as) (S (VP (VBG being) (ADJP (JJ important)) (PP (IN in) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (NP (JJ rheumatoid) (NN arthritis)) (PRN (-LRB- -LRB-) (NP (NN RA)) (-RRB- -RRB-))))))))))))) (. .)))
( (S (S (NP (NN Interleukin) (-LRB- -LRB-) (NN IL) (-RRB- -RRB-) (CD -17)) (VP (VBZ is) (NP (NP (DT an) (JJ important) (NN regulator)) (PP (IN of) (NP (NP (ADJP (ADJP (JJ immune)) (CC and) (ADJP (JJ inflammatory))) (NNS responses)) (, ,) (PP (VBG including) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NP (JJ proinflammatory) (NNS cytokines)) (CC and) (NP (JJ osteoclastic) (NN bone) (NN resorption))))))))))) (. .)))
( (S (S (NP (NP (NN Evidence)) (PP (IN for) (NP (NP (DT the) (NP (NN expression)) (CC and) (NP (JJ proinflammatory) (NN activity))) (PP (IN of) (NP (NN IL-17)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN demonstrated) (PP (PP (IN in) (NP (NN RA) (NN synovium))) (CC and) (PP (IN in) (NP (NP (JJ animal) (NNS models)) (PP (IN of) (NP (NN RA)))))))))) (. .)))
( (S (S (SBAR (IN Although) (S (NP (NP (DT some) (NNS cytokines)) (PRN (-LRB- -LRB-) (NP (NP (NN IL-15)) (CC and) (NP (NN IL-23))) (-RRB- -RRB-))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB regulate) (NP (NN IL-17) (NN production)))))))))) (, ,) (NP (NP (DT the) (JJ intracellular) (NN signaling) (NNS pathways)) (SBAR (WHNP (WDT that)) (S (VP (VBP regulate) (NP (NN IL-17) (NN production)))))) (VP (VBP remain) (ADJP (JJ unknown)))) (. .)))
( (S (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (PRP we)) (VP (VBD investigated) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (DT the) (NP (NP (NN phosphoinositide) (NN 3-kinase)) (PRN (-LRB- -LRB-) (NP (NN PI3K)) (-RRB- -RRB-))) (NN /Akt) (NN pathway))) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (NN IL-17) (NN production)) (PP (IN in) (NP (NN RA)))))))))) (. .)))
( (S (S (NP (NP (NP (JJ Peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN PBMC)) (-RRB- -RRB-))) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN RA)) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 24)) (-RRB- -RRB-))))))) (VP (VBD were) (VP (VBN separated) (, ,) (S (ADVP (RB then)) (VP (VBN stimulated) (PP (IN with) (NP (NP (JJ various) (NNS agents)) (PP (VBG including) (NP (NP (NN anti-CD3)) (, ,) (NP (NN anti-CD28)) (, ,) (NP (NP (NN phytohemagglutinin)) (PRN (-LRB- -LRB-) (NP (NN PHA)) (-RRB- -RRB-))) (CC and) (NP (JJ several) (NP (JJ inflammatory) (NNS cytokines)) (CC and) (NP (NNS chemokines)))))))))))) (. .)))
( (S (S (NP (NN IL-17) (NNS levels)) (VP (VBD were) (VP (VBN determined) (PP (IN by) (NP (NP (JJ sandwich) (JJ enzyme-linked) (JJ immunosorbent) (NN assay)) (CC and) (NP (JJ reverse) (NN transcription–polymerase) (NN chain) (NN reaction))))))) (. .)))
( (S (S (NP (NP (DT The) (NN production)) (PP (IN of) (NP (NN IL-17)))) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN increased) (PP (IN in) (NP (NP (NNS cells)) (VP (VBN treated) (PP (IN with) (NP (JJ anti-CD3) (NN antibody))) (PP (PP (IN with)) (CC or) (PP (IN without) (NP (NP (NP (NN anti-CD28)) (CC and) (NP (NN PHA))) (PRN (-LRB- -LRB-) (NP (NN P) (NN <) (CD 0.05)) (-RRB- -RRB-))))))))))) (. .)))
( (S (PP (IN Among) (NP (VBN tested) (NP (NP (NNS cytokines)) (CC and) (NP (NNS chemokines))))) (, ,) (NP (NP (NN IL-15)) (, ,) (NP (NN monocyte) (NN chemoattractant) (NN protein-1)) (CC and) (NP (NN IL-6))) (VP (VBD upregulated) (NP (NP (NN IL-17) (NN production)) (PRN (-LRB- -LRB-) (NP (NN P) (NN <) (CD 0.05)) (-RRB- -RRB-))) (, ,) (SBAR (IN whereas) (S (NP (NP (NN tumor) (NN necrosis) (NN factor-α)) (, ,) (NP (NN IL-1β)) (, ,) (NP (NN IL-18)) (CC or) (NP (NN transforming) (NN growth) (NN factor-β))) (VP (VBD did) (RB not))))) (. .)))
( (S (S (S (NP (NN IL-17)) (VP (VBD was) (ADVP (RB also)) (VP (VBN detected) (PP (IN in) (NP (NP (DT the) (NNS PBMC)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NN osteoarthritis)))))))))) (, ,) (CC but) (S (NP (PRP$ their) (NN expression) (NNS levels)) (VP (VBD were) (ADJP (ADJP (RB much) (JJR lower)) (PP (IN than) (NP (NP (DT those)) (PP (IN of) (NP (NN RA) (NNS PBMC))))))))) (. .)))
( (S (S (NP (JJ Anti-CD3) (NN antibody)) (VP (VBD activated) (NP (DT the) (NN PI3K/Akt) (NN pathway)))) (: ;) (S (NP (NP (NN activation)) (PP (IN of) (NP (DT this) (NN pathway)))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (JJ pronounced) (NN augmentation)) (PP (IN of) (NP (JJ nuclear) (NN factor) (NN κB) (-LRB- -LRB-) (NN NF-κB) (-RRB- -RRB-) (JJ DNA-binding) (NN activity))))))) (. .)))
( (S (S (NP (NP (NN IL-17) (NN production)) (PP (IN by) (NP (VBN activated) (NN RA) (NNS PBMC)))) (VP (VBZ is) (VP (ADVP (ADVP (RB completely)) (CC or) (ADVP (RB partly))) (VBN blocked) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (DT the) (JJ NF-κB) (NN inhibitor) (NN pyrrolidine) (NN dithiocarbamate)) (CC and) (NP (NP (DT the) (NN PI3K/Akt) (NN inhibitor)) (NP (NP (NN wortmannin)) (CC and) (NP (NP (NN LY294002)) (, ,) (ADVP (RB respectively)))))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (NN activator) (NN protein-1)) (CC and) (NP (JJ extracellular) (JJ signal-regulated) (NN kinase) (CD 1/2))))) (VP (VBD did) (RB not) (VP (VB affect) (NP (NN IL-17) (NN production))))) (. .)))
( (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN signal) (NN transduction) (NNS pathways)) (ADJP (JJ dependent) (PP (IN on) (NP (NP (NN PI3K/Akt)) (CC and) (NP (NN NF-κB)))))) (VP (VBP are) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN overproduction)) (PP (IN of) (NP (NP (DT the) (JJ key) (JJ inflammatory) (NN cytokine) (NN IL-17)) (PP (IN in) (NP (NN RA))))))))))))) (. .)))
( (S (NP (NN Introduction))))
( (S (S (NP (NP (JJ Rheumatoid) (NN arthritis)) (PRN (-LRB- -LRB-) (NP (NN RA)) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN characterized) (PP (IN by) (NP (NP (NP (NNS infiltrations)) (PP (IN of) (NP (NP (NNS macrophages)) (CC and) (NP (NN T) (NNS cells)))) (PP (IN into) (NP (DT the) (NN joint)))) (, ,) (CC and) (NP (JJ synovial) (NN hyperplasia))))))) (. .)))
( (S (S (NP (NP (JJ Proinflammatory) (NNS cytokines)) (VP (VBN released) (PP (IN from) (NP (DT these) (NNS cells))))) (VP (VBP are) (VP (VBN known) (S (VP (TO to) (VP (VB be) (ADJP (JJ important) (PP (IN in) (NP (NP (DT the) (NN destruction)) (PP (IN of) (NP (NNS joints))) (PP (IN in) (NP (NN RA) (NN -LSB-1) (-RRB- -RSB-)))))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ favorable) (JJ clinical) (NNS benefits)) (VP (VBN obtained) (PP (IN with) (NP (NP (NNS inhibitors)) (PP (IN of) (NP (NP (NP (NN tumor) (NN necrosis) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN TNF) (-RRB- -RRB-) (CD -α)) (-RRB- -RRB-))) (CC and) (NP (NN interleukin) (-LRB- -LRB-) (NN IL) (-RRB- -RRB-) (CD -1)))))))) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (NN blockade)) (PP (IN of) (NP (JJ key) (JJ inflammatory) (NNS cytokines)))) (VP (VBZ has) (VP (VBN been) (NP (DT the) (JJ important) (NN issue)) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (JJ new) (JJ therapeutic) (NNS applications)) (PRN (NN -LSB-2) (-RRB- -RSB-)))))))))))) (. .)))
( (S (S (NP (NP (NP (DT A) (ADJP (JJ little) (PP (IN over) (NP (NP (DT a) (NN decade)) (ADVP (RB ago)))))) (, ,) (NP (NP (DT the) (NN primacy)) (PP (IN of) (NP (NN T) (NNS cells))) (PP (IN in) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (JJ autoimmune) (NN disease))))))) (PP (JJ such) (IN as) (NP (NN RA)))) (VP (VBD was) (VP (VBN undisputed) (SBAR (IN because) (S (NP (PRP they)) (VP (VBP are) (NP (NP (DT the) (JJS largest) (NN cell) (NN population)) (VP (VBG infiltrating) (NP (DT the) (NN synovium)))))))))) (. .)))
( (S (ADVP (RB However)) (, ,) (NP (NP (DT a) (NN series)) (PP (IN of) (NP (NNS studies)))) (VP (VBD demonstrated) (NP (NP (NN paucity)) (PP (IN of) (NP (NP (NN T) (JJ cell-derived) (NNS cytokines)) (PP (JJ such) (IN as) (NP (NP (NP (NN IL-2)) (CC and) (NP (NN interferon-γ))) (PP (IN in) (NP (NP (DT the) (NNS joints)) (PP (IN of) (NP (NN RA)))))))))) (, ,) (SBAR (IN whereas) (S (NP (NP (NN macrophage) (CC and) (NN fibroblast) (NNS cytokines)) (PP (VBG including) (NP (NP (NN IL-1)) (, ,) (NP (NN IL-6)) (, ,) (NP (NN IL-15)) (, ,) (NP (NN IL-18)) (CC and) (NP (NN TNF-α))))) (VP (VBD were) (ADJP (JJ abundant) (PP (IN in) (NP (JJ rheumatoid) (NN synovium)))))))) (. .)))
( (S (S (NP (DT This) (NN paradox)) (VP (VBZ has) (VP (VBN questioned) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN T) (NNS cells))) (PP (IN in) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (NN RA) (NN -LSB-3)))))) (-RRB- -RSB-)))) (. .)))
( (S (SBAR (IN Because) (S (NP (PRP we)) (VP (VBP have) (ADVP (RB already)) (VP (VBN demonstrated) (NP (NP (NP (DT the) (VBN enhanced) (NN proliferation)) (PP (IN of) (NP (NP (NN antigen) (JJ specific) (NN T) (NNS cells)) (, ,) (ADVP (RB especially)))) (PP (TO to) (NP (NN type) (CD II) (NN collagen)))) (, ,) (CC and) (NP (NP (DT the) (NN skewing)) (PP (IN of) (NP (NN T) (NN helper) (NN type) (CD 1) (-LRB- -LRB-) (NN Th1) (-RRB- -RRB-) (NNS cytokines))) (PP (IN in) (NP (NN RA) (NN -LSB-4)))) (-RRB- -RSB-)))))) (, ,) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN T) (NNS cells)))) (VP (VBZ needs) (S (VP (TO to) (VP (VB be) (VP (VBN elucidated) (PP (IN in) (NP (JJ different) (NNS aspects)))))))) (. .)))
( (S (S (NP (NN IL-17)) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (JJ inflammatory) (NNS cytokines)) (VP (VBN secreted) (ADVP (RB mainly)) (PP (IN by) (NP (VBN activated) (NN T) (NNS cells))))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB induce) (NP (NP (NN IL-6)) (CC and) (NP (NN IL-8))) (PP (IN by) (NP (NNS fibroblasts) (CD -LSB-5) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (DT This) (NN cytokine)) (VP (VBZ is) (PP (IN of) (NP (NN interest))) (PP (IN for) (NP (CD two) (JJ major) (NNS reasons))))) (: :) (S (ADVP (RB first)) (, ,) (PP (ADVP (RB similarly)) (TO to) (NP (NP (NN TNF-α)) (CC and) (NP (NN IL-1)))) (, ,) (NP (NN IL-17)) (VP (VBZ has) (NP (JJ proinflammatory) (NNS properties)))) (: ;) (S (ADVP (RB second)) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN produced) (PP (IN by) (NP (NN T) (NNS cells) (CD -LSB-6) (-RRB- -RSB-)))))) (. .)))
( (S (NP (JJ Recent) (NNS observations)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NN IL-17)) (VP (MD can) (ADVP (RB also)) (VP (VB activate) (NP (JJ osteoclastic) (NN bone) (NN resorption)) (PP (IN by) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NP (NP (NN RANKL)) (PRN (-LRB- -LRB-) (NP (NP (NN receptor) (NN activator)) (PP (IN of) (NP (JJ nuclear) (NN factor) (NN κB) (NN -LSB-NF-κB) (-RRB- -RSB-) (NN ligand)))) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NN bony) (NN erosion))) (PP (IN in) (NP (NN RA) (NN -LSB-7) (-RRB- -RSB-)))))))))))))))) (. .)))
( (S (S (NP (PRP It)) (ADVP (RB also)) (VP (VP (VBZ stimulates) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NP (NN IL-6)) (CC and) (NP (NN leukemia) (JJ inhibitory) (NN factor)))) (PP (PP (IN by) (NP (NNS synoviocytes))) (, ,) (CC and) (PP (IN of) (NP (NP (NN prostaglandin) (NN E2)) (CC and) (NP (JJ nitric) (NN oxide)))) (PP (IN by) (NP (NNS chondrocytes)))))) (, ,) (CC and) (VP (VBZ has) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VP (VB differentiate)) (CC and) (VP (VB activate) (NP (NP (DT the) (JJ dendritic) (NNS cells)) (CD -LSB-8-10) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (S (NP (NP (NNS Levels)) (PP (IN of) (NP (NN IL-17))) (PP (IN in) (NP (JJ synovial) (NNS fluids)))) (VP (VBD were) (ADJP (ADJP (RB significantly) (JJR higher)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN RA))))) (PP (IN than) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN osteoarthritis)) (PRN (-LRB- -LRB-) (NP (NN OA)) (-RRB- -RRB-)))))))))) (, ,) (CC and) (S (NP (PRP it)) (VP (VBD was) (VP (VBN produced) (PP (IN by) (NP (JJ CD4+) (NN T) (NNS cells))) (PP (IN in) (NP (DT the) (NN synovium) (NN -LSB-11,12))))) (-RRB- -RSB-))) (. .)))
( (S (S (NP (NP (NN IL-15)) (, ,) (VP (VBN secreted) (PP (IN from) (NP (VBN activated) (NNS macrophages)))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB be) (NP (NP (DT an) (JJ important) (NN trigger)) (PP (IN of) (NP (NP (NN IL-17) (NN production)) (PP (IN in) (NP (NP (NN RA) (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN PBMC)) (-RRB- -RRB-)))) (PP (IN by) (NP (NP (NN cyclosporine)) (CC and) (NP (NN steroid) (JJ sensitive) (NNS pathways)) (NP (NN -LSB-13)) (-RRB- -RSB-))))))))))))) (. .)))
( (S (ADVP (RB Recently)) (, ,) (NP (NP (NN Happel)) (CC and) (NP (NNS colleagues))) (ADVP (RB also)) (VP (VBD showed) (SBAR (IN that) (S (NP (NN IL-23)) (VP (MD could) (VP (VB be) (NP (NP (DT an) (JJ efficient) (NN trigger)) (PP (IN of) (NP (NP (NN IL-17) (NN production)) (PP (IN from) (NP (ADJP (CC both) (ADJP (JJ CD4+)) (CC and) (ADJP (JJ CD8+))) (NN T) (NNS cells) (NP (CD -LSB-14))))))))) (-RRB- -RSB-)))) (. .)))
( (S (S (SBAR (IN Although) (S (NP (NP (DT the) (NN contribution)) (PP (IN of) (NP (NN IL-17))) (PP (IN in) (NP (NP (NN joint) (NN inflammation)) (PP (IN in) (NP (NN RA)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN documented) (PP (IN in) (NP (JJR earlier) (NNS studies) (NP (CD -LSB-12,15,16))))))) (-RRB- -RSB-))) (, ,) (NP (NP (DT the) (JJ intracellular) (NN signal) (NN transduction) (NN pathway)) (PP (IN for) (NP (NN IL-17) (NN production)))) (VP (VBZ remains) (ADJP (JJ uncertain)))) (. .)))
( (S (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (NP (PRP we)) (VP (VBD used) (NP (JJ various) (NNS stimuli)) (S (VP (TO to) (VP (VB investigate) (NP (NP (NP (NN IL-17) (NN production)) (PP (IN in) (NP (NP (NN PBMC)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NN RA)))))))) (CC and) (NP (PRP$ its) (NN signaling) (NN transduction) (NN pathway)))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (DT the) (JJ intracellular) (NN signaling) (NN pathway)) (VP (VBG involving) (NP (NP (NP (NP (NN phosphoinositide) (NN 3-kinase)) (PRN (-LRB- -LRB-) (NP (NN PI3K)) (-RRB- -RRB-))) (NN /Akt)) (CC and) (NP (NN NF-κB))))) (VP (MD might) (VP (VB be) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN overproduction)) (PP (IN of) (NP (NP (DT the) (JJ key) (JJ inflammatory) (NN cytokine) (NN IL-17)) (PP (IN in) (NP (NN RA)))))))))))))) (. .)))
( (S (S (NP (DT These) (NNS results)) (VP (MD might) (VP (VB provide) (NP (NP (NP (JJ new) (NNS insights)) (PP (IN into) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (NN RA)))))) (CC and) (NP (NP (JJ future) (NNS directions)) (PP (IN for) (NP (NP (JJ new) (JJ therapeutic) (NNS strategies)) (PP (IN in) (NP (NN RA)))))))))) (. .)))
( (S (NP (NP (NNS Materials)) (CC and) (NP (NNS methods)))))
( (S (S (NP (VBN Informed) (NN consent)) (VP (VBD was) (VP (VBN obtained) (PP (IN from) (NP (NP (NP (CD 24) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NP (CD 5) (NNS men)) (CC and) (NP (CD 19) (NNS women))) (-RRB- -RRB-))) (PP (IN with) (NP (NN RA))) (SBAR (WHNP (WP who)) (S (VP (VBD fulfilled) (NP (NP (DT the) (CD 1987) (JJ revised) (NNS criteria)) (PP (IN of) (NP (NP (DT the) (NNP American) (NNP College)) (PP (IN of) (NP (NN Rheumatology)))))) (PRN (-LRB- -LRB-) (NP (ADVP (RB formerly)) (NP (DT the) (NP (NNP American)) (NN Rheumatism) (NN Association))) (-RRB- -RRB-) (NP (CD -LSB-17)) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN age)) (PP (IN of) (NP (NP (DT the) (NNS patients)) (PP (IN with) (NP (NN RA)))))) (VP (VBD was) (NP (NP (QP (CD 50) (CD ±) (CD 8) (PRN (-LRB- -LRB-) (NP (NN mean) (NN ±) (NN SEM)) (-RRB- -RRB-))) (NNS years)) (PRN (-LRB- -LRB-) (NP (NN range) (CD 23–71) (NNS years)) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (DT All) (NNS medications)) (VP (VBD were) (VP (VBN stopped) (PP (NP (CD 48) (NNS hours)) (IN before) (NP (NP (NN entry)) (PP (TO to) (NP (DT the) (NN study)))))))) (. .)))
( (S (S (NP (NNS Comparisons)) (VP (VBD were) (VP (VBN made) (PP (PP (IN with) (NP (NP (NP (CD 14) (NNS patients)) (PP (IN with) (NP (NN OA)))) (PRN (-LRB- -LRB-) (NP (NP (CD 3) (NNS men)) (CC and) (NP (CD 11) (NNS women))) (-RRB- -RRB-)))) (CC and) (PP (IN with) (NP (NP (NP (CD 14) (JJ healthy) (NNS controls)) (PRN (-LRB- -LRB-) (NP (NP (CD 3) (NNS men)) (CC and) (NP (CD 11) (NNS women))) (-RRB- -RRB-))) (SBAR (WHNP (WP who)) (S (VP (VBD had) (NP (DT no) (JJ rheumatic) (NNS diseases))))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ mean) (NNS ages)) (PP (IN of) (NP (NP (NP (DT the) (NNS patients)) (PP (IN with) (NP (NN OA)))) (CC and) (NP (DT the) (JJ healthy) (NNS controls))))) (VP (VBD were) (NP (NP (NP (CD 50) (NN ±) (CD 8) (NNS years)) (PRN (-LRB- -LRB-) (NP (NN range) (CD 34–68) (NNS years)) (-RRB- -RRB-))) (CC and) (NP (NP (CD 30) (NN ±) (CD 6) (NNS years)) (PRN (-LRB- -LRB-) (NP (NN range) (CD 24–57) (NNS years)) (-RRB- -RRB-)))))) (. .)))
( (S (S (S (NP (VBN Informed) (NN consent)) (VP (VBD was) (VP (VBN obtained)))) (, ,) (CC and) (S (NP (DT the) (NN protocol)) (VP (VBD was) (ADJP (JJ approved) (PP (IN by) (NP (NP (DT the) (JJ Catholic) (NNP University)) (PP (IN of) (NP (NP (NNP Korea)) (NP (JJ Human) (NN Research) (NNP Ethics) (NNP Committee)))))))))) (. .)))
( (S (S (NP (NP (JJ Recombinant) (NN IL-17)) (, ,) (NP (NN IL-18)) (, ,) (NP (NN IL-15)) (, ,) (NP (NP (NN monocyte) (NN chemoattractant) (NN protein-1)) (PRN (-LRB- -LRB-) (NP (NN MCP-1)) (-RRB- -RRB-))) (, ,) (NP (NN macrophage) (JJ inflammatory) (NN protein) (-LRB- -LRB-) (NN MIP) (-RRB- -RRB-) (CD -1α)) (, ,) (NP (NN MIP-1β)) (, ,) (NP (NN IL-6)) (CC and) (NP (NN IL-8))) (VP (VBD were) (VP (VBN purchased) (PP (IN from) (NP (NP (NN R) (NN &) (NN D) (NNS systems)) (PRN (-LRB- -LRB-) (NP (NNP Minneapolis) (, ,) (NN MN) (, ,) (NN USA)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (JJ Recombinant) (NP (NP (NN transforming) (NN growth) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN TGF)) (-RRB- -RRB-))) (NN -β)) (VP (VBD was) (VP (VBN purchased) (PP (IN from) (NP (NP (NNP Peprotech)) (PRN (-LRB- -LRB-) (NP (NNP London) (, ,) (NNP UK)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (JJ Recombinant) (NN TNF-α)) (CC and) (NP (NN IL-1))) (VP (VBD were) (VP (VBN purchased) (PP (IN from) (NP (NP (NNP Endogen) (NNP Inc.)) (PRN (-LRB- -LRB-) (NP (NN Cambridge)) (, ,) (NP (NP (NN MA)) (, ,) (NP (NN USA))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NN Cyclosporin) (NN A)) (VP (VBD was) (VP (VBN provided) (PP (IN by) (NP (NP (NNP Sandos) (NNP Ltd.)) (PRN (-LRB- -LRB-) (NP (NNP Basel) (, ,) (NNP Switzerland)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (NP (NN Phytohemagglutinin)) (PRN (-LRB- -LRB-) (NP (NN PHA)) (-RRB- -RRB-))) (, ,) (NP (NP (NN pyrrolidine) (NN dithiocarbamate)) (PRN (-LRB- -LRB-) (NP (NN PDTC)) (-RRB- -RRB-))) (, ,) (NP (NN rapamycin)) (, ,) (NP (NN dexamethasone)) (CC and) (NP (NN curcumin))) (VP (VBD were) (ADVP (RB all)) (VP (VBN obtained) (PP (IN from) (NP (DT the) (NN Sigma) (JJ Chemical) (NN Co.)))))) (. .)))
( (S (S (PRN (-LRB- -LRB-) (NP (NP (JJ St) (NN Louis)) (, ,) (NP (NN MA)) (, ,) (NP (NN USA))) (-RRB- -RRB-))) (. .)))
( (S (S (NP (NP (JJ Anti-CD3) (JJ monoclonal) (NN antibody)) (CC and) (NP (JJ anti-CD28) (JJ monoclonal) (NN antibody))) (VP (VBD were) (VP (VBN obtained) (PP (IN from) (NP (NP (NNP BD) (NNP Biosciences)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP San) (NNP Diego)) (, ,) (NP (NN CA))) (, ,) (NP (NNP USA))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (NN LY294002)) (, ,) (NP (NN SB203580)) (, ,) (NP (NN FK506)) (, ,) (NP (NN wortmannin)) (CC and) (NP (NN PD98059))) (VP (VBD were) (VP (VBN obtained) (PP (IN from) (NP (NP (NNP Calbiochem)) (PRN (-LRB- -LRB-) (NP (NNP Schwalbach) (, ,) (NNP Germany)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NN PBMC)) (VP (VBD were) (VP (VBN prepared) (PP (IN from) (NP (JJ heparinized) (NN blood))) (PP (IN by) (NP (NN Ficoll-Hypaque) (-LRB- -LRB-) (CD SG1077) (-RRB- -RRB-) (JJ density-gradient) (NN centrifugation)))))) (. .)))
( (S (S (NP (NN Cell) (NNS cultures)) (VP (VBD were) (VP (VBN performed) (SBAR (IN as) (S (VP (VBN described) (ADVP (RB previously)) (S (NP (NN -LSB-18)) (-RRB- -RSB-)))))))) (. .)))
( (S (S (PP (IN In) (NP (JJ brief))) (, ,) (NP (DT the) (NN cell) (NNS suspensions)) (VP (VBD were) (VP (VBN adjusted) (PP (TO to) (NP (NP (DT a) (NN concentration)) (PP (IN of) (NP (NN 106/ml))) (PP (IN in) (NP (NP (NN RPMI) (CD 1640) (NN medium)) (VP (VBN supplemented) (PP (IN with) (NP (NP (ADJP (CD 10) (NN %)) (JJ fetal) (NN calf) (NN serum)) (, ,) (NP (ADJP (CD 100) (NN U/ml)) (NN penicillin)) (, ,) (NP (ADJP (CD 100) (NN mg/ml)) (NN streptomycin)) (CC and) (NP (ADJP (CD 2) (NN mM)) (NN L-glutamine)))))))))))) (. .)))
( (S (S (NP (NP (NN Cell) (NN suspension)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN ml)) (-RRB- -RRB-))) (VP (VBD was) (VP (VP (VBN dispensed) (PP (IN into) (NP (NP (JJ 24-well) (JJ multi-well) (NNS plates)) (PRN (-LRB- -LRB-) (NP (NNP Nunc) (, ,) (NNP Roskilde) (, ,) (NNP Denmark)) (-RRB- -RRB-))))) (, ,) (CC and) (VP (VBN incubated) (PP (IN for) (NP (CD 24) (NNS hours))) (PP (IN at) (NP (NN 37°C))) (PP (IN in) (NP (ADJP (CD 5) (NN %)) (NN CO2))))))) (. .)))
( (S (S (S (ADVP (RB Subsequently)) (, ,) (NP (NP (JJ various) (NNS concentrations)) (PP (IN of) (NP (NP (NN cyclosporin) (NN A)) (PRN (-LRB- -LRB-) (NP (CD 10–500) (NN ng/ml)) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN added) (PP (TO to) (NP (DT the) (NN medium)))))) (CC and) (S (NP (NNS cells)) (VP (VBD were) (VP (VBN incubated) (PP (IN for) (NP (CD 24) (NNS hours))))))) (. .)))
( (S (S (PP (TO To) (NP (DT each) (NN well))) (VP (VBD was) (VP (VBN added) (NP (NP (NN FK506)) (, ,) (NP (NN rapamycin)) (, ,) (NP (NN curcumin)) (, ,) (NP (NN PDTC)) (, ,) (NP (NP (NN LY294002)) (, ,) (NP (NN SB203580)) (, ,) (NP (NN PD98059)) (, ,) (NP (NN dexamethasone)) (CC or) (NP (NN wortmannin))))))) (. .)))
( (S (S (PP (IN After) (NP (NP (NN incubation)) (PP (IN for) (NP (NP (CD 24) (NNS hours)) (PRN (-LRB- -LRB-) (SBAR (IN unless) (S (ADVP (RB otherwise)) (VP (VBN stated)))) (-RRB- -RRB-)))))) (, ,) (NP (JJ cell-free) (NNS media)) (VP (VBD were) (VP (VP (VBN collected)) (CC and) (VP (VBN stored) (PP (IN at) (NP (NN -20°C))) (SBAR (IN until) (S (VP (VBN assayed)))))))) (. .)))
( (S (S (S (NP (DT All) (NNS cultures)) (VP (VBD were) (VP (VBN set) (PRT (RP up)) (PP (IN in) (NP (NN triplicate)))))) (, ,) (CC and) (S (NP (NNS results)) (VP (VBP are) (VP (VBN expressed) (PP (IN as) (NP (NP (NNS means)) (VP (VBG ±) (NP (NN SEM))))))))) (. .)))
( (S (S (NP (JJ Anti-CD4) (NNS microbeads)) (VP (VBD were) (VP (VBN used) (ADVP (RB essentially)) (SBAR (IN as) (S (VP (VBN recommended) (PP (IN by) (NP (DT the) (NN manufacturer))) (PRN (-LRB- -LRB-) (NP (NNP Miltenyi) (-RRB- -RRB-) (CD -LSB-19)) (-RRB- -RSB-)))))))) (. .)))
( (S (S (NP (NN PBMC)) (VP (VBD were) (VP (VBN resuspended) (PP (IN in) (NP (NP (CD 80) (NN μl)) (PP (IN of) (NP (NP (NNS FBS)) (VP (VBG staining) (NP (NN buffer)))))))))) (. .)))
( (S (S (NP (NP (JJ Anti-CD4) (NNS microbeads)) (PRN (-LRB- -LRB-) (NP (CD 20) (NN μl)) (-RRB- -RRB-))) (VP (VBD were) (VP (VP (VBN added)) (CC and) (VP (VBN incubated) (PP (IN for) (NP (CD 15) (NN min))) (PP (IN at) (NP (NN 6–12°C))))))) (. .)))
( (S (S (NP (NP (JJ Saturating) (NNS amounts)) (PP (IN of) (NP (JJ fluorochrome-conjugated) (NNS antibodies)))) (VP (VBD were) (VP (VBN added) (PP (IN for) (NP (DT a) (JJ further) (CD 10) (NN min)))))) (. .)))
( (S (S (NP (NNS Cells)) (VP (VBD were) (VP (VP (VBN diluted) (PP (IN in) (NP (NP (CD 2.5) (NN ml)) (PP (IN of) (NP (NP (NNS FBS)) (VP (VBG staining) (NP (NN buffer)))))))) (, ,) (VP (VBN pelleted)) (, ,) (VP (VBN resuspended) (PP (IN in) (NP (CD 500) (NN μl)))) (CC and) (ADVP (RB magnetically)) (VP (VBN separated))) (, ,) (ADVP (RB usually)) (PP (IN on) (NP (NP (DT an) (NN AutoMACS) (NN magnet)) (VP (VBN fitted) (PP (IN with) (NP (DT a) (NN MACS) (NN MS) (NN column)))))))) (. .)))
( (S (S (NP (NP (ADJP (JJ Flow-through))) (CC and) (NP (CD two) (ADJP (CD 1) (NN ml)) (NNS washes))) (VP (VBD were) (VP (VBN collected) (PP (IN as) (NP (DT the) (JJ negative) (NN fraction)))))) (. .)))
( (S (S (NP (JJ Enriched) (NNS cells)) (VP (VBD were) (VP (VBN collected) (PP (IN in) (NP (NP (CD two) (ADJP (CD 0.5) (NN ml)) (NNS aliquots)) (PP (IN from) (NP (DT the) (NN column))))) (PP (IN after) (NP (NP (NN removal)) (PP (IN from) (NP (DT the) (NN magnet)))))))) (. .)))
( (S (ADVP (RB Alternatively)) (, ,) (NP (NP (NNS cells)) (VP (VBN stained) (PP (IN with) (NP (NN anti-CD4–phycoerythrin))))) (VP (VBD were) (VP (VP (VBN washed)) (, ,) (VP (ADVP (RB magnetically)) (VBN labeled) (PP (IN with) (NP (NP (JJ anti-phycoerythrin) (NNS microbeads)) (PRN (-LRB- -LRB-) (NP (NP (CD 20) (NN μl)) (VP (VBN added) (PP (TO to) (NP (NP (CD 80) (NN μl)) (PP (IN of) (NP (NN cell) (NN suspension))))))) (: ;) (NP (CD 15) (NN min)) (, ,) (NP (NNS 6–12°C)) (-RRB- -RRB-))))) (, ,) (CC and) (ADVP (RB magnetically)) (VP (VBN separated) (SBAR (IN as) (S (VP (VBN described) (ADVP (RB above)))))))) (. .)))
( (S (S (NP (NP (DT The) (NN purity)) (PP (IN of) (NP (NNS cells)))) (VP (VBD was) (VP (VBN assessed) (PP (IN by) (NP (NP (ADJP (NN flow) (JJ cytometric)) (NN analysis)) (PP (IN of) (NP (NP (VBN stained) (NNS cells)) (PP (IN on) (NP (DT a) (NN FACS) (NN Vantage) (NN sorter)))))))))) (. .)))
( (S (S (NP (NP (NP (JJS Most)) (PRN (-LRB- -LRB-) (NP (QP (JJR more) (IN than) (CD 97)) (NN %)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (VBN isolated) (NNS cells)))) (VP (VBD had) (NP (DT the) (NN CD4) (NN T) (NN cell) (NN marker)))) (. .)))
( (S (S (NP (NP (NN IL-17)) (PP (IN in) (NP (NN culture) (NNS supernatants)))) (VP (VBD was) (VP (VBN measured) (PP (IN by) (NP (JJ sandwich) (JJ enzyme-linked) (JJ immunosorbent) (NN assay))) (SBAR (IN as) (S (VP (VBN described) (ADVP (RB previously)) (PRN (QP (CD -LSB-20)) (-RRB- -RSB-)))))))) (. .)))
( (S (PP (IN In) (NP (JJ brief))) (, ,) (NP (NP (DT a) (JJ 96-well) (NN plate)) (PRN (-LRB- -LRB-) (NP (NN Nunc)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN coated) (PP (IN with) (NP (NP (CD 4) (NN μg/ml) (JJ monoclonal) (NNS antibodies)) (PP (IN against) (NP (NN IL-17))))) (PRN (-LRB- -LRB-) (NP (NN R) (NN &) (NN D) (NNS Systems)) (-RRB- -RRB-)) (PP (IN at) (NP (JJ 4°C) (JJ overnight))))) (. .)))
( (S (PP (IN After) (NP (NP (NN blocking)) (PP (IN with) (NP (NP (JJ phosphate-buffered) (NN saline/1) (NN %) (JJ bovine) (NN serum) (NN albumin)) (PRN (-LRB- -LRB-) (NP (NN BSA)) (-RRB- -RRB-)))))) (NP (CD /0.05) (NN %))))
( (S (S (PP (NP (NNP Tween) (CD 20)) (IN for) (NP (NP (CD 2) (NNS hours)) (PP (IN at) (NP (NP (JJ room) (NN temperature)) (PRN (-LRB- -LRB-) (NP (NN 22–25°C)) (-RRB- -RRB-)))))) (, ,) (NP (NP (NN test) (NNS samples)) (CC and) (NP (NP (DT the) (JJ standard) (JJ recombinant) (NN IL-17)) (PRN (-LRB- -LRB-) (NP (NP (NN R)) (NP (NN &) (NN D) (NNS Systems))) (-RRB- -RRB-)))) (VP (VBD were) (VP (VP (VBN added) (PP (TO to) (NP (DT the) (JJ 96-well) (NN plate)))) (CC and) (VP (VBN incubated) (PP (IN at) (NP (JJ room) (NN temperature))) (PP (IN for) (NP (CD 2) (NNS hours))))))) (. .)))
( (S (NP (NNS Plates)) (VP (VBD were) (VP (VP (VBN washed) (NP (CD four) (NNS times)) (PP (IN with) (NP (JJ phosphate-buffered) (NN saline/Tween) (CD 20)))) (, ,) (CC and) (ADVP (RB then)) (VP (VBN incubated) (PP (IN with) (NP (NP (ADJP (NP (CD 500) (NN ng/ml)) (VBN biotinylated)) (NN mouse) (JJ monoclonal) (NNS antibodies)) (PP (IN against) (NP (NP (NN IL-17)) (PRN (-LRB- -LRB-) (NP (NP (NN R)) (NP (NN &) (NN D) (NNS Systems))) (-RRB- -RRB-)))))) (PP (IN for) (NP (CD 2) (NNS hours))) (PP (IN at) (NP (JJ room) (NN temperature)))))) (. .)))
( (S (S (PP (IN After) (NP (VBG washing))) (, ,) (NP (NP (NP (NN streptavidin–alkaline) (NN phosphate–horseradish) (NN peroxidase)) (NN conjugate)) (PRN (-LRB- -LRB-) (NP (NN Sigma)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN incubated) (PP (IN for) (NP (CD 2) (NNS hours))) (, ,) (ADVP (RB then)) (VP (VP (VBN washed) (ADVP (RB again))) (CC and) (VP (VBN incubated) (PP (IN with) (NP (NP (NP (CD 1) (NN mg/ml) (NN p-nitrophenyl) (NN phosphate)) (PRN (-LRB- -LRB-) (NP (NN Sigma)) (-RRB- -RRB-))) (VP (VBN dissolved) (PP (IN in) (NP (NP (NN diethanolamine)) (PRN (-LRB- -LRB-) (NP (NN Sigma)) (-RRB- -RRB-)))) (S (VP (TO to) (VP (VB develop) (NP (DT the) (NN color) (NN reaction))))))))))))) (. .)))
( (S (S (S (NP (DT The) (NN reaction)) (VP (VBD was) (VP (VBN stopped) (PP (IN by) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (ADJP (CD 1) (NN M)) (NN NaOH)))))))) (CC and) (S (NP (NP (DT the) (JJ optical) (NN density)) (PP (IN of) (NP (DT each) (NN well)))) (VP (VBD was) (VP (VBN read) (PP (IN at) (NP (CD 405) (NN nm))))))) (. .)))
( (S (S (NP (NP (DT The) (JJR lower) (NN limit)) (PP (IN of) (NP (NN IL-17) (NN detection)))) (VP (VBD was) (NP (CD 10) (NN pg/ml)))) (. .)))
( (S (S (NP (NP (JJ Recombinant) (JJ human) (NN IL-17)) (VP (VBN diluted) (PP (IN in) (NP (NN culture) (NN medium))))) (VP (VBD was) (VP (VBN used) (PP (IN as) (NP (NP (DT a) (JJ calibration) (JJ standard)) (, ,) (VP (VBG ranging) (PP (IN from) (NP (QP (CD 10) (TO to) (CD 2000)) (NN pg/ml))))))))) (. .)))
( (S (S (NP (DT A) (JJ standard) (NN curve)) (VP (VBD was) (VP (VP (VBN drawn) (PP (IN by) (S (VP (VBG plotting) (NP (NN optical) (NN density)) (PP (IN against) (NP (NP (DT the) (NN log)) (PP (IN of) (NP (NP (DT the) (NN concentration)) (PP (IN of) (NP (JJ recombinant) (NNS cytokines))))))))))) (, ,) (CC and) (VP (VBN used) (PP (IN for) (NP (NP (NN determination)) (PP (IN of) (NP (NP (NN IL-17)) (PP (IN in) (NP (NN test) (NNS samples))))))))))) (. .)))
( (S (S (NP (NN PBMC)) (VP (VBD were) (VP (VBN incubated) (PP (IN with) (NP (NP (JJ various) (NNS concentrations)) (PP (IN of) (NP (NN anti-CD3))))) (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC or) (NP (NN absence))) (PP (IN of) (NP (NP (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NP (NN LY294002)) (, ,) (NP (NN PDTC))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (PP (IN After) (NP (NP (CD 16) (NNS hours)) (PP (IN of) (NP (NN incubation))))) (, ,) (NP (NN mRNA)) (VP (VBD was) (VP (VBN extracted) (PP (IN with) (NP (NP (NN RNAzol) (NN B)) (PRN (-LRB- -LRB-) (NP (NN Biotex) (NP (NNS Laboratories)) (, ,) (NP (NN Houston)) (, ,) (NP (NN TX)) (, ,) (NP (NN USA))) (-RRB- -RRB-)))) (PP (IN in) (NP (NP (NN accordance)) (PP (IN with) (NP (NP (DT the) (NN manufacturer) (POS 's)) (NNS instructions)))))))) (. .)))
( (S (S (NP (NP (JJ Reverse) (NN transcription)) (PP (IN of) (NP (NP (CD 2) (NN μg)) (PP (IN of) (NP (JJ total) (NN mRNA)))))) (VP (VBD was) (VP (VBN performed) (PP (IN at) (NP (NN 42°C))) (S (VP (VBG using) (NP (NP (DT the) (NN Superscript™) (NN reverse) (NN transcription) (NN system)) (PRN (-LRB- -LRB-) (NP (NP (NNP Takara)) (, ,) (NP (NN Shiga)) (, ,) (NP (NNP Japan))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (NN PCR) (NN amplification)) (PP (IN of) (NP (NN cDNA) (NNS aliquots)))) (VP (VBD was) (VP (VBN performed) (PP (IN by) (S (VP (VBG adding) (NP (NP (ADJP (CD 2.5) (NN mM)) (NN dNTPs)) (, ,) (NP (NP (CD 2.5) (NN U)) (PP (IN of) (NP (NP (NN Taq) (NN DNA) (NN polymerase)) (PRN (-LRB- -LRB-) (NP (NN Takara)) (-RRB- -RRB-))))) (CC and) (NP (NP (CD 0.25) (NN μM)) (PP (IN of) (NP (NP (NN sense)) (CC and) (NP (JJ antisense) (NNS primers)))))))))))) (. .)))
( (S (S (NP (DT The) (NN reaction)) (VP (VBD was) (VP (VBN performed) (PP (IN in) (NP (NP (NN PCR) (NN buffer)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD 1.5) (NN mM)) (NN MgCl2)) (, ,) (NP (ADJP (CD 50) (NN mM)) (NN KCl)) (, ,) (NP (ADJP (CD 10) (NN mM)) (NN Tris-HCl))) (, ,) (NP (NN pH) (CD 8.3)) (-RRB- -RRB-)))) (PP (IN in) (NP (NP (DT a) (JJ total) (NN volume)) (PP (IN of) (NP (CD 25) (NN μl)))))))) (. .)))
( (S (NP (NP (DT The) (VBG following) (NN sense) (CC and) (JJ antisense) (NNS primers)) (PP (IN for) (NP (DT each) (NNS molecules)))) (VP (VBD were) (VP (VBN used) (: :) (NP (NP (NN IL-17) (NN sense)) (, ,) (NP (NP (NN 5'-ATG)) (VP (VB ACT) (NP (NN CCT) (NN GGG) (NN AAG) (NN ACC) (NN TCA) (NN TTG-3) (POS ')))) (: ;) (NP (NP (NN IL-17) (NN antisense)) (, ,) (NP (NN 5'-TTA) (NN GGC) (NN CAC) (NN ATG) (NN GTG) (NN GAC) (NN AAT) (NN CGG-3) ('' '))) (: ;) (NP (NP (NN glyceraldehyde-3-phosphate) (NN dehydrogenase)) (PRN (-LRB- -LRB-) (NP (NN GAPDH)) (-RRB- -RRB-)) (NP (NN sense)) (, ,) (NP (NN 5'-CGA) (NN TGC) (NN TGG) (NN GCG) (NN TGA) (NN GTA) (NN C-3)) ('' ')) (: ;) (NP (NN GAPDH) (NN antisense)) (, ,) (NP (NN 5'-CGT) (NN TCA) (NN GCT) (NN CAG) (NN GGA) (NN TGA) (NN CC-3)) ('' ')))) (. .)))
( (S (NP (NNS Reactions)) (VP (VBD were) (VP (VBN processed) (PP (IN in) (NP (DT a) (NN DNA) (JJ thermal) (NN cycler))) (PRN (-LRB- -LRB-) (NP (NP (NNP Perkin-Elmer) (NNP Cetus) (, ,) (NNP Norwalk)) (, ,) (NP (NN CT)) (, ,) (NP (NNP USA))) (-RRB- -RRB-)) (PP (IN through) (NP (NP (NNS cycles)) (PP (IN for) (NP (NP (CD 30) (NNS s)) (PP (IN of) (NP (NP (NN denaturation)) (PP (IN at) (NP (NP (NN 94°C)) (, ,) (NP (NP (CD 1) (NN min)) (PP (IN of) (NP (NN annealing)))))) (PP (IN at) (NP (NP (NN 56°C)) (PP (IN for) (NP (NP (NN GAPDH)) (CC and) (NP (NN IL-17)))))) (, ,) (VP (VBN followed) (PP (IN by) (NP (NP (CD 1) (NN min)) (PP (IN of) (NP (NP (NN elongation)) (PP (IN at) (NP (NN 72°C)))))))))))))))) (. .)))
( (S (S (NP (NN PCR) (NNS rounds)) (VP (VBD were) (VP (VBN repeated) (PP (IN for) (NP (NP (NP (CD 25) (NNS cycles)) (NP (DT each))) (PP (IN for) (NP (CC both) (NP (NN GAPDH)) (CC and) (NP (NN IL-17))))))))) (: ;) (S (NP (DT this)) (VP (VBD was) (VP (VBN determined) (PP (IN as) (S (VP (VBG falling) (PP (IN within) (NP (NP (DT the) (JJ exponential) (NN phase)) (PP (IN of) (NP (NN amplification))) (PP (IN for) (NP (DT each) (NN molecule))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN level)) (PP (IN of) (NP (NN mRNA) (NN expression)))) (VP (VBD was) (VP (VBN presented) (PP (IN as) (NP (NP (DT a) (NN ratio)) (PP (IN of) (NP (NN IL-17) (NN PCR) (NN product))) (PP (IN over) (NP (NN GAPDH) (NN product)))))))) (. .)))
( (S (S (NP (NN PBMC)) (VP (VBD were) (VP (VBN incubated) (PP (IN with) (NP (NP (NN anti-CD3)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN μg/ml)) (-RRB- -RRB-)))) (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC or) (NP (NN absence))) (PP (IN of) (NP (NN LY294002))))) (PRN (-LRB- -LRB-) (NP (CD 20) (NN μM)) (-RRB- -RRB-))))) (. .)))
( (S (S (PP (IN After) (NP (NP (NN incubation)) (PP (IN for) (NP (CD 1) (NN hour))))) (, ,) (NP (JJ whole) (NN cell) (NNS lysates)) (VP (VBD were) (VP (VP (VBN prepared) (PP (IN from) (NP (QP (RB about) (CD 107)) (NNS cells))) (PP (IN by) (NP (NP (NN homogenization)) (PP (IN in) (NP (DT the) (NN lysis) (NN buffer)))))) (, ,) (CC and) (VP (VBN centrifuged) (PP (IN at) (NP (NP (CD 14,000) (NN r.p.m.)) (PRN (-LRB- -LRB-) (NP (CD 19,000) (NN g)) (-RRB- -RRB-)))) (PP (IN for) (NP (CD 15) (NN min))))))) (. .)))
( (S (S (NP (NP (NN Protein) (NNS concentrations)) (PP (IN in) (NP (DT the) (NNS supernatants)))) (VP (VBD were) (VP (VBN determined) (PP (IN with) (NP (DT the) (NN Bradford) (NN method))) (PRN (-LRB- -LRB-) (NP (JJ Bio-Rad)) (, ,) (NP (NP (NNP Hercules)) (, ,) (NP (NN CA)) (, ,) (NP (NNP USA))) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (NN Protein) (NNS samples)) (VP (VBD were) (VP (VP (VP (VBN separated) (PP (IN by) (NP (ADJP (CD 10) (NN %)) (NN SDS–PAGE)))) (CC and) (VP (VBN transferred) (PP (TO to) (NP (DT a) (NN nitrocellulose) (NN membrane))))) (PRN (-LRB- -LRB-) (NP (NNP Amersham) (NNP Pharmacia) (NNP Biotech) (, ,) (NNP Uppsala) (, ,) (NNP Sweden)) (-RRB- -RRB-))))) (. .)))
( (S (S (PP (IN For) (NP (NN western) (NN hybridization))) (, ,) (NP (NN membrane)) (VP (VBD was) (VP (VBN preincubated) (PP (IN with) (NP (ADJP (CD 0.1) (NN %)) (JJ skimmed) (NN milk))) (PP (IN in) (NP (NP (NP (JJ TBS-T) (NN buffer)) (PRN (-LRB- -LRB-) (NP (CD 0.1) (NN %) (NP (NP (NNP Tween) (CD 20)) (PP (IN in) (NP (JJ Tris-buffered) (NN saline))))) (-RRB- -RRB-))) (PP (IN at) (NP (JJ room) (NN temperature))))) (PP (IN for) (NP (CD 2) (NNS hours)))))) (, ,) (NP (NP (RB then) (JJ primary) (NNS antibodies)) (PP (IN against) (NP (NP (NN Akt)) (, ,) (NP (NP (NP (JJ phosphorylated) (NN Akt)) (CC and) (NP (NN IκB-α))) (PRN (-LRB- -LRB-) (NP (NP (NN Cell) (NN Signaling) (NN Technology)) (NP (NNP Inc.) (, ,) (NNP Beverly) (, ,) (NNP MA) (, ,) (NNP USA))) (-RRB- -RRB-))) (, ,) (NP (NP (JJ diluted) (NN 1:1000)) (PP (IN in) (NP (ADJP (CD 5) (NN %)) (NN BSA/TBS-T)))) (, ,)))) (VP (VBD were) (VP (VP (VBN added)) (CC and) (VP (VBN incubated) (S (ADJP (JJ overnight) (PP (IN at) (NP (NN 4°C)))))))) (. .)))
( (S (S (PP (IN After) (S (VP (VBG washing) (NP (CD four) (NNS times)) (PP (IN with) (NP (NN TBS-T)))))) (, ,) (NP (NN horseradish) (JJ peroxidase-conjugated) (JJ secondary) (NNS antibodies)) (VP (VBD were) (VP (VP (VBN added)) (CC and) (VP (VBN allowed) (PP (TO to) (NP (NN incubate))) (PP (IN for) (NP (CD 1) (NN hour))) (PP (IN at) (NP (JJ room) (NN temperature))))))) (. .)))
( (S (S (PP (IN After) (NP (JJ TBS-T) (VBG washing))) (, ,) (NP (VBN hybridized) (NNS bands)) (VP (VBD were) (VP (VBN detected) (PP (IN with) (NP (NP (DT the) (VBN enhanced) (NN chemiluminescence) (-LRB- -LRB-) (NN ECL) (-RRB- -RRB-) (NN detection) (NN kit)) (CC and) (NP (NP (NN Hyperfilm-ECL) (NNS reagents)) (PRN (-LRB- -LRB-) (NP (NNP Amersham) (NNP Pharmacia)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (JJ Nuclear) (NNS proteins)) (VP (VBD were) (VP (VBN extracted) (PP (IN from) (NP (QP (RB about) (CD 5)) (NN ×) (CD 106) (NN PBMC)))))) (. .)))
( (S (NP (NP (NN Oligonucleotide) (NNS probes)) (VP (VBG encompassing) (NP (NP (DT the) (JJ NF-κB) (NN binding) (NN site)) (PP (IN of) (NP (DT the) (NP (NP (JJ human) (NN IL-17) (NN promoter)) (PRN (-LRB- -LRB-) (NP (NN 5'-ATG) (NN ACC) (NN TGG) (NN AAA) (NN TAC) (NN CCA) (NN AAA) (NN TTC-3) ('' ')) (-RRB- -RRB-)))))))) (VP (VBD were) (VP (VBN generated) (PP (IN by) (NP (NP (JJ 5'-end) (NN labeling)) (PP (IN of) (NP (DT the) (NN sense) (NN strand))) (PP (IN with) (NP (NP (NP (CD -LSB-γ-32P) (-RRB- -RSB-) (NN dATP)) (PRN (-LRB- -LRB-) (NP (NNP Amersham) (NNP Pharmacia)) (-RRB- -RRB-))) (CC and) (NP (NP (NN T4) (NN polynucleotide) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN TaKaRa)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (JJ Unincorporated) (NNS nucleotides)) (VP (VBD were) (VP (VBN removed) (PP (IN by) (NP (NP (NN NucTrap) (NN probe) (NN purification) (NNS columns)) (PRN (-LRB- -LRB-) (NP (NP (NNP Stratagene)) (, ,) (NP (NN La) (NN Jolla)) (, ,) (NP (NN CA) (, ,) (NNP USA))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (JJ Nuclear) (NNS extracts)) (PRN (-LRB- -LRB-) (NP (NP (CD 2) (NN μg)) (PP (IN of) (NP (NN protein)))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN incubated) (PP (IN with) (NP (NP (VBN radiolabeled) (NN DNA) (NNS probes)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN ng) (: ;) (CD 100,000) (NN c.p.m.)) (-RRB- -RRB-)))) (PP (IN for) (NP (NP (CD 30) (NN min)) (PP (IN at) (NP (NP (JJ room) (NN temperature)) (PP (IN in) (NP (NP (CD 20) (NN μl)) (PP (IN of) (NP (NP (NN binding) (NN buffer)) (VP (VBG consisting) (PP (IN of) (NP (NP (ADJP (CD 20) (NN mM)) (NN Tris-HCl)) (, ,) (NP (NN pH) (CD 7.9)) (, ,) (NP (CD 50) (NN mM) (NN KCl)) (, ,) (NP (CD 1) (NN mM) (NN dithiothreitol)) (, ,) (NP (ADJP (CD 0.5) (NN mM)) (NN EDTA)) (, ,) (NP (ADJP (CD 5) (NN %)) (NN glycerol)) (, ,) (NP (CD 1) (NN mg/ml) (NN BSA)) (, ,) (NP (ADJP (CD 0.2) (NN %)) (NN Nonidet) (NN P40)) (CC and) (NP (NP (ADJP (CD 50) (NN ng/μl)) (NN poly)) (PRN (-LRB- -LRB-) (NP (NN dI-dC)) (-RRB- -RRB-))))))))))))))))) (. .)))
( (S (S (NP (NNS Samples)) (VP (VBD were) (VP (VBN subjected) (PP (TO to) (NP (NN electrophoresis))) (PP (IN on) (NP (NP (JJ nondenaturing) (ADJP (CD 5) (NN %)) (NN polyacrylamide) (NNS gels)) (PP (IN in) (NP (NP (NP (ADJP (CD 0.5) (NN ×)) (NN Tris-borate-EDTA) (NN buffer)) (PRN (-LRB- -LRB-) (NP (NN pH) (CD 8.0)) (-RRB- -RRB-))) (PP (IN at) (NP (ADJP (CD 100) (NN V.)) (NNS Gels)))))))))) (VP (VBD were) (VP (VP (VBN dried) (PP (IN under) (NP (NN vacuum)))) (CC and) (VP (VBN exposed) (PP (TO to) (NP (NP (NN Kodak) (NN X-OMAT) (NN film)) (PP (IN at) (NP (NP (NN -70°C)) (PP (IN with) (NP (JJ intensifying) (NNS screens)))))))))) (. .)))
( (S (S (NP (NP (JJ Rabbit) (JJ polyclonal) (NNS antibodies)) (PP (IN against) (NP (NN NF-κB) (NNS subunits) (NP (NP (NN p50)) (, ,) (NP (NN p65)) (CC and) (NP (NN c-Rel)))))) (VP (VBD were) (PP (IN from) (NP (NNP Santa) (NNP Cruz) (NN Biotechnology))) (PRN (-LRB- -LRB-) (NP (NNP Santa) (NNP Cruz)) (, ,) (NP (NP (NN CA)) (, ,) (NP (NN USA))) (-RRB- -RRB-)))) (. .)))
( (S (S (PP (IN For) (NP (NN cell) (NN viability) (NNS assays))) (, ,) (NP (DT the) (NP (NN trypan) (JJ blue) (NN dye) (NN exclusion)) (NN method)) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (NN potential)) (PP (IN of) (NP (NP (JJ direct) (JJ cytotoxic) (NN effect)) (PP (IN of) (NP (NNS inhibitors))) (PP (IN on) (NP (NNS cells)))))))))))) (. .)))
( (S (PP (IN After) (NP (NP (NN incubation)) (PP (IN for) (NP (CD 24) (NNS hours))))) (, ,) (S (S (NP (DT the) (NNS cells)) (VP (VBD were) (VP (VBN harvested)))) (CC and) (S (NP (DT the) (NN percentage) (NN cell) (NN viability)) (VP (VBD was) (VP (VBN calculated) (PP (IN with) (NP (NP (DT the) (NN formula) (CD 100) (NN ×)) (PRN (-LRB- -LRB-) (NP (NP (NN number)) (PP (IN of) (NP (NP (JJ viable) (NN cells/number)) (PP (IN of) (NP (ADJP (CC both) (ADJP (JJ viable)) (CC and) (ADJP (JJ dead))) (NNS cells)))))) (-RRB- -RRB-) (NP (NN -LSB-21)) (-RRB- -RSB-)))))))) (. .)))
( (S (S (NP (NNS Data)) (VP (VBP are) (VP (VBN expressed) (PP (IN as) (NP (NP (NNS means)) (VP (VBG ±) (NP (NN SEM)))))))) (. .)))
( (S (S (NP (JJ Statistical) (NN analysis)) (VP (VBD was) (VP (VBN performed) (PP (IN with) (NP (NP (NP (NN Student) (POS 's)) (NN t-test)) (PP (IN for) (NP (VBN matched) (NNS pairs)))))))) (. .)))
( (S (S (NP (NP (NN P) (NNS values)) (ADJP (JJR less) (PP (IN than) (NP (CD 0.05))))) (VP (VBD were) (VP (VBN considered) (ADJP (JJ significant))))) (. .)))
( (S (NP (NNS Results))))
( (S (S (NP (NN PBMC)) (VP (VBD were) (VP (VP (VBN separated)) (CC and) (VP (VBN cultured) (PP (IN with) (NP (NP (NN PHA)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN μg/ml)) (-RRB- -RRB-)))) (PP (IN from) (NP (NP (NP (NNS patients)) (PP (IN with) (NP (NN RA)))) (, ,) (NP (NP (NNS patients)) (PP (IN with) (NP (NN OA)))) (, ,) (CC and) (NP (JJ age-matched) (JJ normal) (NNS controls)))))))) (: ;) (S (NP (NN IL-17) (NNS levels)) (VP (VBD were) (ADVP (RB then)) (VP (VBN determined) (PP (IN in) (NP (NP (DT the) (NN culture) (NNS supernatants)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 1)) (-RRB- -RRB-))))))) (. .)))
( (S (SBAR (IN Although) (S (NP (NP (DT the) (NNS amounts)) (PP (IN of) (NP (JJ basal) (NN IL-17) (NN secretion)))) (VP (VBD were) (RB not) (ADJP (JJ different) (PP (IN between) (NP (NP (NN RA)) (, ,) (NP (NN OA)) (CC and) (NP (NP (JJ normal) (NNS controls)) (PRN (-LRB- -LRB-) (NP (NP (CD 62) (NN ±) (CD 31)) (, ,) (NP (CD 43) (NN ±) (CD 19) (CC and) (CD 43) (NN ±) (CD 10) (NN pg/ml)) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-))))))))) (, ,) (NP (NP (DT the) (NN IL-17) (NN production)) (VP (VBN stimulated) (PP (IN by) (NP (NN PHA))))) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJR higher)) (PP (IN in) (NP (NN RA) (NNS PBMC))) (PP (IN than) (PP (IN in) (NP (NP (DT those)) (PP (IN from) (NP (NP (NP (NP (NNS OA)) (CC and) (NP (NNS controls))) (PRN (-LRB- -LRB-) (NP (CD 768) (NN ±) (CD 295) (CC versus) (CD 463) (NN ±) (CD 211) (NN pg/ml) (NN -LSB-P) (NN <) (CD 0.05)) (-RRB- -RSB-))) (CC and) (NP (NP (NN 241) (NN ±) (CD 29) (NN pg/ml) (NN -LSB-P)) (PRN (QP (RB <) (CD 0.001)) (-RRB- -RSB-) (-RRB- -RRB-)))))))))) (. .)))
( (S (SBAR (IN Because) (S (NP (NN IL-17)) (VP (VBD was) (ADVP (RB already)) (VP (VBN known) (PP (IN from) (NP (JJR earlier) (NNS reports)))) (S (VP (TO to) (VP (VB be) (VP (VBN produced) (ADVP (RB mainly)) (PP (IN by) (NP (VBN activated) (NN T) (NNS cells)))))))))) (, ,) (NP (PRP we)) (VP (VBD investigated) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (JJ different) (NNS concentrations)) (PP (IN of) (NP (NP (NN anti-CD3)) (PRN (-LRB- -LRB-) (NP (QP (CD 1) (, ,) (CD 5) (CC and) (CD 10)) (NN μg/ml)) (-RRB- -RRB-))))))) (PP (IN as) (NP (NP (DT a) (NN T) (NN cell) (NN activation)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD showed) (NP (NP (DT a) (JJ dose-dependent) (NN increase)) (PP (IN in) (NP (NN IL-17) (NNS levels)))) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))))))) (. .)))
( (S (PP (IN On) (DT the) (NN basis) (IN of) (NP (DT this))) (, ,) (NP (PRP we)) (VP (VBP chose) (NP (CD 10) (NN μg/ml)) (PP (IN as) (NP (NP (DT a) (NN stimulation) (NN concentration)) (PP (IN for) (NP (NN anti-CD3)))))) (. .)))
( (S (SBAR (IN As) (S (VP (VBN shown) (PP (IN in) (NP (NN Table) (CD 1)))))) (, ,) (S (S (NP (NN anti-CD3)) (ADVP (RB significantly)) (VP (VBD upregulated) (NP (NP (NN IL-17) (NN production)) (ADJP (CD up) (TO to) (JJ 3.7-fold))))) (, ,) (CC and) (S (NP (NP (DT the) (NN combination)) (PP (IN of) (NP (NP (NN anti-CD28)) (CC and) (NP (NN anti-CD3))))) (VP (VBD produced) (NP (JJR more) (NN IL-17)) (PRN (-LRB- -LRB-) (NP (RB approximately) (RB 1.3-1.5-fold)) (-RRB- -RRB-)))))))
( (S (PP (IN than) (NP (NP (NN anti-CD3)) (ADVP (RB alone)))) (. .)))
( (S (ADVP (RB Furthermore)) (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBN incubated) (PP (IN with) (NP (NP (NN T) (NN cell) (NNS mitogens)) (PP (JJ such) (IN as) (NP (NN PHA)))))))) (, ,) (NP (VBN increased) (NN IL-17) (NN production)) (VP (VBD was) (ADJP (RBR more) (JJ pronounced)) (PP (IN than) (PP (IN with) (NP (NP (ADJP (JJ anti-CD3))) (CC and) (NP (ADJP (JJ anti-CD28)))))) (PRN (-LRB- -LRB-) (NP (NP (NN 588) (NN ±) (CD 85) (CC versus) (CD 211) (NN ±) (CD 1) (NN pg/ml)) (: ;) (NP (NN P) (NN <) (CD 0.05))) (-RRB- -RRB-))) (. .)))
( (S (SBAR (IN Because) (S (NP (NN RA) (NNS PBMC)) (VP (VBP include) (NP (NP (JJ several) (NN cell) (NNS types)) (PP (IN in) (NN addition) (TO to) (NP (NN T) (NNS cells))))))) (, ,) (NP (NP (DT some) (JJ inflammatory) (NNS cytokines)) (VP (VBN released) (PP (IN from) (NP (NP (NNS macrophages)) (CC and) (NP (JJ other) (NNS lymphocytes)))))) (VP (MD might) (VP (VB have) (VP (VBD affected) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NN IL-17))) (PP (IN from) (NP (NN T) (NNS cells))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB evaluate) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (JJ inflammatory) (NNS cytokines)) (VP (VBN released) (PP (IN by) (NP (VBN activated) (NNS PBMC)))))))))) (, ,) (NP (PRP we)) (VP (VBD tested) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (JJ several) (NNS cytokines)) (CC and) (NP (NNS chemokines)))) (PP (IN on) (NP (NN IL-17) (NN production)))))) (. .)))
( (S (S (S (NP (PRP We)) (VP (VBD detected) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN IL-17) (NN level)))) (PP (IN after) (NP (NP (NN stimulation)) (PP (IN with) (NP (NP (NN IL-15)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN ng/ml)) (-RRB- -RRB-)))))))) (, ,) (IN whereas) (S (PP (IN with) (NP (NP (NP (NN IL-1β)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN ng/ml)) (-RRB- -RRB-))) (, ,) (NP (NP (NN TNF-α)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN ng/ml)) (-RRB- -RRB-))) (, ,) (NP (NP (NN IL-18)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN ng/ml)) (-RRB- -RRB-))) (CC or) (NP (NP (NN TGF-β)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN ng/ml)) (-RRB- -RRB-))))) (NP (NP (DT the) (NNS levels)) (PP (IN in) (NP (NN IL-17)))) (VP (VBD were) (ADJP (ADJP (JJ unchanged)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 2a)) (-RRB- -RRB-)))))) (. .)))
( (S (SBAR (WHADVP (WRB When)) (S (VP (VBN treated) (PP (IN with) (NP (NP (NP (NN MCP-1)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN ng/ml)) (-RRB- -RRB-))) (CC or) (NP (NP (NN IL-6)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN ng/ml)) (-RRB- -RRB-)))))))) (, ,) (S (S (NP (NP (JJ significant) (NNS upregulations)) (PP (IN of) (NP (NN IL-17) (NNS proteins)))) (VP (VBD were) (VP (VBN observed) (PRN (-LRB- -LRB-) (S (S (NP (CD 62) (NN ±) (QP (CD 42) (CC and) (CD 50))) (VP (JJ ±) (NP (QP (CD 10) (CC versus) (CD 31) (CD ±) (CD 11)) (NN pg/ml)) (, ,) (ADVP (RB respectively)))) (: ;) (NP (NN P) (JJ <) (CD 0.05))) (-RRB- -RRB-))))) (, ,) (IN whereas) (S (NP (NN none)) (VP (VBD was) (VP (VBN observed) (PP (IN with) (NP (NP (NP (NN IL-8)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN ng/ml)) (-RRB- -RRB-))) (, ,) (NP (NP (NN MIP-1α)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN ng/ml)) (-RRB- -RRB-))) (CC or) (NP (NP (NP (NN MIP-1β)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN ng/ml)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 2b)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (S (VP (VBG Having) (VP (VBN observed) (NP (NP (DT the) (VBN increased) (NN IL-17) (NN production)) (PP (IN in) (NP (NN RA) (NNS PBMC))))))) (, ,) (NP (PRP it)) (VP (VBD was) (ADJP (JJ important) (S (VP (TO to) (VP (VB know) (SBAR (WHNP (WDT which)) (S (NP (NN signal) (NN transduction) (NNS pathways)) (VP (VBD were) (VP (VBN involved))))))))))) (. .)))
( (S (SBAR (IN As) (S (VP (VBN illustrated) (PP (IN in) (NP (NNP Fig.) (CD 3)))))) (, ,) (NP (NP (DT an) (JJ significant) (NN decrease)) (PP (IN in) (NP (JJ anti-CD3-induced) (NN IL-17) (NN production)))) (VP (VBD was) (VP (VBN observed) (SBAR (WHADVP (WRB when)) (S (VP (VBN co-incubated) (PP (IN with) (NP (NP (NN NF-κB) (NN inhibitor)) (, ,) (NP (NP (NP (NP (NN PDTC)) (CC and) (NP (NN dexamethasone))) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (NP (NN anti-CD3)) (ADVP (RB alone))))))) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 38) (NN ±) (QP (CD 5) (CC and) (CD 54))) (JJ ±) (NP (QP (CD 11) (CC versus) (CD 98)) (NN ±)) (CD 19) (NN pg/ml)) (, ,) (ADVP (RB respectively))) (: ;) (NP (NN P) (NN <) (CD 0.05)) (-RRB- -RRB-)))))))))) (. .)))
( (S (NP (NP (NP (NN LY294002)) (CC and) (NP (NN wortmannin))) (, ,) (NP (NP (RB as) (DT an) (NN inhibitor)) (PP (IN of) (NP (NN PI3K)))) (, ,)) (ADVP (RB also)) (ADVP (RB markedly)) (VP (VBD inhibited) (NP (NP (NP (DT the) (JJ anti-CD3-induced) (NN IL-17) (NN production)) (PP (IN in) (NP (NP (NN RA) (NNS PBMC)) (PRN (-LRB- -LRB-) (NP (CD 98) (NN ±) (QP (CD 19) (CC versus) (CD 38) (CD ±)) (CD 10) (NN pg/ml) (NN -LSB-P) (NN <) (CD 0.005)) (-RRB- -RSB-))))) (CC and) (NP (NP (CD 48) (NN ±) (CD 4) (NN pg/ml) (NN -LSB-P)) (PRN (QP (RB <) (CD 0.05)) (-RRB- -RSB-))) (, ,) (ADVP (RB respectively)) (-RRB- -RRB-))) (. .)))
( (S (S (NP (NP (DT The) (NN calcineurin) (NNS inhibitors)) (NP (NP (NN cyclosporin) (NN A)) (CC and) (NP (NN FK506)))) (ADVP (RB also)) (VP (VBD downregulated) (NP (NP (DT the) (NN IL-17) (NN secretion)) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NP (NP (DT the) (JJ mitogen-activated) (NN protein) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN MAPK)) (-RRB- -RRB-))) (NN p38) (NN inhibitor) (NN SB203580)) (VP (VBD did)))) (, ,) (SBAR (IN whereas) (S (NP (NP (NN rapamycin)) (CC and) (NP (NN PD98059))) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NN IL-17) (NNS levels)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 3)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (VP (TO To) (VP (VB evaluate) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (NP (JJ non-specific) (NN inhibition)) (PP (IN by) (NP (DT the) (NN drug))) (PP (IN at) (NP (JJ high) (NNS concentrations))))))))) (, ,) (NP (PRP we)) (VP (VBD observed) (NP (NP (DT the) (NN dose) (NN response)) (PP (IN of) (NP (NP (NN PDTC)) (CC and) (NP (NN LY294002)))) (PP (IN for) (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (NP (NN IL-17) (NN production)) (PP (IN in) (NP (NN PBMC))))))))) (. .)))
( (S (S (NP (EX There)) (VP (VBD were) (NP (NP (JJ dose-dependent) (NNS inhibitions)) (PP (IN of) (NP (NN IL-17) (NN production))) (PP (IN with) (NP (NP (JJ chemical) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 4a)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ other) (NNS inhibitors)) (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN PDTC)) (CC and) (NP (NN LY294002))))))) (VP (VBD showed) (NP (NP (DT the) (JJ same) (NN pattern)) (PP (IN of) (NP (NN inhibition)))))) (. .)))
( (S (S (NP (NP (JJ Cytotoxic) (NNS effects)) (PP (IN on) (NP (NN PBMC))) (PP (IN by) (NP (NP (DT the) (JJ chemical) (NNS inhibitors)) (PP (IN at) (NP (JJ experimental) (NNS concentrations)))))) (VP (VBD were) (RB not) (VP (VBN observed) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 4b)) (-RRB- -RRB-))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB see) (SBAR (IN whether) (S (NP (VBN enhanced) (NN IL-17) (NN production)) (VP (MD could) (VP (VB be) (VP (VBN regulated) (PP (IN at) (NP (DT a) (JJ transcriptional) (NN level))))))))))) (, ,) (NP (JJ semi-quantatitive) (JJ reverse) (NN transcription–polymerase) (NN chain) (NN reaction)) (VP (VBD was) (VP (VBN performed)))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD observed) (NP (NP (DT a) (JJ dose-dependent) (NN increase)) (PP (IN in) (NP (NN IL-17) (NN mRNA) (NNS transcripts)))) (PP (IN after) (NP (NP (NN stimulation)) (PP (IN with) (NP (NN anti-CD3))))))) (: ;) (S (NP (DT this)) (VP (VBD was) (VP (VBN inhibited) (PP (PP (IN by) (NP (DT the) (NN PI3K) (NN inhibitor) (NN LY294002))) (CC and) (PP (IN by) (NP (NP (DT the) (JJ NF-κB) (NN inhibitor) (NN PDTC)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 5)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB determine) (NP (NP (JJ downstream) (NN effector) (NNS molecules)) (PP (IN of) (NP (DT the) (NN PI3K) (NN pathway))))))) (, ,) (NP (PRP we)) (VP (VBD evaluated) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN Akt))) (PP (IN by) (NP (NN western) (NN blotting)))))) (. .)))
( (S (S (SBAR (IN As) (S (VP (VBN shown) (PP (IN in) (NP (NNP Fig.) (CD 6))) (, ,) (PP (IN at) (NP (NP (CD 10) (NN min)) (PP (IN of) (NP (NP (NN incubation)) (PP (IN with) (NP (NP (NP (NN anti-CD3)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN μg/ml)) (-RRB- -RRB-))) (CC or) (NP (NP (NN LY294002)) (PRN (-LRB- -LRB-) (NP (CD 20) (NN μM)) (-RRB- -RRB-)))))))))))) (, ,) (NP (NP (DT no) (NN difference)) (PP (IN in) (NP (NP (DT the) (NNS amounts)) (PP (IN of) (NP (JJ phosphorylated) (NN Akt)))))) (VP (VBD was) (VP (VBN observed)))) (. .)))
( (S (ADVP (RB However)) (, ,) (PP (IN after) (NP (NP (CD 30) (NN min)) (PP (IN of) (NP (NN incubation))))) (, ,) (S (S (NP (VBN phosphorylated) (NN Akt)) (VP (VP (VBD increased)) (PRN (-LRB- -LRB-) (NP (NNP lane) (CD 2)) (-RRB- -RRB-)))) (, ,) (CC and) (S (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN inhibition))) (PP (IN by) (NP (NP (NN LY294002)) (PRN (-LRB- -LRB-) (NP (NNP lane) (CD 3)) (-RRB- -RRB-))))) (VP (VBD reached) (NP (DT a) (NN peak)) (PP (IN at) (NP (CD 60) (NN min))) (, ,) (S (VP (VBG lasting) (PP (TO to) (NP (CD 120–240) (NN min)))))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (JJ non-phosphorylated) (NP (NP (NN Akt)) (CC and) (NP (NN β-actin)))) (VP (VBD remained) (ADJP (JJ unchanged) (ADVP (RB regardless) (PP (IN of) (NP (NN incubation) (NN time))))))) (. .)))
( (S (S (NP (NP (NN PHA)) (, ,) (NP (NN concanavalin) (NN A)) (CC and) (NP (NN IL-15))) (ADVP (RB also)) (VP (VBD demonstrated) (NP (NP (DT the) (JJ same) (NN effect)) (PP (IN on) (NP (JJ phosphorylated) (NN Akt)))) (SBAR (IN as) (S (VP (VBN shown) (PP (IN with) (NP (NP (NN anti-CD3)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (NP (NP (DT an) (NN inhibition)) (PP (IN by) (NP (NP (NN wortmannin)) (CC and) (NP (NN PDTC)))) (PP (CONJP (RB as) (RB well) (IN as)) (PP (IN by) (NP (NN LY294002))))) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (VP (TO To) (VP (VB investigate) (ADVP (RB further)) (NP (NP (DT the) (JJ intracellular) (NN signaling) (NN pathway)) (VP (VBN activated) (PP (IN by) (NP (NP (NP (NN anti-CD3)) (CC plus) (NP (NN anti-CD28))) (, ,) (NP (NN concanavalin) (NN A)) (, ,) (NP (NN PHA)) (CC and) (NP (NN IL-15))))))))) (, ,) (CC and) (S (ADJP (JJ responsible) (PP (IN for) (S (VP (VBG inducing) (NP (NN IL-17) (NN expression)))))) (, ,) (NP (PRP we)) (VP (VBD performed) (NP (NP (NP (DT an) (JJ electrophoretic) (NN mobility-shift) (NN assay)) (PRN (-LRB- -LRB-) (NP (NN EMSA)) (-RRB- -RRB-))) (PP (IN of) (NP (JJ NF-κB) (NN recognition) (NNS sites)))) (PP (IN in) (NP (NP (DT the) (NNS promoters)) (PP (IN of) (NP (NN IL-17))))))) (. .)))
( (S (SBAR (IN As) (S (VP (VBN shown) (PP (IN in) (NP (NNP Fig.) (NN 7a)))))) (, ,) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN from) (NP (NP (NN RA) (NN PBMC)) (VP (VBN stimulated) (PP (IN with) (NP (NP (NN anti-CD3)) (CC plus) (NP (NN anti-CD28)))))))) (PRN (-LRB- -LRB-) (NP (NNP lane) (CD 2)) (-RRB- -RRB-)) (VP (VBD demonstrated) (NP (NP (VBN increased) (NN binding)) (PP (IN of) (NP (NN NF-κB))) (PP (TO to) (NP (NN IL-17) (NNS promoters)))) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (NP (DT that)) (PP (IN of) (NP (NNS controls))))))) (PRN (-LRB- -LRB-) (NP (NNP lane) (CD 1)) (-RRB- -RRB-))) (. .)))
( (S (S (NP (DT A) (NN supershift) (NN assay)) (VP (VBD demonstrated) (NP (NP (VBN shifted) (NNS bands)) (PP (IN in) (NP (NP (NP (NP (NN p65)) (CC and) (NP (NN p50))) (PRN (-LRB- -LRB-) (NP (NNS lanes) (QP (CD 3) (CC and) (CD 4))) (-RRB- -RRB-))) (CONJP (RB not) (IN in)) (NP (NP (NN c-Rel)) (PRN (-LRB- -LRB-) (NP (NNP lane) (CD 5)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (S (PP (IN In) (NP (JJ normal) (NN PBMC))) (NP (DT the) (JJ same) (NN pattern)) (VP (VBD was) (VP (VBN observed)))) (, ,) (CC but) (S (NP (NP (DT the) (NN degree)) (PP (IN of) (NP (NP (JJ NF-κB) (NN activation)) (PP (IN by) (NP (NP (NN anti-CD3)) (CC plus) (NP (NN anti-CD28))))))) (VP (VBD was) (ADJP (RBR less) (JJ intense) (PP (IN than) (NP (NP (DT that)) (PP (IN in) (NP (NP (NN RA) (NNS PBMC)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 7b)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB confirm) (NP (NP (DT the) (NN link)) (PP (IN between) (NP (NP (NN PI3K) (NN activity)) (CC and) (NP (NN NF-κB)))))))) (, ,) (NP (PRP we)) (VP (VBD performed) (NP (NN EMSA)) (S (VP (TO to) (VP (VB determine) (NP (DT the) (JJ NF-κB) (NN binding) (NN activity)) (PP (IN after) (NP (NP (NN treatment)) (PP (IN with) (NP (CC both) (NP (NN LY294002)) (CC and) (NP (NN PDTC))))))))))) (. .)))
( (S (S (NP (DT Both) (NNS agents)) (VP (VBP block) (NP (NP (JJ NF-κB) (JJ DNA-binding) (NN activity)) (PP (IN in) (NP (DT the) (NN IL-17) (NN promoter)))) (PRN (-LRB- -LRB-) (NP (NP (NNP Fig.)) (NP (NN 7c))) (-RRB- -RRB-)))) (. .)))
( (S (S (NP (NP (NN Western) (NN blotting)) (PP (IN for) (NP (NN IκB-α)))) (VP (VBD showed) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (NN degradation)) (PP (IN of) (NP (NN IκB-α))))) (PP (IN by) (NP (NP (NN LY294002)) (CC and) (NP (NN PDTC))))) (PP (IN at) (NP (NP (DT the) (JJ same) (NN time)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 7c)) (-RRB- -RRB-)))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (DT the) (NN AP-1) (NN pathway)) (VP (VBD was) (RB not) (VP (VBN activated) (PP (IN by) (NP (NP (NN stimulation)) (PP (IN with) (NP (NP (NN anti-CD3)) (CC plus) (NP (NN anti-CD28)))))) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-))) (, ,) (S (VP (VBG demonstrating) (SBAR (IN that) (S (NP (NN NF-κB)) (VP (VBZ is) (NP (NP (DT the) (JJ main) (JJ intracellular) (NN signaling) (NN pathway)) (PP (IN in) (NP (NP (NN IL-17) (NN production)) (PP (IN by) (NP (NP (VBN activated) (NN PBMC)) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (NN RA))))))))))))))))) (. .)))
( (S (NP (NN Discussion))))
( (S (S (NP (NN IL-17)) (VP (VBD was) (ADVP (RB first)) (VP (VBN described) (PP (IN as) (NP (NP (DT a) (NN T) (NN cell) (NN product)) (PP (IN with) (NP (JJ proinflammatory) (NNS properties) (CD -LSB-5,22) (-RRB- -RSB-)))))))) (. .)))
( (S (S (NP (NN RA)) (VP (VBZ is) (VP (VBN characterized) (PP (IN by) (NP (NP (NP (NN hyperplasia)) (PP (IN of) (NP (JJ synovial) (NN lining) (NNS cells)))) (CC and) (NP (NP (DT an) (JJ intense) (NN infiltration)) (PP (IN by) (NP (JJ mononuclear) (NNS cells) (CD -LSB-23) (-RRB- -RSB-))))))))) (. .)))
( (S (S (S (NP (NP (JJ Proinflammatory) (NNS cytokines)) (PP (JJ such) (IN as) (NP (NP (NN IL-1)) (CC and) (NP (NN TNF-α))))) (VP (VBP are) (ADJP (JJ abundant) (PP (IN in) (NP (JJ rheumatoid) (NN synovium)))))) (, ,) (IN whereas) (S (NP (NP (DT the) (NN T) (JJ cell-derived) (NNS cytokines)) (, ,) (ADVP (RB especially)) (NP (NP (NN IL-4)) (CC and) (NP (NN interferon-γ))) (, ,)) (VP (VBP have) (ADVP (RB often)) (S (VP (VBD proved) (ADJP (JJ difficult) (S (VP (TO to) (VP (VB detect) (PP (IN in) (NP (NN RA) (NN synovium) (CD -LSB-24))))) (-RRB- -RSB-)))))))) (. .)))
( (S (S (SBAR (IN Although) (S (NP (NN T) (NNS cells)) (VP (MD may) (VP (VB have) (NP (DT a) (NN role)) (PP (IN in) (NP (NP (DT the) (NN augmentation)) (PP (IN of) (NP (JJ rheumatoid) (JJ synovial) (NN inflammation))))))))) (, ,) (NP (NP (DT the) (NN lack)) (PP (IN of) (NP (NN T) (JJ cell-derived) (NNS cytokines)))) (VP (VBZ has) (VP (VBN limited) (NP (PRP$ its) (NN importance))))) (. .)))
( (S (S (PP (IN In) (NP (DT this) (NN respect))) (, ,) (NP (NN IL-17)) (VP (VBZ is) (VP (VBG appealing) (SBAR (IN because) (S (NP (PRP it)) (VP (VBZ has) (VP (VBN been) (VP (VBN described) (PP (IN as) (NP (NP (DT a) (ADJP (NN T) (JJ cell-derived)) (NN cytokine)) (PP (IN with) (NP (JJ proinflammatory) (NNS properties))))))))))))) (. .)))
( (S (S (PP (IN In) (NP (PRP$ our) (NNS studies))) (, ,) (NP (PRP we)) (VP (VBD tried) (S (VP (TO to) (VP (VB evaluate) (SBAR (SBAR (WHADVP (WRB how)) (S (NP (NN IL-17) (NN production)) (VP (VBZ is) (VP (VBN regulated) (PP (IN in) (NP (NN RA) (NNS PBMC))))))) (, ,) (CC and) (SBAR (WHNP (WDT which)) (S (NP (NN signaling) (NN pathway)) (NP (PRP it) (VP (VBN used))))))))))) (. .)))
( (S (S (NP (NP (NNS Levels)) (PP (IN of) (NP (NN IL-17)))) (VP (VBD were) (VP (VBN found) (S (VP (TO to) (VP (VB be) (ADJP (ADJP (JJR higher)) (PP (IN in) (NP (NN RA) (JJ synovial) (NN fluid))) (PP (IN than) (FRAG (PP (IN in) (NP (JJ OA) (JJ synovial) (NN fluid) (CD -LSB-15))) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (EX there)) (VP (VBP are) (NP (NP (JJ few) (NNS data)) (ADJP (JJ available) (PP (IN on) (NP (DT the) (NNS agents)))) (SBAR (WHNP (WDT that)) (S (VP (VBP stimulate) (NP (NP (NN IL-17) (NN production)) (PP (IN in) (NP (NN RA)))) (, ,) (SBAR (IN although) (S (NP (NP (DT the) (JJS highest) (NN level)) (PP (IN of) (NP (NN IL-17) (NN production)))) (VP (MD can) (VP (VB be) (VP (VBN achieved) (PP (IN by) (NP (NP (JJ anti-CD3/anti-CD28) (NN stimulation)) (PP (IN in) (NP (JJ healthy) (NNS individuals) (CD -LSB-25) (-RRB- -RSB-)))))))))))))))) (. .)))
( (S (S (PP (IN In) (NP (PRP$ our) (NNS experiments))) (, ,) (NP (NP (NN PHA)) (PP (IN as) (NP (NP (NNS mitogens)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (ADJP (JJ anti-CD3/anti-CD28) (PP (IN for) (NP (NP (NN signaling)) (PP (IN through) (NP (DT the) (NN T) (NN cell) (NN receptor))))))) (, ,)))) (VP (VBD increased) (NP (NN IL-17) (NN production)) (PP (IN from) (NP (NN RA) (NN PBMC))) (PP (IN in) (NP (DT a) (JJ dose-dependent) (NN manner))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD found) (, ,) (PP (IN by) (NP (NP (DT a) (NN cell) (NN proliferation) (NN assay)) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))) (, ,) (SBAR (IN that) (S (NP (NP (DT this) (NN upregulation)) (PP (IN of) (NP (NN IL-17)))) (VP (MD might) (VP (VB be) (ADJP (JJ due) (PP (PP (TO to) (NP (VBN increased) (JJ cellular) (NN activity))) (CONJP (RB rather) (IN than)) (PP (TO to) (NP (JJ cellular) (NN proliferation))))))))))) (. .)))
( (S (S (NP (NN IL-17)) (VP (VBZ is) (VP (VBN produced) (ADVP (RB mainly)) (PP (IN by) (NP (VBN activated) (JJ CD4+) (NN T) (NNS cells)))) (, ,) (PP (ADVP (RB especially)) (PP (IN for) (NP (NN Th1/Th0) (NNS cells))) (, ,) (RB not) (NP (DT the) (NN Th2) (NN phenotype) (CD -LSB-26) (-RRB- -RSB-))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (PRP it)) (VP (MD can) (ADVP (RB also)) (VP (VB be) (VP (VBN produced) (PP (IN by) (NP (JJ CD8+) (NN T) (NNS cells))) (PP (IN via) (NP (NP (DT an) (NN IL-23) (VBG triggering) (NN mechanism)) (PP (IN in) (NP (JJ Gram-negative) (JJ pulmonary) (NN infection) (NN -LSB-14)))))))) (-RRB- -RSB-)) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NN IL-17) (NN production)) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN augmented) (PP (IN by) (NP (NP (NN T) (NNS cells)) (VP (VBG recognizing) (NP (NN type) (CD II) (NN collagen)) (PP (IN in) (NP (DT a) (JJ collagen-induced) (NN arthritis) (NN model) (CD -LSB-27)))))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (NP (DT A) (JJ complex) (NN interaction)) (PP (IN between) (NP (NP (NNS cells)) (PP (IN in) (NP (JJ inflamed) (NN RA) (NNS joints)))))) (VP (MD might) (VP (VB produce) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (JJ proinflammatory) (NP (NNS cytokines)) (CC and) (NP (NNS chemokines))) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB also)) (VP (VBP activate) (NP (JJ other) (NNS cells)) (PP (IN in) (NP (DT the) (NNS joints)))))))))))) (. .)))
( (S (PP (IN For) (NP (NN example))) (, ,) (NP (NN IL-17)) (VP (VBZ stimulates) (S (NP (JJ rheumatoid) (NNS synoviocytes)) (VP (TO to) (VP (VB secrete) (NP (NP (NP (JJ several) (NNS cytokines)) (PP (JJ such) (IN as) (NP (NP (NN IL-6)) (, ,) (NP (NN IL-8)) (CC and) (NP (NN tumor) (NN necrosis) (JJ factor-stimulated) (NN gene) (CD 6))))) (CONJP (RB as) (RB well) (IN as)) (NP (NN prostaglandin) (NN E2))) (PP (IN in) (NP (FW vitro) (NN -LSB-12,28,29) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (EX There)) (VP (VBP are) (ADVP (RB as) (RB yet)) (NP (NP (JJ few) (NNS data)) (ADJP (JJ available) (PP (IN on) (NP (NP (DT the) (NNS agents)) (SBAR (WHNP (WDT that)) (S (VP (VBP stimulate) (NP (NP (NN IL-17) (NN production)) (PP (IN in) (NP (NN RA))))))))))) (, ,) (SBAR (IN although) (S (NP (DT some) (NP (NP (NNS cytokines)) (PRN (-LRB- -LRB-) (NP (NP (NN IL-15)) (CC and) (NP (NN IL-23))) (-RRB- -RRB-)))) (VP (VBP have) (VP (VBN been) (VP (VBN known) (S (VP (TO to) (VP (VB regulate) (NP (NN IL-17) (NN production) (CD -LSB-13,14) (-RRB- -RSB-)))))))))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB therefore)) (VP (VBD investigated) (NP (NP (NP (DT the) (ADJP (FW in) (FW vitro)) (NN production)) (PP (IN of) (NP (NP (NN IL-17)) (PP (IN in) (NP (NP (NN RA) (NNS PBMC)) (VP (VBG responding) (PP (TO to) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (NNS cytokines/chemokines)) (CC and) (NP (NNS mitogens)))))))))))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NP (NN T) (NN cell) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN TCR)) (-RRB- -RRB-))) (NN ligation))) (S (VP (VBG using) (NP (JJ anti-CD3/anti-CD28)))))) (. .)))
( (S (S (NP (PRP$ Our) (NNS studies)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NN IL-15)) (CC and) (NP (NN MCP-1)) (CONJP (RB as) (RB well) (IN as)) (NP (NN TCR) (NN ligation))) (ADVP (RB significantly)) (VP (VBD increased) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NN IL-17))) (PP (IN in) (NP (NN RA) (NNS PBMC))))))))) (. .)))
( (S (S (S (VP (VBG Adding) (NP (NP (NN IL-15)) (CC or) (NP (NN MCP-1))) (PP (TO to) (NP (NN TCR) (NN ligation))))) (VP (VBD augmented) (NP (NN IL-17) (NN production)) (ADVP (RBR more) (RB markedly)))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NP (NN IL-1)) (CC and) (NP (NN TNF-α))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN known) (S (VP (VP (TO to) (VP (VB have) (NP (JJ proinflammatory) (NNS properties)))) (CC and) (VP (TO to) (VP (VB be) (VP (VBN increased) (PP (IN in) (NP (NN RA) (NNS joints)))))))))))) (, ,)) (VP (VBD did) (RB not) (VP (VB affect) (NP (NN IL-17) (NN production))))) (. .)))
( (S (S (S (NP (PRP$ Our) (NNS data)) (VP (VBD were) (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT a) (JJ recent) (NN report)) (SBAR (IN that) (S (NP (NN IL-15)) (VP (VBD triggered) (NP (NP (ADJP (FW in) (FW vitro)) (NN IL-17) (NN production)) (PP (IN in) (NP (NN PBMC)))))))))))) (, ,) (CC but) (S (NP (NN TNF-α)) (VP (VBD did) (RB not) (VP (VBP do) (ADVP (RB so)) (ADJP (JJ -LSB-13)))) (-RRB- -RSB-))) (. .)))
( (S (SBAR (IN Although) (S (NP (EX there)) (VP (VBD were) (NP (NP (DT no) (NNS data)) (SBAR (WHNP (WDT that)) (S (NP (NN MCP-1)) (ADVP (RB directly)) (VP (VBZ induces) (NP (NN T) (NN cell) (NN activation))))))))) (, ,) (NP (PRP it)) (VP (MD might) (VP (VB exert) (NP (NNS effects)) (PP (ADVP (RB indirectly)) (IN on) (NP (NN T) (NNS cells))) (PP (IN through) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NNS monocytes/macrophages))) (PP (IN in) (NP (NN PBMC) (NNS cultures))))))) (. .)))
( (S (S (SBAR (IN As) (S (VP (VBN reported) (PP (IN for) (NP (JJ normal) (NNS individuals) (CD -LSB-25) (-RRB- -RSB-)))))) (, ,) (NP (NP (NN T) (NN cell) (NN activation)) (PP (IN through) (NP (JJ anti-CD3/anti-CD28)))) (ADVP (RB also)) (VP (VBZ increases) (NP (NP (NN IL-17) (NN induction)) (PP (IN in) (NP (NN RA) (NNS PBMC)))))) (. .)))
( (S (S (SBAR (IN Although) (S (NP (NP (DT the) (NN signaling) (NN pathway)) (PP (IN for) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NNS cytokines/chemokines))) (PP (IN by) (NP (NN IL-17)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN documented) (ADVP (RB widely)) (S (NP (NN -LSB-8,30,31)))))) (-RRB- -RSB-))) (, ,) (NP (DT no) (NNS data)) (VP (VBP have) (VP (VBN been) (ADJP (JJ available) (PP (IN on) (SBAR (WHADVP (WRB how)) (S (NP (NN IL-17) (NN production)) (VP (MD can) (VP (VB be) (VP (VBN regulated) (PP (IN by) (NP (JJ certain) (NN signaling) (NNS pathways))))))))))))) (. .)))
( (S (S (PP (IN By) (S (VP (VBG using) (NP (NN signal) (NN transduction) (NNS inhibitors))))) (, ,) (NP (PRP we)) (ADVP (RB therefore)) (VP (VBD examined) (SBAR (WHNP (WDT which)) (S (NP (NN signaling) (NN pathway)) (VP (VBD was) (ADVP (RB mainly)) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NN IL-17))) (PP (IN in) (NP (NN RA) (NNS PBMC))))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD identified) (SBAR (IN that) (S (NP (NP (JJ anti-CD3-induced) (NN IL-17) (NN production)) (PP (IN in) (NP (NN RA) (NNS PBMC)))) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN hampered) (PP (IN by) (NP (NP (DT the) (NN PI3K) (NN inhibitor) (NN LY294002)) (CC and) (NP (NP (DT the) (JJ NF-κB) (NN inhibitor) (NN PDTC)) (PP (TO to) (NP (NP (JJ comparable) (NNS levels)) (PP (IN of) (NP (NP (JJ basal) (NN production)) (PP (IN without) (NP (NN stimulation)))))))))))))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB also)) (VP (VBD found) (SBAR (IN that) (S (NP (JJ anti-CD3-induced) (NN IL-17) (NN production)) (VP (VBD was) (VP (VBN downregulated) (PP (IN by) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NP (NN SB203580)) (, ,) (NP (DT a) (NN p38) (NN MAPK) (NN inhibitor)))))))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ interesting) (SBAR (IN that) (S (NP (NP (DT a) (NN series)) (PP (IN of) (NP (NN evidence)))) (VP (VBZ supports) (NP (NP (NN crosstalk)) (PP (IN between) (NP (NP (NN NF-κB)) (CC and) (NP (NN p38))))))))))) (. .)))
( (S (S (S (PP (IN In) (NP (NNS myocytes))) (, ,) (NP (NN IκB) (NN kinase-β)) (VP (VBZ is) (VP (VBN activated) (PP (IN by) (NP (NN p38) (NN -LSB-32))))) (-RRB- -RSB-)) (, ,) (CC and) (S (NP (DT the) (VBN activated) (NN p38)) (VP (MD can) (VP (VB stimulate) (NP (NN NF-κB)) (PP (IN by) (NP (NP (DT a) (NN mechanism)) (VP (VBG involving) (NP (NN histone) (NN acetylase) (JJ p300/CREB-binding) (NN protein) (NN -LSB-33) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (PRP$ Our) (NNS results)) (VP (VBD revealed) (SBAR (IN that) (S (NP (NP (NN p38) (NN MAPK)) (NN activation)) (VP (VBD was) (RB not) (VP (VBN affected) (PP (IN by) (NP (NN LY294002)))) (, ,) (SBAR (IN whereas) (S (NP (JJ NF-κB) (NN binding) (NN activity)) (VP (VBD was) (VP (VBN decreased) (PP (IN by) (NP (NP (NN LY294002)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD provided) (NP (NP (DT the) (NN evidence)) (PP (IN for) (NP (NP (DT a) (NN p38) (NN MAPK) (NN pathway)) (ADJP (JJ independent) (PP (IN of) (NP (NN PI3K) (NN activation))))))))))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ direct) (NN relationship)) (PP (IN between) (NP (NP (NN p38)) (CC and) (NP (NN NF-κB)))) (PP (IN for) (NP (NN IL-17) (NN production)))) (VP (VBZ needs) (S (VP (TO to) (VP (VB be) (VP (VBN studied) (PP (IN in) (NP (JJ future) (NNS experiments))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN search)) (PP (IN for) (NP (NP (DT a) (JJ downstream) (NN pathway)) (PP (IN of) (NP (NN PI3K)))))) (VP (VBD seemed) (S (VP (TO to) (VP (VB have) (NP (NP (NP (DT a) (JJ maximal) (NN response)) (PP (IN of) (NP (NP (NN Akt) (NN activation)) (PP (IN at) (NP (CD 1) (NN hour)))))) (CC and) (NP (NP (DT a) (JJ gradual) (NN loss)) (PP (IN of) (NP (NN activity))))) (PP (IN at) (NP (CD 2) (NNS hours)))))))) (. .)))
( (S (S (NP (DT The) (NN fact) (SBAR (IN that) (S (NP (NN Akt)) (VP (VBZ is) (VP (VBN phosphorylated) (PP (IN upon) (NP (JJ anti-CD3) (NN stimulation)))))))) (VP (VBZ suggests) (NP (NP (DT the) (JJ possible) (NN involvement)) (PP (IN of) (NP (NN PI3K))) (PP (IN in) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NN IL-17))) (PP (IN in) (NP (NN RA)))))))) (. .)))
( (S (PP (IN In) (NP (NP (NN view)) (PP (IN of) (NP (DT the) (NN fact) (SBAR (IN that) (S (NP (NN NF-κB)) (VP (VBD was) (ADVP (RB also)) (VP (VBN activated) (PP (IN by) (NP (NP (ADJP (JJ anti-CD3/anti-CD28))) (, ,) (NP (NN IL-15)) (CC or) (NP (NNS mitogens)))) (PP (IN in) (NP (PRP$ our) (NNS experiments))))))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (RBS most) (JJ likely) (SBAR (IN that) (S (NP (DT the) (JJ NF-κB) (NN pathway)) (VP (VBZ is) (ADVP (RB also)) (ADVP (RB actively)) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NN IL-17))) (PP (IN in) (NP (NN RA) (NNS PBMC))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (DT the) (NN AP-1) (NN signal) (NN transduction) (NN pathway)) (, ,) (NP (NP (DT another) (JJ important) (NN signaling) (NN pathway)) (PP (IN for) (NP (NNS cytokines/chemokines)))) (, ,)) (VP (VBD was) (RB not) (VP (VBN activated) (PP (IN in) (NP (PRP$ our) (NNS experiments))) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-))))) (. .)))
( (S (S (SBAR (IN Although) (S (NP (NP (NN PI3K)) (CC and) (NP (NP (PRP$ its) (JJ downstream) (NN kinase) (NN Akt)) (PP (IN in) (NP (NP (NN association)) (PP (IN with) (NP (NN NF-κB))))))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB deliver) (NP (NP (NN activating) (NNS signals)) (PP (IN in) (NP (JJ many) (NN cell) (NNS types)))))))))))) (, ,) (NP (NP (DT the) (NNS data)) (PP (IN on) (NP (DT the) (NN signal) (NN inducing) (NN IL-17)))) (VP (VBP are) (VP (VBG lacking)))) (. .)))
( (S (S (NP (PRP$ Our) (NNS data)) (ADVP (RB clearly)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NN PI3K/Akt)) (CC and) (NP (JJ resultant) (NN NF-κB) (NN activation))) (VP (MD could) (VP (VB be) (NP (DT an) (JJ important) (NN arbitrator)) (PP (IN of) (NP (NP (DT the) (NN upregulation)) (PP (IN of) (NP (NP (NN IL-17)) (PP (IN in) (NP (NN RA))))))) (, ,) (PP (IN on) (DT the) (NN basis) (IN of) (NP (NP (PRP$ our) (NNS experiments)) (VP (VBG showing) (NP (NP (JJ simultaneous) (NN blocking)) (PP (IN of) (NP (NP (JJ NF-κB) (NN binding) (NN activity)) (PP (IN in) (NP (DT the) (NN IL-17) (NN promoter))))) (PP (IN by) (NP (NP (NN PDTC)) (CC and) (NP (NN LY294002)))))))))))))) (. .)))
( (S (PP (VBG Considering) (NP (NP (PRP$ its) (JJ proinflammatory) (NNS activities)) (CC and) (NP (NP (JJ successful) (NN induction)) (PP (IN of) (NP (NP (NN anti-IL-17)) (PP (IN for) (NP (JJ ameliorating) (NN arthritis))))) (PP (IN in) (NP (NN animal) (NNS models) (CD -LSB-2,6,34-36) (-RRB- -RSB-)))))) (, ,) (S (VP (VBG understanding) (NP (DT the) (NN IL-17) (NN signaling) (NN pathway)))) (VP (VBZ is) (NP (NP (DT an) (JJ important) (NN element)) (PP (IN of) (S (VP (VBG developing) (NP (JJ new) (VBN targeted) (NNS therapies)) (PP (IN in) (NP (NN RA)))))))) (. .)))
( (S (NP (NNS Conclusions))))
( (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN detected) (NP (NP (DT a) (ADJP (RBR more) (JJ pronounced)) (NN production)) (PP (IN of) (NP (NN IL-17))) (PP (IN from) (NP (NN RA) (NN PBMC)))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (NN IL-15)) (CC and) (NP (NN MCP-1)) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NN stimulation)) (PP (IN by) (NP (JJ anti-CD3/anti-CD28))))))))))) (. .)))
( (S (NP (PRP We)) (VP (VBP have) (ADVP (RB also)) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (NN upregulation)) (PP (IN of) (NP (NN IL-17))) (PP (IN by) (NP (NP (VBN activated) (NN T) (NNS cells)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN RA)))))))) (VP (MD could) (VP (VB be) (NP (NP (DT the) (NN result)) (PP (IN of) (NP (NN activation)))) (PP (IN via) (NP (NP (DT the) (NN PI3K/Akt) (NN pathway)) (PP (IN with) (NP (JJ resultant) (NN NF-κB) (NN activation))))))))))) (. .)))
( (S (S (NP (PRP$ Our) (NNS data)) (VP (VP (VBP provide) (NP (NP (NNS insights)) (PP (IN into) (NP (NP (JJ cellular) (NNS mechanisms)) (PP (IN of) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (NN IL-17) (NN production)) (PP (IN in) (NP (NN RA))))))))))) (, ,) (CC and) (VP (VBP highlight) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN T) (NNS cells))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (ADVP (RB hitherto)) (VP (VBN been) (VP (VBN neglected) (PP (IN in) (NP (NN RA) (NN pathogenesis)))))))))))) (. .)))
( (S (S (PP (ADVP (RB Together)) (IN with) (NP (NP (JJ recent) (NNS data)) (PP (IN on) (NP (NP (DT the) (JJ successful) (NN introduction)) (PP (IN of) (NP (NN anti-IL-17))) (PP (IN in) (NP (NN RA))))))) (, ,) (NP (PRP$ our) (NNS results)) (VP (VBP have) (VP (VBN added) (NP (NP (NN information)) (PP (IN for) (NP (NP (DT the) (JJ future) (JJ molecular) (NN targeting)) (PP (IN of) (NP (NP (JJ new) (JJ therapeutic) (NNS applications)) (PP (IN in) (NP (NN RA))))))))))) (. .)))
( (S (NP (NNS Abbreviations))))
( (S (S (UCP (NP (NN AP-1)) (, ,) (NP (NP (NP (NP (NP (NN activator) (NN protein-1)) (: ;) (NP (NN BSA) (JJ =) (JJ bovine) (NN serum) (NN albumin)) (: ;) (NP (NN EMSA) (JJ =) (JJ electrophoretic) (NN mobility-shift) (NN assay)) (: ;) (NP (NN GAPDH) (JJ =) (NN glyceraldehyde-3-phosphate) (NN dehydrogenase)) (: ;) (NP (NN IL) (JJ =) (NN interleukin)) (: ;) (NP (NN MAPK) (JJ =) (JJ mitogen-activated) (NN protein) (NN kinase)) (: ;) (NP (NN MCP-1) (JJ =) (NN monocyte) (NN chemoattractant) (NN protein-1)) (: ;) (NP (NN MIP) (JJ =) (NN macrophage) (JJ inflammatory) (NN protein)) (: ;) (CD NF-κB)) (JJ =) (JJ nuclear) (NN factor) (NN κB)) (: ;) (NN OA) (JJ =) (NN osteoarthritis)) (: ;) (NP (NN PBMC) (JJ =) (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (: ;) (NP (NN PDTC) (JJ =) (NN pyrrolidine) (NN dithiocarbamate)) (: ;) (NP (NN PHA) (JJ =) (NN phytohemagglutinin)) (: ;) (NP (NN PI3K) (JJ =) (NN phosphoinositide) (NN 3-kinase)) (: ;) (NP (NN RA) (JJ =) (JJ rheumatoid) (NN arthritis)) (: ;) (NP (NN TGF) (JJ =) (NN transforming) (NN growth) (NN factor)) (: ;) (NP (NN Th) (JJ =) (NN T) (NN helper)) (: ;) (NP (NN TNF) (JJ =) (NN tumor) (NN necrosis) (NN factor))))) (. .)))
( (S (NP (VBG Competing) (NNS interests))))
( (S (S (NP (DT The) (NN author) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-)) (VP (VB declare) (SBAR (IN that) (S (NP (PRP they)) (VP (VBP have) (NP (DT no) (VBG competing) (NNS interests))))))) (. .)))
( (S (NP (NP (NNS Authors) (POS ')) (NNS contributions))))
( (S (S (NP (NN KWK)) (VP (VP (VBD performed) (NP (DT the) (JJ cellular) (JJ immune) (NN response) (NNS studies))) (CC and) (VP (VBD participated) (PP (IN in) (NP (DT the) (NNS immunoassays)))))) (. .)))
( (S (S (NP (NN MLC)) (VP (VP (VBD participated) (PP (IN in) (NP (NP (DT the) (NN design)) (PP (IN of) (NP (DT the) (NN study)))))) (CC and) (VP (VBD performed) (NP (DT the) (JJ statistical) (NN analysis))))) (. .)))
( (S (S (NP (NN MKP)) (VP (VBD participated) (PP (IN in) (NP (NP (DT the) (NN isolation)) (PP (IN of) (NP (DT the) (NNS cells))))))) (. .)))
( (S (S (NP (NN CHY)) (VP (VBN drafted) (NP (DT the) (NN manuscript)))) (. .)))
( (S (S (NP (NN SHP)) (VP (VBD participated) (PP (PP (IN in) (NP (DT the) (JJ molecular) (NN biology))) (CC and) (PP (IN in) (NP (DT the) (NN PCR)))))) (. .)))
( (S (S (NP (NN SHL)) (VP (VP (VBD conceived) (NP (DT the) (NN study))) (, ,) (VP (VBD participated) (PP (IN in) (NP (PRP$ its) (NP (NN design)) (CC and) (NP (NN coordination))))) (CC and) (VP (VBD helped) (PP (TO to) (NP (JJ draft) (DT the) (NN manuscript)))))) (. .)))
( (S (S (NP (NN HYK)) (VP (VBD helped) (PP (TO to) (NP (JJ draft) (DT the) (NN manuscript))))) (. .)))
( (S (S (NP (DT All) (NNS authors)) (VP (VP (VBN read)) (CC and) (VP (JJ approved) (NP (DT the) (JJ final) (NN manuscript))))) (. .)))
( (S (NP (NP (NN Figure)) (CC and) (NP (NN Table)) (NP (NNS captions)))))
( (S (NP (NP (NN Figure) (CD 1)) (: :) (NP (NP (NNS Levels)) (PP (IN of) (NP (NP (NP (NP (NN interleukin)) (PRN (-LRB- -LRB-) (NP (NN IL)) (-RRB- -RRB-))) (CD -17) (NN production)) (PP (IN in) (NP (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (PP (IN from) (NP (NP (NP (NNS patients)) (PP (IN with) (NP (JJ rheumatoid) (NN arthritis))) (PRN (-LRB- -LRB-) (NP (NN RA)) (: ;) (NP (NN n) (JJ =) (CD 24)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN osteoarthritis)) (PRN (-LRB- -LRB-) (NP (NN OA)) (-RRB- -RRB-)))) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 14)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ normal) (NNS individuals)) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 14)) (-RRB- -RRB-)))))))))) (. .))))
( (S (S (NP (DT Each) (JJ peripheral) (NN blood) (JJ mononuclear) (NN cell)) (VP (VBD was) (VP (VBN stimulated) (PP (IN for) (NP (NP (CD 24) (NNS hours)) (PP (PP (IN with)) (CC or) (PP (IN without) (NP (NP (NN phytohemagglutinin)) (PRN (-LRB- -LRB-) (NP (NP (NN PHA)) (: ;) (NP (CD 5) (NN μg/ml))) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NN IL-17)) (VP (VBD was) (VP (VBN measured) (PP (IN in) (NP (NN culture) (NNS supernatants))) (PP (IN by) (NP (JJ sandwich) (JJ enzyme-linked) (JJ immunosorbent) (NN assay)))))) (. .)))
( (S (S (NP (NNS Data)) (VP (VBP are) (VP (VBN expressed) (PP (IN as) (NP (NP (NN means)) (CC and) (NP (NN SEM))))))) (. .)))
( (S (S (NP (NP (CD One) (JJ representative) (NN result)) (PP (IN of) (NP (CD five) (JJ independent) (NNS experiments)))) (VP (VBZ is) (VP (VBN shown)))) (. .)))
( (S (S (NP (NP (NN Student) (POS 's)) (NN t-test)) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB compare) (NP (DT each) (NN group)))))))) (. .)))
( (S (S (S (ADVP (RB *)) (, ,) (NP (NN P)) (VP (JJ <) (NP (CD 0.05)))) (: ;) (S (NP (NN **)) (, ,) (NP (NN P)) (VP (JJ <) (NP (CD 0.001))))) (. .)))
( (S (NP (NP (NN Figure) (CD 2)) (: :) (NP (NP (NN Production)) (PP (IN of) (NP (NN interleukin) (-LRB- -LRB-) (NN IL) (-RRB- -RRB-) (CD -17))) (PP (IN by) (NP (NP (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN PBMC)) (-RRB- -RRB-))) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ rheumatoid) (NN arthritis)) (PRN (-LRB- -LRB-) (NP (NN RA)) (-RRB- -RRB-))))))))) (. .))))
( (S (NP (NP (LST (-LRB- -LRB-) (LS a) (-RRB- -RRB-)) (NN Production)) (PP (IN of) (NP (NN IL-17))) (PP (IN by) (NP (NN cytokine) (NN induction))) (. .))))
( (S (S (NP (NP (NN PBMC)) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (NN RA)))))) (VP (VBD were) (VP (VBN stimulated) (PP (IN for) (NP (CD 24) (NNS hours))) (PP (IN with) (NP (NP (NP (NN IL-15)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN ng/ml)) (-RRB- -RRB-))) (, ,) (NP (NP (NN IL-1β)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN ng/ml)) (-RRB- -RRB-))) (, ,) (NP (NP (NN tumor) (NN necrosis) (NN factor-α)) (PRN (-LRB- -LRB-) (NP (CD TNF-α) (: ;) (CD 10) (NN ng/ml)) (-RRB- -RRB-))) (, ,) (NP (NP (NN IL-18)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN ng/ml)) (-RRB- -RRB-))) (CC and) (NP (NP (NN transforming) (NN growth) (NN factor-β)) (PRN (-LRB- -LRB-) (NP (CD TGF-β) (: ;) (CD 10) (NN ng/ml)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (NNS Levels)) (PP (IN of) (NP (NN IL-17)))) (VP (VBD were) (VP (VBN measured) (PP (IN in) (NP (NN culture) (NNS supernatants))) (PP (IN by) (NP (JJ enzyme-linked) (JJ immunosorbent) (NN assay)))))) (. .)))
( (S (S (NP (DT Each) (NN value)) (VP (VBZ represents) (NP (NP (DT the) (NP (NN mean)) (CC and) (NP (NN SEM))) (PP (IN of) (NP (CD three) (JJ independent) (NNS experiments)))))) (. .)))
( (S (NP (NP (LST (-LRB- -LRB-) (LS b) (-RRB- -RRB-)) (NN Production)) (PP (IN of) (NP (NN IL-17))) (PP (IN by) (NP (NN chemokine) (NN induction))) (. .))))
( (S (S (NP (NN PBMC)) (VP (VBD were) (VP (VBN cultured) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (NP (NN monocyte) (NN chemoattractant) (NN protein-1)) (PRN (-LRB- -LRB-) (NP (NP (NN MCP-1)) (: ;) (NP (CD 10) (NN ng/ml))) (-RRB- -RRB-))) (, ,) (NP (NP (NN macrophage) (JJ inflammatory) (NN protein-1α)) (PRN (-LRB- -LRB-) (NP (NN MIP-1α) (: ;) (CD 10) (NN ng/ml)) (-RRB- -RRB-))) (, ,) (NP (NP (NN MIP-1β)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN ng/ml)) (-RRB- -RRB-))) (, ,) (NP (NP (NP (NP (NN IL-6)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN ng/ml)) (-RRB- -RRB-))) (CC and) (NP (NN IL-8))) (PRN (-LRB- -LRB-) (NP (CD 10) (NN ng/ml)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NN *)) (, ,) (NP (NN P)) (NP (JJR <) (CD 0.05))) (. .)))
( (S (NP (NP (NN Figure) (CD 3)) (: :) (S (NP (NP (NNS Effects)) (PP (IN of) (NP (NP (NN protein) (NN kinase) (NNS inhibitors)) (CC and) (NP (JJ anti-rheumatic) (NN drug)))) (PP (IN on) (NP (NN anti-CD3)))) (VP (VBD triggered) (NP (NP (NP (NP (NN interleukin)) (PRN (-LRB- -LRB-) (NP (NN IL)) (-RRB- -RRB-))) (CD -17) (NN production)) (PP (IN by) (NP (NP (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN PBMC)) (-RRB- -RRB-))) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ rheumatoid) (NN arthritis)))))))))) (. .))))
( (S (S (NP (NN PBMC)) (VP (VBN pretreated) (PP (IN for) (NP (CD 1) (NN hour))) (PP (IN with) (NP (NP (NP (NN pyrrolidine) (NN dithiocarbamate)) (PRN (-LRB- -LRB-) (NP (NN PDTC) (: ;) (CD 300) (NN μM)) (-RRB- -RRB-))) (, ,) (NP (NP (NN curcumin)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN μM)) (-RRB- -RRB-))) (, ,) (NP (NP (NP (NP (NP (NN LY294002)) (PRN (-LRB- -LRB-) (NP (CD 20) (NN μM)) (-RRB- -RRB-))) (, ,) (NP (NP (NN wortmannin)) (PRN (-LRB- -LRB-) (NP (CD 200) (NN nM)) (-RRB- -RRB-))) (, ,) (NP (NP (NN Cyclosporin) (NN A)) (PRN (-LRB- -LRB-) (NP (CD 500) (NN ng/ml)) (-RRB- -RRB-))) (, ,) (NP (NP (NN dexamethasone)) (PRN (-LRB- -LRB-) (NP (NN DEX) (: ;) (CD 100) (NN nM)) (-RRB- -RRB-))) (, ,) (NP (NP (NN FK506)) (PRN (-LRB- -LRB-) (NP (CD 100) (NN ng/ml)) (-RRB- -RRB-))) (, ,) (NP (NP (NN rapamycin)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN ng/ml)) (-RRB- -RRB-))) (, ,) (NP (NP (NN SB203580)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN nM)) (-RRB- -RRB-))) (CC or) (NP (NN PD98059))) (PRN (-LRB- -LRB-) (NP (CD 20) (NN μM)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (JJ anti-CD3) (NN antibody)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN μg/ml)) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (NP (NN Culture) (NN supernatant)) (VP (VBD was) (VP (VBN assayed) (PP (IN for) (NP (NN IL-17))) (SBAR (IN as) (S (VP (VBN described) (PP (IN in) (NP (DT the) (NP (NP (NNS Materials)) (CC and) (NP (NNS methods))) (NN section))))))))) (. .)))
( (S (S (NP (DT Each) (NN value)) (VP (VBZ represents) (NP (NP (DT the) (NP (NN mean)) (CC and) (NP (NN SEM))) (PP (IN of) (NP (CD three) (JJ independent) (NNS experiments)))))) (. .)))
( (S (S (S (ADVP (RB *)) (, ,) (NP (NN P)) (VP (JJ <) (NP (CD 0.05)))) (: ;) (S (NP (NN **)) (, ,) (NP (NN P)) (VP (JJ <) (NP (CD 0.005))))) (. .)))
( (S (NP (NP (NN Figure) (CD 4)) (: :) (NP (NP (JJ Dose-dependent) (NNS effects)) (PP (IN of) (NP (NP (NN LY294002)) (CC or) (NP (NP (NN pyrrolidine) (NN dithiocarbamate)) (PRN (-LRB- -LRB-) (NP (NN PDTC)) (-RRB- -RRB-))))) (PP (IN in) (NP (NP (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN PBMC)) (-RRB- -RRB-))) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ rheumatoid) (NN arthritis)) (PRN (-LRB- -LRB-) (NP (NN RA)) (-RRB- -RRB-))))))))) (. .))))
( (S (S (LST (-LRB- -LRB-) (LS a) (-RRB- -RRB-)) (NP (NP (NN Effect)) (PP (IN of) (NP (NNS inhibitors))) (PP (IN on) (NP (NN interleukin) (-LRB- -LRB-) (NN IL) (-RRB- -RRB-) (CD -17)))) (VP (VB release) (PP (IN by) (NP (NP (JJ anti-CD3-stimulated) (NN PBMC)) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (NN RA))))))))) (. .)))
( (S (S (NP (NP (-LRB- -LRB-) (NN b) (-RRB- -RRB-) (NNS Effects)) (PP (IN of) (NP (NP (NN LY294002)) (CC or) (NP (NN PDTC)))) (PP (IN on) (NP (NN PBMC) (NN viability))))) (. .)))
( (S (S (NP (NN PBMC)) (VP (VBD were) (VP (VBN cultured) (PP (IN at) (NP (NP (DT a) (NN concentration)) (PP (IN of) (NP (NP (CD 2) (NN ×) (CD 105) (NNS cells)) (PP (IN per) (NP (NN well))))))) (PP (IN with) (NP (NP (NP (NN medium)) (, ,) (NP (NN anti-CD3)) (, ,) (NP (NN anti-CD3)) (CC and) (NP (NN LY294002))) (CC or) (NP (NN PDTC)))) (PP (IN under) (NP (NP (DT the) (NNS conditions)) (VP (VBN described) (PP (IN in) (NP (DT the) (NP (NP (NNS Materials)) (CC and) (NP (NNS methods))) (NN section))))))))) (. .)))
( (S (PP (IN After) (NP (NP (CD 24) (NNS hours)) (PP (IN of) (NP (NN treatment))))) (, ,) (NP (NN cell) (NN viability)) (VP (VBD was) (VP (VP (VBN assessed) (PP (IN by) (NP (DT the) (NP (NN trypan) (JJ blue) (NN dye) (NN exclusion)) (NN method)))) (CC and) (VP (VBN expressed) (PP (IN as) (NP (NP (DT a) (NN percentage)) (PP (IN with) (NP (NP (DT the) (NN formula) (CD 100) (NN ×)) (PRN (-LRB- -LRB-) (NP (NP (NN number)) (PP (IN of) (NP (NP (JJ viable) (NN cells/number)) (PP (IN of) (NP (ADJP (CC both) (ADJP (JJ viable)) (CC and) (ADJP (JJ dead))) (NNS cells)))))) (-RRB- -RRB-))))))))) (. .)))
( (S (NP (NP (NN Figure) (CD 5)) (: :) (NP (NP (NNS Effects)) (PP (IN of) (NP (NP (NN LY294002)) (CC or) (NP (NP (NN pyrrolidine) (NN dithiocarbamate)) (PRN (-LRB- -LRB-) (NP (NN PDTC)) (-RRB- -RRB-))))) (PP (IN on) (NP (NP (NP (JJ anti-CD3) (JJ antibody-triggered) (NN interleukin) (-LRB- -LRB-) (NN IL) (-RRB- -RRB-) (CD -17)) (NN mRNA) (NN expression)) (PP (IN by) (NP (NP (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN PBMC)) (-RRB- -RRB-))) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ rheumatoid) (NN arthritis)))))))))) (. .))))
( (S (S (NP (NN PBMC)) (VP (VBD were) (VP (VBN cultured) (PP (IN with) (NP (NN medium))) (ADVP (ADVP (RB only)) (PRN (-LRB- -LRB-) (NP (NNP lane) (CD 1)) (-RRB- -RRB-))) (, ,) (NP (NP (NP (JJ anti-CD3) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NP (CD 1) (NN μg/ml)) (: ;) (NP (NNP lane) (CD 2))) (-RRB- -RRB-))) (, ,) (NP (NP (JJ anti-CD3) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NP (CD 10) (NN μg/ml)) (: ;) (NP (NNP lane) (CD 3))) (-RRB- -RRB-))) (, ,) (NP (NP (NP (NP (JJ anti-CD3) (NN antibody)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN μg/ml)) (-RRB- -RRB-))) (CC plus) (NP (NN LY294002))) (PRN (-LRB- -LRB-) (NP (NP (CD 20) (NN μM)) (: ;) (NP (NNP lane) (CD 4))) (-RRB- -RRB-))) (CC or) (NP (NP (NP (NP (JJ anti-CD3) (NN antibody)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN μg/ml)) (-RRB- -RRB-))) (CC plus) (NP (NN PDTC))) (PRN (-LRB- -LRB-) (NP (NP (CD 300) (NN μM)) (: ;) (NP (NNP lane) (CD 5))) (-RRB- -RRB-)))) (PP (IN for) (NP (CD 12) (NNS hours)))))) (: ;) (S (NP (NNP lane) (CD 6)) (VP (VBZ shows) (NP (DT a) (JJ negative) (NN control)))) (. .)))
( (S (S (NP (NP (JJ Total) (NN RNA)) (PRN (-LRB- -LRB-) (NP (CD 2) (NN μg)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN used) (PP (IN for) (NP (NN cDNA) (NN synthesis))) (PP (IN in) (NP (NP (DT a) (NN volume)) (PP (IN of) (NP (CD 20) (NN μl)))))))) (: ;) (S (NP (NP (CD 1) (NN μl)) (PP (IN of) (NP (DT the) (VBN synthesized) (NN cDNA)))) (VP (VBD was) (VP (VBN used) (PP (IN for) (NP (JJ reverse) (NN transcription–polymerase) (NN chain) (NN reaction))) (SBAR (IN as) (S (VP (VBN described))))))) (. .)))
( (S (S (NP (NP (NN PCR) (NN reaction) (NN product)) (PRN (-LRB- -LRB-) (NP (CD 25) (NN μl)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN separated) (PP (IN on) (NP (DT an) (NN agarose) (NN gel) (NN containing) (NN ethidium) (NN bromide)))))) (. .)))
( (S (S (NP (NP (DT The) (JJ relative) (NNS intensities)) (PP (IN of) (NP (DT the) (NNS bands)))) (VP (VBD were) (VP (VBN revealed) (PP (IN under) (NP (NN UV) (NN radiation)))))) (. .)))
( (S (S (NP (NN Figure) (CD 6)) (: :) (NP (NP (NP (NN Activation)) (PP (IN of) (NP (JJ phosphorylated) (NN Akt))) (PP (IN after) (NP (NP (NP (NN interleukin) (-LRB- -LRB-) (NN IL) (-RRB- -RRB-) (CD -17)) (NN induction)) (PP (IN by) (NP (JJ anti-CD3) (NN antibody)))))) (, ,) (CC and) (NP (NP (PRP$ its) (NN inhibition)) (PP (IN by) (NP (NN LY294002)))))) (. .)))
( (S (S (NP (JJ Peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (VP (VBD were) (VP (VBN cultured) (PP (IN with) (NP (NP (NN medium)) (ADVP (RB only)))) (PRN (-LRB- -LRB-) (NP (NNP lane) (CD 1)) (-RRB- -RRB-)) (, ,) (NP (NP (NP (JJ anti-CD3) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NP (CD 10) (NN μg/ml)) (: ;) (NP (NNP lane) (CD 2))) (-RRB- -RRB-))) (CC or) (NP (NP (NP (NP (JJ anti-CD3) (NN antibody)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN μg/ml)) (-RRB- -RRB-))) (CC plus) (NP (NN LY294002))) (PRN (-LRB- -LRB-) (NP (NP (CD 20) (NN μM)) (: ;) (NP (NNP lane) (CD 3))) (-RRB- -RRB-)))) (PP (IN for) (NP (CD 10–120) (NN min)))))) (. .)))
( (S (S (NP (NN Cell) (NNS lysates)) (VP (VBD were) (VP (VBN analyzed) (PP (IN for) (NP (NP (NN Akt) (NN activation)) (PP (IN by) (NP (NP (NN western) (NN blot) (NN analysis)) (PP (IN of) (NP (NP (ADJP (ADJP (JJ total)) (CC and) (ADJP (JJ Ser473-phosphorylated))) (NN Akt)) (PRN (-LRB- -LRB-) (NP (NN P-Akt)) (-RRB- -RRB-)))))))) (S (VP (VBG using) (NP (JJ specific) (NNS antibodies))))))) (. .)))
( (S (S (NP (NP (NNS Levels)) (PP (IN of) (NP (JJ phosphorylated) (NN Akt)))) (VP (VBD were) (VP (VBN compared) (PP (IN at) (NP (DT each) (NN time) (NN point))) (, ,) (PP (IN after) (NP (NP (NN normalization)) (PP (TO to) (NP (NP (NP (NN Akt)) (CC and) (NP (NN β-actin))) (PP (IN in) (NP (DT the) (JJ same) (NN sample)))))))))) (. .)))
( (S (S (NP (NP (DT A) (JJ representative) (NN example)) (PP (IN of) (NP (CD three) (JJ separate) (NNS experiments)))) (VP (VBZ is) (VP (VBN shown)))) (. .)))
( (S (NP (NP (NN Figure) (CD 7)) (: :) (NP (NP (NNS Effects)) (PP (IN of) (NP (NP (NN anti-CD3)) (CC plus) (NP (NN anti-CD28)))) (PP (IN on) (NP (NP (NP (JJ NF-κB) (NN complex)) (PP (IN in) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN of) (NP (NP (NP (NP (JJ rheumatoid) (NN arthritis)) (PRN (-LRB- -LRB-) (NP (NN RA)) (-RRB- -RRB-))) (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN PBMC)) (-RRB- -RRB-))))))) (CC and) (NP (JJ normal) (NN PBMC))))) (. .))))
( (S (NP (NP (LST (-LRB- -LRB-) (LS a) (-RRB- -RRB-)) (NP (JJ NF-κB) (NN activity)) (PP (IN in) (NP (NP (NP (DT the) (NN absence)) (PRN (-LRB- -LRB-) (NP (NNP lane) (CD 1)) (-RRB- -RRB-))) (CC or) (NP (NP (NN presence)) (PRN (-LRB- -LRB-) (NP (NNP lane) (CD 2)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NN anti-CD3)) (CC plus) (NP (JJ anti-CD28) (NN antibody))))))) (: ;) (NP (NP (NN supershift) (NN assay)) (PP (IN of) (NP (JJ NF-κB) (NN site))) (PP (IN with) (NP (NP (NNS antibodies)) (PP (IN against) (NP (NP (NP (NN p65)) (PRN (-LRB- -LRB-) (NP (NNP lane) (CD 3)) (-RRB- -RRB-))) (, ,) (NP (NP (NN p50)) (PRN (-LRB- -LRB-) (NP (NNP lane) (CD 4)) (-RRB- -RRB-))) (CC and) (NP (NP (NN c-Rel)) (PRN (-LRB- -LRB-) (NP (NNP lane) (CD 5)) (-RRB- -RRB-)))))))) (. .))))
( (S (S (NP (NP (NN PBMC)) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (NN RA)))))) (VP (VP (VBD were) (VP (VBN stimulated) (PP (IN with) (NP (NP (NN anti-CD3)) (CC plus) (NP (NN anti-CD28)))))) (CC and) (VP (VBD were) (VP (VBN used) (PP (IN for) (NP (DT the) (NN supershift) (NN assay))))))) (. .)))
( (S (NP (NP (-LRB- -LRB-) (NN b) (-RRB- -RRB-) (JJ NF-κB) (NN activity)) (PP (IN in) (NP (NP (NP (DT the) (NN absence)) (PRN (-LRB- -LRB-) (NP (NNP lane) (CD 1)) (-RRB- -RRB-))) (CC or) (NP (NP (NN presence)) (PRN (-LRB- -LRB-) (NP (NNP lane) (CD 2)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (JJ anti-CD3) (NN antibody)) (CC plus) (NP (NN anti-CD28)))))) (PP (IN in) (NP (JJ normal) (NN PBMC))) (. .))))
( (S (NP (NP (LST (-LRB- -LRB-) (LS c) (-RRB- -RRB-)) (NN NF-κB) (NN activity)) (PP (IN in) (NP (NP (NP (NP (DT the) (NN absence)) (PRN (-LRB- -LRB-) (NP (NNP lane) (CD 1)) (-RRB- -RRB-))) (CC or) (NP (NP (NN presence)) (PRN (-LRB- -LRB-) (NP (NNP lane) (CD 2)) (-RRB- -RRB-)))) (PP (IN of) (NP (NP (NP (NP (NN anti-CD3)) (, ,) (NP (NN anti-CD3)) (CC plus) (NP (NN LY294002))) (PRN (-LRB- -LRB-) (NP (NNP lane) (CD 3)) (-RRB- -RRB-))) (CC or) (NP (NP (NN anti-CD3)) (CC plus) (NP (NP (NN pyrrolidine) (NN dithiocarbamate)) (PRN (-LRB- -LRB-) (NP (NP (NN PDTC)) (: ;) (NP (NNP lane) (CD 4))) (-RRB- -RRB-)))))))) (. .))))
( (S (S (NP (NNS Arrows)) (VP (VB denote) (NP (NP (DT a) (JJ labeled) (NN oligonucleotide) (NN band)) (VP (VBN shifted) (PP (IN after) (NP (NN NF-κB) (NN binding))))))) (. .)))
( (S (S (NP (DT The) (JJR lower) (NN panel)) (VP (VBZ shows) (NP (NP (DT an) (NN immunoblot)) (PP (IN for) (NP (NP (NN IκB-α)) (CC and) (NP (NN actin))))) (PP (IN at) (NP (DT the) (JJ same) (NN time))))) (. .)))
( (S (NP (NP (NN Table) (CD 1)) (: :) (NP (NP (NN Production)) (PP (IN of) (NP (NP (NN interleukin-17)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (NN anti-CD3)) (CC and) (NP (NNS mitogens)))))))) (PP (IN by) (NP (NP (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (CC and) (NP (NN T) (NNS cells))) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ rheumatoid) (NN arthritis)))))))))))
( (S (NP (JJ Rheumatoid) (NN arthritis) (NN synovium)) (VP (VBZ contains) (NP (NN plasmacytoid) (JJ dendritic) (NNS cells)))))
( (S (NP (NN Abstract))))
( (S (S (NP (PRP We)) (VP (VBP have) (NP (NP (ADJP (RB previously) (VBN described)) (NN enrichment)) (PP (IN of) (NP (NP (JJ antigen-presenting) (JJ HLA-DR+) (JJ nuclear) (NN RelB+) (JJ dendritic) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNS DCs)) (-RRB- -RRB-))))) (PP (IN in) (NP (NP (NP (JJ rheumatoid) (NN arthritis)) (PRN (-LRB- -LRB-) (NP (NN RA)) (-RRB- -RRB-))) (NN synovium))))) (. .)))
( (S (S (NP (NP (NP (JJ CD123+HLA-DR+) (NN plasmacytoid) (NNS DCs)) (PRN (-LRB- -LRB-) (NP (NNS pDCs)) (-RRB- -RRB-))) (CC and) (NP (PRP$ their) (NNS precursors))) (VP (VBP have) (VP (VBN been) (VP (VBN identified) (PP (IN in) (NP (NP (NP (JJ human) (JJ peripheral) (NN blood)) (PRN (-LRB- -LRB-) (NP (NN PB)) (-RRB- -RRB-))) (, ,) (NP (JJ lymphoid) (NN tissue)) (, ,) (CC and) (NP (DT some) (JJ inflamed) (NNS tissues)))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD hypothesized) (NP (NP (NP (NN recruitment)) (PP (IN of) (NP (NN pDCs))) (PP (IN into) (NP (DT the) (JJ inflamed) (ADJP (NN RA) (JJ synovial)) (NN environment)))) (CC and) (NP (NP (PRP$ their) (NN contribution)) (PP (IN as) (NP (NP (NP (JJ antigen-presenting) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNS APCs)) (-RRB- -RRB-))) (CC and) (NP (JJ inflammatory) (NNS cells)))) (PP (IN in) (NP (NN RA))))))) (. .)))
( (S (S (NP (NP (JJ CD11c+) (JJ myeloid) (NNS DCs)) (CC and) (NP (JJ CD123+) (NNS pDCs))) (VP (VP (VBD were) (VP (VBN compared) (PP (IN in) (NP (NP (NP (ADJP (JJ normal))) (CC and) (NP (NN RA)) (NP (NN PB))) (, ,) (NP (NP (JJ synovial) (NN fluid)) (PRN (-LRB- -LRB-) (NP (NN SF)) (-RRB- -RRB-))) (, ,) (CC and) (NP (JJ synovial) (NN tissue)))) (PP (IN by) (NP (NP (NN flow) (NN cytometry)) (, ,) (NP (NN immunohistochemistry)) (, ,) (CC and) (NP (NN electron) (NN microscopy)))))) (CC and) (VP (VBD were) (VP (VBN sorted) (PP (IN for) (NP (JJ functional) (NNS studies))))))) (. .)))
( (S (S (NP (JJ Nuclear) (NN RelB-CD123+) (NNS DCs)) (VP (VBD were) (ADJP (JJ located) (PP (PP (IN in) (NP (NP (JJ perivascular) (NNS regions)) (PP (IN of) (NP (NN RA))))) (, ,) (PP (IN in) (NP (NP (DT a) (JJ similar) (NN frequency)) (PP (TO to) (NP (JJ nuclear) (JJ RelB+CD123-) (NNS DCs))))) (, ,) (CC but) (RB not) (NP (JJ normal) (JJ synovial) (NN tissue) (JJ sublining)))))) (. .)))
( (S (S (ADVP (RB Apart) (PP (IN from) (NP (NP (JJR higher) (NN expression)) (PP (IN of) (NP (NN HLA-DR)))))) (, ,) (NP (NP (DT the) (NP (NNS numbers)) (CC and) (NP (NNS phenotypes))) (PP (IN of) (NP (NN SF) (NNS pDCs)))) (VP (VBD were) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT those)) (PP (IN of) (NP (JJ normal) (NN PB) (NNS pDCs)))))))) (. .)))
( (S (SBAR (IN While) (S (NP (NP (DT the) (NN APC) (NN function)) (PP (IN of) (NP (NN PB) (NNS pDCs)))) (VP (VBD was) (ADJP (RBR less) (JJ efficient) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (NP (NN PB) (JJ myeloid) (NNS DCs))))))))) (, ,) (S (S (NP (NN RA) (NN SF) (NNS pDCs)) (VP (ADVP (RB efficiently)) (VBN activated) (S (VP (VBG resting) (NP (JJ allogeneic) (NN PB) (NN T) (NNS cells)))))) (, ,) (CC and) (S (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NP (NN IFN-γ)) (, ,) (NP (NN IL-10)) (, ,) (CC and) (NP (NN tumor) (NN necrosis) (NN factor) (CD α))))) (VP (VBD were) (VP (VBN produced) (PP (IN in) (NN response) (TO to) (NP (NP (NN incubation)) (PP (IN of) (NP (JJ allogeneic) (NN T) (NNS cells))) (PP (IN with) (NP (NP (DT either) (NN type)) (PP (IN of) (NP (NN SF) (NNS DCs)))))))))) (. .))))
( (S (S (ADVP (RB Thus)) (, ,) (NP (NNS pDCs)) (VP (VP (VBP are) (VP (VBN recruited) (PP (TO to) (NP (NN RA) (JJ synovial) (NN tissue))))) (CC and) (VP (VBP comprise) (NP (NP (DT an) (NN APC) (NN population)) (ADJP (JJ distinct) (PP (IN from) (NP (DT the) (ADJP (RB previously) (VBN described)) (JJ nuclear) (NN RelB+) (JJ synovial) (NNS DCs)))))))) (. .)))
( (S (S (NP (NN pDCs)) (VP (MD may) (VP (VB contribute) (ADVP (RB significantly)) (PP (TO to) (NP (DT the) (JJ local) (JJ inflammatory) (NN environment)))))) (. .)))
( (S (NP (NN Introduction))))
( (S (S (NP (NP (NN Plasmacytoid) (JJ dendritic) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNS pDCs)) (-RRB- -RRB-))) (VP (VBP are) (NP (NP (DT a) (JJ distinct) (NN population)) (PP (IN of) (NP (NP (NP (JJ antigen-presenting) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNS APCs)) (-RRB- -RRB-))) (PP (IN with) (NP (NP (DT the) (NN capacity)) (PP (IN for) (NP (NP (JJ potent) (JJ antigen-presenting) (NN function)) (CC and) (NP (NP (NN production)) (PP (IN of) (NP (NP (JJ large) (NNS amounts)) (PP (IN of) (NP (NP (NNS cytokines)) (, ,) (PP (VBG including) (NP (NP (NP (NP (NN tumor) (NN necrosis) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN TNF)) (-RRB- -RRB-))) (NN -α)) (CC and) (NP (NN IFN-α)))))))))))))))))) (. .)))
( (S (NP (JJ Human) (NNS pDCs)) (VP (MD can) (VP (VB be) (VP (VBN identified) (PP (IN by) (NP (NP (NP (JJ cell-surface) (NN expression)) (PP (IN of) (NP (NN MHC) (NNS molecules)))) (, ,) (NP (NP (DT the) (NN α-chain)) (PP (IN of) (NP (DT the) (NP (NP (NN IL-3) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN CD123)) (-RRB- -RRB-)))))) (, ,) (CC and) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (NP (NP (NN blood) (NN dendritic-cell)) (PRN (-LRB- -LRB-) (NP (NN DC)) (-RRB- -RRB-))) (NNS antigens)) (VP (VBN known) (PP (IN as) (NP (NP (NN BDCA2)) (CC and) (NP (NN BDCA4)))))))))) (PP (IN in) (NP (NP (DT a) (NN proportion)) (PP (IN of) (NP (NP (NNS cells)) (PRN (NN -LSB-1) (-RRB- -RSB-))))))))) (. .)))
( (S (S (PP (IN In) (NP (NP (NN comparison)) (PP (IN with) (NP (JJ CD11c+) (JJ myeloid) (NNS DCs))))) (, ,) (NP (NNS pDCs)) (VP (VBP display) (NP (NP (NP (DT a) (JJ distinct) (NN set)) (PP (IN of) (NP (NN chemokine)))) (CC and) (NP (JJ Toll-like) (NNS receptors)) (NP (NN -LSB-2-4)) (-RRB- -RSB-)))) (. .)))
( (S (S (PP (IN In) (NN response) (TO to) (NP (NP (NNS viruses)) (CC and) (NP (NN CpG) (NN DNA)))) (, ,) (S (NP (NNS pDCs)) (VP (VBP become) (VP (VBN activated) (S (VP (TO to) (VP (VB produce) (NP (NN IFN-α)))))))) (CC and) (S (NP (PRP$ their) (NN APC) (NN function)) (VP (VBZ is) (VP (VBN enhanced) (NP (CD -LSB-5-8) (-RRB- -RSB-)))))) (. .)))
( (S (S (SBAR (IN While) (S (NP (NNS pDCs)) (VP (VBD were) (ADVP (RB first)) (VP (VBN demonstrated) (PP (IN in) (NP (NP (DT the) (NN T-cell) (NNS areas)) (PP (IN of) (NP (NN lymph) (NNS nodes) (CD -LSB-5,9) (-RRB- -RSB-))))))))) (, ,) (NP (NP (NNS precursors)) (PP (IN of) (NP (DT this) (NN DC) (NN population)))) (VP (VBP have) (VP (VBN been) (VP (VBN isolated) (PP (IN from) (NP (NP (JJ several) (NNS sources)) (, ,) (PP (VBG including) (NP (NP (NP (JJ normal) (JJ peripheral) (NN blood)) (PRN (-LRB- -LRB-) (NP (NN PB)) (-RRB- -RRB-))) (, ,) (NP (NN thymus)) (, ,) (NP (JJ fetal) (NN liver)) (, ,) (CC and) (NP (NN bone) (NN marrow) (CD -LSB-10))))))))) (-RRB- -RSB-)) (. .)))
( (S (SBAR (IN Although) (S (NP (PRP they)) (VP (VBP do) (RB not) (VP (VB reside) (PP (IN in) (NP (JJ normal) (JJ peripheral) (NNS tissues))))))) (, ,) (S (NP (NNS pDCs)) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (NN infiltrate) (NP (NP (NP (JJ certain) (JJ inflamed) (NNS tissues)) (CC and) (NP (NN tumor) (NNS sites))) (, ,) (PP (VBG including) (NP (NP (NP (DT the) (NN skin)) (PP (IN in) (NP (NP (NN psoriasis)) (CC and) (NP (NN lupus))))) (, ,) (NP (NP (DT the) (JJ cerebrospinal) (NN fluid)) (PP (IN in) (NP (JJ multiple) (NN sclerosis)))) (, ,) (CC and) (NP (NP (NN melanoma)) (CC and) (NP (JJ ovarian) (NN carcinoma) (CD -LSB-11-15))) (-RRB- -RSB-)))))))))) (. .))))
( (S (S (SBAR (IN While) (S (NP (NNS pDCs)) (VP (VBP play) (NP (DT an) (JJ important) (NN effector) (NN role)) (PP (IN in) (NP (JJ viral) (NN disease))) (, ,) (S (VP (VP (VBG being) (NP (NP (DT the) (JJ major) (NNS producers)) (PP (IN of) (NP (NN IFN-α))))) (CC and) (VP (VBG having) (NP (NP (DT a) (JJ primary) (NN role)) (PP (IN in) (NP (JJ innate) (NN immunity)))))))))) (, ,) (NP (EX there)) (VP (VBZ is) (ADVP (RB also)) (NP (NN evidence) (SBAR (IN that) (S (NP (PRP they)) (VP (MD may) (VP (VB play) (NP (DT an) (JJ immunoregulatory) (NN role))))))) (, ,) (PP (IN through) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NP (NN Th2) (-LRB- -LRB-) (NP (NN T) (NN helper) (CD 2)) (-RRB- -RRB-) (JJ -type) (NNS cytokines)) (CD -LSB-9,16-18) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ synovial) (JJ autoimmune) (NN reaction)) (PP (IN of) (NP (NP (JJ rheumatoid) (NN arthritis)) (PRN (-LRB- -LRB-) (NP (NN RA)) (-RRB- -RRB-))))) (VP (VBZ is) (VP (VBN characterized) (PP (IN by) (NP (NP (NN lymphocyte) (, ,) (NN macrophage) (, ,) (CC and) (NN DC) (NN infiltration)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB progress) (PP (TO to) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ lymphoid) (NN tissue))) (PP (IN in) (NP (JJ established) (NN disease) (NN -LSB-19-21))) (-RRB- -RSB-)))))))))))) (. .)))
( (S (S (NP (NNS DCs)) (VP (VBP are) (ADJP (JJ likely) (S (VP (TO to) (VP (VB contribute) (PP (TO to) (NP (NP (DT the) (NP (NN formation)) (CC and) (NP (NN maintenance))) (PP (IN of) (NP (NP (PDT such) (VBN organized) (JJ lymphoid) (NN tissue)) (CC and) (NP (NN antigen) (NN presentation)))) (PP (IN in) (NP (NP (NN RA)) (CC and) (NP (JJ other) (NP (JJ autoimmune) (NNS lesions)) (CD -LSB-22-24) (-RRB- -RSB-)))))))))))) (. .)))
( (S (NP (PRP We)) (VP (VBP have) (ADVP (RB previously)) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (NN effector) (NN site)) (PP (IN in) (NP (NN RA) (JJ synovial) (NN tissue)))) (VP (VBZ is) (VP (VBN enriched) (PP (IN in) (NP (NP (VBN differentiated) (JJ myeloid) (NNS DCs)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP express) (NP (NP (NN CD33)) (, ,) (NP (NN CD11c)) (, ,) (NP (NN MHC) (CC and) (JJ costimulatory) (NNS molecules)) (, ,) (CC and) (NP (JJ nuclear) (NN RelB) (NN -LSB-21,25)))) (-RRB- -RSB-))))))))))) (. .)))
( (S (S (NP (NP (NN Translocation)) (PP (IN of) (NP (NN RelB))) (PP (TO to) (NP (NP (DT the) (NN nucleus)) (PP (IN of) (NP (JJ myeloid) (NNS DCs)))))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NN APC) (NN function))) (, ,) (PP (ADVP (RB particularly)) (IN through) (NP (NP (VBN increased) (NN expression)) (PP (IN of) (NP (NN MHC) (NNS molecules) (NP (NP (NN CD86)) (CC and) (NP (NN CD40) (NN -LSB-26))) (-RRB- -RSB-)))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ proinflammatory) (NNS cytokines)) (NP (NP (NN TNF-α)) (CC and) (NP (NN IL-1β)))) (VP (VBP are) (NP (NP (JJ key) (NNS contributors)) (PP (TO to) (NP (NP (DT the) (JJ inflammatory) (NN cytokine) (NN cascade)) (PP (IN in) (NP (NN RA) (CD -LSB-27,28))))))) (-RRB- -RSB-)) (. .)))
( (S (S (S (NP (DT This)) (VP (VBZ relates) (PP (TO to) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NNS actions))))))) (, ,) (CC but) (S (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NN endothelium))) (PP (IN by) (NP (NN TNF-α)))) (VP (VBZ is) (ADJP (RB particularly) (JJ important) (PP (IN in) (NP (NP (JJ cellular) (NN recruitment)) (PP (TO to) (NP (DT the) (NN synovium) (CD -LSB-29-31) (-RRB- -RSB-))))))))) (. .)))
( (S (S (SBAR (IN Since) (S (NP (NN RA)) (VP (VBZ is) (VP (VBN characterized) (PP (IN by) (NP (NP (JJ endothelial) (NN activation)) (, ,) (NP (NN leukocyte) (NN recruitment)) (, ,) (CC and) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ high) (JJ endothelial) (NNS venules)))))))))) (, ,) (NP (PRP we)) (VP (VBD hypothesized) (SBAR (IN that) (S (NP (NNS pDCs)) (VP (MD would) (VP (VB be) (VP (VBN enriched) (PP (IN in) (NP (ADJP (ADJP (JJ inflamed)) (CONJP (CC but) (RB not)) (ADJP (JJ normal))) (NN synovium)))))))))) (. .)))
( (S (SBAR (IN Since) (S (NP (NP (DT the) (JJ functional) (NN role)) (PP (IN of) (NP (NN pDCs))) (PP (IN in) (NP (NN disease) (NN pathogenesis)))) (VP (VBZ is) (ADVP (RB only) (RB partly)) (VP (VBN understood))))) (, ,) (NP (PRP we)) (ADVP (RB also)) (VP (VBD wished) (S (VP (TO to) (VP (VB address) (SBAR (SBAR (IN whether) (S (NP (DT these) (NNS cells)) (VP (VBP represent) (NP (NP (DT a) (NN population)) (ADJP (JJ distinct) (PP (IN from) (NP (DT the) (VBN described) (JJ nuclear) (NN RelB+) (JJ synovial) (NNS DCs)))))))) (, ,) (CC and) (SBAR (IN whether) (S (NP (PRP they)) (VP (MD may) (VP (VB contribute) (PP (IN as) (NP (NP (NNS APCs)) (CC or) (NP (JJ inflammatory) (NNS cells)))) (PP (IN in) (NP (NN RA) (CD -LSB-21) (-RRB- -RSB-)))))))))))) (. .)))
( (S (NP (NP (NNS Materials)) (CC and) (NP (NNS methods)))))
( (S (S (NP (NP (CD Thirty) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD fulfilled) (NP (NP (DT the) (NP (NP (NNP American) (NN College)) (PP (IN of) (NP (NN Rheumatology)))) (NNS criteria)) (PP (IN for) (NP (NN RA)))))))) (VP (VBD were) (VP (VBN included) (NP (CD -LSB-32) (-RRB- -RSB-))))) (. .)))
( (S (S (PP (IN Of) (NP (DT these))) (, ,) (S (NP (CD 10)) (VP (VBD provided) (NP (NP (NP (JJ synovial) (NN fluid)) (PRN (-LRB- -LRB-) (NP (NN SF)) (-RRB- -RRB-))) (NNS samples)))) (CC and) (S (NP (CD 27)) (VP (VBD provided) (NP (NN PB) (NNS samples))))) (. .)))
( (S (S (PP (IN Of) (NP (DT the) (CD 30) (NNS patients))) (, ,) (S (NP (CD 80) (NN %)) (VP (VBD were) (ADJP (JJ seropositive)))) (, ,) (S (NP (CD 62) (NN %)) (VP (VBD were) (NP (NN female)))) (, ,) (CC and) (S (NP (CD 73) (NN %)) (VP (VBD were) (VP (VBG taking) (NP (NP (QP (IN at) (JJS least) (CD one)) (JJ disease-modifying) (NN antirheumatic) (NN drug)) (CC or) (NP (NP (JJ low-dose) (NN prednisone)) (CC or) (NP (DT both)))))))) (. .)))
( (S (S (NP (JJ Synovial) (NN tissue)) (VP (VBD was) (VP (VBN obtained) (PP (IN at) (NP (NN arthroscopy))) (PP (IN from) (NP (NP (CD seven) (NNS patients)) (PP (IN with) (NP (NN RA))))) (, ,) (SBAR (WHPP (IN of) (WHNP (WP whom))) (S (S (NP (CD three)) (VP (VBD were) (ADJP (JJ untreated)))) (CC and) (S (NP (CD four)) (VP (VBD were) (VP (VBG taking) (NP (NP (QP (IN at) (JJS least) (CD one)) (JJ disease-modifying) (NN antirheumatic) (NN drug)) (CC and) (NP (JJ low-dose) (NN prednisone))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN duration)) (PP (IN of) (NP (NN disease)))) (VP (VBD ranged) (PP (IN from) (NP (QP (CD 0.5) (TO to) (CD 18)) (NNS years))))) (. .)))
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBD studied) (NP (NP (JJ synovial) (NN tissue)) (PP (IN from) (NP (NP (CD four) (JJ healthy) (NNS individuals)) (PP (IN with) (NP (NP (JJ nonspecific) (NN knee) (NN pain)) (VP (VBG undergoing) (NP (NP (NN arthroscopy)) (, ,) (NP (NP (CD one) (NN patient)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBD had) (NP (NP (JJ psoriatic) (NN arthritis)) (PP (IN for) (NP (CD 8) (NNS years))))))))) (, ,) (CC and) (NP (NP (CD one) (NN patient)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBD had) (NP (NP (JJ ankylosing) (NNS spondylitis)) (PP (IN for) (NP (CD 30) (NNS years))))))))))))))))) (. .)))
( (S (S (NP (NP (DT Each) (NN patient)) (PP (IN with) (NP (NN spondyloarthropathy)))) (VP (VBD was) (VP (VBG taking) (NP (NN sulfasalazine))))) (. .)))
( (S (S (NP (NP (DT No) (NN patient)) (PP (IN in) (NP (DT the) (NN study)))) (VP (VBD was) (VP (VBG taking) (NP (NN biologics))))) (. .)))
( (S (S (NP (JJ Synovial) (NN tissue)) (VP (VBD was) (VP (VBN provided) (PP (IN by) (NP (NP (NN Dr) (NNP Malcolm) (NNP Smith)) (PRN (-LRB- -LRB-) (NP (NP (NNP Repatriation) (NNP Hospital)) (, ,) (NP (NN Adelaide)) (, ,) (NP (NNP Australia))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (NN PB) (JJ buffy) (NNS coats)) (VP (VBN prepared) (PP (IN from) (NP (CD 30) (JJ healthy) (NNS donors))))) (VP (VBD were) (VP (VBN obtained) (PP (IN from) (NP (NP (NP (DT the) (JJ Red) (NN Cross) (NN Blood) (NN Transfusion)) (NN Service)) (PRN (-LRB- -LRB-) (NP (NP (NNP Brisbane) (, ,) (NNP QLD)) (, ,) (NP (NNP Australia))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (DT The) (NN study)) (VP (VBD was) (ADJP (JJ approved) (PP (IN by) (NP (NP (DT the) (NN Research) (NN Ethics) (NN Committee)) (PP (IN of) (NP (DT the) (NN Princess) (NN Alexandra) (NN Hospital)))))))) (. .)))
( (S (S (NP (DT All) (NNS cells)) (VP (VBD were) (VP (VBN cultured) (PP (IN in) (NP (NP (NP (NN RPMI) (CD 1640)) (PRN (-LRB- -LRB-) (NP (NP (NNP Gibco)) (, ,) (NP (NN Life) (NNS Technologies)) (, ,) (NP (NNP Mulgrave) (, ,) (NN VIC) (, ,) (NNP Australia))) (-RRB- -RRB-))) (VP (VBN supplemented) (PP (IN with) (NP (NP (NP (ADJP (CD 10) (NN %)) (NN FCS)) (PRN (-LRB- -LRB-) (NP (NP (NN CSL)) (NP (NP (NNP Ltd) (, ,) (NNP Parkville)) (, ,) (NP (NN VIC)) (, ,) (NP (NNP Australia)))) (-RRB- -RRB-))) (, ,) (NP (NP (CD 0.3) (NN mg/ml) (NN L-glutamine)) (PRN (-LRB- -LRB-) (NP (NN Trace) (NNP Biosciences) (, ,) (NNP Castle) (NNP Hill) (, ,) (NNP NSW) (, ,) (NNP Australia)) (-RRB- -RRB-))) (, ,) (NP (NP (NN 0.12) (NN mg/ml) (NN benzylpenicillin)) (PRN (-LRB- -LRB-) (NP (NN CSL)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (ADJP (CD 10) (NN μg/ml)) (NN gentamicin)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN Delta) (NNP West) (, ,) (NNP Pharmacia)) (CC and) (NP (NNP Upjohn))) (, ,) (NP (NN Spring) (NN Hill)) (, ,) (NP (NNP QLD) (, ,) (NNP Australia))) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ monoclonal) (NNS antibodies)) (VP (VBN used) (PP (IN in) (NP (DT this) (NN study))))) (VP (VBP include) (NP (NP (NN FITC)) (, ,) (NP (NP (NN phycoerythrin)) (PRN (-LRB- -LRB-) (NP (NN PE)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (VBN purified) (NN anti-CD11c)) (PRN (, ,) (NP (NP (NN CD14-PerCP)) (, ,) (NP (NP (NN PE)) (, ,) (VP (VP (VP (VBN biotinylated)) (CC and) (VP (VBN purified) (NP (NP (NN anti-CD123)) (, ,) (NP (NP (NN CD86-FITC)) (PRN (-LRB- -LRB-) (NP (NP (NN all)) (PP (IN from) (NP (NNP BD) (NNP Pharmingen) (, ,) (NNP San) (NNP Diego) (, ,) (NN CA) (, ,) (NN USA) (-RRB- -RRB-) (, ,) (NP (NP (NP (NN BDCA2-FITC)) (PRN (-LRB- -LRB-) (NP (NNP Miltenyi) (NNP Biotech) (, ,) (NNP San) (NNP Francisco) (, ,) (NP (NN CA)) (, ,) (NP (NNP USA))) (-RRB- -RRB-))) (, ,) (NP (NP (NN HLA-DR-biotin)) (PRN (-LRB- -LRB-) (NP (NNP Coulter) (NNP Immunotech) (, ,) (NNP Fullerton) (, ,) (NP (NN CA)) (, ,) (NP (NNP USA))) (-RRB- -RRB-))) (, ,) (NP (NP (NN CD40-FITC)) (PRN (-LRB- -LRB-) (NP (NNP Biolegend) (, ,) (NNP San) (NNP Diego) (, ,) (NP (NN CA)) (, ,) (NP (NNP USA))) (-RRB- -RRB-))) (, ,) (NP (NP (NN CD80-FITC)) (PRN (-LRB- -LRB-) (NP (NP (NNP Cymbus) (NNP Biotech) (, ,) (NNP Chandlers) (NNP Ford)) (, ,) (NP (NNP Hants) (, ,) (NNP UK))) (-RRB- -RRB-))) (, ,) (NP (NN CD68) (-LRB- -LRB-) (NN Kp-1) (, ,) (NN DAKO) (, ,) (NNP Carpinteria)) (, ,) (NP (NN CA)) (, ,)) (NN USA)))) (-RRB- -RRB-))) (, ,) (NP (NP (NN RelB)) (PRN (-LRB- -LRB-) (NP (NP (NN C-19)) (, ,) (NP (NNP Santa) (NNP Cruz) (NNP Biotech) (, ,) (NNP Santa) (NNP Cruz)) (, ,) (NP (NN CA)) (, ,) (NP (NN USA))) (-RRB- -RRB-))) (, ,) (CC and) (NP (VBN biotinylated) (NN Ulex) (NN europaeus) (NN agglutinin) (CD I))))) (-LRB- -LRB-) (NP (NN Vector) (NNS Laboratories)))) (, ,) (NP (NNP Burlingame) (, ,) (NN CA) (, ,) (NNP USA))) (-RRB- -RRB-)))))) (. .)))
( (S (NP (JJ Mononuclear) (NNS cells)) (VP (VBD were) (VP (VBN prepared) (PP (IN from) (NP (JJ normal) (CC or) (NN RA) (NN PB) (CC or) (NN RA) (NN SF))) (PP (IN by) (NP (NP (NN density) (NN gradient) (NN centrifugation)) (PP (IN over) (NP (NP (NN Ficoll-Paque)) (PRN (-LRB- -LRB-) (NP (NNP Pharmacia) (NNP Biotech) (, ,) (NNP Uppsala) (, ,) (NNP Sweden)) (-RRB- -RRB-)))))) (PP (IN as) (NP (VBN described) (NN elsewhere) (CD -LSB-33) (-RRB- -RSB-))))) (. .)))
( (S (S (NP (NN T) (NNS cells)) (VP (VBD were) (VP (VBN purified) (PP (IN from) (NP (NN PB) (JJ mononuclear) (NNS cells))) (PP (IN by) (S (VP (VBG passing) (NP (DT the) (NNS cells)) (PP (IN over) (NP (NP (DT a) (NN nylon) (NN wool) (NN column)) (, ,) (VP (VBN followed) (PP (IN by) (NP (NP (JJ immunomagnetic) (NN depletion)) (PP (IN of) (NP (NP (VBG remaining) (NNS monocytes)) (, ,) (NP (NNS DCs)) (, ,) (NP (NN B) (NNS cells)) (, ,) (CC and) (NP (NN NK) (PRN (-LRB- -LRB-) (NP (JJ natural) (NN killer)) (-RRB- -RRB-)) (NNS cells)))))) (S (VP (VBG using) (NP (NP (JJ monoclonal) (NNS antibodies)) (PP (IN against) (NP (NP (NN CD14)) (, ,) (NP (NN CD16)) (, ,) (NP (NN CD19)) (, ,) (NP (NN CD56)) (, ,) (CC and) (NP (NP (NN HLA-DR)) (PRN (-LRB- -LRB-) (NP (NP (NN all)) (PP (IN from) (NP (NNP BD) (NNP Pharmingen)))) (-RRB- -RRB-))))))))) (, ,) (VP (VBN followed) (PP (IN by) (NP (NP (NN goat) (NN antimouse) (NN immunoglobulin) (JJ magnetic) (NNS beads)) (, ,) (ADVP (RB then)) (NP (NP (NP (NN passage)) (PP (IN through) (NP (NP (DT a) (JJ strong) (JJ magnetic) (NN field)) (PRN (-LRB- -LRB-) (NP (NN MACS) (, ,) (NNP Miltenyi) (NNP Biotech)) (-RRB- -RRB-))))) (, ,) (CC and) (NP (NP (NN collection)) (PP (IN of) (NP (DT the) (JJ unbound) (NN fraction)))))))))))))))) (. .)))
( (S (S (PP (IN On) (NP (NP (NN analysis)) (PP (IN by) (NP (NN flow) (NN cytometry))))) (, ,) (NP (DT the) (JJ unbound) (NN fraction)) (ADVP (RB routinely)) (VP (VBD contained) (NP (ADJP (CD 95–98) (NN %)) (JJ CD3+) (NN T) (NNS cells)))) (. .)))
( (S (S (NP (JJ DC-enriched) (JJ non-T) (NNS cells)) (VP (VBD were) (VP (VBN produced) (PP (IN by) (NP (NP (JJ immunomagnetic) (NN depletion)) (PP (IN of) (NP (NP (NP (NP (NN T)) (, ,) (NP (NN B)) (, ,) (CC and) (NP (NN NK))) (NNS cells)) (PP (IN from) (NP (JJ non-T) (NNS cells))))))) (, ,) (PP (IN by) (NP (NP (NN incubation)) (PP (IN with) (NP (NP (JJ monoclonal) (NNS antibodies)) (PP (IN against) (NP (NP (NN CD19)) (, ,) (NP (NN CD16)) (, ,) (NP (NN CD56)) (, ,) (CC and) (NP (NN CD3))))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB enumerate) (NP (NP (ADJP (ADJP (JJ CD123+)) (CC and) (ADJP (JJ CD11c+))) (NNS subsets)) (PP (IN of) (NP (NN DCs))))))) (, ,) (NP (NP (JJ mononuclear) (NNS cells)) (PP (IN from) (NP (NP (JJ normal) (NN PB)) (CC or) (NP (NN RA) (NN SF))))) (VP (VBD were) (VP (VBN stained) (PP (IN for) (NP (JJ four-colour) (NN flow) (NN cytometry)))) (SBAR (IN as) (S (VP (VBN described) (NP (NN elsewhere) (CD -LSB-33) (-RRB- -RSB-)) (, ,) (S (VP (VBG using) (NP (NP (JJ monoclonal) (NNS antibodies)) (PP (IN against) (NP (NP (NN CD14-PECy5)) (, ,) (NP (NN CD11c-FITC)) (, ,) (NP (NN CD123-PE)) (, ,) (CC and) (NP (NN HLA-DR-APC)))))))))))) (. .)))
( (S (S (NP (JJ Live) (JJ CD14-HLA-DR+) (JJ mononuclear) (NNS cells)) (VP (VBD were) (VP (VBN gated) (PP (IN for) (NP (NN analysis)))))) (. .)))
( (S (S (NP (NN Subset) (NNS percentages)) (VP (VBP are) (VP (VBN expressed) (PP (IN as) (NP (NP (NN percentage)) (PP (IN of) (NP (JJ total) (JJ mononuclear) (NNS cells)))))))) (. .)))
( (S (S (NP (NN Listmode) (NNS data)) (VP (VBD were) (VP (VBN analyzed) (S (VP (VBG using) (NP (NN Winlist) (CD 2.0) (NN software)))) (PRN (-LRB- -LRB-) (NP (NN Verity) (NN Software) (NN House)) (, ,) (NP (NP (NNP Topsham)) (, ,) (NP (NNP ME) (, ,) (NNP USA))) (-RRB- -RRB-))))) (. .)))
( (S (S (PP (IN For) (NP (NN sorting))) (, ,) (NP (NP (NN PB) (CC or) (NN SF) (JJ DC-enriched) (JJ non-T) (NNS cells)) (VP (VBN stained) (PP (IN with) (NP (DT the) (JJ same) (CD four) (NNS markers))))) (VP (VBD were) (VP (VBN sorted) (S (VP (VBG using) (NP (NP (DT the) (NN Moflo) (NN flow) (NN cytometer)) (PRN (-LRB- -LRB-) (NP (NN DAKO)) (-RRB- -RRB-))) (, ,) (PP (VBG gating) (PP (IN on) (NP (ADJP (ADJP (JJ CD14-HLA-DR+)) (CC and) (ADJP (CC either) (ADJP (JJ CD123+CD11c-)) (CC or) (ADJP (JJ CD11c+CD123-)))) (NNS cells)))) (, ,) (ADVP (RB respectively))))))) (. .)))
( (S (S (PP (IN For) (NP (JJ phenotypic) (NN analysis))) (, ,) (NP (NP (JJ mononuclear) (NNS cells)) (PP (IN from) (NP (NP (NN PB)) (CC or) (NP (NN SF))))) (VP (VBD were) (VP (VBN stained) (PP (IN with) (NP (NP (NN CD14-PECy5)) (, ,) (NP (NP (NN CD123-PE)) (CC or) (NP (NN CD11c-PE))) (, ,) (NP (NN HLA-DR-APC)) (, ,) (CC and) (NP (NP (CC either) (NP (DT a) (JJ fourth) (JJ monoclonal) (NN antibody)) (CC or) (NP (NN isotype) (NN control)) (NP (JJ monoclonal) (NN antibody))) (VP (VBN conjugated) (PP (IN with) (NP (NN FITC)))))))))) (. .)))
( (S (S (NP (NNS DCs)) (VP (VBD were) (VP (VBN gated) (SBAR (IN as) (S (VP (VBN described) (ADVP (RB above)))))))) (. .)))
( (S (S (NP (NP (NN Electron) (NN microscopy)) (PP (IN of) (NP (ADJP (RB freshly) (VBN sorted)) (NNS cells)))) (VP (VBD was) (VP (VBN carried) (PRT (RP out)) (PP (IN as) (NP (VBN described) (NN elsewhere) (CD -LSB-5))))) (-RRB- -RSB-)) (. .)))
( (S (S (PP (IN After) (NP (NP (NN fixation)) (PP (IN in) (NP (NP (ADJP (CD 2.5) (NN %)) (NN glutaraldehyde)) (PP (IN in) (NP (JJ phosphate-buffered) (NN saline))))))) (, ,) (NP (DT the) (NNS cells)) (VP (VBD were) (ADJP (JJ post-fixed) (PP (IN with) (NP (NP (DT an) (JJ aqueous) (NN solution)) (PP (IN of) (NP (NP (ADJP (CD 1) (NN %)) (NN OsO4)) (VP (VBG containing) (NP (ADJP (CD 1.5) (NN %)) (NN K4Fe) (-LRB- -LRB-) (NN CN) (-RRB- -RRB-) (CD 6)))))))))) (. .)))
( (S (S (ADVP (RB Subsequently)) (, ,) (NP (DT the) (NNS specimens)) (VP (VBD were) (VP (VP (VBN dehydrated) (PP (IN in) (NP (DT an) (NN alcohol) (NN series)))) (CC and) (ADJP (JJ embedded) (PP (IN into) (NP (NN epon))))))) (. .)))
( (S (S (NP (NP (NN Ultrathin) (NNS sections)) (PRN (-LRB- -LRB-) (NP (CD 50) (NN nm)) (-RRB- -RRB-))) (VP (VBD were) (VP (VP (VBN contrasted) (PP (IN with) (NP (NP (NN lead) (NN citrate)) (CC and) (NP (NN uranyl) (NN acetate))))) (CC and) (VP (VBN studied) (PP (IN with) (NP (NP (DT a) (NN CM100) (NN electron) (NN microscope)) (PRN (-LRB- -LRB-) (NP (NP (NN Philips)) (, ,) (NP (NNP Eindhoven) (, ,) (NNP The) (NNP Netherlands))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (JJ Various) (NNS numbers)) (PP (IN of) (NP (NP (VBN sorted) (NN PB)) (CC or) (NP (NN RA) (NN SF) (NNS DCs))))) (VP (VBD were) (VP (VBN incubated) (PP (IN with) (NP (NP (CD 105) (JJ allogeneic) (NN PB) (NN T) (NNS cells)) (PP (IN in) (NP (JJ triplicate) (NNS wells))))) (PP (IN for) (NP (CD 5) (NNS days)))) (, ,) (SBAR (IN as) (S (VP (VBN described) (NP (NN elsewhere) (CD -LSB-33) (-RRB- -RSB-))))))) (. .)))
( (S (S (S (NP (NNS Supernatants)) (VP (VBD were) (VP (VBN removed) (PP (IN from) (NP (DT some) (NNS cultures)))))) (CC and) (S (NP (NP (CD -LSB-3H) (-RRB- -RSB-) (NN thymidine)) (PRN (-LRB- -LRB-) (NP (NP (CD 1) (NN μCi/well)) (, ,) (NP (NN ICN) (NN Biochemicals))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN added) (PP (TO to) (NP (NP (DT the) (NN remainder)) (PP (IN for) (NP (DT the) (JJ final) (CD 18) (NN h))))))))) (. .)))
( (S (S (S (NP (NNS Cells)) (VP (VBD were) (VP (VBN harvested) (PP (IN onto) (NP (JJ glass-fiber) (NN filter) (NNS mats)))))) (CC and) (S (NP (NP (DT the) (NN incorporation)) (PP (IN of) (NP (CD -LSB-3H) (-RRB- -RSB-) (NN thymidine)))) (VP (VBD was) (VP (VBN determined) (PP (IN by) (NP (NP (JJ liquid) (NN scintillation) (NN spectroscopy)) (PRN (-LRB- -LRB-) (NP (NP (NNP Packard) (NNP Topcount)) (, ,) (NP (NNP Packard) (NN Instrument) (NNP Co)) (, ,) (NP (NNP Meriden)) (, ,) (NP (NN CT)) (, ,) (NP (NNP USA))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (NN IFN-γ)) (, ,) (NP (NN IL-10)) (, ,) (CC and) (NP (NN TNF-α))) (VP (VBD were) (VP (VBN measured) (PP (IN in) (NP (NNS supernatants))) (PP (IN by) (NP (NP (NN ELISA)) (VP (VBG using) (NP (NP (NN OptEIA) (NN ELISA) (NNS kits)) (PRN (-LRB- -LRB-) (NP (NNP BD) (NNP Pharmingen)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (NP (ADJP (ADJP (JJ Frozen)) (CC or) (ADJP (JJ paraffin-embedded))) (NNS sections)) (PP (IN of) (NP (NP (JJ synovial) (NN tissue)) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ untreated) (JJ active) (NN RA)))))))) (VP (VBD were) (VP (VP (VBN obtained) (PP (IN by) (NP (JJ arthroscopic) (NN biopsy)))) (CC and) (VP (VBN supplied) (PP (IN by) (NP (NP (NNP Malcolm) (NNP Smith)) (PRN (-LRB- -LRB-) (NP (NP (NNP Repatriation) (NNP Hospital)) (, ,) (NP (NN Adelaide)) (, ,) (NP (NNP Australia))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (JJ Normal) (JJ synovial) (NN tissue)) (VP (VBD was) (VP (VBN obtained) (PP (IN at) (NP (NN arthroscopy))) (PP (IN from) (NP (NP (NNS patients)) (VP (VBG undergoing) (NP (NN arthroscopy)) (PP (IN for) (NP (NP (JJ nonspecific) (NN knee) (NN pain)) (SBAR (CC and) (WHPP (IN in) (WHNP (WP whom))) (S (NP (DT no) (NN abnormality)) (VP (VBD was) (VP (VBN found))))))))))))) (. .)))
( (S (S (PP (IN After) (NP (NP (NN fixation)) (PP (IN with) (NP (NN acetone))))) (, ,) (NP (NNS sections)) (VP (VBD were) (VP (VP (VBN stained) (PP (IN with) (NP (NP (NN anti-CD11c)) (CC or) (NP (NN anti-CD123)))) (S (VP (VBG using) (NP (DT an) (NN immunoperoxidase) (NN technique))))) (, ,) (CC and) (VP (VBN revealed) (PP (IN with) (NP (NP (NN diaminobenzidine)) (PRN (-LRB- -LRB-) (NP (NN brown)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NN Frozen) (NNS sections)) (VP (VBD were) (VP (VBN double-stained) (PP (IN with) (NP (NP (NP (NNP U.) (FW europaeus) (NN agglutinin) (CD I)) (PRN (-LRB- -LRB-) (NP (NN Ulex)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NN lectin)) (SBAR (WHNP (WDT that)) (S (ADVP (RB specifically)) (VP (VBZ binds) (NP (NP (JJ endothelial) (NNS cells)) (PRN (-LRB- -LRB-) (NP (JJ fast) (JJ red)) (-RRB- -RRB-))))))) (, ,) (CC and) (NP (NP (NN anti-CD123)) (PRN (-LRB- -LRB-) (NP (NN brown)) (-RRB- -RRB-))))) (, ,) (S (VP (VBG using) (NP (DT a) (JJ double) (, ,) (JJ immunoperoxidase–immunoalkaline) (NN phosphatase) (NN technique)) (PP (IN as) (NP (VBN described) (NN elsewhere) (CD -LSB-34) (-RRB- -RSB-)))))))) (. .)))
( (S (S (NP (ADJP (ADJP (JJ Formalin-fixed)) (ADJP (JJ paraffin-embedded))) (NNS sections)) (VP (VBD were) (ADJP (JJ antigen-retrieved) (PP (IN in) (NP (NP (ADJP (CD 10) (NN mM)) (NN citrate) (NN buffer)) (PP (IN at) (NP (NN pH6)))))) (PP (IN in) (NP (DT an) (JJ autoclave))) (, ,) (ADVP (RB then)) (VP (VBN stained) (PP (IN with) (NP (NP (NP (NN anti-CD123)) (PRN (-LRB- -LRB-) (NP (NP (NN diaminobenzidine)) (, ,) (NP (NN brown))) (-RRB- -RRB-))) (UCP (ADVP (RB alone)) (, ,) (CC or) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (NN anti-RelB)) (PRN (-LRB- -LRB-) (NP (NP (NN BCIP)) (, ,) (NP (NN DAKO)) (, ,) (NP (NN purple))) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (NP (NNS Sections)) (VP (VP (VBD were) (ADJP (JJ counterstained) (PP (IN with) (NP (NN hematoxylin)))) (PP (IN except) (SBAR (WHADVP (WRB when)) (S (NP (PRP they)) (VP (VBD had) (VP (VBN been) (VP (VBN double-stained) (PP (IN for) (NP (NP (NN CD123)) (CC and) (NP (NN RelB))))))))))) (CC and) (VP (VBD were) (VP (VBN photographed) (S (VP (VBG using) (NP (NP (DT a) (JJ transmitted-light) (NN microscope)) (PRN (-LRB- -LRB-) (NP (NP (NNP Leitz) (NNP Diaplan)) (, ,) (NP (NNP Leica) (, ,) (NNP Germany))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB quantitate) (NP (NP (NN infiltration)) (PP (IN by) (NP (JJ CD123+) (NNS DCs))))))) (, ,) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NN CD123+Ulex-) (NNS cells)))) (VP (VBD was) (VP (VBN counted) (PP (IN in) (NP (NP (NNS sections)) (VP (VBN double-stained) (PP (IN with) (NP (NP (NN CD123)) (CC and) (NP (NN Ulex)))))))))) (. .)))
( (S (S (S (NP (NNS Cells)) (VP (VBD were) (VP (VBN counted) (PP (IN in) (NP (NP (DT each)) (PP (IN of) (NP (NP (DT the) (JJ entire) (NNS sections)) (PP (IN from) (NP (NP (NP (CD three) (NNS patients)) (CC and) (NP (CD three) (JJ normal) (NNS controls))) (PP (IN at) (NP (JJ high) (NN power)))))))))))) (, ,) (CC and) (S (PP (IN for) (NP (DT each) (NN biopsy))) (NP (DT this) (NN number)) (VP (VBD was) (VP (VBN corrected) (PP (IN for) (NP (NP (DT the) (NN area)) (PP (IN of) (NP (DT the) (NN section) (S (VP (TO to) (VP (VB obtain) (NP (NP (DT the) (NN number)) (PP (IN per) (NP (NNS mm2))))))))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB quantitate) (NP (NP (NN infiltration)) (PP (IN by) (NP (NN CD11c+) (NNS cells))))))) (, ,) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (DT these) (NNS cells)))) (VP (VBD was) (VP (VBN counted) (PP (IN in) (NP (NP (CD three) (JJ high-power) (NNS fields)) (PP (IN of) (NP (NP (DT the) (JJ synovial) (NN sublining)) (PP (IN in) (NP (NP (NNS sections)) (PP (IN from) (NP (NP (CD three) (NNS patients)) (CC and) (NP (CD three) (JJ normal) (NNS controls))))))))))))) (. .)))
( (S (S (NP (NNS Differences)) (VP (VBD were) (VP (VBN analyzed) (S (VP (VBG using) (NP (JJ unpaired) (NN Student) (POS 's) (NNS t-tests))))))) (. .)))
( (S (NP (NNS Results))))
( (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB previously)) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (JJ synovial) (NN tissue)) (PP (IN in) (NP (NP (NN RA)) (CC and) (NP (NN spondyloarthropathy))))) (VP (VBZ is) (VP (VBN enriched) (PP (IN in) (NP (NP (VBN differentiated) (JJ myeloid) (NNS DCs)) (SBAR (WHNP (WDT that)) (S (VP (VBP express) (NP (NP (NN CD33)) (, ,) (NP (NN CD11c)) (, ,) (NP (NN MHC) (NN class) (CD II)) (, ,) (NP (JJ costimulatory) (NNS molecules)) (, ,) (CC and) (NP (JJ nuclear) (NN RelB) (NN -LSB-21,25)))) (-RRB- -RSB-)))))))))))) (. .)))
( (S (S (NP (NP (NN Translocation)) (PP (IN of) (NP (NN RelB))) (PP (TO to) (NP (DT the) (NN nucleus)))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (NP (NN maturation)) (CC and) (NP (NN APC) (NN function))) (PP (IN of) (NP (JJ myeloid) (NNS DCs) (CD -LSB-26) (-RRB- -RSB-)))))))) (. .)))
( (S (S (NP (DT These) (JJ nuclear) (NN RelB+) (NNS DCs)) (VP (VP (VBP are) (ADJP (JJ absent) (PP (IN in) (NP (JJ normal) (JJ synovial) (NN tissue))))) (CC and) (VP (VBP are) (ADJP (JJ rare) (PP (IN in) (NP (NN RA) (NN SF) (CD -LSB-21,23)))))) (-RRB- -RSB-)) (. .)))
( (S (S (VP (TO To) (VP (VB determine) (SBAR (IN whether) (S (NP (ADJP (NN RA) (JJ synovial)) (NN tissue)) (VP (VBD was) (VP (VBN infiltrated) (PP (PP (IN by) (NP (NP (JJ CD123+) (NNS pDCs)) (PP (IN in) (NN addition) (TO to) (NP (NP (JJ CD11c+) (JJ myeloid) (NNS cells)) (, ,) (NP (NN frozen) (JJ synovial) (NN tissue) (NNS sections)) (, ,) (CC either) (NP (ADJP (JJ normal))))))) (CC or) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN RA)) (CC or) (NP (NN spondyloarthropathy)))))))))))))) (, ,) (VP (VBD were) (VP (VBN stained) (PP (IN with) (NP (NP (NN CD11c)) (CC or) (NP (NN CD123)))))) (. .)))
( (S (S (NP (NN CD11c+) (NNS cells)) (VP (VBD were) (VP (VBN found) (UCP (CC both) (PP (IN in) (NP (DT the) (JJ lining) (NN layer))) (CC and) (ADJP (JJ adjacent) (PP (TO to) (NP (NP (NNS vessels)) (PP (IN in) (NP (NP (DT the) (NN sublining)) (PP (IN of) (NP (JJ normal) (JJ synovial) (NN tissue)))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NN CD123)) (ADVP (RB only)) (VP (VBN stained) (NP (NP (JJ endothelial) (NNS cells)) (PP (IN in) (NP (DT the) (JJ normal) (NN tissue)))) (PRN (-LRB- -LRB-) (NP (NP (NNP Fig.)) (NP (NN 1a,1b))) (-RRB- -RRB-)))) (. .)))
( (S (S (PP (IN In) (NP (NN RA) (JJ synovial) (NN tissue))) (, ,) (NP (NN CD11c)) (ADVP (RB again)) (VP (VBN stained) (NP (NP (NNS cells)) (ADJP (JJ adjacent) (PP (PP (TO to) (NP (NNS vessels))) (, ,) (ADVP (RB now)) (PP (IN within) (NP (NP (JJ lymphoid) (NNS aggregates)) (PP (IN in) (NP (DT the) (NN sublining)))))))))) (. .)))
( (S (S (NP (NP (DT A) (NN population)) (PP (IN of) (NP (NP (JJ CD123+) (NNS cells)) (PP (IN with) (NP (JJ dendritic) (NN appearance)))))) (VP (VBD was) (ADVP (RB also)) (VP (VBN stained) (S (ADJP (JJ adjacent) (PP (TO to) (NP (NP (JJ CD123+) (NN blood) (NNS vessels)) (PP (IN in) (NP (NP (NN RA)) (PRN (-LRB- -LRB-) (NP (NP (NNP Fig.) (NNP 1c,1d)) (, ,)) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (NP (NP (NNS Cells)) (VP (VBG expressing) (NP (NP (NN TNF-α)) (PP (IN in) (NP (NN RA) (JJ synovial) (NN tissue)))))) (VP (VBD were) (VP (VBN found) (PP (IN in) (NP (NP (DT a) (JJ similar) (NN location)) (PP (IN in) (NP (NP (JJ serial) (NNS sections)) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-))))))) (, ,) (SBAR (IN as) (S (VP (VBN demonstrated) (ADVP (RB previously)) (NP (CD -LSB-35) (-RRB- -RSB-))))))) (. .)))
( (S (S (VP (TO To) (VP (VB confirm) (NP (NP (DT the) (JJ perivascular) (JJ CD123+) (NNS cells)) (PP (IN in) (NP (JJ synovial) (NN tissue))))))) (, ,) (NP (NP (ADJP (JJ normal))) (CC and) (NP (ADJP (NN RA) (JJ synovial)) (NN tissue))) (VP (VBD were) (VP (VBN double-stained) (PP (PP (IN with) (NP (NP (DT the) (JJ endothelial) (NN cell) (NN marker) (NN Ulex) (NN agglutinin)) (PRN (-LRB- -LRB-) (NP (JJ red)) (-RRB- -RRB-)))) (CC and) (PP (IN with) (NP (NP (NN CD123)) (PRN (-LRB- -LRB-) (NP (NN brown)) (-RRB- -RRB-))))))) (. .)))
( (S (S (SBAR (IN Whereas) (S (NP (NP (DT all) (JJ CD123+) (NNS structures)) (PP (IN in) (NP (JJ normal) (JJ synovial) (NN tissue)))) (VP (VBD colocalized) (PP (IN with) (NP (NP (NN Ulex) (NN agglutinin)) (PRN (-LRB- -LRB-) (NP (NN orange)) (-RRB- -RRB-))))))) (, ,) (NP (NP (JJ single-stained) (JJ CD123+) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN brown)) (-RRB- -RRB-))) (VP (VBD were) (ADJP (ADJP (JJ located) (PP (IN in) (NP (JJ perivascular) (JJ lymphoid) (NNS aggregates)))) (CC and) (PP (IN within) (NP (NP (DT the) (NN lumen)) (PP (IN of) (NP (NP (JJ occasional) (NN blood) (NNS vessels)) (PP (IN in) (NP (NP (ADJP (NN RA) (JJ synovial)) (NN tissue)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NNP 1e,1f)) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (NP (DT These) (JJ CD123+) (NNS cells)) (VP (VBP are) (ADJP (JJ similar) (PP (IN in) (NP (NN appearance))) (PP (TO to) (NP (NP (DT those)) (VP (ADVP (RB previously)) (VBN demonstrated) (PP (IN as) (NP (NP (JJ CD123+) (NNS pDCs)) (PP (IN in) (NP (JJ human) (NN tonsil))) (, ,) (SBAR (SBAR (WHPP (IN in) (WHNP (WDT that))) (S (NP (PRP they)) (VP (VBP are) (ADJP (JJR smaller) (PP (IN than) (NP (JJ CD11c+) (JJ myeloid) (NNS DCs))) (, ,) (PP (IN with) (NP (JJR shorter) (JJ dendritic) (NNS processes))))))) (, ,) (CC and) (S (NP (NN cell) (NNS clusters)) (VP (VBD gave) (NP (NP (DT the) (NN appearance)) (PP (IN of) (NP (NP (ADJP (RB locally) (VBG proliferating)) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 1g) (-RRB- -RRB-) (CD -LSB-5,36)) (-RRB- -RSB-)))))))))))))))) (. .)))
( (S (S (SBAR (IN While) (S (NP (DT some) (NNS macrophages)) (VP (MD can) (VP (VB express) (NP (NN CD123)))))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (NN colocalization)) (PP (IN in) (NP (JJ synovial) (NN tissue))) (PP (IN of) (NP (NP (NN CD123)) (CC and) (NP (NN CD68))))) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (PP (IN aside) (IN from) (NP (DT the) (JJ dendritic) (NN morphology))) (, ,) (NP (PRP we)) (ADVP (RB cannot)) (VP (VBP exclude) (SBAR (IN that) (S (NP (NP (DT some)) (PP (IN of) (NP (NP (DT the) (JJ CD123+) (NNS cells)) (VP (VBN stained))))) (VP (VBP are) (NP (NN mast) (NNS cells) (CD -LSB-37) (-RRB- -RSB-))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (NN CD123+) (NNS cells)) (PP (IN in) (NP (JJ synovial) (NN tissue)))) (VP (VBD were) (ADVP (RB also)) (NP (JJ nuclear) (NN RelB+)))))))) (, ,) (NP (JJ formalin-fixed) (NN tissue)) (VP (VBD was) (ADJP (JJ double-stained) (PP (IN for) (NP (NP (NN RelB)) (CC and) (NP (NN CD123))))) (PP (IN without) (NP (NN hematoxylin) (NN counterstaining))))) (. .)))
( (S (S (NP (DT No) (JJ CD123+) (NNS cells)) (VP (VBD had) (VP (VBD translocated) (NP (NN RelB)) (PP (TO to) (NP (DT the) (NN nucleus))) (, ,) (SBAR (IN although) (S (NP (DT some)) (VP (VBD expressed) (NP (NP (JJ cytoplasmic) (NN RelB)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NNP 1h,1i)) (-RRB- -RRB-))))))))) (. .)))
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (JJ nuclear) (NN staining)) (PP (IN of) (NP (NN RelB)))) (VP (VBD was) (ADJP (JJ evident)) (PP (IN in) (NP (NP (JJ adjacent) (NN CD123-) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NP (NNP Fig.)) (NP (NN 1h))) (, ,) (NP (NNS arrows)) (-RRB- -RRB-))))) (. .)))
( (S (S (S (NP (NP (DT All) (NNS patients)) (PP (IN with) (NP (NN RA)))) (VP (VBD showed) (NP (NP (JJ similar) (NN infiltration)) (PP (IN by) (NP (NN pDCs)))))) (CC and) (S (NP (NP (DT no) (NNS differences)) (PP (IN in) (NP (NP (DT the) (NN cell) (NNS numbers)) (CC or) (NP (NN location))))) (VP (VBD were) (VP (VBN noted) (PP (IN between) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN RA)) (CC or) (NP (NN spondyloarthropathy)))))) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBN quantitated) (NP (NP (NNS pDCs)) (PP (IN in) (NP (ADJP (ADJP (JJ normal)) (CC or) (ADJP (NN RA) (JJ synovial))) (NN tissue)))) (PP (IN by) (S (VP (VBG counting) (NP (NN CD123+Ulex-) (NNS cells)) (PP (IN in) (NP (NP (JJ synovial) (NN tissue) (NNS sections)) (PP (IN from) (NP (NP (NP (NNS patients)) (PP (IN with) (NP (NN RA)))) (CC or) (NP (JJ normal) (NNS controls)))) (VP (VBN stained) (PP (IN with) (NP (NP (NP (NN CD123)) (CC and) (NP (NN Ulex))) (SBAR (IN as) (S (VP (VBN shown) (PP (IN in) (NP (NNP Fig.) (CD 1)))))))))))))))) (. .)))
( (S (S (SBAR (IN Whereas) (S (NP (DT no) (NNS pDCs)) (VP (VBD infiltrated) (NP (DT the) (JJ normal) (NN tissue))))) (, ,) (NP (NP (QP (RB approximately) (CD 22)) (NNS pDCs)) (PP (IN per) (NP (NNS mm2)))) (VP (VBD were) (VP (VBN identified) (PP (IN within) (NP (DT the) (NN RA) (NN tissue))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 2)) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (DT This) (NN number)) (VP (VBZ is) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (JJ nuclear) (JJ RelB+) (VBN differentiated) (NNS DCs))) (VP (VBN identified) (ADVP (RB previously)) (PP (IN in) (NP (ADJP (NN RA) (JJ synovial)) (NN tissue) (CD -LSB-38) (-RRB- -RSB-))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NN CD11c+) (NNS cells)) (VP (VBD infiltrated) (NP (ADJP (CC both) (ADJP (JJ normal)) (CC and) (ADJP (NN RA) (JJ synovial))) (NN tissue)) (, ,) (PP (IN with) (NP (NP (ADJP (RB significantly) (JJR larger)) (NNS numbers)) (PP (IN in) (NP (NP (NP (NN RA)) (PRN (-LRB- -LRB-) (NP (NN P) (NN <) (CD 0.05)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 2)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP conclude) (SBAR (SBAR (IN that) (S (NP (DT the) (JJ CD123+) (NN cell) (NN population)) (VP (VBZ is) (ADVP (RBS most) (RB likely)) (NP (NP (NP (DT a) (JJ pDC) (NN population)) (PP (IN that) (NP (NNS infiltrates) (NP (NP (NN RA)) (CC and) (NP (NN spondyloarthropathy)))))) (CONJP (CC but) (RB not)) (NP (JJ normal) (JJ synovial) (NN tissue)))))) (CC and) (SBAR (IN that) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ distinct) (PP (IN from) (NP (DT the) (VBN described) (JJ nuclear) (NN RelB+) (NN DCs) (CD -LSB-21,36,39) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (NP (NN CD11c+) (NNS cells)) (VP (VBP comprise) (NP (ADJP (ADJP (JJ immature)) (CC and) (ADJP (VBN differentiated))) (NP (JJ myeloid) (NNS DCs)) (CONJP (RB as) (RB well) (IN as)) (NP (NNS monocytes) (CD -LSB-1,34) (-RRB- -RSB-))))) (. .)))
( (S (S (NP (VBN Differentiated) (JJ nuclear) (NN RelB+) (NNS DCs)) (VP (VBP are) (VP (VBN found) (PP (IN within) (NP (DT the) (JJ CD11c+) (NN DC) (NN population))) (PP (PP (IN in) (NP (NP (NN RA)) (CC and) (NP (JJ other) (JJ inflammatory) (NNS arthritides)))) (CC but) (PP (RB not) (IN in) (NP (JJ normal) (JJ synovial) (NN tissue) (CD -LSB-21)))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (NP (NNS Workers)) (PP (IN in) (NP (PRP$ our) (NN laboratory)))) (VP (VBP have) (ADVP (RB previously)) (VP (VBN shown) (SBAR (IN that) (S (NP (NN RA) (NN SF)) (VP (VBZ is) (VP (VBN enriched) (PP (IN in) (NP (NP (JJ CD11c+CD33brightCD14-) (JJ myeloid) (NNS DCs)) (PP (IN with) (NP (JJ efficient) (NN APC) (NN function) (CD -LSB-25,40))))))) (-RRB- -RSB-)))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (SBAR (WHADVP (WRB when)) (S (ADVP (RB freshly)) (VP (VBN isolated)))) (, ,) (NP (NP (RB only) (DT a) (JJ small) (NN proportion)) (PP (IN of) (NP (NN SF) (NN CD33brightCD14-) (NNS DCs)))) (VP (VBP have) (VP (VBN translocated) (NP (NN RelB)) (PP (TO to) (NP (DT the) (NN nucleus)))))) (. .)))
( (S (S (NP (NP (NP (NN RA)) (CC and) (NP (JJ normal) (NN PB))) (JJ mononuclear) (NNS cells)) (VP (VBP contain) (NP (NP (JJ similar) (NNS proportions)) (PP (IN of) (NP (NN CD33brightCD14-) (NN DCs) (CD -LSB-25))))) (-RRB- -RSB-)) (. .)))
( (S (S (VP (TO To) (VP (VB examine) (NP (NP (NP (NN plasmacytoid)) (CC and) (NP (JJ myeloid) (NNS DCs))) (PP (IN in) (NP (NN parallel))))))) (, ,) (NP (PRP we)) (VP (VBD compared) (NP (NP (NN RA) (NN SF)) (PP (IN with) (NP (NP (NN RA)) (CC and) (NP (ADJP (ADJP (JJ healthy)) (, ,) (ADJP (JJ control))) (NN PB)))) (PP (IN for) (NP (NP (DT the) (NN proportion)) (PP (IN of) (NP (NP (NN CD123+)) (CC and) (NP (JJ CD11c+) (JJ HLA-DR+CD14-) (NNS DCs)))))))) (. .)))
( (S (S (PP (IN After) (NP (NP (NN purification)) (PP (IN of) (NP (NP (JJ mononuclear) (NNS cells)) (PP (IN from) (NP (UCP (CC either) (ADJP (JJ normal)) (CC or) (NP (NN RA) (NP (NN PB)) (CC or) (NP (NN RA)))) (NN SF))))) (PP (IN by) (NP (NN gradient) (NN centrifugation))))) (, ,) (NP (NNS cells)) (VP (VBD were) (VP (VBN stained) (PP (IN with) (NP (NP (NN CD123-PE)) (, ,) (NP (NN CD11c-FITC)) (, ,) (NP (NN CD14-PECy5)) (, ,) (CC and) (NP (NN HLA-DR-APC))))))) (. .)))
( (S (S (NP (JJ Polymorphonuclear) (NNS cells)) (VP (VBD were) (VP (VBN excluded) (PP (IN on) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (ADJP (ADJP (JJ forward)) (CC and) (ADJP (JJ side))) (NN light-scatter)))))))) (. .)))
( (S (S (SBAR (IN Since) (S (NP (NP (NNS basophils)) (CC and) (NP (NNS monocytes))) (VP (MD can) (ADVP (RB also)) (VP (VB express) (NP (NN CD123)))))) (, ,) (NP (JJ potential) (JJ CD123+) (NNS non-DCs)) (VP (VBD were) (VP (VBN excluded) (PP (IN by) (S (VP (VBG gating) (NP (JJ CD14-HLA-DR+) (NNS cells) (CD -LSB-10) (-RRB- -RSB-)))))))) (. .)))
( (S (S (PP (IN By) (NP (NN four-color) (NN analysis))) (, ,) (NP (ADJP (ADJP (JJ CD14-HLA-DR+CD123+)) (CC and) (ADJP (JJ CD11c+))) (NN DC) (NNS populations)) (VP (MD could) (VP (VB be) (VP (VBN distinguished) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 3)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NP (DT The) (NNS percentages)) (PP (IN of) (NP (JJ CD123+CD11c-) (NNS pDCs))) (PP (IN in) (NP (NP (NN RA) (NN PB)) (CC and) (NP (JJ normal) (NN PB))))) (VP (VP (VBD were) (ADJP (JJ low))) (CC and) (VP (VBD did) (RB not) (VP (VB differ) (PP (IN from) (NP (DT each) (JJ other))))))) (. .)))
( (S (S (NP (DT This) (NN observation)) (VP (VBZ contrasts) (PP (IN with) (NP (NP (DT the) (NN reduction)) (PP (IN in) (NP (NNS pDCs))) (VP (VBN observed) (PP (IN in) (NP (NP (NN blood)) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ systemic) (NN lupus) (NN erythematosus) (CD -LSB-41) (-RRB- -RSB-)))))))))))) (. .)))
( (S (S (NP (JJ CD11c+CD123-) (JJ myeloid) (NNS DCs)) (VP (VBD were) (ADJP (RBR more) (JJ common)) (PP (IN than) (NP (JJ CD123+) (NNS DCs))) (PP (IN in) (NP (NP (NN patient)) (CC and) (NP (NN control)) (NP (NN blood)))) (PRN (-LRB- -LRB-) (NP (NN P) (JJ <) (CD 0.005)) (-RRB- -RRB-)) (, ,) (PP (IN in) (S (VP (VBG keeping) (PP (IN with) (NP (NP (JJ previous) (NNS studies)) (PP (IN of) (NP (JJ normal) (NN PB) (NN -LSB-1)))))) (-RRB- -RSB-))))) (. .)))
( (S (NP (NN RA) (NN SF)) (VP (VBD contained) (NP (NP (DT a) (ADJP (RB significantly) (JJR greater)) (NN percentage)) (PP (IN of) (NP (JJ CD11c+) (NNS DCs)))) (PP (IN than) (NP (NP (NP (ADJP (JJ normal))) (CC or) (NP (NP (NN RA) (NN PB)) (PRN (-LRB- -LRB-) (NP (NN P) (JJ <) (CD 0.005)) (-RRB- -RRB-))) (NP (NNS –))) (SBAR (IN in) (S (VP (VBP accord) (PP (IN with) (NP (NP (JJ previous) (NNS studies)) (VP (VBG using) (NP (DT the) (NNS markers) (NP (NP (NN CD33)) (CC and) (NP (NN CD14) (NN -LSB-40))) (-RRB- -RSB-))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN proportion)) (PP (IN of) (NP (JJ CD11c+) (NNS DCs))) (PP (IN in) (NP (NN RA) (NN SF)))) (VP (VBD was) (ADJP (ADJP (JJR higher)) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (NP (NP (NN RA) (NN SF) (NN CD123+) (NNS DCs)) (PRN (-LRB- -LRB-) (NP (NN P) (NN <) (CD 0.05)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (SBAR (IN Although) (S (NP (DT the) (NN difference)) (VP (VBD was) (ADJP (JJ small))))) (, ,) (NP (NP (DT the) (NN percentage)) (PP (IN of) (NP (NP (JJ CD123+) (NNS DCs)) (PP (IN in) (NP (NN RA) (NN SF)))))) (VP (VBD was) (ADJP (ADJP (JJR higher)) (PP (IN than) (PP (IN in) (NP (NP (NN RA)) (CC or) (NP (NP (JJ control) (NN PB)) (PRN (-LRB- -LRB-) (NP (NN P) (NN <) (CD 0.05)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (DT The) (NNS data)) (VP (VBP show) (SBAR (SBAR (IN that) (S (NP (JJ CD123+) (NNS DCs)) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (NN RA) (NN SF))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (NP (DT the) (NN ratio)) (PP (IN of) (NP (JJ CD11c+) (TO to) (JJ CD123+) (NNS DCs)))) (VP (VBZ is) (ADJP (JJ similar) (PP (IN in) (NP (NN RA) (NN SF))) (PP (TO to) (NP (NP (DT that)) (PP (IN in) (NP (NP (ADJP (JJ normal))) (CC or) (NP (NN RA)) (NP (NN PB))))))) (PRN (-LRB- -LRB-) (RB approximately) (VP (VBN 10:1)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (PP (IN In) (NP (NN RA) (JJ synovial) (NN tissue))) (, ,) (NP (JJ mature) (JJ myeloid) (JJ nuclear) (ADJP (ADJP (JJ RelB+)) (CC and) (ADJP (JJ CD123+))) (NNS DCs)) (VP (VBP have) (VP (VBN infiltrated) (NP (NP (JJ perivascular) (JJ lymphoid) (NNS aggregates)) (PP (IN in) (NP (JJ similar) (NNS numbers))))))) (. .)))
( (S (S (ADVP (RB Previously)) (, ,) (NP (NP (JJ similar) (NNS numbers)) (PP (IN of) (NP (ADJP (ADJP (JJ immature)) (CC and) (ADJP (JJ mature))) (JJ myeloid) (NNS DCs)))) (VP (VBD were) (VP (VBN identified) (PP (IN in) (NP (NN RA) (JJ synovial) (NN tissue) (CD -LSB-42))))) (-RRB- -RSB-)) (. .)))
( (S (S (ADVP (RB Thus)) (NP (NNS pDCs)) (VP (VBP make) (PRT (RP up)) (NP (NP (QP (RB about) (CD 30)) (NN %)) (PP (IN of) (NP (NP (NNS DCs)) (PP (IN within) (NP (NN RA) (JJ synovial) (NN tissue)))))))) (. .)))
( (S (NP (NP (DT The) (JJ present) (ADJP (CC and) (RB previously) (VBN published)) (NNS data)) (, ,) (VP (VBN taken) (ADVP (RB together))) (, ,)) (VP (VBP show) (SBAR (IN that) (S (NP (CC both) (NP (NNS pDCs)) (CC and) (NP (JJ myeloid) (NNS DCs))) (VP (VBP are) (VP (VBN recruited) (PP (TO to) (NP (NN RA) (NN synovium))) (, ,) (PP (IN with) (NP (NP (DT an) (NN enrichment)) (PP (IN of) (NP (NN pDCs))) (PP (IN in) (NP (NP (JJ synovial) (NN tissue)) (ADJP (JJ relative) (PP (TO to) (NP (NP (NN blood)) (CC or) (NP (NN SF)))))))))))))) (. .)))
( (S (PP (IN In) (NP (JJ normal) (NN PB))) (, ,) (NP (NNS pDCs)) (VP (VBP circulate) (PP (IN as) (NP (NP (NNS precursors)) (PP (IN with) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (NP (NN recruitment)) (PP (IN into) (NP (NP (NNS tissues)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NNS chemokines) (CD -LSB-2,43)))))))))))))) (-RRB- -RSB-) (. .)))
( (S (S (NP (DT These) (NNS precursors)) (VP (VBP exhibit) (NP (DT a) (JJ characteristic) (NN plasmacytoid) (NN morphology)) (PP (IN on) (NP (NN electron) (NN microscopy))) (, ,) (NP (NP (DT a) (JJ cell-surface) (NN phenotype)) (VP (VBN characterized) (PP (PP (IN by) (NP (NP (NN expression)) (PP (IN of) (NP (DT the) (NN BDCA2) (NN antigen))))) (, ,) (PP (IN by) (NP (NP (JJ low) (NNS levels)) (PP (IN of) (NP (NP (JJ costimulatory) (NN molecule)) (NN expression))))) (, ,) (CC and) (PP (IN by) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (NN IFN-α) (NN production))))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (ADJP (JJ viral))) (CC or) (NP (NN immunostimulatory) (NN CpG) (NN DNA) (NNS motifs)) (NP (NN -LSB-1)))))) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB therefore)) (VP (VP (VBD analyzed) (NP (NP (DT the) (NNS characteristics)) (PP (IN of) (NP (VBN sorted) (NN RA) (NN SF) (JJ CD123+) (NNS DCs))))) (CC and) (VP (VBD compared) (NP (PRP them)) (PP (IN with) (NP (NN control) (NN PB) (JJ CD123+) (NNS DCs)))))) (. .)))
( (S (PP (IN On) (NP (NN electron) (JJ microscopic) (NN examination))) (, ,) (NP (NP (ADJP (RB freshly) (VBN sorted)) (NN PB)) (CC and) (NP (NN SF) (NN CD123+) (NNS DCs))) (VP (VBD appeared) (ADJP (JJ similar)) (, ,) (PP (IN with) (NP (NP (DT a) (NN smooth) (NN surface) (CC and) (JJ abundant) (JJ rough) (JJ endoplasmic) (NN reticulum)) (PP (IN in) (NP (DT the) (NN cytoplasm)))))) (. .)))
( (S (S (NP (DT The) (NN nucleus)) (VP (VP (VBD was) (ADJP (ADJP (JJ nonlobulated)) (CC and) (ADJP (JJ abundant))) (PP (IN in) (NP (NN euchromatin)))) (CC and) (VP (VBD contained) (NP (NP (DT a) (JJ distinct) (NN nucleolus)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 4)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (JJ CD11c+) (NN PB) (NNS DCs)) (VP (VBD were) (ADJP (RB morphologically) (JJ distinct) (PP (IN from) (NP (DT the) (JJ CD123+) (NNS pDCs)))) (, ,) (PP (IN with) (NP (NP (DT a) (VBN lobulated) (NN nucleus)) (CC and) (NP (DT some) (JJ phagocytic) (NNS vesicles)))))) (. .)))
( (S (S (NP (NP (JJ CD11c+) (NNS DCs)) (PP (IN from) (NP (NN SF)))) (VP (VBD showed) (NP (NP (JJR more) (NN membrane) (NN ruffling)) (CC and) (NP (JJ phagocytic) (NN activity))) (PP (IN than) (NP (NP (DT those)) (PP (IN from) (NP (NP (NN PB)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 4)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (ADVP (RB Thus)) (NP (NN SF) (NN CD123+) (NNS DCs)) (ADVP (RB morphologically)) (VP (VBP resemble) (NP (NP (JJ CD123+) (NNS DCs)) (PP (IN in) (NP (NN PB)))))) (, ,) (IN whereas) (S (NP (JJ CD11c+) (NN SF) (NNS DCs)) (VP (VBP display) (NP (NP (NP (DT a) (JJR greater) (NN level)) (PP (IN of) (NP (NN ruffling)))) (CC and) (NP (JJ phagocytic) (NN activity))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (PRP$ their) (VBN enhanced) (NN level)) (PP (IN of) (NP (NN activation))))))) (, ,) (PP (IN than) (NP (NP (JJ CD11c+) (VBG circulating) (NNS precursors)) (CD -LSB-21) (-RRB- -RSB-))))) (. .)))
( (S (S (PP (IN On) (NP (JJ four-color) (NN flow) (JJ cytometric) (NN analysis))) (, ,) (NP (JJ gated) (NN RA) (NN SF) (JJ CD14-HLA-DR+CD123+) (NNS DCs)) (VP (VBD expressed) (NP (NP (JJ low) (NNS levels)) (PP (IN of) (NP (NP (NN CD40)) (, ,) (NP (NN CD80)) (, ,) (CC and) (NP (NN CD86))))))) (. .)))
( (S (S (NP (NP (NP (DT All)) (CC or) (NP (DT the) (NN majority))) (PP (IN of) (NP (NN SF) (JJ CD123+) (NNS DCs)))) (VP (VBD expressed) (NP (NP (DT the) (NN BDCA2) (NN marker)) (PP (IN of) (NP (NP (JJ immature) (JJ pDC) (NNS precursors)) (PRN (NN -LSB-1) (-RRB- -RSB-))))))) (. .)))
( (S (NP (DT This) (JJ cell-surface) (NN phenotype)) (ADVP (RB closely)) (VP (VBZ resembles) (NP (NP (DT that)) (PP (IN of) (NP (JJ control) (NN PB) (NN CD123+) (NN DC) (NNS precursors)))) (, ,) (SBAR (IN although) (S (NP (NN BDCA2)) (VP (VBD was) (ADVP (RB consistently)) (VP (VBN expressed) (PP (IN at) (NP (JJ high) (NNS levels))) (PP (ADVP (RB only)) (IN by) (NP (NP (DT a) (NN subset)) (PP (IN of) (NP (NP (JJ CD123+) (JJ HLA-DR+) (NNS cells)) (PP (IN in) (NP (NP (NN PB)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 4b)) (-RRB- -RRB-))))))))))))) (. .)))
( (S (S (NP (NN No) (NN PB) (CC or) (NN SF) (NNS cells)) (VP (VBD expressed) (NP (DT the) (NN DC) (NN differentiation) (NN marker) (NN CD83)) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NN SF) (NN CD123+) (CC and) (JJ CD11c+) (NNS DCs)) (VP (VBD expressed) (NP (NP (JJR higher) (NNS levels)) (PP (IN of) (NP (NN cell-surface) (NN HLA-DR)))) (PP (IN than) (NP (NP (DT the) (JJ corresponding) (NNS cells)) (PP (IN in) (NP (NN PB))))) (, ,) (S (VP (VBG suggesting) (NP (NP (DT some) (JJ cellular) (NN activation)) (PP (IN within) (NP (DT the) (NN SF) (NN environment) (CD -LSB-5,10,44))))))) (-RRB- -RSB-)) (. .)))
( (S (S (ADVP (RB Thus)) (NP (JJ CD123+) (NNS pDCs)) (VP (VBP comprise) (NP (NP (DT a) (JJ small) (NN proportion)) (PP (IN of) (NP (NP (NN RA) (NN SF) (JJ mononuclear) (NNS cells)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VP (VBP are) (ADJP (RB predominantly) (JJ immature))) (CC but) (VP (VBP show) (NP (NP (DT some) (NN evidence)) (PP (IN of) (NP (NN activation)))) (ADVP (FW in) (FW situ))))))))))) (. .)))
( (S (S (NP (NP (DT These) (NNS observations)) (PP (VBG regarding) (NP (NP (NP (NN phenotype)) (CC and) (NP (NN PB))) (CC and) (NP (NN SF) (NNS numbers))))) (VP (VBP are) (ADJP (JJ consistent) (PP (IN with) (NP (NP (NNS findings)) (PP (IN in) (NP (NP (CD two) (JJ recent) (NNS studies)) (NP (CD -LSB-39,45) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB previously)) (VP (VBN shown) (SBAR (IN that) (S (NP (ADJP (RB freshly) (VBN isolated)) (JJ CD33brightCD14-CD11c+) (NN SF) (NNS DCs)) (ADVP (RB efficiently)) (VP (VBP stimulate) (NP (VBG resting) (NN T) (NNS cells)) (PP (IN in) (NP (JJ allogeneic) (JJ mixed) (NN lymphocyte) (NNS reactions) (NP (CD -LSB-21)) (-RRB- -RSB-))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (SBAR (IN whereas) (S (NP (ADJP (RB freshly) (VBN isolated)) (JJ CD11c+) (NN PB) (NNS DCs)) (VP (VBP are) (NP (NP (JJ efficient) (NNS APCs)) (PP (IN in) (NP (JJ mixed) (NN lymphocyte) (NNS reactions))))))) (, ,) (NP (JJ CD123+) (NN PB) (NNS DCs)) (ADVP (RB usually)) (VP (VBP require) (NP (NP (JJ prior) (NN activation)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (NN IL-3)) (CC and) (NP (NN CD154))))))) (PP (IN for) (NP (NP (NN acquisition)) (PP (IN of) (NP (NN APC) (NN function))) (PP (IN in) (NP (DT this) (NN assay))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB analyse) (NP (NP (DT the) (JJ functional) (NN capability)) (PP (IN of) (NP (NN RA) (NN SF) (NNS DCs))))))) (, ,) (NP (JJ CD11c+) (CC and) (JJ CD123+) (NNS DCs)) (VP (VBD were) (VP (VP (VBN sorted) (PP (IN from) (NP (CC either) (NP (JJ normal) (NN PB)) (CC or) (NP (NN RA) (NN SF))))) (CC and) (VP (VBN incubated) (PP (IN with) (NP (ADJP (RB freshly) (VBN isolated)) (JJ normal) (JJ allogeneic) (NN PB) (NN T) (NNS cells))))))) (. .)))
( (S (S (NP (ADJP (RB Freshly) (VBN isolated)) (ADJP (ADJP (NN PB) (JJ CD11c+)) (CONJP (CC but) (RB not)) (ADJP (JJ CD123+))) (NNS DCs)) (ADVP (RB efficiently)) (VP (VBD stimulated) (NP (NP (JJ allogeneic) (NN T-cell) (NN proliferation)) (CC and) (NP (NN IFN-γ)) (CC and) (NP (NN IL-10) (NN production))) (PP (IN in) (NP (JJ mixed) (NN lymphocyte) (NNS reactions))))) (. .)))
( (S (S (NP (NP (NN Addition)) (PP (IN of) (NP (NN IL-3)))) (VP (VBD made) (NP (DT no) (NN difference)) (PP (TO to) (NP (DT the) (NN T-cell) (NN proliferation))) (PP (IN in) (NN response) (TO to) (NP (NP (JJ CD123+) (NNS DCs)) (PRN (-LRB- -LRB-) (NP (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN death)) (PP (IN of) (NP (DT the) (NNS APCs)))) (VP (VBD was) (RB not) (ADJP (JJ responsible))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (DT both) (ADJP (RB freshly) (VBN isolated)) (ADJP (ADJP (JJ CD11c+)) (CC and) (ADJP (JJ CD123+))) (NN SF) (NNS DCs)) (ADVP (RB efficiently)) (VP (VBD stimulated) (NP (NP (NP (NN proliferation)) (CC and) (NP (NN IFN-γ))) (CC and) (NP (NN IL-10) (NN production))) (PP (IN by) (NP (VBG resting) (JJ normal) (JJ allogeneic) (NN T) (NNS cells))) (-LRB- -LRB-) (NP (NNP Fig.) (CD 5)) (-RRB- -RRB-))) (. .)))
( (S (S (NP (DT A) (JJ recent) (NN study)) (VP (VBD demonstrated) (NP (NP (DT the) (NN capacity)) (PP (IN of) (NP (NN RA) (NN SF))) (S (VP (TO to) (VP (VB inhibit) (NP (JJ pDC) (NN differentiation)) (PP (IN in) (NP (FW vitro) (NN -LSB-39) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (DT The) (JJ current) (NNS studies)) (VP (VBP are) (ADJP (JJ consistent)) (, ,) (PP (IN in) (SBAR (IN that) (S (S (NP (NN SF) (NNS pDCs)) (VP (VBD showed) (NP (NP (RB only) (DT some) (NN evidence)) (PP (IN of) (NP (NN activation)))) (ADVP (FW in) (FW situ)))) (, ,) (CC but) (S (SBAR (IN once) (S (VP (VBN incubated) (PP (IN in) (NP (NP (JJ mixed) (NN lymphocyte) (NNS reactions)) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN SF)))))))))) (NP (PRP they)) (VP (VBD displayed) (NP (NP (VBN enhanced) (NN APC) (NN function)) (ADJP (JJ relative) (PP (TO to) (NP (NP (DT that)) (PP (IN of) (NP (NN PB) (NNS pDCs)))))))))))))) (. .)))
( (S (S (SBAR (IN Whereas) (S (NP (NP (NN stimulation)) (PP (IN of) (NP (JJ mixed) (NN lymphocyte) (NNS reactions))) (PP (CC either) (PP (IN by) (NP (NN CD11c+))) (CC or) (PP (IN by) (NP (JJ CD123+) (NN PB) (NNS DCs))))) (VP (VBD resulted) (PP (IN in) (NP (JJ little) (NN TNF-α) (NN production)))))) (, ,) (NP (NP (NN stimulation)) (PP (IN by) (NP (NP (DT either)) (PP (IN of) (NP (NP (DT these) (NNS DCs)) (PP (IN from) (NP (NN RA) (NN SF)))))))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NP (JJ TNF-α) (NN secretion)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 5)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (DT The) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NNS pDCs)) (VP (VBP have) (NP (NP (DT the) (NN capacity)) (PP (IN for) (NP (NP (VBN enhanced) (NN APC) (NN function)) (ADJP (JJ relative) (PP (TO to) (NP (NP (NN PB) (NNS pDCs)) (VP (ADVP (RB once)) (VBN removed) (PP (IN from) (NP (DT the) (NN RA) (NN SF) (NN environment))))))))))))))) (. .)))
( (S (ADVP (RB Furthermore)) (, ,) (PP (IN at) (NP (NP (DT the) (NN time)) (PP (IN of) (NP (NP (NN antigen) (NN presentation)) (PP (IN by) (NP (NN SF) (NNS DCs))) (PP (TO to) (NP (NN T) (NNS cells))))))) (, ,) (S (NP (NP (NN production)) (PP (IN of) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NNS cytokines))))) (PP (IN by) (NP (CC either) (NP (NN T) (NNS cells)) (CC or) (NP (NNS DCs))))) (VP (MD may) (VP (VB be) (VP (VBN stimulated) (, ,) (PP (VBG including) (NP (NN TNF-α))))))) (, ,) (CC and) (S (NP (DT this)) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (NP (NP (NP (DT a) (NN characteristic)) (PP (IN of) (NP (NN RA) (JJ synovial) (NNS DCs)))) (CONJP (RB rather) (IN than)) (NP (NP (DT the) (NN subtype)) (PP (IN of) (NP (VBG stimulating) (NNS DCs)))))))))) (. .)))
( (S (NP (NN Discussion))))
( (S (S (NP (NP (JJ Ongoing) (NN inflammation)) (PP (IN in) (NP (NN RA)))) (VP (VBZ involves) (NP (NP (JJ positive) (NN feedback) (NNS loops)) (PP (IN between) (NP (NP (VBN activated) (NN T) (NNS cells)) (, ,) (NP (NN B) (NNS cells)) (, ,) (NP (NNS DCs)) (, ,) (NP (NNS macrophages)) (, ,) (CC and) (NP (PRP$ their) (NNS products))))) (, ,) (PP (IN with) (NP (NP (JJ destructive) (NNS consequences)) (PP (IN for) (NP (JJ parenchymal) (NNS cells))))))) (. .)))
( (S (S (NP (ADJP (ADJP (JJ Clinical)) (CC and) (ADJP (JJ animal))) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (JJ effector-site) (NNS DCs)) (VP (VP (VBP play) (NP (DT an) (JJ important) (JJ proinflammatory) (NN role)) (PP (IN in) (NP (NP (DT the) (NN perpetuation)) (PP (IN of) (NP (JJ autoimmune) (NN disease)))))) (CC and) (VP (VBP contribute) (PP (TO to) (NP (NP (DT the) (JJ lymph-node-like) (NN organization)) (PP (IN of) (NP (DT that) (NN tissue) (NN -LSB-22,46))))))) (-RRB- -RSB-))))) (. .)))
( (S (S (S (NP (DT This) (NN role)) (VP (MD may) (VP (VB be) (VP (VBN effected) (PP (IN by) (NP (NP (JJ local) (NN antigen) (NN presentation)) (PP (TO to) (NP (ADJP (ADJP (JJ CD4+)) (CC and) (ADJP (JJ CD8+))) (NN effector) (NNS cells))))))))) (, ,) (CC but) (S (NP (NNS DC) (NP (NP (NN cytokine)) (CC and) (NP (NN chemokine) (NN secretion)))) (VP (VBP are) (ADVP (RB also)) (ADJP (JJ important) (NP (CD -LSB-47,48) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (NP (NN TNF-α)) (CC and) (NP (NN IL-1β))) (VP (VBP are) (NP (ADJP (ADJP (JJ important)) (ADJP (JJ downstream)) (ADJP (JJ proinflammatory)) (CC and) (ADJP (JJ destructive))) (NNS cytokines)) (PP (IN in) (NP (NN RA))) (PP (IN for) (NP (NP (JJ somatic) (NNS cells)) (, ,) (SBAR (WHNP (WP$ whose) (NN release)) (S (VP (VBZ is) (VP (VBN promoted) (PP (IN by) (NP (NP (NN activation)) (PP (IN of) (NP (NNS macrophages))))))))))))) (. .)))
( (S (S (S (NP (NN IL-10)) (VP (VBZ is) (ADVP (RB highly)) (VP (VBN expressed) (PP (IN in) (NP (NN RA)))))) (, ,) (CC and) (S (NP (NN IFN-γ)) (VP (VBZ is) (NP (DT an) (JJ important) (NN T-cell) (NN effector) (NN cytokine) (CD -LSB-49,50) (-RRB- -RSB-))))) (. .)))
( (S (PP (IN In) (NP (DT the) (JJ current) (NNS studies))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (, ,) (PP (IN in) (NN addition) (TO to) (NP (NP (DT the) (ADJP (RB previously) (VBN described)) (NN population)) (PP (IN of) (NP (JJ nuclear) (JJ RelB+) (NNS DCs))))) (, ,) (NP (NP (DT a) (JJ further) (NN population)) (PP (IN of) (NP (JJ nuclear) (JJ RelB-CD123+) (NNS pDCs)))) (VP (VBZ is) (ADJP (JJ located) (PP (IN in) (NP (NP (JJ perivascular) (NNS regions)) (PP (IN of) (NP (NP (NN RA)) (CONJP (CC but) (RB not)) (NP (JJ normal) (JJ synovial) (NN tissue) (NN sublining))))))))))) (. .)))
( (S (S (S (ADVP (RB Moreover)) (, ,) (NP (NNS pDCs)) (VP (VBD were) (ADJP (JJ located) (PP (IN within) (NP (NN blood) (NNS vessels)))))) (, ,) (CC and) (S (NP (DT both) (NN DC) (NNS populations)) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (NP (JJ perivascular) (NNS areas)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (NNS cells)) (VP (VBG producing) (NP (NN TNF-α)))) (VP (VBD were) (VP (VBN colocated) (NP (CD -LSB-35) (-RRB- -RSB-)))))))))))) (. .)))
( (S (S (NP (NP (NN Adherence)) (PP (IN of) (NP (NP (NN CD123+)) (CC and) (NP (JJ CD11c+) (NNS DCs)))) (PP (TO to) (NP (JJ TNF-α-activated) (NN endothelium)))) (VP (VBD was) (ADJP (ADJP (JJR higher)) (PP (IN than) (PP (TO to) (NP (VBG resting) (NN endothelium))))) (PP (IN in) (NP (FW vitro))) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))) (. .)))
( (S (S (NP (NN TNF-α)) (VP (VP (VBZ plays) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (DT the) (NN recruitment)) (PP (IN of) (NP (JJ other) (NNS leukocytes))) (PP (TO to) (NP (ADJP (NN RA) (JJ synovial)) (NN tissue) (NN -LSB-29))) (-RRB- -RSB-)))) (, ,) (CC and) (ADVP (DT this) (RBS most) (RB likely)) (VP (VBZ pertains) (PP (TO to) (NP (NP (DT the) (NN recruitment)) (PP (IN of) (NP (NN pDCs))) (PP (TO to) (NP (NP (NN RA)) (CONJP (CC but) (RB not)) (NP (JJ normal) (JJ synovial) (NN tissue)))))) (PP (IN through) (NP (NP (NP (NN expression)) (PP (IN of) (NP (NP (NN adhesion) (NNS molecules)) (PP (JJ such) (IN as) (NP (NP (JJ intercellular) (NN adhesion) (NN molecule) (-LRB- -LRB-) (NN ICAM) (-RRB- -RRB-) (CD -1)) (, ,) (NP (NN CD62-E)) (, ,) (CC and) (NP (NN CD62-P))))))) (CC and) (NP (NP (NN interaction)) (PP (IN with) (NP (NP (PRP$ their) (NNS ligands)) (PP (IN on) (NP (NNS pDCs) (CD -LSB-9,11,51-54) (-RRB- -RSB-))))))))))) (. .)))
( (S (S (ADVP (RB Furthermore)) (, ,) (NP (NN TNF-α)) (VP (VBZ up-regulates) (NP (NP (NN synthesis)) (PP (IN of) (NP (NNS chemokines)))) (PP (IN by) (NP (JJ endothelial) (NNS cells) (NP (CD -LSB-55))))) (-RRB- -RSB-)) (. .)))
( (S (S (PP (IN During) (NP (ADJP (RB experimentally) (VBN elicited)) (JJ allergic) (NN rhinitis))) (, ,) (NP (JJ CD123+HLA-DR+) (NNS pDCs)) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (VP (VBN recruited) (PP (TO to) (NP (JJ human) (JJ nasal) (NN mucosa) (CD -LSB-11)))))))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (NP (DT The) (NN gene)) (PP (IN for) (NP (NN MxA)))) (VP (VP (VBZ is) (ADVP (RB specifically)) (VP (VBN induced) (PP (IN by) (NP (NN IFN-α))))) (CC and) (ADVP (RB therefore)) (VP (VBZ identifies) (NP (NP (DT a) (NN population)) (PP (IN of) (NP (VBN activated) (NNS pDCs))))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NN BDCA2)) (VP (VBZ is) (NP (NP (DT a) (NN marker)) (PP (IN of) (NP (JJ immature) (NNS pDCs)))))) (. .)))
( (S (S (NP (JJ MxA+) (NNS pDCs)) (VP (VBP have) (ADVP (RB previously)) (VP (VBN been) (VP (VBN demonstrated) (PP (IN in) (NP (NP (JJ involved) (NN lupus) (NN skin)) (CC and) (NP (JJ inflamed) (NN tonsil) (NN -LSB-13)) (-RRB- -RSB-))))))) (. .)))
( (S (PP (IN In) (NP (NN RA) (JJ synovial) (NN tissue))) (, ,) (NP (NN BDCA2)) (VP (VBD was) (VP (VBN shown) (S (VP (TO to) (VP (VB stain) (NP (JJR fewer) (NNS cells)) (PP (IN than) (NP (NP (NN CD123)) (CC or) (NP (NN MxA)))))))) (, ,) (S (VP (VBG suggesting) (NP (NP (NP (NN differentiation)) (ADVP (FW in) (FW situ))) (PP (IN of) (NP (NP (DT a) (JJ large) (NN proportion)) (PP (IN of) (NP (NN pDCs))))) (PP (IN into) (NP (NP (NNS cells)) (PP (IN with) (NP (NP (DT a) (NN capacity)) (PP (IN for) (NP (NP (NN production)) (PP (IN of) (NP (NP (NN IFN-α)) (CC and) (NP (JJ other) (NNS cytokines)))))))))))))) (. .)))
( (S (S (ADVP (RB Together)) (, ,) (NP (DT the) (JJ current) (CC and) (JJ previous) (NNS studies)) (VP (VBP demonstrate) (NP (NP (NP (NN recruitment)) (PP (IN of) (NP (NNS pDCs))) (PP (TO to) (NP (JJ normal) (JJ lymphoid) (NNS organs)))) (CONJP (RB as) (RB well) (IN as)) (NP (JJ inflammatory) (NNS sites))) (, ,) (PP (IN with) (NP (NP (JJ local) (NN differentiation)) (, ,) (CONJP (CC but) (RB no)) (NP (NP (NN recruitment)) (PP (TO to) (NP (JJ normal) (JJ peripheral) (NNS tissues)))))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (S (NP (JJ CD11c+) (JJ myeloid) (NNS precursors)) (VP (VBP populate) (NP (JJ normal) (VBG resting) (NNS tissues)) (, ,) (SBAR (IN as) (S (VP (VBN shown) (ADVP (RB here))))))) (, ,) (CC but) (S (NP (JJ additional) (JJ CD11c+) (JJ myeloid) (JJ cellular) (NN recruitment)) (VP (VBZ takes) (NP (NN place)) (PP (IN at) (NP (NP (JJ inflammatory) (NNS sites)) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (NN RelB) (JJ nuclear) (NN translocation)) (VP (VBZ takes) (NP (NN place) (CD -LSB-21,56) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB previously)) (VP (VBN shown) (SBAR (IN that) (S (, ,) (PP (IN like) (NP (JJ synovial) (NNS pDCs))) (, ,) (NP (NP (JJ CD123+) (NNS DCs)) (PP (IN in) (NP (NP (DT the) (NN T-cell) (NN area)) (PP (IN of) (NP (JJ human) (NN tonsil)))))) (VP (VBP are) (ADVP (RB also)) (NP (JJ nuclear) (NN RelB-) (NN -LSB-23))) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (DT The) (NNS data)) (VP (VBP suggest) (SBAR (CC either) (SBAR (IN that) (S (NP (NP (NN activation)) (PP (IN of) (NP (NNS pDCs)))) (VP (VBZ is) (RB not) (VP (VBN associated) (PP (IN with) (NP (NP (NP (JJ nuclear) (NN translocation)) (CC and) (NP (JJ transcriptional) (NN activity))) (PP (IN of) (NP (NN RelB))))))))) (CC or) (SBAR (IN that) (S (NP (NP (NNS conditions)) (PP (IN in) (NP (NP (NN tonsil)) (CC and) (NP (NN synovium))))) (VP (VBP do) (RB not) (VP (VB induce) (NP (JJ sufficient) (NN RelB) (NN translocation)) (PP (IN for) (NP (NP (NN detection)) (PP (IN by) (NP (NN immunohistochemistry) (CD -LSB-26,57))))))) (-RRB- -RSB-)))))) (. .)))
( (S (SBAR (IN As) (S (NP (NP (JJ preliminary) (NNS studies)) (ADJP (FW in) (FW vitro))) (VP (VBP demonstrate) (NP (NP (NP (NN induction)) (PP (IN of) (NP (NN RelB))) (PP (IN in) (NP (NP (NN PB) (NNS pDCs)) (PP (IN after) (NP (NP (NN stimulation)) (PP (IN with) (NP (NP (NN lipopolysaccharide)) (CC and) (NP (NN CpG))))))))) (, ,) (CC and) (NP (NP (VBN reduced) (NN production)) (PP (IN of) (NP (NN IFN-α))) (PP (IN by) (NP (NP (NNS pDCs)) (PP (IN in) (NP (JJ RelB-deficient) (NNS mice)))))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ likely) (SBAR (IN that) (S (NP (NN RelB) (NN activation)) (VP (VBZ does) (VP (VBP accompany) (NP (JJ pDC) (NN activation)))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NN RelB) (NN translocation)) (VP (MD might) (VP (VB be) (ADVP (RB quantitatively)) (VP (VBN reduced))))) (CC or) (S (NP (NN RelB)) (VP (MD might) (VP (VB be) (VP (ADVP (RBR more) (RB rapidly)) (VBN degraded) (PP (IN in) (NP (NP (DT the) (NN nucleus)) (PP (IN of) (NP (NNS pDCs))))) (PP (IN than) (FRAG (PP (IN of) (NP (NP (JJ myeloid) (NNS DCs)) (PP (IN in) (NP (JJ inflamed) (NNS tissues) (NP (CD -LSB-58)))))) (-RRB- -RSB-))))))) (. .)))
( (S (S (PP (IN Of) (NN relevance) (TO to) (NP (DT the) (NN RA) (JJ inflammatory) (NN lesion))) (, ,) (NP (NP (NN stimulation)) (PP (IN of) (NP (NN blood) (JJ pDC) (NNS precursors))) (PP (IN with) (NP (NP (NNS signals)) (PP (VBG including) (NP (NP (NN CD154)) (, ,) (NP (NN influenza) (NN virus)) (, ,) (CC or) (NP (NN CpG) (NNS oligonucleotides))))))) (VP (VBZ induces) (NP (NP (NN production)) (PP (IN of) (NP (NP (JJ large) (NNS amounts)) (PP (IN of) (NP (NP (NNS cytokines)) (, ,) (PP (VBG including) (NP (NP (NP (NN IFN-α)) (, ,) (NP (NN IFN-β)) (, ,) (CC and) (NP (NN TNF-α))) (: ;) (NP (NP (NN induction)) (PP (IN of) (NP (NN DC) (NN differentiation)))) (: ;) (CC and) (NP (NP (NN stimulation)) (PP (IN of) (NP (NN APC) (NN function) (CD -LSB-3,39,44,59)))))))))))) (-RRB- -RSB-)) (. .)))
( (S (SBAR (IN Although) (S (NP (NP (JJ inhibitory) (NNS effects)) (PP (IN of) (NP (NN SF))) (PP (PP (IN on) (NP (NN DC) (NN function))) (, ,) (CC and) (ADVP (RB thus)) (PP (IN on) (NP (NP (NN T-cell) (NN proliferation)) (CC and) (NP (NN cytokine) (NN production))))) (, ,)) (VP (VBP are) (VP (VBN confirmed) (NP (RB here) (CD -LSB-21,39,60) (-RRB- -RSB-)))))) (, ,) (NP (NP (NNS factors)) (PP (IN in) (NP (DT the) (NN RA) (NN SF) (NN environment))) (, ,) (PP (JJ such) (IN as) (NP (NP (NN IL-3)) (CC and) (NP (NN CD154)))) (, ,)) (VP (MD may) (VP (VB be) (ADJP (JJ sufficient) (S (VP (TO to) (VP (NN precondition) (NP (DT the) (NN SF) (NNS pDCs)) (PP (IN for) (NP (JJ efficient) (NN APC) (NN function) (NP (ADJP (FW ex) (FW vivo)) (NN -LSB-36,44) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (NP (NP (NN IFN-γ)) (, ,) (NP (NN IL-10)) (, ,) (CC and) (NP (NN TNF-α))) (VP (VBD were) (VP (VBN produced) (PP (IN in) (NP (NP (JJ mixed) (NN lymphocyte) (NNS reactions)) (VP (VBN stimulated) (PP (PP (IN by) (NP (NP (JJ myeloid) (NN or) (NNS pDCs)) (VP (VBN derived) (PP (IN from) (NP (NP (NN SF)) (CONJP (CC but) (RB not)) (NP (NN PB))))))) (, ,) (PP (RB potentially) (IN by) (NP (NNS DCs))) (CC or) (PP (IN by) (NP (NP (NN T) (NNS cells)) (CC or) (NP (DT both))))))))))) (. .)))
( (S (PP (IN In) (NP (DT the) (NN tissue))) (, ,) (PP (IN as) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NP (NN antigen) (NN presentation)) (PP (IN by) (NP (NP (JJ myeloid) (NNS DCs)) (CC or) (NP (NNS pDCs)))))))) (, ,) (NP (JJ key) (NN effector) (NNS cytokines)) (VP (MD may) (VP (VB be) (VP (VBN produced) (PP (IN in) (NP (NP (NP (NP (JJ perivascular) (NNS areas)) (PP (IN in) (NP (NN RA)))) (, ,) (NP (NP (JJ located)) (ADJP (RB strategically) (JJ close) (PP (TO to) (NP (JJ endothelial) (NNS cells))))) (, ,)) (CONJP (RB as) (RB well) (IN as)) (NP (JJ incoming) (NNS leukocytes))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ is) (RB not) (VP (VBN known) (SBAR (IN whether) (S (NP (NNS pDCs)) (VP (VBP are) (ADJP (JJ capable)) (, ,) (PP (IN like) (NP (JJ myeloid) (NNS DCs))) (, ,) (PP (IN of) (NP (NP (NN migration)) (PP (IN from) (NP (JJ synovial) (NN tissue))) (PP (TO to) (NP (JJ draining) (NN lymph) (NNS nodes))))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (PRP it)) (VP (VBZ seems) (ADJP (JJ probable)) (SBAR (IN that) (S (NP (NP (NP (NNS pDCs)) (VP (VBN conditioned) (PP (IN by) (NP (NP (JJ local) (NN IL-3)) (CC and) (NP (NN CD154)))))) (, ,) (CONJP (CC or) (RB even)) (NP (NP (ADJP (ADJP (JJ viral)) (CC or) (ADJP (JJ bacterial))) (NNS products)) (VP (VBN transported) (PP (TO to) (NP (DT the) (NN synovium))))) (, ,)) (ADVP (RB predominantly)) (VP (VBP play) (NP (JJ local) (ADJP (ADJP (JJ proinflammatory)) (CC and) (ADJP (JJ antigen-presenting))) (NNS roles)) (, ,) (PP (IN through) (NP (NP (NN secretion)) (PP (IN of) (NP (NP (NNS cytokines)) (PP (JJ such) (IN as) (NP (ADJP (ADJP (JJ IFN-α)) (CC and) (ADJP (ADVP (RB possibly)) (JJ TNF-α))) (NN -LSB-61,62) (-RRB- -RSB-)))))))))))) (. .)))
( (S (NP (NN Conclusion))))
( (S (S (NP (NNS pDCs)) (VP (VP (VBP are) (VP (VBN recruited) (PP (TO to) (NP (NN RA) (JJ synovial) (NN tissue))))) (CC and) (VP (VBP comprise) (NP (NP (DT an) (NN APC) (NN population)) (ADJP (JJ distinct) (PP (IN from) (NP (DT the) (ADJP (RB previously) (VBN described)) (JJ nuclear) (NN RelB+) (JJ synovial) (NNS DCs)))))))) (. .)))
( (S (S (NP (NP (DT The) (NN APC) (NN function)) (PP (IN of) (NP (NNS pDCs)))) (VP (VBZ is) (ADJP (ADJP (JJR greater)) (PP (IN in) (NP (NN SF))) (PP (IN than) (PP (IN in) (NP (NN PB))))))) (. .)))
( (S (S (NP (VBN Activated) (NP (NP (NN pDCs)) (CC and) (NP (NN interacting))) (NN T) (NNS cells)) (VP (MD may) (VP (VB contribute) (ADVP (RB significantly)) (PP (TO to) (NP (NP (DT the) (JJ inflammatory) (NN environment)) (PP (IN in) (NP (NN RA)))))))) (. .)))
( (S (NP (NNS Abbreviations))))
( (S (NP (NP (NP (NN APC) (JJ =) (JJ antigen-presenting) (NN cell)) (: ;) (NP (NN DC) (JJ =) (JJ dendritic) (NN cell)) (: ;) (NP (NN ELISA) (JJ =) (NP (NP (JJ enzyme-linked) (JJ immunosorbent) (NN assay)) (: ;) (NP (NN FCS) (JJ =) (JJ fetal) (NN calf) (NN serum)) (: ;) (NP (NN FITC) (JJ =) (NN fluorescein) (NN isothiocyanate)) (: ;) (NP (NN IFN) (JJ =) (NN interferon) (: ;) (NN IL) (JJ =) (NN interleukin)) (: ;)) (NN NK) (JJ =) (JJ natural) (NN killer)) (: ;) (NP (NN PB) (JJ =) (JJ peripheral) (NN blood)) (: ;) (NP (JJ pDC) (JJ =) (NN plasmacytoid) (NN DC)) (: ;) (NP (NN PE) (JJ =) (NN phycoerythrin)) (: ;) (NP (NN RA) (JJ =) (JJ rheumatoid) (NN arthritis)) (: ;) (NP (NN SF) (JJ =) (JJ synovial) (NN fluid))) (: ;) (NP (NN TNF) (JJ =) (NN tumor) (NN necrosis) (NN factor)) (. .))))
( (S (NP (VBG Competing) (NNS interests))))
( (S (S (NP (DT The) (NN author) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-)) (VP (VB declare) (SBAR (IN that) (S (NP (PRP they)) (VP (VBP have) (NP (DT no) (VBG competing) (NNS interests))))))) (. .)))
( (S (NP (NP (NNS Authors) (POS ')) (NNS contributions))))
( (S (S (S (NP (NP (NN LC)) (, ,) (NP (NN RT)) (, ,) (NP (NN LF)) (, ,) (CC and) (NP (NN PP))) (VP (VBD conceived) (NP (DT the) (NNS experiments)))) (CC and) (S (NP (NP (NN LC)) (, ,) (NP (NN AB)) (, ,) (NP (NN LS) (, ,) (NNP JP)) (, ,) (CC and) (NP (NN LF))) (VP (VBD carried) (NP (PRP them)) (ADVP (RP out))))) (. .)))
( (S (S (NP (NP (NN LC)) (, ,) (NP (NN RT)) (, ,) (CC and) (NP (NN LF))) (VP (VBP wrote) (NP (DT the) (NN manuscript)))) (. .)))
( (S (NP (NP (NN Figure)) (CC and) (NP (NN Table)) (NP (NNS captions)))))
( (S (NP (NP (NN Figure) (CD 1)) (: :) (S (NP (NP (JJ Nuclear) (JJ RelB-CD123+) (NN plasmacytoid) (JJ dendritic) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNS pDCs)) (-RRB- -RRB-))) (VP (VBP are) (ADJP (JJ located) (PP (IN in) (NP (NP (JJ close) (NN association)) (PP (IN with) (NP (NP (NNS cells)) (VP (VBG expressing) (NP (NP (NP (NP (NN tumor) (NN necrosis) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN TNF)) (-RRB- -RRB-))) (NN -α)) (PP (IN in) (NP (NP (JJ lymphoid) (NNS aggregates)) (PP (IN of) (NP (NP (NP (JJ rheumatoid) (NN arthritis)) (PRN (-LRB- -LRB-) (NP (NN RA)) (-RRB- -RRB-))) (JJ synovial) (NN tissue)))))))))))))) (. .))))
( (S (NP (NP (NP (NNS Sections)) (PP (IN of) (NP (NP (NP (NN frozen) (JJ normal) (JJ human) (JJ synovial) (NN tissue)) (PRN (-LRB- -LRB-) (NP (NP (NN a)) (, ,) (NP (NN b)) (, ,) (NP (NN e))) (-RRB- -RRB-))) (CC or) (NP (NP (NP (JJ synovial) (NN tissue)) (PP (IN from) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (JJ untreated) (JJ active) (NN RA)))))) (PRN (-LRB- -LRB-) (NP (NP (NN c)) (, ,) (NP (NN f)) (, ,) (NP (NN g))) (-RRB- -RRB-)))))) (CC or) (NP (NP (JJ formalin-fixed) (NNS sections)) (PP (IN from) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (NP (JJ active) (NN RA)) (PRN (-LRB- -LRB-) (NP (NP (NN d)) (, ,) (NP (NN h))) (, ,) (NP (NN i)) (-RRB- -RRB-)))))))) (VP (VBD were) (VP (VBN stained) (PP (IN with) (NP (NP (NP (NN anti-CD11c)) (PRN (-LRB- -LRB-) (NP (NP (NN brown)) (, ,) (NP (NN a)) (, ,) (NP (NN c))) (-RRB- -RRB-))) (, ,) (NP (NP (NN anti-CD123)) (PRN (-LRB- -LRB-) (NP (NP (NN brown)) (, ,) (NP (NN b)) (, ,) (NP (NN d))) (-RRB- -RRB-))) (, ,) (CC or) (NP (NP (NN anti-TNF-α)) (PRN (-LRB- -LRB-) (NP (NP (NN brown)) (, ,) (NP (NN g))) (-RRB- -RRB-))))) (S (VP (VBG using) (NP (DT an) (NN immunoperoxidase) (NN technique)))))) (. .)))
( (S (PP (IN For) (NP (JJ double) (NN staining))) (, ,) (NP (NNS sections)) (VP (VBD were) (VP (VBN stained) (PP (PP (IN with) (NP (NP (NP (NN Ulex)) (PRN (-LRB- -LRB-) (NP (JJ red)) (-RRB- -RRB-))) (CC and) (NP (NP (NN anti-CD123)) (PRN (-LRB- -LRB-) (NP (NN brown)) (, ,) (NP (NP (NN e)) (, ,) (NP (NN f)) (, ,) (NP (NN g))) (-RRB- -RRB-))))) (CC or) (PP (IN with) (NP (NP (NP (NN RelB)) (PRN (-LRB- -LRB-) (NP (NN purple)) (-RRB- -RRB-))) (CC and) (NP (NP (NN CD123)) (PRN (-LRB- -LRB-) (NP (NP (NN brown)) (, ,) (NP (NN h)) (, ,) (NP (NN i))) (-RRB- -RRB-)))))) (S (VP (VBG using) (NP (DT a) (JJ double) (, ,) (JJ immunoperoxidase–immunoalkaline) (NN phosphatase) (NN technique)))))) (. .)))
( (S (S (NP (DT All) (NNS sections)) (VP (VBD were) (ADJP (JJ counterstained) (PP (IN with) (NP (NP (NN hematoxylin)) (PRN (-LRB- -LRB-) (NP (JJ blue)) (-RRB- -RRB-))))) (PP (IN except) (NP (NP (NN h)) (CC and) (NP (CD i)))) (, ,) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (DT the) (NN nucleus)) (PP (IN of) (NP (JJ CD123+) (NNS cells)))) (VP (VBZ appears) (PP (IN as) (NP (DT a) (NN hole)))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ thick) (NN arrow)) (PP (IN in) (NP (NN d)))) (VP (VBZ identifies) (NP (DT a) (NN blood) (NN vessel)))) (. .)))
( (S (S (NP (NN Thin) (NNS arrows)) (VP (VB denote) (NP (NP (NP (JJ representative) (JJ CD123+) (JJ perivascular) (NNS DCs)) (PRN (-LRB- -LRB-) (NP (NN d)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ representative) (JJ double-stained) (NNS vessels)) (PRN (-LRB- -LRB-) (NP (NN e)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (JJ CD123+) (NN cell)) (PP (IN within) (NP (NP (DT a) (NN blood) (NN vessel)) (PRN (-LRB- -LRB-) (NP (NN f)) (-RRB- -RRB-))))) (, ,) (CC and) (NP (NP (NNS nuclei)) (VP (VBN stained) (PP (IN by) (NP (NN RelB) (-LRB- -LRB-) (NN h) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NNS Data)) (VP (VBP are) (NP (NP (JJ representative)) (PP (IN of) (NP (QP (IN at) (JJS least) (CD three)) (JJ separate) (NN RA) (NNS donors))) (PP (IN in) (NP (JJ individual) (NNS experiments)))))) (. .)))
( (S (S (NP (NN Scale) (NNS bars)) (VP (VBP represent) (NP (CD 20) (NN μm)))) (. .)))
( (S (NP (NP (NN Figure) (CD 2)) (: :) (S (NP (NP (NP (JJ CD123+) (JJ dendritic) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNS DCs)) (-RRB- -RRB-))) (CC and) (NP (JJ CD11c+) (NNS cells))) (VP (VBP are) (VP (VBN enriched) (PP (IN in) (NP (NP (NP (NP (JJ rheumatoid) (NN arthritis)) (PRN (-LRB- -LRB-) (NP (NN RA)) (-RRB- -RRB-))) (JJ synovial) (NN tissue)) (PRN (-LRB- -LRB-) (NP (JJ ST)) (-RRB- -RRB-))))))) (. .))))
( (S (S (NP (NN CD123+) (NNS DCs)) (VP (VBD were) (VP (VBN quantitated) (PP (IN by) (S (VP (VBG counting) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NN CD123+Ulex-) (NNS cells)))) (PP (IN in) (NP (NP (NNS sections)) (VP (VBN double-stained) (PP (IN with) (NP (NP (NN CD123)) (CC and) (NP (NN Ulex))))))))))))) (. .)))
( (S (S (S (NP (NNS Cells)) (VP (VBD were) (VP (VBN counted) (PP (IN in) (NP (NP (DT each)) (PP (IN of) (NP (NP (DT the) (JJ entire) (NNS sections)) (PP (IN from) (NP (NP (NP (CD three) (NNS patients)) (CC and) (NP (CD three) (JJ normal) (NNS controls))) (PP (IN at) (NP (JJ high) (NN power)))))))))))) (, ,) (CC and) (S (PP (IN for) (NP (DT each) (NN biopsy))) (NP (DT this) (NN number)) (VP (VBD was) (VP (VBN corrected) (PP (IN for) (NP (NP (DT the) (NN area)) (PP (IN of) (NP (DT the) (NN section) (S (VP (TO to) (VP (VB obtain) (NP (DT the) (NNS number/mm2))))))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB quantitate) (NP (JJ CD11c+) (JJ cellular) (NN infiltration))))) (, ,) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NN CD11c+) (NNS cells)))) (VP (VBD was) (VP (VBN counted) (PP (IN in) (NP (NP (CD three) (JJ high-power) (NNS fields)) (PP (IN of) (NP (NP (DT the) (JJ synovial) (NN sublining)) (PP (IN in) (NP (NP (NNS sections)) (PP (IN from) (NP (NP (CD three) (NNS patients)) (CC and) (NP (CD three) (JJ normal) (NNS controls))))))))))))) (. .)))
( (S (S (NP (NNS Data)) (VP (VBP represent) (NP (NP (NN means) (NN ±) (JJ standard) (NN error)) (PP (IN of) (NP (DT the) (NN mean)))))) (. .)))
( (S (NP (NP (NN Figure) (CD 3)) (: :) (S (NP (NP (NP (JJ CD11c+) (JJ dendritic) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNS DCs)) (-RRB- -RRB-))) (CC and) (NP (JJ CD123+) (NNS DCs))) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (NP (NP (NP (JJ rheumatoid) (NN arthritis)) (PRN (-LRB- -LRB-) (NP (NN RA)) (-RRB- -RRB-))) (JJ synovial) (NN fluid)) (PRN (-LRB- -LRB-) (NP (NN SF)) (-RRB- -RRB-))))))) (. .))))
( (S (S (PP (IN After) (NP (NP (NN purification)) (PP (IN of) (NP (NP (JJ mononuclear) (NNS cells)) (PP (IN from) (NP (CC either) (NP (NP (JJ normal) (CC or) (NN RA) (JJ peripheral) (NN blood)) (PRN (-LRB- -LRB-) (NP (NN PB)) (-RRB- -RRB-))) (CC or) (NP (NN RA) (NN SF)))))))) (, ,) (NP (NNS cells)) (VP (VBD were) (VP (VBN stained) (PP (IN with) (NP (NP (NN CD123-PE)) (, ,) (NP (NN CD11c) (NN FITC)) (, ,) (NP (NN CD14-PECy5)) (, ,) (CC and) (NP (NN HLA-DR-APC))))))) (. .)))
( (S (S (NP (JJ Live) (JJ HLA-DR+CD14-) (JJ mononuclear) (NNS cells)) (VP (VBD were) (VP (VBN gated)))) (: ;) (S (NP (JJ polymorphonuclear) (NNS cells)) (VP (VBD were) (VP (VBN excluded) (PP (IN on) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (ADJP (ADJP (JJ forward)) (CC and) (ADJP (JJ side))) (NN light-scatter)))))))) (. .)))
( (S (S (NP (NN Scatter) (NNS plots)) (VP (VB depict) (NP (NP (NN percentage)) (PP (IN of) (NP (NP (JJ total) (NN PB)) (CC or) (NP (NP (NN SF) (NNS cells)) (VP (VBG expressing) (NP (NP (DT the) (VBN indicated) (NNS markers)) (PP (IN for) (NP (DT all) (NNS donors))))))))))) (. .)))
( (S (NP (NP (NN APC)) (, ,) (NP (NP (JJ antigen-presenting) (NN cell)) (: ;) (NP (NP (NN PBMC)) (, ,) (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (: ;) (NP (NN PE)) (, ,) (NP (NN phycoerythrin)) (: ;) (NP (NN SFMC)) (, ,) (NP (JJ synovial) (NN fluid) (JJ mononuclear) (NNS cells)))) (. .))))
( (S (NP (NP (NN Figure) (CD 4)) (: :) (NP (NP (NP (NN Morphology)) (CC and) (NP (NN cell-surface) (NN phenotype))) (PP (IN of) (NP (NP (NP (JJ dendritic) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN DC)) (-RRB- -RRB-))) (NNS subpopulations)))) (. .))))
( (S (S (LST (-LRB- -LRB-) (LS a) (-RRB- -RRB-)) (NP (NP (ADJP (RB Freshly) (VBN isolated)) (NN CD11c+CD123-) (NNS DCs)) (CC and) (NP (JJ CD123+CD11c-) (NNS DCs))) (VP (VP (VBD were) (VP (VBN sorted) (PP (IN from) (NP (CC either) (NP (NP (JJ normal) (JJ peripheral) (NN blood)) (PRN (-LRB- -LRB-) (NP (NN PB)) (-RRB- -RRB-))) (CC or) (NP (NP (JJ rheumatoid) (NN arthritis)) (PRN (-LRB- -LRB-) (NP (NN RA)) (-RRB- -RRB-))) (NP (NP (JJ synovial) (NN fluid)) (PRN (-LRB- -LRB-) (NP (NN SF)) (-RRB- -RRB-))))) (PP (VBG according) (PP (TO to) (NP (NP (DT the) (JJ gating) (NN strategy)) (VP (VBN outlined) (PP (IN in) (NP (NP (DT the) (NN legend)) (PP (TO to) (NP (NNP Fig.) (CD 3))))))))))) (CC and) (VP (VBD were) (ADVP (RB then)) (VP (VBN prepared) (PP (IN for) (NP (NN transmission) (NN electron) (NN microscopy))))))) (. .)))
( (S (S (NP (NNS Micrographs)) (VP (VBP are) (NP (NP (JJ representative)) (PP (IN of) (NP (CD three) (JJ separate) (NNS donors)))))) (. .)))
( (S (S (NP (NN Scale) (NNS bars)) (VP (VBP represent) (NP (CD 20) (NN μm)))) (. .)))
( (S (S (NP (NP (LST (-LRB- -LRB-) (LS b) (-RRB- -RRB-)) (JJ Normal) (NN PB)) (CC or) (NP (NN RA) (NN SF) (JJ mononuclear) (NNS cells))) (VP (VBD were) (VP (VBN stained) (PP (IN with) (NP (NP (NN CD123-PE)) (, ,) (NP (NN CD14-PECy5)) (, ,) (NP (NN HLA-DR-APC)) (, ,) (CC and) (NP (CC either) (NP (NN isotype) (NN control)) (CC or) (NP (NP (DT the) (VBN depicted) (NN marker)) (VP (VBN labelled) (PP (IN with) (NP (NN FITC))))))))))) (. .)))
( (S (S (NP (NP (JJ Live) (JJ HLA-DR+CD14-CD123+) (NNS cells)) (CC or) (NP (JJ HLA-DR+CD14-CD11c+) (NNS cells))) (VP (VBD were) (VP (VBN gated)))) (: ;) (S (NP (JJ polymorphonuclear) (NNS cells)) (VP (VBD were) (VP (VBN excluded) (PP (IN on) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (ADJP (ADJP (JJ forward)) (CC and) (ADJP (JJ side))) (NN light-scatter)))))))) (. .)))
( (S (S (NP (NP (DT The) (NN expression)) (PP (IN of) (NP (NP (NP (NN isotype) (NN control)) (PRN (-LRB- -LRB-) (NP (JJ dotted) (NNS lines)) (-RRB- -RRB-))) (CC and) (NP (NP (VBN indicated) (NNS markers)) (PRN (-LRB- -LRB-) (NP (JJ continuous) (NNS lines)) (-RRB- -RRB-))))) (PP (IN by) (NP (DT the) (JJ gated) (NNS cells)))) (VP (VBP are) (VP (VBN depicted)))) (. .)))
( (S (S (NP (NNS Data)) (VP (VBP are) (PP (IN from) (NP (NP (CD three) (NNS donors)) (PP (IN of) (NP (NP (JJ normal) (NN PB)) (CC or) (NP (NN RA) (NN SF)))))))) (. .)))
( (S (S (NP (NP (NN APC)) (, ,) (NP (JJ antigen-presenting) (NN cell) (: ;) (NN PE)) (, ,)) (NP (NN phycoerythrin))) (. .)))
( (S (NP (NP (NN Figure) (CD 5)) (: :) (S (NP (S (NP (NP (NN CD123+)) (CC and) (NP (NP (JJ CD11c+) (JJ synovial) (NN fluid)) (PRN (-LRB- -LRB-) (NP (NN SF)) (-RRB- -RRB-))) (NP (NP (JJ dendritic) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNS DCs)) (-RRB- -RRB-)))) (VP (VP (VBP are) (NP (NP (JJ efficient) (JJ antigen-presenting) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNS APCs)) (-RRB- -RRB-)))) (CC and) (VP (VB induce) (NP (NN secretion)) (PP (IN of) (NP (NN tumor) (NN necrosis) (NN factor) (NN α.)))))) (NP (ADJP (RB Freshly) (VBN sorted)) (NN CD123+CD11c-)) (CC or) (NP (NP (JJ CD11c+CD123-) (NNS DCs)) (PP (IN from) (NP (CC either) (NP (NP (NP (JJ normal) (JJ peripheral) (NN blood)) (PRN (-LRB- -LRB-) (NP (NN PB)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NN a–d)) (-RRB- -RRB-))) (CC or) (NP (JJ rheumatoid) (NN arthritis) (-LRB- -LRB-) (NN RA) (-RRB- -RRB-) (NN SF) (-LRB- -LRB-) (CD e–h) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN incubated) (PP (IN with) (NP (CD 105) (VBN purified) (JJ normal) (JJ allogeneic) (NN T) (NNS cells)))))) (. .))))
( (S (S (NP (NN T-cell) (NN proliferation)) (VP (VBD was) (VP (VBN measured) (PP (IN by) (NP (NP (CD -LSB-3H) (-RRB- -RSB-) (NN thymidine) (NN incorporation)) (PP (IN of) (NP (JJ triplicate) (NNS wells))) (PP (IN after) (NP (NP (CD 60) (NNS hours)) (PRN (-LRB- -LRB-) (NP (NN a)) (, ,) (NP (NN e)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (JJ Unstimulated) (NN T-cell) (NN proliferation)) (VP (VBD was) (ADVP (RB routinely)) (NP (CD <500) (NN cpm)))) (. .)))
( (S (S (NP (NNS Data)) (VP (VP (VBP represent) (NP (NP (NN means) (NN ±) (JJ standard) (NN error)) (PP (IN of) (NP (NP (DT the) (NN mean)) (PP (IN of) (NP (JJ triplicate) (NNS wells))))))) (CC and) (VP (VBP are) (PP (IN from) (NP (CD three) (JJ individual) (NP (NP (NN PB)) (CC and) (NP (NN SF))) (NNS donors)))))) (. .)))
( (S (S (NP (NP (DT The) (NNS concentrations)) (PP (IN of) (NP (NP (NN IFNγ)) (, ,) (NP (NN IL-10)) (, ,) (CC and) (NP (NN tumor) (NN necrosis) (NN factor) (PRN (-LRB- -LRB-) (NP (NN TNF)) (-RRB- -RRB-)) (CD -α))))) (VP (VBD were) (VP (VBN measured) (PP (IN in) (NP (NP (NNS supernatants)) (PP (IN of) (NP (NP (JJ allogeneic) (JJ mixed) (NN lymphocyte) (NNS reactions)) (VP (VBN stimulated) (PP (IN by) (NP (NP (NP (VBN sorted) (NN PB)) (PRN (-LRB- -LRB-) (NP (NN b–d)) (-RRB- -RRB-))) (CC or) (NP (NP (NN SF) (NNS DCs)) (PRN (-LRB- -LRB-) (NP (NN f–h)) (-RRB- -RRB-))))))))))))) (. .)))
( (S (S (NP (NNS Data)) (VP (VP (VBP are) (NP (NP (NNS means)) (PP (IN of) (NP (JJ duplicate) (NNS samples))))) (CC and) (VP (VBP are) (PP (IN from) (NP (CD two) (JJ separate) (NN SF) (NNS donors)))))) (. .)))
( (S (NP (NN Transforming) (NN growth) (JJ factor-β-induced) (JJ regulatory) (NN T) (NNS cells)) (VP (VBP referee) (NP (NP (ADJP (JJ inflammatory))) (CC and) (NP (JJ autoimmune) (NNS diseases))))))
( (S (NP (NN Abstract))))
( (S (S (NP (ADJP (RB Naturally) (VBG occurring)) (JJ CD4+CD25+) (JJ regulatory) (NN T) (NNS cells)) (VP (VBP mediate) (NP (NP (JJ immune) (NN suppression)) (S (VP (TO to) (VP (VB limit) (NP (NP (NN immunopathogenesis)) (VP (VBN associated) (PP (IN with) (NP (NP (JJ chronic) (NN inflammation)) (, ,) (NP (JJ persistent) (NNS infections)) (CC and) (NP (JJ autoimmune) (NNS diseases)))))))))))) (. .)))
( (S (S (NP (NP (PRP$ Their) (NN mode)) (PP (IN of) (NP (NN suppression)))) (VP (VP (VBZ is) (ADJP (ADJP (JJ contact-dependent)) (, ,) (ADJP (JJ antigen-nonspecific)))) (CC and) (VP (VBZ involves) (NP (NP (DT a) (JJ nonredundant) (NN contribution)) (PP (IN from) (NP (NP (NP (DT the) (NN cytokine) (NN transforming) (NN growth) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN TGF)) (-RRB- -RRB-))) (NN -β))))))) (. .)))
( (S (S (RB Not) (ADVP (RB only)) (VP (MD can) (ADVP (RB TGF-β)) (VP (VB mediate) (NP (NP (NN cell–cell) (NN suppression)) (PP (IN between) (NP (NP (DT the) (JJ regulatory) (NN T) (NNS cells)) (CC and) (NP (NN CD4+CD25-) (CC or) (JJ CD8+) (NN T) (NNS cells)))))))) (, ,) (CC but) (S (NP (JJ new) (NN evidence)) (ADVP (RB also)) (VP (VBZ reveals) (NP (NP (PRP$ its) (NN role)) (PP (IN in) (NP (NP (DT the) (NN conversion)) (PP (IN of) (NP (NN CD4+CD25-) (NN T) (NNS cells)))))) (, ,) (PP (ADVP (RB together)) (IN with) (NP (NN TCR) (NN antigen) (NN stimulation))) (, ,) (PP (IN into) (NP (DT the) (JJ regulatory) (NN phenotype))))) (. .)))
( (S (S (NP (NP (NN Elemental)) (PP (TO to) (NP (DT this) (NN conversion) (NN process)))) (VP (VBZ is) (NP (NP (NN induction)) (PP (IN of) (NP (NP (NN expression)) (PP (IN of) (NP (NP (DT the) (NN forkhead) (NN transcription) (NN factor)) (, ,) (NP (NN Foxp3))))))))) (. .)))
( (S (NP (NP (DT This) (JJ context-dependent) (NN coercion)) (PP (IN of) (NP (JJ naive) (JJ CD4+) (NN T) (NNS cells))) (PP (IN into) (NP (NP (DT a) (JJ powerful) (NN subset)) (PP (IN of) (NP (JJ regulatory) (NNS cells)))))) (VP (VBZ provides) (NP (NP (DT a) (NN window)) (PP (IN into) (NP (NP (JJ potential) (NN manipulation)) (PP (IN of) (NP (DT these) (NNS cells)))))) (S (VP (TO to) (VP (VBP orchestrate) (NP (JJ therapeutic) (NN intervention)) (PP (IN in) (NP (NP (NNS diseases)) (VP (VBN characterized) (PP (IN by) (NP (JJ inadequate) (NN suppression)))))) (, ,) (PP (RB as) (RB well) (IN as) (NP (NP (DT a) (JJ promising) (NN means)) (PP (IN of) (S (VP (VBG controlling) (NP (NP (JJ pathologic) (NNS situations)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (JJ excessive) (NN suppression)) (VP (VBZ dominates)))))))))))))) (. .)))
( (S (NP (NN Introduction))))
( (S (S (NP (JJ Autoimmune) (NNS diseases)) (VP (VBP are) (VP (VBN characterized) (PP (IN by) (NP (NP (DT a) (NN loss)) (PP (IN of) (NP (NP (NN regulation)) (PP (IN of) (NP (NN T) (NN cell) (NP (NP (NN growth)) (CC and) (NP (NN activation))))))))) (, ,) (PP (IN with) (NP (NP (JJ resultant) (JJ overexuberant) (NN inflammation)) (CC and) (NP (NN tissue) (NN destruction))))))) (. .)))
( (S (S (SBAR (IN Although) (S (NP (NP (NN T) (NN cell) (NNS responses)) (PP (TO to) (NP (JJ foreign) (NNS antigens)))) (VP (VBP are) (ADJP (JJ essential) (PP (TO to) (NP (NP (PRP$ our) (NN protection)) (PP (IN from) (NP (NP (DT a) (NN plethora)) (PP (IN of) (NP (NP (ADJP (RB potentially) (JJ pathogenic)) (NNS agents)) (CC and) (NP (NNS microbes)))))))))))) (, ,) (NP (NP (NN T) (NN cell) (NNS responses)) (PP (TO to) (NP (NN self) (NNS antigens)))) (VP (MD can) (VP (VB be) (ADJP (RB overtly) (JJ deleterious))))) (. .)))
( (S (S (SBAR (IN As) (S (NP (NP (DT the) (NN signaling) (NNS pathways)) (VP (VBN associated) (PP (IN with) (NP (NN T) (NN cell) (NN activation))))) (VP (VBP continue) (S (VP (TO to) (VP (VB be) (ADJP (JJ illuminated)))))))) (, ,) (NP (EX there)) (VP (VBZ is) (ADVP (RB also)) (NP (NP (DT an) (VBG emerging) (NN excitement)) (PP (IN about) (NP (NP (ADJP (RB naturally) (VBG occurring)) (JJ opposing) (NNS forces)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB exert) (NP (NN control)) (PP (IN over) (NP (JJ antigen-activated) (NN T) (NNS cells)))) (S (VP (TO to) (VP (VB prevent) (NP (NP (NN reactivity)) (PP (TO to) (NP (NN self))))))))))))))) (. .)))
( (S (S (NP (NP (NN Suppressor) (NN T) (NNS cells)) (, ,) (VP (VBN implicated) (PP (IN in) (NP (NP (NP (DT this) (JJ regulatory) (NN process)) (NNS decades)) (ADVP (RB ago))))) (, ,)) (VP (VP (VBP fell) (PP (IN into) (NP (NN ill) (NN repute)))) (CC but) (VP (VBP have) (ADVP (RB recently)) (VP (VBN re-emerged) (PP (CONJP (RB not) (RB only)) (PP (IN as) (NP (DT a) (JJ real) (NN population))) (CC but) (PP (IN as) (NP (NP (DT a) (NN population)) (ADJP (JJ crucial) (PP (TO to) (NP (NP (JJ immune) (NN homeostasis)) (, ,) (NP (NP (NN maintenance)) (PP (IN of) (NP (NN tolerance)))) (, ,) (CC and) (NP (NP (NN prevention)) (PP (IN of) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (JJ autoimmune) (NN disease)))))))))))))))) (. .)))
( (S (S (S (NP (PRP$ Their) (NN existence)) (VP (VBZ is) (ADVP (RB no) (RBR longer)) (PP (IN in) (NP (NN question))))) (, ,) (CC but) (S (PP (JJ true) (TO to) (NP (PRP$ their) (NN history))) (NP (NP (NP (DT these) (NNS cells)) (, ,) (NP (NP (PRP$ their) (NN origin)) (, ,) (NP (NN generation)) (, ,) (CC and) (NP (NNS mechanisms)))) (PP (IN of) (NP (NN action)))) (VP (VBP have) (VP (VBN generated) (NP (JJ considerable) (NN controversy)))))) (. .)))
( (S (NP (NP (NN Recognition)) (PP (IN of) (NP (NP (DT the) (JJ potential) (NN impact)) (PP (IN of) (NP (DT these) (NNS cells))) (PP (IN in) (NP (JJ clinical) (JJ cellular) (NN therapy)))))) (VP (VBZ has) (VP (VBN driven) (NP (NP (DT a) (JJ rapid) (NN expansion)) (PP (IN of) (NP (DT the) (NN field)))) (SBAR (IN in) (NN order) (TO to) (S (VP (VP (VB understand)) (CC and) (VP (VBP manipulate) (NP (NP (DT the) (JJ regulatory) (NN T) (NN cell) (NN population)) (S (VP (TO to) (VP (VB devise) (NP (NP (NNS strategies)) (PP (TO to) (NP (NP (NN control) (NN autoimmunity)) (, ,) (NP (NN transplantation) (NN tolerance)) (, ,) (NP (NN tumor) (NN immunity)) (, ,) (NP (NN allergy)) (CC and) (NP (JJ infectious) (NNS diseases)) (, ,) (ADVP (RB particularly)) (NP (NN HIV))))))))))))))) (. .)))
( (S (S (NP (NP (CD One)) (PP (IN of) (S (VP (ADVP (DT the) (RBS most) (RB intensely)) (VBN studied) (PP (IN of) (NP (NP (DT the) (JJ heterogeneous) (NN family)) (PP (IN of) (NP (JJ regulatory) (NN T) (NNS cells))))))))) (VP (VBZ is) (NP (NP (DT a) (NN population)) (PP (IN of) (NP (NP (JJ CD4+) (NN T) (NNS cells)) (VP (VP (ADVP (RB constitutively)) (VBG expressing) (NP (NP (NN CD25) (-LRB- -LRB-) (CD IL-2Rα) (-RRB- -RRB-)) (, ,) (VP (VBN found) (PP (PP (IN in) (NP (NN thymus))) (CC and) (PP (IN in) (NP (JJ peripheral) (JJ lymphoid) (NNS organs))))) (, ,))) (CC and) (VP (VBG comprising) (NP (NP (QP (CD 5) (TO to) (CD 10)) (NN %)) (PP (IN of) (NP (DT the) (JJ total) (JJ CD4+) (NN T) (NNS cells)))) (PP (IN in) (NP (NP (NNS mice)) (CC and) (NP (NNS humans) (CD -LSB-1-5) (-RRB- -RSB-))))))))))) (. .)))
( (S (S (PP (IN On) (DT the) (NN basis) (IN of) (NP (PRP$ their) (JJ unique) (JJ functional) (NNS properties))) (, ,) (NP (NP (DT this) (ADJP (ADJP (JJ small)) (CC but) (ADJP (JJ powerful))) (NN population)) (PP (IN of) (NP (NN T) (NNS cells)))) (VP (VBZ has) (VP (VBN been) (NP (NP (JJ dubbed) (JJ CD4+CD25+) (JJ regulatory) (NN T) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN Treg)) (-RRB- -RRB-)))))) (. .)))
( (S (S (PP (IN In) (NN contrast) (TO to) (NP (NN CD4+CD25-) (NN T) (NNS cells))) (, ,) (NP (ADJP (RB freshly) (VBN isolated)) (NN CD4+CD25+) (NNS Treg)) (VP (VBP are) (ADJP (JJ anergic) (PP (TO to) (NP (NN TCR) (NN stimulation))) (ADVP (FW in) (FW vitro))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (SBAR (IN once) (S (VP (VBN activated)))) (, ,) (NP (DT these) (NNS Treg)) (VP (VP (VBP are) (NP (JJ robust) (NNS suppressors))) (CC and) (VP (MD can) (VP (VB mediate) (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (NN CD4+CD25-) (NN responder) (NN T) (NNS cells)))) (PP (IN by) (NNS means) (IN of) (NP (NP (DT a) (JJ cell-contact-dependent) (NN mechanism)) (VP (VBG involving) (NP (NP (NP (NN transforming) (NN growth) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN TGF)) (-RRB- -RRB-))) (NN -β) (NN -LSB-6-9)))))))) (-RRB- -RSB-) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 1)) (-RRB- -RRB-))) (. .)))
( (S (SBAR (IN Although) (S (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN TGF-β)))) (VP (VBZ has) (RB not) (ADVP (RB yet)) (VP (VBN been) (NP (ADJP (RB universally) (VBN accepted)) (NN -LSB-10,11)))) (-RRB- -RSB-))) (, ,) (NP (NP (DT the) (NN preponderance)) (PP (IN of) (NP (NN evidence)))) (VP (VBZ has) (VP (VBN solidified) (NP (NP (DT a) (NN contribution)) (PP (IN from) (NP (NN TGF-β))) (PP (IN in) (NP (DT the) (JJ regulatory) (NN process) (NN -LSB-6-8,12-15))) (-RRB- -RSB-)))) (. .)))
( (S (S (NP (NP (DT The) (NN essentiality)) (PP (IN of) (NP (DT this) (JJ endogenous) (NN population))) (PP (IN in) (S (VP (VBG protecting) (NP (DT the) (NN host)) (PP (IN from) (NP (NP (JJ disproportionate) (NN T) (NN cell) (NN activation)) (CC and) (NP (JJ autoreactive) (NN effector) (NNS cells)))))))) (VP (VBZ is) (VP (VBN underscored) (PP (CC both) (PP (IN in) (NP (JJ experimental) (NNS models))) (CC and) (PP (IN in) (NP (NP (NNS humans)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (NP (DT the) (NNS numbers)) (CC and/or) (NP (NN function))) (PP (IN of) (NP (NN Treg)))) (VP (VBP are) (VP (VBN compromised) (NP (CD -LSB-6,10,16-20) (-RRB- -RSB-)))))))))))) (. .)))
( (S (PP (IN In) (NP (NNS mice))) (, ,) (NP (NP (NN depletion)) (PP (IN of) (NP (NN CD4+CD25+) (NN T) (NNS cells))) (PP (IN by) (NP (JJ neonatal) (-LRB- -LRB-) (NN day) (CD 3) (-RRB- -RRB-) (NN thymectomy)))) (VP (VBZ leads) (PP (TO to) (NP (NP (JJ spontaneous) (NN development)) (PP (IN of) (NP (NP (JJ organ-specific) (JJ autoimmune) (NNS diseases)) (, ,) (PP (VBG including) (NP (NP (JJ autoimmune) (NN thyroiditis)) (, ,) (NP (NN gastritis)) (, ,) (CC and) (NP (NN wasting) (NN -LSB-19)) (-RRB- -RSB-))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB be) (VP (VBN reversed) (PP (IN by) (NP (NP (JJ adoptive) (NN transfer)) (PP (IN of) (NP (NN Treg) (NN -LSB-21) (-RRB- -RSB-))))))))))))))) (. .)))
( (S (S (NP (NNS Treg)) (VP (VBP are) (ADJP (JJ pivotal) (PP (IN in) (NP (NP (DT the) (NN protection)) (PP (IN of) (NP (JJ lymphopenic) (NNS mice))) (PP (IN from) (NP (NP (VBN induced) (JJ inflammatory) (NN bowel) (NN disease)) (, ,) (NP (JJ experimental) (JJ autoimmune) (NN encephalomyelitis)) (, ,) (NP (NN diabetes)) (, ,) (CC and) (NP (NN allergy) (CD -LSB-16,18,22) (-RRB- -RSB-))))))))) (. .)))
( (S (S (PP (IN In) (NP (JJ infectious) (NNS models))) (, ,) (NP (NN Treg)) (ADVP (RB also)) (VP (VBP influence) (NP (DT the) (NN effector) (JJ immune) (NN response)) (, ,) (SBAR (IN as) (S (VP (VBZ is) (ADJP (JJ evident) (PP (IN in) (NP (FW Leishmania) (JJ major) (NN infection) (CD -LSB-20)))))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (ADJP (CC Both) (ADJP (JJ innate)) (CC and) (ADJP (JJ adaptive))) (JJ immune) (NNS responses)) (VP (VBP are) (ADJP (JJ subject) (PP (TO to) (NP (NN Treg) (NN control)))))) (. .)))
( (S (S (NP (NP (NN Triggering)) (PP (IN of) (NP (JJ dendritic) (NNS cells))) (PP (IN by) (NP (NP (JJ Toll-like) (NN receptor) (NNS ligands)) (VP (VBN expressed) (PP (IN by) (NP (JJ invading) (NNS pathogens))))))) (VP (VBZ leads) (PP (TO to) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NP (JJ soluble) (NNS factors)) (, ,) (PP (VBG including) (NP (NN IL-6))) (, ,) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB render) (NP (NP (NN effector) (NNS cells)) (ADJP (JJ refractory) (PP (TO to) (NP (JJ regulatory) (NN activity) (CD -LSB-23))))))) (-RRB- -RSB-))))))))) (. .)))
( (S (S (ADVP (RB Moreover)) (, ,) (NP (VBN activated) (JJ dendritic) (NNS cells)) (VP (VBP produce) (NP (NN TGF-β)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (ADVP (RB further)) (VP (VB influence) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NN Treg) (CD -LSB-24))))))))) (-RRB- -RSB-)) (. .)))
( (S (S (PP (IN By) (NP (JJ such) (JJ intersecting) (NNS pathways))) (, ,) (NP (NP (DT the) (ADJP (ADJP (JJ innate)) (CC and) (ADJP (JJ regulatory))) (NNS arms)) (PP (IN of) (NP (DT the) (JJ immune) (NN system)))) (VP (VBP have) (NP (DT the) (NN capacity) (S (VP (TO to) (VP (VB exert) (NP (JJ sufficient) (NN control)) (PP (IN over) (NP (DT each) (JJ other)))) (S (VP (TO to) (VP (VB enable) (S (NP (NN effector) (NNS cells)) (VP (TO to) (VP (VB mount) (NP (JJ efficient) (JJ immune) (NNS responses)) (PP (IN with) (NP (JJ minimal) (NN pathology)))))))))))))) (. .)))
( (S (S (PP (IN In) (NP (JJ human) (ADJP (ADJP (JJ infectious)) (, ,) (ADJP (JJ neoplastic)) (, ,) (CC and) (ADJP (JJ autoimmune))) (NNS diseases))) (, ,) (NP (NN Treg) (NNS activities)) (ADVP (RB often)) (VP (VBP mirror) (NP (NP (DT those)) (PP (IN in) (NP (JJ murine) (NNS systems)))))) (. .)))
( (S (S (NP (NP (NNS Numbers)) (PP (IN of) (NP (NN Treg)))) (VP (VBP are) (ADVP (RB reportedly)) (VP (VBN reduced) (PP (IN in) (NP (JJ human) (JJ autoimmune) (NNS diseases) (NP (CD -LSB-17,25) (-RRB- -RSB-)))) (, ,) (SBAR (IN although) (S (NP (NP (PRP$ their) (NN significance)) (PP (IN in) (NP (NP (DT the) (NN evolution)) (PP (IN of) (NP (NNS immunopathogenesis)))))) (VP (VBZ remains) (NP (NP (DT an) (NN area)) (PP (IN of) (NP (JJ continued) (NN exploration)))))))))) (. .)))
( (S (S (S (ADVP (RB Moreover)) (, ,) (NP (VBN increased) (JJ CD4+CD25+) (JJ regulatory) (NN T) (NNS cells)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NN HIV-1) (NN immunodeficiency) (NN -LSB-26)))))) (-RRB- -RSB-)) (, ,) (CC and) (S (PP (IN in) (NP (NN lung) (NN cancer) (NNS patients))) (NP (NP (DT the) (VBN increased) (NNS numbers)) (PP (IN of) (NP (JJ CD4+CD25+) (JJ regulatory) (NN T) (NNS cells)))) (ADVP (RB directly)) (VP (VBP inhibit) (NP (JJ autologous) (NN T) (NN cell) (NN proliferation) (CD -LSB-27) (-RRB- -RSB-))))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (NP (NP (DT this) (ADJP (ADJP (JJ unique)) (CC and) (ADJP (JJ persuasive))) (NN population)) (PP (IN of) (NP (JJ regulatory) (NN T) (NNS cells)))) (VP (VBZ has) (NP (DT a) (JJ crucial) (NN role)) (PP (IN in) (NP (NP (DT the) (NN maintenance)) (PP (IN of) (NP (NP (NN tolerance)) (CC and) (NP (JJ immune) (NN homeostasis)))) (PP (IN through) (NP (JJ immune) (NN suppression))))))) (. .)))
( (S (NP (NP (NN Mechanism)) (PP (IN of) (NP (NN Treg) (NN suppression))))))
( (S (S (NP (NN Treg)) (VP (VBP are) (NP (CC both) (NP (ADJP (JJ anergic))) (, ,) (ADVP (IN at) (JJS least) (FW in) (FW vitro)) (, ,) (CC and) (NP (ADJP (JJ immunosuppressive)))))) (. .)))
( (S (S (NP (NP (DT The) (NN absence)) (PP (IN of) (NP (NN Treg)))) (VP (VBZ results) (PP (IN in) (NP (NP (NP (DT the) (NN breakdown)) (PP (IN of) (NP (NN tolerance)))) (CC and) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ autoimmune) (NNS diseases)))) (NP (CD -LSB-28) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (NP (PRP$ Our) (NN understanding)) (PP (IN of) (NP (NP (DT the) (JJ functional) (NN domain)) (PP (IN of) (NP (DT these) (NNS cells)))))) (VP (VBZ has) (ADVP (RB rapidly)) (ADJP (JJ advanced)) (PP (IN through) (NP (NN cell) (NN culture) (NNS experiments))))) (. .)))
( (S (S (ADVP (FW In) (FW vitro)) (, ,) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN CD4+CD25+) (NN Treg))) (S (VP (TO to) (VP (VB suppress) (NP (NP (NN responder) (NN T) (NN cell) (NN proliferation)) (CC and) (NP (NN cytokine) (NN production))))))) (VP (VP (VBZ requires) (NP (PRP$ their) (NN activation))) (, ,) (VP (VBZ is) (ADJP (JJ dependent) (PP (IN on) (NP (NN cell) (NN contact))))) (, ,) (CC and) (VP (VBZ is) (NP (NN antigen) (JJ nonspecific) (NN -LSB-1,6,10)))) (-RRB- -RSB-)) (. .)))
( (S (S (PP (IN After) (NP (NP (NNS years)) (PP (IN of) (NP (NP (NN searching)) (PP (IN for) (NP (NP (DT the) (JJ elusive) (NN mediator) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-)) (PP (IN of) (NP (NP (NN suppression)) (ADJP (JJ consistent) (PP (IN with) (NP (DT the) (VBN accepted) (JJ cell-contact-dependent) (NN mechanism)))))))))))) (, ,) (NP (JJ membrane-associated) (NN TGF-β)) (VP (VBD was) (VP (VBN identified) (PP (IN as) (NP (DT a) (JJ pivotal) (NN perpetrator) (NN -LSB-6,7,14))))) (-RRB- -RSB-)) (. .)))
( (S (S (PP (IN In) (NP (DT this) (NN regard))) (, ,) (NP (JJ latent) (NN TGF-β)) (VP (VBD was) (ADVP (RB first)) (VP (VBN reported) (S (VP (TO to) (VP (VB be) (ADJP (RB constitutively) (JJ present) (PP (IN on) (NP (NP (DT the) (NN surface)) (PP (IN of) (NP (NN Treg) (CD -LSB-6,7))))))))))) (-RRB- -RSB-)) (: ;) (S (ADVP (RB subsequently)) (, ,) (NP (JJ active) (NN TGF-β)) (VP (VBD was) (VP (VBN identified) (NP (NN -LSB-6,8,14)))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (NP (ADJP (FW In) (FW vitro)) (NN stimulation)) (PP (IN with) (NP (NP (NN anti-CD3)) (CC and) (NP (NP (JJ antigen-presenting) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNS APCs)) (-RRB- -RRB-)))))) (VP (VBZ enhances) (NP (NP (JJ membrane-bound) (JJ active) (NN TGF-β)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (JJ consistent) (PP (IN with) (NP (DT the) (NN requirement) (SBAR (IN that) (S (NP (NN Treg) (NN activation)) (VP (VBZ promotes) (NP (PRP$ their) (JJ suppressive) (JJ potential) (NN -LSB-6,13))) (-RRB- -RSB-) (PRN (-LRB- -LRB-) (FRAG (NP (NN W) (NNP Chen)) (, ,) (NP (JJ unpublished) (NNS data))) (-RRB- -RRB-))))))))))))) (. .)))
( (S (NP (NP (NN Blockade)) (PP (IN of) (NP (JJ cell-surface) (NNS TGF-β))) (PP (PP (IN with) (NP (NN neutralizing) (NNS antibodies))) (, ,) (PP (IN with) (NP (JJ soluble) (NN TGF-β) (NN receptor))) (, ,) (CC or) (PP (IN with) (NP (JJ recombinant) (JJ latency-associated) (NN peptide))))) (VP (VBZ disrupts) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (DT these) (NNS cells))) (S (VP (TO to) (VP (VB block) (NP (NN responder) (NN T) (NN cell) (NN proliferation)))))) (, ,) (S (VP (VBG confirming) (NP (NN TGF-β)) (PP (IN as) (NP (NP (DT an) (NN instrument)) (PP (IN of) (NP (NN suppression) (NN -LSB-6-8,12,13,15,29) (-RRB- -RSB-)))))))) (. .)))
( (S (S (NP (RB Still) (JJ missing)) (VP (VBD was) (NP (NP (DT the) (VBG connecting) (NN link)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (JJ membrane-bound) (NN TGF-β)) (VP (MD could) (VP (VB interact) (PP (IN with) (NP (DT the) (NN CD4+CD25-) (NN responder) (NNS cells)))))))))) (. .)))
( (S (ADVP (RB Recently)) (, ,) (NP (NP (JJ TGF-β) (NN receptor) (NN type) (CD II)) (PRN (-LRB- -LRB-) (NP (NN TβRII)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN detected) (PP (IN at) (NP (JJ elevated) (NNS levels))) (PP (IN on) (NP (NN responder) (NN T) (NNS cells))) (SBAR (IN once) (S (NP (PRP they)) (VP (VBD were) (VP (VBN activated) (PP (IN through) (NP (PRP$ their) (NN TCR))) (, ,) (S (ADVP (RB thereby)) (VP (VBG providing) (NP (NP (DT the) (JJ molecular) (NN bridge)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (NP (NN TGF-β)) (PP (IN on) (NP (DT the) (NN Treg)))) (VP (VBZ orchestrates) (NP (NP (NN suppression)) (PP (IN of) (NP (DT the) (NN responder) (NNS cells) (NP (CD -LSB-6,8,12)))))) (-RRB- -RSB-)))))))))))) (. .)))
( (S (NP (NP (JJ TGF-β) (NN signaling)) (CC and) (NP (NN regulation)))))
( (S (S (NP (NN TGF-β)) (VP (VBZ is) (NP (NP (NP (DT a) (JJ potent) (NN cytokine)) (CC and) (NP (NN growth) (NN factor))) (SBAR (WHNP (WP$ whose) (JJ biological) (NN activity)) (S (VP (VBZ is) (ADVP (RB primarily)) (VP (VBN regulated) (PRN (QP (RB post-translationally) (CD -LSB-30)) (-RRB- -RSB-)) (, ,) (SBAR (IN because) (S (NP (PRP it)) (VP (VBZ is) (VP (VP (VBN transcribed)) (CC and) (VP (VBN translated) (PP (IN as) (NP (NP (DT a) (JJ small) (JJ latent) (NN complex)) (VP (VBN composed) (PP (CONJP (RB not) (RB only)) (PP (IN of) (NP (JJ active) (NN TGF-β))) (, ,) (CONJP (CC but) (RB also)) (PP (IN of) (NP (NP (NP (DT a) (JJ latency-associated) (NN peptide)) (PRN (-LRB- -LRB-) (NP (NN LAP)) (-RRB- -RRB-))) (SBAR (WHPP (TO to) (WHNP (WDT which))) (S (NP (PRP it)) (VP (VBZ is) (ADJP (RB noncovalently) (VBN bound)) (SBAR (CC and) (WHNP (WDT which)) (S (VP (VBZ prevents) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NP (PRP$ its) (JJ specific) (NNS receptors)) (PP (IN on) (NP (DT the) (NN target) (NN cell) (NN surface)))))))))))))))))))))))))))))) (. .)))
( (S (S (NP (DT This) (JJ small) (JJ latent) (NN complex)) (VP (MD can) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (DT the) (JJ latent) (JJ TGF-β1-binding) (NN protein))) (, ,) (S (VP (VBG forming) (NP (NP (DT a) (JJ large) (JJ latent) (NN complex)) (VP (VBN thought) (S (VP (TO to) (VP (VB serve) (PP (IN as) (NP (NP (DT a)) (VP (VBP tether) (PP (IN for) (NP (NP (NN binding) (NNS proteins)) (CC and) (NP (NN matrix) (NNS molecules)) (NP (CD -LSB-31) (-RRB- -RSB-)))))))))))))))))) (. .)))
( (S (PP (IN In) (NP (DT this) (NN configuration))) (, ,) (NP (NN TGF-β)) (VP (VP (VBZ is) (RB not) (ADJP (JJ active))) (CC but) (VP (VBZ requires) (NP (NP (NP (NN cleavage)) (CC or) (NP (NN dissociation))) (PP (IN from) (NP (NN LAP))) (S (VP (TO to) (VP (VB enable) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (PRP$ its) (JJ cognate) (NN receptor) (NN complex)))))))) (PRN (, ,) (NP (NP (NNP TβRII)) (CC and) (NP (NNP TβRI) (CD -LSB-32))) (-RRB- -RSB-)))) (. .)))
( (S (S (NP (NP (NN Activation)) (PP (IN of) (NP (NN TGF-β)))) (VP (MD can) (VP (VB occur) (PP (IN by) (NP (NP (DT any)) (PP (IN of) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NP (NNS mechanisms)) (PP (VBG including) (NP (NP (NN cleavage)) (PP (PP (IN with) (NP (NP (NN plasmin) (CD -LSB-33) (-RRB- -RSB-)) (, ,) (NP (NP (NN interaction)) (PP (IN with) (NP (NN αvβ6) (CD -LSB-34))) (-RRB- -RSB-)) (, ,))) (CC or) (PP (IN through) (NP (NP (DT an) (JJ ill-defined) (NN interaction)) (PP (IN of) (NP (NN LAP))) (PP (IN with) (NP (NP (NP (NN thrombospondin) (CD I)) (PRN (-LRB- -LRB-) (NP (NN TSP-I)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NN ligand)) (PP (IN for) (NP (DT the) (NN CD36) (NN receptor) (CD -LSB-35))) (-RRB- -RSB-)))))))))))))))))) (. .)))
( (S (S (VP (VBG Adding) (NP (NN credence)) (PP (TO to) (NP (NP (DT a) (NN role)) (PP (IN for) (NP (NN TSP-1))))))) (, ,) (NP (DT the) (JJ TSP-1-null) (NNS mice)) (VP (VP (VBP exhibit) (NP (JJ persistent) (NN inflammation)) (, ,) (ADVP (RB particularly)) (PP (IN in) (NP (DT the) (NP (NP (NN pancreas)) (CC and) (NP (NN lung)))))) (, ,) (CC and) (VP (VBP display) (NP (NP (DT a) (NN phenotype)) (PP (IN with) (NP (NP (NNS similarities)) (PP (PP (TO to) (NP (NN TGF-β-null) (NNS mice) (CD -LSB-36,37) (-RRB- -RSB-))) (, ,) (CONJP (IN although)) (PP (TO to) (NP (DT a) (JJR lesser) (NN extent))))))) (SBAR (IN because) (S (NP (NP (JJ alternative) (NNS mechanisms)) (PP (IN of) (NP (NN TGF-β) (NN activation)))) (VP (VB compensate)))))) (. .)))
( (S (S (S (ADVP (RB Nonetheless)) (, ,) (NP (NN TSP-1)) (VP (VBZ is) (NP (NP (DT a) (JJ major) (NN activator)) (PP (IN of) (NP (JJ TGF-β1) (ADJP (FW in) (FW vivo)) (NN -LSB-36))))) (-RRB- -RSB-)) (, ,) (CC and) (S (NP (NP (DT a) (NN TSP) (NN peptide)) (SBAR (WHNP (WDT that)) (S (VP (VBZ activates) (NP (NN TGF-β)))))) (VP (VBZ reverses) (NP (DT the) (JJ TSP-1-null) (NN phenotype)) (PP (IN by) (S (VP (VBG dampening) (NP (DT the) (NN tissue) (NN inflammation)))))))) (. .)))
( (S (PP (IN In) (NP (DT a) (NN feedback) (NN loop))) (, ,) (S (S (NP (NN TGF-β)) (VP (VBZ augments) (NP (NN TSP) (NN secretion)) (PP (IN by) (NP (NP (JJ dendritic) (NNS cells)) (CC and) (NP (NNS macrophages)))))) (, ,) (CC and) (S (NP (JJ TGF-β-treated) (NNS APCs)) (VP (VBP facilitate) (NP (NP (NP (DT the) (NN generation)) (PP (IN of) (NP (JJ regulatory) (NN T) (NNS cells)))) (NP (CD -LSB-38) (-RRB- -RSB-))) (, ,) (S (VP (VBG creating) (NP (NP (DT an) (NN environment)) (ADJP (JJ favorable) (PP (IN for) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NP (NN suppression)) (CC and/or) (NP (NN tolerance)))) (S (VP (TO to) (VP (VB ensure) (NP (NP (DT the) (NN blunting)) (PP (IN of) (NP (DT any) (JJ inflammatory) (NN reaction)))))))))))))))) (. .)))
( (S (S (ADVP (RB Often)) (NP (JJ seeming) (JJ paradoxical) (, ,) (VBN activated) (NN TGF-β)) (VP (VBZ has) (NP (ADJP (CC both) (ADJP (JJ stimulatory)) (CC and) (ADJP (JJ inhibitory))) (NNS influences)) (PP (IN on) (NP (NN T) (NN cell) (NN function) (CD -LSB-6,8)))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (DT These) (ADJP (RB apparently) (JJ disparate)) (NNS effects)) (VP (VBP are) (ADJP (JJ dependent) (PP (IN on) (NP (NN context)))) (, ,) (S (VP (VBG including) (NP (NP (NP (NN state)) (PP (IN of) (NP (NN differentiation)))) (, ,) (NP (NP (NN presence)) (PP (IN of) (NP (NP (JJ other) (NN growth) (NNS factors)) (CC or) (NP (NP (NNS cytokines)) (, ,) (NP (NN matrix) (NNS molecules)) (, ,) (NP (JJ additional) (JJ proximal) (NN cell) (NNS populations)) (, ,))))) (CC and) (NP (NN membrane) (NN receptor) (NNS levels))))))) (. .)))
( (S (S (PP (IN Beyond) (NP (NP (PRP$ its) (NN involvement)) (PP (IN in) (NP (JJ contact-dependent) (NN suppression))))) (, ,) (NP (JJ soluble) (NN TGF-β)) (VP (MD can) (ADVP (RB directly)) (VP (VP (VB inhibit) (NP (NN T) (NN cell) (NN proliferation))) (, ,) (VP (VB suppress) (NP (NN macrophage) (NN activation))) (CC and) (VP (VB modulate) (NP (NP (JJ dendritic) (NN cell) (NN function)) (PP (IN in) (NP (NP (PRP$ its) (NN role)) (PP (IN as) (NP (DT an) (JJ immunoregulatory) (NN cytokine)))))))))) (. .)))
( (S (S (NP (NP (NN Deletion)) (PP (IN of) (NP (DT this) (NN cytokine)))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (JJ lethal) (JJ immune) (NN dysregulation)) (CC and) (NP (JJ multi-organ) (JJ inflammatory) (NN disease) (CD -LSB-39,40) (-RRB- -RSB-))))))) (. .)))
( (S (S (PP (IN In) (S (VP (VBG mediating) (NP (PRP$ its) (JJ suppressive) (NNS effects))))) (, ,) (NP (NN TGF-β)) (VP (VBZ signals) (PP (IN through) (NP (NP (DT the) (NP (NP (NN type) (CD I)) (CC and) (NP (NN type) (CD II))) (JJ TGF-β) (JJ serine–threonine) (NN kinase) (NNS receptors)) (, ,) (NP (NP (NN TβRI)) (CC and) (NP (NN TβRII))))))) (. .)))
( (S (S (NP (NP (NN Interaction)) (PP (IN of) (NP (DT the) (JJ TGF-β) (NN ligand))) (PP (IN with) (NP (NP (DT these) (NNS receptors)) (PP (IN on) (NP (NN target) (NNS cells)))))) (VP (VBZ engages) (NP (NP (DT a) (NN signaling) (NN cascade)) (ADJP (JJ precipitated) (PP (IN by) (NP (NP (DT the) (NN phosphorylation)) (PP (IN of) (NP (NP (JJ cytosolic) (NNS proteins)) (VP (VBN identified) (PP (IN as) (NP (NNP Smads) (CD -LSB-41,42) (-RRB- -RSB-)))))))))))) (. .)))
( (S (SBAR (WHADVP (WRB When)) (S (NP (JJ CD4+CD25+) (NNS Treg)) (VP (VBP are) (VP (VBN co-cultured) (PP (IN with) (NP (JJ TCR-activated) (NN CD4+CD25-) (NN responder) (NN T) (NNS cells))))))) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (DT a) (JJ rapid) (NN engagement)) (PP (IN of) (NP (DT this) (JJ intracellular) (NN signaling) (NN pathway))) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADJP (JJ consistent) (PP (IN with) (NP (NN TGF-β)))) (PP (IN as) (NP (NP (NP (DT the) (NN link)) (PP (IN between) (NP (DT these) (CD two) (NNS cells)))) (CC and) (NP (NP (DT the) (JJ impending) (JJ functional) (NN inhibition)) (VP (VBN manifested) (PP (IN in) (NP (DT the) (NN responder) (NN cell) (NN population) (CD -LSB-6,12,15))))))) (-RRB- -RSB-)))))) (. .)))
( (S (S (PP (IN In) (NP (DT this) (NN regard))) (, ,) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN Smads))) (, ,) (VP (ADVP (RB initially)) (VBN detected) (PP (PP (IN with) (NP (NP (NNS antibodies)) (SBAR (WHNP (WDT that)) (S (VP (VBP recognize) (NP (CC both) (NP (NN Smad2)) (CC and) (NP (NP (NN Smad3) (CD -LSB-6) (-RRB- -RSB-)) (PRN (-LRB- -LRB-) (FRAG (NP (NN W) (NNP Chen)) (, ,) (NP (JJ unpublished) (NNS data))) (-RRB- -RRB-))))))))) (, ,) (CC and) (ADVP (RBR more) (RB recently)) (PP (IN with) (NP (NP (JJ Smad2-specific) (NNS antibodies)) (NP (CD -LSB-15) (-RRB- -RSB-)))))) (, ,)) (VP (VBD occurred) (PP (IN within) (NP (NP (NNS minutes)) (PP (IN after) (NP (NP (NN exposure)) (PP (IN of) (NP (NN responder) (NN T) (NNS cells))) (PP (TO to) (NP (NN Treg))))))))) (. .)))
( (S (S (S (NP (NP (NN Smad2)) (CC and) (NP (NN Smad3))) (VP (VBP serve) (PP (IN as) (NP (JJ receptor-activated) (NN Smad) (NN signaling) (NNS intermediates))))) (, ,) (IN whereas) (S (NP (NN Smad4)) (VP (VBZ is) (NP (NP (DT a) (JJ common) (NN Smad)) (SBAR (IN that) (S (NP (NP (NNS complexes)) (PP (IN with) (NP (NN Smad2/3)))) (VP (TO to) (VP (VB enable) (NP (NP (NN translocation)) (PP (TO to) (NP (DT the) (NN nucleus)))))))))))) (. .)))
( (S (PP (IN Once) (PP (IN within) (NP (DT the) (NN nucleus)))) (, ,) (NP (DT the) (NN Smad) (NN complex)) (VP (MD may) (VP (VB interact) (PP (PP (IN with) (NP (JJ specific) (NN DNA) (NNS sequences))) (CC and) (PP (IN with) (NP (JJ multiple) (JJ specific) (NN transcription) (NNS factors)))) (, ,) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (JJ transcriptional) (NP (NNS coactivators)) (CC and/or) (NP (NNS co-repressors)))))) (, ,) (VP (VBG culminating) (PP (IN in) (NP (NP (NP (DT the) (NN transcription)) (PP (IN of) (NP (NN target) (NNS genes)))) (CC and) (NP (NP (DT the) (NN transduction)) (PP (IN of) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (NNS signals)) (ADJP (JJ dependent) (PP (IN on) (NP (DT the) (NN target) (NN cell) (NN -LSB-41)))))))))))) (-RRB- -RSB-)))) (. .)))
( (S (S (NP (NN Smad2/3)) (VP (VBP are) (VP (VBN anchored) (PP (TO to) (NP (DT the) (NN plasma) (NN membrane))) (PP (IN through) (NP (NP (DT the) (NN Smad) (NN anchor)) (PP (IN for) (NP (NN receptor) (NN activation)))))) (PRN (-LRB- -LRB-) (NP (NN SARA)) (-RRB- -RRB-)) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB probably)) (VP (VBZ increases) (NP (NP (DT the) (NN efficiency)) (PP (IN of) (NP (NN activation)))) (PP (IN by) (NP (DT the) (JJ TGF-β-receptor) (NNS complexes) (NP (CD -LSB-43))))) (-RRB- -RSB-))))) (. .)))
( (S (S (NP (NP (NN Smad2)) (, ,) (CONJP (RB rather) (IN than)) (NP (NN Smad3)) (, ,)) (VP (MD may) (VP (VB be) (NP (DT the) (JJ critical) (NN connector)) (PP (IN in) (NP (NP (DT the) (JJ intracellular) (NN signaling) (NN pathway)) (VP (VBN engaged) (PP (IN in) (NP (DT the) (NN responder) (NNS cells))) (PP (IN by) (NP (NN Treg) (NN surface-bound) (NN TGF-β)))))) (, ,) (SBAR (IN because) (S (NP (NP (NNS mice)) (ADJP (JJ deficient) (PP (IN in) (NP (NN Smad3))))) (VP (VBP respond) (PP (PP (TO to) (NP (NN Treg) (NN suppression))) (CONJP (CC and) (RB also)) (PP (TO to) (NP (JJ exogenous) (JJ TGF-β) (NN -LSB-6))))) (-RRB- -RSB-) (PRN (-LRB- -LRB-) (FRAG (NP (NN W) (NNP Chen)) (, ,) (NP (JJ unpublished) (NNS data))) (-RRB- -RRB-))))))) (. .)))
( (S (S (PP (IN In) (NP (NP (NN addition)) (PP (TO to) (NP (NP (DT that)) (VP (VBN mediated) (PP (IN by) (NP (NN Smad2)))))))) (, ,) (NP (JJ TGF-β) (NN signaling)) (VP (VBZ is) (VP (VBN regulated) (PP (IN by) (NP (JJ complex) (NNS mechanisms))) (PP (IN in) (NP (DT the) (NP (NP (NN cytoplasm)) (CC and) (NP (NN nucleus)))))))) (. .)))
( (S (S (PP (IN Beyond) (S (VP (VBG engaging) (NP (NN Smad) (NN activity))))) (, ,) (NP (NN TGF-β)) (VP (VBZ triggers) (NP (NP (DT the) (NP (NP (JJ extracellular) (JJ signal-related) (NN kinase)) (CC and) (NP (NN p38) (JJ mitogen-activated) (NN kinase))) (NNS pathways)) (CD -LSB-44) (-RRB- -RSB-) (S (VP (TO to) (VP (VB link) (NP (NP (JJ additional) (NN signaling) (NNS cascades)) (VP (VBN involved) (PP (IN in) (S (VP (VBG modulating) (NP (NN cell) (NN function))))))))))))) (. .)))
( (S (S (NP (NP (NNS Perturbations)) (PP (IN in) (NP (DT this) (JJ immunoregulatory) (NN circuit)))) (VP (MD can) (VP (VB occur) (PP (IN through) (NP (NP (NN dysregulation)) (PP (IN of) (NP (NP (DT the) (JJ inhibitory) (NN Smad)) (, ,) (NP (NN Smad7)) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB typically)) (VP (VBZ represses) (NP (NN TGF-β) (NN signaling)) (PP (PP (IN by) (S (VP (VBG interacting) (PP (IN with) (NP (VBN activated) (NN TGF-β) (NNS receptors))) (S (VP (TO to) (VP (VB prevent) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN Smad2/3)))))))))) (CC and/or) (PP (IN by) (S (VP (VBG interfering) (PP (IN with) (NP (NP (NN complex) (NN formation)) (PP (IN between) (NP (NP (NN Smad2/3)) (CC and) (NP (NN Smad4) (CD -LSB-45) (-RRB- -RSB-)))))))))))))))))))) (. .)))
( (S (S (VP (VBG Facilitating) (S (NP (DT the) (JJ inhibitory) (NN Smad) (NNS signals)) (VP (VBP are) (NP (NP (NP (NP (DT the) (NN Smad) (NN ubiquitin) (JJ regulatory) (NNS factors)) (PRN (-LRB- -LRB-) (NP (NN Smurfs)) (-RRB- -RRB-))) (, ,) (NP (NN E3) (NN ubiquitin) (NNS ligases)) (, ,)) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG inducing) (NP (NP (NP (NN polyubiquitination)) (CC and) (NP (NN degradation))) (PP (IN of) (NP (NNP TβRI) (CD -LSB-46,47) (-RRB- -RSB-))))))))))))) (. .)))
( (S (S (NP (NN Smad7)) (VP (VBZ is) (ADJP (JJ inducible) (PP (IN by) (NP (NN TGF-β) (PRP itself))) (PP (PP (IN as) (NP (NP (NN part)) (PP (IN of) (NP (DT a) (NN feedback) (NN loop))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (PP (IN by) (NP (NP (DT the) (ADJP (ADJP (JJ IFN-γ)) (CC and) (ADJP (JJ NF-κB))) (NNS pathways)) (CD -LSB-41) (-RRB- -RSB-))))))) (. .)))
( (S (ADVP (RB Moreover)) (, ,) (NP (NP (DT the) (JJ transcriptional) (NNS co-repressors)) (NP (NP (NN c-Ski)) (CC and) (NP (NN SnoN)))) (, ,) (PP (IN by) (NP (NP (NNS means)) (PP (IN of) (NP (NP (PRP$ their) (NNS interactions)) (PP (IN with) (NP (NN Smad2/3/4))))))) (, ,) (VP (VP (VBP repress) (NP (JJ TGF-β-induced) (NN transcription))) (CC and) (VP (VBP are) (VP (VBN upregulated) (PP (IN by) (NP (NN TGF-β))) (PP (IN as) (NP (NP (DT another) (JJ negative) (NN feedback) (NN loop)) (S (VP (TO to) (VP (VB maintain) (NP (NP (NN control)) (PP (IN of) (NP (DT this) (ADJP (RB incredibly) (JJ powerful)) (NN molecule) (CD -LSB-41) (-RRB- -RSB-)))))))))))) (. .)))
( (S (S (NP (NP (NN Dissection)) (PP (IN of) (NP (DT these) (NNS circuits)))) (VP (MD will) (ADVP (RB probably)) (VP (VBP reveal) (NP (NP (NNS pathways)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (NN suppression)) (VP (MD can) (VP (VB be) (VP (VBN manipulated) (S (VP (TO to) (VP (VBP orchestrate) (NP (NP (NNS changes)) (PP (IN in) (NP (JJ aberrant) (NN immunity)))))))))))))))) (. .)))
( (S (S (SBAR (IN Although) (S (NP (NP (DT the) (NN preponderance)) (PP (IN of) (NP (NN evidence)))) (VP (VBZ supports) (NP (NP (DT a) (JJ major) (NN role)) (PP (IN for) (NP (NN TGF-β))) (PP (IN in) (NP (NP (DT the) (NN mediation)) (PP (IN of) (NP (NN Treg) (JJ suppressive) (NN activity))))))))) (, ,) (NP (EX there)) (VP (VBP are) (ADJP (JJ likely) (S (VP (TO to) (VP (VB be) (NP (NP (NP (JJ additional) (NNS factors)) (CC and/or) (NP (NNS cofactors))) (SBAR (SBAR (WHNP (WDT that)) (S (ADVP (RB secondarily)) (VP (VBP contribute) (PP (TO to) (NP (PRP$ their) (NN function)))))) (CC and) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB become) (ADJP (JJ prevalent) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN TGF-β)))))))))) (CC and/or) (SBAR (IN if) (S (NP (NN TGF-β)) (VP (VBZ is) (VP (VBN dysregulated))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NP (NN identification)) (CC and) (NP (NN intersection)) (NP (NNS points))) (PP (IN of) (NP (JJ such) (NNS pathways)))) (VP (VBP await) (NP (JJ further) (NN study)))) (. .)))
( (S (SINV (PP (IN Among) (NP (NP (DT the) (NNS factors)) (SBAR (WHNP (WDT that)) (S (VP (VBP contribute) (PP (TO to) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NN TGF-β))) (PP (IN in) (NP (NN CD4+CD25+) (NNS Treg)))))))))) (VP (VBP are) (NP (NP (NP (NN CD28)) (, ,) (NP (JJ cytotoxic) (NN T) (NN lymphocyte) (CD antigen-4)) (, ,) (NP (JJ glucocorticoid-induced) (NN TNF) (NN receptor)) (CC and) (NP (JJ forkhead/winged) (NN helix) (CC or) (NN forkhead) (NN box) (NN P3))) (VP (VBN encoded) (PP (IN by) (NP (NN Foxp3) (CD -LSB-48-51) (-RRB- -RSB-)))))) (. .))))
( (S (NP (NP (NN Generation)) (PP (IN of) (NP (NN Treg))))))
( (S (SBAR (IN Although) (S (NP (NN Treg)) (VP (VBD were) (ADVP (RB originally)) (VP (VBN considered) (S (VP (TO to) (VP (VB derive) (PP (ADVP (RB only)) (IN from) (NP (JJ thymic) (NNS precursors))) (NP (NN -LSB-1)) (-RRB- -RSB-) (, ,) (S (S (VP (TO to) (VP (VB be) (VP (VBN exported) (PP (TO to) (NP (DT the) (NN periphery))))))) (, ,) (CC and) (S (VP (TO to) (VP (VB represent) (NP (NP (NP (QP (JJR less) (IN than) (CD 10)) (NN %)) (PP (IN of) (NP (JJ CD4+) (NN T) (NNS cells)))) (NP (CD -LSB-52) (-RRB- -RSB-))) (, ,) (S (ADVP (RB thereby)) (VP (VBG limiting) (NP (NP (PRP$ their) (NN potential)) (PP (IN for) (NP (NN manipulation))) (PP (IN for) (NP (JJ therapeutic) (NNS considerations))))))))))))))))) (, ,) (NP (JJ important) (JJ new) (NN evidence)) (VP (VBZ documents) (SBAR (IN that) (S (NP (NN Treg)) (VP (MD can) (VP (VB be) (VP (VP (VBN expanded)) (CC and/or) (VP (VBN induced) (ADVP (FW de) (FW novo)) (PP (IN from) (NP (NN CD4+CD25-) (NN precursor) (NN T) (NNS cells)))))))))) (. .)))
( (S (S (ADVP (WRB How)) (, ,) (SBAR (WRB where) (, ,) (CC and) (SBAR (IN if) (S (NP (NP (DT the) (NP (NP (NN size)) (CC and) (NP (NN function)))) (PP (IN of) (NP (DT this) (NN population)))) (VP (MD can) (VP (VB be) (ADVP (RB intentionally)) (VP (VBN controlled))))))) (VP (VBZ is) (PP (IN of) (NP (DT the) (JJ utmost) (NN importance))))) (. .)))
( (S (S (S (NP (NP (DT The) (JJ thymic) (NN derivation)) (PP (IN of) (NP (NN Treg)))) (VP (VBZ is) (ADVP (RB genetically)) (ADJP (CONJP (RB as) (RB well) (IN as)) (ADJP (RB developmentally) (VBN regulated)) (, ,)))) (CC but) (S (NP (PRP it)) (VP (VBZ seems) (S (VP (TO to) (VP (VB be) (ADJP (ADJP (JJ constitutive)) (CC and) (ADJP (RB relatively) (JJ stable))))))))) (. .)))
( (S (S (NP (NP (NN Recruitment)) (PP (TO to) (NP (NP (DT a) (NN site)) (PP (IN of) (NP (JJ autoimmune) (NN reactivity)))))) (VP (MD may) (VP (VB increase) (NP (PRP$ their) (NNS numbers)) (ADVP (RB locally))) (, ,) (CC but) (PP (IN in) (NP (DT a) (JJ limited) (NN fashion))))) (. .)))
( (S (S (NP (NP (DT The) (NN ability)) (PP (TO to) (NP (NP (NN coerce) (NN expansion)) (PP (IN of) (NP (JJ functional) (NN Treg)))))) (VP (VBZ opens) (PP (IN up) (NP (NP (NNS possibilities)) (PP (IN for) (NP (NP (DT the) (NN manipulation)) (PP (IN of) (NP (NP (NN inflammation)) (CC and) (NP (NN immunity)))))))))) (. .)))
( (S (S (NP (JJ CD4+CD25+) (NNS Treg)) (VP (VBP undergo) (NP (NP (NN proliferation)) (PP (IN with) (NP (NN TCR) (NN stimulation)))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (NP (JJ high) (NNS doses)) (PP (IN of) (NP (JJ exogenous) (NN IL-2)))) (PRN (-LRB- -LRB-) (NP (QP (JJR more) (IN than) (CD 100)) (NN U/ml)) (-RRB- -RRB-) (NP (ADJP (FW in) (FW vitro)) (NN -LSB-10)) (-RRB- -RSB-)))))))) (. .)))
( (S (S (ADVP (RB Importantly)) (, ,) (NP (DT these) (VBN expanded) (JJ CD4+CD25+) (JJ regulatory) (NN T) (NNS cells)) (VP (VBP preserve) (NP (NP (PRP$ their) (JJ anergic) (NNS features)) (CC and) (NP (JJ immunosuppressive) (NN ability))) (SBAR (IN once) (S (NP (NN IL-2)) (VP (VBZ is) (VP (VBN removed))))))) (. .)))
( (S (S (NP (NP (DT This) (JJ unique) (NN aspect)) (PP (IN of) (NP (NN CD4+CD25+) (NNS Treg)))) (VP (VBZ has) (NP (JJ definite) (JJ potential) (NN application)) (PP (IN in) (S (VP (VBG designing) (NP (NP (NP (JJ future) (JJ clinical) (NN therapy)) (PP (IN for) (NP (JJ autoimmune) (NNS diseases)))) (, ,) (NP (NN inflammation)) (CC and) (NP (NN transplantation)))))))) (. .)))
( (S (ADVP (RB Nonetheless)) (, ,) (NP (NP (DT the) (NN insufficiency)) (PP (IN of) (NP (ADJP (RB naturally) (VBN derived)) (NN CD4+CD25+) (NN Treg))) (PP (IN in) (NP (NP (NN autoimmunity)) (CC and) (NP (JJ other) (JJ immune) (NNS diseases))))) (VP (VBZ has) (VP (VBN driven) (NP (NP (DT the) (NN search)) (PP (IN for) (NP (NNS approaches)))) (S (VP (TO to) (VP (VBP convert) (NP (JJ normal) (JJ naive) (NN CD4+CD25-T) (NNS cells)) (PP (IN into) (NP (JJ CD4+CD25+) (JJ regulatory) (NN T) (NNS cells)))))))) (. .)))
( (S (NP (NP (DT The) (NN generation)) (PP (IN of) (NP (ADJP (RB functionally) (JJ uncompromised)) (NN CD4+CD25+) (NNS Treg)))) (VP (VBZ involves) (NP (NP (DT the) (JJ unique) (NN induction)) (PP (IN of) (NP (JJ forkhead/winged) (NN helix) (NN transcription) (NN factor) (NN Foxp3) (-LRB- -LRB-) (NN Scurfin) (-RRB- -RRB-))) (PP (IN in) (NP (JJ Foxp3-negative) (NN CD4+CD25-) (NNS precursors))))) (. .)))
( (S (S (S (NP (NN Foxp3)) (VP (VBZ is) (VP (ADVP (RB highly)) (VBN conserved)))) (, ,) (CC and) (S (PP (IN in) (NP (CC both) (NP (NNS mice)) (CC and) (NP (NNS humans)))) (NP (ADJP (RB genetically) (JJ defective)) (NN Foxp3)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (ADJP (ADJP (JJ autoimmune)) (CC and) (ADJP (JJ inflammatory))) (NN disease) (CD -LSB-48,53-57) (-RRB- -RSB-))))))) (. .)))
( (S (S (PP (IN In) (NP (NN Foxp3) (JJ null) (NNS mice))) (, ,) (NP (NP (DT the) (NN deficiency)) (PP (IN of) (NP (NN CD4+CD25+) (NN Treg)))) (VP (VBZ results) (PP (IN in) (NP (DT a) (JJ lethal) (JJ autoimmune) (NN syndrome) (CD -LSB-53,55,57)))) (-RRB- -RSB-)) (. .)))
( (S (ADVP (FW In) (FW vitro)) (, ,) (NP (NP (NN gene) (NN transfer)) (PP (IN of) (NP (NN Foxp3)))) (VP (VBZ converts) (NP (JJ naive) (NN CD4+CD25-) (NN T) (NNS cells)) (PP (IN into) (NP (NP (ADJP (ADJP (JJ phenotypic)) (CC and) (ADJP (JJ functional))) (NN Treg) (CD -LSB-48,53,55,56) (-RRB- -RSB-)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (JJ consistent) (PP (IN with) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB rescue) (NP (NP (JJ Foxp3-null) (NNS mice)) (PP (IN with) (NP (NP (JJ adoptive) (NN transfer)) (PP (IN of) (NP (NN Treg) (NN -LSB-55) (-RRB- -RSB-)))))))))))))))))) (. .)))
( (S (S (NP (DT These) (NNS data)) (VP (VBP support) (NP (NP (DT the) (ADJP (ADJP (JJ pivotal)) (CC and) (ADJP (JJ nonredundant))) (NN role)) (PP (IN of) (NP (DT this) (NN transcription) (NN factor))) (PP (IN in) (NP (NP (NN Treg) (NN development)) (CC and) (NP (NN function))))))) (. .)))
( (S (ADVP (RB Conversely)) (, ,) (NP (NP (DT the) (NN overexpression)) (PP (IN of) (NP (NN Foxp3))) (PP (IN in) (NP (DT a) (JJ transgenic) (NN mouse) (NN model)))) (VP (VBZ results) (S (PP (IN in) (NP (NP (VBN enhanced) (NNS numbers)) (PP (IN of) (NP (NP (NN CD4+CD25+) (NN Treg)) (CC and) (, ,) (ADVP (RB furthermore)) (, ,) (NP (JJ Foxp3-expressing) (NN CD4+CD25-)))))) (, ,) (NP (NP (ADJP (CONJP (RB as) (RB well) (IN as)) (ADJP (JJ CD4-CD8+)) (, ,)) (NN T) (NNS cells)) (PP (IN in) (NP (DT these) (JJ transgenic) (NNS mice)))) (ADVP (RB constitutively)) (VP (VBP exhibit) (NP (NP (JJ suppressive) (NNS functions)) (CD -LSB-57) (-RRB- -RSB-))))) (. .)))
( (S (PP (IN Despite) (NP (NP (DT the) (NN success)) (PP (IN of) (NP (NP (DT the) (JJ artificial) (NN gene) (NN transfer)) (PP (IN of) (NP (NN Foxp3))) (PP (IN into) (NP (NN CD4+CD25-) (JJ naive) (NN T) (NNS cells))) (PP (TO to) (NP (NN coerce) (PRP them))))) (PP (IN into) (NP (DT a) (JJ CD4+CD25+) (JJ regulatory) (NN T) (NN cell) (NN phenotype))))) (, ,) (NP (NP (DT the) (NN existence)) (PP (IN of) (NP (NP (DT a) (JJ physiologic) (NN inducer)) (PP (IN of) (NP (NN Foxp3)))))) (VP (VBD was) (ADJP (JJ unknown))) (. .)))
( (S (S (NP (NP (DT The) (JJ recent) (NN elucidation)) (PP (IN of) (NP (NP (DT a) (NN signaling) (NN pathway)) (VP (VBG leading) (PP (TO to) (NP (NP (DT the) (NN conversion)) (PP (IN of) (NP (NN CD4+CD25-) (NNS precursors))) (PP (IN into) (NP (NN Treg))))))))) (VP (VBD revealed) (NP (NP (DT a) (JJ pivotal) (NN role)) (PP (IN for) (NP (JJ TGF-β) (NN -LSB-8,12,14) (-RRB- -RSB-)))))) (. .)))
( (S (ADVP (RB Moreover)) (, ,) (NP (NP (DT the) (JJ genetic) (NN deletion)) (PP (IN of) (NP (NN Foxp3)))) (VP (VBZ results) (PP (IN in) (NP (NP (DT an) (JJ overlapping) (NN phenotype)) (PP (IN with) (NP (DT the) (JJ TGF-β1-null) (NNS mice))))) (NP (CD -LSB-40)) (-RRB- -RSB-) (, ,) (S (VP (VBG implicating) (NP (NP (DT a) (ADJP (ADJP (NN connection)) (CC and/or) (ADJP (JJ shared))) (NN mechanism)) (PP (IN of) (NP (NN action))))))) (. .)))
( (S (S (NP (NP (DT The) (NN induction)) (PP (IN of) (NP (NN gene) (NN expression))) (PP (IN of) (NP (NP (NN Foxp3)) (, ,) (NP (NP (DT a) (NN transcription) (NN factor)) (ADJP (JJ unique) (PP (TO to) (NP (NN Treg) (CD -LSB-48,53-57))))))) (-RRB- -RSB-)) (VP (VBZ is) (, ,) (PP (IN in) (NP (NN fact))) (, ,) (NP (ADJP (NN TGF-β) (JJ dependent)) (CD -LSB-12) (-RRB- -RSB-)))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NN TGF-β)) (VP (VP (VBZ cannot) (VP (VB act) (ADVP (RB independently)) (PP (IN on) (S (NP (NN precursor) (NNS cells)) (VP (TO to) (VP (VB generate) (NP (NN Treg)))))))) (CC but) (VP (VBZ requires) (NP (NP (NN co-stimulation)) (PP (IN through) (NP (NP (NN TCR)) (CC and) (NP (NN IL-2R) (NN -LSB-12,58))))))) (-RRB- -RSB-)) (. .)))
( (S (NP (NP (JJ Naive) (JJ splenic) (NN CD4+CD25-) (NN T) (NNS cells)) (VP (VBN cultured) (PP (IN for) (NP (QP (CD 7) (TO to) (CD 9)) (NNS days))) (PP (IN with) (NP (NP (NN TCR) (NN stimulation)) (CC and) (NP (NN TGF-β)))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NNS APCs))))))) (VP (VB emerge) (PP (IN as) (NP (NN CD4+CD25+) (NN Treg))) (PP (IN with) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB suppress) (NP (JJ CD4+) (NN responder) (NN T) (NN cell) (NN proliferation)))))))) (. .)))
( (S (S (NP (DT A) (JJ similar) (NN conversion) (NN pattern)) (VP (VBZ occurs) (PP (IN in) (NP (NN TCR) (JJ transgenic) (NNS mice))) (SBAR (IN if) (S (NP (DT the) (NN CD4+CD25-) (JJ naive) (NN T) (NNS cells)) (VP (VBP are) (VP (VBN stimulated) (PP (IN with) (NP (NP (JJ specific) (NN antigen)) (CC and) (NP (NP (NNS APCs)) (PP (IN with) (NP (ADJP (RB TGF-β) (VBN added)) (NN -LSB-12) (-RRB- -RSB-)))))))))))) (. .)))
( (S (S (NP (NP (DT This) (NN engagement)) (PP (IN of) (NP (DT the) (NP (NN TCR)) (CC and) (NP (NP (NN co-stimulator) (NNS molecules)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NN CD28) (-RRB- -RRB-) (CD -LSB-49,50,59,60)))) (-RRB- -RSB-))))) (PP (IN in) (NP (NP (NN concert)) (PP (IN with) (NP (NN TβRII) (NN ligation)))))) (VP (VBZ triggers) (NP (NP (NN signaling) (NNS pathways)) (SBAR (WHNP (WDT that)) (S (VP (VBP culminate) (PP (IN in) (NP (NP (NN Foxp3) (NN transcription)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (JJ essential) (PP (TO to) (NP (NP (NN generation)) (PP (IN of) (NP (NN Treg))))))))))))))))) (. .)))
( (S (PP (IN In) (NP (DT this) (NN fashion))) (, ,) (NP (NN TGF-β)) (VP (VP (VBZ is) (RB not) (ADVP (RB only)) (VP (VBN expressed) (PP (IN by) (NP (NN Treg))))) (CC but) (ADVP (RB also)) (VP (VBZ programs) (NP (PRP$ their) (NP (NN development)) (CC and) (NP (NN function))))) (. .)))
( (S (NP (JJ TGF-β-converted) (NNS Treg)) (VP (VBP control) (NP (JJ immune) (NNS responses)) (ADVP (FW in) (FW vivo)))))
( (S (S (PP (IN On) (DT the) (NN basis) (IN of) (NP (NP (DT this) (NN understanding)) (PP (IN of) (NP (NP (DT the) (JJ novel) (NN mechanism)) (VP (VBG underlying) (NP (NP (NN conversion)) (PP (IN of) (NP (NN CD4+CD25-) (NN T) (NNS cells))) (PP (IN into) (NP (ADJP (ADJP (JJ phenotypic)) (CC and) (ADJP (JJ functional))) (NN CD4+CD25+) (NNS Treg))))))))) (, ,) (NP (NP (DT the) (NN expansion)) (PP (IN of) (NP (NN Treg))) (PP (IN for) (NP (JJ therapeutic) (NN consideration)))) (VP (VBZ becomes) (NP (DT an) (JJ achievable) (NN goal)))) (. .)))
( (S (S (PP (VBN Provided) (SBAR (IN that) (S (NP (DT the) (JJ regulatory) (NNS conditions)) (VP (VBP are) (NP (NN met)))))) (, ,) (NP (DT the) (VBN converted) (NN CD4+CD25+) (NNS Treg)) (VP (VBP function) (PP (IN like) (NP (JJ conventional) (NN Treg))) (, ,) (ADVP (IN at) (JJS least) (FW in) (FW vitro)))) (. .)))
( (S (SBAR (IN Although) (S (NP (PRP it)) (VP (VBZ has) (ADVP (RB previously)) (VP (VBN been) (VP (VBN shown) (SBAR (IN that) (S (NP (ADJP (RB naturally) (VBG occurring)) (NN CD4+CD25+) (NNS Treg)) (VP (VBP are) (NP (NP (JJ potent) (NNS inhibitors)) (PP (IN of) (NP (JJ innate/adaptive) (NN immunity) (CD -LSB-61-63)))))))))) (-RRB- -RSB-))) (, ,) (NP (NP (NP (NN induction)) (PP (IN of) (NP (NP (DT a) (NN population)) (PP (IN of) (NP (NN Treg)))))) (CC and) (NP (NP (NN documentation)) (PP (IN of) (NP (PRP$ their) (ADJP (FW in) (FW vivo)) (NN potential))))) (VP (VBD was) (NP (DT an) (JJ important) (JJ next) (NN step))) (. .)))
( (S (S (PP (IN In) (NP (NP (NN pursuit)) (PP (IN of) (NP (DT this) (NN goal))))) (, ,) (NP (JJ recent) (NNS studies)) (VP (VBD demonstrated) (PP (IN for) (NP (DT the) (JJ first) (NN time))) (SBAR (IN that) (S (NP (NP (DT the) (NN transfer)) (PP (IN of) (NP (ADJP (ADVP (FW in) (FW vitro)) (VBN generated)) (NN Treg))) (PP (IN into) (NP (NN disease) (NNS models)))) (VP (VBZ does) (PP (IN in) (NP (NN fact))) (VP (VB ameliorate) (NP (NN pathogenesis) (CD -LSB-12) (-RRB- -RSB-)))))))) (. .)))
( (S (S (ADVP (RB Initially)) (, ,) (NP (PRP it)) (VP (VBD was) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (JJ adoptive) (NN transfer)) (PP (IN of) (NP (ADJP (FW in) (FW vitro)) (JJ TGF-β-converted) (NN Treg))) (PP (ADVP (RB together)) (IN with) (NP (JJ ovalbumin-specific) (NN TCR) (JJ transgenic) (NN T) (NNS cells)))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (JJ profound) (NN inhibition)) (PP (IN of) (NP (NP (JJ antigen-specific) (NN expansion)) (PP (IN of) (NP (JJ naive) (JJ CD4+) (JJ transgenic) (NN T) (NNS cells))))))) (ADVP (FW in) (FW vivo)))))))) (. .)))
( (S (PP (IN Although) (NP (DT the) (JJ TGF-β-converted) (NN CD25+) (NN suppressor) (NN population))) (-LRB- -LRB-) (NP (NN DO11.10))))
( (S (S (S (NP (NP (ADJP (NN TCR) (JJ transgenic))) (PRN (, ,) (NP (JJ KJ1-26+)) (-RRB- -RRB-))) (VP (VBN proliferated) (ADVP (FW in) (FW vivo)) (PP (IN on) (NP (NP (NN immunization)) (PP (IN with) (NP (NN ovalbumin) (NN peptide))))))) (, ,) (NP (NP (DT the) (VBN recovered) (JJ KJ1-26+) (JJ CD4+) (NN T) (NNS cells)) (PP (IN from) (NP (JJ draining) (NN lymph) (NNS nodes)))) (VP (VP (VBD remained) (ADJP (JJ unresponsive) (PP (TO to) (NP (NP (NN re-challenge)) (PP (IN with) (NP (NN ovalbumin) (NN peptide))))) (ADVP (FW in) (FW vitro)))) (, ,) (VP (VBD produced) (NP (DT no) (JJ antigen-specific) (NP (NN IL-4)) (CC and) (NP (NN IFN-γ)))) (, ,) (CC and) (VP (VBD expressed) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NN CD25) (CD -LSB-12)))))) (-RRB- -RSB-)) (PRN (, ,) (NP (DT all) (ADJP (JJ consistent) (PP (IN with) (NP (JJ professional) (NN CD4+CD25+) (JJ regulatory) (NN T) (NNS cells)))) (CD -LSB-64,65)) (-RRB- -RSB-)) (. .)))
( (S (S (ADVP (RB Moreover)) (, ,) (PP (IN in) (NP (NP (DT a) (JJ dramatic) (NN turnaround)) (PP (IN of) (NP (JJ allergen-induced) (JJ asthmatic) (NN lung) (NN disease))))) (, ,) (NP (JJ TGF-β-converted/induced) (NN Treg)) (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBN transferred) (PP (TO to) (NP (DT an) (JJ asthmatic) (NN mouse)))))) (, ,) (VP (VBD suppressed) (NP (NP (JJ allergen-induced) (NN inflammation)) (CC and) (NP (NN pathogenesis) (CD -LSB-12) (-RRB- -RSB-))))) (. .)))
( (S (S (PP (IN In) (NP (DT this) (NN model))) (, ,) (NP (NNS mice)) (VP (VBP are) (VP (VP (VBN immunized) (PP (IN with) (NP (NN house) (NN dust) (JJ mite)))) (CC and) (RB then) (VP (VBN challenged) (ADVP (RB intratracheally)) (PP (IN with) (NP (NP (NN house) (NN dust) (JJ mite)) (S (VP (TO to) (VP (VB induce) (NP (NP (NN airway) (NN hyperreactivity)) (, ,) (NP (NN mucus) (NN accumulation)) (, ,) (NP (NN eosinophilia)) (CC and) (NP (NN IgE) (NN production)))))))))))) (. .)))
( (S (S (NP (NP (NN Delivery)) (PP (IN of) (NP (NN Treg))) (PP (TO to) (NP (DT these) (JJ asthmatic) (NNS mice))) (PP (IN on) (NP (NN day) (CD 0) (CC and) (CD 14)))) (VP (VBD was) (ADJP (JJ able) (S (VP (TO to) (VP (VB prevent) (NP (NP (DT the) (JJ immunopathogenic) (NN response)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 2)) (-RRB- -RRB-))))))) (, ,) (S (VP (VBG confirming) (NP (NP (DT the) (JJ functional) (NNS prowess)) (PP (IN of) (NP (DT these) (ADJP (RB newly) (VBN converted)) (NNS cells)))) (PP (IN in) (NP (NP (DT the) (NN suppression)) (PP (IN of) (NP (NP (ADJP (JJ inflammatory))) (CC and) (NP (NP (JJ immune) (NNS responses)) (ADVP (FW in) (FW vivo))))))))))) (. .)))
( (S (NP (NP (NN Treg)) (PP (IN in) (NP (JJ autoimmune) (NNS diseases))))))
( (S (S (NP (NP (JJ Human) (NP (NP (JJ systemic) (NN lupus) (NN erythematosus)) (PRN (-LRB- -LRB-) (NP (NN SLE)) (-RRB- -RRB-))) (NNS patients)) (CC and) (NP (NP (JJ murine) (NNS models)) (PP (IN of) (NP (NN SLE))))) (VP (VBP manifest) (NP (NP (DT a) (JJ wide) (NN range)) (PP (IN of) (NP (JJ immunological) (NNS abnormalities)))))) (. .)))
( (S (S (NP (NP (DT The) (RBS most) (JJ pervasive)) (PP (IN of) (NP (DT these)))) (VP (VBP include) (NP (NP (DT the) (NN generation)) (PP (IN of) (NP (JJ pathogenic) (NNS autoantibodies)))))) (. .)))
( (S (PP (IN In) (NP (DT this) (NN regard))) (, ,) (S (S (NP (NP (CD 98) (NN %)) (PP (IN of) (NP (JJ human) (NN SLE) (NNS patients)))) (VP (VBP possess) (NP (JJ antinuclear) (NNS antibodies)))) (CC and) (S (NP (NP (QP (CD 50) (TO to) (CD 80)) (NN %)) (PP (IN of) (NP (DT these)))) (VP (VBP have) (NP (NP (JJ anti-double-stranded) (NN DNA) (NNS antibodies)) (, ,) (NP (NP (DT the) (NN result)) (PP (IN of) (NP (NP (JJ unchecked) (NN B) (NN lymphocyte) (NN activation)) (CC and) (NP (NN antibody) (NN production))))) (, ,)) (PP (ADVP (RB probably)) (JJ due) (TO to) (NP (JJ uncontrolled) (NN T) (NN cell) (NNS hyper-responsiveness)))))) (. .)))
( (S (S (NP (NP (CC Both) (NP (NN Th1)) (CC and) (NP (NN Th2))) (NNS responses)) (VP (VBP are) (VP (VBN elevated) (, ,) (SBAR (IN as) (S (VP (VBN demonstrated) (PP (IN by) (NP (NP (NP (DT the) (NN upregulation)) (PP (IN of) (NP (NP (JJ proinflammatory) (NNS cytokines)) (, ,) (ADJP (RB notably) (JJ IFN-γ)) (, ,) (NP (NP (NN IL-6)) (, ,) (NP (NN IL-12)) (, ,) (CC and) (NP (NN IL-10))) (, ,)))) (CONJP (RB as) (RB well) (IN as)) (NP (ADJP (NN T) (JJ cell-dependent)) (NN autoantibody) (NN production)))))))))) (. .)))
( (S (S (ADVP (RB Interestingly)) (, ,) (NP (DT these) (NP (NP (NN T)) (CC and) (NP (NN B))) (NN lymphocyte) (NNS abnormalities)) (VP (VBP have) (VP (VBN been) (VP (VBN attributed) (, ,) (ADVP (ADVP (IN at) (JJS least)) (RB partly)) (, ,) (PP (TO to) (NP (NP (NP (JJ defective) (NN production)) (CC and) (NP (NN function))) (PP (IN of) (NP (NN TGF-β) (CD -LSB-12,66)))))))) (-RRB- -RSB-)) (. .)))
( (S (S (PP (IN In) (NN contrast) (TO to) (NP (JJ strong) (NNS suspicions))) (, ,) (NP (JJ few) (NNS data)) (ADVP (RB yet)) (VP (VBP exist) (PP (IN as) (TO to) (SBAR (IN whether) (S (NP (NP (DT the) (NP (JJ uncontrolled) (NN T) (CC and) (NN B) (NN cell) (NN activation)) (CC and) (NP (NN pathogenesis))) (PP (IN in) (NP (NN SLE)))) (VP (MD can) (VP (VB be) (VP (VBN attributed) (PP (TO to) (NP (NP (DT a) (NN deficiency)) (PP (IN in) (NP (JJ CD4+CD25+) (JJ regulatory) (NN T) (NNS cells))))))))))))) (. .)))
( (S (PP (IN In) (NP (DT this) (NN regard))) (, ,) (NP (CD one) (NN study)) (VP (VBD indicated) (SBAR (IN that) (S (S (NP (JJ CD4+CD25+) (NN T) (NNS cells)) (VP (VBD were) (ADVP (RB significantly)) (VP (VBN decreased) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ active) (NN SLE))))) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (NP (JJ normal) (NNS subjects)) (CC and) (NP (NNS patients)))) (PP (IN with) (NP (NP (DT an) (JJ inactive) (NN stage)) (PP (IN of) (NP (DT the) (NN disease) (NN -LSB-67))))) (-RRB- -RSB-)))))) (, ,) (CC and) (S (PP (IN in) (NP (DT another) (JJ recent) (NN study))) (NP (CD -LSB-68) (-RRB- -RSB-) (NN Treg)) (VP (VBD were) (VP (VBN reported) (S (VP (TO to) (VP (VB be) (ADJP (JJ abnormal) (PP (IN in) (NP (NP (NP (NN number)) (, ,) (NP (NN phenotype)) (, ,) (CC and) (NP (NN function))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ active) (NN SLE))))))))))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (JJ exact) (NN role)) (PP (IN of) (NP (DT the) (VBN decreased) (NN CD4+CD25+) (NN Treg) (NNS levels))) (PP (IN in) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (NN SLE)))))) (VP (VBZ awaits) (NP (NP (NN demonstration)) (PP (IN of) (NP (NP (DT a) (JJ significant) (NN correlation)) (PP (IN between) (NP (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NP (NN CD4+CD25+) (NN Treg)) (CC and) (NP (JJ inactive) (NN disease))))) (CC or) (NP (NN flare) (NN activity) (CD -LSB-69)))))))) (-RRB- -RSB-)) (. .)))
( (S (S (PP (IN In) (NP (NP (JJ rheumatoid) (NN arthritis)) (PRN (-LRB- -LRB-) (NP (NN RA)) (-RRB- -RRB-)))) (, ,) (NP (NP (DT the) (NN relationship)) (PP (IN between) (NP (NP (NP (JJ CD4+CD25+) (NN Treg)) (CC and) (NP (JJ Th1-dependent) (NN pathogenesis))) (PP (IN of) (NP (DT the) (NN disease)))))) (ADVP (RB also)) (VP (VBZ remains) (PP (IN under) (NP (NN study))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBD was) (ADVP (RB recently)) (VP (VBN suggested) (SBAR (LST (CD -LSB-70) (-RRB- -RSB-)) (IN that) (S (NP (NP (DT no) (JJ significant) (NN difference)) (PP (IN in) (NP (JJ suppressive) (NN activity)))) (VP (VBD was) (VP (VBN found) (PP (IN between) (NP (NP (JJ CD4+CD25+) (NN T) (NNS cells)) (PP (IN from) (NP (NP (JJ peripheral) (NN blood)) (PP (IN of) (NP (NP (NN RA) (NNS patients)) (CC and) (NP (JJ healthy) (NN control) (NNS subjects))))))))) (, ,) (SBAR (IN although) (S (NP (DT the) (NNS numbers)) (VP (MD may) (VP (VB be) (ADJP (RBR less) (JJ -LSB-25)))) (-RRB- -RSB-))))))))) (. .)))
( (S (S (ADVP (RB Nonetheless)) (, ,) (NP (NP (NN CD4+CD25+) (NN T) (NNS cells)) (PP (IN from) (NP (JJ synovial) (NN fluid)))) (ADVP (RB reportedly)) (VP (VBD had) (NP (DT a) (ADJP (RB significantly) (JJR higher)) (JJ suppressive) (NN activity)) (PP (IN than) (NP (NP (DT those)) (PP (IN in) (NP (NP (JJ peripheral) (NN blood)) (PP (IN of) (NP (NN RA) (NNS patients))))))))) (. .)))
( (S (S (ADVP (RB Notably)) (, ,) (PP (IN despite) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (DT these) (ADJP (RB highly) (JJ functional)) (NNS Treg)) (PP (IN in) (NP (JJ synovial) (NN fluid))))))) (, ,) (NP (EX there)) (VP (VBD was) (ADVP (RB still)) (NP (NP (JJ ongoing) (NN inflammation)) (PP (IN in) (NP (DT the) (NNS joints)))) (, ,) (S (VP (VBG indicating) (NP (NP (DT the) (JJ complex) (NN picture)) (PP (IN of) (NP (NN RA) (NN pathogenesis))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD might) (VP (VB reflect) (NP (NP (DT a) (JJ prominent) (NN imbalance)) (PP (IN between) (NP (ADJP (ADJP (JJ regulatory)) (CC and) (ADJP (JJ inflammatory))) (NNS checkpoints))))))))))))) (. .)))
( (S (PP (IN In) (NP (DT an) (JJ encouraging) (JJ experimental) (NN therapy) (NN study))) (, ,) (NP (NP (NP (NP (NNS patients)) (PP (IN with) (NP (NN RA))) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN treated) (PP (IN for) (NP (CD 6) (NNS months))) (PP (IN with) (NP (JJ oral) (NN dnaJP1)))))))) (, ,) (NP (NP (DT a) (NN peptide)) (SBAR (WHNP (WDT that)) (S (VP (VBZ induces) (NP (JJ proinflammatory) (NN T) (NN cell) (NNS responses)) (PP (IN in) (NP (JJ naive) (NN RA) (NNS patients))))))) (, ,)) (VP (VBN manifested))) (VP (VBD increased) (NP (NN Foxp3+CD4+CD25+) (NN T) (NNS cells)) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (DT the) (NN treatment)) (VP (VBD induced) (NP (NP (NP (DT the) (NN emergence)) (PRN (-LRB- -LRB-) (NP (NN enhancement)) (-RRB- -RRB-))) (PP (IN of) (NP (NN T) (NNS cells)))) (PP (IN with) (NP (NP (DT the) (JJ regulatory) (NN phenotype)) (CD -LSB-71) (-RRB- -RSB-))))))))) (. .)))
( (S (S (PP (IN In) (NP (JJ short))) (, ,) (PP (IN despite) (NP (NP (DT the) (JJ complex) (NN picture)) (PP (IN of) (NP (NN Treg))) (PP (IN in) (NP (NN autoimmunity))))) (, ,) (NP (PRP it)) (VP (MD can) (VP (VB be) (VP (VBN envisioned) (SBAR (IN that) (S (NP (PRP it)) (VP (MD will) (VP (VB become) (ADJP (JJ feasible) (S (VP (TO to) (VP (VB manipulate) (NP (JJ regulatory) (NN T) (NNS cells)) (PP (IN for) (NP (JJ therapeutic) (NN benefit))))))))))))))) (. .)))
( (S (PP (IN With) (NP (JJ continued) (NNS efforts))) (, ,) (NP (NP (DT a) (JJR better) (NN understanding)) (CC and) (NP (ADJP (RBR more) (JJ advanced)) (NNS techniques))) (VP (MD will) (VP (VB emerge) (PP (IN for) (NP (NP (DT the) (NP (NN induction)) (CC and/or) (NP (NN expansion))) (PP (IN of) (NP (NN Treg))))) (S (VP (TO to) (VP (VB enhance) (NP (NP (PRP$ their) (NN role)) (PP (IN in) (NP (NP (NN autoimmunity)) (, ,) (NP (NN allergy)) (, ,) (CC and) (NP (NN graft) (NN rejection)))))))))) (. .)))
( (S (NP (NN Conclusion))))
( (S (S (S (NP (ADJP (ADJP (JJ Innate)) (CC and) (ADJP (JJ adaptive))) (JJ immune) (NNS responses)) (VP (VBP are) (ADJP (JJ essential) (S (VP (TO to) (VP (VB protect) (NP (DT the) (NN host)) (PP (IN from) (NP (NP (DT a) (NN plethora)) (PP (IN of) (NP (ADJP (RB potentially) (JJ pathogenic)) (NNS microorganisms))))))))))) (, ,) (CC but) (S (NP (NP (NNS countermeasures)) (VP (TO to) (VP (VB prevent) (NP (NP (NN reactivity)) (PP (IN of) (NP (NN self))))))) (VP (VBP are) (ADVP (RB equally)) (ADJP (JJ essential))))) (. .)))
( (S (S (SBAR (IN Although) (S (NP (NP (NN protection)) (PP (IN against) (NP (JJ self-recognition-induced) (NN autoimmunity)))) (VP (VBZ is) (VP (VBN accomplished) (PP (IN in) (NP (JJ large) (NN part))) (PP (IN by) (NP (NP (DT the) (JJ central) (NN deletion)) (PP (IN of) (NP (JJ autoreactive) (NN T) (NNS cells))))) (PP (IN during) (NP (JJ intrathymic) (NN development))))))) (, ,) (S (S (NP (DT this) (NN process)) (VP (VBZ is) (RB not) (ADJP (JJ perfect)))) (CC and) (S (NP (JJ self-reactive) (NNS escapees)) (VP (MD can) (VP (NN wreak) (NP (NN havoc)) (PP (IN on) (NP (DT the) (JJ immune) (NN system)))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (PP (IN among) (NP (NP (DT the) (JJ backup) (NNS pathways)) (PP (IN in) (NP (DT the) (NN periphery) (S (VP (TO to) (VP (VB protect) (NP (PRP us)) (PP (IN from) (NP (NN self-destruction)))))))))) (VP (VBP are) (NP (NP (NN deletion)) (, ,) (NP (NN anergy)) (, ,) (NP (NN ignorance)) (, ,) (CC and) (NP (JJ active) (NN suppression))))) (. .)))
( (S (PP (IN Among) (NP (DT these))) (, ,) (NP (JJ current) (NN interest)) (VP (VBZ has) (VP (VBN zeroed) (PRT (IN in)) (PP (IN on) (NP (NP (JJ CD4+CD25+) (JJ regulatory) (NN T) (NNS cells)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (ADVP (RB profoundly)) (VP (VBP suppress) (NP (NN responder) (NN T) (NN cell) (NP (NP (NN proliferation)) (CC and) (NP (NNS cytokines)))) (ADVP (ADVP (FW in) (FW vitro)) (CC and) (ADVP (FW in) (FW vivo))))))))))) (. .)))
( (S (S (S (ADVP (RB Originally)) (VP (VBN considered) (NP (NP (DT an) (JJ exclusive) (NN product)) (PP (IN of) (NP (DT the) (NN thymus)))))) (, ,) (NP (JJ important) (JJ new) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (DT these) (NNS cells)) (VP (MD can) (VP (VB be) (VP (VP (VBN generated) (PP (IN from) (NP (JJ peripheral) (JJ CD4+) (NN T) (NNS cells)))) (CC and) (VP (VBN expanded) (PP (IN for) (NP (NN delivery))) (PP (IN as) (NP (DT a) (JJ cellular) (JJ therapeutic) (NN strategy))))))))))) (. .)))
( (S (S (NP (NP (NNS Opportunities)) (PP (TO to) (NP (NP (NN use) (NN suppressor) (NN T) (NN cell) (NNS populations)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (JJ debilitating) (JJ autoimmune) (NNS diseases)) (, ,) (NP (NN allergy)) (, ,) (NP (JJ chronic) (JJ infectious) (NNS diseases)) (, ,) (CC and) (NP (NN transplant) (NN rejection))))))))) (VP (VP (VBP are) (ADVP (RB no) (RBR longer)) (NP (NP (DT a) (NN dream)) (PP (IN of) (NP (DT the) (JJ future))))) (CC but) (VP (VBP are) (NP (DT an) (VBG emerging) (NN reality))))) (. .)))
( (S (ADVP (RB Moreover)) (, ,) (SBAR (IN as) (S (NP (PRP we)) (VP (VBP illuminate) (NP (NP (DT the) (NNS mechanisms)) (PP (IN of) (NP (NP (NN regulation)) (PP (IN of) (NP (DT these) (NNS Treg))))))))) (, ,) (NP (PRP it)) (VP (MD might) (ADVP (RB also)) (VP (VB become) (ADJP (JJ feasible) (S (VP (TO to) (VP (VP (VP (VB diminish)) (, ,) (CONJP (RB rather) (IN than)) (VP (VB augment))) (, ,) (NP (PRP$ their) (NN numbers/activity) (S (VP (VP (TO to) (VP (VB promote) (NP (NP (NN tumor) (NN rejection)) (CC and) (NP (NN vaccine) (NNS responses))))) (CC and/or) (VP (TO to) (VP (VB reverse) (NP (NN immunodeficiency) (NNS diseases))))))))))))) (. .)))
( (S (NP (NNS Abbreviations))))
( (S (S (NP (NNS APCs)) (VP (VBG =) (NP (NP (JJ antigen-presenting) (NNS cells)) (: ;) (NP (NP (NP (NN IFN) (JJ =) (NN interferon)) (: ;) (NP (NN IL) (JJ =) (NN interleukin)) (: ;) (NP (NN LAP) (JJ =) (JJ latency-associated) (NN peptide)) (: ;) (NP (NN RA) (JJ =) (JJ rheumatoid) (NN arthritis)) (: ;) (NP (NN SLE) (JJ =) (JJ systemic) (NN lupus) (NN erythematosus)) (: ;) (NP (NNP TβR))) (JJ =) (NN TGF-β) (NN receptor)) (: ;) (NP (NN TCR) (JJ =) (NN T-cell) (NN receptor)) (: ;) (NP (NN TGF) (JJ =) (NN transforming) (NN growth) (NN factor)) (: ;) (NP (NN Th) (JJ =) (NN T) (NN helper) (NN cell)) (: ;) (NP (NP (NN Treg) (JJ =) (JJ regulatory) (NN T) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN s)) (-RRB- -RRB-))) (: ;) (NP (NN TSP) (JJ =) (NN thrombospondin))))) (. .)))
( (S (NP (VBG Competing) (NNS interests))))
( (S (S (NP (DT The) (NN author) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-)) (VP (VB declare) (SBAR (IN that) (S (NP (PRP they)) (VP (VBP have) (NP (DT no) (VBG competing) (NNS interests))))))) (. .)))
( (S (NP (NP (NN Figure)) (CC and) (NP (NN Table)) (NP (NNS captions)))))
( (S (S (NP (NP (NN Figure) (CD 1)) (: :) (NP (JJ Regulatory) (NN T) (NNS cells))) (VP (VBP mediate) (NP (ADJP (ADJP (JJ inflammatory)) (CC and) (ADJP (JJ immune))) (NNS reactions)))) (. .)))
( (S (S (NP (NN CD4+CD25+) (NNS Treg)) (VP (MD can) (VP (VB suppress) (NP (NP (NN CD4+CD25-) (NN T) (NN cell) (NNS responses)) (PP (TO to) (NP (NNS antigens)))) (PP (IN through) (NP (NP (DT a) (ADJP (ADJP (JJ contact-dependent)) (, ,) (ADJP (JJ antigen-nonspecific))) (NN mechanism)) (VP (VBG involving) (NP (NN TGF-β)))))))) (. .)))
( (S (S (NP (NN Treg)) (VP (VBP suppress) (NP (NN CD4+CD25-) (NN responder) (NN T) (NN cell) (NP (NP (NN proliferation)) (CC and) (NP (NN cytokine) (NN production)))) (, ,) (S (VP (VBG reining) (PP (IN in) (NP (NP (NN Th1)) (CC and/or) (NP (NN Th2)) (NP (NN immunity)))))))) (. .)))
( (S (S (PP (IN Without) (NP (NP (JJ adequate) (NN intercession)) (PP (IN by) (NP (NN Treg))))) (, ,) (NP (ADJP (ADJP (JJ Th1-)) (CC or) (ADJP (JJ Th2-dominated))) (NNS responses)) (VP (MD may) (VP (VB become) (ADJP (JJ pathogenic))))) (. .)))
( (S (S (NP (NN Figure) (CD 2) (: :) (NN Treg)) (VP (VBD expanded) (ADVP (FW in) (FW vitro)) (VP (VB suppress) (NP (JJ allergen-induced) (NN asthma)) (ADVP (FW in) (FW vivo))))) (. .)))
( (S (S (NP (NP (NNS Mice)) (VP (VP (VBN sensitized) (PP (TO to) (NP (NN house) (NN dust) (NP (ADJP (JJ mite) (PRN (-LRB- -LRB-) (NP (NN HDM)) (-RRB- -RRB-)) (PP (IN by) (NP (NP (ADJP (ADJP (JJ intraperitoneal)) (PRN (-LRB- -LRB-) (NP (NN ip)) (-RRB- -RRB-))) (NN injection)) (PP (IN with) (NP (NN HDM))) (PP (IN on) (NP (NNS days) (CD 0) (CC and) (CD 7)))))))))) (CC and) (VP (ADVP (RB then)) (VBN challenged) (PP (IN by) (NP (NP (JJ intratracheal) (PRN (-LRB- -LRB-) (NP (PRP it)) (-RRB- -RRB-)) (NN injection)) (PP (IN on) (NP (NNS days) (CD 14) (CC and) (CD 21)))))))) (VP (VBD were) (VP (VBN injected) (ADVP (RB intraperitoneally) (PP (IN on) (NP (NNS days) (CD 0) (CC and) (CD 14)))) (PP (IN with) (NP (NN Treg)))))) (. .)))
( (S (S (PP (NP (CD Three) (NNS days)) (IN after) (NP (NP (DT the) (JJ second) (JJ intratracheal) (NN challenge)) (PP (IN with) (NP (NN HDM))))) (, ,) (NP (DT the) (NNS lungs)) (VP (VBD were) (VP (VBN assessed) (PP (IN for) (NP (NN histopathology))) (PP (IN by) (NP (NP (JJ periodic) (NN acid) (NN Schiff) (NN staining)) (PP (IN for) (NP (NP (NNS mucopolysaccharides)) (PRN (-LRB- -LRB-) (NP (JJ red)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (NP (NP (JJ Inflammatory) (NN pathology)) (CC and) (NP (NN mucin) (NN obstruction))) (PP (IN of) (NP (DT the) (NNS airways)))) (VP (VBD were) (ADVP (RB strikingly)) (VP (VBN reduced) (PP (IN in) (NP (NP (NNS mice)) (VP (VBG receiving) (NP (NN Treg) (NN -LSB-12))))))) (-RRB- -RSB-)) (. .)))
( (S (NP (NP (NN Analysis)) (PP (IN of) (NP (DT the) (NN CCR3) (NN promoter)))) (VP (VBZ reveals) (NP (NP (DT a) (JJ regulatory) (NN region)) (PP (IN in) (NP (NN exon) (CD 1))) (SBAR (WHNP (WDT that)) (S (VP (VBZ binds) (NP (NN GATA-1)))))))))
( (S (NP (NN Abstract))))
( (S (NP (NP (NN Background)) (: :) (S (NP (NP (NP (NN CC) (NN Chemokine) (NN Receptor) (CD 3)) (PRN (-LRB- -LRB-) (NP (NN CCR3)) (-RRB- -RRB-))) (, ,) (NP (NP (DT the) (JJ major) (NN chemokine) (NN receptor)) (VP (VBN expressed) (PP (IN on) (NP (NNS eosinophils))))) (, ,)) (VP (VBZ binds) (ADVP (RB promiscuously)) (PP (TO to) (NP (NP (JJ several) (NNS ligands)) (PP (VBG including) (NP (NNS eotaxins) (QP (CD 1) (, ,) (CD 2) (, ,) (CC and) (CD 3)))))))) (. .))))
( (S (S (SBAR (RB Even) (IN though) (S (NP (NP (DT the) (JJ only) (NNS cells)) (SBAR (WHNP (WDT that)) (S (ADVP (RB consistently)) (VP (VBP accumulate) (PP (VBG following) (NP (NN eotaxin) (NN administration))) (ADVP (FW in) (FW vivo)))))) (VP (VBP are) (NP (NP (JJ myeloid) (NNS cells)) (PRN (-LRB- -LRB-) (NP (ADVP (RB primarily)) (NP (NNS eosinophils))) (-RRB- -RRB-)))))) (, ,) (NP (JJ other) (NN cell) (NNS types)) (VP (VBP have) (ADVP (RB recently)) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB express) (NP (NN CCR3))))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB therefore)) (ADJP (JJ important)) (S (VP (TO to) (VP (VB elucidate) (NP (NP (DT the) (JJ molecular) (NNS mechanisms)) (VP (VBG regulating) (NP (NN receptor) (NN expression))))))))) (. .)))
( (S (NP (NP (NNS Results)) (: :) (S (S (SBAR (IN In) (NN order) (TO to) (S (VP (VB define) (NP (NP (NNS regions)) (ADJP (JJ responsible) (PP (IN for) (NP (NN CCR3) (NN transcription)))))))) (, ,) (NP (DT a) (NN DNAse) (JJ hypersensitive) (NN site)) (VP (VBD was) (VP (VBN identified) (PP (IN in) (NP (NP (DT the) (NN vicinity)) (PP (IN of) (NP (NN exon) (LS 1.) (VP (VBN Coupled) (PP (IN with) (NP (NP (PRP$ our) (JJ previous) (NNS data)) (VP (VBG implicating) (NP (NN exon) (CD 1)) (PP (IN in) (NP (NN CCR3) (NN transcription)))))))))))))) (, ,) (S (NP (PRP we)) (VP (VBD hypothesized) (SBAR (IN that) (S (NP (NN transcription) (NNS factors)) (VP (VBP bind) (PP (TO to) (NP (NN exon-1))))))))) (. .))))
( (S (S (NP (JJ Electrophoretic) (NN mobility) (NN shift) (NN analysis)) (VP (VBD revealed) (SBAR (IN that) (S (NP (NP (JJ nuclear) (NNS proteins)) (PP (IN in) (NP (JJ eosinophilic) (NNS cells)))) (VP (VBD bound) (PP (TO to) (NP (NN exon) (CD 1)))))))) (. .)))
( (S (S (ADVP (RB Furthermore)) (, ,) (NP (NN antibody) (NN interference) (CC and) (NN mutation) (NNS studies)) (VP (VBD demonstrated) (NP (NP (NN GATA-1) (NN binding)) (PP (TO to) (NP (NN exon) (CD 1)))))) (. .)))
( (S (PP (IN In) (NP (NN order))) (VP (TO to) (VP (VB test) (NP (DT the) (JJ 1.6-kb))))))
( (S (S (NP (NP (NN CCR3) (NN promoter) (NN element)) (-LRB- -LRB-) (SBAR (WHNP (WDT that)) (S (VP (VBZ includes) (NP (NN exon) (CD 1))))) (-RRB- -RRB-) (PP (IN for) (NP (NP (ADJP (FW in) (FW vivo)) (NN function)) (, ,) (NP (DT this) (NN region))))) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB generate) (NP (NP (JJ transgenic) (NNS mice)) (SBAR (WHNP (WDT that)) (S (VP (VBD expressed) (NP (DT a) (NN reporter) (NN protein)))))))))))) (. .)))
( (S (S (NP (JJ Strong) (NN transgene) (NN expression)) (VP (VBD was) (VP (VBN achieved) (, ,) (PP (IN with) (NP (NP (DT the) (NN pattern)) (PP (IN of) (NP (NN expression))) (VP (VBG suggesting) (NP (DT a) (JJ broad) (NN acting) (NN promoter)))))))) (. .)))
( (S (NP (NP (NN Conclusion)) (: :) (S (NP (DT The) (NN transcription) (NN factor) (NN GATA-1)) (VP (VBZ binds) (PP (TO to) (NP (NN CCR3) (NN exon) (CD 1))))) (. .))))
( (S (NP (DT The) (JJ 1.6-kb))))
( (S (S (NP (NP (NN CCR3) (NN promoter) (NN element)) (, ,) (SBAR (WHNP (WDT that)) (S (VP (VBZ includes) (NP (NN exon) (CD 1))))) (, ,)) (VP (VBZ is) (NP (NP (DT a) (JJ strong) (NN promoter)) (PP (IN in) (NP (FW vivo)))))) (. .)))
( (S (NP (NN Background))))
( (S (S (NP (NP (NN CCR3)) (, ,) (NP (DT the) (NN eotaxin) (NN receptor)) (, ,)) (VP (VBZ is) (NP (NP (DT the) (JJ major) (NN chemokine) (NN receptor)) (VP (VBN expressed) (PP (IN on) (NP (NP (NNS eosinophils)) (, ,) (NP (NNS basophils)) (CC and) (NP (NP (DT a) (NN subpopulation)) (PP (IN of) (NP (NN Th2) (NNS lymphocytes) (CD -LSB-1-10))) (-RRB- -RSB-)))))))) (. .)))
( (S (ADVP (RB Recently)) (, ,) (NP (NN CCR3)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (VP (TO to) (VP (VB be) (VP (VBN upregulated) (PP (IN on) (NP (NP (NNS neutrophils)) (CC and) (NP (NN monocytoid) (NN U937) (NNS cells)))) (PP (IN by) (NP (NNS interferons))) (ADVP (FW in) (FW vitro))))) (CC and) (VP (TO to) (VP (VB be) (VP (VBN expressed) (PP (IN by) (NP (NP (JJ endothelial) (NNS cells)) (, ,) (NP (JJ epithelial) (NNS cells)) (CC and) (NP (NP (NN mast) (NNS cells)) (PRN (NN -LSB-11-16) (-RRB- -RSB-))))))))))))) (. .)))
( (S (S (NP (NP (NP (DT The) (NN relevance)) (PP (IN of) (NP (DT these) (NNS findings)))) (CC and) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (NN CCR3))) (PP (IN on) (NP (NNS non-leukocytes))))) (VP (VBP remain) (S (VP (TO to) (VP (VB be) (VP (VBN elucidated) (SBAR (IN since) (S (NP (NP (DT the) (JJ only) (NNS cells)) (SBAR (WHNP (WDT that)) (S (ADVP (RB consistently)) (VP (VBP accumulate) (PP (VBG following) (NP (NN eotaxin) (NN administration))) (ADVP (FW in) (FW vivo)))))) (VP (VBP are) (NP (NP (JJ myeloid) (NNS cells)) (PRN (-LRB- -LRB-) (NP (RB primarily) (NNS eosinophils) (-RRB- -RRB-) (CD -LSB-17-20)) (-RRB- -RSB-)))))))))))) (. .)))
( (S (S (PP (TO To) (NP (NN date))) (, ,) (NP (NP (DT the) (NP (JJ complete) (NN mRNA)) (CC and) (NP (JJ genomic) (NN organization))) (PP (IN of) (NP (NP (RB only) (DT a) (JJ limited) (NN number)) (PP (IN of) (NP (NN chemokine) (NNS receptors)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN described) (NP (CD -LSB-21-26) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (DT These) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (ADJP (CD 5) ('' ') (JJ untranslated)) (NN region)) (PRN (-LRB- -LRB-) (NP (CD 5) (`` ') (NN UTR)) (-RRB- -RRB-))) (VP (VP (MD can) (VP (VB be) (ADJP (JJ complex)))) (CC and) (VP (VBP contain) (NP (QP (RB up) (TO to) (CD 11)) (NNS exons)) (PP (IN as) (PP (IN in) (NP (DT the) (NN CXCR2) (NN gene))))))))))) (. .)))
( (S (S (PP (IN As) (NP (DT a) (NN result))) (, ,) (NP (NP (NP (JJ alternative) (NN splicing)) (CC and) (NP (NN transcription))) (VP (VBN directed) (PP (IN by) (NP (JJ multiple) (NNS promoters))))) (VP (MD can) (VP (VBP give) (NP (NN rise)) (PP (TO to) (NP (JJ variable) (NN mRNA) (NNS isoforms)))))) (. .)))
( (S (S (NP (NP (DT The) (NN function)) (PP (IN of) (NP (DT these) (CD 5) (`` ') (JJ untranslated) (NNS exons)))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN examined) (PP (IN except) (PP (IN for) (S (NP (DT a) (JJ single) (NN study)) (VP (VBD focused) (PP (IN on) (NP (NN CCR2))) (, ,) (S (VP (VBG demonstrating) (NP (NP (DT a) (JJ transcriptional) (NN role)) (PP (IN for) (NP (NN exon) (CD 1) (CD -LSB-24) (-RRB- -RSB-)))))))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB previously)) (VP (VBN characterized) (NP (NP (DT the) (NP (JJ genomic) (NN structure)) (CC and) (NP (NN promoter) (NN function))) (PP (IN of) (NP (DT the) (JJ human) (NN CCR3) (NN gene) (CD -LSB-27)))) (-RRB- -RSB-)))) (. .)))
( (S (S (NP (DT The) (NN CCR3) (NN gene)) (VP (VBZ contains) (NP (NP (QP (IN at) (JJS least) (CD 4)) (NNS exons)) (SBAR (WHNP (WDT that)) (S (VP (VBP give) (NP (NN rise)) (PP (TO to) (NP (NP (JJ multiple) (NN mRNA) (NNS species)) (PP (IN by) (NP (JJ alternative) (NN splicing))))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ first) (CD 1.6) (NN kb)) (PP (IN of) (NP (NP (DT the) (CD 5) (`` ') (JJ flanking) (NN region)) (PP (IN of) (NP (NN exon) (CD 1)))))) (VP (VBD had) (NP (JJ strong) (NN promoter) (NN activity)) (PP (IN in) (NP (ADJP (ADJP (JJ eosinophilic)) (, ,) (ADJP (JJ lymphoid)) (CC and) (ADJP (JJ respiratory))) (JJ epithelial) (NN cell) (NNS lines))))) (. .)))
( (S (S (NP (NN Deletion) (NN analysis)) (VP (VBD revealed) (NP (NP (JJ differential) (NN regulation)) (PP (IN of) (NP (DT the) (NN CCR3) (NN promoter))) (PP (IN in) (NP (ADJP (ADJP (JJ eosinophilic)) (CC and) (ADJP (JJ epithelial))) (NN cell) (NNS lines)))) (S (VP (VBG suggesting) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ lineage-specific) (NNS elements)))))))) (. .)))
( (S (S (ADVP (RB Interestingly)) (, ,) (NP (NN exon) (CD 1)) (VP (VBD enhanced) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (DT the) (NN promoter)))))) (. .)))
( (S (S (PP (IN Since) (NP (PRP$ our) (JJ initial) (NN characterization))) (, ,) (NP (CD two) (JJ other) (NNS groups)) (VP (VBP have) (VP (VBN studied) (NP (DT the) (NN CCR3) (NN promoter) (NN -LSB-28,29)))) (-RRB- -RSB-)) (: ;) (ADVP (RB however)) (, ,) (NP (NP (PRP$ their) (NNS studies)) (VP (VBN focused) (PP (IN on) (NP (NP (JJ lymphocytic) (CC and) (JJ monocytic) (NN cell) (NNS lines)) (, ,) (ADVP (RB respectively)) (, ,) (CONJP (RB rather) (IN than)) (NP (NNS eosinophils)))))) (. .)))
( (S (S (NP (NP (NNP Scotet) (FW et) (FW al.)) (CD -LSB-29) (-RRB- -RSB-)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (DT the) (JJ human) (NN CCR3) (NN promoter)) (VP (VBZ is) (VP (JJ active) (ADVP (FW in) (FW vitro)) (PP (IN in) (NP (JJ lymphocytic) (NN cell) (NNS lines))))))))) (. .)))
( (S (S (NP (PRP They)) (ADVP (RB also)) (VP (VBP demonstrate) (NP (NP (DT a) (NN role)) (PP (IN for) (NP (NN chromatin) (NN remodeling))) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (NN CCR3) (NN expression)) (PP (IN in) (NP (NN Th2) (NNS cells)))))))))) (. .)))
( (S (NP (NP (NNP Vijh) (FW et) (FW al.)) (CD -LSB-28) (-RRB- -RSB-)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (DT the) (JJ human) (NN CCR3) (NN promoter)) (VP (VBZ is) (UCP (ADJP (JJ active) (PP (IN in) (NP (NP (NP (JJ monocytic) (NN cell) (NNS lines)) (CC and) (NP (VBN defined) (NP (DT the) (JJ minimal) (NN promoter)))) (SBAR (WHNP (WDT that)) (S (VP (VBZ consists) (PP (IN of) (NP (NP (NP (DT a) (JJ downstream) (NN promoter) (NN element)) (PRN (-LRB- -LRB-) (NP (NN DPE)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (JJ common) (NN element)) (PP (IN in) (NP (NN Drosophila) (NNS genes)))))))))))) (, ,) (CC but) (ADJP (JJ rare) (PP (IN in) (NP (JJ human) (NNS genes))))))))) (. .)))
( (S (S (NP (DT This) (NN element)) (VP (VBZ is) (NP (NP (ADVP (RB upstream)) (PRN (-LRB- -LRB-) (NP (CD 50) (NN bp)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (DT the) (NN exon) (CD 1) (NN sequence)) (VP (VBN studied) (PP (IN in) (NP (DT the) (JJ current) (NN report))))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (SBAR (IN that) (S (NP (NP (CD 5) (`` ') (JJ untranslated) (NNS exons)) (, ,) (CC and) (ADVP (RB sometimes)) (NP (NNS introns)) (, ,)) (VP (MD can) (VP (VB regulate) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NNS genes))) (PP (IN in) (NP (CD two) (JJ different) (NNS ways)))))))))))) (. .)))
( (S (S (NP (DT An) (JJ untranslated) (NN sequence)) (VP (MD can) (VP (VB act) (PP (IN as) (NP (DT a) (JJ tissue-specific) (JJ translational) (NN regulator)))))) (. .)))
( (S (S (NP (DT A) (JJ striking) (NN example)) (VP (VBZ is) (NP (NP (DT the) (NN gonadotropin) (VBG releasing) (NN hormone) (NN gene)) (SBAR (WHNP (WDT which)) (S (VP (VP (VBZ is) (VP (VBN transcribed) (PP (IN in) (NP (JJ multiple) (NN tissue))))) (, ,) (CC but) (VP (MD cannot) (VP (VB be) (VP (VBN translated) (PP (JJ due) (TO to) (NP (NP (DT the) (NN lack)) (PP (IN of) (NP (JJ specific) (NN intron) (NN removal) (CD -LSB-30) (-RRB- -RSB-)))))))))))))) (. .)))
( (S (S (ADVP (RB Alternatively)) (, ,) (NP (NP (JJ untranslated) (NNS regions)) (PRN (-LRB- -LRB-) (NP (NN UTR)) (-RRB- -RRB-))) (VP (MD can) (VP (VB facilitate) (NP (NP (NN transcription)) (PP (IN of) (NP (DT a) (NN gene))))))) (. .)))
( (S (S (NP (NNS Examples)) (VP (VBP include) (NP (NP (NP (DT a) (NN GATA-1) (NN site)) (PP (IN in) (NP (NP (DT the) (NN 5'-UTR)) (PP (IN of) (NP (DT the) (NN γ-globin) (NN gene)))))) (, ,) (NP (NP (DT an) (NN HNF-1) (NN site)) (PP (IN in) (NP (DT the) (NN plasminogen) (NN gene)))) (CC and) (NP (NP (DT a) (NN C/EBP) (NN site)) (PP (IN in) (NP (DT the) (NN CCR2) (NN gene) (NN -LSB-24,31,32)))))) (-RRB- -RSB-)) (. .)))
( (S (S (SBAR (IN While) (S (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NN action)))) (VP (VBZ is) (RB not) (ADVP (RB completely)) (ADJP (JJ clear))))) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN thought) (SBAR (IN that) (S (NP (NP (NN transcription) (NNS factors)) (VP (VBG binding) (PP (TO to) (NP (JJ untranslated) (NNS regions))))) (VP (VBP affect) (NP (NP (NN transcription)) (PP (IN of) (NP (DT the) (NN gene)))) (PP (IN through) (NP (NP (NNS interactions)) (PP (IN with) (NP (DT the) (NN RNA) (NN transcription) (NN complex))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN role)) (PP (IN of) (NP (JJ untranslated) (NNS exons))) (PP (IN in) (NP (DT the) (NN CCR3) (NN gene)))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN studied))))) (. .)))
( (S (S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP (NN DNase) (CD I) (NN hypersensitivity)) (VP (VBD identified) (NP (NP (DT a) (JJ major) (JJ hypersensitive) (NN site)) (ADJP (JJ located) (PP (IN in) (NP (NP (DT the) (NN vicinity)) (PP (IN of) (NP (JJ untranslated) (NN exon) (CD 1))))))))) (. .)))
( (S (S (ADVP (RB Furthermore)) (, ,) (NP (DT the) (NN transcription) (NN factor) (NN GATA-1)) (VP (VBZ is) (VP (VBN shown) (S (VP (TO to) (VP (VB bind) (PP (TO to) (NP (JJ untranslated) (NN exon) (CD 1))))))) (, ,) (S (VP (VBG suggesting) (NP (NP (DT a) (JJ potential) (NN mechanism)) (PP (IN for) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NN CCR3) (NN transcription))) (PP (IN by) (NP (DT this) (NN exon)))))))))) (. .)))
( (S (ADVP (RB Finally)) (, ,) (S (VP (VBG using) (NP (DT a) (JJ transgenic) (NN approach)))) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (DT the) (CD 1.6) (NN kb) (ADJP (CD 5) ('' ') (JJ flanking)) (NN region)) (PP (IN of) (NP (NN CCR3))) (-LRB- -LRB-) (VP (VBG including) (NP (NN exon) (CD 1))) (-RRB- -RRB-)) (VP (VBZ has) (NP (NN promoter) (NN activity)) (ADVP (FW in) (FW vivo)))))) (. .)))
( (S (NP (NNS Results))))
( (S (S (NP (PRP We)) (VP (VBD aimed) (S (VP (TO to) (VP (VB define) (NP (NP (JJ regulatory) (NNS regions)) (PP (IN in) (NP (DT the) (NN CCR3) (NN gene)))) (PP (IN by) (NP (DT a) (JJ gene-wide) (NN search)))))))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (NP (PRP we)) (VP (VBD performed) (NP (NP (NN DNase) (CD I) (NN hypersensitivity)) (PP (IN of) (NP (NN CCR3))) (PP (IN in) (NP (JJ primary) (JJ human) (NNS eosinophils)))))) (. .)))
( (S (S (NP (NP (DT The) (JJ entire) (CD 24) (NN kb)) (PP (IN of) (NP (DT the) (NN CCR3) (NN gene)))) (VP (VBD were) (VP (VBN screened) (PP (IN for) (NP (NN DNase) (CD I) (NN hypersensitivity))) (S (VP (VBG using) (NP (NP (NNS probes)) (ADJP (JJ specific) (PP (IN for) (NP (NP (NP (NP (NN Eco) (NN RI)) (CC and) (NP (NN Hind) (CD III))) (NNS fragments)) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (NN 1A)) (CC and) (NP (NP (NNS data)) (VP (RB not) (VBN shown)))) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (S (NP (QP (RB Only) (CD one)) (JJ hypersensitive) (NN site)) (VP (VBD was) (VP (VBN noted)))) (: ;) (S (NP (DT this)) (VP (VBD was) (PP (IN in) (NP (NP (DT the) (NN area)) (PP (IN of) (NP (NN exon) (CD 1))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1B)) (-RRB- -RRB-))))) (. .)))
( (S (NP (NP (JJ Similar) (NNS results)) (VP (VBD were) (VBN obtained) (PP (IN with) (NP (NNS nuclei))) (PP (IN from) (NP (DT the) (JJ eosinophilic) (NN AML14.3D10)))))))
( (S (S (NP (NN cell) (NN line)) (-LRB- -LRB-) (NP (NNS data)) (VP (RB not) (VBN shown)) (-RRB- -RRB-)) (. .)))
( (S (S (NP (DT This) (NN cell) (NN line)) (VP (VBZ does) (RB not) (VP (VB express) (NP (NN CCR3)) (SBAR (IN unless) (S (VP (VBN induced) (PP (IN with) (NP (NP (JJ butyric) (NN acid)) (CC and) (NP (NN IL-5)))) (: ;) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN chromatin) (NN remodeling)) (PP (IN in) (NP (DT the) (NN HS1) (NN site)))) (VP (VBZ precedes) (NP (NN CCR3) (NN transcription))))))))))))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (NP (PRP$ our) (NN analysis)) (VP (VBD revealed) (NP (NP (NNS areas)) (PP (IN of) (NP (JJ active) (NN chromatin) (NN remodeling))) (PP (IN in) (NP (NP (DT the) (NN vicinity)) (PP (IN of) (NP (NN exon) (CD 1)))))) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (DT this) (NN area)) (VP (MD may) (VP (VB be) (ADJP (JJ important) (PP (IN for) (NP (NN CCR3) (NN transcription)))))))))))) (. .)))
( (S (S (NP (NN DNase) (CD I) (NN hypersensitivity)) (VP (VBD indicated) (SBAR (IN that) (S (NP (NP (DT a) (NN region)) (ADJP (JJ consistent) (PP (IN with) (NP (NN exon) (CD 1))))) (VP (VBZ is) (ADJP (JJ active)) (PP (IN in) (NP (NN CCR3) (NN transcription)))))))) (. .)))
( (S (S (PP (ADVP (RB Together)) (IN with) (S (NP (PRP$ our) (JJ previous) (NNS data)) (VP (VBG showing) (SBAR (IN that) (S (NP (JJ untranslated) (NN exon) (CD 1)) (VP (VBZ has) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NN CCR3) (NN transcription) (NN -LSB-27))))))) (-RRB- -RSB-))) (, ,) (NP (PRP we)) (VP (VBD hypothesized) (SBAR (IN that) (S (NP (JJ nuclear) (NNS proteins)) (VP (VP (VBP bind) (PP (TO to) (NP (NN exon) (CD 1)))) (, ,) (CC and) (PP (IN in) (NP (NN turn))) (VP (VBP regulate) (NP (NP (DT the) (NN transcription)) (PP (IN of) (NP (NN CCR3)))))))))) (. .)))
( (S (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB test) (NP (DT this) (NN hypothesis)))))) (, ,) (NP (NP (DT a) (JJ double-stranded) (NN oligonucleotide) (NN probe)) (SBAR (WHNP (WDT that)) (S (VP (VBZ corresponds) (PP (TO to) (NP (NP (NN bp) (QP (CD +10) (TO to) (CD +60))) (PP (IN of) (NP (DT the) (NN CCR3) (NN gene))))))))) (VP (VBD was) (VP (VP (VBN prepared)) (, ,) (VP (VBN referred) (PP (TO to)) (PP (IN as) (NP (NP (NN E1-FL)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN exon) (CD 1-)) (JJ full) (NN length)) (, ,) (NP (NN Figure) (NN 2A))) (-RRB- -RRB-)))))))) (. .)))
( (S (NP (DT This)) (VP (VBZ is) (NP (NP (DT the) (JJ exact) (NN sequence)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (VP (VBN deleted) (PP (IN in) (NP (DT the) (NN CCR3) (-LRB- -LRB-) (NN -exon1) (-RRB- -RRB-) (NN .pGL3)))))))))))
( (S (S (NP (NP (NN plasmid)) (SBAR (WHNP (WDT that)) (S (VP (VBD demonstrated) (NP (VBN decreased) (NN activity)))))) (VP (VBN compared) (PP (TO to) (NP (DT the) (JJ full) (NN length) (CD 1.6) (NN kb) (NN construct) (CD -LSB-27)))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (NP (JJ Nuclear) (NNS extracts)) (PP (IN from) (NP (NN AML14.3D10) (NNS cells)))) (VP (VBD were) (VP (VP (VBN incubated) (PP (IN with) (NP (DT the) (NN probe)))) (CC and) (VP (VBN resolved) (PP (IN on) (NP (DT a) (NN polyacrylamide) (NN gel))))))) (. .)))
( (S (S (NP (CD Two) (NNS bands)) (VP (VBD were) (ADJP (ADJP (JJ visible)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2B)) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (DT The) (JJ upper) (NN band)) (VP (VBD was) (VP (VBN eliminated) (SBAR (WHADVP (WRB when)) (S (NP (NP (ADJP (RB 150x) (JJ molar)) (NN excess)) (PP (IN of) (NP (DT the) (JJ unlabelled) (NN probe)))) (VP (VBD was) (VP (VBN used) (PRN (-LRB- -LRB-) (NP (NP (NN CC)) (: :) (NP (NP (NN E1-FL)) (PP (IN in) (NP (NN Figure) (NN 2B))))) (-RRB- -RRB-)))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (DT this)) (VP (VBZ is) (NP (DT the) (JJ specific) (NN band)))))))))) (. .)))
( (S (SBAR (IN In) (NN order) (S (VP (TO to) (ADVP (RB precisely)) (VP (VB localize) (NP (NP (DT the) (NN region)) (ADJP (JJ responsible) (PP (IN for) (NP (NN factor) (NN binding))))))))) (, ,) (NP (VBG overlapping) (JJ cold) (NNS competitors)) (VP (VBD were) (VP (VBN used) (: :) (NP (NP (NP (NN E1-A)) (VP (VBG spanning) (PP (IN from) (NP (CD +10) (TO to) (CD +31))))) (, ,) (NP (NP (NN E1-B)) (VP (VBG spanning) (PP (IN from) (NP (CD +25) (TO to) (CD +46))))) (CC and) (NP (NP (NN E1-C)) (VP (VBG spanning) (PP (IN from) (NP (CD +40) (TO to) (CD +60)))))))) (. .)))
( (S (S (NP (DT The) (JJ specific) (NN band)) (VP (VBD was) (VP (VBN eliminated) (PP (IN with) (NP (NP (NN E1-B)) (CC and) (NP (NN E1-C)) (NP (JJ cold) (NNS competitors)))) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (DT the) (NN factor)) (VP (VBZ binds) (PP (IN in) (NP (NP (DT the) (NN region)) (PP (IN between) (NP (NP (NP (CD +25)) (CC and) (NP (CD +60))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2B)) (-RRB- -RRB-)))))))))))))) (. .)))
( (S (PP (IN In) (NP (NN summary))) (, ,) (NP (DT these) (NNS data)) (VP (VBP indicate) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NNS proteins))) (PP (IN in) (NP (NP (DT the) (NNS nuclei)) (PP (IN of) (NP (NN AML14.3D10) (NNS cells))))) (SBAR (WHNP (WDT that)) (S (VP (VBP bind) (PP (TO to) (NP (NP (NN CCR3) (NN exon) (CD 1)) (PP (IN between) (NP (NN bp) (CD 25) (CC and) (CD 60)))))))))) (. .)))
( (S (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB define) (NP (NP (DT the) (NNS proteins)) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG binding) (PP (TO to) (NP (NN CCR3) (NN exon) (CD 1)))))))))))) (, ,) (NP (DT the) (NN exon) (CD 1) (NN sequence)) (VP (VBD was) (VP (VBN analyzed) (S (VP (VBG using) (NP (DT the) (ADJP (RB publicly) (JJ available)) (NN TFSEARCH) (NN engine))))))) (. .)))
( (S (NP (DT This) (NN analysis)) (VP (VBD indicated) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN consensus) (NN DNA-binding) (NNS sites))) (PP (IN in) (NP (DT the) (NN exon) (CD 1) (NN region)))) (PP (IN for) (NP (JJ several) (NN transcription) (NNS factors))) (-LRB- -LRB-) (PP (FW i.e.)))))
( (S (S (NP (NP (NN GATA)) (, ,) (NP (NN AML1)) (, ,) (NP (NN SRY)) (, ,) (NP (NN S8) (NN etc)) (. .)) (-RRB- -RRB-)) (. .)))
( (S (S (NP (NP (NNS Proteins)) (PP (IN of) (NP (DT the) (NN GATA) (NN family)))) (VP (VBP have) (VP (VBN been) (VP (VBN detected) (PP (IN in) (NP (NNS eosinophils))) (PRN (-LRB- -LRB-) (NP (ADVP (RB specifically)) (NP (NP (NN GATA-1)) (, ,) (NP (NN GATA-2)) (CC and) (NP (NP (JJ low) (NNS levels)) (PP (IN of) (NP (NN GATA-3) (-RRB- -RRB-) (CD -LSB-33)))))) (-RRB- -RSB-)))))) (. .)))
( (S (S (ADVP (RB Additionally)) (, ,) (NP (NN GATA-1)) (VP (VBZ transactivates) (NP (NP (DT the) (NN EOS47) (NN promoter)) (, ,) (NP (DT an) (JJ eosinophil-specific) (NN promoter)) (, ,)) (PP (IN through) (NP (NP (DT a) (NN site)) (PP (IN in) (NP (DT the) (CD 5) (POS ') (NN UTR) (CD -LSB-34)))))) (-RRB- -RSB-)) (. .)))
( (S (S (ADVP (RB Therefore)) (, ,) (NP (PRP we)) (VP (VBD hypothesized) (SBAR (IN that) (S (NP (NP (NNS proteins)) (PP (IN of) (NP (DT the) (NN GATA) (NN family)))) (VP (VBP bind) (PP (TO to) (NP (NP (NNS sites)) (PP (IN in) (NP (NN exon) (CD 1)))))))))) (. .)))
( (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB address) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NN GATA) (NNS proteins))) (PP (TO to) (NP (NN CCR3) (NN exon) (CD 1)))))))) (, ,) (NP (PRP we)) (VP (VBD prepared) (NP (NP (NNS oligonucleotides)) (VP (VBG corresponding) (S (VP (TO to) (VP (VB probe) (NP (NP (NN E1-B)) (CC and) (NP (NN -C))) (PP (IN with) (NP (NP (DT the) (NN GATA) (NN site)) (VP (VBN mutated)))))))))) (. .)))
( (S (S (SBAR (IN As) (S (VP (VBN demonstrated) (PP (IN in) (NP (NN Figure) (NN 3A)))))) (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBN used) (PP (IN as) (NP (JJ cold) (NN competitor)))))) (, ,) (NP (DT the) (NN GATA) (JJ mutant) (NN oligonucleotide)) (VP (VBD was) (RB not) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG interfering) (PP (IN with) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (JJ nuclear) (NNS factors))) (PP (TO to) (NP (CC either) (NP (NN CCR3) (NN exon) (CD 1) (NN probe) (NN E1-B)) (CC or) (NP (NN probe) (NN E1-C)))))))))))) (. .)))
( (S (S (ADVP (RB Additionally)) (, ,) (NP (PRP we)) (VP (VBD used) (NP (DT a) (NN GATA) (NN consensus) (NN oligonucleotide)) (PP (IN with) (NP (NP (VBG binding) (NNS sites)) (PP (IN for) (NP (NN GATA) (NNS proteins))))))) (. .)))
( (S (S (NP (DT This) (NN oligonucleotide)) (ADVP (RB completely)) (VP (VBD abolished) (NP (NP (NN binding)) (PP (IN of) (NP (JJ nuclear) (NNS factors))) (PP (TO to) (NP (CC both) (NP (NN CCR3) (NN exon) (CD 1) (NNS probes) (NN E1-B)) (CC and) (NP (NP (NN E1-C)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3A)) (-RRB- -RRB-)))))))) (. .)))
( (S (ADVP (RB Together)) (, ,) (NP (DT these) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NN GATA) (NNS proteins)) (, ,) (ADJP (JJ present) (PP (IN in) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN of) (NP (NN AML14.3D10))))))))))))
( (S (S (NP (NNS cells)) (, ,) (VP (VBP are) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG binding) (PP (TO to) (NP (NN CCR3) (NN exon) (CD 1) (NN sequence))))))))) (. .)))
( (S (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB delineate) (SBAR (WHNP (WDT which)) (S (NP (NN GATA) (NNS factors)) (VP (VBP are) (NP (NP (NN binding)) (PP (TO to) (NP (NN exon) (CD 1))))))))))) (, ,) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN from) (NP (NN AML14.3D10) (NNS cells)))) (VP (VBD were) (VP (VBN incubated) (PP (IN with) (NP (DT the) (JJ radiolabelled) (JJ full-length) (NN CCR3) (NN exon) (CD 1) (NN probe))) (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC or) (NP (NN absence))) (PP (IN of) (NP (NN anti-GATA-1) (NN antibody)))))))) (. .)))
( (S (S (SBAR (IN As) (S (VP (VBN seen) (PP (IN in) (NP (NN Figure) (NN 3B)))))) (, ,) (NP (DT the) (NN GATA-1) (NN antibody)) (VP (VBD was) (ADJP (JJ able) (S (VP (TO to) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NP (DT the) (NN protein) (NN factor)) (PP (IN from) (NP (DT the) (JJ nuclear) (NNS extracts))))) (PP (TO to) (NP (DT the) (JJ radiolabelled) (NN probe))))))))))) (. .)))
( (S (S (SBAR (IN In) (NN order) (S (VP (TO to) (ADVP (RBR more) (RB precisely)) (VP (VB localize) (SBAR (WHPP (TO to) (WHNP (WDT which))) (S (NP (NP (NN part)) (PP (IN of) (NP (NP (NN exon) (CD 1)) (NN GATA-1)))) (VP (VBZ is) (ADJP (JJ capable) (PP (IN of) (NP (NN binding))))))))))) (, ,) (NP (VBG overlapping) (NN oligonucleotide) (NNS probes)) (VP (VBD were) (VP (ADJP (JJ radiolabelled)) (CC and) (VP (VBN incubated) (PP (IN with) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN from) (NP (NN AML14.3D10) (NNS cells))))) (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC and) (NP (NN absence))) (PP (IN of) (NP (DT the) (NN GATA-1) (NN antibody))))))))) (. .)))
( (S (S (NP (DT This) (NN treatment)) (ADVP (RB efficiently)) (VP (VBD inhibited) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NNS probes) (NP (NP (NN E1-B)) (CC and) (NP (NN -C))))) (PP (TO to) (NP (DT the) (JJ nuclear) (NN factor) (-LRB- -LRB-) (NN Figure) (NN 3C) (-RRB- -RRB-)))))) (. .)))
( (S (NP (DT These) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN GATA-1)) (, ,) (ADJP (JJ present) (PP (IN in) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN of) (NP (NN AML14.3D10)))))))))))
( (S (S (NP (NP (NNS cells)) (, ,)) (VP (VBZ is) (ADVP (IN at) (JJS least)) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (NNS factors)) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG binding) (NP (NP (DT the) (NP (NN CCR3) (NN exon) (CD 1))) (PP (IN between) (NP (NN bp) (CD 25) (CC and) (CD 60))))))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB previously)) (VP (VBN characterized) (NP (NP (DT the) (JJ human) (NN CCR3) (NN promoter)) (PP (IN in) (NP (FW vitro) (NN -LSB-27) (-RRB- -RSB-))))))) (. .)))
( (S (SBAR (IN In) (NN order) (S (VP (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP (DT this) (NN region)) (VP (VBD had) (NP (NN promoter) (NN activity)) (ADVP (FW in) (FW vivo))))))) (CC and) (VP (TO to) (VP (VB assess) (NP (NN cell-specificity))))))) (, ,) (NP (PRP we)) (VP (VBD generated) (NP (NP (JJ transgenic) (NNS mice)) (VP (VBG expressing) (NP (DT the) (NN reporter) (NN gene) (NN EGFP)) (PP (IN under) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (DT the) (NP (NP (NN CCR3) (NN promoter)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 4A)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NP (NP (CD 1.6) (NN kb)) (PP (IN of) (NP (DT the) (NN promoter)))) (CC and) (NP (NP (CD 60) (NN base) (NNS pairs)) (PP (IN of) (NP (NN exon) (CD 1))))) (VP (VBD were) (VP (VBN cloned) (ADVP (RB upstream) (PP (IN of) (NP (DT the) (NN EGFP) (NN gene))))))) (. .)))
( (S (S (NP (CD Seven) (JJ transgenic) (NN founder) (NNS lines)) (VP (VBD were) (VP (VBN identified)))) (. .)))
( (S (S (S (NP (NP (CD Two)) (PP (IN of) (NP (DT the) (NN founder) (NNS lines)))) (VP (VBD did) (RB not) (VP (VB transmit) (NP (DT the) (NN transgene)) (PP (TO to) (NP (PRP$ their) (NN offspring)))))) (CC and) (S (NP (CD one) (NN line)) (VP (VBD did) (RB not) (VP (VB show) (NP (NN transgene) (NN expression)) (SBAR (IN as) (S (VP (VBN determined) (PP (IN by) (NP (NP (NN Northern) (NN blotting)) (CC and) (NP (NP (NN RT-PCR)) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NP (CD four)) (PP (IN of) (NP (DT the) (NNS lines))))) (NP (NP (DT the) (NP (NN level)) (CC and) (NP (NN pattern))) (PP (IN of) (NP (NN transgene) (NN expression)))) (VP (VBD varied) (VP (VBG suggesting) (NP (NN integration) (NN site) (NNS effects))))) (. .)))
( (S (S (NP (NP (NP (CD Two)) (PP (IN of) (NP (DT the) (NNS lines)))) (PRN (-LRB- -LRB-) (NP (NP (CD 4.1)) (CC and) (NP (CD 4.2))) (-RRB- -RRB-))) (VP (VP (VBD displayed) (NP (JJ minimal) (NN mRNA) (NN expression))) (CC and) (VP (VBD were) (RB not) (ADVP (RB further)) (VP (VBN analyzed))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (DT the) (JJ other) (CD two) (NNS lines)) (PRN (-LRB- -LRB-) (NP (NP (CD 3.1)) (CC and) (NP (CD 3.2))) (-RRB- -RRB-))) (VP (VBD showed) (NP (NP (JJ high) (NN expression)) (PP (IN of) (NP (DT the) (NN transgene))) (PP (IN in) (NP (JJ multiple) (NNS tissues)))))) (. .)))
( (S (S (NP (NN Line) (CD 3.1)) (VP (VBD displayed) (NP (NP (JJ varying) (NNS levels)) (PP (IN of) (NP (NN mRNA) (NN expression)))) (PP (IN in) (NP (NP (DT all) (NNS organs)) (VP (VBN tested)))))) (: :) (NP (NP (NP (NP (NNS lungs)) (, ,) (NP (NNS kidneys)) (, ,) (NP (NN jejunum))) (, ,) (NP (NP (NN thymus)) (, ,) (NP (NN bone) (NN marrow)) (, ,) (CC and) (NP (NN spleen))) (, ,)) (PP (IN with) (NP (NP (JJS highest) (NN expression)) (PP (IN in) (NP (NP (DT the) (NN thymus)) (PRN (-LRB- -LRB-) (S (PP (IN by) (NP (NP (NN Northern) (NN blot) (NN analysis)) (, ,) (NP (NN Figure) (NN 4B)) (CC and) (NP (NN RT-PCR)))) (, ,) (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-))))))) (. .)))
( (S (SBAR (IN While) (S (NP (PRP we)) (VP (VBN expected) (NP (DT the) (NN transcript)) (S (VP (TO to) (VP (VB be) (PP (IN about) (NP (CD 1) (NN kb))) (PP (IN in) (NP (NP (NN size)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 4A)) (-RRB- -RRB-)))))))))) (, ,) (NP (NP (CD two) (NNS bands)) (NP (NP (CD ~4)) (CC and) (NP (CD 5) (NN kb)))) (VP (VBD were) (ADJP (JJ apparent))) (. .)))
( (S (S (SBAR (IN Since) (S (NP (DT this)) (VP (VBD was) (RB not) (NP (NP (DT the) (NN case)) (PP (IN with) (NP (JJ other) (NNS lines))))))) (, ,) (NP (PRP we)) (VP (VBP suspect) (S (S (NP (PRP it)) (VP (VBZ is) (ADJP (NN integration-site) (JJ specific)))) (CC and) (S (NP (DT another) (NN gene)) (VP (MD may) (VP (VBP have) (VP (VBN been) (VP (VBN transcribed) (PP (ADVP (RB together)) (IN with) (NP (NN GFP))))))))))) (. .)))
( (S (S (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NN size)) (PP (IN of) (NP (DT the) (NN RT-PCR) (VBN amplified) (NN fragment)))) (VP (VBD was) (PP (IN of) (NP (DT the) (VBN expected) (NN size))))) (CC and) (S (NP (DT the) (NN protein)) (VP (VBD was) (ADJP (JJ detectable) (PP (IN by) (NP (NP (NN immunohistochemistry)) (PRN (-LRB- -LRB-) (VP (VB see) (PP (IN below))) (-RRB- -RRB-))))) (S (ADVP (RB thus)) (VP (VBG implying) (SBAR (IN that) (S (NP (DT this)) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (NP (DT the) (NN translation)) (PP (IN of) (NP (DT the) (NN protein)))) (CC and) (NP (NP (NN integrity)) (PP (IN of) (NP (NP (DT the) (NN epitope)) (PP (IN for) (NP (DT the) (NN antibody)))))))))))))))) (. .)))
( (S (S (NP (NP (NN Expression)) (PP (IN in) (NP (NP (DT the) (NNS lungs)) (, ,) (NP (NP (NN jejunum)) (, ,) (NP (NN thymus)) (CC and) (NP (NN kidney)))))) (VP (VBD was) (VP (VBN confirmed) (PP (IN by) (NP (NP (NN anti-GFP) (NN immunohistochemistry)) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (NN 4C)) (CC and) (NP (NP (NNS data)) (VP (ADVP (RB not)) (VBN shown)))) (-RRB- -RRB-))))))) (. .)))
( (S (S (PP (IN In) (NP (DT the) (NN jejunum))) (, ,) (NP (NN staining)) (VP (VBD was) (ADJP (JJ present)) (ADVP (RB predominantly)) (PP (IN in) (NP (NP (JJ stromal) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 4C)) (-RRB- -RRB-)))))) (. .)))
( (S (S (PP (IN Of) (NP (NN note))) (, ,) (NP (NNS eosinophils)) (ADVP (RB normally)) (VP (VP (VBP reside) (PP (IN in) (NP (DT the) (JJ gastrointestinal) (NN tract)))) (CC and) (VP (VBP are) (ADJP (JJ located) (PP (IN in) (NP (NP (DT the) (NN stroma)) (PP (IN of) (NP (DT the) (NN jejunum))))))))) (. .)))
( (S (ADVP (RB However)) (, ,) (PP (IN in) (NP (NP (DT the) (NNS lungs)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (ADVP (RB normally)) (ADJP (JJ devoid) (PP (IN of) (NP (NNS eosinophils)))) (PP (IN at) (NP (NN baseline)))))))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (NN GFP) (NN expression)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (VP (VBN confined) (PP (TO to) (NP (NP (DT the) (JJ alveolar) (NN lining)) (ADJP (JJ consistent) (PP (IN with) (NP (NP (JJ predominant) (NN expression)) (PP (IN in) (NP (NP (NN type) (NN I) (NNS pneumocytes)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 4C)) (-RRB- -RRB-))))))))))))))) (. .)))
( (S (PP (IN In) (NP (DT the) (NN thymus))) (, ,) (PP (VBN compared) (PP (TO to) (NP (NP (NN staining)) (PP (IN without) (NP (NP (JJ primary) (NN antibody)) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-))))))) (, ,) (NP (DT all) (NNS thymocytes)) (VP (VBN stained) (ADJP (JJ positive) (PP (IN for) (NP (NN GFP))))) (. .)))
( (S (S (ADVP (RB Additionally)) (, ,) (PP (IN in) (NP (DT the) (NN kidney))) (NP (DT all) (NNS cells)) (VP (VBD were) (ADJP (ADJP (JJ positive)) (, ,) (CC both) (PP (IN in) (NP (DT the) (NP (NN medulla)) (CC and) (NP (NN cortex))))) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))) (. .)))
( (S (S (NP (NN Line) (CD 3.2)) (VP (VBD displayed) (NP (NP (DT a) (JJ different) (NN pattern)) (PP (IN of) (NP (NN transgene) (NN expression)))))) (. .)))
( (S (S (NP (NN Northern) (NN blot) (NN analysis)) (VP (VBD revealed) (NP (NP (NN expression)) (PP (IN in) (NP (NP (JJ multiple) (NNS organs)) (PP (IN with) (NP (NP (DT the) (NP (NNS lungs)) (CC and) (NP (NNS kidneys))) (VP (VBG expressing) (NP (NP (DT the) (JJS highest) (NNS levels)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 4B)) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (S (ADJP (JJ Consistent) (PP (IN with) (NP (DT this))))) (, ,) (NP (NN protein)) (VP (VBD was) (VP (VBN detected) (PP (IN by) (NP (NN immunohistochemistry))) (PP (IN at) (NP (NP (JJ high) (NNS levels)) (PP (PP (IN in) (NP (NP (NNS lungs)) (CC and) (NP (NNS kidneys)))) (CC and) (ADVP (RB only) (RB marginally)) (PP (IN in) (NP (NP (DT the) (NN jejunum)) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (NN 4C)) (CC and) (NP (NP (NNS data)) (VP (RB not) (VBN shown)))) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (SBAR (IN While) (S (NP (NP (NN staining)) (PP (IN in) (NP (DT the) (NNS lungs)))) (VP (VBD was) (ADJP (JJ comparable) (PP (TO to) (NP (NN line) (CD 3.1))))))) (, ,) (NP (NP (RB only) (DT a) (NN minority)) (PP (IN of) (NP (NP (JJ stromal) (NNS cells)) (CC and) (NP (DT no) (JJ epithelial) (NNS cells))))) (VP (VBD were) (VP (VBN stained) (PP (IN in) (NP (DT the) (NN jejunum)))))) (. .)))
( (S (S (PP (IN In) (NP (DT the) (NN kidney))) (, ,) (NP (ADJP (RB almost) (DT all)) (NNS cells)) (VP (VBD expressed) (NP (NP (DT the) (NN transgene)) (PP (IN in) (NP (DT the) (NN medulla)))) (, ,) (SBAR (IN while) (S (PP (IN in) (NP (DT the) (NN cortex))) (NP (NN staining)) (VP (VBD was) (ADJP (JJ prominent) (PP (IN in) (NP (DT the) (NNS glomeruli))))))))) (. .)))
( (S (S (NP (EX There)) (VP (VBD was) (NP (NP (DT no) (JJ anti-GFP) (NN staining)) (VP (VBN observed) (PP (IN in) (NP (NP (JJ wild) (NN type) (NNS mice)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 4C)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (DT No) (NNS changes)) (PP (IN in) (NP (NN expression)))) (VP (VBD were) (VP (VBN found) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NN transgene)) (VP (VBD was) (VP (VBN crossed) (PP (IN with) (NP (NP (JJ CD2.IL-5) (JJ transgenic) (NNS mice)) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN summary))) (, ,) (NP (NP (DT the) (CD 1.6) (NN kb)) (PP (IN of) (NP (NP (DT the) (CD 5) (`` ') (JJ flanking) (NN region)) (PP (IN of) (NP (DT the) (NN CCR3) (NN gene)))))) (VP (VBZ has) (NP (JJ strong) (NN promoter) (NN activity)) (ADVP (FW in) (FW vivo)))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NP (CC both) (DT the) (NP (NN level)) (CC and) (NP (NN pattern))) (PP (IN of) (NP (NN expression)))) (VP (VP (VBP vary) (PP (IN between) (NP (NN founder) (NNS lines)))) (CC and) (VP (VBP lack) (NP (NN cell) (NN specificity))))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (VBN identified) (NN region)) (PP (IN of) (NP (DT the) (NN CCR3) (NN promoter)))) (VP (VBZ contains) (NP (NP (DT a) (ADJP (RB broadly) (JJ active)) (NN promoter)) (PP (IN with) (NP (ADJP (ADJP (JJ hematopoietic)) (CC and) (ADJP (JJ non-hematopoietic))) (NN activity)))))) (. .)))
( (S (NP (NN Discussion))))
( (S (S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP (NN DNase) (CD I) (NN hypersensitivity)) (VP (VBD implicated) (NP (JJ untranslated) (NN exon) (CD 1)) (PP (IN in) (S (VP (VBG regulating) (NP (NN CCR3) (NN transcription))))))) (. .)))
( (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (JJ nuclear) (NNS proteins)) (VP (VBN derived) (PP (IN from) (NP (JJ eosinophilic) (NNS cells))))) (VP (VBD were) (VP (VBN shown) (S (VP (TO to) (VP (VB bind) (NP (NP (NN CCR3) (NN exon)) (PP (IN between) (NP (NNS nucleotides) (CD +25) (TO to) (CD +60)))))))))) (. .)))
( (S (S (S (VP (VBG Using) (NP (NP (JJ unlabelled) (NNS competitors)) (CC and) (NP (NNS antibodies))))) (, ,) (NP (NP (NP (NNS proteins)) (PP (IN of) (NP (DT the) (NN GATA) (NN family)))) (, ,) (NP (ADVP (RB specifically)) (NP (NN GATA-1))) (, ,)) (VP (VBD were) (VP (VBN shown) (S (VP (TO to) (VP (VB bind) (PP (TO to) (NP (DT this) (NN region))))))))) (. .)))
( (S (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (NP (DT these) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (JJ untranslated) (NN exon) (CD 1)) (, ,) (PP (IN via) (NP (NN GATA-1))) (, ,)) (VP (VBZ has) (NP (DT a) (JJ regulatory) (NN role)) (PP (IN in) (NP (NN CCR3) (NN transcription)))))))) (. .)))
( (S (ADVP (RB Finally)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (DT the) (JJ 1.6-kb)))))))
( (S (S (NP (NP (NN CCR3) (NN promoter) (NN element)) (, ,) (SBAR (WHNP (WDT that)) (S (VP (VBZ includes) (NP (NN exon) (CD 1))))) (, ,)) (VP (VBZ is) (ADVP (RB broadly)) (VP (JJ active) (ADVP (FW in) (FW vivo))))) (. .)))
( (S (S (NP (DT The) (NN HS1) (NN site)) (VP (VBD was) (ADJP (JJ located) (PP (IN in) (NP (NP (DT the) (NN vicinity)) (PP (IN of) (NP (NN exon) (CD 1)))))))) (. .)))
( (S (S (S (VP (VBN Combined) (PP (IN with) (NP (NP (PRP$ our) (JJ previous) (NNS results)) (VP (VBG demonstrating) (NP (VBN diminished) (NN promoter) (NN activity))))) (SBAR (WHADVP (WRB when)) (S (NP (NN exon) (CD 1)) (VP (VBZ is) (VP (VBN deleted) (PP (IN from) (NP (DT the) (NN promoter) (NN construct))))))))) (, ,) (NP (DT these) (NNS data)) (VP (VBD suggested) (SBAR (IN that) (S (NP (ADJP (CD 5) ('' ') (JJ untranslated)) (NN exon) (CD 1)) (VP (MD may) (VP (VB have) (NP (DT a) (JJ regulatory) (NN function)))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (SBAR (IN that) (S (NP (DT the) (CD 5) (`` ') (JJ untranslated) (NNS exons)) (VP (MD may) (VP (VB contain) (NP (NP (NNS sequences)) (SBAR (WHNP (WDT that)) (S (VP (VBP facilitate) (NP (NP (NN transcription)) (PP (IN of) (NP (DT the) (NN gene)))))))))))))))) (. .)))
( (S (S (NP (NNS Examples)) (VP (VBP include) (NP (NP (NP (DT a) (NN GATA-1) (NN site)) (PP (IN in) (NP (NP (DT the) (NN 5'-UTR)) (PP (IN of) (NP (DT the) (NN γ-globin) (NN gene)))))) (, ,) (NP (NP (DT an) (NN HNF-1) (NN site)) (PP (IN in) (NP (DT the) (NN plasminogen) (NN gene)))) (, ,) (NP (NP (DT a) (NN PU.1) (NN site)) (PP (IN in) (NP (DT the) (NN PU.1) (NN gene)))) (CC and) (NP (NP (DT a) (NN C/EBP) (NN site)) (PP (IN in) (NP (DT the) (NN CCR2) (NN gene) (NN -LSB-24,31,32,35)))))) (-RRB- -RSB-)) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (NP (PRP we)) (VP (VBD hypothesized) (SBAR (IN that) (S (NP (JJ nuclear) (NNS proteins)) (VP (VBP bind) (PP (TO to) (NP (NN exon) (CD 1)))))))) (. .)))
( (S (S (NP (NP (PRP$ Our) (NN EMSA) (NN analysis)) (, ,) (VP (VBN coupled) (PP (IN with) (NP (NP (JJ cold) (NNS competitors)) (CC and) (NP (JJ specific) (NNS antibodies))))) (, ,)) (VP (VBZ indicates) (SBAR (IN that) (S (NP (NP (NNS proteins)) (PP (IN of) (NP (DT the) (NN GATA) (NN family)))) (, ,) (ADVP (RB specifically)) (NP (NN GATA-1)) (VP (VBP bind) (PP (TO to) (NP (DT the) (NN CCR3) (NN exon) (CD 1)))))))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (NP (NP (NN GATA-1)) (VP (VBG binding) (PP (TO to) (NP (NN exon) (CD 1))))) (VP (MD may) (VP (VB regulate) (NP (NN CCR3) (NN transcription))))) (. .)))
( (S (S (ADVP (RB Alternatively)) (, ,) (NP (NP (NN GATA-1)) (VP (VBG binding) (PP (TO to) (NP (NN exon) (CD 1))))) (VP (MD may) (VP (VB affect) (NP (NP (NP (NN transcription) (NN start) (NN site)) (NN function)) (, ,) (NP (NN RNA) (NN stability)) (CC or) (NP (NN translation)))))) (. .)))
( (S (S (NP (DT These) (NNS possibilities)) (VP (MD will) (VP (VB be) (VP (VBN addressed) (PP (IN in) (NP (JJ future) (NNS studies))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ important)) (SBAR (IN that) (S (NP (DT this) (NN data)) (VP (VB be) (VP (VBN viewed) (PP (IN with) (SBAR (WHNP (WP what)) (S (VP (VBZ is) (VP (VBN known) (PP (IN about) (NP (NP (JJ other) (JJ myeloid-specific) (NNS promoters)) (, ,) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (ADVP (RB often)) (VP (VBN proven) (S (VP (TO to) (VP (VB be) (ADJP (JJ difficult) (S (VP (TO to) (VP (VB function) (ADVP (RB independently)) (PP (IN in) (NP (FW vivo))))))))))))))))))))))))))) (. .)))
( (S (S (PP (IN For) (NP (NN example))) (, ,) (NP (NP (NNS constructs)) (VP (VBG using) (NP (NP (DT the) (CD 5) (`` ') (JJ flanking) (NN region)) (PP (IN of) (NP (JJ myeloid-specific) (NNS genes)))))) (VP (VBP have) (RB not) (VP (VBN been) (ADJP (JJ useful) (PP (IN for) (NP (NP (JJ transgenic) (NN work)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NP (DT the) (NN CD14) (NN promoter) (CD -LSB-36) (-RRB- -RSB-)) (, ,) (NP (DT the) (NN c-kit) (NN promoter) (CD -LSB-37) (-RRB- -RSB-)) (, ,) (CC or) (NP (DT the) (ADJP (CD 1.7) (NN kb)) (NN CD11b) (NN promoter) (CD -LSB-38))))) (-RRB- -RSB-) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (JJR Better) (NN success)) (VP (VBD was) (VP (VBN obtained) (SBAR (WHADVP (WRB when)) (S (NP (NP (DT the) (JJ entire) (NN gene)) (, ,) (PP (VBG including) (NP (DT the) (JJ open) (NN reading) (NN frame))) (, ,)) (VP (VBD was) (VP (VBN used) (PRN (-LRB- -LRB-) (PP (FW e.g.) (NP (DT the) (JJ human) (NN cathepsin) (NN G))) (, ,) (NP (NP (NN chicken) (NN lysozyme) (CC and) (NN c-fps/fes) (JJ transgenic) (NNS constructs)) (CD -LSB-39-41) (-RRB- -RSB-)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (DT These) (NNS constructs)) (VP (VP (VBD were) (NP (NP (QP (IN at) (JJS least) (CD 6)) (NN kb)) (PP (IN in) (NP (NN size))))) (CC and) (VP (VBD contained) (NP (NP (DT all) (NP (NP (NNS exons)) (CC and) (NP (NNS introns)))) (CC and) (NP (NP (JJ several) (NN kb)) (PP (IN of) (NP (ADJP (CD 5) ('' ') (CC and) (CD 3) ('' ') (JJ flanking)) (NN sequence)))))))) (. .)))
( (S (S (ADVP (RB Presumably)) (, ,) (NP (DT these) (JJR larger) (NNS constructs)) (VP (VBD contained) (NP (NP (NP (DT the) (NN locus) (NN control) (NN region)) (PRN (-LRB- -LRB-) (NP (NN LCR)) (-RRB- -RRB-))) (CC -) (NP (NP (NNS sequences)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (NP (DT the) (NN ability) (S (VP (TO to) (ADVP (RB dominantly)) (VP (VB control) (NP (NP (NN gene) (NN expression)) (PP (IN in) (NP (DT any) (JJ chromosomal) (NN region))))))))))))))) (. .)))
( (S (S (NP (NP (DT This)) (PP (IN in) (NP (NN turn)))) (VP (VBZ allows) (PP (IN for) (NP (NP (DT a) (JJ high) (NN degree)) (PP (IN of) (NP (NP (NN consistency)) (PP (IN among) (NP (NP (JJ independent) (NN mouse) (NNS lines)) (PP (IN with) (NP (NP (NN regard)) (PP (TO to) (NP (NP (NN cell) (NN specificity)) (, ,) (NP (NP (NN level)) (PP (IN of) (NP (NN expression)))) (CC and) (NP (NN proportionality)))) (PP (TO to) (NP (NN gene) (NN copy) (NN number))))))))))))) (. .)))
( (S (S (NP (DT These) (NNS regions)) (VP (MD may) (VP (VB be) (ADJP (JJ located) (PP (IN at) (NP (NP (JJ several) (JJ different) (NNS sites)) (PP (IN in) (NP (DT the) (NN gene))) (, ,) (PP (VBG including) (NP (NP (NNS introns)) (CC and) (NP (NN coding) (NNS exons)))))))))) (: ;) (S (ADVP (RB thus)) (, ,) (NP (NP (NN screening)) (PP (IN with) (NP (NN DNase) (CD I) (NN hypersensitivity)))) (VP (VBZ is) (ADVP (RB usually)) (NP (NP (DT the) (JJ first) (NN method)) (VP (VBN employed) (S (VP (TO to) (VP (VB identify) (NP (DT these) (NNS regions))))))))) (. .)))
( (S (S (NP (NP (JJ Transgenic) (NNS mice)) (VP (VBG expressing) (NP (DT the) (NN EGFP) (NN reporter) (NN gene)) (PP (IN under) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (DT the) (NN CCR3) (NN promoter))))))) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (DT the) (ADJP (CD 1.6) (NN kb)) (NN promoter)) (CC and) (NP (NP (CD 60) (NN bp)) (PP (IN of) (NP (NP (NN exon) (CD 1)) (PP (IN of) (NP (DT the) (NN CCR3) (NN gene))))))) (VP (VBP confer) (NP (JJ strong) (NN promoter) (NN activity)) (ADVP (FW in) (FW vivo))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (DT these) (NNS sequences)) (VP (VBP do) (RB not) (VP (VB contain) (NP (DT the) (JJ entire) (NN LCR)) (, ,) (SBAR (IN since) (S (NP (NP (NN expression)) (PP (IN of) (NP (DT the) (NN reporter) (NN gene)))) (VP (VBD was) (ADJP (JJ variable) (PP (IN among) (NP (JJ multiple) (NN founder) (NNS lines)))))))))) (. .)))
( (S (S (NP (NP (NN DNase) (CD I) (NN hypersensitivity)) (NNS studies)) (VP (VBD discovered) (NP (NP (CD one) (JJ hypersensitive) (NN site)) (PP (IN in) (NP (DT the) (NN CCR3) (NN locus)))))) (. .)))
( (S (S (NP (DT The) (NN HS1) (NN site)) (VP (VBD was) (ADVP (RB apparently)) (RB not) (ADJP (JJ sufficient) (PP (IN for) (NP (JJ integration-site) (JJ independent) (NNS effects)))) (, ,) (SBAR (IN since) (S (NP (PRP it)) (VP (VBZ is) (VP (VBN contained) (PP (IN in) (NP (NP (DT the) (NN promoter) (NN construct)) (VP (VBN used)))))))))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (NP (JJ future) (NNS studies)) (VP (MD will) (VP (VBP need) (S (VP (TO to) (VP (VB broaden) (NP (NP (DT the) (NN search)) (PP (IN for) (NP (DT the) (NN CCR3) (NN LCR)))))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ important)) (S (VP (TO to) (VP (VB note) (SBAR (IN that) (S (NP (NP (DT the) (JJ true) (JJ cellular) (NN specificity)) (PP (IN of) (NP (NN CCR3)))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN established))))))))))) (. .)))
( (S (SBAR (IN While) (S (NP (DT this) (NN gene) (NN product)) (VP (VBZ is) (ADVP (RB often)) (VP (VBN considered) (S (VP (TO to) (VP (VB be) (ADJP (JJ specific) (PP (IN for) (NP (NP (JJ inflammatory) (NNS cells)) (VP (VBN involved) (PP (IN in) (NP (NP (JJ allergic) (NN inflammation)) (PRN (-LRB- -LRB-) (NP (NP (NNS eosinophils)) (, ,) (NP (NN mast) (NNS cells)) (, ,) (CC and) (ADVP (RB possibly)) (NP (NN Th2) (NNS cells))) (-RRB- -RRB-))))))))))))))) (, ,) (S (NP (JJ several) (NNS reports)) (VP (VBP have) (VP (VBN documented) (NP (NN expression)) (PP (IN by) (NP (NP (JJ other) (NN cell) (NNS types)) (PP (VBG including) (NP (NP (JJ additional) (NNS leukocytes)) (PRN (-LRB- -LRB-) (PP (FW e.g.))))))))))))
( (S (S (NP (NP (JJ dendritic) (NNS cells) (-RRB- -RRB-)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NN tissue) (NNS cells)) (PRN (-LRB- -LRB-) (NP (ADJP (ADJP (JJ epithelial)) (CC and) (ADJP (JJ endothelial))) (NNS cells)) (-RRB- -RRB-)))) (NP (CD -LSB-11-16,42) (-RRB- -RSB-))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (NP (PRP it)) (VP (VBZ remains) (S (VP (TO to) (VP (VB be) (VP (VBN determined) (SBAR (IN if) (S (NP (PRP$ our) (NN observation) (SBAR (IN that) (S (NP (DT the) (NN CCR3) (NN promoter)) (VP (VBZ has) (NP (JJ broad) (NN activity)) (ADVP (FW in) (FW vivo)))))) (VP (VBZ represents) (NP (DT the) (JJ true) (JJ endogenous) (NN activity))))))))))) (. .)))
( (S (S (SBAR (IN Since) (S (NP (NN CCR3)) (VP (VBZ is) (VP (VBN expressed) (ADVP (RB strongly)) (PP (IN on) (NP (NNS eosinophils))))))) (, ,) (NP (NP (NN analysis)) (PP (IN of) (NP (NP (DT the) (NNS signals)) (SBAR (WHNP (WDT that)) (S (VP (VBP induce) (NP (PRP$ its) (NN expression)))))))) (VP (MD may) (VP (VB give) (NP (NP (NN insight)) (PP (IN into) (NP (NP (DT the) (JJ molecular) (NNS mechanisms)) (PP (IN for) (NP (NP (DT the) (NN commitment)) (PP (IN of) (NP (JJ myeloid) (NNS progenitors))) (PP (TO to) (NP (DT the) (NN eosinophil) (NN lineage))))))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB generally)) (VP (VBN believed) (SBAR (SBAR (IN that) (S (NP (NN transcription) (NNS factors)) (VP (VBP are) (NP (NP (DT the) (JJ final) (JJ common) (NN pathway)) (VP (VBG driving) (NP (NN differentiation))))))) (CC and) (SBAR (IN that) (S (NP (NP (JJ hematopoietic) (NN commitment)) (PP (TO to) (NP (JJ different) (NNS lineages)))) (VP (VBZ is) (VP (VBN driven) (PP (IN by) (NP (NP (JJ alternative) (NN expression)) (PP (IN of) (NP (NP (JJ specific) (NNS combinations)) (PP (IN of) (NP (NN transcription) (NNS factors) (CD -LSB-43,44) (-RRB- -RSB-))))))))))))))) (. .)))
( (S (S (SBAR (IN Although) (S (NP (DT no) (JJ eosinophil-specific) (NN transcription) (NNS factors)) (VP (VBP have) (VP (VBN been) (VP (VBN reported)))))) (, ,) (NP (NN eosinophil) (NN commitment)) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (VP (VBN regulated) (PP (IN by) (NP (NP (NN GATA-1)) (, ,) (NP (NN PU-1)) (CC and) (NP (NN C/EBP) (NNS proteins)) (NP (CD -LSB-34,45-48) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (S (ADJP (JJ Consistent) (PP (IN with) (NP (DT this))))) (, ,) (NP (NP (NN DNA) (NN binding) (NNS sites)) (PP (IN for) (NP (DT these) (NN transcription) (NNS factors)))) (VP (VBP are) (VP (VBN found) (PP (IN in) (NP (NP (JJ several) (JJ eosinophil-selective) (NNS promoters)) (, ,) (PP (JJ such) (IN as) (NP (NP (DT the) (NN promoter)) (PP (IN for) (NP (NP (NP (JJ major) (JJ basic) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN MBP)) (-RRB- -RRB-))) (, ,) (NP (NP (NN IL-5) (NN receptor) (NN alpha) (-LRB- -LRB-) (NN IL-5Rα) (-RRB- -RRB-) (NN chain)) (CC and) (NP (NN Charcot-Leyden) (NN crystal) (-LRB- -LRB-) (NN CLC) (-RRB- -RRB-) (NN protein)))))))))))) (. .)))
( (S (S (ADVP (RB Specifically)) (, ,) (NP (NP (JJ ectopic) (NN overexpression)) (PP (IN of) (NP (NN GATA-1))) (PP (IN in) (NP (NN chicken) (NNS myeloblasts)))) (VP (VBZ leads) (PP (TO to) (NP (NP (NN transdifferentiation)) (PP (IN into) (NP (NP (NNS eosinophils)) (CC or) (NP (NNS thromboblasts)))))) (PP (VBG depending) (PP (IN on) (NP (NP (DT the) (NN dose)) (VP (VBN used) (S (NP (CD -LSB-47) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (NN GATA-1)) (VP (VBZ transactivates) (NP (NP (JJ several) (JJ eosinophil-selective) (NNS promoters) (NP (CD -LSB-48) (-RRB- -RSB-))) (PP (VBG including) (NP (NP (DT the) (JJ avian) (NN EOS47) (NN promoter)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (DT the) (NN GATA-1) (NN site)) (VP (VBZ is) (ADJP (JJ located) (ADVP (RB downstream) (PP (IN of) (NP (DT the) (NN transcription) (NN start) (NN site) (CD -LSB-34) (-RRB- -RSB-))))))))))))) (. .)))
( (S (NP (NN Conclusion))))
( (S (PP (IN In) (NP (NN summary))) (, ,) (PP (IN in) (NP (DT this) (NN report))) (NP (PRP we)) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (: :) (S (NP (LST (LS 1) (-RRB- -RRB-)) (NN DNase) (NN I) (NN hypersensitivity) (NNS studies)) (VP (VBP implicate) (NP (NP (JJ untranslated) (NN exon) (CD 1)) (PP (IN in) (NP (NN CCR3) (NN transcription)))))) (: ;) (S (NP (LST (LS 2) (-RRB- -RRB-)) (NP (NNS proteins)) (PP (IN of) (NP (NP (DT the) (NN GATA) (NN family)) (, ,) (NP (ADVP (RB specifically)) (NP (NN GATA-1))) (, ,)))) (VP (VBP bind) (PP (TO to) (NP (NP (JJ untranslated) (NN exon) (CD 1)) (PP (IN in) (NP (DT the) (NN CCR3) (NN gene))))))) (: ;) (CC and) (LST (LS 3) (-RRB- -RRB-)) (S (NP (NP (DT the) (ADJP (CD 1.6) (NN kb) (CD 5) ('' ') (JJ flanking)) (NN region)) (PP (IN of) (NP (DT the) (NN CCR3) (NN gene)))) (VP (VBZ is) (ADJP (RB broadly) (JJ active) (PP (IN as) (NP (NP (DT a) (NN promoter)) (ADVP (FW in) (FW vivo))))))))))) (. .)))
( (S (NP (NNS Methods))))
( (S (NP (DT The) (CD AML14.3D10) (NN cell) (NN line) (PRN (-LRB- -LRB-) (ADVP (RB kindly)) (VP (VBN provided) (PP (IN by) (NP (NP (NP (NP (NNP C.C.)) (NN Paul) (, ,) (NNP Dayton) (NNP VA)) (NP (JJ Medical) (NN Center))) (, ,) (NP (NNP Dayton)) (, ,) (NP (NN OH))))) (-RRB- -RRB-)) (CD -LSB-49,50) (-RRB- -RSB-)) (VP (VBD was) (VP (VBN grown) (PP (IN in) (NP (NP (NP (NN RPMI) (CD 1640)) (PRN (-LRB- -LRB-) (NP (NP (NNP Gibco) (NN BRL)) (, ,) (NP (NNP Gaithersburg) (, ,) (NNP MD))) (-RRB- -RRB-))) (VP (VBG containing) (NP (NP (ADJP (CD 10) (NN %)) (NP (NP (JJ fetal) (NN calf) (NN serum)) (PRN (-LRB- -LRB-) (NP (NP (NN FCS)) (, ,) (NP (NN Gibco) (NN BRL))) (-RRB- -RRB-)))) (, ,) (NP (NP (CD 50) (NNS μM) (NN 2-mercaptoethanol)) (PRN (-LRB- -LRB-) (NP (NP (NN Sigma)) (, ,) (NP (NN St.) (NN Louis)) (, ,) (NP (NN MO))) (-RRB- -RRB-))) (, ,) (NP (ADJP (CD 0.1) (NN mM)) (NP (NP (JJ nonessential) (NN amino) (NNS acids)) (PRN (-LRB- -LRB-) (NP (NN Gibco) (NN BRL)) (-RRB- -RRB-)))) (, ,) (NP (NP (ADJP (CD 1) (NN mM)) (NN sodium) (NN pyruvate)) (PRN (-LRB- -LRB-) (NP (NN Sigma)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NN penicillin-streptomycin)) (PRN (-LRB- -LRB-) (NP (NN Gibco) (NN BRL)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (NNS Eosinophils)) (VP (VBD were) (VP (VBN isolated) (PP (IN by) (NP (NN anti-CD16) (JJ negative) (NN selection))) (PP (IN from) (NP (NP (NN granulocyte) (NNS preparations)) (PP (IN of) (NP (ADJP (ADJP (JJ healthy)) (CC or) (ADJP (JJ atopic))) (NNS volunteers)))))) (SBAR (IN as) (S (VP (VBN described) (ADVP (ADVP (RB previously)) (PRN (QP (CD -LSB-51)) (-RRB- -RSB-)))))))) (. .)))
( (S (NP (NNS Nuclei)) (VP (VBD were) (VP (VBN derived) (PP (IN from) (NP (NP (NP (NN cell) (NNS lines)) (CC and) (NP (JJ primary) (NNS cells))) (VP (VBG using) (NP (NP (DT a) (NN polyamine) (NN buffer)) (VP (VBG containing) (NP (NP (ADJP (CD 0.34) (NN M)) (NN sucrose)) (, ,) (NP (NP (ADJP (CD 13.3) (NN mM)) (NN Tris)) (PRN (-LRB- -LRB-) (NP (NN pH7.5)) (-RRB- -RRB-))) (, ,)))))))))))
( (S (NP (NP (ADJP (CD 53.2) (NN mM)) (NN KCl)) (, ,) (NP (NP (ADJP (CD 13.3) (NN mM)) (NN NaCl)) (, ,) (NP (NP (ADJP (CD 2) (NN mM)) (NN EDTA)) (, ,) (NP (ADJP (CD 0.5) (NN mM)) (NN EGTA)) (, ,) (NP (ADJP (CD 0.133) (NN mM)) (NN spermine)) (, ,) (NP (ADJP (CD 0.5) (NN mM)) (NN spermidine)) (, ,) (NP (ADJP (CD 0.1) (NN %)) (NN TritonX-100)) (, ,) (NP (ADJP (CD 2) (NN mM)) (NN MgCl2)) (CC and) (NP (ADJP (RB freshly) (VBN prepared)) (NN 2-mercaptoethanol)))) (CC and) (NP (NP (NN phenylmethylsulfonyl) (NN fluoride)) (PRN (-LRB- -LRB-) (NP (NN PMSF)) (-RRB- -RRB-))) (. .))))
( (S (NP (NNS Nuclei)) (VP (VBD were) (ADVP (RB then)) (VP (VP (VBN centrifuged) (PP (IN at) (NP (CD 2300) (NN g))) (PP (IN for) (NP (NP (CD 30) (NN min)) (PP (IN over) (NP (NP (DT a) (NN cushion)) (PP (IN of) (NP (ADJP (CD 1.2) (NN M)) (NN sucrose)))))))) (CC and) (VP (VBN washed) (PP (ADVP (RB twice)) (JJ prior) (TO to) (NP (NN resuspension))) (PP (IN in) (NP (NP (NP (NP (NN DNase) (CD I)) (NN digestion)) (NN buffer)) (-LRB- -LRB-) (NP (ADJP (CD 60) (NN mM)) (NN KCl)) (, ,) (NP (ADJP (CD 5) (NN mM)) (NN MgCl2)) (, ,) (NP (NP (ADJP (CD 15) (NN mM)) (NN Tris)) (PRN (-LRB- -LRB-) (NP (CD pH7.5)) (-RRB- -RRB-))) (, ,))))))))
( (S (S (NP (NP (ADJP (CD 0.1) (NN mM)) (NN EGTA)) (, ,) (NP (ADJP (CD 0.5) (NN mM)) (NN DTT)) (CC and) (NP (ADJP (CD 5) (NN %)) (NN glycerol))) (-RRB- -RRB-)) (. .)))
( (S (S (S (NP (NNS Nuclei)) (VP (VBD were) (VP (VBN resuspended) (PP (IN at) (NP (NP (DT a) (NN concentration)) (PP (IN of) (NP (NN 2–4) (NN ×) (CD 106) (NN nuclei/ml)))))))) (CC and) (S (NP (NP (JJ gentle) (NN DNase) (CD I)) (NN digestion)) (VP (VBD was) (VP (VBN carried) (PRT (RP out)) (PP (IN in) (NP (NP (DT a) (NN volume)) (PP (IN of) (NP (CD 0.2) (NN ml))))) (PP (IN with) (NP (NP (QP (CD 0) (TO to) (CD 100)) (NNS units)) (PP (IN of) (NP (NN DNase) (CD I))))) (PRN (-LRB- -LRB-) (NP (NNP Roche)) (-RRB- -RRB-)) (PP (IN for) (NP (NP (CD 5) (NNS minutes)) (PP (IN at) (NP (NN 30°C))))))))) (. .)))
( (S (S (PP (VBG Following) (NP (NN DNase) (NN I) (NN treatment))) (, ,) (NP (NNS nuclei)) (VP (VBD were) (VP (VP (VBN lysed)) (CC and) (VP (NN DNA) (VBN purified) (PP (IN by) (NP (NP (NN phenol/chloroform) (NN extraction)) (CC and) (NP (NN ethanol) (NN precipitation)))))))) (. .)))
( (S (S (NP (NN DNA)) (VP (VBD was) (VP (VP (VBN digested) (PP (IN with) (NP (NP (JJ appropriate) (NN restriction) (NNS enzymes)) (PRN (-LRB- -LRB-) (NP (NP (NN Eco) (NN RI)) (CC and) (NP (NN Hind) (CD III))) (-RRB- -RRB-))))) (CC and) (VP (VBN electrophoresed) (PP (IN on) (NP (DT a) (ADJP (CD 0.8) (NN %)) (NN agarose) (NN gel))))))) (. .)))
( (S (S (PP (VBG Following) (NP (NP (NN transfer)) (PP (TO to) (NP (NN nylon) (NNS membranes))))) (, ,) (NP (NN hybridization)) (VP (VBD was) (VP (VBN performed) (S (VP (VBG using) (NP (JJ standard) (NNS procedures))))))) (. .)))
( (S (S (NP (NN Probe) (NNS fragments)) (VP (VBD were) (VP (VBN made) (PP (IN by) (NP (NN PCR))) (SBAR (IN from) (S (NP (JJ genomic) (NN DNA.) (NN Figure) (CD 1)) (VP (VBZ depicts) (NP (NP (DT the) (NP (NN CCR3) (NN gene) (NN structure) (CC and) (NN restriction) (NNS fragments)) (CC and) (NP (PRP$ their) (JJ corresponding) (NNS probes))) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (VP (VBN used) (S (VP (TO to) (VP (VBP span) (NP (DT the) (JJ entire) (NN gene)))))))))))))))) (. .)))
( (S (S (NP (VBN Cultured) (NNS cells)) (VP (VBD were) (VP (VBN washed) (ADVP (RB twice)) (PP (IN with) (NP (NP (NN ice) (JJ cold) (NN phosphate) (JJ buffered) (NN saline)) (PRN (-LRB- -LRB-) (NP (NP (NN PBS)) (, ,) (NP (NN Gibco) (NN BRL))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (QP (CD 2.5) (CD ×) (CD 106)) (NNS cells)) (VP (VBD were) (VP (VBN lysed) (PP (IN in) (NP (NP (NN lysis) (NN buffer) (CD -LSB-100) (NN mM) (JJ N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic) (NN acid) (-LRB- -LRB-) (NNS HEPES) (-RRB- -RRB-)) (, ,) (NP (NP (NN pH) (CD 7.9)) (, ,) (NP (ADJP (CD 10) (NN mM)) (NN KCl)) (, ,) (NP (ADJP (CD 0.1) (NN mM)) (NN EDTA)) (, ,) (NP (ADJP (CD 1.5) (NN mM)) (NN MgCl2)) (, ,) (NP (ADJP (CD 0.2) (NN %)) (NN Nonidet) (NN P-40)) (, ,) (NP (NP (ADJP (CD 1) (NN mM)) (NN dithiothreitol)) (PRN (-LRB- -LRB-) (NP (NN DTT)) (-RRB- -RRB-))) (, ,) (CC and) (NP (ADJP (CD 0.5) (NN mM)) (NN PMSF)) (-RRB- -RSB-)) (, ,) (VP (ADVP (RB briefly)) (VBN vortexed) (PP (IN at) (NP (NP (DT a) (JJ moderate) (NN speed)) (, ,) (VP (ADVP (RB then)) (VBN incubated) (PP (IN on) (NP (NN ice))) (PP (IN for) (NP (CD 5) (NNS minutes)))))))))))) (. .)))
( (S (S (S (NP (NN Sample)) (VP (VBD was) (VP (VBN centrifuged)))) (CC and) (S (NP (DT the) (NN pellet)) (VP (VBD was) (ADVP (RB next)) (VP (VP (VBN resuspended) (PP (IN in) (NP (NP (CD 20) (NN μl)) (PP (IN of) (NP (NP (NN extraction) (NN buffer)) (PRN (-LRB- -LRB-) (NP (CD 20) (NN mM) (NNS HEPES)) (, ,) (NP (NP (NN pH) (CD 7.9)) (, ,) (NP (NP (ADJP (CD 420) (NN mM)) (NN NaCl)) (, ,) (NP (ADJP (CD 0.1) (NN mM)) (NN EDTA))) (, ,) (NP (ADJP (CD 1.5) (NN mM)) (NN MgCl2)) (, ,) (NP (ADJP (CD 25) (NN %)) (NN glycerol)) (, ,) (NP (ADJP (CD 1) (NN mM)) (NN DTT)) (, ,) (CC and) (NP (ADJP (CD 0.5) (NN mM)) (NN PMSF))) (-RRB- -RRB-))))))) (, ,) (VP (ADVP (RB mildly)) (VBN vortexed)) (, ,) (CC and) (VP (VBN incubated) (PP (IN on) (NP (NN ice))) (PP (IN for) (NP (CD 15) (NNS minutes)))))))) (. .)))
( (S (S (NP (NNS Samples)) (VP (VBD were) (VP (VBN centrifuged) (S (VP (TO to) (VP (NN pellet) (NP (DT the) (JJ nuclear) (NN debris)))))))) (. .)))
( (S (S (NP (NNS Supernatants)) (VP (VBD were) (VP (VP (VBN placed) (PP (IN in) (NP (JJ silicon) (JJ coated) (NN microcentrifuge) (NNS tubes)))) (CC and) (VP (VBN stored) (PP (IN at) (NP (NN -80°C))) (PP (IN until) (NP (JJ further) (NN use))))))) (. .)))
( (S (S (NP (NP (JJ Single-stranded) (NNS oligonucleotides)) (VP (VBN based) (PP (IN on) (NP (NP (DT the) (NN sequence)) (PP (IN of) (NP (NP (JJ untranslated) (NN exon) (CD 1)) (PP (IN of) (NP (DT the) (NN CCR3) (NN promoter))))))))) (VP (VBD were) (VP (VBN synthesized) (PP (IN by) (NP (NP (JJ Integrated) (NN DNA) (NNS Technologies)) (, ,) (NP (NP (NNP Inc.)) (PRN (-LRB- -LRB-) (NP (NP (NNP Coralville)) (, ,) (NP (NN IA))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (NP (CD One) (JJ full) (NN length) (CD 51) (NN base) (NN pair)) (PRN (-LRB- -LRB-) (NP (CD +10) (TO to) (CD +60)) (-RRB- -RRB-))) (NN oligonucleotide) (PRN (-LRB- -LRB-) (NP (NN GGTACCACTGGTCTTCTTGTGCTTATCCGGGCAAGAACTTATCGAAATACA)) (-RRB- -RRB-)) (CC and) (NP (NP (CD three) (JJ overlapping) (NNS oligonucleotides)) (PRN (-LRB- -LRB-) (NP (NP (CD +10) (TO to) (CD +31)) (, ,) (NP (CD +25) (TO to) (CD +46)) (, ,) (CC and) (NP (CD +40) (TO to) (CD +60))) (-RRB- -RRB-))) (CC and) (NP (PRP$ their) (JJ reverse) (NNS complements))) (VP (VBD were) (VP (VBN produced) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 2)) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (NP (CD Two)) (PP (IN of) (NP (DT the) (JJ overlapping) (NNS fragments)))) (VP (VBD contained) (NP (NP (JJ putative) (NN GATA) (NN binding) (NNS sites)) (PRN (-LRB- -LRB-) (VP (VBN underlined)) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (NP (CD Two) (NNS mutants)) (CC and) (NP (PRP$ their) (NNS complements))) (VP (VBD were) (ADVP (RB also)) (VP (VBN made) (SBAR (WHNP (WDT which)) (S (VP (VBD changed) (NP (DT the) (NN GATA) (NN sequence) (NN TATC)) (PP (TO to) (NP (NN TTGA))))))))) (. .)))
( (S (S (S (NP (DT This) (NN mutation)) (VP (VBZ does) (RB not) (VP (VB change) (NP (NP (DT the) (NN GC) (NN content)) (PP (IN of) (NP (DT the) (NNS oligonucleotides))))))) (, ,) (CC nor) (SINV (VBZ does) (NP (PRP it)) (VP (VB create) (NP (NP (DT a) (JJ new) (NN transcription) (NN factor) (NN site)) (PP (IN for) (NP (NP (DT any)) (PP (IN of) (NP (NP (DT the) (NN transcription) (NNS factors)) (VP (VBN represented) (PP (IN in) (NP (DT the) (ADJP (RB publicly) (JJ available)) (NN TFSEARCH) (NN engine)))))))))))) (. .)))
( (S (S (NP (DT Each) (NN oligonucleotide)) (VP (VBD was) (VP (VBN resuspended) (PP (TO to) (NP (NP (DT a) (NN concentration)) (PP (IN of) (NP (CD 50) (NN μM))) (PP (IN in) (NP (NP (NN TE) (NN buffer)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD 10) (NN mM)) (NN Tris-Cl)) (, ,) (NP (NN pH) (CD 7.4)) (, ,) (CC and) (NP (NP (ADJP (CD 0.1) (NN mM)) (NN EDTA)) (, ,) (NP (NN Sigma)))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (JJ Complimentary) (JJ single-stranded) (NNS oligonucleotides)) (VP (VBD were) (VP (VBN annealed) (PP (IN at) (NP (NP (DT a) (NN concentration)) (PP (IN of) (NP (CD 10) (NN mM))) (PP (IN in) (NP (NP (NN restriction) (NN enzyme) (NN buffer) (NN M)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD 10) (NN mM)) (NN Tris-Cl)) (, ,) (NP (ADJP (CD 10) (NN mM)) (NN MgCl2)) (, ,) (NP (ADJP (CD 50) (NN mM)) (NN NaCl)) (, ,) (CC and) (NP (ADJP (CD 1) (NN mM)) (NN dithioerythritol))) (, ,) (NP (NNP Roche) (NN Molecular) (NNP Biochemicals) (, ,) (NNP Indianapolis)) (, ,) (NP (NN IN)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (S (NP (NNS Samples)) (VP (VBD were) (VP (VBN placed) (PP (IN in) (NP (NP (DT a) (JJ 95°C) (NN dry) (NN heat) (NN block)) (PP (IN for) (NP (CD 5) (NNS minutes)))))))) (CC and) (S (NP (RB then) (DT the) (NN block)) (VP (VP (VBD was) (VP (VBN removed) (PP (IN from) (NP (DT the) (NN unit))))) (CC and) (VP (VBD allowed) (PP (TO to) (NP (NN cool))) (ADVP (ADVP (RB slowly)) (PP (TO to) (NP (JJ room) (NN temperature)))))))) (. .)))
( (S (S (NP (DT The) (JJ double-stranded) (NNS oligomers)) (VP (VBD were) (ADJP (JJ diluted) (PP (TO to) (NP (NP (CD 1) (NN μM)) (PP (IN with) (NP (NN TE) (NN buffer)))))))) (CC and) (S (NP (CD 30) (NN ng)) (VP (VBD were) (ADJP (JJ end-labelled)) (S (VP (VBG using) (NP (NP (NP (CD -LSB-γ-32P) (-RRB- -RSB-) (NN ATP)) (PRN (-LRB- -LRB-) (NP (NNP NEN) (NN Life) (NNP Science) (, ,) (NNP Boston) (, ,) (NNP MA)) (-RRB- -RRB-))) (CC and) (NP (NP (NN T4) (NN polynucleotide) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN Gibco) (NN BRL)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NN Probe)) (VP (VBD was) (VP (VP (VBN purified) (PP (IN over) (NP (NP (JJ Quick) (NN Spin) (NN G-25) (NN Sephadex) (NNS columns)) (PRN (-LRB- -LRB-) (NP (NNP Roche)) (-RRB- -RRB-))))) (CC and) (VP (VBN recovered) (PP (IN in) (NP (NP (DT a) (NN volume)) (PP (IN of) (NP (CD 50) (NN μl))))))))) (. .)))
( (S (S (NP (NP (NN Protein) (NN content)) (PP (IN of) (NP (DT the) (JJ nuclear) (NNS extracts)))) (VP (VBD were) (VP (VBN determined) (PP (IN by) (NP (NP (NNP Bradford) (-LRB- -LRB-) (NN Coomassie) (-RRB- -RRB-) (NN assay)) (PRN (-LRB- -LRB-) (NP (NP (NN Pierce)) (, ,) (NP (NN Rockford)) (, ,) (NP (NN IL))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (JJ Total) (NN protein)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN μg)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN incubated) (PP (IN on) (NP (NN ice))) (PP (IN for) (NP (CD 10) (NNS minutes))) (PP (IN with) (NP (NP (NN 2X) (NN EMSA) (NN buffer)) (PRN (-LRB- -LRB-) (NP (CD 24) (NN %) (NN glycerol)) (, ,) (NP (CD 0.08) (NN μg/ml) (NN poly) (NN dI-dC)) (, ,) (NP (CD 24) (NN mM) (NNS HEPES)) (, ,) (NP (NP (NN pH) (CD 7.9)) (, ,) (NP (ADJP (CD 8) (NN mM)) (NN Tris-Cl)) (, ,) (NP (NN pH) (CD 7.9)) (, ,) (NP (NP (ADJP (CD 2) (NN mM)) (NN EDTA)) (, ,) (NP (NP (ADJP (CD 2) (NN mM)) (NN DTT)) (, ,) (NP (ADJP (CD 50) (NN mM)) (NN KCl)) (, ,) (CC and) (NP (ADJP (CD 10) (NN mM)) (NN MgCl2))) (, ,))) (-RRB- -RRB-))))) (, ,) (SBAR (CC and) (SBAR (WHADVP (WRB when)) (S (VP (VBN indicated) (, ,) (PP (IN with) (NP (NP (CD 150) (JJ fold) (NN excess)) (PP (IN of) (NP (JJ cold) (NN competitor) (NN oligonucleotide))))))))))) (. .)))
( (S (S (S (NP (JJ Radiolabelled) (JJ oligo) (NN probe)) (VP (VBD was) (VP (VBN added) (PP (TO to) (NP (DT each) (NN sample)))))) (CC and) (S (NP (NN incubation)) (VP (VBD continued) (PP (IN for) (NP (NP (DT an) (JJ additional) (CD 10) (NNS minutes)) (PP (IN on) (NP (NN ice)))))))) (. .)))
( (S (PP (IN For) (NP (NN antibody) (NN supershift) (NNS assays))) (, ,) (NP (NP (NN anti-GATA-1) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NP (NN clone) (NN C20)) (, ,) (NP (NNP Santa) (NNP Cruz) (NN Biotechnology)) (, ,) (NP (NNP Santa) (NNP Cruz)) (, ,) (NP (NN CA))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN added) (PP (VBG following) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NP (DT the) (NN probe) (CC and) (NNS samples)) (VP (VBN incubated) (PP (IN on) (NP (NN ice))) (PP (IN for) (NP (CD one) (NN hour)))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN control) (NNS experiments))) (, ,) (NP (NN isotype-control) (NNS antibodies)) (VP (VBD did) (RB not) (VP (VB have) (NP (DT a) (JJ significant) (NN effect))))) (. .)))
( (S (S (NP (DT The) (JJ DNA-protein) (NNS complexes)) (VP (VBD were) (ADVP (RB then)) (VP (VBN resolved) (PP (IN on) (NP (NP (DT a) (JJ non-denaturing) (ADJP (CD 5) (NN %)) (NN acrylamide) (NN gel) (NN -LSB-29:1) (NN acrylamide/bis-acrylamide)) (, ,) (NP (NP (NN 0.5X) (NN TBE) (NN buffer)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD 44.5) (NN mM)) (NN Tris)) (, ,) (NP (ADJP (CD 44.5) (NN mM)) (NN borate)) (, ,) (CC and) (NP (ADJP (CD 1) (NN mM)) (NN EDTA))) (-RRB- -RRB-))) (, ,) (CC and) (NP (ADJP (CD 25) (NN %)) (NN glycerol)) (-RRB- -RSB-))) (PP (IN at) (NP (NP (JJ constant) (NN current)) (PP (IN of) (NP (NP (CD 30) (NN mA)) (PP (IN for) (NP (QP (RB approximately) (CD 60)) (NNS minutes)))))))))) (. .)))
( (S (S (NP (NNS Gels)) (VP (VBD were) (VP (VP (VBN dried) (PP (IN on) (NP (NN blotting) (NN paper)))) (CC and) (VP (VBN exposed) (PP (TO to) (NP (NN x-ray) (NN film))))))) (. .)))
( (S (S (NP (NP (CD 1.6) (NN kb)) (PP (IN of) (NP (DT the) (NN CCR3) (NN promoter))) (, ,) (PP (VBG including) (NP (NP (CD 60) (NN bp)) (PP (IN of) (NP (JJ untranslated) (NN exon) (CD 1))))) (, ,)) (VP (VBD was) (VP (VBN subcloned) (PP (IN into) (NP (DT the) (NN pEGFP) (NN vector))) (PRN (-LRB- -LRB-) (NP (NP (NNP Clontech) (, ,) (NNP Palo) (NNP Alto)) (, ,) (NP (NN CA))) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (NP (DT The) (JJ transgenic) (NN construct)) (VP (VBG containing) (NP (NP (DT the) (NN promoter)) (, ,) (NP (NP (NN reporter) (NN gene)) (VP (VBD enhanced) (NP (NP (NP (JJ green) (JJ fluorescent) (NN probe)) (PRN (-LRB- -LRB-) (NP (NN EGFP)) (-RRB- -RRB-))) (CC and) (NP (NP (DT the) (NN SV40) (NN polyadenylation) (NN signal)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 4)) (-RRB- -RRB-))))))))) (VP (VBD were) (VP (VP (VBD liberated) (PP (IN by) (NP (NN Afl) (CD II) (CC and) (NN Hind) (CD III) (NN digestion)))) (CC and) (VP (VBN injected) (PP (IN into) (NP (NP (DT the) (NN pronucleus)) (PP (IN of) (NP (NP (JJ fertilized) (NNS eggs)) (PP (IN from) (NP (NN FVB/N) (NNS mice))))))) (PP (IN by) (NP (NP (DT the) (JJ Transgenic) (NN Core) (NN Facility)) (PP (IN at) (NP (NP (NNP Cincinnati) (NNS Children) (POS 's) (NP (NNP Hospital))) (JJ Medical) (NN Center))))))))) (. .)))
( (S (S (NP (JJ Transgenic) (NNS mice)) (VP (VBD were) (VP (VBN identified) (PP (IN by) (NP (NN Southern) (NN blot) (NN analysis))) (PP (IN after) (NP (NP (NN digestion)) (PP (IN with) (NP (NN BamHI))))) (, ,) (S (VP (VBG using) (NP (DT the) (NN SV40) (NN poly) (NN A) (NN fragment)) (PP (IN as) (NP (DT a) (NN probe)))))))) (. .)))
( (S (S (NP (NNS Lines)) (VP (VBD were) (VP (VBN tested) (PP (IN for) (NP (NP (NN expression)) (PP (IN of) (NP (DT the) (NN transgene))) (PP (IN in) (NP (JJ multiple) (NNS organs))))) (PP (IN by) (NP (NP (NN Northern) (NN blotting)) (CC and) (NP (NN RT-PCT))))))) (. .)))
( (S (S (NP (DT The) (NN SV40) (NN poly) (NN A) (NN fragment)) (VP (VBD was) (VP (VBN used) (PP (IN as) (NP (NP (DT a) (NN probe)) (PP (IN for) (NP (NN Northern) (NN blotting)))))))) (. .)))
( (S (S (S (NP (NP (NN PCR) (NNS primers)) (PP (IN for) (NP (NN EGFP)))) (VP (VBD were) (SBAR (IN as) (S (VP (VBZ follows)))))) (: :) (NP (NP (NP (CD 5)) (PRN (`` ') (NP (NN ATGGTGAGCCAAGGGCGAG3)) ('' '))) (CC and) (NP (NP (CD 5)) (PRN (`` ') (NP (NN CTTGTACAGCTCGTCCATG3)) ('' ')))) (. .)) (S (NP (NP (NN RNA) (NN integrity)) (CC and) (NP (NN RT) (NN efficiency))) (VP (VBD was) (VP (VBN verified) (PP (IN by) (S (VP (VBG performing) (NP (NP (NN PCR)) (PP (IN for) (NP (NN β-actin)))) (PP (IN on) (NP (DT the) (JJ same) (NN cDNA) (NNS samples))))))))) (. .)))
( (S (S (NP (NP (NNS Primers)) (VP (VBN used))) (VP (VBD were) (PP (IN as) (NP (NP (VBZ follows)) (: :) (NP (NP (NP (CD 5)) (PRN (`` ') (NP (NN GGAATCCTGTGGCATCCATGAAACT3)) ('' '))) (CC and) (NP (NP (CD 5)) (PRN (`` ') (NP (NN TAAAACGCAGCTCAGTAACAGTCCG3)) ('' ')))))))) (. .)))
( (S (S (NP (NN Immunohistochemistry)) (VP (VBD was) (VP (VBN performed) (PP (IN on) (NP (NN frozen) (NNS sections)))) (ADVP (RB essentially)) (SBAR (IN as) (S (VP (VBN described) (NP (CD -LSB-52) (-RRB- -RSB-))))))) (. .)))
( (S (S (ADVP (RB Briefly)) (, ,) (PP (VBG following) (NP (JJ endogenous) (NN peroxidase) (NN quenching))) (, ,) (NP (NNS slides)) (VP (VBD were) (VP (VP (VBN blocked)) (CC and) (VP (VBN stained) (PP (IN with) (NP (NP (DT a) (JJ rabbit-anti-GFP) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NP (QP (CD AB3080) (IN at) (CD 1:400)) (NN dilution)) (, ,) (NP (NNP Chemicon) (NNP International) (, ,) (NNP Temecula) (, ,) (NN CA))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (DT The) (NNS slides)) (VP (VBD were) (VP (VP (VBN washed)) (CC and) (VP (VBN incubated) (PP (IN with) (NP (NP (VBN biotinylated) (NN goat) (JJ anti-rabbit) (NN antibody)) (CC and) (NP (NP (JJ avidin-peroxidase) (NN complex)) (PRN (-LRB- -LRB-) (NP (NP (NN Vectastain) (NN ABC) (NN Peroxidase) (NN Elite) (NN kit)) (, ,) (NP (NN Vector) (NNS Laboratories))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (DT The) (NNS slides)) (VP (VBD were) (ADVP (RB then)) (VP (VBN developed) (PP (IN by) (NP (NP (NN nickel) (NN diaminobenzidine) (, ,) (VBN enhanced) (NN nickel) (NN cobalt) (NN chloride)) (S (VP (TO to) (VP (VP (VB form) (NP (DT a) (JJ black) (NN precipitate))) (CC and) (VP (ADJP (JJ counterstained)) (PP (IN with) (NP (JJ nuclear) (JJ fast) (JJ red)))))))))))) (. .)))
( (S (NP (NP (NNS Authors) (POS ')) (NNS contributions))))
( (S (S (NP (NN JLC)) (VP (VBD carried) (PRT (RP out)) (NP (DT the) (NN EMSA) (NN analysis)))) (. .)))
( (S (S (NP (NN LEK)) (VP (VBD performed) (NP (DT the) (NN DNAse) (NN hypersensitivity) (NNS studies)))) (. .)))
( (S (S (NP (NN NZ)) (VP (VBD carried) (PRT (RP out)) (NP (NP (DT the) (NP (NN generation)) (CC and) (NP (NN analysis))) (PP (IN of) (NP (JJ transgenic) (NNS mice))) (, ,) (VP (VP (VBN participated) (PP (IN in) (NP (NP (DT the) (NP (NN design)) (CC and) (NP (NN coordination))) (PP (IN of) (NP (DT the) (JJ overall) (NN study)))))) (CC and) (VP (VBN drafted) (NP (DT the) (NN manuscript))))))) (. .)))
( (S (S (NP (NN MER)) (VP (VP (VBD participated) (PP (IN in) (NP (NP (DT the) (NP (NP (NN design)) (CC and) (NP (NN coordination)))) (PP (IN of) (NP (DT the) (JJ overall) (NN study)))))) (CC and) (VP (VBD helped) (PP (TO to) (NP (JJ draft) (DT the) (NN manuscript)))))) (. .)))
( (S (NP (NP (NN Figure)) (CC and) (NP (NN Table)) (NP (NNS captions)))))
( (S (S (NP (NN Figure) (CD 1) (: :) (NN DNase) (CD I) (NN hypersensitivity)) (VP (NNS studies))) (. .)))
( (S (S (PP (IN In) (NP (-LRB- -LRB-) (NN A) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (JJ schematic) (NN representation)) (PP (IN of) (NP (DT the) (NN CCR3) (NN gene)))) (VP (VBZ is) (VP (VBN shown)))) (. .)))
( (S (S (NP (NP (NNS Exons) (NP (CD 1))) (PP (IN through) (NP (NP (CD 4)) (PRN (-LRB- -LRB-) (NP (NN E1) (NN –) (NN E4)) (-RRB- -RRB-))))) (VP (VBP are) (VP (VBN depicted) (PP (IN as) (NP (NP (NNS boxes)) (: ;) (NP (NP (JJ open) (NN box)) (VP (VBZ represents) (NP (DT the) (JJ open) (NN reading) (NN frame)) (, ,) (SBAR (IN while) (S (NP (DT the) (JJ closed) (NN box)) (VP (VBZ represents) (NP (DT the) (JJ untranslated) (NN region)))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN position)) (PP (IN of) (NP (NN Hind) (NP (NP (NP (CD III)) (PRN (-LRB- -LRB-) (NP (NN H)) (-RRB- -RRB-))) (CC and) (NP (NP (NN Eco) (NN RI)) (PRN (-LRB- -LRB-) (NP (NN RI)) (-RRB- -RRB-)))) (NN restriction) (NNS sites)))) (VP (VBZ is) (VP (VBN depicted) (SBAR (IN with) (S (NP (NP (NNS arrows)) (CC and) (NP (NP (NNS probes)) (VP (VBN used) (PP (IN for) (NP (NN DNase) (CD I) (NN hypersensitivity)))))) (VP (VBP are) (VP (VBN depicted) (PP (IN as) (NP (NP (NNS lines)) (PP (IN above) (NP (DT the) (JJ genomic) (NN fragment)))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN position)) (PP (IN of) (NP (JJ hypersensitive) (NN site)))) (VP (VBZ is) (VP (VBN depicted) (PP (IN as) (NP (NN HS1)))))) (. .)))
( (S (S (PP (IN In) (S (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-)))) (, ,) (NP (NP (NN Southern) (NN blot) (NN analysis)) (PP (IN for) (NP (DT the) (NN HS) (NN site)))) (VP (VBZ is) (VP (VBN shown)))) (. .)))
( (S (S (NP (NP (NNS Nuclei)) (PP (IN from) (NP (DT the) (JJ primary) (JJ human) (NNS eosinophils)))) (VP (VBD were) (VP (VBN digested) (PP (IN with) (NP (NP (VBN indicated) (NNS doses)) (PP (IN of) (NP (NN DNase) (CD I))))) (PP (IN for) (NP (NP (CD 5) (NNS minutes)) (PP (IN at) (NP (NN 30°C)))))))) (. .)))
( (S (S (PP (VBG Following) (NP (NP (NN DNA) (NN purification)) (CC and) (NP (NP (NN digestion)) (PP (IN with) (NP (NN restriction) (NNS enzymes))) (-LRB- -LRB-) (VP (VBN shown) (PP (IN in) (NP (NP (NN figure)) (VP (VBZ is) (NP (NN Eco) (NN RI)))))) (-RRB- -RRB-)))) (, ,) (NP (NN DNA)) (VP (VBD was) (VP (VP (VBN electrophoresed) (PP (IN on) (NP (DT an) (NN agarose) (NN gel)))) (CC and) (VP (VBN transferred) (PP (TO to) (NP (NN nylon) (NNS membranes))))))) (. .)))
( (S (S (PP (VBG Following) (NP (NP (NN hybridization)) (PP (IN with) (NP (JJ genomic) (NNS probes))))) (, ,) (NP (NNS membranes)) (VP (VBD were) (VP (VBN exposed) (PP (TO to) (NP (NN film)))))) (. .)))
( (S (S (NP (NN Size) (NNS markers)) (VP (VBP are) (VP (VBN shown) (PP (IN on) (NP (DT the) (JJ right)))))) (. .)))
( (S (S (NP (NP (NP (NN Ethidium) (NN bromide)) (NN staining)) (PP (IN of) (NP (DT the) (NN gel)))) (VP (VBZ is) (ADVP (RB also)) (VP (VBN shown)))) (. .)))
( (S (S (NP (NN Figure) (CD 2)) (: :) (NP (NP (NN Binding)) (PP (IN of) (NP (NN transcription) (NNS factors))) (PP (TO to) (NP (NN CCR3) (NN exon) (CD 1))))) (. .)))
( (S (S (PP (IN In) (NP (-LRB- -LRB-) (NN A) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (JJ schematic) (NN representation)) (PP (IN of) (NP (NP (DT the) (NN CCR3) (NN exon) (NN region)) (VP (VBN used) (PP (IN for) (NP (JJ electrophoretic) (NN mobility) (NN shift) (NNS assays))))))) (VP (VBZ is) (VP (VBN shown)))) (. .)))
( (S (S (NP (NN E1-FL)) (VP (VBZ is) (NP (DT the) (NN exon) (CD 1) (JJ full-length) (NN probe)))) (. .)))
( (S (S (NP (JJ Overlapping) (JJ short) (NNS probes)) (VP (VBP are) (VP (VBN called) (NP (NP (NN E1-A)) (, ,) (NP (NN E1-B)) (CC and) (NP (NN E1-C)) (, ,) (ADVP (RB respectively)))))) (. .)))
( (S (S (NP (DT The) (NN DNA) (NN sequence)) (VP (VBZ is) (VP (VBN shown) (PP (IN with) (NP (NP (NN GATA) (NNS sites)) (VP (VBN boxed))))))) (. .)))
( (S (S (PP (IN In) (S (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-)))) (, ,) (NP (NP (NN EMSA) (NN assay)) (PP (IN with) (NP (NP (DT the) (JJ full-length) (NN probe)) (CC and) (NP (NP (NNS extracts)) (PP (IN from) (NP (JJ eosinophilic) (NN AML14.3D10) (NNS cells))))))) (VP (VBZ is) (VP (VBN shown)))) (. .)))
( (S (S (PP (IN As) (NP (NP (JJ cold) (NNS competitors)) (PRN (-LRB- -LRB-) (NP (NN CC)) (-RRB- -RRB-)))) (, ,) (NP (NP (DT the) (NP (NP (JJ full-length) (NN probe)) (CC and) (NP (JJ short) (NNS probes))) (NN E1-A)) (PP (IN through) (NP (NN C)))) (VP (VBD were) (VP (VBN used)))) (. .)))
( (S (S (NP (DT The) (NN arrow)) (VP (VBZ depicts) (NP (DT the) (JJ specific) (NN band)))) (. .)))
( (S (S (NP (NP (DT A) (JJ representative) (NN experiment)) (, ,) (PP (IN of) (NP (CD three) (JJ similar) (NNS experiments))) (, ,)) (VP (VBZ is) (VP (VBN shown)))) (. .)))
( (S (S (NP (NN Figure) (CD 3)) (: :) (NP (NP (NN Binding)) (PP (IN of) (NP (NN GATA) (NNS factors))) (PP (TO to) (NP (NN CCR3) (NN exon) (CD 1))))) (. .)))
( (S (S (PP (IN In) (NP (-LRB- -LRB-) (NN A) (-RRB- -RRB-))) (, ,) (NP (NP (NN EMSA) (NN assay)) (PP (IN with) (NP (NP (NP (NNS probes) (NP (NP (NP (NN E1-B)) (PRN (-LRB- -LRB-) (NP (JJ left) (NN panel)) (-RRB- -RRB-))) (CC and) (NP (NN E1-C)))) (PRN (-LRB- -LRB-) (NP (JJ right) (NN panel)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN from) (NP (NN AML14.3D10) (NNS cells))))))) (VP (VBZ is) (VP (VBN shown)))) (. .)))
( (S (S (NP (CD Three) (JJ cold) (NNS competitors)) (VP (VBD were) (VP (VBN used) (PP (IN in) (NP (DT each) (NN case))) (: :) (NP (NP (NP (NP (DT the) (NN probe)) (NP (PRP itself))) (PRN (-LRB- -LRB-) (NP (NP (NP (NN E1-B-WT)) (CC and) (NP (NN E1-C-WT))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-))) (, ,) (NP (NP (DT the) (NN probe)) (PP (IN with) (NP (NP (NP (DT the) (NN GATA) (NN site)) (VP (VBN mutated) (PRN (-LRB- -LRB-) (NP (NP (NP (NN E1-B-mut)) (CC and) (NP (NN E1-C-mut))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-)))) (CC and) (NP (NP (DT the) (NN GATA) (NN consensus) (NN oligonucleotide)) (PRN (-LRB- -LRB-) (NP (NN GATA) (NNS cons)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NP (DT A) (JJ representative) (NN experiment)) (, ,) (PP (IN of) (NP (CD three) (JJ similar) (NNS experiments))) (, ,)) (VP (VBZ is) (VP (VBN shown)))) (. .)))
( (S (S (PP (IN In) (S (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-)))) (, ,) (NP (NP (NN EMSA) (NN assay)) (PP (IN with) (NP (NP (NP (DT the) (JJ full-length) (NN probe)) (PRN (-LRB- -LRB-) (NP (NN E1-FL)) (-RRB- -RRB-))) (CC and) (NP (NP (NNS extracts)) (PP (IN from) (NP (JJ eosinophilic) (NN AML14.3D10) (NNS cells)))))) (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC or) (NP (NN absence))) (PP (IN of) (NP (NP (NNS antibodies)) (PP (IN against) (NP (NN GATA-1)))))))) (VP (VBZ is) (VP (VBN shown)))) (. .)))
( (S (S (NP (DT The) (NN arrow)) (VP (VBZ depicts) (NP (DT the) (JJ specific) (NN band)))) (. .)))
( (S (S (IN In) (S (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (, ,) (S (NP (NP (NN EMSA) (NN assay)) (PP (IN with) (NP (NP (NP (NP (NP (NP (NNS probes) (NP (NP (NP (NN E1-B)) (PRN (-LRB- -LRB-) (NP (JJ left) (NN panel)) (-RRB- -RRB-))) (CC and) (NP (NN E1-C)))) (PRN (-LRB- -LRB-) (NP (JJ right) (NN panel)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN from) (NP (NN AML14.3D10) (NNS cells)))) (CC and) (NP (JJ cold) (NN competitor) (NN probe))) (NP (PRP itself))) (PRN (-LRB- -LRB-) (NP (NP (NN CC)) (: :) (NP (NP (NN E1-B)) (CC and) (NP (NN CC))) (: :) (NP (NN E1-C)) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-))) (CC or) (NP (NP (NN anti-GATA-1) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NN GATA-1) (NN atb)) (-RRB- -RRB-)))))) (VP (VBZ is) (VP (VBN shown)))))) (. .)))
( (S (S (NP (NN Figure) (CD 4)) (: :) (NP (DT The) (NN CCR3/EGFP) (JJ transgenic) (NNS mice))) (. .)))
( (S (S (PP (IN In) (NP (-LRB- -LRB-) (NN A) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (JJ schematic) (NN representation)) (PP (IN of) (NP (DT the) (JJ transgenic) (NN construct)))) (VP (VBZ is) (VP (VBN shown)))) (. .)))
( (S (S (NP (NP (DT The) (JJ genomic) (NN fragment)) (VP (VBG encoding) (NP (NP (CD 1.6) (NN kb)) (PP (IN of) (NP (DT the) (NN CCR3) (NN promoter))) (PP (VBG including) (NP (NP (CD 60) (NN bp)) (PP (IN of) (NP (NP (NN exon) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN E1)) (-RRB- -RRB-)))))))) (, ,)) (VP (VBD was) (VP (VBN cloned) (PP (IN into) (NP (DT the) (NN Hind) (CD III) (CC and) (NN Bam) (NN HI) (NNS sites))) (ADVP (RB upstream) (PP (IN from) (NP (DT the) (NN EGFP) (NN gene)))) (PP (IN in) (NP (DT the) (NN pEGFP1) (NN vector)))))) (. .)))
( (S (S (NP (NP (DT The) (NNS positions)) (PP (IN of) (NP (NN restriction) (NNS sites)))) (VP (VBP are) (VP (VBN indicated)))) (. .)))
( (S (S (PP (IN In) (S (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-)))) (, ,) (NP (NP (NN Northern) (NN blot) (NN analysis)) (PP (IN of) (NP (NP (JJ multiple) (NNS tissues)) (PP (IN from) (NP (JJ transgenic) (NNS mice)))))) (VP (VBZ is) (VP (VBN shown)))) (. .)))
( (S (S (NP (NP (NP (NN RNA)) (VP (VBD was) (VP (VBN isolated) (PP (IN from) (NP (NP (NP (DT the) (NN spleen)) (, ,) (NP (NN lung)) (, ,) (NP (NN thymus)) (, ,) (NP (NN kidney)) (CC and) (NP (NN jejunum))) (PP (IN of) (NP (NP (NN CCR3/EGFP) (JJ transgenic) (NNS mice)) (PRN (-LRB- -LRB-) (NP (NNS lines) (QP (CD 3.1) (CC and) (CD 3.2))) (-RRB- -RRB-)))))))) (. .) (CD 10)) (NP (NN μg) (JJ total) (NN RNA))) (VP (VBD was) (VP (VP (VBN electrophoresed) (PP (IN on) (NP (DT an) (NN agarose) (NN gel)))) (, ,) (VP (VBN transferred) (PP (TO to) (NP (NN nylon) (NNS membranes)))) (CC and) (VP (VBN probed) (PP (IN with) (NP (DT the) (NN SV40) (NN polyA) (NN probe)))) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB detect) (NP (NP (NN expression)) (PP (IN of) (NP (DT the) (NN transgene))))))))))) (. .)))
( (S (S (NP (NP (NN Position)) (PP (IN of) (NP (NP (NN 28S)) (CC and) (NP (NN 18S))))) (VP (VBZ is) (VP (VBN depicted) (PP (IN with) (NP (NN arrows)))))) (. .)))
( (S (S (NP (NP (NP (NN Ethidium) (NN bromide)) (NN staining)) (PP (IN of) (NP (DT the) (NN gel)))) (VP (VBZ is) (ADVP (RB also)) (VP (VBN shown)))) (. .)))
( (S (S (PP (IN In) (NP (-LRB- -LRB-) (NN C) (-RRB- -RRB-))) (, ,) (NP (NP (NN immunohistochemistry)) (VP (VBG using) (NP (DT an) (NN anti-GFP) (NN antibody)))) (VP (VBZ is) (VP (VBN shown)))) (. .)))
( (S (S (NP (NNS Organs)) (VP (VBD were) (VP (VBN collected) (, ,) (NP (NP (NP (NN frozen) (NNS sections)) (VP (VBN obtained))) (CC and) (NP (NP (NN anti-GFP) (NN immunohistochemistry)) (VP (VBN performed))))))) (. .)))
( (S (S (NP (JJ Positive) (NN staining)) (VP (VBZ is) (VP (VBN represented) (PP (IN as) (NP (JJ black) (NN precipitate)))))) (. .)))
( (S (NP (NP (NP (NP (NN Accumulation)) (PP (IN of) (NP (JJ marginal) (NN zone) (NN B) (NNS cells)))) (CC and) (NP (NP (VBN accelerated) (NN loss)) (PP (IN of) (NP (JJ follicular) (JJ dendritic) (NNS cells))))) (PP (IN in) (NP (JJ NF-κB) (JJ p50-deficient) (NNS mice))))))
( (S (NP (NN Abstract))))
( (S (NP (NP (NN Background)) (: :) (S (NP (NP (NP (JJ Marginal) (NN zone)) (PRN (-LRB- -LRB-) (NP (JJ MZ)) (-RRB- -RRB-))) (NN B) (NNS cells)) (VP (VBP play) (NP (JJ important) (NNS roles)) (PP (IN in) (NP (NP (DT the) (JJ early) (NNS phases)) (PP (IN of) (NP (JJ humoral) (JJ immune) (NNS responses))))))) (. .))))
( (S (S (PP (IN In) (NN addition) (TO to) (S (VP (VBG possessing) (NP (NP (DT an) (JJ inherent) (NN capacity)) (S (VP (TO to) (ADVP (RB rapidly)) (VP (VB differentiate) (PP (IN into) (NP (NN antibody) (NN secreting) (NNS cells)))))))))) (, ,) (NP (JJ MZ) (NN B) (NNS cells)) (ADVP (RB also)) (VP (VB help) (S (VP (TO to) (VP (VB regulate) (NP (NP (DT the) (NN fate)) (PP (IN of) (NP (ADJP (CC both) (ADJP (JJ T-independent)) (CC and) (ADJP (JJ T-dependent))) (NN blood-borne) (NNS antigens))) (PP (IN in) (NP (DT the) (NN spleen))))))))) (. .)))
( (S (S (PP (IN For) (NP (JJ T-dependent) (NNS antigens))) (, ,) (NP (JJ MZ) (NN B) (NNS cells)) (VP (VBP bind) (NP (JJ IgM-antigen) (NNS complexes)) (PP (IN in) (NP (DT a) (JJ complement-dependent) (NN manner))))) (. .)))
( (S (S (SBAR (IN Once) (S (NP (JJ MZ) (NN B) (NNS cells)) (VP (VBP bind) (NP (NP (JJ IgM-containing) (JJ immune) (NNS complexes)) (PRN (-LRB- -LRB-) (NP (NN IgM-IC)) (-RRB- -RRB-)))))) (, ,) (NP (PRP they)) (VP (VBP transport) (NP (PRP them)) (PP (IN into) (NP (NP (NN B) (NN cell) (NNS follicles)) (PP (IN for) (NP (NP (NN deposition)) (PP (IN onto) (NP (NP (NP (JJ follicular) (JJ dendritic) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNS FDCs)) (-RRB- -RRB-))) (, ,) (NP (NP (DT an) (JJ important) (NN component)) (PP (IN of) (NP (NP (NP (VBN secreted) (NN IgM)) (POS 's) (NN ability)) (S (VP (TO to) (VP (VB enhance) (NP (JJ adaptive) (JJ immune) (NNS responses)))))))))))))))) (. .)))
( (S (S (S (VP (TO To) (ADVP (RB further)) (VP (VB define) (NP (NP (DT the) (NN requirement)) (PP (IN for) (NP (JJ MZ) (NN B) (NNS cells))) (PP (IN in) (NP (NP (NN IgM-IC)) (NN deposition))))))) (, ,) (NP (NP (NNS mice)) (ADJP (JJ deficient) (PP (IN in) (NP (NP (DT the) (JJ NF-κB) (NN protein) (NN p50)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB lack) (NP (JJ MZ) (NN B) (NNS cells)))))))))) (, ,))))) (VP (VBD were) (VP (VBN analyzed) (PP (IN for) (NP (PRP$ their) (NN ability) (S (VP (TO to) (VP (VB trap) (NP (NP (NN IgM-IC)) (PP (IN onto) (NP (NNS FDCs)))))))))))) (. .)))
( (S (NP (NP (NNS Results)) (: :) (S (NP (NP (NP (NNS Mice)) (PRN (-LRB- -LRB-) (NP (NP (CD 2) (NNS months)) (PP (IN of) (NP (NN age)))) (-RRB- -RRB-))) (ADJP (JJ deficient) (PP (IN in) (NP (NP (NN p50)) (PRN (-LRB- -LRB-) (NP (NN p50-/-)) (-RRB- -RRB-)))))) (VP (VBD had) (NP (NP (JJ small) (NNS numbers)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells)))) (, ,) (SBAR (IN as) (S (VP (VBN determined) (PP (IN by) (NP (NP (NP (NN cell) (NN surface) (NN phenotype)) (CC and) (NP (NN localization))) (PP (IN in) (NP (DT the) (JJ splenic) (JJ MZ)))))))))) (. .))))
( (S (S (NP (DT These) (NNS cells)) (VP (VBD bound) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NN IgM-IC)))) (ADVP (CC both) (ADVP (FW in) (FW vivo)) (CC and) (ADVP (FW in) (FW vitro))))) (. .)))
( (S (S (PP (JJ Subsequent) (TO to) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NN IgM-IC))) (PP (IN by) (NP (NP (DT the) (JJ MZ) (NN B) (NNS cells)) (PP (IN in) (NP (JJ p50-/-) (NNS mice))))))) (, ,) (NP (NP (JJ small) (NNS amounts)) (PP (IN of) (NP (NN IgM-IC)))) (VP (VBD were) (VP (VBN found) (ADJP (JJ localized) (PP (IN on) (NP (NN FDCs))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (DT the) (JJ MZ) (NN B) (NNS cells)) (VP (VBD retained) (NP (PRP$ their) (NN ability) (S (VP (TO to) (VP (VBP transport) (NP (DT these) (NNS complexes)) (PP (IN into) (NP (JJ splenic) (NNS follicles)))))))))))))))) (. .)))
( (S (S (ADVP (RB Strikingly)) (, ,) (NP (JJ MZ) (NN B) (NNS cells)) (VP (VBD accumulated) (PP (IN with) (NP (NN age))) (PP (IN in) (NP (JJ p50-/-) (NNS mice))))) (. .)))
( (S (S (PP (IN By) (NP (NP (CD 6) (NNS months)) (PP (IN of) (NP (NN age))))) (, ,) (NP (JJ p50-/-) (NNS mice)) (VP (VBD contained) (NP (NP (JJ normal) (NNS numbers)) (PP (IN of) (NP (DT these) (NNS cells)))) (SBAR (IN as) (S (VP (VBN defined) (PP (PP (IN by) (NP (NP (NP (NN CD21/CD23) (NN profile)) (CC and) (NP (JJ high) (NN level) (NN expression))) (PP (IN of) (NP (NP (NN CD1d)) (, ,) (NP (NN CD9)) (, ,) (CC and) (NP (NN IgM)))))) (, ,) (CC and) (PP (IN by) (NP (NP (PRP$ their) (NN positioning)) (PP (IN around) (NP (DT the) (JJ marginal) (NN sinus))))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NP (NNS FDCs)) (PP (IN from) (NP (DT these) (JJR older) (JJ p50-/-) (NNS mice)))) (VP (VBD exhibited) (NP (DT a) (VBN reduced) (NN capacity) (S (VP (TO to) (VP (VP (VB trap) (NP (NN IgM-IC))) (CC and) (VP (VBP retain) (NP (NN complement) (NNS components))))))))) (. .)))
( (S (NP (NP (NN Conclusion)) (: :) (S (NP (DT These) (NNS results)) (VP (VBP demonstrate) (SBAR (IN that) (S (SBAR (IN while) (S (NP (NP (DT the) (NN p50) (NN component)) (PP (IN of) (NP (DT the) (JJ NF-κB) (NN transcription) (NN complex)))) (VP (VBZ plays) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (DT the) (JJ early) (NN development)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells)))))))) (, ,) (NP (JJ MZ) (NN B) (NNS cells)) (VP (MD can) (VP (VP (VB develop)) (CC and) (VP (VB accumulate) (PP (IN in) (NP (NP (NNS mice)) (VP (VBG lacking) (NP (DT this) (NN protein)))))))))))) (. .))))
( (S (S (NP (DT These) (NNS results)) (VP (VP (VBP highlight) (NP (NP (DT the) (NN interface)) (PP (IN between) (NP (NP (JJ genetic) (NNS deficiencies)) (CC and) (NP (NN age)))))) (, ,) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (JJ different) (NN transcription) (NNS factors)) (VP (MD may) (VP (VB play) (NP (JJ distinct) (NNS roles)) (PP (IN in) (NP (NP (DT the) (NP (NN development)) (CC and) (NP (NN maintenance))) (PP (IN of) (NP (NN cell) (NNS populations))) (PP (IN at) (NP (JJ different) (NNS ages)))))))))))) (. .)))
( (S (NP (NN Background))))
( (S (S (NP (JJ Secreted) (NN IgM) (NNS antibodies)) (VP (VBP play) (NP (JJ important) (NNS roles)) (PP (IN in) (NP (NP (DT the) (JJ initial) (NNS phases)) (PP (IN of) (NP (JJ humoral) (JJ immune) (NNS responses))))))) (. .)))
( (S (PP (IN Unlike) (NP (JJ other) (NN antibody) (NNS isotypes))) (, ,) (NP (VBN secreted) (NN IgM)) (ADVP (RB uniquely)) (VP (VBZ functions) (PP (IN as) (NP (DT an) (JJ adjuvant))) (, ,) (S (VP (VBG promoting) (NP (NP (JJ primary) (NN antibody) (NNS responses)) (PP (TO to) (NP (NP (JJ sub-immunogenic) (NNS doses)) (PP (IN of) (NP (JJ T-dependent) (NNS antigens) (NP (CD -LSB-1-7)))))))) (-RRB- -RSB-))) (. .)))
( (S (S (NP (NP (DT The) (NN adjuvanticity)) (PP (IN of) (NP (NN IgM)))) (VP (VBZ is) (ADJP (RB completely) (JJ dependent) (PP (IN on) (NP (DT an) (JJ intact) (NN complement) (NN system) (CD -LSB-7-9) (-RRB- -RSB-)))))) (. .)))
( (S (SBAR (IN While) (S (NP (NP (NNS mice)) (ADJP (JJ deficient) (PP (IN in) (NP (VBN secreted) (NN IgM))))) (VP (VBP make) (NP (NP (JJ protective) (NN antibody) (NNS responses)) (PP (TO to) (NP (NNS pathogens))))))) (, ,) (NP (DT these) (NNS responses)) (VP (VBP are) (VP (VBN delayed) (PP (VBN compared) (PP (TO to) (NP (NP (NP (DT the) (JJ immune) (NN response)) (PP (IN of) (NP (NN IgM) (JJ sufficient) (NNS mice)))) (CD -LSB-10-13) (-RRB- -RSB-) (S (ADVP (RB Interestingly)) (, ,) (NP (NNS pathogens)) (VP (ADVP (RBR more) (RB readily)) (VP (VB disseminate) (PP (IN into) (NP (JJ vital) (NNS organs))) (PP (IN in) (NP (JJ secreted) (JJ IgM-deficient) (NNS mice)))) (, ,) (CONJP (RB rather) (IN than)) (VP (VB concentrate) (NP (PRP them)) (PP (IN into) (NP (JJ secondary) (JJ lymphoid) (NNS organs)))))) (NP (NN -LSB-14)) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (DT This)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (DT an) (JJ important) (NN role)) (PP (IN for) (NP (NN IgM)))) (VP (VBZ is) (S (VP (TO to) (VP (VB serve) (PP (IN as) (NP (NP (DT an) (NN arbiter)) (PP (IN of) (NP (NN antigen) (NN localization))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB contribute) (PP (TO to) (NP (PRP$ its) (JJ adjuvant) (NN function) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-))))))))))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB investigate) (SBAR (WHADVP (WRB how)) (S (NP (NN IgM)) (VP (VBZ affects) (NP (NP (DT the) (NN localization)) (PP (IN of) (NP (JJ foreign) (NN antigen)))))))))) (, ,) (NP (DT a) (NN system)) (VP (VBD was) (VP (VBN developed) (S (VP (TO to) (VP (VBP follow) (NP (NP (DT the) (NN fate)) (PP (IN of) (NP (NP (NP (JJ IgM-containing) (JJ immune) (NNS complexes)) (PRN (-LRB- -LRB-) (NP (NN IgM-IC)) (-RRB- -RRB-))) (VP (VBG following) (NP (NP (PRP$ their) (JJ intravenous) (-LRB- -LRB-) (NN i.v.) (-RRB- -RRB-) (NN administration)) (S (LST (CD -LSB-7,15) (-RRB- -RSB-)) (NP (NN IgM-IC)) (VP (ADVP (RB first)) (VB localize) (PP (TO to) (NP (NP (NP (DT the) (JJ splenic) (JJ marginal) (NN zone)) (PRN (-LRB- -LRB-) (NP (JJ MZ)) (-RRB- -RRB-))) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (PRP they)) (VP (VP (VBP are) (VP (VBN phagocytized) (PP (IN by) (NP (JJ MZ) (NNS macrophages))))) (CC and) (VP (VBP are) (ADVP (RB also)) (VP (VBN bound) (PP (TO to) (NP (JJ MZ) (NN B) (NNS cells))))))))))))))))))))))) (. .)))
( (S (S (NP (NP (NN Binding)) (PP (IN of) (NP (NN IgM-IC))) (PP (TO to) (NP (JJ MZ) (NN B) (NNS cells)))) (VP (VBZ is) (ADJP (ADVP (RB strictly)) (NN complement) (JJ dependent)))) (. .)))
( (S (S (NP (DT The) (JJ MZ) (NN B) (NNS cells)) (ADVP (RB subsequently)) (VP (VBP transport) (NP (NP (DT the) (NN IgM-IC)) (PP (IN into) (NP (NP (DT the) (NN B) (NN cell) (NNS follicles)) (SBAR (WHADVP (WRB where)) (S (NP (PRP they)) (VP (VBP are) (VP (VBN deposited) (PP (IN onto) (NP (NP (JJ follicular) (JJ dendritic) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN FDCs)) (-RRB- -RRB-) (NP (NN -LSB-15)) (-RRB- -RSB-))))))))))))) (. .)))
( (S (NP (NP (DT The) (JJ important) (NN role)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells))) (PP (IN in) (NP (DT this) (NN process)))) (VP (VBD was) (VP (VBN established) (PP (IN by) (S (VP (VBG monitoring) (NP (NP (NN IgM-IC) (NN deposition)) (PP (IN onto) (NP (NNS FDCs))) (PP (IN in) (NP (NP (NNS mice)) (SBAR (WHNP (WDT that)) (S (VP (VBD lacked) (NP (JJ MZ) (NN B) (NNS cells)) (, ,) (PP (CC either) (PP (IN as) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NP (NP (DT a) (JJ genetic) (NN lesion)) (PRN (-LRB- -LRB-) (NP (JJ CD19-deficient) (NNS mice)) (-RRB- -RRB-))) (SBAR (WHNP (WDT that)) (S (VP (VBD inhibited) (NP (JJ MZ) (NN B) (NN cell) (NN survival))))))))) (, ,) (CC or) (PP (IN by) (NP (NP (PRP$ their) (NN depletion)) (VP (VBG using) (NP (NN pertussis) (NN toxin))))))))))))))))) (. .)))
( (S (S (PP (IN In) (NP (DT these) (NNS mice))) (, ,) (NP (NP (JJ little)) (PP (IN if) (NP (DT any) (NN IgM-IC)))) (VP (VBD was) (VP (VBN deposited) (PP (IN onto) (NP (NNS FDCs)))))) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (JJ adoptive) (NN transfer)) (PP (IN of) (NP (NN B) (NNS cells))) (PP (IN with) (NP (NP (VBN bound) (NN IgM-IC)) (PP (IN into) (NP (NNS mice)))))) (VP (VBD led) (PP (TO to) (NP (NP (NN IgM-IC) (NN deposition)) (PP (IN onto) (NP (NNS FDCs))))))) (. .)))
( (S (PP (IN In) (NP (DT these) (NNS mice))) (, ,) (NP (NP (VBN transferred) (JJ MZ) (NN B) (NNS cells)) (PP (IN in) (NP (NP (JJ close) (NN proximity)) (PP (TO to) (NP (NNS FDCs)))))) (VP (VBD were) (VP (VBN found) (S (VP (TO to) (VP (VB have) (NP (NP (NN IgM-IC)) (VP (VP (VBN capped)) (CC and) (VP (VBN directed) (PP (IN toward) (NP (DT the) (NN FDC) (NNS dendrites)))))))))) (, ,) (S (ADVP (RB strongly)) (VP (VBG suggesting) (S (NP (NN IgM-IC)) (VP (VBD was) (VP (VBG being) (VP (VBN transferred) (PP (TO to) (NP (NN FDCs))) (PP (IN by) (NP (JJ MZ) (NN B) (NNS cells) (NP (CD -LSB-15))))))) (-RRB- -RSB-))))) (. .)))
( (S (S (VP (TO To) (ADVP (RB further)) (VP (VB investigate) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells))) (PP (IN in) (NP (NN IgM-IC) (NN transport))))))) (, ,) (NP (PRP we)) (VP (VBD used) (NP (NP (NNS mice)) (ADJP (JJ deficient) (PP (IN in) (NP (NP (NN p50)) (, ,) (NP (NP (DT a) (NN member)) (PP (IN of) (NP (NP (DT the) (JJ NF-κB) (NN family)) (PP (IN of) (NP (NN transcription) (NNS factors) (CD -LSB-16))))) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (DT These) (NNS mice)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB lack) (NP (JJ MZ) (NN B) (NNS cells))))))) (, ,) (S (VP (VBG suggesting) (NP (NP (DT an) (JJ unambiguous) (NN role)) (PP (IN for) (NP (NP (DT this) (NN component)) (PP (IN of) (NP (DT the) (JJ NF-κB) (NN transcription) (NN factor) (NN complex))))) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (DT this) (NN subset)) (PP (IN of) (NP (NN B) (NNS cells) (CD -LSB-17) (-RRB- -RSB-)))))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (S (NP (NP (JJ small) (NNS numbers)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells)))) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (JJ young) (JJ p50-/-) (NNS mice)))))) (, ,) (CC and) (S (NP (DT these) (NNS cells)) (VP (VBP are) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG binding) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NN IgM-IC)))) (ADVP (ADVP (FW in) (FW vivo)) (CC and) (ADVP (FW in) (FW vitro))))))))))))) (. .)))
( (S (S (ADVP (RB Interestingly)) (, ,) (NP (JJ MZ) (NN B) (NNS cells)) (VP (VBD were) (VP (VBN found) (S (VP (TO to) (VP (VB accumulate) (PP (IN with) (NP (NN age))) (PP (IN in) (NP (NP (JJ p50-/-) (NNS mice)) (SBAR (WHPP (IN such) (WHNP (WDT that))) (S (PP (IN by) (NP (CD 6) (NNS months))) (NP (DT a) (JJ normal) (JJ sized) (JJ MZ) (NN B) (NN cell) (NN compartment)) (VP (VBD was) (ADJP (JJ present))))))))))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB also)) (VP (VBD found) (SBAR (IN that) (S (NP (JJ p50-/-) (NNS mice)) (VP (VBD exhibited) (NP (NP (DT an) (VBN accelerated) (NN loss)) (PP (IN of) (NP (NN FDC) (NNS networks)))) (, ,) (SBAR (IN as) (S (VP (VBN assessed) (PP (IN by) (NP (JJ intense) (NN CD21) (NN staining))))))))))) (. .)))
( (S (S (NP (DT These) (NNS data)) (VP (VP (VBP indicate) (SBAR (IN that) (S (NP (JJ MZ) (NN B) (NNS cells)) (VP (MD can) (VP (VB develop) (PP (IN in) (NP (NP (DT the) (JJ complete) (NN absence)) (PP (IN of) (NP (NN p50)))))))))) (, ,) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (JJ transcriptional) (NNS requirements)) (PP (IN for) (NP (NP (DT the) (NP (NN development)) (CC and/or) (NP (NN survival))) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells)))))) (VP (MD might) (VP (VB differ) (PP (IN in) (NP (ADJP (ADJP (JJ young)) (CC and) (ADJP (JJ old))) (NNS mice)))))))))) (. .)))
( (S (NP (NNS Results))))
( (S (S (NP (CD Two) (ADJP (NN month) (JJ old)) (NP (NP (ADJP (ADJP (JJ p50-/-)) (CC or) (ADJP (JJ control))) (NN C57BL/6)) (PRN (-LRB- -LRB-) (NP (NN B6)) (-RRB- -RRB-))) (NNS mice)) (VP (VBD were) (VP (VBN injected) (PP (IN with) (NP (NP (NN IgM-IC)) (CC and) (NP (NP (DT the) (NNS spleens)) (VP (VBN removed) (ADVP (NP (CD 16) (NN h)) (RB later))))))))) (. .)))
( (S (PP (VBN Based) (PP (IN on) (NP (NP (NP (DT the) (VBN reported) (NN lack)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells))) (PP (IN in) (NP (JJ p50-/-) (NNS mice) (CD -LSB-17) (-RRB- -RSB-)))) (CC and) (NP (NP (DT the) (NN requirement)) (PP (IN for) (NP (JJ MZ) (NN B) (NNS cells))) (PP (IN in) (NP (NP (DT the) (NP (NN transport)) (CC and) (NP (NN deposition))) (PP (IN of) (NP (NP (NN IgM-IC)) (PP (IN onto) (NP (NNS FDCs) (CD -LSB-15) (-RRB- -RSB-))))))))))) (, ,) (NP (PRP we)) (VP (VBN expected) (SBAR (IN that) (S (NP (NN IgM-IC)) (VP (MD would) (RB not) (VP (VB be) (VP (VBN found) (ADJP (JJ localized) (PP (IN on) (NP (NN FDCs))) (PP (IN in) (NP (NP (DT the) (JJ splenic) (NNS follicles)) (PP (IN of) (NP (DT these) (NNS mice)))))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NP (NN immunohistochemistry)) (PRN (-LRB- -LRB-) (NP (NN IH)) (-RRB- -RRB-))) (VP (VBD revealed) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN IgM-IC))) (PP (IN on) (NP (NN FDCs)))) (PP (IN in) (NP (NP (JJ p50-/-) (NNS mice)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 1)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NP (DT The) (NN amount)) (PP (IN of) (NP (NN IgM-IC))) (VP (VBN localized) (PP (IN in) (NP (NP (DT the) (NN spleen) (NNS follicles)) (PP (IN of) (NP (JJ p50-/-) (NNS mice))))))) (VP (VBD was) (ADJP (ADJP (RB substantially) (JJR less)) (PP (IN than) (PP (IN in) (NP (NN control) (NN B6) (NNS mice))))) (, ,) (CC but) (ADVP (RB none-the-less)) (ADJP (RB readily) (JJ detectable)))) (. .)))
( (S (NP (DT These) (NNS results)) (VP (MD could) (VP (VB indicate) (NP (NP (DT either)) (SBAR (WHNP (WDT that)) (S (S (NP (NN IgM-IC)) (VP (MD can) (VP (VBP traffic) (PP (TO to) (NP (NN FDCs))) (PP (IN by) (NP (NP (DT a) (ADJP (RB previously) (JJ unanticipated)) (NN mechanism)) (ADJP (JJ independent) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells))))))))) (, ,) (CC or) (S (NP (JJ p50-/-) (NNS mice)) (VP (MD may) (VP (VB possess) (NP (NP (JJ small) (NNS numbers)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells))) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB still)) (ADJP (JJ functional) (PP (IN for) (S (VP (VBG transporting) (NP (NN IgM-IC)) (PP (IN into) (NP (NNS follicles))))))))))))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB help) (S (VP (VB discriminate) (PP (IN between) (NP (DT these) (NNS alternatives)))))))) (, ,) (NP (NP (JJ splenic) (NN B) (NNS cells)) (PP (IN from) (NP (JJ p50-/-) (NNS mice)))) (VP (VBD were) (VP (VBN analyzed) (PP (IN for) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells))))) (PP (IN by) (NP (NN FACS)))))) (. .)))
( (S (S (NP (JJ MZ) (NN B) (NNS cells)) (VP (MD can) (VP (VB be) (ADVP (RB phenotypically)) (VP (VBN distinguished) (PP (IN from) (NP (NP (JJ other) (NN B) (NN cell) (NNS subsets)) (PP (IN in) (NP (DT the) (NN spleen))))) (PP (VBN based) (PP (IN on) (NP (NP (NNP CD21/23) (CD -LSB-18,19) (-RRB- -RSB-)) (CC and) (NP (NNP B220/CD1d) (CD -LSB-20,21) (-RRB- -RSB-))))))))) (. .)))
( (S (NP (NP (NNS profiles)) (. .))))
( (S (S (SBAR (IN As) (S (VP (VBN shown) (PP (IN in) (NP (NN Figure) (CD 2)))))) (, ,) (NP (JJ MZ) (NN B) (NNS cells)) (VP (VBD were) (, ,) (SBAR (IN as) (S (VP (VBN expected) (NP (CD -LSB-17) (-RRB- -RSB-))))) (, ,) (VP (ADVP (RB severely)) (VBN reduced) (PP (IN in) (NP (JJ p50-/-) (NNS mice)))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NP (JJ small) (NNS numbers)) (PP (IN of) (NP (NN B) (NNS cells)))) (VP (VBP fell) (PP (IN within) (NP (DT the) (NP (NNP CD21hi/CD23lo)) (CC and) (NP (NNP B220+/CD1dhi)) (NP (NNS gates)))) (, ,) (PP (IN at) (NP (NP (CD ~10) (NN %)) (PP (IN of) (NP (NP (DT the) (NN frequency)) (VP (VBN found) (PP (IN in) (NP (NP (DT the) (NN B) (NN cell) (NN compartment)) (PP (IN of) (NP (NN control) (NN B6) (NNS mice)))))))))))) (. .)))
( (S (S (S (S (VP (TO To) (VP (VB determine) (SBAR (IN if) (S (NP (DT these) (JJ MZ) (NN B) (NNS cells)) (VP (MD could) (VP (VB bind) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NN IgM-IC))))))))))) (, ,) (NP (NP (NN spleen) (NNS cells)) (PP (IN from) (NP (NP (NNS mice)) (SBAR (WHNP (WDT that)) (S (VP (VBD had) (VP (VBN been) (VP (VBN injected) (ADVP (NP (CD 1) (NN h)) (RBR earlier)))))))))) (VP (VBD were) (VP (VBN isolated)))) (CC and) (S (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN IgM-IC))) (PP (IN on) (NP (NN B) (NN cell) (NNS subsets)))) (VP (VBD was) (VP (VBN determined) (PP (IN by) (NP (NN FACS))))))) (. .)))
( (S (SBAR (WHADVP (WRB When)) (S (NP (NN IgM-IC)) (VP (VBD were) (VP (VBN injected) (PP (IN into) (NP (NN B6) (NNS mice))))))) (, ,) (NP (DT the) (NNS complexes)) (VP (VBD were) (VP (VBN found) (S (VP (VBN associated) (PP (IN with) (NP (NP (JJ MZ) (NN B) (NNS cells)) (PP (IN at) (NP (NP (JJ high) (NNS levels)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2A)) (-RRB- -RRB-))))))))) (, ,) (SBAR (IN as) (S (VP (VBN expected) (PP (IN from) (NP (NP (NP (NP (PRP$ their) (JJ high) (NN level) (NN expression)) (PP (IN of) (NP (DT the) (NN complement) (NN receptor) (NN CR2) (-LRB- -LRB-) (NN CD21) (-RRB- -RRB-)))) (CC and) (NP (NP (NN localization)) (PP (IN at) (NP (DT the) (JJ marginal) (NN sinus))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ facilitates) (NP (NP (NN exposure)) (PP (TO to) (NP (NN blood-borne) (NN IgM-IC) (CD -LSB-15) (-RRB- -RSB-))))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (JJ little)) (PP (IN if) (NP (NP (DT any)) (PP (IN of) (NP (DT the) (NN IgM-IC)))))) (VP (VBD were) (ADJP (JJ present) (PP (IN on) (NP (JJ follicular) (-LRB- -LRB-) (NN FO) (-RRB- -RRB-) (NN B) (NNS cells)))))) (. .)))
( (S (S (PP (IN In) (NP (JJ p50-/-) (NNS mice))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (JJ discernable) (NN binding)) (PP (IN of) (NP (NN IgM-IC))) (PP (TO to) (NP (NP (JJ MZ) (NN B) (NNS cells)) (PRN (-LRB- -LRB-) (ADVP (RB as)) (VP (VBN defined) (PP (IN by) (NP (NP (DT a) (NN shift)) (PP (IN in) (NP (DT the) (NN FACS) (NN profile)))))) (-RRB- -RRB-))))) (SBAR (IN while) (S (, ,) (SBAR (IN as) (S (VP (VBN seen) (PP (IN in) (NP (NN B6) (NNS mice)))))) (, ,) (NP (NN IgM-IC)) (VP (VBD did) (RB not) (VP (VB bind) (PP (TO to) (NP (NP (NN FO) (NN B) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2A)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (DT the) (NNS cells)) (PP (IN in) (NP (NP (DT the) (NN CD21hi) (NN gate)) (PP (IN in) (NP (JJ p50-/-) (NNS mice)))))) (VP (VBD were) (NP (JJ authentic) (JJ MZ) (NN B) (NNS cells))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB confirm) (NP (DT this))))) (, ,) (NP (NP (DT the) (NN capacity)) (PP (IN of) (NP (DT these) (NNS cells))) (S (VP (TO to) (VP (VB bind) (NP (NN IgM-IC)))))) (VP (VBD was) (VP (VBN determined) (S (VP (VBG using) (NP (NP (ADJP (FW in) (FW vitro)) (NN binding) (NNS assays)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2B)) (-RRB- -RRB-)))))))) (. .)))
( (S (SBAR (WHADVP (WRB When)) (S (NP (JJ p50-/-) (NN B) (NNS cells)) (VP (VBD were) (VP (VBN incubated) (PP (IN with) (NP (NN IgM-IC))) (ADVP (FW in) (FW vitro)))))) (, ,) (NP (JJ MZ) (NN B) (NNS cells)) (VP (VBD bound) (NP (NP (JJR higher) (NNS levels)) (PP (IN of) (NP (NN IgM-IC)))) (SBAR (IN than) (SINV (VBD did) (NP (NP (NN FO) (NN B) (NNS cells)) (PRN (-LRB- -LRB-) (NP (QP (CD 3) (TO to) (CD 5)) (NNS times) (SBAR (IN as) (S (VP (VBN assessed) (PP (IN by) (NP (NN mean) (NN fluorescence) (NN intensity))))))) (-RRB- -RRB-))))) (, ,) (S (ADJP (JJ similar) (PP (TO to) (NP (NP (NNS results)) (VP (VBG using) (NP (NN B) (NNS cells)) (PP (IN from) (NP (NN B6) (NNS mice))))))))) (. .)))
( (S (S (VP (VB Note) (SBAR (IN that) (S (NP (NP (DT the) (NNS spleens)) (PP (IN of) (NP (JJ p50-/-) (NNS mice)))) (VP (VBP contain) (NP (NP (DT an) (VBN increased) (NN number)) (PP (IN of) (NP (NN CD21loCD23lo) (NN B) (NNS cells)))) (PRN (-LRB- -LRB-) (NP (NNP Fig.)) (NP (NN 2A)) (: ;) (S (VP (VB see) (ADVP (RB also)) (NP (NP (NNP Fig.)) (NP (NN 3A))))) (-RRB- -RRB-))))))) (. .)))
( (S (S (ADVP (IN While)) (NP (PRP we)) (VP (VBP have) (RB not) (VP (VBN explored) (NP (NP (DT the) (NN identity)) (PP (IN of) (NP (DT these) (NNS cells))) (PP (IN in) (NP (NN detail))))))) (. .)))
( (S (S (NP (PRP they)) (VP (VBP are) (ADJP (JJ likely) (S (VP (TO to) (VP (VB reflect) (NP (NP (VBN increased) (NNS numbers)) (PP (IN of) (NP (JJ immature) (`` ``) (JJ transitional) (NN '') (NN B) (NN cell) (NNS subsets)))) (, ,) (SBAR (IN since) (S (NP (NP (DT the) (NN number)) (PP (IN of) (NP (JJ AA4.1+) (NN B) (NNS cells)))) (LST (CD -LSB-22) (-RRB- -RSB-)) (PP (IN in) (NP (NP (DT the) (NNS spleens)) (PP (IN of) (NP (DT these) (NNS mice))))) (VP (VBP are) (VP (VBN increased) (PRN (-LRB- -LRB-) (NP (RB up) (TO to) (RB 2-fold)) (-RRB- -RRB-)) (PP (IN over) (NP (NP (DT those)) (PP (IN in) (NP (JJ age-matched) (NN control) (NN B6) (NNS mice))))))))))))))) (. .)))
( (S (S (SBAR (IN As) (S (VP (VBN expected) (PP (IN from) (NP (NP (PRP$ their) (JJ low) (NNS levels)) (PP (IN of) (NP (NN CD21)))))))) (, ,) (ADVP (RB however)) (, ,) (NP (NP (DT this) (NN population)) (PP (IN of) (NP (NNS cells)))) (VP (VBZ does) (RB not) (VP (VB bind) (NP (NN IgM-IC)) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (JJ MZ) (NN B) (NNS cells)) (VP (MD can) (VP (VB be) (VP (VBN distinguished) (PP (IN as) (NP (NP (NN IgMhi) (NN B) (NNS cells)) (VP (VBN positioned) (ADVP (IN outside) (PP (IN of) (NP (DT the) (JJ marginal) (NN sinus))))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (DT the) (JJ MZ) (NN B) (NNS cells)) (PP (IN in) (NP (JJ p50-/-) (NNS mice)))) (VP (VBD were) (VP (VBN positioned) (ADVP (RB correctly)) (PP (IN around) (NP (NP (DT the) (JJ marginal) (NN sinus)) (PP (IN of) (NP (DT the) (NN spleen)))))))))))) (, ,) (NP (NP (NN immunofluorescence)) (PRN (-LRB- -LRB-) (PP (IN IF)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN performed) (PP (IN on) (NP (NN spleen) (NNS sections))) (S (VP (VBG using) (NP (NP (NP (NN anti-IgM)) (CC and) (NP (NN anti-MOMA-1))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VP (NNS stains) (NP (JJ marginal) (NN metallophilic) (NNS macrophages))) (CC and) (VP (VBZ delineates) (NP (DT the) (JJ MZ) (NN -LSB-23))))))))))) (-RRB- -RSB-)) (. .)))
( (S (S (PP (IN In) (NP (NN control) (NN B6) (NNS mice))) (, ,) (NP (NP (NN IgMhi) (NNS cells)) (PRN (-LRB- -LRB-) (PP (IN in) (NP (JJ red))) (-RRB- -RRB-))) (VP (VBD were) (ADJP (JJ present) (PP (IN in) (NP (DT the) (JJ MZ)))) (, ,) (PP (IN outside) (PP (IN of) (NP (NP (DT the) (JJ MOMA-1+) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2C)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NN IgMhi) (JJ MZ) (NN B) (NNS cells)) (VP (VBD were) (ADVP (RB also)) (VP (VBN found) (PP (IN outside) (IN of) (NP (DT the) (NN MOMA-1) (NN ring))) (PP (PP (IN in) (NP (JJ p50-/-) (NNS mice))) (, ,) (CC but) (PP (IN in) (NP (VBN reduced) (NNS numbers))))) (, ,) (SBAR (IN as) (S (VP (VBN expected) (PP (IN from) (NP (NP (DT the) (JJ drastic) (NNS reductions)) (PP (IN in) (NP (NP (JJ MZ) (NN B) (NNS cells)) (PP (IN in) (NP (NP (DT these) (NNS mice)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2A)) (-RRB- -RRB-))))))))))))) (. .)))
( (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (NP (DT these) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (JJ p50-/-) (NNS mice)) (VP (VBP contain) (NP (NP (JJ small) (NNS numbers)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells))) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB correctly)) (ADJP (JJ positioned) (PP (IN around) (NP (NP (DT the) (JJ marginal) (NN sinus)) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (PRP they)) (VP (MD can) (VP (VP (NN encounter) (NP (NN blood-borne) (NN IgM-IC))) (CC and) (VP (VBP transport) (NP (PRP them)) (PP (IN into) (NP (JJ splenic) (NNS follicles))) (PP (IN for) (NP (NP (NN deposition)) (PP (IN onto) (NP (NNS FDCs))))))))))))))))))))) (. .)))
( (S (S (SBAR (WHADVP (WRB When)) (S (NP (JJR older) (JJ p50-/-) (NNS mice)) (VP (VBD were) (VP (VBN analyzed) (PP (IN for) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells))))))))) (, ,) (NP (NP (VBN increased) (NNS frequencies)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells)))) (VP (VBD were) (VP (VBN detected)))) (. .)))
( (S (S (PP (IN At) (NP (NP (CD 4) (NNS months)) (PP (IN of) (NP (NN age))))) (, ,) (NP (DT some) (JJ p50-/-) (NNS mice)) (VP (VBD contained) (NP (NP (VBN increased) (NNS numbers)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells)))) (, ,) (SBAR (IN whereas) (S (NP (NNS others)) (VP (VBD did) (RB not)))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (DT these) (NNS cells)) (VP (MD might) (VP (VB be) (VP (VBG emerging) (PP (IN around) (NP (DT this) (NN time) (NN period))) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (PP (IN By) (NP (NP (CD 6) (NNS months)) (PP (IN of) (NP (NN age))))) (, ,) (NP (DT a) (ADJP (RB phenotypically) (JJ distinct)) (JJ MZ) (NN B) (NN cell) (NN population)) (VP (VBD was) (VP (VBN detected) (PP (IN in) (NP (NP (DT all)) (PP (IN of) (NP (NP (DT the) (QP (JJR more) (IN than) (CD 10)) (NNS mice)) (VP (VBN analyzed)))))) (, ,) (SBAR (IN as) (S (VP (VBN determined) (PP (IN by) (NP (DT the) (NN CD21/23) (NN profile))))))))) (. .)))
( (S (S (PP (IN In) (NP (DT these) (NNS mice))) (, ,) (NP (JJ MZ) (NN B) (NNS cells)) (VP (VBD were) (ADJP (JJ present)) (PP (IN at) (NP (NP (NNS frequencies)) (ADJP (JJ comparable) (PP (TO to) (NP (NP (DT those)) (VP (VBN found) (PP (IN in) (NP (NP (NN B6) (NNS mice)) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (NN 3A)) (, ,) (NP (JJ left) (NNS panels))) (-RRB- -RRB-)))))))))) (, ,) (SBAR (IN although) (S (NP (NP (DT the) (JJ total) (NN number)) (PP (IN of) (NP (JJ splenic) (NN B) (NNS cells)))) (VP (VBD did) (RB not) (VP (VB appear) (S (VP (TO to) (VP (VB change)))))))))) (. .)))
( (S (PP (IN At) (NP (NP (DT all) (NNS ages)) (VP (VBN tested)))) (, ,) (S (S (NP (ADJP (ADJP (JJ p50-/-)) (CC and) (ADJP (JJ B6))) (NNS mice)) (VP (VBD had) (NP (NP (JJ similar) (NNS frequencies)) (PP (IN of) (NP (NP (NN T) (CC and) (NN B) (NNS cells)) (PP (IN in) (NP (PRP$ their) (NNS spleens)))))))) (, ,) (CC and) (S (NP (PRP$ their) (NN spleen) (NNS sizes)) (VP (VBD were) (ADVP (RB also)) (ADJP (ADJP (JJ similar)) (PRN (-LRB- -LRB-) (NP (JJ unpublished) (NNS results)) (-RRB- -RRB-))))) (, ,) (CC and) (S (NP (NP (DT the) (NN cellularity)) (PP (IN of) (NP (NP (DT the) (NNS spleens)) (PRN (-LRB- -LRB-) (S (S (ADVP (RB as)) (VP (VBN determined) (PP (IN by) (NP (NN IH))))) (: ;) (S (VP (VB see) (PP (IN for) (NP (NN example) (NP (NNP Fig.) (NN 5B))))))) (-RRB- -RRB-))))) (VP (VBD were) (ADVP (RB also)) (ADJP (JJ similar)) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (DT the) (VBN increased) (NN number)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells)))) (VP (VBD was) (ADJP (JJ selective) (PP (IN for) (NP (NP (DT this) (NN subset)) (PP (IN of) (NP (NNS cells)))))))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB confirm) (NP (NP (DT the) (JJ phenotypic) (NN identity)) (PP (IN of) (NP (DT the) (JJ CD21hi/CD23lo) (NN B) (NNS cells)))) (PP (IN as) (NP (JJ MZ) (NN B) (NNS cells)))))) (, ,) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (JJ other) (NNS markers)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells))) (, ,) (PP (VBG including) (NP (NP (NN CD1d) (CD -LSB-20) (-RRB- -RSB-)) (CC and) (NP (NN CD9) (CD -LSB-24) (-RRB- -RSB-)))) (, ,)))) (VP (VBD was) (VP (VBN assessed)))) (. .)))
( (S (S (SBAR (IN As) (S (VP (VBN shown) (PP (IN in) (NP (NN Figure) (CD 4A)))))) (, ,) (NP (NP (NNS populations)) (PP (IN of) (NP (NN B220+) (NN B) (NNS cells))) (PP (IN with) (NP (NP (NNP CD1dhi)) (CC and) (NP (NNP CD9hi)) (NP (NNS phenotypes))))) (VP (VBD were) (ADJP (JJ present) (PP (IN in) (NP (JJ p50-/-) (NNS mice)))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells))))))))) (. .)))
( (S (S (NP (NP (DT The) (NNS frequencies)) (PP (IN of) (NP (DT these) (NNS cells)))) (VP (VBD were) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT those)) (PP (IN in) (NP (JJ aged-matched) (NN control) (NN B6) (NNS mice)))))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB also)) (VP (VBD assessed) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NN IgM)))) (PP (IN on) (NP (DT the) (JJ CD21hiCD23lo) (NNS cells))) (, ,) (SBAR (IN since) (S (NP (JJ MZ) (NN B) (NNS cells)) (VP (VBP express) (NP (NP (JJR higher) (NNS levels)) (PP (IN of) (NP (NN IgM)))) (PP (VBN compared) (PP (IN with) (NP (CD FO) (NN B) (NNS cells) (CD -LSB-25) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (NP (JJ MZ) (NN B) (NNS cells)) (PP (IN from) (NP (JJ p50-/-) (NNS mice)))) (ADVP (RB clearly)) (VP (VBD expressed) (NP (NP (JJR higher) (NNS levels)) (PP (IN of) (NP (NN IgM)))) (PP (PP (IN than) (PP (IN on) (NP (NP (NN FO) (NN B) (NNS cells)) (PP (IN from) (NP (DT these) (JJ same) (NNS mice)))))) (, ,) (CC and) (PP (IN at) (NP (NP (NNS levels)) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT those)) (PP (IN in) (NP (NP (NN control) (NNS mice)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 4B)) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (NP (DT These) (NN B) (NNS cells)) (VP (VBD were) (ADVP (RB also)) (ADJP (JJ positioned) (PP (IN within) (NP (NP (DT the) (JJ MZ)) (PP (IN in) (NP (NP (JJ p50-/-) (NNS mice)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 4C)) (-RRB- -RRB-))))))) (, ,) (SBAR (IN as) (S (VP (VBN indicated) (PP (IN by) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (JJ IgM+) (NNS cells)) (ADJP (JJ outside) (PP (IN of) (NP (DT the) (JJ marginal) (NN sinus)))))))) (SBAR (IN as) (S (VP (VBN revealed) (PP (IN by) (NP (NN laminin) (NN staining) (CD -LSB-26) (-RRB- -RSB-))))))))))) (. .)))
( (S (S (PP (IN As) (NP (JJ further) (NN evidence) (SBAR (IN that) (S (NP (DT the) (VBG accumulating) (NNS cells)) (VP (VBD were) (NP (JJ functional) (JJ MZ) (NN B) (NNS cells))))))) (, ,) (NP (NNS cells)) (VP (VBD were) (VP (VBN tested) (PP (IN for) (NP (PRP$ their) (NN capacity) (S (VP (TO to) (VP (VB bind) (NP (NN IgM-IC)) (ADVP (ADVP (FW in) (FW vivo)) (CC and) (ADVP (FW in) (FW vitro))))))))))) (. .)))
( (S (S (NP (NP (JJ MZ) (NN B) (NNS cells)) (PP (PP (IN from) (NP (ADJP (CD 2) (CC and) (CD 6) (NN month)) (JJ old) (NN B6) (NNS mice))) (CC or) (PP (IN from) (NP (ADJP (CD 6) (NN month)) (JJ old) (JJ p50-/-) (NNS mice))))) (VP (VBD had) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NP (NN IgM-IC)) (VP (VBN bound) (PP (VBG following) (NP (NN i.v.))))))))) (. .)))
( (S (S (S (NP (NN injection))) (, ,) (IN whereas) (S (NP (NN FO) (NN B) (NNS cells)) (VP (VBD bound) (NP (NP (ADJP (JJ little))) (CC or) (NP (DT no)) (NP (NP (JJ IgM-IC)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3A)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (DT An) (ADJP (FW in) (FW vitro)) (NN binding) (NN assay)) (ADVP (RB also)) (VP (VBD demonstrated) (NP (NP (DT the) (NN capacity)) (PP (IN of) (NP (NP (DT the) (JJ MZ) (NN B) (NNS cells)) (PP (IN from) (NP (JJ p50-/-) (NNS mice))))) (S (VP (TO to) (VP (VB bind) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NN IgM-IC)))) (PP (VBN compared) (PP (TO to) (NP (NP (NN FO) (NN B) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3B)) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (NP (DT the) (NNS data)) (VP (VBP demonstrate) (SBAR (IN that) (S (SBAR (IN while) (S (NP (JJ few) (JJ MZ) (NN B) (NNS cells)) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (JJ young) (JJ p50-/-) (NNS mice))))))) (, ,) (NP (PRP they)) (VP (VP (VBP do) (VP (VB develop))) (CC and) (VP (VBP accumulate) (PP (IN with) (NP (NP (NN age)) (, ,) (NP (NP (JJ such)) (SBAR (IN that) (S (PP (IN by) (NP (CD 6) (NNS months))) (NP (PRP they)) (VP (VP (VBP have) (VP (VBN reached) (NP (JJ normal) (NNS levels)))) (CC and) (VP (MD can) (ADVP (RB functionally)) (VP (VB bind) (NP (NN IgM-IC)) (PP (IN at) (NP (JJ high) (NNS levels))) (, ,) (SBAR (IN as) (S (VP (MD would) (VP (VB be) (VP (VBN expected) (PP (IN from) (NP (NP (PRP$ their) (VBN increased) (NN expression)) (PP (IN of) (NP (NP (NN CR1/2)) (PRN (-LRB- -LRB-) (NP (NN CD21/35)) (-RRB- -RRB-)))))))))))))))))))))))) (. .)))
( (S (S (PP (IN In) (NP (DT an) (NN effort) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (DT the) (NN repopulation)) (PP (IN of) (NP (JJR older) (JJ p50-/-) (NNS mice))) (PP (IN with) (NP (JJ MZ) (NN B) (NNS cells)))) (VP (VBD enabled) (NP (JJ efficient) (NN IgM-IC) (NN trapping)))))))))) (, ,) (NP (NNS mice)) (VP (VBD were) (VP (VP (VBN injected) (PP (IN with) (NP (NN IgM-IC)))) (CC and) (VP (VBN analyzed) (PP (IN for) (NP (NN FDC) (NN deposition))))))) (. .)))
( (S (PP (IN Despite) (NP (NP (DT the) (JJ normal) (NNS levels)) (CC and) (NP (NP (NN positioning)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells)))))) (, ,) (NP (DT no) (NN IgM-IC) (NN deposition)) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NP (DT the) (NNS spleens)) (PP (IN of) (NP (NP (ADJP (NP (CD 6) (NN month)) (JJ old)) (JJ p50-/-) (NNS mice)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 5A)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (DT The) (NN failure)) (PP (IN of) (NP (DT the) (NN IgM-IC))) (S (VP (TO to) (VP (VB localize) (PP (IN in) (NP (NP (DT the) (NNS follicles)) (PP (IN of) (NP (DT these) (NNS mice))))))))) (VP (MD could) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN FDCs))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (SBAR (IN as) (S (VP (VBN shown) (PP (IN in) (NP (NN Figure) (NN 5B)))))) (, ,) (NP (NNS FDCs)) (VP (VBD were) (ADJP (JJ present) (PP (IN in) (NP (DT these) (NNS mice)))) (, ,) (SBAR (IN as) (S (VP (VBN assessed) (PP (IN by) (NP (NN CD21) (NN staining)))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (PRP they)) (VP (VBD appeared) (S (VP (TO to) (VP (VB be) (ADJP (ADJP (RB much) (JJR smaller)) (CC and) (ADJP (NP (DT the) (NNS dendrites)) (RBR less) (JJ pronounced)) (PP (IN than) (PP (IN in) (NP (JJ age-matched) (NN B6) (NNS mice))))) (, ,) (ADJP (RB as) (JJ evident) (PP (IN from) (NP (NP (DT the) (VBN diminished) (NN area)) (PP (IN of) (NP (NP (JJ intense) (NN CD21) (NN staining)) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (NN 5B)) (, ,) (NP (JJ right) (NNS panels))) (: ;) (S (VP (VB see) (NP (NNS arrows)))) (-RRB- -RRB-)))))))))))) (. .)))
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NNS follicles)) (PP (IN with) (NP (JJ intense) (NN CD21) (NN staining)))))) (VP (VBD was) (VP (VBN reduced) (PP (IN in) (NP (DT the) (ADJP (CD 6) (NN month)) (JJ old) (JJ p50-/-) (NNS mice))) (PP (VBN compared) (PP (IN with) (NP (NP (ADJP (NN age) (JJ matched)) (NN B6) (NNS mice)) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (NN 5B)) (, ,) (NP (NP (CD 4×) (NN view)) (PP (IN in) (NP (JJ left) (NNS panels))))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NP (NNS FDCs)) (PP (IN from) (NP (JJ p50-/-) (NNS mice))))) (S (VP (TO to) (VP (VBP retain) (NP (NN complement) (NNS fragments)))))) (VP (MD might) (VP (VB be) (VP (VBN diminished) (PP (IN at) (NP (NP (CD 6) (NNS months)) (PP (IN of) (NP (NN age)))))))))))) (. .)))
( (S (ADVP (RB Interestingly)) (, ,) (NP (CD 6) (NN month) (JJ old) (NN B6) (NNS mice)) (ADVP (RB also)) (VP (VBD exhibited) (NP (DT some) (VBN reduced) (NN capacity) (S (VP (TO to) (VP (VB trap) (NP (NP (NP (NN IgM-IC)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 5A)) (-RRB- -RRB-))) (CC and) (NP (ADJP (RB slightly) (VBN reduced)) (NN CD21) (NN staining))) (PP (VBN compared) (PP (IN with) (NP (NP (JJR younger) (NNS mice)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 5B)) (-RRB- -RRB-))))))))) (, ,) (S (VP (VBG suggesting) (NP (NP (DT a) (NN loss)) (PP (IN of) (NP (NN FDC) (NN function)))) (VP (MD may) (ADVP (RB also)) (VP (VB be) (VP (VBG occurring) (ADVP (RB naturally)) (PP (IN with) (NP (NN age))))) (, ,) (PP (IN as) (NP (ADJP (RB previously) (VBN observed)) (NN -LSB-27))) (-RRB- -RSB-))))) (. .)))
( (S (S (ADJP (JJ Consistent) (PP (IN with) (NP (DT this))))) (, ,) (NP (NP (NNS FDCs)) (PP (IN in) (NP (NP (ADJP (CD 6) (NN month)) (JJ old) (NN p50-/-)) (CC and) (NP (NN B6) (NNS mice))))) (VP (MD could) (RB not) (VP (VB be) (VP (VBN detected) (PP (IN by) (NP (NP (NN FDC-M2) (NN staining)) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))) (, ,) (PP (IN in) (NP (NP (NN contrast)) (PP (IN with) (NP (NP (JJR younger) (NNS mice)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 1)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (NN FDC-M2)) (VP (VBZ is) (NP (NP (DT a) (NN FDC) (JJ specific) (NN antibody) (CD -LSB-28) (-RRB- -RSB-)) (SBAR (WHNP (WDT that)) (S (VP (VBZ detects) (NP (NP (DT the) (NN complement) (NN component) (NN C4)) (PP (IN on) (NP (NN FDCs) (CD -LSB-29))))) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (DT The) (NNS data)) (VP (VBP indicate) (S (NP (NP (DT the) (NN loss)) (PP (IN of) (NP (NN FDC) (NN function)))) (VP (MD may) (VP (VB be) (VP (VBN accelerated) (PP (IN in) (NP (NP (NNS mice)) (VP (VBG lacking) (NP (NN p50))))))))))) (. .)))
( (S (ADVP (RB Together)) (, ,) (NP (DT the) (NNS data)) (VP (VBP imply) (SBAR (IN that) (S (NP (NP (DT the) (NN lack)) (PP (IN of) (NP (NP (NN FDC) (NN localization)) (PP (IN of) (NP (NN IgM-IC))))) (PP (IN in) (NP (ADJP (CD 6) (NN month)) (JJ old) (JJ p50-deficient) (NNS mice)))) (VP (VP (VBZ is) (RB not) (ADJP (JJ due) (PP (TO to) (NP (NP (JJ functional) (NN inactivity)) (PP (IN of) (NP (NP (DT the) (JJ MZ) (NN B) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (VP (VBN accumulated) (PP (IN in) (NP (DT these) (NNS mice))))))))))))) (, ,) (CC but) (VP (VBZ reflects) (NP (NP (DT a) (NN loss)) (PP (IN of) (NP (NP (NN FDCs)) (CC and/or) (NP (NN FDC) (NN function)))) (PP (IN by) (NP (DT this) (NN age))))))))) (. .)))
( (S (NP (NN Discussion))))
( (S (NP (PRP$ Our) (NNS data)) (VP (VBP demonstrate) (SBAR (IN that) (S (SBAR (IN while) (S (NP (JJ NF-κB) (JJ p50-/-) (NNS mice)) (VP (VBP are) (ADVP (RB clearly)) (ADJP (JJ deficient) (PP (IN in) (NP (JJ MZ) (NN B) (NNS cells))) (PP (IN for) (NP (NP (DT the) (JJ first) (CD 2) (NNS months)) (PP (IN of) (NP (NN life))))))))) (, ,) (NP (JJ MZ) (NN B) (NNS cells)) (VP (VBP appear) (PP (IN with) (NP (NN age))) (, ,) (SBAR (JJ such) (IN that) (S (PP (IN by) (NP (CD 6) (NNS months))) (NP (DT a) (JJ normal) (JJ splenic) (JJ MZ) (NN B) (NN cell) (NN compartment)) (VP (VBZ has) (VP (VBN been) (VP (VBN reconstituted)))))))))) (. .)))
( (S (S (NP (EX There)) (VP (VBP are) (NP (NP (QP (IN at) (JJS least) (CD four)) (ADJP (ADJP (JJ distinct)) (CC but) (ADJP (RB not) (RB mutually) (JJ exclusive))) (NNS mechanisms)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB account) (PP (IN for) (NP (NP (DT the) (JJ late) (NN appearance)) (PP (IN of) (NP (NNS cells))) (PP (IN within) (NP (NP (DT the) (JJ MZ)) (PP (IN of) (NP (JJ p50-/-) (NNS mice)))))))))))))) (. .)))
( (S (S (ADVP (RB First)) (, ,) (NP (DT these) (NN B) (NNS cells)) (VP (MD could) (VP (VB be) (NP (NP (NN memory) (NN B) (NNS cells)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB accumulate) (PP (IN in) (NP (DT the) (JJ MZ) (NN -LSB-30)))))))))))))) (-RRB- -RSB-)) (. .)))
( (S (S (SBAR (IN While) (S (NP (PRP we)) (VP (VBP cannot) (ADVP (RB formally)) (NP (NP (NN rule)) (PP (IN out) (NP (DT this) (NN possibility))))))) (, ,) (NP (NP (NN B) (NNS cells)) (PP (IN from) (NP (JJ p50-/-) (NNS mice)))) (VP (VBP respond) (ADVP (RB poorly)) (PP (TO to) (NP (JJ antigenic) (NN challenge))) (, ,) (NP (NP (ADJP (RB especially) (JJ T-dependent)) (NNS antigens)) (CD -LSB-16) (-RRB- -RSB-)))) (. .)))
( (S (S (ADVP (RB Consequently)) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ unlikely) (SBAR (IN that) (S (NP (NN memory) (NN B) (NNS cells)) (VP (MD would) (VP (VB be) (VP (VBN generated) (PP (IN in) (NP (DT these) (NNS mice))) (, ,) (ADVP (RB irrespective) (PP (IN of) (NP (PRP$ their) (NN age)))))))))))) (. .)))
( (S (ADVP (RB Alternatively)) (, ,) (NP (NP (DT the) (NN emergence)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells))) (PP (IN in) (NP (JJ p50-/-) (NNS mice)))) (VP (MD could) (VP (VB represent) (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (DT these) (NNS cells)))) (PP (IN through) (NP (JJ homeostatic) (NN proliferation)))) (, ,) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NNS cells)) (VP (VBP proliferate) (PP (TO to) (NP (NN fill) (NNS niches))) (PP (IN in) (NN response) (TO to) (NP (NP (NNS deficits)) (PP (IN in) (NP (NP (JJ specific) (NNS subsets)) (PP (IN of) (NP (NNS cells) (CD -LSB-31)))))))) (-RRB- -RSB-)))) (. .)))
( (S (S (SBAR (IN While) (S (NP (NP (JJ splenic) (NN B) (NNS cells)) (PP (IN from) (NP (JJ p50-/-) (NNS mice)))) (VP (MD will) (VP (VB undergo) (NP (JJ homeostatic) (NN proliferation)) (PP (IN as) (NP (NP (DT a) (NN consequence)) (PP (IN of) (NP (NP (PRP$ their) (NN transfer)) (PP (IN into) (NP (NN SCID) (NNS recipients) (CD -LSB-32) (-RRB- -RSB-))))))))))) (, ,) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NP (DT the) (JJ few) (JJ MZ) (NN B) (NNS cells)) (PP (IN in) (NP (DT the) (JJ p50-/-) (NN donor) (NN spleen))))) (S (VP (TO to) (VP (VB expand) (NP (JJ following) (NN transfer)))))) (VP (VBD was) (RB not) (VP (VBN examined) (NP (NN -LSB-32)))) (-RRB- -RSB-)) (. .)))
( (S (S (ADVP (RB Nevertheless)) (, ,) (NP (PRP we)) (VP (NN view) (S (NP (PRP it)) (ADJP (RB as) (JJ unlikely) (SBAR (IN that) (S (NP (JJ homeostatic) (NN proliferation)) (VP (VBZ accounts) (PP (IN for) (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells))) (PP (IN in) (NP (NP (DT the) (NNS spleens)) (PP (IN of) (NP (JJR older) (JJ p50-/-) (NNS mice))))))) (, ,) (SBAR (IN since) (S (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (NP (NNS cells)) (VP (VBN brought) (PRT (IN on)) (PP (IN by) (NP (JJ homeostatic) (NN proliferation))))))) (VP (VBZ is) (ADVP (RB generally)) (VP (VBN observed) (PP (IN over) (NP (NP (DT a) (ADJP (RB much) (JJR shorter)) (NN period)) (PP (IN of) (NP (NP (NN time)) (, ,) (NP (NP (NNS days)) (PP (TO to) (NP (NP (DT a) (VB couple)) (PP (IN of) (NP (NP (NNS weeks)) (, ,) (CONJP (RB rather) (IN than)) (NP (NP (DT the) (NNS months)) (VP (VBN required) (S (VP (TO to) (VP (VB reconstitute) (NP (JJ MZ) (NN B) (NNS cells)) (PP (IN in) (NP (JJ p50-/-) (NNS mice)))))))))))))))))))))))))))) (. .)))
( (S (S (NP (DT A) (JJ third) (NN possibility)) (VP (VBZ is) (SBAR (IN that) (S (NP (NP (DT a) (JJ NF-κB) (JJ p50-dependent) (NN signal) (NN transduction) (NN pathway)) (SBAR (WHNP (WDT that)) (S (VP (VBZ activates) (NP (NP (DT a) (ADJP (RB developmentally) (VBN required)) (NN transcription) (NN program)) (PP (IN in) (NP (NP (JJ MZ) (NN B) (NNS cells)) (CC or) (NP (PRP$ their) (NNS precursors))))))))) (VP (VBZ is) (VP (VBN overcome) (PP (IN by) (NP (NP (JJ compensatory) (NNS mechanisms)) (PP (IN with) (NP (NN aging))))))))))) (. .)))
( (S (S (NP (JJ NF-κB) (NN p50)) (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NP (NNS pathways)) (ADJP (JJ crucial) (PP (IN for) (NP (NP (NN B) (NN cell) (NN development)) (CC and) (NP (NN maturation))))) (, ,) (PP (VBG including) (NP (NP (NP (NP (NP (NN B) (NN cell) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN BCR)) (-RRB- -RRB-))) (NN signalling)) (CC and) (NP (NP (NNS responses)) (PP (TO to) (NP (NP (NNS members)) (PP (IN of) (NP (DT the) (NN TNF) (NN family)))))) (NP (CD -LSB-33-35) (-RRB- -RSB-) (NN Signal) (NN strength))) (PP (IN through) (NP (DT the) (NN BCR)))))))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN proposed) (S (VP (TO to) (VP (VB be) (NP (NP (DT an) (JJ important) (NN determinant)) (PP (IN of) (NP (NP (NN B) (NN cell) (NN lineage) (NN fate) (NNS decisions)) (, ,) (PP (VBG including) (NP (NP (DT the) (JJ MZ) (NN B) (NN cell) (NN pool)) (S (LST (CD -LSB-36,37) (-RRB- -RSB-)) (NP (NN BAFF) (NN signalling)) (VP (VBZ is) (ADVP (RB also)) (ADJP (JJ important) (PP (IN for) (NP (NP (DT the) (NN selection)) (PP (IN of) (NP (NN B) (NNS cells))) (PP (IN into) (NP (DT the) (JJ MZ) (NN B) (NN cell) (NN pool) (CD -LSB-38) (-RRB- -RSB-)))))) (, ,) (SBAR (IN while) (S (NP (DT an) (JJ intact) (JJ LT-β) (NN R) (NN signalling) (NN pathway)) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (DT the) (JJ proper) (NN positioning)) (PP (IN of) (NP (DT these) (NNS cells) (NP (CD -LSB-39) (-RRB- -RSB-))))))))))))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN accumulation)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells))) (PP (IN in) (NP (JJR older) (JJ p50-/-) (NNS mice)))) (VP (MD could) (VP (VB reflect) (NP (JJ compensatory) (NNS mechanisms)) (PP (IN in) (NP (NP (NP (CD one)) (CC or) (NP (JJR more))) (PP (IN of) (NP (NP (DT these) (NN signal) (NN transduction) (NNS pathways)) (ADJP (JJ important) (PP (IN for) (NP (NP (DT the) (NP (NN emergence)) (CC or) (NP (NN maintenance))) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells))))))))))))) (. .)))
( (S (S (NP (DT A) (JJ fourth) (NN possibility)) (VP (VBZ is) (SBAR (IN that) (S (NP (NP (DT the) (JJ small) (NNS numbers)) (PP (IN of) (NP (NP (JJ MZ) (NN B) (NNS cells)) (SBAR (WHNP (WDT that)) (S (ADVP (RB successfully)) (VP (VB emerge) (PP (IN in) (NP (JJ p50-/-) (NNS mice))))))))) (VP (VBP survive) (PP (IN for) (NP (NP (JJ extended) (NNS periods)) (PP (IN of) (NP (NN time))))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (DT the) (JJ slow) (NN accumulation)) (PP (IN of) (NP (NP (DT this) (NN subset)) (PP (IN of) (NP (NP (NNS cells)) (PP (IN with) (NP (NN age)))))))))))))))) (. .)))
( (S (S (NP (NP (NNP Hao)) (CC and) (NP (NNP Rajewsky) (CD -LSB-40) (-RRB- -RSB-))) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NP (DT the) (NN half-life)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells)))) (VP (VBZ is) (ADJP (JJR greater) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (NP (NN FO) (NN B) (NNS cells)))))))))))) (. .)))
( (S (ADVP (RB Thus)) (, ,) (NP (NP (DT a) (JJ simple) (NN explanation)) (PP (IN for) (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells))) (PP (IN in) (NP (NP (JJ p50-/-) (NNS mice)) (PP (IN with) (NP (NN age)))))))) (VP (VBZ is) (SBAR (IN that) (S (S (NP (DT these) (NNS cells)) (ADVP (RB preferentially)) (VP (VBP survive))) (, ,) (CC and) (S (ADVP (RB thus)) (NP (NP (NP (NP (PRP$ their) (NN frequency)) (ADJP (JJ relative) (PP (TO to) (NP (DT the) (NN FO) (NN B) (NN cell) (NN pool))))) (CC and) (NP (JJ other) (NN B) (NNS cells))) (PP (IN in) (NP (DT the) (NN spleen)))) (VP (VBZ increases) (ADVP (RB slowly)) (PP (IN with) (NP (NN age)))))))) (. .)))
( (S (S (NP (NP (NN B) (NNS cells)) (PP (IN from) (NP (JJ p50-/-) (NNS mice)))) (VP (VP (VBP are) (VP (VBN compromised) (PP (IN in) (NP (PRP$ their) (NN ability) (S (VP (TO to) (VP (VB respond) (PP (TO to) (NP (JJ specific) (NN antigen) (NN challenge)))))))))) (, ,) (CC and) (VP (VBP are) (ADJP (RB completely) (JJ unresponsive) (PP (TO to) (NP (NP (JJ mitogenic) (NNS substances)) (PP (JJ such) (IN as) (NP (NN LPS) (CD -LSB-16)))))))) (-RRB- -RSB-)) (. .)))
( (S (ADVP (RB However)) (, ,) (NP (PRP$ our) (NN data)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (JJ MZ) (NN B) (NNS cells)) (PP (IN from) (NP (JJ p50-/-) (NNS mice)))) (VP (VBP display) (NP (DT some) (NN functionality)) (, ,) (S (VP (VBG including) (NP (NP (NP (DT the) (NP (NN binding)) (, ,) (NP (NN transport)) (CC and) (NP (NN deposition))) (PP (IN of) (NP (NP (NN IgM-IC)) (PP (IN onto) (NP (NNS FDCs)))))) (, ,) (NP (NP (DT a) (NN function)) (ADJP (JJ unique) (PP (TO to) (NP (JJ MZ) (NN B) (NNS cells) (NP (CD -LSB-15)))))))))) (-RRB- -RSB-)))) (. .)))
( (S (S (PP (IN Like) (NP (JJ IgM-containing) (JJ T-dependent) (JJ immune) (NNS complexes))) (, ,) (NP (JJ MZ) (NN B) (NNS cells)) (ADVP (RB also)) (VP (VBP bind) (NP (NN T-independent) (NN type) (CD 2) (-LRB- -LRB-) (NN TI-2) (-RRB- -RRB-) (NNS antigens)) (PP (IN in) (NP (DT a) (NN complement) (CC and) (NN CR1/2-dependent) (NN manner) (CD -LSB-41)))) (-RRB- -RSB-)) (. .)))
( (S (S (S (PP (IN Despite) (NP (DT the) (NN fact) (SBAR (IN that) (S (NP (JJ p50-/-) (NNS mice)) (VP (VBP are) (ADVP (RB widely)) (VP (VBN considered) (S (VP (TO to) (VP (VB be) (ADJP (JJ devoid) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells))))))))))))) (, ,) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (JJ small) (NNS numbers)) (PP (IN of) (NP (DT these) (NN B) (NNS cells))))) (PP (IN in) (NP (JJ p50-/-) (NNS mice)))) (VP (VBD were) (PP (IN in) (NP (NN fact))) (VP (VBN noted) (PP (IN in) (NP (NP (DT the) (JJ initial) (NNS studies)) (PP (IN of) (NP (NP (NNP Pillai)) (CC and) (NP (NNS colleagues))))))))) (, ,) (CC and) (S (NP (DT these)) (VP (VBD appeared) (S (VP (TO to) (VP (VB bind) (NP (NP (JJ low) (NNS levels)) (PP (IN of) (NP (NN TI-2) (NNS antigens) (CD -LSB-17) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NP (JJ further) (NN analysis)) (PP (IN of) (NP (NP (DT the) (NNS consequences)) (PP (IN of) (NP (DT this) (NN binding))) (, ,) (PP (JJ such) (IN as) (NP (NP (DT the) (NN transfer)) (PP (IN of) (NP (JJ immune) (NNS complexes))) (PP (TO to) (NP (NN FDCs))))) (, ,)))) (VP (VBD was) (RB not) (VP (VBN evaluated)))) (. .)))
( (S (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (DT the) (JJ current) (NN study)))) (VP (CONJP (RB not) (RB only)) (VP (VBP extend) (NP (DT these) (JJ previous) (NNS studies))) (, ,) (CC but) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (CD one) (NN consequence)) (PP (IN of) (NP (NP (DT the) (JJ small) (NN amount)) (PP (IN of) (NP (NN IgM-IC) (NN binding)))))) (VP (VBZ manifests) (NP (PRP itself)) (PP (IN by) (NP (NP (DT the) (ADJP (ADJP (JJ limited)) (, ,) (CONJP (CC but) (RB none-the-less)) (ADJP (JJ detectable)) (, ,)) (NN deposition)) (PP (IN of) (NP (DT these) (NNS complexes))) (PP (IN onto) (NP (NNS FDCs))))))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (DT this) (NN function)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells)))) (VP (VBZ is) (ADJP (RB completely) (JJ independent) (PP (IN of) (NP (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN NF-κB)))) (, ,) (NP (NP (QP (IN at) (JJS least) (DT those)) (NNS complexes)) (VP (VBG containing) (NP (NN p50)))))))))))) (. .)))
( (S (NP (DT These) (NNS results)) (VP (VBP extend) (NP (NP (JJ other) (NN evidence)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells))) (PP (IN through) (NP (NP (NN engagement)) (PP (IN of) (NP (DT the) (NN BCR)))))) (VP (MD may) (RB not) (VP (VB be) (VP (VBN required) (PP (IN for) (NP (NP (NP (NN transport)) (CC and) (NP (NN deposition))) (PP (IN of) (NP (NN IgM-IC))))))) (, ,) (SBAR (IN since) (S (NP (NP (JJ MZ) (NN B) (NNS cells)) (PP (IN from) (NP (NP (JJ CD19-deficient) (NNS mice)) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB also)) (VP (VBP have) (NP (NP (NNS deficits)) (PP (IN in) (NP (JJ MZ) (NN B) (NNS cells))))))) (, ,)))) (VP (VBP are) (ADVP (RB also)) (ADJP (JJ functional)) (PP (IN in) (NP (DT this) (NN assay) (NN -LSB-15)))) (-RRB- -RSB-))))))))) (. .)))
( (S (ADVP (RB Together)) (, ,) (NP (DT these) (NNS results)) (VP (VBP raise) (NP (NP (DT the) (NN question)) (PP (IN of) (SBAR (IN whether) (S (NP (JJ MZ) (NN B) (NNS cells)) (VP (VBP require) (NP (NN activating) (NNS signals)) (S (VP (TO to) (VP (VB migrate) (PP (IN into) (NP (NN B) (NN cell) (NNS follicles))) (PP (VBG following) (NP (NP (NN IgM-IC) (NN binding)) (PP (TO to) (NP (NN CR1/2)))))))))))))) (. .)))
( (S (S (NP (JJ MZ) (NN B) (NN cell) (NN migration)) (VP (MD can) (VP (VB be) (VP (VBN detected) (PP (IN in) (NP (NP (CD 1) (NN h) (QP (CC or) (JJR less))) (PP (IN after) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NN IgM-IC) (CD -LSB-15)))))))))) (-RRB- -RSB-)) (. .)))
( (S (NP (NP (DT The) (NN binding)) (PP (IN of) (NP (NN IgM-IC))) (PP (TO to) (NP (DT these) (NNS cells)))) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (NP (NP (CD one)) (CC or) (NP (JJR more))) (PP (IN of) (NP (NP (DT the) (NNS mechanisms)) (VP (VBN proposed) (S (VP (TO to) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (NP (JJ MZ) (NN B) (NN cell) (NN positioning))) (, ,) (S (VP (VBG including) (NP (NP (NP (NN retention)) (PP (IN by) (NP (NNS macrophages))) (PP (IN within) (NP (DT the) (JJ MZ) (NN -LSB-42))) (-RRB- -RSB-)) (, ,) (NP (NP (JJ integrin-mediated) (NN retention)) (CD -LSB-39) (-RRB- -RSB-)) (, ,) (CC or) (NP (NP (NN responsiveness)) (PP (TO to) (NP (NNS lysophospholipids))) (PP (IN in) (NP (DT the) (NN blood) (NN -LSB-43)))) (-RRB- -RSB-)))))))))))))) (. .)))
( (S (S (SBAR (IN Once) (S (VP (VBN released)))) (, ,) (NP (DT the) (JJ MZ) (NN B) (NNS cells)) (VP (MD would) (VP (VB be) (VP (VBN expected) (S (VP (TO to) (VP (VB migrate) (PP (IN into) (NP (NNS follicles))) (PP (IN in) (NN response) (TO to) (NP (NP (NNS chemoattractants)) (PP (JJ such) (IN as) (NP (NN BLC) (CD -LSB-44) (-RRB- -RSB-)))))))))))) (. .)))
( (S (S (NP (DT These) (NNS considerations)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (JJ follicular) (NN migration)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells)))) (VP (MD may) (VP (VB be) (NP (NP (DT the) (`` ``) (NN default) (NN '')) (NN pathway)) (, ,) (SBAR (IN whereas) (S (NP (NP (NP (NN BCR)) (NN engagement)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB direct) (NP (JJ MZ) (NN B) (NNS cells)) (PP (PP (RB not) (IN into) (NP (DT the) (NNS follicles))) (CC but) (PP (TO to) (NP (DT the) (NN T-B) (NN interface) (CD -LSB-45-47))) (-RRB- -RSB-))))))))) (, ,)) (ADVP (RB actively)) (VP (VBZ alters) (NP (NP (DT the) (NN fate)) (PP (IN of) (NP (NP (NN antigen) (JJ specific) (JJ MZ) (NNS cells)) (PP (ADVP (RB away)) (IN from) (NP (JJ follicular) (NN migration))))))))))))))) (. .)))
( (S (S (PP (IN Despite) (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (NP (NP (NN frequency)) (-LRB- -LRB-) (CC and) (NP (NNS numbers)) (-RRB- -RRB-)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells))))) (PP (IN in) (NP (JJ p50-/-) (NNS mice))))) (, ,) (NP (NP (DT the) (NN deposition)) (PP (IN of) (NP (NN IgM-IC))) (PP (IN within) (NP (DT the) (NNS follicles)))) (VP (VP (VBZ does) (RB not) (VP (VB improve) (PP (IN with) (NP (NN age))))) (, ,) (CC but) (VP (VBZ declines) (ADVP (RB severely))))) (. .)))
( (S (S (NP (DT This)) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (NN function)) (PP (IN of) (NP (NN FDCs))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VP (VBP are) (ADJP (ADJP (JJR fewer)) (PP (IN in) (NP (NN number))))) (CC and) (VP (VBP are) (ADJP (RBR less) (JJ pronounced))))))))) (, ,) (SBAR (IN as) (S (VP (VBN evidenced) (PP (IN by) (NP (NP (NN CD21) (NN staining)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 5)) (-RRB- -RRB-)))))))))))) (. .)))
( (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (VBN decreased) (NN ability)) (PP (IN of) (NP (NN FDCs))) (S (VP (TO to) (VP (VBP retain) (NP (NN complement) (VBG containing) (JJ immune) (NNS complexes)))))) (VP (VBD observed) (PP (IN in) (NP (JJ old) (NNS mice))) (NP (CD -LSB-27)) (-RRB- -RSB-) (, ,) (VP (VB appear) (S (VP (TO to) (VP (VB emerge) (PP (IN with) (NP (NP (VBN accelerated) (NNS kinetics)) (PP (IN in) (NP (JJ p50-/-) (NNS mice)))))))))) (. .)))
( (S (S (NP (JJ NF-κB) (NN p50)) (VP (VBZ is) (NP (NP (RB only) (CD one)) (PP (IN of) (NP (NP (DT a) (VBG growing) (NN number)) (PP (IN of) (NP (NP (NNS genes)) (, ,) (PP (VBG including) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NN transcription) (NNS factors))))) (, ,) (SBAR (WHNP (WP$ whose) (NN expression)) (S (VP (VBZ influences) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells))))))))) (-LRB- -LRB-) (VP (VBN reviewed) (PP (IN in) (NP (NN -LSB-48)))) (-RRB- -RSB-) (-RRB- -RRB-)))) (, ,) (S (VP (VBG highlighting) (NP (NP (DT the) (JJ complex) (NNS interactions)) (SBAR (WHNP (WDT that)) (S (VP (MD must) (VP (VBP converge) (S (VP (TO to) (VP (VB generate) (NP (DT this) (NN B) (NN cell) (NN compartment)))))))))))))) (. .)))
( (S (S (NP (DT The) (NN fact) (SBAR (IN that) (S (NP (NP (DT the) (NNS requirements)) (PP (IN for) (NP (NP (JJ individual) (NNS proteins)) (, ,) (PP (JJ such) (IN as) (NP (NN p50))) (, ,)))) (VP (MD could) (VP (VB change) (PP (IN with) (NP (NN age)))))))) (VP (VBZ suggests) (SBAR (SBAR (IN that) (S (NP (JJ compensatory) (NNS mechanisms)) (VP (VBP exist) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB overcome) (NP (JJ cellular) (NNS defects))))))))) (, ,) (CC and/or) (SBAR (IN that) (S (NP (NP (QP (JJR more) (IN than) (CD one)) (NN pathway)) (S (VP (TO to) (VP (VB generate) (NP (DT these) (NNS cells)))))) (VP (MD may) (VP (VB exist)))))))) (. .)))
( (S (NP (NN Conclusion))))
( (S (S (NP (DT These) (NNS experiments)) (VP (VBP demonstrate) (NP (DT the) (JJ profound) (NN influence) (S (NP (NN age)) (VP (MD can) (VP (VB exert) (PP (IN on) (NP (JJ cellular) (NNS populations))) (PP (IN in) (NP (ADJP (RB genetically) (VBN modified)) (NNS mice))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN appearance)) (PP (IN of) (NP (NP (JJ large) (NNS numbers)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells))))) (PP (IN in) (NP (ADJP (CD 6) (NN month)) (JJ old) (JJ p50-/-) (NNS mice)))) (VP (VBZ suggests) (SBAR (IN that) (S (NP (JJ compensatory) (NNS mechanisms)) (VP (VBP overcome) (NP (NP (DT the) (NNS deficits)) (VP (VBN caused) (PP (IN by) (NP (NN p50-deficiency)))))))))) (. .)))
( (S (S (PP (CC Both) (PP (IN in) (NP (ADJP (ADJP (JJ young)) (CC and) (ADJP (JJ old))) (JJ p50-/-) (NNS mice)))) (, ,) (NP (DT these) (JJ MZ) (NN B) (NNS cells)) (VP (VBP appear) (S (VP (TO to) (VP (VBP retain) (NP (DT some) (NN functionality)) (, ,) (SBAR (IN as) (S (VP (VBN assessed) (PP (IN by) (NP (PRP$ their) (NN ability) (S (VP (TO to) (VP (VB bind) (, ,) (VP (VBP transport)) (CC and) (VP (VB deposit) (NP (NP (NN IgM-IC)) (PP (IN onto) (NP (NNS FDCs)))))))))))))))))) (. .)))
( (S (S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP (NNS FDCs)) (VP (VBP are) (ADJP (JJ unable) (S (VP (TO to) (VP (VB maintain) (NP (PRP$ their) (JJ functional) (NN capacity) (S (VP (TO to) (VP (VB trap) (NP (NN IgM-IC)) (PP (IN in) (NP (NP (JJ aged) (JJ p50-/-) (NNS mice)) (VP (VBG indicating) (SBAR (IN that) (S (, ,) (SBAR (IN while) (S (NP (JJ MZ) (NN B) (NNS cells)) (VP (VBP recover) (PP (IN with) (NP (NN age)))))) (, ,) (NP (JJ other) (JJ immune) (NNS defects)) (VP (VBP become) (ADJP (RBR more) (JJ pronounced)) (PP (IN as) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NP (NN deficiency)) (PP (IN in) (NP (NP (DT this) (NN member)) (PP (IN of) (NP (NP (DT the) (JJ NF-κB) (NN family)) (PP (IN of) (NP (NN transcription) (NNS factors))))))))))))))))))))))))))) (. .)))
( (S (NP (NNS Methods))))
( (S (S (NP (NP (NP (NP (NN C57BL/6J)) (CC and) (NP (NN NF-κB) (NN p50) (NN deficient))) (PRN (-LRB- -LRB-) (NP (NP (NN B6)) (: ;) (NP (JJ 129P2-Nfkb1tm1Bal) (-RRB- -RRB-) (NN -LSB-16))) (-RRB- -RSB-))) (NNS mice)) (VP (VBD were) (VP (VBN purchased) (PP (IN from) (NP (NP (NN Jackson) (NNS Laboratories)) (PRN (-LRB- -LRB-) (NP (NP (NN Bar) (VBP Harbor)) (, ,) (NP (NN ME))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NNS Mice)) (VP (VBD were) (VP (VBN maintained) (PP (IN in) (NP (DT the) (NP (NP (NN Laboratory) (NN Animal) (NN Sciences) (NN Center)) (, ,) (NP (NNP Boston) (NNP University))) (JJ Medical) (NN Center)))))) (. .)))
( (S (S (NP (DT All) (NNS studies)) (VP (VBD were) (VP (VP (VBN reviewed) (PP (IN by) (NP (DT an) (JJ Institutional) (NN Animal) (NN Care) (CC and) (NN Use) (NN Committee)))) (CC and) (VP (VBN carried) (PRT (RP out)) (PP (IN in) (NP (NP (NN accordance)) (PP (IN with) (NP (NP (JJ established) (NNS guidelines)) (VP (VBG according) (PP (TO to) (NP (NP (JJ National) (NNS Institutes)) (PP (IN of) (NP (NN Health)))))))))))))) (. .)))
( (S (S (NP (NP (NNS Mice)) (PP (IN of) (NP (DT both) (NNS sexes)))) (VP (VBD were) (VP (VBN used) (PP (IN at) (NP (NP (QP (CD 2) (TO to) (CD 6)) (NNS months)) (PP (IN of) (NP (NN age))))) (SBAR (IN as) (S (VP (VBN described))))))) (. .)))
( (S (S (S (NP (NNS Mice)) (VP (VBD were) (VP (VBN injected) (ADVP (RB i.v.)) (PP (IN with) (NP (NP (DT a) (NN mixture)) (PP (IN of) (NP (NP (QP (CD 15) (TO to) (CD 20) (NN μg)) (DT each)) (PP (IN of) (NP (NN NP12-BSA-biotin))))))) (PRN (-LRB- -LRB-) (NP (NN Biosearch) (NNS Technologies)) (, ,) (NP (NP (NNP Novato)) (, ,) (NP (NN CA))) (-RRB- -RRB-))))) (CC and) (S (NP (NN affinity)) (VP (VBN purified) (NP (NP (JJ pentameric) (NN IgM) (NN anti-NP) (JJ monoclonal) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NN B1-8)) (-RRB- -RRB-))) (PP (ADVP (RB exactly)) (IN as) (NP (ADJP (RB previously) (VBN described)) (NN -LSB-7,15) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (NP (ADJP (FW In) (FW vitro)) (NNS assays)) (VP (TO to) (VP (VB assess) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NN IgM-IC))) (PP (TO to) (NP (JJ MZ) (NN B) (NNS cells))))))) (VP (VBD were) (VP (VBN performed) (PP (IN as) (NP (ADJP (RB previously) (VBN described)) (NN -LSB-15) (-RRB- -RSB-)))))) (. .)))
( (S (ADVP (RB Briefly)) (, ,) (NP (NN IgM-IC)) (VP (VBD were) (VP (VP (VBN formed) (PP (IN by) (S (VP (VBG mixing) (NP (NP (NP (NP (CD 1) (NN μg)) (NP (DT each))) (PP (IN of) (NP (NN NP-BSA-biotin)))) (CC and) (NP (NP (NN B1-8) (NN IgM)) (PP (IN in) (NP (NN RPMI))))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (ADJP (CD 10) (NN %)) (JJ fresh) (NN mouse) (NN serum))))) (PP (IN as) (NP (NP (DT a) (NN source)) (PP (IN of) (NP (NN complement))))))))) (CC and) (VP (VBN incubated) (PP (IN for) (NP (NP (CD 30) (NNS minutes)) (PP (IN at) (NP (NN 37°C)))))))) (. .)))
( (S (S (NP (NP (NNS Splenocytes)) (PRN (-LRB- -LRB-) (NP (CD 107)) (-RRB- -RRB-))) (VP (VBD were) (VP (VP (VBN resuspended) (PP (IN in) (NP (DT the) (NN IgM-IC)))) (CC and) (VP (VBN incubated) (PP (IN at) (NP (NN 37°C))) (PP (IN for) (NP (DT an) (JJ additional) (CD 30) (NNS minutes))))))) (. .)))
( (S (S (NP (NNS Cells)) (VP (VBD were) (VP (VP (VBN washed)) (CC and) (VP (VBN analyzed) (PP (IN by) (NP (NN flow) (NN cytometry))))))) (. .)))
( (S (S (NP (NP (NN Staining)) (PP (IN of) (NP (NN spleen) (NNS sections)))) (VP (VBD was) (VP (VBN performed) (ADVP (RB exactly)) (PP (IN as) (NP (ADJP (RB previously) (VBN described)) (NN -LSB-7,15))) (-RRB- -RSB-)))) (. .)))
( (S (ADVP (RB Briefly)) (, ,) (NP (NNS spleens)) (VP (VBD were) (VP (VP (VBN removed)) (CC and) (VP (VBP snap) (VP (VP (VBN frozen) (PP (IN in) (NP (NP (NN O.C.T.) (NN Compound)) (PRN (-LRB- -LRB-) (NP (NP (NN Tissue) (NN Tek)) (, ,) (NP (NN Torrance)) (, ,) (NP (NN CA))) (-RRB- -RRB-))))) (CC and) (VP (VBN stored) (PP (IN at) (NP (NN -80°C)))))))) (. .)))
( (S (NP (CD 6) (JJ μm) (NNS sections)) (VP (VBD were) (VP (VP (VBN cut) (PRN (-LRB- -LRB-) (NP (NP (NNP IEC) (NNP Microtome) (, ,) (NNP Needham)) (, ,) (NP (NN MA))) (-RRB- -RRB-))) (CC and) (ADJP (JJ fixed) (PP (IN in) (NP (NN acetone))) (PP (IN at) (NP (NP (NN -20°C)) (PP (IN for) (NP (CD 10) (NN min)))))))) (. .)))
( (S (S (NP (NNS Sections)) (VP (VBD were) (VP (VP (VBN incubated) (PP (IN with) (NP (ADJP (CD 0.3) (NN %)) (NN H2O2/PBS))) (PP (IN for) (NP (CD 5) (NN min)))) (CC and) (VP (VBN blocked) (PP (IN with) (NP (ADJP (CD 3) (NN %)) (JJ normal) (NN rabbit) (CC or) (NN rat) (NN serum))))))) (. .)))
( (S (S (NP (DT All) (NNS antibodies)) (VP (VBD were) (VP (VBN diluted) (PP (IN in) (NP (ADJP (CD 5) (NN %)) (NN BSA))) (PP (IN in) (NP (NNS PBS)))))) (. .)))
( (S (S (NP (JJ Primary) (NNS antibodies)) (VP (VBD used) (VP (VBN included) (: :) (NP (NP (NN anti-CD3-FITC) (-LRB- -LRB-) (CD 1/200) (-RRB- -RRB-)) (, ,) (NP (NP (NP (NN anti-CD3-biotin) (-LRB- -LRB-) (CD 1/200) (-RRB- -RRB-)) (, ,) (NP (NN anti-CD21/35-FITC) (-LRB- -LRB-) (CD 1/100) (-RRB- -RRB-)) (, ,)) (PRN (-LRB- -LRB-) (NP (NP (NN all)) (PP (IN from) (NP (NNP BD) (NNP Biosciences) (, ,) (NNP San) (NNP Diego)))) (-RRB- -RRB-))) (, ,) (NP (NP (NN ER-TR9)) (PRN (-LRB- -LRB-) (NP (CD 1/200)) (: ;) (NP (NN BMA) (JJ Biomedical)) (, ,) (NP (NNP Augst) (, ,) (NNP Switzerland)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NN anti-FDC-M2)) (PRN (-LRB- -LRB-) (NP (CD 1/200)) (: ;) (NP (NNP Immunokontact) (, ,) (NN Frankfurt) (, ,) (NNP Germany)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (JJ Secondary) (NNS antibodies)) (VP (VBD included) (NP (NP (NP (NN anti-FITC-HRP)) (PRN (-LRB- -LRB-) (NP (CD 1/100)) (: ;) (NP (NNP Roche) (NN Molecular) (NNP Biochemicals) (, ,) (NNP Indianapolis)) (, ,) (NP (FW IN)) (-RRB- -RRB-))) (, ,) (NP (NP (NN goat) (NN anti-rat) (NN IgG-HRP)) (PRN (-LRB- -LRB-) (NP (CD 1/500)) (: ;) (NP (NNP Jackson) (NNP Immunoresearch) (, ,) (NNP West) (NNP Grove)) (, ,) (NP (NN PA)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NP (NP (NN goat) (NN anti-rat) (NN IgM)) (PRN (-LRB- -LRB-) (NP (NN Fab) ('' ')) (-RRB- -RRB-))) (NN 2-HRP)) (PRN (-LRB- -LRB-) (NP (NP (CD 1/1000)) (: ;) (NP (NNP Jackson) (NNP Immunoresearch))) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NP (NN NP12-BSA-biotin)) (CC and) (NP (NN anti-CD3-biotin))) (VP (VBD was) (VP (VP (VBN visualized) (PP (IN by) (NP (NP (NP (NP (NN alkaline) (NN phosphatase)) (PRN (-LRB- -LRB-) (NP (NN AP)) (-RRB- -RRB-))) (NN -streptavidin)) (PRN (-LRB- -LRB-) (NP (NN 1/400)) (: ;) (NP (JJ Molecular) (NNS Probes)) (, ,) (NP (NNP Eugene)) (, ,) (CC OR) (-RRB- -RRB-))))) (CC and) (VP (VBN developed) (PP (IN with) (NP (NP (NN napthol)) (ADJP (NN AS-MX) (JJ phosphate/Fast) (JJ blue) (NN BB) (NN base) (PRN (-LRB- -LRB-) (FRAG (NP (NN Sigma)) (, ,) (NP (NN St.) (NN Louis)) (, ,) (NP (NN MO))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (NP (NN Visualization)) (PP (IN of) (NP (NN antibody) (NNS stains)))) (VP (VBD was) (VP (VBN accomplished) (S (VP (VBG using) (NP (NP (NP (NP (NN horse) (NN radish) (NN peroxidase)) (PRN (-LRB- -LRB-) (NP (NN HRP)) (-RRB- -RRB-))) (VBN conjugated) (JJ secondary) (NNS antibodies)) (VP (VBN developed) (PP (IN with) (NP (NP (NP (NN 3-amino-9-ethylcarbazole)) (PRN (-LRB- -LRB-) (NP (NN Sigma)) (-RRB- -RRB-))) (CC and) (NP (NN H202))))))))))) (. .)))
( (S (PP (IN After) (NP (NN staining))) (, ,) (NP (NNS sections)) (VP (VBD were) (VP (VBN covered) (PP (IN with) (NP (NP (JJ crystal) (NP (VB mount))) (PRN (-LRB- -LRB-) (NP (NNP Biomedia) (, ,) (NNP Foster) (NNP City)) (, ,) (NP (NN CA)) (-RRB- -RRB-)))) (PP (IN before) (S (VP (VBG examining) (PP (IN by) (NP (NP (JJ digital) (NN microscopy)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP Zeiss) (, ,) (NNP Axiovert)) (ADJP (CD 200) (NN M))) (, ,) (NP (NNP Oberkochen) (, ,) (NNP Germany))) (-RRB- -RRB-))))))))) (. .)))
( (S (SBAR (IN Unless) (S (ADVP (RB otherwise)) (VP (VBN noted)))) (, ,) (NP (DT all) (NNS images)) (VP (VBD were) (VP (VBN obtained) (S (VP (VBG using) (NP (NP (NP (DT a) (JJ 10×) (NN objective)) (PRN (-LRB- -LRB-) (NP (NP (JJ initial) (NN magnification)) (PP (IN of) (NP (NN 100×)))) (-RRB- -RRB-))) (SBAR (IN unless) (S (ADVP (RB otherwise)) (VP (VBN noted) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (NNP Fig.) (CD 4)))) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NNS Sections)) (VP (VBD were) (ADVP (RB initially)) (VP (VBN treated) (PP (IN as) (PP (IN for) (NP (NN IH))))))) (. .)))
( (S (NP (NP (NNS Antibodies)) (VP (VBN utilized))) (VP (VBD included) (NP (NP (NN anti-MOMA-1)) (PRN (-LRB- -LRB-) (NP (NP (NN 1/25)) (: ;) (NP (NNP Serotec) (, ,) (NNP Raleigh) (NN NC))) (-RRB- -RRB-))) (PP (VBN visualized) (PP (IN with) (NP (NP (NP (DT a) (NN goat) (NN anti-rat) (NN IgG-AMCA)) (PRN (-LRB- -LRB-) (NP (NP (CD 1/100)) (: ;) (NP (NNP Jackson) (NNP Immunoresearch))) (-RRB- -RRB-))) (, ,) (NP (NP (JJ anti-IgM-Texas) (JJ Red)) (PRN (-LRB- -LRB-) (NP (NP (CD 1/100)) (: ;) (NP (NNP BD) (NNP Biosciences))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (JJ anti-laminin)) (PRN (-LRB- -LRB-) (NP (NP (NN 1/500)) (: ;) (NP (NN Sigma))) (-RRB- -RRB-)))))) (S (VP (VBN visualized) (PP (IN with) (NP (NP (DT an) (JJ anti-rabbit) (NN IgG-FITC)) (PRN (-LRB- -LRB-) (NP (NP (CD 1/100)) (: ;) (NP (NNP Jackson) (NNP Immunoresearch))) (-RRB- -RRB-))))))) (. .)))
( (S (S (S (NP (DT All) (NNS sections)) (VP (VBD were) (VP (VBN covered) (PP (IN with) (NP (NP (NN Fluoromount) (NN G)) (PRN (-LRB- -LRB-) (NP (NNP Jackson) (NNP Immunoresearch)) (-RRB- -RRB-))))))) (CC and) (S (NP (DT a)) (VP (VBP cover) (NP (NN slip)) (PP (IN before) (S (VP (VBG examining) (PP (IN by) (NP (JJ digital) (NN microscopy)))))) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP Zeiss) (, ,) (NNP Axiovert)) (ADJP (CD 200) (NN M))) (, ,) (NP (NNP Oberkochen) (, ,) (NNP Germany))) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (NNS Splenocytes)) (VP (VBD were) (VP (VP (VBN isolated) (PP (IN at) (NP (DT the) (VBN indicated) (NNS times)))) (CC and) (VP (VBN stained) (PP (IN as) (NP (VBZ follows))))))) (. .)))
( (S (S (NP (DT The) (NN lymphocyte) (NN gate)) (VP (VBD was) (VP (VBN utilized) (PP (IN for) (NP (NN all) (NN analysis)))))) (. .)))
( (S (S (NP (NNS Cells)) (VP (VBD were) (VP (VBN analyzed) (S (VP (VBG using) (NP (NP (NP (DT a) (NN FACScan)) (PRN (-LRB- -LRB-) (NP (NNP Becton) (NNP Dickinson) (, ,) (NNP Franklin) (NNP Lakes) (, ,) (NNP NJ)) (-RRB- -RRB-))) (CC and) (NP (NP (NN FlowJo) (NN software)) (PRN (-LRB- -LRB-) (NP (NN Tree) (NNP Star) (, ,) (NNP Ashland)) (, ,) (CC OR) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (NP (NNS Antibodies)) (VP (VBN utilized))) (VP (VBD were) (NP (NP (NN anti-B220-FITC) (-LRB- -LRB-) (CD 1/200) (-RRB- -RRB-)) (, ,) (NP (NN anti-B220-biotin) (-LRB- -LRB-) (CD 1/200) (-RRB- -RRB-)) (, ,) (NP (NN anti-B220-PE) (-LRB- -LRB-) (CD 1/200) (-RRB- -RRB-)) (, ,) (NP (NN anti-CD21/35-FITC) (-LRB- -LRB-) (CD 1/200) (-RRB- -RRB-)) (, ,) (NP (NN anti-CD23-PE) (-LRB- -LRB-) (CD 1/200) (-RRB- -RRB-)) (, ,) (CC and) (NP (NP (NP (NN anti-CD1d-FITC)) (CC or) (NP (NN PE) (-LRB- -LRB-) (CD 1/100) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP BD) (NNP Biosciences)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NP (NN Streptavidin-Cy5)) (PRN (-LRB- -LRB-) (NP (NP (CD 1/200)) (: ;) (NP (NNP BD) (NNP Biosciences))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN used) (S (VP (VP (TO to) (VP (VB identify) (NP (NP (NP (DT the) (NN NP) (NN antigen)) (PRN (-LRB- -LRB-) (NP (NN NP12-BSA-biotin)) (-RRB- -RRB-))) (VP (VBN associated) (PP (IN with) (NP (NNS lymphocytes))))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (VP (TO to) (VP (VB visualize) (NP (JJ biotin-labelled) (NNS antibodies))))))))) (. .)))
( (S (NP (NP (NNS Authors) (POS ')) (NNS contributions))))
( (S (NP (NP (NN A.R.F.)) (. .))))
( (S (S (VP (VP (VBD performed) (NP (NP (DT the) (NNS experiments)) (VP (VBN reported) (PP (IN in) (NP (DT this) (NN manuscript)))))) (CC and) (VP (VBD participated) (PP (IN in) (NP (DT the) (NNS data) (NP (NP (NN interpretation)) (CC and) (NP (NN analysis)))))))) (. .)))
( (S (S (NP (NN R.B.C.)) (ADVP (RB originally)) (VP (VP (VBD conceived) (PP (IN of) (NP (DT the) (NN study)))) (, ,) (VP (VBD participated) (PP (IN in) (NP (NP (NN data) (NN interpretation)) (CC and) (NP (NN analysis))))) (, ,) (CC and) (VP (VBZ takes) (NP (NP (JJ overall) (NN responsibility)) (PP (IN for) (NP (NP (DT the) (NN conduct)) (PP (IN of) (NP (DT the) (NNS studies))))))))) (. .)))
( (S (S (NP (DT Both) (NNS authors)) (VP (VBP have) (NP (NP (NP (VBN read)) (CC and) (NP (NN approve))) (PP (IN of) (NP (DT the) (JJ final) (NN manuscript)))))) (. .)))
( (S (NP (NP (NN Figure)) (CC and) (NP (NN Table)) (NP (NNS captions)))))
( (S (NP (NP (NN Figure) (CD 1)) (: :) (S (NP (JJ p50-/-) (NNS mice)) (VP (VBP trap) (ADJP (JJ IgM-IC)) (ADVP (RBR less) (RB efficiently)) (PP (IN on) (NP (NN FDCs))))) (. .))))
( (S (S (NP (NP (NN Localization)) (PP (IN of) (NP (NN IgM-IC))) (PP (IN in) (NP (ADJP (ADJP (JJ B6)) (CC or) (ADJP (JJ p50-/-))) (NNS mice)))) (VP (VBD was) (VP (VBN determined) (PP (IN by) (NP (NP (NN IH) (CD 16) (NN h)) (PP (IN after) (NP (NN injection)))))))) (. .)))
( (S (S (S (NP (NN ER-TR9)) (VP (VBZ identifies) (NP (NP (JJ marginal) (NN zone) (NNS macrophages)) (PRN (-LRB- -LRB-) (NP (NN MZM)) (-RRB- -RRB-))))) (CC and) (S (NP (NN FDC-M2)) (VP (VBZ identifies) (NP (NN FDCs))))) (. .)))
( (S (S (NP (NP (NN IgM-IC)) (-LRB- -LRB-) (SBAR (WHNP (WDT which)) (S (VP (VP (VBP appear) (ADJP (JJ blue) (PP (IN in) (NP (NP (DT this)) (CC and) (NP (DT all)) (NP (JJ subsequent) (NNS figures)))))) (CC and) (VP (VBP are) (VP (VBN identified) (PP (IN by) (NP (NNS arrows)))))))) (-RRB- -RRB-)) (VP (VBP are) (VP (VBN localized) (PP (TO to) (NP (NN FDCs))) (PP (IN in) (NP (NP (NNS spleens)) (PP (IN from) (NP (NP (DT both) (NNS groups)) (PP (IN of) (NP (NNS mice)))))))))) (, ,) (CC but) (S (NP (NP (NNS FDCs)) (PP (IN from) (NP (NN B6) (NNS mice)))) (VP (VBP show) (NP (ADJP (RBR more) (JJ intense)) (NN staining)) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (ADJP (RBR more) (JJ IgM-IC))) (VP (VBP are) (VP (VBN trapped) (PP (IN in) (NP (DT these) (NNS mice))))))))))) (. .)))
( (S (S (NP (DT All) (NN IH) (NNS stains)) (VP (VP (VBD were) (VP (VBN performed) (PP (IN on) (NP (JJ serial) (NNS sections))))) (CC and) (VP (VBD were) (VP (VBN developed) (NP (NN side-by-side)) (PP (IN for) (NP (NP (JJ identical) (NNS periods)) (PP (IN of) (NP (NN time))))))))) (. .)))
( (S (NP (NP (NN Figure) (CD 2)) (: :) (S (NP (JJ p50-/-) (NNS mice)) (VP (VBP contain) (NP (NP (VBN reduced) (NNS numbers)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells))) (SBAR (WHNP (WDT that)) (S (VP (VBP bind) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NP (NN IgM-IC)) (FW A.) (NP (NN B) (NN cell) (NNS subsets)) (CC and) (NP (NN IgM-IC) (NN binding))))))))))) (. .))))
( (S (S (NP (NP (NNS Splenocytes)) (PP (IN from) (NP (ADJP (ADJP (JJ B6)) (CC or) (ADJP (JJ p50-/-))) (NNS mice)))) (VP (VBD were) (VP (VBN analyzed) (PP (IN for) (NP (NN B) (NN cell) (NNS subsets))) (PP (IN by) (NP (NP (NN FACS)) (VP (VBG using) (NP (NP (NN CD21/CD23)) (CC or) (NP (NN B220/CD1d)) (NP (NN expression))))))))) (. .)))
( (S (S (NP (NP (NNS Histograms)) (PP (IN on) (NP (DT the) (JJ right)))) (VP (VBP show) (NP (NP (NN binding)) (PP (IN of) (NP (NN IgM-IC))) (PP (TO to) (NP (NP (ADJP (JJ MZ))) (CC and) (NP (NN FO) (NN B) (NNS cells)) (NP (NP (CD 1) (NN h)) (PP (IN after) (NP (NN i.v.))))))))) (. .)))
( (S (S (NP (NP (NN injection)) (PRN (-LRB- -LRB-) (NP (JJ shaded) (NN region)) (-RRB- -RRB-))) (: ;) (NP (JJ clear) (NNS profiles)) (VP (VBP represent) (NP (JJ uninjected) (NN control) (NNS mice)))) (. .)))
( (S (SBAR (IN Although) (S (NP (NP (NN spleen) (NNS cells)) (PP (IN from) (NP (JJ p50-/-) (NNS mice)))) (VP (VBD contained) (NP (NP (VBN reduced) (NNS numbers)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells))))))) (, ,) (NP (NP (DT the) (NNS cells)) (ADJP (JJ present) (PP (IN in) (NP (DT the) (JJ MZ) (NN B) (NN cell) (NN gate))))) (VP (VBP bind) (NP (NP (NN IgM-IC)) (PP (IN at) (NP (JJ high) (NNS levels))) (PP (IN over) (NP (NP (NN background)) (, ,) (ADJP (JJ similar) (PP (TO to) (NP (NP (NNS levels)) (PP (IN of) (NP (NP (NN binding)) (PP (IN of) (NP (NN IgM-IC))) (PP (TO to) (NP (NN B6) (JJ MZ) (NN B) (NNS cells)))))))))))) (. .)))
( (S (S (NP (ADJP (FW B.) (FW In) (FW vitro)) (NN binding) (NN assay)) (VP (VBG showing) (NP (NP (NN binding)) (PP (IN of) (NP (NN IgM-IC))) (PP (TO to) (NP (NP (NP (JJ MZ) (NN B) (NNS cells)) (PRN (-LRB- -LRB-) (NP (JJ shaded) (NN region)) (-RRB- -RRB-))) (PP (VBN compared) (PP (IN with) (NP (NP (NN FO) (NN B) (NNS cells)) (PRN (-LRB- -LRB-) (NP (JJ clear) (NN region)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NP (JJ MZ) (NN B) (NNS cells)) (PP (IN from) (NP (ADJP (CC both) (ADJP (JJ B6)) (CC and) (ADJP (JJ p50-/-))) (NNS mice)))) (VP (VBP bind) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NN IgM-IC)))) (PP (VBN compared) (PP (TO to) (NP (NN FO) (NN B) (NNS cells)))))) (. .)))
( (S (NP (JJ C.) (NN Immunofluorescence)) (VP (VBZ shows) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (NN IgMhi) (NNS cells)) (PRN (-LRB- -LRB-) (NP (JJ red)) (-RRB- -RRB-)))) (PP (IN in) (NP (NP (DT the) (JJ MZ)) (SBAR (IN as) (S (VP (VBN demarcated) (PP (IN by) (NP (ADJP (ADJP (JJ MOMA-1)) (PRN (-LRB- -LRB-) (NP (NP (JJ marginal) (NN metallophilic) (NNS macrophages)) (, ,) (NP (ADJP (JJ blue)))) (-RRB- -RRB-))) (NN staining)))))))))) (. .)))
( (S (S (NP (JJ p50-/-) (NNS mice)) (VP (VBP possess) (NP (NP (DT some) (JJ IgM+) (NNS cells)) (PP (IN in) (NP (NP (DT the) (JJ MZ) (JJ outside)) (PP (IN of) (NP (DT the) (NN MOMA-1) (NN ring)))))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (ADJP (RB appropriately) (VBN positioned)) (JJ MZ) (NN B) (NNS cells))) (PP (IN in) (NP (DT these) (NNS mice))))))))) (. .)))
( (S (NP (NP (NN Figure) (CD 3)) (: :) (S (NP (JJ p50-/-) (NNS mice)) (VP (VBP accumulate) (NP (NP (JJ MZ) (NN B) (NNS cells)) (PP (IN with) (NP (NN age))) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (NP (DT the) (NN capacity) (S (VP (TO to) (VP (VB bind) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NN IgM-IC))) (S (NP (NP (FW A.) (NN FACS) (NN profile)) (PP (IN of) (NP (NP (NNS splenocytes)) (PP (IN from) (NP (NP (NP (ADJP (NP (QP (CD 2) (CC and) (CD 6)) (NN month)) (JJ old)) (NN B6)) (CC and) (NP (CD 6) (NN month))) (JJ p50-/-) (NNS mice)))))) (VP (VBP reveal) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (JJ normal) (NNS numbers)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells))))) (PP (IN in) (NP (NP (NNS spleens)) (PP (IN of) (NP (DT the) (JJ p50-/-) (NNS mice))))))))))))))))))) (. .))))
( (S (S (NP (NNS Histograms)) (VP (VBP illustrate) (NP (NP (NN binding)) (PP (IN of) (NP (NN IgM-IC))) (PP (TO to) (NP (JJ p50-/-) (JJ MZ) (NN B) (NNS cells)))) (SBAR (IN as) (S (VP (VBN described) (PP (IN in) (NP (NN Figure) (NN 2A)))))))) (. .)))
( (S (S (NP (ADJP (FW B.) (FW In) (FW vitro)) (NN IgM-IC) (NN binding) (NN assay))) (. .)))
( (S (S (S (VP (VBG Binding) (PP (TO to) (NP (NP (JJ MZ) (NN B) (NNS cells)) (PRN (-LRB- -LRB-) (NP (JJ shaded) (NNS profiles)) (-RRB- -RRB-)))))) (: ;) (NP (NP (NN binding)) (PP (TO to) (NP (NP (NN FO) (NN B) (NNS cells)) (PRN (-LRB- -LRB-) (NP (JJ clear) (NNS profiles)) (-RRB- -RRB-)))))) (. .)))
( (S (NP (NP (NN Figure) (CD 4)) (: :) (S (NP (NP (NP (ADJP (ADJP (JJ Phenotypic)) (CC and) (ADJP (JJ histological))) (NN analysis)) (PP (IN of) (NP (JJ MZ) (NN B) (NNS cells))) (PP (IN in) (NP (JJ p50-/-) (NNS mice)))) (NP (NP (FW A.) (NN FACS) (NN profile)) (PP (IN of) (NP (NP (NNS splenocytes)) (PP (IN from) (NP (NP (NP (ADJP (NP (QP (CD 2) (CC and) (CD 6)) (NN month)) (JJ old)) (NN B6)) (CC and) (NP (CD 6) (NN month))) (JJ old) (JJ p50-/-) (NNS mice))))))) (VP (VBN revealed) (PP (IN by) (NP (NP (NNP B220/CD1d)) (CC and) (NP (NNP B220/CD9)) (NP (NNS profiles)))))) (. .))))
( (S (S (NP (FW B.) (NP (NN FACS) (NNS histograms)) (VP (VBG showing) (NP (NP (NN IgM) (NNS levels)) (PP (IN on) (NP (NP (JJ MZ) (CC and) (NN FO) (NN B) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (ADJP (JJ shaded)) (CC and) (ADJP (JJ clear))) (NNS regions)) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-))))))) (ADVP (RB as)) (VP (VBN determined) (PP (IN by) (NP (NN CD21/23) (NNS profiles))))) (. .)))
( (S (S (NP (NP (NNS Cells)) (ADJP (JJ present) (PP (IN in) (NP (NP (DT the) (JJ MZ) (NN B) (NN cell) (NN gate)) (PP (IN in) (NP (JJ p50-/-) (NNS mice))))))) (VP (VBP express) (NP (NP (JJR higher) (NNS levels)) (PP (IN of) (NP (NN IgM)))) (PP (VBN compared) (PP (IN with) (NP (NN FO) (NN B) (NNS cells)))) (, ,) (ADVP (JJ similar) (PP (TO to) (NP (NN B6) (NNS mice)))))) (. .)))
( (S (NP (NP (NN C.)) (PP (IN IF))) (VP (VBZ reveals) (NP (NP (NP (ADJP (RB well) (VBN demarcated)) (NN IgMhi) (NNS cells)) (PRN (-LRB- -LRB-) (PP (IN in) (NP (JJ red))) (-RRB- -RRB-))) (PP (IN in) (NP (NP (DT the) (JJ MZ) (JJ outside)) (PP (IN of) (NP (NP (DT the) (NN laminin) (NN staining)) (-LRB- -LRB-) (SBAR (WHNP (WDT which)) (S (VP (VBZ identifies) (NP (DT the) (JJ marginal) (NN sinus))))))))) (: ;)) (PP (IN in) (NP (NP (CD green) (-RRB- -RRB-)) (PP (IN in) (NP (ADJP (CD 6) (NN month)) (JJ p50-/-) (NNS mice)))))) (. .)))
( (S (NP (NP (NN Figure) (CD 5)) (: :) (S (S (NP (NP (JJ Deteriorated) (NN FDCs)) (PP (IN in) (NP (JJ aged) (JJ p50-/-) (NNS mice)))) (VP (VBZ correlates) (PP (IN with) (NP (NP (VBN reduced) (JJ IgM-IC) (NN localization)) (NNP A.) (CD 2) (NN month))))) (CC and) (S (NP (NP (ADJP (CD 6) (NN month)) (JJ old) (NN B6) (NNS mice)) (CC and) (NP (ADJP (CD 6) (NN month)) (JJ old) (JJ p50-/-) (NNS mice))) (VP (VBD were) (VP (VP (VBN injected) (PP (IN with) (NP (NN IgM-IC)))) (CC and) (VP (VBN analyzed) (PP (IN by) (NP (NN IH))) (PP (IN for) (NP (NP (NN IgM-IC) (NN localization)) (ADJP (NP (CD 16) (NN h)) (JJR later))))))))) (. .))))
( (S (S (NP (NN IgM-IC)) (VP (VP (VBD were) (ADJP (JJ present) (PP (IN on) (NP (NN FDCs))) (PP (IN in) (NP (ADJP (CD 2) (CC and) (CD 6) (NN month)) (NN B6) (NNS mice)))) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (NNS arrows)))) (-RRB- -RRB-))) (, ,) (CC but) (VP (VBD were) (RB not) (VP (VBN deposited) (PP (IN onto) (NP (NNS FDCs))) (PP (IN in) (NP (JJ p50-/-) (NNS mice))))))) (. .)))
( (S (S (NP (NP (FW B.) (JJ Intense) (NN CD21) (NN staining)) (PRN (-LRB- -LRB-) (VP (VBN designated) (PP (IN by) (NP (NNS arrows)))) (-RRB- -RRB-))) (VP (VBD was) (ADJP (RBR less) (JJ visible)) (PP (IN in) (NP (NP (DT the) (NNS spleens)) (PP (IN of) (NP (JJ p50-/-) (NNS mice))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NN FDC) (NNS networks)) (VP (VBD were) (ADVP (RB poorly)) (VP (VBN developed) (PP (IN in) (NP (DT these) (NNS mice))))))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (VBN reduced) (NN IgM-IC) (NN localization)) (VP (MD may) (VP (VB be) (VP (VBN attributed) (PP (TO to) (NP (NP (DT the) (NN loss)) (PP (IN of) (NP (JJ functional) (NN FDC) (NNS networks))) (PP (IN in) (NP (JJ p50-/-) (NNS mice)))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NNS magnifications)) (VP (VBN noted))) (VP (VBP refer) (PP (TO to) (NP (NP (NP (DT the) (JJ objective)) (VP (VBN used))) (, ,) (RB not) (NP (DT the) (JJ absolute) (NN magnification)))))) (. .)))
( (S (NP (NP (JJ Differential) (JJ clinical) (NN efficacy)) (PP (IN of) (NP (JJ anti-CD4) (JJ monoclonal) (NNS antibodies))) (PP (IN in) (NP (NN rat) (JJ adjuvant) (NN arthritis)))) (VP (VBZ is) (VP (VBN paralleled) (PP (IN by) (NP (NP (JJ differential) (NN influence)) (PP (IN on) (NP (NP (NP (JJ NF-κB) (NN binding) (NN activity)) (CC and) (NP (NN TNF-α) (NN secretion))) (PP (IN of) (NP (NN T) (NNS cells)))))))))))
( (S (NP (NN Abstract))))
( (S (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB analyze) (NP (NP (DT the) (JJ differential) (NNS effects)) (PP (IN of) (NP (NP (NP (CD three) (JJ anti-CD4) (JJ monoclonal) (NNS antibodies)) (PRN (-LRB- -LRB-) (NP (NNS mAbs)) (-RRB- -RRB-))) (-LRB- -LRB-) (PP (IN with) (NP (JJ distinct) (NN epitope) (NNS specifities))) (-RRB- -RRB-))) (PP (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (NN rat) (JJ adjuvant) (NN arthritis)) (PRN (-LRB- -LRB-) (NP (NN AA)) (-RRB- -RRB-)))))) (CC and) (PP (IN on) (NP (NP (NN T-cell) (NN function)) (CC and) (NP (NN signal) (NN transduction))))))))))) (. .)))
( (S (S (NP (NN Rat) (NN AA)) (VP (VBD was) (ADVP (RB preventively)) (VP (VBN treated) (PP (IN by) (NP (NP (JJ intraperitoneal) (NN injection)) (PP (IN of) (NP (DT the) (JJ anti-CD4) (NNS mAbs) (NP (NP (NN W3/25)) (, ,) (NP (NN OX35)) (, ,) (CC and) (NP (NN RIB5/2))))))) (PRN (-LRB- -LRB-) (UCP (PP (PP (IN on) (NP (NNS days) (QP (CD -1) (, ,) (CD 0) (, ,) (CD 3) (, ,) (CC and) (CD 6)))) (, ,) (FW i.e.) (NP (NP (CD 1) (NN day)) (PP (IN before) (NP (NN AA) (NN induction)))) (, ,) (PP (IN on) (NP (NP (DT the) (NN day)) (PP (IN of) (NP (NN induction) (NN -LSB-day) (CD 0) (-RRB- -RSB-)))))) (, ,) (CC and) (ADVP (RB thereafter))) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (NP (DT The) (NNS effects)) (PP (IN on) (NP (NN T-cell) (NN reactivity))) (PP (IN in) (NP (NP (NP (FW vivo)) (PRN (-LRB- -LRB-) (NP (JJ delayed-type) (NN hypersensitivity)) (-RRB- -RRB-))) (, ,) (NP (ADJP (FW ex) (FW vivo)) (PRN (-LRB- -LRB-) (NP (JJ ConA-induced) (NN proliferation)) (-RRB- -RRB-))) (, ,) (CC and) (NP (ADJP (FW in) (FW vitro)) (PRN (-LRB- -LRB-) (NP (JJ mixed) (NN lymphocyte) (NN culture)) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN assessed)))) (. .)))
( (S (S (NP (NP (DT The) (ADJP (FW in) (FW vitro)) (NNS effects)) (PP (IN of) (NP (JJ anti-CD4) (NN preincubation))) (PP (IN on) (NP (NP (ADJP (NP (NP (NN T-cell) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN TCR)) (-RRB- -RRB-))) (JJ /CD3-induced)) (NN cytokine) (NN production)) (CC and) (NP (NN signal) (NN transduction))))) (VP (VBD were) (ADVP (RB also)) (VP (VBN analyzed)))) (. .)))
( (S (SBAR (IN While) (S (NP (NP (JJ preventive) (NN treatment)) (PP (IN with) (NP (NP (NN OX35)) (CC and) (NP (NN W3/25))))) (ADVP (RB significantly)) (VP (VBD ameliorated) (NP (NN AA)) (PP (IN from) (NP (DT the) (NN onset)))))) (, ,) (NP (NP (NN treatment)) (PP (IN with) (NP (NN RIB5/2)))) (ADVP (RB even)) (VP (VP (VBD accelerated) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (NN AA)))) (PP (IN by) (NP (NP (QP (RB approximately) (CD 2)) (NNS days)) (PRN (-LRB- -LRB-) (NP (NN day) (CD 10)) (-RRB- -RRB-))))) (, ,) (CC and) (VP (VBD ameliorated) (NP (DT the) (NN arthritis)) (PP (ADVP (RB only)) (IN in) (NP (NP (DT the) (JJ late) (NN phase)) (PRN (-LRB- -LRB-) (NP (NN day) (CD 27)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NP (JJ Differential) (JJ clinical) (NNS effects)) (PP (IN at) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (NN AA)))))) (VP (VBD were) (VP (VBN paralleled) (PP (IN by) (S (NP (NP (DT a) (JJ differential) (NN influence)) (PP (IN of) (NP (DT the) (NNS mAbs))) (PP (IN on) (NP (NP (NN T-cell) (NNS functions)) (, ,) (NP (NP (FW i.e.) (FW in) (NN comparison)) (PP (IN with) (NP (NP (NN OX35)) (CC and) (NP (NN W3/25))))) (, ,) (NP (DT the) (`` ') (VBG accelerating) (`` ') (NN mAb) (NN RIB5/2))))) (VP (VP (VBD failed) (S (VP (TO to) (VP (VB increase) (NP (NP (NP (DT the) (JJ delayed-type) (NN hypersentivity)) (PRN (-LRB- -LRB-) (NP (NN DTH)) (-RRB- -RRB-))) (PP (TO to) (NP (FW Mycobacterium) (FW tuberculosis)))))))) (, ,) (VP (VBD increased) (NP (NP (NP (DT the) (ADJP (FW in) (FW vitro)) (NN tumor) (NN necrosis) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN TNF)) (-RRB- -RRB-))) (NN -α) (NN secretion))) (, ,) (CC and) (VP (ADVP (RBR more) (RB strongly)) (VBD induced) (NP (JJ NF-κB) (NN binding) (NN activity)) (PP (IN after) (NP (NP (JJ anti-CD4) (NN preincubation)) (CC and) (NP (NP (JJ subsequent) (NN TCR/CD3-stimulation.)) (S (PP (VBG Depending) (PP (IN on) (NP (PRP$ their) (NN epitope) (NN specificity)))) (, ,) (NP (JJ different) (JJ anti-CD4) (NNS mAbs)) (ADVP (RB differentially)) (VP (VBP influence) (NP (NP (JJ individual) (JJ proinflammatory) (NNS functions)) (PP (IN of) (NP (NN T) (NNS cells)))))))))))))))) (. .)))
( (S (S (NP (DT This) (JJ fine) (NN regulation)) (VP (VP (MD may) (VP (VB explain) (NP (NP (DT the) (JJ differential) (NN efficacy)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NN AA)))))))) (CC and) (VP (MD may) (VP (VB contribute) (PP (TO to) (NP (NP (DT the) (NN understanding)) (PP (IN of) (NP (NP (JJ such) (NNS treatments)) (PP (IN in) (NP (JJ other) (NNS immunopathologies))))))))))) (. .)))
( (S (NP (NN Introduction))))
( (S (S (NP (NP (JJ CD4+) (NN T) (NNS cells)) (CC and) (NP (PRP$ their) (NN cytokine) (NNS products))) (VP (VBP play) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (JJ rheumatoid) (NN arthritis)) (CC and) (NP (NP (JJ experimental) (NNS models)) (PP (IN of) (NP (NN arthritis)))))) (, ,) (S (ADVP (RB therefore)) (VP (VBG representing) (NP (NP (JJ potential) (JJ therapeutic) (NNS targets)) (CD -LSB-1) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (DT A) (JJ specific) (JJ therapeutic) (NN approach)) (VP (VBZ is) (NP (NP (DT the) (JJ direct) (NN targeting)) (PP (IN of) (NP (JJ CD4+) (NN T) (NNS cells))) (PP (IN by) (NP (NP (NN use)) (PP (IN of) (NP (NP (NP (JJ monoclonal) (NNS antibodies)) (PRN (-LRB- -LRB-) (NP (NNS mAbs)) (-RRB- -RRB-))) (PP (IN against) (NP (DT the) (NN CD4) (NN coreceptor)))))))))) (. .)))
( (S (S (NP (JJ Anti-CD4) (NNS mAbs)) (VP (VBP induce) (NP (CC either) (NP (NN cell) (NN depletion) (NN -LSB-2) (-RRB- -RSB-)) (CC or) (NP (NP (JJ functional) (NN inactivation)) (PP (IN of) (NP (NN T) (NNS cells)))) (NP (NN -LSB-3,4)) (-RRB- -RSB-)) (, ,) (SBAR (IN although) (S (NP (NP (NN activation)) (PP (IN of) (NP (NN T-cell) (NNS functions)))) (VP (VBZ has) (ADVP (RB also)) (VP (VBN been) (VP (VBN reported) (S (NP (NN -LSB-5)) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (DT These) (JJ contrasting) (NNS effects)) (VP (MD may) (VP (VB explain) (NP (NP (DT the) (NN variability)) (PP (IN in) (NP (NP (DT the) (JJ clinical) (NN efficacy)) (PP (IN of) (NP (JJ different) (JJ anti-CD4) (NNS mAbs)))))) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (JJ rheumatoid) (NN arthritis)) (PRN (, ,) (PP (FW i.e.) (NP (NP (JJ promising) (JJ initial) (NN efficacy)) (PP (IN in) (NP (NP (NP (JJ open) (JJ anti-CD4) (NNS trials)) (CD -LSB-6,7) (-RRB- -RSB-)) (, ,) (NP (NP (JJ subsequent) (JJ disappointing) (JJ double-blind) (JJ clinical) (NNS trials)) (PRN (-LRB- -LRB-) (VP (VBN reviewed) (PP (IN in) (NP (NN -LSB-8)))) (-RRB- -RSB-) (-RRB- -RRB-))) (, ,) (CC and) (, ,) (ADVP (RB finally)) (, ,) (NP (NP (DT a) (NN revival)) (PP (IN of) (NP (NP (DT the) (JJ anti-CD4) (NN treatment) (NN principle)) (PP (IN with) (NP (ADJP (ADJP (JJ new)) (, ,) (ADJP (JJ humanized))) (JJ anti-CD4) (NNS mAbs)))))))))) (NP (NN -LSB-9,10)) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN focus)) (PP (IN of) (NP (DT the) (JJ present) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB analyze) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (DT the) (JJ anti-CD4) (NNS mAbs)) (NP (NP (NN W3/25)) (, ,) (NP (NN OX35)) (, ,) (CC and) (NP (NN RIB5/2))))) (PP (IN in) (NP (NP (NP (NN rat) (JJ adjuvant) (NN arthritis)) (PRN (-LRB- -LRB-) (NP (NN AA)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (JJ well-known) (, ,) (RB clearly) (JJ CD4+) (JJ T-cell-dependent) (JJ experimental) (NN arthritis) (NN model)) (CD -LSB-11-13) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (NP (DT These) (NNS mAbs)) (VP (VP (VBP target) (NP (NP (JJ different) (NNS epitopes)) (PP (IN of) (NP (DT the) (NN CD4) (NN molecule))))) (CC and) (VP (VBP do) (RB not) (VP (VB compete) (PP (IN for) (NP (NN CD4) (NN binding) (CD -LSB-14) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (PRP They)) (VP (VBP are) (ADJP (RB equally) (JJ effective) (PP (IN in) (S (VP (VBG suppressing) (NP (NN AA)) (PP (IN upon) (NP (NP (NN treatment)) (PP (IN of) (NP (NP (JJ established) (NN disease) (CD -LSB-11,12) (-RRB- -RSB-)) (PRN (-LRB- -LRB-) (CC and) (NP (NNS authors) (NP (JJ own) (JJ unpublished) (NNS observations))) (-RRB- -RRB-)))))))))))) (. .)))
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (JJ preventive) (NN treatment)) (PP (IN with) (NP (NP (DT the) (JJ anti-CD4) (NNS mAbs)) (NP (NP (NN W3/25)) (, ,) (NP (NN OX35)) (, ,) (CC and) (NP (NP (NN RIB5/2)) (PRN (-LRB- -LRB-) (UCP (PP (PP (IN on) (NP (NP (NNS days)) (PP (NP (QP (CD -1) (, ,) (CD 0) (, ,) (CD 3) (, ,) (CC and) (CD 6) (, ,) (FW i.e.) (CD 1)) (NN day)) (IN before) (NP (NN AA) (NN induction))))) (, ,) (PP (IN on) (NP (DT the) (NN day))) (PP (IN of) (NP (NN induction) (NN -LSB-day) (CD 0))) (-RRB- -RSB-)) (, ,) (CC and) (ADVP (RB thereafter))) (-RRB- -RRB-))))))) (VP (VBD had) (NP (JJ opposite) (NNS effects)) (PP (IN in) (NP (NP (DT the) (NN induction) (NN phase)) (PP (IN of) (NP (NN AA)))))) (. .)))
( (S (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB explain) (NP (DT this) (JJ differential) (NN efficacy)))))) (, ,) (NP (JJ several) (NNS parameters)) (VP (VBD were) (VP (VBN analyzed)))) (. .)))
( (S (NP (NNS Methods))))
( (S (S (PP (IN For) (NP (NNS animals))) (, ,) (NP (NP (NN arthritis) (NN model)) (, ,) (NP (NNS antibodies)) (, ,) (CC and) (NP (NP (NN affinity) (NN determination)) (PRN (-LRB- -LRB-) (NP (NN surface) (NN plasmon) (NN resonance)) (-RRB- -RRB-))) (, ,)) (VP (VB see) (NP (JJ Supplementary) (NN material)))) (. .)))
( (S (S (S (NP (NN T-cell) (NN reactivity)) (VP (VBD was) (VP (VBN measured) (ADVP (FW in) (FW vivo)) (PP (PP (IN by) (NP (NP (JJ delayed-type) (NN hypersensitivity)) (PRN (-LRB- -LRB-) (NP (NN DTH)) (-RRB- -RRB-)))) (CC and) (ADVP (FW in) (FW vitro)) (PP (IN by) (NP (NP (NN proliferation) (NN assay)) (CC or) (NP (JJ mixed) (NN lymphocyte) (NN culture)))))))) (, ,) (CC and) (S (NP (NNS cytokines)) (VP (VBD were) (VP (VBN measured) (PP (IN by) (NP (NP (NN bioassay)) (CC or) (NP (NN ELISA)))) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (NP (JJ Supplementary) (NN material) (: ;)) (PP (IN for) (NP (NP (NP (NN tumor) (NN necrosis) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN TNF)) (-RRB- -RRB-))) (NN -α) (NN -LSB-15)))))) (-RRB- -RSB-) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NNS Cells)) (VP (VBD were) (VP (VBN stimulated) (PP (IN by) (NP (NP (NP (NN preincubation)) (PP (IN with) (NP (JJ anti-CD4) (NNS mAbs)))) (CC and) (NP (NP (JJ subsequent) (NN stimulation)) (PP (IN of) (NP (NN T-cell) (NNS receptors))))))))) (. .)))
( (S (S (NP (NP (JJ Electrophoretic) (NN mobility) (NN shift) (NN assay)) (PRN (-LRB- -LRB-) (NP (NN EMSA)) (-RRB- -RRB-))) (VP (VBD was) (SBAR (IN as) (S (VP (VBN described) (PP (IN in) (NP (DT the) (JJ Supplementary) (NN material)))))))) (. .)))
( (S (PP (IN For) (NP (JJ statistical) (NN analysis))) (, ,) (NP (PRP we)) (VP (VBD used) (NP (NP (DT the) (ADJP (NN Mann–Whitney) (-LRB- -LRB-) (NN U) (-RRB- -RRB-) (JJ test/Spearman)) (NN rank) (NN correlation)) (PRN (-LRB- -LRB-) (NP (NN P) (NN ≤) (CD 0.05)) (: ;) (S (VP (VB see) (NP (JJ Supplementary) (NN material)))) (-RRB- -RRB-)))) (. .)))
( (S (NP (NNS Results))))
( (S (NP (NP (JJ Preventive) (NN treatment)) (PP (IN with) (NP (DT the) (JJ anti-CD4) (NNS mAbs) (NP (NP (CD W3/25)) (CC and) (NP (CD OX35)))))) (VP (VBD led) (PP (TO to) (NP (NP (DT a) (ADJP (ADJP (JJ marked)) (, ,) (ADJP (JJ significant))) (NN suppression)) (PP (IN of) (NP (NP (DT the) (NN arthritis) (NN score)) (PP (IN from) (NP (NN day) (CD 13) (TO to) (CD 30))))) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (NP (JJ PBS-treated) (NNS animals)) (PRN (-LRB- -LRB-) (NP (NP (NN P)) (: ≤) (NP (CD 0.05)) (: ;) (NP (NNP Fig.) (CD 1))) (-RRB- -RRB-))))))))) (. .)))
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (DT the) (JJ anti-CD4) (NN mAb) (NN RIB5/2)) (ADVP (RB significantly)) (VP (VP (VBN accelerated) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (DT the) (NN arthritis))) (PP (IN by) (NP (NP (QP (RB approximately) (CD 2)) (NNS days)) (PRN (-LRB- -LRB-) (NP (NN P) (NN ≤) (CD 0.01)) (: ;) (NP (NNS days) (CD 11)) (, ,) (NP (CD 12)) (: ;) (S (VP (VB see) (NP (NNP Fig.) (CD 1)))) (-RRB- -RRB-)))))) (, ,) (VP (VBG resulting) (PP (IN in) (NP (NP (DT an) (VBN aggravated) (JJ clinical) (NN score)) (PP (IN on) (NP (DT these) (NNS days)))))) (, ,) (CC and) (VP (VBD ameliorated) (NP (JJ clinical) (NNS signs)) (PP (ADVP (RB only)) (IN from) (NP (NP (NN day) (CD 27)) (PRN (-LRB- -LRB-) (NP (NN P) (NN ≤) (CD 0.05)) (: ;) (S (VP (VB see) (NP (NNP Fig.) (CD 1)))) (-RRB- -RRB-)))))) (. .)))
( (S (S (S (NP (NP (DT The) (VBG accelerating) (NN effect)) (PP (IN of) (NP (DT the) (NN mAb) (NN RIB5/2)))) (VP (VBD was) (VP (VBN reproduced) (PP (IN in) (NP (CD two) (JJ additional) (NN treatment) (NNS experiments)))))) (, ,) (CC and) (S (NP (DT this) (NN effect)) (VP (VBD was) (VP (VBN observed) (PP (IN despite) (NP (NP (DT a) (JJ variable) (NN onset)) (PP (IN of) (NP (NN AA))))) (PP (IN in) (NP (NP (NP (DT the) (JJ PBS-treated) (NNS animals)) (PRN (-LRB- -LRB-) (NP (NN day) (CD 9) (TO to) (CD 11)) (-RRB- -RRB-))) (: ;) (NP (NP (FW i.e.)) (S (PP (IN in) (NP (DT all) (NNS experiments))) (, ,) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (NN AA)))) (VP (VBD occurred) (NP (NP (CD 2) (NNS days)) (ADJP (JJR earlier) (PP (IN than) (PP (IN in) (NP (DT the) (NNS controls))))))))))))))) (. .)))
( (S (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB identify) (NP (NP (JJ potential) (NNS mechanisms)) (PP (IN for) (NP (DT these) (JJ differential) (NNS effects)))))))) (, ,) (NP (NP (NP (DT the) (JJ molecular) (NNS properties)) (PP (IN of) (NP (DT the) (NNS mAbs)))) (CC and) (NP (NP (PRP$ their) (NN influence)) (PP (IN on) (NP (NN T-cell) (NN effector) (NNS functions)))) (ADVP (ADVP (FW in) (FW vivo)) (CC and) (ADVP (FW in) (FW vitro)))) (VP (VBD were) (VP (VBN investigated)))) (. .)))
( (S (PP (IN For) (NP (NP (DT the) (NN sake)) (PP (IN of) (NP (NN simplicity))))) (, ,) (NP (PRP we)) (VP (VBP refer) (PP (TO to) (NP (DT the) (NN mAb) (NN RIB5/2))) (PP (IN as) (NP (NP (NP (`` ') (NP (VBG accelerating)) ('' ')) (PRN (-LRB- -LRB-) (SBAR (IN although) (S (NP (DT this) (NN term)) (VP (VBZ is) (ADJP (JJ applicable) (PP (ADVP (RB only)) (TO to) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (NN AA))))))))) (-RRB- -RRB-))) (CC and) (NP (NP (DT the) (NNS mAbs) (NP (NP (CD W3/25)) (CC and) (NP (CD OX35)))) (ADJP (RB as) (`` ') (JJ ameliorating) ('' ')))))) (. .)))
( (S (S (NP (NP (NN Calculation)) (PP (IN of) (NP (NP (DT the) (NN affinity) (NN constant)) (PRN (-LRB- -LRB-) (NP (NN KA)) (-RRB- -RRB-))))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ comparable) (NNS values)) (PP (IN for) (NP (NP (NP (NN OX35)) (CC and) (NP (NN RIB5/2))) (PRN (-LRB- -LRB-) (VP (VB see) (NP (NN Supplementary) (NN Table) (CD 1))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (DT the) (NN affinity)) (PP (IN of) (NP (NN W3/25)))) (VP (VBD was) (ADVP (RB 50-fold)) (NP (NP (DT that)) (PP (IN for) (NP (DT the) (CD two) (JJ other) (NNS mAbs)))))) (. .)))
( (S (S (SBAR (IN While) (S (NP (NP (NP (DT the) (NN association) (NN rate) (NNS constants)) (PRN (-LRB- -LRB-) (NP (NN kass)) (-RRB- -RRB-))) (PP (IN for) (NP (DT all) (CD three) (NNS mAbs)))) (VP (VBD were) (PP (IN within) (NP (NP (DT the) (JJ same) (NN order)) (PP (IN of) (NP (NN magnitude)))))))) (, ,) (NP (NP (JJ striking) (NNS differences)) (PRN (-LRB- -LRB-) (NP (CD up) (TO to) (RB 40-fold)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN observed) (PP (IN for) (NP (NP (DT the) (NN dissociation) (NN rate) (NNS constants)) (PRN (-LRB- -LRB-) (NP (NN kdiss)) (-RRB- -RRB-))))))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (SBAR (IN although) (S (NP (NP (NNS differences)) (PP (IN in) (NP (JJ overall) (NN affinity)))) (VP (VBD did) (RB not) (VP (VBP match) (NP (JJ differential) (JJ clinical) (NN efficacy)))))) (, ,) (NP (DT the) (VBG accelerating) (NN mAb) (NN RIB5/2)) (VP (VBD displayed) (NP (DT the) (JJS highest) (NN kdiss)))) (. .)))
( (S (S (NP (NN T-cell) (NN reactivity)) (VP (VBD was) (VP (VBN investigated) (PP (IN on) (NP (NP (NN day) (CD 13)) (PP (IN of) (NP (NN AA))))) (, ,) (PP (FW i.e.))) (SBAR (WHADVP (WRB when)) (S (NP (NP (DT the) (JJ clinical) (NNS differences)) (PP (IN between) (NP (DT the) (ADJP (ADJP (VBG accelerating)) (CC and) (ADJP (VBG ameliorating))) (JJ anti-CD4) (NNS mAbs)))) (VP (VBD were) (ADJP (JJ maximal))))))) (. .)))
( (S (PP (VBN Compared) (PP (TO to) (NP (DT the) (JJ PBS-treated) (NN control) (NN group)))) (, ,) (NP (DT the) (JJ ameliorating) (NN mAb) (NN OX35)) (VP (VBD induced) (NP (NP (DT a) (JJ significant) (NN increase)) (PP (IN of) (NP (DT the) (NN DTH)))) (PP (IN in) (NN response) (TO to) (NP (NP (DT the) (JJ arthritogen) (NN Mycobacterium) (NN tuberculosis)) (PRN (-LRB- -LRB-) (NP (NP (NN Supplementary)) (NP (NNP Fig.) (CD 1))) (-RRB- -RRB-))))) (. .)))
( (S (S (S (NP (NP (DT The) (JJ other) (JJ ameliorating) (JJ anti-CD4) (NN mAb)) (, ,) (NP (NN W3/25)) (, ,)) (ADVP (RB also)) (VP (VBD induced) (NP (DT an) (NN increase)))) (, ,) (CC but) (S (NP (JJ statistical) (NN significance)) (VP (VBD was) (RB not) (VP (VBN reached))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NN treatment)) (PP (IN with) (NP (NP (DT the) (VBG accelerating) (JJ anti-CD4) (NN mAb)) (, ,) (NP (NN RIB5/2)) (, ,)))) (VP (VBD had) (ADVP (RB virtually)) (NP (NP (DT no) (NN influence)) (PP (IN on) (NP (DT the) (NN DTH)))))) (. .)))
( (S (PP (IN Upon) (NP (NP (NN stimulation)) (PP (IN with) (NP (NP (NN concanavalin) (NN A)) (PRN (-LRB- -LRB-) (NP (NN ConA)) (-RRB- -RRB-)))))) (, ,) (NP (NP (JJ total) (NN T) (NNS cells)) (PP (IN from) (NP (JJ RIB5/2-treated) (NNS animals)))) (VP (VBD showed) (NP (JJR lower) (NN proliferation) (NNS rates)) (PP (IN than) (NP (NP (DT those)) (PP (IN from) (NP (NP (ADJP (ADJP (JJ W3/25-)) (CC or) (ADJP (JJ OX35-treated))) (NNS rats)) (PRN (-LRB- -LRB-) (NP (NP (NN Supplementary)) (NP (NNP Fig.) (CD 2))) (-RRB- -RRB-))))))) (. .)))
( (S (S (PP (IN In) (NP (DT the) (JJ mixed) (NN lymphocyte) (NN culture))) (, ,) (NP (NN RIB5/2)) (VP (VBD was) (ADVP (RB also)) (NP (NP (DT the) (ADJP (RBS most) (JJ potent)) (NN inhibitor)) (PP (IN of) (NP (NN T-cell) (NN activation)))) (PP (IN in) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (JJ total) (NN T) (NNS cells))))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (DT this)) (VP (VBD was) (RB not) (VP (VBN observed) (PP (IN in) (NP (NP (VBN purified) (JJ CD4+) (NN T) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NP (NN Supplementary)) (NP (NNP Fig.) (CD 4))) (-RRB- -RRB-))))))) (. .)))
( (S (S (S (S (VP (TO To) (VP (VB simulate) (NP (DT the) (JJ preventive) (JJ therapeutic) (NN application)) (PP (IN in) (NP (NP (NNS AA)) (, ,) (PP (FW i.e.) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (JJ CD4+) (NN T) (NNS cells))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ anti-CD4) (NNS mAbs)))))))))))) (, ,) (NP (VBN purified) (NN spleen) (JJ CD4+) (NN T) (NNS cells)) (VP (VBD were) (VP (VBN incubated) (PP (IN with) (NP (JJ anti-CD4) (NN mAb)))))) (CC and) (S (, ,) (PP (IN after) (NP (NN cross-linking))) (, ,) (VP (VBN stimulated) (PP (IN with) (NP (NP (JJ plate-bound) (NN anti-T-cell-receptor) (-LRB- -LRB-) (NN TCR) (-RRB- -RRB-) (NN α/β) (NN mAb)) (PRN (-LRB- -LRB-) (NP (ADJP (RB so) (VBN called)) (JJ anti-CD4) (NN preincubation)) (-RRB- -RRB-))))))) (. .)))
( (S (ADVP (RB Interestingly)) (, ,) (NP (NP (JJ anti-CD4) (NN preincubation)) (PP (IN with) (NP (DT the) (VBG accelerating) (JJ anti-CD4) (NN mAb) (CD RIB5/2)))) (VP (VBD led) (PP (TO to) (NP (NP (DT a) (ADJP (RB significantly) (JJR higher)) (NN TNF-α) (NN secretion)) (, ,) (PP (IN in) (NP (NP (NN comparison)) (PP (CC both) (PP (IN with) (NP (DT the) (NN isotype) (NN control))) (CC and) (PP (IN with) (NP (DT the) (CD two) (JJ other) (JJ anti-CD4) (NNS mAbs)))))) (, ,) (NP (NP (NP (NN W3/25)) (CC and) (NP (NN OX35))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 2)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NP (JJ Differential) (NN induction)) (PP (IN of) (NP (NN TNF-α))) (PP (IN by) (NP (NN RIB5/2)))) (VP (VBD was) (ADVP (RB also)) (VP (VBN seen) (PP (IN after) (NP (NN CD4-cross-linking))) (PP (PP (IN on) (NP (NP (DT the) (JJ CD4+) (NN T-cell) (NN clone)) (NN A2b))) (CC or) (PP (IN on) (NP (NP (JJ TCR-stimulated) (JJ CD4+) (NN T-cell) (NNS blasts)) (PRN (-LRB- -LRB-) (NP (NP (DT both) (NNS data) (NNS sets)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (PP (IN For) (NP (NP (NN IFN-γ)) (, ,) (NP (NN IL-10)) (, ,) (CC and) (NP (NN IL-4)))) (, ,) (VP (VB see) (NP (JJ Supplementary) (NN material)))) (. .)))
( (S (S (SBAR (IN Because) (S (NP (DT the) (CD three) (JJ anti-CD4) (NNS mAbs)) (VP (VBP recognize) (NP (NP (JJ distinct) (NNS epitopes)) (PP (IN of) (NP (NP (DT the) (NN CD4) (NN molecule)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NN signaling) (NNS cascades))))))))))))) (, ,) (NP (NP (DT the) (NN influence)) (PP (IN of) (NP (DT these) (NNS mAbs))) (PP (IN on) (NP (JJ early) (NN signaling) (NNS events)))) (VP (VBD was) (ADVP (RB also)) (VP (VBN investigated)))) (. .)))
( (S (S (NP (NP (DT No) (NN influence)) (PP (IN at) (NP (NP (DT all)) (PP (IN of) (NP (DT the) (JJ anti-CD4) (NNS mAbs)))))) (VP (VBD was) (VP (VBN found) (PP (IN for) (NP (NP (NP (NN calcium) (NN influx)) (PRN (-LRB- -LRB-) (NP (JJ primary) (JJ CD4+) (NN spleen) (NN T) (NNS cells)) (-RRB- -RRB-))) (, ,) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NP (JJ src-homology-domain-containing) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN Shc)) (-RRB- -RRB-))))) (, ,) (CC or) (NP (NP (DT the) (NN translocation)) (PP (IN of) (NP (NP (NP (JJ nuclear) (NN factor) (IN of) (VBN activated) (NN T) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN NF-AT)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (CC both) (NP (JJ primary) (JJ CD4+) (NN T) (NNS cells)) (CC and) (NP (NN clone) (NN A2b))) (-RRB- -RRB-))))) (, ,) (CC and) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NP (NN p59fyn)) (PRN (-LRB- -LRB-) (NP (NN A2b)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN activity)) (PP (IN of) (NP (DT the) (JJ CD4-associated) (NN p56lck))) (PP (IN after) (NP (NP (NN CD4) (NN cross-linking)) (PRN (-LRB- -LRB-) (NP (NN A2b)) (-RRB- -RRB-))))) (VP (VBD was) (ADVP (RB comparably)) (VP (VBN increased) (PP (IN by) (NP (DT all) (CD three) (JJ anti-CD4) (NNS mAbs))) (PRN (-LRB- -LRB-) (S (NP (DT all) (DT the) (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (NP (DT The) (NN binding) (NNS activities)) (PP (IN of) (NP (NP (DT the) (NN transcription) (NNS factors)) (NP (NP (NP (NN activator) (NN protein-1)) (PRN (-LRB- -LRB-) (NP (NN AP-1)) (-RRB- -RRB-))) (CC and) (NP (NN NF-κB)))))) (VP (VBD were) (VP (VBN determined) (PP (IN in) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN of) (NP (NP (NN spleen) (JJ CD4+) (NN T) (NNS cells)) (VP (VBN preincubated) (PP (IN with) (NP (JJ anti-CD4) (NNS mAbs))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN activity)) (PP (IN of) (NP (NN AP-1)))) (VP (VBD was) (ADVP (ADVP (RB slightly)) (CC but) (ADVP (RB significantly))) (VP (VBN decreased) (PP (IN by) (NP (NP (NN pretreatment)) (PP (IN with) (NP (DT all) (CD three) (JJ anti-CD4) (NNS mAbs))))) (, ,) (PP (TO to) (NP (NP (DT a) (JJ similar) (NN degree)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 3)) (-RRB- -RRB-))))))) (. .)))
( (S (ADVP (RB Interestingly)) (, ,) (NP (NP (NN preincubation)) (PP (IN with) (NP (NP (DT the) (VBG accelerating) (JJ anti-CD4) (NN mAb)) (, ,) (NP (NN RIB5/2)) (, ,)))) (VP (VBD induced) (NP (NP (DT a) (ADJP (RB significantly) (JJR higher)) (NN binding) (NN activity)) (PP (IN of) (NP (NN NF-κB)))) (SBAR (IN than) (SINV (VBD did) (NP (NP (NN preincubation)) (PP (IN with) (NP (NP (DT the) (NP (JJ ameliorating) (NN W3/25)) (CC and) (NP (NN OX35))) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB only) (RB moderately)) (VP (VBD increased) (NP (DT the) (JJ NF-κB) (NN binding) (NN activity)) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (NNP Fig.) (CD 3)))) (-RRB- -RRB-))))))))))) (. .)))
( (S (NP (NN Discussion))))
( (S (S (NP (DT The) (JJ present) (NN study)) (VP (VBZ shows) (NP (NP (JJ differential) (JJ clinical) (NN efficacy)) (PP (IN of) (NP (CD three) (JJ anti-CD4) (NNS mAbs))) (PP (IN in) (NP (NP (DT the) (JJ preventive) (NN treatment)) (PP (IN of) (NP (NN AA)))))))) (. .)))
( (S (S (NP (NP (DT The) (NN lack)) (PP (IN of) (NP (NP (JJ differential) (JJ clinical) (NN efficacy)) (PP (IN of) (NP (DT the) (JJ same) (NNS mAbs))) (PP (IN in) (NP (JJ established) (NNS AA)))))) (VP (MD may) (VP (VB be) (VP (VBN explained) (PP (IN by) (NP (NP (DT a) (ADJP (RB completely) (JJ divergent)) (JJ immunological) (NN constellation)) (PP (IN in) (NP (NP (NN connection)) (PP (IN with) (NP (NP (DT the) (JJ known) (JJ differential) (NNS effects)) (PP (IN of) (NP (JJ anti-CD4) (NNS mAbs))) (PP (IN on) (NP (NP (ADJP (JJ naive))) (CC and) (NP (NN memory)) (NP (NN T) (NNS cells)))))))))))))) (. .)))
( (S (SBAR (IN Although) (S (NP (NP (JJ successful) (NN treatment)) (PP (IN with) (NP (JJ anti-CD4) (NNS mAbs)))) (VP (VBZ has) (VP (VBN been) (VP (VBN achieved) (PP (IN in) (NP (JJ various) (NN arthritis) (NNS models)))))) (LST (CD -LSB-12,16-18) (-RRB- -RSB-)))) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (DT no) (NN evidence)) (PP (IN for) (NP (NP (DT a) (JJ differential) (NN efficacy)) (PP (IN of) (NP (JJ anti-CD4) (NNS mAbs))) (PP (IN in) (NP (NP (NN arthritis) (NNS models)) (PP (TO to) (NP (NN date))))))))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (NP (DT this) (NN finding)) (VP (MD may) (VP (VB represent) (NP (NP (DT the) (JJ experimental) (NN counterpart)) (PP (IN of) (NP (NP (DT the) (VBG conflicting) (NNS results)) (VP (VBN observed) (ADVP (RB thus) (RB far)) (PP (IN in) (NP (NP (NNS studies)) (PP (IN of) (NP (JJ human) (JJ rheumatoid) (NN arthritis) (CD -LSB-6,8,10))))))))))) (-RRB- -RSB-)) (. .)))
( (S (S (PP (IN In) (NN contrast) (TO to) (NP (NP (DT a) (VBN reported) (NN study)) (PP (IN of) (NP (NP (JJ experimental) (JJ allergic) (NN encephalomyelitis)) (CD -LSB-19) (-RRB- -RSB-))))) (, ,) (NP (DT the) (JJ present) (NN study)) (VP (VBD did) (RB not) (VP (VB confirm) (NP (NP (DT a) (NN role)) (PP (IN for) (NP (DT the) (NN mAb) (NN isotype))) (PP (IN in) (NP (NN AA))))) (, ,) (SBAR (IN as) (S (NP (NP (DT the) (NNS isotypes)) (PP (IN of) (NP (DT the) (CD three) (JJ anti-CD4) (NNS mAbs)))) (VP (VBD did) (RB not) (VP (VBP match) (NP (NP (PRP$ their) (JJ differential) (JJ preventive) (NNS effects)) (PP (IN in) (NP (NN AA)))))))))) (. .)))
( (S (S (NP (DT The) (JJ ameliorating) (NN mAb) (NN W3/25)) (VP (VBD had) (NP (DT a) (ADJP (RB very) (JJ high)) (NN affinity)) (, ,) (SBAR (IN as) (S (ADVP (RB previously)) (VP (VBN reported) (NP (CD -LSB-20) (-RRB- -RSB-)) (, ,) (SBAR (IN whereas) (S (NP (NP (DT the) (NN affinity)) (PP (IN of) (NP (NP (DT the) (JJ other) (JJ ameliorating) (NN mAb)) (, ,) (NP (NN OX35)) (, ,)))) (VP (VBD was) (ADJP (JJ comparable) (PP (TO to) (NP (NP (DT that)) (PP (IN of) (NP (NP (DT the) (VBG accelerating) (NN mAb)) (, ,) (NP (NN RIB5/2))))))))))))))) (. .)))
( (S (S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP (NP (DT a) (NN contribution)) (PP (IN of) (NP (NP (DT the) (ADJP (RB strikingly) (JJR higher)) (NN kdiss)) (PP (IN of) (NP (DT the) (NN mAb) (NN RIB5/2))))) (PP (TO to) (NP (PRP$ its) (JJ differential) (JJ clinical) (NNS effects)))) (VP (MD cannot) (VP (VB be) (VP (VBN excluded))) (, ,) (PP (IN in) (NN analogy) (TO to) (NP (NP (ADJP (ADJP (JJ high)) (CC and) (ADJP (JJ low))) (NN kdiss)) (PP (IN for) (NP (NP (ADJP (ADJP (JJ agonistic)) (CC and) (ADJP (JJ antagonistic))) (NNS TCR-peptides)) (, ,) (ADVP (RB respectively)) (NP (CD -LSB-21) (-RRB- -RSB-)))))))) (. .)))
( (S (S (PP (IN In) (NP (NP (NN spite)) (PP (IN of) (NP (DT these) (NNS considerations))))) (, ,) (NP (NP (NN recognition)) (PP (IN of) (NP (JJ different) (NNS epitopes))) (PP (IN by) (NP (DT the) (NNS mAbs) (NP (NP (CD -LSB-14) (-RRB- -RSB-)) (, ,) (PP (IN with) (NP (NP (JJ distinct) (JJ functional) (NNS consequences)) (PP (IN for) (NP (DT the) (NN target) (NNS cells))))) (, ,))))) (VP (VBZ remains) (NP (NP (DT the) (ADJP (RBS most) (JJ likely)) (NN explanation)) (PP (IN for) (NP (PRP$ their) (JJ differential) (JJ clinical) (NN efficacy) (CD -LSB-22))))) (-RRB- -RSB-)) (. .)))
( (S (SBAR (IN While) (S (NP (NP (DT the) (VBG binding) (NNS sites)) (PP (IN of) (NP (NP (NN W3/25)) (CC and) (NP (NN OX35))))) (VP (VBP are) (ADJP (JJ situated) (PP (IN in) (NP (NP (NP (DT the) (NN C´–C´´) (NN region)) (PP (IN of) (NP (NN domain) (NN D1)))) (CC and) (NP (NP (DT the) (NN B–C) (NN region)) (PP (IN of) (NP (NP (NP (NN domain) (NN D2)) (PP (IN of) (NP (DT the) (NN CD4) (NN molecule)))) (, ,) (ADVP (RB respectively)) (NP (NN -LSB-23))))))))) (-RRB- -RSB-))) (, ,) (NP (PRP we)) (VP (MD could) (ADVP (RB roughly)) (VP (VB localize) (NP (NP (DT the) (NN epitope)) (PP (IN of) (NP (NN RIB5/2)))) (PP (IN in) (NP (NP (DT the) (NN F–G) (NN region)) (PP (IN of) (NP (NN domain) (NN D1))))) (, ,) (SBAR (IN as) (S (VP (VBN demonstrated) (PP (IN by) (NP (NP (JJ effective) (NN competition)) (PP (IN with) (NP (NP (DT the) (NN mAb) (NN OX65)) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))) (, ,) (VP (VBN known) (S (VP (TO to) (VP (VB bind) (NP (NP (DT this) (NN region)) (PP (IN of) (NP (DT the) (NN CD4) (NN molecule) (CD -LSB-23) (-RRB- -RSB-))))))))))))))) (. .)))
( (S (S (NP (NP (NN Binding)) (PP (IN of) (NP (JJ anti-CD4) (NNS mAbs))) (PP (TO to) (NP (NP (JJ separate) (NNS epitopes)) (PP (IN of) (NP (DT the) (NN CD4) (NN molecule)))))) (VP (MD could) (VP (VB result) (PP (IN in) (NP (NP (JJ differential) (NNS effects)) (PP (IN on) (NP (NN T-cell) (NNS functions))))) (PP (IN by) (S (VP (VBG inducing) (NP (NP (NP (JJ distinct) (JJ conformational) (NNS changes)) (PP (IN of) (NP (DT the) (JJ extracellular)))) (CC and) (NP (NP (DT the) (JJ intracellular) (NNS parts)) (PP (IN of) (NP (DT the) (NN CD4)))))))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (VBN modified) (NN interaction)) (PP (IN with) (NP (JJ other) (VBG signaling) (NNS molecules)))))))) (, ,) (SBAR (IN as) (S (VP (VBZ has) (VP (VBN been) (VP (VBN discussed) (ADVP (RB recently)) (PP (IN with) (NP (NP (NN regard)) (PP (TO to) (NP (DT the) (NN aspartate) (NN receptor) (CD -LSB-24) (-RRB- -RSB-)))))))))))) (. .)))
( (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (NP (DT the) (JJ ameliorating) (JJ anti-CD4) (NNS mAbs)) (NP (NP (NP (NN W3/25)) (CC and) (NP (NN OX35))) (PRN (-LRB- -LRB-) (CONJP (CC but) (RB not)) (NP (NP (DT the) (VBG accelerating) (NN mAb)) (, ,) (NP (NN RIB5/2))) (-RRB- -RRB-)))) (ADVP (RB numerically/significantly)) (VP (VBD increased) (NP (NP (DT the) (NN DTH)) (PP (TO to) (NP (DT the) (NN arthritogen) (NN M.) (NN tuberculosis))))) (. .)))
( (S (S (PP (IN In) (NP (DT the) (JJ total) (NN T-cell) (NN population))) (, ,) (NP (NP (CD two)) (PP (IN of) (NP (NP (DT the) (CD three) (JJ anti-CD4) (NNS mAbs)) (-LRB- -LRB-) (PP (CC and) (PP (IN in) (NP (VBN purified) (JJ CD4+) (NN T) (NNS cells))) (, ,) (NP (DT all) (CD three) (JJ anti-CD4) (NNS mAbs))) (-RRB- -RRB-)))) (VP (VBD increased) (NP (NP (DT the) (ADJP (FW in) (FW vitro)) (NN reactivity)) (PP (TO to) (NP (NN ConA)))))) (. .)))
( (S (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (JJ CD4+) (NN T) (NNS cells))))) (, ,) (NP (DT this) (VBN increased) (NN reactivity)) (VP (VBD was) (ADVP (RB negatively)) (VP (VBN correlated) (PP (IN with) (NP (NP (DT the) (JJ clinical) (NN score)) (PP (IN of) (NP (JJ individual) (NNS animals)))))))) (. .)))
( (S (NP (NP (DT The) (JJ successful) (NN mode)) (PP (IN of) (NP (NP (NN action)) (PP (IN of) (NP (JJ anti-CD4) (NNS mAbs))) (PP (IN in) (NP (NNS arthritides)))))) (VP (MD may) (ADVP (RB therefore)) (VP (VB be) (VP (VBN based) (PP (IN on) (S (VP (VBG increasing) (NP (NP (NP (DT the) (NN reactivity)) (PP (IN of) (NP (NP (DT a) (NN subpopulation)) (PP (IN of) (NP (JJ regulatory) (NN T) (NNS cells)))))) (, ,) (NP (NP (DT an) (NN interpretation)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN supported) (PP (IN by) (NP (NP (LST (LS i) (-RRB- -RRB-)) (NP (DT the) (NN increase)) (PP (IN of) (NP (NN T-cell) (NN reactivity))) (PP (IN in) (NP (NP (DT some) (NNS patients)) (VP (ADVP (RB successfully)) (VBN treated) (PP (IN with) (NP (JJ anti-CD4) (NNS mAbs))) (PRN (NP (NN -LSB-6)) (-RRB- -RSB-) (, ,) (NP (LST (LS ii) (-RRB- -RRB-)) (NP (DT an) (VBN increased) (NN DTH)) (PP (TO to) (NP (NP (NNS antigens)) (PP (IN like) (NP (NP (NN tetanus) (NN toxoid)) (PP (IN in) (NP (ADJP (ADJP (RBR less) (JJ active)) (CC versus) (ADJP (JJ active))) (JJ rheumatoid) (NN arthritis) (CD -LSB-25)))))))) (-RRB- -RSB-)))))) (, ,) (NP (NP (LST (LS iii) (-RRB- -RRB-)) (NP (DT the) (VBN reduced) (NN responsiveness)) (PP (TO to) (NP (NP (JJ poly-specific) (NN stimulation)) (PP (IN of) (NP (NP (NN spleen) (NNS cells)) (PP (IN from) (NP (NP (NNS rats)) (PP (IN with) (NP (JJ acute) (NNS AA))))))))) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (JJ healthy) (NNS animals)))))) (CD -LSB-26) (-RRB- -RSB-)) (, ,) (CC and) (NP (LST (LS iv) (-RRB- -RRB-)) (NP (DT the) (ADJP (RB almost) (JJ complete)) (NN restoration)) (PP (IN of) (NP (NN T-cell) (NN responsiveness))) (PP (IN upon) (NP (NP (NN disease) (NN resolution/transition)) (PP (IN into) (NP (DT the) (JJ chronic) (NN phase) (NN -LSB-27)))))) (-RRB- -RSB-))))))))))))))) (. .)))
( (S (S (NP (DT The) (VBG accelerating) (NN mAb) (NN RIB5/2)) (ADVP (RB significantly)) (VP (VBD increased) (NP (NP (DT the) (NN secretion)) (PP (IN of) (NP (NN TNF-α)))) (, ,) (SBAR (IN as) (S (VP (VBN observed) (PP (IN in) (NP (JJ primary) (JJ CD4+) (NN T) (NNS cells))) (PP (CC both) (PP (IN upon) (NP (JJ anti-CD4) (NN preincubation))) (CC and) (PP (IN upon) (NP (NN CD4) (NN cross-linking))) (PP (IN after) (NP (NP (NN stimulation)) (PP (IN with) (NP (NN TCR)))))) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (NNP Fig.) (CD 2)))) (-RRB- -RRB-))))))) (. .)))
( (S (PP (IN In) (NP (NP (NN view)) (PP (IN of) (NP (NP (DT the) (JJ known) (ADJP (ADJP (JJ local)) (CC and) (ADJP (JJ systemic))) (NN importance)) (PP (IN of) (NP (NN TNF-α))) (PP (IN in) (NP (NP (JJ experimental) (NN AA) (NN -LSB-28-30) (-RRB- -RSB-)) (CC and) (NP (NP (JJ human) (JJ rheumatoid) (NN arthritis)) (CD -LSB-31) (-RRB- -RSB-)))))))) (, ,) (NP (DT this) (NN effect)) (VP (MD may) (VP (VB contribute) (PP (TO to) (NP (NP (DT the) (NN acceleration)) (PP (IN of) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (NN AA))))))) (PP (IN after) (NP (NP (NN pretreatment)) (PP (IN with) (NP (DT the) (NN mAb) (NN RIB5/2))))))) (. .)))
( (S (S (NP (DT This) (NN finding)) (VP (MD may) (VP (VB be) (ADJP (JJ important) (PP (IN for) (NP (NP (DT the) (NN understanding)) (PP (IN of) (NP (NP (NN pathogenesis)) (PP (IN in) (NP (NN arthritis)))))))) (PP (IN despite) (NP (NP (JJ predominant) (NN production)) (PP (IN of) (NP (NN TNF-α))) (PP (IN by) (NP (NP (NNS macrophages/monocytes)) (-LRB- -LRB-) (VP (VBN reviewed) (PP (IN in) (NP (NN -LSB-32)))) (-RRB- -RSB-) (-RRB- -RRB-))))) (, ,) (SBAR (IN since) (S (NP (NP (NN TNF-α) (NN production)) (PP (IN by) (NP (NN T) (NNS cells)))) (VP (VBZ has) (VP (VBN been) (VP (VBN demonstrated) (PP (CC both) (PP (IN in) (NP (NP (DT the) (JJ synovial) (NN membrane)) (CD -LSB-33) (-RRB- -RSB-))) (CC and) (PP (IN in) (NP (NP (JJ lymphoid) (NNS organs)) (PRN (-LRB- -LRB-) (NP (NNS authors) (NP (JJ own) (JJ unpublished) (NNS observations))) (-RRB- -RRB-))))))))))))) (. .)))
( (S (SBAR (IN Since) (S (NP (NN TNF-α) (NN production)) (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB be) (VP (VBN regulated) (ADVP (RB predominantly)) (PP (IN by) (NP (JJ NF-κB) (NN -LSB-34))) (-RRB- -RSB-))))))))) (, ,) (NP (PRP it)) (VP (VBD was) (S (VP (VBG revealing) (SBAR (IN that) (S (NP (NP (DT the) (VBG accelerating) (NN mAb)) (, ,) (NP (NN RIB5/2))) (, ,) (PP (IN besides) (S (VP (VBG inducing) (NP (NN TNF-α) (NN secretion))))) (, ,) (ADVP (RB also)) (VP (ADVP (RB strongly)) (VBD upregulated) (NP (JJ NF-κB) (NN binding) (NN activity)))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBD was) (ADJP (RB especially) (JJ striking)) (SBAR (IN because) (S (NP (NP (NN binding)) (PP (IN of) (NP (NP (NP (DT another) (JJ major) (NN transcription) (NN factor)) (VP (VBN involved) (PP (IN in) (NP (NN T-cell) (NN activation))))) (, ,) (NP (NN AP-1) (CD -LSB-35) (-RRB- -RSB-)) (, ,)))) (VP (VBD was) (ADVP (RB even) (RB slightly)) (VP (VBN downregulated) (PP (IN by) (NP (DT the) (JJ anti-CD4) (NNS mAbs))) (, ,) (PP (IN in) (NP (NP (NN line)) (PP (IN with) (NP (NP (ADJP (RB recently) (VBN published)) (NNS data)) (PRN (PP (IN in) (NP (JJ murine) (NNS cells))) (NP (NN -LSB-36)) (-RRB- -RSB-)))))))))))) (. .)))
( (S (S (NP (NP (DT These) (NNS findings)) (PP (IN in) (NP (PRP$ our) (NN study)))) (VP (VBP support) (, ,) (ADVP (RB again)) (, ,) (NP (DT the) (NN notion) (SBAR (IN that) (S (NP (NP (JJ NF-κB-mediated) (NN upregulation)) (PP (IN of) (NP (NP (JJ TNF-α) (NN secretion)) (PRN (-LRB- -LRB-) (CC or) (ADVP (RB vice) (RB versa)) (-RRB- -RRB-))))) (VP (MD may) (VP (VB contribute) (PP (TO to) (NP (NP (DT the) (NN acceleration)) (PP (IN of) (NP (NN disease) (NN onset))) (PP (IN in) (NP (NN AA))))) (PP (IN upon) (NP (NP (JJ preventive) (NN treatment)) (PP (IN with) (NP (NN RIB5/2)))))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ differential) (JJ clinical) (NN efficacy)) (PP (IN of) (NP (JJ anti-CD4) (NNS mAbs)))) (VP (VP (VBZ is) (RB not) (ADJP (JJ restricted) (PP (TO to) (NP (NN arthritis))))) (CC but) (VP (VBZ is) (ADVP (RB also)) (VP (VBN observed) (PP (IN in) (NP (NN transplantation) (NNS models))) (NP (CD -LSB-37)) (-RRB- -RSB-))))) (. .)))
( (S (ADVP (RB However)) (, ,) (SBAR (IN while) (S (NP (NP (JJ preventive) (NN treatment)) (PP (IN with) (NP (DT the) (JJ anti-CD4) (NN mAb) (NN RIB5/2)))) (VP (VBZ leads) (PP (TO to) (NP (NP (DT an) (NN acceleration)) (PP (IN of) (NP (NN AA)))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB very) (JJ effective)) (JJ anti-CD4) (NN mAb)) (PP (IN for) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NN tolerance))) (PP (IN in) (NP (NN transplantation) (NNS models) (CD -LSB-14,37) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBZ indicates) (SBAR (SBAR (IN that) (S (NP (NP (JJ clinical) (NN efficacy)) (-LRB- -LRB-) (CC and) (NP (PRP$ its) (NN time) (NN course)) (-RRB- -RRB-)) (VP (MD may) (VP (VB depend) (PP (IN on) (NP (DT the) (JJ actual) (JJ immunological) (NN constellation))))))) (CC and) (SBAR (IN that) (S (NP (DT a) (JJ given) (JJ anti-CD4) (NN mAb)) (VP (MD may) (VP (VB have) (NP (JJ beneficial) (NNS effects)) (PP (ADVP (RB only)) (IN in) (NP (NP (JJ particular) (NNS pathologies)) (CC and/or) (NP (NP (NNS stages)) (PP (IN of) (NP (NN disease))))))))))))) (. .)))
( (S (S (PP (IN From) (NP (NP (DT the) (NNS results)) (PP (IN of) (NP (DT the) (JJ present) (NN study))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ evident) (SBAR (IN that) (S (NP (NP (NP (DT the) (JJ individual) (NNS features)) (CC and) (NP (NNS effects))) (PP (IN of) (NP (DT a) (JJ particular) (JJ anti-CD4) (NN mAb)))) (VP (VBP have) (S (VP (TO to) (VP (VB be) (VP (VBN assessed) (PP (IN before) (NP (NP (NN treatment) (NNS trials)) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB predict) (NP (PRP$ its) (JJ clinical) (NN efficacy)) (ADVP (FW in) (FW vivo)))))))))))))))))) (. .)))
( (S (S (NP (DT This)) (VP (MD may) (VP (VB require) (NP (NP (JJ several) (ADJP (ADJP (FW in) (FW vivo)) (, ,) (ADJP (FW ex) (FW vivo)) (, ,) (CC or) (ADJP (FW in) (FW vitro))) (NNS assays)) (PP (IN of) (NP (NN T-cell) (NN function))) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB reveal) (NP (NP (JJ subtle) (NNS differences)) (PP (IN between) (NP (JJ anti-CD4) (NNS mAbs)))))))))))) (. .)))
( (S (S (NP (NP (JJ Experimental) (NNS models)) (PP (JJ such) (IN as) (NP (NP (JJ transgenic) (NNS mice)) (VP (VBG expressing) (NP (NP (ADJP (JJ human))) (CONJP (CC but) (RB not)) (NP (NN mouse)) (NP (NN CD4))))))) (VP (MD may) (VP (VB make) (NP (NP (PRP it)) (ADJP (JJ possible) (S (VP (TO to) (VP (VB address) (NP (JJ such) (NNS questions)) (PP (IN in) (NP (DT the) (JJ future) (NN -LSB-38))))) (-RRB- -RSB-))))))) (. .)))
( (S (ADVP (RB Recently)) (, ,) (NP (JJ preclinical) (NN testing)) (VP (VBZ has) (VP (VBN been) (VP (VBN exploited) (PP (IN in) (NP (JJ murine) (JJ CD4-knockout/human) (JJ CD4-transgenic) (-LRB- -LRB-) (JJ huCD4-transgenic) (-RRB- -RRB-) (NNS systems))) (S (VP (TO to) (VP (VB assess) (NP (NP (DT the) (JJ immunological) (NNS effects)) (PP (IN of) (NP (DT a) (JJ particular) (NN anti-human-CD4) (NN mAb))) (PP (IN in) (NP (JJ various) (NN disease) (NNS models) (CD -LSB-39,40) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (NP (JJ Analogous) (JJ preclinical) (NN testing)) (VP (MD may) (VP (VB prove) (ADJP (JJ useful) (PP (ADVP (RB also)) (IN for) (NP (NP (DT the) (NN comparison)) (PP (IN of) (NP (NP (JJ anti-human-CD4) (NNS mAbs)) (VP (VBG targeting) (NP (JJ distinct) (NNS epitopes))))))))))) (. .)))
( (S (NP (JJ Supplementary) (NN material))))
( (S (S (NP (NP (JJ Female) (NN Lewis) (NNS rats)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 8–16) (NNS weeks)) (ADJP (JJ old))) (: ;) (NP (NN body) (NN weight) (NP (CD 150–220) (NN g)))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN obtained) (PP (PP (IN from) (NP (NP (NNP Charles) (NNP River)) (PRN (-LRB- -LRB-) (NP (NNP Sulzfeld) (, ,) (NNP Germany)) (-RRB- -RRB-)))) (CC or) (PP (IN from) (NP (NP (DT the) (JJ Medical) (JJ Experimental) (NN Center)) (PP (IN of) (NP (NP (DT the) (NNP University)) (PP (IN of) (NP (NN Leipzig))))))))))) (. .)))
( (S (S (NP (NP (JJ Female) (JJ inbred) (NN Wistar–Prob) (NNS rats)) (PRN (-LRB- -LRB-) (ADJP (NP (CD 12–16) (NNS weeks)) (JJ old)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN bred) (PP (IN in) (NP (DT the) (JJ Medical) (JJ Experimental) (NN Center)))))) (. .)))
( (S (S (NP (DT The) (NNS animals)) (VP (VBD were) (VP (VBN kept) (PP (IN under) (NP (NP (JJ standard) (NNS conditions)) (, ,) (NP (NP (CD two)) (PP (IN per) (NP (NN cage)))))) (, ,) (PP (IN with) (NP (NP (NP (NN food)) (CC and) (NP (NN water)) (NP (NN ad) (NN libitum))) (CC and) (NP (DT a) (ADJP (CD 12) (CD h/12) (NN h)) (NN light/dark) (NN cycle))))))) (. .)))
( (S (NP (NP (DT The) (NN mouse) (NN anti-rat-CD4) (NNS mAbs)) (NP (NP (NN W3/25)) (, ,) (NP (NN OX35)) (, ,) (CC and) (NP (NP (NN RIB5/2)) (PRN (-LRB- -LRB-) (NP (NP (NN IgG1)) (, ,) (NP (NN IgG2a)) (, ,) (CC and) (NP (NN IgG2a)) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-))))) (VP (VBD were) (VP (VP (VBN used) (PP (IN as) (NP (NN ascites) (NN fluid))) (PP (IN for) (NP (ADJP (FW in) (FW vivo)) (NN treatment)))) (CC or) (VP (VBN purified) (PP (IN on) (NP (NP (NP (NP (NP (NN Protein) (NN A–sepharose)) (PRN (-LRB- -LRB-) (PP (IN for) (NP (NP (NN OX35)) (CC and) (NP (NN RIB5/2)))) (-RRB- -RRB-))) (CC or) (NP (NP (NN Protein) (NN G–sepharose)) (PRN (-LRB- -LRB-) (PP (IN for) (NP (NN W3/25))) (-RRB- -RRB-)))) (NNS columns)) (PRN (-LRB- -LRB-) (NP (NNP Pharmacia) (, ,) (NNP Freiburg) (, ,) (NNP Germany)) (-RRB- -RRB-)))) (PP (IN for) (NP (DT all) (ADJP (FW in) (FW vitro)) (NNS experiments)))))) (. .)))
( (S (S (NP (NP (DT The) (JJ maximal) (NN endo-toxin) (NN content)) (PP (IN of) (NP (DT the) (NNS ascites)))) (VP (VBD was) (NP (NP (NP (CD 58) (NN IU/ml)) (PRN (-LRB- -LRB-) (NP (NN W3/25)) (-RRB- -RRB-))) (, ,) (NP (NP (CD 17) (NN IU/ml)) (PRN (-LRB- -LRB-) (NP (NN RIB5/2)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (CD 5) (NN IU/ml)) (PRN (-LRB- -LRB-) (NP (NN OX35)) (-RRB- -RRB-)))))) (: ;) (S (NP (NP (DT the) (JJ final) (NN endotoxin) (NNS concentrations)) (PP (IN for) (NP (ADJP (FW in) (FW vitro)) (NNS experiments)))) (VP (VBD were) (ADJP (ADJP (JJR less)) (PP (IN than) (NP (CD 1) (NN IU/ml)))))) (. .)))
( (S (PP (IN For) (NP (NN flow) (NN cytometry))) (, ,) (NP (NP (ADJP (RB directly) (JJ FITC-labeled)) (NN W3/25)) (CC and) (NP (NP (NP (NP (NN OX35)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNS gifts)) (PP (IN from) (NP (NN P) (NN Kühnlein)))) (, ,) (NP (NP (NNP Institute)) (PP (IN of) (NP (NP (NNP Virology) (, ,) (NNP University)) (PP (IN of) (NP (NNP Würzburg))))))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (DT the) (NNS mAbs) (NN G4.18)) (PRN (-LRB- -LRB-) (NP (NN anti-CD3)) (, ,) (NP (NNP Pharmingen) (, ,) (NNP Hamburg) (, ,) (NNP Germany)) (-RRB- -RRB-))) (, ,) (NP (NP (NN OX8)) (PRN (-LRB- -LRB-) (NP (NP (JJ anti-CD8) (, ,) (NNP Serotec) (, ,) (NNP Oxford)) (: ;) (NP (NNP UK))) (-RRB- -RRB-))) (, ,) (NP (NP (NN OX81)) (PRN (-LRB- -LRB-) (NP (NN anti-IL4) (, ,) (NNP Pharmingen)) (-RRB- -RRB-))) (, ,) (NP (NP (NN A5-4)) (PRN (-LRB- -LRB-) (NP (JJ anti-IL-10) (, ,) (NNP Pharmingen)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NN DB-1))) (PRN (-LRB- -LRB-) (NP (CD anti-IFN-γ)) (, ,) (NP (NNP Serotec)) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN used))) (. .)))
( (S (S (NP (NNS MAbs) (NP (NP (NP (CD MOPC21)) (PRN (-LRB- -LRB-) (NP (NN IgG1)) (-RRB- -RRB-))) (, ,) (NP (NP (CD UPC10)) (PRN (-LRB- -LRB-) (NP (NP (NN IgG2a)) (, ,) (NP (NP (DT both)) (PP (IN from) (NP (NN Sigma)))) (, ,) (NP (NNP Deisenhofen) (, ,) (NNP Germany))) (-RRB- -RRB-))) (CC and) (NP (NP (NP (NN mouse) (NN anti-glucose-oxidase) (NN FITC/phycoerythrin)) (PRN (-LRB- -LRB-) (NP (NN PE)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NP (NN IgG1)) (, ,) (NP (NN IgG2a)) (, ,) (NP (NN Dako)) (, ,) (NP (NNP Hamburg) (NNP Germany))) (-RRB- -RRB-))))) (VP (VBD served) (PP (IN as) (NP (JJ isotype-matched) (JJ control) (NNS antibodies))))) (. .)))
( (S (S (NP (DT The) (JJ anti-TCRα/β) (NN mAb) (NN R73)) (VP (VBD was) (NP (NP (DT a) (NN kind) (NN gift)) (PP (IN of) (NP (NP (NN T) (NN Hünig)) (PRN (-LRB- -LRB-) (NP (NP (NN Institute)) (PP (IN of) (NP (NP (NNP Virology) (, ,) (NNP University)) (PP (IN of) (NP (NNP Würzburg)))))) (-RRB- -RRB-))))))) (. .)))
( (S (PP (IN For) (NP (NP (NP (NN sandwich) (NN ELISA)) (NN analysis)) (PP (IN of) (NP (NN cytokine) (NNS concentrations))))) (, ,) (NP (DT the) (VBG following) (NNS antibodies)) (VP (VBD were) (VP (VBN used) (: :) (NP (NP (NP (NN DB-1)) (PRN (-LRB- -LRB-) (NP (NN anti-IFN-γ)) (-RRB- -RRB-))) (, ,) (NP (NP (VBN biotinylated) (NN rabbit) (NN anti-rat) (NN IFN-γ)) (PRN (-LRB- -LRB-) (CC both) (NP (NP (NNP Biosource)) (, ,) (NP (NNP Ratingen) (, ,) (NNP Germany))) (-RRB- -RRB-))) (: ;) (NP (NN rabbit) (NN anti-rat) (NN IL-2)) (, ,) (NP (NP (VBN biotinylated) (NN A38-3)) (PRN (-LRB- -LRB-) (NP (NP (NN anti-IL-2)) (, ,) (CC both) (NP (NN Pharmingen))) (-RRB- -RRB-))) (, ,) (NP (NN A5-7)) (, ,) (NP (NP (VBN biotinylated) (NN A5-6)) (PRN (-LRB- -LRB-) (NP (DT both) (JJ anti-IL-10) (, ,) (NNP Pharmingen)) (-RRB- -RRB-))) (: ;) (NP (NP (CD OX81)) (PRN (-LRB- -LRB-) (NP (NN anti-IL-4)) (-RRB- -RRB-))) (, ,) (NP (NP (VBN biotinylated) (NN rabbit) (NN anti-rat) (NN IL-4)) (PRN (-LRB- -LRB-) (NP (NN Biosource)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (DT The) (NNS mAbs)) (VP (VBD were) (VP (VP (VBN bound) (PP (TO to) (NP (DT a) (NN BIAcore) (NN surface))) (PP (IN via) (NP (NN goat) (JJ anti-mouse) (NN Ig-Fc)))) (CC and) (VP (VBN incubated) (PP (IN with) (NP (NP (JJ various) (NNS concentrations)) (PP (IN of) (NP (NP (JJ soluble) (NN rat) (NN CD4)) (PRN (-LRB- -LRB-) (NP (NP (DT a) (NN gift)) (PP (IN of) (NP (NP (NP (NN N)) (NNP Barclay)) (, ,) (NP (NNP Oxford) (, ,) (NNP UK))))) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (S (NP (DT The) (NNS data)) (VP (VBD were) (VP (VBN analyzed) (PP (IN in) (NP (NP (NN accordance)) (PP (IN with) (NP (NP (DT the) (NN method)) (PP (IN of) (NP (NNP Karlsson) (FW et) (NN al.-LSB-S1))))))))) (-RRB- -RSB-)) (, ,) (CC and) (S (NP (NP (NP (DT the) (NN association) (NN rate) (NN constant)) (NP (NN kass))) (, ,) (NP (NP (DT the) (NN dissociation) (NN rate) (NN constant)) (NP (NN kdiss))) (, ,) (CC and) (NP (NP (DT the) (NN affinity) (NN constant)) (NP (NP (NN KA)) (PRN (-LRB- -LRB-) (NP (NN kass/kdiss)) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN calculated))))) (. .)))
( (S (S (NP (NP (NN Lewis) (NNS rats)) (PRN (-LRB- -LRB-) (ADJP (NP (CD 8–12) (NNS weeks)) (JJ old)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN given) (NP (NP (CD 0.5) (NN mg) (NP (NP (JJ heat-inactivated) (NN M.) (NN tuberculosis)) (PRN (-LRB- -LRB-) (NP (NP (NN Difco)) (, ,) (NP (NN Detroit)) (, ,) (NP (NN MI)) (, ,) (NP (NN USA))) (-RRB- -RRB-)))) (PP (IN in) (NP (ADJP (CD 100) (NN μl)) (NN paraffin) (NN oil)))) (PRN (-LRB- -LRB-) (NP (NP (NNP Riedel) (FW de) (FW Haën)) (, ,) (NP (NNP Seelze) (, ,) (NNP Germany))) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN injected) (ADVP (RB intradermally)) (PP (IN into) (NP (NP (DT the) (NN base)) (PP (IN of) (NP (DT the) (NN tail))))))))))) (. .)))
( (S (PP (IN For) (NP (JJ preventive) (NN treatment))) (, ,) (NP (NP (DT the) (NNS rats)) (PRN (-LRB- -LRB-) (NP (NP (NN n) (JJ =) (CD 6)) (PP (IN in) (NP (DT each) (NN group)))) (-RRB- -RRB-))) (VP (VBD received) (NP (NP (NP (NP (CD 3) (NN mg)) (PP (IN of) (NP (NN RIB5/2)))) (, ,) (NP (NP (CD 3) (NN mg)) (PP (IN of) (NP (NN W3/25)))) (, ,) (CC or) (NP (CD 2) (NN mg))) (PP (IN of) (NP (NN OX35)))) (ADVP (ADVP (RB intraperitoneally)) (PRN (-LRB- -LRB-) (FRAG (ADJP (JJ corresponding) (PP (TO to) (NP (QP (CD 17.1) (CC and) (CD 11.4)) (NN mg/kg))) (, ,) (ADVP (RB respectively)) (, ,) (PP (IN on) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (DT a) (NN mean) (NN body) (NN weight)))))) (PP (IN of) (NP (CD 175) (NN g)))) (-RRB- -RRB-))) (PP (IN on) (NP (NP (NNS days)) (PP (PP (NP (QP (CD -1) (, ,) (CD 0) (, ,) (CD 3) (, ,) (CC and) (CD 6) (, ,) (FW i.e.) (CD 1)) (NN day)) (IN before) (NP (NN AA) (NN induction))) (, ,) (PP (IN on) (NP (NP (DT the) (NN day)) (PP (IN of) (NP (NP (NN induction)) (PRN (-LRB- -LRB-) (NP (NN day) (CD 0)) (-RRB- -RRB-)))))) (, ,) (CC and) (ADVP (RB thereafter)))))) (. .)))
( (S (S (NP (NP (NP (DT The) (JJR lower) (NN dose)) (PP (IN of) (NP (NN OX35)))) (PRN (-LRB- -LRB-) (NP (CD 2) (NN mg)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN chosen) (PP (IN on) (DT the) (NN basis) (IN of) (NP (NP (JJ previous) (NNS experiments)) (VP (VBG demonstrating) (NP (NP (PRP$ its) (JJ high) (JJ clinical) (NN efficacy)) (PP (IN in) (NP (NN AA) (NN -LSB-S2) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (NP (DT The) (JJ control) (NN group)) (VP (VBD received) (NP (JJ PBS) (NN -LSB-S3) (-RRB- -RSB-)))) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (JJ preventive) (NN treatment)) (PP (IN with) (NP (NP (DT an) (JJ isotype-matched) (NN mAb)) (PP (IN from) (NP (NN birth)))))) (VP (VBD had) (VP (VBN shown) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (NN rat) (NNS AA))) (PP (IN in) (NP (DT a) (JJ previous) (NN study) (NN -LSB-S3))) (-RRB- -RSB-))))) (. .)))
( (S (PP (IN For) (NP (NP (NN determination)) (PP (IN of) (NP (DT the) (NN arthritis) (NN score))))) (, ,) (NP (DT each) (NN paw)) (VP (VBD was) (VP (VBN graded) (PP (VBG according) (PP (TO to) (NP (NP (DT the) (NN extent)) (PP (IN of) (NP (NP (NP (NN erythema)) (CC and) (NP (NN edema))) (PP (IN of) (NP (DT the) (JJ periarticular) (NN tissue)))))))) (, ,) (PP (IN on) (NP (NP (DT a) (NN scale)) (PP (IN of) (NP (NP (NN 0–4)) (PRN (, ,) (SBAR (WHADVP (WRB where)) (FRAG (NP (NP (JJ 0=no) (NN inflammation)) (, ,) (NP (NP (JJ 1=unequivocal) (NN inflammation)) (PP (IN of) (NP (CD one) (NN paw) (NN joint)))) (, ,) (NP (NP (JJ 2=unequivocal) (NN inflammation)) (PP (IN of) (NP (NP (QP (IN at) (JJS least) (CD two)) (NN paw) (NNS joints)) (CC or) (NP (NP (JJ moderate) (NN inflammation)) (PP (IN of) (NP (CD one) (NN paw) (NN joint))))))) (, ,) (NP (NP (NN 3=severe) (NN inflammation)) (PP (IN of) (NP (QP (CD one) (CC or) (JJR more)) (JJ paw) (NNS joints)))) (, ,) (CC and) (NP (NN 4=maximum) (NN inflammation))) (PP (IN of) (NP (QP (CD one) (CC or) (JJR more)) (JJ paw) (NNS joints))) (ADJP (JJ -LSB-S4)))) (, ,) (NP (NNP S5)) (-RRB- -RSB-)))))))) (. .)))
( (S (S (NP (DT The) (NNS scores)) (VP (VBD were) (ADVP (RB then)) (VP (VBN added) (S (VP (TO to) (VP (VB obtain) (NP (NP (DT the) (JJ total) (NN score)) (PRN (-LRB- -LRB-) (NP (NP (JJ maximal) (JJ possible) (NN score)) (PP (IN of) (NP (CD 16))) (PP (IN for) (NP (DT each) (NN animal)))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (PP (IN For) (NP (NP (NP (NN determination)) (PP (IN of) (NP (NN cell) (NN depletion)))) (CC and) (NP (NP (NN modulation)) (PP (IN of) (NP (NN surface) (NNS molecules)))))) (, ,) (NP (NP (NN blood) (NNS samples)) (PRN (-LRB- -LRB-) (NP (CD 100) (NN μl)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN taken) (PP (IN via) (NP (JJ retro-orbital) (NN puncture))) (PP (IN on) (NP (NP (NN day) (CD 8)) (CC or) (NP (NN day) (CD 13)))) (PP (IN after) (NP (NP (NN induction)) (PP (IN of) (NP (NN AA)))))))) (. .)))
( (S (S (NP (JJ Whole-blood) (NNS cells)) (VP (VBD were) (VP (VBN stained) (PP (IN with) (NP (NP (JJ saturating) (NNS amounts)) (PP (IN of) (NP (NP (ADJP (RB directly) (JJ FITC-labeled)) (NN W3/25)) (, ,) (NP (NN OX35)) (, ,) (NP (NN G4.18)) (, ,) (NP (NN OX8)) (, ,) (CC or) (NP (JJ respective) (NN isotype)))))) (, ,) (S (VP (VBN followed) (PP (IN by) (NP (NN erythrocyte) (NN lysis)))))))) (. .)))
( (S (S (S (NP (CD Ten) (NN thousand) (NNS events)) (VP (VBD were) (VP (VBN analyzed) (S (VP (VBG using) (NP (DT an) (NN Epics) (NN XL) (NN flow) (NN cytometer)))) (PRN (-LRB- -LRB-) (NP (NP (NNP Coulter)) (, ,) (NP (NNP Krefeld) (, ,) (NNP Germany))) (-RRB- -RRB-))))) (CC and) (S (NP (DT the) (NNS results)) (VP (VBD displayed) (PP (IN as) (NP (NN histograms)))))) (. .)))
( (S (S (VP (TO To) (VP (VB assess) (NP (DT the) (NN DTH))))) (, ,) (NP (NP (NP (DT either) (CD 10) (NNS μg)) (PP (IN of) (NP (NP (DT the) (JJ arthritogen) (NN M.) (NN tuberculosis)) (PP (IN in) (NP (CD 50) (JJ μl) (NNS PBS)))))) (, ,) (CC or) (NP (CD 50) (NN μl) (NNS PBS) (RB only)) (, ,)) (VP (VBD were) (VP (VBN injected) (ADVP (RB intradermally)) (PP (IN into) (NP (NP (DT the) (NN pinna)) (PP (IN of) (NP (NP (DT the) (JJ left)) (CC or) (NP (DT the) (JJ right) (NN ear)))))) (, ,) (ADVP (RB respectively)) (, ,) (PP (IN on) (NP (NP (NN day) (CD 13)) (PP (IN after) (NP (NP (NN induction)) (PP (IN of) (NP (NN AA))))))))) (. .)))
( (S (S (PP (NP (CD One) (NN day)) (IN after) (NP (NN injection))) (, ,) (NP (NP (DT the) (NN swelling)) (PP (IN of) (NP (DT the) (NNS ears)))) (VP (VBD was) (VP (VBN determined) (PP (IN with) (NP (NP (DT a) (NN gauge)) (PRN (-LRB- -LRB-) (NP (NNP Hahn) (NNP &) (NNP Kolb) (, ,) (NNP Stuttgart) (, ,) (NNP Germany)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NN Swelling)) (VP (VBD was) (VP (VBN expressed) (PP (IN as) (NP (NP (NP (DT the) (NN difference)) (PRN (-LRB- -LRB-) (NP (NN mm)) (-RRB- -RRB-))) (PP (IN between) (NP (NP (DT the) (NNS thickness)) (PP (IN of) (NP (DT the) (ADJP (ADJP (JJ left)) (CC and) (ADJP (DT the) (JJ right))) (NN ear)))))))))) (. .)))
( (S (S (NP (NN T) (NNS cells)) (VP (VBD were) (VP (VBN purified) (PP (IN from) (NP (NNS spleens))) (PP (IN as) (NP (VBN described) (NN elsewhere) (CD -LSB-S6))))) (-RRB- -RSB-)) (. .)))
( (S (S (S (ADVP (RB Briefly)) (, ,) (NP (DT the) (NNS spleens)) (VP (VBD were) (VP (VBN passed) (PP (IN through) (NP (DT a) (NN stainless) (NN steel) (NN sieve)))))) (CC and) (S (NP (DT the) (VBG resulting) (NN suspension)) (VP (VBD was) (VP (VBN centrifuged) (PP (IN through) (NP (NP (NN Lymphoprep)) (PRN (-LRB- -LRB-) (NP (NNP Pharmacia)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (NNS Cells)) (VP (VBN contained) (PP (IN in) (NP (DT the) (NN interphase))))) (VP (VBD were) (ADVP (RB then)) (VP (VP (VBN washed) (ADVP (RB twice))) (CC and) (VP (VBN loaded) (PP (IN onto) (NP (NP (DT a) (NN 10-ml) (NN syringe)) (PP (IN with) (NP (NP (CD 1.2) (NN g) (NN nylon) (NN wool)) (PRN (-LRB- -LRB-) (NP (NP (NNP Polyscience)) (, ,) (NP (NNP Eppelheim) (, ,) (NNP Germany))) (-RRB- -RRB-)))))))))) (. .)))
( (S (PP (IN After) (NP (NP (NN incubation)) (PP (IN for) (NP (CD 1) (NN hour))) (PP (IN at) (NP (ADJP (QP (CD 37°C) (, ,) (CD 5)) (NN %)) (NN CO2))))) (, ,) (NP (DT the) (NNS cells)) (VP (VBD were) (VP (VBN eluted) (PP (IN with) (NP (NP (NN RPMI) (NN 1640/GlutaMaxI) (NN con-)) (VP (VBG taining) (NP (NP (NP (ADJP (CD 10) (NN %)) (NN FCS)) (, ,) (NP (ADJP (CD 15) (NN mM)) (NN HEPES)) (, ,) (NP (ADJP (CD 100) (NN U/ml)) (NN penicillin)) (, ,) (CC and) (NP (ADJP (CD 100) (NN μg/ml)) (NN streptomycin))) (PRN (-LRB- -LRB-) (ADVP (RB thereafter)) (VP (VBN called) (NP (NP (NN R10F)) (, ,) (NP (NP (DT all)) (PP (IN from) (NP (NNP GIBCO-BRL) (, ,) (NNP Eggenstein) (, ,) (NNP Germany)))))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (DT The) (VBG resulting) (JJ total) (NN T-cell) (NN suspension)) (VP (VBD was) (ADJP (NP (NN ≥) (CD 95) (NN %)) (JJ CD3+)) (, ,) (SBAR (IN as) (S (VP (VBN evaluated) (PP (IN by) (NP (NN flow) (NN cytometry)))))))) (. .)))
( (S (S (NP (DT Either) (VBN purified) (JJ total) (NN T) (NNS cells)) (VP (VBD were) (ADVP (RB directly)) (VP (VBN used) (PP (IN for) (NP (NN proliferation) (NNS assays)))))) (, ,) (CC or) (S (NP (JJ CD4+) (NN T) (NNS cells)) (VP (VBD were) (ADVP (RB first)) (ADVP (RB negatively)) (VP (VBN purified) (PP (IN by) (S (VP (VP (VBG adding) (NP (NP (CD 5) (NN μg/1×107) (NNS cells)) (VP (VBG OX8) (NP (NP (NN mAb)) (PP (IN for) (NP (CD 30) (NN min))) (PP (IN on) (NP (NN ice))))))) (CC and) (VP (, ,) (PP (IN after) (NP (VBG washing))) (, ,) (NP (NP (CD 75) (NN μl) (NN Dynabeads-M450)) (VP (VBN coupled) (PP (TO to) (NP (NP (NN goat) (JJ anti-mouse) (NN IgG)) (PRN (-LRB- -LRB-) (NP (NNP Dynal) (, ,) (NNP Hamburg) (, ,) (NNP Germany)) (-RRB- -RRB-))))))))))))) (. .)))
( (S (S (NP (DT The) (NN suspension)) (VP (VBD was) (ADVP (RB again)) (VP (VP (VBN incubated) (PP (IN for) (NP (CD 30) (NN min))) (PP (IN on) (NP (NN ice)))) (CC and) (ADVP (RB then)) (VP (VBN separated) (PP (IN by) (NP (NP (DT a) (JJ magnetic) (NN particle) (NN concentrator)) (PRN (-LRB- -LRB-) (NP (NNP MPC®) (, ,) (NNP Dynal)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (DT The) (NN purity)) (PP (IN of) (NP (JJ CD4+) (NN T-cell) (NNS populations)))) (VP (VBD was) (ADVP (RB always)) (NP (NN ≥) (CD 95) (NN %)) (, ,) (SBAR (IN as) (S (VP (VBN assessed) (PP (IN by) (NP (NN flow) (NN cytometry)))))))) (. .)))
( (S (PP (IN For) (NP (NP (NN enrichment)) (PP (IN of) (NP (NP (JJ dendritic) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN DC)) (-RRB- -RRB-)))))) (, ,) (NP (NP (NNS suspensions)) (PP (IN of) (NP (NP (NN spleen) (NNS cells)) (PP (IN from) (NP (JJ healthy) (NNS rats)))))) (VP (VBD were) (VP (VP (VBN subjected) (PP (TO to) (NP (DT an) (JJ overnight) (NN adhesion) (NN step))) (PP (IN on) (NP (NP (NN Petri) (NNS dishes)) (PRN (-LRB- -LRB-) (NP (NNP Falcon®) (, ,) (NNP Becton) (NNP Dickinson) (, ,) (NNP Heidelberg) (, ,) (NNP Germany)) (-RRB- -RRB-))))) (CC and) (ADVP (RB then)) (VP (VBN centrifuged) (PP (IN through) (NP (NP (CD 2) (NN ml)) (PP (IN of) (NP (NP (DT a) (ADJP (CD 14.5) (NN %)) (NN metrizamide) (NN solution)) (PRN (-LRB- -LRB-) (NP (NN Sigma)) (-RRB- -RRB-)))))) (PP (IN in) (NP (NN R10F)))))) (. .)))
( (S (S (NP (NNS DC)) (VP (VBD were) (ADVP (RB then)) (ADJP (JJ irradiated) (PP (IN with) (NP (CD 15) (NN Gy)))) (S (VP (TO to) (VP (VB prevent) (NP (PRP$ their) (NN proliferation)) (PP (IN in) (NP (JJ subsequent) (NNS assays)))))))) (. .)))
( (S (PP (IN For) (NP (NN proliferation) (NNS assays))) (, ,) (NP (NP (QP (CD 1) (NN ×) (CD 105)) (VBN purified) (NN total)) (CC or) (NP (NP (JJ CD4+) (NN spleen) (NN T) (NNS cells)) (PP (IN per) (NP (NP (NN well)) (PP (IN of) (NP (JJ 96-well) (NN round-bottom) (NNS plates))))))) (VP (VBD were) (VP (VBN incubated) (PP (IN with) (NP (NP (NP (CD 1) (NN ×) (CD 104) (NN DC)) (PP (IN per) (NP (NN well)))) (CC and) (NP (NP (CD 1) (NN μg/ml) (NN ConA)) (PRN (-LRB- -LRB-) (NP (NN Sigma)) (-RRB- -RRB-))))) (PP (IN for) (NP (CD 72) (NNS hours))))) (. .)))
( (S (S (NP (NP (ADJP (QP (RB Then) (CD 1)) (NN μCi/well)) (NN 3H-thymidine)) (PRN (-LRB- -LRB-) (NP (NNP Amersham-Buchler) (, ,) (NNP Braunschweig) (, ,) (NNP Germany)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN added)))) (. .)))
( (S (S (S (PP (IN After) (NP (NP (DT an) (JJ additional) (NN incubation)) (PP (IN for) (NP (CD 16) (NNS hours))))) (, ,) (NP (NNS cells)) (VP (VBD were) (VP (VBN harvested) (PP (IN onto) (NP (NN fiber) (NNS filters)))))) (CC and) (S (NP (JJ cell-bound) (NN radioactivity)) (VP (VBD was) (VP (VBN measured) (PP (IN by) (NP (NP (JJ β-scintillation) (NN counting)) (PRN (-LRB- -LRB-) (NP (NNP Matrix96®) (, ,) (NNP Canberra) (NNP Packard) (, ,) (NNP Dreieich) (, ,) (NNP Germany)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (NP (NP (JJ Total) (NN T) (NNS cells)) (CC or) (NP (VBN purified) (JJ CD4+) (NN T) (NNS cells))) (PP (IN from) (NP (NP (NNS spleens)) (PP (IN of) (NP (JJ healthy) (NN Lewis) (NNS rats)))))) (, ,) (CC and) (NP (NP (JJ allogeneic) (NNS DC)) (PP (IN from) (NP (NP (NNS spleens)) (PP (IN of) (NP (NN Wistar–Prob) (NNS rats)))))) (, ,)) (VP (VBD were) (VP (VBN prepared) (SBAR (IN as) (S (VP (VBN described) (ADVP (RB above)))))))) (. .)))
( (S (S (NP (NP (NN Total)) (CC or) (NP (JJ CD4+) (NN T) (NNS cells))) (VP (VBD were) (VP (VBN seeded) (PP (IN at) (NP (NP (CD 4) (NN ×) (CD 105) (NNS cells)) (PP (IN per) (PP (RB well) (IN in) (NP (NP (JJ 96-well) (JJ flat-bottom) (NNS plates)) (, ,) (PP (ADVP (RB together)) (IN with) (NP (NP (QP (CD 1) (, ,) (CD 2) (, ,) (CC or) (CD 4)) (NN ×) (CD 104) (NN DC) (IN per) (RB well)) (CC and) (NP (NP (QP (CD 1) (, ,) (CD 5) (, ,) (CC or) (CD 10)) (NN μg/ml)) (PP (IN of) (NP (DT the) (JJ respective) (VBN purified) (JJ anti-CD4) (NN mAb)))) (-LRB- -LRB-) (CC or) (NP (NN isotype) (NN control) (NNS mAbs)) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (PP (IN After) (NP (NP (NN incubation)) (PP (IN for) (NP (NP (CD 72) (NNS hours)) (PRN (-LRB- -LRB-) (NP (CD 37°C) (, ,) (CD 5) (NN %) (NN CO2)) (-RRB- -RRB-)))))) (, ,) (S (NP (NP (NN bromodeoxyuridine)) (PRN (-LRB- -LRB-) (NP (NN BrdU)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN added)))) (CC and) (S (NP (NN incubation)) (VP (VBD was) (VP (VBN continued) (PP (IN for) (NP (DT an) (JJ additional) (CD 16) (NNS hours))))))) (. .)))
( (S (S (NP (DT The) (NN proliferation)) (VP (VBD was) (VP (VBN determined) (PP (IN by) (NP (DT a) (NN BrdU) (NN cell-proliferation) (NN ELISA))) (PRN (-LRB- -LRB-) (NP (NP (NNP Boehringer) (NNP Mannheim)) (, ,) (NP (NNP Mannheim) (, ,) (NNP Germany))) (-RRB- -RRB-)) (PP (IN in) (NP (NP (NN accordance)) (PP (IN with) (NP (NP (DT the) (NN supplier) (POS 's)) (NNS recommendations)))))))) (. .)))
( (S (PP (IN For) (NP (JJ anti-CD4) (NN preincubation))) (, ,) (NP (NN spleen) (JJ CD4+) (NN T) (NNS cells)) (VP (VBD were) (VP (VP (VBN incubated) (PP (IN with) (NP (NP (DT the) (NP (JJ anti-CD4) (NNS mAbs)) (CC or) (NP (NN isotype) (NN control) (NNS mAbs))) (PRN (-LRB- -LRB-) (NP (CD 10) (NN μg) (IN per) (CD 1) (NN ×) (CD 107) (NNS cells)) (-RRB- -RRB-)))) (PP (IN for) (NP (CD 30) (NN min))) (PP (IN at) (NP (NN 4°C)))) (CC and) (VP (VBN washed) (ADVP (RB once))))) (. .)))
( (S (S (NP (DT The) (VBN bound) (NNS mAbs)) (VP (VBD were) (ADVP (RB then)) (VP (VBN cross-linked) (PP (IN with) (NP (NP (NN goat) (JJ anti-mouse) (NN IgG)) (PRN (-LRB- -LRB-) (NP (NP (NN Jackson) (NN Lab)) (, ,) (NP (QP (CD 20) (CD μg/1) (CD ×) (CD 107)) (NNS cells))) (-RRB- -RRB-)))) (PP (IN for) (NP (NP (CD 1) (NN hour)) (PP (IN at) (NP (NN 37°C)))))))) (. .)))
( (S (S (PP (IN After) (NP (VBG washing))) (, ,) (NP (NP (DT the) (NNS cells)) (PRN (-LRB- -LRB-) (NP (QP (CD 1) (CD ×) (CD 106)) (PP (PP (IN per) (NP (NN ml))) (CC and) (PP (IN per) (NP (NN well))))) (-RRB- -RRB-))) (VP (VBD were) (VP (VP (VBN seeded) (PP (IN in) (NP (NP (JJ 24-well) (NNS plates)) (VP (ADVP (RB previously)) (VBN coated) (PP (IN with) (NP (NN R73))))))) (CC and) (VP (VBN harvested) (PP (IN after) (NP (QP (CD 24) (CC and) (CD 48)) (NNS hours))))))) (. .)))
( (S (S (NP (JJ Anti-CD4-preincubated) (NNS cells)) (VP (VBD were) (VP (VBN washed) (, ,) (UCP (ADJP (JJ fixed) (PP (IN with) (NP (NP (ADJP (CD 4) (NN %)) (NN paraformaldehyde)) (PP (IN in) (NP (NNS PBS)))))) (, ,) (ADJP (ADJP (JJ permeabilized)) (PRN (-LRB- -LRB-) (NP (NP (NP (ADJP (CD 0.5) (NN %)) (NN saponin)) (PP (IN in) (NP (NNS PBS)))) (, ,) (NP (ADJP (CD 1) (NN %)) (NN FCS)) (, ,) (NP (ADJP (CD 0.01) (NN %)) (NN NaN3))) (: ;) (S (PP (IN for) (NP (DT this) (NN step))) (, ,) (VP (VBN supplemented) (PP (IN with) (NP (ADJP (CD 10) (NN %)) (NN rat) (NN serum))))) (-RRB- -RRB-))) (, ,) (CC and) (VP (VBN incubated) (PP (IN with) (NP (NP (ADJP (CD 1) (NN μg)) (NN anti-IFN-γ) (NN FITC)) (, ,) (NP (NN anti-IL-4) (NN PE)) (, ,) (NP (JJ anti-IL-10) (NN PE)) (, ,) (CC or) (NP (ADJP (RB directly) (VBN labeled)) (NN isotype-control) (NNS mAbs)))) (PP (IN for) (NP (NP (CD 30) (NN min)) (PP (IN at) (NP (NN 4°C)))))))))) (. .)))
( (S (S (NP (NN FACS) (NN analysis)) (VP (VBD was) (VP (VBN performed) (S (VP (VBG using) (NP (NP (DT a) (JJ FACScan®) (NN flow) (NN cytometer)) (PRN (-LRB- -LRB-) (NP (NNP Becton) (NNP Dickinson)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (NN Detection)) (PP (IN of) (NP (NN TNF-α)))) (VP (VBD was) (VP (VBN performed) (S (VP (VBG using) (NP (NP (DT a) (NN bioassay)) (VP (VBN based) (PP (IN on) (NP (NP (DT the) (NN lysis)) (PP (IN of) (NP (DT the) (NN WEHI164/13) (NN cell) (NN line))) (PP (IN after) (NP (NP (NN exposure)) (PP (TO to) (NP (NN TNF-α)))))))))))))) (. .)))
( (S (S (NP (NN Assay) (NN specificity)) (VP (VBD was) (VP (VBN ensured) (PP (IN by) (S (VP (VBG adding) (NP (DT a) (NN neutralizing) (NN mAb)) (PP (TO to) (NP (NN rat) (NN TNF-α) (-LRB- -LRB-) (CD 100) (NN μg/ml) (: ;) (NN clone) (NN 45418.111))))))))) (: ;)))
( (S (S (NP (NN R&D) (NNS Systems)) (, ,) (NP (NNP Wiesbaden) (, ,) (NNP Germany) (-RRB- -RRB-))) (. .)))
( (S (S (NP (NN Culture) (NNS supernatants)) (VP (VBD were) (VP (VBN analyzed) (PP (IN for) (NP (NP (NN IFN-γ)) (, ,) (NP (NN IL-2)) (, ,) (NP (NN IL-4)) (, ,) (CC and) (NP (NN IL-10)))) (PP (IN by) (NP (NP (NN sandwich) (NN ELISA)) (PP (IN with) (NP (DT the) (JJ above-mentioned) (NN capture) (CC and) (NN detection) (NNS antibodies)))))))) (. .)))
( (S (S (NP (JJ Recombinant) (NN cytokine) (NNS standards)) (VP (VBD were) (SBAR (IN as) (S (VP (VBZ follows)))))) (: :) (S (NP (NP (NP (CD IFN-γ)) (PRN (-LRB- -LRB-) (NP (NN Laboserv)) (-RRB- -RRB-))) (, ,) (NP (NP (NP (NN IL-2)) (, ,) (NP (NN IL-10)) (, ,) (CC and) (NP (NN IL-4))) (PRN (-LRB- -LRB-) (NP (NN Pharmingen)) (-RRB- -RRB-))))) (: ;) (S (NP (NP (NN range)) (PP (IN for) (NP (NP (NN IFN-γ)) (, ,) (NP (NN IL-2)) (, ,) (CC and) (NP (NN IL-10))))) (VP (VBD was) (NP (CD 39–5000) (NN pg/ml)))) (: ;) (S (NP (NP (NN range)) (PP (IN for) (NP (NN IL-4)))) (VP (VBD was) (NP (CD 9.85–1250) (NN pg/ml)))) (. .)))
( (S (S (NP (NP (NN Cytokine) (NNS concentrations)) (PP (IN in) (NP (DT the) (NN culture) (NNS supernatants)))) (VP (VBD were) (VP (VBN calculated) (PP (IN from) (NP (NP (DT a) (JJ standard) (NN curve)) (VP (VBG using) (NP (NP (DT the) (NN software) (NN EasyFit)) (PRN (-LRB- -LRB-) (NP (NP (NN SLT)) (, ,) (NP (NN Crailsheim)) (, ,) (NP (NNP Germany))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (VBN Purified) (NN spleen) (JJ CD4+) (NN T) (NNS cells)) (VP (VBD were) (VP (VP (VBN preincubated) (PP (IN with) (NP (DT the) (JJ anti-CD4) (NNS mAbs))) (PP (IN as) (NP (JJ above)))) (CC and) (RB then) (ADVP (RB either)) (VP (VBN stimulated) (PP (PP (IN on) (NP (NP (JJ anti-CD3) (JJ mAb-precoated) (JJ 6-well) (NNS plates)) (PRN (-LRB- -LRB-) (NP (NP (CD 1) (NN ×) (CD 107) (NNS cells)) (PP (IN per) (NP (NN well)))) (-RRB- -RRB-)))) (CC or) (PP (IN with) (NP (NP (DT a) (NN combination)) (PP (IN of) (NP (NP (NP (NN phorbol) (NN myristoyl) (NN acetate)) (PRN (-LRB- -LRB-) (NP (NP (NN PMA)) (: ;) (NP (CD 10) (NN ng/ml))) (-RRB- -RRB-))) (CC and) (NP (NP (NN ionomycin)) (PRN (-LRB- -LRB-) (NP (CD 250) (NN ng/ml)) (-RRB- -RRB-)))))))) (PP (IN for) (NP (NP (CD 4) (NNS hours)) (PP (IN at) (NP (NN 37°C))))))))) (. .)))
( (S (S (PP (IN After) (NP (NN stimulation))) (, ,) (NP (DT the) (NNS cells)) (VP (VBD were) (VP (VP (VBN washed) (ADVP (RB once)) (PP (IN with) (NP (NNS PBS)))) (CC and) (VP (VBN microcentrifuged) (PRN (-LRB- -LRB-) (NP (CD 10,000) (NN ×) (NN g)) (-RRB- -RRB-)) (PP (IN at) (NP (NN 4°C))) (PP (IN for) (NP (CD 1) (NN min))))))) (. .)))
( (S (S (NP (DT The) (NN pellet)) (VP (VBD was) (VP (VP (VBN resuspended) (PP (IN in) (NP (CD 400) (NN μl) (JJ ice-cold) (NP (NP (NN buffer) (NN A)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN mM) (NNS HEPES)) (, ,) (NP (ADJP (CD 10) (NN mM)) (NN KCl)) (, ,) (NP (NP (ADJP (CD 0.1) (NN mM)) (NN EDTA)) (, ,) (NP (ADJP (CD 0.1) (NN mM)) (NN EGTA)) (, ,) (NP (ADJP (CD 0.5) (NN mM)) (NN PMSF)) (, ,) (NP (ADJP (CD 1) (NN mM)) (NN dithiothreitol)) (, ,) (CC and) (NP (ADJP (CD 1) (NN mM)) (NN Na3VO4))) (-RRB- -RRB-)))))) (CC and) (VP (VBN placed) (PP (IN on) (NP (NN ice))) (PP (IN for) (NP (CD 15) (NN min))))))) (. .)))
( (S (S (S (ADVP (RB Subsequently)) (, ,) (NP (NP (CD 25) (NNS μl)) (PP (IN of) (NP (NP (DT a) (ADJP (CD 10) (NN %)) (NP (NN Nonidet) (NN P-40)) (NN solution)) (PRN (-LRB- -LRB-) (NP (NNP Boehringer) (NNP Mannheim)) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN added) (PP (TO to) (NP (DT the) (NN sample)))))) (CC and) (S (NP (DT the) (NNS cells)) (VP (VBD were) (VP (VBN homogenized) (PP (IN by) (S (VP (VBG vortexing) (PP (IN for) (NP (CD 30) (NN s))) (S (VP (VBN followed) (PP (IN by) (NP (NP (NN microcentrifugation)) (PP (IN for) (NP (CD 1) (NN min)))))))))))))) (. .)))
( (S (S (NP (DT The) (JJ nuclear) (NNS pellets)) (VP (VBD were) (VP (VP (VBN resuspended) (PP (IN in) (NP (NP (CD 50) (NN μl)) (PP (IN of) (NP (NP (NN buffer) (NN B)) (PRN (-LRB- -LRB-) (NP (CD 20) (NN mM) (NNS HEPES)) (, ,) (NP (NP (ADJP (CD 400) (NN mM)) (NN NaCl)) (, ,) (NP (NP (ADJP (CD 0.1) (NN mM)) (NN EDTA)) (, ,) (NP (ADJP (CD 0.1) (NN mM)) (NN EGTA)) (, ,) (NP (ADJP (CD 2) (NN mM)) (NN PMSF)) (, ,) (NP (ADJP (CD 1) (NN mM)) (NN dithiothreitol)) (, ,) (CC and) (NP (ADJP (CD 1) (NN mM)) (NN Na3VO4)))) (-RRB- -RRB-))))))) (CC and) (VP (VBN shaken) (PP (IN for) (NP (NP (CD 15) (NN min)) (PP (IN at) (NP (NN 4°C))))))))) (. .)))
( (S (S (PP (IN After) (NP (NP (NN microcentrifugation)) (PP (IN for) (NP (NP (CD 5) (NN min)) (PP (IN at) (NP (NN 4°C))))))) (, ,) (NP (DT the) (NNS supernatants)) (VP (VBD were) (VP (VP (VBN aliquoted)) (CC and) (VP (VBN stored) (PP (IN at) (NP (NN -70°C))) (PP (IN until) (NP (JJ further) (NN use))))))) (. .)))
( (S (NP (NP (DT The) (JJ nuclear) (NNS extracts)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN μg) (JJ total) (NN protein)) (-RRB- -RRB-))) (VP (VBD were) (SBAR (IN than) (S (VP (VBN incubated) (PP (IN with) (NP (NP (CD 2) (NN ×) (CD 108) (NN cpm)) (PP (IN of) (NP (NP (NP (JJ 32P-labeled) (, ,) (JJ double-stranded) (NN oligonucleotide) (NN probe)) (PRN (-LRB- -LRB-) (NP (NP (NN sense) (NN strand)) (ADVP (RB only))) (: ;) (NP (NP (NP (NP (NN AP-1)) (: :) (NP (NP (JJ 5'-CGC) (NN TTG) (NN ATG) (NN AGT) (NN CAG) (NN CCG) (NN GAA-3)) ('' ')) (: ;) (NP (NN NF-κB)) (: :) (NP (NN 5'-AGT) (NN TGA) (NN GGG))) (JJ GAC) (NN TTT) (NN CCC) (NN AGG) (NN C-3) (POS ')) (: ;) (NP (NP (DT both)) (PP (IN from) (NP (NNP Promega) (, ,) (NNP Mannheim) (, ,) (NNP Germany)))) (: ;) (NP (NN NF-AT)) (: :) (NP (JJ 5'-CGC) (NN CCA) (NN AAG) (NN AGG) (NN AAA) (NN ATT) (NN TGT) (NN TTC) (NN ATA-3) (POS ')) (: ;) (NP (NNP Santa) (NNP Cruz) (, ,) (NNP Heidelberg) (, ,) (NNP Germany))) (-RRB- -RRB-))) (PP (IN in) (NP (NP (ADJP (CD 25) (NN μl)) (NN binding) (NN buffer)) (PRN (-LRB- -LRB-) (FRAG (NP (ADJP (CD 1) (NN M)) (NN Tris)) (, ,) (NP (ADJP (CD 1) (NN M)) (JJ boric) (NN acid)) (, ,) (NP (ADJP (CD 0.02) (NN M)) (NN EDTA)) (, ,) (NP (ADJP (CD 5) (NN %)) (NN glycerol))) (-RRB- -RRB-)))))) (VP (VBN supplemented) (PP (IN with) (NP (NP (NP (NN poly) (NN -LSB-dI-dC) (-RRB- -RSB-)) (PRN (-LRB- -LRB-) (NP (CD 0.16) (NN mg/ml) (NP (NNP Pharmacia))) (-RRB- -RRB-))) (CC and) (NP (ADJP (CD 2) (NN mM)) (NN dithiothreitol))))))))))) (. .)))
( (S (S (NP (DT The) (NNS samples)) (VP (VBD were) (VP (VBN separated) (PP (IN on) (NP (DT a) (ADJP (CD 4) (NN %)) (NN polyacrylamide) (NN gel))) (PP (IN at) (NP (CD 200) (NN V)))))) (. .)))
( (S (S (PP (IN After) (NP (NP (NN scanning)) (PP (IN in) (NP (NP (DT a) (NN phosphor) (NN imager)) (PRN (-LRB- -LRB-) (NP (NP (CD BAS-1000)) (, ,) (NP (NP (NP (NNP Fuij)) (NP (NN Photo) (NN Film) (NN Co.))) (NP (NNP Ltd) (, ,) (NNP Japan)))) (-RRB- -RRB-)))))) (, ,) (NP (DT the) (NNS bands)) (VP (VBD were) (VP (VBN quantified) (S (VP (VBG using) (NP (DT the) (NN PCBAS) (NN 2.09g) (NN software)))) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP Fuij)) (NP (NN Photo) (NN Film) (NN Co.))) (NP (NNP Ltd))) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (NP (NNS Differences)) (PP (IN between) (NP (JJ experimental) (NNS groups)))) (VP (VBD were) (VP (VBN evaluated) (PP (IN with) (NP (DT the) (JJ two-tailed) (JJ nonparametric) (NN Mann–Whitney) (-LRB- -LRB-) (NN U) (-RRB- -RRB-) (NN test)))))) (. .)))
( (S (S (NP (DT The) (JJ Spearman) (NN rank) (NN correlation) (NN test)) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB verify) (SBAR (IN whether) (S (NP (NP (DT the) (FW ex) (NN vivo  3H-thymidine) (NN uptake)) (PP (IN of) (NP (JJ CD4+) (NN T) (NNS cells)))) (VP (VBD correlated) (PP (IN with) (NP (NP (DT the) (NN arthritis) (NN score)) (PP (IN of) (NP (JJ individual) (NNS rats)))))))))))))) (. .)))
( (S (S (NP (JJ Statistical) (NN significance)) (VP (VBD was) (VP (VBN accepted) (PP (IN at) (NP (NP (NN P)) (CC ≤) (NP (CD 0.05))))))) (. .)))
( (S (S (NP (NP (NP (JJ Total) (NN T) (NNS cells)) (CC and) (NP (JJ CD4+) (NN T) (NNS cells))) (PP (IN from) (NP (NP (NNS spleens)) (PP (IN of) (NP (NP (JJ individual) (NNS rats)) (PRN (-LRB- -LRB-) (NP (NP (NN day) (CD 13)) (PP (IN of) (NP (NNS AA)))) (-RRB- -RRB-))))))) (VP (VBD were) (VP (VBN stimulated) (ADVP (FW in) (FW vitro)) (PP (IN with) (NP (NN ConA)))))) (. .)))
( (S (S (NP (NP (DT The) (ADJP (FW in) (FW vitro)) (NN proliferation) (NNS rates)) (PP (IN of) (NP (NP (JJ total) (NN T) (NNS cells)) (PP (IN from) (NP (ADJP (ADJP (JJ OX35-)) (CC and) (ADJP (JJ W3/25-treated))) (NNS animals))))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (JJ polyspecific) (NN stimulation)) (PP (IN with) (NP (NN ConA)))))))) (VP (VBD were) (ADJP (ADJP (JJR higher)) (PP (IN than) (NP (NP (DT those)) (PP (IN of) (NP (JJ PBS-treated) (NNS rats)))))) (, ,) (SBAR (IN while) (S (NP (NP (NN T) (NNS cells)) (PP (IN of) (NP (DT the) (JJ RIB5/2-treated) (NNS rats)))) (VP (VBD showed) (NP (NP (NN proliferation) (NNS rates)) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT those)) (PP (IN of) (NP (NP (NN T) (NNS cells)) (PP (IN from) (NP (NP (JJ PBS-treated) (NNS animals)) (PRN (-LRB- -LRB-) (NP (NP (NN Supplementary)) (NP (NNP Fig.) (CD 2))) (-RRB- -RRB-))))))))))))))) (. .)))
( (S (S (NP (NP (NN ConA) (NN stimulation)) (PP (IN of) (NP (JJ CD4+) (NN T) (NNS cells)))) (VP (VBD resulted) (PP (IN in) (NP (NP (ADJP (RB generally) (JJR lower)) (NN proliferation) (NNS rates)) (PP (IN than) (NP (NP (DT those)) (PP (IN of) (NP (NP (JJ total) (NN T) (NNS cells)) (PP (IN in) (NP (JJ PBS-treated) (NNS rats))))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NNS values)) (PP (IN of) (NP (NP (JJ CD4+) (NN T) (NNS cells)) (PP (IN from) (NP (JJ individual) (, ,) (JJ anti-CD4-treated) (NNS animals)))))) (VP (VBD were) (ADJP (ADJP (RB always) (JJR higher)) (PP (IN than) (NP (NP (DT those)) (PP (IN of) (NP (NP (DT the) (JJ PBS-treated) (NN control) (NN group)) (PRN (-LRB- -LRB-) (NP (NN Supplementary) (NNP Fig.) (NN 3a)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (EX There)) (VP (VBD was) (NP (NP (DT a) (ADJP (RB highly) (JJ significant)) (JJ negative) (NN correlation)) (PP (IN between) (NP (NP (NP (DT the) (NN degree)) (PP (IN of) (NP (NP (DT the) (JJ ConA-induced) (NN proliferation)) (PP (IN of) (NP (JJ CD4+) (NN spleen) (NN T) (NNS cells)))))) (CC and) (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (DT the) (NN arthritis) (NN score)))))) (, ,) (PP (FW i.e.) (NP (NP (DT the) (JJR lower) (NP (DT the) (NN arthritis) (NN score))) (, ,) (NP (DT the) (JJR higher) (NP (NP (DT the) (NN proliferation) (NN rate)) (PRN (-LRB- -LRB-) (NP (JJ Supplementary) (NNP Fig.) (NN 3b)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (PP (IN In) (NP (DT these) (NNS experiments))) (, ,) (NP (NP (DT the) (JJ inhibitory) (NN potency)) (PP (IN of) (NP (DT the) (JJ anti-CD4) (NNS mAbs))) (PP (IN on) (NP (NP (DT the) (JJ mixed) (NN lymphocyte) (NN culture)) (, ,) (NP (NP (DT an) (NN equivalent)) (PP (IN of) (NP (DT a) (NN transplant) (NN rejection)))) (, ,)))) (VP (VBD was) (VP (VBN investigated) (PP (IN as) (NP (NP (DT a) (NN model)) (PP (IN for) (NP (JJ MHC-dependent) (NN T-cell) (NN activation)))))))) (. .)))
( (S (S (NP (DT The) (JJ anti-CD4) (NNS mAbs)) (ADVP (RB moderately)) (VP (VBD inhibited) (NP (NP (DT the) (NN proliferation)) (PP (IN of) (NP (JJ total) (NN spleen) (NN T) (NNS cells)))) (, ,) (PP (VBG depending) (PP (IN on) (NP (NP (DT the) (NN stimulator) (NN cell) (NN concentration)) (PRN (-LRB- -LRB-) (NP (NN Supplementary) (NNP Fig.) (NN 4a)) (-RRB- -RRB-))))))) (. .)))
( (S (NP (DT The) (VBG accelerating) (NN mAb) (NN RIB5/2)) (VP (VBD led) (PP (TO to) (NP (NP (JJ significant) (NN inhibition)) (PP (IN at) (NP (NP (DT all) (NNS concentrations)) (PP (IN of) (NP (NP (NP (NN mAb)) (PRN (-LRB- -LRB-) (NP (QP (CD 1) (, ,) (CD 5) (, ,) (CC and) (CD 10)) (NN μg/ml)) (: ;) (S (NP (QP (RB only) (CD 1)) (NN μg/ml)) (VP (VBZ is) (VP (VBN shown) (PP (IN in) (NP (JJ Supplementary) (NNP Fig.) (NN 4a)))))) (-RRB- -RRB-))) (CC and) (NP (NN DC)))))))) (, ,) (SBAR (IN whereas) (S (NP (DT the) (JJ other) (CD two) (JJ anti-CD4) (NNS mAbs)) (ADVP (RB significantly)) (VP (VBD inhibited) (NP (DT the) (NN proliferation)) (PP (ADVP (RB only)) (IN in) (NP (DT some) (NNS cases))))))) (. .)))
( (S (ADVP (RB Furthermore)) (, ,) (NP (NN RIB5/2)) (VP (VBD inhibited) (NP (NP (DT the) (NN proliferation)) (PP (TO to) (NP (NP (NP (DT a) (ADJP (RB statistically) (JJ significant)) (NN degree)) (PP (IN at) (NP (CD 1) (NN μg/ml)))) (CC and) (NP (CD 2) (NN ×) (NN 104) (NN DC/well))))) (ADVP (ADVP (RBR more) (RB strongly)) (PP (IN than) (NP (CC both) (NP (NN W3/25)) (CC and) (NP (NN OX35)))))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (NP (DT these) (JJ differential) (NNS results)) (PRN (-LRB- -LRB-) (ADVP (RB inversely)) (-RRB- -RRB-)) (VP (VBP match) (NP (NP (DT the) (JJ differential) (JJ clinical) (NN efficacy)) (VP (VBN seen) (PP (IN with) (NP (DT the) (CD three) (NNS mAbs))))))) (. .)))
( (S (S (NP (DT The) (NN possibility) (SBAR (IN that) (S (NP (JJ CD8+) (NN T) (NNS cells)) (VP (MD would) (VP (VB mask) (NP (NP (DT the) (JJ inhibitory) (NN potency)) (PP (IN of) (NP (DT the) (JJ anti-CD4) (NNS mAbs)))) (PP (IN on) (NP (NP (DT the) (NN proliferation)) (PP (IN of) (NP (NP (JJ CD4+) (NN T) (NNS cells)) (PP (IN in) (NP (DT a) (JJ total) (NN T-cell) (NN population)))))))))))) (VP (VBD was) (VP (VBN excluded) (PP (IN by) (S (VP (VBG using) (NP (VBN purified) (JJ CD4+) (NN T) (NNS cells)))))))) (. .)))
( (S (S (NP (PRP They)) (VP (VBD showed) (NP (NP (DT a) (JJ clearer) (NN inhibition)) (PP (IN of) (NP (NP (PRP$ their) (NN proliferation) (NNS rates)) (PRN (-LRB- -LRB-) (NP (QP (CD 50) (TO to) (CD 80)) (NN %)) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (DT the) (NN isotype))))) (-RRB- -RRB-))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN used) (PP (IN as) (NP (NN responder) (NNS cells)))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (PP (IN in) (NN contrast) (TO to) (NP (DT the) (JJ total) (NN T-cell) (NN population))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (JJ significant) (NN difference)) (PP (IN in) (NP (DT the) (JJ inhibitory) (NN potency))) (PP (IN among) (NP (DT the) (CD three) (JJ anti-CD4) (NNS mAbs)))) (PRN (-LRB- -LRB-) (NP (JJ Supplementary) (NNP Fig.) (NN 4b)) (-RRB- -RRB-)))) (. .)))
( (S (S (SBAR (IN In) (NN order) (TO to) (S (VP (VB characterize) (NP (NP (DT the) (ADJP (ADJP (VBG depleting)) (CC and) (ADJP (VBG modulating))) (NN capacity)) (PP (IN of) (NP (DT the) (CD three) (NNS mAbs))))))) (, ,) (NP (NP (NN FACS)) (PP (IN of) (NP (JJ peripheral) (NN blood) (JJ mononu-clear) (NNS cells)))) (VP (VBD was) (VP (VBN performed) (PP (IN on) (NP (NP (NNS days) (CD 8) (CC and) (CD 13)) (PP (IN of) (NP (NP (NN AA)) (PRN (-LRB- -LRB-) (NP (NP (NN Supplementary) (NN Table) (NN 2A)) (, ,) (NP (NN B))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (NP (CD Two) (JJ different) (JJ anti-CD4) (NNS mAbs)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD W3/25)) (CC and) (NP (CD OX35))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP do) (RB not) (VP (VB compete) (PP (IN for) (NP (NN CD4) (NN binding)))))))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN employed) (S (VP (TO to) (VP (VB differentiate) (PP (VBG coating) (PP (IN with) (NP (JJ therapeutic) (NN mAb)))) (PP (IN from) (NP (NP (NN depletion)) (PP (IN of) (NP (JJ CD4+) (NN T) (NN cells/CD4-modulation))))))))))) (. .)))
( (S (PP (IN After) (NP (NP (NN treatment)) (PP (IN with) (NP (NN W3/25))))) (, ,) (NP (NP (NP (DT the) (NN percentage)) (CC and/or) (NP (NP (NN MFI)) (PRN (-LRB- -LRB-) (NP (NN mean) (NN fluorescence) (NN intensity)) (-RRB- -RRB-)))) (PP (IN of) (NP (NP (JJ CD3+) (NNS cells)) (PP (IN in) (NP (NP (DT the) (JJ peripheral) (NN blood)) (PP (IN on) (NP (NNS days) (CD 8) (CC and) (CD 13)))))))) (VP (VBD was) (ADJP (ADJP (RB numerically) (JJR lower)) (PP (IN than) (PP (IN in) (NP (DT the) (JJ PBS-treated) (NN control) (NN group))))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (DT a) (ADJP (RB significantly) (JJR lower)) (NN MFI)) (PP (IN on) (NP (NP (NN day) (CD 13)) (PRN (-LRB- -LRB-) (NP (NP (NN note)) (: :) (NP (NP (DT the) (NN fact)) (SBAR (WHNP (WDT that)) (S (PP (IN on) (NP (NN day) (CD 8))) (NP (NP (QP (RB only) (CD two)) (NNS animals)) (PP (IN of) (NP (DT the) (JJ W3/25-treated) (NN group)))) (VP (VBD were) (VP (VBN investigated) (ADVP (RB likely)) (VP (VBN prevented) (NP (JJ statistical) (NN significance) (-RRB- -RRB-))))))))))))))))) (. .)))
( (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (DT a) (NN decrease)) (PP (IN of) (NP (JJ CD4+) (NNS cells)))) (VP (VBD was) (VP (VBN observed) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NNS cells)) (VP (VBD were) (VP (VBN stained) (PP (IN with) (NP (NN OX35))) (PRN (-LRB- -LRB-) (FRAG (ADJP (RBR more) (JJ prominent)) (PP (IN on) (NP (NN day) (CD 13)))) (: ;) (S (VP (VB see) (NP (JJ Supplementary) (NN Table) (NN 2B)))) (-RRB- -RRB-))))))))) (. .)))
( (S (PP (IN After) (NP (NP (ADJP (FW ex) (FW vivo)) (NN staining)) (PP (IN with) (NP (NN W3/25) (NN –))))) (NP (NP (DT the) (NN mAb)) (VP (ADVP (RB also)) (VBN used) (PP (IN for) (NP (NN treatment))) (PP (IN –) (NP (NP (NP (NP (QP (RB only) (CD 7)) (NN %)) (PRN (-LRB- -LRB-) (NP (NN day) (CD 8)) (-RRB- -RRB-))) (CC and) (NP (NP (CD 28) (NN %)) (PRN (-LRB- -LRB-) (NP (NN day) (CD 13)) (-RRB- -RRB-)))) (PP (IN of) (NP (DT the) (JJ peripheral) (NN blood) (NP (JJ mononuclear) (NNS cells)))))))) (VP (VBD were) (ADJP (JJ CD4+))) (. .)))
( (S (S (S (NP (DT This) (NN fact))) (, ,) (CC and) (S (NP (NP (DT the) (JJ positive) (NN staining)) (PP (IN with) (NP (DT an) (JJ anti-mouse) (NN IgG))) (PP (IN on) (NP (NP (NNS days) (CD 8) (CC and) (CD 13)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 18) (NN %)) (CC and) (NP (CD 9) (NN %))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-)))) (, ,)) (VP (VBD showed) (SBAR (IN that) (S (NP (DT the) (JJ therapeutic) (JJ anti-CD4) (NN mAb)) (VP (VBD was) (ADJP (JJ present) (PP (IN on) (NP (NP (DT the) (NNS cells)) (CONJP (RB as) (RB long) (IN as)) (NP (NP (CD 7) (NNS days)) (PP (IN after) (NP (NP (DT the) (JJ last) (NN injection)) (PP (IN of) (NP (DT the) (NN mAb))))))))))))))) (. .)))
( (S (S (PP (IN After) (NP (NP (NN treatment)) (PP (IN with) (NP (NN W3/25))))) (, ,) (NP (NP (DT the) (NN percentage)) (PP (IN of) (NP (JJ CD8+) (NNS cells)))) (VP (VBD did) (RB not) (VP (VB show) (NP (DT any) (JJ significant) (NNS changes)) (PP (IN on) (NP (NNS days) (CD 8) (CC or) (CD 13)))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (NP (DT the) (NN MFI)) (PP (IN for) (NP (NN CD8))) (PP (IN on) (NP (NN day) (CD 13)))) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN decreased) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (JJ Supplementary) (NN Table) (NN 2B)))) (-RRB- -RRB-))))) (. .)))
( (S (S (ADVP (RB Therefore)) (, ,) (NP (DT the) (JJ anti-CD4) (NN mAb) (CD W3/25)) (VP (VBD induced) (NP (NP (ADJP (RB only) (JJ weak)) (NN depletion)) (PP (IN of) (NP (JJ CD4+) (NNS cells)))) (, ,) (SBAR (IN as) (S (VP (VBN indicated) (PP (IN by) (NP (NP (JJ unchanged) (NNS percentages)) (PP (IN of) (NP (JJ CD8+) (NNS cells)))))))))) (. .)))
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (NP (NN modulation)) (PP (IN of) (NP (DT the) (NP (NN CD4)) (CC and) (NP (NN co-modulation)))) (PP (IN of) (NP (DT the) (NN CD3) (NN surface) (NNS molecules)))) (CC and) (NP (NP (JJ indirect) (NN modulation)) (PP (IN of) (NP (DT the) (NN CD8) (NN molecule))))) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (JJ Supplementary) (NN Table) (NN 2B)))) (-RRB- -RRB-))) (. .)))
( (S (S (NP (DT The) (JJ anti-CD4) (NN mAb) (NN W3/25)) (ADVP (RB therefore)) (VP (VBD represented) (NP (DT a) (ADJP (ADJP (ADVP (RB weakly)) (VBG depleting)) (, ,) (CC but) (ADJP (VBG modulating))) (NN antibody)))) (. .)))
( (S (S (PP (IN In) (NP (NP (DT the) (JJ peripheral) (NN blood)) (PP (IN of) (NP (JJ OX35-treated) (NNS rats))))) (, ,) (NP (NP (DT the) (NN percentage)) (PP (IN of) (NP (JJ CD3+) (NNS cells)))) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJR lower)) (PP (IN than) (PP (IN in) (NP (JJ PBS-treated) (NNS animals))))) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (NP (NN Supplementary) (NN Table) (NN 2A)) (, ,) (NP (NN B))))) (-RRB- -RRB-)))) (. .)))
( (S (S (NP (NP (DT The) (NN percentage)) (PP (IN of) (NP (NP (JJ CD4+) (NNS cells)) (PP (IN in) (NP (DT the) (JJ OX35-treated) (NN group)))))) (VP (VBD was) (ADVP (RB also)) (ADJP (ADJP (RB significantly) (JJR lower)) (PP (IN than) (NP (NP (DT that)) (PP (PP (IN of) (NP (DT the) (JJ PBS) (NN control))) (, ,) (CC both) (PP (IN upon) (NP (NP (NN staining)) (PP (IN with) (NP (NP (NN W3/25)) (CC and) (NP (NP (NN OX35)) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (NP (NN Supplementary) (NN Table) (NN 2A)) (, ,) (NP (NN B))))) (-RRB- -RRB-))))))))))))) (. .)))
( (S (S (NP (DT The) (ADJP (RB therapeutically) (VBN applied)) (NN OX35)) (VP (VBD was) (ADVP (RB no) (RBR longer)) (ADJP (JJ present) (PP (IN on) (NP (NP (DT the) (NNS cells)) (PP (IN at) (NP (DT this) (NN stage)))))) (, ,) (SBAR (IN as) (S (VP (VBN demonstrated) (PP (IN by) (NP (NP (JJ negative) (NN staining)) (PP (IN for) (NP (NN mouse) (NN IgG)))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN percentage)) (PP (IN of) (NP (NP (JJ CD8+) (NNS cells)) (PP (IN of) (NP (JJ OX35-treated) (NNS rats)))))) (VP (VBD was) (ADVP (CC either) (ADVP (RB significantly)) (CC or) (ADVP (RB numerically))) (VP (VBN increased) (S (VP (VBN compared) (PP (TO to) (NP (NP (DT the) (JJ PBS-treated) (NN control)) (PP (IN on) (NP (NN day) (CD 8) (CC or) (CD 13))))) (, ,) (ADVP (RB respectively))))))) (, ,) (IN whereas) (S (NP (NP (DT the) (NN MFI)) (PP (IN of) (NP (DT the) (NN CD8) (NN molecule)))) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN decreased) (PP (IN on) (NP (DT both) (NNS days)))))) (. .)))
( (S (S (PP (IN In) (NP (NP (NN comparison)) (PP (IN with) (NP (NN W3/25))))) (, ,) (NP (DT the) (NN mAb) (NN OX35)) (VP (VBD induced) (NP (NP (DT a) (JJR clearer) (NN depletion)) (PP (IN of) (NP (NP (JJ CD4+) (NNS cells)) (PP (IN of) (NP (DT the) (JJ peripheral) (NN blood)))))) (, ,) (SBAR (IN as) (S (VP (VBN indicated) (PP (IN by) (NP (NP (DT a) (JJ significant) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN percentage)) (PP (IN of) (NP (JJ CD8+) (NNS cells)))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (DT the) (NN mAb) (NN OX35)) (VP (VBD induced) (NP (NP (NN CD4-modulation)) (CC and) (NP (NN CD3-co-modulation))) (, ,) (SBAR (IN as) (S (VP (VBN shown) (PP (IN by) (NP (NP (NP (DT a) (JJ profound) (NN decrease)) (PP (IN of) (NP (JJ CD4+) (NNS cells)))) (CC and) (NP (NP (DT a) (NN decrease)) (PP (IN of) (NP (NP (DT the) (NN MFI)) (PP (IN for) (NP (NN CD4))))))))))))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (NP (NN OX35)) (VP (VBD represented) (NP (DT a) (ADJP (ADJP (VBG depleting)) (CC and) (ADJP (VBG modulating))) (NN antibody)))) (. .)))
( (S (S (NP (NN RIB5/2)) (ADVP (RB also)) (VP (VBD induced) (NP (NP (DT a) (JJ significant) (NN reduction)) (PP (IN of) (NP (JJ CD3+) (NNS cells))) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (NP (DT the) (JJ PBS) (NN group)) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (NP (NN Supplementary) (NN Table) (NN 2A)) (, ,) (NP (NN B))))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN percentage)) (PP (IN of) (NP (JJ CD4+) (NNS cells)))) (VP (VBD was) (ADVP (RB also)) (ADVP (RB significantly)) (VP (VBN decreased) (PP (IN on) (NP (NNS days) (CD 8) (CC and) (CD 13)))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (JJ significant) (NN increase)) (PP (IN of) (NP (JJ CD8+) (NNS cells))) (PP (IN in) (NP (NP (DT the) (NN periphery)) (PP (IN of) (NP (JJ RIB5/2-treated) (NNS rats)))))) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (NP (DT the) (JJ PBS-treated) (NN control)) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (NP (NN Supplementary) (NN Table) (NN 2A)) (, ,) (NP (NN B))))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (ADVP (RB Similarly) (PP (TO to) (NP (NP (DT the) (NNS findings)) (PP (IN for) (NP (NN mAb) (CD OX35)))))) (, ,) (NP (NN mAb) (NN RIB5/2)) (VP (VBD induced) (NP (NP (NN T-cell) (NN depletion)) (CC and) (NP (NN CD4) (NN modulation))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (NP (DT the) (NN degree)) (PP (IN of) (NP (JJ peripheral) (NN T-cell) (NN depletion)))) (VP (VBD was) (ADJP (ADJP (JJR stronger)) (PP (IN than) (PP (IN in) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN OX35))))))))) (. .)))
( (S (ADVP (RB Thus)) (, ,) (SBAR (SBAR (IN since) (S (NP (NP (ADJP (CC both) (ADJP (VBG ameliorating)) (CC and) (ADJP (VBG accelerating))) (NNS mAbs)) (PRN (-LRB- -LRB-) (NP (NP (NN OX35)) (CC and) (NP (NN RIB5/2))) (-RRB- -RRB-))) (VP (VBD depleted) (NP (JJ CD4+) (NN T) (NNS cells)) (PP (IN from) (NP (JJ peripheral) (NN blood)))))) (, ,) (CC and) (SBAR (IN since) (S (NP (DT all) (CD three) (NNS mAbs)) (VP (VBD were) (ADJP (JJ modulating)))))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (JJ apparent) (VBP match)) (PP (IN of) (NP (DT these) (NNS parameters)))) (PP (IN with) (NP (DT the) (JJ clinical) (NN efficacy)))) (. .)))
( (S (S (NP (NP (JJ Intracellular) (NN staining)) (PP (IN of) (NP (NP (NNS cells)) (VP (VBN preincubated) (PP (IN with) (NP (NP (JJ anti-CD4) (NNS mAbs)) (CC or) (NP (NN isotype) (NNS controls)))))))) (VP (VBD showed) (NP (NP (DT a) (ADJP (RB uniformly) (JJ high)) (NN expression)) (PP (IN for) (NP (NP (NN IFN-γ)) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (JJ Supplementary) (NNP Fig.) (NN 5a)) (, ,) (NP (NN b)) (: ;)) (PP (IN between) (NP (ADJP (NP (NP (CD 80) (NN %)) (CC and) (NP (CD 100) (NN %))) (JJ positive)) (NNS cells)))) (: ;) (NP (NN MFI) (QP (RB approximately) (CD 30)))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (EX There)) (VP (VBD were) (NP (NP (DT no) (NNS differences)) (PP (IN between) (NP (DT the) (JJ anti-CD4) (ADJP (ADJP (JJ mAb-treated)) (CC or) (ADJP (JJ isotype-treated))) (NNS cultures))) (PP (IN for) (NP (NP (DT the) (NN concentration)) (PP (IN of) (NP (NN IFN-γ))) (PP (IN in) (NP (NP (DT the) (NN supernatant)) (PRN (-LRB- -LRB-) (NP (JJ Supplementary) (NNP Fig.) (NN 5c)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (DT The) (JJ anti-CD4) (NN mAb) (CD W3/25)) (VP (VBD induced) (NP (NP (DT a) (ADJP (RB significantly) (JJR higher)) (NN percentage)) (PP (IN of) (NP (JJ IL-4-positive) (NNS cells)))) (PP (IN at) (NP (QP (CD 24) (CC and) (CD 48)) (NNS hours))) (SBAR (IN than) (SINV (VBD did) (NP (DT the) (NN isotype) (NN control) (-LRB- -LRB-) (NN Supplementary) (NNP Fig.) (CD 5d) (-RRB- -RRB-)))))) (: ;) (S (NP (DT the) (NN MFI)) (VP (VBD was) (ADVP (RB also)) (ADJP (ADJP (RB significantly) (JJR higher)) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (NP (NP (NN OX35)) (CC and) (NP (NN RIB5/2))) (PRN (-LRB- -LRB-) (NP (JJ Supplementary) (NNP Fig.) (NN 5e)) (-RRB- -RRB-))))))))) (. .)))
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (EX there)) (VP (VBD were) (NP (NP (DT no) (JJ significant) (NNS differences)) (PP (IN of) (NP (DT the) (NN IL-4) (NN concentration))) (PP (IN in) (NP (NP (NP (DT the) (NN supernatant)) (PP (IN of) (NP (DT the) (NNS cultures)))) (PRN (-LRB- -LRB-) (NP (JJ Supplementary) (NNP Fig.) (NN 5f)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (DT This) (NN observation)) (VP (MD may) (VP (VB be) (ADJP (JJ attributable) (PP (TO to) (NP (NP (DT a) (VBN delayed) (NN secretion)) (PP (IN of) (NP (NP (NN IL-4)) (CC or) (NP (NP (NN consumption)) (PP (IN of) (NP (DT the) (NN cytokine))) (PP (IN during) (NP (NN culture)))))))))))) (. .)))
( (S (S (PP (IN At) (NP (CD 24) (NN h))) (, ,) (NP (NP (DT a) (JJ numerical) (NN increase)) (PP (IN of) (NP (NP (DT the) (NN percentage)) (PP (IN of) (NP (JJ IL-10-positive) (NNS cells)))))) (VP (MD could) (VP (VB be) (VP (VBN detected) (PP (IN after) (NP (NP (NN preincubation)) (PP (IN with) (NP (NP (DT the) (JJ ameliorating) (NN mAb) (NN W3/25)) (CC and) (NP (DT the) (VBG accelerating) (NN mAb) (NN RIB5/2)))))))))) (, ,) (IN whereas) (S (NP (NP (DT the) (JJ other) (JJ ameliorating) (NN mAb)) (, ,) (NP (NN OX35)) (, ,)) (VP (VBD induced) (NP (NP (DT a) (JJ significant) (NN increase)) (PRN (-LRB- -LRB-) (NP (JJ Supplementary) (NNP Fig.) (NN 5g)) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (DT This) (NN increase)) (VP (VBD was) (ADVP (RB no) (RBR longer)) (VP (VBN observed) (PP (IN at) (NP (NP (CD 48) (NN h)) (PRN (-LRB- -LRB-) (NP (NN Supplementary) (NNP Fig.) (NN 5g)) (-RRB- -RRB-))))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (DT the) (NN MFI)) (PP (IN for) (NP (NN IL-10)))) (VP (VBD was) (VP (VBN increased) (NP (CC both) (NP (CD 24) (NN h)) (CC and) (NP (CD 48) (NN h))) (PP (IN after) (NP (NP (NN pretreatment)) (PP (IN with) (NP (JJ anti-CD4) (NNS mAbs)))))))) (. .)))
( (S (S (S (PP (IN At) (NP (CD 24) (NN h))) (, ,) (NP (NP (RB only) (DT the) (NN increase)) (VP (VBN induced) (PP (IN by) (NP (DT the) (NN mAb) (NN OX35))))) (VP (VBD was) (ADJP (JJ significant)))) (, ,) (CC but) (S (PP (IN at) (NP (CD 48) (NN h))) (NP (DT all) (CD three) (NNS mAbs)) (VP (VBD induced) (NP (NP (DT a) (JJ significant) (NN increase)) (PP (IN of) (NP (NP (DT the) (NN MFI)) (PRN (-LRB- -LRB-) (NP (JJ Supplementary) (NNP Fig.) (NN 5h)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (NN Preincubation)) (PP (IN with) (NP (DT all) (JJ anti-CD4) (NNS mAbs)))) (VP (VBD induced) (NP (NP (DT a) (ADJP (RB significantly) (JJR higher)) (NN secretion)) (PP (IN of) (NP (NN IL-10)))) (SBAR (IN than) (SINV (VBD did) (NP (DT the) (NN isotype) (NN control)))) (, ,) (PP (CONJP (RB not) (RB only)) (PP (IN after) (NP (CD 24) (NN h))) (, ,) (CONJP (CC but) (RB also)) (PP (IN after) (NP (NP (CD 48) (NNS hours)) (PRN (-LRB- -LRB-) (S (NP (DT the) (JJ latter) (NN increase)) (VP (VBD did) (RB not) (VP (VB reach) (NP (NP (JJ statistical) (NN significance)) (PP (IN in) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN OX35))))))))) (-RRB- -RRB-))))))) (. .)))
( (S (NP (NP (NN None)) (PP (IN of) (NP (DT the) (NNS parameters)))) (, ,) (ADVP (RB however)) (, ,) (VP (VBD showed) (NP (NP (JJ significant) (NNS differences)) (PP (IN among) (NP (NP (DT the) (CD three) (JJ different) (JJ anti-CD4) (NNS mAbs)) (PRN (-LRB- -LRB-) (NP (JJ Supplementary) (NNP Fig.) (NN 5i)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (JJ nondepleting) (JJ anti-CD4) (NNS mAbs))) (PP (IN for) (NP (NP (NN treatment)) (PP (IN of) (NP (JJ human) (JJ rheumatoid) (NN arthritis)))))) (VP (VBZ is) (VP (VBG being) (VP (VBN discussed) (PP (IN at) (NP (NN present))))))) (: ;) (S (NP (JJ such) (NN treatment)) (VP (MD would) (VP (VB be) (VP (VBN intended) (S (VP (TO to) (VP (VB influence) (NP (NP (DT the) (NN reactivity)) (PP (IN of) (NP (JJ CD4+) (NN T) (NNS cells))))))))) (, ,) (CONJP (RB rather) (IN than)) (VP (VB remove) (NP (PRP them)) (ADVP (RB completely))) (PRN (-LRB- -LRB-) (ADVP (ADVP (RB particularly)) (SBAR (IN since) (S (NP (NN depletion)) (VP (MD may) (VP (VB induce) (NP (JJ transient) (NN immunodeficiency))))))) (-RRB- -RRB-)))) (. .)))
( (S (S (PP (IN In) (NP (FW vivo))) (, ,) (NP (NP (DT the) (ADJP (ADJP (VBG depleting)) (CC and) (ADJP (VBG modulating))) (NNS capacities)) (PP (IN of) (NP (DT the) (CD three) (JJ anti-CD4) (NNS mAbs)))) (VP (VBD were) (ADJP (JJ different)))) (. .)))
( (S (S (SBAR (IN Whereas) (S (NP (NN W3/25)) (VP (VBD was) (NP (DT a) (ADJP (ADJP (RB weakly) (VBG depleting)) (, ,) (CC but) (ADJP (RB clearly) (VBG modulating)) (, ,)) (NN mAb))))) (, ,) (NP (NP (NN RIB5/2)) (CC and) (NP (NN OX35))) (VP (VBD were) (NP (ADJP (ADJP (ADVP (ADVP (RB moderately)) (CC or) (ADVP (RB strongly))) (VBG depleting)) (CC and) (ADJP (VBG modulating))) (NNS mAbs)) (, ,) (ADVP (RB respectively)))) (: ;) (S (NP (DT this) (NN pattern)) (VP (VBD did) (RB not) (VP (VBP match) (NP (NP (DT the) (NN treatment) (NNS effects)) (PP (IN of) (NP (DT the) (CD three) (NNS mAbs))))))) (. .)))
( (S (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (JJ CD4+) (NN T-cell) (NN depletion)) (VP (VBD was) (VP (VBN assessed) (PP (ADVP (RB only)) (IN in) (NP (NP (DT the) (JJ peripheral) (NN blood)) (, ,) (NP (NP (DT the) (NN compartment)) (ADJP (RBS most) (RB easily) (JJ accessible) (PP (ADVP (RB also)) (IN in) (NP (NNS humans)))))))))) (. .)))
( (S (PP (IN Because) (NP (NP (NN depletion/modulation)) (PP (IN in) (NP (JJ peripheral) (NN blood))))) (VP (MD may) (VP (VB differ) (PP (IN from) (NP (NP (DT that)) (PP (IN in) (NP (JJ other) (NNS compartments))))) (-LRB- -LRB-) (NP (FW e.g.))))))
( (S (S (S (NP (JJ lymphoid) (NNS organs)) (-RRB- -RRB-)) (, ,) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (NP (DT the) (NNS terms)) (PRN (`` ') (NP (VBG depleting)) ('' '))) (CC or) (NP (`` ') (NN nondepleting) ('' '))))) (VP (VBZ has) (S (VP (TO to) (VP (VB be) (ADJP (JJ restricted) (PP (TO to) (NP (DT the) (NN blood))))))))) (. .)))
( (S (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (DT the) (NNS mAbs) (NP (NP (CD W3/25)) (CC and) (NP (CD OX35))))))) (, ,) (ADVP (RB however)) (, ,) (NP (NP (NNS studies)) (PP (IN with) (NP (ADJP (ADJP (JJ marked)) (, ,) (ADJP (JJ antibody-coated))) (NNS cells)))) (VP (VBP indicate) (NP (NP (DT a) (NN redistribution)) (PP (IN of) (NP (DT the) (NNS cells))) (PP (IN from) (NP (JJ lymphoid) (NNS organs))) (PP (TO to) (NP (DT the) (NN liver)))) (, ,) (S (ADVP (RB possibly)) (VP (VBG including) (NP (NP (NN phagocytosis)) (CC and) (NP (NP (NN depletion)) (PP (IN of) (NP (DT the) (JJ opsonized) (POS ') (NNS cells) (POS '))) (PP (IN by) (NP (NP (NN liver) (NNS macrophages)) (PRN (-LRB- -LRB-) (NP (JJ unpublished) (NNS observations)) (-RRB- -RRB-)))))))))) (. .)))
( (S (NP (NP (JJ Contrasting) (JJR earlier) (NNS findings)) (VP (VBG concerning) (NP (NP (DT the) (VBG depleting) (NN capacity)) (PP (IN of) (NP (DT the) (NN mAb) (NN RIB5/2) (NN -LSB-S7) (, ,) (NN S8) (-RRB- -RSB-)))))) (VP (MD may) (VP (VB be) (ADJP (JJ attributable) (PP (TO to) (NP (NP (NP (JJ different) (NN time) (NNS points)) (PP (IN of) (NP (NN investigation)))) (, ,) (NP (NP (JJ different) (NNS amounts)) (PP (IN of) (NP (NP (VBN injected) (NN mAb)) (CC or) (NP (NP (NN number)) (PP (IN of) (NP (JJ therapeutic) (NNS injections))))))) (, ,) (CC and) (NP (NP (JJ different) (JJ experimental) (NNS models)) (PRN (-LRB- -LRB-) (NP (NP (JJ personal) (NN communication)) (, ,) (NP (NP (NN Dr) (NN M)) (NP (NNP Lehmann) (, ,) (NNP University)) (PP (IN of) (NP (NN Rostock))))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (JJ Differential) (NNS effects)) (PP (IN of) (NP (DT the) (CD three) (JJ anti-CD4) (NNS mAbs))) (PP (IN on) (NP (DT the) (JJ mixed) (NN lymphocyte) (NN culture)))) (VP (VBD were) (VP (VBN noted) (ADVP (RB only) (RB occasionally)) (, ,) (PP (ADVP (RB especially)) (IN with) (NP (NP (JJ total) (NN T) (NNS cells)) (PP (IN as) (NP (NNS responders)))))))) (. .)))
( (S (S (NP (DT The) (VBG accelerating) (NN mAb) (NN RIB5/2)) (VP (VBD was) (ADVP (RB again)) (ADJP (RBR more) (JJ effective)))) (. .)))
( (S (S (NP (NP (DT The) (NN observation)) (PP (IN of) (NP (JJ differential) (NNS effects))) (PP (ADVP (RB only)) (PP (IN with) (NP (JJ total) (NN T) (NNS cells))) (, ,) (CONJP (CC but) (RB not)) (PP (IN in) (NP (JJ CD4+) (NN T) (NNS cells))) (, ,))) (VP (VP (VBZ indicates) (NP (NP (DT a) (JJ differential) (NN contribution)) (PP (IN of) (NP (DT the) (ADJP (ADJP (JJ CD4+)) (CC and) (ADJP (JJ CD8+))) (NN T-cell) (NN subpopulation))))) (CC and) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (NNS interactions)) (PP (IN between) (NP (NP (ADJP (ADJP (JJ CD4+)) (CC and) (ADJP (JJ CD8+))) (NN T) (NNS cells)) (PRN (NN -LSB-S9) (-RRB- -RSB-))))) (VP (VBP are) (ADJP (JJ critical) (PP (IN for) (NP (NP (NN T-cell) (NN activation)) (CC and) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ anti-CD4) (NNS mAbs))) (PP (IN on) (NP (DT this) (NN process))))))))))))) (. .)))
( (S (S (SBAR (IN Whereas) (S (S (NP (NN IFN-γ) (NN secretion)) (VP (VBD was) (ADVP (RB completely)) (VP (VBN unaffected) (PP (IN by) (NP (JJ anti-CD4) (NN preincubation)))))) (CC and) (S (NP (NN IL-4)) (VP (VBD was) (ADVP (RB only)) (VP (VBN increased) (PP (IN by) (NP (DT the) (NN mAb) (NN W3/25))) (PRN (-LRB- -LRB-) (FRAG (RB as) (ADJP (RB previously) (VBN reported)) (: ;) (FRAG (NP (NN -LSB-S10)) (-RRB- -RSB-))) (-RRB- -RRB-))))))) (, ,) (NP (NN IL-10) (NN secretion)) (VP (VBD was) (ADVP (RB strikingly)) (VP (VBN induced) (PP (IN by) (NP (DT all) (CD three) (JJ anti-CD4) (NNS mAbs)))))) (. .)))
( (S (PP (ADVP (IN At) (JJS least)) (IN in) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (DT the) (JJ ameliorating) (NNS mAbs) (NP (NP (CD W3/25)) (CC and) (NP (CD OX35))))))) (, ,) (NP (DT this) (NN effect)) (VP (VP (VBZ is) (ADJP (JJ compatible) (PP (IN with) (NP (NP (DT the) (JJ anti-inflammatory) (NN role)) (PP (IN of) (NP (NN IL-10))) (PP (IN in) (NP (NP (NN arthritis) (CD -LSB-S11)) (PRN (, ,) (NP (NN S12)) (-RRB- -RSB-)))))))) (CC and) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (ADVP (RB also)) (PP (IN after) (NP (NP (JJ anti-CD4) (NN therapy)) (PP (IN in) (NP (NN transplantation) (NN -LSB-S13) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (DT The) (NN fact) (SBAR (IN that) (S (NP (NP (DT the) (JJ total) (NN number)) (PP (IN of) (NP (ADJP (ADJP (JJ IFN-γ-positive)) (CC and) (ADJP (JJ IL-4-/IL-10-positive))) (NN T) (NNS cells)))) (VP (VBZ exceeds) (NP (CD 100) (NN %)))))) (VP (VBZ indicates) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN TH0) (NNS cells))) (PP (IN in) (NP (DT this) (JJ particular) (JJ experimental) (NN system)))))) (. .)))
( (S (NP (NNS Abbreviations))))
( (S (S (NP (NP (NP (NP (NP (NP (NP (NP (NP (NN AA) (JJ =) (NN rat) (JJ adjuvant) (NN arthritis)) (: ;) (NP (NN AP-1) (JJ =) (NN activator) (NN protein-1)) (: ;) (NP (NN ConA) (JJ =) (NN concanavalin) (NN A)) (: ;) (NP (NN DC) (JJ =) (JJ dendritic) (NNS cells)) (: ;) (CD DTH)) (JJ =) (JJ delayed-type) (NN hypersensitivity)) (: ;) (NP (NN ELISA) (JJ =) (JJ enzyme-linked) (JJ immunosorbent) (NN assay)) (: ;) (NP (NN FACS) (JJ =) (NN flowcytometry)) (: ;) (NP (NN FCS) (JJ =) (JJ fetal) (NN calf) (NN serum)) (: ;) (NP (NN FITC) (JJ =) (NN fluorescein) (NN isothiocyanate)) (: ;) (NP (NN HEPES) (JJ =) (NN N-))) (PRN (-LRB- -LRB-) (NP (NN 2-hydroxyethyl)) (-RRB- -RRB-)) (JJ piperazine-N'-) (PRN (-LRB- -LRB-) (NP (JJ 2-ethanesulfonic) (NN acid)) (-RRB- -RRB-))) (: ;) (NP (NP (NP (NN IFN) (JJ =) (NN interferon) (: ;) (NN IL) (JJ =) (NN interleukin) (: ;) (NN KA) (JJ =) (NN affinity) (NN constant)) (: ;) (NP (NN kass) (JJ =) (NN association) (NN rate) (NN constant)) (: ;) (NP (NP (NN kdiss) (JJ =) (NN dissociation) (NN rate) (NN constant)) (: ;) (NP (NN mAb) (JJ =) (JJ monoclonal) (NN antibody))) (: ;) (CD MFI)) (JJ =) (NN mean) (NN fluorescence) (NN intensity)) (: ;) (NP (NN MHC) (JJ =) (JJ major) (NN histocompatibility) (NN complex)) (: ;) (NP (NP (NN NF-AT) (JJ =) (JJ nuclear) (NN factor)) (PP (IN of) (NP (VBN activated) (NN T) (NNS cells)))) (: ;)) (NNS PBS)) (ADJP (JJ =) (NP (NP (JJ phosphate-buffered) (NN saline)) (: ;) (NP (NN PE) (JJ =) (NN phycoerythrin)) (: ;) (NP (NN PMA) (JJ =) (NN phorbol) (NN myristoyl) (NN acetate)) (: ;) (NP (NN PMSF) (JJ =) (NN phenylmethylsulfonyl) (NN fluoride)) (: ;))) (NN RPMI) (JJ =)) (NNP Roswell) (NNP Park) (NNP Memorial) (NNP Institute) (NN -LSB-medium) (-RRB- -RSB-))) (: ;) (S (NP (NN SEM)) (VP (VBG =) (NP (NP (JJ standard) (NN error)) (PP (IN of) (NP (NP (DT the) (NN mean) (: ;) (NN Shc) (JJ =) (NN src-homology-domain-containing-protein)) (: ;) (NP (NN TNF) (JJ =) (NN tumor) (NN necrosis) (NN factor))))))) (: ;) (S (NP (NN TCR)) (VP (VBG =) (NP (NN T-cell) (NN receptor)))) (. .)))
( (S (NP (NP (NN Figure)) (CC and) (NP (NN Table)) (NP (NNS captions)))))
( (S (NP (NP (NN Figure) (CD 1)) (: :) (NP (NP (NN Arthritis) (NN score)) (PP (IN after) (NP (NP (JJ preventive) (NN treatment)) (PP (IN of) (NP (NP (NN rat) (JJ adjuvant) (NN arthritis)) (PRN (-LRB- -LRB-) (NP (NN AA)) (-RRB- -RRB-)))) (PP (IN with) (NP (NP (JJ various) (JJ anti-CD4) (NNS mAbs)) (CC or) (NP (NP (NN PBS) (-LRB- -LRB-) (NNS controls) (-RRB- -RRB-)) (PRN (-LRB- -LRB-) (NP (NN means) (NN ±) (NN SEM)) (: ;) (S (NP (NN n)) (VP (JJ =) (NP (CD 6)) (PP (IN for) (NP (DT all) (NNS groups))))) (-RRB- -RRB-)))))))) (. .))))
( (S (S (NP (NNS Arrows)) (VP (VBP show) (NP (NP (DT the) (NNS days)) (PP (IN of) (NP (NN treatment)))) (PRN (-LRB- -LRB-) (NP (NNS days) (QP (CD -1) (, ,) (CD 0) (, ,) (CD 3) (, ,) (CD 6))) (-RRB- -RRB-)))) (. .)))
( (S (S (NP (NP (NN Treatment)) (PP (IN with) (NP (NP (NN W3/25)) (CC and) (NP (NN OX35))))) (ADVP (RB significantly)) (VP (VBD suppressed) (NP (NP (NN AA)) (PP (IN from) (NP (NN day) (CD 13)))) (PP (IN until) (NP (NN day) (CD 30))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NN RIB5/2)) (VP (VP (VBD accelerated) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (NN AA)))) (PP (IN by) (NP (CD 2) (NNS days)))) (CC and) (VP (VBD led) (PP (TO to) (NP (NP (JJ significant) (NN improvement)) (PP (ADVP (RB only)) (IN in) (NP (NP (DT the) (JJ late) (NN phase)) (PRN (-LRB- -LRB-) (PP (IN from) (NP (NN day) (CD 27))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (S (NP (JJ **) (NN P)) (VP (JJ ≤) (NP (CD 0.01)))) (, ,) (NP (NN *) (NN P)) (VP (JJ ≤) (NP (CD 0.05)) (, ,) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (JJ PBS-treated) (NNS rats))))))) (. .)))
( (S (S (NP (NP (CD One) (NN representative)) (PP (IN of) (NP (CD three) (NNS experiments)))) (VP (VBZ is) (VP (VBN shown)))) (. .)))
( (S (NP (NP (NN Supplementary) (NN Figure) (CD 1)) (: :) (S (NP (NP (ADJP (FW In) (FW vivo)) (JJ delayed-type) (NN hypersensitivity)) (PP (TO to) (NP (NN Mycobacterium) (NN tuberculosis)))) (VP (PP (IN on) (NP (NP (NN day) (CD 13)) (PP (IN after) (NP (NP (JJ preventive) (NN treatment)) (PP (IN of) (NP (NN AA))))) (, ,) (PP (FW i.e.)))) (SBAR (WHADVP (WRB when)) (S (NP (NP (DT the) (JJ clinical) (NNS differences)) (PP (IN between) (NP (DT the) (ADJP (ADJP (VBG accelerating)) (CC and) (ADJP (VBG ameliorating))) (JJ anti-CD4) (NNS mAbs)))) (VP (VBD were) (ADJP (JJ maximal))))))) (. .))))
( (S (S (NP (DT The) (NNS data)) (VP (VBP are) (VP (VBN expressed) (PP (IN as) (NP (NP (NP (NN means)) (NP (NP (NN ±) (NN SEM)) (PRN (-LRB- -LRB-) (S (NP (NN n)) (VP (JJ =) (NP (NP (NP (CD 6)) (PP (IN for) (NP (DT all) (NNS groups)))) (, ,) (NP (NP (CD one) (NN representative)) (PP (IN of) (NP (CD three) (ADJP (FW in) (FW vivo)) (NNS experiments))))))) (-RRB- -RRB-)))) (PP (IN of) (NP (NP (DT the) (NN difference)) (PP (IN between) (NP (NP (DT the) (NN swelling)) (PP (IN of) (NP (NP (NP (DT the) (JJ left)) (PRN (-LRB- -LRB-) (NP (JJ mycobacterium-treated)) (-RRB- -RRB-))) (CC and) (NP (DT the) (JJ right) (-LRB- -LRB-) (JJ PBS-treated) (-RRB- -RRB-) (NNS ears))))))))))))) (. .)))
( (S (S (NP (NN *) (NN P)) (VP (JJ ≤) (NP (CD 0.05)) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (JJ PBS-treated) (NNS rats))))))) (. .)))
( (S (S (NP (NP (JJ Supplementary) (NN Figure) (CD 2) (: :) (NP (NP (NN Concanavalin) (NN A)) (PRN (-LRB- -LRB-) (NP (NN ConA)) (-RRB- -RRB-))) (NN reactivity)) (PP (IN of) (NP (NP (NP (JJ total) (NN spleen) (NN T) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NP (NN day) (CD 13)) (PP (IN of) (NP (JJ adjuvant) (NN arthritis)))) (-RRB- -RRB-))) (PP (IN from) (NP (NNS rats)))))) (ADVP (RB preventively)) (VP (VBN treated) (PP (IN with) (NP (JJ anti-CD4) (NNS mAbs))))) (. .)))
( (S (S (NP (NP (NN Proliferation) (NNS data)) (PP (IN from) (NP (NP (CD two) (JJ individual) (NNS animals)) (PP (IN of) (NP (DT each) (NN treatment) (NN group)))))) (VP (VBP are) (VP (VBN expressed) (PP (IN as) (NP (NP (NNS means)) (VP (VBG ±) (NP (NP (NN SEM)) (PP (IN of) (NP (NP (JJ triplicate) (NNS cultures)) (PP (IN from) (NP (CD one) (ADJP (FW in) (FW vivo)) (NN experiment)))))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ corresponding) (NN arthritis) (NN score)) (PP (IN for) (NP (DT the) (NNS animals)))) (VP (VBZ is) (VP (VBN shown) (PP (IN below) (NP (DT the) (NN graph)))))) (. .)))
( (S (S (NP (NN Supplementary) (NN Figure) (CD 4)) (: :) (NP (NP (NP (JJ Mixed) (NN lymphocyte) (NN culture)) (PP (IN of) (NP (NP (NP (NP (JJ total)) (PRN (-LRB- -LRB-) (NP (NN a)) (-RRB- -RRB-))) (CC and) (NP (JJ CD4+) (-LRB- -LRB-) (NN b) (-RRB- -RRB-) (NN spleen) (NN T) (NNS cells))) (PP (IN from) (NP (JJ normal) (NN Lewis) (NNS rats))))) (PP (IN with) (NP (NP (JJ different) (NNS densities)) (PP (IN of) (NP (JJ allogeneic) (-LRB- -LRB-) (NN Wistar–Prob) (-RRB- -RRB-) (NN stimulator) (NNS cells))))) (, ,) (VP (VBN supplemented) (PP (IN with) (NP (NP (NN isotype) (NNS controls)) (PRN (-LRB- -LRB-) (NP (NN IgG1)) (, ,) (NP (NN IgG2a)) (-RRB- -RRB-))))) (, ,)) (CC or) (NP (NP (DT the) (JJ anti-CD4) (NNS mAbs)) (NP (NP (NN W3/25)) (, ,) (NP (NN OX35)) (, ,) (CC and) (NP (NP (NN RIB5/2)) (PP (IN at) (NP (CD 1) (NN μg/ml)))))))) (. .)))
( (S (S (NP (NNS Data)) (VP (VBP are) (VP (VBN expressed) (PP (IN as) (NP (NP (NNS means)) (VP (VBG ±) (NP (NP (NN SEM)) (PP (IN of) (NP (DT the) (JJ relative) (NN absorbance)))) (PP (IN from) (NP (NP (CD three) (JJ independent) (NNS experiments)) (PRN (-LRB- -LRB-) (NP (NP (NNS triplicates)) (PP (IN in) (NP (DT each) (NN experiment)))) (-RRB- -RRB-))))))) (, ,) (S (VP (VBN normalized) (PP (TO to) (NP (NP (DT the) (NN absorbance)) (PP (IN of) (NP (NP (JJ PBS-treated) (NNS cultures)) (PRN (-LRB- -LRB-) (NP (CD =100) (NN %)) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (S (NP (NN *) (NN P)) (VP (JJ ≤) (NP (CD 0.05)) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (DT the) (JJ respective) (NN isotype) (NN control))))))) (, ,) (S (NP (NN #) (NN P)) (VP (JJ ≤) (NP (CD 0.05)) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (NP (NN W3/25)) (, ,) (NP (NN §P) (NN ≤) (CD 0.05)))))) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (NN OX35)))))))) (. .)))
( (S (NP (NP (NN Figure) (CD 2)) (: :) (NP (NP (NN Production)) (PP (IN of) (NP (NN TNF-α))) (PP (IN by) (NP (NP (NN spleen) (JJ CD4+) (NN T) (NNS cells)) (PP (IN after) (NP (NP (JJ anti-CD4) (NN preincubation)) (, ,) (SBAR (IN as) (S (VP (VBN measured) (PP (IN by) (NP (NP (NN bioassay)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN means) (NN ±) (NN SEM)) (PP (IN of) (NP (CD three) (NNS experiments)))) (: ;) (NP (NP (JJ pooled) (NN T) (NNS cells)) (PP (IN from) (NP (NP (CD three) (JJ normal) (NNS rats)) (NP (DT each)))))) (-RRB- -RRB-)))))))))))) (. .))))
( (S (S (NP (NP (DT The) (VBG accelerating) (NN mAb)) (, ,) (NP (NN RIB5/2)) (, ,)) (VP (VBD induced) (NP (NP (DT a) (ADJP (RB significantly) (JJR stronger)) (NN increase)) (PP (IN of) (NP (JJ secreted) (NNS TNF-α)))) (PP (IN than) (NP (DT the) (JJ other) (NNS mAbs))))) (. .)))
( (S (S (NP (NN Specificity)) (VP (VBD was) (VP (VBN ensured) (PP (IN by) (S (VP (VBG adding) (NP (DT a) (NN neutralizing) (NN anti-TNF-α) (NN mAb)) (PP (TO to) (NP (NP (NNS supernatants)) (PP (IN from) (NP (JJ RIB5/2-treated) (NNS cultures))))))))))) (. .)))
( (S (S (NP (NN *) (NN P)) (VP (JJ ≤) (NP (CD 0.05)) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (NP (DT the) (NN isotype) (NN control)) (, ,) (NP (NP (NN #) (NN P)) (VP (JJ ≤) (NP (CD 0.05)) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (NP (NN W3/25)) (, ,) (NP (NN §P) (NN ≤) (CD 0.05)))))) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (NN OX35))))))))))))) (. .)))
( (S (NP (NP (NN Figure) (CD 3)) (: :) (NP (NP (NP (NN Electromobility) (NN shift) (NN assay)) (PRN (-LRB- -LRB-) (NP (NN EMSA)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN from) (NP (NP (JJ CD4+) (NN T) (NNS cells)) (PRN (-LRB- -LRB-) (VP (VP (VBN preincubated) (PP (IN with) (NP (JJ anti-CD4) (NNS mAbs)))) (CC or) (VP (VBN stimulated) (PP (IN with) (NP (NN PMA/ionomycin))))) (-RRB- -RRB-)))))) (PP (IN for) (NP (NP (NP (NN AP-1)) (PRN (-LRB- -LRB-) (NP (NN a)) (-RRB- -RRB-))) (CC and) (NP (NP (NN NF-κB)) (PRN (-LRB- -LRB-) (NP (NN b)) (-RRB- -RRB-)))))) (. .))))
( (S (S (NP (NP (CD One) (JJ representative) (NN phosphoimage)) (PP (IN of) (NP (CD three) (JJ independent) (NNS experiments)))) (VP (VBZ is) (VP (VBN shown) (PRN (-LRB- -LRB-) (NP (JJ upper) (NNS panels)) (-RRB- -RRB-))))) (. .)))
( (S (NP (NP (NN Quantification)) (PP (IN of) (NP (NP (DT the) (NNS bands)) (PP (IN of) (NP (DT all) (CD three) (NNS experiments)))))) (VP (VBZ is) (VP (VBN shown) (PP (PP (IN below)) (PRN (-LRB- -LRB-) (NP (NN means) (NN ±) (NN SEM)) (-RRB- -RRB-))))) (. .)))
( (S (S (S (NP (DT All) (CD three) (JJ anti-CD4) (NNS mAbs)) (ADVP (RB slightly)) (VP (VBD decreased) (NP (DT the) (NN AP-1) (NN activity)))) (, ,) (CC and) (S (NP (NN RIB5/2)) (VP (VBD induced) (NP (NP (DT a) (ADJP (ADJP (JJ profound)) (, ,) (ADJP (JJ significant))) (NN increase)) (PP (IN of) (NP (JJ NF-κB) (NN activity))))))) (. .)))
( (S (S (NP (NN *) (NN P)) (VP (JJ ≤) (NP (NP (NP (CD 0.05)) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (NP (DT the) (NN isotype) (NN control)) (, ,) (NP (NP (NN #) (NN P) (NN ≤) (CD 0.05)) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (NN W3/25))))))))))) (, ,) (NP (CD §P) (NN ≤) (CD 0.05))) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (NP (NN OX35)) (, ,) (NP (NN &P) (NN ≤) (CD 0.05)))))) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (NN RIB5/2))))))) (. .)))
( (S (NP (NP (NN Supplementary) (NN Figure) (CD 3)) (: :) (NP (NP (NP (NP (NP (NN Concanavalin) (NN A)) (PRN (-LRB- -LRB-) (NP (NN ConA)) (-RRB- -RRB-))) (NN reactivity)) (PRN (-LRB- -LRB-) (NP (NN a)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NP (JJ CD4+) (NN spleen) (NN T) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NP (NN day) (CD 13)) (PP (IN of) (NP (JJ adjuvant) (NN arthritis)))) (-RRB- -RRB-))) (PP (IN from) (NP (ADJP (RB preventively) (VBN treated)) (NNS rats))))) (PP (IN with) (NP (JJ anti-CD4) (NNS mAbs)))) (. .))))
( (S (S (NP (NP (NN Proliferation) (NNS data)) (PP (IN from) (NP (NP (CD two) (JJ individual) (NNS animals)) (PP (IN of) (NP (DT each) (NN group)))))) (VP (VBP are) (VP (VBN expressed) (PP (IN as) (NP (NP (NNS means)) (VP (VBG ±) (NP (NP (NN SEM)) (PP (IN of) (NP (JJ triplicate) (NNS cultures)))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ corresponding) (NN arthritis) (NN score)) (PP (IN for) (NP (DT the) (NNS animals)))) (VP (VBZ is) (VP (VBN shown) (PP (IN in) (NP (DT the) (NN middle)))))) (. .)))
( (S (S (NP (NP (DT The) (NN correlation)) (PP (IN between) (NP (NP (NP (NN reactivity)) (PP (TO to) (NP (NN ConA)))) (CC and) (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (NN arthritis))))))) (VP (VBZ is) (VP (VBN shown) (PP (IN in) (NP (-LRB- -LRB-) (NN b) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NNS Normals)) (VP (VBD =) (NP (ADJP (ADJP (JJ normal)) (, ,) (ADJP (JJ untreated))) (NNS rats)))) (. .)))
( (S (S (NP (NN Supplementary) (NN Figure) (CD 5)) (: :) (NP (NP (NN Production)) (PP (IN of) (NP (NP (NP (NN IFN-γ)) (PRN (-LRB- -LRB-) (NP (NP (NN a)) (, ,) (NP (NN b)) (, ,) (NP (NN c))) (-RRB- -RRB-))) (, ,) (NP (NP (NN IL-4)) (PRN (-LRB- -LRB-) (NP (NP (NN d)) (, ,) (NP (NN e)) (, ,) (NP (NN f))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NN IL-10)) (PRN (-LRB- -LRB-) (NP (NP (NN g)) (, ,) (NP (NN h)) (, ,) (NP (CD i))) (-RRB- -RRB-))))) (PP (IN by) (NP (NN spleen) (JJ CD4+) (NN T) (NNS cells))) (PP (IN after) (NP (NN anti-CD4-preincubation))))) (. .)))
( (S (NP (NP (NP (NP (NN Percentage)) (PP (IN of) (NP (NP (JJ cytokine-positive) (NNS cells)) (PRN (-LRB- -LRB-) (NP (JJ upper) (NNS panels)) (-RRB- -RRB-))))) (, ,) (NP (NP (NP (PRP$ their) (NN mean) (NN fluorescence) (NN intensity)) (PRN (-LRB- -LRB-) (NP (CD MFI)) (-RRB- -RRB-))) (PP (IN after) (NP (NP (JJ intracellular) (NN staining)) (PRN (-LRB- -LRB-) (NP (JJ middle) (NNS panels)) (-RRB- -RRB-))))) (, ,) (CC and) (NP (NN secretion))) (PP (IN of) (NP (DT the) (NN cytokine))) (PP (IN into) (NP (NN cell) (NN culture) (NN supernatant)))) (PP (IN as) (VP (VBN measured) (PP (IN by) (NP (NN ELISA))) (PRN (-LRB- -LRB-) (NP (JJR lower) (NNS panels)) (-RRB- -RRB-)))) (, ,) (VP (VBN shown) (PP (IN as) (NP (NP (NN means) (NN ±) (NN SEM)) (PP (IN of) (NP (NP (CD three) (JJ independent) (NNS experiments)) (PRN (-LRB- -LRB-) (NP (NP (JJ triplicate) (NNS determinations)) (PP (IN in) (NP (NP (JJ pooled) (NNS cells)) (PP (IN from) (NP (NP (CD three) (JJ normal) (NNS rats)) (PP (IN in) (NP (DT each) (NN experiment)))))))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NN *) (NN P)) (VP (JJ ≤) (NP (NP (NP (CD 0.05)) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (NN isotype) (NN control)))))) (, ,) (NP (NP (NN #) (NN P) (NN ≤) (CD 0.05)) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (NP (NN W3/25)) (, ,) (NP (NP (NN §P) (NN ≤) (CD 0.05)) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (NN OX35)))))) (, ,) (NP (NP (NN &P) (NN ≤) (CD 0.05)) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (NN RIB5/2)))))))))))))) (. .)))
( (S (S (PP (IN For) (ADJP (JJ key) (PP (TO to) (NP (NNS bars))))) (, ,) (VP (VB see) (NP (NN Supplementary) (NN Figure) (CD 4)))) (. .)))
( (S (NP (NP (NN Supplementary) (NN Table) (CD 1)) (: :) (NP (NP (NN Affinity) (NN data)) (PP (IN of) (NP (DT the) (JJ anti-CD4) (NN mAb)))))))
( (S (NP (NP (NN Supplementary) (NN Table) (CD 2)) (: :) (NP (NP (JJ Cytofluorometric) (NNS analyses)) (PP (IN of) (NP (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (PP (IN on) (NP (NP (NP (NP (NN day) (CD 8)) (PRN (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-))) (CC and) (NP (NP (NN day) (CD 13)) (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-)))) (PP (IN of) (NP (NP (JJ anti-CD4) (NN treatment)) (PRN (-LRB- -LRB-) (NP (NP (NNS data)) (PP (IN from) (NP (NP (CD one) (NN representative)) (PP (IN of) (NP (CD three) (ADJP (FW in) (FW vivo)) (NNS experiments)))))) (-RRB- -RRB-))))))))) (. .))))
( (S (NP (NP (NN Tissue) (NN factor)) (PP (IN as) (NP (DT a) (JJ proinflammatory) (NN agent))))))
( (S (NP (NN Abstract))))
( (S (S (NP (NP (NN Tissue) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN TF)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (JJ transmembrane) (NN glycoprotein)) (CC and) (NP (NP (DT the) (JJ main) (NN triggering) (NN element)) (PP (IN of) (NP (NN blood) (NN coagulation))))))) (. .)))
( (S (S (NP (NP (NN TF) (NN expression)) (PP (IN on) (NP (NP (NNS monocytes)) (CC and) (NP (JJ endothelial) (NNS cells))))) (VP (VP (VBZ is) (VP (VBN induced) (PP (IN by) (NP (NP (NN exposure)) (PP (TO to) (NP (NP (NN endotoxin)) (, ,) (NP (NN tumor) (NN necrosis) (NN factor)) (, ,) (CC and) (NP (NN IL-1)))))))) (CC and) (VP (VBZ is) (VP (VBN considered) (S (VP (TO to) (VP (VB appear) (PP (IN in) (NP (NP (NN consequence)) (PP (IN of) (NP (NN inflammation)))))))))))) (. .)))
( (S (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB assess) (NP (NP (DT the) (JJ proinflammatory) (NN capacity)) (PP (IN of) (NP (NN TF) (PRP itself)))))))) (, ,) (NP (NP (DT the) (JJ recombinant) (JJ extracellular) (NN domain)) (PP (IN of) (NP (NN TF)))) (VP (VBD was) (VP (VBN injected) (ADVP (RB intra-articularly)) (PP (IN into) (NP (JJ healthy) (NNS mice)))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB characterize) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (JJ immune) (NNS cells))) (PP (IN in) (NP (DT the) (JJ TF-induced) (NN arthritis))))))) (, ,) (NP (NP (NNS mice)) (VP (VBN deprived) (PP (IN of) (NP (NP (NNS lymphocytes)) (, ,) (NP (NNS neutrophils)) (CC and) (NP (NNS monocytes)))))) (VP (VBD were) (VP (VBN used)))) (. .)))
( (S (S (NP (NP (JJ Histomorphological) (NN analysis)) (PP (IN of) (NP (DT the) (NNS joints))) (PP (IN with) (NP (NP (NN respect)) (PP (TO to) (NP (NP (JJ inflammatory) (NN cell) (NN infiltration)) (, ,) (NP (NN pannus) (NN formation)) (CC and) (NP (NN erosion) (NN formation))))))) (VP (VBD revealed) (NP (NP (NN development)) (PP (IN of) (NP (NN arthritis)))) (PP (IN in) (NP (NP (CD 80) (NN %)) (PP (IN of) (NP (NP (NNS animals)) (VP (VBN injected) (PP (IN with) (NP (NN TF)))))))))) (. .)))
( (S (S (PP (IN In) (NP (NP (JJS most)) (PP (IN of) (NP (DT the) (NNS cases))))) (NP (JJ synovial) (NN proliferation)) (VP (VBD was) (VP (VBN accompanied) (PP (IN by) (NP (NP (NN pannus) (NN formation)) (CC and) (NP (NN cartilage) (NN destruction))))))) (. .)))
( (S (S (NP (JJ Inflammatory) (NN cell) (NN infiltrate)) (VP (VBD consisted) (PP (IN of) (NP (JJ CD4-Mac1+) (NNS macrophages))))) (. .)))
( (S (S (NP (NP (NN Depletion)) (PP (IN of) (NP (NNS monocytes)))) (VP (VBD was) (, ,) (ADVP (RB however)) (, ,) (RB not) (S (ADVP (RB enough)) (VP (TO to) (VP (VB abolish) (NP (NN inflammation))))))) (. .)))
( (S (S (ADVP (RB Indeed)) (, ,) (NP (NP (JJ combined) (NN deficiency)) (PP (IN of) (NP (NP (NNS monocytes)) (CC and) (NP (NNS lymphocytes))))) (VP (VBD was) (VP (VBN required) (S (VP (TO to) (VP (VB prevent) (NP (NN inflammation)) (PP (VBG following) (NP (NP (DT the) (NN injection)) (PP (IN of) (NP (NN TF))))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD observed) (SBAR (IN that) (S (NP (NN TF)) (VP (VP (VBD induced) (NP (NP (NN chemokine) (NN production)) (PRN (-LRB- -LRB-) (NP (NP (NN MIP-1α)) (CC and) (NP (NN RANTES))) (-RRB- -RRB-)))) (, ,) (CC but) (VP (VBD did) (RB not) (VP (VB induce) (NP (NP (DT a) (JJ proliferative) (NN response)) (CC nor) (NP (NP (NN cytokine) (NN release)) (PP (IN by) (NP (NN mouse) (NN spleen) (NNS cells)))))))))))) (. .)))
( (S (S (NP (NN TF)) (VP (VBZ has) (NP (NP (NP (JJ strong) (JJ inflammatogenic) (NNS properties)) (VP (VBN mediated) (ADVP (RB predominantly)) (PP (IN by) (NP (NNS monocytes))))) (CC and) (NP (NP (PRP$ their) (NN release)) (PP (IN of) (NP (NNS chemokines))))))) (. .)))
( (S (S (NP (PRP$ Our) (NN study)) (VP (VBZ shows) (SBAR (IN that) (S (NP (NN TF)) (VP (MD can) (ADVP (RB simultaneously)) (VP (VB trigger) (NP (DT the) (JJ immune) (CC and) (NN coagulation) (NNS systems)))))))) (. .)))
( (S (NP (NN Introduction))))
( (S (S (NP (NP (NN Tissue) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN TF)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (JJ transmembrane) (NN glycoprotein)) (CC and) (NP (NP (DT the) (JJ major) (JJ cellular) (NN trigger)) (PP (IN of) (NP (NN blood) (NN coagulation))))))) (. .)))
( (S (S (NP (NP (NN Assembly)) (PP (IN of) (NP (DT a) (NN complex))) (PP (IN between) (NP (NP (NN TF)) (CC and) (NP (NP (NN factor) (NN VII)) (PRN (-LRB- -LRB-) (NP (NN FVII)) (-RRB- -RRB-)))))) (VP (VBZ initiates) (NP (NN fibrin) (NN formation)))) (. .)))
( (S (S (PP (IN Besides) (NP (NP (PRP$ its) (NN role)) (PP (IN in) (NP (NN blood) (NN coagulation))))) (, ,) (NP (NN TF)) (VP (VBZ is) (ADVP (RB also)) (ADJP (JJ important) (PP (IN for) (NP (NP (DT the) (JJ vascular) (NN development)) (VP (VP (VBG regulating) (NP (JJ embryonic) (NN angiogenesis))) (CC and) (VP (VBG supporting) (NP (NP (ADJP (ADJP (JJ proliferative)) (CC and) (ADJP (JJ invasive))) (NNS capacities)) (PP (IN of) (NP (NNS cells) (CD -LSB-1-4) (-RRB- -RSB-))))))))))) (. .)))
( (S (S (NP (NP (NP (NN Expression)) (PP (IN of) (NP (NN TF))) (PP (IN on) (NP (DT the) (NN cell) (NN surface)))) (CC and) (NP (NP (PRP$ its) (NN appearance)) (PP (IN as) (NP (DT a) (JJ soluble) (NN molecule))))) (VP (VBP are) (NP (NP (JJ characteristic) (NNS features)) (PP (IN of) (NP (ADJP (ADJP (JJ acute)) (CC and) (ADJP (JJ chronic))) (NN inflammation)))) (PP (IN in) (NP (NP (NNS conditions)) (PP (JJ such) (IN as) (NP (NP (NN sepsis)) (, ,) (NP (NN atherosclerosis)) (, ,) (NP (NN Crohn) (POS 's) (NN desease)) (, ,) (NP (JJ systemic) (NN lupus) (NN erythematosus)) (, ,) (CC and) (NP (NN rejection) (NNS reactions)) (NP (NN -LSB-5-9)) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (NP (DT The) (NN role)) (PP (IN of) (NP (NN TF))) (PP (IN in) (NP (DT the) (JJ inflammatory) (NN process)))) (VP (VBZ is) (NP (NP (DT a) (NN matter)) (PP (IN of) (NP (NN discussion)))))) (. .)))
( (S (S (NP (NP (DT A) (NN variety)) (PP (IN of) (NP (NP (JJ inflammatory) (NNS stimuli)) (, ,) (PP (VBG including) (NP (NP (NNS mitogens)) (, ,) (NP (JJ bacterial) (NN cell) (NNS products)) (, ,) (NP (NP (NNS components)) (PP (IN of) (NP (DT the) (NN complement) (NN system)))) (CC and) (NP (NNS cytokines)))) (, ,)))) (VP (VBP are) (VP (VBN known) (S (VP (TO to) (VP (VB promote) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN TF))) (PP (IN on) (NP (NP (DT the) (NN surface)) (PP (IN of) (NP (NP (JJ endothelial) (NNS cells)) (CC and) (NP (NNS monocytes) (CD -LSB-10) (-RRB- -RSB-))))))))))))) (. .)))
( (S (S (NP (NN T) (NNS cells)) (VP (VBP regulate) (NP (NN TF) (NN expression)))) (: :) (S (NP (NN upregulation)) (VP (VBZ is) (VP (VBN achieved) (PP (IN by) (NP (NN Th1) (NNS cytokines))) (, ,) (SBAR (IN while) (S (NP (JJ Th2-derived) (NNS cytokines)) (VP (VBP are) (ADVP (RB mostly)) (NP (JJ inhibitory) (NN -LSB-11))) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (NN TF)) (, ,) (PP (IN in) (NP (NN turn))) (, ,) (VP (MD may) (VP (VB participate) (PP (IN in) (S (NP (JJ cellular) (NNS interactions)) (VP (VBG promoting) (NP (NP (NN leukocyte) (NN adhesion)) (CC and) (NP (JJ transendothelial) (NN migration) (CD -LSB-12,13)))) (-RRB- -RSB-)))))) (. .)))
( (S (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (NP (PRP we)) (VP (VBD investigated) (NP (NP (DT the) (NN capacity)) (PP (IN of) (NP (NN TF))) (S (VP (TO to) (VP (VB induce) (NP (NN inflammation)) (PP (IN by) (S (VP (VBG injecting) (NP (NP (JJ human) (JJ recombinant) (NN TF)) (PRN (-LRB- -LRB-) (NP (NN rTF)) (-RRB- -RRB-))) (PP (IN into) (NP (NP (NN joint) (NNS cavities)) (PP (IN of) (NP (JJ healthy) (NNS mice)))))))))))))) (. .)))
( (S (S (NP (NP (JJ Histomorphological) (NN investigation)) (PP (IN of) (NP (DT the) (VBN injected) (NNS joints)))) (VP (VBD showed) (NP (NP (NP (DT a) (JJ remarkable) (JJ cellular) (NN infiltration)) (PP (IN of) (NP (NN synovia)))) (CC and) (ADVP (RB occasionally)) (NP (NN cartilage) (NN destruction))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NN TF)) (VP (VBZ possesses) (NP (JJ strong) (JJ proinflammatory) (NNS properties))))))))) (. .)))
( (S (S (NP (NP (NN Expression)) (PP (IN of) (NP (NN TF))) (PP (IN on) (NP (NP (NNS monocytes)) (CC and) (NP (JJ synovial) (NNS cells))))) (VP (MD may) (VP (VB be) (ADJP (JJ crucial) (PP (IN for) (S (VP (VBG potentiating) (NP (NP (DT the) (JJ initial) (NNS stages)) (PP (IN of) (NP (NP (NN inflammation)) (PP (IN in) (NP (NNS joints))))))))))))) (. .)))
( (S (NP (NP (NNS Materials)) (CC and) (NP (NNS methods)))))
( (S (S (NP (NN BALB/c) (CC and) (NN NMRI) (NNS mice)) (VP (VBD were) (VP (VBN purchased) (PP (IN from) (NP (NN ALAB))) (PRN (-LRB- -LRB-) (NP (NNP Stockholm) (, ,) (NNP Sweden)) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (NP (JJ Severe) (JJ combined) (JJ immunodeficient) (-LRB- -LRB-) (NN SCID) (-RRB- -RRB-) (NNS mice)) (CC and) (NP (PRP$ their) (JJ congenic) (NN strain) (CD CB17))) (VP (VBD were) (VP (VBN purchased) (PP (IN from) (NP (NP (NNP M&B)) (PRN (-LRB- -LRB-) (NP (NNP Bomholtvej) (, ,) (NNP Denmark)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (DT All) (NNS mice)) (VP (VBD were) (VP (VBN housed) (PP (IN in) (NP (NP (DT the) (JJ animal) (NN facility)) (PP (IN of) (NP (NP (DT the) (NN Department)) (PP (IN of) (NP (NP (NNP Rheumatology) (, ,) (NNP University)) (PP (IN of) (NP (NN Göteborg)))))))))))) (. .)))
( (S (S (NP (NP (JJ Female) (NNS mice)) (PP (IN 6–8) (NP (NP (NNS weeks)) (PP (IN of) (NP (NN age)))))) (VP (VBD were) (VP (VBN used) (PP (IN in) (NP (PDT all) (DT the) (NNS experiments)))))) (. .)))
( (S (NP (NP (DT This) (NN version)) (PP (IN of) (NP (NN rTF)))) (VP (VBZ contains) (NP (NP (NP (NP (NP (DT the) (JJ extracellular) (NN domain)) (PP (IN of) (NP (JJ human) (NN TF)))) (, ,) (NP (NN amino) (NN acid) (NNS residues))) (NP (NN 1–219) (CD -LSB-14) (-RRB- -RSB-))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ retains) (NP (DT the) (NN ability) (S (VP (VP (TO to) (VP (VB bind) (PP (TO to) (NP (NP (NN FVII)) (CC and) (NP (NN FVIIa)))))) (CC and) (VP (TO to) (VP (VB enhance) (NP (NP (JJ enzymatic) (NN activity)) (PP (IN of) (NP (NN FVIIa)))))))))))))) (. .)))
( (S (S (NP (NN rTF) (NN preparation)) (VP (VBD was) (VP (VP (VBN dissolved) (PP (IN in) (NP (NP (NN Hepes) (JJ buffered) (NN saline)) (PRN (-LRB- -LRB-) (NP (NP (NNP Hepes)) (ADJP (CD 30) (NN mM))) (, ,) (NP (NP (NP (NN NaCl)) (ADJP (CD 100) (NN mM))) (, ,) (NP (ADJP (CD 0.02) (NN %)) (NN Na-azide) (: ;) (CD pH7.5))) (-RRB- -RRB-))))) (CC and) (VP (VBN kept) (PP (IN in) (NP (NP (NNS aliquots)) (PP (IN at) (NP (NP (CD -70°C)) (PP (IN until) (NP (NN use))))))))))) (. .)))
( (S (S (NP (NP (CD Two) (NNS preparations)) (PP (IN of) (NP (NN TF)))) (VP (VBD were) (VP (VBN used) (SBAR (WHNP (WDT that)) (S (VP (VBD contained) (NP (NP (CD 3.7) (NN μg/ml)) (CC and) (NP (NP (CD 32) (NN ng/ml)) (PP (IN of) (NP (NP (NN lipopolysaccharide)) (PRN (-LRB- -LRB-) (NP (NN LPS)) (-RRB- -RRB-)))))) (, ,) (ADVP (RB respectively)))))))) (. .)))
( (S (S (S (NP (NP (DT No) (JJ significant) (NN difference)) (PP (IN in) (NP (NP (DT the) (NNS results)) (VP (VBN obtained) (PP (IN with) (NP (DT these) (CD two) (NNS preparations))))))) (VP (VBD was) (VP (VBN observed)))) (CC and) (S (NP (DT the) (NNS results)) (VP (VBD were) (ADVP (RB thus)) (ADJP (JJ pooled))))) (. .)))
( (S (S (NP (NN NMRI) (NN strain) (NNS mice)) (VP (VBD were) (VP (VBN used) (PP (IN in) (NP (DT the) (NNS experiments))) (SBAR (IN unless) (S (VP (VBN stated) (ADVP (RB otherwise)))))))) (. .)))
( (S (S (NP (NP (NN Induction)) (PP (IN of) (NP (NN arthritis)))) (VP (VBD was) (VP (VBN performed) (PP (IN by) (NP (NP (NN injection)) (PP (IN of) (NP (NP (NN rTF)) (PP (IN in) (NP (NP (DT a) (NN volume)) (PP (IN of) (NP (ADJP (CD 20) (NN μl)) (NN intra-articularly))))))) (PP (IN into) (NP (DT the) (JJ right) (NN knee) (NN joint)))))))) (. .)))
( (S (S (NP (NN Control) (NNS experiments)) (VP (VBD were) (VP (VBN performed) (PP (IN by) (S (VP (VBG injecting) (NP (NP (DT an) (JJ equivalent) (NN amount)) (PP (IN of) (NP (NN LPS) (NN preparation))) (PP (IN in) (NP (NN Hepes) (JJ buffered) (NN saline)))) (PP (IN into) (NP (DT the) (JJ contralateral) (JJ knee) (NN joint))))))))) (. .)))
( (S (S (NP (NN Neutrophil) (NN depletion)) (VP (VBD was) (VP (VBN performed) (PP (IN by) (NP (NP (JJ intraperitoneal) (NN injection)) (PP (IN of) (NP (NP (DT the) (JJ monoclonal) (NN antibody) (CD RB6-8C5)) (PRN (-LRB- -LRB-) (S (NP (NN hybridoma)) (VP (VBD was) (ADVP (RB kindly)) (VP (VBN provided) (PP (IN by) (NP (NP (NN Dr) (NN R) (NNP Coffman)) (, ,) (NP (NN DNAX) (NN Research) (NN Institute)) (, ,) (NP (NNP Palo) (NNP Alto)) (, ,) (NP (NN CA) (, ,) (NNP USA))))))) (-RRB- -RRB-)))))) (PP (NP (CD two) (NNS hours)) (IN before) (NP (DT the) (NN rTF) (NN injection)))) (, ,) (SBAR (IN as) (S (VP (VBN described) (ADVP (RB previously)) (S (NP (NN -LSB-15)) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (NP (DT The) (NN IgG) (NN rat) (NN antiovalbumin) (JJ monoclonal) (NN antibody)) (-LRB- -LRB-) (VP (ADVP (RB kindly)) (VBN provided) (PP (IN by) (NP (NP (NN Dr) (NNP E) (NNP Telemo) (, ,) (NNP Department)) (PP (IN of) (NP (NP (JJ Clinical) (NN Immunology) (, ,) (NNP University)) (PP (IN of) (NP (NNP Göteborg) (, ,) (NNP Sweden)))))))) (-RRB- -RRB-)) (VP (VBD was) (VP (VBN injected) (PP (IN into) (NP (DT the) (JJ control) (NN group)))))) (. .)))
( (S (S (NP (NN Monocyte) (NN depletion)) (VP (VBD was) (VP (VBN induced) (PP (IN by) (NP (NP (JJ subcutaneous) (NN injection)) (PP (IN of) (NP (NN etoposide))))) (PRN (-LRB- -LRB-) (NP (NNP Bristol-Myers) (NNP Squibb) (, ,) (NNP Bromma) (, ,) (NNP Sweden)) (: ;) (NP (CD 12.5) (NN mg/kg) (NN body) (NN weight)) (, ,) (NP (PP (IN in) (NP (NP (DT a) (NN volume)) (PP (IN of) (NP (ADJP (CD 100) (NN μl)) (NN -LSB-16))))) (-RRB- -RSB-)) (-RRB- -RRB-)) (PP (IN on) (NP (NP (NP (CD three) (JJ consecutive) (NNS days)) (PP (IN before))) (CC and) (NP (NP (CD three) (JJ consecutive) (NNS days)) (PP (IN after) (NP (NP (NN injection)) (PP (IN of) (NP (NN rTF))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN impact)) (PP (IN of) (NP (NNS lymphocytes)))) (VP (VBD was) (VP (VBN studied) (PP (IN by) (S (VP (VBG injecting) (NP (NN rTF)) (PP (IN into) (NP (NP (NN SCID) (NNS mice)) (VP (VBG lacking) (NP (NP (NP (NN B)) (CC and) (NP (NN T)) (NP (NNS lymphocytes))) (CC and) (NP (NP (PRP$ their) (JJ congenic) (NN strain)) (, ,) (NP (NN CB17))))))))))))) (. .)))
( (S (NP (DT This)) (VP (VBD was) (VP (VBN achieved) (PP (IN by) (S (VP (VBG using) (NP (NP (NP (JJ mini-osmotic) (NNS pumps)) (PRN (-LRB- -LRB-) (NP (NP (NN model) (NN 2002)) (, ,) (NP (NN Alza) (NN Corp)) (, ,) (NP (NNP Palo) (NNP Alto)) (, ,) (NP (NN CA)) (, ,) (NP (NN USA))) (-RRB- -RRB-))) (VP (VBN filled) (PP (IN with) (NP (NP (JJ buffered) (NN solution)) (VP (VBG containing) (NP (NP (NP (ADJP (CD 200) (NN U/ml)) (NN ancrod)) (PRN (-LRB- -LRB-) (NP (NP (NN Sigma) (JJ Chemical) (, ,) (JJ St) (NN Louis)) (, ,) (NP (NN MO)) (, ,) (NP (NN USA))) (-RRB- -RRB-))) (VP (VBN implanted) (PP (ADVP (RB subcutaneously)) (NP (CD three) (NNS days)) (IN before) (NP (NP (DT the) (NN injection)) (PP (IN of) (NP (NN rTF) (CD -LSB-17) (-RRB- -RSB-))))))))))))))))) (. .)))
( (S (S (NP (NP (JJ Histological) (NN examination)) (PP (IN of) (NP (NNS joints)))) (VP (VBD was) (VP (VBN done) (PP (IN after) (NP (NP (NN paraffin) (NN embedding)) (, ,) (NP (ADJP (JJ cutting))) (, ,) (CC and) (NP (NP (NN staining)) (PP (IN with) (NP (NP (NN hematoxylin)) (CC and) (NP (NN eosin)))))))))) (. .)))
( (S (S (NP (PDT All) (DT the) (NNS slides)) (VP (VBD were) (VP (VP (VBN coded)) (CC and) (VP (VBN evaluated)) (ADVP (RB blindly))))) (. .)))
( (S (S (NP (DT The) (NNS specimens)) (VP (VBD were) (VP (VBN evaluated) (PP (IN with) (NP (NP (NN respect)) (PP (TO to) (NP (NP (NP (NN occurrence)) (PP (IN of) (NP (JJ synovial) (NN hypertrophy)))) (, ,) (NP (NP (JJ inflammatory) (NNS cells)) (PP (IN in) (NP (JJ synovial) (JJ sublining) (NN compartment)))) (, ,) (NP (NN pannus) (NN formation)) (CC and) (NP (NN cartilage) (CC and/or) (JJ subchondral) (NN bone) (NN destruction))))))))) (. .)))
( (S (S (NP (NP (NN Intensity)) (PP (IN of) (NP (NP (JJ synovial) (NN inflammation)) (PRN (-LRB- -LRB-) (NP (NN arthritis) (NN index)) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN graded) (ADVP (RB arbitrarily)) (PP (IN from) (NP (CD 0) (TO to) (CD 3)))))) (. .)))
( (S (S (PP (IN For) (NP (JJ immunohistochemical) (NN examination))) (, ,) (NP (DT the) (JJ knee) (NNS joints)) (VP (VBD were) (VP (VP (VBN removed)) (CC and) (VP (VBN demineralized) (PP (IN as) (NP (VBN described) (NN -LSB-18)))))) (-RRB- -RSB-)) (. .)))
( (S (NP (NP (JJ Serial) (NNS cryosections)) (PP (IN of) (NP (CD 6) (JJ μm) (NNS thickness)))) (VP (VBD were) (VP (VBN stained) (PP (IN with) (NP (NP (NN rat) (JJ monoclonal) (NNS antibodies)) (VP (VBN directed) (PP (IN against) (NP (NP (NP (NN mouse) (NN CD11b)) (PRN (-LRB- -LRB-) (NP (NP (NN Mac-1)) (: ;) (NP (NN M) (CD 1/70))) (-RRB- -RRB-))) (CC or) (NP (NP (NN CD4)) (PRN (-LRB- -LRB-) (NP (NN GK1.5)) (-RRB- -RRB-))))))))))))
( (S (S (NP (-LRB- -LRB-) (NP (DT both) (NNS antibodies)) (PP (IN from) (NP (NP (NP (NNP PharMingen) (, ,) (NNP San) (NNP Diego)) (, ,) (NP (NN CA))) (, ,) (NP (NNP USA)))) (-RRB- -RRB-)) (, ,) (ADVP (RB then)) (VP (VBN incubated) (PP (IN with) (NP (NP (NP (VBN biotinylated) (JJ secondary) (NNS antibodies)) (PRN (-LRB- -LRB-) (NP (NP (NN DAKO) (NN A/S)) (, ,) (NP (NNP Gosulp) (, ,) (NNP Denmark))) (-RRB- -RRB-))) (CC and) (NP (NP (NN avidin-biotin-peroxidase) (NNS complexes)) (PRN (-LRB- -LRB-) (NP (NN ABC)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (DT All) (NNS sections)) (VP (VBD were) (ADJP (JJ counterstained) (PP (IN with) (NP (NP (NN Mayer) (POS 's)) (NN hematoxylin)))))) (. .)))
( (S (S (NP (NP (NP (JJ Murine) (NN splenocyte) (NN suspension)) (PRN (-LRB- -LRB-) (NP (NN cell) (NN density) (CD 2) (NN ×) (NN 106/ml)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (JJ Iscove) (POS 's) (NN medium)) (VP (VBN supplemented) (PP (IN with) (NP (NP (ADJP (CD 10) (NN %)) (NP (NP (JJ fetal) (NN calf) (NN serum)) (PRN (-LRB- -LRB-) (NP (NN FCS)) (-RRB- -RRB-)))) (, ,) (NP (ADJP (CD 2) (NN nM)) (NN L-glutamine)) (, ,) (NP (NN mercaptoethanol)) (CC and) (NP (ADJP (CD 50) (NN μg/ml)) (NN gentamicin)))))))) (VP (VBD was) (VP (VBN stimulated) (PP (IN with) (NP (NN rTF))) (PP (IN at) (NP (NP (DT a) (JJ final) (NN concentration)) (PP (IN of) (NP (NN 0.1–10) (NN μg/ml)))))))) (. .)))
( (S (S (PP (IN At) (NP (VBN defined) (NN time) (NNS points))) (, ,) (NP (NNS supernatants)) (VP (VBD were) (VP (VBN collected) (PP (IN for) (NP (NP (NN determination)) (PP (IN of) (NP (NP (NP (NN cytokine)) (CC and) (NP (NN chemokine))) (NNS levels)))))))) (. .)))
( (S (S (NP (NN Proliferation)) (VP (VBD was) (VP (VBN determined) (PP (IN by) (NP (NP (DT the) (NN incorporation)) (PP (IN of) (NP (NP (ADJP (NN -LSB-3H) (-RRB- -RSB-) (JJ -thymidine))) (PRN (-LRB- -LRB-) (NP (JJ specific) (NN activity)) (, ,) (NP (CD 42) (NN Ci/mmol)) (: ;) (NP (NNP Amersham) (NNP International) (, ,) (NNP Buckinghamshire)) (, ,) (NP (NN UK)) (-RRB- -RRB-)))) (PP (IN into) (NP (NP (NP (NN splenocyte) (NN suspension)) (PRN (-LRB- -LRB-) (NP (NN cell) (NN density) (CD 4) (NN ×) (NN 105/ml)) (-RRB- -RRB-))) (, ,) (VP (VBN stimulated) (PP (IN for) (NP (CD 72) (NNS hours))) (PP (IN with) (NP (CC either) (NP (NN rTF)) (CC or) (NP (NP (NN LPS)) (PP (IN at) (NP (NP (DT a) (JJ final) (NN concentration)) (PP (IN of) (NP (CD 0.1–10) (NN μg/ml)))))))))))))))) (. .)))
( (S (S (NP (DT The) (NNS results)) (VP (VBD were) (VP (VBN expressed) (PP (IN as) (NP (NP (DT a) (NN stimulation) (NN index)) (PRN (-LRB- -LRB-) (NP (NP (NNS counts)) (PP (IN per) (NP (NN minute)))) (, ,) (NP (NN mean) (NN ±) (JJ standard) (NN deviation)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (DT The) (NN level)) (PP (IN of) (NP (NP (NN interleukin) (-LRB- -LRB-) (NN IL) (-RRB- -RRB-) (CD -6)) (PP (IN in) (NP (DT the) (JJ rTF-stimulated) (NNS supernatants)))))) (VP (VBD was) (VP (VBN determined) (PP (IN by) (NP (NP (DT a) (NN bioassay)) (VP (VBG measuring) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN test) (NNS samples))) (PP (IN on) (NP (NP (DT the) (NN growth)) (PP (IN of) (NP (DT the) (NP (JJ IL-6-dependent) (NN cell) (NN line)) (NP (NN B13.29) (NN -LSB-19)))))) (-RRB- -RSB-)))))))) (. .)))
( (S (S (NP (DT The) (NNS results)) (VP (VBD were) (VP (VP (VBN analyzed) (PP (IN by) (NP (NP (NN incorporation)) (PP (IN of) (NP (NP (ADJP (NN -LSB-3H) (-RRB- -RSB-) (JJ -thymidine) (PP (IN after) (NP (CD 72) (NNS hours))))) (NN stimulation)))))) (CC and) (VP (VBN compared) (PP (TO to) (NP (NP (NNS results)) (PP (IN with) (NP (NP (DT the) (JJ standard) (NNS dilutions)) (PP (IN of) (NP (NP (JJ recombinant) (NN mouse) (NN IL-6)) (PRN (-LRB- -LRB-) (NP (NN Genzyme)) (, ,) (NP (NN Cambridge)) (, ,) (NP (NP (NN MA)) (, ,) (NP (NN USA))) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NNS levels)) (PP (IN of) (NP (NP (NN macrophage) (JJ inflammatory) (NN protein) (-LRB- -LRB-) (NN MIP) (-RRB- -RRB-) (CD -1α)) (CC and) (NP (NP (NN RANTES)) (-LRB- -LRB-) (VP (VBN regulated) (PP (IN on) (NP (NP (NN activation) (JJ normal) (NN T-cell)) (VP (VP (VBN expressed)) (CC and) (VP (VBN secreted)))))) (-RRB- -RRB-))))) (VP (VBD were) (VP (VP (VBN measured) (PP (IN by) (NP (NP (DT an) (JJ enzyme-linked) (JJ immunosorbent) (NN assay)) (VP (VBG using) (NP (NP (NN Quantikine) (NN M) (NNS kits)) (PRN (-LRB- -LRB-) (NP (NP (NN R&D) (NNS Systems)) (, ,) (NP (NP (NNP Minneapolis)) (, ,) (NP (NN MN)) (, ,) (NP (NNP USA)))) (-RRB- -RRB-))))))) (CC and) (VP (VBN expressed) (PP (IN in) (NP (NN pg/ml))))))) (. .)))
( (S (S (NP (NP (DT The) (NNS differences)) (PP (IN in) (NP (NP (DT the) (NP (NN incidence)) (CC and) (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (NN arthritis))))) (PP (IN in) (NP (DT the) (NNS groups)))))) (VP (VBD were) (VP (VBN analyzed) (PP (IN by) (NP (NP (NP (DT the) (NN Fisher) (POS 's)) (NN test)) (CC and) (NP (NN Mann–Whitney) (NN U) (NN test)))) (, ,) (ADVP (RB respectively))))) (. .)))
( (S (NP (NNS Results))))
( (S (S (NP (NP (DT The) (NN ability)) (PP (IN of) (NP (NN rTF))) (VP (TO to) (VP (VB induce) (NP (NN arthritis))))) (VP (VBD was) (VP (VBN evaluated) (PP (IN by) (NP (NP (NN injection)) (PP (IN of) (NP (NP (NN rTF)) (PP (IN in) (NP (NP (NP (DT the) (NNS doses)) (NP (QP (CD 0.2) (, ,) (CD 2.0) (, ,) (CC and) (CD 20)) (NN μg))) (PRN (-LRB- -LRB-) (NP (QP (CD 0.004) (, ,) (CD 0.04) (, ,) (CC and) (CD 0.4)) (NN nmol)) (-RRB- -RRB-)))))) (PP (IN into) (NP (NP (DT the) (JJ knee) (NN joint)) (PP (IN of) (NP (NN NMRI) (NNS mice)))))))))) (. .)))
( (S (PP (NP (CD Four) (NNS days)) (IN after) (NP (DT the) (NN inoculation))) (, ,) (NP (NP (NP (JJ morphological) (NNS signs)) (PP (IN of) (NP (NN arthritis)))) (-LRB- -LRB-) (NP (JJ synovial) (NN tissue) (NN hypertrophy)) (, ,) (CC and) (NP (JJ inflammatory) (NN cell) (NNS infiltrates)) (-RRB- -RRB-)) (VP (VBD were) (VP (VBN found) (PP (IN in) (NP (NP (NP (CD 33) (NN %)) (, ,) (NP (CD 56) (NN %)) (CC and) (NP (CD 83) (NN %))) (PP (IN of) (NP (NNS joints))))) (, ,) (ADVP (RB respectively)))) (. .)))
( (S (S (NP (NP (NN Control) (NNS mice)) (VP (VBN injected) (PP (IN with) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NN LPS))) (ADJP (JJ equivalent) (PP (TO to) (NP (NP (PRP$ its) (NN concentration)) (PP (IN in) (NP (DT the) (NN rTF) (NN preparation)))))))))) (VP (VBD exhibited) (NP (NN arthritis)) (PP (ADVP (RB only)) (IN in) (NP (NP (CD 28) (NN %)) (PP (IN of) (NP (NP (NNS cases)) (PRN (-LRB- -LRB-) (NP (NP (NN 13/15)) (CC versus) (NP (NN 4/14))) (: ;) (NP (NN P) (NN <) (CD 0.01)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (DT The) (NN arthritis) (NN index)) (PP (IN of) (NP (DT the) (JJ rTF-induced) (NN arthritis)))) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJR higher)) (PP (IN in) (NP (NP (NNS joints)) (VP (VBN injected) (PP (IN with) (NP (NP (CD 20) (NN μg)) (PP (IN of) (NP (NN rTF)))))))) (PP (IN than) (PP (IN in) (NP (NP (DT the) (NNS controls)) (PRN (-LRB- -LRB-) (NP (NP (CD 1.73) (CC versus) (CD 0.23)) (: ;) (NP (NN P) (JJ <) (CD 0.01))) (-RRB- -RRB-)))))))) (. .)))
( (S (ADVP (RB Moreover)) (, ,) (NP (NP (CD 6/13) (NNS joints)) (VP (VBN injected) (PP (IN with) (NP (NP (CD 20) (NN μg)) (PP (IN of) (NP (NN rTF))))))) (VP (VBD developed) (NP (NP (JJ extrasynovial) (NNS features)) (PP (IN of) (NP (NP (NN arthritis)) (PRN (-LRB- -LRB-) (NP (NN pannus) (NN formation)) (, ,) (NP (NN n) (JJ =) (CD 2)) (: ;) (NP (NP (NN cartilage) (NN destruction)) (, ,) (NP (NN n) (JJ =) (CD 3)) (CC and) (NP (JJ periarticular) (NN bone) (NN destruction))) (, ,) (NP (NN n) (JJ =) (CD 1)) (-RRB- -RRB-))))) (PP (VBN compared) (PP (TO to) (NP (NP (RB only) (CD one)) (PP (IN in) (NP (DT the) (NN control) (NN group))))))) (. .)))
( (S (S (PP (IN In) (NP (DT all) (JJ further) (NNS experiments))) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NP (CD 20) (NN μg)) (PP (IN of) (NP (NN TF))))) (PP (IN per) (NP (NN knee)))) (VP (VBD was) (VP (VBN used)))) (. .)))
( (S (S (NP (NP (NNS Dynamics)) (PP (IN of) (NP (JJ rTF-induced) (NN arthritis)))) (VP (VBD were) (VP (VBN assessed) (ADVP (RB morphologically)) (PP (IN on) (NP (NP (NP (NNS days) (QP (CD 4) (, ,) (CD 14))) (CC and) (NP (CD 60))) (PP (IN after) (NP (DT the) (NN rTF) (NN injection)))))))) (. .)))
( (S (S (S (NP (NP (NP (DT The) (JJS highest) (NN frequency)) (PP (IN of) (NP (NN arthritis)))) (CC and) (NP (NP (NN severity)) (PP (IN of) (NP (NN inflammation))))) (VP (VBD was) (VP (VBN observed) (PP (IN on) (NP (NN day) (CD 4))) (PP (IN after) (NP (NN injection)))))) (CC and) (S (NP (PRP it)) (VP (VBD diminished) (ADVP (RB significantly)) (PP (IN by) (NP (NNS days) (CD 14) (CC and) (CD 60))) (PRN (-LRB- -LRB-) (NP (NP (NN 13/15)) (CC versus) (NP (CD 2/8) (CC and) (CD 2/6))) (, ,) (NP (NN P) (NN <) (CD 0.05)) (: ;) (NP (NNP Fig.) (NN 1a)) (, ,) (NP (NN b)) (-RRB- -RRB-))))) (. .)))
( (S (S (ADVP (RB Notably)) (, ,) (NP (NP (NN erosion)) (CC and/or) (NP (NN pannus) (NN formation))) (VP (VBD were) (ADVP (RB always)) (VP (VBN found) (PP (PP (IN in) (NP (NP (NNS cases)) (PP (IN of) (NP (JJ long) (JJ lasting) (NN arthritis))))) (CC but) (PP (IN in) (NP (NP (NN none)) (PP (IN of) (NP (DT the) (NNS controls))))))))) (. .)))
( (S (S (NP (NP (NN Sensitivity)) (PP (TO to) (NP (NN rTF)))) (VP (VBD varied) (PP (IN between) (NP (DT the) (JJ healthy) (NN mouse) (NNS strains))))) (. .)))
( (S (S (NP (NP (NP (CD Four) (NNS days)) (PP (IN after) (NP (NP (DT the) (NN injection)) (PP (IN of) (NP (NP (NN rTF)) (PRN (-LRB- -LRB-) (NP (CD 20) (NN μg/knee)) (-RRB- -RRB-)))) (PP (IN into) (NP (NP (NN NMRI)) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 15)) (-RRB- -RRB-))))))) (, ,) (NP (NP (CD CB17) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 8)) (-RRB- -RRB-)) (CC and) (NN BALB/c) (NNS mice)) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 8)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ morphological) (NNS signs)) (PP (IN of) (NP (NN arthritis))))) (VP (VBD were) (VP (VBN registered) (PP (IN in) (NP (NP (NP (CD 80) (NN %)) (, ,) (NP (CD 75) (NN %)) (CC and) (NP (CD 50) (NN %))) (PP (IN of) (NP (JJ knee) (NNS joints))) (, ,) (ADVP (RB respectively))))))) (. .)))
( (S (S (NP (DT These) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NN susceptibility)) (PP (TO to) (NP (NP (JJ inflammatory) (NN potential)) (PP (IN of) (NP (NN rTF)))))) (VP (VBZ is) (ADJP (JJ dependent) (PP (IN on) (NP (NP (JJ genetic) (NN background)) (PP (IN of) (NP (DT the) (NN host))))))))))) (. .)))
( (S (S (NP (NP (JJ Immunochemical) (NN staining)) (PP (IN of) (NP (NN joint) (NNS sections)))) (VP (VBD revealed) (NP (NP (JJ dense) (NNS infiltrates)) (VP (VBG consisting) (PP (IN of) (NP (NP (JJ Mac-1+) (JJ mononuclear) (NNS cells)) (PP (IN in) (NP (DT the) (JJ synovial) (NN tissue))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (PDT all) (DT the) (NNS sections)) (VP (VBD were) (ADJP (JJ negative) (PP (IN for) (S (VP (VBG staining) (PP (IN with) (NP (JJ CD4-specific) (NNS antibodies))))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBD allowed) (S (NP (PRP us)) (VP (TO to) (VP (VB conclude) (SBAR (IN that) (S (NP (NP (DT the) (JJ inflammatory) (NN infiltrate)) (VP (VBN observed) (PP (IN after) (NP (NP (DT the) (NN injection)) (PP (IN of) (NP (NN rTF))))))) (VP (VBD consisted) (ADVP (RB predominantly)) (PP (IN of) (NP (NP (NNS macrophages)) (VP (VBN accompanied) (PP (IN by) (NP (NP (JJ few)) (PP (IN if) (NP (NP (DT any) (NNS neutrophils)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 2)) (-RRB- -RRB-))))))))))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB evaluate) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (JJ different) (JJ immune) (NNS cells))) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ rTF-induced) (NN inflammation))))))))) (, ,) (NP (NN cell) (NN depletion) (NNS procedures)) (VP (VBD were) (VP (VBN performed)))) (. .)))
( (S (NP (NP (NNS Mice)) (VP (VBN pretreated) (PP (IN with) (NP (VBG lysing) (NP (JJ antineutrophil) (NNS antibodies)))))) (VP (VBD showed) (NP (NP (DT no) (NN reduction)) (PP (IN in) (NP (NP (DT the) (NP (NN frequency)) (CC or) (NP (NN intensity))) (PP (IN of) (NP (NN arthritis)))))) (VP (VBD compared) (PP (TO to) (NP (NP (NNS controls)) (SBAR (WHNP (WDT that)) (S (VP (VBD received) (NP (NP (NN antiovalbumin) (NNS antibodies)) (PRN (-LRB- -LRB-) (NP (NP (NN 5/8)) (CC versus) (NP (ADJP (JJ 7/8))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NP (NNS Mice)) (VP (VBN injected) (PP (IN with) (NP (NP (NN etoposide)) (, ,) (CONJP (CC and) (RB thereby)) (VP (VBN deprived) (PP (IN of) (NP (NN monocyte/macrophage) (NN cell) (NN population)))) (, ,))))) (VP (VBD demonstrated) (NP (NP (DT a) (NN tendency)) (PP (TO to) (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (NP (NN frequency)) (CONJP (CC but) (RB not)) (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (NN arthritis))))))))) (PRN (-LRB- -LRB-) (NP (NP (NN 6/8)) (CC versus) (NP (NN 4/7))) (: ;) (NP (NP (RB not) (JJ significant)) (: ;) (NP (NNP Fig.) (CD 3))) (-RRB- -RRB-)))) (. .)))
( (S (S (NP (NP (JJ Intra-articular) (NN injection)) (PP (IN of) (NP (NN rTF))) (PP (IN into) (NP (NP (NN SCID) (NNS mice)) (ADJP (JJ deficient) (PP (IN for) (NP (NP (NN T-)) (CC and) (NP (NNS B-lymphocytes)))))))) (VP (VBD revealed) (NP (DT no) (NN difference)) (PP (IN in) (NP (NP (DT the) (NN frequency)) (PP (IN of) (NP (NN arthritis))))) (PP (VBN compared) (PP (TO to) (NP (NP (JJ congenic) (NP (CD CB17) (NNS mice)) (NN strain)) (PRN (-LRB- -LRB-) (NP (NP (NN 11/15)) (CC versus) (NP (NN 12/15))) (, ,) (FRAG (ADVP (RB not)) (ADJP (JJ significant))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (NNS experiments)))) (VP (VBD indicated) (SBAR (IN that) (S (NP (NP (VBN isolated) (NN depletion)) (PP (IN of) (NP (CC neither) (NP (NN monocyte)) (CC nor) (NP (NN lymphocyte) (NN cell) (NNS populations))))) (VP (VBD was) (S (ADVP (RB enough)) (VP (TO to) (VP (VB abolish) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (JJ rTF-induced) (NN arthritis)))))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB test) (SBAR (IN if) (S (NP (DT a) (JJ combined) (NN lymphocyte) (CC and) (NN monocyte) (NN cell) (NN depletion)) (VP (VBD was) (ADJP (JJ efficient) (PP (IN in) (NP (NP (NN prevention)) (PP (IN of) (NP (JJ rTF-induced) (NN cell) (NN infiltration)))))))))))) (, ,) (NP (NP (NN SCID) (NNS mice)) (VP (VBN treated) (PP (IN with) (NP (NN etoposide))))) (VP (VBD were) (ADVP (RB intra-articularly)) (VP (VBN injected) (PP (IN with) (NP (NN rTF)))))) (. .)))
( (S (S (NP (NP (QP (RB Only) (CD one) (IN of) (CD seven)) (NNS mice)) (PP (IN in) (NP (DT this) (NN group)))) (VP (VBD developed) (NP (NN arthritis)) (PP (IN in) (NN response) (TO to) (NP (NP (NN injection)) (PP (IN of) (NP (NN rTF))))) (, ,) (S (VP (VBG demonstrating) (SBAR (IN that) (S (NP (NP (NN interaction)) (PP (IN between) (NP (NP (NNS macrophages)) (CC and) (NP (NNS lymphocytes))))) (VP (VBZ is) (ADJP (JJ essential) (PP (IN for) (NP (NP (JJ cellular) (NN infiltration)) (PP (IN of) (NP (NP (NN synovium)) (PP (VBG following) (NP (NP (NN rTF) (NN injection)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 3)) (-RRB- -RRB-)))))))))))))))) (. .)))
( (S (S (NP (NP (JJ Systemic) (NN depletion)) (PP (IN of) (NP (NN fibrinogen))) (PP (IN with) (NP (NN ancrod))) (ADVP (ADVP (RB prior)) (PP (TO to) (NP (NN rTF) (NN injection))))) (VP (VBD did) (RB not) (VP (VB reduce) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (JJ rTF-induced) (NN arthritis))) (PP (IN in) (NP (NN 6/8) (NN NMRI) (NNS mice))))))) (. .)))
( (S (S (NP (NP (NNS Effects)) (PP (IN of) (NP (NN rTF))) (PP (IN on) (NP (JJ lymphoid) (NNS cells)))) (VP (VBD were) (VP (VBN investigated) (PP (IN by) (S (VP (VBG incubating) (NP (NN mouse) (NNS splenocytes)) (PP (IN with) (NP (NP (NN rTF)) (PRN (-LRB- -LRB-) (NP (NP (CD 0.1) (NN μg/ml)) (, ,) (NP (CD 1) (NN μg/ml)) (, ,) (NP (CD 5) (NN μg/ml)) (, ,) (CC or) (NP (CD 10) (NN μg/ml))) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NP (NN Investigation)) (PP (IN of) (NP (NP (NNS supernatants)) (PP (IN after) (NP (NP (CD 48) (NNS hours)) (PP (IN of) (NP (NP (NN stimulation)) (PP (IN for) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NP (NN IL-6)) (, ,) (NP (NN RANTES)) (, ,) (CC and) (NP (NN MIP-1α))))))))))))) (VP (VBD demonstrated) (NP (NP (DT a) (JJ dose-dependent) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NNS chemokines)))))))) (. .)))
( (S (S (NP (DT The) (NN increase)) (VP (VP (VBD was) (ADJP (JJ pronounced) (PP (IN for) (NP (NN MIP-1α)))) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 73) (NN ±) (CD 33) (NN pg/ml)) (PP (IN in) (NP (JJ non-stimulated) (NNS cells)))) (CC versus) (NP (NP (QP (CD 139) (NN ±) (CD 32)) (NN pg/ml)) (PP (IN after) (NP (NP (NN stimulation)) (PP (IN with) (NP (NP (CD 5) (NN μg/ml)) (PP (IN of) (NP (NN rTF))))))))) (: ;) (S (NP (NN n)) (VP (JJ =) (NP (CD 3)))) (-RRB- -RRB-))) (CC but) (VP (VBD was) (ADJP (RB only) (JJ marginal) (PP (IN for) (NP (NN RANTES)))) (PRN (-LRB- -LRB-) (NP (NP (QP (CD 256) (NN ±) (CD 46)) (NN pg/ml)) (CC versus) (NP (QP (CD 365) (NN ±) (CD 32)) (NN pg/ml))) (: ;) (S (NP (NN n)) (VP (JJ =) (NP (CD 3)))) (-RRB- -RRB-))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (CC neither) (NP (NP (NN change)) (PP (IN in) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN IL-6)))))) (CC nor) (NP (NP (NN proliferation)) (PP (IN of) (NP (NNS lymphocytes))))) (VP (VBD was) (VP (VBN observed)))) (. .)))
( (S (NP (NN Discussion))))
( (S (S (NP (NP (NN Inflammation)) (CC and) (NP (NN thrombosis))) (VP (VBP are) (VP (VBN linked) (PP (IN in) (NP (JJ many) (JJ clinical) (NNS conditions)))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN presumed) (SBAR (IN that) (S (NP (JJ proinflammatory) (NNS mediators)) (VP (VB potentiate) (NP (NP (NN activation)) (PP (IN of) (NP (NP (NN blood) (NN coagulation)) (CC and) (NP (NP (NP (NN serine) (NNS proteases)) (PP (IN of) (NP (DT the) (NN coagulation) (NN system)))) (, ,) (NP (NP (RB especially) (DT the) (JJ terminal) (NN enzyme) (NN thrombin)) (, ,) (VP (VBN known) (PP (IN for) (NP (NP (ADJP (ADJP (JJ proinflammatory)) (CC and) (ADJP (JJ mitogenic/chemotactic))) (NNS effects)) (PP (CC both) (PP (IN in) (NP (NN circulation))) (CC and) (PP (RB locally) (IN in) (NP (JJ synovial) (NN tissue) (CD -LSB-20-22))) (-RRB- -RSB-)))))))))))))))) (. .)))
( (S (S (NP (NP (DT An) (NN indication)) (PP (IN of) (NP (NP (DT the) (NN importance)) (PP (IN of) (NP (NN TF))) (PP (IN in) (NP (DT the) (JJ inflammatory) (NN process)))))) (VP (VBD was) (VP (VBN obtained) (PP (IN in) (NP (NP (DT the) (JJ animal) (NN model)) (PP (IN of) (NP (NN sepsis))) (, ,) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (JJ TF-dependent) (NN procoagulant) (NN activity)) (VP (VBD correlated) (PP (IN with) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NP (NN tumor) (NN necrosis)) (ADJP (JJ factor-α) (NP (CD -LSB-23)))))))))))))) (-RRB- -RSB-)) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NN modulation)) (PP (IN of) (NP (JJ TF-dependent) (NN coagulation))) (PP (IN by) (NP (NP (NN administration)) (PP (IN of) (NP (CC either) (NP (NN TF-pathway) (NN inhibitor)) (CC or) (NP (NN anti-TF) (NNS antibodies))))))) (VP (VP (VBD decreased) (NP (NP (JJ circulating) (NNS levels)) (PP (IN of) (NP (NP (NN IL-6)) (CC and) (NP (NN IL-8) (CD -LSB-24,25) (-RRB- -RSB-)))))) (, ,) (CC and) (VP (VBD diminished) (NP (NP (NN proliferation)) (CC and) (NP (JJ perivascular) (NN cell) (NN infiltration) (CD -LSB-26,27))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (DT This) (NN study)) (VP (VBZ shows) (SBAR (IN that) (S (NP (DT the) (NN TF) (NN molecule)) (VP (VBZ possesses) (NP (JJ strong) (JJ proinflammatory) (NNS properties)) (, ,) (S (VP (VBG causing) (NP (NN arthritis))))))))) (. .)))
( (S (S (NP (JJ Histological) (NN analysis)) (VP (VBD revealed) (SBAR (IN that) (S (NP (JJ TF-induced) (NN synovitis)) (VP (MD could) (VP (VB be) (VP (VBN attributed) (ADVP (RB mostly)) (PP (TO to) (NP (JJ infiltrating) (NNS macrophages)))))))))) (. .)))
( (S (S (NP (NP (JJ Mononuclear) (NN cell) (NN influx)) (PP (IN into) (NP (NN synovia)))) (VP (VBZ is) (NP (NP (DT an) (JJ early) (NN finding)) (PP (IN in) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (JJ asymptomatic) (NNS subjects)))))) (, ,) (S (VP (VBG preceding) (NP (NP (ADJP (RB clinically) (JJ overt)) (NN arthritis)) (PP (IN in) (NP (NN RA) (CD -LSB-28,29) (-RRB- -RSB-)))))))) (. .)))
( (S (S (ADVP (RB Furthermore)) (, ,) (NP (JJ synovial) (NN macrophage) (NN infiltration)) (VP (VP (VBZ is) (NP (NP (DT a) (JJ characteristic) (NN feature)) (PP (IN of) (NP (ADJP (CC both) (ADJP (JJ autoimmune)) (CC and) (ADJP (JJ bacterial))) (NN arthritis) (CD -LSB-30,31) (-RRB- -RSB-))))) (CC and) (VP (VBZ is) (NP (NP (DT a) (NN determinant)) (PP (IN of) (NP (NN joint) (NNS erosions) (CD -LSB-32,33)))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (PRP$ Our) (NN observation)) (, ,) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (DT an) (VBN increased) (JJ TF-dependent) (NN procoagulant) (NN activity)) (PP (IN in) (NP (NP (NP (NN blood)) (CC and) (NP (JJ synovial) (NN fluid))) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NN RA))))))))))) (, ,) (VP (VBZ implies) (NP (NP (NN participation)) (PP (IN of) (NP (NN TF))) (PP (PP (IN in) (S (VP (VBG triggering) (NP (NP (DT the) (JJ initial) (NNS steps)) (PP (IN of) (NP (NN inflammation)))) (PP (IN during) (NP (NN RA)))))) (CC and/or) (PP (IN in) (S (VP (VBG rendering) (NP (DT the) (NN inflammation) (JJ chronic))))))))) (. .)))
( (S (S (NP (NP (NN Composition)) (PP (IN of) (NP (NP (JJ inflammatory) (NN infiltrate)) (CC and) (NP (NN cell) (NN depletion) (NNS studies))))) (VP (VBD showed) (SBAR (IN that) (S (NP (NN TF)) (VP (VBZ exerts) (NP (PRP$ its) (JJ proinflammatory) (NNS properties)) (PP (IN in) (NP (NP (DT a) (JJ cell-specific) (NN manner)) (VP (VBG targeting) (NP (DT the) (NN macrophage/) (NN monocyte) (NN population)))))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBZ is) (RB not) (ADJP (JJ surprising)) (S (VP (VBG taking) (PP (IN into) (NP (NN consideration))) (SBAR (IN that) (S (NP (NNS macrophages/monocytes)) (VP (VBP are) (NP (NP (DT the) (JJ only) (NNS cells)) (PP (IN in) (NP (DT the) (NN blood) (NN circulation) (NN compartment))) (SBAR (WHNP (WDT which)) (S (VP (VBP express) (NP (NP (NN TF)) (PP (IN on) (NP (PRP$ their) (NN surface) (CD -LSB-8,34))))) (-RRB- -RSB-))))))))))) (. .)))
( (S (S (ADVP (RB Moreover)) (, ,) (NP (PRP we)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (DT an) (NN interaction)) (PP (IN between) (NP (NP (NNS monocytes)) (CC and) (NP (NNS lymphocytes))))) (VP (VBD was) (NP (NP (DT a) (NN prerequisite)) (PP (IN of) (NP (DT the) (JJ TF-induced) (NN arthritis))))))))) (. .)))
( (S (S (NP (VBN Activated) (NN T) (NNS cells)) (VP (VBD were) (ADJP (JJ able) (S (VP (TO to) (VP (VB induce) (NP (NN TF) (NN production)) (PP (IN by) (S (VP (VBG stimulating) (NP (NNS monocytes)) (PP (IN through) (NP (NN CD40) (NN ligand) (CD -LSB-35,36) (-RRB- -RSB-)))))))))))) (. .)))
( (S (S (NP (DT This) (NN mechanism)) (VP (MD may) (VP (VB contribute) (PP (TO to) (NP (NP (DT a) (JJ positive) (NN feedback)) (ADJP (JJ essential) (PP (IN for) (NP (NP (NN maintenance)) (PP (IN of) (NP (JJ TF-induced) (NN inflammation))))))))))) (. .)))
( (S (S (ADVP (RB Interestingly)) (, ,) (NP (NP (NNS neutrophils)) (, ,) (NP (JJ other) (JJ principal) (JJ inflammatory) (NNS cells)) (, ,)) (VP (VBD were) (RB not) (ADJP (JJ sensitive) (PP (TO to) (NP (NN TF) (NN stimulation)))))) (: –) (S (NP (DT these) (NNS cells)) (VP (VP (VBD were) (ADVP (RB neither)) (VP (VBN found) (PP (IN in) (NP (JJ synovial) (NNS tissues))))) (CC nor) (VP (VBD affected) (NP (NN arthritis) (NN frequency)) (PP (IN in) (NP (DT the) (NN depletion) (NNS experiments)))))) (. .)))
( (S (S (NP (NP (JJ Mononuclear) (NNS cells)) (VP (VBG composing) (NP (NP (DT the) (JJ inflammatory) (NN infiltrate)) (PP (IN in) (NP (NN synovia)))))) (VP (VBD were) (ADVP (RB mostly)) (NP (JJ Mac-1+) (JJ CD4-) (NNS cells)))) (. .)))
( (S (S (NP (NP (JJ Abundant) (NN expression)) (PP (IN of) (NP (NN Mac-1) (NN molecule))) (PP (IN on) (NP (DT the) (NN monocyte) (NN surface)))) (VP (VBZ indicates) (NP (NP (DT a) (JJ principal) (NN role)) (PP (IN of) (NP (NN β2-integrins))) (PP (IN in) (NP (NP (NN cell) (NN activation)) (PP (VBG following) (NP (NP (NN exposure)) (PP (TO to) (NP (NN TF)))))))))) (. .)))
( (S (S (NP (NP (CD Two) (NNS methods)) (PP (IN of) (NP (JJ such) (NN activation)))) (VP (MD may) (VP (VB be) (VP (VBN considered))))) (. .)))
( (S (S (NP (NN TF)) (VP (MD may) (VP (VB attract) (NP (NN Mac-1+) (NNS cells)) (PP (ADVP (RB indirectly)) (IN by) (S (VP (VBG increasing) (NP (NP (NN formation)) (PP (IN of) (NP (NP (NN coagulation) (NNS proteins)) (VP (VBN known) (PP (IN as) (NP (NP (NN Mac-1) (NNS ligands)) (, ,) (PP (FW e.g.)))))))))))))) (. .)))
( (S (NP (NP (NP (NN Factor) (NN X)) (CC and) (NP (NN fibrinogen))) (. .))))
( (S (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (JJ high) (NN incidence)) (PP (IN of) (NP (JJ TF-induced) (NN arthritis))) (PP (IN in) (NP (JJ defibrinated) (NNS mice)))) (VP (VBZ favors) (NP (NP (DT a) (JJ direct) (JJ stimulatory) (NN effect)) (PP (IN of) (NP (NN TF))) (PP (IN on) (NP (JJ sensitive) (NNS cells)))))) (. .)))
( (S (S (NP (NP (NN Treatment)) (PP (IN of) (NP (NNS macrophages))) (PP (IN with) (NP (NN TF))) (ADVP (FW in) (FW vitro))) (VP (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB increase) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (JJ β2-chain-containing) (NN adhesion) (NNS molecules)) (NP (CD -LSB-37) (-RRB- -RSB-))))))))))) (CC and) (VP (VBZ supports) (NP (NP (DT the) (NN idea)) (PP (IN of) (NP (JJ direct) (JJ TF-induced) (NN Mac-1) (NN expression))))))) (. .)))
( (S (NP (NP (NN Lack)) (PP (IN of) (NP (NP (JJ CD4+) (NNS cells)) (ADJP (JJ responsible) (PP (IN for) (NP (NP (NN peptide) (NN presentation)) (PP (IN through) (NP (NN MHC) (NN class) (CD II) (NNS molecules))))))))) (VP (VBZ shows) (SBAR (IN that) (S (NP (DT this) (NN mechanism)) (VP (VBZ is) (RB not) (ADJP (JJ compulsory) (PP (IN for) (NP (JJ TF-induced) (JJ synovial) (NN infiltration)))) (, ,) (PP (IN in) (NN contrast) (TO to) (NP (JJ experimental) (NN glomerulonephritis))) (SBAR (WHADVP (WRB where)) (S (NP (NP (JJ simultaneous) (NN expression)) (PP (IN of) (NP (NP (NN TF)) (CC and) (NP (NN MHC) (NN class) (CD II) (NNS molecules))))) (VP (VBD was) (VP (VP (VBN observed)) (CC and) (VP (ADVP (RB efficiently)) (VBN blocked) (PP (IN by) (NP (NN anti-TF) (NNS antibodies) (CD -LSB-38,39) (-RRB- -RSB-)))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN way)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NN TF)) (VP (VBZ interacts) (PP (IN with) (NP (NNS macrophages))))))) (VP (VBZ is) (RB not) (ADJP (JJ clear)))) (. .)))
( (S (S (NP (NP (NN Exposure)) (PP (IN of) (NP (NN spleen) (NN cell) (NNS cultures))) (PP (TO to) (NP (NN TF)))) (VP (VBD did) (RB not) (VP (VB induce) (NP (NP (DT the) (NN release)) (PP (IN of) (NP (JJ proinflammatory) (NNS cytokines))))))) (. .)))
( (S (S (NP (DT These) (NNS results)) (VP (VB favor) (NP (DT the) (NN suggestion) (SBAR (IN that) (S (NP (NN TF)) (VP (VP (VBZ acts) (ADVP (RB directly)) (PP (IN on) (NP (JJ inflammatory) (NNS cells)))) (CC and) (VP (ADVP (RB not)) (PP (IN by) (NP (DT a) (JJ cytokine-mediated) (NN mechanism)))))))))) (. .)))
( (S (S (NP (NP (JJ TF-mediated) (NN release)) (PP (IN of) (NP (NN chemoattractant) (NNS molecules))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VB recruit) (NP (NP (JJ inflammatory) (NNS cells)) (PP (IN from) (NP (NP (DT the) (NN circulation)) (CC or) (NP (JJ surrounding) (NNS tissues)))))))) (, ,)) (VP (VBZ is) (NP (DT an) (JJ alternative) (NN possibility)))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (ADJP (FW in) (FW vitro)) (NN splenocyte) (NN stimulation)) (PP (IN with) (NP (NN TF)))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (JJ selective) (NN release)) (PP (IN of) (NP (DT the) (NN monocyte) (NN chemoattractant) (NN molecule) (CD MIP-1α))))))))))) (. .)))
( (S (S (NP (DT This) (NN observation)) (VP (MD may) (VP (VB explain) (NP (NP (DT the) (NN dominance)) (PP (IN of) (NP (JJ mononuclear) (NNS cells))) (PP (IN in) (NP (NP (DT the) (JJ synovial) (JJ inflammatory) (NNS infiltrates)) (PP (IN of) (NP (NP (DT the) (NNS joints)) (VP (VBN injected) (PP (IN with) (NP (NN TF)))))))))))) (. .)))
( (S (S (ADVP (RB Altogether)) (NP (PRP$ our) (NNS observations)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN TF)) (VP (MD may) (VP (VB play) (NP (DT an) (JJ active) (NN role)) (PP (IN during) (NP (NN arthritis))) (PP (IN by) (NP (NP (ADJP (ADJP (JJ direct)) (CC and/or) (ADJP (JJ indirect))) (NN stimulation)) (PP (IN of) (NP (NP (NN influx)) (PP (IN of) (NP (NNS monocytes))) (PP (IN into) (NP (DT the) (JJ synovial) (NN tissue))))))))))))) (. .)))
( (S (NP (NNS Abbreviations))))
( (S (S (S (NP (NN FCS)) (VP (VBG =) (NP (NP (JJ fetal) (NN calf) (NN serum)) (: ;) (NP (NN FVII) (JJ =) (NN factor) (NN VII)) (: ;) (NP (NN IL) (JJ =) (NN interleukin) (: ;) (NN LPS) (JJ =) (NN lipopolysaccharide)) (: ;) (NP (NN MIP) (JJ =) (NN macrophage) (JJ inhibitory) (NN protein))))) (: ;) (S (NP (NN RA)) (VP (VBG =) (NP (JJ rheumatoid) (NN arthritis)))) (: ;) (S (NP (NN RANTES)) (VP (VBG =) (VP (VBN regulated) (PP (IN on) (NP (NP (NN activation) (JJ normal) (NN T-cell)) (VP (VP (VBN expressed)) (CC and) (VP (VBN secreted)))))))) (: ;) (NP (NN RTF) (JJ =) (JJ recombinant) (NN TF)) (: ;) (NP (NP (NN SCID)) (ADJP (JJ =) (JJ severe) (JJ combined) (JJ immunodeficient))) (: ;) (NP (NN TF) (JJ =) (NN tissue) (NN factor))) (. .)))
( (S (NP (NP (NN Figure)) (CC and) (NP (NN Table)) (NP (NNS captions)))))
( (S (NP (NP (NN Figure) (CD 1)) (: :) (NP (NP (NNS Measurements)) (PP (IN of) (NP (NN arthritis))) (PP (IN in) (NP (JJ murine) (NN knee) (NNS joints)))) (. .))))
( (S (S (NP (NP (NP (LST (-LRB- -LRB-) (LS a) (-RRB- -RRB-)) (NN Arthritis) (NN index)) (CC and) (NP (LST (-LRB- -LRB-) (LS b) (-RRB- -RRB-)) (NP (NN incidence)) (PP (IN of) (NP (NN arthritis))) (PP (IN after) (NP (NP (JJ intra-articular) (NN injection)) (PP (IN of) (NP (NN TF))))))) (PRN (-LRB- -LRB-) (NP (CD 20) (NN μg/joint)) (-RRB- -RRB-))) (ADVP (RB as)) (VP (VBN evaluated) (PP (IN by) (NP (JJ histological) (NN examination))))) (. .)))
( (S (S (NP (NN Arthritis) (NN index)) (VP (VBD was) (VP (VBN assessed) (SBAR (IN as) (S (VP (VBN described) (PP (IN in) (NP (DT the) (NP (NP (NNS Materials)) (CC and) (NP (NNS methods))) (NN section))))))))) (. .)))
( (S (S (NP (NNS Asterisks)) (VP (VBP indicate) (NP (NP (JJ significant) (NNS differences)) (PP (IN of) (NP (DT the) (NNS means))) (PP (IN between) (NP (NP (NP (DT the) (NNS mice)) (VP (VBG receiving) (NP (NN TF)))) (CC and) (NP (DT the) (NNS controls))))))) (. .)))
( (S (S (NP (NP (NN Figure) (CD 2)) (: :) (NP (NP (JJ Morphological) (NNS changes)) (PP (IN in) (NP (DT the) (NN joint))) (PP (IN after) (NP (NP (NN injection)) (PP (IN of) (NP (NN TF)))))) (. .)) (NP (LST (-LRB- -LRB-) (LS a) (-RRB- -RRB-)) (NN Histopathology) (PP (IN of) (NP (NP (NP (DT an) (JJ arthritic) (NN knee) (NN joint)) (NP (NP (CD four) (NNS days)) (PP (IN after) (NP (NP (NN injection)) (PP (IN of) (NP (NN TF))))))) (PRN (-LRB- -LRB-) (NP (CD 20) (NN μg/joint)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NP (NN Infiltration)) (PP (IN of) (NP (JJ mononuclear) (NNS cells))) (PP (IN in) (NP (JJ synovial) (NN tissue)))) (VP (VBZ is) (ADJP (JJ apparent)))) (. .)))
( (S (NP (NP (JJ Original) (NN magnification) (NN ×20)) (. .))))
( (S (S (LST (-LRB- -LRB-) (LS b) (-RRB- -RRB-)) (NP (NP (JJ Immunohistochemical) (NN staining)) (PP (IN of) (NP (DT an) (JJ arthritic) (NN knee) (NN joint)))) (, ,) (VP (VBG showing) (NP (NP (NNS cells)) (VP (VBG expressing) (NP (NN Mac-1)))))) (. .)))
( (S (NP (NP (JJ Original) (NN magnification) (NN ×40)) (. .))))
( (S (S (NP (NP (NP (NN JC)) (, ,) (NP (NN joint) (NN cavity)) (: ;) (NP (NN C))) (, ,) (NP (NP (NN cartilage)) (: ;) (NP (NN SH)) (, ,) (NP (JJ synovial) (NN hyperplasy)) (: ;) (NP (NN P)) (, ,) (NP (NN pannus)) (: ;) (NP (NN Er)) (, ,) (NP (NN bone) (NN erosion)) (: ;) (NP (ADJP (JJ ST)))) (, ,)) (NP (JJ synovial) (NN tissue))) (. .)))
( (S (S (NP (NNS Arrows)) (VP (VBP indicate) (NP (NP (JJ inflammatory) (NNS cells)) (PP (IN in) (NP (NP (NN synovia)) (, ,) (NP (NN pannus) (NN formation)) (CC and) (NP (NN cartilage) (NN destruction))))))) (. .)))
( (S (S (NP (NP (NN Figure) (CD 3)) (: :) (NP (NP (NNS Lymphocytes)) (CC and) (NP (NNS monocytes)))) (VP (VBP are) (ADJP (JJ mandatory) (PP (IN for) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ TF-induced) (NN arthritis)))))))) (. .)))
( (S (S (NP (NP (NN Incidence)) (PP (IN of) (NP (NN arthritis)))) (VP (VBD was) (VP (VBN assessed) (PP (IN in) (NP (NP (NNS mice)) (VP (VBN depleted) (PP (IN of) (NP (JJ various) (JJ immune) (NNS cells))))))))) (. .)))
( (S (S (NP (NP (JJ Significant) (NNS differences)) (PP (IN of) (NP (NP (NN incidence)) (PP (IN of) (NP (NN arthritis))))) (PP (IN between) (NP (DT the) (NNS groups)))) (VP (VBP are) (VP (VBN indicated)))) (. .)))
( (S (NP (NP (JJ Predictive) (NN screening)) (PP (IN for) (NP (NP (NNS regulators)) (PP (IN of) (NP (NP (JJ conserved) (JJ functional) (NN gene) (NNS modules)) (PRN (-LRB- -LRB-) (NP (NN gene) (NNS batteries)) (-RRB- -RRB-)))))) (PP (IN in) (NP (NNS mammals))))))
( (S (NP (NN Abstract))))
( (S (NP (NP (NN Background)) (: :) (S (NP (NP (DT The) (NN expression)) (PP (IN of) (NP (NP (NN gene) (NNS batteries)) (, ,) (NP (NP (JJ genomic) (NNS units)) (PP (IN of) (NP (NP (ADJP (RB functionally) (VBN linked)) (NNS genes)) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN activated) (PP (IN by) (NP (NP (JJ similar) (NNS sets)) (PP (IN of) (NP (ADJP (ADJP (JJ cis-)) (CC and) (ADJP (JJ trans-acting))) (NNS regulators)))))))))))) (, ,)))) (VP (VBZ has) (VP (VBN been) (VP (VBN proposed) (PP (IN as) (NP (NP (DT a) (JJ major) (NN determinant)) (PP (IN of) (NP (NP (NN cell) (NN specialization)) (PP (IN in) (NP (NNS metazoans))))))))))) (. .))))
( (S (S (NP (PRP We)) (VP (VBD developed) (NP (NP (DT a) (JJ predictive) (NN procedure)) (S (VP (TO to) (VP (VB screen) (NP (NP (UCP (NP (DT the) (NN mouse)) (CC and) (ADJP (JJ human))) (NNS genomes)) (CC and) (NP (NNS transcriptomes))) (PP (IN for) (NP (NP (NNS cases)) (PP (IN of) (NP (JJ gene-battery-like) (NN regulation))))))))))) (. .)))
( (S (NP (NP (NNS Results)) (: :) (S (PP (IN In) (NP (NP (DT a) (NN screen)) (SBAR (WHNP (WDT that)) (S (VP (VBD covered) (NP (NP (CD ~40)) (PP (IN per) (NP (NP (NN cent)) (PP (IN of) (NP (DT all) (JJ annotated) (JJ protein-coding) (NNS genes))))))))))) (, ,) (NP (PRP we)) (VP (VBD identified) (NP (CD 21)) (VP (VBD co-expressed) (NP (NN gene) (NNS clusters)) (PP (IN with) (NP (ADJP (RB statistically) (VBN supported)) (VBG sharing) (PP (IN of) (NP (JJ cis-regulatory) (NN sequence) (NNS elements)))))))) (. .))))
( (S (S (NP (NP (CD 66) (VBN predicted) (NNS cases)) (PP (IN of) (NP (JJ over-represented) (NN transcription) (NN factor) (NN binding) (NNS motifs)))) (VP (VP (VBD were) (VP (VBN validated) (PP (IN against) (NP (DT the) (NN literature))))) (CC and) (VP (VBP fell) (PP (IN into) (NP (CD three) (NNS categories)))))) (: :) (NP (NP (LST (-LRB- -LRB-) (LS i) (-RRB- -RRB-)) (NP (ADJP (RB previously) (VBN described)) (NNS cases)) (PP (IN of) (NP (NN gene) (JJ battery-like) (NN regulation)))) (, ,) (NP (LST (-LRB- -LRB-) (LS ii) (-RRB- -RRB-)) (NP (ADJP (RB previously) (VBN unreported)) (NNS cases)) (PP (IN of) (NP (NP (NN gene) (JJ battery-like) (NN regulation)) (PP (IN with) (NP (NP (DT some) (NN support)) (PP (IN in) (NP (NP (DT a) (JJ limited) (NN number)) (PP (IN of) (NP (NNS genes)))))))))) (, ,) (CC and) (NP (NP (LST (-LRB- -LRB-) (LS iii) (-RRB- -RRB-)) (VBN predicted) (NNS cases)) (SBAR (WHNP (WDT that)) (S (ADVP (RB currently)) (VP (VBP lack) (NP (JJ experimental) (NN support))))))) (. .)))
( (S (NP (DT The) (JJ novel) (NNS predictions)) (VP (VBP include) (PP (IN for) (NP (NN example) (NP (NN Sox) (CD 17)) (CC and) (NP (NN RFX) (NN transcription) (NN factor)))) (NP (NP (NP (VBG binding) (NNS sites)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (VP (VBN detected) (PP (IN in) (NP (NP (CD ~10) (NN %)) (PP (IN of) (NP (DT all) (NN testis) (JJ specific) (NNS genes)))))))))) (, ,) (NP (NP (CC and) (NN HNF-1) (CC and) (CD 4) (NN binding) (NNS sites)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (VP (VBN detected) (PP (IN in) (NP (NP (CD ~30) (NN %)) (PP (IN of) (NP (DT all) (NN kidney) (JJ specific) (NNS genes))))) (ADVP (RB respectively))))))))) (. .)))
( (S (S (NP (DT The) (NNS results)) (VP (VBP are) (ADJP (RB publicly) (JJ available) (PP (IN at))))) (. .)))
( (S (NP (NP (NN Conclusion)) (: :) (S (NP (NP (CD 21)) (VP (VBD co-expressed) (NP (NN gene) (NNS clusters)))) (VP (VBD were) (VP (VBN enriched) (PP (IN for) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (CD 66) (JJ shared) (JJ cis-regulatory) (NN sequence) (NNS elements)))))))) (. .))))
( (S (S (NP (NP (DT A) (NN majority)) (PP (IN of) (NP (DT these) (NNS predictions)))) (VP (VBP represent) (NP (NP (JJ novel) (NNS cases)) (PP (IN of) (NP (NP (JJ potential) (NN co-regulation)) (PP (IN of) (NP (ADJP (RB functionally) (VBN coupled)) (NNS proteins)))))))) (. .)))
( (S (S (S (NP (JJ Critical) (JJ technical) (NNS parameters)) (VP (VBD were) (VP (VBN evaluated)))) (, ,) (CC and) (S (NP (NP (DT the) (NNS results)) (CC and) (NP (DT the) (NNS methods))) (VP (VBP provide) (NP (NP (DT a) (JJ valuable) (NN resource)) (PP (IN for) (NP (JJ future) (JJ experimental) (NN design))))))) (. .)))
( (S (NP (NN Background))))
( (S (S (VP (TO To) (VP (VB understand) (SBAR (WHADVP (WRB how)) (S (NP (NN gene) (NN expression)) (VP (VBZ is) (VP (VBN coordinated) (S (VP (TO to) (VP (VB produce) (NP (NP (NN hundreds)) (PP (IN of) (NP (NN cell) (NNS phenotypes))) (PP (IN from) (NP (NP (DT an) (JJ identical) (NN complement)) (PP (IN of) (NP (NNS genes)))))))))))))))) (VP (VBZ is) (NP (NP (DT a) (JJ principal) (NN challenge)) (PP (IN in) (NP (JJ mammalian) (NN genome) (NN research))))) (. .)))
( (S (S (NP (NP (DT A) (ADJP (RB commonly) (VBN suggested)) (NN model)) (PP (IN for) (NP (NP (JJ terminal) (NN differentiation)) (PP (IN in) (NP (NNS metazoans)))))) (VP (VBZ is) (SBAR (IN that) (S (NP (NP (DT the) (NN core) (NNS features)) (PP (IN of) (NP (DT the) (JJ cellular) (NN phenotype)))) (VP (VBP are) (VP (VBN mediated) (PP (IN by) (NP (NP (DT a) (NN set)) (PP (IN of) (NP (NP (NNS genes)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN regulated) (PP (IN as) (NP (DT a) (NN gene) (NN battery))))))) (, ,) (PP (FW i.e.) (NP (NP (DT a) (NN set)) (PP (IN of) (NP (NP (ADJP (RB functionally) (VBN coupled)) (NNS genes)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN activated) (PP (IN by) (NP (NP (JJ similar) (ADJP (ADJP (JJ cis-)) (CC and) (ADJP (JJ trans-acting))) (NNS regulators)) (NP (CD -LSB-1-3) (-RRB- -RSB-)))))))))))))))))))))) (. .)))
( (S (SBAR (IN Although) (S (NP (DT the) (NN gene) (NN battery)) (VP (VBZ is) (NP (DT an) (JJ idealized) (NN concept))))) (, ,) (NP (NP (JJ concrete) (NNS examples)) (PP (IN of) (NP (NN gene) (JJ battery-like) (NN regulation)))) (VP (VBP have) (VP (VBN been) (VP (VBN found) (PP (IN in) (FRAG (PP (IN for) (NP (NN example) (NN muscle) (NNS subtypes) (NP (NP (CD -LSB-4-7) (-RRB- -RSB-)) (, ,) (NP (NNS megakaryocytes) (CD -LSB-8) (-RRB- -RSB-)) (, ,) (NP (NP (DT the) (NN epidermis)) (CD -LSB-9) (-RRB- -RSB-)) (CC and) (NP (NNS lymphocytes)) (NP (CD -LSB-10,11))))) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (NP (DT A) (JJ key) (NN step)) (PP (IN in) (NP (NP (DT the) (NN elucidation)) (PP (IN of) (NP (NN gene) (JJ battery-like) (NN regulation)))))) (VP (VBZ is) (S (VP (TO to) (VP (VP (VB detect)) (CC and) (ADVP (RB functionally)) (VP (VB test) (NP (NP (DT the) (JJ cis) (JJ regulatory) (NNS elements)) (SBAR (WHNP (WDT that)) (S (VP (VBP mediate) (NP (DT the) (NN co-regulation)))))))))))) (. .)))
( (S (S (NP (NP (DT A) (NN number)) (PP (IN of) (NP (JJ computation-based) (NNS methods)))) (VP (VBP have) (VP (VBN been) (VP (VBN proposed) (S (VP (TO to) (VP (VBP do) (NP (DT this))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN micro-organisms))) (, ,) (NP (JJ computational) (NNS methods)) (VP (VBP have) (VP (VBN proven) (ADJP (JJ useful) (S (VP (TO to) (VP (VB detect) (NP (NP (NNS modules)) (PP (IN of) (NP (JJ co-regulated) (NNS genes) (CD -LSB-12,13) (-RRB- -RSB-))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NNS mammals))) (, ,) (S (NP (NP (JJ predictive) (NNS models)) (VP (VBN based) (PP (IN on) (NP (NP (VBN assumed) (NN co-regulation)) (PP (IN at) (NP (DT the) (JJ cis) (NN level))))))) (VP (VBP have) (VP (VBN been) (VP (VBN constructed) (PP (IN for) (NP (ADJP (ADJP (JJ liver-)) (CC and) (ADJP (JJ skeletal))) (JJ muscle-selective) (NN gene) (NN regulation) (CD -LSB-14,15) (-RRB- -RSB-))))))) (, ,) (CC and) (S (NP (JJ general) (NNS tools)) (VP (VBP have) (VP (VBN been) (VP (VBN developed) (PP (IN for) (NP (NP (DT the) (JJ regulatory) (NN analysis)) (PP (IN of) (NP (VBD co-expressed) (NNS genes) (CD -LSB-16-18) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT this) (NN work)))) (VP (VBZ is) (S (VP (TO to) (VP (VB screen) (NP (NP (DT the) (NP (NP (NN mouse)) (CC and) (NP (JJ human) (NNS genomes)))) (CC and) (NP (NNS transcriptomes))) (PP (IN for) (NP (NP (NNS instances)) (SBAR (WHADVP (WRB where)) (S (NP (NP (VBG sharing)) (PP (IN of) (NP (JJ cis-regulatory) (NNS sequences)))) (VP (VBZ is) (ADVP (RB statistically)) (VP (VBN coupled) (PP (TO to) (NP (NP (VBN conserved) (NN co-expression)) (PP (IN of) (NP (NP (NNS genes)) (, ,) (PP (FW i.e.) (NP (NP (NNS cases)) (SBAR (WHNP (WDT that)) (S (VP (VBP fall) (PP (PP (IN within)) (CC or) (PP (IN near) (NP (DT the) (JJ idealized) (NN gene) (NN battery) (NN concept)))))))))))))))))))))))) (. .)))
( (S (S (NP (DT Another) (NN aim)) (VP (VBZ is) (S (VP (TO to) (ADVP (RB critically)) (VP (VB investigate) (NP (JJ technical) (NNS parameters))) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB maximize) (NP (NP (DT the) (NN sensitivity)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (NP (NN co-regulation)) (PP (IN of) (NP (VBD co-expressed) (NNS genes)))) (VP (MD can) (VP (VB be) (VP (VBN detected))))))))))))))) (. .)))
( (S (PP (IN In) (NP (NP (DT a) (NN screen)) (SBAR (WHNP (WDT that)) (S (VP (VBD covered) (NP (NP (CD ~40)) (PP (IN per) (NP (NP (NN cent)) (PP (IN of) (NP (NP (DT all) (JJ protein-coding) (NNS genes)) (VP (VBG according) (PP (TO to) (NP (DT the) (JJ latest) (NN Ensembl) (NN annotation)))))))))))))) (, ,) (NP (PRP we)) (VP (VBD identified) (NP (NP (CD 21) (ADJP (VBD co-expressed)) (NN gene) (NNS clusters)) (PP (IN with) (NP (NP (CD 66) (NNS cases)) (PP (IN of) (NP (ADJP (RB statistically) (VBN supported)) (VBG sharing) (PP (IN of) (NP (JJ cis-regulatory) (NN sequence) (NNS motifs))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ predictive) (NN value)) (PP (IN of) (NP (NP (DT the) (NN assignment)) (PP (IN of) (NP (NN transcription) (NN factor) (NN binding) (NNS sites)))))) (VP (VBD was) (ADVP (RB experimentally)) (VP (VBN evaluated) (PP (IN on) (NP (NP (NN EBF) (NN binding) (NNS sites)) (PP (IN in) (NP (NP (DT a) (NN set)) (PP (IN of) (NP (NN B-cell) (VBD expressed) (NN gene) (NNS clusters)))))))))) (. .)))
( (S (S (NP (NP (DT The) (VBN predicted) (NNS cases)) (PP (IN of) (NP (NN co-regulation)))) (VP (VBP include) (NP (NP (NP (JJ several) (ADJP (RB previously) (VBN known)) (NN prototype) (NNS examples)) (PP (IN of) (NP (ADJP (NN tissue) (JJ specific)) (NN regulation)))) (, ,) (CONJP (CC but) (RB also)) (NP (JJ novel) (NNS predictions))))) (. .)))
( (S (S (NP (DT All) (NNS data)) (VP (VBP are) (VP (VBN made) (ADJP (JJ available) (PP (TO to) (NP (NP (DT the) (NN research) (NN community)) (PP (IN in) (NP (NP (DT the) (NN form)) (PP (IN of) (NP (NP (DT an) (JJ internet) (NN resource)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB serve) (PP (IN as) (NP (NP (DT a) (VBG starting) (NN point)) (PP (IN for) (NP (JJ further) (NN analysis))))))))))))))))))) (. .)))
( (S (NP (NNS Results))))
( (S (S (NP (DT The) (NN analysis)) (VP (VBD was) (VP (VBN based) (PP (IN on) (NP (DT the) (NN assumption) (SBAR (IN that) (S (NP (NP (JJ homologous) (NNS genes)) (PP (IN in) (NP (NP (NN mouse)) (CC and) (NP (ADJP (JJ human)))))) (VP (VBP are) (ADJP (JJ equivalent) (PP (IN in) (NP (NP (JJ most) (NNS aspects)) (PP (IN of) (NP (NP (NN regulation)) (CC and) (NP (NN function))))))))))))))) (. .)))
( (S (S (PP (IN In) (NP (JJ particular))) (, ,) (NP (PRP we)) (VP (VBN assumed) (SBAR (IN that) (S (NP (DT the) (JJ transcriptional) (NN regulation)) (VP (VBZ is) (VP (VBN conserved) (PP (IN for) (NP (JJ orthologous) (NNS genes))))))))) (. .)))
( (S (S (PP (IN For) (NP (NN example))) (, ,) (NP (NP (DT the) (NN mouse) (NN gene) (NN Myh1)) (CC and) (NP (DT the) (JJ human) (NN gene) (NN MYH1))) (VP (VBP are) (VP (VBN assumed) (S (VP (VP (TO to) (VP (VB share) (NP (NN expression) (NN pattern)))) (CC and) (VP (TO to) (VP (VB share) (NP (JJ important) (JJ cis-regulatory) (NNS sequences))))))))) (. .)))
( (S (ADVP (IN Below)) (, ,) (NP (DT the) (NN term) (`` ') (NN ortholog) (NN pair) ('' ')) (VP (MD will) (VP (VB be) (VP (VBN applied) (PP (IN as) (NP (NP (DT a) (JJ two-species) (NN equivalent)) (PP (IN of) (NP (`` ') (NN gene) ('' '))))) (, ,) (SBAR (WHPP (IN for) (WHNP (WDT which))) (S (NP (NP (NN expression)) (CC and) (NP (NN sequence) (NNS data))) (ADVP (WRB where)) (VP (VBN retrieved) (PP (IN for) (NP (CC both) (NP (NN mouse)) (CC and) (NP (ADJP (JJ human))))))))))) (. .)))
( (S (S (NP (NN Ensembl) (NN gene) (NNS annotations) (CD -LSB-19,20) (-RRB- -RSB-)) (VP (VBD were) (VP (VBN applied) (PP (IN thoughout) (NP (DT the) (NN analysis)))))) (. .)))
( (S (S (NP (NP (JJ Previous) (NNS results)) (PP (IN by) (NP (NP (PRP$ our) (NN group)) (CC and) (NP (NNS others))))) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (JJ statistical) (NN analysis)) (PP (IN of) (NP (NP (NN gene) (NN expression) (NNS profiles)) (PP (IN in) (NP (NP (DT a) (JJ large) (NN compendium)) (PP (IN of) (NP (NN expression) (NNS data)))))))) (VP (MD can) (VP (VP (VB predict) (NP (NP (NNS targets)) (PP (IN of) (NP (NN differentiation) (NNS processes))))) (, ,) (CC and) (VP (VB identify) (NP (NP (ADJP (RB functionally) (VBN coupled)) (NNS genes)) (CD -LSB-12,21,22) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (PP (IN In) (NP (DT the) (JJ following) (NN analysis))) (, ,) (NP (PRP we)) (ADVP (RB specifically)) (VP (VBD focused) (PP (IN on) (NP (NP (DT a) (NN compendium)) (VP (VBN derived) (PP (IN from) (NP (NP (DT the) (ADJP (RB recently) (VBN completed)) (NP (NNP Novartis)) (NN expression) (NNS atlas)) (PRN (-LRB- -LRB-) (NP (NNP SymAtlas) (-RRB- -RRB-) (CD -LSB-23)) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (DT These) (NNS data)) (VP (VP (VBP contain) (NP (NP (NN transcription) (NNS profiles)) (PP (IN for) (NP (NP (NP (CD 140) (NN mouse)) (CC and) (NP (JJ human) (NNS tissues))) (VP (VBN generated) (PP (IN by) (NP (NP (NN hybridization)) (PP (IN on) (NP (JJ customized) (NN Affymetrix) (NNS chips)))))))))) (, ,) (CC and) (VP (VBP cover) (NP (NP (DT a) (JJ large) (NN fraction)) (PP (IN of) (NP (NP (DT the) (NN mouse)) (CC and) (NP (ADJP (JJ human))) (NP (JJ protein-coding) (NNS genes)))))))) (. .)))
( (S (S (NP (NP (NN Sequence) (NN annotation)) (PP (IN of) (NP (DT the) (NP (NNP Novartis)) (NNS probes)))) (VP (VBD linked) (NP (UCP (NP (DT the) (NN mouse)) (CC and) (ADJP (JJ human))) (NNS data)) (PP (TO to) (NP (NP (QP (RB approximately) (CD 17.000)) (JJ unique) (NN Ensembl) (NN gene) (NNS identities)) (PP (IN in) (NP (NP (JJ each) (NNS species)) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 1)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (PP (IN Between) (NP (DT the) (CD two) (NNS datasets))) (, ,) (NP (CD 13282) (JJ non-redundant) (NN ortholog) (NNS pairs)) (VP (MD could) (VP (VB be) (VP (VBN identified) (PP (IN by) (NP (NP (NN linkage)) (PP (IN of) (NP (NP (JJ reciprocal) (NN Ensembl) (NN homology) (NNS assignments)) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 1)) (-RRB- -RRB-)))))))))) (. .)))
( (S (PP (IN In) (NP (JJ later) (NNS steps))) (, ,) (NP (PRP we)) (VP (VBN excluded) (NP (NP (NNS genes)) (SBAR (WHPP (IN for) (WHNP (WDT which))) (S (NP (JJ regulatory) (NN sequence)) (VP (MD could) (RB not) (VP (VB be) (VP (VBN extracted) (PRN (-LRB- -LRB-) (NP (NNS Methods)) (-RRB- -RRB-)))))))) (, ,) (S (VP (VBG leaving) (NP (NN 9561) (NN ortholog) (NNS pairs)) (PP (IN for) (NP (NP (NN clustering)) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 1)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (DT The) (JJ final) (NN dataset)) (VP (VBD included) (NP (NP (CD ~40) (NN %)) (PP (IN of) (NP (DT the) (NP (NN mouse)) (CC and) (NP (JJ human) (NN Ensembl) (JJ annotated) (NNS genes))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBN clustered) (NP (NP (DT the) (NN mouse/human) (NN ortholog) (NNS pairs)) (VP (VBN based) (PP (IN on) (NP (PRP$ their) (NN expression) (NNS profiles))))) (PP (IN across) (NP (DT the) (NP (NP (CD 140) (NN mouse)) (CC and) (NP (JJ human) (NNS tissues))) (-LRB- -LRB-) (NNS Methods) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD computed) (NP (NNS clusters)) (PP (IN at) (NP (NP (JJ cut-off) (NNS levels)) (VP (VBG ranging) (PP (IN from) (NP (NP (NP (NN Pearson) (POS 's) (NN correlation) (NN coefficient)) (PRN (-LRB- -LRB-) (ADVP (RB hereafter)) (VP (VBN termed) (NP (NN PCC))) (-RRB- -RRB-))) (CD 0.61) (TO to) (CD 0.99)))))))) (. .)))
( (S (S (PP (IN At) (NP (NP (DT the) (JJS lowest) (VBN applied)) (JJ cut-off))) (, ,) (NP (NP (CD 57) (NN %)) (PP (IN of) (NP (DT all) (NN ortholog) (NNS pairs))) (PP (IN in) (NP (DT the) (NNS data)))) (VP (VBD were) (NP (NP (NNS members)) (PP (IN of) (NP (DT a) (NN cluster)))))) (. .)))
( (S (S (NP (DT The) (NN cluster) (NNS sizes)) (VP (VBD were) (VP (VBN distributed) (PP (IN in) (NP (DT a) (JJ skewed) (NN manner))) (, ,) (PP (IN with) (NP (NP (DT a) (JJ predominant) (NN formation)) (PP (IN of) (NP (NP (JJ small) (NNS clusters)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1A)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (DT All) (NNS analyses)) (ADVP (RB hereafter)) (VP (VBD were) (VP (VBN performed) (PP (IN at) (NP (NP (DT a) (NN PCC)) (VP (VBG =) (NP (NP (CD 0.75) (JJ cut-off)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD generated) (NP (NP (CD 160) (NNS clusters)) (PP (IN with) (NP (CD 2407) (NN ortholog) (NNS pairs)))))))))))))) (. .)))
( (S (S (NP (DT This) (RB relatively) (JJ stringent) (JJ cut-off)) (VP (VBD was) (VP (VBN chosen) (S (VP (TO to) (VP (VB reduce) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (JJ non-relevant) (NNS genes))) (PP (IN in) (NP (DT the) (NNS clusters)))))))))) (. .)))
( (S (S (NP (DT A) (JJR higher) (JJ cut-off)) (VP (VBD did) (RB not) (VP (VB seem) (ADJP (JJ reasonable) (PP (IN given) (NP (NP (DT the) (NN noise-level)) (PP (IN of) (NP (NP (DT the) (NN microarray) (NNS experiments)) (PRN (-LRB- -LRB-) (S (SBAR (IN as) (S (VP (VBN judged) (PP (IN by) (NP (NP (DT the) (NN Pearson) (NN correlation)) (PP (PP (IN between) (NP (VBN replicated) (NNS samples))) (CC and) (PP (IN between) (NP (NP (NNS probes)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN annotated) (PP (IN for) (NP (DT the) (JJ same) (NN gene))))))))))))))) (, ,) (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (S (VP (VBG According) (PP (TO to) (NP (DT the) (NN definition))))) (, ,) (NP (DT a) (NN gene) (NN battery)) (VP (MD should) (VP (VBP encode) (NP (ADJP (RB functionally) (VBN linked)) (NNS proteins))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD used) (NP (NP (NP (NP (NN Gene) (NN Ontology)) (PRN (-LRB- -LRB-) (NP (VB GO)) (-RRB- -RRB-))) (NNS terms)) (, ,) (NP (NP (JJ protein-protein) (NNS interactions)) (PRN (-LRB- -LRB-) (PP (IN from) (NP (DT the) (ADJP (VB BIND)) (NN database) (CD -LSB-24) (-RRB- -RSB-))) (-RRB- -RRB-))) (, ,) (CC and) (NP (JJ manual) (NN curation))) (S (VP (TO to) (VP (VB assess) (NP (JJ functional) (NN linkage)) (PP (IN within) (NP (PRP$ our) (NN expression) (NNS clusters)))))))) (. .)))
( (S (ADVP (RB First)) (, ,) (NP (PRP we)) (VP (VBD investigated) (NP (NP (DT the) (NN relationship)) (PP (IN between) (NP (NP (NP (NP (NN expression) (NN profile)) (NN similarity)) (PP (IN of) (NP (CD two) (NN ortholog) (NNS pairs)))) (CC and) (NP (NP (PRP$ their) (JJ relative) (NN probability) (S (VP (VP (TO to) (VP (VB share) (NP (DT a) (JJ functional) (NN annotation) (NN term)))) (CC or) (VP (TO to) (VP (VB encode) (NP (NN interacting) (NNS proteins))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1B)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (EX There)) (VP (VBD was) (NP (NP (DT a) (JJ consistent) (NN correlation)) (PP (IN between) (NP (NP (NN co-expression)) (CC and) (NP (NP (DT the) (JJ relative) (NN probability)) (PP (IN for) (NP (CD two) (NNS genes))) (S (VP (VP (TO to) (VP (VB share) (NP (DT a) (NN GO-term)))) (CC or) (VP (TO to) (VP (VB encode) (NP (NP (NN interacting) (NNS proteins)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1B)) (-RRB- -RRB-))))))))))))) (. .)))
( (S (ADVP (RB Second)) (, ,) (NP (PRP we)) (VP (VBD studied) (NP (NP (DT the) (JJ statistical) (NN over-representation)) (PP (IN of) (NP (NP (VB GO) (NNS terms)) (CC and) (NP (NP (NN interacting) (NNS proteins)) (VP (VBG inside) (NP (NP (DT the) (NNS clusters)) (PRN (-LRB- -LRB-) (NP (NNS Methods)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (NP (NN 30/32) (NNS clusters)) (PP (IN with) (NP (QP (CD ten) (CC or) (JJR more)) (NN ortholog) (NNS pairs)))) (VP (VBD contained) (NP (QP (IN at) (JJS least) (CD one)) (JJ over-represented) (VB GO) (NP (NN term))))) (. .)))
( (S (S (NP (NP (DT The) (NN proportion)) (PP (IN of) (NP (NP (JJ small) (NNS clusters)) (PP (IN with) (NP (JJ over-represented) (VB GO) (NNS terms)))))) (VP (VBD was) (ADJP (JJR lower)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ reflects) (NP (NP (DT a) (NN lack)) (PP (IN of) (NP (JJ statistical) (NN power))) (PP (IN in) (NP (JJ small) (NNS clusters))))))))) (. .)))
( (S (S (NP (NP (NNS Genes)) (VP (VBG encoding) (NP (NN interacting) (NN protein) (NNS pairs)))) (VP (VBD were) (ADVP (RB also)) (VP (VBN over-represented) (PP (IN inside) (NP (NNS clusters)))))) (. .)))
( (S (S (NP (NP (CD 35) (NNS cases)) (PP (IN of) (NP (NP (JJ protein-protein) (NN interaction)) (PP (IN between) (NP (NP (CD two) (NNS genes)) (PP (IN in) (NP (DT the) (JJ same) (NN cluster)))))))) (VP (VBD were) (VP (VBN found)))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (CD 1000) (NNS simulations)) (PP (IN on) (NP (JJ permuted) (NNS data)))) (VP (VBD revealed) (NP (NP (DT a) (NN median)) (PP (IN of) (NP (NP (CD 9) (NNS interactions)) (PRN (-LRB- -LRB-) (NP (NP (NNS observations)) (VP (VBG ranging) (PP (IN between) (NP (NP (CD 5)) (CC and) (NP (CD 21)))))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (DT The) (VB BIND) (NNS data)) (VP (VBD contained) (NP (NP (QP (RB only) (CD 600)) (NNS interactions)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB be) (VP (VBN mapped) (PP (TO to) (NP (NP (DT the) (NN dataset)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ explains) (NP (NP (DT the) (ADJP (RB seemingly) (JJ low)) (NN number)) (PP (IN of) (NP (CD 35) (NNS interactions))))))))))))))))) (. .)))
( (S (S (ADVP (RB Finally)) (, ,) (NP (DT the) (NNS clusters)) (VP (VBD were) (VP (VBN annotated) (PP (IN by) (NP (JJ manual) (NN curation)))))) (. .)))
( (S (S (NP (CD Six) (NNS examples)) (VP (VBP are) (VP (VBN shown) (PP (IN in) (NP (NP (NNS Figures) (QP (CD 2) (, ,) (CD 3) (, ,) (CD 4))) (, ,) (NP (NP (CD 5)) (, ,) (NP (CD 6)) (, ,) (NP (CD 7)) (, ,) (CC and) (NP (NP (NNS clusters)) (PP (IN with) (NP (VBN predicted) (NNS regulators))))))) (S (VP (VBP are) (VP (VBN listed) (PP (IN in) (NP (NN Table) (CD 2))))))))) (. .)))
( (S (S (PP (IN For) (NP (DT a) (JJ full) (NN overview))) (, ,) (VP (VB see) (NP (DT the) (NN web) (NN supplement)))) (. .)))
( (S (NP (JJ Several) (NNS clusters)) (ADVP (RB clearly)) (VP (VBP represent) (NP (NP (NN gene) (NNS sets)) (SBAR (WHNP (WDT that)) (S (VP (VBP mediate) (NP (NP (VBN specialized) (NNS features)) (PP (IN of) (NP (JJ different) (NN cell) (NNS types))) (, ,) (PP (VBG including) (NP (NP (NP (NN smooth) (NN muscle) (JJ specific) (NNS genes)) (PRN (-LRB- -LRB-) (NP (NP (NN cluster) (CD 40)) (, ,) (NP (NN Figure) (CD 2))) (-RRB- -RRB-))) (, ,) (NP (NP (NN B) (JJ lymphocyte-specific) (NNS genes)) (PRN (-LRB- -LRB-) (NP (NP (NN cluster) (CD 16)) (, ,) (NP (NN Figure) (CD 3))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NP (NNS genes)) (VP (ADVP (RB selectively)) (VBN expressed) (PP (IN in) (NP (DT the) (NN testis))))) (PRN (-LRB- -LRB-) (NP (NP (NN cluster) (CD 5)) (, ,) (NP (NP (NN part)) (VP (VBN shown) (PP (IN in) (NP (NN Figure) (CD 4)))))) (-RRB- -RRB-))))))))))) (. .)))
( (S (ADVP (RB Further)) (, ,) (NP (PRP we)) (VP (VBD detected) (NP (NP (NNS clusters)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (ADJP (JJ related) (PP (TO to) (NP (NP (NP (JJ cellular) (NNS processes)) (CC or) (NP (NNS organelles))) (, ,) (PP (VBG including) (NP (NP (NP (JJ endoplasmatic) (NN reticulum)) (PRN (-LRB- -LRB-) (NP (NN cluster) (CD 13) (, ,) (NN Figure) (CD 5)) (-RRB- -RRB-))) (, ,) (NP (NP (NN protein) (NN synthesis)) (PRN (-LRB- -LRB-) (NP (NN cluster) (CD 1) (, ,) (NN Figure) (CD 6)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NP (NNS modulators)) (PP (IN of) (NP (JJ transcriptional) (NN regulation)))) (PRN (-LRB- -LRB-) (NP (NN cluster) (CD 65) (, ,) (NN Figure) (CD 7)) (-RRB- -RRB-))))))))))))) (. .)))
( (S (S (NP (NP (DT A) (JJ grand) (NN majority)) (PP (IN of) (NP (DT the) (NNS clusters)))) (VP (VBD were) (VP (VBN defined) (PP (IN by) (NP (NP (NNS peaks)) (PP (IN at) (NP (NP (JJ different) (NNS amplitudes)) (PP (IN in) (NP (JJ several) (NNS tissues)))))))))) (. .)))
( (S (S (PP (IN As) (NP (DT an) (NN example))) (, ,) (NP (NP (DT the) (JJ endoplasmatic) (NN reticulum) (NN cluster)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 5)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN defined) (PP (IN by) (NP (NP (DT a) (RB highly) (JJ variant) (NN profile)) (PP (IN with) (NP (NP (JJ strong) (NN expression)) (PP (IN in)))))) (, ,) (PP (IN for) (NP (NN example))) (, ,) (NP (JJ exocrine) (NNS glands))))) (. .)))
( (S (S (ADVP (RB Generally)) (, ,) (NP (DT the) (NN cluster) (NNS profiles)) (VP (VBD were) (VP (VBN conserved) (PP (IN between) (NP (NNS species))) (, ,) (PP (IN in) (NP (DT the) (NN sense) (SBAR (IN that) (S (NP (NNS clusters)) (VP (VBD were) (VP (VBN defined) (PP (IN by) (NP (NP (NNS peaks)) (PP (IN in) (NP (DT the) (JJ same) (NNS organs)))))))))))))) (. .)))
( (S (S (NP (DT This) (NN effect)) (VP (VBD was) (ADJP (RBR more) (JJ pronounced)) (PP (IN for) (NP (NP (NNS clusters)) (PP (IN with) (NP (NP (NN expression)) (PP (IN in) (NP (DT a) (JJ single) (NN organ))))) (, ,) (PP (JJ such) (IN as) (NP (DT the) (NN testis))))) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))) (. .)))
( (S (S (PP (IN In) (NP (NN combination))) (, ,) (NP (NP (DT the) (ADJP (VB GO)) (NN term) (NN enrichment)) (, ,) (NP (DT the) (JJ protein-protein) (NN interaction)) (, ,) (CC and) (NP (DT the) (JJ manual) (NN curation))) (ADVP (RB convincingly)) (VP (VBP show) (SBAR (IN that) (S (NP (JJ clustered) (NNS genes)) (VP (VBP are) (ADVP (RB functionally)) (VP (VBN linked))))))) (. .)))
( (S (S (PP (IN In) (NP (NP (DT the) (JJ next) (NN part)) (PP (IN of) (NP (DT the) (NN analysis))))) (, ,) (NP (JJ individual) (NN ortholog) (NNS pairs)) (VP (VBD were) (VP (VBN scored) (PP (IN for) (NP (NN transcription) (NN factor) (NN binding) (NNS sites)))))) (. .)))
( (S (S (NP (NN Binding) (NNS motifs)) (VP (VBD were) (VP (VBN represented) (PP (IN in) (NP (NP (DT the) (NN form)) (PP (IN of) (NP (NP (NN Position) (NN Frequency) (NNS Matrices)) (PRN (-LRB- -LRB-) (NP (ADVP (RB hereafter)) (VBN denoted) (NNS PFMs)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (PP (VBN Based) (PP (IN on) (NP (NP (DT a) (JJ fixed) (NN amount)) (PP (IN of) (NP (NP (JJ upstream) (NN DNA) (NN sequence)) (PP (IN in) (NP (DT each) (NN ortholog) (NN pair)))))))) (, ,) (NP (DT a) (JJ statistical) (NN score)) (VP (VBD was) (VP (VBN computed) (S (VP (TO to) (VP (VB predict) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (NP (DT a) (NN site)) (PP (IN in) (NP (DT the) (NN sequence) (S (VP (TO to) (VP (VB bind) (NP (NP (DT the) (NN factor)) (VP (VBG corresponding) (PP (TO to) (NP (NP (DT a) (NN PFM)) (-LRB- -LRB-) (VP (VBN described) (PP (IN in) (NP (NN detail))) (PP (IN in) (NP (NNS Methods)))) (-RRB- -RRB-))))))))))))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBN extracted) (NP (ADJP (ADJP (JJ upstream)) (CC +) (ADJP (JJ intronic))) (NN sequence)) (PP (IN from) (NP (DT the) (NN Ensembl) (NN database))) (, ,) (PP (IN in) (NP (NP (NNS amounts)) (PP (IN of) (NP (QP (CD 2) (, ,) (CD 6) (CC or) (CD 15)) (NN kb))) (PP (IN per) (NP (NP (NN gene)) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (NP (NNS Methods)) (PP (IN for) (NP (NP (NNS details)) (PP (IN on) (NP (NNS boundaries)))))))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (DT A) (NN filter)) (VP (VBD was) (VP (VBN applied) (SBAR (WHNP (WDT that)) (S (VP (VBD removed) (NP (NP (NN ortholog) (NNS pairs)) (SBAR (WHPP (IN for) (WHNP (WDT which))) (S (NP (DT the) (NN transcription) (NN start)) (VP (VBD differed) (PP (IN between) (NP (NP (DT the) (CD two) (NNS species)) (PRN (-LRB- -LRB-) (NP (CD >1000) (NN bp) (NN difference)) (, ,) (S (VP (VB see) (NP (NNS Methods)))) (-RRB- -RRB-)))))))))))))) (. .)))
( (S (S (NP (NN Filtering)) (VP (VBD was) (ADJP (JJ successful) (PP (IN for) (NP (NP (CD 12239) (JJ unique) (NN ortholog) (NNS pairs)) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 1)) (-RRB- -RRB-))))))) (. .)))
( (S (S (PP (IN In) (NP (DT a) (JJ subsequent) (NN filter))) (, ,) (NP (NP (NN DNA) (NN sequence)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (RB not) (VP (VBN conserved) (PP (IN between) (NP (NP (NN mouse)) (CC and) (NP (ADJP (JJ human)))))))))) (VP (VBD was) (VP (VBN removed) (, ,) (NP (JJ so-called) (JJ phylogenetic) (NN footprinting))))) (. .)))
( (S (S (NP (JJ Phylogenetic) (NN footprinting)) (VP (VBD was) (VP (VBN applied) (PP (IN at) (NP (JJ different) (NN stringency))) (, ,) (S (VP (TO to) (VP (VB allow) (NP (NP (DT the) (VBG following) (NN optimization)) (PP (IN of) (NP (DT the) (NN protocol)))) (PRN (-LRB- -LRB-) (PP (IN below)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (ADVP (RB Furthermore)) (, ,) (NP (DT all) (NN exon) (NN sequence)) (VP (VBD was) (VP (VBN removed) (PP (IN from) (NP (DT the) (NN analysis) (-LRB- -LRB-) (NNS Methods) (-RRB- -RRB-)))))) (. .)))
( (S (S (ADVP (RB Finally)) (, ,) (NP (DT the) (NNS sequences)) (VP (VBD were) (VP (VBN matched) (PP (IN with) (NP (NP (DT the) (NN expression) (NNS data)) (VP (VBN based) (PP (IN on) (NP (NP (NN annotation)) (, ,) (NP (NP (DT the) (VB overlap)) (VP (VBG being) (NP (NP (CD 9561) (NN ortholog) (NNS pairs)) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 1)) (-RRB- -RRB-))))))))))))) (. .)))
( (S (S (NP (NN 322) (NN vertebrate) (NNS PFMs)) (VP (VBD were) (VP (VBN downloaded) (PP (IN from) (NP (DT the) (NN TRANSFAC) (CC and) (NN JASPAR) (NNS databases))) (NP (CD -LSB-25,26)) (-RRB- -RSB-)))) (. .)))
( (S (SBAR (IN Since) (S (NP (DT the) (NNS databases)) (VP (VBD appeared) (S (VP (TO to) (VP (VB contain) (NP (ADJP (ADJP (JJ redundant)) (CC or) (ADJP (JJ equivalent))) (NNS entries)))))))) (, ,) (NP (ADJP (RB highly) (JJ similar)) (NNS PFMs)) (VP (VBD were) (VP (VP (VBN grouped)) (CC and) (VP (VBN merged) (S (VP (VBG using) (NP (NP (JJ single) (NN linkage) (JJ hierarchical) (NN clustering)) (CC and) (NP (NP (DT a) (NN PFM) (NN distance) (NN measure)) (VP (VBN defined) (PP (IN in) (NP (NP (CD -LSB-27) (-RRB- -RSB-)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD reduced) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NN PFMs)))) (PP (IN from) (NP (CD 322) (TO to) (CD 266))) (PRN (-LRB- -LRB-) (NP (NNS Methods)) (-RRB- -RRB-))))))))))))))) (. .)))
( (S (NP (DT This) (NN step)) (VP (VP (VBD reduced) (NP (DT the) (NN redundancy))) (, ,) (CC but) (VP (VBD did) (RB not) (VP (VB merge) (NP (DT all) (ADJP (RB identically) (VBN annotated)) (NNS PFMs)) (PRN (-LRB- -LRB-) (NP (NP (VB see) (PP (IN for) (NP (NN example)))) (NP (NP (DT the) (NP (NP (JJ redundant) (NN serum) (NN response) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN SRF)) (-RRB- -RRB-))) (NNS PFMs)) (PP (IN in) (NP (NN Table) (CD 2)))) (, ,) (NP (NN cluster) (CD 40))) (-RRB- -RRB-))))) (. .)))
( (S (PP (IN After) (NP (NP (DT the) (NP (NN retrieval)) (CC and) (NP (JJ preprocessing))) (PP (IN of) (NP (CC both) (NP (NNS sequences)) (CC and) (NP (NNS PFMs)))))) (, ,) (NP (DT all) (JJ individual) (NNS sequences)) (VP (VBD were) (VP (VBN tested) (PP (IN for) (NP (NP (NN PFM) (NNS matches)) (VP (VBG using) (NP (NP (NP (DT the) (NN MAST) (NN software)) (CD -LSB-28) (-RRB- -RSB-)) (, ,) (NP (NP (DT a) (NN software)) (PP (IN for) (S (VP (VBG identifying) (NP (NP (ADJP (ADJP (JJ single)) (CC or) (ADJP (JJ multiple))) (NNS motifs)) (PP (IN in) (NP (NNS sequences)))))))))))))) (. .)))
( (S (S (NP (NN MAST)) (VP (VBD was) (VP (VBN set) (S (VP (TO to) (VP (VB compute) (NP (NP (CD one) (NN p-value)) (PP (IN for) (NP (DT each) (NN PFM)))) (PP (IN with) (NP (NP (NN respect)) (PP (TO to) (NP (JJ each) (NN sequence) (-LRB- -LRB-) (NNS Methods) (-RRB- -RRB-))))))))))) (. .)))
( (S (PP (VBN Based) (PP (IN on) (NP (NP (DT the) (NNS p-values)) (VP (VBN obtained) (PP (IN from) (NP (DT the) (NN MAST) (NN software))))))) (, ,) (NP (DT a) (JJ composite) (NN score)) (VP (VBD was) (VP (VBN defined) (PP (IN as) (NP (NP (NP (DT the) (NN product)) (PP (IN of) (NP (NP (DT the) (NN p-value)) (PP (IN in) (NP (DT the) (NN mouse)))))) (CC and) (NP (NP (JJ human) (NNS sequences)) (PP (IN of) (NP (DT an) (NN ortholog) (NN pair)))))) (PRN (-LRB- -LRB-) (NP (NNS Methods)) (-RRB- -RRB-)))) (. .)))
( (S (S (NP (NP (DT A) (JJ composite) (NN score)) (ADJP (JJ close) (PP (TO to) (NP (CD 0))))) (VP (VBZ indicates) (SBAR (IN that) (S (NP (NP (UCP (CC both) (NP (DT the) (NN mouse)) (CC and) (ADJP (JJ human))) (NN promoter) (NN sequence)) (PP (IN in) (NP (DT the) (NN ortholog) (NN pair)))) (VP (VBZ contains) (NP (NP (NN sequence) (NNS elements)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (PP (IN in) (NP (NP (ADJP (RB very) (JJ good)) (NN agreement)) (PP (IN with) (NP (DT a) (JJ certain) (NN PFM)))))))))))))) (. .)))
( (S (S (VP (TO To) (VP (VB address) (NP (NP (DT the) (JJ biological) (NN validity)) (PP (IN of) (NP (NP (DT the) (NN MAST) (NN composite) (NNS scores)) (PP (IN within) (NP (NP (DT the) (NN context)) (PP (IN of) (NP (NP (DT a) (NN set)) (PP (IN of) (NP (VBD co-expressed) (NNS genes))))))))))))) (, ,) (NP (PRP we)) (VP (VBD screened) (NP (NP (CD 48) (NN ortholog) (NNS pairs)) (ADJP (JJ present) (PP (IN in) (NP (NP (NN B-cell) (VBN expressed) (NNS clusters)) (PP (IN for) (NP (JJ individual) (NN EBF) (NNS sites)))))))) (. .)))
( (S (S (PP (IN In) (NP (NN all))) (, ,) (NP (NP (CD 24) (JJ individual) (NN EBF) (NNS sites)) (PP (IN in) (NP (CD 15) (JJ different) (NN ortholog) (NNS pairs)))) (VP (VBD were) (VP (VBN detected) (PRN (-LRB- -LRB-) (NP (NP (JJ supplementary) (NNS data)) (, ,) (NP (JJ additional) (NN file) (CD 1))) (-RRB- -RRB-))))) (. .)))
( (S (S (VP (TO To) (VP (VB test) (NP (NP (NP (DT the) (NN functionality)) (PRN (-LRB- -LRB-) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NN EBF) (NN binding))))) (-RRB- -RRB-))) (PP (IN of) (NP (DT these) (NNS sites))))))) (, ,) (S (NP (PRP we)) (VP (VBD examined) (NP (NP (DT the) (NN potential)) (PP (IN of) (NP (NP (CD 22) (NN basepair) (NN duplex) (NNS oligo-nucleotides)) (VP (VBG spanning) (NP (DT the) (JJ presumed) (NNS sites))))) (S (VP (TO to) (VP (VB compete) (PP (IN for) (NP (NN protein) (NN binding))) (PP (IN in) (NP (NP (JJ Electrophoretic) (NN Mobility) (NN Shift) (NNS Assays)) (PRN (-LRB- -LRB-) (NP (NP (NN EMSA)) (: :) (NP (NN s))) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NN EBF) (NN binding) (NN capacity)) (VP (VBD was) (VP (VBN assayed) (S (VP (VBG using) (NP (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN from) (NP (DT the) (JJ pre-B) (NN cell) (NN line) (CD 40-EI)))) (, ,) (NP (NP (DT a) (JJ labelled) (NN mouse) (NN mb-1) (NN promoter)) (JJ high) (NN affinity) (NN EBF) (NN site) (CD -LSB-29) (-RRB- -RSB-)) (, ,) (CC and) (NP (NP (NN competitor) (NNS oligo-nucleotides)) (VP (VBG covering) (NP (DT the) (JJ new) (JJ potential) (VBG binding) (NNS sites)))))))))) (. .)))
( (S (PP (IN In) (DT the) (NN absence) (IN of) (NP (NN competitor) (NN oligo-nucleotide))) (, ,) (NP (NP (DT a) (JJ prominent) (NN DNA/protein) (NN complex)) (PRN (-LRB- -LRB-) (NP (NN mb-1/EBF)) (-RRB- -RRB-))) (VP (MD could) (VP (VB be) (VP (VBN detected) (SBAR (IN whereas) (S (NP (DT this) (NN complex)) (VP (VBD was) (ADJP (JJ undetectable)) (PP (IN after) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NP (DT a) (CD 300) (NN fold) (JJ molar) (NN excess)) (PP (IN of) (NP (NP (DT the) (JJ unlabeled) (NN binding) (NN site)) (PRN (-LRB- -LRB-) (NP (NN mb-1)) (-RRB- -RRB-)))))))))))))) (. .)))
( (S (S (NP (NP (NP (DT The) (NN identity)) (PP (IN of) (NP (DT the) (NN protein)))) (CC and) (NP (NP (DT the) (NN specificity)) (PP (IN of) (NP (DT the) (NN binding))))) (VP (VBD were) (VP (VBN verified) (PP (PP (IN by) (NP (NP (NN competition)) (PP (IN with) (NP (DT a) (ADJP (NP (NN point)) (VBN mutated)) (NN mb-1/EBF) (NN site))))) (CC and) (PP (IN by) (NP (NP (DT the) (NN inclusion)) (PP (IN of) (NP (DT an) (ADJP (NN EBF) (JJ specific)) (NN antibody)))))) (PP (IN into) (NP (NP (DT the) (NN reaction) (NN mixture)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 8B)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (DT The) (JJ point) (VBN mutated) (NN EBF) (NN binding) (NN site)) (VP (VBD was) (ADJP (JJ unable) (S (VP (TO to) (VP (VB abolish) (NP (NN complex) (NN formation)) (PP (ADVP (RB even)) (IN in) (NP (NP (DT a) (JJ 1000-fold) (JJ molar) (NN excess)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 8B)) (-RRB- -RRB-)))))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (PRP we)) (VP (VBP detect) (NP (NP (NP (JJ specific) (NN protein) (NN DNA) (NNS interactions)) (PP (IN with) (NP (DT this) (JJ experimental) (NN set)))) (NP (NP (RB up.) (CD 18)) (PP (IN out) (IN of) (NP (DT the) (CD 24) (JJ new) (NN binding) (NNS sites))))) (VP (VBD competed) (PP (IN for) (NP (NN complex) (NN formation))) (SBAR (WHADVP (WRB when)) (S (VP (VBN added) (PP (IN in) (NP (NP (NN a) (CD 300-)) (CC or) (NP (JJ 1000-fold) (JJ molar) (NN excess)))))))) (, ,) (CC and) (ADVP (RB thus)) (VP (VBP have) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB bind) (NP (NN EBF)) (ADVP (ADVP (FW in) (FW vitro)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 8A)) (-RRB- -RRB-))))))))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP conclude) (SBAR (SBAR (IN that) (S (NP (NP (DT the) (JJ large) (NN majority)) (PP (IN of) (NP (NN binding) (NNS sites)))) (VP (VBD were) (ADJP (JJ able) (S (VP (TO to) (ADVP (RB functionally)) (VP (VB interact) (PP (IN with) (NP (DT the) (VBN predicted) (NN protein)))))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (NP (DT the) (JJ composite) (NN score)) (PP (IN in) (NP (NN principle)))) (VP (VBD detected) (NP (NN factor) (NN binding)))))))) (. .)))
( (S (S (NP (PRP It)) (VP (MD should) (ADVP (RB however)) (VP (VB be) (VP (VBN emphasized) (SBAR (IN that) (S (S (NP (NP (DT the) (NN quality)) (PP (IN of) (NP (NNS predictions)))) (VP (VBZ is) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN quality)) (PP (IN of) (NP (DT the) (NP (NN binding) (NN site)) (NNS descriptions)))))))) (, ,) (CC and) (S (NP (DT the) (NN result)) (VP (VBZ does) (RB not) (ADVP (RB necessarily)) (VP (VB imply) (SBAR (IN that) (S (NP (JJ other) (VBN predicted) (NNS factors)) (VP (VBP bind))))))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB test) (SBAR (IN whether) (S (NP (DT the) (VBN identified) (NNS clusters)) (VP (VBP represent) (NP (JJ potential) (NN gene) (NNS batteries)))))))) (, ,) (S (ADVP (FW i.e.)) (VP (VBP contain) (NP (JJ shared) (JJ cis-regulatory) (NNS elements))))) (, ,) (NP (PRP we)) (VP (VBN designed) (NP (NP (DT a) (NN procedure)) (S (VP (TO to) (VP (VB detect) (NP (NP (JJ significant) (NN over-representation)) (PP (IN of) (NP (NP (NNS orthologs)) (SBAR (WHNP (WDT that)) (S (VP (VBP match) (NP (DT a) (NN PFM) (NN inside) (NN a) (NN cluster))))))))))))) (. .)))
( (S (S (NP (DT The) (NN procedure)) (VP (VBZ is) (VP (VBN based) (PP (IN on) (NP (NP (DT a) (NN modification)) (PP (IN of) (NP (NP (NN Fisher) (POS 's) (JJ exact) (NN test)) (, ,) (SBAR (WHNP (WDT which)) (S (NP (NP (NNS tests)) (PP (IN for) (NP (NP (NN dependency)) (PP (IN between) (NP (CD two) (NNS events))))) (-LRB- -LRB-) (PP (IN in) (NP (NP (DT this) (NN case) (NP (NP (NN cluster) (NN membership)) (CC vs) (NP (NN detection)))) (PP (IN of) (NP (DT a) (NN motif))))) (-RRB- -RRB-) (CD -LSB-30) (-RRB- -RSB-))))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD introduced) (NP (NP (DT a) (NN procedure)) (S (VP (TO to) (VP (VB optimize) (NP (NP (DT the) (JJ composite) (NN score) (NNS thresholds)) (PP (IN for) (NP (JJ individual) (NNS PFMs)))))))))) (. .)))
( (S (PP (IN In) (NP (JJ brief))) (, ,) (NP (PRP we)) (VP (VBD selected) (NP (NP (DT the) (NN threshold)) (SBAR (WHNP (WDT that)) (S (VP (VBD gave) (NP (DT the) (JJS lowest) (NN Fisher) (NN test) (NN p-value)) (PP (IN in) (NP (DT any) (CD one) (NN cluster)))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBD was) (VP (VBN based) (PP (IN on) (NP (DT the) (NN assumption) (SBAR (IN that) (S (NP (NP (JJ non-random) (NN distribution)) (PP (IN of) (NP (NNS detections))) (PP (IN over) (NP (NNS clusters)))) (VP (VBZ reflects) (NP (JJ biological) (NN function)))))))) (, ,) (SBAR (IN as) (S (VP (VBZ has) (VP (VBN been) (VP (VBN proposed) (PP (IN in) (NP (NN -LSB-31) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN Fisher) (NN test) (NNS p-values)) (PP (IN with) (NP (DT the) (VBN optimized) (NNS thresholds)))) (VP (VBP are) (ADVP (RB hereafter)) (VP (VBN termed) (S (NP (NN p-scores)))))) (. .)))
( (S (S (NP (NP (DT The) (NNS tests)) (PP (IN of) (NP (NP (JJ multiple) (NN detection) (NNS thresholds)) (, ,) (NP (JJ multiple) (NNS clusters)) (CC and) (NP (CD 266) (NNS PFMs))))) (VP (VBD led) (PP (TO to) (NP (DT a) (NN need) (S (VP (TO to) (VP (VB compensate) (PP (IN for) (NP (NN mass) (NN testing)))))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBD was) (VP (VBN done) (PP (IN by) (S (VP (VBG estimating) (NP (NP (NP (JJ false) (NN discovery) (NNS rates)) (PRN (-LRB- -LRB-) (NP (NN FDR)) (-RRB- -RRB-))) (VP (VBN based) (PP (IN on) (NP (NN simulations))) (PP (IN on) (NP (JJ randomized) (NNS data))))))))))) (. .)))
( (S (PP (IN In) (NP (JJ brief))) (, ,) (NP (PRP we)) (VP (VP (VBD compared) (NP (DT the) (NN outcome)) (SBAR (SBAR (WHADVP (WRB when)) (S (VP (VBG using) (NP (JJ permuted))))) (CC and) (SBAR (WHADVP (WRB when)) (S (VP (VBG using) (NP (VBN observed) (NNS data)) (PP (IN at) (NP (JJ different) (NNS p-scores)))))))) (, ,) (CC and) (VP (VBD defined) (NP (DT the) (NN FDR)) (PP (IN as) (NP (NP (DT the) (NN ratio)) (PP (IN between) (NP (NP (DT the) (CD two)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 9A)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (DT This) (NN procedure)) (VP (VBD allowed) (S (NP (PRP us)) (VP (TO to) (VP (VB choose) (NP (NP (DT a) (NN significance) (NN threshold)) (PP (IN with) (NP (NP (DT a) (JJ controlled) (VBN expected) (NN number)) (PP (IN of) (NP (JJ spurious) (NNS detections))))))))))) (. .)))
( (S (S (NP (NNS Simulations)) (VP (VBD were) (VP (VBN repeated) (NP (CD 100) (NNS times))))) (. .)))
( (S (S (SBAR (IN Since) (S (NP (NP (NN optimization)) (PP (IN of) (NP (NN detection) (NNS thresholds)))) (VP (VBD were) (VP (VBN repeated) (PP (IN in) (NP (DT each) (NN simulation) (NN round))))))) (, ,) (NP (NP (DT no) (NNS bias)) (PP (IN in) (NP (NP (NN disfavour)) (PP (IN of) (NP (DT the) (NN control) (NN case)))))) (VP (VBD was) (VP (VBN introduced)))) (. .)))
( (S (S (VP (VBG Using) (NP (DT the) (VBN described) (NN algorithm)))) (, ,) (NP (PRP we)) (VP (VBD analyzed) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NNS times)) (S (NP (DT a) (NN motif)) (VP (VBD was) (VP (VBN over-represented) (SBAR (WHADVP (WRB when)) (S (VP (VBG using) (NP (NP (JJ different) (NNS amounts)) (PP (IN of) (NP (NP (NP (NP (NN DNA) (NN sequence)) (PP (IN per) (NP (NN gene)))) (PRN (-LRB- -LRB-) (NP (QP (CD 2) (, ,) (CD 6) (CC or) (CD 15)) (NN kb)) (-RRB- -RRB-))) (CC and) (NP (JJ different) (NN stringency))))) (PP (IN in) (NP (NP (DT the) (JJ phylogenetic) (NN footprinting)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD >0) (NN %)) (PRN (-LRB- -LRB-) (S (VP (VB keep) (NP (DT all) (NN sequence)))) (-RRB- -RRB-))) (, ,) (NP (CD >60) (NN %)) (, ,) (NP (CD >70) (NN %)) (, ,) (NP (CD >80) (NN %)) (CC or) (NP (ADJP (CD >90) (NN %)) (NN identity))) (-RRB- -RRB-)))))))))))))) (. .)))
( (S (S (NP (DT The) (NN analysis)) (VP (VBD was) (VP (VBN performed) (PP (PP (IN at) (NP (ADJP (CD 10) (NN %)) (JJ false) (NN discovery) (NN rate))) (CC and) (PP (IN with) (NP (NP (DT the) (NN clustering)) (VP (VBN obtained) (PP (IN at) (NP (NP (NN PCC)) (ADJP (JJ =) (NP (CD 0.75) (NN clustering) (JJ cut-off)))))))))))) (. .)))
( (S (S (PP (IN At) (NP (DT all) (NN DNA) (NNS amounts))) (, ,) (NP (JJR higher) (NN stringency) (JJ phylogenetic) (NN footprinting)) (VP (VP (VBD appeared) (S (VP (TO to) (VP (VB be) (ADJP (JJ beneficial)))))) (, ,) (CC and) (PP (IN between) (NP (NP (NN DNA) (NNS amounts)) (, ,) (NP (NP (CD 2) (NN kb)) (CC and) (NP (CD 4) (NN kb))))) (VP (VBD compared) (ADVP (RB favourably)) (PP (IN over) (NP (NP (CD 15) (NN kb)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 9C)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (JJ optimal) (NNS results)) (VP (VBP are) (VP (VBN obtained) (SBAR (WHADVP (WRB when)) (S (VP (VBG using) (NP (NP (DT a) (JJ limited) (NN amount)) (PP (IN of) (NP (NN sequence))) (PP (IN per) (NP (NP (NN gene)) (PRN (-LRB- -LRB-) (VP (VB see) (NP (NN Discussion))) (-RRB- -RRB-)))))))))))))) (. .)))
( (S (S (NP (NP (DT A) (JJ potential) (JJ confounding) (NN factor)) (PP (IN in) (NP (DT the) (NN analysis)))) (VP (VBZ is) (SBAR (IN that) (S (NP (NP (NN similarity)) (PP (IN in) (NP (JJ upstream) (NN sequence)))) (VP (MD may) (VP (VB be) (ADJP (JJ attributable) (PP (TO to) (NP (NP (NNS factors)) (CONJP (JJ other) (IN than)) (NP (JJ shared) (JJ cis-regulatory) (NNS elements))))))))))) (. .)))
( (S (S (NP (DT The) (ADJP (RBS most) (JJ important)) (JJ such) (NN factor)) (VP (VBZ is) (ADJP (JJ likely) (S (VP (TO to) (VP (VB be) (ADJP (NN gene) (JJ paralogy)))))) (, ,) (SBAR (IN since) (S (NP (JJ over-represented) (NNS motifs)) (VP (MD might) (ADVP (RB simply)) (VP (VB represent) (NP (NP (NNS matches)) (PP (TO to) (NP (NP (ADJP (ADJP (JJ non-functional)) (PRN (-LRB- -LRB-) (ADJP (ADVP (RB not) (RB yet)) (JJ diverged)) (-RRB- -RRB-))) (NN sequence)) (PP (IN in) (NP (DT a) (VBD co-expressed) (NN gene) (NN family)))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN total))) (, ,) (NP (NP (CD 22343) (NNS cases)) (PP (IN of) (NP (JJ pairwise) (JJ paralogy)))) (VP (VBD were) (VP (VBN detected) (PP (IN in) (NP (NP (DT the) (NN dataset)) (PP (IN of) (NP (NP (CD 9561) (NN ortholog) (NNS pairs)) (VP (VBG using) (NP (NN BLAST)))))))))) (. .)))
( (S (S (NP (NP (DT All) (NNS genes)) (PP (IN with) (NP (NP (NNS transcripts) (NNS matches)) (PP (IN at) (NP (NP (DT a) (NN BLAST) (NN E-value)) (ADJP (JJR less) (PP (IN than) (NP (CD 1.0))))))))) (VP (VBD were) (VP (VBN defined) (PP (IN as) (NP (JJ potential) (NNS paralogs)))))) (. .)))
( (S (S (PP (IN Of) (NP (NP (DT the) (CD 2407) (NN ortholog) (NNS pairs)) (SBAR (WHNP (WDT that)) (VP (VBN clustered))))) (, ,) (NP (NN 219) (NNS genes)) (VP (VBD had) (NP (NP (DT a) (NN paralog)) (PP (IN inside) (NP (DT the) (JJ same) (NN cluster)))))) (. .)))
( (S (S (NP (DT This)) (VP (VBD was) (ADVP (RB clearly)) (NP (DT an) (NN over-representation) (SBAR (IN since) (S (NP (NP (JJ filling) (NNS clusters)) (PP (IN with) (NP (NP (JJ random) (NNS genes)) (PP (IN from) (NP (DT the) (NN dataset)))))) (VP (VBD produced) (NP (NP (DT an) (NN average)) (PP (IN of) (NP (NP (CD 122) (NNS genes)) (PP (IN with) (NP (NP (DT a) (NN paralog)) (VP (VBG inside) (NP (NP (DT a) (NN cluster)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNS values)) (PP (IN between) (NP (CD 104) (TO to) (CD 131)))) (VP (VBN observed) (PP (IN in) (NP (CD 10) (NN randomization) (NNS rounds))))) (-RRB- -RRB-))))))))))))))) (. .)))
( (S (PP (IN In) (NP (DT a) (JJ side-by-side) (NN comparison))) (, ,) (NP (PRP we)) (ADVP (RB therefore)) (VP (VBD analyzed) (NP (NP (DT the) (NN effect)) (PP (IN of) (S (VP (VBG removing) (NP (NNS paralogs)) (PP (IN from) (NP (NP (DT a) (NN cluster)) (PP (IN before) (NP (NP (NN testing)) (PP (IN for) (NP (NP (JJ over-represented) (NNS motifs)) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (NNS Methods)))) (-RRB- -RRB-)))))))))))) (, ,) (SBAR (IN as) (S (VP (VBN opposed) (PP (TO to) (NP (NP (ADJP (RB not) (VBG removing)) (NNS paralogs)) (CC but) (NP (NP (DT the) (JJ same) (NN number)) (PP (IN of) (NP (ADJP (RB randomly) (VBN selected)) (NNS genes)))))))))) (. .)))
( (S (S (NP (DT The) (NNS results)) (VP (VBD showed) (NP (NP (DT no) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (JJ over-represented) (NNS motifs)))))) (SBAR (WHADVP (WRB when)) (S (VP (VBG allowing) (NP (NNS paralogs)) (PP (IN in) (NP (NP (DT the) (JJ same) (NN cluster)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 9B)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (DT The) (JJ final) (NN analysis)) (VP (VBD was) (VP (VBN performed) (PP (IN with) (NP (NP (CD 2) (NN kb) (NN sequence)) (CC and) (NP (NP (ADJP (CD 80) (NN %)) (JJ phylogenetic) (NN footprinting)) (PRN (-LRB- -LRB-) (S (NP (NP (NNS results)) (VP (VBN generated) (PP (IN with) (NP (NP (NNS variations)) (PP (IN of) (NP (DT these) (NNS parameters))))))) (VP (VBP are) (VP (VBN found) (PP (IN in) (NP (DT the) (NN web) (NN supplement)))))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (ADVP (RB Again)) (, ,) (NP (NP (DT the) (NN clustering)) (VP (VBN generated) (PP (IN at) (NP (NP (NN PCC)) (VP (VBG =) (NP (CD 0.75))))))) (VP (VBD was) (VP (VBN chosen) (PP (IN for) (NP (NN analysis)))))) (. .)))
( (S (S (NP (DT The) (NN over-representation) (NN algorithm)) (VP (VBD was) (NP (NN run)) (PP (IN in) (NP (DT the) (JJ above) (NNS cases))) (, ,) (S (VP (VBG using) (NP (CD 100) (NNS simulations)) (S (VP (TO to) (VP (VBP estimate) (NP (NP (JJ false) (NN discovery) (NN rate)) (NNS thresholds))))))))) (. .)))
( (S (S (NP (NP (NP (JJ Over-represented) (NNS motifs)) (PP (IN with) (NP (NN FDR)))) (: :) (NP (NP (NP (NN s)) (ADJP (QP (JJR less) (IN than) (CD 2.5)) (NN %))) (CC and) (NP (CD 10) (NN %)))) (VP (VBD were) (VP (VBN recorded)))) (. .)))
( (S (S (S (NP (NP (JJ Key) (NNS features)) (PP (IN of) (NP (DT these) (NNS results)))) (VP (VBP are) (VP (VBN presented) (PP (IN in) (NP (NNS Tables) (CD 2) (CC and) (CD 3)))))) (, ,) (CC and) (S (NP (DT the) (JJ complete) (NNS results)) (VP (VBP are) (ADJP (JJ available) (PP (IN by) (NP (NN web) (NN browser))))))) (. .)))
( (S (S (NP (NP (DT A) (JJ predictive) (NN screen)) (VP (VBN performed) (PP (IN with) (NP (DT these) (NNS settings))))) (VP (VBD associated) (NP (CD 66) (NNS motifs)) (PP (TO to) (NP (NP (NN co-expression)) (PP (IN in) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (NP (CD 21) (NNS clusters)) (PP (IN at) (NP (NN FDR) (NNS thresholds) (NP (NP (CD 2.5) (NN %)) (CC and) (NP (NP (CD 10) (NN %)) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 2)) (-RRB- -RRB-)))))))))))))) (. .)))
( (S (S (NP (EX There)) (VP (VBD was) (NP (NP (DT a) (JJ clear) (NN tendency)) (PP (IN for) (NP (NNS motifs))) (S (VP (VP (TO to) (VP (VB be) (VP (VBN detected) (PP (IN in) (NP (JJS most) (JJ large) (NNS clusters)))))) (, ,) (CC and) (PP (IN for) (NP (JJR smaller) (NNS clusters))) (VP (TO to) (VP (VB lack) (NP (JJ over-represented) (NNS motifs))))))))) (. .)))
( (S (S (NP (DT This)) (VP (MD can) (VP (VB be) (ADVP (RB directly)) (VP (VBN explained) (PP (IN by) (NP (DT the) (NN fact) (SBAR (SBAR (IN that) (S (NP (NP (RB even) (DT a) (JJ high) (NN degree)) (PP (IN of) (NP (NP (NN motif) (NN presence)) (PP (IN in) (NP (DT a) (JJ small) (NN cluster)))))) (VP (MD can) (VP (VB be) (VP (VBN attributed) (PP (TO to) (NP (JJ spurious) (NNS detections)))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (DT the) (NN Fisher) (NN test)) (VP (VBZ accounts) (PP (IN for) (NP (DT that))))))))))))) (. .)))
( (S (S (S (NP (DT The) (JJ over-represented) (NNS motifs)) (VP (VBD were) (VP (VBN validated) (PP (IN against) (NP (DT the) (NN literature)))))) (, ,) (CC and) (S (VP (VBP fell) (PP (IN into) (NP (CD three) (JJ main) (NNS categories)))))) (: :) (NP (NP (LST (LS 1) (-RRB- -RRB-)) (NP (ADJP (RB previously) (VBN described)) (NNS cases)) (PP (IN of) (NP (JJ gene-battery-like) (NN regulation)))) (, ,) (NP (LST (LS 2) (-RRB- -RRB-)) (NP (ADJP (RB previously) (VBN unreported)) (NNS cases)) (PP (IN of) (NP (NP (NN gene) (JJ battery-like) (NN regulation)) (PP (IN with) (NP (NP (DT some) (NN support)) (PP (IN in) (NP (NP (DT a) (JJ limited) (NN number)) (PP (IN of) (NP (NNS genes)))))))))) (, ,) (CC and) (NP (LST (LS 3) (-RRB- -RRB-)) (NP (JJ hypothetical) (NNS cases)) (PP (IN of) (NP (NP (NN gene) (NN battery) (NN regulation)) (PRN (-LRB- -LRB-) (NP (NP (NN Table) (CD 3)) (, ,) (NP (NN Discussion))) (-RRB- -RRB-)))))) (. .)))
( (S (S (PP (IN In) (NP (DT the) (JJ typical) (NN case))) (, ,) (NP (DT an) (JJ over-represented) (NN motif)) (VP (VBD did) (RB not) (VP (VBP cover) (NP (NP (DT all) (NN cluster) (NNS members)) (CONJP (CC but) (RB rather)) (NP (NN a) (NN fraction)))))) (. .)))
( (S (S (NP (DT The) (JJ average) (NN coverage)) (VP (VBD was) (NP (CD 15) (NN %)) (, ,) (PP (IN with) (NP (NP (NNS observations)) (VP (VBG ranging) (PP (IN from) (NP (QP (CD 1) (NN %) (TO to) (CD 100)) (NN %)))))))) (. .)))
( (S (S (NP (DT The) (JJ limited) (NN coverage)) (VP (MD can) (VP (VB be) (VP (VBN exemplified) (PP (IN by) (NP (NP (DT the) (ADJP (ADJP (RB relatively) (JJ large)) (PRN (-LRB- -LRB-) (NP (CD 104) (NN ortholog) (NNS pairs)) (-RRB- -RRB-))) (NN cluster)) (PP (IN of) (NP (NP (JJ liver-selective) (NNS genes)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD contained) (NP (CD 8) (JJ over-represented) (NNS motifs)) (PP (IN at) (NP (NP (CD FDR<10) (NN %)) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (DT the) (NN PFM) (NN annotation)) (VP (VBD implied) (NP (NP (NN HNF1)) (, ,) (NP (NN HNF4)) (, ,) (NP (NN ARP1)) (, ,) (NP (NN PPAR-γ)) (, ,) (CC and) (NP (NN COUP-TF))) (PP (IN as) (NP (NP (DT the) (VBG binding) (NNS factors)) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 2)) (-RRB- -RRB-)))))))))))))))))))) (. .)))
( (S (S (NP (DT These) (JJ different) (NNS motifs)) (VP (VBD were) (VP (VBN detected) (PP (IN in) (NP (QP (IN between) (CD 8) (CC and) (CD 19)) (NN ortholog) (NNS pairs))) (, ,) (S (VP (VBG indicating) (NP (NP (DT a) (NN cluster) (NN coverage)) (PP (IN of) (NP (QP (JJR less) (IN than) (CD 20)) (NN %))))))))) (. .)))
( (S (S (NP (NP (DT An) (NN example)) (PP (IN of) (NP (ADJP (RB very) (JJ high)) (NN coverage)))) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NP (DT the) (NN cluster)) (SBAR (WHNP (WDT that)) (S (VP (VBD contained) (NP (NP (NN smooth) (NN muscle) (NN differentiation) (NNS markers)) (, ,) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (NP (CD 6/7)) (PRN (-LRB- -LRB-) (NP (CD 86) (NN %)) (-RRB- -RRB-))) (NN ortholog) (NNS pairs)) (VP (VBD were) (ADJP (JJ positive) (PP (IN for) (NP (DT a) (NP (NP (NN Serum) (NN Response) (NN Factor)) (PRN (-LRB- -LRB-) (NP (NN SRF)) (-RRB- -RRB-))) (NN motif)))))))))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD compared) (NP (NP (PRP$ our) (NNS results)) (PP (IN for) (NP (NN HNF-1)))) (PP (TO to) (NP (NP (DT a) (JJ whole-genome) (JJ experimental) (NN screen)) (PP (IN for) (NP (NP (NNS targets)) (PP (IN of) (NP (NP (DT this) (NN factor)) (PP (IN in) (NP (NNS hepatocytes) (CD -LSB-32) (-RRB- -RSB-))))))))))) (. .)))
( (S (S (NP (NP (NP (CD 28) (NN %)) (PRN (-LRB- -LRB-) (NP (NN 29/104)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (DT the) (NN ortholog) (NNS pairs)) (VP (VBG inside) (NP (DT the) (NN liver) (NN cluster)))))) (VP (VBD contained) (NP (NP (ADJP (RB experimentally) (VBN verified)) (NN HNF-1) (NNS sites)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ indicates) (NP (DT a) (ADJP (ADJP (JJ high)) (CONJP (CC but) (RB not)) (ADJP (JJ complete))) (NN coverage)))))))) (. .)))
( (S (S (NP (NP (NN Cross-comparison)) (PP (IN of) (NP (ADJP (RB experimentally) (CC and) (RB computationally) (VBN identified)) (NN HNF-1) (NNS targets)))) (VP (VBD showed) (NP (NP (DT a) (CD 69) (NN %) (NN –) (CD 71) (NN %)) (NP (NP (NN agreement)) (PRN (-LRB- -LRB-) (NP (NP (NNS results)) (PP (IN for) (NP (NP (DT the) (CD two) (JJ different) (NN HNF-1) (NNS PFMs)) (PP (IN at) (NP (CD 2) (NN kb/gene))) (VP (VBN masked) (PP (IN for) (NP (ADJP (CD 90) (NN %)) (JJ phylogenetic) (NN conservation))))))) (-RRB- -RRB-)))))) (. .)))
( (S (S (PP (IN As) (NP (NP (DT a) (NN complement)) (PP (TO to) (S (VP (VBG using) (NP (NN database) (NNS motifs))))))) (, ,) (NP (PRP we)) (VP (VBN applied) (NP (ADJP (FW de) (FW novo)) (NN motif) (NN elicitation)) (S (VP (TO to) (VP (VB screen) (NP (NP (DT the) (JJ regulatory) (NN sequence)) (PP (IN of) (NP (DT each) (NN cluster)))) (PP (IN for) (NP (NP (JJ over-represented) (NN DNA) (NNS motifs)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (RB not) (ADJP (JJ present) (PP (IN in) (NP (NNS databases)))))))))))))) (. .)))
( (S (S (NP (NP (DT A) (JJ two-step) (NN procedure)) (VP (VBN based) (PP (IN on) (NP (DT the) (NN MEME) (NN algorithm) (CD -LSB-33) (-RRB- -RSB-))))) (VP (VBD was) (VP (VBN developed) (PRN (-LRB- -LRB-) (NP (NNS Methods)) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (DT a) (NN cluster))) (S (VP (TO to) (VP (VB define) (NP (DT a) (NN PFM)))))) (VP (MD will) (VP (VB lead) (PP (TO to) (NP (NP (DT a) (NN bias)) (SBAR (WHADVP (WRB when)) (S (VP (VBG testing) (PP (IN for) (NP (NN over-representation))))))))))) (. .)))
( (S (S (NP (NP (DT A) (NN simulation)) (SBAR (WHNP (WDT that)) (S (VP (VBD involved) (NP (NP (NN motif) (NN elicitation)) (PP (IN from) (NP (JJ randomized) (NNS clusters)))))))) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB account) (PP (IN for) (NP (DT this) (NN bias)))))) (PRN (-LRB- -LRB-) (NP (NNS Methods)) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (CD 28) (ADJP (FW de) (FW novo)) (NNS motifs)) (VP (VBD were) (VP (VBN identified) (SBAR (IN as) (S (VP (VBN over-represented) (PP (IN in) (NP (NP (NN relation)) (PP (TO to) (NP (DT the) (NN null) (NN simulation))))) (PRN (-LRB- -LRB-) (NP (NP (JJ Supplementary) (NNS data)) (, ,) (NP (JJ additional) (NN file) (CD 1))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (PP (IN Of) (NP (DT these) (CD 28) (NNS motifs))) (, ,) (NP (CD 13)) (VP (VBD matched) (NP (NP (DT a) (VBN described) (NN database) (NN motif)) (PRN (-LRB- -LRB-) (VP (VBN based) (PP (IN on) (NP (NP (DT the) (NN PFM) (NN similarity) (NN score)) (VP (VBN described) (PP (PP (IN in) (NP (NNS Methods))) (CC and) (PP (IN in) (NP (NP (NN footnote)) (PP (IN of) (NP (JJ supplementary) (NN table)))))))))) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (NP (NN 9/13)) (PP (IN of) (NP (DT the) (VBG matching) (NNS motifs)))) (VP (VBD corresponded) (PP (TO to) (NP (NP (NNS motifs)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (VP (VBN over-represented) (PP (IN in) (NP (NN Table) (CD 3))))))))))) (. .)))
( (S (S (NP (DT The) (VBG remaining) (CD 15) (NNS motifs)) (VP (MD may) (VP (VB represent) (NP (JJ novel) (JJ regulatory) (NNS elements))))) (. .)))
( (S (S (NP (NP (DT These) (NNS motifs)) (, ,) (CC and) (NP (NP (DT a) (NN description)) (PP (IN of) (NP (DT the) (NN procedure)))) (, ,)) (VP (VBP are) (ADJP (JJ available) (PP (IN in) (NP (DT the) (JJ supplementary) (NN information)))))) (. .)))
( (S (NP (NN Discussion))))
( (S (S (NP (DT The) (NN gene) (NN battery) (NN theory)) (VP (VBZ predicts) (SBAR (IN that) (S (NP (NP (DT the) (NN core) (NNS features)) (PP (IN of) (NP (VBN differentiated) (NNS cells)))) (VP (VBP are) (VP (VBN encoded) (PP (IN by) (NP (NP (NN gene) (NNS batteries)) (, ,) (PP (FW i.e.) (NP (NP (NNS groups)) (PP (IN of) (NP (NP (ADJP (ADJP (RB functionally) (VBN coupled)) (, ,) (ADJP (VBD co-expressed))) (NNS genes)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN regulated) (PP (IN by) (NP (NP (JJ similar) (NNS sets)) (PP (IN of) (NP (JJ cis-regulatory) (NNS elements))))))))))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ primary) (NN aim)) (PP (IN of) (NP (DT this) (NN article)))) (VP (VBD was) (S (VP (TO to) (VP (NN survey) (NP (UCP (NP (DT the) (NN mouse)) (CC and) (ADJP (JJ human))) (NNS genomes)) (PP (IN for) (NP (NP (NNS cases)) (SBAR (WHNP (WDT that)) (S (VP (VBP fall) (UCP (PP (IN within)) (CC or) (ADJP (JJ close) (PP (TO to) (NP (DT the) (JJ idealized) (NN gene) (NN battery) (NN concept))))))))))))))) (. .)))
( (S (S (NP (NP (JJ Hierarchical) (NN clustering)) (PP (IN of) (NP (NP (DT an) (JJ extensive) (NN compendium)) (PP (IN of) (NP (NN micro-array) (NN expression) (NNS data))))) (PP (IN in) (NP (NP (NN mouse)) (CC and) (NP (ADJP (JJ human)))))) (VP (VBD identified) (NP (NP (JJ large) (NNS numbers)) (PP (IN of) (NP (VBD co-expressed) (NN gene) (NNS groups)))))) (. .)))
( (S (S (NP (NP (DT A) (JJ grand) (NN majority)) (PP (IN of) (NP (DT the) (JJR larger) (NNS clusters)))) (VP (VBD were) (ADVP (RB significantly)) (VP (VBN enriched) (PP (IN for) (NP (NP (NNS genes)) (SBAR (WHNP (WDT that)) (S (VP (VBD shared) (NP (NP (CD one)) (CC or) (NP (JJ several) (NNS GO-terms))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (VBD co-expressed) (NNS genes)) (VP (VBP are) (ADVP (RB functionally)) (VP (VBN coupled))))))))))))))) (. .)))
( (S (S (ADVP (RB Moreover)) (, ,) (NP (NNS interactions)) (VP (VBD were) (ADVP (RB significantly)) (ADJP (RBR more) (JJ common)) (PP (IN between) (NP (NP (NNS proteins)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN encoded) (PP (IN by) (NP (NP (JJ clustered) (NNS pairs)) (VP (VBD compared) (PP (TO to) (NP (ADJP (RB randomly) (VBN chosen)) (NNS pairs)))))))))))))) (. .)))
( (S (NP (CD 21) (NNS clusters)) (, ,) (ADVP (RB finally)) (, ,) (VP (VBD were) (ADVP (RB significantly)) (VP (VBN enriched) (PP (IN for) (NP (NP (NNS genes)) (SBAR (WHNP (WDT that)) (S (VP (VBD shared) (NP (JJ potential) (JJ cis-regulatory) (NNS elements)))))))))))
( (S (S (NP (NP (DT The)) (VP (VBN predicted) (PP (IN over) (NP (NP (VBN represented) (NNS motifs)) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 2)) (-RRB- -RRB-)))))) (VP (VBP fell) (PP (IN into) (NP (NP (CD three) (JJ principal) (NNS categories)) (: :) (S (LST (-LRB- -LRB-) (LS i) (-RRB- -RRB-)) (S (NP (NNS predictions)) (PP (IN in) (NP (NP (NN agreement)) (PP (IN with) (NP (VBN described) (NN gene) (NNS batteries))))) (, ,) (LST (-LRB- -LRB-) (LS ii) (-RRB- -RRB-)) (NP (NNS predictions)) (VP (VBN supported) (PP (IN by) (NP (NP (DT a) (JJ limited) (NN number)) (PP (IN of) (NP (NP (NP (NNS observations)) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (DT the) (NN analysis)) (VP (VBD predicted) (NP (NN gene) (JJ battery-like) (NN regulation))))) (, ,)) (CC and) (NP (LST (-LRB- -LRB-) (LS iii) (-RRB- -RRB-)) (NP (JJ novel) (NNS predictions)) (PP (IN of) (NP (JJ hypothetical) (NN gene) (NNS batteries))))))))))))))) (. .)))
( (S (S (NP (DT The) (NNS findings)) (VP (VBP are) (VP (VBN summarized) (PP (IN with) (NP (NP (NN respect)) (PP (TO to) (NP (NP (DT these) (NNS categories)) (PP (IN in) (NP (NN Table) (CD 3)))))))))) (. .)))
( (S (S (PP (IN For) (NP (NN type) (-LRB- -LRB-) (NN i) (-RRB- -RRB-) (NNS predictions))) (NP (DT the) (NN method)) (VP (VBZ is) (ADJP (JJ useful) (PP (IN for) (S (VP (VBG proposing) (NP (JJ new) (NN target) (NNS genes)))))))) (. .)))
( (S (PP (IN As) (NP (DT an) (NN example))) (, ,) (NP (DT the) (NN smooth) (NN muscle) (NN cluster)) (VP (VBZ contains) (NP (CD 4) (JJ validated) (NP (NP (NN serum) (NN response) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN SRF)) (-RRB- -RRB-))) (NNS targets))) (PRN (-LRB- -LRB-) (NP (NP (NNP Acta2) (, ,) (NNP Actg2) (, ,) (NNP Myl11)) (, ,) (NP (NNP Tagln) (-RRB- -RRB-) (CD -LSB-5))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (DT The) (NN method)) (VP (VBZ identifies) (NP (NP (NP (CD two) (JJR more) (NNS genes)) (PP (IN in) (NP (DT this) (NN cluster)))) (, ,) (NP (NP (NNP Myl9)) (CC and) (NP (NNP Lpp)))) (PP (IN as) (NP (NP (JJ potential) (NN SRF) (NNS targets)) (PP (IN in) (NP (NP (JJ smooth) (NN muscle)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 2)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (DT The) (NNS findings)) (PP (IN in) (NP (NP (CD two) (NNS clusters)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (JJ relevant) (PP (IN for) (NP (NP (NP (NNS lymphocytes)) (PRN (-LRB- -LRB-) (NP (NN cluster) (CD 4)) (PP (IN in) (NP (DT the) (NN web) (NN supplement))) (-RRB- -RRB-))) (CC and) (NP (NP (NNS B-lymphocytes)) (PRN (-LRB- -LRB-) (NP (NN cluster) (CD 16) (, ,) (NN Figure) (CD 3)) (-RRB- -RRB-)))))))))))) (VP (VBP are) (NP (NP (JJ further) (NNS examples)) (PP (IN of) (NP (NN type) (-LRB- -LRB-) (NN i) (-RRB- -RRB-) (NNS predictions)))))) (. .)))
( (S (S (NP (NN Cluster) (CD 4)) (VP (VBZ contains) (NP (NP (NNS genes)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN expressed) (PP (IN by) (NP (JJ various) (NN lymphocyte) (NNS populations)))))))))) (. .)))
( (S (S (NP (ADJP (RB Significantly) (VBN enriched)) (NNS motifs)) (VP (VBD were) (NP (NP (NN Irf1/Irf2)) (, ,) (NP (NN NF-kappaB)) (, ,) (CC and) (NP (NN ISRE))))) (. .)))
( (S (S (NP (NP (NN Irf1)) (CC and) (NP (NN Ir2))) (VP (VBP appear) (S (VP (TO to) (VP (VB bind) (NP (DT the) (JJ same) (NNS sites)))) (LST (CD -LSB-34) (-RRB- -RSB-))))) (. .)))
( (S (S (NP (NN Irf1) (JJ knockout) (NNS mice)) (VP (VBP are) (VP (VBN impaired) (PP (IN in) (NP (PRP$ their) (NN myelopoiesis) (CD -LSB-35) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (NN NFkappaB)) (VP (VBZ is) (NP (NP (DT a) (JJ well-known) (NN regulator)) (PP (IN of) (NP (NP (NN inflammation)) (CC and) (NP (JJ immune) (NNS functions)) (NP (NN -LSB-36)) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (NN Cluster) (CD 16)) (VP (VBZ contains) (NP (NP (NNS genes)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB specifically)) (VP (VBN expressed) (PP (IN in) (NP (NNS B-lymphocytes)))))))))) (. .)))
( (S (S (NP (NN SpiB)) (VP (VBD was) (VP (VBN identified) (PP (IN as) (NP (NP (DT the) (ADJP (RBS most) (JJ over-represented)) (NN PFM)) (VP (VBN followed) (PP (IN by) (NP (NP (NN AREB6)) (CC and) (NP (NN Oct-1)))))))))) (. .)))
( (S (S (NP (NP (JJ Knockout)) (PP (IN of) (NP (NN SpiB)))) (VP (VBD caused) (NP (NP (JJ specific) (NNS defects)) (PP (IN in) (NP (NN B-cell) (ADJP (RB terminally) (VBN differentiated)) (NNS functions)))) (PRN (QP (CD -LSB-37)) (-RRB- -RSB-)))) (. .)))
( (S (S (NP (NN AREB6)) (VP (VBZ is) (NP (DT a) (JJ hematopoietic) (JJ transcriptional) (NN repressor) (CD -LSB-38) (-RRB- -RSB-)))) (. .)))
( (S (SBAR (IN Whereas) (S (NP (NN Oct-1)) (VP (VBZ seems) (S (VP (TO to) (VP (VB be) (ADJP (JJ dispensable) (PP (IN for) (NP (NN B-cell) (NN development) (CD -LSB-39) (-RRB- -RSB-)))))))))) (, ,) (NP (PRP it)) (VP (VBZ regulates) (NP (NN B) (NN lymphocyte) (NNS genes)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (JJ specific) (NNS co-activators) (NP (CD -LSB-40))))))) (-RRB- -RSB-) (. .)))
( (S (S (PP (IN In) (NP (NN type) (-LRB- -LRB-) (NN ii) (-RRB- -RRB-) (NNS cases))) (, ,) (NP (NP (DT a) (NN regulator)) (PP (IN with) (NP (NP (DT some) (NN degree)) (PP (IN of) (NP (NN documentation)))))) (VP (VBZ is) (ADVP (RB statistically)) (VP (VBN supported) (S (VP (TO to) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (NP (NN gene) (JJ battery-like) (NN regulation))))))))) (. .)))
( (S (PP (IN As) (NP (DT an) (NN example))) (, ,) (S (S (NP (NN RFX) (NN family) (NNS proteins)) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB regulate) (NP (NP (DT a) (JJ limited) (NN number)) (PP (IN of) (NP (NP (NNS genes)) (PP (IN in) (NP (NN spermatogenesis))))))))))))) (, ,) (CC and) (S (NP (NN SOX17)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (VP (VBN expressed) (PP (IN in) (NP (DT the) (NN testis) (NN -LSB-41-43))) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (NNS motifs)) (VP (VBG corresponding) (PP (TO to) (NP (DT these) (NNS factors))))) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (NP (CD 8–11) (NN %)) (PP (IN of) (NP (NP (JJ testis-selective) (NNS genes)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 4)) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (NP (NP (CD 29) (NN %)) (PP (IN of) (NP (JJ kidney-specific) (NNS genes)))) (VP (VBD were) (VP (VBN covered) (PP (IN by) (NP (NP (NP (NN HNF-1)) (CC and) (NP (NN HNF-4))) (NNS sites)))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (DT these) (NNS genes)) (VP (MD may) (VP (VB be) (NP (NP (JJ general) (NNS regulators)) (PP (IN in) (NP (DT the) (NN kidney)))))))))))) (. .)))
( (S (S (ADVP (RB Finally)) (, ,) (NP (NN type) (-LRB- -LRB-) (CD iii) (-RRB- -RRB-) (NNS cases)) (VP (VBP represent) (NP (NP (JJ novel) (NNS predictions)) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB be) (VP (VBN viewed) (PP (IN as) (NP (NP (JJ testable) (NNS hypotheses)) (PP (IN of) (NP (JJ regulatory) (NNS mechanisms))))))))))))) (. .)))
( (S (S (NP (NP (DT A) (JJ complete) (NN list)) (PP (IN of) (NP (NP (NNS PFMs)) (PP (IN in) (NP (NP (DT the) (JJ different) (NNS categories)) (PP (IN with) (NP (NP (NNS references)) (PP (TO to) (NP (DT the) (NN literature)))))))))) (VP (VBZ is) (VP (VBN presented) (PP (IN in) (NP (NP (NN Table)) (S (LST (LS 3.)) (NP (NNS Examples)) (VP (VBP include) (NP (NP (NP (DT a) (JJ potential) (JJ functional) (NN role)) (PP (IN for) (NP (DT an) (JJ Ikaros-like) (NN motif))) (PP (IN in) (NP (NP (JJ retina-selective) (NNS genes)) (PRN (-LRB- -LRB-) (NP (NP (NN cluster) (CD 44)) (PP (IN in) (NP (DT the) (NN web) (NN supplementary)))) (-RRB- -RRB-))))) (, ,) (CC and) (NP (NP (DT a) (NN Pax) (NN family) (NN factor)) (VP (VBG acting) (PP (IN on) (NP (NP (JJ extracellular) (NN matrix) (NNS genes)) (PP (IN with) (NP (NP (JJ strong) (NN expression)) (PP (IN in) (NP (NP (NNS arteries)) (PRN (-LRB- -LRB-) (NP (NP (NN cluster) (CD 8)) (PP (IN in) (NP (DT the) (NN web) (NN supplementary)))) (-RRB- -RRB-)))))))))))))))))) (. .)))
( (S (S (ADVP (RB Interestingly)) (, ,) (NP (NP (DT a) (NN combination)) (PP (IN of) (NP (NP (NN Ets) (NN family) (NN factor) (NNS motifs)) (, ,) (NP (JJ Nuclear) (JJ respiratory) (NN factor) (NNS motifs)) (, ,) (CC and) (NP (NN E2F) (NNS motifs))))) (VP (VBD was) (VP (VBN detected) (PP (IN in) (NP (NP (JJ several) (NNS clusters)) (PP (IN of) (NP (NP (DT a) (JJ housekeeping) (NN character)) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 3)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (DT The) (NN gene) (NN battery) (NN concept)) (VP (VBZ predicts) (SBAR (IN that) (S (NP (JJ upstream) (NN transcription) (NNS factors)) (VP (VBP coordinate) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN target) (NNS genes)))) (PP (IN through) (S (VP (VBG binding) (PP (TO to) (NP (NP (JJ similar) (JJ cis-regulatory) (NNS elements)) (PP (IN in) (NP (DT the) (NN target) (NNS genes))))))))))))) (. .)))
( (S (PP (IN In) (NP (DT a) (JJ recent) (NN report))) (, ,) (NP (NP (NP (NNP Alloco)) (CC and) (NP (NNS co-workers))) (CD -LSB-44) (-RRB- -RSB-)) (VP (VBD studied) (NP (NP (DT the) (NN relationship)) (PP (IN between) (NP (NP (NN co-expression)) (PP (IN in) (NP (NP (NP (NN yeast)) (PRN (-LRB- -LRB-) (SBAR (IN as) (S (VP (VBN determined) (PP (IN by) (NP (NN correlation))) (PP (IN in) (NP (NP (DT a) (NN set)) (PP (IN of) (NP (NN 610) (NNS arrays)))))))) (-RRB- -RRB-))) (CC and) (NP (NP (DT the) (NN probability)) (PP (IN of) (NP (VBG sharing) (NP (NP (DT a) (NN transcription) (NN factor)) (PRN (-LRB- -LRB-) (SBAR (IN as) (S (VP (VBN determined) (PP (IN by) (NP (NNS experiments)))))) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (PP (IN In) (NP (PRP$ their) (NNS experiments))) (, ,) (NP (NP (NP (DT an) (NN expression) (NN profile)) (NN correlation)) (PP (IN of) (NP (NN 0.85)))) (VP (VBD implied) (NP (NP (DT a) (NN probability)) (PP (IN of) (NP (NP (NN transcription) (NN factor)) (VP (VBG sharing) (PP (IN of) (NP (CD >0.5))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ incomplete) (NN coverage)) (PP (IN in) (NP (PRP$ our) (NN analysis)))) (VP (MD may) (ADVP (RB similarly)) (VP (VB indicate) (SBAR (IN that) (S (NP (NP (JJ other) (NNS mechanisms)) (PP (IN than) (NP (NN co-regulation)))) (VP (VBP contribute) (PP (TO to) (NP (DT the) (VBN coordinated) (NN expression))))))))) (. .)))
( (S (S (ADVP (RB Importantly)) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (RB technically) (JJ difficult) (S (VP (TO to) (VP (ADVP (RB accurately)) (VB quantify) (NP (NP (DT the) (NN fraction)) (PP (IN of) (NP (NNS genes)))) (PP (IN in) (NP (NP (DT a) (NN cluster)) (SBAR (WHNP (WDT that)) (S (VP (VBP respond) (PP (TO to) (NP (DT a) (NN factor)))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN presence)) (PP (IN of) (NP (JJ false) (JJ positive) (NN gene) (NN cluster) (NNS members)))) (VP (VBZ reduces) (NP (DT the) (NN coverage)))) (. .)))
( (S (S (NP (NP (NN Uncertainty)) (PP (IN in) (NP (NP (DT the) (NN motif) (NN assignment)) (PP (TO to) (NP (NN ortholog) (NNS pairs)))))) (VP (MD may) (ADVP (RB also)) (VP (VB reduce) (NP (DT the) (NN coverage))))) (. .)))
( (S (S (PP (IN In) (NP (NP (CD one) (NN case)) (NN study))) (, ,) (NP (PRP we)) (VP (MD could) (VP (VB use) (NP (NP (NNS data)) (PP (IN from) (NP (DT an) (JJ independent) (JJ experimental) (NN screen)))) (S (VP (TO to) (VP (VB confirm) (SBAR (IN that) (S (NP (DT the) (JJ liver-selective) (NN cluster)) (VP (VBD had) (NP (NP (DT a) (JJ limited) (NN coverage)) (PP (IN of) (NP (NP (NN HNF-1) (NNS responders)) (PRN (-LRB- -LRB-) (NP (NNS results)) (-RRB- -RRB-)))))))))))))) (. .)))
( (S (S (NP (JJ Further) (NNS experiments)) (VP (VBP are) (VP (VBN required) (S (VP (TO to) (VP (VB resolve) (SBAR (WHPP (TO to) (WHNP (WP what) (NN extent))) (S (NP (NP (DT the) (NN lack)) (PP (IN of) (NP (NN coverage)))) (VP (VBZ reflects) (NP (NP (JJ alternative) (JJ regulatory) (NNS mechanisms)) (CC or) (NP (JJ technical) (NNS limitations)))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NNS tissues)) (PP (IN in) (NP (DT the) (NN dataset)))) (VP (VBP represent) (NP (NP (NNS samples)) (PP (IN of) (NP (JJ limited) (JJ morphological) (NN resolution)))) (PP (IN at) (NP (DT a) (JJ fixed) (NN time) (NN point))))) (. .)))
( (S (S (PP (IN As) (NP (DT a) (NN consequence))) (, ,) (NP (NP (VBD co-expressed) (NN gene) (NNS groups)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (JJ active)) (PP (PP (IN under) (NP (JJ specific) (JJ developmental) (NNS phases))) (, ,) (PP (IN under) (NP (JJ specific) (JJ environmental) (NNS stresses))) (, ,) (CC or) (PP (IN in) (NP (ADJP (ADJP (JJ small)) (CC and) (ADJP (JJ localized))) (JJ anatomical) (NNS structures)))))))) (VP (VBP are) (ADJP (JJ likely) (S (VP (TO to) (VP (VB escape) (NP (NN detection)))))))) (. .)))
( (S (S (ADVP (RB Moreover)) (, ,) (NP (NP (VBD co-expressed) (NN gene) (NNS groups)) (PP (IN with) (NP (NP (DT a) (NN peak)) (PP (IN in) (NP (CD one) (NN tissue) (RB only)))))) (VP (VBP are) (ADJP (JJ unresolved) (PP (IN for) (NP (JJ single) (NN cell) (NNS types)))))) (. .)))
( (S (S (NP (NP (JJ Low) (NN coverage)) (PP (IN of) (NP (NNS motifs))) (PP (IN in) (NP (JJ such) (NNS clusters)))) (VP (MD may) (VP (VBP reflect) (NP (NP (JJ contaminating) (NNS genes)) (SBAR (WHNP (WDT that)) (S (VP (VBP derive) (PP (IN from) (NP (DT another) (NN cell) (NN type)))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN Affymetrix) (NN technology)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (VP (VBN used) (S (VP (TO to) (VP (VB generate) (NP (DT the) (NN expression) (NNS measurements)))))))))) (VP (VBZ has) (VP (VBN been) (VP (VP (VBN validated)) (CC and) (VP (VBP match) (NP (NP (NNS results)) (VP (VBN obtained) (PP (IN with) (NP (NP (NN tag)) (VP (VBG sampling) (PP (IN for) (NP (ADJP (RB sufficiently) (JJ abundant)) (NNS genes))) (NP (CD -LSB-45,46)) (-RRB- -RSB-))))))))))) (. .)))
( (S (S (NP (JJ Low) (NN intensity) (NNS signals)) (VP (VBD did) (RB not) (VP (VB correlate) (ADVP (RB well))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (JJ such) (NNS genes)) (VP (VBP are) (ADJP (RBR less) (JJ likely)) (S (VP (TO to) (VP (VB form) (NP (NNS clusters)) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (NP (NP (JJ Cross) (NN hybridization)) (PP (IN between) (NP (JJ related) (NNS genes)))) (VP (MD may) (, ,) (PP (IN in) (NP (NN theory))) (, ,) (VP (VB contribute) (PP (TO to) (NP (VBG correlating) (NN expression) (NNS levels)))))) (. .)))
( (S (NP (PRP We)) (VP (MD can) (VP (VB exclude) (SBAR (IN that) (S (NP (NNS clusters)) (ADVP (RB primarily)) (VP (VBP form) (PP (IN as) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NN cross-hybridization))))) (, ,) (SBAR (SBAR (IN since) (S (NP (NP (-LRB- -LRB-) (CD 1) (-RRB- -RRB-) (NNS members)) (PP (IN of) (NP (JJ well-characterized) (NN gene) (NNS families)))) (VP (VBP appear) (PP (IN in) (NP (NP (JJ different) (PRN (-LRB- -LRB-) (NP (NP (DT the)) (VP (VBN expected))) (-RRB- -RRB-)) (NNS clusters)) (PRN (-LRB- -LRB-) (NP (NP (NN eg) (NN smooth) (NN muscle)) (CC and) (NP (JJ cardiac) (NNS actins))) (-RRB- -RRB-))))))) (CC and) (SBAR (IN since) (S (LST (-LRB- -LRB-) (LS 2) (-RRB- -RRB-)) (VBD co-expressed) (NP (NNS genes)) (VP (VBD tended) (S (VP (VP (TO to) (VP (VBP share) (VP (VB GO) (NP (NNS terms))))) (CC or) (VP (TO to) (VP (VB encode) (NP (VBG interacting) (NNS proteins)) (PP (TO to) (NP (NP (DT a) (JJR higher) (NN degree)) (SBAR (IN than) (S (NP (PRP they)) (VP (VBD tended) (S (VP (TO to) (VP (VB be) (NP (NP (NNS paralogs)) (PRN (-LRB- -LRB-) (NP (NP (JJ supplementary) (NNS data)) (, ,) (NP (JJ additional) (NN file) (CD 1))) (-RRB- -RRB-)))))))))))))))))))))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB cannot)) (ADVP (RB however)) (VP (VBP exclude) (NP (NP (JJ subtle) (NNS effects)) (ADJP (JJ related) (PP (TO to) (NP (NN cross-hybridization))))) (, ,) (SBAR (IN since) (S (NP (NP (NNS results)) (PP (IN with) (NP (NN cDNA) (NNS microarrays)))) (VP (VBP indicate) (NP (DT this) (NN possibility) (CD -LSB-47) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (NP (NN Transcription) (NNS factors)) (PP (IN in) (NP (DT the) (JJ same) (NN family)))) (ADVP (RB often)) (VP (VP (VBP have) (NP (JJ similar) (NN DNA) (NN binding) (NNS properties))) (CC and) (VP (VBP bind) (PP (TO to) (NP (NP (DT the) (JJ same) (NNS sites)) (PP (IN on) (NP (NN target) (NNS genes)))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBZ leads) (PP (TO to) (NP (NP (DT an) (NN ambiguity)) (PP (IN in) (NP (NP (DT the) (NN interpretation)) (PP (IN of) (NP (NN PFM) (NNS annotations))))))))) (. .)))
( (S (NP (DT The) (NN MEF2) (NN motif)) (, ,) (VP (VBZ is) (PP (IN for) (NP (NN example))) (NP (NP (DT a) (NN receptor)) (PP (IN for) (NP (NP (DT the) (JJ mammalian) (NN MEF2A)) (, ,) (NP (NN MEF2B)) (, ,) (NP (NN MEFC)) (CC and) (NP (NN MEFD) (NN transcription) (NNS factors) (NP (CD -LSB-48)))))) (-RRB- -RSB-)) (. .)))
( (S (S (ADVP (RB Similarly)) (, ,) (NP (DT the) (NN E2F) (NN motif)) (VP (VBZ is) (NP (NP (DT a) (NN receptor)) (PP (IN for) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (CD 9) (NN E2F) (NN family) (NNS proteins))))) (SBAR (WHNP (WDT that)) (S (VP (VBP form) (NP (NP (NNS heterodimers)) (PP (IN with) (NP (NP (NP (DT another) (NN family)) (PP (IN of) (NP (NNS proteins)))) (, ,) (NP (DT the) (NN DP) (NNS proteins)) (, ,)))) (PP (IN in) (NP (NP (DT a) (NN way)) (SBAR (WHNP (WDT that)) (S (VP (VBZ affects) (NP (DT the) (NN binding) (NN affinity) (CD -LSB-49) (-RRB- -RSB-))))))))))))) (. .)))
( (S (S (S (NP (JJ Different) (NN E2F) (NNS proteins)) (VP (VBP act) (PP (IN at) (NP (NP (JJ different) (NNS stages)) (PP (IN in) (NP (DT the) (NN cell) (NN cycle) (CD -LSB-50) (-RRB- -RSB-))))))) (, ,) (CC and) (S (NP (DT this)) (VP (VBZ is) (RB not) (VP (VBN captured) (PP (IN by) (NP (PRP$ our) (NN method))))))) (. .)))
( (S (S (NP (CD One) (JJ additional) (NN data) (NN limitation)) (VP (VBZ is) (SBAR (IN that) (S (NP (NP (DT a) (NN fraction)) (PP (IN of) (NP (NN Ensembl) (NNS transcripts)))) (VP (MD may) (VP (VB lack) (NP (NP (NN sequence)) (PP (IN in) (NP (PRP$ their) (CD 5) (`` ') (NNS ends)))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN accuracy)) (PP (IN of) (NP (PRP$ our) (NN transcription) (NNS starts)))) (VP (VBZ is) (ADVP (RB therefore)) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN quality)) (PP (IN of) (NP (DT the) (NN Ensembl) (NN transcript) (NN database)))))))) (. .)))
( (S (S (NP (PRP$ Our) (NN approach)) (VP (VBZ is) (ADJP (RB technically) (JJ related) (PP (TO to) (NP (DT the) (NP (NNP Toucan)) (CC and) (NP (NNP ConFac)) (NP (NNS tools) (CD -LSB-17,51) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (NP (JJ Important) (NNS differences)) (CC and) (NP (NNS extensions))) (VP (VBP are) (NP (NP (NP (DT the) (NN introduction)) (PP (IN of) (NP (DT a) (JJ composite) (JJ scoring) (NN system)))) (, ,) (NP (NP (DT a) (NN procedure)) (S (VP (TO to) (VP (VB optimize) (NP (NN PFM) (NNS thresholds)))))) (, ,) (CC and) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NN simulation))))) (PP (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (DT the) (JJ whole) (NN clustering) (S (VP (TO to) (VP (VB measure) (NP (NNS significances))))))))))) (. .)))
( (S (S (S (NP (NP (DT The) (NN performance)) (PP (IN of) (NP (DT the) (NN method)))) (VP (VBD was) (RB not) (VP (VBN affected) (PP (IN by) (NP (NP (DT the) (NN removal)) (PP (IN of) (NP (NP (JJ paralogous) (NNS genes)) (PP (IN from) (NP (NP (DT the) (NNS clusters)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 9B)) (-RRB- -RRB-))))))))))) (, ,) (CC and) (S (NP (NP (NN clustering)) (PP (IN of) (NP (JJ such) (NNS genes)))) (VP (VBZ is) (ADVP (RB clearly)) (RB not) (NP (NP (DT a) (JJ significant) (NN source)) (PP (IN of) (NP (JJ false) (JJ positive) (NN motif) (NN prediction))))))) (. .)))
( (S (S (ADVP (RB Consequently)) (, ,) (NP (PRP we)) (VP (VBD decided) (S (VP (TO to) (VP (VB include) (NP (DT the) (NNS paralogs)) (PP (IN in) (NP (DT the) (JJ final) (NN analysis))) (SBAR (IN since) (S (NP (PRP we)) (VP (VBP believe) (SBAR (IN that) (S (NP (NP (NN co-expression)) (PP (IN of) (NP (JJ such) (NNS genes)))) (VP (MD may) (VP (VB be) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (JJ shared) (JJ cis-regulatory) (NNS elements)))))))))))))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB further)) (VP (VBD evaluated) (NP (NP (DT the) (NNS effects)) (PP (IN of) (S (VP (VBG using) (NP (JJ different) (NN DNA) (NNS amounts)) (PP (IN in) (NP (DT the) (NN analysis))))))))) (. .)))
( (S (S (PP (IN In) (NP (JJ principal))) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN motivated) (S (VP (TO to) (VP (VB include) (NP (NP (DT a) (JJ substantial) (NN amount)) (PP (IN of) (NP (NN DNA) (NN sequence))) (PP (IN per) (NP (NN gene))))))) (, ,) (SBAR (IN since) (S (NP (JJ mammalian) (NNS enhancers)) (VP (VBP are) (ADVP (RB frequently)) (ADJP (JJ located) (ADVP (RB far) (RB upstream)) (PP (PP (IN in) (NP (NP (NN relation)) (PP (TO to) (NP (DT the) (NN transcription) (NN start))))) (, ,) (CC or) (ADVP (RB downstream)) (PP (IN in) (NP (JJ intronic) (NN DNA))))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NNS benefits)) (PP (IN of) (S (VP (VBG including) (NP (ADJP (RB as) (JJ much)) (NN sequence)) (PP (IN as) (NP (JJ possible))))))) (VP (MD must) (VP (VB be) (ADJP (JJ balanced) (PP (IN against) (NP (NP (DT the) (NN risk)) (PP (IN of) (S (VP (VBG introducing) (NP (NP (JJ vast) (NNS amounts)) (PP (IN of) (NP (JJ non-informative) (NN sequence)))) (PP (IN into) (NP (DT the) (NN analysis)))))))))))) (. .)))
( (S (S (NP (DT The) (NN evaluation)) (ADVP (RB clearly)) (VP (VBN favoured) (S (VP (VBG using) (NP (NP (NP (JJ limited) (NNS amounts)) (PP (IN of) (NP (NN DNA)))) (, ,) (CC and) (NP (NP (JJ high) (NN stringency) (JJ phylogenetic) (NN footprinting)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 9C)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (DT The) (JJ optimal) (JJ future) (JJ alternative)) (VP (MD may) (VP (VB be) (S (VP (TO to) (VP (VB assemble) (NP (NP (DT a) (JJ small) (NN amount)) (PP (IN of) (NP (NN DNA)))) (PP (IN from) (NP (NP (DT a) (JJ large) (NN area)) (PP (IN of) (NP (NP (DT the) (NN genome)) (VP (VBG using) (NP (NP (NNS algorithms)) (SBAR (WHNP (WDT that)) (S (VP (VBP sort) (PRT (RP out)) (NP (NP (JJ regulatory) (NN DNA) (NNS regions)) (ADJP (RBR more) (JJ efficient))) (PP (IN than) (NP (JJ phylogenetic) (NN footprinting)))))))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN approach)) (VP (VBN presented) (ADVP (RB here)))) (VP (VBZ needs) (S (VP (TO to) (VP (VB be) (VP (VBN extended) (S (VP (TO to) (VP (VB generate) (NP (NP (ADJP (RBR more) (JJ complete)) (NNS models)) (PP (IN of) (NP (NN gene) (NN battery) (NN regulation))))))))))))) (. .)))
( (S (S (NP (NP (NP (NN Modelling)) (PP (IN of) (NP (JJ cis-regulatory) (NN element) (NNS combinations)))) (CC and) (NP (NP (DT the) (NP (JJ relative) (NN position)) (CC and) (NP (NN spacing))) (PP (IN of) (NP (NNS elements))))) (VP (VBP are) (NP (NP (NNS examples)) (PP (IN of) (NP (JJ such) (NNS extensions)))))) (. .)))
( (S (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NN PCC))) (PP (IN as) (NP (NP (DT a) (NN measure)) (PP (IN of) (NP (NN co-expression)))))) (VP (MD may) (VP (VBP need) (S (VP (TO to) (VP (VB be) (VP (VBN reconsidered) (SBAR (IN if) (S (VP (VBG extending) (NP (NP (DT the) (NN approach)) (PP (TO to) (NP (ADJP (RB very) (JJ large)) (NNS datasets)))))))))))) (, ,) (SBAR (IN since) (S (NP (DT this) (NN measure)) (VP (MD may) (VP (VB be) (ADJP (JJ sensitive) (PP (TO to) (NP (NP (JJ noninformative) (NNS signals)) (PP (IN in) (NP (NP (DT a) (NN majority)) (PP (IN of) (NP (NNS samples)))))))))))))) (. .)))
( (S (S (ADVP (RB Further)) (, ,) (NP (NP (DT the) (NN expression) (NNS levels)) (PP (IN of) (NP (NP (JJ potential) (NNS trans-regulators)) (CC and) (NP (NP (NNS co-factors)) (PRN (-LRB- -LRB-) (VP (VBN based) (PP (IN on) (NP (NN protein) (NN interaction) (NNS networks)))) (-RRB- -RRB-)))))) (VP (MD can) (VP (VB be) (VP (VBN introduced))))) (. .)))
( (S (ADVP (RBS Most) (RB likely)) (, ,) (NP (DT the) (NN method)) (VP (MD will) (VP (VB benefit) (PP (IN from) (NP (NP (DT a) (ADJP (RBR more) (JJ accurate)) (NN identification)) (PP (IN of) (NP (JJ regulatory) (NNS regions))))))) (PRN (-LRB- -LRB-) (NP (NNP Crawford-04)) (-RRB- -RRB-))))
( (S (NP (NN Conclusion))))
( (S (S (NP (PRP We)) (VP (VBD screened) (NP (NP (DT the) (NN mouse)) (CC and) (NP (JJ human) (NNS genomes)) (CC and) (NP (NNS transcriptomes))) (PP (IN for) (NP (NP (NNS instances)) (PP (IN of) (NP (NN gene) (JJ battery-like) (NN regulation))))))) (. .)))
( (S (S (NP (JJ Comparative) (NN clustering)) (VP (VBD was) (ADJP (RB highly) (JJ predictive) (PP (IN of) (NP (NP (NN gene) (NN function)) (CC and) (NP (NN protein) (NN interaction))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ indicates) (SBAR (IN that) (S (NP (JJ potential) (NN gene) (NNS batteries)) (VP (MD could) (VP (VB be) (VP (VBN identified) (NP (DT this) (NN way)))))))))))) (. .)))
( (S (PP (VBN Based) (PP (IN on) (NP (NP (NP (DT a) (JJ statistical) (JJ composite) (NN score)) (PP (IN for) (NP (NP (NNS motifs)) (PP (IN in) (NP (NN ortholog) (NNS pairs)))))) (, ,) (CC and) (NP (NP (DT a) (NN simulation) (NN approach)) (S (VP (TO to) (VP (VB determine) (NP (NN significance) (NNS levels))))))))) (, ,) (NP (PRP we)) (VP (VBD found) (NP (NP (CD 21) (NNS instances)) (PP (IN of) (NP (ADJP (RB statistically) (VBN supported)) (NN gene) (NN battery-like) (NN regulation))) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (VP (VBN conserved) (PP (IN between) (NP (NP (NN mouse)) (CC and) (NP (ADJP (JJ human))))))))))) (. .)))
( (S (S (NP (DT These)) (VP (VBD included) (NP (NP (JJ known) (NNS cases)) (PP (IN of) (NP (NN gene) (NN battery) (NN regulation))) (PP (IN in) (NP (NP (NNS tissues)) (PP (JJ such) (IN as) (NP (NP (NN muscle)) (, ,) (NP (NNS lymphocytes)) (, ,) (NP (NNS erythrocytes)) (, ,) (CC and) (NP (NN liver))))))))) (. .)))
( (S (S (NP (NP (DT A) (JJ second) (NN category)) (PP (IN of) (NP (NNS predictions)))) (VP (VBD included) (NP (NNS regulators)) (PP (PP (IN with) (NP (NP (DT some) (NN degree)) (PP (IN of) (NP (NN documentation))))) (, ,) (FW e.g.) (PP (IN in) (NP (NP (NN testis)) (, ,) (NP (NN kidney)) (, ,) (CC and) (NP (JJ endoplasmatic) (NN reticulum))))))) (. .)))
( (S (S (ADVP (RB Finally)) (, ,) (NP (NP (NN new) (NN candidate) (NN gene) (NNS batteries)) (PP (IN with) (NP (ADJP (RB statistically) (VBN enriched)) (JJ cis-regulatory) (NNS motifs)))) (VP (VBD were) (VP (VBN listed)))) (. .)))
( (S (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (DT this) (NN investigation)))) (VP (VP (VBZ emphasizes) (NP (NP (DT the) (NN need)) (S (VP (TO to) (VP (VB study) (NP (NP (NN differentiation)) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (JJR larger) (JJ transcriptional) (NNS units))))))))))) (, ,) (CC and) (VP (VBZ extends) (NP (NP (DT the) (NN methodology)) (PP (IN for) (S (VP (VBG doing) (NP (DT this))))))))) (. .)))
( (S (NP (NNS Methods))))
( (S (S (NP (NP (NN Target) (NNS sequences)) (PP (IN for) (NP (NP (DT the) (NP (NNP Novartis)) (NN Gene) (NN Atlas) (NN V2) (NN mouse)) (CC and) (NP (ADJP (JJ human))) (NP (NN expression) (NNS datasets))))) (VP (LST (CD -LSB-23) (-RRB- -RSB-)) (VBD were) (VP (VBN matched) (PP (IN against) (NP (NP (DT the) (NN Ensembl) (NN -LSB-20) (-RRB- -RSB-) (NN collection)) (PP (IN of) (NP (NP (UCP (NP (NN mouse)) (CC and) (ADJP (JJ human))) (NNS transcripts)) (VP (VBG using) (NP (NN BLAST) (CD -LSB-52) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (PP (IN In) (NP (NP (NNS cases)) (SBAR (WHADVP (WRB where)) (S (NP (DT the) (NN E-value)) (VP (VBD exceeded) (NP (CD 10-20))))))) (, ,) (NP (DT the) (NN BLAST) (NN search)) (VP (VBD was) (VP (VBN re-done) (PP (IN against) (NP (NN Ensembl) (NN gene) (NNS sequences)))))) (. .)))
( (S (S (SBAR (IN If) (S (NP (EX there)) (VP (VBD was) (NP (RB no) (VBP match)) (PP (IN below) (NP (NN 10-20)))))) (, ,) (NP (DT the) (NN probe) (NN set)) (VP (VBD was) (VP (VBN excluded) (PP (IN from) (NP (JJ further) (NN analysis)))))) (. .)))
( (S (S (NP (DT The) (VBG resulting) (NNS datasets)) (VP (VBD covered) (NP (NP (NP (NP (CD 17552) (NN mouse)) (CC and) (NP (NN 16929))) (JJ human) (JJ unique) (NN Ensembl) (NNS genes)) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 1)) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (JJ Mouse/human) (JJ orthologous) (NN gene) (NNS pairs)) (VP (VBD were) (VP (VBN formed) (S (VP (VBG using) (NP (NN Ensembl) (NN homology) (NNS maps))))))) (. .)))
( (S (S (NP (NP (JJ Redundant) (NNS occurrences)) (PP (IN of) (NP (NP (DT the) (JJ same) (NN gene)) (PP (IN in) (NP (QP (JJR more) (IN than) (CD one)) (NN ortholog) (NN pair)))))) (VP (VBD were) (VP (VBN avoided) (PP (VBG according) (PP (TO to) (NP (DT the) (VBG following) (NN procedure))))))) (: :) (S (NP (NP (DT the) (NN Ensembl) (JJ human) (NNS orthologs)) (PP (IN for) (NP (DT each) (NN Ensembl) (NN mouse) (NN gene)))) (VP (VBD were) (VP (VBN identified)))) (. .)))
( (S (S (SBAR (WHADVP (WRB When)) (S (NP (QP (JJR more) (IN than) (CD one)) (NN ortholog)) (VP (VBD was) (VP (VBN assigned) (PP (TO to) (NP (DT a) (NN mouse) (NN gene))))))) (, ,) (NP (NP (DT the) (NN one)) (PP (IN with) (NP (NP (DT the) (JJS lowest) (JJ positional) (NN disagreement) (NN d)) (PRN (-LRB- -LRB-) (VP (VBN defined) (PP (IN below))) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN chosen)))) (. .)))
( (S (S (NP (DT The) (NN procedure)) (VP (VBD was) (VP (VBN repeated) (PP (IN for) (NP (DT all) (NN Ensembl) (JJ human) (NNS genes)))))) (. .)))
( (S (S (S (NP (ADJP (RB Reciprocally) (VBG matching)) (NN ortholog) (NNS pairs)) (VP (VBD were) (VP (VBN identified)))) (, ,) (CC and) (S (NP (NNS others)) (VP (VBD were) (VP (VBN excluded) (PP (IN from) (NP (JJ further) (NN analysis))))))) (. .)))
( (S (S (NP (NP (DT The) (NN mouse) (CC and) (JJ human) (NN expression) (NNS profiles)) (PP (IN of) (NP (DT each) (NN ortholog) (NN pair)))) (VP (VBD were) (VP (VP (VBN normalized) (PP (IN with) (NP (NP (NN respect)) (PP (TO to) (NP (ADJP (ADJP (JJ mean)) (CC and) (ADJP (JJ standard))) (NN deviation)))))) (CC and) (VP (VBN combined) (PP (IN into) (NP (DT a) (JJ single) (JJR larger) (NN profile))))) (, ,) (S (ADVP (RB finally)) (VP (VBG yielding) (NP (DT an) (NN expression) (NN dataset)) (PP (IN with) (NP (NP (CD 13282) (JJ non-redundant) (NN ortholog) (NNS pairs)) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 1)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (PP (IN For) (NP (DT each) (NN ortholog) (NN pair))) (, ,) (NP (NP (NN mouse)) (CC and) (NP (JJ human) (NN candidate) (JJ regulatory) (NN sequence))) (VP (VBD was) (VP (VBN extracted) (PP (IN from) (NP (NN Ensembl)))))) (. .)))
( (S (S (NP (DT The) (NN sequence) (NN extraction) (NN algorithm)) (VP (VP (VBZ starts) (PP (IN with) (NP (DT an) (NN ortholog) (NN pair)))) (, ,) (VP (VBZ localizes) (NP (NP (DT the) (CD 5) (`` ') (NN end)) (PP (IN of) (NP (DT the) (NN transcript)))) (PP (IN in) (NP (NP (DT the) (NN genome)) (PP (IN in) (NP (DT each) (NNS species)))))) (, ,) (CC and) (VP (VBZ computes) (NP (NP (DT a) (NN value)) (SBAR (WHNP (WDT that)) (S (VP (NNS measures) (NP (NP (DT the) (JJ positional) (NN disagreement)) (PP (IN between) (NP (DT the) (NN transcript) (CD 5) (`` ') (NNS ends)))) (PP (IN in) (NP (DT the) (CD two) (NNS species)))))))))) (. .)))
( (S (S (SBAR (IN If) (S (NP (DT the) (NN disagreement)) (VP (VBZ is) (ADJP (RB too) (JJ large))))) (, ,) (NP (DT the) (NN ortholog) (NN pair)) (VP (VBZ is) (VP (VBN excluded) (PP (IN from) (NP (DT the) (NN analysis)))))) (. .)))
( (S (S (PP (IN Of) (NP (NP (DT the) (CD 12239) (NN ortholog) (NNS pairs)) (PP (IN in) (NP (DT the) (NN expression) (NN dataset))))) (, ,) (NP (CD 9561)) (VP (VBD satisfied) (NP (NP (DT this) (NN criterion)) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 1)) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (NP (DT A) (JJ full) (NN description)) (PP (IN of) (NP (DT the) (NN sequence) (NN extraction) (NN procedure)))) (VP (VBZ is) (ADJP (JJ available) (PP (IN in) (NP (DT the) (NN online) (NN supplement)))))) (. .)))
( (S (S (NP (NP (CD Three) (JJ different) (NNS lengths)) (PP (IN of) (NP (NN DNA)))) (VP (VBD were) (VP (VBN extracted) (: :) (NP (NP (CD 2) (NN kb)) (, ,) (NP (CD 6) (NN kb)) (CC and) (NP (CD 15) (NN kb)))))) (. .)))
( (S (S (S (NP (DT The) (ADJP (CD 2) (NN kb)) (NN dataset)) (VP (VBD contained) (NP (NP (JJ nucleotide) (NNS positions)) (VP (VBG ranging) (PP (IN from) (NP (CD -2000) (TO to) (CD -1))) (PP (JJ relative) (TO to) (NP (DT the) (NN transcription) (NN start))))))) (, ,) (S (NP (DT the) (ADJP (CD 6) (NN kb)) (NN dataset)) (VP (VBD contained) (NP (NNS positions) (CD -4000) (TO to) (CD +2000)))) (CC and) (S (NP (DT the) (ADJP (CD 15) (NN k)) (NN dataset)) (VP (VBD contained) (NP (NNS positions) (CD -10000) (TO to) (CD +5000))))) (. .)))
( (S (S (NP (DT The) (NN sequence) (NNS datasets)) (VP (VBD were) (VP (VBN subjected) (PP (TO to) (NP (NP (JJ phylogenetic) (NN footprinting)) (, ,) (PP (FW i.e.) (NP (NP (NN removal)) (PP (IN of) (NP (ADJP (RB poorly) (VBN conserved)) (NN sequence)))))))))) (. .)))
( (S (S (NP (NP (UCP (NP (DT The) (NN mouse)) (CC and) (ADJP (JJ human))) (NNS sequences)) (PP (IN of) (NP (DT each) (NN ortholog) (NN pair)))) (VP (VBD were) (VP (VBN aligned) (PP (IN by) (NP (NP (NN use)) (PP (IN of) (NP (NP (DT the) (NN LAGAN) (NN software) (NN -LSB-53) (-RRB- -RSB-)) (PRN (-LRB- -LRB-) (NP (JJ standard) (NNS settings)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (NN Similarity)) (VP (VBD was) (VP (VBN defined) (PP (IN as) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (JJ identical) (NNS nucleotides))) (PP (IN in) (NP (DT a) (ADJP (CD 20) (NN bp)) (NN window)))))))) (. .)))
( (S (S (NP (NP (NNS Nucleotides)) (PP (IN in) (NP (NP (NNS windows)) (PP (IN with) (NP (NN similarity))) (PP (IN below) (NP (DT the) (NN threshold)))))) (VP (VBD were) (VP (VBN removed)))) (. .)))
( (S (S (PP (IN In) (NP (NN all))) (, ,) (NP (CD five) (JJ different) (NN similarity) (NN threshold)) (VP (VBD were) (VP (VBN applied) (: :) (NP (NP (NP (CD >0) (NN %)) (PRN (-LRB- -LRB-) (S (NP (DT no) (NN footprinting) (NNS –)) (VP (VBP use) (NP (DT all) (NN sequence)))) (-RRB- -RRB-))) (, ,) (NP (CD >60) (NN %)) (, ,) (NP (CD >70) (NN %)) (, ,) (NP (CD >80) (NN %)) (CC and) (NP (ADJP (CD >90) (NN %)) (NN identity)))))) (. .)))
( (S (S (NP (DT Each) (NN candidate) (JJ regulatory) (NN sequence)) (VP (VBD was) (VP (VBN aligned) (PP (TO to) (NP (NP (DT the) (JJ corresponding) (NNS transcripts)) (PRN (-LRB- -LRB-) (NP (NP (JJ pairwise) (NN BLAST)) (, ,) (NP (NN e-value) (NN threshold) (CD 0.01))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (NNS Nucleotides)) (VP (VBG aligning) (PP (IN with) (NP (QP (CD one) (CC or) (JJR more)) (NNS transcripts))))) (VP (VBD were) (VP (VBN removed)))) (. .)))
( (S (S (NP (NP (DT The) (NN set)) (PP (IN of) (NP (NP (CD 9561) (NNS orthologs) (NNS pairs)) (, ,) (SBAR (WHPP (IN for) (WHNP (WDT which))) (S (NP (CC both) (NP (JJ regulatory) (NN sequence)) (CC and) (NP (NN expression) (NNS data))) (VP (MD could) (VP (VB be) (VP (VBN assembled)))))) (, ,)))) (VP (VBD were) (VP (VBN clustered) (PP (IN with) (NP (NP (NN respect)) (PP (TO to) (NP (NN expression) (NN pattern))))) (S (VP (VBG using) (NP (NP (NP (JJ hierarchical) (NN clustering) (CD -LSB-54) (-RRB- -RSB-)) (PP (IN with) (NP (JJ average) (NN group) (NN linkage)))) (CC and) (NP (NP (NN Pearson) (POS 's) (NN correlation)) (NN coefficient))) (PP (IN as) (NP (NN distance) (NN measure)))))))) (. .)))
( (S (S (PP (IN In) (NP (DT the) (JJ average) (NN group) (NN linkage) (NN algorithm))) (, ,) (NP (NN cluster) (NNS distances)) (VP (VBP are) (VP (VBN defined) (PP (IN as) (NP (NP (DT the) (NNS distances)) (PP (IN between) (NP (NN cluster) (NNS means)))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD defined) (NP (DT the) (NN cluster) (NN mean)) (PP (IN as) (NP (NP (DT the) (JJ arithmetic) (NN mean)) (PP (IN of) (NP (DT all) (NN cluster) (NNS members))))))) (. .)))
( (S (S (NP (NP (NN Correlation) (NNS thresholds)) (PP (IN between) (NP (NP (CD 0.61)) (CC and) (NP (CD 0.99))))) (VP (VBD were) (VP (VBN applied) (PP (IN in) (NP (NP (NNS steps)) (PP (IN of) (NP (CD 0.01)))))))) (. .)))
( (S (S (NP (NP (NNS Motifs)) (VP (VBN represented) (PP (IN as) (NP (NP (NN position) (NN frequency) (NNS matrices)) (PRN (-LRB- -LRB-) (NP (NNS PFMs)) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN downloaded) (PP (IN from) (NP (DT the) (NP (NP (NN TRANSFAC) (CD -LSB-55) (-RRB- -RSB-)) (CC and) (NP (NN JASPAR) (CD -LSB-25) (-RRB- -RSB-))) (NNS databases)))))) (. .)))
( (S (S (NP (NN Non-vertebrate) (NNS matrices)) (VP (VBD were) (VP (VBN filtered) (PRT (RP out))))) (. .)))
( (S (S (NP (ADJP (RB Highly) (JJ similar)) (NNS matrices)) (VP (VBD were) (VP (VP (VBN grouped)) (CC and) (VP (VBN merged) (S (VP (VBG using) (NP (JJ single) (NN linkage) (JJ hierarchical) (NN clustering)))))) (, ,) (S (VP (VBG reducing) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NNS PFMs)) (PP (IN from) (NP (CD 322) (TO to) (CD 266)))))))))) (. .)))
( (S (S (NP (NP (NNS Distances)) (PP (IN between) (NP (NNS matrices)))) (VP (VBD were) (VP (VBN calculated) (S (VP (VBG using) (NP (DT a) (JJ probabilistic) (NN method) (NN -LSB-56) (-RRB- -RSB-))))))) (. .)))
( (S (S (S (NP (NP (JJ Individual) (NNS positions)) (PP (IN between) (NP (NNS matrices)))) (VP (VBD were) (VP (VBN compared) (S (VP (VBG using) (NP (DT the) (NN chi) (NN square) (NN test))))))) (, ,) (CC and) (S (NP (NP (NNS p-values)) (PP (IN for) (NP (DT all) (JJ overlapping) (NNS positions)))) (VP (VBD were) (VP (VBN combined) (S (VP (VBG using) (NP (DT the) (JJ geometric) (NN mean)))))))) (. .)))
( (S (S (NP (NP (NP (NN Sense)) (CC and) (NP (NN antisense))) (PP (IN of) (NP (NNS motifs)))) (VP (VBD were) (VP (VBN compared) (SBAR (IN for) (S (NP (NP (DT all) (JJ possible) (NNS frameshifts)) (PP (IN with) (NP (QP (IN at) (JJS least) (CD 75)) (NN %)))) (VP (VBP overlap))))))) (. .)))
( (S (S (S (NP (NP (JJ Clustered) (NNS motifs)) (PRN (-LRB- -LRB-) (NP (NN score) (NN >) (CD 0.5)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN added) (ADVP (RB together)) (PP (IN in) (NP (JJ overlapping) (NNS positions)))))) (, ,) (CC and) (S (NP (JJ flanking) (NNS positions)) (VP (VBD were) (VP (VBN discarded))))) (. .)))
( (S (S (NP (NNS PFMs)) (VP (VBD were) (VP (VBN transformed) (PP (IN into) (NP (NP (NN position) (NN weight) (NNS matrices)) (PRN (-LRB- -LRB-) (NP (NN PWM)) (: :) (NP (NNS s)) (-RRB- -RRB-)))) (S (VP (TO to) (VP (VB make) (S (NP (PRP them)) (ADJP (JJ compatible) (PP (IN with) (NP (NP (DT the) (NN MAST) (NN software)) (PRN (-LRB- -LRB-) (VP (VB see) (PP (IN below))) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN value)) (PP (IN of) (NP (DT each) (NN matrix) (NN element)))) (VP (VBD was) (VP (VBN calculated) (S (VP (VBG according) (PP (TO to) (NP (DT the) (VBG following) (NN formula)))))))) (: :)))
( (S (S (SBAR (WHADVP (WRB where)) (S (S (NP (NN n)) (VP (VBZ is) (NP (NP (DT the) (NN raw) (NN count)) (PP (IN from) (NP (NP (DT the) (JJ corresponding) (NN position)) (PP (IN in) (NP (DT the) (NN PFM)))))))) (, ,) (S (NP (NN N)) (VP (VBZ is) (NP (NP (DT the) (NP (DT the) (NN number))) (PP (IN of) (NP (NP (NNS observations)) (PRN (-LRB- -LRB-) (NP (NP (NN sum)) (PP (IN of) (NP (NP (DT each) (NN position/column)) (PP (IN in) (NP (DT the) (NN PFM)))))) (-RRB- -RRB-))))))) (, ,) (CC and) (S (VP (VBP are) (NP (NP (NNS pseudocounts)) (CC and) (NP (NP (NN p)) (PRN (-LRB- -LRB-) (NP (NN b)) (-RRB- -RRB-)))))))) (VP (VBZ is) (NP (NP (DT the) (NN background) (NN frequency)) (PP (IN of) (NP (DT the) (JJ corresponding) (NN nucleotide)))))) (. .)))
( (S (S (PP (IN For) (NP (DT each) (NN ortholog) (NN pair))) (, ,) (NP (UCP (CC both) (NP (NN mouse)) (CC and) (ADJP (JJ human) (JJ regulatory))) (NNS sequences)) (VP (VBD were) (VP (VBN scored) (PP (IN for) (NP (NP (DT all) (NN motif) (NN PWM) (POS 's)) (VP (VBG using) (NP (DT the) (NN MAST) (NN software) (CD -LSB-57))))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (NN MAST)) (VP (VBD was) (VP (VBN set) (S (VP (TO to) (VP (VB compute) (NP (NP (JJ whole-sequence) (NNS p-values)) (PRN (-LRB- -LRB-) (NP (JJ -seqp) (NN setting)) (-RRB- -RRB-))) (, ,) (S (VP (VBG using) (NP (NP (DT a) (JJ first) (NN order) (NN Markov) (NN chain)) (NN background)))))))))) (. .)))
( (S (S (NP (DT The) (NN Markov) (NN chain)) (VP (NN background) (NP (NP (NNS data)) (SBAR (WHADVP (WRB where)) (S (VP (VBN computed) (PP (IN from) (NP (NP (VBD unmasked) (JJ genomic) (NN sequence) (NN -4000)) (ADJP (JJ upstream) (PP (TO to) (NP (NP (CD +2000) (JJ downstream)) (PP (IN in) (NP (DT all) (NN ortholog) (NNS pairs)))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NNS p-values)) (VP (VBN reported) (PP (IN by) (NP (NN MAST))) (PP (IN for) (NP (NP (UCP (NP (DT the) (NN mouse)) (CC and) (ADJP (JJ human))) (NNS sequences)) (PP (IN of) (NP (DT an) (NN ortholog) (NN pair))))))) (VP (VBD were) (VP (VBN multiplied) (PP (IN for) (NP (DT each) (NN PWM)))))) (. .)))
( (S (S (NP (DT The) (NN result)) (VP (VBD was) (VP (VBN treated) (PP (IN as) (NP (NP (DT a) (JJ composite) (NN score)) (SBAR (WHNP (WDT that)) (S (VP (VBZ reflects) (NP (NP (DT the) (JJ overall) (`` ``) (NN signal) (NN '')) (PP (IN for) (NP (NP (DT a) (JJ certain) (NN binding) (NN site)) (PP (IN in) (NP (NP (DT the) (JJ regulatory) (NNS sequences)) (PP (IN of) (NP (DT an) (NN ortholog) (NN pair)))))))))))))))) (. .)))
( (S (S (NP (DT The) (JJ composite) (NN score)) (VP (VP (VBZ is) (NP (NP (DT a) (NN product)) (PP (IN of) (NP (CD two) (NNS p-values))))) (CC but) (VP (MD should) (RB not) (VP (VB be) (VP (VBN interpreted) (PP (IN as) (NP (DT a) (NN p-value)))))) (, ,) (SBAR (IN since) (S (NP (DT the) (UCP (NP (NN mouse)) (CC and) (ADJP (JJ human))) (NNS sequences)) (VP (VBP are) (ADJP (RB highly) (JJ dependent))))))) (. .)))
( (S (S (NP (NNS Clusters)) (VP (VBD were) (VP (VBN evaluated) (PP (IN for) (NP (NP (NN over-representation)) (PP (IN of) (NP (VB GO) (NNS terms))))) (S (VP (VBG using) (NP (NN Fisher) (POS 's) (JJ exact) (NN test) (CD -LSB-30)))))) (-RRB- -RSB-)) (. .)))
( (S (S (PP (JJ Due) (TO to) (NP (NP (DT the) (JJ large) (NN number)) (PP (IN of) (NP (NP (NNS tests)) (PRN (-LRB- -LRB-) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NNS clusters)) (VP (NNS times) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (VB GO) (NNS terms)))))))) (-RRB- -RRB-)))))) (, ,) (NP (DT the) (VBG resulting) (NNS p-values)) (VP (VBD were) (VP (VBN corrected) (S (VP (VBG using) (NP (DT the) (NN Bonferroni) (NN method) (CD -LSB-30)))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (DT The) (NN test)) (VP (VBD was) (VP (VBN applied) (PP (TO to) (NP (NP (DT the) (CD 9561) (NN ortholog) (NNS pairs)) (PP (IN with) (NP (CC both) (NP (NN sequence)) (CC and) (NP (NN expression) (NNS data))))))))) (. .)))
( (S (S (NP (DT These)) (VP (VBD constituted) (NP (DT the) (NN population)))) (. .)))
( (S (S (PP (IN For) (NP (DT each) (NN PWM))) (, ,) (NP (NP (NNS genes)) (PP (IN with) (NP (NP (NN MAST) (NN composite) (NNS scores)) (PP (IN below) (NP (DT a) (NN threshold)))))) (VP (VBD were) (VP (VBN defined) (PP (IN as) (NP (NP (VBN labeled)) (CC and) (NP (NP (DT the) (NNS others)) (PP (IN as) (NP (JJ unlabeled))))))))) (. .)))
( (S (S (ADVP (RB Further)) (, ,) (NP (DT each) (NN cluster)) (VP (VBD was) (VP (VBN considered) (PP (IN as) (NP (NP (DT a) (NN sample)) (PP (IN from) (NP (DT the) (NN population)))))))) (. .)))
( (S (S (NP (DT The) (NN algorithm)) (VP (VP (VBZ is) (ADVP (RB briefly)) (VP (VBN sketched) (ADVP (RB here)))) (CC and) (VP (VBZ is) (ADJP (JJ available) (PP (IN in) (NP (NN detail)))) (PP (IN in) (NP (DT the) (NN online) (NN supplement)))))) (: :)))
( (S (S (ADVP (RB First)) (, ,) (NP (NN ortholog) (NNS pairs)) (VP (VBD were) (VP (VBN permuted) (PP (IN across) (NP (DT the) (NN dataset))) (, ,) (S (VP (VBG making) (S (NP (DT each)) (VP (VBP cluster) (NP (NP (DT a) (JJ random) (NN selection)) (PP (IN of) (NP (NNS genes))))))))))) (. .)))
( (S (S (ADVP (RB Second)) (, ,) (NP (DT an) (JJ optimal) (NN composite) (NN score) (NN threshold)) (VP (VBD was) (VP (VBN found) (PP (IN for) (NP (DT each) (NN PWM)))))) (. .)))
( (S (S (NP (DT This)) (VP (VBD was) (VP (VBN done) (PP (IN by) (S (VP (VBG computing) (NP (NP (DT the) (NN Fischer) (NN test) (NN p-value)) (PP (IN for) (NP (NP (NN over-representation)) (PP (IN of) (NP (VBN labeled) (NN ortholog) (NNS pairs))))) (PP (IN for) (NP (DT all) (NNS clusters) (NP (NN k))))) (PP (IN at) (NP (NP (DT a) (NN range)) (PP (IN of) (NP (NP (NN detection) (NNS thresholds)) (VP (VBG ranging) (PP (IN from) (NP (CD 10-8) (TO to) (CD 10-3))) (PP (IN in) (NP (NP (JJ stepwise) (NNS increases)) (PP (IN by) (NP (NP (DT a) (NN factor)) (PP (IN of) (NP (CD 100.5)))))))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN threshold)) (VP (VBN chosen) (PP (IN for) (NP (DT each) (NN PWM))))) (VP (VBD was) (NP (NP (DT the) (CD one)) (SBAR (WHNP (WDT that)) (S (VP (VBD gave) (NP (NP (DT the) (JJS best) (NN p-value)) (PP (IN for) (NP (NP (DT that) (NN PWM)) (PP (IN in) (NP (DT any) (NN cluster)))))))))))) (. .)))
( (S (S (NP (NP (NNS P-values)) (PP (IN for) (NP (NP (NN over-representation)) (PP (IN of) (NP (DT all) (NNS motifs))) (PP (IN in) (NP (DT all) (NNS clusters)))))) (VP (VBD were) (ADVP (RB finally)) (VP (VBN calculated) (S (VP (VBG using) (NP (DT the) (VBN optimized) (NNS thresholds))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP refer) (PP (TO to) (NP (DT this) (NN statistic))) (PP (IN as) (NP (DT the) (NN p-score))))) (. .)))
( (S (S (NP (DT This) (JJ whole) (NN procedure)) (VP (VBD was) (VP (VBN repeated) (PP (IN for) (NP (NP (CD 100) (NNS iterations)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD resulted) (PP (IN in) (NP (NP (JJ empirical) (NNS estimates)) (PP (IN of) (SBAR (WHADVP (WRB how)) (S (NP (NP (JJ many) (JJ over-represented) (NNS motifs)) (NP (PRP we))) (VP (MD could) (VP (VB expect) (PP (IN below) (NP (NP (DT a) (JJ certain) (NN p-score)) (PP (IN under) (NP (DT the) (JJ null) (NN hypothesis)))))))))))))))))))) (. .)))
( (S (S (NP (DT This) (NN step)) (VP (VBD was) (UCP (ADJP (JJ identical) (PP (TO to) (NP (NN step) (CD 1)))) (CC but) (PP (IN without) (NP (NP (NNS permutations)) (CC and) (NP (NNS repetitions))))))) (. .)))
( (S (PP (IN After) (NP (DT the) (NN simulation))) (, ,) (NP (PRP we)) (VP (VBD defined) (NP (NP (DT the) (JJ false) (NN discovery) (NN rate)) (PRN (-LRB- -LRB-) (NP (NN FDR)) (-RRB- -RRB-))) (PP (IN at) (NP (NN p-score) (NN p))) (PP (IN as) (NP (NP (DT the) (VBN expected) (NN number)) (PP (IN of) (NP (NP (JJ over-represented) (NNS motifs)) (PP (IN in) (NP (DT the) (NN null) (NN simulation))))) (, ,) (VP (VBN divided) (PP (IN by) (NP (NP (DT the) (JJ corresponding) (NN value)) (PP (IN in) (NP (DT the) (VBN observed) (NNS data))))))))) (. .)))
( (S (S (NP (NP (NP (NN 40-EI)) (CC and) (NP (NN 230–238))) (NNS cells)) (VP (VBD were) (VP (VBN grown) (PP (IN in) (NP (NP (NN RPMI) (NN medium)) (VP (VBN supplemented) (PP (IN with) (NP (NP (NP (ADJP (CD 10) (NN %)) (NN FCS)) (, ,) (NP (CD 10) (NN mM) (NNS HEPES)) (, ,) (NP (ADJP (CD 2) (NN mM)) (NN pyruvate)) (, ,) (NP (ADJP (CD 50) (NN μM)) (NN 2-mercaptoethanol)) (CC and) (NP (ADJP (CD 50) (NN μg)) (NN gentamicin))) (PP (IN per) (NP (NP (NN ml)) (PRN (-LRB- -LRB-) (NP (JJ complete) (NN RPMI) (NNS media)) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (NP (NP (NN STAT) (NN activation)) (PP (IN in) (NP (NN 230–238) (NNS cells)))) (VP (VBD was) (VP (VBN achieved) (PP (IN by) (NP (NP (CD 5) (NNS hours)) (PP (IN of) (NP (NP (NN incubation)) (PP (IN with) (NP (CD 0.5) (NN ng/ml) (JJ recombinant) (NP (NP (NN mouse) (NN interferon) (NN gamma)) (PRN (-LRB- -LRB-) (NP (NNP Immunokontact) (, ,) (NNP Germany)) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (NP (JJ Nuclear) (NNS extracts)) (VP (VBD were) (VP (VBN prepared) (PP (VBG according) (PP (TO to) (NP (NP (NNP Schreiber) (FW et) (FW al.)) (CD -LSB-58) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (NN DNA) (NNS probes)) (VP (VBD were) (VP (VP (VBN labelled) (PP (IN with) (NP (CD γ-LSB-32P) (-RRB- -RSB-) (NN ATP))) (PRN (-LRB- -LRB-) (NP (NP (NNP Amersham) (NNP Biosciences)) (, ,) (NP (NN UK))) (-RRB- -RRB-)) (PP (IN by) (NP (NP (NN incubation)) (PP (IN with) (NP (NP (NN T4) (NN polynucleotide) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NP (NN Roche) (NN Diagnostics)) (, ,) (NP (NNP Mannheim) (, ,) (NNP Germany))) (-RRB- -RRB-))))))) (, ,) (CC and) (VP (VBN purified) (PP (IN on) (NP (NP (DT a) (JJ mini) (NN Quick) (NN Spin) (JJ Oligo) (NN Column)) (PRN (-LRB- -LRB-) (NP (NP (NN Roche) (NN Diagnostics)) (, ,) (NP (NN Sweden))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (JJ Nuclear) (NNS extracts)) (VP (VBD were) (VP (VBN incubated) (PP (IN with) (NP (JJ labelled) (NN probe))) (PRN (-LRB- -LRB-) (NP (NP (CD 20,000) (NN cpm)) (, ,) (NP (NP (CD 3) (NN fmol) (-RRB- -RRB-)) (PP (IN for) (NP (NP (CD 30) (NN min)) (PP (IN at) (NP (JJ room) (NN temperature))))) (PP (IN in) (NP (NP (NN binding) (NN buffer)) (PRN (-LRB- -LRB-) (NP (ADJP (CD 10) (NN mM)) (NN HEPES) (NN -LSB-pH) (CD 7.9)) (-RRB- -RSB-))))) (, ,) (NP (ADJP (CD 70) (NN mM)) (NN KCl)) (, ,) (NP (ADJP (CD 1) (NN mM)) (NN dithiothreitol)) (, ,) (NP (ADJP (CD 1) (NN mM)) (NN EDTA)) (, ,) (NP (ADJP (CD 2.5) (NN mM)) (NN MgCl2)) (, ,) (NP (ADJP (CD 4) (NN %)) (NN Glycerol))) (-RRB- -RRB-)) (PP (IN with) (NP (NP (NP (ADJP (CD 0.75) (NN μg)) (NN Poly)) (PRN (-LRB- -LRB-) (NP (NN dI/dC)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP Amersham) (NNP Pharmacia) (NNP Biotech) (, ,) (NNP UK)) (-RRB- -RRB-))))))) (. .)))
( (S (S (SBAR (WHADVP (WRB When)) (S (NP (NN EBF-binding)) (VP (VBD was) (VP (VBN investigated))))) (, ,) (NP (ADJP (CD 1) (NN mM)) (NN ZnCl2)) (VP (VBD was) (VP (VBN supplemented) (PP (TO to) (NP (DT the) (NN mixture)))))) (. .)))
( (S (S (NP (DT The) (NNS samples)) (VP (VBD were) (VP (VBN separated) (PP (IN on) (NP (NP (DT a) (ADJP (CD 6) (NN %)) (NN polyacrylamide) (NN TBE) (NN gel)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VP (VBN dried)) (CC and) (VP (VBN subjected) (PP (TO to) (NP (NN autoradiography))))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NP (DT the) (NN supershift) (NNS experiments)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 8B)) (-RRB- -RRB-)))) (, ,) (NP (NP (NN DNA) (NNS competitors)) (CC or) (NP (NP (NNS antibodies)) (PRN (-LRB- -LRB-) (NP (NP (NN anti-EBF) (NN SC-15333)) (, ,) (NP (JJ anti-Actin) (NN SC-1616)) (, ,) (NP (NNP Santa) (NNP Cruz) (NNP Biotech))) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN added) (PP (NP (CD 10) (NN min)) (IN before) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (DT the) (NN DNA) (NN probe)))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB visualize) (NP (DT the) (VBN super-shifted) (NN complex))))) (, ,) (NP (DT the) (JJ unbound) (NN probe)) (VP (VBD was) (NP (NN run)) (ADVP (RP out) (PP (IN of) (NP (DT the) (NN gel)))))) (. .)))
( (S (S (NP (DT The) (JJ following) (NNS Oligonucleotides)) (VP (VBD were) (VP (VBN used) (PP (IN for) (NP (NP (NN EMSA)) (: :) (NP (NN mb-1) (NN sense)) (: :) (NP (NN 5'-AGCCACCTCTCAGGGGAATTGTGG-3) (POS ')) (: ;) (NP (NN mb-1) (JJ antisense)) (: :) (NP (NN 5'-CCACAATTCCCCTGAGAGGTGGCT-3) ('' ')) (: ;) (NP (VBN mutated) (NN mb-1sense)) (: :) (NP (NN 5'-AGCCACCTCTCAGCCGTTTTGTGG-3) (POS ')) (: ;) (NP (NP (VBN mutated) (NN mb-1)) (ADJP (JJ antisense))) (: :) (NP (NN 5'-CCACAAAACGGCTGAGAGGTGGCT-3) ('' '))))))) (: ;)))
( (S (NP (NP (NN List)) (PP (IN of) (NP (NNS abbreviations))))))
( (S (NP (NP (NN EBF)) (NP (JJ Early) (NN B) (NN cell) (NN factor)))))
( (S (NP (NN EMSA) (JJ Electrophoretic) (NN Mobility) (NN Shift) (NN Assay))))
( (S (VP (VB GO) (NP (NP (NN term) (NN Gene) (NN Ontology)) (NN term)))))
( (S (NP (NP (NN PCC) (NN Pearson) (POS 's)) (NN correlation) (NN coefficient))))
( (S (NP (NN PFM) (NN Position) (NN frequency) (NN matrix))))
( (S (NP (NN PWM) (NN Position) (NN weight) (NN matrix))))
( (S (NP (NP (NNS Authors) (POS ')) (NNS contributions))))
( (S (NP (NP (DT The) (JJ overall) (JJ computational) (NN strategy)) (VP (VBN applied))) (VP (VBD was) (VP (VBN conceived) (PP (IN by) (NP (NP (NP (NN SN)) (, ,) (NP (NN EL)) (CC and) (NP (NN PM))) (PP (ADVP (RB together)) (PP (IN with) (NP (NP (NN EK)) (, ,) (NP (NN PL)))) (, ,) (CC and) (PP (IN ON))))))) (. .)))
( (S (S (S (NP (NP (NN SN)) (CC and) (NP (NN EL))) (VP (VBD performed) (NP (NP (DT the) (NN bulk)) (PP (IN of) (NP (DT the) (NN analysis)))))) (CC and) (S (NP (DT the) (NN manuscript)) (VP (VBD was) (VP (VBN drafted) (PP (IN by) (NP (NP (NP (NN SN)) (, ,) (NP (NN EL)) (CC and) (NP (NN PL))) (PP (IN with) (NP (NP (NNS contributions)) (PP (IN from) (NP (DT all) (NNS authors))))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ experimental) (NN validation)) (PP (IN of) (NP (NN EBF) (NNS sites)))) (VP (VBD was) (VP (VP (VBN conceived)) (CC and) (VP (VBN performed) (PP (IN by) (NP (NP (NN RM)) (CC and) (NP (NN MS)))))))) (. .)))
( (S (S (NP (NP (DT The) (ADJP (FW de) (FW novo)) (NN detection)) (PP (IN of) (NP (NNS motifs)))) (VP (VBD was) (VP (VP (VBN conceived)) (CC and) (VP (VBN performed) (PP (IN by) (NP (NN EK))))))) (. .)))
( (S (NP (NP (NN Figure)) (CC and) (NP (NN Table)) (NP (NNS captions)))))
( (S (S (NP (NN Figure) (CD 1)) (: :) (NP (NN Cluster) (NN statistics) (NN A))) (: :) (S (NP (NN Histogram)) (VP (VBG showing) (NP (NP (DT the) (NN log) (NN number)) (PP (IN of) (NP (NNS clusters)))) (PP (IN as) (NP (NP (DT a) (NN function)) (PP (IN of) (NP (NN log) (NN cluster) (NN size))))) (, ,) (PP (VBN based) (PP (IN on) (NP (NP (DT the) (NN clustering)) (PP (IN at) (NP (NP (NN Pearson) (NN correlation) (NN coefficient) (CD 0.75)) (JJ cut-off)))))))) (. .)))
( (S (NP (NP (NNS Numbers)) (PP (IN on) (NP (DT the) (NN x) (NN axis)))) (VP (VB denote) (NP (NP (NP (NP (NP (NN cluster) (NN size) (NNS intervals)) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))) (, ,) (NP (-LRB- -LRB-) (CD 3–4) (-RRB- -RRB-)) (, ,)) (PRN (-LRB- -LRB-) (NP (NN 5–8)) (-RRB- -RRB-))) (, ,) (NP (NP (NP (-LRB- -LRB-) (CD 9–16) (-RRB- -RRB-)) (, ,) (NP (NN ..)) (. .)) (NN B)) (: :) (NP (NN Co-expression))) (PP (IN as) (NP (NP (DT a) (NN predictor)) (PP (IN for) (NP (NP (JJ shared) (NN function)) (, ,) (NP (NN protein) (NN interaction)) (CC and) (NP (JJ paralogy))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD identified) (NP (NP (DT all) (NN gene) (NNS pairs)) (SBAR (WHNP (WDT that)) (S (VP (VBD correlated) (PP (PP (IN above)) (CC or) (PP (IN below) (NP (DT a) (NN threshold) (NP (NP (NN T)) (PRN (-LRB- -LRB-) (NP (NN X-axis)) (-RRB- -RRB-)))))))))))) (. .)))
( (S (NP (PRP We)) (VP (VBD measured) (NP (NP (NP (DT the) (NN fraction)) (PP (IN of) (NP (NP (JJ such) (NNS pairs)) (SBAR (WHPP (IN for) (WHNP (WDT which))) (S (NP (EX there)) (VP (VBD was) (S (LST (-LRB- -LRB-) (LS i) (-RRB- -RRB-)) (NP (NP (DT a) (ADJP (VB BIND)) (NN database) (JJ protein-protein) (NN interaction)) (VP (VBN recorded) (PP (IN in) (NP (JJ human))))) (, ,) (LST (-LRB- -LRB-) (LS ii) (-RRB- -RRB-)) (PP (IN at) (NP (QP (JJS least) (CD one)) (JJ shared) (NP (NN gene) (NN ontology)) (NN term)))))))))) (, ,) (CC and) (NP (LST (-LRB- -LRB-) (LS iii) (-RRB- -RRB-)) (NP (NN evidence)) (PP (IN of) (NP (JJ paralogy)))))) (. .)))
( (S (NP (PRP We)) (ADVP (RB then)) (VP (VBD computed) (NP (NP (DT the) (JJ relative) (NN probability)) (PP (IN for) (NP (NNS genes)))) (PP (IN above) (NP (NP (NN T)) (PP (IN with) (NP (DT this) (NN feature))))) (, ,) (S (VP (VBN compared) (PP (TO to) (NP (NP (NN gene) (NNS pairs)) (PP (IN below) (NP (NP (NNP T.)) (S (PP (IN At) (NP (NN expression) (NN correlation) (NN 0.80))) (, ,) (NP (NN co-expression)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (RB 100-fold) (JJ relative) (NN probability)) (PP (IN for) (NP (NNS genes))) (S (S (VP (TO to) (VP (VB encode) (NP (NN protein) (NNS interactors))))) (, ,) (NP (NP (DT a) (JJ 10-fold) (NN probability)) (PP (IN for) (NP (NNS genes)))) (VP (TO to) (VP (VB share) (NP (NP (JJ functional) (NN annotation)) (, ,) (CONJP (CC but) (RB only)) (NP (NP (DT a) (JJ 3-fold) (NN probability)) (PP (IN for) (NP (NNS genes))) (S (VP (TO to) (VP (VB be) (NP (NNS paralogs)))))))))))))))))))))) (. .)))
( (S (NP (NP (NN C)) (: :) (NP (NP (NN Fraction)) (PP (IN of) (NP (NNS clusters))) (PP (IN with) (NP (NP (QP (IN at) (JJS least) (CD one)) (JJ over-represented) (VB GO) (NP (NN term)) (PRN (-LRB- -LRB-) (NP (NN Y) (NN axis)) (-RRB- -RRB-))) (, ,) (PP (IN as) (NP (NP (DT a) (NN function)) (PP (IN of) (NP (NP (NN cluster) (NN size)) (PRN (-LRB- -LRB-) (NP (NN X) (NN axis)) (-RRB- -RRB-))))))))) (. .))))
( (S (S (NP (VB GO) (NN term) (NNS over-representations)) (VP (VBD were) (VP (VBN computed) (PP (IN at) (NP (DT a) (ADJP (CD 10) (NN %)) (JJ false) (NN discovery) (NN rate)))))) (. .)))
( (S (NP (NP (NN Figure) (CD 2)) (: :) (NP (DT A) (JJ smooth) (NN muscle) (NN differentiation) (NN battery)) (: :) (S (NP (NP (DT The) (NN bar) (NN chart)) (PRN (-LRB- -LRB-) (NP (JJ left)) (-RRB- -RRB-))) (VP (VBZ illustrates) (NP (NP (DT the) (JJ average) (NN expression) (NN level)) (PP (IN of) (NP (NN cluster) (NNS members)))) (PRN (-LRB- -LRB-) (NP (NN Y) (NN axis)) (-RRB- -RRB-)) (PP (IN across) (NP (NP (NP (ADJP (RB arbitrarily) (VBN ordered)) (NNS tissues)) (PRN (-LRB- -LRB-) (NP (NN X) (NN axis)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (CD two) (NNS species)) (PRN (-LRB- -LRB-) (NP (NP (JJ red) (JJ =) (NN mouse)) (CC and) (NP (JJ blue) (JJ =) (JJ human))) (-RRB- -RRB-)))))))) (. .))))
( (S (S (NP (CD Three) (NNS tables) (NN list)) (VP (VBN over-represented) (NP (NP (JJ functional) (NNS terms)) (PRN (-LRB- -LRB-) (NP (JJ upper) (JJ small) (NN table)) (-RRB- -RRB-))) (, ,) (PP (IN over) (NP (NP (NP (NP (VBN represented) (NNS motifs)) (PRN (-LRB- -LRB-) (NP (NNS PFMs)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (JJ middle) (NN table)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NN cluster) (NNS members)) (PRN (-LRB- -LRB-) (NP (JJR lower) (NN table)) (-RRB- -RRB-))))))) (. .)))
( (S (NP (NP (NN Figure) (CD 3) (: :) (NN B-lymphocyte) (NN differentiation) (NN battery)) (: :) (S (NP (NP (NNS Tables)) (CC and) (NP (NNS charts))) (VP (VBP are) (VP (VBN organized) (PP (IN as) (PP (IN in) (NP (NN figure) (CD 2))))))) (. .))))
( (S (S (NP (NP (NP (NN Figure) (CD 4)) (: :) (NP (NN Testis) (JJ selective) (NN battery)) (: :)) (PP (IN Over) (NP (NP (NN representation)) (PP (IN of) (NP (NP (NN RFX)) (CC and) (NP (NN SOX17)) (NP (NNS motifs))))))) (VP (VBZ indicates) (NP (NP (JJ new) (NNS roles)) (PP (IN for) (NP (DT these) (NNS factors)))) (PP (IN as) (NP (NP (NNS coordinators)) (PP (IN of) (NP (NN testis) (JJ selective) (NN gene) (NN expression))))))) (. .)))
( (S (S (NP (NP (NNS Tables)) (CC and) (NP (NNS charts))) (VP (VBP are) (VP (VBN organized) (PP (IN as) (PP (IN in) (NP (NN figure) (CD 2))))))) (. .)))
( (S (NP (NP (NN Figure) (CD 5)) (: :) (NP (JJ Endoplasmatic) (NN reticulum) (JJ associated) (NNS genes)) (: :) (S (PP (IN Over) (NP (NP (NN representation)) (PP (IN of) (NP (NN XBP-1))))) (, ,) (NP (NP (NN NRF)) (CC and) (NP (NN RTS) (NNS motifs))) (VP (VBP suggest) (NP (NP (JJ novel) (NNS functions)) (PP (IN for) (NP (NP (NN NRF)) (CC and) (NP (NN ETS) (NN family) (NNS factors)))) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (JJ ER-related) (NNS genes)))))))) (. .))))
( (S (S (NP (NP (NNS Tables)) (CC and) (NP (NNS charts))) (VP (VBP are) (VP (VBN organized) (PP (IN as) (PP (IN in) (NP (NN figure) (CD 2))))))) (. .)))
( (S (S (NP (NP (NN Figure) (CD 6)) (: :) (NP (JJ Ribosomal) (NNS genes)) (: :) (NP (NP (NNS Tables)) (CC and) (NP (NNS charts)))) (VP (VBP are) (VP (VBN organized) (PP (IN as) (PP (IN in) (NP (NN figure) (CD 2))))))) (. .)))
( (S (S (NP (NP (NP (NN Figure) (CD 7)) (: :) (NP (NN NF-kappaB) (NN pathway)) (: :)) (PP (IN Over) (NP (NP (NN representation)) (PP (IN of) (NP (NP (NN REL)) (CC and) (NP (NN NFkappaB)) (NP (NNS motifs))))))) (VP (VBZ indicates) (VP (VB feed) (ADVP (RB back)) (NP (NN signalling))))) (. .)))
( (S (S (NP (NP (NNS Tables)) (CC and) (NP (NNS charts))) (VP (VBP are) (VP (VBN organized) (PP (IN as) (PP (IN in) (NP (NN figure) (CD 2))))))) (. .)))
( (S (S (NP (NP (NN Figure) (CD 8)) (: :) (NP (NP (NN EMSA) (NN validation)) (PP (IN of) (NP (NN EBF) (NN binding) (NNS sites)))) (: :) (NP (NN A)) (: :) (NP (DT The) (NN figure))) (VP (VBZ displays) (NP (NP (NNS EMSAs)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (NN binding)) (PP (IN of) (NP (NN EBF))) (PP (TO to) (NP (DT a) (NN mb-1) (NN promoter) (NN EBF) (NN site)))) (VP (VBZ is) (VP (VBN competed) (PRT (IN for)) (PP (IN by) (NP (NP (DT the) (NN inclusion)) (PP (IN of) (NP (NP (CD 300) (CC or) (JJ 1000-fold) (JJ molar) (NN excess)) (PP (IN of) (NP (NP (JJ unlabelled) (NNS oligonucleotides)) (SBAR (WHNP (WDT that)) (S (VP (VBP correspond) (PP (TO to) (NP (DT the) (VBN predicted) (NNS motifs))))))))))))))))))) (. .)))
( (S (S (NP (NP (NP (DT The) (NN name)) (PP (IN of) (NP (DT the) (NN gene)))) (CC and) (NP (NP (DT the) (NN position)) (PP (IN of) (NP (DT the) (NN motif))))) (VP (VBZ is) (VP (VBN given) (PP (IN in) (NP (DT the) (NN figure)))))) (. .)))
( (S (S (PRN (-LRB- -LRB-) (NP (NN m)) (-RRB- -RRB-)) (VP (VBZ indicates) (NP (NP (NN mouse)) (CC and) (NP (ADJP (-LRB- -LRB-) (NP (NN h)) (-RRB- -RRB-) (JJ human)))))) (. .)))
( (S (S (S (NP (`` ``) (NN EBF) (NN '')) (VP (VBZ shows) (NP (NP (DT the) (NN position)) (PP (IN of) (NP (DT the) (NN DNA/protein) (NN complex)))))) (, ,) (CC and) (S (NP (`` ``) (NN Probe) (NN '')) (VP (VBZ indicates) (NP (NP (DT the) (NN position)) (PP (IN of) (NP (JJ free) (NN DNA))))))) (. .)))
( (S (S (VP (VB See) (NP (NP (JJ supplementary) (NN information)) (PP (IN for) (NP (NP (DT a) (JJ detailed) (NN description)) (PP (IN of) (NP (DT the) (NNS sites)))))))) (. .)))
( (S (NP (NP (NN B)) (: :) (S (NP (DT The) (NN mb-1) (NN promoter) (NN EBF) (NN site)) (VP (VBZ interacts) (ADVP (RB specifically)) (PP (IN with) (NP (NP (NN EBF) (NN protein)) (PP (IN in) (NP (DT a) (JJ pre-B) (NN cell) (JJ nuclear) (NN extract))))))) (. .))))
( (S (S (NP (DT The) (NN figure)) (VP (VBZ displays) (NP (NP (DT an) (NN autoradiogram)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (DT a) (JJ labelled) (NN EBF) (NN binding) (NN site)) (PP (IN from) (NP (DT the) (NN mb-1) (NN promoter)))) (VP (VBZ has) (VP (VBN been) (VP (VBN incubated) (PP (IN with) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN from) (NP (NP (NN 40EI) (NN pre-B) (NNS cells)) (CC and) (NP (NNS competitors)) (CC or) (NP (NNS antibodies)))))) (SBAR (IN as) (S (VP (VBN indicated)))))))))))) (. .)))
( (S (NP (NN EBF)) (VP (VBZ denotes) (NP (NP (NP (DT the) (JJ bound) (NN EBF) (NN protein)) (CC and) (NP (NN EBF-SS)) (NP (DT the) (VBN super-shifted) (NN complex))) (VP (VBN obtained) (PP (IN by) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (DT the) (ADJP (NN EBF) (JJ reactive)) (NN antibody))) (PP (TO to) (NP (DT the) (NN reaction) (NN mixture)))))))) (. .)))
( (S (S (NP (NN Figure) (CD 9)) (: :) (NP (JJ False) (NN discovery) (NN rate) (NN estimation))) (. .)))
( (S (NP (NP (NN A)) (: :) (NP (NP (NN Illustration)) (PP (IN of) (SBAR (WHADVP (WRB how)) (S (NP (NP (JJ false) (NN discovery) (NNS rates)) (PRN (-LRB- -LRB-) (NP (NNS FDRs)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN estimated) (PP (IN by) (NP (NP (NN use)) (PP (IN of) (NP (NNS simulations))))))))))) (. .))))
( (S (S (NP (NP (NNS Values)) (PP (IN on) (NP (DT the) (NN y) (NN axis)))) (VP (VBP represent) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NNS motifs)))) (PP (IN below) (NP (NP (DT a) (JJ certain) (NN p-score)) (PRN (-LRB- -LRB-) (NP (NN x) (NN axis)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NNS Triangles)) (VP (VBP show) (NP (NP (NNS results)) (PP (IN for) (NP (VBN observed) (NNS data)))))) (, ,) (S (NP (JJ filled) (NNS circles)) (VP (VBP show) (NP (NP (NNS results)) (PP (IN for) (NP (NP (JJ permuted) (NNS data)) (PRN (-LRB- -LRB-) (S (NP (NN error) (NNS bars)) (VP (VBP show) (NP (NP (DT the) (ADJP (CD 90) (NN %)) (NN confidence) (NN interval)) (PP (IN from) (NP (CD 100) (NNS simulations)))))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (DT The) (NN FDR)) (VP (VBD was) (VP (VBN calculated) (PP (IN as) (NP (NP (DT the) (NN ratio)) (PP (IN between) (NP (NP (DT the) (JJ simulated) (NN expectation)) (CC and) (NP (DT the) (NN observation))))))))) (. .)))
( (S (S (NP (JJ Red) (JJ dotted) (NN line)) (: :) (NP (NP (DT The) (NN number)) (PP (IN of) (NP (NP (NNS clusters)) (PP (IN with) (NP (QP (IN at) (JJS least) (CD one)) (JJ enriched) (NN motif))))))) (. .)))
( (S (S (VP (NN Note) (PP (IN that) (NP (NP (JJ several) (NNS motifs)) (SBAR (WHADVP (WRB where)) (S (VP (VBN over-represented) (PP (IN in) (NP (DT the) (JJ same) (NN cluster)))))))))) (. .)))
( (S (S (NP (NP (NN B) (: :) (NN Removal)) (PP (IN of) (NP (JJ paralogous) (NNS genes))) (PP (IN from) (NP (DT each) (NN cluster)))) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (VBN detected) (NNS motifs))))))) (. .)))
( (S (S (ADVP (RB Consequently)) (, ,) (NP (VBD co-expressed) (NNS paralogs)) (VP (VBZ is) (RB not) (NP (NP (DT an) (JJ important) (NN source)) (PP (IN of) (NP (JJ false) (NNS positives)))))) (. .)))
( (S (NP (NP (NN C)) (: :) (S (NP (NP (NP (DT The) (NN amount)) (PP (IN of) (NP (NN DNA))) (VP (VBN used) (PP (IN per) (NP (NN gene))))) (, ,) (CC and) (NP (DT the) (JJ phylogenetic) (NN footprinting) (NN stringency))) (VP (VBZ has) (NP (DT a) (JJ strong) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (VBN detected) (JJ over-represented) (NNS motifs))))))) (. .))))
( (S (S (NP (DT The) (NN sensitivity)) (VP (VBZ is) (ADJP (ADJP (JJR higher)) (SBAR (WHADVP (WRB when)) (S (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NN DNA)))) (VP (VBZ is) (VP (VBN reduced)))))))) (. .)))
( (S (S (NP (NP (NN Error) (NNS bars)) (PP (IN in) (NP (NP (NN B)) (CC and) (NP (NN C))))) (VP (VBD were) (VP (VBN obtained) (PP (IN by) (S (VP (VBG using) (NP (NP (DT the) (NP (NP (CD 5th)) (CC and) (NP (CD 95th))) (NNS percentiles)) (PP (IN in) (NP (DT the) (NN simulation) (S (VP (TO to) (VP (VB define) (NP (DT the) (NN FDR)))))))))))))) (. .)))
( (S (NP (NP (NN Table) (CD 1)) (: :) (NP (NP (NN Gene) (NN coverage)) (PP (IN of) (NP (DT the) (NN analysis)))))))
( (S (NP (NP (NN Table) (CD 2)) (: :) (NP (NP (JJ over-represented) (NNS motifs)) (VP (VBN detected) (PP (IN at) (NP (ADJP (CD <10) (NN %)) (JJ false) (NN discovery) (NN rate))))))))
( (S (NP (NP (NN Table) (CD 3)) (: :) (NP (NP (NN Interpretation)) (PP (IN of) (NP (JJ over-represented) (NNS motifs))) (PP (IN with) (NP (NP (NN respect)) (PP (TO to) (NP (VBN published) (NN evidence)))))) (. .))))
( (S (-LRB- -LRB-) (VP (VB See) (NP (NP (NN footnote)) (PP (IN for) (NP (NP (NN definition)) (PP (IN of) (NP (DT the) (NNS categories))))) (. .))) (-RRB- -RRB-)))
( (S (S (NP (NN BMP-6)) (VP (VBZ inhibits) (NP (NP (NN growth)) (PP (IN of) (NP (JJ mature) (JJ human) (NN B) (NNS cells)))))) (: ;) (NP (NP (NP (NN induction)) (PP (IN of) (NP (NN Smad) (NN phosphorylation)))) (CC and) (NP (NP (NN upregulation)) (PP (IN of) (NP (NN Id1)))))))
( (S (NP (NN Abstract))))
( (S (NP (NP (NN Background)) (: :) (S (NP (NP (NN Bone) (NN morphogenetic) (NNS proteins)) (PRN (-LRB- -LRB-) (NP (NN BMPs)) (-RRB- -RRB-))) (VP (VP (VBP belong) (PP (TO to) (NP (DT the) (NN TGF-β) (NN superfamily)))) (CC and) (VP (VBP are) (NP (NP (JJ secreted) (NNS proteins)) (PP (IN with) (NP (NP (JJ pleiotropic) (NNS roles)) (PP (IN in) (NP (JJ many) (JJ different) (NN cell) (NNS types))))))))) (. .))))
( (S (S (NP (NP (DT A) (JJ potential) (NN role)) (PP (IN of) (NP (NN BMP-6))) (PP (IN in) (NP (DT the) (JJ immune) (NN system)))) (VP (VBZ has) (VP (VBN been) (VP (VBD implied) (PP (IN by) (NP (NP (JJ various) (NNS studies)) (PP (IN of) (NP (ADJP (ADJP (JJ malignant)) (CC and) (ADJP (JJ rheumatoid))) (NNS diseases))))))))) (. .)))
( (S (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (PRP we)) (VP (VBD explored) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN BMP-6))) (PP (IN in) (NP (JJ normal) (JJ human) (JJ peripheral) (NN blood) (NN B) (NNS cells)))))) (. .)))
( (S (NP (NP (NNS Results)) (: :) (S (S (NP (DT The) (NN B) (NNS cells)) (VP (VBD were) (VP (VBN found) (S (VP (TO to) (VP (VB express) (NP (NP (NP (NN BMP) (NN type) (CD I)) (CC and) (NP (NN type) (CD II))) (NNS receptors)))))))) (CC and) (S (NP (NN BMP-6)) (ADVP (RB rapidly)) (VP (VBD induced) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN Smad1/5/8))))))) (. .))))
( (S (S (ADVP (RB Furthermore)) (, ,) (NP (NN Smad-phosphorylation)) (VP (VBD was) (VP (VBN followed) (PP (IN by) (NP (NP (NN upregulation)) (PP (IN of) (NP (NP (NN Id1) (NN mRNA)) (CC and) (NP (NN Id1) (NN protein))))))) (, ,) (SBAR (IN whereas) (S (NP (NP (NN Id2)) (CC and) (NP (NN Id3)) (NP (NN expression))) (VP (VBD was) (RB not) (VP (VBN affected))))))) (. .)))
( (S (ADVP (RB Furthermore)) (, ,) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP (NN BMP-6)) (VP (VBD had) (NP (DT an) (JJ antiproliferative) (NN effect)) (PP (CC both) (IN in) (NP (NP (NP (JJ naïve) (-LRB- -LRB-) (JJ CD19+CD27-) (-RRB- -RRB-) (CC and) (NN memory) (NN B) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN CD19+CD27+)) (-RRB- -RRB-))) (VP (VBN stimulated) (PP (IN with) (NP (NP (NP (NN anti-IgM)) (ADVP (RB alone))) (CC or) (NP (NP (DT the) (JJ combined) (NN action)) (PP (IN of) (NP (NP (NN anti-IgM)) (CC and) (NP (NN CD40L)))))))))))))) (. .)))
( (S (S (ADVP (RB Additionally)) (, ,) (NP (NN BMP-6)) (VP (VBD induced) (NP (NN cell) (NN death)) (PP (IN in) (NP (VBN activated) (NN memory) (NN B) (NNS cells))))) (. .)))
( (S (S (ADVP (RB Importantly)) (, ,) (NP (NP (DT the) (JJ antiproliferative) (NN effect)) (PP (IN of) (NP (NN BMP-6))) (PP (IN in) (NP (NNS B-cells)))) (VP (VBD was) (ADVP (RB completely)) (VP (VBD neutralized) (PP (IN by) (NP (NP (DT the) (JJ natural) (NN antagonist)) (, ,) (NP (NN noggin))))))) (. .)))
( (S (S (ADVP (RB Furthermore)) (, ,) (NP (NN B) (NNS cells)) (VP (VBD were) (VP (VBN demonstrated) (S (VP (TO to) (VP (VB upregulate) (NP (NN BMP-6) (NN mRNA)) (PP (IN upon) (NP (NP (NN stimulation)) (PP (IN with) (NP (NN anti-IgM))))))))))) (. .)))
( (S (NP (NP (NN Conclusion)) (: :) (S (PP (IN In) (NP (JJ mature) (JJ human) (NN B) (NNS cells))) (, ,) (NP (NN BMP-6)) (VP (VP (VBD inhibited) (NP (NN cell) (NN growth))) (, ,) (CC and) (ADVP (RB rapidly)) (VP (VBD induced) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NP (NN Smad1/5/8)) (VP (VBN followed) (PP (IN by) (NP (NP (DT an) (NN upregulation)) (PP (IN of) (NP (NN Id1)))))))))))) (. .))))
( (S (NP (NN Background))))
( (S (S (NP (NP (NNS Members)) (PP (IN of) (NP (DT the) (NP (NP (NN transforming) (NN growth) (NN factor) (CD β)) (PRN (-LRB- -LRB-) (NP (NN TGF-β)) (-RRB- -RRB-))) (NN superfamily)))) (VP (VBP play) (NP (JJ central) (NNS roles)) (PP (IN in) (S (VP (VBG controlling) (NP (NP (JJ cellular) (NN proliferation)) (, ,) (NP (NN differentiation)) (, ,) (NP (NN migration)) (CC and) (NP (NN apoptosis)) (NP (NN -LSB-1)) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (DT These) (NNS cytokines)) (VP (MD can) (VP (VB be) (VP (VBN divided) (PP (IN into) (NP (NP (CD three) (NNS subgroups)) (: :) (NP (NP (NN TGF-β)) (, ,) (NP (DT the) (NN activins/inhibins)) (, ,) (CC and) (NP (NP (NP (DT the) (NN bone) (NN morphogenetic) (NNS proteins)) (PRN (-LRB- -LRB-) (NP (NN BMPs)) (-RRB- -RRB-))) (, ,) (SBAR (WHPP (IN of) (WHNP (WDT which))) (S (NP (DT the) (JJ latter)) (VP (VBP constitute) (NP (DT the) (JJS largest) (NN family))))))))))))) (. .)))
( (S (S (NP (NNS BMPs)) (VP (VBP are) (NP (NP (CD 30–38) (NN kDa) (ADJP (ADJP (JJ hetero-)) (CC or) (ADJP (JJ homodimeric))) (NNS proteins)) (VP (ADVP (RB originally)) (VBN identified) (PP (IN by) (NP (PRP$ their) (NN ability) (S (VP (TO to) (VP (VB induce) (NP (JJ ectopic) (NN cartilage) (CC and) (NN bone) (NN formation) (CD -LSB-2,3)))))))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (JJ Several) (NNS studies)) (VP (VP (VBP have) (VP (VBN demonstrated) (NP (NP (DT an) (JJ essential) (NN role)) (PP (IN of) (NP (DT these) (NNS proteins))) (PP (IN during) (NP (NN embryogenesis)))))) (, ,) (CC and) (ADVP (RBR more) (RB recently)) (, ,) (ADVP (RB also)) (PP (IN in) (NP (NP (JJ adult) (NNS tissues)) (PRN (NN -LSB-1) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (NN TGF-β)) (VP (VP (VBZ has) (VP (VBN been) (ADVP (RB intensively)) (VP (VBN studied) (PP (IN in) (NP (ADJP (ADJP (JJ normal)) (CC and) (ADJP (JJ malignant))) (JJ haematopoietic) (NNS cells)))))) (CC and) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (ADJP (RBS most) (JJ potent)) (JJ endogenous) (JJ negative) (NNS regulators)) (VP (VBN known) (PP (TO to) (NP (NN date)))))))))) (. .)))
( (S (S (NP (NN -LSB-4)) (-RRB- -RSB-)) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN BMPs))) (PP (IN in) (NP (DT the) (JJ immune) (NN system)))) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB widely)) (VP (VBN investigated))))) (. .)))
( (S (S (PP (IN In) (NP (DT that) (NN respect))) (, ,) (NP (NP (NN BMP-) (CD 2)) (, ,) (NP (NP (CD -4)) (CC and) (NP (CD -7)))) (VP (VBP have) (VP (VBN been) (VP (VBN found) (S (VP (TO to) (VP (VB control) (NP (NP (NP (NP (NN differentiation)) (PP (IN of) (NP (JJ hematopoietic) (NN stem) (NNS cells)))) (CD -LSB-5) (-RRB- -RSB-)) (CC and) (NP (JJ early) (NN T) (NN cell) (NN development) (CD -LSB-6,7) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (NP (NN BMP-6)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB reduce) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (JJ cobblestone-area-forming) (NNS cells)) (PRN (PP (IN of) (NP (JJ normal) (JJ human) (JJ haematopoietic) (NNS cells))) (NP (NN -LSB-8)) (-RRB- -RSB-)))))))))))) (. .)))
( (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (NN BMP-2)) (, ,) (NP (CD -4)) (, ,) (NP (CD 6)) (CC and) (NP (CD -7))) (VP (VBD had) (NP (DT an) (ADJP (ADJP (JJ antiproliferative)) (CC and) (ADJP (NN a) (JJ proapoptotic))) (NN effect)) (PP (IN on) (NP (NP (NP (JJ multiple) (NN myeloma)) (NNS cells)) (NN -LSB-9-11)))) (-RRB- -RSB-)) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (PP (IN by) (NP (NN gene) (NN expression) (NN profiling))) (, ,) (NP (NN BMP-6)) (ADVP (RB significantly)) (VP (VP (VBD increased) (NP (NP (DT the) (JJ predictive) (NN value)) (PP (IN for) (NP (DT a) (NN multi-gene) (NN signature) (NN test))))) (CC and) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (JJ poor) (NN outcome)) (PP (IN in) (NP (NP (JJ diffuse) (JJ large) (NN B) (NN cell) (NNS lymphomas)) (PRN (-LRB- -LRB-) (NP (NN DLBCL) (-RRB- -RRB-) (CD -LSB-12)) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (NP (NN BMP-6)) (, ,) (PP (IN like) (NP (DT the) (JJ other) (NN BMP) (NNS members))) (, ,) (VP (VBZ signals) (PP (IN through) (NP (NP (NP (NN ligation)) (CC and) (NP (NN heterodimerzation))) (PP (IN of) (NP (NN BMP) (NN type) (NP (NP (CD I) (NN -LSB-activin-like-kinase)) (PRN (-LRB- -LRB-) (NP (NN ALK)) (-RRB- -RRB-) (-RRB- -RSB-))) (CC and) (NP (NN type) (CD II)) (NP (NN serine-threonine) (NN kinase) (NNS receptors)))) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB subsequently)) (VP (VBZ propagates) (NP (NP (DT the) (NN signal)) (ADJP (JJ downstream) (PP (IN by) (S (VP (VBG phosphorylating) (NP (NN Smad) (NNS proteins)))))))))))))) (. .)))
( (S (S (NP (NN BMP-6)) (VP (MD can) (VP (VB signal) (PP (IN through) (NP (NP (DT the) (NN ligation)) (PP (IN of) (NP (NP (NP (DT the) (NN type) (NN I) (NNS receptors)) (NP (NP (NN Act-RIA)) (, ,) (NP (NN BMP-RIA)) (, ,) (CC and) (NP (NN BMP-RIB)))) (CC and) (NP (NP (DT the) (NP (NN type) (CD II)) (NNS receptors)) (NP (NP (NN BMP-RII)) (, ,) (NP (NN Act-RIIA)) (CC and) (NP (NN Act-RIIB)))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP lead) (PP (TO to) (NP (NP (DT the) (NN phosphorylation)) (PP (IN of) (NP (NP (DT the) (NN receptor) (NN Smads)) (PRN (-LRB- -LRB-) (NP (NP (NN Smad-1)) (, ,) (NP (NN Smad-5)) (, ,) (CC and) (NP (NN Smad-8))) (-RRB- -RRB-)))))))))))))) (. .)))
( (S (S (NP (DT The) (NN R-) (NNS Smads)) (VP (VP (ADVP (RB then)) (VBP form) (NP (NP (NNS complexes)) (PP (IN with) (NP (NP (DT the) (NN co-Smad)) (PRN (-LRB- -LRB-) (NP (NN Smad4)) (-RRB- -RRB-)))))) (CC and) (VP (VBP are) (VP (VBN translocated) (PP (IN into) (NP (NP (DT the) (NN nucleus)) (SBAR (WHADVP (WRB where)) (S (NP (PRP they)) (VP (VBP exert) (NP (NN gene) (NN regulation) (CD -LSB-1,13) (-RRB- -RSB-))))))))))) (. .)))
( (S (S (PP (IN Given) (NP (NP (DT the) (VBN reported) (NN role)) (PP (IN of) (NP (NN BMP-6))) (PP (IN in) (NP (NP (NN B-cell) (NNS malignancies)) (CC and) (NP (JJ haematopoietic) (NN progenitor) (NNS cells)))))) (, ,) (NP (PRP we)) (VP (VBD wanted) (S (VP (TO to) (VP (VB explore) (NP (NP (PRP$ its) (JJ potential) (NN role)) (PP (IN in) (NP (JJ normal) (JJ human) (NN B) (NNS cells))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD studied) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN BMP-6))) (PP (IN on) (NP (NP (NN proliferation)) (CC and) (NP (NN apoptosis)))) (PP (IN on) (NP (ADJP (ADJP (JJ resting)) (CC and) (ADJP (JJ stimulated))) (NN B) (NNS cells)))))) (. .)))
( (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN BMP) (NNS receptors)))) (CC and) (NP (NN BMP-6))) (VP (VBD induced) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NN Smad) (NN signalling) (NN pathway)))) (PP (IN with) (NP (NP (JJ subsequent) (NN regulation)) (PP (IN of) (NP (DT the) (NN target) (NNS genes) (NP (NNP Id1–Id4)))) (, ,) (VP (VBD were) (VP (VBN resolved))))))) (. .)))
( (S (S (ADVP (RB Finally)) (, ,) (NP (PRP we)) (VP (VBD investigated) (SBAR (IN whether) (S (NP (NN B) (NNS cells)) (ADVP (RB also)) (VP (VBD were) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG producing) (NP (NN BMP-6))))))))))) (. .)))
( (S (NP (NNS Results))))
( (S (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NN BMP-6))) (PP (IN on) (NP (ADJP (ADJP (JJ normal)) (CC and) (ADJP (JJ neoplastic))) (JJ hematopoietic) (NNS cells)))) (VP (VBD prompted) (S (NP (PRP us)) (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN BMP-6))) (PP (IN on) (NP (JJ normal) (JJ human) (NN B) (NNS cells))))))))) (. .)))
( (S (S (NP (NP (DT All) (NNS experiments)) (PP (IN in) (NP (DT this) (NN study)))) (VP (VBD were) (VP (VBN performed) (PP (IN under) (NP (JJ serum-free) (NNS conditions))) (SBAR (IN as) (S (NP (NN FCS)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB interfere) (PP (IN with) (NP (NP (JJ BMP-signalling) (NN -LSB-14) (-RRB- -RSB-)) (PRN (-LRB- -LRB-) (NP (JJ own) (NNS observations)) (-RRB- -RRB-))))))))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB study) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN BMP-6))) (PP (IN on) (NP (NN proliferation))))))) (, ,) (NP (NP (NNS B-cells)) (PP (IN from) (NP (JJ healthy) (NNS volunteers)))) (VP (VBD were) (VP (VBN stimulated) (PP (IN with) (NP (NP (NN anti-IgM)) (CC and/or) (NP (NN CD40L)))) (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC or) (NP (NN absence))) (PP (IN of) (NP (NP (CD BMP-6)) (PP (IN for) (NP (CD three) (NNS days)))))))))) (. .)))
( (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (NN BMP-6)) (VP (VBD led) (PP (TO to) (NP (NP (DT a) (CD 35) (NN %) (NN mean) (NN reduction)) (PP (IN of) (NP (NP (JJ anti-IgM-) (JJ induced) (NN DNA) (NN synthesis)) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 8)) (: ;) (NP (NN p) (JJ ≤) (NN 0.0002)) (, ,) (NP (NN Figure) (NN 1A)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (JJ Similar) (NNS results)) (VP (VBD were) (VP (VBN obtained) (PP (IN for) (NP (NP (NN B) (NNS cells)) (VP (VBN treated) (PP (IN with) (NP (NP (NN anti-IgM)) (CC and) (NP (NN CD40L)))) (PRN (-LRB- -LRB-) (NP (CD 26) (NN %) (NN mean) (NN reduction)) (, ,) (S (S (NP (NN n)) (VP (JJ =) (NP (CD 6)))) (: ;) (S (NP (NN p)) (VP (JJ ≤) (NP (CD 0.023))))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ BMP-6-induced) (NN inhibition)) (PP (IN of) (NP (NN proliferation)))) (VP (VBD was) (ADJP (JJ dose-dependent)) (PP (IN in) (NP (CC both) (NP (NP (JJ peripheral) (NN B) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1B)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (DT the) (NN Burkitt) (NN lymphoma) (NN cell) (NN line)) (NP (NN Ramos))) (PRN (-LRB- -LRB-) (FRAG (NP (NP (ADJP (CD 40) (NN %)) (NN reduction)) (PP (IN of) (NP (NN DNA) (NN synthesis)))) (, ,) (NP (NN Figure) (NN 1C))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (DT The) (JJ BMP-6) (NNS effects)) (VP (MD could) (VP (VB be) (VP (VBN reversed) (PP (IN by) (NP (NP (NN addition)) (PP (IN of) (NP (NP (DT the) (JJ extracellular) (NN inhibitor) (NN Noggin)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1D)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (ADVP (RB Similarly)) (, ,) (NP (NP (DT a) (NN combination)) (PP (IN of) (NP (NP (DT the) (JJ soluble) (NN BMP) (NNS receptors)) (NP (NP (NN BMP-RIB-Fc)) (CC and) (NP (NN BMP-RII-Fc)))))) (ADVP (RB also)) (VP (VBD neutralized) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN BMP-6)))) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))) (. .)))
( (S (S (ADVP (RB Next)) (, ,) (NP (PRP we)) (VP (VBD wanted) (S (VP (TO to) (VP (VB test) (SBAR (IN whether) (S (NP (NN BMP-6)) (VP (VBD had) (NP (JJ different) (NN effect)) (PP (IN on) (NP (UCP (ADJP (JJ naïve)) (CC and) (NP (NN memory))) (NN B) (NNS cells))))))))))) (. .)))
( (S (S (NP (NP (NP (NN Naïve) (-LRB- -LRB-) (CD CD19+CD27-) (-RRB- -RRB-)) (CC and) (NP (NN memory) (-LRB- -LRB-) (CD CD19+CD27+) (-RRB- -RRB-))) (NN B) (NNS cells)) (VP (VBD were) (VP (VP (VBN isolated) (PP (IN from) (NP (JJ peripheral) (NN blood))) (PP (IN by) (NP (NP (NN cell) (NN sorting)) (PP (IN of) (NP (JJ immunobead-isolated) (CD CD19+) (NN B) (NNS cells) (CD -LSB-15) (-RRB- -RSB-)))))) (, ,) (CC and) (VP (VBN tested) (PP (IN for) (NP (PRP$ their) (NN capacity) (S (VP (TO to) (VP (VB proliferate) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN BMP-6)))))))))))))) (. .)))
( (S (ADVP (RB However)) (, ,) (NP (NN BMP-6)) (VP (VBD inhibited) (NP (NP (JJ anti-IgM) (JJ induced) (NN DNA) (NN synthesis)) (PP (IN in) (NP (DT the) (CD two) (NNS subpopulations)))) (PP (TO to) (NP (DT a) (JJ similar) (NN extent))) (, ,) (PP (IN with) (NP (NP (DT a) (JJ mean) (NN reduction)) (PP (IN of) (NP (NP (NN DNA-synthesis)) (PP (IN of) (NP (NP (NP (NP (CD 45) (NN %)) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 5)) (: ;) (NP (NN p) (NN ≤) (CD 0,004)) (-RRB- -RRB-))) (PP (IN for) (NP (JJ naïve) (NN B) (NNS cells)))) (CC and) (NP (NP (NP (CD 48) (NN %)) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 5)) (: ;) (NP (NN p) (NN ≤) (NN 0,001)) (-RRB- -RRB-))) (PP (IN for) (NP (NP (NN memory) (NN B) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1E)) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (ADVP (RB Next)) (, ,) (NP (PRP we)) (VP (VBD wanted) (S (VP (TO to) (VP (VB establish) (SBAR (IN whether) (S (NP (NN BMP-6)) (ADVP (RB also)) (VP (MD could) (VP (VB affect) (NP (NP (DT the) (NN viability)) (PP (IN of) (NP (JJ normal) (NN B) (NNS cells))))))))))))) (. .)))
( (S (S (NP (NN Cell) (NN viability)) (VP (VBD was) (VP (VBN determined) (PP (IN by) (NP (NP (NP (NP (NN propidium) (NN iodide)) (PRN (-LRB- -LRB-) (NP (NN PI)) (-RRB- -RRB-))) (NN staining)) (PP (IN after) (NP (NN culture))) (PP (PP (IN with)) (CC or) (PP (IN without) (NP (NN BMP-6)))) (PP (IN for) (NP (CD 48) (NNS hours)))))))) (. .)))
( (S (ADVP (RB Interestingly)) (, ,) (NP (NN BMP-6)) (VP (VBD showed) (NP (NP (DT a) (ADJP (ADJP (JJ small)) (, ,) (CC but) (ADJP (JJ reproducible))) (NN mean) (NN increase)) (PP (IN of) (NP (NP (NN cell) (NN death)) (PP (IN from) (NP (NP (QP (CD 17) (TO to) (CD 23)) (NN %)) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 5)) (: ;) (S (NP (NN p)) (VP (JJ ≤) (NP (CD 0,003)))) (-RRB- -RRB-)))))) (PP (IN in) (NP (JJ anti-IgM) (VBN stimulated) (JJ CD27+) (NN memory) (NN B) (NNS cells))))) (. .)))
( (S (ADVP (RB Furthermore)) (, ,) (NP (NN Ramos) (NNS cells)) (VP (VBD showed) (NP (NP (DT a) (JJ mean) (NN increase)) (PP (IN in) (NP (NN cell) (NN death)))) (PP (IN from) (NP (QP (CD 20) (TO to) (CD 50)) (NN %))) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 3)) (, ,) (NP (NP (NN p) (NN <) (CD 0,001)) (, ,) (NP (NN figure) (CD 3))) (-RRB- -RRB-)) (PP (IN after) (NP (NN BMP-6) (NN treatment)))) (. .)))
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NN cell) (NN death)) (PP (IN of) (NP (NP (NP (JJ total) (NN CD19+) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 6)) (: ;) (NP (NN p) (NN ≤) (CD 0,32)) (: ;) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-))) (CC or) (NP (NN CD27-IgG-) (JJ naïve) (NN B) (NNS cells))))) (VP (VBD was) (RB not) (ADVP (RB significantly)) (VP (VBN affected) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 5)) (: ;) (NP (NN p) (NN ≤) (CD 0,65)) (, ,) (NP (NN figure) (CD 2)) (-RRB- -RRB-)))) (. .)))
( (S (S (NP (NP (JJ Detailed) (NN knowledge)) (PP (VBG regarding) (NP (NP (NN expression)) (PP (IN of) (NP (JJ different) (NN BMP) (NNS receptors))) (PP (IN in) (NP (NN B) (NNS cells)))))) (VP (VBZ is) (ADVP (RB currently)) (RB not) (ADJP (JJ available)))) (. .)))
( (S (S (S (VP (TO To) (ADVP (RB further)) (VP (VB elucidate) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN BMPs))) (PP (IN in) (NP (JJ human) (NN B) (NNS cells))))))) (, ,) (NP (PRP we)) (VP (VBD performed) (NP (NP (NN western) (NN blot) (NN analysis)) (PP (IN for) (NP (NP (NN type) (CD I)) (CC and) (NP (NN type) (CD II)) (NP (NN BMP) (NNS receptors))))))) (. .)))
( (S (NP (DT This) (NN analysis)) (VP (VBD revealed) (SBAR (IN that) (S (NP (NP (NP (DT the) (NN type) (NN I) (NNS receptors)) (NP (NP (NN Act-RIA)) (, ,) (NP (NN BMP-RIB)))) (CC and) (NP (NP (DT the) (NN type) (NN II) (NNS receptors)) (NP (NP (NN BMP-RII)) (CC and) (NP (NN Act-RIIb))))) (VP (VBP are) (VP (VBN expressed) (PP (IN on) (NP (NP (VBG resting) (JJ human) (NNS B-cells)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 4)) (-RRB- -RRB-))))))))) (. .)))
( (S (NP (NN Ramos) (NNS cells)) (VP (VP (VBD expressed) (NP (NP (NP (DT the) (NN type) (NN I) (NNS receptors)) (NP (NP (NN Act-RIA)) (, ,) (ADVP (RB weakly)) (NP (NN BMP-RIB)))) (CC and) (NP (DT the) (NN type) (NN II) (NN receptor) (CD BMP-RII)))) (, ,) (CC but) (VP (ADVP (RBR more) (RB weakly)) (PP (IN than) (NP (NP (JJ normal) (NN B) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 4)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NN HL60) (NNS cells)) (VP (VBD were) (VP (VBN used) (PP (IN for) (NP (NP (NN comparison)) (CC and) (NP (ADJP (RB weakly) (VBN expressed)) (NP (NP (NN Act-RIA)) (CC and) (NP (NN BMP-RII))))))))) (. .)))
( (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (NP (DT these) (NNS data)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (JJ normal) (JJ human) (NN B) (NNS cells)) (CC and) (NP (NN Ramos) (NNS cells))) (VP (VBP express) (NP (NP (DT a) (NN set)) (PP (IN of) (NP (NN BMP) (NNS receptors))) (, ,) (VP (ADVP (RB previously)) (VBN shown) (S (VP (TO to) (VP (VB bind) (NP (NN BMP-6) (NN -LSB-16)))))) (-RRB- -RSB-)))))) (. .)))
( (S (S (PP (IN Upon) (NP (NN ligand) (NN binding))) (, ,) (NP (DT the) (NN type) (CD II) (NN receptor)) (VP (VP (VBZ transphosphorylates)) (CC and) (VP (VBZ activates) (NP (DT the) (NN type) (NN I) (NN receptor))))) (. .)))
( (S (S (NP (NN Type) (NN I) (NNS receptors)) (VP (MD can) (VP (VB signal) (PP (IN via) (NP (JJ several) (NNS pathways)))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD examined) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN BMP-6))) (PP (IN on) (NP (NN Smad) (NN phosphorylation)))) (, ,) (SBAR (IN as) (S (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN Smad)))) (VP (VBZ is) (VP (VBN considered) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (JJ major) (NN signalling) (NN pathway)) (PP (IN for) (NP (NNS BMPs) (CD -LSB-17) (-RRB- -RSB-))))))))))))) (. .)))
( (S (S (NP (NN B) (NNS cells)) (VP (VBD were) (VP (VP (VBN cultured) (PP (IN in) (NP (JJ serum-free) (NNS media))) (PP (IN over) (NP (NN night)))) (CC and) (ADVP (RB then)) (VP (VBN treated) (PP (IN with) (NP (NN BMP-6))) (PP (IN for) (NP (JJ various) (NN time) (NNS points))))))) (. .)))
( (S (S (S (NP (JJ Total) (NN protein) (NNS lysates)) (VP (VBD were) (VP (VBN prepared)))) (, ,) (CC and) (S (NP (NP (DT the) (NNS amounts)) (PP (IN of) (NP (NP (DT the) (VBN phosphorylated) (NNS forms)) (PP (IN of) (NP (NN Smad1/5/8)))))) (VP (VBD were) (VP (VBN determined) (PP (IN by) (NP (NN western) (NN blot) (NN analysis))))))) (. .)))
( (S (S (ADVP (RB Interestingly)) (, ,) (NP (NP (NN treatment)) (PP (IN with) (NP (ADJP (CD 500) (NN ng/ml)) (NN BMP-6)))) (VP (VBD induced) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN Smad)))))) (. .)))
( (S (S (NP (DT The) (JJ BMP-6) (VBN induced) (NN phosphorylation)) (VP (VP (VBD was) (ADJP (JJ high)) (PP (IN at) (NP (NP (DT the) (JJS earliest) (NN time) (NN point)) (VP (VBN tested)))) (PRN (-LRB- -LRB-) (NP (CD 15) (NNS minutes)) (-RRB- -RRB-))) (, ,) (CC and) (VP (VBD remained) (ADJP (JJ high)) (PP (IN for) (NP (QP (IN at) (JJS least) (CD 48)) (NNS hours))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 5)) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (DT A) (JJ similar) (NN phosphorylation)) (VP (VBD was) (VP (VBN observed) (PP (PP (IN in) (NP (NN Ramos) (NNS cells))) (, ,) (CC but) (PP (RB not) (IN in) (NP (NP (NN HL60) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 6)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (ADVP (RB Furthermore)) (, ,) (NP (PRP we)) (ADVP (RB also)) (VP (VBD tested) (SBAR (IN whether) (S (NP (NP (JJ other) (JJ known) (JJ downstream) (NN signalling) (NNS pathways)) (PP (IN of) (NP (NN BMP-6)))) (VP (MD could) (VP (VB be) (VP (VBN triggered) (PP (IN by) (NP (NN BMP-6))) (PP (IN in) (NP (JJ human) (NN B) (NNS cells)))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (PRP we)) (VP (VBD did) (RB not) (VP (VB observe) (NP (NP (DT any) (JJ significant) (NNS changes)) (PP (IN in) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NP (NN phospho-STAT3)) (CC or) (NP (NN phospho-p38)))))) (PP (IN upon) (NP (NP (QP (CD BMP-6)) (NN treatment)) (PP (IN of) (NP (NN B) (NNS cells)))))) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-))))) (. .)))
( (S (S (ADVP (RB Next)) (, ,) (NP (PRP we)) (VP (VBD wanted) (S (VP (TO to) (VP (VB explore) (SBAR (IN whether) (S (NP (NP (DT the) (ADJP (NN BMP-6) (JJ induced)) (NN phosphorylation)) (PP (IN of) (NP (NN Smad) (NN 1/5/8)))) (VP (ADVP (RB also)) (MD could) (VP (VB induce) (NP (NP (JJ transcriptional) (NNS changes)) (PP (IN of) (NP (NN target) (NNS genes))))))))))))) (. .)))
( (S (PP (IN In) (NP (DT this) (NN regard))) (, ,) (NP (NP (DT the) (NNS inhibitors)) (PP (IN of) (NP (NP (NN DNA) (NN binding) (NNS proteins)) (PRN (-LRB- -LRB-) (NP (NNS Ids)) (-RRB- -RRB-))))) (VP (VBP are) (VP (VBN considered) (S (VP (TO to) (VP (VB be) (NP (NP (DT some)) (PP (IN of) (NP (NP (DT the) (JJ major) (NN target) (NNS genes)) (PP (IN for) (NP (JJ Smad-signalling) (NN -LSB-17)))))))) (-RRB- -RSB-)))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (NP (NN B) (NNS cells)) (VP (VBD were) (VP (VP (VBN pre-incubated) (PP (IN over) (NP (NP (NN night)) (PP (IN in) (NP (NN X-VIVO) (CD 15)))))) (, ,) (CC and) (VP (ADVP (RB then)) (VBN cultured) (PP (IN in) (NP (NP (NN medium)) (UCP (ADVP (RB alone)) (CC or) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN BMP-6)))))))) (PP (IN for) (NP (NP (JJ various) (NN time) (NNS points)) (PP (IN before) (NP (NP (NN preparation)) (PP (IN of) (NP (JJ total) (NN RNA))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN amount)) (PP (IN of) (NP (NN Id1–Id4) (NN mRNA)))) (VP (VBD was) (VP (VBN quantified) (PP (IN by) (NP (JJ real-time) (NN RT-PCR)))))) (. .)))
( (S (S (ADVP (RB Interestingly)) (, ,) (NP (PRP we)) (VP (VBD observed) (NP (NP (DT a) (JJ specific) (JJ four-fold) (NN upregulation)) (PP (IN of) (NP (NN Id1) (NN mRNA))) (PP (IN in) (NP (NP (JJ BMP-6-treated) (NN B) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 7)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (DT The) (NN up-regulation)) (PP (IN of) (NP (NN Id1) (NN mRNA)))) (VP (VP (VBD was) (ADJP (JJ characteristic) (PP (IN of) (NP (DT an) (JJ early) (JJ inducible) (NN gene))) (, ,) (PP (IN with) (NP (JJ maximal) (NN upregulation)))) (PP (NP (CD two) (NNS hours)) (IN after) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NN BMP-6)))))) (CC and) (VP (VBD returned) (PP (TO to) (NP (NN baseline))) (PP (IN after) (NP (CD 24) (NNS hours)))))) (. .)))
( (S (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (DT no) (JJ significant) (NNS changes)) (VP (VBD were) (VP (VBN observed) (PP (IN for) (NP (NP (NN Id2)) (CC and) (NP (NN Id3)) (NP (NN mRNA))))))) (, ,) (IN whereas) (S (NP (NNS Id4-transcripts)) (VP (VBD were) (RB not) (ADJP (ADJP (JJ detectable)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 7)) (, ,) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NN Western) (NN blot) (NN analysis)) (VP (VBD revealed) (SBAR (IN that) (S (NP (NP (DT the) (JJ BMP-6-induced) (NN upregulation)) (PP (IN of) (NP (NN Id1) (NN mRNA)))) (ADVP (RB also)) (VP (VBD was) (VP (VBN correlated) (PP (IN with) (NP (NP (NN upregulation)) (PP (IN of) (NP (NP (NN Id1) (NN protein)) (PP (IN as) (NP (NN well))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN increase)) (PP (IN in) (NP (NN Id1) (NN protein) (NN level)))) (VP (VP (VBD was) (ADJP (JJ detectable) (PP (IN after) (NP (CD one) (NN hour))))) (CC and) (VP (VBD increased) (PP (IN until) (NP (CD 24) (NNS hours))) (PP (IN after) (NP (NN BMP-6) (NN addition))) (, ,) (S (VP (VBG showing) (NP (NP (DT a) (JJ 16-fold) (NN upregulation)) (PP (VBN compared) (PP (IN with) (NP (NP (NP (NN t0)) (PRN (-LRB- -LRB-) (NP (NN p) (JJ ≤) (NN 0.020)) (, ,) (S (NP (NN n)) (VP (JJ =) (NP (CD 4)))) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NN Figure) (QP (CD 8) (CC and) (CD 9))) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NP (NN line)) (PP (IN with) (NP (DT the) (NN mRNA) (NNS data))))) (, ,) (NP (NP (DT no) (JJ consistent) (NN change)) (PP (IN in) (NP (NP (DT the) (NNS amounts)) (PP (IN of) (NP (NP (NN Id2)) (CC and) (NP (NN Id3)) (NP (NN protein))))))) (VP (MD could) (VP (VB be) (VP (VBN observed) (PRN (-LRB- -LRB-) (NP (NN Figure) (QP (CD 8) (CC and) (CD 9))) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD were) (ADJP (JJ able) (S (VP (TO to) (VP (VB block) (NP (NP (DT the) (ADJP (NN Id1) (JJ specific)) (NN band)) (PP (IN with) (NP (DT a) (NN blocking) (NN peptide)))))))) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))) (. .)))
( (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (S (NP (DT these) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN Id1)) (VP (MD could) (VP (VB be) (NP (NP (DT a) (JJ possible) (NN target) (NN gene)) (PP (IN for) (S (VP (VBG mediating) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN BMP-6))) (PP (IN in) (NP (JJ human) (NN B) (NNS cells))))))))) (, ,) (SBAR (IN whereas) (S (NP (NP (NN Id2)) (CC and) (NP (NN Id3))) (RB not) (VP (VBP seem) (S (VP (TO to) (VP (VB be) (VP (VBN involved))))))))))))) (. .)))
( (S (S (NP (DT The) (NN fact) (SBAR (IN that) (S (NP (NN BMP-6)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB act) (PP (IN as) (NP (NP (DT an) (JJ autocrine) (NN stimulator)) (PP (IN in) (NP (NNS chondrocytes) (NP (NP (CD -LSB-18) (-RRB- -RSB-)) (CC and) (NP (NP (NN ovarium)) (CD -LSB-19) (-RRB- -RSB-))))))))))))))) (, ,)) (VP (VBD prompted) (S (NP (PRP us)) (VP (TO to) (VP (VB investigate) (SBAR (IN whether) (S (NP (JJ normal) (JJ human) (NN B) (NNS cells)) (VP (MD could) (VP (VB produce) (NP (NN BMP-6)) (PP (IN upon) (NP (NN stimulation)))))))))))) (. .)))
( (S (S (NP (NP (NN Ramos) (NNS cells)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (VP (VBN been) (VP (VBN described) (S (VP (TO to) (VP (VB express) (NP (NP (NP (NN BMP-6) (NN mRNA)) (PRN (QP (RB endogenously) (CD -LSB-20)) (-RRB- -RSB-))) (, ,) (CC and) (NP (DT the) (NN T) (NN cell) (NN line) (NN Jurkat))))))))))) (, ,)) (VP (VBD served) (PP (IN as) (NP (ADJP (ADJP (JJ positive)) (CC and) (ADJP (JJ negative))) (NNS controls))) (, ,) (ADVP (RB respectively)))) (. .)))
( (S (S (NP (NP (JJ Endogenous) (JJ BMP-6) (NN mRNA) (NNS levels)) (PP (IN in) (NP (JJ normal) (NN B) (NNS cells)))) (VP (VBD were) (VP (VBN quantified) (PP (IN by) (NP (JJ real-time) (NN RT-PCR))) (PP (IN after) (NP (NP (NN stimulation)) (PP (IN with) (NP (NN anti-IgM))) (PP (IN for) (NP (JJ different) (NN time) (NNS points)))))))) (. .)))
( (S (ADVP (RB Interestingly)) (, ,) (NP (NP (DT the) (NN up-regulation)) (PP (IN of) (NP (NN BMP-6) (NN mRNA)))) (VP (VBD was) (NP (NP (NN characteristic)) (PP (IN of) (NP (DT an) (JJ early-to) (NN intermediate) (JJ inducible) (NN gene)))) (PP (IN with) (NP (JJ maximal) (NN upregulation))) (PP (NP (CD four) (NNS hours)) (IN after) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NN anti-IgM)))))) (. .)))
( (S (S (NP (NP (DT The) (NN level)) (PP (IN of) (NP (NN BMP-6) (NN mRNA)))) (VP (VBD was) (PP (ADVP (RB back)) (TO to) (NP (NN baseline))) (PP (IN after) (NP (CD 24) (NNS hours))) (PP (IN upon) (NP (NP (NN stimulation)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 10)) (-RRB- -RRB-)))))) (. .)))
( (S (S (ADVP (RB Furthermore)) (, ,) (NP (CC both) (NP (NN FCS)) (CC and) (NP (JJ human) (NN AB-serum))) (VP (VBD induced) (NP (NP (JJ significant) (NN upregulation)) (PP (IN of) (NP (NN BMP-6) (NN mRNA)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 11)) (-RRB- -RRB-)))) (. .)))
( (S (S (ADVP (RB Interestingly)) (, ,) (PP (IN in) (NP (DT a) (JJ separate) (NN study))) (NP (PRP we)) (VP (VBP have) (VP (VBN found) (SBAR (IN that) (S (NP (JJ normal) (JJ human) (NN T) (NNS cells)) (VP (VBP do) (RB not) (VP (VB express) (NP (NN BMP-6) (NN mRNA)) (PP (IN after) (NP (NP (NN activation)) (PRN (-LRB- -LRB-) (NP (NNP Sivertsen) (FW et) (FW al)) (, ,) (NP (NP (NN manuscript)) (PP (IN in) (NP (NN preparation)))) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (ADVP (RB Next)) (, ,) (NP (PRP we)) (VP (VP (VBD wanted) (S (VP (TO to) (VP (VB detect) (NP (NP (JJ BMP-6) (NN protein)) (PP (IN in) (NP (JJ normal) (NNS B-cells)))))))) (CC and) (VP (VBD tested) (NP (JJ various) (ADJP (RB commercially) (JJ available)) (NNS antibodies))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (PP (IN in) (NP (PRP$ our) (NNS hands))) (NP (DT these) (CD anti-BMP-6) (NNS antibodies)) (VP (VBD did) (RB only) (VP (VB recognize) (NP (NP (DT the) (JJ recombinant) (NN BMP-6) (NN protein)) (CC and) (RB not) (NP (DT the) (JJ native) (NN protein)))))) (. .)))
( (S (NP (NN Discussion))))
( (S (S (S (NP (JJ Recent) (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (NP (NP (DT an) (JJ important) (NN role)) (PP (IN for) (NP (NN BMP) (NN superfamily) (NNS members))) (PP (IN in) (NP (NP (JJ hematopoietic) (NN stem) (NNS cells)) (, ,) (NP (JJ early) (NP (NP (NNS thymocytes) (CD -LSB-6,7) (-RRB- -RSB-)) (CC and) (NP (NN B-cell) (NNS malignancies))) (CD -LSB-8,11,12) (-RRB- -RSB-)))))))) (, ,) (CC but) (S (NP (NP (DT a) (NN role)) (PP (IN for) (NP (NN BMPs))) (PP (IN in) (NP (JJ normal) (JJ human) (NN B) (NNS cells)))) (VP (VBZ has) (ADVP (RB previously)) (RB not) (VP (VBN been) (VP (VBN reported)))))) (. .)))
( (S (S (NP (DT The) (JJ present) (NN study)) (VP (VBD demonstrated) (NP (NP (DT a) (JJ significant) (JJ antiproliferative) (NN effect)) (PP (IN of) (NP (NN BMP-6))) (PP (IN in) (NP (JJ peripheral) (NN blood) (NN CD19+) (NN B) (NNS cells)))))) (. .)))
( (S (S (ADVP (RB Additionally)) (, ,) (NP (NN BMP-6)) (VP (VBD induced) (NP (NN cell) (NN death)) (PP (PP (IN in) (NP (JJ CD27+) (NN memory) (NN B) (NNS cells))) (CONJP (RB as) (RB well) (IN as)) (PP (IN in) (NP (DT a) (NP (NP (NN Burkitt) (NN lymphoma) (NN cell) (NN line)) (PRN (-LRB- -LRB-) (NP (NN Ramos)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (ADVP (RB Importantly)) (, ,) (NP (NN BMP-6)) (VP (VBD induced) (NP (NP (DT a) (ADJP (ADJP (JJ rapid)) (CC and) (ADJP (JJ marked))) (NN increase)) (PP (IN in) (NP (NN Smad-1/5/8) (NN phosphorylation)))))) (. .)))
( (S (S (ADVP (RB Furthermore)) (, ,) (NP (DT the) (ADJP (NN BMP-6) (JJ induced)) (NN Smad) (NN phosphorylation)) (VP (VBD was) (VP (VBN followed) (PP (IN by) (NP (NP (DT a) (JJ selective) (NN upregulation)) (PP (IN of) (NP (NP (NN Id1) (NN mRNA)) (CC and) (NP (JJ subsequent) (NN Id1) (NN protein))))))))) (. .)))
( (S (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (NP (DT the) (VBN demonstrated) (JJ antiproliferative) (NN effect)) (PP (IN of) (NP (NN BMP-6))) (PP (IN in) (NP (JJ anti-IgM) (JJ treated) (NN B) (NNS cells)))) (VP (VBD was) (ADJP (ADJP (JJ significant)) (CC and) (ADJP (JJ dose-dependent))))) (. .)))
( (S (S (ADVP (RB Importantly)) (, ,) (NP (NP (DT the) (JJ anti-proliferative) (NN effect)) (PP (IN of) (NP (NN BMP-6)))) (VP (MD could) (VP (VB be) (ADVP (RB completely)) (VP (VBD neutralized) (PP (IN by) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (DT a) (JJ natural) (NN inhibitor)) (, ,) (NP (NN Noggin)))))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBZ is) (PP (IN in) (NP (NP (NN line)) (PP (IN with) (NP (NNS others))))) (, ,) (S (VP (VBG showing) (SBAR (IN that) (S (NP (NN Noggin)) (VP (MD can) (VP (VB function) (PP (IN as) (NP (DT a) (JJ BMP-6) (NN antagonist) (NN -LSB-21,22))))) (-RRB- -RSB-))))))) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (DT the) (NN combination)) (PP (IN of) (NP (NP (JJ soluble) (NN BMP-RIB-Fc)) (CC and) (NP (NN BMP-RII-Fc) (NN fusion) (NNS proteins))))) (ADVP (RB also)) (VP (VBD neutralized) (NP (NP (DT the) (JJ anti-proliferative) (NN effect)) (PP (IN of) (NP (NN BMP-6))) (PP (IN in) (NP (JJ human) (NN B) (NNS cells)))))) (. .)))
( (S (S (ADVP (RB Interestingly)) (, ,) (PP (IN as) (PP (IN for) (NP (JJ other) (NN TGF) (NN family) (NNS members)))) (, ,) (NP (JJ bifunctional) (NNS effects)) (VP (VBP have) (ADVP (RB also)) (VP (VBN been) (VP (VBN demonstrated) (PP (IN for) (NP (NN BMPs))))))) (. .)))
( (S (SBAR (IN Whereas) (S (NP (NP (JJ several)) (PP (IN of) (NP (DT the) (NNS BMPs)))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB promote) (NP (NN proliferation)) (PP (IN in) (NP (NP (JJ various) (NN cell) (NNS types)) (PP (VBG including) (NP (NNS condrocytes) (CD -LSB-23) (-RRB- -RSB-))))))))))))) (, ,) (NP (NN liver) (NN -LSB-24) (-RRB- -RSB-) (CC and) (NP (NP (NN granulosa) (NNS cells) (CD -LSB-25) (-RRB- -RSB-)) (, ,) (NP (NP (JJ antiproliferative) (NNS effects)) (CC and) (NP (NP (NN induction)) (PP (IN of) (NP (NN apoptosis))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN for) (NP (NP (NN B)) (CC and) (NP (NN T)) (NP (NN lineage) (NNS cells))))))) (. .)))
( (S (S (NP (JJ Similar) (NNS effects)) (SBAR (IN as) (S (VP (VBN demonstrated) (PP (IN for) (NP (NP (NN BMP-6)) (PP (IN on) (NP (NP (JJ human) (NN B) (NNS cells)) (PP (IN in) (NP (DT the) (JJ present) (NN study)))))))))) (, ,) (VP (VBD were) (VP (VBN demonstrated) (PP (IN for) (NP (NP (NP (NN BMP-2)) (, ,) (NP (CD 4)) (, ,) (NP (CD 6)) (CC and) (NP (CD -7))) (PRN (PP (IN in) (NP (JJ human) (NN myeloma) (NNS cells))) (NP (NN -LSB-9-11)) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (NP (JJ Other) (NNS members)) (PP (IN of) (NP (DT the) (NN BMP-family)))) (VP (VBP have) (ADVP (RB also)) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB induce) (NP (NN apoptosis))))) (PRN (, ,) (PP (VBG including) (PP (IN in) (NP (NN mouse) (NN B) (NN lineage) (NNS cells)))) (NP (CD -LSB-26)) (-RRB- -RSB-)))))) (. .)))
( (S (S (ADVP (RB Additionally)) (, ,) (NP (NN BMP-4)) (VP (VBZ inhibits) (NP (NN thymocyte) (NN proliferation) (CD -LSB-6))) (-RRB- -RSB-)) (. .)))
( (S (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (NP (DT these) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN BMPs))) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (NN proliferation)) (CC and) (NP (NN apoptosis))))))) (VP (VBZ is) (ADJP (RB highly) (NP (NN cell) (NN type)) (JJ dependent))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB examine) (SBAR (WHADVP (WRB how)) (S (NP (NN BMP-6)) (VP (VBZ exerts) (NP (PRP$ its) (JJ functional) (NNS effects)) (PP (IN in) (NP (NN B) (NNS cells))))))))) (, ,) (NP (PRP we)) (VP (VBD analysed) (NP (NN BMP) (NN receptor) (NN expression)) (PP (IN by) (NP (NN western) (NN blot) (NN analysis))))) (. .)))
( (S (S (NP (JJ Human) (JJ peripheral) (NN B) (NNS cells)) (VP (VBD were) (VP (VBN found) (S (VP (TO to) (VP (VB express) (NP (NP (NP (DT the) (NN BMP) (NN type) (NN I) (NNS receptors)) (NP (NP (NN Act-RIA)) (CC and) (NP (NN BMP-RIB)))) (, ,) (CC and) (NP (NP (DT the) (NN type) (NNS II-receptors) (NP (NP (NN BMP-RII)) (CC and) (NP (NN Act-RIIb)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP signal) (PP (IN after) (NP (NP (NN binding)) (PP (IN of) (NP (NP (JJ several) (NNS BMPs)) (, ,) (PP (VBG including) (NP (NN BMP-6) (NN -LSB-16,13))))))))))) (-RRB- -RSB-)))))))) (. .)))
( (S (S (S (VP (TO To) (ADVP (RB further)) (VP (VB explore) (NP (JJ BMP-6) (JJ induced) (NN signalling))))) (, ,) (NP (NP (NN activation)) (PP (IN of) (NP (JJ several) (NNS pathways)))) (VP (VBZ is) (ADJP (JJ possible)))) (. .)))
( (S (S (NP (NP (DT The) (JJ major) (NN signalling) (NN pathway)) (VP (VBN known) (PP (TO to) (NP (NN date)))) (, ,)) (VP (VBZ is) (NP (NP (NN activation)) (PP (IN of) (NP (NN R-Smads) (CD -LSB-13,27))))) (-RRB- -RSB-)) (. .)))
( (S (S (PP (IN In) (NP (DT that) (NN respect))) (, ,) (NP (NNS BMPs)) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB exert) (NP (JJ antiproliferative) (NNS effects)) (PP (IN in) (NP (NN B) (NN lineage) (NNS cells))) (PP (IN via) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN R-Smad) (CD -LSB-11,28))))))))))) (-RRB- -RSB-)) (. .)))
( (S (S (ADVP (RB Furthermore)) (, ,) (NP (NN BMP-2)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB induce) (NP (NP (NN activation)) (PP (IN of) (NP (NN STAT3)))) (PP (IN in) (NP (NN myeloma) (NNS cells) (CD -LSB-9))) (-RRB- -RSB-)))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN R-Smad)))) (VP (VBD was) (RB not) (VP (VBN investigated) (PP (IN in) (NP (DT that) (NN study)))))) (. .)))
( (S (S (NP (NN BMP-2)) (VP (VBZ has) (ADVP (RB also)) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB induce) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN p38) (CD -LSB-29)))))) (-RRB- -RSB-)))))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NP (NN p38)) (, ,) (NP (NN STAT3)) (CC and) (NP (NN Smad1/5/8))))) (VP (VBP represent) (NP (NP (JJ important) (JJ BMP-signalling) (NNS pathways)) (SBAR (SBAR (WHNP (WDT that)) (S (VP (VBD mediated) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NNS BMPs))))))) (CC and) (SBAR (RB even) (S (NP (NP (NN cross-talk)) (PP (IN between) (NP (DT these) (NNS pathways)))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (NP (CD -LSB-29,30) (-RRB- -RSB-))))))))))) (. .)))
( (S (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (PRP we)) (VP (VBD were) (RB not) (ADJP (JJ able) (S (VP (TO to) (VP (VB detect) (NP (NP (JJ BMP-6-induced) (NNS changes)) (PP (IN in) (NP (NP (DT the) (NN phosphorylation) (NN status)) (PP (IN of) (NP (NP (NN STAT3)) (CC or) (NP (NN p38)))) (PP (IN in) (NP (JJ human) (JJ peripheral) (NN B) (NNS cells)))))))))))) (. .)))
( (S (S (ADVP (RB Instead)) (, ,) (NP (NP (DT a) (ADJP (ADJP (JJ rapid)) (CC and) (ADJP (JJ marked))) (NN phosphorylation)) (PP (IN of) (NP (NN Smad1/5/8)))) (VP (VBD was) (VP (VBN revealed)))) (. .)))
( (S (S (PP (IN In) (NP (DT a) (JJ parallel) (NN study))) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN found) (SBAR (IN that) (S (NP (JJ other) (NN BMPs)) (ADVP (RB also)) (VP (VBD induced) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN Smad1/5/8)))) (PP (IN in) (NP (JJ peripheral) (NN B) (NNS cells))) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP are) (ADVP (RB currently)) (VP (VBG pursuing) (S (NP (NN microarray) (NNS studies)) (VP (TO to) (VP (VB identify) (NP (NP (DT the) (NP (NN signalling) (NNS pathways)) (CC and) (NP (NN target) (NNS genes))) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB differently)) (VP (VBN regulated) (PP (IN by) (NP (NP (DT the) (JJ various) (NNS BMPs)) (PP (IN in) (NP (JJ human) (NN B) (NNS cells)))))))))))))))) (. .)))
( (S (S (NP (NP (NN Upregulation)) (PP (IN of) (NP (NN Id1))) (PP (IN via) (NP (NN Smad1/5/8) (NN phosphorylation)))) (VP (VBZ is) (NP (NP (DT a) (JJ known) (NN mechanism)) (PP (IN for) (NP (NN BMP-6) (NN signalling)))) (PRN (PP (IN in) (NP (JJ other) (NN cell) (NNS systems))) (NP (CD -LSB-31,32)) (-RRB- -RSB-)))) (CC and) (S (NP (NP (NN regulation)) (PP (IN of) (NP (NN Id-proteins)))) (VP (VBZ is) (VP (VBN thought) (S (VP (TO to) (VP (VB be) (NP (NP (DT an) (JJ important) (NN mechanism)) (PP (IN for) (NP (JJ Smad-signalling) (NN -LSB-17) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (JJ real-time) (NN RT-PCR) (NNS experiments)) (VP (VBD revealed) (NP (NP (DT a) (JJ specific) (JJ four-fold) (NN upregulation)) (PP (IN for) (NP (NN Id1))) (PP (IN in) (NP (JJ BMP-6-treated) (NN B) (NNS cells)))) (, ,) (SBAR (IN while) (S (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NN Id2–Id4)))) (VP (VBD remained) (ADJP (JJ unchanged))))))) (. .)))
( (S (S (PP (IN In) (NP (NP (NN agreement)) (PP (IN with) (NP (DT this))))) (, ,) (NP (NN western) (NN blot) (NN analysis)) (VP (VBD demonstrated) (NP (NP (DT an) (NN upregulation)) (PP (IN of) (NP (NN Id1) (NN protein)))) (, ,) (SBAR (IN while) (S (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NP (NN Id2)) (CC and) (NP (NN Id3)) (NP (NN protein) (NNS levels))))) (VP (VBD remained) (ADJP (JJ unchanged))))))) (. .)))
( (S (S (S (ADVP (RB Previously)) (, ,) (NP (NN Id1)) (VP (VBZ has) (VP (VBN been) (VP (VBN considered) (S (VP (RB not) (TO to) (VP (VB be) (VP (VBN expressed) (PP (IN in) (NP (NP (JJ later) (JJ developmental) (NNS stages)) (PP (IN than) (NP (NN pro-B) (NNS cells) (CD -LSB-33,34) (-RRB- -RSB-))))))))))))) (, ,) (CC and) (S (NP (PRP$ its) (JJ constitutive) (NN expression)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB impair) (NP (NN mouse) (NN B) (NN cell) (NN development) (CD -LSB-35) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (PRP$ our) (NN demonstration)) (PP (IN of) (NP (NP (DT the) (JJ time-dependent) (NN upregulation)) (PP (IN of) (NP (NN Id1) (NP (NP (NN mRNA)) (CC and) (NP (NN protein))))) (PP (IN in) (NP (JJ mature) (JJ normal) (JJ human) (NN B) (NNS cells)))))) (VP (VBZ is) (PP (IN of) (NP (JJ particular) (NN interest))))) (. .)))
( (S (PP (IN In) (NP (DT that) (NN respect))) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN noteworthy) (SBAR (IN that) (S (NP (NP (JJ TGF-β) (NN signalling)) (PP (IN in) (NP (ADJP (ADJP (JJ early)) (CC and) (ADJP (JJ mature))) (NN B) (NNS cells)))) (VP (VBZ induces) (NP (NP (CC both) (NP (NN Id2)) (CC and) (NP (NN Id3)) (NP (NN expression) (CD -LSB-36,37) (-RRB- -RSB-))) (, ,) (CONJP (CC but) (RB not)) (NP (NP (NN Id1)) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (ADVP (RB Interestingly)) (, ,) (NP (DT these) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (JJ various) (NNS members)) (PP (IN of) (NP (DT the) (NN TGF-β) (NN family)))) (VP (VBP regulate) (NP (NN Id) (NNS proteins)) (ADVP (RB differently))))))) (. .)))
( (S (S (NP (NP (NN Id2)) (CC and) (NP (NN Id3))) (VP (VBP are) (VP (VBN considered) (S (VP (TO to) (VP (VB be) (NP (NP (DT the) (NN Id) (NNS proteins)) (VP (ADVP (RB mainly)) (VBN expressed) (PP (IN in) (NP (NP (JJ mature) (NN B) (NNS cells)) (PRN (NN -LSB-38) (-RRB- -RSB-)))))))))))) (. .)))
( (S (S (NP (DT The) (JJ present) (NN study)) (ADVP (RB also)) (VP (VBD found) (NP (NP (NP (NN Id2)) (CC and) (NP (NN Id3)) (NP (NN protein))) (PP (IN in) (NP (NN B) (NNS cells)))) (S (VP (TO to) (VP (VB be) (ADVP (RBR more) (RB highly)) (VP (VBN expressed) (PP (IN than) (NP (NN Id1))) (PP (IN in) (NP (VBG resting) (NN B) (NNS cells))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NN BMP-6)) (VP (VBD did) (RB not) (VP (VB induce) (NP (JJ significant) (NNS changes)) (PP (IN in) (NP (NP (DT the) (NN protein) (NN expression)) (PP (IN of) (NP (NP (NN Id2)) (CC and) (NP (NN Id3))))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN believed) (SBAR (IN that) (S (NP (NN Id) (NNS proteins)) (VP (VP (VB block) (NP (NN differentiation))) (CC and) (VP (VB promote) (NP (NP (NN proliferation)) (PP (IN in) (NP (JJ various) (NN cell) (NNS types) (NP (CD -LSB-39,33))))))) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (NN Id) (NNS proteins)) (VP (VBP act) (PP (IN as) (NP (NP (JJ dominant-negative) (NNS inhibitors)) (PP (IN of) (NP (NP (NN E-proteins)) (CC and) (NP (NN Pax5)) (NP (NN function)))))) (PP (IN by) (S (VP (VBG forming) (NP (NNS dimers)) (PP (IN with) (NP (DT these) (NNS proteins)))))) (, ,) (S (VP (VBG making) (S (NP (PRP them)) (ADJP (JJ unable)) (S (VP (TO to) (VP (VB bind) (NP (NN DNA)))))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN proposed) (SBAR (IN that) (S (NP (NP (DT the) (NN balance)) (PP (IN among) (NP (NP (NN E-proteins)) (, ,) (NP (NN Pax5)) (CC and) (NP (NN Id) (NNS proteins))))) (VP (MD might) (VP (VB have) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (VBN activated) (NN B) (NNS cells) (CD -LSB-38))))) (-RRB- -RSB-))))))) (. .)))
( (S (S (PP (IN In) (NP (DT that) (NN respect))) (, ,) (NP (NNS E-proteins)) (VP (VBP have) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (CC both) (NP (DT the) (NN promotion)) (CC and) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (NP (NN cell) (NN survival)) (CC and) (NP (NN growth))) (PP (IN at) (NP (NP (JJ different) (NNS points)) (PP (IN in) (NP (NN lymphocyte) (NN development) (CD -LSB-40))))))))))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (NP (DT The) (ADJP (ADJP (JJ antiproliferative)) (CC and) (ADJP (NN death) (VBG inducing))) (NN effect)) (PP (IN of) (NP (NN BMP-6))) (PP (IN in) (NP (NP (NN B) (NNS cells)) (PP (IN with) (NP (NP (JJ concomitant) (NN upregulation)) (PP (IN of) (NP (NN Id1) (NN protein)))))))) (VP (VBZ is) (ADVP (RB therefore)) (PP (IN in) (NP (NP (NN line)) (PP (IN with) (NP (DT the) (NN view) (SBAR (IN that) (S (NP (NN Id) (NNS proteins)) (VP (VBP are) (VP (VBN required) (PP (IN for) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NP (NP (NN growth) (NN arrest)) (CC and) (NP (NN apoptosis))) (PP (IN in) (NP (NN B-lymphocyte) (NNS progenitors))))) (PP (IN by) (NP (NN TGF-β) (CD -LSB-40) (-RRB- -RSB-))))))))))))))) (. .)))
( (S (S (ADVP (RB Furthermore)) (, ,) (NP (NN Id) (NNS proteins)) (VP (VBP are) (VP (VBN known) (PP (IN as) (NP (NP (JJ important) (NNS parts)) (PP (IN of) (NP (NP (NN signalling) (NNS pathways)) (VP (VBN involved) (PP (IN in) (NP (NP (NN development)) (, ,) (NP (NN cell) (NN cycle)) (CC and) (NP (NN tumorigenesis) (CD -LSB-32))))))))))) (-RRB- -RSB-)) (. .)))
( (S (S (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB well)) (VP (VBN established) (SBAR (IN that) (S (NP (NP (JJ various) (NNS members)) (PP (IN of) (NP (DT the) (NN Id) (NN family)))) (VP (VBP are) (VP (VBN overexpressed) (PP (IN in) (NP (NP (DT a) (NN range)) (PP (IN of) (NP (JJ human) (NNS tumours)))))))))))) (CC and) (S (ADVP (RB generally)) (, ,) (NP (NN Id1)) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (NP (NP (DT the) (NN family) (NN member)) (VP (ADVP (RBS most) (RB widely)) (VBN overexpressed) (PP (IN in) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ human) (NNS malignancies) (CD -LSB-41) (-RRB- -RSB-))) (, ,) (PP (VBG including) (NP (NP (JJ multiple) (NN myeloma)) (CD -LSB-42,32) (-RRB- -RSB-))))))))))))) (. .)))
( (S (S (ADVP (RB Additionally)) (, ,) (NP (PRP$ our) (NNS findings) (SBAR (IN that) (S (NP (NN BMP-6)) (VP (VBZ activates) (NP (NP (JJ intracellular) (NN signalling) (NNS pathways)) (PP (IN in) (NP (JJ human) (NN B) (NNS cells)))))))) (VP (MD might) (VP (VB be) (PP (IN of) (NP (JJ potential) (JJ pathophysiological) (NN significance))) (PP (IN in) (NP (NP (NN lymphoma)) (CC and) (NP (NN inflammation))))))) (. .)))
( (S (S (NP (NP (JJ High) (NN BMP-6) (NN mRNA) (NN expression)) (PP (IN in) (NP (NN DLBCL)))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB correlate) (PP (TO to) (NP (JJ unfavourable) (NN outcome) (CD -LSB-12))))) (-RRB- -RSB-)))))) (. .)))
( (S (S (PP (IN In) (NP (DT this) (NN respect))) (, ,) (NP (PRP it)) (VP (VBZ is) (PP (IN of) (NP (NN interest))) (SBAR (IN that) (S (NP (NP (VBN targeted) (NN expression)) (PP (IN of) (NP (NP (NN Id1)) (PP (TO to) (NP (NNS B-lymphocytes)))))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ aberrant) (NN B) (NN cell) (NN development)) (, ,) (NP (JJ massive) (NN apoptosis)) (, ,) (CC and) (NP (NP (JJ subsequent) (NN development)) (PP (IN of) (NP (NN B) (NN cell) (NNS lymphomas) (NP (CD -LSB-35))))) (-RRB- -RSB-)))))))) (. .)))
( (S (S (S (ADVP (RB Moreover)) (, ,) (NP (NN BMP-6)) (VP (VBZ has) (VP (VBN been) (VP (VBN suggested) (S (VP (TO to) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (NP (NP (JJ rheumatoid) (NN arthritis)) (PRN (-LRB- -LRB-) (NP (NN RA) (-RRB- -RRB-) (CD -LSB-43,44)) (-RRB- -RSB-))))))))))) (CC and) (S (NP (NP (JJ elevated) (NNS levels)) (PP (IN of) (NP (NP (NN Id1)) (CC and) (NP (NN Id3))))) (VP (VBP have) (VP (VBN been) (VP (VBN found) (PP (IN in) (NP (NP (DT the) (NN synovia)) (PP (IN of) (NP (NN RA-patients) (CD -LSB-45) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (ADVP (RB Altogether)) (, ,) (NP (DT these) (NNS results)) (VP (VBP point) (PP (TO to) (NP (NP (DT an) (JJ important) (NN role)) (PP (IN for) (NP (NN Id) (NNS proteins))) (PP (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (JJ normal) (NN B) (NN cell) (NN homeostasis))))) (CC and) (PP (IN in) (NP (NP (NNS diseases)) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (NN B) (NNS cells)) (VP (VBP are) (VP (VBN involved)))))))))))) (. .)))
( (S (S (NP (PRP It)) (VP (MD will) (ADVP (RB therefore)) (VP (VB be) (ADJP (JJ important) (S (VP (TO to) (ADVP (RB further)) (VP (VB elucidate) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN Id-1))) (PP (IN in) (NP (JJ human) (NN B) (NNS cells)))) (PP (IN by) (ADJP (JJ selective) (PP (IN over) (NP (NP (NN expression)) (CC or) (NP (NP (NN inhibition)) (PP (IN of) (NP (NN Id-1) (NN gene) (NN expression))))))))))))))) (. .)))
( (S (PP (IN Given) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN BMP-6))) (PP (IN in) (NP (NP (JJ mature) (JJ human) (NN B) (NNS cells)) (VP (VBN demonstrated) (ADVP (RB here))))))) (, ,) (NP (NP (NN identification)) (PP (IN of) (NP (JJ BMP-6) (NN producing) (NNS cells))) (ADVP (FW in) (FW vivo)) (PP (IN with) (NP (NP (NN possibility)) (PP (IN of) (NP (NP (NN interaction)) (PP (IN with) (NP (NP (NN naïve)) (CC and) (NP (NN memory) (NN B) (NNS cells))))))))) (VP (MD might) (VP (VB contribute) (PP (TO to) (NP (NP (DT the) (NN understanding)) (PP (IN of) (NP (JJ mature) (NN B) (NN cell) (NN biology))))))) (. .)))
( (S (S (NP (NP (JJ High) (NN BMP-6) (NN mRNA) (NN expression)) (PP (IN in) (NP (NN DLBCL)))) (VP (VBZ has) (VP (VBN been) (VP (VBN detected) (PP (IN by) (NP (NN gene) (NN expression) (NN profiling) (CD -LSB-12) (-RRB- -RSB-))))))) (. .)))
( (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (NN production)) (PP (IN of) (NP (JJ BMP-6) (NNS transcripts))) (PP (IN in) (NP (JJ normal) (VBN activated) (NN B) (NNS cells)))) (VP (VBD was) (VP (VBN detected) (PP (IN in) (NP (DT the) (JJ same) (NN study)))))) (. .)))
( (S (S (PP (IN Of) (NP (NN note))) (, ,) (NP (DT an) (NN autocrine) (NN BMP-6) (NN loop)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN by) (NP (NNS others))) (PP (PP (IN in) (NP (NNS chondrocytes))) (CC and) (PP (IN in) (NP (DT the) (NN ovarium) (NN -LSB-46,19,18))))))) (-RRB- -RSB-)) (. .)))
( (S (S (ADVP (RB Therefore)) (, ,) (NP (PRP we)) (VP (VBD wanted) (S (VP (TO to) (VP (VB explore) (NP (NP (DT the) (NN possibility)) (PP (IN for) (NP (NP (DT an) (NN autocrine) (NN BMP-6) (NN loop)) (PP (IN in) (NP (JJ human) (NN B) (NNS cells))))))))))) (. .)))
( (S (NP (PRP We)) (VP (VP (VBD analysed) (NP (NP (DT the) (NN expression) (NN BMP-6) (NN mRNA)) (PP (IN in) (NP (JJ peripheral) (NN blood) (NN B) (NNS cells)))) (PP (IN by) (NP (JJ real-time) (NN PCR)))) (, ,) (CC and) (VP (VBP report) (ADVP (RB here)) (NP (NP (DT the) (NN upregulation)) (PP (IN of) (NP (JJ endogenous) (JJ BMP-6) (NNS transcripts))) (PP (IN after) (NP (NP (NN stimulation)) (PP (IN with) (NP (NP (NN FCS)) (, ,) (NP (JJ human) (NN AB-serum)) (CC and) (, ,) (ADVP (RBS most) (RB importantly)) (, ,) (NP (NN anti-IgM))))))))) (. .)))
( (S (ADVP (RB However)) (, ,) (NP (PRP$ our)) (VP (VBZ attempts) (S (VP (TO to) (VP (VB study) (NP (NP (JJ BMP-6) (NN protein) (NNS levels)) (VP (VBD were) (NP (NN unsuccessful)) (PP (JJ due) (TO to) (NP (NP (NNS problems)) (PP (IN with) (NP (NP (NP (JJ unspecific) (NN binding)) (PP (IN of) (NP (NP (DT the) (JJ anti-BMP-6) (NNS antibodies)) (VP (VBN tested))))) (, ,) (CC and) (NP (NP (NN lack)) (PP (IN of) (NP (NP (JJ specific) (NN staining)) (PP (IN in) (NP (NP (NN control) (NNS cells)) (VP (VBN known) (S (VP (TO to) (VP (VB express) (NP (NN BMP-6) (NN mRNA))))))))))))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (DT the) (JJ recombinant) (NN protein)) (VP (VBD was) (ADVP (RB readily)) (VP (VBN detected)))) (. .)))
( (S (S (PP (IN In) (NP (DT that) (NN respect))) (, ,) (NP (JJ few) (NNS investigators)) (VP (VBP have) (VP (VBN detected) (NP (NN BMP-6) (NN protein)) (PP (PP (IN in) (NP (NNS humans))) (, ,) (ADVP (RB especially)) (PP (IN in) (NP (JJ non-pathogenic) (NN tissue))))))) (. .)))
( (S (NP (NP (DT The) (NN possibility)) (PP (IN of) (NP (NN BMP-6) (NN production))) (PP (IN in) (NP (JJ human) (NNS B-cells)))) (VP (VBZ is) (PP (IN in) (NP (NP (NN line)) (PP (IN with) (NP (NP (DT a) (JJ recent) (NN work)) (SBAR (WHNP (WDT that)) (S (VP (VBD reported) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NN BMP-6))) (PP (IN in) (NP (NN mouse) (NN B) (NNS cells)))) (, ,) (S (VP (VBG infiltrating) (NP (NP (DT the) (NN bone) (NN marrow)) (PP (IN of) (NP (NP (NNS mice)) (PP (IN with) (NP (JJ inflammatory) (NN arthritis) (CD -LSB-43))))))))) (-RRB- -RSB-)))))))) (. .)))
( (S (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (NP (DT a) (NN role)) (PP (IN for) (NP (NN BMPs))) (PP (IN in) (NP (NP (DT the) (JJ inflammatoric) (NN process)) (PP (IN of) (NP (NN arthritis)))))) (VP (VBD was) (VP (VBN suggested)))) (. .)))
( (S (S (NP (NP (DT The) (NN upregulation)) (PP (IN of) (NP (DT the) (NNS BMP-6-transcripts))) (PP (IN after) (NP (NN IgM-crosslinking)))) (VP (VBZ is) (PP (IN of) (NP (JJ pathophysiologic) (NN interest) (CD -LSB-12) (-RRB- -RSB-))))) (. .)))
( (S (S (S (NP (NP (DT A) (NN loss)) (PP (IN of) (NP (NN TGF-β-responsiveness)))) (VP (VBZ has) (VP (VBN been) (VP (VBN suggested) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (JJ critical) (NN contribution)) (PP (TO to) (NP (JJ malignant) (NN transformation) (CD -LSB-47,48)))))) (-RRB- -RSB-)))))) (CC and) (S (NP (JJ similar) (JJ oncogenic) (NNS mechanisms)) (VP (VBP have) (VP (VBN been) (VP (VBN postulated) (PP (IN for) (NP (NN BMPs)))))))) (. .)))
( (S (S (NP (NP (NNS Lines)) (PP (IN of) (NP (NN evidence)))) (VP (VBP suggest) (NP (NN -LSB-49)) (-RRB- -RSB-) (SBAR (IN that) (S (PP (IN at) (NP (NP (JJ early) (NNS stages)) (PP (IN of) (NP (NN carcinogenesis))))) (, ,) (NP (NN BMP-6)) (VP (VP (VBZ is) (RB not) (NP (DT a) (NN tumour) (NN promoter))) (, ,) (CC but) (VP (VBZ suppresses) (NP (ADJP (ADJP (JJ benign)) (CC and) (ADJP (JJ malignant))) (NN tumour) (NN outgrowth)))))))) (. .)))
( (S (S (NP (DT These) (NNS findings)) (VP (VBP are) (PP (IN in) (NP (NP (JJ good) (NN agreement)) (PP (IN with) (NP (NP (JJ previous) (NNS findings)) (PP (IN for) (NP (JJ other) (NN TGF-β) (NN family) (NNS members))) (, ,) (PP (VBG including) (NP (NP (NN TGF-β1)) (CC and) (NP (NN BMP-4) (CD -LSB-50) (-RRB- -RSB-)))))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (JJ cellular) (NN context)) (PP (IN of) (NP (DT the) (NN BMP) (NN target) (NN cell)))) (VP (MD might) (VP (VB define) (NP (DT the) (JJ various) (VBN observed) (NNS effects)))))))))) (. .)))
( (S (PP (IN In) (NP (NP (NN contrast)) (PP (TO to) (NP (NP (DT the) (NN upregulation)) (PP (IN of) (NP (NN BMP-6) (NN transcript))) (PP (IN in) (NP (NN B) (NNS cells))))))) (, ,) (NP (PRP we)) (VP (VBD were) (RB not) (ADJP (JJ able) (S (VP (TO to) (VP (VB detect) (NP (NN BMP-6) (NNS transcripts)) (PP (IN in) (NP (JJ human) (JJ peripheral) (NN blood) (NP (NP (ADJP (ADJP (JJ CD4+)) (CC or) (ADJP (JJ CD8+))) (NN T) (NNS cells)) (PRN (-LRB- -LRB-) (UCP (ADJP (JJ resting)) (CC or) (VP (VBN stimulated) (PP (IN with) (NP (NP (NP (NP (NP (ADJP (JJ anti-CD3))) (CC and) (NP (ADJP (JJ anti-CD28)))) (PRN (: ;) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-))) (PRN (, ,) (NP (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (NNS findings)) (PP (IN in) (NP (NN T) (NN cell) (NNS lines)))))) (CD -LSB-20)) (-RRB- -RSB-))) (CC and) (NP (NP (NN T) (NNS cells)) (PP (IN in) (NP (NNS mice)))) (NP (NN -LSB-43)))))) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (NP (NP (JJ Other) (JJ potential) (JJ BMP-6) (NNS sources)) (PP (IN for) (NP (JJ mature) (NN B) (NNS cells))) (ADVP (FW in) (FW vivo))) (VP (MD might) (VP (VB be) (NP (NP (JJ other) (NNS cells)) (PP (IN of) (NP (NP (DT the) (JJ immune) (NN system)) (CC or) (NP (NN tissue))))) (PP (IN with) (NP (NP (NN contact)) (PP (TO to) (NP (DT the) (JJ hematopoietic) (NN system)))))))) (. .)))
( (S (S (NP (NP (CD One) (ADJP (RB well) (VBN recognized)) (NN source)) (PP (IN for) (NP (NN BMP-6) (NN production)))) (VP (VBZ is) (NP (NP (DT the) (JJ human) (NN bone) (CC and) (NN bone) (NN marrow)) (NN stroma) (NN -LSB-51,8))) (-RRB- -RSB-)) (. .)))
( (S (S (S (ADVP (RB Furthermore)) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN noteworthy) (SBAR (IN that) (S (NP (NP (JJ human) (JJ umbilical) (NN vein) (JJ endothelial) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN HUVEC)) (-RRB- -RRB-))) (ADVP (RB highly)) (VP (VBP express) (NP (NN BMP-6) (NN mRNA) (CD -LSB-52))))))) (-RRB- -RSB-)) (, ,) (CC and) (S (NP (JJ vascular) (NN endothelium)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB produce) (NP (NN BMP-6) (CD -LSB-53) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (NP (DT These) (NNS studies)) (VP (MD might) (VP (VB imply) (NP (NP (DT a) (NN role)) (PP (IN for) (NP (NN BMP-6))) (PP (IN in) (NP (NP (JJ transendothelial) (NN migration)) (PP (IN of) (NP (NN B) (NNS cells))))))))) (. .)))
( (S (S (NP (JJ BMP-6) (NN mRNA)) (VP (VBZ has) (VP (VBN been) (VP (VBN demonstrated) (PP (PP (IN in) (NP (JJ murine) (NN macrophage) (NN cell) (NNS lines))) (, ,) (CC but) (PP (RB not) (IN in) (NP (NNS humans) (CD -LSB-54) (-RRB- -RSB-)))))))) (. .)))
( (S (S (PP (IN In) (NP (NP (NN accordance)) (PP (IN with) (NP (DT these) (NNS findings))))) (, ,) (NP (NP (JJ other) (JJ human) (NN cell) (NNS lines)) (PP (IN of) (NP (NP (NN neutrophil)) (CC and) (NP (JJ monocytic) (NN origin))))) (VP (VBP have) (VP (VBN been) (VP (VBN described) (S (VP (TO to) (VP (VB be) (ADJP (JJ negative) (PP (IN for) (NP (DT the) (NN BMP-6) (NN transcript) (NN -LSB-20)))))))))) (-RRB- -RSB-)) (. .)))
( (S (S (PP (TO To) (NP (PRP$ our) (NN knowledge))) (, ,) (NP (EX there)) (VP (VBZ is) (ADVP (RB currently)) (NP (NP (DT no) (NN report)) (PP (IN about) (NP (NP (NN BMP-6) (NN production)) (PP (IN of) (NP (JJ human) (JJ dendritic) (NNS cells)))))))) (. .)))
( (S (NP (NN Conclusion))))
( (S (S (PP (IN In) (NP (NN conclusion))) (, ,) (NP (PRP$ our) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (NP (NN BMP-6)) (VP (VBZ induces) (NP (NP (NN activation)) (PP (IN of) (NP (JJ intracellular) (NN Smad) (NN signalling))) (PP (IN in) (NP (JJ mature) (JJ human) (NNS B-cells)))) (PP (IN with) (NP (NP (JJ consecutive) (NN production)) (PP (IN of) (NP (NN Id1) (NN protein)))))))))) (. .)))
( (S (S (ADVP (RB Furthermore)) (, ,) (NP (PRP we)) (VP (VBP report) (SBAR (IN that) (S (NP (NN BMP-6)) (VP (VBZ has) (NP (DT an) (JJ antiproliferative) (NN effect)) (PP (IN in) (NP (NP (NN B) (NNS cells)) (VP (VBN stimulated) (PP (IN with) (NP (NP (NP (NN anti-IgM)) (ADVP (RB alone))) (CC or) (NP (NP (DT the) (JJ combined) (NN action)) (PP (IN of) (NP (NP (NN anti-IgM)) (CC and) (NP (NN CD40L))))))))))))))) (. .)))
( (S (S (ADVP (RB Additionally)) (, ,) (NP (NN BMP-6)) (VP (VBZ induces) (NP (NN cell) (NN death)) (PP (IN in) (NP (NP (VBN activated) (NN memory) (NN B) (NNS cells)) (CC and) (NP (NN Ramos) (NNS cells)))))) (. .)))
( (S (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (NP (DT these) (NNS results)) (VP (VBP provide) (NP (NP (DT a) (NN rationale)) (S (VP (TO to) (ADVP (RB further)) (VP (VB examine) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN BMP-6) (NN signalling))) (PP (PP (IN in) (NP (JJ normal) (NN B) (NN cell) (NN biology))) (CONJP (RB as) (RB well) (IN as)) (PP (IN in) (NP (NP (NP (JJ pathologic) (NNS conditions)) (PP (IN like) (NP (NN B) (NN cell) (NNS malignancies)))) (CC and) (NP (JJ autoimmune) (NNS disorders)))))))))))) (. .)))
( (S (NP (NNS Methods))))
( (S (SBAR (IN If) (S (VP (RB not) (VBN specified)))) (, ,) (NP (DT all) (NNS cells)) (VP (VBD were) (VP (VBN cultured) (PP (IN in) (NP (ADJP (NN X-VIVO) (NN 15™) (-LRB- -LRB-) (NP (NNP BioWhittaker) (, ,) (NNP Verviers) (, ,) (NNP Belgium)) (-RRB- -RRB-) (JJ serum-free)) (NN medium))) (PP (IN at) (NP (NP (NN 37°C)) (CC and) (NP (ADJP (CD 5) (NN %)) (NN CO2)))) (PP (IN in) (NP (NN air))))) (. .)))
( (S (S (NP (JJ Peripheral) (NN blood)) (VP (VBD was) (VP (VBN provided) (PP (IN by) (NP (DT the) (NN Blood) (NN Bank))) (PP (PP (IN at) (NP (NP (NN Buskerud) (JJ Regional) (NN Hospital)) (PP (IN with) (NP (NP (JJ formal) (NN agreement)) (PP (IN by) (NP (DT the) (NNS patients))))))) (, ,) (CC and) (NP (NP (NN approval)) (PP (IN by) (NP (DT the) (JJ regional) (NN ethics) (NN committee)))))))) (. .)))
( (S (S (NP (NP (ADJP (RB Highly) (VBN purified)) (VBG resting) (JJ human) (NNS B-lymphocytes)) (PRN (-LRB- -LRB-) (NP (CD CD19+) (NNS cells)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN isolated) (PP (IN from) (NP (DT the) (JJ peripheral) (NN blood))) (PP (IN by) (S (VP (VBG rosetting) (PP (IN with) (NP (JJ immunomagnetic) (NNS beads)))))) (PRN (-LRB- -LRB-) (NP (NP (NNP Dynabeads) (CD M450)) (: ;) (NP (NNP Dynal) (, ,) (NNP Oslo)) (, ,) (NP (NNP Norway))) (-RRB- -RRB-))) (SBAR (IN as) (S (VP (VBN described) (NP (CD -LSB-55) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (DT This) (NN procedure)) (VP (VBZ yields) (ADJP (ADJP (JJR less)) (PP (IN than) (NP (NP (ADJP (CD 0.5) (NN %)) (NN T) (NNS cells)) (, ,) (NP (ADJP (CD 0.1) (NN %)) (NN NK) (NNS cells)) (, ,) (CC and) (NP (ADJP (CD 0.5) (NN %)) (NNS monocytes))))) (SBAR (IN as) (S (VP (VBN judged) (PP (IN by) (NP (JJ indirect) (NN immunofluorescence) (VBG staining)))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ following) (NN cell) (NNS lines)) (PP (IN from) (NP (JJ human) (JJ lymphoid) (NNS malignancies)))) (VP (VBD were) (VP (VBN maintained) (PP (IN in) (NP (NP (NP (NN RPMI) (CD 1640)) (PRN (-LRB- -LRB-) (NP (NN PAA) (NNS Laboratories) (NP (NNP GmbH) (, ,) (NNP Pasching) (, ,) (NNP Austria))) (-RRB- -RRB-))) (VP (VP (VBN supplemented) (PP (IN with) (NP (NP (NP (ADJP (CD 10) (NN %)) (JJ foetal) (JJ bovine) (NN serum)) (PRN (-LRB- -LRB-) (NP (NN FCS)) (-RRB- -RRB-))) (, ,) (NP (CD 100) (NNS units/ml) (NN penicillin) (NN G)) (, ,) (CC and) (NP (NP (CD 100) (NNS units/ml)) (PP (IN of) (NP (NN streptomycin) (NN sulphate)))) (, ,) (CC but) (NP (ADJP (JJ serum-starved) (PP (IN for) (NP (QP (IN at) (JJS least) (CD four)) (NNS hours)))))))) (CC and) (VP (VBN cultured) (PP (IN in) (NP (NN X-VIVO) (NN 15™))))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN included) (PP (IN in) (NP (NNS experiments))))))))) (: :) (NP (NP (JJ EBV-negative) (NN BL) (NN cell) (NNS lines)) (NP (NP (NP (NN Ramos)) (PRN (-LRB- -LRB-) (NP (NN ECACC) (CD 85030802)) (-RRB- -RRB-))) (, ,) (NP (NN HL60) (-LRB- -LRB-) (CD JCRB0085) (-RRB- -RRB-)))) (. .)))
( (S (S (NP (DT The) (VBG following) (NNS reagents)) (VP (VBD were) (VP (VBN used) (PP (IN at) (NP (VBN indicated) (NNS concentrations))) (: :) (NP (NP (JJ recombinant) (JJ human) (-LRB- -LRB-) (JJ rhu) (-RRB- -RRB-) (NN BMP-6)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN μg/ml)) (, ,) (SBAR (IN if) (S (RB not) (VP (VBN specified) (ADVP (RB otherwise)) (PRN (-RRB- -RRB-) (, ,) (NP (NP (JJ rhu) (NN BMP-RIB/ALK-6/Fc) (NN Chimera)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN μg/ml)) (-RRB- -RRB-))) (, ,) (S (S (NP (NP (NP (JJ rhu) (NN BMPR-II/Fc) (NN Chimera)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN μg/ml)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (JJ recombinant) (NN mouse) (NN Noggin)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN μg/ml)) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN purchased) (PP (IN from) (NP (NP (NN R&D) (NNS Systems)) (PRN (-LRB- -LRB-) (NP (NNP Abingdon) (, ,) (NNP UK)) (-RRB- -RRB-))))))) (: ;) (S (NP (NP (JJ Anti-IgM) (NN F) (-LRB- -LRB-) (NN ab) (-RRB- -RRB-) (CD 2) (NNS fragments)) (PP (IN of) (NP (NP (JJ rabbit) (JJ polyclonal) (NNS antibodies)) (PP (TO to) (NP (NP (NP (JJ human) (NN IgM) (JJ heavy) (NN chain)) (PRN (-LRB- -LRB-) (NP (CD 37.5) (NN μg/ml)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN obtained) (PP (IN from) (NP (NP (NN Dako)) (, ,) (NP (NNP Copenhagen) (, ,) (NNP Denmark)) (CC and) (NP (NP (JJ rhu) (NN CD40) (NN ligand)) (PRN (-LRB- -LRB-) (NP (NN CD40L)) (, ,) (NP (CD 10) (NN ng/ml)) (-RRB- -RRB-)))))))))))) (VP (VBD was) (NP (NP (DT a) (NN gift)) (PP (IN from) (NP (NNP Immunex) (NNP Corp.) (-LRB- -LRB-) (NNP Seattle) (, ,) (NNP WA))))))) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NP (NNS Antibodies)) (PP (IN against) (NP (DT the) (JJ human) (NNS BMP-receptors) (NP (NP (NN Act-RIA)) (, ,) (NP (NN BMP-RIB)) (, ,) (NP (NN BMPR-II)) (, ,) (NP (NN Act-RIIA)) (CC and) (NP (NN Act-RIIb)))))) (VP (VBD were) (VP (VBN purchased) (PP (IN from) (NP (NP (NP (NN R) (NN &) (NN D)) (NNS Systems)) (PRN (-LRB- -LRB-) (NP (NNP Abingdon) (, ,) (NNP UK)) (-RRB- -RRB-))))))) (. .)))
( (S (NP (NP (NN Detection)) (PP (IN of) (NP (DT the) (NN BMP-6-protein)))) (VP (VBZ has) (VP (VBN been) (VP (VBN tried) (PP (IN with) (NP (NP (DT the) (JJ following) (NNS antibodies)) (: :) (NP (NP (NP (NN goat) (JJ polyclonal) (NN anti-BMP-6)) (PRN (-LRB- -LRB-) (NP (NNP Santa) (NNP Cruz) (, ,) (NNP San) (NNP Diego) (, ,) (NP (NN CA)) (, ,) (NP (NNP USA))) (-RRB- -RRB-))) (, ,) (NP (NP (NP (JJ monoclonal) (NN mouse) (NN anti-BMP-6)) (CC and) (NP (JJ polyclonal) (NN goat) (NN anti-BMP-6))) (PP (IN from) (NP (NP (NN R) (NN &) (NN D) (NNS Systems)) (PRN (-LRB- -LRB-) (NP (NNP Abingdon) (, ,) (NNP UK)) (-RRB- -RRB-))))) (, ,) (CC and) (NP (NP (NN mouse) (JJ monoclonal) (NN anti-BMP-6)) (PRN (-LRB- -LRB-) (NP (NP (NNP Chemicon) (NNP International) (NNP Inc) (, ,) (NNP Temecula)) (, ,) (NP (NN CA)) (, ,) (NP (NNP USA))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (NP (NN Characterisation)) (PP (IN of) (NP (JJ BMP-signalling) (NNS pathways)))) (VP (VBD was) (VP (VBN done) (PP (IN by) (NP (NP (NN use)) (PP (IN of) (NP (NP (NN anti-phospho-Smad1)) (, ,) (NP (CD -5)) (, ,) (NP (NP (NN -and) (CD 8) (JJ polyclonal) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NNP Chemicon) (, ,) (NNP Temecula)) (, ,) (NP (NP (NN CA)) (, ,) (NP (NN USA))) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (S (NP (NP (NN Expression) (NNS levels)) (PP (IN of) (NP (NN Id1–3) (NNS proteins)))) (VP (VBD were) (VP (VBN detected) (PP (IN with) (NP (JJ polyclonal) (NN rabbit) (NN antibody)))))) (CC and) (S (NP (NN detection)) (VP (VBD was) (VP (VBN blocked) (PP (IN with) (NP (NP (NN blocking) (NN peptide)) (PP (IN from) (NP (NP (NNP Santa) (NNP Cruz) (NN Biotechnology)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP Santa) (NNP Cruz) (, ,) (NNP San) (NNP Diego)) (, ,) (NP (NN CA))) (, ,) (NP (NNP USA))) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (RB As) (JJ secondary) (NNS antibodies)) (VP (VBD served) (NP (NP (NP (ADJP (ADJP (JJ anti-mouse)) (, ,) (ADJP (JJ anti-goat)) (CC or) (ADJP (JJ anti-rabbit))) (NN IgG-) (NN horseradish) (NN peroxidase)) (PRN (-LRB- -LRB-) (NP (NN HRP)) (-RRB- -RRB-))) (PP (IN from) (NP (NN Dakocytomation)))) (PP (IN AS) (NP (NP (-LRB- -LRB-) (NP (NNP Copenhagen) (, ,) (NNP Denmark)) (-RRB- -RRB-)) (PP (IN for) (NP (NN immunoblot) (NN analysis))))))) (. .)))
( (S (S (NP (NN Anti-β-actin)) (VP (VBD was) (PP (IN from) (NP (NN Santa-Cruz))))) (. .)))
( (S (S (PP (IN From) (NP (NP (NNP Becton) (NNP Dickinson)) (PRN (-LRB- -LRB-) (NP (NP (NNP San) (NNP Jose)) (, ,) (NP (NN CA))) (-RRB- -RRB-)))) (, ,) (NP (PRP we)) (VP (VBN purchased) (NP (NP (NN anti-CD19-PE)) (, ,) (NP (NN anti-CD19-FITC))))) (. .)))
( (S (S (NP (NP (DT The) (NNS antibodies)) (VP (VBN used) (PP (IN for) (NP (NN cell) (NN sorting))))) (VP (VBD were) (NP (NP (NP (NN anti-CD19) (NN PC5)) (PP (IN from) (NP (NP (NNP Immunotech) (NNP SA)) (PRN (-LRB- -LRB-) (NP (NNP Marseille) (, ,) (NNP France)) (-RRB- -RRB-))))) (CC and) (NP (NP (CD anti-CD27) (NNS PE)) (PP (IN from) (NP (NP (NNP Becton) (NNP Dickinson) (, ,) (NNP Biosciences) (NNP Pharmingen)) (PRN (-LRB- -LRB-) (NP (NP (NNP San) (NNP Diego)) (, ,) (NP (NN CA)) (, ,) (NP (NNP USA))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (ADJP (RB Highly) (VBN purified)) (ADJP (ADJP (JJ CD19+CD27-)) (CC or) (ADJP (JJ CD19+CD27+))) (NNS cells)) (VP (VBD were) (VP (VBN obtained) (PP (IN by) (S (VP (VBG staining) (NP (NN CD19+) (NNS cells)) (PP (IN with) (NP (NP (CD anti-CD27) (NN PE)) (CC and) (NP (NN CD19)) (NP (NN PC5) (NNS mAbs)))) (PP (IN for) (NP (NP (CD 30) (NNS minutes)) (PP (IN at) (NP (NN 4°C))))) (, ,) (S (VP (VBN followed) (PP (IN by) (S (VP (VBG washing) (PP (IN with) (NP (NP (NNS PBS)) (CC and) (NP (NP (NN sorting)) (PP (IN on) (NP (NN FACS) (NN DiVa)))))) (PP (IN from) (NP (NNP Becton) (NNP Dickinson)))))))))))))) (. .)))
( (S (S (NP (NP (NN B) (NNS cells)) (PP (IN from) (NP (NP (JJ peripheral) (NN blood)) (CC or) (NP (VBN cultured) (NNS cell-lines))))) (VP (VBD were) (VP (VBN lysed) (PP (IN in) (NP (NP (NN lysis) (NN buffer)) (PRN (-LRB- -LRB-) (NP (NP (NN glycerol) (CD 10) (NN %)) (, ,) (NP (NN β-mercaptoethanol) (CD 5) (NN %)) (, ,) (NP (ADJP (CD 0.0625) (NN M)) (NN Tris-HCL) (NN -LSB-pH) (CD 6.8) (-RRB- -RSB-)) (, ,) (NP (NN sodium) (NN dodecyl) (NN sulphate) (NN -LSB-SDS))) (-RRB- -RSB-) (NP (CD 2.5) (NN %) (NN w/vol)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (NP (JJ Total) (NN protein)) (PRN (-LRB- -LRB-) (NP (CD 30–100) (NN μg)) (-RRB- -RRB-))) (PP (IN from) (NP (DT each) (NN sample)))) (VP (VBD was) (UCP (NP (NP (NN run)) (PP (IN on) (NP (ADJP (ADJP (CD 10) (NN %)) (CC or) (ADJP (CD 12) (NN %))) (NN SDS/polyacrylamide) (-LRB- -LRB-) (NN SDS/PAGE) (-RRB- -RRB-) (NNS gels)))) (CC and) (VP (VBN blotted) (PP (IN onto) (NP (NP (JJ nitrocellulose) (NNS filters)) (PRN (-LRB- -LRB-) (NP (NP (NNP Protran)) (: ;) (NP (NNP Schleicher) (NNP &Schuell) (NNP GmbH) (, ,) (NNP Dassel) (, ,) (NNP Germany))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (NN Blocking)) (, ,) (NP (VBG washing)) (CC and) (NP (NP (NN incubation)) (PP (IN of) (NP (DT the) (NNS filters))) (PP (IN with) (NP (JJ primary) (NNS antibodies))))) (VP (VBD were) (VP (VBN done) (PP (VBG according) (PP (TO to) (NP (NP (DT the) (NN manufacturer) (POS 's)) (NNS protocols)))) (PP (IN at) (NP (NP (JJ room) (NN temperature)) (PRN (-LRB- -LRB-) (NP (NN RT)) (-RRB- -RRB-))))))) (. .)))
( (S (PP (IN After) (S (VP (VBG washing) (PP (IN with) (NP (NP (ADJP (CD TBS/0.1) (NN %)) (NN Tween-20)) (PRN (-LRB- -LRB-) (NP (NN TBS-T)) (-RRB- -RRB-))))))) (, ,) (S (S (NP (DT the) (NNS filters)) (VP (VBD were) (VP (VBN incubated) (PP (IN with) (NP (NP (NP (NN horseradish) (NN peroxidase)) (PRN (-LRB- -LRB-) (NP (NN HRP)) (-RRB- -RRB-))) (VP (VBN coupled) (PP (TO to) (NP (JJ relevant) (JJ secondary) (NNS antibodies)))))) (PRN (-LRB- -LRB-) (S (VP (VB see) (ADVP (RB above)))) (-RRB- -RRB-)) (PP (IN for) (NP (CD 60) (NNS minutes))) (PP (IN at))))) (CC RT.) (S (NP (NN Enzyme) (NN activity)) (VP (VBD was) (VP (VBN visualised) (PP (IN by) (NP (NP (DT the) (VBN enhanced) (NN chemiluminescence) (NN system)) (, ,) (NP (NP (NNP ECL+PLUS)) (PRN (-LRB- -LRB-) (NP (NP (NNP Amersham) (, ,) (NNP Buckinghamshire)) (, ,) (NP (NN UK))) (-RRB- -RRB-))))))))) (. .)))
( (S (NP (JJ Densitometric) (NN analysis)) (VP (VBD was) (VP (VBN performed) (PP (IN by) (NP (NN scanning) (NN hyperfilms))) (PP (IN on) (NP (NP (DT a) (JJ Personal) (NN Densitometer) (NN SI)) (PRN (-LRB- -LRB-) (NP (NP (JJ Molecular) (NNS Dynamics)) (, ,) (NP (NN Sunnyvale))) (, ,) (NP (NN CA)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NP (NN Quantification)) (PP (IN of) (NP (NP (NN Id1)) (, ,) (NP (NN Id2)) (CC and) (NP (NN Id3)) (NP (NN protein))))) (VP (VBD was) (VP (VBN calculated) (PP (IN by) (S (VP (VBG normalizing) (NP (NP (DT the) (JJ specific) (NN protein) (NNS bands)) (PP (TO to) (NP (NP (NN β-actin)) (VP (VBG using) (NP (NP (NN Image) (NN Quant) (CD 5.5) (NN software)) (PRN (-LRB- -LRB-) (NP (JJ Molecular) (NNS Dynamics)) (-RRB- -RRB-))))))))))))) (. .)))
( (S (S (NP (NP (JJ Endogenous) (NN expression)) (PP (IN of) (NP (DT the) (NN BMP-6) (NN gene)))) (VP (VBD was) (VP (VBN examined) (PP (IN by) (NP (JJ reverse) (NN transcription-polymerase) (NN chain) (NN reaction)))))) (. .)))
( (S (S (NP (JJ Total) (NN RNA)) (VP (VBD was) (VP (VBN isolated) (S (VP (VBG using) (NP (ADJP (RB Absolutely) (JJ RNA™)) (NN RT-PCR) (NN Miniprep) (NN Kit)))) (PRN (-LRB- -LRB-) (NP (NP (NNP Stratagene) (NNP Europe)) (, ,) (NP (NN Amsterdam)) (, ,) (NP (NNP Netherland))) (-RRB- -RRB-)) (PP (VBG according) (PP (TO to) (NP (DT the) (NNS manufacturers) (NNS instructions))))))) (. .)))
( (S (S (NP (NP (NN Quantification)) (PP (IN of) (NP (DT the) (VBN isolated) (JJ total) (NN RNA)))) (VP (VBD was) (VP (VBN achieved) (PP (IN by) (S (VP (VBG using) (NP (JJ spectrophotometric) (NN OD260) (NNS measurements)))))))) (. .)))
( (S (S (NP (NP (JJ Equal) (NNS amounts)) (PP (IN of) (NP (NN RNA)))) (VP (VBD were) (ADVP (RB then)) (VP (VB reverse) (VP (VBN transcribed) (PP (TO to) (NP (NP (NN cDNA)) (PP (IN with) (NP (NP (JJ TaqMan®) (JJ Reverse) (NN Transcription) (NNS Reagents)) (PRN (-LRB- -LRB-) (NP (NP (VBN Applied) (NN Biosystems)) (, ,) (NP (NNP Foster) (NNP City)) (, ,) (NP (NN CA)) (, ,) (NP (NNP U.S.A))) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB measure) (NP (NP (NN mRNA) (NN expression)) (PP (IN of) (NP (NN BMP6))))))) (, ,) (NP (NP (NN Id1–Id4)) (CC and) (NP (NN PGK1) (NN PCR))) (VP (VBD were) (VP (VBN carried) (PRT (RP out)) (PP (IN with) (NP (JJ TaqMan®) (JJ universal) (NN master) (NN mix)))))) (. .)))
( (S (S (NP (NP (NNS Primers)) (CC and) (NP (NNS probes))) (VP (VBD were) (VP (VBN provided) (PP (IN by) (NP (NP (NN Assay-on-Demand)) (PRN (-LRB- -LRB-) (NP (VBN Applied) (NN Biosystems)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NN PCR) (NNS reactions)) (VP (VBD were) (VP (VBN carried) (PRT (RP out)) (PP (IN in) (NP (NP (DT a) (JJ final) (NN volume)) (PP (IN of) (NP (NP (NP (CD 25) (NN μl)) (PRN (-LRB- -LRB-) (NP (NN BMP-6)) (-RRB- -RRB-))) (CC or) (NP (NP (CD 20) (NN μl)) (PRN (-LRB- -LRB-) (NP (NN ID1)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN cDNA)) (VP (VBN added) (PP (TO to) (NP (DT each) (NN reaction))))) (VP (VBD was) (ADJP (JJ equivalent) (PP (TO to) (NP (NP (DT the) (NN input)) (PP (IN of) (NP (NP (CD 20) (NN ng)) (PP (IN of) (NP (JJ total) (NN RNA)))))))))) (. .)))
( (S (S (NP (DT The) (NN gene) (NN expression)) (VP (VBD was) (VP (VBN quantified) (S (VP (VBG using) (NP (NP (NP (DT the) (JJ standard) (NN curve) (NN method)) (PRN (-LRB- -LRB-) (NP (NN BMP6)) (-RRB- -RRB-))) (, ,) (CC or) (NP (NP (DT the) (JJ comparative) (NN CT) (NN method)) (PRN (-LRB- -LRB-) (NP (NN Id1)) (-RRB- -RRB-))))))) (SBAR (IN as) (S (VP (VBN described) (PP (IN in) (NP (NP (NN ABI7700) (NN User) (NN Bulletin) (CD 2)) (PRN (-LRB- -LRB-) (NP (VBN Applied) (NN Biosystems)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (DT The) (NN expression)) (VP (VBD was) (ADVP (RB then)) (VP (VBN normalized) (PP (TO to) (NP (NP (DT the) (NN expression) (NN level)) (PP (IN of) (NP (NN PGK1)))))))) (. .)))
( (S (S (NP (NN PGK1)) (VP (VBD was) (VP (VBN chosen) (, ,) (SBAR (IN because) (S (NP (PRP it)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB have) (NP (NP (JJ low) (NN expression) (NN variability)) (PP (IN among) (NP (NN lymphocyte) (NNS specimens) (CD -LSB-56)))))))))) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (NP (NN Expression) (NNS levels)) (PP (IN in) (NP (NN B) (NNS cells)))) (VP (VBD were) (ADVP (RB then)) (ADJP (JJ related) (PP (TO to) (NP (NP (DT the) (NN expression) (NNS levels)) (PP (IN in) (NP (NN Ramos) (NNS cells)))))))) (. .)))
( (S (PP (IN For) (NP (NP (NN estimation)) (PP (IN of) (NP (NN DNA) (NN synthesis))))) (, ,) (NP (CD CD19+) (NNS cells)) (PRN (-LRB- -LRB-) (NP (CD 7.5) (NN ×) (NN 104) (NN cells/0.2)))))
( (S (NP (NP (NN ml)) (-RRB- -RRB-) (CC or) (NP (NN Ramos) (NNS cells)) (-LRB- -LRB-) (NP (CD 1) (NN ×) (CD 104) (NN cells/0.2)))))
( (S (S (NP (NN ml) (-RRB- -RRB-)) (VP (VBD were) (VP (VBN cultured) (PP (IN in) (NP (NN triplicate))) (PP (IN in) (NP (JJ microtiter) (NNS wells)))))) (. .)))
( (S (S (NP (DT The) (NNS cells)) (VP (VBD were) (VP (VBN pulsed) (PP (IN with) (NP (ADJP (CD 3.7) (NN ×)) (NN 104Bq) (NN -LSB-3H) (-RRB- -RSB-) (NN thymidine))) (PRN (-LRB- -LRB-) (NP (NP (NNP Amersham) (, ,) (NNP Buckinghamshire)) (, ,) (NP (NN UK))) (-RRB- -RRB-)) (PP (IN for) (NP (NP (DT the) (JJ last) (CD 16) (NN h)) (PP (IN of) (NP (DT a) (JJ 72-h) (NN incubation)))))))) (. .)))
( (S (S (S (NP (DT The) (NNS cells)) (VP (VBD were) (VP (VBN harvested) (S (VP (VBG using) (NP (NP (DT an) (JJ automated) (NN cell) (NN harvester)) (PRN (-LRB- -LRB-) (NP (NNP Packard) (NN Instrument) (NNP Company) (, ,) (NNP Meriden) (, ,) (NP (NN CT)) (, ,) (NP (NNP USA))) (-RRB- -RRB-)))))))) (CC and) (S (NP (CD -LSB-3H) (-RRB- -RSB-) (NN thymidine) (NN incorporation)) (VP (VBD was) (VP (VBN determined) (PP (IN in) (NP (NP (DT a) (NN scintillation) (VB counter)) (PRN (-LRB- -LRB-) (NP (NNP TopCount) (, ,) (NNP Packard) (NN Instrument) (NNP Company) (NNP Inc.) (, ,) (NNP Meriden)) (, ,) (NP (NN CT)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NN Cell) (NN death)) (VP (VBD was) (VP (VBN measured) (PP (IN by) (NP (JJ vital) (NN dye) (NN exclusion) (NN test))) (PP (IN by) (S (VP (VBG staining) (NP (NP (NNS cells)) (PP (IN with) (NP (NP (NP (ADJP (CD 5) (NN μg/ml)) (NN propidium) (NN iodide)) (PRN (-LRB- -LRB-) (NP (NN -LSB-PI)) (-RRB- -RSB-))) (PRN (: ;) (NP (NNP Calbiochem) (NNP Corp.)) (: ;) (NP (NN La) (NN Jolla)) (, ,) (NP (NN CA)) (: ;) (NP (CD 5) (NN mg/ml)) (-RRB- -RRB-))))) (PP (IN for) (NP (NP (CD one) (NN minute)) (PP (IN on) (NP (NN ice))))))))))) (. .)))
( (S (S (NP (NP (QP (IN At) (JJS least) (CD 1,000)) (NNS cells)) (PP (IN per) (NP (NN sample)))) (VP (VBD were) (NP (NN run)) (PP (IN on) (NP (DT a) (JJ BD) (NN FACSCalibur) (NN flow) (NN cytometer))))) (. .)))
( (S (S (NP (NP (DT The) (JJ statistical) (NN significance)) (PP (IN of) (NP (NP (NNS differences)) (PP (IN between) (NP (NNS groups)))))) (VP (VBD was) (VP (VBN determined) (S (VP (VBG using) (NP (DT the) (JJ paired) (JJ two-tailed) (NN Wilcoxon) (JJ nonparametric) (NN test)) (, ,) (PP (IN by) (S (VP (VBG applying) (NP (NP (CD SPSS10.1) (NN software)) (PRN (-LRB- -LRB-) (NP (NN SPSS) (NNP Inc.) (, ,) (NNP Chicago) (, ,) (NN IL) (, ,) (NN USA)) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (NP (NP (NN P) (NNS values)) (ADJP (JJR less) (PP (IN than) (NP (CD 0.05))))) (VP (VBD were) (VP (VBN considered) (ADJP (JJ significant))))) (. .)))
( (S (NP (NP (NN List)) (PP (IN of) (NP (NNS abbreviations))))))
( (S (NP (NP (NN BMP)) (, ,) (NP (NN Bone) (NN morphogenetic) (NN protein)))))
( (S (NP (NP (NN DLBCL)) (, ,) (NP (JJ diffuse) (JJ large) (NN B) (NN cell) (NN lymphoma)))))
( (S (NP (NP (NN Id)) (, ,) (NP (NP (NN inhibitor)) (PP (IN of) (NP (NN dna) (NN binding)))))))
( (S (NP (NP (NN Smad)) (, ,) (NP (NP (DT the) (NN name) (NN Smad)) (VP (VBZ originates) (PP (IN from) (NP (NP (DT the) (NN Drosophila) (NN protein)) (, ,) (NP (NN MAD)))))) (CC and) (NP (NP (DT the) (ADJP (FW Caenorhabditis) (FW elegans)) (NNS proteins)) (, ,) (NP (NP (CD sma-2)) (, ,) (NP (CD 3)) (CC and) (NP (CD 4)))))))
( (S (NP (NP (NN STAT)) (, ,) (NP (NP (NN signal) (NP (NP (NN transducer)) (CC and) (NP (NN activator)))) (PP (IN of) (NP (NN transcription)))))))
( (S (NP (NP (NNS Authors) (POS ')) (NNS contributions))))
( (S (S (NP (NN CK)) (VP (VP (VBN designed)) (CC and) (VP (VBN conducted) (NP (NNS experiments))) (, ,) (VP (VB oversaw) (NP (NN research))) (, ,) (CC and) (VP (VBP wrote) (NP (NN paper))))) (. .)))
( (S (S (NP (NN EAS)) (VP (VP (VP (VBN designed)) (CC and) (VP (VBN conducted) (NP (NNS experiments)))) (, ,) (NP (NN oversaw) (NN research)))) (. .)))
( (S (S (NP (NN MEH)) (VP (VP (VP (VBN designed)) (CC and) (VP (VBN conducted) (NP (NNS experiments)))) (, ,) (NP (NN oversaw) (NN research)))) (. .)))
( (S (S (NP (NN LF)) (VP (VP (VBN designed)) (CC and) (VP (VBN conducted) (NP (NNS experiments))))) (. .)))
( (S (S (NP (NNS EBS)) (VP (VP (VBN designed) (NP (NNS experiments))) (, ,) (VP (VB oversaw) (NP (NN research))) (, ,) (CC and) (VP (VBP wrote) (NP (NN paper))))) (. .)))
( (S (S (NP (NN JHM)) (VP (VP (VBN designed)) (CC and) (VP (VBN conducted) (NP (NNS experiments))) (, ,) (VP (VB oversaw) (NP (NN research))) (, ,) (CC and) (VP (VBP wrote) (NP (NN paper))))) (. .)))
( (S (NP (NP (NN Figure)) (CC and) (NP (NN Table)) (NP (NNS captions)))))
( (S (S (NP (NN Figure) (CD 1) (: :) (NN BMP-6)) (VP (VBZ inhibits) (NP (NP (NN proliferation)) (PP (IN of) (NP (JJ human) (NN B) (NNS cells)))))) (. .)))
( (S (S (NP (ADJP (NN A) (-RRB- -RRB-) (JJ CD19+)) (NN B) (NNS cells)) (VP (VBD were) (VP (VP (VBN isolated) (PP (IN from) (NP (JJ peripheral) (NN blood)))) (CC and) (VP (VBN stimulated) (PP (IN in) (NP (NP (NP (NNS triplicates)) (PP (IN with) (NP (NP (NP (NN anti-IgM)) (PRN (-LRB- -LRB-) (NP (CD 37.5) (NN μg/ml)) (-RRB- -RRB-))) (CC or) (NP (NN anti-IgM))))) (CC and) (NP (NP (NN CD40) (NN ligand)) (PRN (-LRB- -LRB-) (NP (NP (NN CD40L)) (: ;) (NP (CD 10) (NN ng/ml))) (-RRB- -RRB-))))) (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC or) (NP (NN absence))) (PP (IN of) (NP (NN BMP-6))))) (PP (IN for) (NP (CD 72) (NNS hours))))))) (. .)))
( (S (S (NP (NN DNA) (NN synthesis)) (VP (VBD was) (VP (VBN measured) (PP (IN by) (NP (ADJP (NN -LSB-3H) (-RRB- -RSB-) (JJ -thymidine)) (NN incorporation))) (PP (IN for) (NP (DT the) (JJ last) (CD 18) (NNS hours)))))) (. .)))
( (S (NP (NNS Data)) (VP (VBP are) (VP (VBN given) (PP (IN as) (NP (NP (JJ relative) (NN proliferation)) (VP (VBN obtained) (PP (IN by) (S (VP (VBG normalizing) (NP (NP (NP (DT the) (JJ mean) (NNS counts)) (PP (IN per) (NP (NN minute)))) (PRN (-LRB- -LRB-) (NP (NN cpm)) (-RRB- -RRB-))) (PP (IN for) (NP (NP (DT each) (NN stimulation)) (PP (TO to) (NP (NP (NP (NP (DT the) (JJ mean) (NN cpm)) (VP (VBN obtained) (PP (IN for) (NP (JJ anti-IgM) (VBN stimulated) (NNS cells))))) (NP (CD ±) (NN SEM)) (. .)) (PRN (-LRB- -LRB-) (NP (NP (JJ mean) (NN cpm)) (ADJP (JJ =) (NP (QP (CD 25) (CD 352)) (PP (IN for) (NP (JJ anti-IgM) (VBN stimulated) (NNS cells)))))) (, ,) (NP (NP (NP (NN *) (NN p) (NN ≤) (NN 0.0002)) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 8)) (-RRB- -RRB-))) (, ,) (NP (NP (NN **) (NN p) (NN ≤) (NN 0.023)) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 6)) (-RRB- -RRB-))))))))))))))))) (. .)))
( (S (S (LST (LS B) (-RRB- -RRB-)) (NP (NP (ADJP (NN Dose) (JJ dependent)) (NN inhibition)) (PP (IN of) (NP (NN BMP-6))) (PP (IN of) (NP (NN anti-IgM)))) (VP (VBD induced) (NP (NP (NN DNA-synthesis)) (PP (IN of) (NP (NP (NP (CD CD19+) (NN B) (NNS cells)) (PRN (-LRB- -LRB-) (NP (JJ relative) (NN proliferation) (NN ±) (NN SEM)) (, ,) (NP (NN n) (JJ =) (CD 3)) (-RRB- -RRB-))) (CC and) (NP (LST (LS C) (-RRB- -RRB-)) (NP (NP (DT the) (NN Burkitt) (NN lymphoma) (NN cell) (NN line)) (NP (NP (NN Ramos)) (PRN (-LRB- -LRB-) (NP (NP (JJ relative) (NN proliferation) (NN ±) (NN SEM)) (, ,) (NP (NN n) (JJ =) (CD 3))) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (S (NP (NN Ramos) (NNS cells)) (VP (VBD were) (VP (VBN cultured) (PP (IN for) (NP (CD 72) (NNS hours)))))) (CC and) (S (NP (ADJP (NN -LSB-3H) (-RRB- -RSB-) (JJ -thymidine))) (VP (VBD were) (VP (VBN added) (PP (IN for) (NP (DT the) (JJ last) (CD 4) (NNS hours))))))) (. .)))
( (S (S (NP (NP (NP (LST (LS D) (-RRB- -RRB-)) (NN Noggin)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN μg/ml)) (-RRB- -RRB-))) (CC and) (NP (NP (NN BMP-6)) (PRN (-LRB- -LRB-) (NP (QP (CD 0,25) (CC or) (CD 1)) (NN μg/ml)) (-RRB- -RRB-)))) (VP (VBD were) (VP (VP (VBN preincubated) (PP (IN for) (NP (CD 1) (NN h))) (PP (IN at) (NP (NN 37°C)))) (CC and) (RB then) (VP (VBN added) (PP (TO to) (NP (DT the) (CD CD19+) (NN B) (NNS cells))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (NN anti-IgM)) (PRN (-LRB- -LRB-) (NP (CD 37.5) (NN μg/ml)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (S (NP (NNS Cells)) (VP (VBD were) (VP (VBN cultured) (PP (IN for) (NP (CD 72) (NN h)))))) (CC and) (S (NP (NN DNA) (NN synthesis)) (VP (VBD was) (VP (VBN measured) (PP (IN by) (NP (NN 3H-thymidine) (NN incorporation))))))) (. .)))
( (S (S (NP (NP (CD One) (NN representative)) (PP (IN of) (NP (CD three) (JJ separate) (NNS experiments)))) (VP (VBZ is) (VP (VBN shown) (PRN (-LRB- -LRB-) (NP (NP (NN mean) (NN cpm) (NN ±) (NN SD)) (PP (IN of) (NP (NNS triplicates)))) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (ADJP (NN E) (-RRB- -RRB-) (RB Highly) (VBN purified)) (ADJP (ADJP (JJ CD19+CD27-)) (CC or) (ADJP (JJ CD19+CD27+))) (NNS cells)) (VP (VBD were) (VP (VP (VBN obtained) (PP (IN by) (NP (NP (NN cell) (NN sorting)) (PP (IN of) (NP (NN CD19+) (NNS cells)))))) (CC and) (VP (VBN stimulated) (PP (IN with) (NP (NN anti-IgM))) (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC or) (NP (NN absence))) (PP (IN of) (NP (NN BMP-6))))))) (, ,) (SBAR (IN as) (S (VP (VBN indicated) (PP (IN for) (NP (CD 72) (NNS hours)))))))) (. .)))
( (S (S (NP (NN DNA) (NN synthesis)) (VP (VBD was) (ADVP (RB measuredby)) (NP (ADJP (NN -LSB-3H) (-RRB- -RSB-) (JJ -thymidine)) (NN incorporation)))) (. .)))
( (S (NP (NNS Data)) (VP (VBP are) (VP (VBN given) (PP (IN as) (NP (NP (JJ relative) (NN proliferation)) (VP (VBN obtained) (PP (IN by) (S (VP (VP (VBG normalizing) (NP (NP (DT the) (JJ mean) (NN cpm)) (PP (IN for) (NP (DT each) (NN stimulation))) (PP (TO to) (NP (NP (DT the) (JJ mean) (NN cpm)) (VP (VBN obtained) (PP (IN for) (NP (JJ anti-IgM) (VBN stimulated) (NNS cells)))))))) (PRN (-LRB- -LRB-) (NP (NP (JJ mean) (NN cpm)) (ADJP (JJ =) (NP (NP (CD 18) (NP (NP (CD 221)) (PP (IN for) (NP (JJ CD19+CD27-) (JJ naïve) (NN B) (NNS cells))))) (, ,) (S (S (NP (JJ mean) (NN cpm)) (VP (JJ =) (NP (CD 8) (NP (CD 930))) (PP (IN for) (NP (JJ CD19+CD27+) (NN memory) (NN B) (NNS cells))))) (, ,) (S (NP (NN n)) (VP (JJ =) (NP (CD 5)))))))) (: ;) (NP (NN *) (NN p) (NN ≤) (CD 0,004)) (, ,) (NP (NN **) (NN p) (NN ≤) (CD 0.001)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NN Figure) (CD 2) (: :) (NN BMP-6)) (VP (VBZ induces) (NP (NN cell) (NN death)) (PP (IN in) (NP (NN B) (NNS cells))))) (. .)))
( (S (S (NP (NP (JJ CD19+CD27-) (NN naïve) (NN B) (NNS cells)) (CC or) (NP (JJ CD19+CD27+) (NN memory) (NN B) (NNS cells))) (VP (VBD were) (VP (VBN cultured) (PP (IN for) (NP (CD 48) (NN h))) (PP (IN with) (NP (NP (NN BMP-6)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN μg/ml)) (-RRB- -RRB-)))) (PP (PP (IN with)) (CC or) (PP (IN without) (NP (NP (NN anti-IgM)) (PRN (-LRB- -LRB-) (NP (CD 37.5) (NN μg/ml)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (NN Cell) (NN death)) (PRN (-LRB- -LRB-) (PP (IN PI+) (NP (NNS cells))) (-RRB- -RRB-))) (VP (VBD was) (ADVP (RB then)) (VP (VBN measured) (PP (IN by) (NP (NN flow) (NN cytometry) (NN analysis)))))) (. .)))
( (S (S (NP (NNS Data)) (VP (VBP are) (VP (VBN shown) (PP (IN as) (NP (NP (NN mean) (NN percentage)) (PP (IN PI+) (NP (NP (NNS cells)) (PP (IN from) (NP (NP (CD five) (JJ independent) (NNS donors)) (PRN (-LRB- -LRB-) (NP (CD ±) (NN SEM)) (: ;) (S (NP (NN p)) (VP (JJ ≤) (NP (CD 0,003)))) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (NP (NP (NP (NN Figure) (CD 3)) (: :) (NP (NN Ramos))) (NNS cells)) (VP (VBD were) (VP (VBN cultured) (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC or) (NP (NN absense))) (PP (IN of) (NP (NP (CD BMP-6)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN μg/ml)) (-RRB- -RRB-)))))) (PP (IN for) (NP (CD 48) (NN h))) (PP (IN before) (NP (NP (NN analysis)) (PP (IN of) (NP (NN cell) (NN death))) (PP (IN by) (NP (NN PI) (NN staining)))))))) (. .)))
( (S (S (NP (NNS Data)) (VP (VBP are) (VP (VBN shown) (PP (IN as) (NP (NP (NN mean) (NN percentage)) (PP (IN PI+) (NP (NP (NNS cells)) (PRN (-LRB- -LRB-) (NP (CD ±) (NN SEM)) (, ,) (NP (NN n) (JJ =) (CD 3)) (, ,) (S (NP (NN p)) (VP (JJ ≤) (NP (CD 0,001)))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (NN Figure) (CD 4) (: :) (CD CD19+) (NN B) (NNS cells)) (VP (VBP express) (NP (NP (NP (NN BMP) (NN type) (CD I)) (CC and) (NP (NN type) (CD II))) (NNS receptors)))) (. .)))
( (S (S (NP (JJ Total) (NN cell) (NNS lysates)) (VP (VBD were) (VP (VP (VBN prepared) (PP (IN from) (NP (NP (NP (NP (NP (DT the) (JJ myeloid) (NN cell) (NN line)) (NN HL60)) (, ,) (NP (DT the) (NN cell) (NN line) (NN Ramos)) (CC or) (NP (NN CD19+) (NN B))) (NNS cells)) (VP (VBN isolated) (PP (IN from) (NP (JJ peripheral) (NN blood))))))) (CC and) (VP (VBN analyzed) (PP (IN by) (NP (NP (NN western) (NN blot)) (PP (IN for) (NP (NP (NN expression)) (PP (IN of) (NP (NP (NN BMP) (NN type) (CD I)) (CC and) (NP (NN type) (CD II)) (NP (NNS receptors)))))))))))) (. .)))
( (S (S (NP (NP (CD One) (JJ representative) (NN experiment)) (PP (IN of) (NP (CD four)))) (VP (VBZ is) (VP (VBN shown)))) (. .)))
( (S (NP (NP (NN Figure) (CD 5)) (: :) (NP (NP (JJ BMP-6-induced) (NN phosphorylation)) (PP (IN of) (NP (NN Smad1/5/8))) (PP (PP (IN in) (NP (NP (NN CD19+) (NN B) (NNS cells)) (CC and) (NP (NN Ramos)))) (, ,) (CC but) (PP (RB not) (IN in) (NP (NN HL60) (NNS cells))))) (. .))))
( (S (NP (NP (NN CD19+) (NN B) (NNS cells)) (, ,) (CC or) (NP (NP (DT the) (NN cell) (NNS lines)) (NP (NP (NN Ramos)) (CC or) (NP (NN HL60)))))))
( (S (NP (NP (NN Figure) (CD 6)) (: :) (S (VP (VBD were) (VP (VBN cultured) (PP (IN in) (NP (NN X-vivo) (CD 15))) (PP (IN over) (NP (NP (NN night)) (PP (IN before) (NP (NP (NN treatment)) (PP (IN with) (NP (NN BMP-6))) (PP (PP (IN for) (NP (CD 30) (NNS minutes))) (, ,) (CC or) (PP (IN for) (NP (NP (DT the) (VBN indicated) (NN time) (NNS points)) (SBAR (IN before) (S (NP (JJ total) (NN cell) (NNS lysates)) (VP (VBD were) (VP (VBN prepared))))))))))))))) (. .))))
( (S (S (NP (NP (DT The) (NN amount)) (PP (IN of) (NP (VBN phosphorylated) (NN Smad) (NN 1/5/8)))) (VP (VBD was) (VP (VBN determined) (PP (IN by) (NP (JJ western-blot) (NN analysis)))))) (. .)))
( (S (S (NP (DT The) (NNS membranes)) (VP (VBD were) (VP (VBN reprobed) (PP (IN for) (NP (NN Smad1)))))) (. .)))
( (S (S (NP (NP (CD One) (JJ representative) (NN experiment)) (PP (IN of) (NP (CD three)))) (VP (VBZ is) (VP (VBN shown)))) (. .)))
( (S (S (NP (NN Figure) (CD 7) (: :) (NN BMP-6)) (VP (VBD induced) (NP (NP (NN upregulation)) (PP (IN of) (NP (NN Id1)))) (PP (IN at) (NP (DT the) (NP (NP (NN mRNA)) (CC and) (NP (NN protein))) (NN level))))) (. .)))
( (S (S (NP (CD CD19+) (NN B) (NNS cells)) (VP (VBD were) (VP (VBN cultured) (PP (IN in) (NP (NN X-vivo) (CD 15))) (PP (IN over) (NP (NP (NN night)) (PP (IN before) (NP (NP (NN treatment)) (PP (IN with) (NP (NN BMP-6))) (PP (IN for) (NP (DT the) (VBN indicated) (NN time) (NNS points)))))))))) (. .)))
( (S (S (NP (JJ Total) (NN RNA)) (VP (VBD was) (VP (VBN extracted)))) (CC and) (S (NP (NP (NN Id1)) (, ,) (NP (NN Id2)) (CC or) (NP (NN Id3-expression))) (VP (VBD was) (VP (VBN analysed) (PP (IN by) (NP (JJ real-time) (NN RT-PCR)))))) (: ;) (S (NP (NNS values)) (VP (VBP are) (VP (VP (VBN normalised) (PP (TO to) (NP (NP (DT the) (NN expression) (NN level)) (PP (IN of) (NP (NN PGK1) (NN mRNA)))))) (CC and) (VP (VBN expressed) (PP (IN as) (NP (NP (JJ relative) (NN quantification)) (PRN (-LRB- -LRB-) (NP (NP (JJ 2-average) (NN ΔΔCT) (NN –)) (ADJP (JJ relative) (PP (TO to) (NP (NP (NP (NP (NN Id1)) (, ,) (NP (NN Id2)) (CC or) (NP (NN Id3))) (NN expression)) (PP (IN in) (NP (DT the) (JJ cell-line) (NN Ramos))))))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (CD One) (NN representative)) (PP (IN of) (NP (CD three) (JJ independent) (NNS experiments)))) (VP (VBZ is) (VP (VBN shown)))) (. .)))
( (S (S (NP (NN Figure) (CD 8) (: :) (NN Id) (NN protein) (NN expression)) (VP (VBD was) (VP (VBN determined) (PP (IN by) (NP (JJ western-blot) (NN analysis)))))) (. .)))
( (S (S (S (NP (NN CD19+) (NN B) (NNS cells)) (VP (VBD were) (VP (VBN cultured) (PP (IN in) (NP (NN X-vivo) (CD 15))) (PP (IN over) (NP (NP (NN night)) (PP (IN before) (NP (NP (NN treatment)) (PP (IN with) (NP (NN BMP-6))))))) (PP (IN for) (NP (DT the) (VBN indicated) (NN time) (NNS points)))))) (CC and) (S (NP (NN cell) (NNS lysates)) (VP (VBD were) (VP (VBN prepared))))) (. .)))
( (S (S (NP (NP (CD One) (JJ representative) (NN experiment)) (PP (IN of) (NP (CD three)))) (VP (VBZ is) (VP (VBN shown)))) (. .)))
( (S (S (NP (NN HeLa) (NNS cells)) (VP (VBD were) (VP (VBN used) (PP (IN as) (NP (NP (DT a) (JJ positive) (NN control)) (PP (IN for) (NP (NN Id1) (NN protein) (NN detection)))))))) (. .)))
( (S (NP (NP (NN Figure) (CD 9)) (: :) (NP (NP (JJ Relative) (NN protein) (NN expression)) (PP (IN of) (NP (NP (NN Id1)) (, ,) (NP (NN Id2)) (CC and) (NP (NN Id3))))) (. .))))
( (S (S (NP (NP (NNS Quantifications)) (PP (IN of) (NP (NP (NN Id1)) (, ,) (NP (NN Id2)) (CC and) (NP (NN Id3)) (NP (NN protein) (NNS levels))))) (VP (VBD were) (VP (VP (VBN performed) (S (VP (VBG using) (NP (NN β-actin)) (PP (IN as) (NP (NN normalization)))))) (CC and) (VP (VBN expressed) (PP (IN as) (NP (NP (NN mean) (NN ±) (NN SEM)) (PRN (-LRB- -LRB-) (NP (NN Id1)) (: :) (NP (NP (NN n)) (ADJP (JJ =) (NP (CD 4)))) (, ,) (NP (NN *) (NN p) (NN ≤) (NN 0.020)) (: ;) (NP (NP (NN Id2)) (CC and) (NP (NN Id3))) (: :) (S (NP (NN n)) (VP (JJ =) (NP (CD 3)))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (NN Figure) (CD 10)) (: :) (NP (NN Anti-IgM))) (ADVP (RB rapidly)) (VP (VBZ upregulates) (NP (NP (NN BMP-6) (NN mRNA) (NN expression)) (PP (IN in) (NP (JJ human) (NNS B-cells)))))) (. .)))
( (S (S (NP (JJ CD19-positive) (NN B) (NNS cells)) (VP (VBD were) (VP (VP (VBN cultured) (PP (IN in) (NP (NN X-vivo) (CD 15))) (PP (IN over) (NP (NN night)))) (CC and) (VP (VBN stimulated) (PP (IN with) (NP (NN anti-IgM))) (PP (IN for) (NP (DT the) (VBN indicated) (NN time) (NNS periods))))) (, ,) (SBAR (IN before) (S (NP (JJ total) (NN RNA)) (VP (VBD was) (VP (VBN extracted))))))) (. .)))
( (S (NP (NP (DT The) (NN expression)) (PP (IN of) (NP (NN BMP-6) (NN mRNA))) (PP (IN by) (NP (JJ realtime) (NN RT-PCR)))) (: ;) (S (NP (NNS values)) (VP (VBP are) (VP (VP (VBN normalised) (PP (TO to) (NP (NP (DT the) (NN expression) (NN level)) (PP (IN of) (NP (NN PGK1) (NN mRNA)))))) (CC and) (VP (VBN expressed) (PP (IN as) (NP (NP (JJ relative) (NN quantification)) (PRN (-LRB- -LRB-) (NP (NP (JJ 2-average) (NN ΔΔCT) (NN –)) (ADJP (JJ relative) (PP (TO to) (NP (NP (NN BMP-6) (NN expression)) (PP (IN in) (NP (DT the) (JJ cell-line) (NN Ramos)))))))))))))) (. .)))
( (S (S (NP (NP (CD One) (NN representative)) (PP (IN of) (NP (CD five) (JJ independent) (NNS experiments)))) (VP (VBZ is) (VP (VBN shown)))) (. .)))
( (S (S (NP (NP (NN Figure) (CD 11)) (: :) (NP (NP (JJ Fetal) (NN calf) (NN serum)) (CC and) (NP (JJ human) (NN AB) (NN serum)))) (VP (VBZ upregulates) (NP (NP (NN BMP-6) (NN mRNA) (NN expression)) (PP (IN in) (NP (JJ human) (NNS B-cells)))))) (. .)))
( (S (S (NP (JJ CD19-positive) (NN B) (NNS cells)) (VP (VBD were) (VP (VBN cultured) (PP (IN in) (NP (NN X-vivo) (CD 15))) (PP (PP (IN over) (NP (NN night))) (CC and) (PP (IN with) (NP (NP (JJ fetal) (NN calf) (NN serum)) (CC or) (NP (JJ human) (NN AB) (NN serum))))) (PP (IN at) (NP (DT the) (VBN indicated) (NNS dilutions))) (PP (IN for) (NP (CD four) (NNS hours)))) (, ,) (SBAR (IN before) (S (NP (JJ total) (NN RNA)) (VP (VBD was) (VP (VBN extracted))))))) (. .)))
( (S (NP (NP (DT The) (NN expression)) (PP (IN of) (NP (NN BMP-6) (NN mRNA))) (PP (IN by) (NP (JJ realtime) (NN RT-PCR)))) (: ;) (S (NP (NNS values)) (VP (VBP are) (VP (VP (VBN normalised) (PP (TO to) (NP (NP (DT the) (NN expression) (NN level)) (PP (IN of) (NP (NN PGK1) (NN mRNA)))))) (CC and) (VP (VBN expressed) (PP (IN as) (NP (NP (JJ relative) (NN quantification)) (PRN (-LRB- -LRB-) (NP (NP (JJ 2-average) (NN ΔΔCT) (NN –)) (ADJP (JJ relative) (PP (TO to) (NP (NP (NN BMP-6) (NN expression)) (PP (IN in) (NP (DT the) (JJ cell-line) (NN Ramos)))))))))))))) (. .)))
( (S (S (NP (NP (CD One) (NN representative)) (PP (IN of) (NP (CD three) (JJ independent) (NNS experiments)))) (VP (VBZ is) (VP (VBN shown)))) (. .)))
( (S (NP (NP (NP (NN Control)) (PP (IN of) (NP (NN gene) (NN expression))) (PP (IN during) (NP (NN T) (NN cell) (NN activation)))) (: :) (NP (NP (JJ alternate) (NN regulation)) (PP (IN of) (NP (NP (NN mRNA) (NN transcription)) (CC and) (NP (NN mRNA) (NN stability))))))))
( (S (NP (NN Abstract))))
( (S (NP (NP (NN Background)) (: :) (S (NP (NN Microarray) (NN technology)) (VP (VBZ has) (VP (VBN become) (ADJP (RB highly) (JJ valuable) (PP (IN for) (S (VP (VBG identifying) (NP (NP (JJ complex) (JJ global) (NNS changes)) (PP (IN in) (NP (NN gene) (NN expression) (NNS patterns))))))))))) (. .))))
( (S (S (NP (NP (DT The) (JJ effective) (NN correlation)) (PP (IN of) (NP (NP (VBN observed) (NNS changes)) (PP (IN in) (NP (NP (NN gene) (NN expression)) (PP (IN with) (NP (JJ shared) (NN transcription) (JJ regulatory) (NNS elements)))))))) (VP (VBZ remains) (ADJP (JJ difficult) (S (VP (TO to) (VP (VB demonstrate) (NP (NN convincingly)))))))) (. .)))
( (S (S (NP (NP (CD One) (NN reason)) (PP (IN for) (NP (DT this) (NN difficulty)))) (VP (MD may) (VP (VB result) (PP (IN from) (NP (NP (DT the) (JJ intricate) (NN convergence)) (PP (IN of) (NP (NP (UCP (CC both) (ADJP (JJ transcriptional)) (CC and) (NP (NN mRNA) (NN turnover))) (NNS events)) (SBAR (WHNP (WDT which)) (S (, ,) (ADVP (RB together)) (, ,) (ADVP (RB directly)) (VP (VBP influence) (NP (JJ steady-state) (NN mRNA) (NNS levels)))))))))))) (. .)))
( (S (NP (NP (NNS Results)) (: :) (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (JJ relative) (NN contribution)) (PP (IN of) (NP (NP (NN gene) (NN transcription)) (CC and) (NP (NP (NNS changes)) (PP (IN in) (NP (NP (NN mRNA) (NN stability)) (NN regulation)))))) (PP (TO to) (NP (NP (JJ standard) (NNS analyses)) (PP (IN of) (NP (NN gene) (NN expression)))))))))) (, ,) (NP (PRP we)) (VP (VBD used) (NP (NP (CD two) (JJ distinct) (NN microarray) (NNS methods)) (SBAR (WHNP (WDT which)) (S (ADVP (RB individually)) (VP (VB measure) (NP (NP (JJ nuclear) (NN gene) (NN transcription)) (CC and) (NP (NP (NNS changes)) (PP (IN in) (NP (NN polyA) (NN mRNA) (NN gene) (NN expression))))))))))) (. .))))
( (S (S (NP (NN Gene) (NN expression) (NNS profiles)) (VP (VBD were) (VP (VBN obtained) (PP (IN from) (NP (CC both) (NP (NP (NN polyA) (NN mRNA)) (PRN (-LRB- -LRB-) (NP (JJ whole-cell)) (-RRB- -RRB-))) (CC and) (NP (JJ nuclear) (ADJP (ADJP (JJ run-on)) (PRN (-LRB- -LRB-) (ADJP (RB newly) (VBN transcribed)) (-RRB- -RRB-))) (NN RNA)))) (PP (IN across) (NP (NP (DT a) (NN time) (NN course)) (PP (IN of) (NP (NP (CD one) (NN hour)) (PP (VBG following) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (JJ human) (NN Jurkat) (NN T) (NNS cells))) (PP (IN with) (NP (NP (NN PMA)) (CC plus) (NP (NN ionomycin))))))))))))) (. .)))
( (S (NP (JJ Comparative) (NN analysis)) (VP (VBD revealed) (SBAR (IN that) (S (NP (NP (NN regulation)) (PP (IN of) (NP (NN mRNA) (NN stability)))) (VP (MD may) (VP (VB account) (PP (IN for) (NP (NP (QP (RB as) (JJ much) (IN as) (CD 50)) (NN %)) (PP (IN of) (NP (NP (DT all) (NNS measurements)) (PP (IN of) (NP (NP (NNS changes)) (PP (IN in) (NP (NN polyA) (NN mRNA))) (PP (IN in) (NP (DT this) (NN system)))))))))) (, ,) (SBAR (IN as) (S (VP (VBD inferred) (PP (IN by) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (DT any) (JJ corresponding) (NN regulation)) (PP (IN of) (NP (JJ nuclear) (NN gene) (NN transcription) (NN activity))) (PP (IN for) (NP (NP (DT these) (NNS groups)) (PP (IN of) (NP (NNS genes)))))))))))))))) (. .)))
( (S (S (NP (NP (NNS Genes)) (SBAR (WHNP (WDT which)) (S (VP (VBD displayed) (NP (NP (JJ dramatic) (NNS elevations)) (PP (IN in) (NP (CC both) (NP (NN mRNA)) (CC and) (NP (JJ nuclear) (JJ run-on) (NN RNA))))))))) (VP (VBD were) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (VP (VBN inhibited) (PP (IN by) (NP (NP (NP (NP (NN Actinomycin) (NN D)) (PRN (-LRB- -LRB-) (NP (NN ActD)) (-RRB- -RRB-))) (NN pre-treatment)) (PP (IN of) (NP (NNS cells))))) (SBAR (IN while) (S (NP (NP (JJ large) (NNS numbers)) (PP (IN of) (NP (NP (NNS genes)) (VP (VBN regulated) (PP (ADVP (RB only)) (IN through) (NP (JJ altered) (NN mRNA) (NN turnover))) (PRN (-LRB- -LRB-) (ADVP (CC both) (ADVP (RB up)) (CC and) (ADVP (RB down))) (-RRB- -RRB-)))))) (VP (VBD were) (ADJP (JJ ActD-resistant)))))))))))) (. .)))
( (S (S (NP (NP (JJ Consistent) (NNS patterns)) (PP (IN across) (NP (DT the) (NN time) (NN course)))) (VP (VBD were) (VP (VBN observed) (PP (IN for) (NP (CC both) (NP (VBN transcribed)) (CC and) (NP (JJ stability-regulated) (NNS genes))))))) (. .)))
( (S (NP (NP (NN Conclusion)) (: :) (S (NP (PRP We)) (VP (VBP propose) (SBAR (IN that) (S (NP (NP (NN regulation)) (PP (IN of) (NP (NN mRNA) (NN stability)))) (VP (VBZ contributes) (ADVP (RB significantly)) (PP (TO to) (NP (NP (DT the) (VBN observed) (NNS changes)) (PP (IN in) (NP (NP (NN gene) (NN expression)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (JJ external) (NNS stimuli))))))))) (, ,) (SBAR (IN as) (S (VP (VBN measured) (PP (IN by) (NP (JJ high) (NN throughput) (NNS systems))))))))))) (. .))))
( (S (NP (NN Background))))
( (S (NP (ADJP (RB Virtually) (DT all)) (NN microarray) (NNS studies) (JJ to-date)) (VP (VBP have) (VP (VBN measured) (NP (NP (NNS changes)) (PP (IN in) (NP (JJ steady-state) (NN mRNA) (NNS levels)))) (PP (IN by) (S (VP (VP (VP (VBG harvesting) (NP (JJ total) (JJ cellular) (NN RNA))) (CC and) (VP (VBG using) (S (NP (PRP it)) (VP (TO to) (VP (VB generate) (NP (NNS probes)) (PP (IN through) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (NNS strategies)) (PP (VBG including) (NP (NP (NN end-labeling)) (PP (IN of) (NP (VBN purified) (NN mRNA) (NN -LSB-1)))))))))))) (-RRB- -RSB-))) (, ,) (VP (VBG incorporating) (NP (NP (DT a) (ADJP (VB label) (PP (IN into) (NP (DT the) (JJ first) (NN strand)))) (NN cDNA)) (VP (VBN made) (PP (IN from) (NP (NN mRNA) (NN -LSB-2)))) (-RRB- -RSB-))) (, ,) (CC or) (VP (VBG attaching) (NP (DT a) (NN T7) (NN RNA) (NN polymerase) (NN promoter)) (PP (IN during) (NP (NN cDNA) (NN synthesis))) (, ,) (ADVP (RB then)) (NP (NP (NN labeling)) (PP (IN of) (NP (DT the) (VBG resulting) (NN RNA) (NN -LSB-3)))))) (-RRB- -RSB-))))) (. .)))
( (S (ADVP (RBR More) (RB recently)) (, ,) (NP (JJ several) (NNS groups)) (VP (VBP have) (VP (VBN demonstrated) (NP (NP (DT the) (NN feasibility)) (PP (IN of) (S (VP (VBG hybridizing) (NP (ADJP (RB metabolically) (VBN labeled)) (NNS mRNAs)) (PP (ADVP (RB directly)) (IN from) (NP (NP (NP (NP (JJ nuclear) (JJ run-on)) (PRN (-LRB- -LRB-) (NP (NN NRO)) (-RRB- -RRB-))) (NNS reactions)) (PP (TO to) (NP (NN nylon) (NN filter) (NNS microarrays))))) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB investigate) (NP (NN nascent) (NNS transcripts) (CD -LSB-1,4-6) (-RRB- -RSB-)))))))))))) (. .)))
( (S (NP (NP (NNP Schuhmacher) (FW et) (FW al.)) (CD -LSB-5) (-RRB- -RSB-)) (, ,) (PP (IN in) (NP (JJ particular))) (, ,) (VP (VP (VBN used) (NP (NP (DT a) (NN B) (NN cell) (NN line)) (VP (VBG carrying) (NP (DT a) (ADJP (ADJP (JJ conditional)) (, ,) (ADJP (JJ tetracycline-regulated))) (NN myc) (NN gene))))) (, ,) (CC and) (VP (VBD found) (SBAR (IN that) (S (NP (NN myc) (NN induction)) (VP (VBD resulted) (PP (IN in) (NP (NP (RB only) (DT a) (JJ small)) (VP (VBP overlap) (PP (IN in) (NP (JJ regulated) (NNS mRNAs))) (PP (IN at) (NP (CD 4) (NNS hours) (JJ post-induction))) (SBAR (WHADVP (WRB when)) (S (VP (VBG comparing) (NP (NP (NN polyA) (NN mRNA)) (CC and) (NP (NN NRO) (NN RNA))) (PP (IN on) (NP (NNS microarrays)))))))))))))) (. .)))
( (S (S (NP (DT This) (JJ early) (NN work)) (VP (VBD provided) (NP (NN evidence) (SBAR (IN that) (S (NP (NP (JJ transcriptional) (NN activation)) (PP (IN of) (NP (NNS genes)))) (VP (VBZ does) (RB not) (ADVP (RB necessarily)) (VP (VB lead) (PP (TO to) (NP (NP (DT a) (JJ corresponding) (NN increase)) (PP (IN of) (NP (PRP$ their) (JJ steady-state) (NN mRNA) (NNS levels)))))))))))) (. .)))
( (S (ADVP (RBR More) (RB recently)) (, ,) (NP (PRP$ our) (NN laboratory)) (VP (VBZ has) (VP (VBN examined) (NP (NP (DT the) (NN relationship)) (PP (IN between) (NP (NP (ADJP (ADJP (RB newly) (VBN transcribed)) (PRN (-LRB- -LRB-) (NP (NN NRO)) (-RRB- -RRB-))) (NN RNA)) (CC and) (NP (NN polyA) (NN mRNA))))) (PP (IN in) (NP (NP (DT a) (NN stress) (NN model)) (VP (VBG using) (NP (JJ human) (JJ non-small) (NN lung) (NN carcinoma) (NN H1299) (NNS cells))))))) (. .)))
( (S (S (PP (IN In) (NN response) (TO to) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (NNS stresses)) (PRN (-LRB- -LRB-) (NP (NP (NN ultraviolet) (NN light)) (, ,) (NP (NN heat) (NN shock)) (, ,) (CC or) (NP (NN prostaglandin))) (-RRB- -RRB-)))))) (, ,) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (RB approximately) (NN half)) (PP (IN of) (NP (NP (DT the) (VBN observed) (NNS changes)) (PP (IN in) (NP (NP (NN mRNA) (NNS levels)) (PP (IN of) (NP (JJ stress-regulated) (NNS genes)))))))) (VP (VBD were) (VP (VBN accompanied) (PP (IN by) (NP (NP (DT a) (JJ corresponding) (NN increase)) (CC or) (NP (NP (NN decrease)) (PP (IN in) (NP (NN gene) (NN transcription)))))) (SBAR (IN as) (S (VP (VBN measured) (PP (IN by) (NP (NN NRO)))))))))))) (. .)))
( (S (S (NP (NP (DT The) (VBG remaining) (NN half)) (PP (IN of) (NP (NP (JJ stress-altered) (NNS changes)) (PP (IN in) (NP (NN gene) (NN expression)))))) (VP (VBD was) (ADJP (RB largely) (JJ attributable) (PP (TO to) (NP (NP (NNS changes)) (PP (IN in) (NP (NN mRNA) (NN turnover)))))) (, ,) (S (ADVP (RB thus)) (VP (VBG suggesting) (SBAR (IN that) (S (, ,) (PP (IN on) (NP (DT a) (JJ global) (NN level))) (, ,) (NP (NP (NNS changes)) (PP (IN in) (NP (NN mRNA) (NN turnover)))) (ADVP (RB profoundly)) (VP (VBP influence) (NP (NP (NN gene) (NN expression) (NNS patterns)) (CD -LSB-6) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (JJ Several) (NNS questions)) (, ,) (ADVP (RB however)) (, ,) (VP (VBD remained) (S (VP (TO to) (VP (VB be) (VP (VBN answered) (PP (IN from) (NP (DT these) (JJR earlier) (NNS studies))))))))) (. .)))
( (S (SBAR (IN Since) (S (PP (IN in) (NP (CC both) (DT the) (NN myc) (NN induction) (CC and) (NN stress) (NNS experiments))) (, ,) (SBAR (IN as) (S (VP (VBN mentioned) (ADVP (RB above))))) (, ,) (NP (NP (NNS measurements)) (PP (IN of) (NP (CC both) (NP (ADJP (RB newly) (VBN transcribed))) (CC and) (NP (NN polyA) (NNS mRNAs))))) (VP (VBD were) (VP (VBN made) (PP (IN at) (NP (DT a) (JJ single) (NN time) (NN point))))))) (, ,) (NP (EX there)) (VP (VBD existed) (NP (NP (DT a) (JJ reasonable) (NN possibility)) (PP (IN of) (NP (NP (JJ temporal) (NNS disjunctions)) (PP (IN between) (NP (NP (NP (DT the) (NN timing)) (PP (IN of) (NP (NN mRNA) (JJ new) (NN gene) (NN synthesis)))) (CC and) (NP (NP (DT the) (NNS rates)) (PP (IN of) (NP (NP (NN accumulation)) (PP (IN of) (NP (NN mRNA))) (PP (IN in) (NP (DT the) (NN cell)))))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ second) (NN question)) (VP (VBG remaining) (VP (VBN unanswered)))) (VP (VBZ is) (SBAR (IN whether) (CC or) (RB not) (S (NP (NP (ADJP (RB highly) (JJ significant)) (NNS levels)) (PP (IN of) (NP (NP (NP (NN mRNA) (NN stability)) (NN regulation)) (PRN (-LRB- -LRB-) (NP (NP (QP (RB >) (CD 50)) (NN %)) (PP (IN of) (NP (NP (DT all) (VBN measured) (NN gene) (NN expression)) (PP (IN in) (NP (DT the) (NN stress) (NN example)))))) (-RRB- -RRB-))))) (VP (VBZ is) (ADJP (JJ common) (PP (TO to) (NP (JJ different) (JJ biological) (NN model) (NNS systems))))))))) (. .)))
( (S (SBAR (IN In) (NN order) (TO to) (S (VP (VB begin) (S (VP (TO to) (VP (VB address) (NP (DT these) (NNS questions)))))))) (NP (PRP we)) (VP (VBD investigated) (NP (NP (NNS changes)) (PP (IN at) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NP (NN transcription)) (CC and) (NP (JJ total) (JJ cellular) (NN mRNA) (NN abundance))))))) (ADVP (RB simultaneously)) (PP (IN across) (NP (NP (DT a) (NN time) (NN course)) (PP (IN of) (NP (NP (NN activation)) (VP (VBG using) (NP (NN Jurkat) (NN T) (NNS cells)))))))) (. .)))
( (S (S (NP (NN T-cell) (NN activation)) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (ADJP (ADVP (RBS most) (RB widely)) (VBN studied)) (NNS models)) (PP (IN of) (NP (NP (JJ cellular) (NN response)) (PP (TO to) (NP (JJ exogenous) (NN stimulation)))))))))) (. .)))
( (S (S (NP (DT The) (JJ initial) (NNS events)) (VP (VBP include) (NP (NP (NP (JJ rapid) (NN signaling)) (PP (IN via) (NP (JJ protein-protein) (NNS interactions)))) (, ,) (NP (NP (NN phosphorylation/dephosphorylation)) (PP (IN of) (NP (NN target) (NN signaling) (NNS molecules)))) (, ,) (CC and) (NP (NP (NN release)) (PP (IN of) (NP (NN Ca2+))) (PP (IN from) (NP (JJ intracellular) (NNS stores))))))) (. .)))
( (S (S (NP (NP (JJ Subsequent) (NN activation)) (PP (IN of) (NP (NN signal) (NN transduction) (NNS cascades)))) (VP (VBZ culminates) (PP (IN in) (NP (NP (DT the) (NN implementation)) (PP (IN of) (NP (NP (NN gene) (NN expression) (NNS patterns)) (ADJP (JJ characteristic) (PP (IN of) (NP (DT the) (JJ immune) (NN response)))))))))) (. .)))
( (S (NP (NP (JJ Initial) (NN microarray) (NNS studies)) (VP (VBG using) (NP (NN T) (NNS cells)))) (VP (VBP have) (VP (VBN focused) (PP (IN on) (NP (NP (NN gene) (NN expression) (NNS changes)) (VP (VBG occurring) (NP (NP (JJ several) (NNS hours)) (PP (IN after) (NP (NN activation) (NN -LSB-7-13))) (-RRB- -RSB-))))) (, ,) (SBAR (RB even) (IN though) (S (NP (NP (JJR earlier) (NN work)) (VP (VBG using) (NP (JJR more) (JJ traditional) (NNS methods)))) (VP (VBD had) (VP (VBN defined) (NP (NP (DT the) (NN commitment) (NN period)) (PP (IN for) (NP (NN T-cell) (NN activation))) (, ,) (PP (VBG including) (NP (NP (NN alteration)) (PP (IN in) (NP (NN gene) (NN expression) (NNS patterns)))))) (, ,) (PP (IN as) (S (VP (VBG occurring) (PP (IN between) (NP (NP (CD 1–2) (NN h)) (PP (IN after) (NP (NP (NN exposure)) (PP (TO to) (NP (DT the) (NN activating) (NN agent) (NN -LSB-14)))))))) (-RRB- -RSB-))))))))) (. .)))
( (S (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB investigate) (NP (DT these) (JJR earlier) (NN gene) (NN expression) (NNS changes)))))) (NP (PRP we)) (VP (VBP chose) (S (VP (TO to) (VP (VB examine) (NP (NP (DT a) (NN time) (NN course)) (PP (IN of) (NP (NP (NN activation)) (VP (VBG spanning) (NP (NP (DT the) (JJ first) (NN hour)) (PP (IN after) (NP (NN stimulation))))))))))))) (. .)))
( (S (SBAR (IN While) (S (NP (NP (DT a) (JJ recent) (NN study)) (PP (IN by) (NP (NP (NNP Garcia-Martinez) (FW et) (FW al.)) (CD -LSB-15) (-RRB- -RSB-))) (PP (IN in) (NP (NP (NN yeast)) (VP (VBG using) (NP (DT a) (JJ similar) (NN approach)))))) (VP (VBD demonstrated) (NP (NP (JJ large) (NNS shifts)) (PP (IN in) (NP (NN mRNA) (NN stability)))) (PP (VBG following) (NP (DT a) (JJ glucose-to-galactose) (NN shift)))))) (, ,) (NP (NP (DT the) (NN work)) (VP (VBN presented) (ADVP (RB here)))) (VP (VBZ is) (NP (NP (DT the) (JJ first) (JJ systematic) (NN accounting)) (PP (IN of) (NP (NP (DT the) (NNS changes)) (PP (IN in) (NP (NP (CC both) (NP (NN gene) (NN transcription)) (CC and) (NP (NN mRNA) (NN stability))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (DT a) (JJ major) (JJ cellular) (NN activation) (NN event)) (PP (IN over) (NP (NP (DT a) (VBN defined) (NN time) (NN period)) (PP (IN in) (NP (JJR higher) (NNS eukaryotes))))))))))))))) (. .)))
( (S (NP (NNS Results))))
( (S (S (S (NP (NN T-cell) (NN commitment)) (VP (VBZ is) (VP (VBN believed) (S (VP (TO to) (VP (VB occur) (ADVP (RB early)) (PP (IN during) (NP (NN activation))))))))) (CC and) (S (ADVP (RB therefore)) (NP (NP (NNS changes)) (PP (IN in) (NP (NN gene) (NN expression))) (PP (IN during) (NP (NP (DT the) (JJS earliest) (NNS stages)) (PP (IN of) (NP (NN induction)))))) (VP (VBP are) (PP (IN of) (NP (JJ particular) (NN interest)))))) (. .)))
( (S (S (NP (NP (DT An) (JJ experimental) (NN model)) (VP (VBG using) (NP (NP (JJ human) (NN Jurkat) (NN T) (NNS cells)) (VP (VBN activated) (PP (IN with) (NP (NP (NN PMA)) (CC and) (NP (NN ionomycin)))))))) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB investigate) (NP (NP (JJ early) (NNS changes)) (PP (IN in) (NP (NP (NN gene) (NN expression)) (PRN (-LRB- -LRB-) (NP (NP (QP (RB up) (TO to) (CD one)) (NN hour)) (PP (IN of) (NP (NN stimulation)))) (-RRB- -RRB-))))))))) (, ,) (S (VP (VBG focusing) (PP (IN on) (NP (NP (DT both) (NNS changes)) (PP (IN in) (NP (NP (NN mRNA) (NN transcription) (NNS rates)) (CONJP (RB as) (RB well) (IN as)) (NP (NN polyA) (NN mRNA) (NNS levels)))))))))) (. .)))
( (S (S (NP (CD One) (NN hour)) (VP (VBD was) (VP (VBN chosen) (SBAR (IN in) (NN order) (S (VP (VP (TO to) (VP (VB examine) (NP (NP (NN gene) (JJ regulatory) (NNS events)) (VP (VBG occurring) (ADVP (RB immediately)) (PP (IN after) (NP (NN activation))))))) (CC and) (VP (TO to) (VP (VB avoid) (, ,) (PP (IN for) (NP (DT the) (JJS most) (NN part))) (, ,) (NP (NP (DT the) (NN influence)) (PP (IN of) (NP (NP (JJ secondary) (NN gene) (JJ regulatory) (NNS mechanisms)) (VP (VBG taking) (NP (NN place)) (PP (IN at) (NP (NP (JJ later) (NN time) (NNS points)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (VBN increased) (NN synthesis)) (PP (IN of) (NP (NN transcription) (NNS factors))))) (-RRB- -RRB-)))))))))))))))) (. .)))
( (S (S (NP (NN NRO) (NN RNA)) (VP (VBD was) (VP (VBN prepared) (PP (IN from) (NP (NP (NP (NP (VBN isolated) (NN cell) (NNS nuclei)) (PRN (-LRB- -LRB-) (NP (NNS Methods)) (-RRB- -RRB-))) (CC and) (NP (NN polyA) (NN mRNA))) (PP (IN from) (NP (JJ intact) (NNS cells)))))))) (. .)))
( (S (S (NP (NN Figure) (CD 1)) (VP (VBZ shows) (NP (NP (DT an) (NN example)) (PP (IN of) (NP (NP (JJ filter) (NNS images)) (VP (VBN obtained) (PP (IN after) (NP (NP (NN hybridization)) (PP (IN of) (NP (NP (NNS arrays)) (VP (VBG using) (NP (CC either) (NP (NN NRO) (NN RNA)) (CC or) (NP (NN polyA) (NN mRNA)))))))))))))) (. .)))
( (S (S (NP (NP (NNS Cells)) (VP (VBN stimulated) (PP (IN for) (NP (CD 30) (NNS minutes))))) (VP (VBD exhibited) (NP (NP (JJ moderate) (NNS changes)) (PP (IN in) (NP (NP (NN gene) (NN expression)) (PP (IN in) (NP (DT the) (NN mRNA) (NNS arrays)))))))) (. .)))
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NN NRO) (NN RNA) (NNS arrays)) (VP (VBD revealed) (NP (NP (ADJP (ADJP (JJ rapid)) (CC and) (ADJP (JJ robust))) (NNS changes)) (PP (IN in) (NP (NN transcription))) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (ADJP (JJ evident)) (PP (IN as) (NP (QP (RB early) (IN as) (CD 5)) (NNS minutes))) (PP (VBG following) (NP (NN induction)))))))) (. .)))
( (S (ADVP (RB Unexpectedly)) (, ,) (NP (NP (DT a) (JJ careful) (NN analysis)) (PP (IN of) (NP (NP (DT all) (JJ significant) (NNS changes)) (PP (IN in) (NP (NP (NN gene) (NN expression)) (PP (IN across) (NP (DT the) (NN time) (NN course)))))))) (VP (VBD revealed) (SBAR (IN that) (S (NP (DT these) (NP (NP (JJ early-response) (NNS genes)) (PRN (-LRB- -LRB-) (ADVP (RB as)) (VP (VBN identified) (PP (IN by) (NP (NN NRO)))) (-RRB- -RRB-)))) (VP (VBD were) (NP (NP (DT a) (ADJP (RB relatively) (JJ small)) (NN subset)) (PP (IN of) (NP (NP (DT all)) (PP (IN of) (NP (NP (DT the) (NNS genes)) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (VP (VBN regulated))))) (PRN (-LRB- -LRB-) (VP (VB see) (PP (IN below))) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN all))) (, ,) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (NP (CD 4608) (NNS genes)) (, ,) (PP (VBG including) (NP (NP (NNS sets)) (PP (IN of) (NP (NP (NNS genes)) (VP (VBN enriched) (PP (IN for) (NP (NP (JJ immune) (NN response)) (CC and) (NP (NN signal) (NN transduction)) (NP (NN function))))))))) (, ,)))) (VP (VBD were) (VP (VBN polled) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 2)) (-RRB- -RRB-))))) (. .)))
( (S (PP (IN Of) (NP (DT these) (NNS genes))) (, ,) (NP (CD 2386)) (VP (VBD showed) (NP (NP (JJ significant) (NN regulation)) (PRN (-LRB- -LRB-) (NP (NN p) (NN <) (CD 0.001)) (, ,) (CC or) (NP (NN Z) (NN ratio) (NN >) (NN ±) (CD 1.5)) (-RRB- -RRB-))) (PP (IN during) (NP (NP (DT the) (NN time) (NN course)) (PP (IN of) (NP (NP (CD one) (NN hour)) (PP (IN post) (NP (NP (NN activation)) (PP (IN by) (NP (CC either) (NP (VBG changing) (NN gene) (NN transcription)) (CC or) (NP (NN polyA) (NN mRNA) (NNS levels))))))))))) (. .)))
( (S (S (NP (DT These) (ADJP (RB significantly) (VBN regulated)) (NNS genes)) (VP (VBD were) (VP (VBN chosen) (PP (IN for) (NP (JJ further) (NN analysis)))))) (. .)))
( (S (NP (NP (DT The) (NN distribution)) (CC and) (NP (NP (NP (NN direction)) (PRN (-LRB- -LRB-) (NP (NP (NN increase)) (, ,) (NP (NN decrease)) (, ,) (CC or) (NP (DT no) (NN change))) (-RRB- -RRB-))) (PP (IN of) (NP (NP (JJ significant) (NNS changes)) (PP (IN in) (NP (NN gene) (NN expression))) (PP (CC either) (PP (IN at) (NP (NP (DT the) (JJ transcriptional) (NN level)) (PRN (-LRB- -LRB-) (NP (NN NRO)) (-RRB- -RRB-)))) (CC or) (PP (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NP (NN polyA) (NN mRNA)) (PRN (-LRB- -LRB-) (NP (JJ whole-cell)) (-RRB- -RRB-))))))))))) (VP (VBP are) (VP (VBN displayed) (PP (IN in) (NP (NP (DT the) (NN table)) (PP (IN in) (NP (NN Figure) (LS 2.) (S (NP (NP (DT The) (JJ single) (ADJP (RBS most) (JJ common)) (NN expression) (NN event)) (PRN (-LRB- -LRB-) (NP (CD 55.2) (NN %)) (-RRB- -RRB-))) (VP (VBD was) (NP (NP (DT an) (NN up)) (CC or) (NP (JJ down) (NN regulation))) (PP (IN at) (NP (QP (CD one) (CC or) (JJR more)) (NN time) (NNS points))) (SBAR (IN as) (S (VP (VBN measured) (PP (IN in) (NP (NP (NN mRNA)) (PP (IN without) (NP (NP (DT a) (JJ corresponding) (PRN (-LRB- -LRB-) (ADVP (CC either) (ADVP (RB up)) (CC or) (ADVP (RB down))) (-RRB- -RRB-)) (NN regulation)) (SBAR (IN as) (S (VP (VBN measured) (PP (IN by) (NP (NN transcription))) (PP (IN at) (NP (DT any) (NN time) (NN point))))))))))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ second) (JJS largest) (NN group)) (PP (IN of) (NP (NP (JJ regulated) (NNS genes)) (PRN (-LRB- -LRB-) (NP (CD 27.4) (NN %)) (-RRB- -RRB-))))) (VP (VBD showed) (NP (NP (NNS changes)) (PP (IN in) (NP (NN transcription)))) (PP (IN with) (NP (NP (DT no) (JJ corresponding) (NN change)) (PP (IN in) (NP (NN polyA) (NN mRNA))))))) (. .)))
( (S (NP (NP (NNS Examples)) (PP (IN of) (NP (NP (NNS genes)) (VP (ADVP (RB dramatically)) (VBN up-regulated) (PP (IN in) (NP (DT this) (JJ second) (NN class))))))) (VP (VBD included) (NP (NP (NN CD69)) (, ,) (NP (NP (DT a) (NN type) (CD II) (NN transmembrane) (NN receptor)) (VP (VBN involved) (PP (IN in) (NP (NP (NN lymphocyte) (NN proliferation)) (CC and) (NP (NP (NP (DT a) (JJ classic) (NN marker)) (PP (IN of) (NP (JJ early) (NN T) (NN cell) (NN activation)))) (: ;) (NP (NP (NN PPP3C)) (, ,) (NP (NP (DT the) (JJ catalytic) (NN subunit)) (PP (IN of) (NP (NP (DT the) (JJ calmodulin-activated) (NN phosphatase)) (, ,) (NP (NN calcineurin)) (, ,))) (SBAR (WHNP (WDT which)) (S (VP (VBZ plays) (NP (DT a) (JJ central) (NN role)) (PP (IN in) (NP (NP (NN signal) (NN transduction)) (PP (IN from) (NP (DT the) (NN T) (NN cell) (NN receptor))) (PP (TO to) (NP (DT the) (NN nucleus)))))))))) (: ;) (ADVP (RB as) (RB well) (PP (IN as) (NP (NP (JJ several) (NNS members)) (PP (IN of) (NP (NP (DT the) (NN JUN) (NN family)) (PP (IN of) (NP (NP (NP (NN transcription) (NN factor)) (NP (JJ immediate) (JJ early) (NN response) (NNS genes))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 3A)) (-RRB- -RRB-)))))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (ADJP (ADJP (JJ final)) (, ,) (ADJP (RB relatively) (JJ minor))) (NNS groups)) (PP (IN of) (NP (JJ regulated) (NNS genes)))) (VP (VBD included) (NP (NP (NNS genes)) (SBAR (WHNP (WDT which)) (S (VP (VBD were) (VP (VBN regulated) (PP (IN at) (NP (CC both) (DT the) (NP (ADJP (JJ transcriptional))) (CC and) (NP (DT the) (NN polyA) (NN mRNA) (NNS levels)))) (PP (IN in) (NP (CC either) (NP (NP (DT the) (JJ same)) (PRN (-LRB- -LRB-) (NP (CD 8.4) (NN %)) (-RRB- -RRB-))) (CC or) (NP (NP (JJ opposite) (NNS directions)) (PRN (-LRB- -LRB-) (NP (CD 9) (NN %)) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (NP (NP (DT The) (ADJP (RB relatively) (JJ low)) (NN concordance)) (PP (IN between) (NP (NP (NP (JJ transcriptional) (NN production)) (PP (IN of) (NP (NN mRNA)))) (CC and) (NP (NP (PRP$ its) (VBN measured) (NN appearance)) (PP (IN in) (NP (NN polyA) (NN mRNA) (NNS levels))))))) (VP (VBD was) (ADJP (RB somewhat) (JJ surprising)) (, ,) (SBAR (IN although) (S (NP (NP (JJ clear) (NNS examples)) (PP (IN of) (NP (VBN coordinated) (JJ step-wise) (NN production)))) (VP (VBD were) (VP (VBN noted) (PP (IN for) (NP (DT some) (JJ key) (NNS genes)))) (, ,) (SBAR (IN as) (S (PP (IN for) (NP (NN example))) (, ,) (NP (NP (DT the) (JJ early) (NN response) (NNS genes)) (NP (NP (NN EGR1)) (CC and) (NP (NN ETR101)))) (-LRB- -LRB-) (VP (ADVP (RB previously)) (VBN shown) (S (VP (TO to) (VP (VB be) (VP (VBN induced) (PP (IN at) (NP (CD 30) (NNS minutes))) (PP (IN by) (NP (NP (NN phorbol) (NN ester) (NN treatment)) (PP (IN of) (NP (DT a) (JJ human) (JJ promyelocytic) (NN leukemia) (NN cell) (NN line) (CD -LSB-16) (-RRB- -RSB-) (CC and) (NP (NP (NP (NP (, ,) (NP (NP (DT the) (JJ apoptosis-related) (NNS genes) (NP (NP (NP (NN DAP)) (PRN (-LRB- -LRB-) (NP (NP (JJ death-associated) (NN protein)) (, ,) (NP (NP (NN mediator)) (PP (IN of) (NP (JJ interferon-gamma-induced) (NN apoptosis))))) (-RRB- -RRB-))) (CC and) (NP (NN CASP3)))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (DT the) (JJ immune) (NN response))) (NN signal) (NN transducer)) (CC and) (NP (NN activator))) (PP (IN of) (NP (NN transcription) (PRN (-LRB- -LRB-) (NP (NN STAT)) (-RRB- -RRB-)) (CD 6)))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 3A)) (-RRB- -RRB-))))))))))))))))))) (. .)))
( (S (S (NP (NP (JJ Dramatic) (NN activation)) (PP (IN of) (NP (NP (JJ immune) (NN response)) (, ,) (NP (JJ immediate-early) (NN response) (NNS genes)) (, ,) (CC and) (NP (JJ apoptosis-related) (NNS genes))))) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (DT the) (JJ nuclear) (JJ run-on) (NN RNA))) (ADVP (RB as) (RB early)) (PP (IN as) (NP (CD 5) (NNS minutes))) (PP (VBG following) (NP (NP (NN activation)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 3A)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (DT This) (NN group)) (PP (IN of) (NP (NNS genes)))) (VP (VBD included) (NP (NP (NP (JJ immediate-early) (NN response) (NNS genes)) (VP (ADVP (RB commonly)) (VBN up-regulated) (PP (IN during) (NP (NP (JJ cellular) (NN activation)) (PRN (-LRB- -LRB-) (NP (NN ETR101)) (, ,) (NP (NP (NP (NN Myb)) (, ,) (NP (NN Myc)) (, ,) (CC and) (NP (NNS genes))) (PP (IN of) (NP (DT the) (NN JUN) (CC and) (NN EGR) (NNS families)))) (-RRB- -RRB-)))))) (, ,) (NP (NP (NNS genes)) (VP (ADVP (RB specifically)) (VBN associated) (PP (IN with) (NP (NP (DT an) (JJ early) (NN response)) (PP (IN in) (NP (NP (JJ immune) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN IL6)) (, ,) (NP (NP (NN IL8)) (, ,) (NP (NN STAT4)) (, ,) (NP (NN STAT6)) (, ,) (NP (NNP PPP3C) (, ,) (NNP NFKBIA)) (, ,) (NP (NN IRF5)) (, ,) (CC and) (NP (NN CD69))) (-RRB- -RRB-)))))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NNS genes)) (VP (VBN involved) (PP (IN in) (S (VP (VBG regulating) (NP (NP (NN apoptosis)) (PRN (-LRB- -LRB-) (NP (NN BCL2A1)) (, ,) (NP (NP (NN CASP3)) (, ,) (NP (NN CASP9)) (, ,) (NP (NN CASP10)) (, ,) (CC and) (NP (NN DAP))) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (S (NP (NP (JJ Many)) (PP (IN of) (NP (DT these) (JJ same) (NNS genes)))) (VP (VBD were) (ADVP (RB eventually)) (VP (VBN up-regulated) (PP (IN in) (NP (NN polyA) (NN mRNA))) (ADVP (RB later)) (PP (IN in) (NP (DT the) (NN time) (NN course)))))) (CC and) (S (NP (NP (PRP$ their) (NN increase)) (PP (IN in) (NP (NP (NN expression)) (PP (IN after) (NP (CD one) (NN hour)))))) (VP (VBD was) (ADVP (RB independently)) (VP (VBN validated) (PP (IN by) (NP (NP (JJ single) (JJ end-point) (NN PCR)) (VP (ADVP (RB validation)) (VBG using) (NP (NP (NN GS320) (NN technology)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 3B)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NP (DT A) (ADJP (RB particularly) (JJ interesting)) (NN example)) (PP (IN of) (NP (DT the) (NN dichotomy))) (PP (IN between) (NP (NP (NN transcription)) (CC and) (NP (NP (NNS changes)) (PP (IN in) (NP (NN polyA) (NN mRNA) (NNS levels))))))) (VP (VBD was) (VP (VBN seen) (PP (IN in) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NP (DT the) (NNS mRNAs)) (VP (VBG encoding) (NP (NP (NP (NN NFKB1)) (PRN (-LRB- -LRB-) (NP (NN NF-kappa) (NN B)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (JJ key) (NN mediator)) (PP (IN of) (NP (NP (DT the) (JJ transcriptional) (NN control)) (PP (IN of) (NP (NP (NNS genes)) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (JJ immune) (NN response)) (CC and) (NP (JJ acute) (NN phase) (NNS reactions)))))))))) (, ,) (CC and) (NP (NP (PRP$ its) (NN inhibitor)) (, ,) (NP (NP (NN NFKBIA)) (PRN (-LRB- -LRB-) (NP (NN NF-kappa) (NN B) (NN inhibitor) (NN A)) (-RRB- -RRB-))))))))))))) (. .)))
( (S (S (NP (CC Both) (NP (NN NFKB1)) (CC and) (NP (NN NFKBIA))) (VP (VBP have) (ADVP (RB previously)) (VP (VBN been) (VP (VBN shown) (PP (IN by) (NP (NN microarray) (NN analysis))) (S (VP (TO to) (VP (VB be) (ADVP (RB significantly)) (VP (VBN induced) (PP (IN in) (NP (NP (NN polyA) (NN mRNA)) (PP (IN between) (NP (CD 3–4) (NNS hrs))))) (PP (VBG following) (NP (NP (NN phorbol) (CC or) (NN lectin) (NN activation)) (PP (IN of) (NP (CC either) (NP (NN Jurkat)) (CC or) (NP (JJ human) (JJ peripheral) (NN blood) (NNS lymphocytes)) (NP (NN -LSB-7,8,11,17)) (-RRB- -RSB-))))))))))))) (. .)))
( (S (S (SBAR (IN As) (S (VP (VBN demonstrated) (ADVP (RB here)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 3C)) (-RRB- -RRB-))))) (, ,) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NN NFKB1) (NN mRNA)))) (ADVP (RB clearly)) (VP (VBZ increases) (PP (IN between) (NP (NP (CD 30) (NNS minutes)) (CC and) (NP (NP (CD one) (NN hour)) (PP (IN at) (NP (DT the) (JJ transcriptional) (NN level)))))) (PP (IN without) (NP (NP (DT a) (JJ detectable) (JJ corresponding) (NN increase)) (PP (IN in) (NP (NN polyA) (NN mRNA))))) (PP (IN during) (NP (DT that) (NN time))) (PRN (-LRB- -LRB-) (S (S (S (NP (JJ subsequent) (NN PCR) (NN analysis)) (VP (VBD did) (VP (VB show) (NP (DT some) (NN increase)) (PP (IN at) (NP (NP (DT the) (JJ steady-state) (NN level)) (PP (IN between) (NP (QP (CD 0) (CC and) (CD 60)) (NNS minutes))) (PP (IN for) (NP (DT the) (NN NFKB1) (NN gene)))))))) (CC but) (S (NP (DT this) (NN increase)) (VP (VBD failed) (VP (TO to) (VP (VB meet) (NP (DT the) (NN significance) (NNS thresholds))))))) (VP (VBN set) (PP (IN for) (NP (DT the) (NN microarray) (NN analysis))))) (-RRB- -RRB-)))) (. .)))
( (S (S (NP (NN NFKBIA)) (, ,) (PP (IN on) (NP (DT the) (JJ other) (NN hand))) (, ,) (VP (VBZ is) (ADVP (RB rapidly)) (VP (VBN induced) (ADVP (RB transcriptionally)) (PP (TO to) (NP (DT a) (JJ maximum) (NN level))) (PP (IN by) (NP (CD 30) (NNS minutes)))) (, ,) (S (VP (VBG returning) (PP (RB essentially) (TO to) (NP (NN baseline))) (PP (IN within) (NP (CD one) (NN hour))))))) (. .)))
( (S (S (NP (NP (NN Meanwhile)) (, ,) (NP (NN NFKBIA) (JJ steady-state) (NNS levels))) (VP (MD can) (VP (VB be) (VP (VBN seen) (S (VP (TO to) (ADVP (RB gradually)) (VP (VB rise) (PP (IN across) (NP (NP (DT the) (JJ first) (NN hour)) (PP (IN of) (NP (DT the) (NN time) (NN course)))))))))))) (. .)))
( (S (S (NP (NP (NN Analysis)) (PP (IN of) (NP (NP (NP (DT the) (NNS dynamics)) (PP (IN of) (NP (NN gene) (NN expression))) (PP (IN for) (NP (NN NFKB1)))) (CC and) (NP (NP (PRP$ its) (NN inhibitor)) (VP (ADVP (RB as)) (VBN deduced) (PP (IN from) (NP (JJ conventional) (NNS microarrays)))))))) (VP (MD might) (VP (VB suggest) (SBAR (SBAR (IN that) (S (PP (IN by) (NP (NP (CD one) (NN hour)) (NN NFKB1) (NN production))) (VP (VBD had) (RB not) (ADVP (RB yet)) (VP (VBN begun) (PRN (-LRB- -LRB-) (S (VP (VBN contradicted) (PP (IN by) (NP (DT the) (NN NRO) (NNS data))) (ADVP (RB here)))) (-RRB- -RRB-)))))) (, ,) (CC and) (ADVP (RB also)) (SBAR (IN that) (S (NP (NP (DT the) (NN mRNA)) (PP (IN for) (NP (NP (DT the) (NN inhibitor)) (PP (IN of) (NP (NN NKFKB1)))))) (VP (VBZ is) (ADJP (RB steadily) (VBG increasing)) (PRN (-LRB- -LRB-) (SBAR (WRB when) (S (, ,) (PP (IN in) (NP (NN fact))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ clear) (PP (IN from) (NP (NP (NN NRO) (NNS data)) (SBAR (WHNP (WDT that)) (S (NP (NP (ADJP (RB virtually) (DT all)) (NNS increases)) (PP (IN in) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NN NFKBIA)))))) (VP (VBP have) (VP (VBN concluded) (PP (IN by) (NP (CD one) (NN hour))))))))))))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (DT These) (NNS data)) (VP (VBP provide) (NP (NP (DT a) (JJ clear) (NN example)) (PP (IN of) (SBAR (WHADVP (WRB how)) (S (NP (NP (NN information)) (PP (IN from) (NP (JJ nuclear) (JJ run-on) (NNS microarrays)))) (VP (MD can) (VP (VB enhance) (NP (NP (NNS studies)) (PP (IN of) (NP (NP (NN gene) (NN activation)) (CC and) (NP (NN feedback) (NNS mechanisms))))))))))))) (. .)))
( (S (S (NP (NP (NN Consistency)) (PP (IN at) (NP (DT each) (NN time) (NN point))) (PP (IN for) (NP (NP (NNS genes)) (VP (VBN regulated) (PP (IN by) (NP (NP (JJ activation-induced) (NNS changes)) (PP (IN in) (NP (NN mRNA) (NN stability))))))))) (VP (MD can) (VP (VB be) (VP (VBN seen) (PP (IN in) (NP (NP (DT a) (NN graph)) (PP (IN of) (NP (NP (NP (DT the) (NN Z) (NN ratio) (NNS differences)) (PRN (-LRB- -LRB-) (NP (NNS Methods)) (-RRB- -RRB-))) (PP (IN between) (NP (NP (NP (NN NRO)) (CC and) (NP (NN polyA) (NN mRNA))) (VP (VBN calculated) (PP (IN for) (NP (DT all) (NNS genes))) (PP (IN at) (NP (NP (DT all) (NN time) (NNS points)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 4A)) (-RRB- -RRB-))))))))))))))) (. .)))
( (S (S (NP (DT These) (JJ putative) (JJ stability-regulated) (NNS genes)) (VP (VBD exhibited) (NP (NP (DT a) (ADJP (RB very) (JJ high)) (NN degree)) (PP (IN of) (NP (NN consistency)))) (PP (IN at) (NP (NP (PDT all) (DT the) (NN time) (NNS points)) (VP (VBN measured)))))) (. .)))
( (S (S (NP (DT This) (NN replicability)) (VP (VBZ is) (ADVP (RB further)) (VP (VBN illustrated) (PP (IN in) (NP (NP (DT the) (NN heat) (NN map)) (PP (IN of) (NP (NP (VBN clustered) (NN gene) (NN expression)) (PP (IN in) (NP (NP (NN Figure) (NNS 4B)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (DT the) (NN data)) (PP (IN for) (NP (DT each) (NN gene)))) (VP (VBZ has) (VP (VBN been) (ADVP (RB independently)) (VP (VBN normalized) (PP (TO to) (NP (NP (NP (PRP$ its) (NN baseline)) (PRN (-LRB- -LRB-) (NP (CD 0) (NN time)) (-RRB- -RRB-))) (NN level))))))))))))))))) (. .)))
( (S (S (NP (NP (JJ Large) (NNS numbers)) (PP (IN of) (NP (NNS genes))) (SBAR (IN as) (S (VP (VBN measured) (PP (IN in) (NP (DT the) (NN polyA) (NN mRNA))))))) (VP (VBP are) (ADVP (ADVP (RB consistently)) (CC and) (ADVP (RB strongly))) (VP (VBN regulated) (PP (VBG following) (NP (NN activation)))))) (. .)))
( (S (S (S (NP (NP (DT Some)) (PP (IN of) (NP (DT these) (NNS changes)))) (VP (VBP are) (VP (VBD mirrored) (PP (IN by) (NP (NP (NNS changes)) (PP (IN in) (NP (NP (NN gene) (NN transcription)) (PRN (-LRB- -LRB-) (NP (NN NRO)) (-RRB- -RRB-))))))))) (CC but) (S (NP (JJS most)) (VP (VBP are) (RB not)))) (. .)))
( (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB compare) (NP (NP (NNS changes)) (PP (IN in) (NP (NP (NN gene) (NN expression) (NNS patterns)) (PP (IN at) (NP (NP (DT the) (JJ transcriptional)) (CC and) (NP (NN polyA) (NN mRNA) (NNS levels))))))) (PP (IN in) (NP (DT a) (JJ systematic) (NN fashion))))))) (, ,) (NP (NP (DT a) (JJ simple) (NN barcode)) (PP (IN of) (NP (NP (CD 1)) (, ,) (NP (CD -1)) (, ,) (CC or) (NP (CD 0))))) (VP (VBD was) (VP (VBN applied) (PP (TO to) (NP (NP (DT all) (JJ significant) (NNS changes)) (PP (IN in) (NP (NN gene) (NN expression))))) (S (VP (VBG indicating) (NP (NP (NN up)) (, ,) (NP (NN down)) (, ,) (CC or) (NP (DT no) (NN change))) (, ,) (ADVP (RB respectively)))))) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (DT a) (NN value)) (PP (IN of) (NP (NP (CD -1)) (, ,) (NP (CD 0)) (, ,) (CC or) (NP (NP (CD 1)) (PRN (-LRB- -LRB-) (ADJP (ADJP (JJ low)) (, ,) (ADJP (JJ moderate)) (, ,) (CC or) (ADJP (JJ high))) (-RRB- -RRB-)))))) (VP (VBD was) (VP (VBN assigned) (PP (TO to) (NP (DT each) (NN gene))) (PP (VBG according) (PP (TO to) (NP (NP (PRP$ its) (JJ relative) (NN intensity)) (PP (IN at) (NP (NP (NN baseline)) (PRN (-LRB- -LRB-) (NP (CD 0) (NN time)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NP (DT An) (NN analysis)) (PP (IN of) (NP (NP (DT the) (NN distribution)) (PP (IN of) (NP (NP (DT these) (NN gene) (NN expression) (NNS patterns)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 5)) (-RRB- -RRB-))))))) (VP (VBD revealed) (SBAR (SBAR (IN that) (S (NP (NP (DT both)) (PP (IN at) (NP (NP (DT the) (NP (ADJP (JJ transcriptional))) (CC and) (NP (DT the) (JJ steady-state) (NNS levels)) (NP (CD two) (NNS thirds))) (PP (IN of) (NP (DT all) (NNS genes)))))) (VP (VBD were) (VP (JJ restricted) (PP (TO to) (NP (NP (RB just) (CD one)) (PP (IN of) (NP (NP (CD 20) (NNS patterns)) (-LRB- -LRB-) (PP (RP out) (PP (IN of) (NP (NP (DT a) (JJ possible) (NN number)) (PP (IN of) (NP (CD 729)))))) (-RRB- -RRB-))))))))) (CC and) (SBAR (IN that) (S (NP (NP (NN half)) (PP (IN of) (NP (DT these) (NNS patterns)))) (VP (VBD were) (VP (VBN shared) (PP (IN between) (NP (DT the) (CD two) (NNS groups)))))))))) (. .)))
( (S (S (NP (NP (DT An) (JJ interesting) (NN distinction)) (PP (IN between) (NP (DT the) (CD two) (NNS groups)))) (VP (VBD was) (SBAR (IN that) (S (SBAR (IN whereas) (S (NP (NP (NN up-regulation)) (PP (IN from) (NP (NP (DT a) (ADJP (RB moderately) (JJ high)) (NN level)) (PP (IN of) (NP (NN baseline) (NN expression)))))) (VP (VBD was) (ADVP (RB highly)) (VP (VBN favored) (PP (IN for) (NP (JJ new) (NN gene) (NN synthesis))))))) (, ,) (NP (NP (NN down-regulation)) (PP (IN from) (NP (NP (DT a) (ADJP (RB moderately) (JJ high)) (NN level)) (PP (IN of) (NP (NN baseline) (NN expression)))))) (VP (VBD was) (ADVP (RB very) (RB highly)) (VP (VBN favored) (PP (IN during) (NP (NN polyA) (NN mRNA) (NN regulation))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 6)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (PP (IN In) (NP (NN fact))) (, ,) (NP (NP (NN down-regulation)) (, ,) (NP (RB as) (DT a) (JJ consistent) (NN trend)) (, ,)) (VP (VBD was) (ADJP (ADVP (RB much) (RBR less)) (JJ common) (PP (IN among) (NP (NP (JJ transcriptional-regulated)) (PP (IN than) (NP (NP (JJ steady-state-regulated) (NNS genes)) (, ,) (PP (IN with) (NP (NP (NNS implications)) (PRN (-LRB- -LRB-) (VP (VB see) (PP (IN below))) (-RRB- -RRB-)))))) (PP (IN as) (PP (TO to) (NP (NP (DT the) (NNS roles)) (S (NP (NP (DT these) (NNS modes)) (PP (IN of) (NP (NN regulation)))) (VP (VBP play) (PP (IN in) (NP (NP (NN concert)) (PP (IN for) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (NN gene) (NN expression))))))))))))))))) (. .)))
( (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB confirm) (SBAR (IN that) (S (NP (NN stability) (NN regulation)) (VP (VBD was) (PP (IN in) (NP (NN fact))) (NP (NP (DT a) (JJ reasonable) (NN explanation)) (PP (IN for) (NP (NP (DT the) (NN observation)) (PP (IN that) (S (NP (NP (DT the) (NN expression) (NNS levels)) (PP (IN of) (NP (NP (JJ large) (NNS numbers)) (PP (IN of) (NP (NNS genes)))))) (VP (VBD were) (VP (VBG changing) (PP (PP (IN at) (NP (DT the) (JJ whole) (NN cell))) (CONJP (CC but) (RB not)) (NP (DT the) (JJ transcriptional) (NN level))))))))))))))))) (, ,) (NP (NP (DT a) (NN series)) (PP (IN of) (NP (NNS experiments)))) (VP (VBD were) (VP (VBN carried) (PRT (RP out)) (PP (IN in) (SBAR (WHNP (WDT which)) (S (NP (NP (NN activation)) (PP (IN of) (NP (NN Jurkat) (NNS cells)))) (VP (VBD was) (VP (VBN carried) (PRT (RP out)) (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC or) (NP (NN absence))) (PP (IN of) (NP (DT the) (NN transcription) (NN inhibitor) (NN Actinomycin))) (S (NP (NP (NNP D.) (NN Analysis)) (PP (IN of) (NP (NN polyA) (NN mRNA)))) (VP (VBD demonstrated) (NP (NP (DT the) (JJ strong) (NN inhibition)) (PP (IN of) (NP (NP (NN mRNA) (NNS levels)) (PP (IN for) (NP (NP (NNS genes)) (VP (ADVP (RB previously)) (VBN shown) (S (VP (TO to) (VP (VB be) (ADVP (RB transcriptionally)) (VP (VBN up-regulated) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 7A)) (-RRB- -RRB-))))))))))))))))))))))) (. .)))
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (JJ large) (NNS numbers)) (PP (IN of) (NP (NP (NNS genes)) (SBAR (WHNP (WDT which)) (S (VP (VBD were) (ADVP (RB significantly)) (VP (VBN regulated) (PP (PP (IN in) (NP (NN polyA) (NN mRNA))) (CC but) (PP (RB not) (IN in) (NP (NN NRO) (NN RNA))))))))))) (VP (VBD were) (RB not) (VP (VBN affected) (PP (IN by) (NP (NP (NN Actinomycin) (NN D) (NN treatment)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 7B) (NNP &7C)) (-RRB- -RRB-)))))) (. .)))
( (S (S (PP (IN Among) (NP (DT these) (JJ unaffected) (NNS genes))) (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (NN bias)) (PP (IN towards) (NP (NP (RB presumptively) (JJ de-stablized) (NNS genes)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 7C)) (-RRB- -RRB-))))) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (NP (DT the) (JJR earlier) (NN conclusion)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 6B)) (-RRB- -RRB-))) (SBAR (IN that) (S (NP (NN down-regulation)) (VP (VBZ is) (NP (NP (DT the) (JJ predominant) (NN motif)) (PP (IN in) (NP (JJ overall) (NN polyA) (NN mRNA) (NNS levels))))))))))))) (. .)))
( (S (S (SBAR (IN Although) (S (NP (NP (DT an) (NN examination)) (PP (IN of) (NP (NP (DT the) (JJ functional) (NNS classifications)) (PP (IN of) (NP (ADJP (ADJP (NP (NN stability)) (VBN regulated)) (CC versus) (ADJP (RB transcriptionally) (JJ regulated))) (NNS genes)))))) (VP (VBD yielded) (NP (DT no) (JJ obvious) (NNS trends))))) (, ,) (NP (DT some) (JJ biological) (NNS pathways)) (VP (VBP appear) (S (VP (TO to) (VP (VB be) (ADVP (ADVP (RB differentially)) (, ,) (CC and) (ADVP (RB sometimes)) (, ,) (ADVP (RB exhaustively))) (VP (VBN regulated) (PP (IN by) (NP (NP (DT each) (NN type)) (PP (IN of) (NP (NN expression) (NN event))))))))))) (. .)))
( (S (S (NP (NP (CD One) (NN example)) (PP (IN of) (NP (DT this)))) (VP (MD can) (VP (VB be) (VP (VBN seen) (PP (IN in) (NP (NP (DT the) (JJ apoptotic) (NNS pathways)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (ADVP (RB comprehensively)) (VP (VBN regulated) (PP (IN during) (NP (DT the) (NN Jurkat) (NN activation) (NN scenario) (NN -LSB-16,18,19))))) (-RRB- -RSB-))))))))) (. .)))
( (S (SBAR (IN As) (S (VP (VP (MD can) (VP (VB be) (VP (VBN seen) (PP (IN from) (NP (NP (NP (DT the) (NN pathway) (NN schematic)) (VP (VBN illustrated) (PP (IN in) (NP (NN Figure) (CD 8))))) (, ,) (NP (NP (DT some) (JJ major) (NNS effectors)) (PP (IN of) (NP (NN apoptosis) (NP (ADJP (JJ such) (PP (IN as) (NP (NN CASP) (CD 3) (, ,) (CD 4) (, ,) (CD 8) (, ,) (CD 9) (, ,) (CD &10) (PRN (-LRB- -LRB-) (VP (VBN up-regulated)) (-RRB- -RRB-)))))) (CC and) (NP (NN BCL2) (-LRB- -LRB-) (VP (VBN down-regulated)) (-RRB- -RRB-)))))))))) (, ,) (VP (VBP are) (VP (VBN controlled) (PP (IN by) (NP (NP (JJ new) (NN gene) (NN synthesis)) (PP (IN while) (NP (NP (JJ other) (NNS factors)) (PP (JJ such) (IN as) (NP (NN CASP) (CD 1) (, ,) (CD 6)))))))))))) (, ,) (NP (NP (NP (NN &7)) (PRN (-LRB- -LRB-) (VP (VBN up-regulated)) (-RRB- -RRB-))) (CC and) (NP (NP (NN BCL2L2)) (PRN (-LRB- -LRB-) (VP (VBN down-regulated)) (-RRB- -RRB-)))) (VP (VBP appear) (S (VP (TO to) (VP (VB be) (VP (VBN regulated) (PP (IN by) (NP (NP (NN stability) (NNS processes)) (ADVP (RB alone))))))))) (. .)))
( (S (S (ADVP (RB Regardless) (PP (IN of) (NP (NP (DT the) (JJ cellular) (NN rationale)) (PP (IN for) (S (VP (VBG regulating) (PP (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NP (JJ new) (NN gene) (NN synthesis)) (CC or) (NP (NN mRNA) (NN stability)))))))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ clear) (PP (IN from) (NP (DT these) (NNS data)))) (SBAR (IN that) (S (S (NP (EX there)) (VP (VBZ is) (NP (DT a) (JJ strong) (JJ internal) (NN coherence)))) (: :) (S (NP (NP (NNS genes)) (VP (VBN regulated) (PP (IN by) (NP (CD one) (NN mechanism))))) (VP (VBP do) (RB not) (VP (VBP crossover) (PP (TO to) (NP (DT the) (JJ other))) (PP (IN within) (NP (NP (DT the) (NN time) (NN frame)) (VP (VBN investigated))))))))))) (. .)))
( (S (S (NP (NP (JJ Common) (NNS patterns)) (PP (IN of) (NP (NN transcription) (NN factor) (NN binding) (NNS sites))) (PP (IN in) (NP (NP (DT the) (JJ upstream) (NN promoter) (NNS regions)) (PP (IN of) (NP (NP (NNS groups)) (PP (IN of) (NP (NP (NNS genes)) (SBAR (WHNP (WP$ whose) (NN transcription)) (S (VP (VBD was) (ADVP (RB significantly)) (VP (VBN up-regulated)))))))))))) (VP (VBD were) (VP (VBN detected)))) (. .)))
( (S (S (NP (NP (DT An) (NN enrichment)) (PP (IN of) (NP (NP (NN transcription) (JJ factor-binding) (NNS sites)) (PP (IN for) (NP (CC both) (NP (NN NFAT)) (CC and) (NP (NN NFκB))))))) (VP (VBD was) (VP (VBN found) (PP (IN in) (NP (NP (DT the) (NN promoter) (NNS regions)) (PP (IN of) (NP (NP (NNS genes)) (VP (ADVP (RBS most) (RB significantly)) (VBN up-regulated) (PP (IN at) (NP (CD 1) (NN hour))) (SBAR (IN as) (S (VP (VBN shown) (PP (IN in) (NP (NN Figure) (CD 9)))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN frequency)) (SBAR (WHPP (IN with) (WHNP (WDT which))) (S (NP (CC both) (NP (NN NFAT-)) (CC and) (NP (JJ NFκB-binding) (NNS sites))) (VP (VBD were) (VP (VBN found) (PP (IN in) (NP (NP (DT the) (NNS promoters)) (PP (IN of) (NP (NP (DT this) (NN group)) (PP (IN of) (NP (NNS genes)))))))))))) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJR greater)) (PP (IN than) (NP (NP (DT that)) (VP (VBN seen) (PP (IN for) (NP (NP (NP (JJ other) (NNS genes)) (PP (IN in) (NP (DT the) (NN array) (NN -LSB-e.g.)))) (, ,) (NP (NP (NNS genes)) (VP (VBN down-regulated) (PP (IN at) (NP (DT this) (NN time) (NN point))))) (CC or) (NP (NP (NNS genes)) (VP (VBN selected) (PP (IN at) (NP (JJ random) (JJ -LSB-supplemental) (NNS data) (-RRB- -RSB-))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN discovery)) (SBAR (WHNP (WDT that)) (S (NP (NP (NN NFAT-)) (CC and) (NP (JJ NFκB-binding) (NNS sites))) (VP (VBD were) (VP (VBN enriched) (PP (IN in) (NP (NP (DT the) (NNS promoters)) (PP (IN of) (NP (DT these) (NNS genes)))))))))) (VP (VBD was) (RB not) (ADJP (JJ unexpected)) (, ,) (SBAR (IN since) (S (NP (NP (DT these) (NN transcription) (NNS factors)) (, ,) (CONJP (IN along) (IN with)) (NP (NP (NN AP-1) (NNS components)) (NP (NP (NN Fos)) (CC and) (NP (NN Jun)))) (, ,)) (VP (VBP constitute) (NP (NP (DT the) (JJ major) (NN transcription) (NNS factors)) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (JJ early) (NNS stages)) (PP (IN of) (NP (NN T-cell) (NN activation)))))))))))) (. .)))
( (S (S (ADVP (RB Indeed)) (, ,) (NP (NP (DT the) (NN frequency)) (PP (IN of) (NP (NP (NNS genes)) (VP (VP (ADVP (RB significantly)) (VBN up-regulated) (PP (IN in) (NP (NN NRO) (NN RNA)))) (CC and) (VP (VBN enriched) (PP (IN for) (NP (NN AP-1) (NN binding) (NNS sites)))))))) (VP (VBZ peaks) (PP (IN during) (NP (NP (DT the) (NN time) (NN course)) (PRN (-LRB- -LRB-) (NP (JJ supplemental) (NNS data)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NP (JJ Many)) (PP (IN of) (NP (NP (NP (DT the) (NNS genes)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB transcriptionally)) (VP (VBN upregulated) (PP (IN at) (NP (CD 1) (NN hour)))))))) (, ,) (PP (JJ such) (IN as) (NP (NN CD69))) (, ,)))) (VP (VBP are) (ADJP (JJ elevated) (PP (IN throughout) (NP (NP (DT the) (NN time)) (VP (VBN examined))))) (, ,) (SBAR (IN although) (S (NP (NP (NP (DT a) (JJ few) (NNS genes)) (PP (VBG including) (NP (NP (NN PTEN)) (, ,) (NP (NN DUSP5)) (, ,) (CC and) (NP (NN NFκB1))))) (NP (PRP itself)) (, ,)) (VP (VBP show) (NP (JJ elevated) (NN transcription)) (PP (ADVP (RB only)) (IN after) (NP (CD 60) (NNS minutes)))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ simultaneous) (NN increase)) (PP (IN of) (NP (NP (NN NFκB1) (NN gene) (NN transcription)) (PRN (-LRB- -LRB-) (PP (IN between) (NP (NP (CD 30) (NNS minutes)) (CC and) (NP (CD 1) (NN hour)))) (-RRB- -RRB-)))) (VP (VBN combined) (PP (IN with) (NP (NP (DT a) (JJ noticeable) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN transcription)) (PP (IN of) (NP (NP (NNS genes)) (VP (VBG containing) (NP (NP (JJ NFκB-binding) (NNS sites)) (PRN (-LRB- -LRB-) (PP (IN at) (NP (CD one) (NN hour))) (-RRB- -RRB-)))))))))))) (VP (VBZ demonstrates) (NP (NP (DT the) (JJ synchronous) (NN relationship)) (PP (IN between) (NP (NP (NP (DT the) (NN appearance)) (PP (IN of) (NP (DT this) (NN transcription) (NN factor)))) (CC and) (NP (PRP$ its) (JJ downstream) (NNS targets))))) (PP (IN at) (NP (DT the) (VBN indicated) (NN time) (NNS points))))) (. .)))
( (S (NP (NN Discussion))))
( (S (S (NP (NP (DT The) (NN absence)) (PP (IN of) (NP (NP (JJ significant) (NN regulation)) (PP (IN at) (NP (DT the) (JJ transcriptional) (NN level))) (PP (IN during) (NP (NP (DT a) (NN time)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NN gene) (NN expression)) (VP (VBZ is) (ADVP (RB strongly)) (VP (VBN perturbed) (PP (IN at) (NP (DT the) (NN polyA) (NN mRNA) (NN level))) (PP (IN during) (NP (NN T) (NN cell) (NN activation)))))))))))) (VP (VBZ reveals) (SBAR (IN that) (S (NP (JJ many) (NNS genes)) (VP (VBP are) (VP (VBG being) (VP (VBN regulated) (PP (IN through) (NP (NP (NNS changes)) (PP (IN in) (NP (NN stability)))))))))))) (. .)))
( (S (S (S (NP (NP (DT The) (NN lack)) (PP (IN of) (NP (NP (JJ detectable) (JJ transcriptional) (NN regulation)) (PP (IN of) (NP (NP (JJ large) (NNS numbers)) (PP (IN of) (NP (JJ steady-state) (NN mRNA) (NN gene) (NNS changes)))))))) (VP (VBZ is) (ADJP (RB particularly) (JJ striking)))) (S (NP (NP (NN insofar)) (PP (IN as) (NP (DT the) (NN NRO) (NNS measurements)))) (VP (VBP are) (ADJP (JJ likely) (S (VP (TO to) (VP (VB be) (ADJP (ADJP (RB even) (RBR more) (JJ sensitive) (PP (TO to) (NP (NP (NNS changes)) (PP (IN in) (NP (NN gene) (NN expression)))))) (PP (IN than) (NP (NN polyA) (NN mRNA) (NNS measurements)))) (SBAR (IN since) (S (NP (PRP they)) (VP (VBP are) (NP (NP (DT a) (JJ direct) (NN measure)) (PP (IN of) (NP (ADJP (RB newly) (VBN synthesized)) (NN mRNA)))))))))))))) (. .)))
( (S (S (NP (DT This) (NN finding)) (VP (VBZ is) (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (NN work)) (PP (IN of) (NP (NNP Raghavan) (FW et)))))))) (. .)))
( (S (S (PP (FW al.)) (NP (CD -LSB-12,20) (-RRB- -RSB-) (SBAR (WHNP (WP who)) (S (ADVP (RB also)) (VP (VBN noted) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (JJ numerous) (NNS transcripts)) (VP (VBG exhibiting) (NP (NP (JJ stimulus-dependent) (NNS changes)) (PP (IN in) (NP (NN mRNA) (NN decay))))))) (PP (IN in) (NP (NP (JJ human) (NN T) (NNS lymphocytes)) (VP (VBN treated) (PP (IN for) (NP (CD 3) (NNS hours))) (PP (IN with) (NP (NP (ADJP (JJ anti-CD3))) (CC and/or) (NP (ADJP (JJ anti-CD28))) (NP (NNS antibodies))))))))))))) (. .)))
( (S (S (S (NP (DT These) (NNS experiments)) (VP (VBD were) (VP (VBN carried) (PRT (RP out)) (PP (IN by) (S (VP (VBG arresting) (NP (NN transcription)) (PP (IN with) (NP (NP (NN Actinomycin) (NN D)) (PRN (-LRB- -LRB-) (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC or) (NP (NN absence))) (PP (IN of) (NP (NN activation))))) (-RRB- -RRB-)))))))))) (, ,) (CC and) (S (NP (NN mRNA) (NN turnover) (NNS rates)) (VP (VBD were) (ADVP (RB globally)) (VP (VBN measured) (PP (IN by) (S (VP (VBG applying) (NP (NN polyA) (NN mRNA)) (PP (TO to) (NP (NNS microarrays)))))))))) (. .)))
( (S (ADVP (RB Similarly)) (, ,) (PP (IN in) (NP (DT this) (JJ current) (NN work))) (, ,) (NP (NP (NNS patterns)) (PP (IN of) (NP (NP (NP (NN Actinomycin) (NN D)) (JJ resistant) (NNS changes)) (PP (IN in) (NP (NP (NN gene) (NN expression)) (PP (IN among) (NP (NP (NNS groups)) (PP (IN of) (NP (NP (NNS genes)) (VP (ADVP (RB significantly)) (VBN regulated) (PP (ADVP (RB only)) (IN at) (NP (DT the) (NN polyA) (NN mRNA) (NN level))))))))))))) (VP (VBZ supports) (NP (DT the) (NN observation) (SBAR (IN that) (S (NP (NP (JJ large) (NNS numbers)) (PP (IN of) (NP (NNS genes)))) (VP (VBP are) (VP (VBN regulated) (ADVP (RB primarily)) (PP (IN by) (NP (NN stability))) (PP (IN during) (NP (NN T) (NN cell) (NN activation))))))))) (. .)))
( (S (S (NP (NP (DT The) (ADJP (ADJP (JJR smaller)) (, ,) (CONJP (CC but) (RB still)) (ADJP (JJ substantial)) (, ,)) (NN group)) (PP (IN of) (NP (NNS genes))) (SBAR (WHNP (WDT which)) (S (VP (VBD displayed) (NP (JJ significant) (JJ transcriptional) (NN regulation)) (PP (IN without) (NP (NP (DT any) (JJ corresponding) (NNS changes)) (PP (IN in) (NP (NN polyA) (NN mRNA)))))))) (, ,)) (VP (VP (MD may) (ADVP (RB either)) (VP (VB be) (NP (NP (DT a) (NN reflection)) (PP (IN of) (NP (NP (DT the) (VBN enhanced) (NN sensitivity)) (PP (IN of) (NP (JJ transcriptional) (NN detection)))))))) (CC or) (, ,) (ADVP (RB perhaps)) (, ,) (VP (VB result) (PP (IN from) (NP (NP (DT a) (JJ persistent) (NN lag)) (PP (IN between) (NP (NP (NNS changes)) (PP (IN in) (NP (NP (JJ transcriptional) (NN output)) (CC and) (NP (NP (PRP$ their) (NN reflection)) (PP (IN in) (NP (JJ steady-state) (NN mRNA) (NNS levels))))))))))))) (. .)))
( (S (S (NP (PDT Such) (DT a) (NN lag)) (VP (MD might) (VP (VB arise) (PP (IN from) (NP (NP (NNS differences)) (PP (IN in) (NP (NP (NN scale)) (PP (IN of) (NP (NP (DT the) (JJ absolute) (NN size)) (PP (IN of) (NP (NN mRNA) (NNS pools))) (PP (IN between) (NP (NP (ADJP (RB newly) (VBN transcribed))) (CC and) (NP (NN polyA) (NN mRNA))))))))))))) (. .)))
( (S (PP (IN In) (NP (DT this) (NN scenario))) (, ,) (NP (NP (NNS changes)) (PP (IN in) (NP (NP (DT the) (NNS amounts)) (PP (IN of) (NP (NN mRNA))))) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (RB readily) (JJ detectable) (PP (IN by) (NP (JJ nuclear) (JJ run-on)))))))) (VP (MD may) (VP (VB be) (ADJP (RB too) (JJ small) (S (VP (TO to) (VP (VB have) (NP (NP (DT an) (JJ immediate) (JJ detectable) (NN impact)) (PP (IN on) (NP (DT the) (JJ steady-state) (NN RNA) (NNS pools)))) (, ,) (PP (ADVP (RB possibly)) (IN for) (NP (NP (JJ long) (NNS periods)) (PP (IN of) (NP (NN time))))))))))) (. .)))
( (S (S (NP (DT Another) (NN possibility)) (VP (VBZ is) (SBAR (IN that) (S (NP (NP (DT the) (JJ nascent) (NNS mRNAs)) (PP (IN of) (NP (NP (DT some)) (PP (IN of) (NP (DT these) (NNS genes)))))) (VP (VBP are) (ADVP (RB so)) (VP (ADVP (RB rapidly)) (VBN degraded) (SBAR (IN that) (S (NP (PRP they)) (ADVP (RB never)) (ADVP (RB significantly)) (VP (NN impact) (PP (IN on) (NP (NP (NN polyA) (NN mRNA) (NNS levels)) (PP (IN at) (NP (NN all)))))))))))))) (. .)))
( (S (S (SBAR (IN As) (S (ADVP (RB previously)) (VP (VBN noted) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 6)) (-RRB- -RRB-))))) (, ,) (NP (NP (NN up-regulation)) (PP (IN of) (NP (NN gene) (NN expression)))) (VP (VBD was) (NP (NP (DT a) (JJ dominant) (NN trend)) (PP (IN for) (NP (ADJP (RB transcriptionally) (VBN regulated)) (NNS genes)))) (SBAR (IN while) (S (NP (NN down-regulation)) (VP (VBD was) (ADVP (RB dramatically)) (VP (VBN favored) (PP (IN for) (NP (NP (NNS genes)) (VP (VBN regulated) (PP (IN at) (NP (DT the) (NN polyA) (NN mRNA) (NN level)))))))))))) (. .)))
( (S (S (PP (IN From) (NP (NP (DT the) (NN standpoint)) (PP (IN of) (NP (NP (DT an) (JJ overall) (JJ cellular) (NN economy)) (PP (IN of) (NP (NN gene) (NN expression))))))) (, ,) (NP (NP (JJ effective) (NN control)) (PP (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN transcription)))))) (VP (MD can) (VP (VB be) (VP (VBN achieved) (ADVP (RB primarily)) (PP (IN by) (NP (NP (VBG turning)) (PP (IN on) (NP (JJ new) (NN gene) (NN transcription))))) (, ,) (SBAR (IN while) (S (PP (IN at) (NP (DT the) (JJ whole-cell) (NN level))) (, ,) (NP (ADJP (ADJP (JJ rapid)) (CC and) (ADJP (JJ effective))) (NN regulation)) (VP (MD can) (VP (VB be) (VP (VBN achieved) (PP (IN by) (NP (NP (JJ massive) (NNS shifts)) (PP (IN in) (NP (NP (DT the) (NN stability)) (PP (IN of) (NP (JJ existing) (NN mRNA) (NNS pools)))))))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN fact))) (, ,) (NP (NP (DT the) (JJ single) (ADJP (RBS most) (JJ dramatic)) (JJ regulatory) (NN event)) (ADJP (RB experimentally) (VBN observed))) (VP (VBD was) (NP (NP (DT the) (JJ rapid) (NN clearance)) (PP (IN of) (NP (NP (JJ large) (NNS pools)) (PP (IN of) (NP (JJ steady-state) (NN mRNA)))))) (, ,) (PP (ADVP (RB presumably)) (IN as) (NP (NP (NN result)) (PP (IN of) (NP (NP (DT a) (ADJP (ADJP (JJ sudden)) (CC and) (ADJP (JJ demanding))) (NN change)) (PP (IN in) (NP (JJ cellular) (NNS conditions))))))))) (. .)))
( (S (S (NP (NNS Questions)) (VP (VBP remain) (ADJP (JJ as) (PP (TO to) (NP (DT the) (NN extent) (SBAR (IN that) (S (NP (NP (DT this) (NN type)) (PP (IN of) (NP (NN regulation)))) (VP (MD may) (VP (VB occur) (PP (IN under) (NP (VBG differing) (JJ biological) (NNS scenarios)))))))))))) (. .)))
( (S (S (NP (NP (JJ Global) (NN regulation)) (PP (IN of) (NP (NN mRNA) (NN stability)))) (VP (VBZ has) (ADVP (RB thus) (RB far)) (VP (VBN been) (ADVP (RB systematically)) (VP (VBN studied) (PP (IN under) (NP (NP (NNS conditions)) (PP (IN of) (NP (NP (NN stress)) (CC and) (NP (JJ cellular) (NN activation)))))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ remains) (S (VP (TO to) (VP (VB be) (VP (VBN determined) (SBAR (IN whether) (CC or) (RB not) (S (NP (NP (NNS changes)) (PP (IN in) (NP (NN mRNA) (NN stability)))) (VP (VBP are) (ADJP (JJ responsible) (PP (IN for) (S (VP (VBG altering) (NP (NP (NN gene) (NN expression) (NNS programs)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (JJ other) (JJ biological) (NNS conditions))))))))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN existence)) (PP (IN of) (NP (DT these) (JJ regulatory) (NNS paradigms)))) (VP (MD may) (VP (VB require) (NP (NP (DT a) (NN reevaluation)) (PP (IN of) (NP (NP (DT the) (JJ common) (NN model)) (PP (IN of) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (NN gene) (NN expression))))) (SBAR (WHNP (WDT which)) (S (ADVP (RB essentially)) (VP (VBZ invokes) (NP (NP (DT the) (VBG turning)) (PP (IN on) (NP (NP (CC and)) (PP (RP off) (PP (IN of) (NP (NP (NN gene) (NN transcription)) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB explain) (NP (NP (NNS changes)) (PP (IN in) (NP (NN polyA) (NN mRNA) (NNS levels))))))))))))))))))))))) (. .)))
( (S (NP (NN Conclusion))))
( (S (SBAR (IN Although) (S (NP (NN stability) (NN regulation)) (VP (MD might) (ADVP (RB reasonably)) (VP (VB be) (VP (VBN considered) (PP (IN as) (NP (DT a) (JJ cellular) (NN measure))) (S (VP (TO to) (VP (NN bridge) (NP (NP (DT the) (NN gap)) (PP (IN between) (NP (NP (DT the) (ADJP (RB very) (JJ rapid)) (NNS events)) (PP (IN of) (NP (NP (NN signal) (NN transduction)) (CC and) (NP (NP (NP (DT the) (JJR longer) (NN term)) (NN induction)) (PP (IN of) (NP (NP (JJ cellular) (NNS programs)) (VP (VBG involving) (NP (NP (DT the) (VBN coordinated) (NN transcription)) (PP (IN of) (NP (NP (NNS batteries)) (PP (IN of) (NP (JJ new) (NN gene) (NN synthesis))))))))))))))))))))))) (, ,) (NP (DT the) (JJ current) (NNS data)) (ADVP (RB actually)) (VP (VBZ suggests) (ADVP (RB otherwise))) (. .)))
( (S (S (NP (NP (CD One)) (PP (IN of) (NP (NP (DT the) (NNS goals)) (PP (IN in) (NP (DT this) (NN work)))))) (VP (VBD was) (S (VP (TO to) (VP (VB examine) (NP (NP (NP (NNS changes)) (PP (IN in) (NP (NP (NN gene) (NN expression)) (PP (IN due) (TO to) (NP (JJ altered) (NN transcription)))))) (CC and) (NP (NP (DT those)) (ADJP (JJ due) (PP (TO to) (NP (NP (JJ altered) (NN turnover)) (PP (IN across) (NP (NP (DT a) (NN time) (NN course)) (VP (VBG allowing) (NP (JJ sufficient) (NN time)) (PP (IN for) (NP (NP (DT the) (NN resolution)) (PP (IN of) (NP (NP (NN time) (NNS disparities)) (PP (IN between) (NP (NP (JJ new) (NN mRNA) (NN synthesis)) (CC and) (NP (NP (PRP$ their) (NN appearance)) (PP (IN as) (NP (JJ measurable) (JJ cellular) (NNS pools))))))))))))))))))))))) (. .)))
( (S (S (NP (NP (JJ Sufficient) (NN time)) (PP (IN for) (NP (NP (JJ effective) (NN transcription)) (CC and) (NP (JJ even) (NN translation))))) (VP (VBD was) (ADVP (RB clearly)) (VP (VBN demonstrated) (PP (IN by) (NP (NP (DT the) (NN example)) (PP (IN of) (NP (NP (NN NFKB1) (NN mRNA) (NN induction)) (VP (VBN followed) (PP (IN by) (NP (NP (DT the) (NN transcription)) (PP (IN of) (NP (PRP$ its) (JJ downstream) (NNS targets))))))))))))) (. .)))
( (S (S (NP (NP (NNS Patterns)) (PP (IN of) (NP (ADJP (NP (NN stability)) (VBN regulated)) (NNS genes)))) (VP (VBD were) (, ,) (PP (IN in) (NP (DT this) (JJ model) (NN system))) (, ,) (ADJP (ADJP (JJ non-random)) (CC and) (ADJP (RB surprisingly) (JJ persistent) (PP (IN throughout) (NP (NP (DT the) (JJ entire) (NN time) (NN course)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN stability)) (NN regulation)) (VP (VBD was) (NP (NP (DT a) (JJ major) (NN component)) (PP (IN in) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (NN gene) (NN expression)))))) (PP (IN for) (NP (NP (JJ significant) (NNS periods)) (PP (IN of) (NP (NN time))))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN presence)) (PP (IN of) (NP (NP (ADJP (ADJP (RB highly) (JJ active)) (CC and) (ADJP (JJ global))) (NN regulation)) (PP (IN of) (NP (NN polyA) (NN mRNA) (NNS levels))) (PP (IN by) (NP (JJ stability-altering) (NNS mechanisms)))))) (VP (VBZ suggests) (NP (NP (DT a) (JJ new) (JJ significant) (NN level)) (PP (IN of) (NP (NP (NN regulation)) (PP (IN in) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (NP (NN gene) (NN expression)) (SBAR (WHNP (WDT which)) (S (VP (VP (VBZ spans) (NP (NP (JJ wide) (JJ phylogenetic) (NNS distances)) (PP (IN from) (NP (NP (NN yeast) (CD -LSB-15) (-RRB- -RSB-)) (PP (TO to) (NP (NNS humans))))))) (, ,) (VP (VBZ emphasizes) (NP (NP (DT a) (JJ possible) (JJ parsimonious) (NN role)) (PP (IN for) (NP (JJ new) (NN gene) (NN synthesis)))) (PP (IN in) (NN response) (TO to) (S (VP (VBG changing) (NP (JJ cellular) (NNS environments)))))) (, ,) (CC and) (VP (MD may) (VP (VB help) (S (VP (TO to) (VP (VB explain) (NP (NP (DT some)) (PP (IN of) (NP (NP (DT the) (NNS difficulties)) (VP (VBN encountered) (PP (IN in) (VP (VBZ attempts) (S (VP (TO to) (ADVP (RB comprehensively)) (VP (VB correlate) (NP (NP (JJ clustered) (NNS changes)) (PP (IN in) (NP (NN polyA) (NN mRNA)))) (PP (IN with) (NP (JJ common) (NN promoter) (JJ regulatory) (NNS elements))))))))))))))))))))))))))))) (. .)))
( (S (NP (NNS Methods))))
( (S (S (NP (DT The) (JJ human) (NN Jurkat) (NN E6-1) (NN T) (NN cell) (NN line)) (VP (VBD was) (VP (VBN cultured) (PP (IN in) (NP (NP (NP (NN RPMI-1640) (NN medium)) (PRN (-LRB- -LRB-) (NP (NNP GIBCO-BRL) (, ,) (NNP Gaithersburg)) (, ,) (NP (NN MD)) (-RRB- -RRB-))) (VP (VP (VBN supplemented) (PP (IN with) (NP (NP (NP (ADJP (CD 10) (NN %)) (NN FCS)) (PRN (-LRB- -LRB-) (NP (NNP Hyclone) (, ,) (NNP Logan)) (, ,) (NP (NN UT)) (-RRB- -RRB-))) (CC and) (NP (NNS antibiotics))))) (, ,) (CC and) (VP (VBN incubated) (PP (IN at) (NP (NP (NN 37°C)) (, ,) (NP (ADJP (CD 5) (NN %)) (NN CO2))))))))))) (. .)))
( (S (S (NP (NNS Cells)) (VP (VBD were) (VP (VBN stimulated) (PP (IN with) (NP (NP (NP (ADJP (CD 40) (NN ng/ml)) (NN phorbol) (NN 12-myristate) (NN 13-acetate)) (PRN (-LRB- -LRB-) (NP (NN PMA)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (CD 1) (NN μM) (NN ionomycin)) (PRN (-LRB- -LRB-) (NP (NP (NN Sigma)) (, ,) (NP (NN St.) (NN Louis)) (, ,) (NP (NN MO))) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NN P+I)) (-RRB- -RRB-)))))))) (. .)))
( (S (NP (NP (NN Actinomycin) (NN D)) (PRN (-LRB- -LRB-) (NP (NNP A.G.))))))
( (S (S (NP (NP (JJ Scientific)) (PRN (, ,) (NP (NP (NNP San) (NNP Diego)) (, ,) (NP (NN CA))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN added) (PP (IN at) (NP (NP (CD 10) (NN ug/ml) (CD 30) (NNS minutes)) (ADJP (JJ prior) (PP (TO to) (NP (NP (NN activation)) (PP (IN with) (NP (NP (NN PMA)) (CC +) (NP (CD I)))))))))))) (. .)))
( (S (NP (NP (NP (NN Isolation)) (PP (IN of) (NP (NNS nuclei)))) (CC and) (NP (NP (NN preparation)) (PP (IN of) (NP (JJ nuclear) (JJ run-on) (-LRB- -LRB-) (NN NRO) (-RRB- -RRB-) (NN RNA))))) (VP (VBD were) (SBAR (IN as) (S (VP (VBN described) (NP (CD -LSB-6,21) (-RRB- -RSB-)) (PP (IN with) (NP (DT some) (NNS modifications))))))) (. .)))
( (S (S (ADVP (RB Briefly)) (, ,) (NP (NP (NN ~108) (NNS cells)) (PP (IN per) (NP (NN sample)))) (VP (VBD were) (VP (VP (VBN pelleted)) (, ,) (VP (VBN washed) (PP (IN with) (NP (NNS PBS)))) (, ,) (VP (VBN resuspended) (PP (IN in) (NP (NP (JJ ice-cold) (NN lysis) (NN buffer)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD 20) (NN mM)) (NN Tris-HCl) (NN -LSB-pH) (CD 7.4) (-RRB- -RSB-)) (, ,) (NP (ADJP (CD 20) (NN mM)) (NN NaCl)) (, ,) (NP (ADJP (CD 5) (NN mM)) (NN MgCl2)) (, ,) (NP (ADJP (CD 0.25) (NN %)) (NN -LSB-v/v))) (-RRB- -RSB-) (NP (NN NP-40)) (-RRB- -RRB-))))) (, ,) (CC and) (VP (VBN incubated) (PP (IN on) (NP (NN ice))) (PP (IN for) (NP (CD 5) (NN min))))))) (. .)))
( (S (S (NP (NNS Nuclei)) (VP (VBD were) (VP (VP (VBN spun) (ADVP (RB down))) (, ,) (VP (VBN resuspended) (PP (IN in) (NP (NP (NN storage) (NN buffer)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD 50) (NN mM)) (NN Tris-HCl) (NN -LSB-pH) (CD 8.3) (-RRB- -RSB-)) (, ,) (NP (ADJP (CD 5) (NN mM)) (NN MgCl2)) (, ,) (NP (ADJP (CD 0.1) (NN mM)) (NN EDTA-NaOH) (NN -LSB-pH) (CD 8.0) (-RRB- -RSB-)) (, ,) (NP (ADJP (CD 40) (NN %)) (NN -LSB-v/v) (-RRB- -RSB-) (NN glycerol))) (-RRB- -RRB-))))) (CC and) (VP (VBN stored) (PP (IN at) (NP (NN -80°C))) (PP (IN until) (NP (NN use))))))) (. .)))
( (S (S (NP (NP (JJ Thawed) (NNS nuclei)) (PRN (-LRB- -LRB-) (NP (CD 200-μl) (NNS aliquots)) (-RRB- -RRB-))) (VP (VBD were) (VP (VP (VBN mixed) (PP (IN with) (NP (NP (NP (CD 200) (NN μl)) (PP (IN of) (NP (NP (NN reaction) (NN buffer)) (PRN (-LRB- -LRB-) (NP (ADJP (CD 5) (NN mM)) (NN Tris-HCl) (NN -LSB-pH) (CD 8.0)) (-RRB- -RSB-))))) (, ,) (NP (ADJP (CD 0.15) (NN mM)) (NN KCl)) (, ,) (NP (ADJP (CD 2.5) (NN mM)) (NN MgCl2)) (, ,) (NP (ADJP (CD 2.5) (NN mM)) (NN DTT)) (, ,) (NP (NP (CD 0.5) (NN mM)) (PP (IN of) (NP (NP (NP (DT each) (NN ATP)) (, ,) (NP (NN UTP)) (, ,) (NP (NN GTP) (-RRB- -RRB-)) (CC plus) (NP (CD 500) (NN μCi) (IN of) (NN -LSB-α-33P) (-RRB- -RSB-) (NN UTP))) (PRN (-LRB- -LRB-) (NP (CD 3,000) (NN Ci/mmol)) (, ,) (NP (CD 10) (NN mCi/ml)) (: ;) (NP (NN ICN)) (-RRB- -RRB-))))) (, ,)))) (CC and) (VP (VBN incubated) (PP (IN for) (NP (NP (CD 30) (NN min)) (PP (IN at) (NP (NN 30°C))))) (PP (IN with) (NP (NN shaking))))))) (. .)))
( (S (S (NP (NNS Samples)) (VP (VBD were) (ADVP (RB then)) (VP (VBN incubated) (PP (IN with) (NP (NP (NN DNase) (CD I)) (PRN (-LRB- -LRB-) (NP (NP (NN 100U)) (, ,) (NP (ADJP (JJ RNase-free))) (: ;) (NP (NN Roche) (NN Diagnostics))) (-RRB- -RRB-)))) (PP (PP (IN for) (NP (NP (CD 20) (NN min)) (PP (IN at) (NP (NN 37°C))))) (, ,) (CC and) (PP (IN with) (NP (NP (NP (NN proteinase) (NN K)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN μg/μl)) (-RRB- -RRB-))) (PP (IN for) (NP (NP (CD 1) (NN h)) (PP (IN at) (NP (NN 37°C))))))))))) (. .)))
( (S (S (ADVP (RB Finally)) (, ,) (NP (JJ nascent) (NN RNA)) (VP (VBD was) (VP (VBN purified) (PP (IN by) (NP (NN Sephadex) (NN G-50) (NN column) (NN filtration)))))) (. .)))
( (S (S (PP (IN For) (NP (NP (DT the) (NN preparation)) (PP (IN of) (NP (NN polyA) (NN mRNA) (JJ cellular) (NN RNA))))) (, ,) (NP (ADJP (ADJP (JJ resting)) (CC or) (ADJP (JJ stimulated))) (NN Jurkat) (NNS cells)) (VP (VBD were) (VP (VBN lysed) (PP (IN in) (NP (NP (NN STAT60™)) (PRN (-LRB- -LRB-) (NP (NP (NN TEL-TEST)) (, ,) (NP (NNP INC.) (, ,) (NNP Friendswood)) (, ,) (NP (NN TX))) (-RRB- -RRB-)))) (PP (IN as) (NP (VBN described) (NN -LSB-6))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (NP (NN RNA) (NN concentration)) (CC and) (NP (NN quality))) (VP (VBD were) (VP (VBN assessed) (UCP (ADVP (RB spectrophotometrically)) (CC and) (PP (IN by) (NP (NN agarose) (NN gel) (NN electrophoresis))))))) (. .)))
( (S (S (NP (NN NRO) (NN RNA)) (VP (VBD was) (VP (VBN stored) (PP (IN at) (NP (NN -80°C))) (PP (IN until) (NP (NN use)))))) (. .)))
( (S (S (NP (NN PolyA) (NN mRNA) (NNS samples)) (VP (VBD were) (VP (VP (VBN radiolabeled)) (CC and) (VP (VBN hybridized) (PP (IN as) (NP (ADJP (RB previously) (VBN described)) (NN -LSB-22)))))) (-RRB- -RSB-)) (. .)))
( (S (PP (IN In) (NP (JJ brief))) (, ,) (NP (NP (CD 5) (NN μg)) (PP (IN of) (NP (JJ total) (NN mRNA))) (PP (IN for) (NP (DT each) (NN sample)))) (VP (VBD was) (VP (VBN annealed) (, ,) (PP (IN in) (NP (CD 16) (NN μl) (NN H2O))) (, ,) (PP (IN with) (NP (NP (CD 1) (NN μg)) (PP (IN of) (NP (NP (NP (NP (NN 24-mer) (NN poly)) (PRN (-LRB- -LRB-) (NP (NN dT)) (-RRB- -RRB-))) (NN primer)) (PRN (-LRB- -LRB-) (NP (NP (NN Research) (NNS Genetics)) (, ,) (NP (NN Alabama))) (-RRB- -RRB-)))))) (, ,) (PP (IN by) (S (VP (VP (VBG heating) (PP (IN at) (NP (NN 65°C))) (PP (IN for) (NP (CD 10) (NN min)))) (CC and) (VP (VBG cooling) (PP (IN on) (NP (NN ice))) (PP (IN for) (NP (CD 2) (NN min))))))))) (. .)))
( (S (S (NP (DT The) (NN RT) (NN reaction)) (VP (VBD was) (VP (VBN performed) (PP (IN by) (S (VP (VBG adding) (NP (NP (NP (CD 8) (NN μl)) (PP (IN of) (NP (NP (NP (NN 5X) (JJ first) (NN strand) (NN RT) (NN buffer)) (PRN (-LRB- -LRB-) (NP (NP (NN Life) (NNS Technologies)) (PRN (, ,) (NP (NNP Rockville) (, ,) (NNP MD)) (-RRB- -RRB-))) (, ,) (NP (NP (NP (CD 4) (NN μl)) (PP (IN of) (NP (ADJP (CD 20) (NN mM)) (NNS dNTPs)))) (CC minus) (NP (NN dCTP))) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NP (NNP Pharmacia)) (, ,) (NP (NNP Piscataway) (, ,) (NNP NJ))) (-RRB- -RRB-))))) (, ,) (NP (NP (CD 4) (NN μl)) (PP (IN of) (NP (ADJP (CD 0.1) (NN M)) (NN DTT)))) (, ,) (NP (NP (NP (CD 40) (NN U)) (PP (IN of) (NP (NN RNAseOUT)))) (PRN (-LRB- -LRB-) (NP (NN Life) (NNS Technologies)) (-RRB- -RRB-))) (, ,) (NP (NP (CD 6) (NN μl)) (PP (IN of) (NP (NP (NP (CD 3000) (NN Ci/mmol) (NN α-33P) (NN dCTP)) (PRN (-LRB- -LRB-) (NP (NN ICN) (NP (NNP Biomedicals) (, ,) (NNP Costa)) (NN Mesa)) (, ,) (NP (NN CA)) (-RRB- -RRB-))) (PP (TO to) (NP (DT the) (NN RNA/primer) (NN mixture))))))) (PP (TO to) (NP (NP (DT a) (JJ final) (NN volume)) (PP (IN of) (NP (CD 40) (NN μl))))))))))) (. .)))
( (S (S (S (NP (NP (NP (CD Two) (NN μl)) (PRN (-LRB- -LRB-) (NP (CD 400) (NN U)) (-RRB- -RRB-))) (PP (IN of) (NP (NN Superscript) (CD II) (NP (NP (JJ reverse) (NN transcriptase)) (PRN (-LRB- -LRB-) (NP (NN Life) (NNS Technologies)) (-RRB- -RRB-)))))) (VP (VBD was) (ADVP (RB then)) (VP (VBN added)))) (, ,) (CC and) (S (NP (DT the) (NN sample)) (VP (VBD was) (VP (VBN incubated) (PP (IN for) (NP (CD 60) (NN min))) (PP (IN at) (NP (NN 42°C))))))) (. .)))
( (S (S (NP (DT The) (NN reaction)) (VP (VBD was) (VP (VBN stopped) (PP (IN by) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NP (CD five) (NNS μl)) (PP (IN of) (NP (ADJP (CD 0.5) (NN M)) (NN EDTA)))))))))) (. .)))
( (S (S (NP (DT The) (NNS samples)) (VP (VBD were) (VP (VBN incubated) (PP (IN at) (NP (NN 65°C))) (PP (IN for) (NP (NP (CD 30) (NN min)) (PP (IN after) (NP (NP (NN addition)) (PP (IN of) (NP (NP (CD 10) (NN μl)) (PP (IN of) (NP (ADJP (CD 0.1) (NN M)) (NN NaOH))))))))) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VP (VB hydrolyze)) (CC and) (VP (VB remove) (NP (NN RNA)))))))))) (. .)))
( (S (NP (DT The) (NNS samples)) (VP (VBD were) (NP (NN pH)) (VP (VP (VBD neutralized) (PP (IN by) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NP (CD 25) (NN μl)) (PP (IN of) (NP (NP (ADJP (CD 0.5) (NN M)) (NN Tris)) (, ,) (NP (NN pH) (CD 8.0)) (, ,)))))))) (CC and) (VP (VBN purified) (S (VP (VBG using) (NP (NP (JJ Bio-Rad) (CD 6) (NN purification) (NNS columns)) (PRN (-LRB- -LRB-) (NP (NP (NNP Hercules)) (, ,) (NP (NN CA))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (DT An) (NN aliquout)) (PP (IN of) (NP (DT each) (JJ labled) (NN sample)))) (VP (VBD was) (VP (VBN quantitated) (PP (IN by) (NP (NP (JJ liquid) (NN scintillation) (NN counting)) (VP (VBG using) (NP (DT a) (NN Beckman) (NN LS) (NN 6500)))))))) (. .)))
( (S (S (NP (DT The) (JJ entire) (VBG remaining) (NN sample)) (VP (VBD was) (VP (VBN stored) (PP (IN at) (NP (NN -20°C))) (PP (IN until) (NP (NN use)))))) (. .)))
( (S (S (NP (NP (NN Microarray) (NN construction)) (CC and) (NP (NN hybridization))) (VP (VBD were) (NP (ADJP (RB previously) (VBN described)) (NN -LSB-23))) (-RRB- -RSB-)) (. .)))
( (S (ADVP (RB Briefly)) (, ,) (NP (NP (NN NIA) (JJ Human) (VBN Focused) (NNS Arrays)) (VP (VBG consisting) (PP (IN of) (NP (NP (DT a) (NN set)) (PP (IN of) (NP (CD 4600) (JJ spotted) (NNS cDNAs))) (, ,) (VP (VP (VBN arrayed) (PP (IN in) (NP (NN duplicate))) (, ,) (S (VP (VBG representing) (NP (NP (DT a) (NN set)) (PP (IN of) (NP (NP (CD 2742) (JJ non-redundant) (NNS genes)) (PRN (-LRB- -LRB-) (VP (VBN enriched) (PP (IN in) (NP (NP (NNS genes)) (VP (VBN involved) (PP (IN in) (NP (NP (JJ immune) (NN function)) (CC and) (NP (NN signal) (NN transduction)))))))) (-RRB- -RRB-)))))))) (, ,) (VP (VBD were) (VP (VBN printed) (PP (IN on) (NP (NP (NNP Nytran)) (CC +) (NP (NNP Supercharge)) (NP (NN nylon) (NNS membranes)))) (PRN (-LRB- -LRB-) (NP (NNP Schleicher) (NNP &) (NNP Schuell) (, ,) (NNP Keene) (, ,) (NNP NH)) (-RRB- -RRB-)))) (, ,) (CC and) (VP (VBN hybridized) (PP (IN with) (NP (NN -LSB-α-33P))))) (-RRB- -RSB-))) (NP (JJ dCTP-labeled) (NN cDNA) (CC or) (NN -LSB-α-33P) (-RRB- -RSB-) (NN UTP) (NN RNA) (NNS probes)))) (VP (JJ overnight) (PP (IN at) (NP (NP (NN 50°C)) (PP (IN as) (NP (NP (ADJP (RB previously) (VBN described)) (CD -LSB-22) (-RRB- -RSB-)) (, ,) (NP (NP (NNS protocols)) (ADJP (JJ available) (PP (IN at))))))))) (. .)))
( (S (NP (VBN Hybridized) (NNS arrays)) (VP (VBD were) (VP (VBN rinsed) (PP (IN in) (NP (NP (CD 2) (NN X) (NN SSC)) (CC and) (NP (ADJP (CD 0.1) (NN %)) (NN SDS)))) (ADVP (RB twice)) (PP (IN at) (NP (NP (NN 55°C)) (VP (VBN followed) (PP (IN by) (NP (NP (NNS washes)) (PP (IN in) (NP (NP (NP (CD 2) (NN X) (NN SSC)) (CC and) (NP (ADJP (CD 0.1) (NN %)) (NN SDS))) (PP (IN at) (NP (NN 55°C)))))))))))) (. .)))
( (S (S (NP (NNS Microarrays)) (VP (VBD were) (VP (VP (VBN exposed) (PP (IN for) (NP (CD 1–3) (NN d)))) (CC and) (VP (VBN scanned) (S (VP (VBG using) (NP (NP (DT a) (NN PhosphorImager)) (PRN (-LRB- -LRB-) (NP (JJ Molecular) (NNS Dynamics)) (, ,) (NP (NNP Sunnyvale)) (, ,) (NP (NN CA)) (-RRB- -RRB-))) (PP (IN at) (NP (DT a) (JJ 50-μm) (NN pixel) (NN resolution))))))))) (. .)))
( (S (S (NP (NP (NN ArrayPro) (NN software)) (PRN (-LRB- -LRB-) (NP (NP (NN MediaCybernetics)) (, ,) (NP (NN Silver) (NN Spring)) (, ,) (NP (NN MD))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VBP convert) (NP (DT the) (NN hybridization) (NNS signals)) (PP (IN into) (NP (NN raw) (NN intensity) (NNS values))))))))) (: ;) (S (NP (NP (NNS data)) (VP (VBN generated))) (VP (VBD were) (VP (VBN transferred) (PP (IN into) (NP (NP (JJ Microsoft) (NN Excel)) (PP (IN for) (NP (JJ further) (NN analysis)))))))) (. .)))
( (S (S (NP (JJ Single) (NN endpoint) (NN PCR)) (VP (VBD was) (VP (VBN carried) (PRT (RP out)) (PP (IN on) (NP (NP (NP (NN polyA) (NN mRNA)) (PP (IN for) (NP (NN gene) (NN detection)))) (CC and) (NP (NP (JJ relative) (JJ quantitative) (NN comparison)) (PP (IN between) (NP (NP (NP (NN baseline)) (PRN (-LRB- -LRB-) (NP (CD 0) (NN time)) (-RRB- -RRB-))) (CC and) (NP (NN I) (NN hour)) (NP (NP (NN activation)) (PRN (-LRB- -LRB-) (PP (IN with) (NP (NN PMA) (NN +I))) (-RRB- -RRB-))))))))))) (. .)))
( (S (PP (IN In) (NP (JJ brief))) (, ,) (S (S (NP (NP (NN GS320) (NNS libraries)) (PP (IN for) (NP (CC both) (NP (NN control)) (CC and) (NP (VBN activated) (NN polyA) (NN mRNA))))) (VP (VBD were) (VP (VBN prepared) (SBAR (IN as) (S (VP (VP (VBN described) (NP (CD -LSB-24) (-RRB- -RSB-))) (, ,) (VP (VBN normalized) (S (VP (VBG using) (NP (NP (DT a) (NN panel)) (PP (IN of) (NP (JJ ribosomal) (NN protein) (NNS genes))))))))))))) (, ,) (CC and) (S (NP (JJ specific) (NNS genes)) (VP (VBD were) (VP (VBN amplified) (PP (IN in) (NP (NN duplicate))) (S (VP (VBG using) (NP (JJ predefined) (NN GS320) (NNS primers)))))))) (. .)))
( (S (S (NP (NP (NN RNA) (NNS samples)) (PRN (-LRB- -LRB-) (NP (NP (ADVP (RB typically)) (NN n)) (ADJP (JJ =) (NP (CD 3) (TO to) (NP (ADJP (NN n) (JJ =)) (CD 5))))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN prepared) (PP (IN from) (NP (NP (JJ multiple) (NNS experiments)) (, ,) (SBAR (WHNP (NP (DT each)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBD consisted) (PP (IN of) (NP (NP (DT a) (JJ consecutive) (NN series)) (PP (IN of) (NP (NN time) (NNS points))))))))))))) (. .)))
( (S (S (NP (NP (JJ Equal) (NNS amounts)) (PP (IN of) (NP (NP (NP (JJ total) (NN RNA)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN μg)) (-RRB- -RRB-))) (CC or) (NP (NP (NN NRO) (NN RNA)) (PRN (-LRB- -LRB-) (NP (CD 108) (NN cell-equivalents)) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN used) (PP (IN in) (NP (DT each) (NN hybridization)))))) (. .)))
( (S (S (NP (NP (NN Raw) (NN intensity) (NNS data)) (PP (IN for) (NP (DT each) (NN experiment)))) (VP (VBD was) (VP (VBN transformed) (PP (TO to) (NP (NN log10))) (, ,) (ADVP (RB then)) (VP (VBN used) (PP (IN for) (NP (NP (DT the) (NN calculation)) (PP (IN of) (NP (NN Z) (NNS scores)))))) (SBAR (IN as) (S (VP (VBN described) (S (NP (CD -LSB-22) (-RRB- -RSB-) (JJ -LSB-see) (JJ Additional) (NN file) (CD 1) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (NP (JJ Significant) (NNS changes)) (PP (IN in) (NP (NN gene) (NN expression)))) (VP (VBD were) (VP (VBN calculated) (PP (IN in) (NP (NP (DT the) (NN form)) (PP (IN of) (NP (NP (NN Z) (NNS ratios)) (CC and/or) (NP (NP (NN Z) (NN test) (NNS values)) (PRN (-LRB- -LRB-) (NP (CD -LSB-25) (-RRB- -RSB-)) (-RRB- -RRB-))))))) (, ,) (S (VP (VBG using) (NP (NN Z) (NN score) (NNS values)) (PP (IN in) (NP (DT all) (NNS calculations)))))))) (. .)))
( (S (S (NP (NN Z) (NNS ratios)) (VP (VBP constitute) (NP (NP (DT a) (NN measure)) (PP (IN of) (NP (NP (DT the) (NN change)) (PP (IN in) (NP (NP (NN gene) (NN expression)) (PP (IN of) (NP (NP (DT a) (JJ given) (NN gene)) (PP (IN from) (NP (NP (PRP$ its) (NN baseline) (NN value)) (PRN (-LRB- -LRB-) (PP (IN in) (NP (NP (DT this) (NN case)) (PP (IN –) (NP (NN time) (CD 0))))) (-RRB- -RRB-)))) (, ,) (VP (VBN expressed) (PP (IN in) (NP (NP (NNS units)) (PP (IN of) (NP (NP (JJ standard) (NN deviation)) (PP (IN from) (NP (NP (DT the) (JJ average) (NN change)) (PP (IN of) (NP (NP (DT all) (NNS genes)) (PP (IN for) (NP (DT that) (NN comparison))))))))))))))))))))) (. .)))
( (S (S (NP (NN Z) (NNS ratios)) (VP (VP (VBP are) (NP (NP (DT a) (JJ direct) (NN measure)) (PP (IN of) (NP (DT the) (NN likelihood) (SBAR (IN that) (S (NP (DT an) (VBN observed) (NN change)) (VP (VBZ is) (NP (NP (DT an) (NN outlier)) (PP (IN in) (NP (DT an) (ADJP (RB otherwise) (JJ normal)) (NN distribution))))))))))) (CC and) (, ,) (PP (IN as) (NP (JJ such))) (, ,) (VP (VBP are) (ADJP (JJ independent) (PP (IN from) (NP (JJ underlying) (NN intensity) (NNS values))))))) (. .)))
( (S (S (SBAR (IN Since) (S (NP (NP (DT the) (NNS contents)) (PP (IN of) (NP (NP (DT the) (NN population)) (PP (IN of) (NP (NP (JJ nuclear) (JJ run-on)) (CC and) (NP (NN polyA) (NN mRNA))))))) (VP (VBP are) (ADJP (JJ different) (PP (IN in) (NP (CC both) (NP (NN complexity)) (CC and) (NP (NN number)))))))) (, ,) (NP (NN care)) (VP (VBD was) (VP (VBN taken) (S (VP (RB not) (TO to) (VP (VB compare) (NP (ADJP (NP (NN Z) (NN score)) (VBN normalized)) (NNS intensities)) (ADVP (RB directly)))))))) (. .)))
( (S (S (NP (NP (NNS Comparisons)) (PP (IN between) (NP (NN Z) (NNS ratios)))) (, ,) (ADVP (RB however)) (, ,) (VP (VB test) (PP (IN for) (NP (NP (NN equivalence)) (PP (IN of) (NP (NP (JJ significant) (NNS changes)) (PP (IN between) (NP (NP (DT the) (ADJP (ADJP (JJ transcriptional)) (CC and) (ADJP (JJ steady-state))) (NNS changes)) (PP (IN in) (NP (NN gene) (NN expression))))))))) (NP (NP (DT each)) (ADJP (JJ relative) (PP (TO to) (NP (PRP$ its) (JJ own) (NN population))))))) (. .)))
( (S (S (NP (DT All) (NN gene) (NN expression) (NNS changes)) (VP (VBD were) (VP (VBN assessed) (PP (IN through) (NP (NP (NN comparison)) (PP (IN with) (NP (NP (JJ untreated) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN time) (CD 0)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (NP (NP (DT A) (NN Z) (NN ratio) (NN value)) (PP (IN of) (NP (NN ±) (CD 1.50)))) (CC and/or) (NP (NP (DT a) (NN Z) (NN test) (NN value)) (NP (NN p) (NN <) (CD 0.0001)))) (VP (VBD were) (NP (NP (DT the) (NN significance) (NNS thresholds)) (VP (VBN used) (PP (IN in) (NP (DT this) (NN study))))))) (. .)))
( (S (S (NP (JJ Hierarchical) (NN clustering)) (VP (VBD was) (VP (VBN performed) (S (VP (VBG using) (NP (NP (DT the) (NN Cluster) (CC and) (NN TreeView) (NN software) (NN programs)) (, ,) (VP (VBN developed) (PP (IN at) (NP (NNP Stanford) (NNP University) (CD -LSB-26)))) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (DT The) (NN clustering) (NN algorithm)) (VP (VBD was) (VP (VBN set) (S (VP (TO to) (VP (VB complete) (NP (NN linkage) (NN clustering)) (S (VP (VBG using) (NP (DT the) (JJ uncentered) (NN Pearson) (NN correlation)))))))))) (. .)))
( (S (S (NP (NP (NN Mapping)) (PP (IN of) (NP (NP (NN transcription) (NN factor) (NN binding) (NNS sites)) (PP (IN in) (NP (VBN selected) (NNS genes)))))) (VP (VBD was) (VP (VBN performed) (S (VP (VBG using) (NP (NN software)) (PP (IN from) (NP (NNP Genomatix) (NN Software) (NNP Gmbh) (, ,) (NNP Munich) (, ,) (NNP Germany)))))))) (. .)))
( (S (S (VP (VB See) (NP (JJ Additional) (NN file) (CD 2)) (PP (IN for) (NP (NP (DT a) (JJ complete) (NN description)) (PP (IN of) (NP (DT the) (NN analysis))))))) (. .)))
( (S (NP (NNS Abbreviations))))
( (S (NP (NP (NP (NN NRO)) (, ,) (NP (JJ nuclear) (JJ run-on)) (: ;) (NP (NN P+I))) (, ,) (NP (NP (NN PMA)) (CC plus) (NP (NN Ionomycin)) (: ;) (NP (NN ActD)) (, ,) (NP (NN Actinomycin) (NN D))))))
( (S (NP (NP (NNS Authors) (POS ')) (NNS contributions))))
( (S (S (NP (NP (NN CC)) (CC and) (NP (NN JF))) (VP (VBD performed) (NP (NP (DT the) (NN microarray) (NNS assays)) (PRN (-LRB- -LRB-) (NP (NP (NN JF-NRO) (NN RNA)) (, ,) (NP (NN CC-polyA) (NN mRNA))) (-RRB- -RRB-))))) (. .)))
( (S (S (S (NP (NN CC)) (VP (VBN carried) (PRT (RP out)) (NP (JJ statistical) (NN analysis)))) (, ,) (CC and) (S (VP (VBN drafted) (NP (NP (DT the) (NN manuscript)) (PRN (-LRB- -LRB-) (PP (IN with) (NP (NN MG) (NN &) (NNS KGB))) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NP (NN JR)) (CC and) (NP (NN LD))) (VP (VBD performed) (NP (DT the) (NN PCR) (NN validation) (NNS assays)))) (. .)))
( (S (S (NP (NP (NN TW) (JJ assisted)) (PP (IN with) (NP (NP (NN promoter) (NN analysis)) (CC and) (NP (NN YSC-C))))) (VP (VBD participated) (PP (IN in) (NP (NP (DT the) (NN design)) (PP (IN of) (NP (DT the) (NN study))))))) (. .)))
( (S (S (NP (DT All) (NNS authors)) (VP (VP (VBN read)) (CC and) (VP (JJ approved) (NP (DT the) (JJ final) (NN manuscript))))) (. .)))
( (S (NP (NP (NN Figure)) (CC and) (NP (NN Table)) (NP (NNS captions)))))
( (S (NP (NP (NN Figure) (CD 1)) (: :) (NP (NP (NN Hybridization) (NNS images)) (PP (IN of) (NP (NP (NN polyA) (NN mRNA)) (CC and) (NP (NP (NP (JJ nuclear) (JJ run-on)) (PRN (-LRB- -LRB-) (NP (NN NRO)) (-RRB- -RRB-))) (NN RNA))))) (. .))))
( (S (S (NP (VBN Depicted)) (VP (VBP are) (NP (NP (NNS signals)) (PP (IN in) (NP (NP (NP (NNS fields)) (PP (IN of) (NP (NP (NNS arrays)) (VP (VBG corresponding) (PP (TO to) (NP (NP (NP (JJ untreated)) (PRN (-LRB- -LRB-) (NP (NN time) (CD 0)) (-RRB- -RRB-))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (CD 5)) (, ,))))))) (CC and) (NP (NP (CD 30) (NN min)) (PP (IN after) (NP (NP (NN induction)) (PP (IN of) (NP (NN Jurkat) (NNS cells))))) (S (VP (VBG using) (NP (NP (ADJP (CD 40) (NN ng/ml)) (NN PMA)) (CC and) (NP (NP (ADJP (CD 1) (NN μM)) (NN Ionomycin)) (PRN (-LRB- -LRB-) (NP (NN P+I)) (-RRB- -RRB-)))))))))))) (. .)))
( (S (NP (JJ Two-color) (NNS overlays)) (VP (NN contrast) (NP (CC either) (NP (NP (NP (CD 5) (NN min)) (CC or) (NP (CD 30) (NN min))) (PRN (-LRB- -LRB-) (NP (JJ red)) (-RRB- -RRB-))) (CC versus) (NP (NP (CD 0)) (PRN (-LRB- -LRB-) (NP (CD green)) (-RRB- -RRB-)))) (PP (IN for) (NP (NP (NP (NN polyA) (NN mRNA)) (CC and) (NP (NN NRO))) (NNS RNAs)))) (. .)))
( (S (NP (NP (NN Figure) (CD 2)) (: :) (NP (NP (NNS Distributions)) (PP (IN of) (NP (ADJP (RB significantly) (VBN regulated)) (NNS genes))) (PP (IN in) (NP (CC both) (NP (NN polyA) (NN mRNA)) (CC and) (NP (NP (NP (JJ nuclear) (JJ run-on)) (PRN (-LRB- -LRB-) (NP (NN NRO)) (-RRB- -RRB-))) (NN RNA))))) (. .))))
( (S (S (PP (IN For) (NP (DT this) (NN analysis))) (, ,) (NP (DT a) (NN gene)) (VP (VBD was) (VP (VBN considered) (S (VP (TO to) (VP (VP (VB be) (NP (NN up-))) (CC or) (VP (VBN down-regulated) (PP (IN in) (NP (CC either) (NP (NN polyA) (NN mRNA) (NN RNA)) (CC or) (NP (NP (NN NRO) (NN RNA)) (PRN (-LRB- -LRB-) (NP (JJ Altered) (NN Gene) (NN Expression)) (-RRB- -RRB-))))) (SBAR (IN if) (S (NP (PRP it)) (VP (VBD was) (ADJP (RB significantly) (JJ different) (PP (IN from) (NP (DT the) (NN baseline)))) (PP (IN at) (NP (DT any) (NN point))) (PP (IN during) (NP (NP (DT the) (NN time) (NN course)) (PP (IN of) (NP (NN activation))))))))))))))) (: ;) (S (NP (DT all) (JJ other) (NNS genes)) (VP (VBP are) (PP (IN in) (NP (NP (DT the) (`` ') (JJ Unaltered) (NN Gene) (NN Expression) ('' ')) (NN category))))) (. .)))
( (S (S (NP (NP (DT The) (NN number)) (PP (CC and) (IN per) (NP (NP (NN cent)) (PP (IN of) (NP (NP (NNS genes)) (PP (IN in) (NP (NP (DT each)) (PP (IN of) (NP (CD 8) (JJ possible) (JJ regulatory) (NNS categories)))))))))) (VP (VBP are) (VP (VBN displayed)))) (. .)))
( (S (NP (NP (NN Figure) (CD 3)) (: :) (NP (NP (NN Comparison)) (PP (IN between) (NP (NP (NP (NN polyA) (NN mRNA)) (CC and) (NP (JJ nuclear) (JJ run-on) (NN RNA))) (PP (IN of) (NP (JJ immediate) (JJ early) (NN gene) (NN activation))) (PP (IN in) (NP (NN Jurkat) (NN T) (NNS cells)))))) (. .))))
( (S (NP (NP (NN A.1) (NN Heatmap)) (PP (IN of) (NP (NP (JJ relative) (NN gene) (NN expression) (NNS intensities)) (PRN (-LRB- -LRB-) (NP (NN Z) (NNS scores)) (-RRB- -RRB-)))) (. .))))
( (S (NP (NP (CD A.2) (NN Graphical) (NN representation)) (PP (IN of) (NP (NP (DT the) (JJ same) (NNS data)) (VP (VBG illustrating) (NP (NP (DT an) (ADJP (RB immediately) (JJ apparent)) (NN up-regulation)) (PP (IN of) (NP (NP (NN gene) (NN expression)) (PP (IN in) (NP (NP (NN NRO)) (CONJP (CC but) (RB not)) (NP (NN polyA) (NN mRNA)))))))))) (. .))))
( (S (NP (NP (NNP B.)) (NP (NP (JJ Single) (JJ end-point) (NN PCR) (NN validation)) (PP (IN of) (NP (NP (NN up-regulation)) (PP (IN in) (NP (NN polyA) (NN mRNA))))) (PP (IN by) (NP (NP (CD 1) (NN hour)) (PP (IN of) (NP (NP (DT a) (NN subset)) (PP (IN of) (NP (NP (NNS genes)) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (VP (VBN activated) (PP (IN within) (NP (CD 5) (NNS minutes))) (PP (IN by) (NP (JJ nuclear) (JJ run-on) (NN RNA))))))))))))))) (. .))))
( (S (NP (NP (NN C.) (NNS Patterns)) (PP (IN of) (NP (NP (NP (NN polyA) (NN mRNA)) (CC and) (NP (JJ nuclear) (JJ run-on) (NN RNA) (NNS levels))) (PP (IN for) (NP (NP (NN NFKB1)) (CC and) (NP (NP (PRP$ its) (NN inhibitor)) (PRN (-LRB- -LRB-) (NP (NN NFKBIA)) (-RRB- -RRB-))))))) (. .))))
( (S (NP (NP (NN Figure) (CD 4)) (: :) (S (NP (NP (JJ Global) (NN comparison)) (PP (IN of) (NP (NP (NN gene) (NN expression) (NNS changes)) (PP (IN in) (NP (NP (NN polyA) (NN mRNA)) (CC and) (NP (NN NRO) (NN RNA.)) (NP (NNP A.)))) (PP (IN At) (NP (DT each) (NN time) (NN period)))))) (VP (VBD indicated) (S (NP (NNS columns)) (VP (VBP correspond) (PP (TO to) (NP (NP (DT the) (NNS values)) (VP (VBN derived) (PP (IN by) (S (VP (VBG subtracting) (NP (NP (DT the) (NN Z) (NN ratio)) (PP (IN of) (NP (NN NRO) (NN RNA)))) (PP (IN from) (NP (NP (DT the) (NN Z) (NN ratio)) (PP (IN of) (NP (NN polyA) (NN mRNA))) (PP (IN for) (NP (DT every) (NN gene))))))))))))))) (. .))))
( (S (S (NP (NP (NN Equivalency)) (PP (IN between) (NP (NNS calculations)))) (VP (VBZ varies) (PP (IN around) (NP (CD 0))))) (, ,) (S (NP (NN data)) (VP (VP (VBZ is) (VP (VBN aligned) (S (VP (VBG using) (NP (DT a) (JJ combined) (JJ average) (NN index)))))) (, ,) (CC and) (VP (VBZ is) (VP (VBN displayed) (PP (IN from) (ADJP (ADJP (JJ left)) (TO to) (ADJP (JJ right)))) (S (VP (TO to) (VP (VB represent) (NP (NP (DT the) (JJS highest) (JJ average) (JJ positive) (NN Z) (NN ratio) (NN difference)) (TO to) (NP (DT the) (JJS lowest) (JJ average) (JJ negative) (NN Z) (NN ratio) (NN difference)))))))))) (. .)))
( (S (S (NP (NP (NNS Columns)) (PP (IN in) (NP (JJ red)))) (VP (VBP correspond) (PP (TO to) (NP (NP (NNS genes)) (VP (VBG exhibiting) (NP (NP (JJ significant) (NNS differences)) (PRN (-LRB- -LRB-) (NP (NP (NN Z) (NN ratio) (NN difference) (NNS values)) (ADJP (ADJP (JJR greater)) (CC or) (ADJP (JJR less) (PP (IN than) (NP (NN ±) (CD 1.5)))))) (-RRB- -RRB-))) (PP (IN in) (NP (NN gene) (NN expression) (NNS changes)))))) (SBAR (WHADVP (WRB when)) (S (VP (VBG comparing) (NP (NP (NP (NN polyA) (NN mRNA)) (CC and) (NP (NN NRO) (NN RNA))) (PP (IN for) (NP (DT each) (NN gene)))) (PP (IN at) (NP (DT each) (NN time) (NN point)))))))) (. .)))
( (S (NP (NP (FW B.) (JJ Hierarchical) (NN clustering)) (PP (IN of) (NP (NP (DT all) (JJ significant) (NNS changes)) (PP (IN in) (NP (NP (NN gene) (NN expression)) (PP (IN in) (NP (CC either) (NP (NN NRO)) (CC or) (NP (NN polyA) (NN mRNA)))))))) (PP (IN across) (NP (NP (DT the) (NN time) (NN course)) (PP (IN of) (NP (NN activation))))) (. .))))
( (S (S (NP (NP (NP (DT The) (JJ median) (NN Z) (NN score)) (NN data)) (PP (IN for) (NP (DT each) (NN gene)))) (VP (VBZ is) (ADVP (RB individually)) (VP (VBN normalized) (PP (TO to) (NP (NP (PRP$ its) (NN baseline) (NN value)) (PP (IN in)) (PP (IN for) (NP (NP (DT the) (NN sake)) (PP (IN of) (NP (DT this) (NN comparison)))))))))) (. .)))
( (S (S (NP (NN Figure) (CD 5)) (: :) (NP (NP (NN Frequency) (NN distribution)) (PP (IN of) (NP (NP (NN gene) (NN expression) (NNS patterns)) (VP (VBN generated) (PP (IN from) (NP (NP (NN polyA) (NN mRNA)) (CC or) (NP (NN NRO) (NN RNA))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN top) (CD 20) (NN patterns)) (PP (IN for) (NP (DT each) (NN method)))) (VP (VBZ is) (VP (VBN shown)))) (. .)))
( (S (S (NP (NP (JJ Significant) (NNS changes)) (PP (IN in) (NP (NN gene) (NN expression)))) (VP (VBD were) (VP (VBN assigned) (NP (QP (DT a) (CD 1) (, ,) (CD -1) (, ,) (CC or) (CD 0)) (PP (IN for) (NP (NP (NN up)) (, ,) (NP (NN down)) (, ,) (CC or) (NP (DT no) (NN change)) (, ,) (ADVP (RB respectively)))))))) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (DT a) (NN value)) (PP (IN of) (NP (NP (CD -1)) (, ,) (NP (CD 0)) (, ,) (CC or) (NP (NP (CD 1)) (PRN (-LRB- -LRB-) (ADJP (ADJP (JJ low)) (, ,) (ADJP (JJ moderate)) (, ,) (CC or) (ADJP (JJ high))) (-RRB- -RRB-)))))) (VP (VBD was) (VP (VBN assigned) (PP (TO to) (NP (DT each) (NN gene))) (PP (VBG according) (PP (TO to) (NP (NP (PRP$ its) (JJ relative) (NN intensity)) (PP (IN at) (NP (NP (NN baseline)) (PRN (-LRB- -LRB-) (NP (CD 0) (NN time)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (S (NP (NP (DT The) (JJ absolute) (NNS numbers)) (PP (IN of) (NP (NP (NNS genes)) (PP (IN in) (NP (DT each) (NN pattern)))))) (VP (VBP are) (VP (VBN reported) (PP (IN in) (NP (DT the) (NN column) (JJ labeled) (NN Top) (CD 20)))))) (CC and) (S (NP (NP (DT the) (NN percentage)) (PP (IN of) (NP (NP (DT those) (NNS genes)) (ADJP (JJ relative) (PP (TO to) (NP (DT all) (ADJP (RB significantly) (VBN regulated)) (NNS genes))))))) (VP (MD can) (VP (VB be) (VP (VBN found) (PP (IN in) (NP (DT the) (NN column) (JJ labeled) (NN %) (NN Sig)))))))) (. .)))
( (S (S (NP (NNS Totals)) (VP (VBP are) (SBAR (IN as) (S (VP (VBN indicated) (PP (IN at) (NP (NP (DT the) (NN bottom)) (PP (IN of) (NP (DT each) (NN column)))))))))) (. .)))
( (S (NP (NP (JJ Filled-in) (NNS boxes) (NN denote) (NNS patterns)) (VP (ADVP (RB equally)) (VBN shared) (PP (IN in) (NP (DT the) (NN top) (CD 20))) (PP (IN between) (NP (DT both) (NNS methods)))))))
( (S (NP (NP (NN Figure) (CD 6)) (: :) (S (NP (NP (JJ Differential) (NN distribution)) (PP (IN of) (NP (NP (NP (JJ transcriptional) (CC and) (NN polyA) (NN mRNA) (NN up-)) (PRN (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-))) (CC or) (NP (NP (NN down-)) (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-)))))) (VP (VBD regulated) (NP (NN gene) (NN expression) (NNS patterns)) (PP (IN during) (NP (NN Jurkat) (NN T) (NN cell) (NN activation))))) (. .))))
( (S (S (NP (NP (DT The) (NN number)) (PP (IN of) (NP (NP (NNS genes)) (VP (ADVP (RB consistently)) (VBN regulated) (PRN (-LRB- -LRB-) (ADVP (ADVP (RB up)) (CC or) (ADVP (RB down))) (PP (IN at) (NP (DT every) (NN time) (NN point))) (-RRB- -RRB-)))))) (VP (VBP are) (VP (VBN correlated) (PP (IN with) (NP (NP (PRP$ their) (JJ relative) (NN expression) (NNS baselines)) (PRN (-LRB- -LRB-) (NP (NP (NN Z) (NN score)) (: :) (NP (CD high>1)) (, ,) (NP (NN 1>medium>-1)) (, ,) (NP (NN low<-1))) (-RRB- -RRB-))))))) (. .)))
( (S (NP (NP (NN Figure) (CD 7)) (: :) (S (NP (NP (NN Persistence)) (PP (IN of) (NP (NP (JJ stability-regulated) (NNS changes)) (PP (IN in) (NP (NP (NN gene) (NN expression)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (NN Actinomycin) (NNP D.) (NNP A.) (NN Effect)) (PP (IN of) (NP (NN Actinomycin) (NN D))) (PP (IN on) (NP (NP (DT the) (ADJP (-LRB- -LRB-) (NN P+I) (-RRB- -RRB-) (JJ -induced)) (NNS changes)) (PP (IN in) (NP (NP (DT the) (NN expression) (NNS patterns)) (PP (IN of) (NP (NN gene)))))))))))))))) (VP (VBD deemed) (S (VP (TO to) (VP (VB be) (ADVP (RB transcriptionally)) (VP (VBN regulated))))))) (. .))))
( (S (S (NP (NN Z) (NN ratio) (NNS comparisons)) (VP (VBP are) (VP (VBN made) (PP (TO to) (NP (DT the) (NN baseline) (NN or) (JJ unactivated) (NN state)))))) (. .)))
( (S (S (NP (NP (NNP B.) (NN Lack)) (PP (IN of) (NP (NP (DT an) (NN effect)) (PP (IN of) (NP (NN Actinomycin) (NN D))) (PP (IN on) (NP (NP (DT the) (ADJP (-LRB- -LRB-) (NN P+I) (-RRB- -RRB-) (JJ -induced)) (NNS changes)) (PP (IN in) (NP (NP (DT the) (NN expression) (NNS patterns)) (PP (IN of) (NP (NNS genes)))))))))) (VP (VBD deemed) (S (VP (TO to) (VP (VB be) (ADJP (NN stability) (JJ regulated))))))) (. .)))
( (S (S (NP (NP (NP (DT The) (JJ absolute) (NNS differences)) (PRN (-LRB- -LRB-) (NP (NN Z) (NN diff)) (-RRB- -RRB-))) (PP (IN between) (NP (NP (DT the) (ADJP (ADJP (JJ activated)) (CC and) (ADJP (JJ un-activated))) (NN state)) (PP (IN for) (NP (CC both) (NP (NN polyA) (NN mRNA)) (CC and) (NP (NN NRO) (NN RNA)))))) (PP (IN for) (NP (NP (DT a) (NN subset)) (PP (IN of) (NP (DT these) (NNS genes)))))) (VP (VBZ is) (VP (VBN shown)))) (. .)))
( (S (NP (NP (NN C.) (NN Comparison)) (PP (IN of) (NP (NP (DT the) (NN Z) (NNS ratios)) (PP (IN for) (NP (NP (DT all) (ADJP (RB significantly) (VBN regulated)) (NNS genes)) (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC or) (NP (NN absence))) (PP (IN of) (NP (NP (NN Actinomycin) (NN D)) (VP (VBG showing) (NP (NP (DT no) (JJ corresponding) (NN regulation)) (PP (IN in) (NP (NN NRO) (NN RNA))))))))))))) (. .))))
( (S (S (S (NP (NN Data)) (VP (VBZ is) (VP (VBN sorted) (PP (IN by) (NP (NP (NP (NN polyA) (NN mRNA)) (PRN (-LRB- -LRB-) (PP (IN without) (NP (NN ActD))) (-RRB- -RRB-))) (NNS values)))))) (CC and) (S (NP (NP (DT a) (NN significance) (NN threshold)) (PP (IN of) (NP (NP (NN Z) (NNS ratios)) (VP (VBG >) (NP (NN ±) (CD 1.5)))))) (VP (VBD was) (VP (VBN used) (PP (IN for) (NP (DT these) (NNS calculations))))))) (. .)))
( (S (NP (NP (NN Figure) (CD 8)) (: :) (S (NP (NP (NN Regulation)) (PP (IN of) (NP (JJ apoptotic) (NNS pathways))) (PP (IN during) (NP (NN T) (NN cell) (NN activation)))) (VP (VBZ involves) (NP (NP (NNS changes)) (PP (IN in) (NP (NP (NN gene) (NN expression)) (PP (IN by) (NP (CC both) (NP (ADJP (NN mRNA) (JJ transcriptional))) (CC and) (NP (NN mRNA) (NN stability)) (NP (NNS mechanisms))))))))) (. .))))
( (S (S (NP (NP (NNS Genes)) (ADJP (JJ colored) (PP (IN in) (NP (NP (ADJP (JJ red))) (CC and) (NP (ADJP (JJ blue))))))) (VP (VBD were) (UCP (ADJP (JJ up-)) (CC or) (VP (VBN down-regulated) (PP (IN in) (NP (NP (NN polyA) (NN mRNA)) (ADVP (RB only)))))))) (. .)))
( (S (S (NP (NP (NNS Genes)) (ADJP (JJ colored) (PP (IN in) (NP (NP (ADJP (JJ yellow))) (CC and) (NP (ADJP (JJ purple))))))) (VP (VBD were) (UCP (ADJP (JJ up-)) (CC or) (VP (VBN down-regulated) (PP (IN in) (NP (NN NRO) (NN RNA))))))) (. .)))
( (S (NP (NN Pathway)) (VP (VBZ is) (PP (IN from) (NP (NP (DT a) (NN Kegg) (NN map)) (VP (VBN modified) (PP (IN in) (NP (NN Genmapp2.0)))))))))
( (S (S (NP (NN -LSB-27)) (-RRB- -RSB-)) (. .)))
( (S (S (NP (NN Figure) (CD 9)) (: :) (NP (NP (NN Enrichment)) (PP (IN of) (NP (NP (NN NFAT)) (CC and) (NP (NN NFκB)) (NP (NN transcription) (JJ factor-binding) (NNS sites)))) (PP (IN in) (NP (NP (DT the) (NN promoter) (NNS regions)) (PP (IN of) (NP (NP (NNS genes)) (VP (VBN upregulated) (PP (IN after) (NP (NP (CD 60) (NN min)) (PP (IN of) (NP (NP (NN treatment)) (PP (IN of) (NP (JJ human) (NN Jurkat) (NN T) (NNS cells))) (PP (IN with) (NP (NP (NN PMA)) (CC +) (NP (NN Ionomycin))))))))))))))) (. .)))
( (S (S (NP (NP (NN Color) (NN gradient)) (PP (IN from) (NP (JJ bright) (JJ red))) (PP (TO to) (NP (JJ bright) (NN green)))) (VP (VP (VBZ is) (ADJP (RB directly) (JJ proportional) (PP (TO to) (NP (NN Z) (NNS ratios))))) (CC and) (VP (VBZ indicates) (NP (NP (NP (DT the) (NN increase)) (PRN (-LRB- -LRB-) (NP (JJ red)) (-RRB- -RRB-))) (CC or) (NP (NP (NN decrease) (-LRB- -LRB-) (CD green) (-RRB- -RRB-)) (PP (IN of) (NP (NP (NN gene) (NN expression)) (ADJP (JJ relative) (PP (TO to) (NP (NN baseline)))))))) (PP (IN at) (NP (NP (DT each)) (PP (IN of) (NP (DT the) (VBN indicated) (NN time) (NNS points)))))))) (. .)))
( (S (NP (NP (NN Optimisation)) (PP (IN of) (NP (NP (DT the) (NN RT-PCR) (NN detection)) (PP (IN of) (NP (ADJP (RB immunomagnetically) (VBN enriched)) (NN carcinoma) (NNS cells))))))))
( (S (NP (NN Abstract))))
( (S (NP (NP (NN Background)) (: :) (S (NP (NP (JJ Immunomagnetic) (NN enrichment)) (VP (VBN followed) (PP (IN by) (NP (NP (NN RT-PCR)) (PRN (-LRB- -LRB-) (NP (JJ immunobead) (NN RT-PCR)) (-RRB- -RRB-)))))) (VP (VBZ is) (NP (NP (DT an) (JJ efficient) (NN methodology)) (S (VP (TO to) (VP (VB identify) (NP (JJ disseminated) (NN carcinoma) (NNS cells)) (PP (IN in) (NP (DT the) (NP (NN blood)) (CC and) (NP (NN bone) (NN marrow)))))))))) (. .))))
( (S (S (NP (DT The) (NN RT-PCR) (NNS assays)) (VP (MD must) (VP (VB be) (ADJP (CC both) (ADJP (JJ specific) (PP (IN for) (NP (DT the) (NN tumor) (NNS cells)))) (CC and) (ADJP (RB sufficiently) (JJ sensitive) (S (VP (TO to) (VP (VB enable) (NP (NP (NN detection)) (PP (IN of) (NP (JJ single) (NN tumor) (NNS cells)))))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN developed) (NP (NP (DT a) (NN method)) (S (VP (TO to) (VP (VB test) (NP (NP (NN RT-PCR) (NNS assays)) (PP (IN for) (NP (DT any) (NN cancer))))))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBZ has) (VP (VBN been) (VP (VBN investigated) (S (VP (VBG using) (NP (NP (DT a) (NN panel)) (PP (IN of) (NP (NP (NN RT-PCR) (NNS markers)) (ADJP (JJ suitable) (PP (IN for) (NP (NP (DT the) (NN detection)) (PP (IN of) (NP (NN breast) (NN cancer) (NNS cells))))))))))))))) (. .)))
( (S (NP (NP (NNS Methods)) (: :) (S (PP (IN In) (NP (DT the) (NN assay))) (, ,) (NP (DT a) (JJ single) (NN cell) (JJ line-derived) (NN tumor) (NN cell)) (VP (VBZ is) (VP (VBN added) (PP (TO to) (NP (NP (NP (CD 100) (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNS PBMNCs)) (-RRB- -RRB-))) (SBAR (WHPP (IN after) (WHNP (WDT which))) (S (S (NP (NN mRNA)) (VP (VBZ is) (VP (VBN isolated)))) (CC and) (S (NP (NN reverse)) (VP (VBN transcribed) (PP (IN for) (NP (NN RT-PCR) (NN analysis)))))))))))) (. .))))
( (S (S (NP (NP (NNS PBMNCs)) (PP (IN without) (NP (VBN added) (NN tumor) (NNS cells)))) (VP (VBP are) (VP (VBN used) (PP (IN as) (NP (NN specificity) (NNS controls)))))) (. .)))
( (S (S (NP (NP (DT The) (ADJP (RB previously) (VBN studied)) (NNS markers)) (NP (NP (NP (JJ epidermal) (NN growth) (NN factor) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN EGFR)) (-RRB- -RRB-))) (, ,) (NP (NP (NN mammaglobin) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN MGB1)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ epithelial) (NN cell) (NN adhesion) (NN molecule)) (PRN (-LRB- -LRB-) (NP (NN EpCAM/TACSTD1)) (-RRB- -RRB-))) (, ,) (NP (NN mucin) (CD 1) (-LRB- -LRB-) (NN MUC1) (-RRB- -RRB-)) (, ,) (NP (NP (JJ carcinoembryonic) (NN antigen)) (PRN (-LRB- -LRB-) (NP (NN CEA)) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN tested)))) (. .)))
( (S (S (NP (NP (CD Two) (JJ new) (JJ epithelial-specific) (NNS markers)) (NP (NP (NN ELF3)) (CC and) (NP (NN EphB4)))) (VP (VBD were) (ADVP (RB also)) (VP (VBN tested)))) (. .)))
( (S (NP (NP (NNS Results)) (: :) (S (NP (NN MUC1)) (VP (VBD was) (NP (NN unsuitable)) (SBAR (IN as) (S (NP (JJ strong) (NN amplification)) (VP (VBD was) (VP (VBN detected) (PP (IN in) (NP (CD 100) (NN cell) (NN PBMNC) (NNS controls))))))))) (. .))))
( (S (S (NP (NP (NN Expression)) (PP (IN of) (NP (NP (NN ELF3)) (, ,) (NP (NN EphB4)) (, ,) (NP (NN EpCAM)) (, ,) (NP (NN EGFR)) (, ,) (NP (NN CEA)) (CC and) (NP (NN MGB1))))) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB be) (ADJP (CC both) (ADJP (JJ specific) (PP (IN for) (NP (NP (DT the) (NN tumor) (NN cell)) (, ,) (SBAR (IN as) (S (VP (VBN demonstrated) (PP (IN by) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (DT a) (NN signal)) (PP (IN in) (NP (QP (JJS most) (CD 100)) (NN cell) (NN PBMNC) (NNS controls)))))))))) (, ,)))) (CC and) (ADJP (JJ sensitive))) (S (ADVP (RB enough)) (VP (TO to) (VP (VB detect) (NP (NP (DT a) (JJ single) (NN tumor) (NN cell)) (PP (IN in) (NP (NP (CD 100) (NNS PBMNCs)) (VP (VBG using) (NP (NP (DT a) (JJ single) (NN round)) (PP (IN of) (NP (NN RT-PCR))))))))))))))))) (. .)))
( (S (NP (NP (NNS Conclusions)) (: :) (S (NP (NP (NN ELF3)) (, ,) (NP (NN EphB4)) (, ,) (NP (NN EpCAM)) (, ,) (NP (NN EGFR)) (, ,) (NP (NN CEA)) (CC and) (NP (NN MGB1))) (VP (VBP are) (NP (NP (JJ appropriate) (NN RT-PCR) (NNS markers)) (PP (IN for) (NP (NP (NN use)) (PP (IN in) (NP (NP (DT a) (NN marker) (NN panel)) (S (VP (TO to) (VP (VB detect) (NP (JJ disseminated) (NN breast) (NN cancer) (NNS cells)) (PP (IN after) (NP (JJ immunomagnetic) (NN enrichment))))))))))))) (. .))))
( (S (NP (NN Background))))
( (S (S (NP (NP (NP (JJ Reverse) (NN transcriptase-polymerase) (NN chain) (NN reaction)) (PRN (-LRB- -LRB-) (NP (NN RT-PCR)) (-RRB- -RRB-))) (NNS assays)) (VP (VBP have) (VP (VBN been) (VP (VBN developed) (PP (IN for) (NP (NP (DT the) (NN detection)) (PP (IN of) (NP (JJ disseminated) (NN carcinoma) (NNS cells))))) (PP (IN by) (S (VP (VBG targeting) (NP (NN epithelial) (CC or) (NN tumor) (JJ specific) (NN mRNA)) (PP (IN in) (NP (NP (NN bone) (NN marrow)) (, ,) (NP (JJ peripheral) (NN blood)) (, ,) (CC or) (NP (NP (NN lymph) (NNS nodes)) (PRN (-LRB- -LRB-) (VP (VBN reviewed) (PP (IN in) (NP (NN -LSB-1)))) (-RRB- -RSB-) (-RRB- -RRB-)))))))))))) (. .)))
( (S (ADVP (RB However)) (NP (NNS limitations)) (VP (MD may) (VP (VB arise) (PP (IN from) (NP (NP (NP (JJ deficient) (NN expression)) (PP (IN in) (NP (VBG circulating) (NN tumor) (NNS cells)))) (CC or) (NP (NP (JJ low) (NN level) (JJ illegitimate) (NN expression)) (PP (IN in) (NP (JJ haematopoietic) (NNS cells)))))) (, ,) (SBAR (RB particularly) (IN if) (S (NP (DT a) (JJ nested) (NN PCR) (NN approach)) (VP (VBZ is) (VP (VBN used) (NP (NN -LSB-2-5)) (-RRB- -RSB-))))))) (. .)))
( (S (NP (PRP We)) (VP (VBD developed) (NP (NP (DT an) (JJ immunobead-based) (NN technique)) (PP (IN for) (NP (NP (DT the) (NN enrichment)) (PP (IN of) (NP (JJ epithelial) (NNS cells))))) (S (VP (TO to) (VP (VB increase) (NP (NP (DT the) (NN signal)) (PP (TO to) (NP (NN noise) (NN ratio))) (PP (IN for) (NP (NN PCR) (NN based) (NNS protocols) (NP (CD -LSB-6)))) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBD was) (ADVP (RB subsequently)) (VP (VBN adapted) (PP (TO to) (NP (NN RT-PCR) (NN methodology) (CD -LSB-7))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN shown) (NP (NP (JJ immunobead) (NN RT-PCR) (VBZ is)) (PP (IN of) (NP (JJ sufficient) (NN sensitivity)))) (S (VP (TO to) (VP (VB identify) (NP (CD 1) (NN tumor) (JJ epithelial) (NN cell)) (PP (IN in) (NP (NP (DT a) (NN background)) (PP (IN of) (NP (CD 106) (NN blood) (NNS cells) (CD -LSB-7,8) (-RRB- -RSB-))))))))))) (. .)))
( (S (S (NP (DT A) (JJ recent) (NN study)) (VP (VP (VBD compared) (NP (JJ immunobead) (NN RT-PCR)) (PP (IN with) (NP (NP (JJ regular) (NN RT-PCR)) (VP (VBG using) (NP (NN CEA)) (PP (IN as) (NP (NP (DT the) (NN marker)) (PP (IN for) (NP (NP (NN colon) (NN cancer) (NNS cells)) (VP (VBN spiked) (PP (IN into) (NP (JJ normal) (NN blood) (NNS samples)))))))))))) (CC and) (VP (VBD confirmed) (SBAR (IN that) (S (NP (DT the) (JJ immunobead) (NN RT-PCR) (NN method)) (VP (VBZ is) (ADJP (ADJP (RBR more) (JJ sensitive)) (CC and) (ADJP (JJ specific)) (PP (IN than) (NP (DT the) (JJ regular) (NN RT-PCR) (NN method) (CD -LSB-9) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (NP (NP (QP (RB Up) (TO to) (CD 100)) (JJ peripheral) (NN blood) (NNS leukocytes)) (PRN (-LRB- -LRB-) (NP (NNS PBLs)) (-RRB- -RRB-))) (VP (MD may) (VP (VB be) (ADVP (RB concurrently)) (VP (VBN isolated) (PP (IN with) (NP (DT the) (NN tumor) (NNS cells))) (PP (IN during) (NP (DT the) (JJ immunobead) (NN method) (NN -LSB-10))) (-RRB- -RSB-))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB previously)) (VP (VBD had) (NP (NP (JJ similar) (NNS levels)) (PP (IN of) (NP (NN PBL) (NN contamination)))))) (. .)))
( (S (S (ADVP (RB Now) (SBAR (IN that) (S (NP (PRP we)) (VP (VP (VBP carry) (PRT (RP out)) (NP (NP (NNS incubations)) (PP (IN at) (NP (NN 4°C))))) (CC and) (VP (VBP take) (PRT (RP off)) (NP (NP (DT the) (NN cell) (NNS pellets)) (PP (IN from) (NP (DT the) (NNS magnets))) (PP (IN for) (NP (VBG washing))))))))) (, ,) (NP (ADJP (RB considerably) (JJR fewer) (PP (IN than) (NP (CD 10)))) (NNS cells)) (VP (VBP are) (VP (VBN isolated) (PRN (-LRB- -LRB-) (NP (JJ unpublished) (NNS observations)) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB nevertheless)) (ADJP (JJ important)) (S (VP (TO to) (VP (VB assess) (SBAR (IN whether) (S (NP (NP (DT this) (JJ small) (NN number)) (PP (IN of) (NP (NNS cells)))) (VP (MD can) (VP (VB lead) (PP (TO to) (NP (JJ false) (NNS positives))) (PP (JJ due) (TO to) (NP (JJ illegitimate) (NN expression)))))))))))) (. .)))
( (S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP introduce) (NP (NP (DT a) (JJ new) (NN strategy)) (PP (IN for) (NP (NP (DT the) (NN testing)) (PP (IN of) (NP (NP (NN RT-PCR) (NNS assays)) (VP (VBG using) (NP (NP (DT a) (NN method)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (DT a) (JJ single) (NN tumor) (NN cell)) (VP (VBZ is) (VP (VBN mixed) (PP (IN with) (NP (NP (CD 100) (NNS PBMNCs)) (ADJP (JJ prior) (PP (TO to) (NP (NN RT-PCR) (NN analysis)))))))))))))))))) (. .)))
( (S (S (NP (NP (CD 100) (NNS PBMNCs)) (PP (IN without) (NP (VBN added) (NN tumor) (NNS cells)))) (VP (VBP are) (VP (VBN used) (PP (IN as) (NP (NN specificity) (NNS controls)))))) (. .)))
( (S (S (NP (DT This) (NN method)) (VP (VBZ has) (VP (VBN allowed) (NP (NP (DT the) (NN identification)) (PP (IN of) (NP (NP (DT a) (NN panel)) (PP (IN of) (NP (NP (NN RT-PCR) (NNS markers)) (PP (IN of) (NP (NP (JJ sufficient) (NN sensitivity)) (CC and) (NP (NN specificity)))) (PP (IN for) (NP (JJ immunobead) (NN RT-PCR))))))))))) (. .)))
( (S (S (NP (DT This) (NN study)) (VP (VBZ includes) (NP (NP (NP (NP (DT an) (NN assessment)) (PP (IN of) (NP (NP (CD 2) (ADJP (RB previously) (VBN untested)) (NNS markers)) (NP (NP (NN ELF3)) (PRN (-LRB- -LRB-) (ADVP (RB also)) (VP (VBN known) (PP (IN as) (NP (NN ESX) (-RRB- -RRB-) (CD -LSB-11)))) (-RRB- -RSB-)))))) (CC and) (NP (NN EphB4 -LSB-12)) (-RRB- -RSB-)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT the) (ADJP (RB previously) (VBN studied)) (NNS markers)) (NP (NP (NN mucin) (CD 1) (-LRB- -LRB-) (NN MUC1) (-RRB- -RRB-)) (, ,) (NP (NP (NP (JJ carcinoembryonic) (NN antigen)) (PRN (-LRB- -LRB-) (NP (NN CEA)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ epidermal) (NN growth) (NN factor) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN EGFR)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ epithelial) (NN cell) (NN adhesion) (NN molecule)) (PRN (-LRB- -LRB-) (NP (NN EpCAM)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (NN mammaglobin) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN MGB1)) (-RRB- -RRB-))) (NNS markers)))))))) (. .)))
( (S (S (SBAR (IN Whether) (S (NP (DT a) (NN RT-PCR)) (VP (VBZ is) (ADJP (JJ useful))))) (VP (VBZ depends) (PP (CONJP (RB not) (RB only)) (PP (IN on) (NP (NP (DT the) (NN marker)) (VP (VBN used)))) (CONJP (CC but) (RB also)) (PP (IN on) (NP (NP (DT the) (NN assay) (NN conditions)) (PP (IN for) (NP (DT that) (NN marker)))))))) (. .)))
( (S (S (NP (DT A) (JJ useful) (NN marker)) (VP (MD will) (VP (VB be) (ADJP (CC both) (ADJP (JJ sensitive) (RB enough) (S (VP (TO to) (VP (VB enable) (NP (NP (NN detection)) (PP (IN of) (NP (DT a) (JJ single) (NN tumor) (NN cell)))))))) (CC and) (ADJP (JJ specific))) (S (ADVP (RB enough)) (VP (TO to) (ADVP (RB not)) (VP (VB be) (VP (VBN amplified) (PP (IN from) (NP (NNS PBLs)))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (SBAR (IN as) (S (NP (JJ immunomagnetic) (NN cell) (NNS isolates)) (VP (VBP have) (NP (NP (ADJP (RB very) (JJ low)) (NN contamination)) (PP (IN by) (NP (NNS PBLs))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ desirable)) (S (VP (TO to) (VP (VB check) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (NP (JJ illegitimate) (NN expression)) (PP (IN in) (NP (NP (DT the) (ADJP (RB very) (JJ low)) (NN number)) (PP (IN of) (NP (NP (NNS PBLs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN retained) (PP (IN after) (NP (DT an) (JJ immunobead) (NN harvest))))))))))))))))))) (. .)))
( (S (S (VP (TO To) (VP (VB test) (NP (NP (CC both) (NP (NN specificity)) (CC and) (NP (NN sensitivity))) (PP (IN of) (NP (PRP$ our) (VBN chosen) (NNS markers))))))) (, ,) (NP (PRP we)) (VP (VBD developed) (NP (NP (DT an) (NN assay)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (DT a) (JJ single) (NN tumor) (NN cell)) (VP (VBZ is) (VP (VBN deposited) (PP (IN into) (NP (NP (DT a) (JJ microcentrifuge) (NN tube)) (VP (VBG containing) (NP (CD 100) (JJ normal) (NNS PBMNCs))))))))))) (. .)))
( (S (S (NP (CD 100) (NNS PBMNCs)) (VP (VBD were) (VP (VBN chosen) (SBAR (IN as) (S (NP (PRP we)) (VP (VBP believe) (SBAR (IN that) (S (NP (DT this) (NN number)) (VP (VBZ covers) (NP (NP (DT the) (JJ maximum) (NN amount)) (PP (IN of) (NP (NN PBMNC) (NN contamination)))) (SBAR (IN that) (S (NP (NP (PRP we)) (CC or) (NP (NNS others))) (VP (VBP are) (ADJP (JJ likely) (PP (TO to) (NP (NN encounter)))))))))))))))) (. .)))
( (S (NP (NNS Methods))))
( (S (S (NP (JJ Peripheral) (NN blood)) (VP (VBD was) (VP (VBN collected) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (NN polycythemia) (NN vera))) (SBAR (WHNP (WP who)) (S (VP (VBD presented) (PP (IN for) (NP (NN treatment))) (PP (IN at) (NP (NP (NNP The) (NNP Queen) (NNP Elizabeth) (NNP Hospital)) (, ,) (NP (NN Adelaide)) (, ,) (NP (NNP Australia)))))))))))) (. .)))
( (S (S (NP (NP (NP (VBN Informed) (NN consent)) (VP (VBD was) (VP (VBN obtained) (PP (IN in) (NP (DT all) (NNS cases)))))) (CC and) (NP (NN ethics) (NN approval))) (VP (VBD was) (VP (VBN obtained) (PP (IN from) (NP (NP (DT The) (NNP Queen) (NNP Elizabeth) (NNP Hospital) (NNP Ethics)) (PP (IN of) (NP (JJ Human) (NN Research) (NN Committee)))))))) (. .)))
( (S (S (NP (NN Mononuclear) (NNS cells)) (VP (VBD were) (VP (VP (VBN collected) (PP (IN by) (NP (NN centrifugation))) (PP (IN through) (NP (DT a) (NN Ficoll) (NN gradient)))) (, ,) (VP (VBN washed) (PP (IN with) (NP (NP (JJ phosphate-buffered) (NN saline)) (PRN (-LRB- -LRB-) (NP (NN PBS)) (-RRB- -RRB-))))) (CC and) (VP (VBN counted) (S (VP (VBG using) (NP (DT a) (NN haemocytometer)))))))) (. .)))
( (S (S (PP (IN In) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (DT this) (NN investigation))))) (, ,) (NP (NP (NNS PBMNCs)) (PP (IN from) (NP (CD eight) (JJ different) (NNS patients)))) (VP (VBD were) (VP (VBN used)))) (. .)))
( (S (S (NP (NP (DT The) (NN breast) (NN cancer) (NN cell) (NNS lines)) (NP (NP (NN MDA-MB-453)) (, ,) (NP (ADJP (JJ T47-D))) (, ,) (NP (NN MDA-MB-468)) (, ,) (NP (NN MCF-7)) (, ,))) (VP (VBD were) (VP (VBN cultured) (PP (IN in) (NP (NP (NP (NP (NN DMEM)) (, ,) (NP (NN pH) (CD 7.4))) (PRN (-LRB- -LRB-) (NP (NNP Invitrogen) (, ,) (NNP Carlsbad)) (, ,) (NP (NN CA)) (-RRB- -RRB-))) (VP (VBN supplemented) (PP (IN with) (NP (NP (NP (ADJP (CD 100) (NN U/ml)) (NN penicillin)) (, ,) (NP (ADJP (CD 100) (NN μg/ml)) (NN streptomycin)) (, ,) (NP (ADJP (CD 160) (NN μg/ml)) (NN L-glutamine)) (CC and) (NP (ADJP (CD 10) (NN %)) (NP (NP (JJ heat-inactivated) (JJ fetal) (JJ bovine) (NN serum)) (PRN (-LRB- -LRB-) (NP (NNP JRH) (NNP Biosciences) (, ,) (NNP Lenexa)) (, ,) (NP (NN KS)) (-RRB- -RRB-))))) (PP (IN in) (NP (NP (CD 75) (NN cm2) (JJ vented) (NN tissue) (NN culture) (NNS flasks)) (PP (IN at) (NP (NP (NN 37°C)) (PP (IN in) (NP (DT a) (ADJP (CD 5) (NN %)) (NN CO2) (NN environment))))))))))))))) (. .)))
( (S (S (NP (NN Log) (NN phase) (NNS cells)) (VP (VBD were) (VP (VP (VBN collected) (PP (IN at) (NP (ADJP (QP (JJR less) (IN than) (CD 90)) (NN %)) (NN confluency))) (PP (IN by) (NP (NP (NP (NN trypsin)) (NN digestion)) (CC and) (NP (NN centrifugation)))) (PP (IN for) (NP (CD 5) (NN min))) (PP (IN at) (NP (CD 1000) (NN rpm)))) (, ,) (VP (VBN resuspended) (PP (IN in) (NP (NP (NN phosphate) (JJ buffered) (NN saline)) (PRN (-LRB- -LRB-) (NP (NN PBS)) (-RRB- -RRB-))))) (CC and) (VP (VBN counted) (S (VP (VBG using) (NP (DT a) (NN haemocytometer)))))))) (. .)))
( (S (S (NP (DT The) (NN cell) (NNS lines)) (VP (VBD were) (VP (VBN purchased) (PP (IN from) (NP (NP (DT the) (NP (NNP American)) (NN Type) (NN Culture) (NN Collection)) (PRN (-LRB- -LRB-) (NP (NNP ATCC) (, ,) (NNP Rockville) (, ,) (NNP MD)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (DT A) (JJ dilute) (NN suspension)) (PP (IN of) (NP (DT a) (NN cell) (NN line)))) (VP (VBD was) (VP (VBN prepared) (PP (IN in) (NP (NP (NP (NN calcium)) (CC and) (NP (NN magnesium))) (JJ free) (NN Dulbecco) (POS 's) (NNS PBS)))))) (. .)))
( (S (S (NP (JJ Single) (NNS cells)) (VP (VBD were) (VP (VP (VBN visualised) (S (VP (VBG using) (NP (DT an) (VBN inverted) (NN phase) (NN microscope))))) (CC and) (VP (VBN selected) (PP (IN by) (S (VP (VBG using) (NP (NP (DT a) (NN micropipette)) (S (VP (TO to) (VP (VB draw) (PRT (RP up)) (NP (NP (DT the) (NN cell)) (PP (IN in) (NP (DT a) (CD 1) (NN μl) (NN volume))))))))))))))) (. .)))
( (S (S (NP (DT The) (NN cell)) (VP (VBD was) (VP (VBN deposited) (PP (IN into) (NP (NP (DT a) (ADJP (CD 0.5) (NN ml)) (NN microcentrifuge) (NN tube)) (VP (VBG containing) (NP (NP (CD 100) (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (PP (IN in) (NP (NP (CD 1) (NN μl)) (PP (IN of) (NP (NP (NP (NN calcium)) (CC and) (NP (NN magnesium))) (JJ free) (NN Dulbecco) (POS 's) (NNS PBS)))))))))))) (. .)))
( (S (S (NP (NP (NNS Aliquots)) (SBAR (WHNP (WDT that)) (S (VP (VBD contained) (NP (CD 100) (JJ mononuclear) (NNS cells)))))) (ADVP (RB only)) (VP (VBD were) (VP (VBN included) (PP (IN as) (NP (NP (NNS controls)) (PP (IN for) (NP (NP (DT the) (NN specificity)) (PP (IN of) (NP (DT the) (NN RT-PCR)))))))))) (. .)))
( (S (S (NP (DT The) (NN cell) (NN mixture)) (VP (VBD was) (VP (VBN lysed) (PP (IN in) (NP (NP (DT a) (ADJP (CD 15) (NN μl)) (NN volume)) (PP (IN of) (NP (NP (NN solution)) (VP (VBG containing) (NP (NP (NP (ADJP (CD 0.3) (NN %)) (NN v/v) (NN Nonidet) (NN P-40) (NN detergent)) (PRN (-LRB- -LRB-) (NP (NN Sigma)) (-RRB- -RRB-))) (, ,) (NP (NP (ADJP (CD 500) (NN ng)) (JJ random) (NNS hexamers)) (PRN (-LRB- -LRB-) (NP (NNP Pharmacia) (, ,) (NNP Uppsala) (, ,) (NNP Sweden)) (-RRB- -RRB-))) (, ,) (NP (NP (NP (CD 20) (NN U)) (PP (IN of) (NP (NN RNasin)))) (PRN (-LRB- -LRB-) (NP (NNP Promega) (, ,) (NNP Madison) (, ,) (NNP WI)) (-RRB- -RRB-))) (CC and) (NP (ADJP (CD 10) (NN mM)) (NN DTT))))))))))) (. .)))
( (S (PP (VBG Following) (NP (NP (NN 70°C) (NN denaturation)) (PP (IN for) (NP (CD 3) (NNS minutes))))) (, ,) (NP (JJ reverse) (NN transcription)) (VP (VBD was) (VP (VBN initiated) (PP (IN by) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NP (NP (JJ 5×) (JJ First) (NN Strand) (NN Buffer)) (, ,) (NP (NP (CD 200) (NN U)) (PP (IN of) (NP (NP (NP (NN Superscript) (CD II)) (PRN (-LRB- -LRB-) (NP (NNP Invitrogen)) (-RRB- -RRB-))) (, ,) (NP (NP (CD 0.5) (NN mM)) (PP (IN of) (NP (NP (DT each) (NN deoxynucleotide) (NN triphosphate)) (PRN (-LRB- -LRB-) (NP (NNP Roche) (, ,) (NNP Mannheim) (, ,) (NNP Germany)) (-RRB- -RRB-)))))))) (, ,)) (PP (IN with) (NP (NP (JJ Ultra-pure) (NN water)) (PRN (-LRB- -LRB-) (NP (NNP Fisher) (NNP Biotech) (, ,) (NNP Perth) (, ,) (NNP Australia)) (-RRB- -RRB-)))))) (PP (TO to) (NP (NP (DT a) (JJ final) (NN volume)) (PP (IN of) (NP (CD 30) (NN μl))))))))) (. .)))
( (S (S (S (NP (DT The) (NN reaction)) (VP (VBD was) (VP (VBN incubated) (PP (IN at) (NP (NN 42°C))) (PP (IN for) (NP (CD 50) (NNS minutes)))))) (, ,) (CC and) (S (NP (RB then) (DT the) (JJ reverse) (NN transcriptase)) (VP (VBD was) (VP (VBN inactivated) (PP (IN at) (NP (NN 70°C))) (PP (IN for) (NP (CD 10) (NNS minutes))))))) (. .)))
( (S (PP (IN After) (NP (JJ reverse) (NN transcription))) (, ,) (NP (NP (CD 4) (NN μl)) (PP (IN of) (NP (NN cDNA)))) (VP (VBD was) (VP (VBN used) (PP (IN as) (NP (NP (DT the) (NN template)) (PP (IN in) (NP (NP (DT a) (JJ single) (NN round)) (PP (IN of) (NP (NP (NN PCR) (NN amplification)) (PP (IN with) (NP (NP (NP (NP (CD 200) (NN nM)) (PP (IN of) (NP (DT each) (NN gene) (JJ specific) (NN primer) (NN pair)))) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 1)) (-RRB- -RRB-))) (, ,) (NP (NP (NP (CD 1) (NN U)) (PP (IN of) (NP (JJ Hot) (NN Star) (NN Taq)))) (PRN (-LRB- -LRB-) (NP (NP (NN Qiagen)) (, ,) (NP (NN Valencia)) (, ,) (NP (NN CA))) (-RRB- -RRB-))) (, ,) (NP (ADJP (CD 2.5) (NN mM)) (NN MgCl2)) (, ,) (CC and) (NP (NP (CD 200) (NN μM)) (PP (IN of) (NP (DT each) (NN deoxynucleotide) (NN triphosphate)))))))))))) (, ,) (PP (IN in) (NP (DT the) (VBN supplied) (NN PCR) (NN buffer))))) (. .)))
( (S (NP (NN Cycling) (NNS conditions)) (VP (VBD included) (NP (DT an) (JJ initial) (NN denaturation) (NN step)) (PP (IN at) (NP (NP (NN 95°C)) (PP (IN for) (NP (CD 15) (NNS minutes))))) (, ,) (ADVP (RB then)) (NP (NP (NP (CD 1) (NN minute)) (PP (IN at) (NP (NP (DT each)) (PP (IN of) (NP (NP (NN 94°C)) (, ,) (NP (NN 66–68°C)) (CC and) (NP (NN 72°C)))))) (PP (IN for) (NP (CD 45–55) (NNS cycles)))) (CC and) (NP (NP (DT a) (JJ final) (NN extension)) (PP (IN of) (NP (CD 7) (NNS minutes))) (PP (IN at) (NP (NN 72°C)))))) (. .)))
( (S (S (NP (NN Amplification) (NNS products)) (VP (VBD were) (VP (VBN visualised) (PP (IN by) (NP (NP (NN ethidium) (NN bromide)) (NN staining))) (PP (VBG following) (NP (NN separation))) (PP (IN by) (NP (NN electrophoresis))) (PP (IN through) (NP (NN agarose) (NNS gels)))))) (. .)))
( (S (PP (IN In) (NP (DT each) (NN case))) (NP (NP (DT an) (NN RT) (JJ negative) (NN control)) (, ,) (VP (VBN made) (PRT (RP up)) (PP (IN of) (NP (NP (DT the) (NNS components)) (PP (IN of) (NP (NP (DT the) (NN RT) (NN reaction) (NN mixture)) (PP (IN with) (CC or) (PP (IN without) (NP (NN lysis) (NN mix))) (, ,) (CC and) (PP (IN without) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NN RNA))))))))))) (, ,)) (VP (VBD was) (VP (VBN used) (PP (IN as) (NP (DT the) (NN template))) (PP (IN in) (NP (DT the) (NN PCR) (NN reaction))) (PRN (-LRB- -LRB-) (S (S (NP (DT no) (NN cDNA)) (VP (VBN made))) (CC and) (S (ADVP (RB therefore)) (NP (DT no) (NN amplification)) (VP (VBN expected)))) (-RRB- -RRB-)))) (. .)))
( (S (S (NP (DT The) (NN PCR) (JJ negative) (NN control)) (VP (VP (VBZ contains) (NP (NP (DT the) (NNS reagents)) (PP (IN of) (NP (DT the) (NN PCR) (NN reaction))))) (CC but) (VP (VBZ lacks) (NP (NN template))))) (. .)))
( (S (S (NP (NN Cell) (NN line) (NN cDNA)) (VP (VBD was) (VP (VBN included) (PP (IN as) (NP (NP (DT a) (JJ positive) (NN control)) (PP (IN for) (NP (DT the) (NN PCR) (NN reaction)))))))) (. .)))
( (S (S (NP (NP (JJ Genomic) (NN DNA)) (PRN (-LRB- -LRB-) (NP (CD 100) (NN ng)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB confirm) (SBAR (IN that) (S (NP (NP (DT a) (NN product)) (PP (IN of) (NP (JJ equal) (NN size))) (PP (TO to) (NP (DT the) (NN cDNA) (NN product)))) (VP (MD would) (RB not) (VP (VB be) (VP (VBN amplified) (PP (IN from) (NP (DT the) (NN DNA))) (PP (IN in) (NP (DT the) (NN cell) (NN lysate)))))))))))))) (. .)))
( (S (NP (NNS Results))))
( (S (S (NP (NP (DT The) (NN expression)) (PP (IN of) (NP (NP (DT each)) (PP (IN of) (NP (DT the) (NN RT-PCR) (NNS markers)))))) (VP (VBD was) (VP (VBN assessed) (PP (IN for) (NP (NP (PRP$ its) (NN suitability)) (PP (IN as) (NP (DT a) (NN breast) (NN cancer) (NN marker)))))))) (. .)))
( (S (S (NP (NN RNA)) (VP (VBD was) (VP (VBN extracted) (PP (IN from) (NP (CD seven) (NN breast) (NN cancer) (NN cell) (NNS lines))) (, ,) (S (NP (NN reverse)) (VP (VBN transcribed) (PP (IN into) (NP (NN cDNA)))))) (ADVP (RB then)) (VP (VBN amplified) (S (VP (VBG using) (NP (NP (NNS primers)) (ADJP (JJ specific) (PP (IN for) (NP (NP (DT the) (JJ different) (NNS markers)) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 1)) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (NP (NP (NNS Transcripts)) (VP (VBG corresponding) (PP (TO to) (NP (NN EpCAM))))) (VP (VBD were) (VP (VBN amplified) (PP (IN from) (NP (NP (DT all)) (PP (IN of) (NP (NP (DT the) (NN cell) (NNS lines)) (VP (VBN tested)))))) (PRN (-LRB- -LRB-) (NP (NP (NNP Fig.) (LS 1.)) (, ,) (NP (NN panel) (CD 1))) (-RRB- -RRB-))))) (. .)))
( (S (NP (DT This)) (VP (VP (VBZ validates) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (NNS antibodies)) (SBAR (WHNP (WDT that)) (S (VP (VBP recognise) (NP (NP (NNS epitopes)) (PP (IN of) (NP (DT this) (NN protein)))))))))) (PP (IN as) (NP (NP (DT the) (JJ immunobead) (VB label)) (PRN (PP (IN for) (NP (NP (JJ magnetic) (NN isolation)) (PP (IN of) (NP (DT the) (NN breast) (NN carcinoma) (NNS cells))))) (NP (CD -LSB-6)) (-RRB- -RSB-))))) (CC and) (VP (VBZ confirms) (NP (NP (JJR earlier) (NNS results)) (SBAR (WHNP (WDT which)) (S (VP (VBD showed) (NP (JJ uniform) (JJ bright) (NN fluorescence)) (PP (IN in) (NP (NP (NP (NN breast) (NN cancer) (NN cell) (NNS lines)) (CC and) (NP (NNS biopsies))) (VP (VBN stained) (PP (IN with) (NP (NP (NP (CD one)) (PP (IN of) (NP (DT these) (NNS antibodies)))) (, ,) (NP (NN Ber-Ep4) (CD -LSB-7) (-RRB- -RSB-))))))))))))) (. .)))
( (S (S (NP (NP (NN ELF3)) (, ,) (NP (NN EphB4)) (CC and) (NP (NN MUC1))) (VP (VBD were) (VP (VBN amplified) (PP (IN in) (NP (DT all) (NN cell) (NNS lines))) (PP (IN at) (NP (ADJP (RB consistently) (JJ high)) (NNS levels))) (PRN (-LRB- -LRB-) (NP (NP (NNP Fig.) (CD 1)) (, ,) (NP (NNS panels) (QP (CD 2) (, ,) (CD 3) (CC and) (CD 4)))) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (NN EGFR) (NN expression)) (VP (VBD was) (ADVP (RB also)) (ADJP (RB easily) (JJ detectable)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 1)) (, ,) (NP (NN panel) (CD 5)) (-RRB- -RRB-)) (SBAR (RB even) (IN though) (S (NP (JJ several) (NNS reports)) (VP (VBP have) (VP (VBN suggested) (S (NP (PRP it)) (VP (VP (VBZ is) (VP (VBN expressed) (PP (IN at) (NP (JJ low) (NNS levels))) (PP (IN in) (NP (NP (NN MCF-7)) (CC and) (NP (ADJP (JJ T47-D))))))) (CC and) (VP (VBZ is) (RB not) (VP (VBN expressed) (PP (IN in) (NP (NN MDA-MB-453) (CD -LSB-13,14) (-RRB- -RSB-))))))))))))) (. .)))
( (S (S (S (NP (NN MGB1) (NNS transcripts)) (VP (VBD were) (VP (VBN amplified) (PP (IN from) (NP (NP (DT all) (NN cell) (NNS lines)) (PP (IN except) (IN for) (NP (NN MCF-7))))) (PRN (-LRB- -LRB-) (NP (NP (NNP Fig.) (CD 1)) (, ,) (NP (NN panel) (CD 2))) (-RRB- -RRB-))))) (CC and) (S (NP (NN CEA)) (VP (VBD was) (VP (VBN amplified) (PP (IN from) (NP (DT all) (NN cell) (NNS lines))) (PP (IN except) (NP (NN PMC42))) (PRN (-LRB- -LRB-) (NP (NP (NNP Fig.)) (NP (CD 1) (NN panel) (CD 6))) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NP (NP (NNS Tubes)) (SBAR (WHNP (WDT that)) (S (VP (VBD contained) (NP (CD 100) (NN PBMNCs)))))) (CC and) (NP (CD one) (NN tumor) (NN cell))) (VP (VBD were) (VP (VBN used) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN sensitivity)) (PP (IN of) (NP (DT each) (NN RT-PCR) (NN marker)))))))))) (. .)))
( (S (S (S (NP (NP (JJS Most)) (PP (IN of) (NP (DT the) (NN sensitivity) (NNS tests)))) (VP (VBD were) (VP (VBN performed) (S (VP (VBG using) (NP (NN MDA-MB-453) (NNS cells))))))) (CC but) (S (NP (CD four) (JJ different) (NN breast) (NN cancer) (NN cell) (NNS lines)) (VP (VBP have) (VP (VBN been) (VP (VBN included) (PP (IN in) (NP (NP (DT this) (NN part)) (PP (IN of) (NP (DT the) (NN study))))) (, ,) (S (NP (NP (NP (CD two)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (ADJP (NN ER) (JJ negative)) (PRN (-LRB- -LRB-) (NP (NP (NN MDA-MB-453)) (, ,) (CC and) (NP (NN MDA-MB-468))) (-RRB- -RRB-))))))) (CC and) (NP (NP (CD two)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (ADJP (NN ER) (JJ positive)) (PRN (-LRB- -LRB-) (NP (NP (NN MCF-7)) (CC and) (NP (JJ T47-D))) (-RRB- -RRB-)))))))))))))) (. .)))
( (S (S (VP (VBG Analysing) (NP (NP (DT the) (NNS samples)) (SBAR (WHPP (TO to) (WHNP (WDT which))) (S (NP (DT a) (JJ single) (NN breast) (NN cancer) (NN cell)) (VP (VBD had) (VP (VBN been) (VP (VBN added) (PP (TO to) (NP (CD 100) (NN PBMNC))))))))))) (VP (VBD showed) (SBAR (IN that) (S (NP (PRP we)) (VP (MD can) (VP (VB detect) (NP (DT the) (NN tumor) (NN cell)) (ADVP (RBS most) (RB often)) (PP (IN with) (NP (NP (NP (NN ELF3)) (PRN (-LRB- -LRB-) (NP (NN 40/43) (NN –) (CD 93) (NN %)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (NN EpCAM)) (PRN (-LRB- -LRB-) (NP (CD 36/40) (NN –) (CD 89) (NN %)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNS Figures) (NP (CD 2) (CC and) (CD 3))) (, ,) (NP (NNS tables) (CD 2) (CC and) (CD 3)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NN EphB4) (JJ specific) (NN amplification)) (VP (VBD detected) (NP (NP (CD 31/40)) (PRN (-LRB- -LRB-) (NP (CD 77.5) (NN %)) (-RRB- -RRB-))))) (. ,)))
( (S (S (NP (NN MUC1)) (NP (NP (NP (CD 10/20)) (PRN (-LRB- -LRB-) (NP (CD 67) (NN %)) (-RRB- -RRB-))) (, ,) (NP (NP (NN CEA) (NN 9/20)) (PRN (-LRB- -LRB-) (NP (CD 45) (NN %)) (-RRB- -RRB-))) (, ,) (NP (NP (NN EGFR) (NN 19/43)) (PRN (-LRB- -LRB-) (NP (CD 44) (NN %)) (-RRB- -RRB-))) (CC and) (NP (NP (NN MGB1) (NN 9/35)) (PRN (-LRB- -LRB-) (NP (CD 26) (NN %)) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (NP (NNS Tubes)) (SBAR (WHNP (WDT that)) (S (VP (VBD contained) (NP (CD 100) (NN PBMNCs)) (ADVP (RB only)))))) (VP (VBD were) (VP (VBN included) (S (VP (TO to) (VP (VB determine) (NP (NP (NN specificity)) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 2)) (-RRB- -RRB-))))))))) (. .)))
( (S (PP (IN After) (S (VP (VBG combining) (NP (NP (DT the) (NNS data)) (VP (VBN obtained) (PP (IN from) (NP (NP (NP (JJ several) (JJ different) (NNS experiments)) (CC and) (NP (JJ several) (JJ different) (JJ normal) (NNS individuals))) (PP (IN in) (NP (NP (NNS reactions)) (VP (VBG using) (NP (NP (DT the) (JJ appropriate) (NN number)) (PP (IN of) (NP (NN amplification) (NNS cycles)))))))))))))) (, ,) (NP (PRP we)) (VP (VBD found) (NP (NP (DT no) (NN expression)) (PP (IN of) (NP (NP (NP (NN EGFR) (-LRB- -LRB-) (CD 0/27) (-RRB- -RRB-)) (, ,) (NP (NP (NN MGB1) (-LRB- -LRB-) (CD 0/24) (-RRB- -RRB-)) (, ,) (NP (NN EphB4) (-LRB- -LRB-) (CD 0/21) (-RRB- -RRB-)) (, ,) (NP (NN EpCAM) (-LRB- -LRB-) (CD 0/21) (-RRB- -RRB-)) (CC or) (NP (NN CEA) (-LRB- -LRB-) (CD 0/18) (-RRB- -RRB-))) (, ,)) (PRN (-LRB- -LRB-) (NP (NP (NNS Figures) (QP (CD 2) (CC and) (CD 3))) (, ,) (NP (NN Table) (CD 2))) (-RRB- -RRB-)))))) (. .)))
( (S (S (ADVP (RB Only)) (NP (NP (NN ELF3)) (CC and) (NP (NN MUC1))) (VP (VBD gave) (NP (JJ positive) (NNS bands)))) (. .)))
( (S (S (NP (DT These) (NNS results)) (VP (VBD were) (PP (IN for) (NP (NP (CD 45) (NNS cycles)) (PP (IN of) (NP (NN amplification))))) (PP (IN except) (PP (IN for) (NP (NP (NN CEA)) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (NP (NN run)) (PP (IN for) (NP (CD 55) (NNS cycles))))))))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB also)) (VP (VBD examined) (NP (NP (NP (NN ELF3)) (, ,) (NP (NN EphB4)) (CC and) (NP (NN MUC1))) (PP (IN at) (NP (CD 55) (NNS cycles))) (PP (IN in) (NP (NP (DT a) (JJ small) (NN number)) (PP (IN of) (NP (NNS experiments)))))))) (. .)))
( (S (NP (PRP We)) (VP (VBD amplified) (NP (NP (NNS transcripts)) (SBAR (WHNP (WDT that)) (S (VP (VBD corresponded) (PP (TO to) (NP (NP (NP (NN ELF3)) (PRN (-LRB- -LRB-) (NP (NN 1/6)) (-RRB- -RRB-))) (, ,) (NP (NP (NN EphB4)) (PRN (-LRB- -LRB-) (NP (NN 3/12)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (NN MUC1)) (PRN (-LRB- -LRB-) (NP (NN 3/12)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (DT some)) (PP (IN of) (NP (DT the) (NN PBMNC) (NN control) (NNS tubes))))))))))))) (. .)))
( (S (S (NP (DT The) (NP (NP (NN ELF3)) (CC and) (NP (NN EphB4))) (NNS bands)) (VP (VP (VBD were) (ADJP (JJ visible)) (PP (VBG following) (NP (NP (NN ethidium) (NN bromide)) (NN staining)))) (CC but) (VP (VBD were) (ADJP (RBR less) (JJ intense)) (PP (PP (IN than) (NP (NP (DT the) (NN band)) (VP (VBN amplified) (PP (IN after) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (DT a) (JJ single) (NN tumor) (NN cell)))))))) (CC and) (PP (IN in) (NP (NP (DT no) (NNS cases)) (VP (VBD were) (NP (NP (DT all) (CD three)) (PP (IN of) (NP (NP (DT the) (NN PBMNC) (NNS controls)) (ADJP (JJ positive) (PP (IN in) (NP (DT the) (JJ same) (NN experiment)))))))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VB assume) (SBAR (IN that) (S (NP (DT the) (NN ELF3) (NN band)) (VP (VBZ is) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NP (NN amplification)) (PP (IN of) (NP (JJ illegitimate) (NNS transcripts))))))))))) (. .)))
( (S (S (NP (DT This) (NN band)) (VP (VBD was) (VP (VBN eliminated) (SBAR (WHADVP (WRB when)) (S (S (NP (NP (QP (RB only) (CD 35)) (NNS cycles)) (PP (IN of) (NP (NP (NN amplification)) (PRN (-LRB- -LRB-) (NP (NN 0/15)) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN performed)))) (CC but) (S (SBAR (IN because) (S (NP (NP (RB only) (DT a) (JJ small) (NN amount)) (PP (IN of) (NP (NN product)))) (VP (VBD was) (VP (VBN amplified) (PP (IN after) (NP (QP (CD 45) (CC or) (CD 55)) (NNS cycles))) (PP (IN in) (NP (DT these) (NNS controls))))))) (NP (PRP we)) (VP (MD could) (VP (VB distinguish) (NP (NP (NNS samples)) (SBAR (WHNP (WDT that)) (S (VP (VBD contained) (NP (NP (NN tumor) (NNS cells)) (CC and) (NP (NP (DT those)) (SBAR (WHNP (WDT that)) (S (VP (VBD did) (ADVP (RB not)) (PP (IN through) (NP (NP (NN comparison)) (PP (IN of) (NP (NP (DT the) (NN intensity)) (PP (IN of) (NP (NNS bands)))))))))))))))))))))))) (. .)))
( (S (S (S (VP (VBG Analysing) (NP (NP (DT the) (NNS samples)) (SBAR (WHPP (TO to) (WHNP (WDT which))) (S (NP (DT a) (JJ single) (NN breast) (NN cancer) (NN cell)) (VP (VBD had) (VP (VBN been) (VP (VBN added) (PP (TO to) (NP (CD 100) (NN PBMNC))))))))))) (VP (VBD showed) (SBAR (IN that) (S (NP (PRP we)) (VP (MD could) (ADVP (RB still)) (VP (VB detect) (NP (DT the) (NN tumor) (NN cell)) (ADVP (RBS most) (RB often)) (PP (IN with) (NP (NP (NN ELF3)) (PRN (-LRB- -LRB-) (NP (CD 15/16) (NN –) (CD 94) (NN %)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NP (NNS Tests)) (VP (VBG using) (NP (JJ single) (NN tumour) (NNS cells)) (PP (IN in) (NP (DT a) (CD 100) (NN PBMNC) (NN background))))) (VP (VBD detected) (NP (NP (NP (CD 15/16)) (PRN (-LRB- -LRB-) (NP (CD 94) (NN %)) (-RRB- -RRB-))) (PP (IN of) (NP (NN tumour) (NNS cells)))) (PP (IN after) (NP (CD 35) (NNS cycles))))) (. .)))
( (S (S (PP (IN Unlike) (NP (NN ELF3))) (, ,) (NP (DT the) (NN MUC1) (NN PBMNC) (NN band)) (VP (VBD was) (PP (IN of) (NP (NP (JJ comparable) (NN intensity)) (PP (TO to) (NP (NP (DT those)) (VP (VBN achieved) (PP (IN after) (NP (NN tumor) (NN cell) (NN addition)))))))) (S (VP (VBG making) (S (NP (PRP it)) (ADJP (JJ impossible) (S (VP (TO to) (VP (VB distinguish) (NP (NP (NNS samples)) (SBAR (WHNP (WDT that)) (S (VP (VBP contain) (NP (NN tumor) (NNS cells)))))) (PP (IN from) (NP (NP (DT those)) (SBAR (WHNP (WDT that)) (S (VP (VBP do) (RB n't) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 2)) (-RRB- -RRB-)))))))))))))))) (. .)))
( (S (NP (NN Discussion))))
( (S (S (NP (NP (DT The) (NN development)) (PP (IN of) (NP (NP (VBN optimized) (NNS methods)) (PP (IN for) (S (VP (VBG detecting) (NP (NN tumor) (NNS cells)) (PP (IN in) (NP (NP (DT the) (NP (JJ peripheral) (NN blood)) (CC and) (NP (NN bone) (NN marrow))) (PP (IN of) (NP (NN cancer) (NNS patients))))))))))) (VP (MD may) (VP (VB enhance) (NP (PRP$ our) (NN ability) (S (VP (TO to) (VP (VB identify) (NP (DT those) (NNS patients)) (PP (IN in) (NP (NP (NN need)) (PP (IN of) (NP (JJ further) (NN therapy)))))))))))) (. .)))
( (S (S (NP (NP (JJ Nested) (NN RT-PCR)) (PP (IN of) (NP (NNS PBMNCs)))) (VP (VBZ has) (VP (VBN been) (NP (NP (DT the) (ADJP (RBS most) (JJ common)) (NN method)) (S (VP (TO to) (VP (VB detect) (NP (JJ epithelial) (NN –) (JJ specific) (NNS markers))))))))) (. .)))
( (S (PP (IN Due) (PP (TO to) (NP (NP (DT the) (JJ high) (NN level)) (PP (IN of) (NP (NP (NN sensitivity)) (PP (IN of) (NP (JJ nested) (NN RT-PCR)))))))) (, ,) (NP (NP (ADJP (RB even) (JJ low)) (NNS levels)) (PP (IN of) (NP (NP (JJ illegitimate) (NN transcription)) (PP (IN in) (NP (NNS PBMNCs)))))) (VP (MD can) (VP (VB cause) (NP (JJ false-positive) (NNS results) (CD -LSB-2-5) (-RRB- -RSB-)))) (. .)))
( (S (S (S (NP (JJ Nested) (NN RT-PCR)) (VP (VBZ is) (ADVP (RB also)) (ADJP (RBR more) (NN time) (JJ consuming)))) (CC and) (S (NP (JJ stringent) (NNS procedures)) (VP (VBP need) (S (VP (TO to) (VP (VB be) (VP (VBN observed) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB minimise) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ false) (NNS positives)))) (PP (JJ due) (TO to) (NP (NN PCR) (NN product) (NN cross) (NN contamination)))))))))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB thus)) (NP (NN desirable) (SBAR (IN that) (S (NP (DT the) (NN RT-PCR)) (VP (VBZ is) (VP (VBN performed) (PP (IN in) (NP (NP (DT a) (JJ single) (NN round)) (S (VP (TO to) (VP (VB avoid) (NP (JJ potential) (NN contamination) (NNS problems)))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (JJ immunobead) (NN enrichment))) (ADVP (ADVP (RB prior)) (PP (TO to) (NP (JJ reverse) (NN transcription))))) (VP (VBZ has) (VP (VBN allowed) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (DT a) (JJ single) (NN round)) (PP (IN of) (NP (NN PCR) (NN amplification))))) (S (VP (TO to) (VP (VB screen) (NP (DT a) (JJ whole) (NN blood) (NN sample))))))))) (. .)))
( (S (S (S (NP (PRP$ Our) (JJ original) (NN methodology)) (VP (VBD used) (NP (NP (NP (NN blotting)) (CC and) (NP (NN detection))) (PP (IN with) (NP (DT an) (NN oligonucleotide)))) (S (VP (TO to) (VP (VB increase) (NP (NN sensitivity) (CD -LSB-7) (-RRB- -RSB-))))))) (CC but) (S (NP (DT this)) (VP (VBZ is) (ADVP (RB no) (RBR longer)) (ADJP (JJ necessary) (PP (IN with) (NP (NP (DT the) (ADJP (RBR more) (JJ efficient)) (NN RT-PCR) (NNS assays)) (VP (VBN presented) (ADVP (RB here)))))) (, ,) (PP (IN in) (NP (NP (JJ particular)) (PP (IN because) (PP (IN of) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (DT a) (JJ hot) (NN start) (NN Taq) (NN polymerase))))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB improve) (NP (NN RT-PCR) (NN detection)) (ADVP (RB further))))) (, ,) (S (NP (NP (DT the) (NN identification)) (PP (IN of) (NP (NP (JJ epithelial) (CC or) (NN carcinoma) (NN cell) (JJ specific) (NNS markers)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN expressed) (PP (IN at) (NP (DT a) (JJ sufficient) (NN level) (S (VP (TO to) (VP (VB enable) (NP (NP (NN detection)) (PP (IN of) (NP (DT a) (JJ single) (NN cell)))) (PP (IN after) (NP (NP (QP (RB only) (CD one)) (NN round)) (PP (IN of) (NP (JJ non-nested) (NN PCR))))))))))))))))) (VP (VBP are) (VP (VBN needed))))) (. .)))
( (S (S (PP (IN For) (NP (DT this) (NN reason))) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN used) (NP (NP (JJ single) (NN tumor) (NNS cells)) (PP (IN in) (NP (NP (DT a) (NN background)) (PP (IN of) (NP (CD 100) (NNS PBMNCs)))))) (S (VP (TO to) (VP (VB screen) (NP (CD seven) (JJ different) (NN RT-PCR) (NNS assays))) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB identify) (NP (NP (DT the) (JJS best) (NNS ones)) (PP (IN for) (NP (NP (NN inclusion)) (PP (IN in) (NP (NP (DT a) (NN panel)) (PP (IN for) (NP (NP (DT the) (JJ immunobead) (NN RT-PCR) (NN based) (NN detection)) (PP (IN of) (NP (VBG circulating) (NN tumor) (NNS cells))))))))))))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD used) (NP (NN breast) (NN cancer) (NN cell) (NNS lines)) (PP (IN as) (NP (NP (DT the) (NN source)) (PP (IN of) (NP (NN tumor) (NNS cells))))))) (. .)))
( (S (S (SBAR (IN Whereas) (S (NP (NN breast) (NN cancer) (NN cell) (NNS lines)) (VP (MD may) (VP (VB have) (NP (NP (JJ different) (NNS levels)) (PP (IN of) (NP (NP (NN expression)) (PP (IN of) (NP (NNS markers)))))) (PP (VBN compared) (PP (TO to) (NP (JJ disseminated) (NN breast) (NN cancer) (NNS cells)))))))) (, ,) (NP (NP (NNS cells)) (PP (PP (IN from) (NP (JJ different) (NNS individuals))) (, ,) (CC and) (RB even) (PP (IN within) (NP (DT an) (NN individual))) (, ,))) (VP (VBP are) (ADJP (JJ likely) (S (VP (TO to) (VP (VB display) (NP (JJ considerable) (NN heterogeneity)))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD sought) (S (VP (TO to) (VP (VB overcome) (NP (DT this) (NN difficulty)) (PP (IN by) (S (VP (VBG using) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NN cell) (NNS lines)))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NN cell) (NNS lines)))) (VP (VBZ has) (NP (NP (DT the) (JJ great) (NN advantage)) (PP (IN of) (S (VP (VBG providing) (NP (JJ reproducible) (NNS controls)) (S (VP (TO to) (VP (VB test) (NP (NP (DT the) (NN sensitivity)) (PP (IN of) (NP (DT the) (NN RT-PCR) (NNS assays))) (PP (IN during) (NP (NP (NNS studies)) (PP (IN of) (NP (NN patient) (NN material))))))))))))))) (. .)))
( (S (S (NP (DT The) (JJ immunobead) (NN enrichment) (NN step)) (VP (VBZ relies) (PP (IN on) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NP (NP (DT an) (JJ epithelial) (NN cell) (NN adhesion) (NN molecule)) (PRN (-LRB- -LRB-) (NP (NN EpCAM)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NP (JJ current) (NN gene) (NN symbol)) (, ,) (NP (NN TACTSD1)) (, ,) (NP (JJ tumor-associated) (NN calcium) (NN signal) (NN transducer) (CD 1))) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN recognized) (PP (IN by) (NP (NP (DT an) (NN antibody)) (PP (IN on) (NP (NNS immunobeads))))))))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD considered) (NP (DT this)) (S (VP (TO to) (VP (VB be) (NP (DT an) (JJ appropriate) (JJ positive) (NN control)) (, ,) (SBAR (IN as) (S (NP (NP (DT any) (NN cell)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN detected) (S (VP (VBG using) (NP (DT the) (NNS immunobeads))))))))) (VP (MD should) (VP (VB express) (NP (DT the) (NN EpCAM) (NN gene))))))))))) (. .)))
( (S (S (S (NP (NP (DT All)) (PP (IN of) (NP (DT the) (NN breast) (NN cancer) (NN cell) (NNS lines)))) (VP (VBD expressed) (NP (DT the) (NN EpCAM) (NN gene)))) (CC and) (S (NP (DT no) (NN message)) (VP (VBD was) (VP (VBN detected) (PP (IN in) (NP (NP (DT any)) (PP (IN of) (NP (NP (CD 24) (NNS aliquots)) (SBAR (WHNP (WDT that)) (S (VP (VBD contained) (NP (CD 100) (NN PBMNC))))))))))))) (. .)))
( (S (S (NP (NP (NNS Tests)) (PP (IN of) (NP (NP (DT the) (NP (NP (JJ single) (NN tumor) (NN cell)) (CC and) (NP (CD 100) (NN PBMNC))) (NNS aliquots)) (PP (IN with) (NP (NN EpCAM)))))) (VP (VBD showed) (SBAR (IN that) (S (NP (PRP it)) (VP (VBD was) (ADVP (RB also)) (VP (VBN expressed) (PP (TO to) (NP (DT a) (JJ sufficient) (NN level) (S (VP (TO to) (VP (VB enable) (NP (NP (NN detection)) (PP (IN of) (NP (DT the) (NN tumor) (NN cell))) (PP (IN in) (NP (CD 31/35) (PRN (-LRB- -LRB-) (NP (CD 89) (NN %)) (-RRB- -RRB-)) (NNS cases)))) (PP (IN after) (NP (NP (CD 45) (NNS cycles)) (PP (IN of) (NP (NN PCR) (NN amplification)))))))))))))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB therefore)) (VP (VB consider) (NP (NN EpCAM)) (PP (NP (NP (DT a) (JJ useful) (NN addition)) (PP (TO to) (NP (DT a) (NN marker) (NN panel)))) (IN for) (NP (NP (DT the) (NN detection)) (PP (IN of) (NP (NN breast) (NN tumor) (NNS cells))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ possible)) (SBAR (IN that) (S (NP (NP (DT the) (NN sensitivity)) (PP (IN with) (NP (DT this) (NN marker)))) (VP (MD can) (VP (VB be) (VP (VBN improved) (SBAR (IN if) (S (NP (JJR more) (NN PCR) (NNS cycles)) (VP (VBP are) (VP (VBN performed)))))))))))) (. .)))
( (S (S (NP (NN Mucin) (CD 1) (-LRB- -LRB-) (NN MUC1) (-RRB- -RRB-)) (VP (VBZ is) (NP (NP (DT another) (JJ epithelial) (NN glycoprotein)) (VP (VBN expressed) (PP (IN in) (NP (NN breast) (JJ epithelial) (NNS cells))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB commonly) (VBN used) (PP (IN if) (NP (JJ controversial)))) (NN marker)) (PP (IN for) (NP (NP (NN detection)) (PP (IN of) (S (VP (VBG circulating) (NP (NN tumor) (NNS cells) (CD -LSB-5) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (ADVP (RB Recently)) (, ,) (NP (PRP it)) (VP (VBD was) (VP (VBN reported) (SBAR (WHPP (IN that) (WHNP (WDT that))) (S (NP (NP (JJ immunomagnetic) (NN separation)) (VP (VBN followed) (PP (IN by) (NP (JJ MUC1-specific) (JJ real) (NN time) (NN RT-PCR))))) (VP (VBD allowed) (NP (NP (DT the) (JJ semi-quantitative) (NN detection)) (PP (IN of) (NP (VBG circulating) (JJ mammary) (NNS cells)))) (SBAR (IN if) (S (NP (NP (NN amplification)) (PP (IN above) (NP (NP (DT a) (NN cycle) (NN threshold) (NN value)) (PP (IN of) (NP (CD 38)))))) (VP (VBD was) (VP (VBN obtained) (NP (CD -LSB-15) (-RRB- -RSB-)))))))))))) (. .)))
( (S (S (S (VP (VBG Using) (NP (PRP$ our) (NN assay)))) (, ,) (NP (NN MUC1) (NNS transcripts)) (VP (VBD were) (VP (VBN detected) (PP (IN in) (NP (NP (NN 1/6) (CD 100) (NN PBMNC) (JJ only) (NNS samples)) (CC and) (NP (NN 10/15) (NN tumor) (NN cell) (NNS samples))))))) (. .)))
( (S (SBAR (IN Although) (S (NP (PRP we)) (VP (VBD did) (RB not) (VP (VB use) (NP (JJ real-time) (NN PCR)) (PP (IN for) (NP (PRP$ our) (NN assay))))))) (, ,) (S (S (NP (NP (DT the) (NN intensity)) (PP (IN of) (NP (NP (DT the) (JJ positive) (NNS bands)) (PP (IN in) (NP (DT the) (NN PBMNC) (JJ only) (NNS samples)))))) (VP (VBD was) (ADJP (JJ comparable) (PP (TO to) (NP (NP (DT that)) (VP (VBN obtained) (PP (IN with) (NP (DT the) (NN tumor) (NN cell) (NNS samples))))))))) (CC and) (S (NP (PRP it)) (VP (VBD was) (VP (VBN concluded) (SBAR (IN that) (S (NP (NP (NN detection)) (PP (IN of) (NP (NN MUC1) (NNS transcripts)))) (VP (MD would) (VP (VB result) (PP (IN in) (NP (ADJP (RB too) (JJ many)) (ADJP (ADJP (JJ false)) (ADJP (JJ positive))) (NNS results))) (S (VP (TO to) (VP (VBP warrant) (NP (NP (PRP$ its) (NN inclusion)) (PP (IN in) (NP (PRP$ our) (NN panel))))))))))))))) (. .)))
( (S (S (ADVP (RB Interestingly)) (, ,) (PP (IN during) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (DT this) (NN study))))) (NP (PRP it)) (VP (VBD was) (VP (VBN reported) (PP (IN that) (S (NP (NP (DT a) (NN majority)) (PP (IN of) (NP (NP (NP (NP (NN CK)) (-LRB- -LRB-) (CC +) (-RRB- -RRB-) (NP (NN /MUC1)) (-LRB- -LRB-) (CC +) (-RRB- -RRB-)) (NN tumor) (NNS cells)) (VP (VBG circulating) (PP (IN in) (NP (NP (DT the) (NN blood)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ advanced) (NN breast) (NN cancer))))))))))) (ADVP (RB also)) (VP (VBD displayed) (NP (NP (JJ apoptotic) (NNS features)) (PP (JJ such) (IN as) (NP (NP (DT an) (`` ``) (NN inclusion) (NN type) (NN '')) (NP (NN cytokeratin) (NN staining) (NN pattern)) (CC and) (NP (JJ nuclear) (NN condensation))))) (PP (IN with) (NP (NP (JJ apoptosis-related) (NN DNA) (NN strand) (NNS breaks)) (CD -LSB-16) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBD was) (VP (VBN concluded) (SBAR (IN that) (S (NP (NP (DT the) (JJ predictive) (NN value)) (PP (IN of) (NP (JJ such) (NP (NP (NN CK)) (-LRB- -LRB-) (CC +) (-RRB- -RRB-) (NP (NN /MUC1)) (-LRB- -LRB-) (CC +) (-RRB- -RRB-)) (JJ positive) (NNS cells)))) (VP (MD should) (VP (VB be) (VP (VBN considered) (ADVP (RB separately)))) (SBAR (WHADVP (WRB when)) (S (VP (VBG analysing) (NP (NN tumor) (NN cell) (NN dissemination))))) (, ,) (S (ADVP (RB further)) (VP (VBG supporting) (NP (PRP$ our) (NN decision) (S (VP (RB not) (TO to) (VP (VB include) (NP (NN MUC1)))))))))))))) (. .)))
( (S (S (S (NP (NP (JJ Elevated) (NNS levels)) (PP (IN of) (NP (NN serum) (NN carcinoembryonic) (NN antigenCEA)))) (VP (VBP are) (ADVP (RB commonly)) (VP (VBN used) (PP (IN as) (NP (NP (DT a) (JJ clinical) (NN tool)) (PP (IN in) (NP (NP (DT the) (NP (NN diagnosis)) (CC and) (NP (NN monitoring))) (PP (IN of) (NP (NN metastasis)))))))))) (CC but) (S (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NN CEA))) (PP (IN as) (NP (DT an) (JJ immunobead) (NN RT-PCR) (NN marker) (CD -LSB-17))) (-RRB- -RSB-)) (VP (VBZ has) (VP (VBN given) (NP (VBG varying) (NNS results)))))) (. .)))
( (S (S (NP (NN CEA)) (VP (VBZ has) (VP (VBN been) (VP (VBN considered) (S (VP (TO to) (VP (VB show) (NP (DT no) (JJ diagnostic) (NN value)) (PP (IN as) (NP (NP (DT a) (NN RT-PCR) (NN marker)) (PP (IN for) (NP (NP (DT the) (NN detection)) (PP (IN of) (NP (NNS micrometastases))))))) (PP (IN because) (S (NP (PRP it)) (VP (VBZ is) (VP (VBN expressed) (PP (IN in) (NP (NP (DT the) (NP (NN blood)) (CC and) (NP (NN lymph) (NNS nodes))) (PP (IN of) (NP (NP (NNS patients)) (PP (IN without) (NP (NN cancer) (NN -LSB-5))))))))) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (PP (IN in) (NP (NP (DT a) (NN comparison)) (PP (IN of) (NP (NP (JJ immunobead) (NN RT-PCR)) (CC and) (NP (JJ regular) (NN RT-PCR) (NN amplification)))))) (, ,) (NP (PRP it)) (VP (VBD was) (VP (VBN shown) (SBAR (IN that) (S (NP (JJ immunobead) (NN isolation)) (VP (VBZ increases) (NP (NP (DT the) (NN specificity)) (PP (IN of) (NP (NN CEA -LSB-8))))) (-RRB- -RSB-)))))) (. .)))
( (S (S (VP (VBG Using) (NP (NP (CD 55) (NN PCR) (NNS cycles)) (PP (IN for) (NP (NN CEA)))))) (, ,) (NP (PRP we)) (VP (VP (VBD found) (NP (NN amplification)) (PP (IN in) (NP (NP (NN none)) (PP (IN of) (NP (DT the) (CD PBMNC) (JJ only) (NNS samples)))))) (CC and) (VP (VBN gained) (NP (DT a) (JJ positive) (NN result)) (PP (IN for) (NP (NP (CD 45) (NN %)) (PP (IN of) (NP (NP (NP (DT the) (JJ single) (NN tumor) (NN cell) (NNS samples)) (NP (PRP we))) (VP (VBN tested)))))))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (NP (NN CEA)) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (ADJP (RB very) (JJ useful)) (NN marker)) (SBAR (WHADVP (WRB when)) (S (NP (JJ immunobead) (NN enrichment)) (VP (VBZ is) (VP (VBN performed) (ADVP (ADVP (RB prior)) (PP (TO to) (NP (NN RT-PCR)))))))))))))) (. .)))
( (S (S (NP (NP (JJ Epidermal) (NN growth) (NN factor) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NP (NN EGFR)) (, ,) (NP (NN HER1)) (, ,) (NP (NN ErbB1))) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (NN tyrosine) (NN kinase)) (SBAR (WHNP (WP$ whose) (NN activation)) (S (VP (VBZ plays) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (NP (NN cell) (NN proliferation)) (, ,) (NP (NN differentiation)) (CC and) (NP (NN survival))) (PP (IN with) (NP (NP (DT a) (JJ pivotal) (NN role)) (PP (IN in) (NP (NP (NP (NN maintenance)) (CC and) (NP (NN repair))) (PP (IN of) (NP (JJ epithelial) (NNS tissues))))))))))))))))) (. .)))
( (S (S (NP (NN EGFR)) (VP (VBZ is) (VP (VBN overexpressed) (PP (IN in) (NP (NP (CD 50–70) (NN %)) (PP (IN of) (NP (NP (NP (JJ human) (JJ primary) (NN breast)) (, ,) (NP (NN lung)) (, ,) (CC and) (NP (NN colon))) (NNS carcinomas))))) (NP (CD -LSB-18)) (-RRB- -RSB-)))) (. .)))
( (S (S (NP (NP (DT A) (NN study)) (VP (VBG using) (NP (NP (NP (JJ nested) (NN RT-PCR)) (CC and) (NP (NN Southern) (NN blotting))) (VP (TO to) (VP (VB detect) (NP (NN EGFR) (NNS transcripts)) (PP (IN in) (NP (NP (NN blood) (NNS samples)) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ metastatic) (NN colon) (NN cancer)))))))))))) (VP (VBD found) (SBAR (IN that) (S (NP (NP (CD 10.5) (NN %)) (PP (IN of) (NP (JJ healthy) (NNS donors)))) (VP (VBD were) (ADJP (JJ positive)) (SBAR (WHNP (WDT which)) (S (VP (VBZ suggests) (SBAR (IN that) (S (NP (PRP$ their) (NN assay)) (VP (VBD detected) (NP (JJ illegitimate) (NN transcription))))))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NP (NN none)) (PP (IN of) (NP (NP (DT the) (CD 27) (NN PBMNC) (JJ only) (NNS aliquots)) (VP (VBN tested) (PP (IN in) (NP (PRP$ our) (NN assay))))))) (VP (VBD yielded) (NP (NP (NN EGFR) (NN amplification) (NNS products)) (CC and) (NP (NP (CD 19/43)) (PRN (-LRB- -LRB-) (NP (CD 44) (NN %)) (-RRB- -RRB-)))))) (S (NP (JJ single) (NN tumor) (NNS cells)) (VP (VBD were) (VP (VBN detected)))) (. .)))
( (S (S (S (NP (NP (DT A) (NN comparison)) (PP (IN of) (NP (NP (DT the) (NNS results)) (VP (VBN obtained) (PP (IN for) (NP (NP (DT the) (CD two) (NN ER) (JJ positive) (NN cell) (NNS lines)) (PRN (-LRB- -LRB-) (NP (CD 6/20)) (-RRB- -RRB-))))))) (PP (IN with) (NP (NP (DT those)) (VP (VBN obtained) (PP (IN for) (NP (NP (DT the) (CD two) (NN ER) (JJ negative) (NN cell) (NNS lines)) (PRN (-LRB- -LRB-) (NP (NN 13/23)) (-RRB- -RRB-)))))))) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NN ER) (NN status)) (VP (MD will) (VP (VB affect) (NP (NP (DT the) (NN efficacy)) (PP (IN of) (NP (DT this) (NN marker)))))))))) (CC but) (S (NP (PRP it)) (VP (VBZ remains) (NP (DT a) (JJ useful) (NN marker))))) (. .)))
( (S (S (NP (NN Mammaglobin) (CD 1) (-LRB- -LRB-) (NN MGB1) (-RRB- -RRB-) (NN expression)) (VP (VP (VBZ is) (ADJP (JJ limited) (PP (TO to) (NP (JJ mammary) (NN epithelium))))) (CC and) (VP (VBZ is) (ADVP (RB often)) (VP (VBN up-regulated) (PP (IN in) (NP (JJ human) (NN breast) (NN cancer) (CD -LSB-20) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (DT The) (NN gene)) (VP (VBZ has) (VP (VBN been) (VP (VBN localised) (PP (TO to) (NP (NN chromosome) (CD 11q13))) (PP (IN in) (NP (NP (DT a) (NN region)) (VP (ADVP (RB frequently)) (VBN amplified) (PP (IN in) (NP (NN breast) (NN cancer)))))))))) (. .)))
( (S (S (S (VP (VBG Using) (NP (JJ nested) (NN RT-PCR)))) (, ,) (NP (PRP it)) (VP (VBD was) (VP (VBN shown) (SBAR (IN that) (S (NP (NN MGB1) (NNS transcripts)) (VP (VBP are) (ADJP (JJ detectable) (PP (IN in) (NP (NP (NN blood)) (PP (IN from) (NP (NN breast) (NN cancer) (NNS patients) (CD -LSB-21) (-RRB- -RSB-)))))))))))) (. .)))
( (S (NP (NP (NP (NNP Marchetti) (FW et) (FW al)) (. .)) (, ,) (NP (-LRB- -LRB-) (CD 2001) (-RRB- -RRB-))) (VP (VP (VBD analysed) (NP (NP (NN lymph) (NNS nodes)) (PP (IN from) (NP (NN breast) (NN cancer) (CC and) (JJ normal) (NNS patients))))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN MGB1)) (VP (VBZ is) (NP (NP (DT a) (ADJP (ADJP (RBR more) (JJ sensitive)) (CC and) (ADJP (RBR more) (JJ specific))) (NN RT-PCR) (NN marker)) (PP (IN than) (NP (NP (DT a) (NN panel)) (PP (IN of) (NP (NP (CD six) (JJ other) (NNS markers)) (SBAR (WHNP (WDT that)) (S (VP (VBD included) (NP (NP (NN CEA)) (, ,) (NP (NN CK19)) (CC and) (NP (NN MUC1-LSB-22)))) (-RRB- -RSB-))))))))))))) (. .)))
( (S (S (NP (NN MGB1) (NNS transcripts)) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN by) (NP (PRP us))) (PP (IN in) (NP (NP (DT any)) (PP (IN of) (NP (DT the) (NN PBMNC) (JJ only) (NNS aliquots)))))))) (. .)))
( (S (S (S (PP (IN In) (NP (PRP$ our) (NNS hands))) (, ,) (NP (NN MGB1) (NNS transcripts)) (VP (VBD were) (ADVP (RB only)) (VP (VBN detected) (PP (IN in) (NP (NP (NP (CD 9/35)) (PRN (-LRB- -LRB-) (NP (CD 26) (NN %)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (DT the) (JJ single) (NN tumor) (NNS cells)) (VP (VBN tested))))))))) (CC but) (S (SBAR (IN because) (S (NP (DT this) (NN marker)) (VP (VBZ is) (ADJP (JJ mammary-specific))))) (, ,) (NP (NP (PRP$ its) (NN inclusion)) (PP (IN in) (NP (NP (DT a) (NN panel)) (PP (IN of) (NP (NN RT-PCR) (NNS markers)))))) (VP (VBZ is) (VP (VBN warranted))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ possible)) (SBAR (IN that) (S (NP (NP (DT the) (NN sensitivity)) (PP (IN with) (NP (DT this) (NN marker)))) (VP (MD can) (VP (VB be) (VP (VBN improved) (SBAR (IN if) (S (NP (JJR more) (NN PCR) (NNS cycles)) (VP (VBP are) (VP (VBN performed)))))))))))) (. .)))
( (S (NP (NP (NN ELF3)) (, ,) (VP (ADVP (RB also)) (VBN known) (PP (IN as) (ADJP (JJ Epithelial-Specific) (PP (IN with) (NP (NP (NN serine) (NN bo) (NN X)) (PRN (-LRB- -LRB-) (NP (NN ESX)) (-RRB- -RRB-))))))) (, ,)) (VP (VP (VBZ is) (NP (NP (DT a) (NN member)) (PP (IN of) (NP (NP (DT the) (NN Ets) (JJ multigene) (NN family)) (PP (IN of) (NP (JJ transcriptional) (NNS regulators))))))) (CC and) (VP (VBZ is) (VP (VBN localised) (PP (TO to) (NP (NN chromosome) (CD 1q32))) (PP (IN in) (NP (NP (DT a) (NN region)) (VP (VBN known) (S (VP (TO to) (VP (VB be) (VP (VBN amplified) (PP (IN in) (NP (NP (CD 50) (NN %)) (PP (IN of) (NP (JJ early) (NN breast) (NNS cancers))))) (S (LST (CD -LSB-11,23) (-RRB- -RSB-)) (NP (NN .ELF3) (NN mRNA) (NN expression)) (VP (VBZ is) (ADJP (JJ restricted) (PP (TO to) (NP (NP (NNS tissues)) (PP (IN of) (NP (JJ epithelial) (NN origin))) (, ,) (PP (VBG including) (NP (NP (ADJP (ADJP (JJ normal)) (CC and) (ADJP (JJ malignant))) (JJ human) (JJ mammary) (JJ ductal) (NN epithelium)) (PP (IN with) (NP (NP (DT no) (NN expression)) (VP (VBN reported) (PP (IN in) (NP (JJ lympho-haematopoietic) (NNS tissues))))))))))))))))))))))) (. .)))
( (S (PP (IN In) (NP (PRP$ our) (NN assay))) (, ,) (NP (JJ faint) (NNS bands)) (VP (VBD were) (ADJP (JJ visible) (PP (IN at) (NP (CD 188) (NN bp)))) (PP (CC both) (PP (IN after) (NP (NP (CD 45) (NNS cycles)) (PRN (-LRB- -LRB-) (NP (NN 1/6)) (-RRB- -RRB-)))) (CC and) (PP (IN after) (NP (NP (CD 55) (NNS cycles)) (PRN (-LRB- -LRB-) (NP (NN 5/30)) (-RRB- -RRB-))))) (PP (IN in) (NP (DT the) (NN PBMNC) (JJ only) (NNS aliquots)))) (. .)))
( (S (S (ADVP (RB However)) (NP (NP (DT the) (JJ strong) (NN intensity)) (PP (IN of) (NP (NP (DT the) (NNS bands)) (PP (IN for) (NP (NP (NP (NP (DT the) (NN 40/43)) (PRN (-LRB- -LRB-) (NP (CD 93) (NN %)) (-RRB- -RRB-))) (NNS samples)) (PP (IN with) (NP (DT a) (JJ single) (NN tumor) (NN cell)))))))) (VP (VBD was) (VP (VBN considered) (S (ADJP (JJ indicative) (PP (IN of) (NP (NP (DT a) (JJ positive) (NN result)) (PP (IN in) (NP (DT these) (NNS cases)))))))))) (. .)))
( (S (S (S (VP (VBG Decreasing) (NP (DT the) (NN cycle) (NN number)) (PP (TO to) (NP (NP (CD 35)) (VP (VP (VBD eliminated) (NP (NP (DT the) (JJ weak) (NN band)) (PP (IN in) (NP (NP (DT the) (NN PBMNC) (RB only) (NNS aliquots)) (PRN (-LRB- -LRB-) (NP (NN 0/15)) (-RRB- -RRB-)))))) (, ,) (CC yet) (ADVP (RB still)) (VP (VBD allowed) (NP (NP (JJ consistent) (NN detection)) (PP (IN of) (NP (DT the) (NN tumor) (NNS cells)))) (PP (IN in) (NP (PRP$ our) (NN assay))) (PRN (-LRB- -LRB-) (NP (CD 15/16) (: –) (CD 94) (NN %)) (-RRB- -RRB-)))))))) (CC and) (S (ADVP (RB therefore)) (NP (NN ELF3)) (VP (VBZ is) (NP (NP (DT a) (JJ useful) (NN marker)) (PP (IN for) (NP (NP (NN inclusion)) (PP (IN in) (NP (PRP$ our) (NN panel))))))))) (. .)))
( (S (S (NP (NN EphB4)) (VP (VP (VBZ is) (NP (NP (DT a) (NN member)) (PP (IN of) (NP (NP (DT the) (NN Eph) (NN family)) (PP (IN of) (NP (NN receptor) (NN protein) (NN tyrosine) (NNS kinases))))))) (CC and) (VP (VBZ has) (ADVP (RB recently)) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB be) (VP (VBN up-regulated) (PP (IN in) (NP (NP (NNS cancers)) (PP (IN from) (NP (NP (NN prostate)) (, ,) (NP (NN breast)) (, ,) (NP (NN endometrium)) (, ,) (NP (NN lung)) (CC and) (NP (NN colon)) (NP (NN -LSB-12,24-27)) (-RRB- -RSB-)))))))))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN thought) (S (VP (TO to) (VP (VB play) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (DT the) (NP (NN development)) (CC and) (NP (NN oncogenesis))) (PP (IN of) (NP (JJ various) (NNS tissues))) (PP (IN through) (NP (NP (NNS modifications)) (PP (TO to) (NP (NP (JJ cell-cell) (NN communication)) (CC and) (NP (NN adhesion)))))))))))))) (. .)))
( (S (SBAR (IN Although) (S (NP (NN EphB4)) (VP (VBD was) (VP (VBN detected) (PP (IN in) (NP (DT some) (NN PBMNC) (NN cell) (JJ only) (NNS controls))) (PP (IN at) (NP (CD 55) (NNS cycles))))))) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NP (NN intensity)) (PP (IN of) (NP (NP (DT the) (JJ corresponding) (NNS bands)) (PP (IN on) (NP (NN agarose) (NNS gels)))))))) (VP (VBD was) (UCP (ADJP (JJ low)) (CC and) (VP (VBG decreasing) (NP (DT the) (NN cycle) (NN number)) (PP (TO to) (NP (NP (CD 45)) (VP (VBD resulted) (PP (IN in) (NP (NP (DT no) (JJ positive) (NNS samples)) (PP (RP out) (PP (IN of) (NP (CD 21) (NNS tests)))))))))))) (. .)))
( (S (S (VP (VBG Using) (NP (NN EphB4) (JJ specific) (NNS primers)) (PP (IN with) (NP (CD 45) (NNS cycles))))) (NP (PRP we)) (VP (MD could) (VP (VB detect) (NP (NP (CD 77.5) (NN %)) (PP (IN of) (NP (NP (JJ single) (NN tumor) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN 31/40)) (-RRB- -RRB-))))) (S (VP (VBG proving) (NP (DT this)) (S (VP (TO to) (VP (VB be) (NP (NP (DT an) (JJ useful) (NN marker)) (PP (IN in) (NP (DT this) (NN assay))))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ various) (NNS markers)) (VP (VBN used))) (ADVP (RB here)) (VP (VBP show) (NP (NP (JJ different) (NNS degrees)) (PP (IN of) (NP (NN heterogeneity)))) (VP (VBZ i.e) (NP (NP (DT the) (NNS numbers)) (PP (IN of) (NP (JJ single) (NN tumor) (NNS cells)))) (SBAR (IN that) (S (NP (PRP they)) (VP (VBP are) (VP (VBN detected) (PP (IN in))))))))) (. .)))
( (S (S (ADVP (RB Interestingly)) (, ,) (NP (DT the) (ADJP (RBR more) (JJ heterogeneous)) (NNS markers)) (ADVP (RB also)) (VP (VBD gave) (NP (DT the) (JJS least) (JJ false) (NNS positives)) (PP (IN in) (NP (DT the) (NNS controls))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ unclear)) (SBAR (IN whether) (S (NP (DT this)) (VP (VBZ is) (ADJP (ADJP (JJ due) (PP (TO to) (NP (NP (DT the) (NN sensitivity)) (PP (IN of) (NP (DT the) (NN test)))))) (CC or) (ADJP (JJ due) (PP (TO to) (NP (NP (JJ stochastic) (NNS differences)) (PP (IN in) (SBAR (IN whether) (S (NP (DT a) (NN cell)) (VP (VBZ expresses) (NP (NP (DT a) (NN transcript)) (CC or) (RB not))))))))))))))) (. .)))
( (S (S (S (NP (NP (NN Heterogeneity)) (PP (IN at) (NP (DT the) (JJ single) (NN cell) (NN level)))) (VP (MD must) (VP (VB be) (VP (VBN taken) (PP (IN into) (NP (NN account))) (SBAR (WHADVP (WRB when)) (S (VP (VBG designing) (NP (DT an) (NN RT-PCR) (NN assay))))))))) (CC and) (S (NP (DT this) (NN study)) (VP (VBZ is) (NP (DT the) (JJ first) (CD one)) (S (VP (TO to) (VP (VB address) (NP (DT this)))))))) (. .)))
( (S (S (S (VP (VBG Using) (NP (NP (DT a) (NN panel)) (PP (IN of) (NP (JJ several) (NNS markers)))))) (VP (MD will) (VP (VB reduce) (NP (NP (DT this) (NN source)) (PP (IN of) (NP (NN error))))))) (. .)))
( (S (S (NP (DT This)) (VP (MD can) (VP (VB be) (VP (VBN seen) (PP (IN in) (NP (NN table) (CD 3))) (SBAR (WHADVP (WRB where)) (S (NP (RB nearly) (DT every) (NN tumour) (NN cell)) (VP (VBZ is) (ADJP (JJ positive) (PP (IN for) (NP (QP (JJR more) (IN than) (CD one)) (NN marker))))))))))) (. .)))
( (S (S (S (NP (CD One) (NN T-47D) (NN cell)) (VP (VBZ is) (ADJP (JJ negative) (PP (IN for) (NP (NP (DT all) (CD 5) (NNS markers)) (VP (VBN tested))))))) (CC and) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ possible)) (SBAR (IN that) (S (NP (DT this) (NN cell)) (VP (VBD was) (RB not) (ADJP (JJ viable)) (PP (IN at) (NP (NP (DT the) (NN time)) (PP (IN of) (NP (NN selection))))))))))) (. .)))
( (S (S (NP (DT The) (NN need) (S (VP (TO to) (VP (VB be) (ADJP (CC both) (ADJP (JJ specific)) (CC and) (ADJP (JJ sensitive))))))) (VP (MD may) (VP (VBP entail) (S (VP (VBG finding) (NP (NP (DT a) (NN balance)) (PP (IN between) (NP (DT the) (NP (NN specificity)) (CC and) (NP (NN sensitivity)))))))))) (. .)))
( (S (S (NP (NP (PRP$ Our) (NNS findings)) (PP (IN in) (NP (DT the) (NN PBMNC)))) (VP (VBP suggest) (SBAR (IN that) (S (NP (JJ illegitimate) (NN transcription)) (VP (VBZ occurs) (PP (IN in) (NP (NP (DT all) (NNS cells)) (CONJP (RB rather) (IN than)) (NP (DT a) (NN subset))))))))) (. .)))
( (S (S (SBAR (WHADVP (WRB When)) (S (S (NP (NP (JJ large) (NNS numbers)) (PP (IN of) (NP (NNS cells)))) (VP (VBP are) (ADJP (JJ present)))) (CC or) (S (NP (DT the) (NN assay)) (VP (VBZ is) (ADJP (RB very) (JJ sensitive)))))) (, ,) (NP (JJ false) (NNS positives)) (VP (MD will) (VP (VB be) (ADJP (JJ common))))) (. .)))
( (S (S (NP (NN ELF3)) (VP (VBD had) (NP (NP (DT a) (ADJP (RB fairly) (JJ high)) (JJ false) (JJ positive) (NN rate)) (PP (IN of) (NP (NP (NN amplification)) (PP (IN in) (NP (NN PBMNC)))))) (PP (IN at) (NP (CD 45) (NNS cycles))) (PP (ADVP (RB presumably)) (JJ due) (TO to) (S (VP (VBG detecting) (NP (JJ illegitimate) (NN transcription)) (PP (IN in) (NP (NP (DT a) (ADJP (RB very) (JJ small)) (NN number)) (PP (IN of) (NP (DT these) (NNS cells)))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NN ELF3)) (VP (VBD was) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (ADJP (RBR more) (JJ robust)) (NNS markers)) (VP (VBG giving) (NP (NP (ADJP (RB very) (JJ strong)) (NN amplification)) (PP (IN of) (NP (JJ single) (NN tumour) (NNS cells)))) (PP (IN at) (NP (CD 45) (NNS cycles))))))))) (. .)))
( (S (S (NP (NP (NN Amplification)) (PP (IN from) (NP (DT the) (NNS controls)))) (VP (VBD was) (VP (VBN eliminated) (SBAR (WHADVP (WRB when)) (S (NP (NP (QP (RB only) (CD 35)) (NNS cycles)) (PP (IN of) (NP (NN amplification)))) (VP (VBD were) (VP (VBN performed)))))))) (. .)))
( (S (S (SBAR (IN Because) (S (NP (NP (RB only) (DT a) (JJ small) (NN amount)) (PP (IN of) (NP (NN product)))) (VP (VBD was) (VP (VBN amplified) (PP (IN after) (NP (CD 45) (NNS cycles))) (PP (IN in) (NP (DT these) (NNS controls))))))) (NP (PRP we)) (VP (MD could) (VP (VB distinguish) (NP (NP (NNS samples)) (SBAR (WHNP (WDT that)) (S (VP (VBD contained) (NP (NP (NN tumor) (NNS cells)) (CC and) (NP (NP (DT those)) (SBAR (WHNP (WDT that)) (S (VP (VBD did) (ADVP (RB not)) (PP (IN through) (NP (NP (NN comparison)) (PP (IN of) (NP (NP (DT the) (NN intensity)) (PP (IN of) (NP (NNS bands))))))))))))))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (ADJP (ADJP (DT this)) (CC and) (ADJP (JJ similar))) (NNS markers)) (VP (MD will) (VP (VB be) (ADJP (JJ useful)) (PP (IN in) (NP (NP (DT a) (JJ real-time) (NN PCR) (NN methodology)) (SBAR (WHADVP (WRB where)) (S (NP (JJ positive) (NNS signals)) (VP (MD can) (VP (VB be) (ADVP (RBR more) (RB readily)) (VP (VBN differentiated) (PP (IN from) (NP (NN background) (NNS signals) (CD -LSB-15) (-RRB- -RSB-)))))))))))))))) (. .)))
( (S (S (SBAR (IN As) (S (VP (VBN mentioned)))) (, ,) (NP (CD one) (NN question)) (VP (VBZ is) (SBAR (IN whether) (S (NP (NN cell) (NNS lines)) (VP (VBP are) (ADJP (RB truly) (JJ representative) (PP (IN of) (S (VP (VBG circulating) (NP (NN tumor) (NNS cells))))))))))) (. .)))
( (S (S (S (NP (NP (DT A) (JJ large) (NN number)) (PP (IN of) (NP (VBG circulating) (NN tumor) (NNS cells)))) (VP (VBP are) (VP (VBN believed) (S (VP (TO to) (VP (VB be) (PP (IN in) (NP (NN G0) (NN -LSB-1) (-RRB- -RSB-))))))))) (, ,) (IN whereas) (S (NP (NP (DT the) (NN cell) (NN line) (NNS controls)) (VP (VBN used))) (VP (VBP are) (PP (IN from) (NP (NN log) (NN phase) (NNS cells)))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD compared) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NN ELF3)) (, ,) (NP (NN EphB4)) (CC and) (NP (NN EGFR)))) (PP (IN in) (NP (NP (NNS cells)) (VP (VBN grown) (PP (PP (IN under) (NP (NP (NNS conditions)) (PP (IN of) (NP (NN serum) (NN starvation))))) (, ,) (PP (IN during) (NP (NN log) (NN phase))) (CC and) (PP (IN at) (NP (NP (JJ full) (NN confluence)) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VB saw) (NP (DT no) (JJ appreciable) (NN difference)) (PP (IN in) (NP (NP (DT the) (NN expression) (NNS levels)) (PP (IN of) (NP (NP (DT any)) (PP (IN of) (NP (DT these) (CD 3) (NNS genes))))))) (PP (IN under) (NP (NP (DT any)) (PP (IN of) (NP (NP (DT the) (NNS conditions)) (VP (VBN tested)))))))) (. .)))
( (S (S (SBAR (IN Whereas) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ difficult) (S (VP (TO to) (VP (VB model) (NP (NP (DT the) (JJ clinical) (NN situation)) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (NP (NNS patterns)) (PP (IN of) (NP (NN gene) (NN expression)))) (VP (VBP are) (ADJP (JJ likely) (S (VP (TO to) (VP (VB be) (ADJP (JJ heterogeneous))))))))))))))))) (, ,) (NP (NP (DT the) (NN assay)) (VP (VBN presented) (PP (IN in) (NP (DT this) (NN communication))))) (VP (VBZ is) (ADJP (JJ useful) (PP (PP (IN for) (S (VP (VBG testing) (NP (JJ potential) (NN RT-PCR) (NNS markers))))) (CC and) (PP (IN as) (NP (NP (DT a) (JJ meaningful) (NN control)) (PP (IN in) (NP (NP (DT the) (NN determination)) (PP (IN of) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ disseminated) (NN tumor) (NNS cells))) (PP (IN in) (NP (JJ clinical) (NNS samples))))))))))))) (. .)))
( (S (S (S (VP (TO To) (ADVP (RB fully)) (VP (VB validate) (NP (DT these) (NNS markers))))) (, ,) (NP (NP (DT a) (JJ clinical) (NN study)) (VP (VBG using) (NP (ADJP (RB immunomagnetically) (VBN enriched)) (NNS cells)) (PP (IN from) (NP (NNS patients))))) (VP (VBZ is) (VP (VBN needed)))) (. .)))
( (S (S (NP (PDT Such) (DT a) (NN study)) (VP (VBZ is) (ADVP (RB currently)) (PP (IN in) (NP (NN progress))))) (. .)))
( (S (NP (NNS Conclusions))))
( (S (S (NP (JJ Immunobead) (NN RT-PCR)) (VP (VBZ is) (NP (NP (DT a) (JJ powerful) (NN methodology)) (PP (IN for) (NP (NP (DT the) (NN detection)) (PP (IN of) (NP (JJ disseminated) (NN carcinoma) (NNS cells)))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP need) (NP (NP (NN RT-PCR) (NNS assays)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (JJ sensitive) (RB enough) (S (VP (TO to) (VP (VB detect) (NP (NP (ADJP (RB very) (JJ low)) (NNS numbers)) (PP (IN of) (NP (JJ captured) (NN carcinoma) (NNS cells))) (S (SBAR (IN As) (S (NP (JJ haematopoietic) (NNS cells)) (VP (MD may) (VP (VB be) (ADVP (RB non-specifically)) (VP (VBN retained) (PP (IN during) (NP (NP (JJ immunomagnetic) (NN enrichment)) (PP (IN of) (NP (JJ epithelial) (NNS cells)))))))))) (, ,) (NP (DT these) (NN RT-PCR) (NNS markers)) (ADVP (RB also)) (VP (VBP need) (S (VP (TO to) (VP (VB be) (VP (VBN tested) (PP (IN for) (NP (PRP$ their) (NN specificity)))))))))))))))))))) (. .)))
( (S (S (NP (NP (DT A) (NN set)) (PP (IN of) (NP (NN RT-PCR) (NNS markers)))) (VP (VBZ has) (VP (VBN been) (VP (VBN tested) (PP (IN for) (NP (PRP$ their) (NN ability) (S (VP (TO to) (VP (VB detect) (NP (NP (DT a) (JJ single) (NN carcinoma) (NN cell)) (VP (VBG using) (NP (NP (DT a) (JJ single) (NN round)) (PP (IN of) (NP (NP (NP (NN PCR)) (CC and) (NP (NN ethidium) (NN bromide))) (NN visualization))))))))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN identified) (NP (NP (CD six) (JJ useful) (NNS markers)) (SBAR (WHNP (WDT that)) (S (VP (VBP include) (NP (NP (NP (DT the) (ADJP (RB previously) (VBN described)) (NNS markers)) (NP (NP (NN EpCAM)) (, ,) (NP (NN EGFR)) (, ,) (NP (NN CEA)) (CC and) (NP (NN MGB1)))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (CD two) (JJ novel) (NNS markers)) (NP (NP (NN EphB4)) (, ,) (CC and) (NP (NN ELF3)))))))))))) (. .)))
( (S (S (S (NP (NP (DT This) (NN panel)) (PP (IN of) (NP (NNS markers)))) (VP (MD should) (VP (VB allow) (NP (NP (DT the) (NN detection)) (PP (IN of) (NP (ADJP (RB virtually) (DT every)) (NN tumor) (NN cell))))))) (CC and) (S (NP (DT this) (NN means) (SBAR (IN that) (S (NP (DT a) (JJ positive) (NN result)) (VP (MD will) (VP (VB be) (VP (VBN obtained) (NP (DT each) (NN time) (NP (DT an) (JJ immunobead) (NN harvest))))))))) (VP (VBZ has) (VP (VBN captured) (NP (QP (IN at) (JJS least) (CD one)) (NN breast) (NN cancer) (NN cell)))))) (. .)))
( (S (S (NP (NP (JJS Most)) (PP (IN of) (NP (DT these) (NNS markers)))) (VP (MD will) (ADVP (RB also)) (VP (VB be) (ADJP (JJ useful) (PP (IN in) (NP (NP (DT the) (NN analysis)) (PP (IN of) (NP (NP (JJ other) (NNS carcinomas)) (PP (JJ such) (IN as) (NP (NP (NN colon)) (, ,) (NP (NN lung)) (CC and) (NP (NN prostate)))))))))))) (. .)))
( (S (NP (VBG Competing) (NNS interests))))
( (S (S (NP (NN None)) (VP (VBD declared))) (. .)))
( (S (NP (NN Pre-publication) (NN history))))
( (S (S (NP (NP (DT The) (JJ pre-publication) (NN history)) (PP (IN for) (NP (DT this) (NN paper)))) (VP (MD can) (VP (VB be) (VP (VBN accessed) (ADVP (RB here)))))) (: :)))
( (S (NP (NP (NN Figure)) (CC and) (NP (NN Table)) (NP (NNS captions)))))
( (S (NP (NP (NN Figure) (CD 1)) (: :) (NP (NP (NN Expression)) (PP (IN of) (NP (CD seven) (NN RT-PCR) (NNS markers))) (PP (IN in) (NP (NP (DT a) (NN panel)) (PP (IN of) (NP (CD seven) (NN breast) (NN cancer) (NN cell) (NNS lines)))))) (. .))))
( (S (S (S (NP (DT Each) (NN marker)) (VP (VBZ is) (VP (VBN shown) (PP (IN in) (NP (DT a) (JJ separate) (NN panel)))))) (CC and) (S (NP (NP (DT the) (NN size)) (PP (IN of) (NP (DT the) (VBN amplified) (NN product)))) (VP (VBZ is) (VP (VBN indicated) (SBAR (IN in) (S (S (NP (NP (NP (NN base) (NNS pairs)) (PRN (-LRB- -LRB-) (NP (NN bp)) (-RRB- -RRB-))) (NN M)) (VP (VBZ indicates) (NP (DT the) (NN pUC19/HpaII) (NN marker)))) (, ,) (S (NP (NN -ve)) (VP (VBZ indicates) (NP (DT the) (NN RT-PCR) (JJ negative) (NN control)))))))))) (. .)))
( (S (S (NP (JJ Weak) (JJ genomic) (NN or) (NN primer) (NN dimer) (NNS bands)) (VP (VBP are) (VP (VBN seen) (PP (IN for) (NP (DT some) (NNS RT-PCRs)))))) (. .)))
( (S (NP (NP (NN Figure) (CD 2)) (: :) (NP (NP (NN Expression)) (PP (IN of) (NP (CD seven) (NN RT-PCR) (NNS markers))) (PP (IN in) (NP (NP (CD 5) (JJ separate) (JJ single) (NN MDA-MB-453) (NNS cells)) (VP (VBN lysed) (PP (IN with) (NP (CD 100) (JJ normal) (NN PBMNC))))))) (. .))))
( (S (S (NP (NNP Lane) (NN M)) (VP (VBD –) (NP (NP (NN pUC19/HpaII) (JJ molecular) (NN weight)) (NP (NN marker))))) (. .)))
( (S (S (NP (DT The) (VBG following) (CD 3) (NNS lanes)) (VP (VBP are) (NP (NP (NNS amplifications)) (PP (IN from) (NP (CD 100) (NN PBMNC) (RB only)))))) (. .)))
( (S (S (S (NP (DT The) (VBG following) (CD 5) (NNS lanes)) (VP (VBP are) (NP (NP (NNS amplifications)) (PP (IN from) (NP (NP (CD one) (NN MDA-MB-453) (NN cell)) (PP (IN in) (NP (CD 100) (NN PBMNC)))))))) (, ,) (S (NP (NP (NNP Lane)) (NN C)) (VP (VBZ is) (NP (DT the) (NN cDNA) (JJ positive) (NN control)))) (, ,) (S (NP (NNP Lane) (NN G)) (VP (VBZ is) (NP (NP (DT the) (JJ genomic) (NN DNA) (NN control)) (PRN (-LRB- -LRB-) (NP (NN G)) (-RRB- -RRB-))))) (, ,) (S (NP (NP (NNP Lane)) (NN R)) (VP (VBZ is) (NP (DT the) (NN RT) (NN –) (JJ negative) (NN control))))) (: ;) (S (NP (NP (NNS Lanes)) (VP (VBN labelled) (S (NP (NN N))))) (VP (VBP are) (NP (DT the) (NN PCR) (JJ negative) (NNS controls)))) (. .)))
( (S (S (NP (JJ Genomic) (NNS bands)) (VP (MD can) (VP (VB be) (VP (VBN seen) (PP (IN for) (NP (JJ many) (NN ELF3) (NNS amplifications))))))) (. .)))
( (S (NP (NP (NN Figure) (CD 3)) (: :) (NP (NP (NN Expression)) (PP (IN of) (NP (CD seven) (NN RT-PCR) (NNS markers))) (PP (IN in) (NP (NP (CD 5) (JJ separate) (JJ single) (NN MCF-7) (NNS cells)) (VP (VBN lysed) (PP (IN with) (NP (CD 100) (JJ normal) (NN MNC))))))) (. .))))
( (S (S (NP (NNP Lane) (NN M)) (VP (VBD –) (NP (NP (NN pUC19/HpaII) (JJ molecular) (NN weight)) (NP (NN marker))))) (. .)))
( (S (S (NP (DT The) (VBG following) (CD 3) (NNS lanes)) (VP (VBP are) (NP (NP (NNS amplifications)) (PP (IN from) (NP (CD 100) (NN PBMNC) (RB only)))))) (. .)))
( (S (S (S (NP (DT The) (VBG following) (CD 5) (NNS lanes)) (VP (VBP are) (NP (NP (NNS amplifications)) (PP (IN from) (NP (NP (CD one) (NN MCF-7) (NN cell)) (PP (IN in) (NP (CD 100) (NN PBMNC)))))))) (, ,) (S (NP (NP (NNP Lane)) (NN C)) (VP (VBZ is) (NP (DT the) (NN cDNA) (JJ positive) (NN control)))) (, ,) (S (NP (NNP Lane) (NN G)) (VP (VBZ is) (NP (NP (DT the) (JJ genomic) (NN DNA) (NN control)) (PRN (-LRB- -LRB-) (NP (NN G)) (-RRB- -RRB-))))) (, ,) (S (NP (NP (NNP Lane)) (NN R)) (VP (VBZ is) (NP (DT the) (NN RT) (NN –) (JJ negative) (NN control))))) (: ;) (S (NP (NP (NNS Lanes)) (VP (VBN labelled) (S (NP (NN N))))) (VP (VBP are) (NP (DT the) (NN PCR) (JJ negative) (NNS controls)))) (. .)))
( (S (S (NP (JJ Genomic) (NNS bands)) (VP (MD can) (VP (VB be) (VP (VBN seen) (PP (IN for) (NP (JJ many) (NN ELF3) (NNS amplifications))))))) (. ,)))
( (S (NP (NP (NN Table) (CD 1)) (: :) (NP (NP (NN Primer) (NNS sequences)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN sense)) (PRN (-LRB- -LRB-) (NP (NN s)) (-RRB- -RRB-))) (CC and) (NP (NP (NN anti-sense)) (PRN (-LRB- -LRB-) (ADVP (RB as)) (-RRB- -RRB-)))) (-RRB- -RRB-))) (, ,) (NP (NP (NP (NP (JJ melting) (NNS temperatures)) (PRN (-LRB- -LRB-) (NP (NN Tm)) (-RRB- -RRB-))) (, ,) (NP (NP (NN annealing) (NN temperature)) (CC and) (NP (VBN expected) (NN product) (NN size)))) (PP (IN in) (NP (NP (NNS nucleotides)) (PRN (-LRB- -LRB-) (NP (NN nt)) (-RRB- -RRB-)))) (PP (IN for) (NP (NP (DT each)) (PP (IN of) (NP (DT the) (CD seven) (VBN selected) (NN marker) (NNS genes)))))) (. .))))
( (S (NP (NP (NN Table) (CD 2)) (: :) (NP (NP (NN Comparison)) (PP (IN of) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (DT the) (CD seven) (VBN selected) (NNS markers))) (PP (PP (IN in) (NP (NP (DT either) (CD 100) (NNS PBMNCs)) (ADVP (RB only)))) (, ,) (CC or) (PP (IN after) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NP (DT a) (JJ single) (NN tumor) (NN cell)) (PP (IN from) (NP (NP (CD one)) (PP (IN of) (NP (CD four) (JJ different) (NN cell) (NNS lines))))))))))))) (. .))))
( (S (NP (NP (NN Table) (CD 3)) (: :) (NP (NP (NN Profile)) (PP (IN of) (NP (NN gene) (NN expression))) (PP (IN from) (NP (NP (NP (CD 10) (JJ different) (NNS experiments)) (NP (DT each))) (VP (VBG using) (NP (CD 5) (JJ single) (NN tumour) (NN cell/100) (NN PBMNC) (NNS aliquots)) (PP (IN from) (NP (CD four) (JJ different) (NN cell) (NNS lines))))))) (. .))))
( (S (NP (DT The) (NN Ews-ERG) (NN Fusion) (NN Protein)) (VP (MD Can) (VP (VB Initiate) (NP (NN Neoplasia)) (PP (IN from) (NP (JJ Lineage-Committed) (JJ Haematopoietic) (NNS Cells)))))))
( (S (NP (NN Abstract))))
( (S (S (NP (DT The) (NN EWS-ERG) (NN fusion) (NN protein)) (VP (VBZ is) (VP (VBN found) (PP (IN in) (NP (NP (JJ human) (NNS sarcomas)) (PP (IN with) (NP (DT the) (JJ chromosomal) (NN translocation) (NP (NP (NN t) (-LRB- -LRB-) (CD 21) (: ;) (CD 22) (-RRB- -RRB-)) (PRN (-LRB- -LRB-) (NP (CD q22) (: ;) (CD q12)) (-RRB- -RRB-))) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (DT the) (NN translocation)) (VP (VBZ is) (VP (VBN considered) (S (VP (TO to) (VP (VB be) (NP (NP (DT an) (VBG initiating) (NN event)) (PP (IN in) (NP (NN sarcoma) (NN formation)))) (PP (IN within) (NP (JJ uncommitted) (JJ mesenchymal) (NNS cells))) (, ,) (ADVP (RB probably)) (NP (NP (JJ long-lived) (NNS progenitors)) (ADJP (JJ capable) (PP (IN of) (NP (NN self) (NN renewal))))))))))))))))))) (. .)))
( (S (S (NP (DT The) (NN fusion) (NN protein)) (VP (MD may) (RB not) (ADVP (RB therefore)) (VP (VB have) (NP (DT an) (JJ oncogenic) (NN capability)) (PP (IN beyond) (NP (DT these) (NNS progenitors)))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB assess) (SBAR (IN whether) (S (NP (NN EWS-ERG)) (VP (MD can) (VP (VB be) (NP (NP (DT a) (NN tumour) (NN initiator)) (PP (IN in) (NP (NP (NNS cells)) (CONJP (JJ other) (IN than)) (NP (JJ mesenchymal) (NNS cells)))))))))))) (, ,) (S (NP (PRP we)) (VP (VBP have) (VP (VBN analysed) (NP (NP (NN Ews-ERG) (NN fusion) (NN protein)) (NN function)) (PP (IN in) (NP (NP (DT a) (JJ cellular) (NN environment)) (ADJP (RB not) (JJ typical) (PP (IN of) (NP (NP (DT that)) (VP (VBN found) (PP (IN in) (NP (NP (JJ human) (NNS cancers)) (, ,) (ADVP (RB namely)) (, ,) (NP (VBN committed) (JJ lymphoid) (NNS cells)))))))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN used) (NP (NP (NN Ews-ERG) (NN invertor) (NNS mice)) (VP (VBG having) (NP (NP (DT an) (JJ inverted) (NN ERG) (NN cDNA) (NN cassette)) (VP (VBN flanked) (PP (IN by) (NP (NP (JJ loxP) (NNS sites)) (VP (VBD knocked) (PP (IN in) (NP (DT the) (NN Ews) (NN intron) (CD 8))))))))) (, ,) (VP (VBN crossed) (PP (IN with) (NP (NP (NNS mice)) (VP (VBG expressing) (NP (NN Cre) (NN recombinase)) (PP (IN under) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (DT the) (NN Rag1) (NN gene))) (S (VP (TO to) (VP (VB give) (NP (NP (JJ conditional) (, ,) (JJ lymphoid-specific) (NN expression)) (PP (IN of) (NP (DT the) (NN fusion) (NN protein))))))))))))))))) (. .)))
( (S (S (NP (JJ Clonal) (NN T) (NN cell) (NNS neoplasias)) (VP (VBP arose) (PP (IN in) (NP (DT these) (NNS mice))))) (. .)))
( (S (S (NP (NP (DT This) (JJ conditional) (NN Ews) (NN gene) (NN fusion) (NN model)) (PP (IN of) (NP (NN tumourigenesis)))) (VP (VBZ shows) (SBAR (IN that) (S (S (NP (NN Ews-ERG)) (VP (MD can) (VP (VB cause) (NP (JJ haematopoietic) (NNS tumours))))) (CC and) (S (NP (DT the) (NN precursor) (NNS cells)) (VP (VBP are) (NP (VBN committed) (NNS cells)))))))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (NP (NN Ews-ERG)) (VP (MD can) (VP (VB function) (PP (IN in) (NP (NP (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP do) (RB not) (VP (VB have) (S (VP (TO to) (VP (VB be) (NP (NP (JJ pluripotent) (NNS progenitors)) (CC or) (NP (JJ mesenchymal) (NNS cells))))))))))))))) (. .)))
( (S (NP (NN Introduction))))
( (S (S (NP (JJ Chromosomal) (NNS translocations)) (VP (VP (VBP are) (ADJP (JJ characteristic) (PP (IN of) (NP (JJ many) (JJ human) (NNS cancers))))) (, ,) (CC and) (VP (VBP are) (ADVP (RB especially) (RB well)) (VP (VBN studied) (PP (IN in) (NP (NP (NNS leukaemias)) (, ,) (NP (NNS lymphomas)) (, ,) (CC and) (NP (NNS sarcomas)) (NP (NN -LSB-1,2) (-RRB- -RSB-)))))))) (. .)))
( (S (S (S (NP (JJ Epithelial) (NNS tumours)) (ADVP (RB also)) (VP (VBP carry) (NP (JJ chromosomal) (NNS translocations)))) (, ,) (CC but) (S (SBAR (IN while) (S (NP (NP (DT those)) (PP (IN in) (NP (NP (NNS leukaemias)) (, ,) (NP (NNS lymphomas)) (, ,) (CC and) (NP (NNS sarcomas))))) (VP (VBP tend) (S (VP (TO to) (VP (VB be) (NP (JJ reciprocal) (NNS translocations)))))))) (, ,) (NP (NP (DT those)) (PP (IN in) (NP (NNS carcinomas)))) (VP (VBP are) (ADVP (RB often)) (NP (NP (JJ non-reciprocal) (NNS translocations)) (CD -LSB-3) (-RRB- -RSB-))))) (. .)))
( (S (S (NP (NP (DT The) (JJ main) (NNS outcomes)) (PP (IN of) (NP (DT the) (JJ reciprocal) (NNS translocations)))) (VP (VBP are) (NP (CC either) (NP (NP (VBN forced) (NN oncogene) (NN expression)) (PRN (, ,) (SBAR (IN as) (S (VP (VBN found) (PP (IN in) (NP (JJ lymphoid) (NNS malignancies)))))) (, ,))) (CC or) (NP (NP (NN gene) (NN fusion)) (, ,) (VP (VBN found) (PP (IN in) (NP (CC both) (NP (NNS leukaemias)) (CC and) (NP (NNS sarcomas)))))) (NP (NN -LSB-1,2)))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (NN Gene) (NN fusion)) (VP (VBZ occurs) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NN translocation) (NNS breakpoints)) (VP (VP (VBP are) (PP (IN within) (NP (NP (NP (DT the) (NNS introns)) (PP (IN of) (NP (NNS genes)))) (, ,) (NP (NP (JJ such)) (SBAR (IN that) (S (NP (DT the) (CD two) (VBN translocated) (NNS chromosomes)) (VP (VBP have) (NP (JJ new) (NN exon) (NN organisation)))))))) (, ,) (S (VP (VBG leading) (PP (TO to) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (JJ chimaeric) (NN mRNA) (NNS species)))))))) (CC and) (, ,) (PP (IN in) (NP (NN turn))) (, ,) (NP (JJ chimaeric) (NNS proteins))))))) (. .)))
( (S (S (NP (DT Some) (NNS translocations)) (VP (MD must) (VP (VB function) (PP (IN within) (NP (NN stem) (NNS cells))) (S (VP (TO to) (VP (VB initiate) (NP (NN disease)) (SBAR (IN while) (S (NP (NNS others)) (VP (VBP function) (PP (IN in) (NP (CC both) (NP (NN stem) (NNS cells)) (CC and) (NP (ADJP (RBR more) (VBN committed)) (NNS cells)))) (S (VP (TO to) (VP (VB provide) (NP (NP (ADJP (ADJP (JJ related)) (CC or) (ADJP (JJ distinct))) (NNS functions)) (PRN (-LRB- -LRB-) (VP (VBN reviewed) (PP (IN in) (NP (NN -LSB-4)))) (-RRB- -RSB-) (-RRB- -RRB-))))))))))))))) (. .)))
( (S (NP (JJ Different) (NN tumour) (NNS phenotypes)) (VP (MD can) (VP (VB result) (PP (IN from) (NP (NP (JJ specific) (NNS versions)) (PP (IN of) (NP (JJ related) (NN fusion) (NNS proteins))))) (PRN (, ,) (S (S (PP (IN for) (NP (NN instance))) (, ,) (NP (NP (DT the) (NP (NP (NN Philadelphia) (NN t)) (PRN (-LRB- -LRB-) (NP (CD 9) (: ;) (CD 22)) (-RRB- -RRB-))) (NN translocation)) (-LRB- -LRB-) (SBAR (WHNP (WDT which)) (S (VP (VBZ yields) (NP (DT the) (NN BCR-ABL) (JJ -LSB-breakpoint) (NN cluster) (NN region) (NN gene–Abelson) (NN leukaemia) (NN oncogene) (-RRB- -RSB-) (NN fusion))))) (-RRB- -RRB-)) (VP (VBZ occurs) (PP (IN in) (NP (ADJP (CC both) (ADJP (JJ myeloid-)) (CC and) (ADJP (JJ lymphoid-lineage))) (NNS tumours))))) (, ,) (S (VP (VBN dictated) (PP (IN by) (NP (NP (DT the) (NN position)) (PP (IN of) (NP (DT the) (NN translocation) (NN junction))) (PP (IN within) (NP (DT the) (NN BCR) (NN gene) (NN -LSB-5)))))))) (-RRB- -RSB-)))) (. .)))
( (S (S (NP (NP (DT The) (JJ biological) (NNS consequences)) (PP (IN of) (NP (DT the) (NN BCR-ABL) (NN fusion)))) (VP (VBP have) (VP (VBN been) (VP (VBN studied) (PP (IN in) (NP (NP (NN relation)) (PP (TO to) (NP (NN stem) (NN cell) (NNS properties) (NP (CD -LSB-6–8))))))))) (-RRB- -RSB-)) (. .)))
( (S (NP (DT These) (NNS studies)) (VP (VBP show) (SBAR (IN that) (S (S (NP (DT the) (NN BCR-ABL) (NN fusion) (NN protein)) (VP (VBZ does) (RB not) (VP (VB confer) (NP (JJ self-renewal) (NN potential)) (PP (IN on) (NP (VBN committed) (JJ myeloid) (NNS progenitors)))))) (, ,) (IN whereas) (S (NP (NP (JJ other) (NN translocation) (NN fusion) (NNS proteins)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN MOZ-TIF2))) (-RRB- -RRB-))) (VP (VBP do) (NP (NN -LSB-7))) (-RRB- -RSB-))))) (. .)))
( (S (S (NP (DT The) (NN MLL) (PRN (-LRB- -LRB-) (NP (JJ mixed) (NN lineage) (NN leukaemia)) (-RRB- -RRB-)) (NN gene)) (VP (VBZ has) (NP (NP (QP (JJR more) (IN than) (CD 30)) (JJ known) (NN fusion) (NNS partners)) (CD -LSB-9,10) (-RRB- -RSB-)))) (, ,) (CC and) (S (NP (NP (JJ retroviral) (NN transduction) (NNS experiments)) (PP (IN with) (NP (NN MLL-ENL) (NN fusion)))) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (DT the) (JJ multipotent) (JJ myeloid) (NNS progenitors)) (CC and) (NP (VBN committed) (JJ myeloid) (NNS progenitors))) (VP (MD could) (VP (VB respond) (PP (TO to) (NP (DT an) (NN MLL) (NN fusion) (NN protein)))) (S (VP (TO to) (VP (VB become) (ADJP (JJ leukaemic))))) (, ,) (S (VP (VBG suggesting) (NP (NP (DT the) (NN existence)) (PP (IN of) (NP (NN cancer) (NN stem) (NNS cells))) (ADJP (JJ distinct) (PP (IN from) (NP (NP (JJ multipotent) (NN stem) (NNS cells)) (PP (IN of) (NP (NP (DT the) (NN tissue)) (PP (IN of) (NP (NN origin) (CD -LSB-11)))))))) (-RRB- -RSB-))))))))) (. .)))
( (S (SBAR (IN While) (S (NP (DT some) (NNS translocations)) (VP (VBP have) (NP (DT these) (JJ dual) (NNS properties))))) (, ,) (NP (NNS others)) (ADVP (RB only)) (VP (VBP function) (PP (IN in) (NP (NP (VBN committed) (NNS cells)) (PP (JJ such) (IN as) (NP (NP (DT those) (NNS translocations)) (VP (VBN mediated) (PP (IN by) (NP (NP (DT the) (JJ RAG-VDJ) (PRN (-LRB- -LRB-) (NP (NP (NN recombinase) (NN activating) (NN gene)) (CC and) (NP (NP (NP (NN variable)) (, ,) (NP (VBG joining)) (, ,) (NP (NN diversity))) (NNS regions))) (-RRB- -RRB-)) (NN recombinase)) (PP (IN of) (NP (DT the) (JJ lymphoid) (NN lineage) (NN -LSB-1) (-RRB- -RSB-))))))))))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (NP (NP (ADJP (RB naturally) (VBG occurring)) (NNS translocations)) (, ,) (NP (NP (ADJP (JJ such) (PP (IN as) (NP (NP (DT that)) (PP (IN of) (NP (NN LMO2)))))) (PRN (-LRB- -LRB-) (NP (NN LIM) (NN domain) (QP (RB only) (CD 2))) (-RRB- -RRB-))) (PP (IN in) (NP (NN T) (NN cell) (JJ acute) (NN leukaemia)))) (, ,)) (ADVP (RB only)) (VP (VBP function) (PP (IN in) (NP (VBN committed) (NNS cells))))) (. .)))
( (S (S (NP (JJ Such) (NNS issues)) (VP (VBP are) (RB not) (VP (VBN confined) (PP (TO to) (NP (JJ haematopoietic) (NNS malignancies)))))) (. .)))
( (S (S (NP (NP (DT The) (NN EWS-FUS) (NN family)) (, ,) (VP (ADVP (RB typically)) (VBN involved) (PP (IN in) (NP (NN sarcoma) (NN aetiology)))) (, ,)) (VP (VBZ exhibits) (NP (NP (NNS characteristics)) (PP (IN of) (NP (NN tumour) (NNS initiators) (CD -LSB-12–15) (-RRB- -RSB-)))))) (. .)))
( (S (NP (NP (DT The) (NN EWS) (NN gene)) (, ,) (PP (IN at) (NP (NN Chromosome) (CD 22) (NN band) (CD q12))) (, ,)) (VP (VBD was) (VP (VP (ADVP (RB first)) (VBN identified) (PP (IN in) (NP (NN Ewing) (POS 's) (NN sarcoma))) (PP (IN by) (NP (NP (PRP$ its) (NN association)) (PP (IN with) (NP (NP (NN FLI1)) (CC and) (NP (NN ATF1) (CD -LSB-16,17) (-RRB- -RSB-))))))) (CC and) (VP (ADVP (RB subsequently)) (VBN found) (PP (IN in) (NP (NP (NNS subsets)) (PP (IN of) (NP (NP (NP (NN Ewing) (POS 's) (NN sarcoma)) (PP (IN with) (NP (CC either) (NP (NN ERG)) (CC or) (NP (NN ETV1))))) (, ,) (NP (CC and) (NP (NP (NN E1AF)) (CC and) (NP (NN FEV) (CD -LSB-17–21))) (-RRB- -RSB-))))))))) (. .)))
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP (DT the) (NN EWS) (NN gene)) (VP (VBZ is) (VP (VBN involved) (PP (PP (IN in) (NP (JJ other) (NNS sarcomas))) (CC and) (PP (IN with) (NP (NP (ADJP (CC yet) (ADJP (JJ different))) (NNS partners)) (, ,) (PP (JJ such) (IN as) (NP (NP (NN WT1)) (PRN (-LRB- -LRB-) (NP (NN Wilms) (NN tumour) (CD 1) (NN gene)) (-RRB- -RRB-)))))) (PP (IN in) (NP (NP (JJ desmoplastic) (JJ small) (NN round) (NN cell) (NN sarcoma) (CD -LSB-22) (-RRB- -RSB-) (CC or) (NP (NNP CHN))) (PP (IN in) (NP (JJ myxoid) (NN chondrosarcoma) (NN -LSB-23))))) (-RRB- -RSB-)))) (. .)))
( (S (S (NP (NP (DT A) (JJ further) (NN ramification)) (PP (IN of) (NP (DT this) (NN infidelity)))) (VP (VBZ is) (SBAR (IN that) (S (S (NP (NP (DT the) (NN FUS) (NN gene)) (, ,) (VP (ADVP (RB first)) (VBN identified) (PP (IN by) (NP (NP (PRP$ its) (NN fusion)) (PP (IN with) (NP (DT the) (NN CHOP) (NN gene))) (PP (IN in) (NP (NP (NP (NN t) (-LRB- -LRB-) (CD 12) (: ;) (CD 16) (-RRB- -RRB-)) (PP (IN of) (NP (JJ malignant) (JJ myxoid) (NN liposarcoma)))) (CC and) (NP (ADJP (JJ related) (PP (TO to) (NP (DT the) (NN EWS) (NN gene)))) (NN -LSB-24,25)))) (-RRB- -RSB-)))) (, ,)) (VP (VBZ has) (ADVP (RB also)) (VP (VBN been) (VP (VBN found) (PP (IN in) (NP (NP (NN Ewing) (POS 's) (NN sarcoma)) (VP (VBN fused) (PP (IN with) (NP (DT the) (NN ERG) (NN gene)))))))))) (, ,) (CC but) (S (ADVP (RB also)) (NP (DT a) (JJ similar) (NN FUS-ERG) (NN fusion)) (VP (VBZ has) (VP (VBN been) (VP (VBN described) (PP (IN in) (NP (DT some) (JJ acute) (JJ myeloid) (NNS leukaemias) (NP (CD -LSB-26–28) (-RRB- -RSB-)))))))))))) (. .)))
( (S (S (ADVP (RB Finally)) (, ,) (NP (DT the) (NN EWS) (NN gene)) (VP (MD can) (ADVP (RB also)) (VP (VB be) (VP (VBN involved) (PP (IN with) (NP (DT the) (NN CHOP) (NN gene))) (PP (IN by) (NP (NP (JJ chromosomal) (NN translocation)) (PP (IN in) (NP (NP (JJ malignant) (JJ myxoid) (NN liposarcoma) (CD -LSB-29) (-RRB- -RSB-)) (, ,) (ADJP (JJ analogous) (PP (TO to) (NP (NN FUS-CHOP)))))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ chromosomal) (NNS translocations)) (PP (IN in) (NP (NP (NN Ewing) (POS 's)) (CC and) (NP (JJ other) (NNS sarcomas))))) (VP (VBP are) (VP (VBN considered) (PP (IN as) (NP (JJ primary) (VBG initiating) (NNS events)))))) (. .)))
( (S (S (ADVP (RB Thus)) (NP (DT the) (NN EWS) (NNS fusions)) (VP (VP (VBP function) (PP (IN in) (NP (DT the) (NN cancer) (NN precursor) (NN cell)))) (CC and) (VP (VBP are) (VP (VBN required) (PP (IN throughout) (NP (NN tumour) (NN formation))) (PP (IN until) (NP (NP (DT the) (NN emergence)) (PP (IN of) (NP (DT the) (JJ overt) (NN cancer))))) (, ,) (SBAR (IN because) (S (NP (DT the) (JJ chromosomal) (NN translocation)) (VP (VBZ is) (ADJP (JJ present) (PP (IN in) (NP (NP (DT the) (NN cancer)) (PP (IN at) (NP (NP (DT the) (NN time)) (PP (IN of) (NP (NN presentation))))))))))))))) (. .)))
( (S (S (NP (DT The) (NN fusion) (NN protein)) (VP (MD may) (ADVP (RB therefore)) (VP (VB be) (ADJP (JJ instructive)) (PP (IN by) (S (VP (VBG imparting) (NP (NP (DT a) (NN phenotype)) (PP (IN on) (NP (DT the) (NN cell)))) (PP (IN by) (S (VP (VBG affecting) (NP (NP (DT a) (JJ specific) (NN differentiation) (NN programme)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD must) (VP (VB be) (NP (NP (NN part)) (PP (IN of) (NP (NP (DT the) (JJ genetic) (NN make-up)) (PP (IN of) (NP (DT the) (NN cancer) (NN stem) (NN cell)))))) (, ,) (SBAR (IN since) (S (NP (DT the) (JJ chromosomal) (NN translocation)) (VP (VBZ is) (NP (DT an) (ADJP (ADJP (VBG initiating)) (CC and) (ADJP (JJ persistent))) (NN feature))))))))))))))))))) (. .)))
( (S (S (NP (DT The) (JJ pre-existing) (NN chromosomal) (NN translocation)) (VP (VBZ creates) (NP (NP (DT a) (JJ cellular) (NN environment)) (VP (VBG allowing) (NP (JJ secondary) (NNS mutations)) (S (VP (TO to) (VP (VB arise) (PP (IN in) (NP (NN progeny) (NNS cells)))))))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (JJ overt) (NN cancer))))))) (. .)))
( (S (S (NP (NP (JJ Conditional) (NN mouse) (NNS models)) (PP (IN of) (NP (DT the) (ADJP (ADJP (JJ EWS-)) (CC and) (ADJP (JJ FUS-associated))) (JJ chromosomal) (NNS translocations)))) (VP (MD should) (VP (VBP give) (NP (NP (NNS insights)) (PP (IN into) (SBAR (WHADVP (WRB how)) (S (NP (DT these) (NNS fusions)) (VP (VBP influence) (NP (DT the) (JJ malignant) (NN phenotype)))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN analysed) (SBAR (SBAR (IN whether) (S (NP (NN EWS) (NNS fusions)) (VP (VBP function) (ADVP (RB only)) (PP (IN in) (NP (NP (DT the) (NN domain)) (PP (IN of) (NP (JJ mesenchymal) (NNS progenitors)))))))) (CC and) (SBAR (IN whether) (S (NP (PRP they)) (VP (VBP function) (PP (IN in) (NP (JJ other) (NN cell) (NNS lineages))) (, ,) (ADVP (RB specifically)) (PP (IN within) (NP (VBN committed) (NNS cells))) (, ,) (SBAR (IN as) (S (VP (VBZ has) (VP (VBN been) (VP (VBN demonstrated) (PP (IN for) (NP (NN MLL) (NNS fusions) (CD -LSB-11) (-RRB- -RSB-))))))))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN developed) (NP (NP (NN mouse) (NNS models)) (VP (VBG mimicking) (NP (JJ chromosomal) (NNS translocations)) (PP (IN by) (S (VP (VBG employing) (NP (NP (JJ homologous) (NN recombination)) (PP (IN in) (NP (JJ embryonic) (NN stem) (-LRB- -LRB-) (NN ES) (-RRB- -RRB-) (NNS cells)))) (S (VP (TO to) (VP (VB create) (NP (NP (JJ mutant) (NNS alleles)) (PP (IN in) (NP (NNS mice))))))))))))))) (. .)))
( (S (S (NP (DT These) (NNS methods)) (VP (VBD were) (NP (CC either) (NP (NP (DT the) (JJ knock-in) (NN model)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD involved) (S (VP (VBG fusing) (NP (DT the) (NN MLL) (NN gene) (NN partner) (NN AF9)) (PP (IN into) (NP (DT the) (NN mouse) (NN Mll) (NN gene))))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (JJ acute) (JJ myeloid) (NNS leukaemias))) (PP (IN in) (NP (NNS mice) (CD -LSB-30,31) (-RRB- -RSB-)))))))) (, ,)) (CC or) (NP (NP (DT the) (NN translocator) (NN model)) (CD -LSB-32,33) (-RRB- -RSB-))) (S (VP (TO to) (VP (VB give) (NP (ADJP (FW de) (FW novo)) (NP (JJ chromosomal) (NNS translocations))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (JJ cell-specific) (NNS leukaemias) (CD -LSB-34) (-RRB- -RSB-)))))))))) (. .)))
( (S (NP (PRP We)) (VP (VBP have) (VP (VBN applied) (NP (NP (DT a) (JJ new) (JJ conditional) (NN chromosomal) (NN translocation) (NN model)) (-LRB- -LRB-) (VP (VBN designated) (NP (DT the) (JJ invertor) (NN model))) (-RRB- -RRB-) (CD -LSB-35) (-RRB- -RSB-)) (PP (TO to) (NP (DT the) (NN EWS-ERG) (NN gene) (NN fusion) (S (VP (TO to) (VP (VB gain) (NP (NP (NNS insights)) (PP (IN into) (NP (NP (DT the) (JJ functional) (NN significance)) (PP (IN of) (NP (DT the) (NN fusion) (NN protein))) (PP (IN in) (NP (NN tumourigenesis))))))))))))) (. .)))
( (S (S (NP (NN Invertor) (NNS mice)) (VP (VBP are) (VP (VBN made) (PP (IN by) (S (VP (VBG knocking) (NP (NP (DT a) (JJ floxed) (NN cDNA) (NN cassette)) (PP (IN into) (NP (NP (DT the) (NN intron)) (PP (IN of) (NP (DT a) (NN target) (NN gene)))))) (ADVP (RB downstream) (PP (IN of) (NP (DT the) (NN mouse) (NN exon)))) (ADJP (JJ equivalent) (PP (TO to) (NP (NP (DT that)) (VP (ADVP (RB usually)) (VBN involved) (PP (IN in) (NP (JJ human) (JJ chromosomal) (NNS translocations) (NP (CD -LSB-35) (-RRB- -RSB-)))))))))))))) (. .)))
( (S (S (NP (DT The) (JJ floxed) (NN cassette)) (VP (VP (VBZ is) (VP (VBN introduced) (PP (IN into) (NP (NP (DT the) (NN intron)) (PP (IN in) (NP (DT a) (JJ reverse) (JJ transcriptional) (NN orientation))))))) (CC and) (VP (MD can) (VP (VB be) (VP (VBN inverted) (PP (IN by) (NP (NN Cre) (NN recombinase))) (S (VP (TO to) (VP (VB create) (NP (NP (DT a) (NN transcription) (NN unit)) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG generating) (NP (NP (DT an) (JJ appropriate) (NN fusion) (NN mRNA)) (PRN (-LRB- -LRB-) (VP (VB see) (PP (IN below) (NP (CC and) (NN Figure) (NN 1A)))) (-RRB- -RRB-)))))))))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN sought) (S (VP (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (DT an) (NN Ews-ERG) (NN fusion)) (VP (MD can) (VP (VB be) (ADJP (JJ oncogenic) (PP (IN in) (NP (NP (DT a) (NN cell) (NN type)) (VP (RB not) (ADVP (RB generally)) (VBN associated) (PP (IN with) (NP (JJ human) (NNS tumours))) (PRN (-LRB- -LRB-) (ADVP (RB specifically)) (PP (IN in) (NP (JJ lymphoid) (NNS cells))) (-RRB- -RRB-)))))))))))) (CC and) (ADVP (RB also)) (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NN Ews-ERG) (NN fusion)) (VP (MD can) (VP (VB initiate) (NP (NN leukaemia)) (PP (IN from) (NP (VBN committed) (NNS cells)))))))))))))) (. .)))
( (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (JJ clonal) (NN T) (NN cell) (NN lymphoma)) (VP (VBP arose) (PP (IN in) (NP (DT the) (NN invertor) (NN model))) (SBAR (WHADVP (WRB when)) (S (NP (NN Cre) (NN expression)) (VP (VBD was) (VP (VBN controlled) (PP (IN by) (NP (DT the) (JJ lymphocyte-specific) (NN Rag1) (NN gene))))))) (, ,) (S (VP (VBG showing) (SBAR (IN that) (S (NP (NN Ews-ERG)) (VP (VBZ is) (ADJP (JJ leukaemogenic) (PP (IN in) (NP (JJ lymphoid) (NNS cells))))))))))))) (. .)))
( (S (S (NP (PRP$ Our) (NNS results)) (VP (VP (VBP show) (SBAR (IN that) (S (NP (NN Ews-ERG)) (VP (MD can) (VP (VB function) (PP (IN as) (NP (DT an) (NN oncogene))) (PP (IN in) (NP (NP (VBN committed) (NNS cells)) (PP (IN of) (NP (NNS mice)))))))))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN EWS-ERG)) (VP (VBZ is) (ADJP (JJ able) (S (VP (TO to) (VP (VB contribute) (PP (TO to) (NP (NP (NN neoplasia)) (PP (IN in) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ cellular) (NNS contexts))))))) (ADVP (FW in) (FW vivo)))))))))))) (. .)))
( (S (NP (NNS Results))))
( (S (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (JJ homologous) (NN recombination))) (S (VP (TO to) (VP (VB generate) (NP (NN oncogene) (NNS fusions)))))) (VP (VBD was) (VP (VBN established) (PP (IN with) (NP (NP (DT the) (NN creation)) (PP (IN of) (NP (DT the) (NN Mll-AF9) (NN mouse) (NN model) (CD -LSB-30))))))) (-RRB- -RSB-)) (. .)))
( (S (NP (PRP We)) (VP (VBD attempted) (NP (NP (DT a) (JJ similar) (NN approach)) (S (VP (TO to) (VP (VB make) (NP (NP (NN Ews) (NNS fusions)) (PP (IN of) (NP (NP (DT the) (NN type)) (VP (VBN found) (PP (IN in) (NP (NP (JJ specific) (JJ human) (NNS sarcomas)) (CC and) (NP (NP (NNS leukaemias)) (PRN (-LRB- -LRB-) (S (NP (NN Figure) (NN S1)) (VP (VBZ shows) (NP (NP (NNS sequences)) (PP (IN of) (NP (NP (NP (NN Chop)) (, ,) (NP (NN ATF1)) (, ,) (CC and) (NP (NN Fli1))) (PP (ADVP (RB together)) (IN with) (NP (NP (NN AF9) (NNS sequences)) (VP (VBN used) (PP (IN for) (NP (DT the) (JJ knock-in) (NN targeting) (NNS clones))))))))))) (-RRB- -RRB-)))))))))))))) (. .)))
( (S (SBAR (IN While) (S (NP (PRP we)) (VP (VBD were) (ADJP (JJ able) (S (VP (TO to) (VP (VB obtain) (NP (JJ homologous) (NN recombination) (NN knock-in) (NNS clones)))))) (PP (CC either) (PP (IN with) (NP (NP (DT a) (NN vector)) (VP (VBG carrying) (NP (RB only) (DT a) (NN transfer) (NN cassette))))) (CC or) (PP (IN with) (NP (DT the) (NN Ews-AF9) (NN control) (NN fusion))))))) (, ,) (NP (DT no) (NNS clones)) (VP (VBD were) (VP (VBN obtained) (PP (IN with) (NP (NP (DT any)) (PP (IN of) (NP (NP (DT the) (NN Ews) (NNS fusions)) (ADJP (JJ equivalent) (PP (TO to) (NP (NP (DT those)) (VP (ADVP (RB naturally)) (VBN found) (PP (IN in) (NP (NP (JJ human) (NNS cancers)) (PRN (-LRB- -LRB-) (NP (NN Table) (NN S1)) (-RRB- -RRB-)))))))))))))) (. .)))
( (S (S (ADVP (RB Furthermore)) (, ,) (NP (NNS chimaeras)) (VP (MD could) (VP (VB be) (VP (VBN made) (PP (IN with) (NP (NP (DT the) (NN Ews) (NN cassette)) (CC and) (NP (NP (DT the) (NN Ews-AF9) (NN knock-in)) (PRN (-LRB- -LRB-) (NP (NN Table) (NN S1)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD concluded) (SBAR (IN that) (S (NP (NP (NN Ews) (NNS fusions)) (PP (IN of) (NP (NP (DT the) (NN type)) (VP (ADVP (RB naturally)) (VBN associated) (PP (IN with) (NP (JJ human) (NNS cancers))))))) (VP (MD could) (VP (VB be) (ADJP (JJ lethal)) (PP (IN in) (NP (NN ES) (NNS cells))) (, ,) (S (VP (VBG obviating) (NP (NP (DT the) (NN generation)) (PP (IN of) (NP (VBN targeted) (NNS cells)))))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB recently)) (VP (VBN developed) (NP (NP (DT a) (JJ new) (JJ conditional) (NN knock-in) (NN method)) (VP (VBN based) (PP (IN on) (NP (NP (NN inversion)) (PP (IN of) (NP (DT a) (JJ loxP-flanked) (NN cDNA) (NN cassette))))))) (PP (IN by) (NP (NN Cre) (NN recombinase) (CD -LSB-35) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (DT This) (JJ Ews-ERG) (NN invertor) (NN model)) (VP (VBZ is) (ADVP (RB diagrammatically)) (VP (VBN shown) (PP (IN in) (NP (NN Figure) (NN 1A)))))) (. .)))
( (S (S (PP (IN In) (NP (NN outline))) (, ,) (NP (NP (JJ homologous) (NN recombination)) (PP (IN in) (NP (NN mouse) (NN ES) (NNS cells)))) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB introduce) (NP (DT a) (JJ floxed) (NN ERG) (NN cDNA) (NN cassette)) (ADVP (RB downstream) (PP (IN of) (NP (NP (NN Ews) (NN exon) (CD 7.)) (S (NP (DT The) (NN cassette)) (VP (VBD comprised) (NP (NP (DT a) (JJ short) (JJ intronic) (NN sequence)) (, ,) (NP (DT an) (NN acceptor) (NN splice) (NN site)) (, ,) (NP (NN ERG) (NN cDNA)) (, ,) (NP (DT a) (NN polyA) (NN site)) (, ,) (CC and) (NP (NP (DT a) (NN neomycin) (NN gene)) (-LRB- -LRB-) (VP (TO to) (VP (VB select) (NP (JJ homologous) (JJ recombinant) (NN ES) (NNS cells)))) (-RRB- -RRB-) (, ,) (VP (VBN placed) (PP (IN in) (NP (NP (DT the) (JJ opposite) (NN transcription) (NN orientation)) (PP (TO to) (NP (DT the) (NN Ews) (NN gene))))))))))))))))))) (. .)))
( (S (NP (NP (NN Expression)) (PP (IN of) (NP (NN Cre) (NN recombinase)))) (VP (VBZ inverts) (NP (DT the) (NN cassette)) (, ,) (S (VP (VBG bringing) (NP (DT the) (NN acceptor) (NN splice) (NN site)) (PP (IN into) (NP (NP (DT the) (JJ correct) (NN orientation)) (PP (IN with) (NP (DT the) (NP (NN Ews) (NN exon) (CD 7)) (NN donor) (NN splice) (NN site))))) (, ,) (S (VP (TO to) (VP (VB allow) (NP (NP (JJ post-transcriptional) (NN production)) (PP (IN of) (NP (NN Ews-ERG) (NN fusion) (NN mRNA))))))) (PRN (-LRB- -LRB-) (S (NP (NN Figure) (NN 1B)) (VP (VBZ shows) (NP (NP (DT the) (JJ post-inversion) (JJ genomic) (NN sequence)) (PP (IN at) (NP (NP (DT the) (NN junction)) (PP (IN of) (NP (NP (NN Ews)) (CC and) (NP (NN ERG))))))))) (-RRB- -RRB-))))) (. .)))
( (S (S (S (NP (VBN Targeted) (NN ES) (NNS cells)) (VP (VBD were) (VP (VBN injected) (PP (IN into) (NP (NNS blastocysts)))))) (, ,) (CC and) (S (NP (DT these)) (VP (VBD yielded) (NP (NP (JJ normal) (NNS numbers)) (PP (IN of) (NP (NNS chimaeras))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD gave) (NP (NN rise)) (PP (TO to) (NP (NP (JJ heterozygous) (NNS carriers)) (PP (IN of) (NP (NP (DT the) (JJ Ews-ERG) (NN invertor) (NN allele)) (PRN (-LRB- -LRB-) (NP (NN invertor) (NNS mice)) (-RRB- -RRB-))))))))))))) (. .)))
( (S (S (PP (IN In) (NP (DT these) (JJ invertor) (NNS mice))) (, ,) (NP (NN Ews-ERG) (NN protein)) (VP (VP (MD can) (ADVP (RB only)) (VP (VB be) (VP (VBN made) (PP (IN after) (NP (JJ Cre-mediated) (NN inversion)))))) (CC and) (ADVP (RB thus)) (VP (MD can) (VP (VB be) (ADJP (RB cell-specifically) (JJ dependent) (PP (IN on) (NP (NN Cre) (NN expression)))))))) (. .)))
( (S (NP (PRP We)) (VP (VBD investigated) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN Ews-ERG) (NN fusion) (NN protein))) (S (VP (TO to) (VP (VB contribute) (PP (TO to) (NP (NN leukaemogenesis))) (PP (IN by) (S (VP (VBG causing) (NP (NP (DT the) (NN inversion)) (PP (IN of) (NP (DT the) (JJ ERG-containing) (NN cassette))) (PP (IN in) (NP (JJ lymphoid) (NNS cells)))) (S (VP (VBG using) (NP (NP (NN Rag1-Cre) (NN knock-in) (NNS mice)) (CD -LSB-36) (-RRB- -RSB-)))))))))))) (. .)))
( (S (PP (RB Out) (IN of) (NP (NP (DT the) (NN cohort)) (PP (IN of) (NP (NP (CD 29) (NNS mice)) (VP (VBG carrying) (NP (CC both) (NP (NN Ews-ERG)) (CC and) (NP (NN Rag1-Cre) (NNS genes)))))))) (, ,) (NP (NP (CD 25) (NNS mice)) (PRN (-LRB- -LRB-) (NP (CD 86) (NN %)) (-RRB- -RRB-))) (VP (VBD developed) (NP (NP (NN leukaemia)) (VP (VBN associated) (PP (IN with) (NP (NN thymoma))))) (PP (IN within) (NP (CD 500) (NN d))) (, ,) (SBAR (IN whereas) (S (NP (NP (DT the) (JJ Ews-ERG-only) (NN cohort)) (PRN (-LRB- -LRB-) (NP (CD 20) (NNS mice)) (-RRB- -RRB-))) (VP (VBD did) (RB not) (VP (VB display) (NP (NN neoplasia)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 2)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (NN Blood) (NNS smears)) (PP (IN at) (NP (NP (DT the) (NN time)) (PP (IN of) (NP (NN sacrifice))) (PP (IN of) (NP (NN Ews-ERG) (: ;) (NN Rag1-Cre) (NNS mice)))))) (ADVP (RB typically)) (VP (VBD showed) (NP (NP (JJ elevated) (NNS numbers)) (PP (IN of) (NP (JJ large) (NNS leukocytes)))) (, ,) (PP (IN with) (NP (NP (JJ lymphoid) (NN morphology)) (PP (IN of) (NP (NP (JJ different) (NNS maturities)) (, ,) (PP (VBG including) (NP (NP (NNS lymphoblasts)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 2)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NN bone) (NN marrow) (NNS sections)) (VP (VBD showed) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NP (JJ infiltrating) (NNS lymphoblasts)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 2)) (-RRB- -RRB-))))))) (. .)))
( (S (S (S (NP (NP (DT The) (JJ diseased) (NNS mice)) (NP (DT all))) (VP (VBD had) (NP (NP (JJ large) (NNS thymomas)) (, ,) (VP (ADVP (RB usually)) (VBN associated) (PP (IN with) (NP (NP (NP (NN splenomegaly)) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 1)) (-RRB- -RRB-))) (CC and) (NP (NN lymphadenopathy)))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN histology)) (PP (IN of) (NP (NNS spleens)))) (VP (VBD showed) (NP (NP (NP (DT either) (JJ complete) (NN loss)) (PP (IN of) (NP (NP (JJ normal) (NN architecture)) (PRN (-LRB- -LRB-) (NP (NP (NN loss)) (PP (IN of) (NP (VBN demarcated) (JJ white) (CC and) (JJ red) (NN pulp)))) (-RRB- -RRB-))))) (, ,) (NP (JJ partial) (NN loss)) (, ,) (CC or) (NP (NP (JJ normal) (NN architecture)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN S2)) (-RRB- -RRB-))))))) (. .)))
( (S (S (ADVP (RB Similarly)) (, ,) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NP (NN infiltration)) (PP (IN of) (NP (JJ leukaemic) (NNS lymphocytes))) (PP (IN into) (NP (NP (NN liver)) (CC and) (NP (NN kidney))))))) (VP (VBD varied) (, ,) (PP (IN with) (NP (NP (DT some)) (VP (VBG having) (NP (NP (NP (JJ large) (NNS amounts)) (PP (IN of) (NP (JJ perivascular) (NNS deposits)))) (CC and) (NP (NNS others)) (NP (JJ marginal) (NNS levels)))))))) (. .)))
( (S (S (NP (DT All) (NNS mice)) (VP (VBD had) (NP (NN thymomas)) (PP (IN with) (NP (NP (JJ homogeneous) (NN presence)) (PP (IN of) (NP (JJ large) (JJ leukaemic) (NNS cells))))))) (. .)))
( (S (S (NP (DT These) (NNS characteristics)) (, ,) (PP (ADVP (RB together)) (IN with) (NP (NP (NN evidence)) (PP (IN of) (NP (NP (JJ clonal) (NN Tcrb) (NN gene) (NNS rearrangements)) (CC and) (NP (NP (NN expression)) (PP (IN of) (NP (NP (JJ TCR-associated) (NN CD8)) (CC and) (NP (NP (NN CD4)) (PRN (-LRB- -LRB-) (VP (VB see) (PP (IN below))) (-RRB- -RRB-)))))))))) (, ,) (VP (VBP permit) (NP (NP (NN diagnosis)) (PP (IN of) (NP (JJ large) (NN cell) (JJ anaplastic) (NN T) (NN cell) (NN lymphoma)))) (PP (VBG according) (PP (TO to) (NP (NP (DT the) (JJ Bethesda) (NNS proposals)) (PP (IN for) (NP (NP (JJ lymphoid) (NNS tumours)) (PP (IN in) (NP (NNS mice) (CD -LSB-37) (-RRB- -RSB-)))))))))) (. .)))
( (S (NP (DT The) (NN Ews-ERG) (NN fusion)) (VP (VBZ appears) (ADJP (JJ crucial) (PP (IN for) (NP (NP (NNS malignancies)) (PP (IN in) (NP (DT the) (JJ invertor) (NNS mice)))))) (, ,) (SBAR (IN as) (S (NP (NN disease)) (ADVP (RB only)) (VP (VBP arose) (PP (IN in) (NP (NP (NNS mice)) (PP (IN with) (NP (CC both) (NP (NP (DT the) (NP (NP (NN Ews-ERG)) (CC and) (NP (NN Rag1-Cre))) (NNS genes)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 2)) (-RRB- -RRB-))) (CC and) (NP (NP (VBN comprised) (JJ clonal) (NNS tumours)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 3)) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN presence)) (PP (IN of) (NP (NN Ews-ERG) (NN mRNA)))) (VP (VBD was) (VP (VBN confirmed) (PP (IN in) (NP (NP (NNS spleens)) (PP (IN of) (NP (DT these) (NNS mice))))) (, ,) (S (ADJP (JJ identical) (PP (IN with) (NP (NP (DT that)) (PP (IN in) (NP (NP (NN Ews-ERG) (NN ES) (NNS cells)) (VP (VBN transfected) (PP (IN with) (NP (NP (NN Cre) (NN expression) (NNS plasmids)) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (NN Figure) (NN S1)))) (-RRB- -RRB-)))))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NP (DT the) (JJ steady) (NN state)) (NN orientation)) (PP (IN of) (NP (DT the) (JJ loxP-flanked) (NN ERG) (NN cassette)))) (VP (VBD was) (VP (VBN studied) (S (VP (VBG using) (NP (NN filter) (NN hybridisation))))))) (CC and) (S (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP (DT the) (NN ERG) (NN sequence)) (VP (VBD had) (VP (VBN become) (VP (VBN inverted) (PP (IN into) (NP (NP (DT the) (NN 5′)) (PP (TO to) (NP (NN 3′) (NN orientation))) (PP (IN with) (NP (NP (NN respect)) (PP (TO to) (NP (DT the) (NN Ews) (NN gene))))))) (PP (IN in) (NP (NP (DT each) (NN case)) (PP (IN of) (NP (NP (NN thymoma)) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (NN 3A)) (: ;) (NP (NN Table) (CD 1))) (-RRB- -RRB-))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ other) (NNS tissues)) (VP (VBN examined))) (VP (VBP have) (NP (NP (JJ little) (NN evidence)) (PP (IN of) (NP (DT an) (JJ inverted) (NN band)))))) (. .)))
( (S (ADVP (RB Finally)) (, ,) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (DT the) (NN Ews-ERG) (NN fusion) (NN protein)))) (VP (VBD was) (VP (VBN shown) (PP (IN by) (NP (NP (NN Western) (NN blotting)) (PP (IN of) (NP (NN thymoma) (NNS proteins))))) (S (VP (VBG using) (NP (NP (NNS antibodies)) (VP (VBG binding) (PP (TO to) (NP (CC either) (NP (NN Ews)) (CC or) (NP (NN ERG))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD detected) (ADVP (RB respectively)) (NP (NP (DT the) (JJ normal) (NN mouse) (NN Ews) (CC or) (NN Erg) (NNS proteins)) (CC and) (NP (NP (DT the) (NN Ews-ERG) (NN fusion) (NN molecule)) (PP (IN in) (NP (NN thymoma) (NN T) (NNS cells))) (PP (IN of) (NP (DT an) (NN Ews-ERG))))))))))))) (: ;) (NP (NP (NN Rag1-Cre) (NN mouse)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3D)) (-RRB- -RRB-))) (. .)))
( (S (S (S (S (NP (NP (NNS Studies)) (PP (IN of) (NP (NN progenitor) (NN gene) (NN expression)))) (VP (VBP have) (VP (VBN indicated) (NP (NP (DT the) (JJ promiscuous) (NN expression)) (PP (IN of) (NP (JJ lymphoid) (NNS markers))))))) (VP (VBZ precedes) (NP (NN lineage) (NN commitment) (CD -LSB-38) (-RRB- -RSB-)))) (CC and) (S (ADVP (RB thus)) (, ,) (NP (DT the) (NN Rag1-Cre) (NN allele)) (VP (MD might) (VP (VB be) (VP (VBG expressing) (PP (IN in) (NP (NP (NNS cells)) (VP (VBN destined) (S (VP (TO to) (VP (VB become) (ADJP (JJ non-lymphoid))))))))))))) (. .)))
( (S (S (NP (DT The) (NN Rag1-Cre) (NN knock-in) (NN allele)) (VP (VBD was) (ADVP (RB previously)) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (ADJP (JJ specific) (PP (IN for) (NP (NP (JJ lymphoid) (NNS cells)) (VP (VBG using) (NP (NP (DT a) (NN reporter) (NN assay)) (ADJP (JJ dependent) (PP (IN on) (NP (NP (JJ Cre-mediated) (NN deletion)) (PP (IN of) (NP (NP (DT a) (JJ loxP-flanked) (-LRB- -LRB-) (JJ floxed) (-RRB- -RRB-) (NN segment)) (PP (IN of) (NP (DT the) (NN Lmo2) (NN gene) (NN -LSB-36)))))))) (-RRB- -RSB-)))))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN sustained) (NP (DT these) (NNS observations)) (S (VP (VBG using) (NP (NP (DT an) (JJ additional) (NN reporter) (NN assay)) (, ,) (ADVP (RB namely)) (NP (DT the) (NN ROSA-loxSTOP-lacZ) (-LRB- -LRB-) (NN ROSA26-R) (-RRB- -RRB-) (NN allele) (NN -LSB-39) (-RRB- -RSB-) (SBAR (WHADVP (WRB where)) (S (NP (NN β-galactosidase) (-LRB- -LRB-) (NN βgal) (-RRB- -RRB-) (NN expression)) (VP (VBZ is) (VP (VBN activated) (PP (IN by) (NP (NP (NN deletion)) (PP (IN of) (NP (DT a) (NN loxP-pA) (NN site)))))))))))))))) (. .)))
( (S (S (S (NP (NP (JJ Haematopoietic) (NNS populations)) (PP (IN from) (NP (NP (NNS mice)) (VP (VBG carrying) (NP (DT both) (NP (NP (NN Rag1-Cre)) (CC and) (NP (NN ROSA26-R))) (NNS alleles)))))) (VP (VBD were) (VP (VBN stained) (PP (IN with) (NP (NP (JJ fluorescent) (NNS antibodies)) (VP (VBG binding) (PP (TO to) (NP (JJ various) (NN surface) (NNS markers))))))))) (, ,) (CC and) (S (NP (NN flow) (NN cytometry)) (VP (VBD was) (VP (VBN carried) (PRT (RP out)) (PP (IN for) (NP (NP (NN co-detection)) (PP (IN of) (NP (NP (ADJP (ADJP (JJ antibody-)) (CC and) (ADJP (JJ βgal-derived))) (NN fluorescence)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN S3)) (-RRB- -RRB-)))))))))) (. .)))
( (S (NP (JJ βgal) (NN signal)) (VP (VP (VBD was) (VP (VBN found) (PP (IN in) (NP (NP (NP (NN thymus)) (CC and) (NP (NN spleen))) (PRN (-LRB- -LRB-) (NP (QP (RB almost) (PDT all)) (NNS cells)) (-RRB- -RRB-)))) (, ,) (CC and) (PP (IN in) (NP (NP (NN bone) (NN marrow)) (, ,) (NP (NP (DT a) (NN population)) (PP (IN of) (NP (NN βgal+) (NNS cells)))))) (VP (VB exist)))) (CC but) (VP (VBD did) (RB not) (VP (VB co-express) (PP (IN with) (NP (NP (NN CD34)) (, ,) (NP (NN Sca1)) (, ,) (NP (NN Ckit)) (, ,) (CC or) (NP (NP (CD Ter119)) (PRN (-LRB- -LRB-) (CC or) (NP (NP (NN Mac1)) (, ,) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (DT This) (NN means)) (PP (IN that) (NP (DT the) (NN Rag1-Cre)))) (VP (VBZ is) (ADJP (JJ restricted) (PP (TO to) (NP (JJ lymphoid) (NNS cells)))) (, ,) (SBAR (IN as) (S (ADVP (RB previously)) (VP (VBN shown) (NP (CD -LSB-36) (-RRB- -RSB-))))))) (. .)))
( (S (S (S (NP (DT The) (NN Rag1-Cre) (NN gene)) (VP (VBZ is) (VP (VBN expressed) (PP (IN in) (NP (DT both) (NN B) (CC and) (NN T) (NNS cells)))))) (, ,) (CC but) (S (NP (JJ only) (NN T) (NN cell) (NNS tumours)) (VP (VBP have) (VP (VBN arisen) (PP (IN in) (NP (DT the) (NN Ews-ERG) (: ;) (NN Rag1-Cre) (NN invertor) (NN line))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ possible) (NN inversion)) (PP (IN of) (NP (DT the) (NN Ews-ERG) (NN gene))) (PP (IN in) (NP (NN B) (NNS cells)))) (VP (VBD was) (VP (VBN investigated) (S (VP (VBG using) (NP (NP (NN RT-PCR) (NN analysis)) (PP (IN of) (NP (NP (VBN expressed) (NN Ews-ERG) (NN fusion) (NN mRNA)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 4)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (S (NP (NN RNA)) (VP (VBD was) (VP (VBN prepared) (PP (PP (IN from) (NP (NP (JJ whole) (NN spleen)) (CC or) (NP (NN thymus)))) (CC or) (PP (IN from) (NP (NP (NP (JJ flow-sorted) (NN B220+) (NN spleen) (NNS cells)) (PRN (-LRB- -LRB-) (NP (CD 3,400) (NNS cells)) (-RRB- -RRB-))) (CC or) (NP (NP (NN Thy1.2+) (NN spleen) (NNS cells)) (PRN (-LRB- -LRB-) (NP (CD 6,400) (NNS cells)) (-RRB- -RRB-))))))))) (CC and) (S (NP (NN RT-PCR)) (VP (VBN performed)))) (. .)))
( (S (S (NP (NP (NN Pax5)) (CC and) (NP (NN CD3)) (NP (NNS primers) (CD -LSB-38) (-RRB- -RSB-))) (VP (VBD were) (VP (VBN used) (PP (IN for) (NP (NP (JJ specific) (NN detection)) (PP (IN of) (NP (NP (NP (NN B) (NN cell)) (CC and) (NP (NN T) (NN cell))) (NNS transcripts))))) (, ,) (ADVP (RB respectively))))) (. .)))
( (S (NP (NN Pax5) (NNS transcripts)) (VP (VP (VBD were) (VP (VBN detected) (PP (IN in) (NP (NP (NN cDNA)) (VP (VBN made) (PP (IN from) (NP (NP (NP (NN spleen)) (CC and) (NP (NN B220+))) (VBN sorted) (NNS cells)))))))) (, ,) (CC and) (VP (NP (NN CD3)) (PP (IN in) (NP (DT the) (NP (NP (NN spleen)) (, ,) (NP (NN thymus)) (CC and) (NP (NN thy1.2+)))))))))
( (S (S (NP (NP (VBN sorted) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (NN 4A)) (CC and) (NP (NN 4B))) (-RRB- -RRB-)))) (. .)))
( (S (S (NP (NP (DT No) (NN evidence)) (PP (IN of) (NP (NN CD3) (NN expression)))) (VP (VBD was) (VP (VBN found) (PP (PP (IN in) (NP (DT the) (VBN sorted) (NN B220+) (NNS cells))) (, ,) (CC or) (PP (IN of) (NP (NN Pax5)))) (PP (IN in) (NP (DT the) (VBN sorted) (NN Thy1.2+) (NNS cells)))) (, ,) (S (VP (VBG showing) (SBAR (IN that) (S (NP (DT the) (VBN sorted) (NNS cells)) (VP (VBD were) (ADJP (RB practically) (JJ free) (PP (IN of) (S (VP (VBG contaminating) (NP (NN T) (CC or) (NN B) (NNS cells)) (, ,) (ADVP (RB respectively))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN presence)) (PP (IN of) (NP (NN Ews-ERG) (NN fusion) (NN RNA)))) (VP (VBD was) (VP (VBN analysed) (PP (IN with) (NP (NN RT-PCR) (NNS primers))) (, ,) (S (VP (VBG yielding) (NP (NP (DT a) (NN product)) (VP (VBG spanning) (NP (NP (DT the) (NN fusion) (NN junction)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (VP (VBN detected) (PP (IN with) (NP (DT an) (JJ internal) (NN junction) (NN probe))))))))))))))) (. .)))
( (S (S (NP (JJ Ews-ERG) (NN RT-PCR) (NN product)) (VP (VBD was) (VP (VBN detected) (PP (PP (IN in) (NP (NP (DT the) (JJ unfractionated) (NN spleen)) (CC and) (NP (NN thymus)) (NP (NNS sources)))) (, ,) (CONJP (RB as) (RB well) (IN as)) (PP (IN in) (NP (DT the) (VBN purified) (, ,) (NP (VBN sorted) (NN B220+) (CC and) (NN Thy1.2+) (NNS cells)))))))) (. .)))
( (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (JJ Cre-mediated) (NN inversion)) (PP (IN of) (NP (DT the) (NN Ews-ERG) (NN gene)))) (VP (VBZ occurs) (PP (IN in) (NP (NP (CC both) (NP (NN T)) (CC and) (NP (NN B))) (NNS cells))))) (. .)))
( (S (S (NP (NP (DT The) (NN presence)) (PP (IN of) (NP (NN thymomas))) (PP (IN in) (NP (DT all) (JJ afflicted) (NN Ews-ERG) (: ;) (NN Rag1-Cre) (NNS mice)))) (VP (VBD suggested) (SBAR (IN that) (S (NP (NP (DT the) (JJ haematological) (NN malignancy)) (PP (IN in) (NP (DT these) (NNS mice)))) (VP (VBD comprised) (NP (NN T) (NNS cells))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBD was) (VP (VBN confirmed) (PP (PP (IN by) (NP (NP (NN FACS) (NN analysis)) (PP (IN of) (NP (NN T) (NN cell) (NN surface) (NNS markers))))) (CC and) (PP (IN by) (NP (NP (NN determination)) (PP (IN of) (NP (NP (NN T) (NN cell)) (CC or) (NP (NN B) (NN cell) (NN receptor) (NN gene) (NN rearrangement) (NN status)))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN majority)) (PP (IN of) (NP (JJ normal) (NN mouse) (JJ thymic) (NN T) (NNS cells)))) (VP (VBP express) (NP (NP (NP (NP (CC both) (NP (DT the) (NN CD4)) (CC and) (NP (NN CD8))) (NN surface) (NNS markers)) (PRN (-LRB- -LRB-) (NP (JJ double) (JJ positive) (NN -LSB-DP) (-RRB- -RSB-) (NNS cells)) (-RRB- -RRB-))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NP (DT the) (JJ pan-T) (NN cell) (NN marker) (NN Thy1)) (PRN (-LRB- -LRB-) (NP (NN CD90)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NP (NN wt)) (PP (IN in) (NP (NN Figure) (CD 5)))) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NP (DT The) (NN situation)) (PP (IN with) (NP (NP (DT the) (NNS thymomas)) (PP (IN of) (NP (NN invertor) (NNS mice)))))) (VP (VBD varied) (PP (PP (PP (IN from) (NP (NP (ADVP (RB mainly)) (NP (NP (JJ CD4+CD8+) (NN DP) (NNS cells)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN M2))) (PP (IN in) (NP (NN Figure) (CD 5))) (-RRB- -RRB-)))) (TO to) (NP (ADVP (RB mainly)) (NP (JJ CD8+) (JJ single) (JJ positive) (-LRB- -LRB-) (NN SP) (-RRB- -RRB-) (NNS cells))))) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN M3))) (PP (IN in) (NP (NN Figure) (CD 5))) (-RRB- -RRB-))) (PP (TO to) (NP (ADJP (RB mainly) (JJ double) (JJ negative)) (NNS cells))) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN M4))) (PP (IN in) (NP (NN Figure) (CD 5))) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (NP (CD Thirteen)) (PP (IN of) (NP (NP (DT the) (NN cohort)) (PP (IN of) (NP (CD 25) (JJ leukaemic) (NN invertor) (NNS mice)))))) (VP (VBD were) (VP (VBN analysed) (PP (IN for) (NP (PRP$ their) (JJ thymic) (NN T) (NN cell) (NN profile))) (PP (IN by) (NP (NP (NN FACS)) (PRN (-LRB- -LRB-) (VP (VBN summarized) (PP (IN in) (NP (NN Table) (CD 1)))) (-RRB- -RRB-))))))) (. .)))
( (S (S (SBAR (IN While) (S (NP (PRP we)) (VP (VBD found) (NP (DT either) (JJ CD8+) (NN SP) (CC or) (JJ CD4+CD8+) (NN DP) (NNS thymomas))))) (, ,) (NP (NN none)) (VP (VBD showed) (NP (DT a) (JJ CD4+) (NN SP) (NN phenotype)))) (. .)))
( (S (S (NP (NP (CD Two)) (PP (IN of) (NP (DT the) (NNS thymomas)))) (VP (VBD had) (NP (NP (DT a) (JJ mixed) (NN phenotype)) (VP (VBG comprising) (ADVP (RB mainly)) (NP (JJ CD8+) (NN SP) (NNS cells)) (, ,) (PP (IN with) (NP (NP (DT a) (NN sub-population)) (PP (IN of) (NP (NP (NN DP) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN M3)) (CC and) (NP (NN M6))) (PP (IN in) (NP (NN Table) (CD 1)))) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN clonality)) (PP (IN of) (NP (DT these) (NN T) (NN cell) (NNS tumours)))) (VP (VBD was) (VP (VBN assessed) (PP (IN by) (NP (NP (NN filter) (NN hybridisation)) (PP (IN of) (NP (JJ genomic) (NN thymoma) (NN DNA))) (PP (IN with) (NP (NP (NP (DT a) (NP (NN T) (NN cell) (NN receptor)) (NN β) (NN probe)) (PRN (-LRB- -LRB-) (NP (NN Tcrb)) (-RRB- -RRB-))) (PP (IN from) (NP (DT the) (NN Jβ2) (NN region) (NP (NP (CD -LSB-40) (-RRB- -RSB-)) (PRN (-LRB- -LRB-) (ADVP (RB diagrammatically)) (VP (VBN shown) (PP (IN in) (NP (NN Figure) (NN 3B)))) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (NP (DT The) (NN probe)) (VP (VBZ detects) (NP (NP (DT a) (JJ 5-kb) (NN band)) (PP (IN in) (NP (NP (JJ non-lymphoid) (NN DNA)) (VP (VBG corresponding) (PP (TO to) (NP (DT the) (JJ intact) (NN Tcrb) (NN gene))))))))) (: ;) (S (SBAR (IN if) (S (NP (NP (NP (NN V-D-J)) (CC or) (NP (NN D-J))) (NNS joins)) (VP (VBP have) (VP (VBN occurred))))) (, ,) (NP (JJ new) (NN restriction) (NNS fragments)) (VP (VBP are) (VP (VBN created) (, ,) (S (VP (VBG giving) (NP (NN rise)) (PP (TO to) (NP (NP (JJ “rearranged) (NN '') (NNS bands)) (PP (IN on) (NP (DT the) (NN hybridisation) (NN autoradiograph)))))))))) (. .)))
( (S (S (NP (NN Figure) (NN 3B)) (VP (VBZ shows) (NP (NP (DT the) (NN rearrangement) (NN status)) (PP (IN of) (NP (NP (CD 12)) (PP (IN of) (NP (DT the) (JJ Ews-ERG) (NNS thymomas)))))))) (. .)))
( (S (S (NP (NP (DT All)) (PP (IN except) (NP (NP (NP (NP (CD one)) (PRN (-LRB- -LRB-) (NP (NN M9)) (-RRB- -RRB-))) (VP (VBD showed) (NP (QP (IN at) (JJS least) (CD one)) (JJ rearranged) (NN Jβ2) (NN allele)))) (CC and) (NP (JJ several))))) (VP (VBP have) (NP (NP (CD two) (JJ rearranged) (NNS alleles)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN M18))) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (NP (JJ Variable) (NNS amounts)) (PP (IN of) (NP (JJ residual) (NN germ) (NN line) (NN allele)))) (VP (VBD were) (ADJP (JJ present)))) (. .)))
( (S (S (NP (NP (DT The) (NN Tcrb) (NN rearrangement) (NN status)) (PP (IN of) (NP (NP (DT the) (NN cohort)) (PP (IN of) (NP (NN Ews-ERG) (JJ leukaemic) (NNS mice)))))) (VP (VBZ is) (VP (VBN summarized) (PP (IN in) (NP (NN Table) (CD 1)))))) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (DT the) (NN status)) (PP (IN of) (NP (DT the) (NN immunoglobulin) (NN locus)))) (VP (VBD was) (VP (VBN examined) (PP (IN with) (NP (NP (DT a) (NN probe)) (PP (IN from) (NP (NP (DT the) (NN region)) (PP (IN between) (NP (NN JH) (CC and) (NN Cμ) (NNS segments) (NP (NP (CD -LSB-41) (-RRB- -RSB-)) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (NN Figure) (NN 3C)))) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (NP (JJ Single) (NN Igh) (NN allele) (NNS rearrangements)) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (NP (RB about) (NN half)) (PP (IN of) (NP (NP (DT the) (NN cohort)) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 1)) (-RRB- -RRB-)))))) (, ,) (PP (VBG including) (NP (NP (NNS ones)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (NN FACS) (NN analysis)) (CC and) (NP (NN Tcrb) (NN clonality) (NNS hybridisations))) (VP (VBD showed) (NP (DT the) (NNS tumours)) (S (VP (TO to) (VP (VB be) (NP (JJ clonal) (NN T) (NN cell) (NNS malignancies))))))))))))) (. .)))
( (S (S (NP (DT The) (NN Igh) (NNS rearrangements)) (VP (VBP are) (ADVP (RB therefore)) (ADJP (JJ likely) (S (VP (TO to) (VP (VB be) (NP (JJ abortive) (NNS rearrangements)))))))) (. .)))
( (S (S (NP (NP (NN Confirmation)) (SBAR (IN that) (S (NP (NP (DT the) (NN Tcrb) (NNS rearrangements)) (VP (VBN observed) (PP (IN by) (NP (NNS hybridisations))))) (VP (VBD were) (PP (JJ due) (TO to) (NP (JJ productive) (NN V-D-J) (NNS joins))))))) (VP (VBD was) (VP (VBN made) (PP (IN by) (NP (NP (NN sequence) (NN analysis)) (PP (IN of) (NP (NP (DT the) (NN Tcrb) (NNS genes)) (PP (IN in) (NP (NP (CD four)) (PP (IN of) (NP (DT the) (NNS cases)))))))))))) (. .)))
( (S (NP (NP (NN PCR) (NN amplification)) (PP (IN from) (NP (NN thymoma) (NN DNA)))) (VP (VBD was) (VP (VBN carried) (PRT (RP out)) (PP (IN with) (NP (NP (NP (NP (NNS pools)) (PP (IN of) (NP (NP (JJ Vβ) (NNS primers)) (CC and) (NP (NP (DT a) (NN Jβ2) (JJ reverse) (NN primer)) (PRN (-LRB- -LRB-) (NP (NP (NN primer) (NNS sequences)) (PP (IN from) (NP (NN -LSB-42,43)))) (-RRB- -RSB-) (-RRB- -RRB-)))))) (CC and) (NP (NNS sequences))) (VP (VBN identified) (PP (IN with) (NP (DT the) (NNP ImMunoGeneTics) (NN database) (CD -LSB-44,45) (-RRB- -RSB-)))))))) (. .)))
( (S (S (NP (NN Table) (CD 2)) (VP (VBZ shows) (NP (NP (DT the) (NN V-D-J) (NN junctional) (NNS sequences)) (VP (VBG indicating) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (JJ productive) (NN T) (NN cell) (NN receptor) (CD β)) (NNS genes)))))))) (. .)))
( (S (S (PP (IN In) (NP (DT all) (NNS cases))) (, ,) (NP (NN N-region) (NN diversity)) (VP (VBZ is) (ADJP (JJ present) (PP (IN between) (NP (DT the) (NN V-D) (CC and) (NN D-J) (NNS junctions)))))) (. .)))
( (S (S (PP (IN In) (NP (NP (DT the) (NN thymoma) (NN DNA)) (PP (IN from) (NP (NN M2))))) (, ,) (NP (DT a) (JJ non-productive) (NN join)) (VP (VBZ has) (ADVP (RB also)) (VP (VBN occurred) (, ,) (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (DT the) (JJ productive) (NN one))))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (DT an) (JJ out-of-frame) (NN joint)))))))) (. .)))
( (S (NP (NN Discussion))))
( (S (S (NP (NP (JJ Human) (NNS cancers)) (PP (IN of) (NP (JJ mesenchymal) (NN origin)))) (VP (VBP involve) (NP (NP (DT the) (NN EWS) (NN gene)) (PP (IN with) (NP (NP (JJ various) (NN partner) (NNS genes)) (, ,) (PP (JJ such) (IN as) (PP (IN in) (NP (DT the) (NN chromosomal) (NN translocation) (NP (NP (NN t) (-LRB- -LRB-) (CD 21) (: ;) (CD 22) (-RRB- -RRB-)) (PRN (-LRB- -LRB-) (NP (CD q22) (: ;) (CD q12) (-RRB- -RRB-) (SBAR (WHADVP (WRB where)) (S (NP (NN EWS)) (VP (VBZ fuses) (PP (IN with) (NP (NN ERG))) (S (VP (TO to) (VP (VB encode) (NP (DT a) (JJ novel) (NN EWS-ERG) (NN fusion) (NN protein) (CD -LSB-18))))))))) (-RRB- -RSB-))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NN EWS) (NN gene) (NNS fusions)) (PP (IN with) (NP (JJ various) (NNS partners)))) (VP (VBP are) (VP (VBN described) (PP (IN in) (NP (NP (JJ clear) (NN cell) (NN sarcoma)) (, ,) (NP (JJ desmoplastic) (JJ small) (NN round) (NN cell) (NNS tumours)) (, ,) (NP (NN chondrosarcoma)) (, ,) (CC and) (NP (JJ myxoid) (NN liposarcoma))))) (, ,) (S (VP (VBG suggesting) (SBAR (SBAR (IN that) (S (NP (NN EWS) (NN fusion) (NNS proteins)) (VP (VBP are) (ADJP (JJ functional) (PP (IN for) (NP (NP (JJ various) (NN cell) (NNS types)) (PP (IN of) (NP (JJ mesenchymal) (NN origin))))))))) (CC and) (SBAR (IN that) (S (NP (NP (NNS restrictions)) (PP (IN in) (NP (NNS humans)))) (VP (VBP are) (VP (VBN dictated) (ADVP (RB largely)) (PP (IN by) (NP (NP (DT the) (NNS cells)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (DT the) (JJ chromosomal) (NNS translocations)) (VP (VBP occur))))))))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD tested) (NP (NP (DT the) (NN hypothesis)) (PP (IN of) (NP (NN cell) (NN type) (NN specificity)))) (PP (IN by) (S (VP (VBG assessing) (NP (NP (DT the) (JJ possible) (NN universality)) (PP (IN of) (NP (NN EWS-ERG)))) (PP (IN as) (NP (DT an) (NN oncogene)))))))) (. .)))
( (S (S (NP (PRP$ Our) (JJ experimental) (NN system)) (VP (VBD was) (VP (VBN designed) (S (VP (TO to) (VP (VB invoke) (NP (NP (ADJP (ADJP (JJ conditional)) (, ,) (ADJP (JJ cell-specific))) (NN expression)) (PP (IN of) (NP (DT the) (NN Ews-ERG) (NN fusion)))) (S (VP (TO to) (VP (VB analyse) (NP (NP (DT the) (NN target) (NN cell)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (PRP it)) (VP (MD can) (VP (VB function))))))))))))))) (. .)))
( (S (S (NP (NP (JJ Consistent) (NN EWS-ERG) (NN occurrence)) (PP (IN in) (NP (JJ human) (NNS sarcomas)))) (VP (VBZ suggests) (SBAR (IN that) (S (NP (PRP it)) (VP (MD may) (ADVP (RB only)) (VP (VB function) (PP (IN in) (NP (NP (JJ mesenchymal) (NNS cells)) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (PRP it)) (VP (MD may) (VP (VB function) (PP (PP (IN in) (NP (NP (NN initiation)) (PP (IN of) (NP (DT the) (NN cancer))))) (CONJP (RB as) (RB well) (IN as)) (PP (IN in) (NP (NP (NN maintenance)) (PP (IN of) (NP (NP (DT the) (NN cancer) (NN stem) (NN cell)) (PRN (-LRB- -LRB-) (PP (FW i.e.)) (, ,) (NP (NP (NNS cells)) (PP (IN within) (NP (NP (DT the) (NN tumour)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBP have) (NP (JJ self-renewing) (NN capacity))) (CC and) (VP (VBP maintain) (NP (DT the) (NN tumour))))))))) (-RRB- -RRB-))))))))))))))))))) (. .)))
( (S (S (NP (PRP$ Our) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (NP (NNS lymphomas)) (VP (VBP arise) (SBAR (WHADVP (WRB when)) (S (NP (NN Ews-ERG)) (VP (VBZ is) (ADVP (RB aberrantly)) (VP (VBN expressed) (PP (IN in) (NP (NP (DT the) (VBN committed) (NNS cells)) (PP (IN of) (NP (DT the) (JJ lymphoid) (NN lineage)))))))))))))) (. .)))
( (S (S (NP (DT The) (NN Ews-ERG) (NN invertor) (NN allele)) (VP (VBD was) (VP (VBN activated) (PP (IN in) (NP (NNS lymphocytes))) (, ,) (S (VP (VBG using) (NP (NP (DT the) (NN Rag1-Cre) (NN knock-in) (NNS mice)) (CD -LSB-36) (-RRB- -RSB-))))) (, ,) (S (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP (JJ lymphoid) (NNS malignancies)) (VP (MD would) (VP (VB arise)))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (NN invertor) (NN Ews-ERG) (NNS mice)) (VP (VBP develop) (NP (JJ clonal) (NN T) (NN cell) (NNS malignancies))))))) (. .)))
( (S (S (S (NP (DT The) (NN T) (NNS cells)) (VP (VBD were) (PP (IN of) (NP (JJ varying) (NNS phenotypes))))) (CC but) (S (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NNS cases)))) (VP (VP (VBD expressed) (NP (NN CD8)) (PP (IN on) (NP (DT the) (NN cell) (NN surface)))) (CC and) (VP (VBD had) (NP (NP (JJ productive) (NN V-D-Jβ) (NNS rearrangements)) (, ,) (ADJP (JJ indicative) (PP (IN of) (NP (JJ mature) (NN T) (NNS cells))))))))) (. .)))
( (S (S (SBAR (IN Since) (S (NP (NP (JJ Cre-mediated) (NN inversion)) (PP (IN through) (NP (JJ loxP) (NNS sites)))) (VP (VBZ recreates) (NP (DT the) (JJ loxP) (NN sequence))))) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (NN potential)) (PP (IN for) (NP (NP (DT the) (NN cassette)) (PP (TO to) (NP (NN flip)))))) (ADVP (ADVP (RB back)) (CC and) (ADVP (RB forth))) (PP (IN with) (NP (JJ continued) (NN Cre) (NN expression))))) (. .)))
( (S (S (NP (DT This)) (VP (VBD had) (NP (DT no) (JJ obvious) (JJ deleterious) (NN effect)) (PP (IN on) (NP (NP (NN tumourigenesis)) (PP (IN in) (NP (DT the) (JJ Ews-ERG) (NNS invertors))))) (SBAR (IN as) (S (VP (VBN judged) (PP (IN by) (NP (NP (JJ various) (NNS criteria)) (PRN (-LRB- -LRB-) (NP (NP (NN tumour) (NN penetrance)) (, ,) (NP (JJ consistent) (NN T) (NN cell) (NN phenotype)) (, ,) (CC and) (NP (NN pathology))) (-RRB- -RRB-))))))))) (. .)))
( (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN invertor) (NN allele)) (PP (IN of) (NP (JJ transformed) (NNS cells)))) (VP (MD may) (VP (VB be) (ADJP (JJ fixed) (PP (IN in) (NP (NP (DT the) (JJ correct) (NN orientation)) (PP (IN for) (NP (NP (NN synthesis)) (PP (IN of) (NP (NN Ews-ERG) (NN mRNA)))))))) (SBAR (WHADVP (WRB when)) (S (NP (NN Rag1-Cre)) (VP (VBZ is) (ADVP (RB no) (RBR longer)) (ADJP (JJ effective))))))) (. .)))
( (S (S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP (NP (DT the) (NN lack)) (PP (IN of) (NP (JJ CD4+) (NN SP) (NNS thymomas)))) (VP (VBZ is) (ADJP (JJ difficult) (S (VP (TO to) (VP (VBP encompass) (PP (IN with) (NP (DT this) (NN explanation))))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (JJ other) (JJ biological) (NNS mechanisms)) (VP (MD may) (VP (VB be) (VP (VBN involved) (PP (IN in) (NP (DT this) (NN bias)))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN Rag1-Cre) (NN mouse) (NN line)) (VP (VBN used))) (ADVP (RB constitutively)) (VP (VBZ expresses) (NP (NN Cre)) (PP (IN in) (NP (JJ lymphoid) (NNS cells) (CD -LSB-36) (-RRB- -RSB-))))) (, ,) (CC and) (S (NP (DT the) (VBG resulting) (NN Ews-ERG) (NN fusion)) (VP (VBZ causes) (NP (NN T) (NN lymphocyte) (NNS tumours)) (PP (IN in) (NP (NP (NNS mice)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (RB not) (VP (VBN known) (PP (IN in) (NP (NP (DT the) (NN spectrum)) (PP (IN of) (NP (JJ EWS-associated) (JJ human) (NNS cancers))))))))))))) (. .)))
( (S (S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP (NN FUS-ERG)) (VP (VBZ has) (VP (VBN been) (VP (VBN found) (PP (IN in) (NP (NNS leukaemias))) (, ,) (PP (IN albeit) (NP (NN myeloid) (NN type) (CD -LSB-26,46)))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (DT This)) (VP (VBZ implies) (SBAR (IN that) (S (NP (DT the) (JJ EWS-FUS) (NN fusion) (NNS proteins)) (VP (MD could) (VP (VB be) (ADJP (JJ effective)) (PP (IN in) (NP (NP (DT a) (NN spectrum)) (PP (IN of) (NP (NN cell) (NNS types))) (, ,) (VP (ADVP (JJR broader) (IN than) (RB normally)) (VBN seen) (PP (IN in) (NP (NP (JJ human) (NNS malignancies)) (PRN (-LRB- -LRB-) (PP (FW i.e.)) (, ,) (NP (NP (NNS sarcomas)) (CC and) (NP (JJ myeloid) (NNS leukaemias))) (-RRB- -RRB-))))))))))))) (. .)))
( (S (S (PP (IN In) (NP (DT some) (NNS cells))) (, ,) (NP (PRP it)) (VP (MD may) (VP (VB be) (SBAR (IN that) (S (S (NP (NN EWS-FUS) (NNS fusions)) (VP (VBP are) (ADJP (JJ lethal)))) (CC and) (S (ADVP (RB thus)) (NP (NP (DT those) (NNS cells)) (VP (VBG acquiring) (NP (DT a) (NN translocation)))) (VP (MD would) (VP (VBP die))))))))) (: ;) (S (PP (IN in) (NP (NNS others))) (, ,) (NP (DT the) (NN fusion) (NN protein)) (VP (VP (MD may) (VP (VB be) (VP (VBN tolerated)))) (CC and) (ADVP (RB thus)) (VP (MD may) (VP (VB become) (NP (NNS tumours)))))) (. .)))
( (S (PP (IN In) (NP (DT this) (NN respect))) (, ,) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (NN B) (NN cell) (NNS tumours)) (PP (IN in) (NP (DT the) (JJ Ews-ERG) (NNS invertors)))))) (VP (VBZ is) (PP (IN of) (NP (NN interest))) (SBAR (IN as) (S (NP (DT both) (NP (NP (NN B)) (CC and) (NP (NN T))) (NNS cells)) (VP (VBP undergo) (NP (NP (NN inversion)) (PP (IN of) (NP (NP (DT the) (NN Ews-ERG) (NN cassette)) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (NN Figure) (CD 4)))) (-RRB- -RRB-))))) (SBAR (IN because) (S (NP (NN Rag1-Cre)) (VP (VBZ is) (VP (VBN expressed) (PP (IN in) (NP (DT both) (NN cell) (NNS types) (NP (NP (CD -LSB-36) (-RRB- -RSB-)) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (NN Figure) (NN S3)))) (-RRB- -RRB-))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN absence)) (PP (IN of) (NP (NN B) (NN cell) (NNS tumours)))) (VP (MD may) (VP (VB reflect) (NP (NP (NN toxicity)) (PP (IN of) (NP (DT the) (NN fusion) (NN protein))) (PP (IN for) (NP (NN B) (NNS cells)))) (SBAR (IN although) (S (NP (DT this)) (VP (VBZ seems) (ADJP (JJ unlikely) (VP (VBN given) (SBAR (IN that) (S (NP (PRP we)) (VP (MD can) (VP (VB detect) (NP (NP (DT the) (NN fusion) (NN mRNA)) (PP (IN in) (NP (VBN selected) (NN B220+) (NN B) (NNS lymphocytes)))) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (NN Figure) (CD 4)))) (-RRB- -RRB-)))))))))))))) (. .)))
( (S (S (ADVP (RB Alternatively)) (, ,) (NP (PRP it)) (VP (MD may) (VP (NN mean) (SBAR (SBAR (IN that) (S (NP (NN Ews-ERG)) (VP (VBZ does) (RB not) (VP (VB function) (PP (IN in) (NP (NN B) (NNS cells))))))) (CC or) (SBAR (IN that) (S (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NN B) (NN cell) (NNS tumours)))) (VP (VBZ is) (VP (VBN inhibited) (PP (IN by) (NP (NP (DT the) (NN T) (NN cell) (NNS malignancies)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VP (VB arise) (ADVP (RBR earlier))) (CC and) (ADVP (RB then)) (VP (VB dominate) (NP (DT the) (JJ lymphoid) (NN compartment))))))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN ability)) (PP (IN of) (NP (NN Ews-ERG))) (S (VP (TO to) (ADVP (RB specifically)) (VP (VB cause) (NP (NN B) (NN cell) (NNS tumours)))))) (VP (MD could) (VP (VB be) (VP (VBN evaluated) (PP (IN by) (S (VP (VBG using) (NP (NP (JJ B-cell-specific) (JJ Cre-expressing) (NN mouse) (NNS lines)) (PP (JJ such) (IN as) (NP (NN CD19-Cre))))))))))) (. .)))
( (S (S (NP (PRP$ Our) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (NN Ews-ERG) (NN fusion)) (, ,) (VP (ADVP (RB normally)) (VBN restricted) (PP (TO to) (NP (NP (NNS sarcomas)) (PP (IN in) (NP (NNS humans)))))) (, ,)) (VP (MD can) (VP (VB initiate) (NP (NN T) (NN lymphocyte) (NNS tumours)) (, ,) (SBAR (IN if) (ADVP (RB conditionally)) (VP (VBN expressed) (PP (IN in) (NP (VBN committed) (JJ lymphoid) (NNS cells))))))))))) (. .)))
( (S (S (NP (NP (NN Leukaemogenesis)) (PP (IN in) (NP (NN Ews-ERG) (NN invertor) (NNS mice)))) (ADVP (RB thus)) (VP (VBZ concurs) (PP (IN with) (NP (DT the) (NN hypothesis) (SBAR (IN that) (S (NP (NN EWS) (NNS fusions)) (VP (MD can) (VP (VB cause) (NP (NP (NN neoplasia)) (VP (VBG arising) (PP (IN in) (NP (JJ various) (NN cell) (NNS types))))))))))))) (. .)))
( (S (ADVP (RB Further)) (, ,) (NP (PRP$ our) (NNS data)) (VP (VBP imply) (SBAR (IN that) (S (NP (NP (DT the) (JJ cellular) (NN context)) (PP (IN of) (NP (NP (JJ EWS-associated) (JJ chromosomal) (NNS translocations)) (PP (IN in) (NP (NNS humans)))))) (VP (VBZ does) (RB not) (VP (VB have) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (NN stem) (NN cell)) (CC or) (NP (RB even) (DT a) (JJ multi-potent) (NN progenitor))) (, ,) (SBAR (IN as) (S (NP (NP (VBN committed) (NN lymphocyte) (NNS precursors)) (VP (VBG expressing) (NP (NN Rag) (NN recombinase) (NNS genes)))) (VP (VBP are) (NP (NP (DT the) (JJ leukaemic) (NNS precursors)) (PP (IN in) (NP (PRP$ our) (JJ invertor) (NN model))))))))))))))) (. .)))
( (S (S (NP (DT The) (JJ same) (NNS conclusions)) (VP (MD can) (VP (VB be) (VP (VBN applied) (PP (TO to) (NP (NP (JJ FUS-associated) (JJ chromosomal) (NNS translocations)) (SBAR (WHNP (WDT that)) (S (VP (VBP seem) (S (VP (TO to) (VP (VB be) (ADJP (RB largely) (JJ interchangeable) (PP (IN with) (NP (NNS EWS))))))) (, ,) (PP (VBN given) (NP (NP (DT the) (NN spectrum)) (PP (IN of) (NP (NP (NNS cancers)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (DT these)) (VP (VBP are) (VP (VBN found) (NP (CC and) (NP (NP (DT the) (NN relatedness)) (PP (IN of) (NP (NN FUS-)))) (CC and) (NP (NP (JJ EWS-coded) (NNS proteins)) (NP (CD -LSB-24,25) (-RRB- -RSB-))))))))))))))))))))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (NP (NP (NP (NN EWS)) (CC or) (NP (NN FUS))) (JJ chromosomal) (NNS translocations)) (ADVP (RB probably)) (VP (VBP arise) (ADVP (RBR more)) (PP (PP (IN by) (NP (NP (NN virtue)) (PP (IN of) (NP (NP (NN accessibility)) (PP (IN of) (NP (DT the) (NNS genes))) (PP (TO to) (NP (JJ chromosomal) (NNS translocations))))))) (CONJP (IN than)) (PP (IN by) (NP (NP (DT the) (JJ precise) (JJ cellular) (NN specificity)) (PP (IN of) (NP (DT the) (JJ resultant) (NN fusion) (NNS proteins)))))))) (. .)))
( (S (NP (NP (NNS Materials)) (CC and) (NP (NNS Methods)))))
( (S (S (NP (DT The) (NN Ews) (JJ genomic) (NN targeting) (NN clone)) (VP (VBD was) (VP (VBN constructed) (PP (IN from) (NP (NP (JJ γ) (NN phage) (NN DNA)) (VP (VBN isolated) (PP (IN from) (NP (NN mouse) (CD 129) (NN DNA) (NN -LSB-47) (-RRB- -RSB-))))))))) (. .)))
( (S (S (S (NP (NP (DT The) (JJ knock-in) (NNS clones)) (PP (IN for) (NP (NP (JJ potential) (NN Ews) (NNS fusions)) (PP (IN with) (NP (NP (NN AF9)) (, ,) (NP (NN Fli1)) (, ,) (NP (NN Chop)) (, ,) (CC and) (NP (NN ATF1))))))) (VP (VBD were) (VP (VBN made) (S (VP (VBG using) (NP (DT a) (NN transfer) (NN vector) (NN pC2A-neo) (CD -LSB-35) (-RRB- -RSB-))))))) (, ,) (CC and) (S (NP (NP (DT the) (NNS sequences)) (PP (IN of) (NP (DT these) (NN cDNA) (NNS cassettes)))) (VP (VBP are) (VP (VBN given) (PP (IN in) (NP (NN Figure) (NN S1))))))) (. .)))
( (S (S (NP (NN Knock-in)) (VP (VBD was) (VP (VBN achieved) (PP (IN by) (NP (JJ homologous) (NN recombination))) (PP (IN as) (NP (VBN described) (NN -LSB-47) (-RRB- -RSB-)))))) (. .)))
( (S (NP (DT The) (JJ ERG) (NN inversion) (NN knock-in) (NN cassette) (CD -LSB-35) (-RRB- -RSB-)) (VP (VBD was) (VP (VBN prepared) (S (VP (VBG using) (NP (NP (NN cDNA)) (VP (VBN made) (PP (IN from) (NP (JJ human) (NN colon) (NN carcinoma) (NP (NP (NN COLO320) (NN mRNA)) (PRN (-LRB- -LRB-) (S (NP (NP (DT the) (NN sequence)) (PP (IN of) (NP (DT the) (NN ERG) (NN segment))) (, ,) (VP (VBG corresponding) (PP (TO to) (NP (NP (DT the) (NN part)) (PP (IN of) (NP (NN ERG))) (VP (VBN found) (PP (IN in) (NP (JJ EWS-ERG) (NN fusion) (NN -LSB-19))))))) (-RRB- -RSB-)) (VP (VBZ is) (VP (VBN shown) (S (NP (NN Figure) (NN S1)))))) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (S (NP (NP (DT A) (NN diagram)) (PP (IN of) (NP (NP (JJ overall) (NN structure)) (PP (IN of) (NP (DT the) (NN ERG) (NN inversion) (NN cassette)))))) (VP (VBZ is) (VP (VBN shown) (PP (IN in) (NP (NN Figure) (NN 1A)))) (, ,) (S (VP (VBG indicating) (NP (NP (DT the) (JJ initial) (NN orientation)) (PP (IN of) (NP (NP (DT the) (JJ ERG) (NN inversion) (NN cassette)) (PRN (-LRB- -LRB-) (NP (NP (CD 3′) (TO to) (CD 5′)) (PP (IN with) (NP (NP (NN respect)) (PP (TO to) (NP (NN Ews)))))) (-RRB- -RRB-))))))))) (CC and) (S (NP (DT this)) (VP (VBD was) (VP (VBN determined) (PP (IN by) (NP (NP (NP (NN restriction) (NN site)) (NN mapping)) (CC and) (NP (JJ genomic) (NN DNA) (NN sequencing)))))))) (. .)))
( (S (S (PP (IN After) (NP (NP (NN identification)) (PP (IN of) (NP (VBN targeted) (NN ES) (NNS cells))))) (, ,) (S (NP (DT these)) (VP (VBD were) (VP (VBN injected) (PP (IN into) (NP (NN C57BL/6) (NNS blastocysts)))))) (, ,) (S (NP (JJ chimaeric) (NNS mice)) (VP (VBD were) (VP (VBN produced)))) (, ,) (CC and) (S (NP (NP (NN germ) (NN line) (NN transmission)) (PP (IN of) (NP (DT the) (NN inversion) (NN knock-in) (NN allele)))) (VP (VBD was) (VP (VBN obtained))))) (. .)))
( (S (S (NP (DT These) (NNS mice)) (VP (VBD were) (VP (VBN bred) (PP (IN with) (NP (NP (NNS mice)) (VP (VBG expressing) (NP (NN Cre)) (PP (IN from) (NP (DT a) (NN Rag1) (NN knock-in) (NN -LSB-36)))))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (NP (NN Specificity)) (PP (IN of) (NP (NP (NN expression)) (PP (IN of) (NP (DT the) (NN Rag1-Cre) (NN allele)))))) (VP (VP (VBZ has) (ADVP (RB previously)) (VP (VBN been) (VP (VBN described) (NP (CD -LSB-36) (-RRB- -RSB-))))) (CC and) (VP (VBD was) (VP (VBN sustained) (S (VP (VBG using) (NP (DT the) (NN ROSA26-R) (NN reporter) (NNS mice) (NP (NP (CD -LSB-39) (-RRB- -RSB-)) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (NN Figure) (NN S3)))) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (S (NP (JJ Genomic) (NN DNA)) (VP (VBD was) (VP (VBN prepared) (PP (IN from) (NP (NP (NNS tissues)) (VP (VBG using) (NP (NP (NN proteinase) (NN K) (NN digestion)) (CC and) (NP (NN phenol-chloroform) (NN extraction))))))))) (, ,) (CC and) (S (NP (NN filter) (NNS hybridisations)) (VP (VBD were) (VP (VBN carried) (PRT (RP out)) (PP (IN with) (NP (NP (JJ radiolabelled) (NNS probes)) (PP (IN as) (NP (VBN described) (NN -LSB-48,49) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (NP (DT The) (NNS probes)) (VP (VBN used) (S (VP (TO to) (VP (VB detect) (NP (NP (NN antigen) (NN receptor)) (NN gene) (NNS rearrangements))))))) (VP (VBD were) (NP (NP (NP (DT a) (NP (JJ heavy-chain) (NN Ig) (NN μ) (NN intron) (NN enhancer)) (NN probe)) (CD -LSB-41) (-RRB- -RSB-)) (CC and) (NP (NP (DT a) (NP (NN T) (NN cell) (NN receptor)) (NN Jβ2) (NN probe)) (CD -LSB-40) (-RRB- -RSB-))))) (. .)))
( (S (S (NP (NP (NN T) (NN cell) (NN receptor)) (NN V-D-Jβ) (NN junction) (NNS sequences)) (VP (VBD were) (VP (VBN obtained) (PP (IN by) (NP (NP (NP (NN PCR) (NN amplification)) (PP (IN from) (NP (NP (NN thymoma) (NN DNA)) (PP (IN with) (NP (NP (NNS pools)) (PP (IN of) (NP (NN Vβ) (NNS primers)))))))) (CC and) (NP (NP (DT a) (JJ Jβ2) (JJ reverse) (NN primer)) (PRN (-LRB- -LRB-) (NP (NP (NN primer) (NNS sequences)) (PP (IN from) (NP (NN -LSB-42,43)))) (-RRB- -RSB-) (-RRB- -RRB-)))))))) (, ,) (CC and) (S (NP (DT the) (NN product)) (VP (VBD was) (VP (VBN fractionated) (PP (IN on) (NP (NN agarose))) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (DT a) (JJ single) (VBN amplified) (NN band)))))))))) (. .)))
( (S (S (S (PP (IN In) (NP (NN turn))) (, ,) (NP (DT each) (NN band)) (VP (VBD was) (VP (VBN eluted)))) (CC and) (S (NP (DT the) (NN sequence)) (VP (VP (VBN obtained) (S (VP (VBG using) (NP (DT the) (NN Jβ2N) (NN primer) (NN -LSB-43))) (-RRB- -RSB-))) (CC and) (VP (VBN identified) (PP (IN by) (NP (NP (NN comparison)) (PP (IN with) (NP (DT the) (NNP ImMunoGeneTics) (NN database) (CD -LSB-44,45) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (NN RT-PCR)) (VP (VBD was) (VP (VBN carried) (PRT (RP out)) (PP (IN on) (NP (NN cDNA))) (PP (IN as) (NP (VBN described) (NN -LSB-34) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (NN RNA)) (VP (VBD was) (VP (VBN prepared) (S (VP (VBG using) (NP (NN RNeasy)))) (PRN (-LRB- -LRB-) (NP (NP (NNP Quiagen)) (, ,) (NP (NNP Valencia) (, ,) (NNP California)) (, ,) (NP (JJ United) (NNS States))) (-RRB- -RRB-)) (PP (IN from) (NP (NP (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (VP (VP (VBN labelled) (PP (IN with) (NP (JJ FITC-conjugated) (NNS antibodies)))) (CC and) (VP (VBN isolated) (PP (IN by) (NP (NN flow) (NN cytometry))))))))))))) (. .)))
( (S (S (S (NP (NNS Sequences)) (VP (VBP have) (VP (VBN been) (VP (VBN described) (PP (IN for) (NP (NP (NN Pax5)) (CC and) (NP (NN CD3) (NN RT-PCR)) (NP (NNS primers) (CD -LSB-38) (-RRB- -RSB-)))))))) (, ,) (CC and) (S (NP (NP (DT the) (NNS sequences)) (PP (IN of) (NP (DT the) (NN Ews-ERG) (NNS primers)))) (VP (VBD were) (NP (NP (NP (JJ 5′-) (NN CCACAGGATGGTAACAAGCCTGC-3′)) (PRN (-LRB- -LRB-) (NP (NN Ews)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ 5′-) (NN CGAACTTGTAGGCGTAGC-3′)) (PRN (-LRB- -LRB-) (NP (NN ERG)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (DT The) (NN hybridisation) (NN probe)) (VP (VBD was) (NP (NP (DT a) (JJ 303-bp) (NN fragment)) (PP (IN of) (NP (NN Ews-ERG) (NN residing)))) (PP (IN within) (NP (DT the) (NN RT-PCR) (NN product))))) (. .)))
( (S (S (NP (NP (DT A) (NN cohort)) (PP (IN of) (NP (NNS mice)))) (VP (VBD was) (VP (VBN established) (PP (IN by) (S (VP (VBG inter-breeding) (NP (NP (DT the) (NN Ews-ERG) (NN invertor) (NN line)) (PP (IN with) (NP (DT a) (NN Rag1-Cre) (NN line))) (S (LST (CD -LSB-36) (-RRB- -RSB-)) (VP (TO to) (VP (VB generate) (NP (NP (NNS littermates)) (PP (IN with) (NP (NP (NP (NNP Ews-ERG)) (CC +) (NP (NNP Rag1-Cre))) (CC or) (NP (NNP Ews-ERG)) (NP (NNS genotypes))))))))))))))) (. .)))
( (S (S (NP (NNS Genotypes)) (VP (VBD were) (VP (VBN determined) (S (VP (VBG using) (NP (NP (NN filter) (NN hybridisation)) (PP (IN of) (NP (NP (JJ genomic) (NN DNA)) (PP (IN from) (NP (DT a) (JJ small) (NN tail) (NN biopsy))))))))))) (. .)))
( (S (S (S (NP (NP (DT The) (NN health) (NN status)) (PP (IN of) (NP (DT these) (NNS mice)))) (VP (VBD was) (VP (VBN monitored)))) (, ,) (CC and) (S (SBAR (IN if) (S (NP (NP (NNS signs)) (PP (IN of) (NP (NN ill) (NN health)))) (VP (VBD appeared)))) (, ,) (S (S (NP (NNS mice)) (VP (VBD were) (VP (VBN sacrificed)))) (CC and) (S (NP (DT a) (NN post-mortem)) (VP (VBD was) (VP (VBN carried) (PRT (RP out)))))))) (. .)))
( (S (S (NP (NN Tissue) (NNS samples)) (VP (VBD were) (VP (VBN removed) (PP (IN for) (NP (JJ single) (NN cell) (NN preparation))) (PP (PP (IN for) (NP (NP (NN determination)) (PP (IN of) (NP (NP (NN surface) (NN protein) (NN expression)) (NN phenotype))))) (, ,) (PP (IN for) (NP (JJ nucleic) (NN acid) (NN preparation))) (, ,) (CC or) (PP (IN for) (NP (NP (NN fixation)) (PP (IN in) (NP (NP (ADJP (CD 10) (NN %)) (NN formalin)) (PP (IN for) (NP (NN histology))))))))))) (. .)))
( (S (S (NP (NN Blood) (NNS smears)) (VP (VBD were) (VP (VP (VBN prepared)) (CC and) (VP (VBN stained) (PP (IN with) (NP (NN May-Grünwald-Giemsa))))))) (. .)))
( (S (S (PP (IN For) (NP (NN histology))) (, ,) (NP (JJ fixed) (NNS tissues)) (VP (VBD were) (ADJP (JJ embedded) (PP (IN in) (NP (NP (NN wax) (CC and) (NN 0.4-μ) (NNS sections)) (VP (VBN made)) (, ,) (VP (VBN stained) (PP (IN with) (NP (NP (NN haematoxylin)) (CC and) (NP (NN eosin)))))))) (PP (IN after) (NP (NN mounting))) (PP (IN on) (NP (NNS slides))))) (. .)))
( (S (S (NP (NN FACS) (NN analysis)) (VP (VBD was) (VP (VBN conducted) (S (VP (VBG using) (NP (NP (DT a) (NN FACSCalibur)) (PP (IN with) (NP (NP (JJ fluorescent) (NNS antibodies)) (VP (VBN purchased) (PP (IN from) (NP (NP (NNP BD) (NNP Biosciences)) (PRN (-LRB- -LRB-) (NP (NP (NNP San) (NNP Jose)) (, ,) (NP (NNP California)) (, ,) (NP (JJ United) (NNS States))) (-RRB- -RRB-))))))))))))) (. .)))
( (S (S (NP (NNS Data)) (VP (VBD were) (VP (VBN analysed) (PP (IN with) (NP (NP (NN CellQuest) (NN software)) (PRN (-LRB- -LRB-) (NP (NNP BD) (NNP Biosciences)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NN Western) (NN protein) (NN detection)) (VP (VBD was) (VP (VBN carried) (RP out) (SBAR (IN as) (S (VP (VBN described) (NP (CD -LSB-36) (-RRB- -RSB-)) (S (VP (VBG using) (NP (NP (NP (CD 18) (NNS μg)) (PP (IN of) (NP (NN protein))) (PP (IN per) (NP (NNP lane)))) (CC and) (NP (NP (NNS proteins)) (VP (VBN fractionated) (PP (IN on) (NP (ADJP (QP (CD 4) (NN %) (CD –20)) (NN %)) (NN SDS-PAGE)))))))))))))) (. .)))
( (S (S (NP (DT The) (VBN separated) (NNS proteins)) (VP (VBD were) (ADJP (JJ electro-transferred) (PP (TO to) (NP (NP (NP (NN PVDF) (NN nylon) (NNS membranes)) (PRN (-LRB- -LRB-) (NP (NP (NNP Millipore)) (, ,) (NP (NNP Billerica) (, ,) (NNP Massachusetts)) (, ,) (NP (JJ United) (NNS States))) (-RRB- -RRB-))) (CC and) (NP (NP (JJ specific) (NNS proteins)) (VP (VBN detected) (S (VP (VBG using) (NP (NP (NP (JJ anti-Ews) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NNP Santa) (NNP Cruz) (NN Biotechnology) (, ,) (NNP Santa) (NNP Cruz) (, ,) (NNP California)) (, ,) (NP (JJ United) (NNS States)) (: ;) (S (VP (VBN raised) (PP (IN against) (NP (NP (DT the) (NN amino) (NN terminus)) (PP (IN of) (NP (NN Ews))))))) (-RRB- -RRB-))) (CC or) (NP (NP (JJ anti-ERG) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NNP Santa) (NNP Cruz) (NN Biotechnology)) (: ;) (S (VP (VBN raised) (PP (IN against) (NP (NP (DT the) (NN carboxy) (NN terminus)) (PP (IN of) (NP (NN ERG))))))) (-RRB- -RRB-))))))))))))) (. .)))
( (S (S (NP (NP (NN Antibody)) (VP (VBD bound) (PP (TO to) (NP (NN filter))))) (VP (VBD was) (VP (VBN detected) (S (VP (VBG using) (NP (NP (JJ secondary) (NNS antibodies)) (CC and) (NP (NN ECL))) (PP (IN as) (VP (VBN described) (PP (IN by) (NP (DT the) (NN manufacturer))) (PRN (-LRB- -LRB-) (NP (NP (NNP Amersham) (NNP Biosciences) (, ,) (NNP Amersham)) (, ,) (NP (JJ United) (NN Kingdom))) (-RRB- -RRB-))))))))) (. .)))
( (S (NP (NP (NN Figure)) (CC and) (NP (NN Table)) (NP (NNS captions)))))
( (S (NP (NP (NN Figure) (CD 1)) (: :) (S (NP (NP (NN Strategy)) (PP (IN for) (S (VP (VBG Generating) (NP (NN Ews-ERG) (NN Invertor) (NN Gene)) (PP (IN by) (NP (JJ Homologous) (NN Recombination))))))) (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP (NP (DT The) (NN method)) (PP (IN for) (S (VP (VBG making) (NP (NN invertor) (NNS mice)))))) (VP (VBZ is) (VP (VBN described) (PP (IN in) (NP (NN detail) (QP (RB elsewhere) (CD -LSB-35)))))) (-RRB- -RSB-)) (. .))))
( (S (PP (IN In) (NP (NN summary))) (, ,) (NP (NP (NP (NP (DT an) (JJ invertor) (NN cassette)) (VP (VBG comprising) (NP (NP (DT a) (JJ short) (JJ intronic) (NN region)) (PP (IN with) (NP (NP (DT an) (NN acceptor) (NN splice) (NN site)) (, ,) (NP (NP (JJ human) (NN ERG) (NN cDNA) (NN sequence)) (PRN (-LRB- -LRB-) (VP (VBN shown) (PP (IN in) (NP (NN Figure) (NN S1)))) (-RRB- -RRB-))) (, ,) (NP (DT a) (NN polyA) (NN site)) (, ,)))))) (CC and) (NP (DT the) (NN MC1neopA) (NN gene) (NN all))) (VP (VBN flanked) (PP (IN by) (NP (NP (JJ loxP) (NNS sites)) (-LRB- -LRB-) (VP (VBN depicted) (PP (IN by) (NP (JJ black) (NNS triangles)))) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBD knocked) (PP (IN in)) (, ,) (S (VP (VBG using) (NP (JJ homologous) (NN recombination)) (, ,) (PP (IN into) (NP (NN Ews) (NN intron) (CD 8))))))) (. .)))
( (S (S (NP (NP (DT The) (NN transcription) (NN orientation)) (PP (IN of) (NP (DT the) (VBN targeted) (NN ERG) (NN cDNA) (NN invertor) (NN cassette)))) (VP (VBD was) (ADJP (JJ opposite) (PP (IN from) (NP (NP (DT that)) (PP (IN of) (NP (DT the) (JJ endogenous) (NN Ews) (NN gene)))))) (PP (IN after) (NP (JJ initial) (JJ homologous) (NN recombination))))) (. .)))
( (S (S (NP (NP (NN Germ) (NN line) (NN carrier) (NNS mice)) (PP (IN of) (NP (DT this) (VBN targeted) (NN allele)))) (VP (VBD were) (VP (VBN crossed) (PP (IN with) (NP (JJ Cre-expressing) (NN mouse) (NNS strains) (CD -LSB-36) (-RRB- -RSB-)))))) (, ,) (CC and) (S (, ,) (SBAR (IN as) (S (VP (VBN indicated) (PP (IN in) (NP (NP (DT the) (JJ right) (NN hand) (NN side)) (PP (IN of) (NP (DT the) (NN diagram)))))))) (, ,) (NP (DT the) (NN invertor) (NN cassette)) (VP (VBZ is) (VP (VBD turned) (SBAR (IN around) (S (VP (TO to) (VP (VB create) (NP (NP (DT a) (NN transcription) (NN orientation)) (ADJP (JJ identical) (PP (IN with) (NP (NP (DT that)) (PP (IN of) (NP (NN Ews)))))))))))))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (PP (IN after) (NP (NN transcription))) (, ,) (NP (DT a) (NN pre-mRNA)) (VP (VBZ is) (VP (VBN made) (PP (IN with) (NP (NP (DT the) (NN donor) (NN splice) (NN site)) (PP (IN of) (NP (NN Ews) (NN exon) (CD 7))) (ADJP (JJ adjacent) (PP (TO to) (NP (NP (DT the) (NN acceptor) (NN site)) (PP (IN of) (NP (DT the) (NN invertor) (NN cassette))))))))) (, ,) (S (VP (VBG allowing) (NP (NP (JJ post-transcriptional) (NN fusion)) (PP (IN of) (NP (NN Ews))) (PP (IN with) (NP (NN ERG)))) (PP (IN in) (NP (NP (DT an) (JJ analogous) (NN format)) (PP (TO to) (NP (NP (DT that)) (VP (VBN found) (PP (IN in) (NP (NP (JJ human) (NNS sarcomas)) (PP (IN with) (NP (NN t) (-LRB- -LRB-) (CD 21) (: ;) (CD 22) (-RRB- -RRB-))))))))))))) (. .)) (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-))))
( (S (S (NP (NP (JJ Genomic) (NN sequence)) (ADJP (JJ adjacent) (PP (TO to) (NP (NP (DT the) (NP (NN Ews) (NN exon) (CD 7)) (CC and) (NP (DT the) (NN ERG) (NN invertor) (NN cassette))) (PRN (-LRB- -LRB-) (S (NP (DT the) (VBN derived) (NN amino) (NN acid) (NN sequence)) (VP (VBZ is) (VP (VBN shown) (PP (IN in) (NP (NP (DT the) (JJ single) (NN letter)) (VP (VBP code))))))) (-RRB- -RRB-)))))) (VP (VBN obtained) (PP (IN from) (NP (NP (NN DNA)) (PP (PP (IN of) (NP (NN ES) (NNS cells))) (CC and) (PP (IN of) (NP (NN thymus)))))) (PP (IN after) (NP (JJ Cre-mediated) (NN inversion))))) (. .)))
( (S (S (NP (DT The) (NN Ews) (NN intron) (JJ 7/8) (NN donor) (NN splice) (NN site)) (VP (VBZ is) (VP (VBN indicated) (PP (IN by) (NP (DT an) (NN arrow)))))) (. .)))
( (S (NP (NP (DT The) (JJ boxed) (NN sequence)) (-LRB- -LRB-))))
( (S (NP (NN TCTAG/))))
( (S (NP (NN CGAT) (-RRB- -RRB-)) (VP (VBZ corresponds) (PP (TO to) (NP (NP (DT the) (NN ligation)) (PP (IN of) (NP (NP (JJ filled-in) (NP (NP (NP (NN XbaI)) (PRN (-LRB- -LRB-) (NP (NN Ews) (JJ genomic)) (-RRB- -RRB-))) (CC and) (NP (NP (NN ClaI)) (PRN (-LRB- -LRB-) (NP (NN ERG) (NN invertor) (NN cassette)) (-RRB- -RRB-)))) (NNS sites)) (PRN (-LRB- -LRB-) (SBAR (IN for) (S (NP (JJ detailed) (NN description)) (VP (VB see) (NP (CD -LSB-35) (-RRB- -RSB-))))) (-RRB- -RRB-))))))) (. .)))
( (S (NP (NP (DT The) (JJ boxed) (NN XbaI) (NN site)) (-LRB- -LRB-))))
( (S (NP (NN TCTAGA) (-RRB- -RRB-)) (VP (VBZ corresponds) (PP (TO to) (NP (NP (DT the) (NN position)) (PP (IN of) (NP (NP (NN cloning)) (PP (IN of) (NP (NP (DT the) (NN mouse) (NN Af4) (JJ intronic) (NN sequence)) (PRN (-LRB- -LRB-) (NP (JJ shaded)) (-RRB- -RRB-)))))) (PP (IN in) (NP (DT the) (NN ERG) (NN invertor) (NN cassette)))))) (. .)))
( (S (PP (IN On) (NP (NP (DT the) (JJ 3′) (NN side)) (PP (IN of) (NP (DT the) (VBN fused) (NN XbaI-ClaI) (NNS sites))))) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (DT a) (JJ loxP) (NN site)) (VP (VBG originating) (PP (IN from) (NP (NP (NP (DT the) (JJ ERG) (NN invertor) (NN cassette)) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (NN Figure) (NN S1)))) (-RRB- -RRB-))) (VP (VBN followed) (PP (IN by) (NP (NP (DT the) (NP (NP (NN Af4) (NN intron) (CD 4)) (PRN (-LRB- -LRB-) (NP (JJ shaded)) (-RRB- -RRB-)))) (ADVP (RB upstream) (PP (IN of) (NP (DT the) (NN ERG) (NN cDNA) (NN sequence)))))))))))) (. .)))
( (S (S (NP (DT The) (NN Af4) (NN acceptor) (NN splice) (NN site)) (VP (VP (VBZ is) (VP (VBN indicated) (PP (IN by) (NP (DT an) (NN arrow))))) (, ,) (CC and) (VP (VBZ is) (VP (VBN followed) (PP (IN by) (NP (DT the) (NN ERG) (NN cDNA) (NN sequence))))))) (. .)))
( (S (S (NP (NP (DT A) (NNP NotI) (NN site)) (VP (VBN used) (PP (IN for) (S (VP (VBG cloning) (NP (DT the) (VBN amplified) (NN ERG) (NN sequence))))))) (VP (VBZ is) (VP (VBN boxed) (PRN (-LRB- -LRB-) (S (VP (VB see) (ADVP (RB also)) (NP (NN Figure) (NN S1)))) (-RRB- -RRB-)) (PRN (-LRB- -LRB-) (NP (NP (NN note)) (PRN (S (S (NP (DT this) (NN sequence)) (VP (VBZ is) (ADJP (JJ non-contiguous)))) (CC and) (S (NP (DT the) (NNS dots)) (VP (VBP represent) (NP (DT a) (NN gap)))) (: ;) (S (NP (DT the) (JJ full) (NN sequence)) (VP (VBZ appears) (PP (IN in) (NP (NN -LSB-35)))))) (-RRB- -RSB-))) (-RRB- -RRB-))))) (. .)))
( (S (NP (NP (NN Figure) (CD 2)) (: :) (S (NP (NP (NP (NN Incidence)) (PP (IN of) (NP (JJ Haematological) (NN Malignancy)))) (CC and) (NP (NP (NNS Characteristics)) (PP (IN of) (NP (NP (NNP Ews-ERG) (NNP Invertor) (NNP MiceCohorts)) (PP (IN of) (NP (NP (CD 29) (NN Ews-ERG) (: ;) (NN Rag1-Cre) (NNS mice)) (CC and) (NP (CD 20) (NN Ews-ERG) (NN control) (NNS mice)))))))) (VP (VBD were) (VP (VBN monitored) (PP (IN over) (NP (NP (DT a) (NN period)) (PP (IN of) (NP (QP (RB approximately) (CD 17)) (NN mo)))))))) (. .))))
( (S (S (S (NP (NNS Mice)) (VP (VBD were) (VP (VBN culled)))) (CC and) (S (NP (NP (DT a) (NN post-mortem)) (VP (VBN conducted) (PP (IN when) (NP (NP (NNS signs)) (PP (IN of) (NP (NN ill) (NN health))))))) (VP (VBD were) (VP (VBN observed))))) (. .)))
( (S (S (NP (NN Leukaemia/lymphoma)) (VP (VBD was) (VP (VBN established) (PP (IN by) (NP (NP (JJ various) (NNS criteria)) (PRN (-LRB- -LRB-) (NP (VB see) (NP (NP (NNS Materials)) (CC and) (NP (NNS Methods)))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NN Top) (NN panel)) (VP (VBZ shows) (NP (NP (DT the) (NN survival) (NN curve)) (PP (IN of) (NP (NN Ews-ERG) (: ;) (NN Rag1-Cre) (-LRB- -LRB-) (NN +Cre) (-RRB- -RRB-) (CC or) (JJ Ews-ERG) (-LRB- -LRB-) (NN −Cre) (-RRB- -RRB-) (NNS mice)))) (PP (IN as) (NP (NP (DT a) (NN function)) (PP (IN of) (NP (NP (NN time)) (PRN (-LRB- -LRB-) (NP (NNS days)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NN Bottom) (NN panel)) (VP (VBZ shows) (NP (NP (DT the) (NN histology)) (PP (IN of) (NP (NP (NP (NN blood)) (CC and) (NP (NN bone) (NN marrow))) (PP (IN from) (NP (JJ leukaemic) (NNS mice)))))) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP M21)) (CC and) (NP (NNP M20))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-)))) (. .)))
( (S (S (NP (NN Blood) (NNS smears)) (VP (VBD were) (VP (VP (VBN stained) (PP (IN with) (NP (NN May-Grünwald-Giemsa) (NN stain)))) (CC and) (VP (VBN photographed) (PP (IN at) (NP (NN 400×) (NN magnification))))) (, ,) (SBAR (IN whilst) (S (NP (NN bone) (NN marrow)) (VP (VBD was) (VP (VBN photographed) (PP (IN at) (NP (NN 1,000×))))))))) (. .)))
( (S (NP (NP (NN Figure) (CD 3)) (: :) (S (NP (NP (NN Clonality)) (PP (IN of) (NP (NN T) (NN Cell) (NN Neoplasias) (NN inEws-ERG) (NN Invertor) (JJ MiceGenomic) (NN DNA)))) (VP (VBD was) (VP (VBN prepared) (PP (IN from) (NP (NP (JJ various) (NNS tissues)) (PP (IN of) (NP (NP (JJ invertor) (NNS mice)) (PP (IN with) (NP (NN thymomas)))))))))) (. .))))
( (S (S (NP (JJ Genomic) (NN analysis)) (VP (VBD was) (VP (VBN carried) (PRT (RP out)) (S (VP (VBG using) (NP (NN filter) (NN hybridisation)) (S (VP (VP (TO to) (VP (VB assess) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (DT the) (JJ inverted) (NN ERG) (NN cassette))) (PP (IN in) (NP (NP (DT the) (NN tumour) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-))))))) (, ,) (CC and) (VP (TO to) (VP (VB assess) (SBAR (IN whether) (S (NP (NP (DT the) (NNS lymphocytes)) (VP (VBN involved) (PP (IN in) (NP (DT the) (NNS tumours))))) (VP (VBD were) (NP (NP (NP (NP (NP (NP (NP (JJ clonal) (NN T)) (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-))) (CC or) (NP (NN B) (NNS cells))) (PRN (-LRB- -LRB-) (NP (NN C)) (-RRB- -RRB-))) (. .)) (PRN (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-))) (NN Inversion) (NN hybridisation) (NN autoradiograph)))))))))))))) (. .)))
( (S (S (NP (NN DNA)) (VP (VBD was) (VP (VP (VBN prepared) (PP (IN from) (NP (NP (DT the) (NP (NN thymoma)) (CC and) (NP (JJ other) (NNS tissues))) (PP (IN of) (NP (NN M18)))))) (, ,) (VP (VBN cleaved) (PP (IN with) (NP (NN EcoRI)))) (CC and) (VP (VBN hybridised) (PP (TO to) (NP (NP (DT the) (JJ 5′) (NN Ews) (NN probe)) (-LRB- -LRB-) (SBAR (WHNP (WDT which)) (S (VP (VBZ detects) (NP (NP (DT a) (JJ 5-kb) (JJ targeted) (NN ERG) (NN cassette) (NN fragment)) (CC or) (NP (DT a) (JJ 6.5-kb) (JJ Cre-inverted) (NN fragment)))))) (-RRB- -RRB-))))))) (. .)))
( (S (S (SBAR (IN If) (S (NP (DT the) (NN ERG) (NN cassette)) (VP (VBZ is) (VP (VBN inverted) (PP (IN by) (NP (NN Cre) (NN activity))))))) (, ,) (NP (NP (DT the) (NN size)) (PP (IN of) (NP (DT the) (NN EcoRI) (NN fragment)))) (VP (VBZ increases) (PP (IN from) (NP (DT the) (JJ initial) (JJ targeted) (NN gene) (NN size))) (, ,) (SBAR (IN as) (S (VP (VBN indicated) (PP (IN in) (NP (NP (DT the) (NNS maps)) (PP (IN below) (NP (DT the) (NN figure)))))))))) (. .)))
( (S (S (NP (NP (DT The) (NNS data)) (VP (VBN shown))) (VP (VBP are) (PP (IN for) (NP (NP (NN DNA)) (VP (VBN extracted) (PP (IN from) (NP (NP (NP (NN spleen)) (PRN (-LRB- -LRB-) (NP (NN spl)) (-RRB- -RRB-))) (, ,) (NP (NP (NN thymus)) (PRN (-LRB- -LRB-) (NP (NN thy)) (-RRB- -RRB-))) (, ,) (NP (NP (NN liver)) (PRN (-LRB- -LRB-) (NP (NN liv)) (-RRB- -RRB-))) (, ,) (NP (NP (NN kidney)) (PRN (-LRB- -LRB-) (NP (NN kid)) (-RRB- -RRB-))) (CC or) (NP (NP (NN tail)) (PRN (-LRB- -LRB-) (S (NP (NN ES) (NN cell) (NN DNA)) (VP (VBZ is) (VP (VBN used) (PP (IN as) (NP (DT a) (NN control)))))) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ Cre-mediated) (JJ inverted) (NN band)) (PRN (-LRB- -LRB-) (NP (CD ∼6.5) (NN kb)) (-RRB- -RRB-))) (VP (VBZ is) (ADJP (JJ evident) (PP (IN in) (NP (NP (NN thymus) (NN DNA)) (PRN (-LRB- -LRB-) (NP (NN thymoma)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (DT The) (NN summary)) (PP (IN of) (NP (NP (DT the) (NNS data)) (PP (IN from) (NP (NP (DT the) (NN cohort)) (PP (IN of) (NP (NN invertor) (NNS mice)))))))) (VP (VBZ is) (PP (IN in) (NP (NN Table) (CD 2))))) (. .)))
( (S (S (VP (VB Note) (SBAR (IN that) (S (S (PP (IN despite) (NP (NP (JJ extensive) (NN infiltration)) (PP (IN of) (NP (NP (NN spleen)) (VP (VBN detected) (PP (IN by) (NP (NN histology)))))))) (, ,) (NP (PRP we)) (ADVP (RB cannot)) (VP (VB see) (NP (NP (DT the) (JJ inverted) (NN band)) (PP (IN by) (NP (NN Southern) (NN blot)))))) (: ;) (S (NP (DT this)) (ADVP (RB presumably)) (VP (VBZ reflects) (NP (NP (JJ regional) (NN clustering)) (PP (IN of) (NP (NP (JJ neoplastic) (NNS cells)) (PP (IN in) (NP (NN spleen)))))))))))) (. .)))
( (S (S (NP (NN Restriction) (NN fragment) (NNS sizes)) (VP (VBP are) (VP (VBN represented) (PP (IN as) (NP (NP (NP (NN germ) (NN line)) (PRN (-LRB- -LRB-) (NP (NN GL)) (-RRB- -RRB-))) (, ,) (NP (NP (NP (JJ inverted) (NN allele)) (PP (IN of) (NP (NP (NN ERG) (NN cassette)) (PRN (-LRB- -LRB-) (NP (NN inv)) (-RRB- -RRB-))))) (CC and) (NP (NP (JJ initial) (JJ targeted) (NN Ews) (NN allele)) (PRN (-LRB- -LRB-) (NP (NN Tgt)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN organisation)) (PP (IN of) (NP (DT the) (VBN targeted) (NN Ews) (NN allele)))) (VP (VBZ is) (VP (VBN indicated) (NP (NN underneath))))) (. .)))
( (S (S (NP (DT The) (NN hybridisation) (NN autoradiograph)) (VP (VBZ shows) (NP (NP (NP (DT the) (NN location)) (PP (IN of) (NP (NN Ews) (NN exon) (CD 7)))) (CC and) (NP (NP (NP (NP (DT the) (JJ initial) (JJ targeted) (NN orientation)) (PRN (-LRB- -LRB-) (NP (NN bottom)) (-RRB- -RRB-))) (CC or) (NP (JJ inverted) (NN orientation))) (PP (IN of) (NP (NN ERG) (NN invertor) (NN cassette))))) (PP (IN after) (NP (NP (JJ Cre-mediated) (NN recombination)) (PRN (-LRB- -LRB-) (NP (NN top)) (-RRB- -RRB-)))))) (. .)))
( (S (NP (NP (NN a)) (, ,) (NP (NP (NN acceptor) (NN splice) (NN site.)) (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-))))))
( (S (S (NP (NP (NN Autoradiograph)) (VP (VBG showing) (NP (NP (NN rearrangement)) (PP (IN of) (NP (NN T) (NN cell) (NN receptor)))))) (VP (VBZ β) (NP (NN locus)))) (. .)))
( (S (NP (NP (NP (DT A) (NN T) (NN cell) (NN receptor)) (PRN (NN Jβ2) (NN probe) (NN -LSB-40) (-RRB- -RSB-))) (PRN (-LRB- -LRB-) (ADVP (RB diagrammatically)) (VP (VBN shown) (PP (IN below) (NP (DT the) (NN autoradiograph)))) (-RRB- -RRB-))) (VP (VBZ detects) (NP (DT a) (JJ 5-kb) (NN germ) (NN line) (NN HindIII) (NN Jβ2) (NN band)) (SBAR (IN whilst) (S (NP (NP (NN V-D-Jβ2) (NNS joins)) (PP (IN in) (NP (NN T) (NNS cells)))) (VP (VBP result) (PP (IN in) (NP (NP (JJ new) (JJ HindIII-sized) (NNS bands)) (PP (VBG depending) (PP (IN on) (NP (NP (DT the) (NN nature)) (PP (IN of) (NP (DT the) (NN rearrangement)))))))))))) (. .)))
( (S (S (NP (NP (DT Each)) (PP (IN of) (NP (NP (CD 12) (NN thymoma) (NNS DNAs)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (VP (VBN compared)))))))) (VP (VBD showed) (NP (QP (CD one) (CC or) (CD two)) (NN Jβ2) (NNS alleles) (JJ rearranged)) (, ,) (S (VP (VBG signifying) (SBAR (IN that) (S (NP (DT these) (NNS tumours)) (VP (VBD were) (NP (JJ clonal) (NN T) (NNS cells))))))))) (. .)))
( (S (S (PP (IN In) (NP (DT some) (NN thymoma) (NNS samples))) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (ADJP (RB almost) (JJ complete)) (NN absence)) (PP (IN of) (NP (DT the) (NN germ) (NN line) (NN band)))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (DT the) (NNS thymuses)) (PP (IN of) (NP (DT these) (NNS mice)))) (VP (VBP are) (ADVP (RB solely)) (VP (VBN comprised) (PP (IN of) (NP (JJ malignant) (JJ clonal) (NN T) (NNS cells))))))))))) (. .)))
( (S (S (NP (NP (NN DNA) (NN sequence) (NN analysis)) (PP (IN of) (NP (NP (DT the) (NN V-D-J) (NNS junctions)) (PP (IN of) (NP (NNS mice) (NP (NP (NN M2)) (, ,) (NP (NN M5)) (, ,) (NP (NN M13)) (, ,) (CC and) (NP (NN M18)))))))) (VP (VBD showed) (NP (JJ functional) (NN V-D-J) (NNS joins)) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (NN Table) (CD 2)))) (-RRB- -RRB-))) (. .)) (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-))))
( (S (S (NP (NN Autoradiograph)) (VP (VBG showing) (NP (NP (NN rearrangement) (NN status)) (PP (IN of) (NP (NN immunoglobulin) (NN heavy-chain) (NNS genes)))))) (. .)))
( (S (S (NP (NP (DT A) (NN Cμ) (NN intron) (NN probe) (CD -LSB-41) (-RRB- -RSB-)) (PRN (-LRB- -LRB-) (ADVP (RB diagrammatically)) (VP (VBN shown) (PP (IN below) (NP (DT the) (NN autoradiograph)))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB hybridise) (NP (NP (DT a) (NN set)) (PP (IN of) (NP (NN thymoma) (NNS DNAs)))) (PP (IN for) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ Igh) (JJ rearranged) (NNS bands))))))))))) (. .)))
( (S (S (NP (QP (RB Only) (CD two)) (NNS samples)) (VP (VBD showed) (NP (NN rearrangements.)))) (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-))))
( (S (NP (NP (NN Detection)) (PP (IN of) (NP (NN Ews-Erg) (NN fusion) (NN protein))) (PP (IN in) (NP (NN thymoma) (NNS cells))) (. .))))
( (S (S (NP (JJ Single) (NN cell) (NNS suspensions)) (VP (VBD were) (VP (VP (VBN made) (PP (IN of) (NP (NP (NN T) (NNS cells)) (PP (PP (IN from) (NP (NP (DT a) (JJ normal) (NN thymus)) (PRN (-LRB- -LRB-) (NP (NN wt)) (-RRB- -RRB-)))) (CC or) (PP (IN from) (NP (NP (DT the) (NN thymoma)) (PP (IN of) (NP (NP (NN M6)) (, ,) (NP (NP (NN protein)) (VP (VBN fractionated) (PP (IN on) (NP (ADJP (QP (CD 4) (NN %) (CD –20)) (NN %)) (NN acrylamide) (NN gel))))) (, ,))))))))) (CC and) (VP (VBN transferred) (PP (TO to) (NP (NN nylon) (NNS membranes))))))) (. .)))
( (S (S (NP (JJ Specific) (NNS proteins)) (VP (VBD were) (VP (VBN detected) (PP (IN with) (NP (NP (NN anti-Ews)) (CC or) (NP (NN anti-ERG) (NN antibody))))))) (. .)))
( (S (S (NP (NP (NN Figure) (CD 4)) (: :) (S (NP (NP (NP (NN B)) (CC and) (NP (NN T))) (NNS Cells)) (VP (VBP Express) (NP (NP (DT the) (NN Ews-ERG) (NN Fusion) (NN RNAA) (JJ 96-d-old) (NN mouse)) (PP (IN with) (NP (DT both) (NN Ews-ERG) (CC and) (NN Rag1-Cre) (NNS alleles))))))) (VP (VBD was) (VP (VBN used) (PP (IN as) (NP (NP (DT a) (NN source)) (PP (IN of) (NP (NP (NP (NN spleen)) (CC and) (NP (NN thymus))) (NNS cells)))))))) (. .)))
( (S (NP (NP (JJ Single) (NN cell) (NNS suspensions)) (PP (IN of) (NP (NN spleen) (NNS cells)))) (VP (VBD were) (VP (VBN labelled) (PP (PP (IN with) (NP (NN anti-B220))) (CC or) (PP (IN with) (NP (NN anti-Thy1.2))))))))
( (S (S (CC and) (VP (VBD were) (VP (VBN purified) (S (VP (VBG using) (NP (DT a) (NN MoFlo) (NN preparative) (NN flow) (NN cytometer))))))) (. .)))
( (S (S (NP (VBN Estimated) (NNS purities)) (VP (VBD were) (VP (VBN achieved) (PP (IN of) (NP (QP (JJR greater) (IN than) (CD 95)) (NN %)))))) (. .)))
( (S (NP (NN cDNA)) (VP (VBD was) (VP (VBN prepared) (PP (IN from) (NP (NP (NN RNA)) (VP (VBN extracted) (PP (PP (IN from) (NP (VBN sorted) (NNS cells))) (CC or) (PP (IN from) (NP (NP (NNS aliquots)) (PP (IN of) (NP (NP (NP (NP (JJ unsorted) (NNS populations)) (CC and) (NP (NN RT-PCR))) (PRN (-LRB- -LRB-) (NP (NP (QP (RB approximately) (CD 3,400)) (NN B220+) (CC or) (CD 6,400) (NN Thy1.2+) (NN cell) (NNS equivalents)) (PP (IN per) (NP (NN PCR) (NN reaction)))) (-RRB- -RRB-))) (VP (VBN carried) (PRT (RP out)) (PP (IN with) (NP (NP (NP (JJ specific) (NN Pax5)) (PRN (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-))) (, ,) (NP (NP (NN CD3)) (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-))) (CC or) (NP (NP (NN Ews-ERG)) (PRN (-LRB- -LRB-) (NP (NN C)) (-RRB- -RRB-))) (NP (NNS primers))))))))))))))) (. .)))
( (S (S (NP (NN PCR) (NN reaction) (NNS products)) (VP (VBD were) (VP (VP (VBN fractionated) (PP (IN on) (NP (NP (NP (ADJP (CD 1) (NN %)) (NN agarose) (NNS gels)) (CC and) (NP (DT either))) (VP (VBN stained) (PP (IN with) (NP (NN ethidium) (NN bromide))))))) (CC and) (VP (VBN photographed) (PRN (-LRB- -LRB-) (NP (NP (NN A)) (CC and) (NP (NN B))) (-RRB- -RRB-)))))) (CC or) (S (NP (NN gel)) (VP (VP (VBN blotted)) (CC and) (VP (VBN hybridised) (PP (IN with) (NP (DT an) (NN Ews-ERG) (NN probe)))))) (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-))))
( (S (NP (NP (NN Figure) (CD 5)) (: :) (S (S (NP (NP (NN Analysis)) (PP (IN of) (NP (NP (NN Cell) (NN Surface) (NNS Antigens)) (PP (IN of) (NP (NP (NN Thymomas)) (PP (IN from) (NP (NN Ews-ERG) (NN Invertor) (NNS Mice))))))) (VP (VBG Using) (NP (NN Flow) (NN CytometryThymus) (NN tissue)))) (VP (VBD was) (ADJP (JJ resected) (PP (IN from) (NP (NP (NNS mice)) (PP (IN with) (NP (NN thymoma)))))))) (CC and) (S (NP (NN FACS) (NN analysis)) (VP (VBN performed) (S (VP (TO to) (VP (VB determine) (NP (NP (NN T) (NN cell) (NN phenotype)) (-LRB- -LRB-) (VP (VBN summarised) (PP (IN in) (NP (NN Table) (CD 1)))) (-RRB- -RRB-)))))))) (. .))))
( (S (S (NP (NP (DT The) (NNS data)) (PP (IN in) (NP (DT the) (NN figure)))) (VP (VBP show) (NP (NP (JJ representative) (NN flow) (NNS diagrams)) (PP (IN of) (NP (NP (CD three) (JJ tumour-bearing) (NNS mice)) (PRN (-LRB- -LRB-) (NP (NP (NN M2)) (, ,) (NP (NN M3)) (, ,) (CC and) (NP (NN M4))) (-RRB- -RRB-))))) (PP (VBN compared) (PP (IN with) (NP (NP (DT a) (JJ wild-type) (NN C57BL/6) (NN control)) (PRN (-LRB- -LRB-) (NP (NN wt)) (-RRB- -RRB-))))) (, ,) (S (VP (VP (VBG using) (NP (NP (NP (NN anti-Thy1)) (PRN (-LRB- -LRB-) (NP (NN y-axis)) (-RRB- -RRB-))) (CC plus) (NP (NN anti-B220) (-LRB- -LRB-) (NN x-axis) (-RRB- -RRB-) (NNS antibodies)))) (CC or) (VP (VBG using) (NP (JJ anti-CD8) (-LRB- -LRB-) (NN y-axis) (-RRB- -RRB-) (CC plus) (JJ anti-CD4) (-LRB- -LRB-) (NN x-axis) (-RRB- -RRB-) (NNS antibodies))))))) (. .)))
( (S (S (S (NP (DT The) (CD three) (NNS thymomas)) (VP (VBP show) (NP (NP (DT a) (NN range)) (PP (IN of) (NP (NP (NP (NP (NN CD4)) (CC and) (NP (NN CD8))) (NN co-expression) (NNS phenotypes)) (VP (VBG characterizing) (NP (NP (DT the) (NNS thymomas)) (VP (VBN generated) (PP (IN in) (NP (DT the) (NN Ews-ERG) (: ;) (NN Rag1-Cre) (JJ invertor) (NNS mice))))))))))) (. .)) (. .)))
( (S (NP (NP (NN Table) (CD 1)) (: :) (NP (NP (NN Tumour) (NNS Characteristics)) (PP (IN of) (NP (NP (NN Ews-ERG) (NN Invertor) (NNS Mice)) (VP (VBG Expressing) (NP (NP (NN Cre) (NN Recombinase)) (PP (IN from) (NP (DT the) (NN Rag1) (NN Gene)))))))))))
( (S (NP (NP (NN Table) (CD 2)) (: :) (NP (NP (NNS Sequences)) (PP (IN of) (NP (JJ Rearranged) (NN TCR) (NN Jβ) (NNS Loci))) (PP (IN in) (NP (NN Ews-ERG) (NN Thymoma) (NN DNA)))))))
( (S (NP (NP (DT A) (NN role)) (PP (IN for) (NP (DT the) (NN Tec) (NN family) (NN kinase) (NN ITK))) (PP (IN in) (S (VP (VBG regulating) (NP (NN SEB) (JJ induced) (NN Interleukin-2) (NN production)) (ADVP (FW in) (FW vivo)) (PP (IN via) (NP (NN c-jun) (NN phosphorylation)))))))))
( (S (NP (NN Abstract))))
( (S (NP (NP (NN Background)) (: :) (S (NP (NP (NN Exposure)) (PP (TO to) (NP (NP (NP (JJ Staphylococcal) (NN Enterotoxin) (NN B)) (PRN (-LRB- -LRB-) (NP (NN SEB)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (JJ bacterial) (NN superantigen)) (VP (VBN secreted) (PP (IN by) (NP (DT the) (JJ Gram-positive) (NNS bacteria))) (ADVP (FW Staphyloccocus) (FW aureus)))) (, ,)))) (VP (VBZ results) (PP (IN in) (NP (NP (NP (DT the) (NN expansion)) (CC and) (NP (NP (NP (JJ eventual) (JJ clonal) (NN deletion)) (CC and) (NP (NN anergy))) (PP (IN of) (NP (NN Vβ8+) (NN T) (NNS cells))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (JJ massive) (NN cytokine) (NN release)) (, ,) (PP (VBG including) (NP (NP (NN Interleukin-2)) (PRN (-LRB- -LRB-) (NP (NN IL-2)) (-RRB- -RRB-)))))))) (. .))))
( (S (S (NP (DT This) (NN IL-2)) (VP (VP (VBZ is) (ADVP (RB rapidly)) (VP (VBN secreted) (PP (VBG following) (NP (NP (NN exposure)) (PP (TO to) (NP (NN SEB))))))) (CC and) (VP (MD may) (VP (VB contribute) (PP (TO to) (NP (NP (DT the) (NNS symptoms)) (VP (VBN seen) (PP (VBG following) (NP (NP (NN exposure)) (PP (TO to) (NP (DT this) (JJ bacterial) (NN toxin)))))))))))) (. .)))
( (S (S (NP (DT The) (NP (NN Tec) (NN family) (NN kinase)) (NN ITK)) (VP (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (ADJP (JJ important) (PP (IN for) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NN IL-2))) (PP (IN by) (NP (NP (NN T) (NNS cells)) (VP (VBN stimulated) (ADVP (FW in) (FW vitro)))))))))))))) (CC and) (VP (MD may) (VP (VB represent) (NP (NP (DT a) (JJ good) (NN target)) (PP (IN for) (S (VP (VBG blocking) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (DT this) (NN cytokine)))) (ADVP (FW in) (FW vivo)))))))))) (. .)))
( (S (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP (NN ITK)) (VP (VBZ represents) (NP (PDT such) (DT a) (NN target))))))))) (, ,) (NP (NP (NNS mice)) (VP (VBG lacking) (NP (NN ITK)))) (VP (VBD were) (VP (VBN analyzed) (PP (IN for) (NP (NP (PRP$ their) (NN response)) (PP (TO to) (NP (NN SEB) (NN exposure)))))))) (. .)))
( (S (NP (NP (NNS Results)) (: :) (S (NP (PRP It)) (VP (VBD was) (VP (VBN found) (SBAR (IN that) (S (NP (NP (NN T) (NNS cells)) (PP (IN from) (NP (NP (NNS mice)) (VP (VBG lacking) (NP (NN ITK)))))) (VP (VBD exhibited) (NP (NP (ADJP (RB significantly) (VBN reduced)) (JJ proliferative) (NNS responses)) (PP (TO to) (NP (NN SEB) (NN exposure)))) (ADVP (ADVP (FW in) (FW vitro)) (, ,) (CONJP (RB as) (RB well) (IN as)) (ADVP (FW in) (FW vivo))))))))) (. .))))
( (S (S (NP (NP (NN Examination)) (PP (IN of) (NP (NN IL-2) (NN production)))) (VP (VBD revealed) (SBAR (IN that) (S (NP (NN ITK) (JJ null) (NNS mice)) (VP (VBD produced) (NP (NP (VBN reduced) (NNS levels)) (PP (IN of) (NP (DT this) (NN cytokine)))) (ADVP (FW in) (FW vitro)) (, ,) (ADVP (CC and) (ADVP (RBR more) (RB dramatically))) (, ,) (PP (IN in) (NP (FW vivo)))))))) (. .)))
( (S (S (NP (NP (ADJP (FW In) (FW vivo)) (NN analysis)) (PP (IN of) (NP (NP (NN c-jun) (NN phosphorylation)) (, ,) (VP (ADVP (RB previously)) (VBN shown) (S (VP (TO to) (VP (VB be) (ADJP (JJ critical) (PP (IN for) (S (VP (VBG regulating) (NP (NN IL-2) (NN production)))))))))) (, ,)))) (VP (VBD revealed) (SBAR (IN that) (S (NP (DT this) (NN pathway)) (VP (VBD was) (ADVP (RB specifically)) (VP (VBN activated) (PP (PP (IN in) (NP (NP (NP (NP (NN SEB) (JJ reactive) (NN Vβ8+)) (PRN (-LRB- -LRB-) (CONJP (CC but) (RB not)) (NP (JJ non-reactive) (NN Vβ6+)) (-RRB- -RRB-))) (NN T) (NNS cells)) (PP (IN from) (NP (JJ WT) (NNS mice))))) (, ,) (CC but) (PP (RB not) (IN in) (NP (NP (JJ Vβ8+) (NN T) (NNS cells)) (PP (IN from) (NP (NN ITK) (JJ null) (NNS mice)))))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NN toxicity) (NN analysis)) (VP (VBD indicated) (SBAR (IN that) (S (NP (NP (CC both) (NP (NN WT)) (CC and) (NP (NN ITK))) (JJ null) (NNS animals)) (VP (VBD were) (ADVP (RB similarly)) (VP (VBN affected) (PP (IN by) (NP (NN SEB) (NN exposure))))))))) (. .)))
( (S (NP (NP (NN Conclusion)) (: :) (S (NP (DT These) (NNS data)) (VP (VBP show) (SBAR (IN that) (S (NP (NN ITK)) (VP (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (NN IL-2) (NN production)) (VP (VBN induced) (PP (IN by) (NP (NN SEB))) (ADVP (FW in) (FW vivo))))))) (, ,) (CC and) (VP (MD may) (VP (VB regulate) (NP (NP (NNS signals)) (VP (VBG leading) (NP (NN IL-2) (NN production)))) (, ,) (PP (IN in) (NP (NN part))) (PP (IN by) (S (VP (VBG regulating) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN c-jun)))))))))))))) (. .))))
( (S (S (NP (DT The) (NNS data)) (ADVP (RB also)) (VP (VBP suggest) (SBAR (IN that) (S (S (VP (VBG perturbing) (NP (NP (NN T) (NN cell) (NN activation) (NNS pathways)) (VP (VBG leading) (PP (TO to) (NP (NN IL-2))))))) (VP (VBZ does) (RB not) (ADVP (RB necessarily)) (VP (VB lead) (PP (TO to) (NP (NP (JJ improved) (NNS responses)) (PP (TO to) (NP (NN SEB) (NN toxicity))))))))))) (. .)))
( (S (NP (NN Background))))
( (S (S (NP (NP (NNS Superantigens)) (PRN (-LRB- -LRB-) (NP (NNS SAGs)) (-RRB- -RRB-))) (VP (VBP are) (NP (NP (JJ microbial) (NNS toxins)) (PP (IN of) (NP (ADJP (ADJP (JJ bacterial)) (CC and) (ADJP (JJ viral))) (NN origin)))) (PP (IN with) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB activate) (NP (NP (CD 5–20) (NN %)) (PP (IN of) (NP (DT the) (NN T) (NN cell) (NN population))))))))) (, ,) (S (VP (VBG causing) (NP (NP (NN T) (NN cell) (NN activation)) (, ,) (NP (NN cytokine) (NN release)) (CC and) (NP (JJ systemic) (NN shock) (NN -LSB-1,2)))) (-RRB- -RSB-)))) (. .)))
( (S (NP (JJS Most) (NNS SAGs)) (VP (VBP share) (NP (NP (NP (DT the) (NN ability)) (S (VP (TO to) (ADVP (RB simultaneously)) (VP (VB bind) (NP (DT the) (NN class) (CD II) (JJ major) (NN histocompatibility) (NN complex) (NNS molecules)))))) (CC and) (NP (NP (DT the) (JJ variable) (NN region)) (PP (IN of) (NP (DT the) (NN T) (NN cell) (NN receptor) (NN β-chain))))) (, ,) (PP (IN without) (NP (DT the) (NN need) (S (VP (TO to) (VP (VB be) (VP (VBN processed) (PP (IN by) (NP (NP (NN antigen) (NN presenting) (NNS cells)) (PRN (NN -LSB-1,2) (-RRB- -RSB-))))))))))) (. .)))
( (S (ADVP (RB Thus)) (NP (NN SEB)) (VP (MD can) (VP (VP (VB interact) (ADVP (RB directly)) (PP (IN with) (NP (NP (NN MHC) (NN class) (CD II) (NNS molecules)) (PP (IN on) (NP (NNS APCs)))))) (CC and) (VP (VB activate) (NP (NP (NN T) (NNS cells)) (VP (VBG bearing) (NP (DT the) (JJ proper) (NN TcR) (NN Vβ) (NNS chains))))))) (. .)))
( (S (S (NP (NP (DT The) (NN result)) (PP (IN of) (NP (DT this) (NN interaction)))) (VP (VBZ is) (NP (NP (JJ large-scale) (NN stimulation)) (PP (IN of) (NP (NP (DT any) (NN T) (NN cell)) (SBAR (WHNP (WDT that)) (S (VP (VBZ expresses) (NP (DT the) (JJ proper) (NN TCR) (NN Vβ) (NN chain)))))))))) (. .)))
( (S (S (NP (NP (DT A) (NN number)) (PP (IN of) (NP (NNS studies)))) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (SBAR (WHADVP (WRB when)) (S (NP (NNS mice)) (VP (VBP are) (VP (VBN challenged) (PP (IN with) (NP (NP (DT a) (NN SAG)) (PP (JJ such) (IN as) (NP (NP (JJ Staphylococcal) (NN Enterotoxin) (NN B)) (PRN (-LRB- -LRB-) (NP (NN SEB)) (-RRB- -RRB-)))))))))) (, ,) (NP (NN toxicity)) (VP (VBZ results) (PP (IN from) (NP (NP (JJ massive) (NN induction)) (PP (IN of) (NP (NP (NNS cytokines)) (VP (VBN derived) (PP (IN from) (NP (NP (NN T-helper-type-1) (-LRB- -LRB-) (NN TH1) (-RRB- -RRB-) (NN type) (NNS cells)) (PP (JJ such) (IN as) (NP (NP (NN IL-2)) (, ,) (NP (NN IFN-γ)) (, ,) (NP (NN TNF-α)) (CC and) (NP (JJ TNF-β) (NN -LSB-1,3)))))))))))) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (DT This) (NN cytokine) (NN production)) (VP (VBZ is) (VP (VBN accompanied) (PP (IN by) (NP (NP (NN expansion)) (PP (IN of) (NP (NP (DT the) (NNS numbers)) (PP (IN of) (NP (NN SEB) (JJ reactive) (NN T) (NNS cells))))))) (, ,) (S (VP (VBN followed) (PP (IN by) (NP (NP (NN cell) (NN death)) (CC and) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (JJ functional) (`` ``) (NN anergy) (NN '') (CD -LSB-4-6) (-RRB- -RSB-))))))))))) (. .)))
( (S (PP (IN In) (NP (NN order))) (SBAR (IN for) (S (NP (DT a) (NN T) (NN cell)) (VP (TO to) (VP (VB be) (VP (VBN activated) (NP (NP (NN antigen) (NN presenting) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN APC)) (-RRB- -RRB-)))))))) (VP (MD must) (VP (VB present) (NP (NN antigen)) (, ,) (UCP (CC either) (NP (DT an) (JJ antigenic) (NN peptide)) (CC or) (ADJP (JJ SAG))))) (. .)))
( (S (S (ADVP (FW In) (FW vitro)) (, ,) (NP (NP (DT this) (NN interaction)) (PP (IN with) (NP (DT the) (NN TcR)))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB lead) (PP (TO to) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NP (NN tyrosine) (NNS kinases)) (, ,) (PP (VBG including) (NP (NP (DT the) (NN Src) (NN family) (NN kinase) (NN Lck)) (, ,) (NP (DT the) (NN Syk) (NN family) (NN kinase) (NN Zap-70)) (CC and) (NP (NP (DT the) (NN Tec) (NN family) (NN kinase) (NN ITK)) (PRN (-LRB- -LRB-) (SBAR (IN for) (S (NP (NN review)) (VP (VB see) (NP (CD -LSB-7-10) (-RRB- -RSB-))))) (-RRB- -RRB-)))))))))))))))))) (. .)))
( (S (S (NP (DT This)) (ADVP (RB then)) (VP (VBZ results) (PP (IN in) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NP (NN signaling) (NNS pathways)) (PP (VBG including) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (NN MAPK) (NN family)) (PP (IN of) (NP (NP (NNS kinases)) (, ,) (NP (NP (NN ERK)) (, ,) (NP (NN JNK)) (CC and) (NP (NN p38))))))))))))))) (, ,) (S (VP (VBN followed) (PP (IN by) (NP (NN transcription) (NN factor) (NN activation) (CD -LSB-10)))))) (-RRB- -RSB-)) (. .)))
( (S (S (ADVP (FW In) (FW vivo)) (, ,) (NP (NP (NN activation)) (PP (IN of) (NP (DT these) (NN T) (NNS cells)))) (VP (VBD lead) (PP (TO to) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NN cytokine) (NN secretion))) (PP (IN within) (NP (NP (NNS hours)) (PP (IN of) (NP (NN SEB) (NN exposure) (CD -LSB-1,3)))))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (NN ITK)) (VP (VBZ is) (VP (VBN expressed) (ADVP (RB primarily)) (PP (IN in) (NP (NP (NN T) (NNS cells)) (, ,) (NP (NN NK) (NNS cells)) (CC and) (NP (NN mast) (NNS cells) (CD -LSB-11-13)))) (-RRB- -RSB-)))) (. .)))
( (S (S (PP (IN In) (NP (NN T) (NNS cells))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADVP (RB rapidly)) (VP (VBN activated) (PP (VBG following) (NP (NN TcR) (NN crosslinking))) (PP (IN in) (NP (FW vitro) (NN -LSB-14,15) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (NP (NNS Mice)) (VP (VBG lacking) (NP (NN ITK)))) (VP (VBP exhibit) (NP (NP (NP (NP (VBN reduced) (NN proliferation)) (CC and) (NP (NN IL-2) (NN production))) (ADVP (FW in) (FW vitro))) (, ,) (CC and) (NP (VBN reduced) (NN T) (NN cell) (NN differentiation))) (ADVP (ADVP (FW in) (FW vitro)) (CC and) (ADVP (FW in) (FW vivo))) (, ,) (SBAR (IN with) (S (NP (NN TH2) (NN cell) (NN differentiation)) (ADVP (RB preferentially)) (VP (VBD affected) (NP (NN -LSB-15-19))) (-RRB- -RSB-))))) (. .)))
( (S (S (NP (NP (DT The) (VBN observed) (VBN reduced) (NN proliferation)) (PP (IN of) (NP (NN ITK) (NN null) (NN T) (NNS cells))) (ADVP (FW in) (FW vitro))) (VP (VBZ is) (ADJP (NN IL-2) (JJ dependent)) (SBAR (IN as) (S (NP (PRP it)) (VP (MD could) (VP (VB be) (VP (VBN rescued) (PP (IN by) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (JJ exogenous) (NN IL-2) (CD -LSB-20)))))))) (-RRB- -RSB-))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (DT these) (NNS animals)) (VP (VBP are) (RB not) (ADVP (RB entirely)) (VP (VBN immunocompromised) (, ,) (PP (IN with) (NP (NP (JJ residual) (NNS responses)) (PP (IN against) (NP (NP (NN LCM)) (, ,) (NP (NN Vaccinia)) (CC and) (NP (CC VS) (NP (NNS viruses)) (CD -LSB-21) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN tested) (SBAR (IN whether) (S (NP (NN ITK) (JJ null) (NNS mice)) (VP (VBP are) (ADJP (JJ susceptible) (PP (TO to) (NP (NN SEB) (JJ induced) (NN IL-2) (NN secretion)))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP show) (ADVP (RB here)) (SBAR (IN that) (S (NP (NP (NNS mice)) (VP (VBG lacking) (NP (NN ITK)))) (VP (VBP have) (NP (NP (ADJP (RB much) (VBN reduced)) (NN IL-2) (NN production)) (CC and) (NP (NN T) (NN cell) (NN expansion))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN SEB))) (ADVP (ADVP (FW in) (FW vitro)) (CC and) (ADVP (FW in) (FW vivo)))))))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB also)) (VP (VBP show) (SBAR (SBAR (IN that) (S (NP (NN SEB)) (VP (VBD induced) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (DT the) (NN JNK) (NN MAPK) (NN pathway))) (PP (IN in) (NP (VBG responding) (NN T) (NNS cells)))) (ADVP (FW in) (FW vivo))))) (, ,) (CC and) (SBAR (IN that) (S (NP (NN ITK) (NN null) (NN T) (NNS cells)) (VP (VBD were) (ADJP (JJ defective) (PP (IN in) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (DT this) (NN pathway))) (ADVP (FW in) (FW vivo))))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NN toxicity) (NN analysis)) (VP (VBD indicated) (SBAR (IN that) (S (NP (NP (CC both) (NP (NN WT)) (CC and) (NP (NN ITK))) (JJ null) (NNS animals)) (VP (VBD were) (ADVP (RB similarly)) (VP (VBN affected) (PP (IN by) (NP (NN SEB) (NN exposure))))))))) (. .)))
( (S (S (NP (PRP$ Our) (NNS data)) (VP (VBP suggest) (SBAR (SBAR (IN that) (S (NP (NN ITK)) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (JJ full) (NN IL-2) (NN secretion)) (PP (VBG following) (NP (NN SEB) (NN exposure))))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (DT this)) (VP (MD may) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (DT the) (NN JNK) (NN pathway))) (PP (IN by) (NP (NN ITK))))) (ADVP (FW in) (FW vivo)))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (S (VP (VBG reducing) (NP (NN T) (NN cell) (NNS signals)))) (VP (VBZ does) (RB not) (ADVP (RB necessarily)) (VP (VB lead) (PP (TO to) (NP (NP (ADJP (RBR better) (JJ physiological)) (NNS responses)) (PP (TO to) (NP (NN SEB) (NN exposure)))))))) (. .)))
( (S (NP (NNS Results))))
( (S (S (NP (PRP It)) (VP (VBZ has) (ADVP (RB previously)) (VP (VBN been) (VP (VBN reported) (SBAR (IN that) (S (NP (NP (NN T) (NNS cells)) (PP (IN from) (NP (NP (NNS mice)) (VP (VBG lacking) (NP (NN ITK)))))) (VP (VBP exhibit) (NP (ADJP (RB much) (VBN reduced)) (NN proliferation)) (PP (IN in) (NN response) (TO to) (NP (NP (ADJP (JJ anti-CD3))) (CC or) (NP (NN TcR) (NNS antibodies)) (NP (ADJP (FW in) (FW vitro)) (NN -LSB-15,16,18))))) (-RRB- -RSB-))))))) (. .)))
( (S (S (PP (IN By) (NP (NN contrast))) (, ,) (NP (DT these) (NN T) (NNS cells)) (VP (VP (VBD did) (RB not) (VP (VB have) (NP (DT any) (NNS defects)))) (CC and) (ADVP (RB actually)) (VP (VBD had) (NP (JJR higher) (JJ proliferative) (NNS responses)) (PP (VBG following) (NP (NN anti-CD28/PMA) (NN stimulation) (CD -LSB-20))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (DT These) (NNS data)) (VP (VBP do) (RB not) (VP (VB provide) (NP (JJ clear) (NNS answers)) (PP (IN as) (TO to) (SBAR (IN whether) (S (NP (NN ITK)) (VP (MD would) (VP (VB present) (NP (NP (DT a) (JJ good) (NN target)) (PP (PP (IN for) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (NN SEB)) (VP (VBD induced) (NP (NN T) (NN cell) (NN activation)) (ADVP (FW in) (FW vivo))))))) (, ,) (CC and) (PP (IN in) (NP (JJ particular))))) (, ,) (PP (IN in) (NP (NP (DT the) (NN cytokine) (NN response)) (VP (VBN observed) (PP (VBG following) (NP (NN SAG) (NN exposure)))))))))))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB therefore)) (ADVP (RB first)) (VP (VBD tested) (SBAR (IN whether) (S (NP (NN ITK) (NN null) (NN T) (NNS cells)) (VP (MD could) (VP (VB respond) (PP (TO to) (NP (NP (NN SEB) (NN stimulation)) (PP (IN by) (NP (NN proliferation))))) (ADVP (FW in) (FW vitro)))))))) (. .)))
( (S (S (S (NP (NP (NP (JJ Pooled) (NNS splenocytes)) (CC and) (NP (NP (NN lymph) (NN node)) (NNS cells))) (PP (IN from) (NP (NP (NP (NN WT)) (CC or) (NP (NN ITK))) (JJ null) (NNS animals)))) (VP (VBD were) (VP (VBN cultured) (ADVP (FW in) (FW vitro)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (JJ varying) (NNS concentrations)) (PP (IN of) (NP (NP (NN SEB)) (PRN (-LRB- -LRB-) (NP (NP (CD 5) (NN μg/ml)) (, ,) (NP (CD 0.5) (NN μg/ml)) (, ,) (NP (CD 0.05) (NN μg/ml)) (, ,) (NP (CD 0.005) (NN μg/ml)) (, ,) (CC and) (NP (CD 0.0005) (NN μg/ml))) (-RRB- -RRB-))))))))))) (, ,) (CC and) (S (NP (NN proliferation)) (VP (VBN analyzed) (PP (IN over) (NP (DT a) (JJ 5-day) (NN period)))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (NN WT) (NNS cells)) (VP (VBD responded) (ADVP (RB normally)) (PP (IN by) (S (VP (VBG proliferating) (PP (IN between) (NP (NNS days) (CD 2) (CC and) (CD 3)))))) (, ,) (PP (IN with) (NP (NP (JJ maximum) (NN proliferation)) (VP (VBN observed) (PP (IN at) (NP (NP (NN day) (CD 5)) (CC and) (NP (NP (NP (DT the) (ADJP (CD 5) (NN μg/ml)) (NN dose)) (PP (IN of) (NP (NN SEB)))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 1a)) (-RRB- -RRB-))))))))))))) (. .)))
( (S (S (NP (NP (NN Analysis)) (PP (IN of) (NP (NP (DT the) (NN dose) (NN response)) (PP (IN at) (NP (CD 5) (NNS days)))))) (VP (VBD indicated) (SBAR (IN that) (S (NP (DT the) (JJ WT) (NNS cells)) (VP (VBD responded) (PP (IN in) (NP (DT a) (ADJP (NN dose) (JJ dependent)) (NN fashion))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 1b)) (-RRB- -RRB-))))))) (. .)))
( (S (S (PP (IN By) (NP (NN contrast))) (, ,) (NP (NP (NNS cells)) (PP (IN from) (NP (NN ITK) (NNS mice)))) (VP (VBD showed) (NP (ADJP (RB very) (JJ little)) (NN response)) (, ,) (ADVP (RB regardless) (PP (IN of) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NN SEB))) (VP (VBN used) (PP (IN for) (NP (NP (NN stimulation)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP Fig.)) (NP (NN 1a))) (, ,) (NP (NN b))) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB next)) (VP (VBD determined) (SBAR (IN if) (S (NP (DT the) (JJ same) (NNS results)) (VP (MD would) (VP (VB be) (VP (VBN obtained) (PP (IN in) (NP (NP (VBN purified) (NN T) (NN cell) (NNS populations)) (PP (IN from) (NP (DT these) (NNS mice)))))))))))) (. .)))
( (S (S (NP (NN T) (NNS cells)) (VP (VBD were) (VP (VP (VBN purified) (PP (IN from) (NP (NP (NP (NN WT)) (CC and) (NP (NN ITK))) (JJ null) (NNS mice)))) (, ,) (CC and) (VP (VBN stimulated) (PP (IN with) (NP (NP (JJ varying) (NN dose)) (PP (IN of) (NP (NN SEB)))))) (, ,) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NNS APCs)))))))) (. .)))
( (S (NP (NP (NN Analysis)) (PP (IN of) (NP (NP (DT the) (NNS data)) (PP (IN over) (NP (DT the) (CD 5) (NNS days)))))) (VP (VBD indicated) (SBAR (IN that) (S (PP (IN in) (DT the) (NN presence) (IN of) (NP (NP (NP (DT the) (JJS highest) (NN concentration)) (PP (IN of) (NP (NP (NN SEB)) (VP (VBN tested))))) (PRN (-LRB- -LRB-) (NP (CD 10) (NN μg/ml)) (-RRB- -RRB-)))) (, ,) (NP (NN WT) (NN T) (NNS cells)) (VP (VBD responded) (ADVP (RBR more) (RB robustly)) (PP (IN than) (NP (NN ITK) (NN null) (NN T) (NNS cells))) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (NNP Fig.) (CD 1c)))) (-RRB- -RRB-)))))) (. .)))
( (S (S (ADVP (RB Indeed)) (, ,) (PP (IN at) (NP (NP (PDT all) (DT the) (NNS doses)) (VP (VBN tested)))) (, ,) (NP (PRP$ our) (NN analysis)) (VP (VBD indicated) (SBAR (IN that) (S (NP (NN ITK) (NN null) (NN T) (NNS cells)) (VP (VBD responded) (ADJP (RBR less) (PP (IN than) (NP (JJ WT) (NN T) (NNS cells)))) (PP (IN on) (NP (NP (NN day) (QP (CD 3) (, ,) (CD 4) (CC and) (CD 5))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 1d–f)) (-RRB- -RRB-)))) (, ,) (SBAR (IN while) (S (NP (NN proliferation)) (VP (VBD was) (ADJP (JJ equivalent)) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN PMA)) (CC and) (NP (NN Ionomycin))) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB bypass) (NP (NN TcR) (NNS signals)) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-))))))))))))))))) (. .)))
( (S (S (NP (DT These) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN ITK) (NN null) (NN T) (NNS cells)) (VP (VBP have) (NP (NP (ADJP (RB significantly) (VBN reduced)) (JJ proliferative) (NNS responses)) (PP (TO to) (NP (NN SEB)))) (ADVP (FW in) (FW vitro))))))) (. .)))
( (S (S (NP (NN Interleukin-2)) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (NNS cytokines)) (VP (VBN induced) (PP (IN by) (NP (NP (NN exposure)) (PP (TO to) (NP (NN SEB) (CD -LSB-22)))))))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (NN ITK)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB regulate) (NP (NN IL-2) (NN secretion)) (ADVP (FW in) (FW vitro)) (PP (PP (IN by) (NP (NP (NN T) (NNS cells)) (VP (VBN stimulated) (NN anti-CD3/TcR) (NNS antibodies)))) (CC or) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN peptide) (NN antigen) (NN -LSB-15,18,23,24))))) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB therefore)) (VP (VBD determined) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NN IL-2))) (PP (IN in) (NP (NP (NNS supernatants)) (PP (IN from) (NP (NP (NNS cells)) (VP (ADVP (RB similarly)) (VBN stimulated) (PP (IN with) (NP (NN SEB))))))))) (ADVP (FW in) (FW vitro)) (-LRB- -LRB-) (NP (NNP Fig.) (CD 2)) (-RRB- -RRB-))) (. .)))
( (S (S (SBAR (IN While) (S (NP (NN WT) (NN T) (NNS cells)) (VP (VBD responded) (PP (TO to) (NP (NN SEB))) (PP (IN by) (NP (NP (NN secretion)) (PP (IN of) (NP (NN IL-2))) (PP (IN within) (NP (NP (CD 24) (NN hrs.)) (PP (IN of) (NP (NP (NN stimulation)) (PP (IN in) (NP (NP (DT a) (NN dose) (JJ dependent) (NN manner)) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (NP (NP (NNP Fig.)) (NP (NN 2a))) (PP (IN for) (NP (ADJP (CD 5) (NN μg/ml)) (NN dose)))))) (-RRB- -RRB-)))))))))) (, ,) (S (VP (VBG starting) (PP (IN at) (NP (NP (DT the) (ADJP (CD 0.5) (NN μg/ml)) (NN SEB) (NN concentration)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NNP 2bi)) (-RRB- -RRB-))))))))) (, ,) (NP (NN ITK) (NN null) (NN T) (NNS cells)) (VP (VBD made) (NP (ADJP (RB very) (JJ little)) (NN IL-2)))) (, ,) (CC and) (S (NP (NP (DT the) (JJ small) (NN amount)) (PP (IN of) (NP (NN IL-2))) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (VP (VBN made)))))) (VP (VBD was) (ADVP (RB only)) (PP (IN at) (NP (NP (DT the) (JJS highest) (NN concentration)) (PP (IN of) (NP (NN SEB))) (VP (VBN tested)))) (PRN (-LRB- -LRB-) (NP (CD 5) (NN μg/ml)) (-RRB- -RRB-)))) (. .)))
( (S (S (NP (NN ITK) (NN null) (NN T) (NNS cells)) (ADVP (RB consistently)) (VP (VBN secreted) (NP (RBR less) (NN IL-2)) (PP (IN over) (NP (NP (DT the) (NP (JJ 5-day) (NN period)) (CC and) (NP (NN dose) (NN range))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 2b)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (DT These) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (SBAR (IN as) (S (ADVP (RB previously)) (VP (VBN reported) (PP (IN for) (NP (NP (NN TcR)) (CC or) (NP (JJ antigenic) (NN stimulation))))))) (, ,) (NP (NN ITK)) (VP (VBZ regulates) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NN IL-2)))) (ADVP (FW in) (FW vitro)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN SEB) (NN stimulation) (CD -LSB-15,18,23,24)))))) (-RRB- -RSB-))))) (. .)))
( (S (SBAR (IN While) (S (NP (DT these) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN ITK)) (VP (VBZ regulates) (NP (NN T) (NN cell) (NN proliferation)) (PP (IN in) (NN response) (TO to) (NP (NN SEB))) (ADVP (FW in) (FW vitro)))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ possible)) (SBAR (IN that) (S (PP (IN within) (NP (NP (DT the) (NN context)) (PP (IN of) (NP (NP (NN antigen) (NN presentation)) (CC and) (NP (JJ optimal) (JJ co-stimulatory) (NNS signals)))) (ADVP (FW in) (FW vivo)))) (, ,) (NP (NN ITK) (NN null) (NN T) (NNS cells)) (VP (MD may) (VP (VB exhibit) (NP (DT a) (JJR better) (NN response))))))) (. .)))
( (S (NP (NP (NN Exposure)) (PP (IN of) (NP (NNS animals))) (PP (TO to) (NP (NN SEB)))) (VP (VBZ results) (PP (IN in) (NP (NP (DT an) (NN expansion)) (PP (IN of) (NP (DT the) (NN SEB) (JJ reactive) (NN T) (NN cell) (NN population))) (PP (IN with) (NP (NP (DT a) (NN peak)) (PP (IN of) (NP (NP (QP (IN around) (CD 2)) (NNS days)) (PP (IN post) (NP (NN exposure) (CD -LSB-2,4)))))))))) (-RRB- -RSB-) (. .)))
( (S (SBAR (IN In) (NN order) (TO to) (S (VP (VB determine) (SBAR (IN if) (S (NP (NP (DT the) (VBN reduced) (JJ proliferative) (NNS responses)) (VP (VBN seen) (PP (IN with) (NP (DT the) (NN ITK) (NN null) (NN T) (NNS cells))) (ADVP (FW in) (FW vitro)))) (VP (VBD was) (ADVP (RB also)) (VP (VBN seen) (PP (IN in) (NP (FW vivo)))))))))) (, ,) (NP (PRP we)) (VP (VP (VBD exposed) (NP (NN WT) (CC and) (NN ITK) (NN null) (NNS animals)) (PP (TO to) (NP (NN SEB)))) (CC and) (VP (VBD determined) (NP (NP (DT the) (NNS percentages)) (PP (IN of) (NP (NP (NNP Vβ8)) (CC and) (NP (NNP Vβ6)) (NP (JJ positive) (NNS cells)))) (PP (IN in) (NP (DT the) (JJ CD4+) (NN population)))) (PP (IN by) (NP (NP (NN flow) (NN cytometry)) (PP (IN after) (NP (NP (QP (CD 2) (, ,) (CD 4) (CC and) (CD 5)) (NNS days)) (PP (IN as) (NP (NP (DT a) (NN measure)) (PP (IN of) (NP (NN T) (NN cell) (NN expansion))))))))))) (. .)))
( (S (S (S (NP (NP (NN T) (NNS cells)) (VP (VBG bearing) (NP (NN Vβ8) (NN TcR) (NNS chains)))) (VP (VBP are) (ADJP (JJ responsive) (PP (TO to) (NP (NN SEB) (NN stimulation)))) (SBAR (IN while) (S (NP (NP (DT those)) (SBAR (WHNP (WDT that)) (S (VP (VB bear) (NP (NN Vβ6) (NN TcR) (NNS chains)))))) (VP (VBP are) (RB not)))))) (, ,) (IN so) (S (NP (PRP we)) (VP (VBD analyzed) (NP (NP (DT these) (CD two) (NNS populations)) (PP (IN of) (NP (NN T) (NNS cells))))))) (. .)))
( (S (SBAR (IN As) (S (ADVP (RB previously)) (VP (VBN reported)))) (, ,) (PP (IN in) (NP (JJ WT) (NNS animals))) (, ,) (NP (PRP we)) (VP (VBD observed) (NP (NP (DT an) (ADJP (QP (RB approximately) (CD 4)) (JJ fold)) (NN expansion)) (PP (IN in) (NP (NN Vβ8) (JJ CD4+) (NN T) (NNS cells)))) (PP (IN in) (NP (NP (NN spleen)) (CC and) (NP (NN lymph) (NNS nodes)))) (PP (VBG following) (NP (NP (NN SEB) (NN exposure)) (PRN (-LRB- -LRB-) (ADVP (RB as)) (VP (VBN compared) (PP (TO to) (NP (NP (NN exposure)) (PP (TO to) (NP (NP (NN PBS)) (, ,) (NP (NN fig) (NN 3a)) (, ,) (NP (NN b))))))) (-RRB- -RRB-)))) (, ,) (SBAR (IN while) (S (NP (JJ Vβ6) (JJ CD4+) (NN T) (NN cell) (NNS populations)) (VP (VBD were) (ADJP (RB largely) (JJ unchanged)) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))))) (. .)))
( (S (PP (IN By) (NP (NN contrast))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (ADJP (RB statistically) (RB significantly) (JJR less)) (NN expansion)) (PP (IN of) (NP (NN ITK) (NN null) (NN Vβ8+CD4+) (NN T) (NNS cells)))) (PP (VBG following) (NP (NN SEB) (NN exposure))) (, ,) (SBAR (IN although) (S (NP (NP (DT these) (NNS cells)) (VP (ADVP (RB still)) (VBN expanded))) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP Fig.)) (NP (NN 3a))) (, ,) (NP (NN b))) (-RRB- -RRB-)) (SBAR (IN As) (S (ADVP (RB previously)) (VP (VBN reported)))) (, ,) (NP (NP (DT the) (NNS percentages)) (PP (IN of) (NP (NP (NN T) (NNS cells)) (VP (VBG bearing) (NP (NN Vβ6)))))) (VP (VBD did) (RB not) (VP (VB change) (PP (IN over) (NP (NP (DT this) (NN period)) (PP (IN in) (NP (NP (NP (CC either) (NP (DT the) (NN WT)) (CC or) (NP (NN ITK))) (JJ null) (NNS mice)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNS data)) (VP (RB not) (VBN shown))) (CC and) (NP (NN -LSB-4))) (-RRB- -RSB-) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (ADVP (RB Thus)) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN ITK)))) (VP (VBZ results) (PP (IN in) (NP (VBN reduced) (NN T) (NN cell) (NN expansion))) (ADVP (FW in) (FW vivo)) (PP (IN in) (NN response) (TO to) (NP (NN SEB))))) (. .)))
( (S (S (NP (NP (NN T) (NNS cells)) (PP (IN from) (NP (NN ITK) (JJ null) (NNS mice)))) (VP (VP (VBP proliferate) (NP (JJR less)) (ADVP (ADVP (FW in) (FW vitro)) (CC and) (ADVP (FW in) (FW vivo)))) (, ,) (CC and) (VP (VB secrete) (NP (ADJP (RB significantly) (JJR less)) (NN IL-2)) (ADVP (FW in) (FW vitro)) (PP (IN in) (NN response) (TO to) (NP (NN SEB)))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB therefore)) (VP (VBD determined) (SBAR (IN if) (S (NP (PRP they)) (VP (MD would) (ADVP (RB also)) (VP (VB secrete) (NP (RBR less) (NN IL-2)) (PP (VBG following) (NP (NN SEB) (NN stimulation))) (ADVP (FW in) (FW vivo)))))))) (. .)))
( (S (S (S (NP (NP (NNS Groups)) (PP (IN of) (NP (NNS mice)))) (VP (VBD were) (VP (VBN exposed) (PP (TO to) (NP (NN SEB))) (ADVP (RB i.v.))))) (CC and) (S (PP (IN at) (NP (JJ various) (NN time) (NNS points))) (NP (PRP$ their) (NN serum)) (VP (VBD was) (VP (VP (VBN taken)) (CC and) (VP (VBN analyzed) (PP (IN for) (NP (NN IL-2) (NN production)))))))) (. .)))
( (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN comparison)) (PP (TO to) (NP (ADJP (FW in) (FW vitro)) (NN IL-2) (NN production))))) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NN WT) (NNS mice)) (VP (VBD were) (VP (VBN exposed) (PP (TO to) (NP (NN SEB))) (ADVP (FW in) (FW vivo)))))) (NP (PRP they)) (VP (VBD produced) (NP (NN IL-2)) (PP (IN within) (NP (NP (CD 1) (NN hr.)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD peaked) (PP (IN at) (PP (IN around) (NP (CD 2) (NNS hrs))))))))))))) (. .)))
( (S (S (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 4)) (-RRB- -RRB-))) (. .)))
( (S (PP (IN In) (NP (NN addition))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (DT the) (ADJP (FW in) (FW vitro)) (NN stimulation))))) (, ,) (NP (NN ITK) (JJ deficient) (NNS mice)) (VP (VB secrete) (NP (NP (ADJP (RB significantly) (JJR less)) (NN IL-2)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN SEB)))))) (ADVP (FW in) (FW vivo)) (-LRB- -LRB-) (NP (NNP Fig.) (CD 4)) (-RRB- -RRB-)) (. .)))
( (S (PP (VBN Based) (PP (IN on) (NP (DT these) (NNS data)))) (NP (PRP we)) (VP (VBP conclude) (SBAR (SBAR (IN that) (S (NP (ADJP (FW in) (FW vivo)) (NN IL-2) (NN production)) (VP (VBZ occurs) (ADJP (ADJP (JJR earlier)) (SBAR (IN than) (S (VP (VBN observed) (ADVP (FW in) (FW vitro))))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (NN ITK) (NN null) (NN T) (NNS cells)) (VP (VBP continue) (S (VP (TO to) (VP (VBP exhibit) (NP (NP (NNS defects)) (PP (IN in) (NP (NP (NN IL-2) (NN production)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN SEB)))))))) (ADVP (FW in) (FW vivo)) (, ,) (PP (ADVP (RB even)) (IN in) (NP (NP (DT the) (JJ presumed) (NN presence)) (PP (IN of) (NP (JJ adequate) (JJ costimulatory) (NNS signals))) (ADVP (FW in) (FW vivo)))))))))))) (. .)))
( (S (S (NP (DT The) (NN JNK) (NN MAPK) (NN pathway)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (ADJP (JJ essential) (PP (IN for) (NP (NP (NN IL-2) (NN production)) (PP (IN upon) (NP (NP (NN stimulation)) (PP (IN of) (NP (NN T) (NNS cells))) (PP (IN by) (NP (DT the) (NP (NN TcR)) (CC and) (NP (NN CD28)) (NP (ADJP (FW in) (FW vitro)) (NN -LSB-25-28)))) (-RRB- -RSB-))))))))))))) (. .)))
( (S (S (NP (DT This) (NN pathway)) (VP (VBZ leads) (PP (TO to) (NP (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN c-jun)))) (CC and) (NP (NP (NN activation)) (PP (IN of) (NP (NP (DT an) (NN AP-1) (NN transcription) (NN factor) (NN complex)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NN IL-2) (NN transcription) (CD -LSB-28) (-RRB- -RSB-)))))))))))))) (. .)))
( (S (SBAR (IN While) (S (NP (NP (NN activation)) (PP (IN of) (NP (NP (DT the) (NN JNK) (NN pathway)) (VP (VBG leading) (PP (TO to) (NP (NP (NP (NN phosphorylation)) (CC and) (NP (NN activation))) (PP (IN of) (NP (NN c-jun))))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN demonstrated) (PP (IN in) (NP (NN T) (NNS cells))) (PP (PP (VBG following) (NP (NP (NP (NP (NN TcR)) (CC and) (NP (NN CD28))) (NN crosslinking)) (ADVP (FW in) (FW vitro)))) (, ,) (CONJP (RB as) (RB well) (IN as)) (PP (IN by) (NP (NN peptide) (NN antigen) (NN stimulation)))) (ADVP (FW in) (FW vivo))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (RB not) (VP (VB clear) (SBAR (IN whether) (S (NP (DT the) (NN SAG) (NN SEB)) (VP (VBZ activates) (NP (DT this) (NN pathway)) (PP (IN in) (NP (FW vivo) (NN -LSB-29,30) (-RRB- -RSB-)))))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB therefore)) (VP (VBD tested) (SBAR (IN whether) (S (NP (NN SEB)) (VP (MD could) (VP (VB induce) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN c-jun)))) (PP (IN in) (NP (NP (JJ WT) (NN T) (NNS cells)) (VP (VBN stimulated) (PP (IN with) (NP (NN SEB))) (ADVP (FW in) (FW vivo))))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VBP do) (NP (DT this))))) (, ,) (NP (PRP we)) (VP (VBN adapted) (NP (NP (DT a) (NN method)) (VP (ADVP (RB initially)) (VBN used) (PP (IN by) (NP (NP (NNP Jenkins)) (CC and) (NP (NNS colleagues)))))) (S (VP (TO to) (VP (VB analyze) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN c-jun)))) (PP (VBG following) (NP (NP (ADJP (FW in) (FW vivo)) (NN exposure)) (PP (IN of) (NP (NN antigen)))))))))) (. .)))
( (S (S (PP (IN In) (NP (DT this) (NN protocol))) (, ,) (NP (NNS mice)) (VP (VBD were) (VP (VBN exposed) (PP (TO to) (NP (NN SEB))) (, ,) (ADVP (RB then)) (NP (NP (NNS cells)) (PP (IN from) (NP (NP (NN lymph) (NNS nodes)) (, ,) (NP (NP (NP (NN spleen)) (CC and) (NP (NN blood))) (ADJP (ADJP (RB rapidly) (VBN isolated)) (CC and) (ADJP (JJ fixed)))) (, ,) (CC and) (NP (NP (NNS antibodies)) (ADJP (JJ specific) (PP (IN for) (NP (NP (VBN phosphorylated) (NN c-jun)) (VP (VBN used) (S (VP (TO to) (VP (VB analyze) (NP (PRP$ its) (NN phosphorylation)))))))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NNS cells)) (VP (VBD were) (VP (VBN stained) (PP (IN with) (NP (NP (NNS antibodies)) (ADJP (JJ specific) (PP (TO to) (NP (NP (NNP Vβ8)) (CC or) (NP (NNP Vβ6))))))) (S (VP (TO to) (VP (VB detect) (NP (ADJP (ADJP (NN SEB) (JJ responsive)) (CC and) (ADJP (JJ non-responsive))) (NN T) (NNS cells)) (ADVP (RB respectively)))))))) (. .)))
( (S (S (NP (NN Flow) (NN cytometry)) (VP (VBD was) (VP (VBN employed) (S (VP (TO to) (VP (VB detect) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN c-jun) (CD -LSB-30)))))) (-RRB- -RSB-))))) (. .)))
( (S (S (NP (NN Figure) (CD 5)) (VP (VBZ demonstrates) (PP (IN that) (NP (CD 1) (NN hr))))) (. .)))
( (S (S (PP (IN after) (NP (NP (JJ intravenous) (NN exposure)) (PP (TO to) (NP (NN SEB))))) (, ,) (NP (NP (JJ Vβ8+) (NN SEB) (JJ reactive) (NN T) (NNS cells)) (PP (IN in) (NP (NP (NN spleen)) (CC and) (NP (NN lymph) (NNS nodes))))) (VP (VBP contain) (NP (NP (JJR higher) (NNS levels)) (PP (IN of) (NP (NP (VBN phosphorylated) (NN c-jun)) (PRN (-LRB- -LRB-) (NP (NN cf)))))))) (. .)))
( (S (NP (NP (NNS Figs)) (. .))))
( (S (S (NP (NP (NN 5a)) (, ,) (NP (NN b) (CD iii))) (NP (NNP &) (CD iv) (-RRB- -RRB-))) (. .)))
( (S (S (NP (JJ Similar) (NNS results)) (VP (VBD were) (VP (VBN found) (PP (IN in) (NP (NP (NNS animals)) (VP (VBN exposed) (PP (TO to) (NP (NN SEB))) (ADVP (ADVP (RB i.p.)) (PRN (-LRB- -LRB-) (NP (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (PP (IN By) (NP (NN contrast))) (, ,) (NP (NP (NP (NN T) (NNS cells)) (ADJP (JJ non-reactive) (PP (TO to) (NP (NP (NN SEB)) (PP (IN in) (NP (DT the) (JJ same) (NNS animals))))))) (, ,) (NP (NP (DT those)) (VP (VBG bearing) (NP (JJ Vβ6+) (NNS TcRs)))) (, ,)) (VP (VBD did) (RB not) (VP (VB have) (NP (NP (DT any) (NN increase)) (PP (IN in) (NP (NP (VBN phosphorylated) (NN c-jun)) (PRN (-LRB- -LRB-) (NP (NN cf))))))))) (. .)))
( (S (NP (NP (NNS Figs)) (. .))))
( (S (S (NP (NP (NN 5a)) (, ,) (NP (NN b)) (, ,)) (NP (NN i) (NN &) (CD ii) (-RRB- -RRB-))) (. .)))
( (S (S (NP (DT This)) (VP (VBZ demonstrates) (SBAR (IN that) (S (PP (IN in) (NP (DT the) (JJ same) (NN animal))) (, ,) (ADVP (RB only)) (NP (NP (DT those) (NN T) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBP interact) (PP (IN with))) (CC and) (VP (MD can) (VP (VB be) (VP (VBN activated) (PP (IN by) (NP (NN SEB)))))))))) (VP (VBP respond) (PP (IN by) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN c-jun))))) (, ,) (SBAR (IN while) (S (PP (IN at) (NP (DT the) (JJ same) (NN time))) (, ,) (NP (NP (DT those) (NN T) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (RB not) (ADJP (JJ reactive)))))) (VP (VBP are) (RB not) (VP (VBN activated) (, ,) (S (VP (VBG demonstrating) (NP (NN specificity))))))))))))) (. .)))
( (S (S (ADVP (RB Similarly)) (, ,) (NP (NP (NNS animals)) (VP (VBN injected) (PP (IN with) (NP (NNS PBS))))) (VP (VBD showed) (NP (NP (DT no) (JJ such) (NN change)) (PP (IN in) (NP (VBN phosphorylated) (NN c-jun))) (PP (IN in) (NP (CC either) (DT the) (ADJP (ADJP (NN SEB) (JJ reactive)) (CC or) (ADJP (JJ non-reactive))) (NN T) (NN cell) (NNS populations)))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (DT this)) (VP (VBD was) (NP (NP (DT an) (ADJP (NN SEB) (JJ mediated)) (NN event)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 5a–b)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NP (JJ Other) (NNS controls)) (PP (VBG including) (NP (JJ secondary) (NNS reagents)))) (ADVP (RB alone)) (VP (VBP demonstrate) (NP (NP (DT the) (NN specificity)) (PP (IN of) (NP (NN antibody) (NN staining)))) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB next)) (VP (VBD determined) (SBAR (IN whether) (S (NP (NP (NN T) (NNS cells)) (VP (VBG lacking) (NP (NN ITK)))) (VP (MD could) (VP (VB induce) (NP (NN c-jun) (NN phosphorylation)) (PP (IN in) (NN response) (TO to) (NP (NN SEB) (NN activation))) (ADVP (FW in) (FW vivo)))))))) (. .)))
( (S (S (NP (NN ITK) (JJ null) (NNS mice)) (VP (VBD were) (VP (VBN exposed) (PP (TO to) (NP (NN SEB))) (SBAR (IN as) (S (VP (VBN described) (ADVP (RB above)))))))) (, ,) (CC and) (S (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN c-jun)))) (VP (VBN determined) (PP (IN in) (NP (NP (NP (NP (JJ Vβ8+) (NN T) (NN cell) (NN population)) (PRN (-LRB- -LRB-) (NP (NN SEB) (JJ reactive)) (-RRB- -RRB-))) (CC or) (NP (NP (JJ Vβ6+) (NN T) (NN cell) (NN population)) (PRN (-LRB- -LRB-) (NP (JJ non-reactive)) (-RRB- -RRB-)))) (PP (IN in) (NP (DT the) (JJ same) (NNS animals))))))) (. .)))
( (S (S (NP (DT These) (NNS experiments)) (VP (VBP show) (SBAR (IN that) (S (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN ITK))))) (, ,) (NP (NN SEB)) (VP (VBZ does) (RB not) (VP (VB lead) (PP (TO to) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN c-jun))) (PP (IN in) (NP (DT either) (NN T) (NN cell) (NN population))))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 6a–d)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN ITK)))) (VP (VBZ results) (PP (IN in) (NP (NP (DT the) (NN lack)) (PP (IN of) (NP (NP (NN SEB) (NN phosphorylation)) (PP (IN of) (NP (NN c-jun))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD could) (VP (VB affect) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (DT these) (NN T) (NNS cells))) (S (VP (TO to) (VP (VB produce) (NP (NN IL-2)))))))))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB determine) (SBAR (IN if) (S (NP (NP (DT this) (NN lack)) (PP (IN of) (NP (NN c-jun) (NN phosphorylation))) (PP (IN in) (NP (NP (NN ITK) (NN null) (NN T) (NNS cells)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN SEB)))))))) (VP (VBD reflected) (NP (NP (JJ global) (NN nonresponsiveness)) (PP (IN in) (NP (DT these) (NNS cells)))))))))) (, ,) (S (NP (PRP we)) (VP (VBD determined) (SBAR (IN whether) (S (NP (DT these) (NNS cells)) (VP (VBD were) (ADVP (RB indeed)) (VP (VBN activated) (PP (IN by) (NP (NN SEB) (NN exposure)))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VBP do) (NP (DT this))))) (, ,) (NP (PRP we)) (VP (VBD measured) (NP (NP (NNS increases)) (PP (IN in) (NP (NP (NN CD69) (NN expression)) (, ,) (NP (NP (DT a) (NN cell) (NN surface) (NN protein)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADVP (RB rapidly)) (VP (VBN expressed) (PP (IN by) (NP (VBN activated) (NN T) (NNS cells))) (PP (IN in) (NP (DT a) (ADJP (NN Ras/MAPK) (JJ dependent)) (NN manner) (CD -LSB-31-33) (-RRB- -RSB-))))))))))))) (. .)))
( (S (S (NP (JJ Similar) (NNS experiments)) (VP (VBD were) (VP (VBN performed) (PP (IN as) (NP (NP (DT those)) (VP (VBG examining) (NP (NN c-jun) (NN phosphorylation)))))) (, ,) (SBAR (WHPP (IN except) (WHNP (WDT that))) (S (NP (PRP we)) (VP (VBD used) (NP (NP (JJ specific) (NNS antibodies)) (PP (IN against) (NP (NN CD69)))) (S (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP (DT the) (NN SEB) (JJ reactive) (NNS cells)) (VP (VBD had) (VP (VBN been) (VP (VBN activated)))))))))))))) (. .)))
( (S (S (NP (NN Figure) (CD 7)) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (NP (NP (JJ Vβ8+CD4+) (NN T) (NNS cells)) (CONJP (CC but) (RB not)) (NP (NN Vβ6+CD4+) (NN T) (NNS cells))) (PP (IN from) (NP (DT both) (NN WT) (CC and) (NN ITK) (JJ null) (NNS mice)))) (VP (VBD exhibited) (NP (NP (NNS increases)) (PP (IN in) (NP (NN CD69) (NN expression) (CD 2) (NNS hours)))) (PP (VBG following) (NP (NN SEB) (NN exposure))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (PP (IN in) (NP (DT both) (NNS cases))) (, ,) (NP (DT the) (NN T) (NNS cells)) (VP (VBD were) (VP (VBG responding) (PP (TO to) (NP (NP (NN SEB) (NN activation)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 7)) (-RRB- -RRB-))))))))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NN SEB)) (VP (VBD induced) (NP (NP (NN CD69) (NN expression)) (PP (IN on) (NP (NP (DT a) (JJR higher) (NN percentage)) (PP (IN of) (NP (JJ Vβ8+CD4+) (NN SEB) (VBG responding) (NN T) (NNS cells))))) (PP (IN in) (NP (JJ WT) (NNS mice)))) (PP (IN than) (PP (IN in) (NP (NP (NN ITK) (JJ null) (NNS mice)) (PRN (-LRB- -LRB-) (NP (NP (NP (QP (CD 73.5) (CC +/-) (CD 12)) (NN %)) (PP (IN in) (NP (NN WT)))) (CC vs.) (NP (NP (QP (CD 43.6) (CC +/-) (CD 0.5)) (NN %)) (PP (IN in) (NP (NN ITK) (NN null))))) (-RRB- -RRB-))))))) (. .)))
( (S (ADVP (RB However)) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (NN difference)) (PP (IN in) (NP (NP (DT the) (NN MFI)) (PP (IN of) (NP (NP (NN CD69) (NN expression) (NN WT) (VBG responding) (NN T) (NNS cells)) (CC vs.) (NP (NN ITK) (NN null) (VBG responding) (NN T) (NNS cells))))))) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 362.5) (JJ _+/-) (NP (CD 6.3))) (PP (IN in) (NP (NN WT)))) (CC vs.) (NP (NP (CD 375) (CC +/-) (CD 11.3)) (PP (IN in) (NP (NN ITK) (NN null))))) (-RRB- -RRB-))) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (NN difference)) (PP (IN in) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN CD25))) (PP (IN on) (NP (NP (NP (NN WT)) (CC or) (NP (NN ITK))) (NN null) (NN T) (NNS cells)))))) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))) (. .)))
( (S (ADVP (RB Thus)) (NP (NP (DT the) (NN lack)) (PP (IN of) (NP (ADJP (NN SEB) (JJ induced)) (NN c-jun) (NN phosphorylation))) (PP (IN in) (NP (NN ITK) (NN null) (NN T) (NNS cells)))) (VP (VBZ seems) (S (VP (TO to) (VP (VB reflect) (NP (NP (DT the) (JJ specific) (NN role)) (PP (IN of) (NP (NN ITK))) (PP (IN in) (S (VP (VBG regulating) (NP (NP (DT this) (NN event)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN SEB) (NN exposure)))))) (ADVP (FW in) (FW vivo)))))))))) (. .)))
( (S (S (NP (NP (NN Exposure)) (PP (IN of) (NP (NNS mice))) (PP (TO to) (NP (NP (NN SEB)) (CC and) (NP (NN LPS))))) (VP (VBZ results) (PP (IN in) (NP (NP (NN toxicity)) (VP (VBG culminating) (PP (IN in) (NP (NN death) (NN -LSB-1) (-RRB- -RSB-)))))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB therefore)) (VP (VBD analyzed) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NN exposure)) (PP (TO to) (NP (NN SEB/LPS))))) (PP (IN on) (NP (NN ITK) (JJ null) (NNS mice)))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (PP (IN in) (NN contrast) (TO to) (NP (NP (DT the) (NNS results)) (PP (IN with) (NP (NP (NN IL-2) (NN secretion)) (CC and) (NP (NN T) (NN cell) (NN expansion)))))) (, ,) (NP (DT both) (NNS mice)) (VP (VBD were) (VP (VBN affected) (ADVP (RB similarly)) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 1)) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (NP (RB Thus) (DT the) (JJ same) (NN proportion)) (PP (IN of) (NP (NNS mice)))) (VP (VBD became) (ADJP (JJ sick)) (PP (VBG following) (NP (NP (NP (NN exposure)) (PP (TO to) (NP (NN SEB)))) (CC and) (NP (NN LPS)))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (SBAR (IN although) (S (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN ITK)))) (VP (VBZ affects) (NP (NN IL-2) (NN secretion)) (PP (VBG following) (NP (NN SEB) (NN exposure)))))) (, ,) (NP (PRP$ its) (NN absence)) (VP (VBZ does) (RB not) (VP (VB affect) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN SEB))) (S (VP (TO to) (VP (VB induce) (NP (NN sickness)) (PP (IN in) (NP (DT these) (NNS mice))))))))))))))) (. .)))
( (S (NP (NN Discussion))))
( (S (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB well)) (VP (VBN established) (SBAR (IN that) (S (NP (NP (NN exposure)) (PP (TO to) (NP (NN SEB)))) (VP (VBZ results) (PP (IN in) (NP (NP (JJ large) (NN scale) (NN cytokine) (NN production)) (, ,) (SBAR (WHNP (WDT which)) (S (PP (IN in) (NP (NN part))) (VP (VBZ is) (ADJP (JJ responsible) (PP (IN for) (NP (NP (NNS symptoms)) (PP (IN of) (NP (NP (NN exposure)) (PP (TO to) (NP (DT this) (NN toxin) (NN -LSB-1,2,35))))) (-RRB- -RSB-))))))))))))))) (. .)))
( (S (S (NP (NN T) (NNS cells)) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (ADJP (RB largely) (JJ responsible) (PP (IN for) (NP (DT this) (JJ excessive) (NN cytokine) (NN production) (CD -LSB-35,36)))))) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (NP (JJ Current) (NNS suggestions)) (PP (IN for) (S (ADVP (RB pharmacologically)) (VP (VBG blocking) (NP (NP (DT the) (NNS symptoms)) (PP (IN of) (NP (NN SEB) (NN exposure)))))))) (VP (VBP include) (NP (NP (NN T) (NN cell) (NN signal) (NN transduction) (NNS inhibitors)) (PP (JJ such) (IN as) (NP (NP (NN CsA)) (CC and) (NP (NN Perfenidone))))))) (, ,) (S (ADVP (RB however)) (, ,) (NP (DT these) (NNS agents)) (VP (VBP have) (NP (NP (JJ significant) (JJ side) (NNS effects)) (CD -LSB-37,38) (-RRB- -RSB-)))) (. .)))
( (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP present) (NP (NP (DT a) (JJ promising) (NN target)) (PP (IN for) (NP (NP (NN inhibition) (NN IL-2) (NN production)) (VP (VBN induced) (PP (IN by) (NP (NP (NN SEB) (NN exposure)) (, ,) (NP (DT the) (NN tyrosine) (NN kinase) (NN ITK))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NNS mice)) (VP (VBG lacking) (NP (NN ITK)))) (VP (VP (VBP have) (NP (ADJP (RB significantly) (VBN reduced)) (NN T) (NN cell) (NN expansion))) (CC and) (VP (NP (NN IL-2) (NN secretion)) (PP (IN upon) (NP (NP (NN exposure)) (PP (TO to) (NP (NP (NN SEB)) (ADVP (FW in) (FW vivo)))))))))))) (. .)))
( (S (ADVP (RB Furthermore)) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (ADJP (NN SEB) (JJ induced)) (NN signaling) (NN pathway)) (VP (VBG leading) (PP (TO to) (NP (NP (NN c-jun) (NN phosphorylation)) (, ,) (NP (NP (DT an) (NN indication)) (PP (IN of) (NP (NN JNK) (NN pathway) (NN activation)))) (, ,))))) (VP (VBZ is) (VP (ADVP (RB significantly)) (VBN reduced) (PP (IN in) (NP (NN ITK) (NN null) (NN T) (NNS cells))) (, ,) (SBAR (IN although) (S (S (NP (DT these) (NN T) (NNS cells)) (VP (MD could) (VP (VB respond) (PP (TO to) (NP (NN SEB) (NN activation))) (PP (IN by) (S (VP (VBG upregulating) (NP (NN CD69)))))))) (, ,) (CC and) (S (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (NN difference)) (PP (IN in) (NP (NP (DT the) (JJ overall) (NN toxicity)) (PP (IN of) (NP (NN SEB/LPS))))) (PP (IN in) (NP (DT these) (NNS mice)))) (PP (VBN compared) (PP (TO to) (NP (JJ WT) (NNS mice))))))))))))) (. .)))
( (S (NP (NP (JJ Previous) (NN work)) (VP (VBN performed) (ADVP (FW in) (FW vitro)))) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NN ITK)) (VP (VBZ is) (VP (VBN required) (SBAR (IN for) (S (NP (DT the) (JJ anti-TcR/CD3) (NN antibody)) (VP (VBD mediated) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NN transcription) (NN factor) (NN NFAT)))) (, ,) (PP (IN via) (NP (NP (NN regulation)) (PP (IN of) (NP (NP (NN calcium) (NN influx)) (PP (IN into) (NP (NN TcR) (JJ stimulated) (NN T) (NNS cells) (NP (CD -LSB-19,39)))))))) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (NN ITK) (NN null) (NN T) (NNS cells)) (ADVP (RB also)) (VP (VBP exhibit) (NP (VBN reduced) (NN AP-1) (NN DNA) (NN binding) (NN activity)) (SBAR (WHADVP (WRB when)) (S (VP (VBN stimulated) (ADVP (FW in) (FW vitro)) (PP (IN with) (NP (JJ anti-CD3) (NNS antibodies) (CD -LSB-19) (-RRB- -RSB-)))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ has) (ADVP (RB also)) (VP (VBN been) (VP (VBN shown) (SBAR (IN that) (S (NP (NN JNK) (NN activation)) (VP (VBZ lies) (PP (IN in) (NP (NN part))) (ADVP (RB downstream) (PP (IN of) (NP (NN ITK)))) (PP (VBG following) (NP (NN TcR) (NN crosslinking))) (PP (IN in) (NP (FW vitro) (NN -LSB-23) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (S (ADVP (RB However)) (, ,) (NP (DT these) (NNS experiments)) (VP (VBD were) (VP (VBN performed) (ADVP (FW in) (FW vitro))))) (CC and) (S (NP (PRP it)) (VP (VBZ is) (RB not) (ADJP (JJ clear)) (SBAR (IN that) (S (NP (NP (NNS effects)) (VP (VBN seen) (ADVP (FW in) (FW vitro)))) (VP (MD would) (VP (VB reflect) (SBAR (WHNP (WP what)) (S (VP (VBZ happens) (PP (IN in) (NP (FW vivo))) (, ,) (SBAR (IN since) (S (NP (JJ other) (JJ cell-cell) (NNS interactions)) (VP (MD may) (VP (VB allow) (PP (IN for) (NP (NP (NN activation)) (PP (IN of) (NP (NP (NNS pathways)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (RB not) (VP (VBN seen) (S (VP (VBG using) (NP (NP (ADJP (FW in) (FW vitro)) (NN activation)) (PP (IN with) (NP (NNS antibodies)))))))))))))))))))))))))))) (. .)))
( (S (S (NP (PRP$ Our) (NNS data)) (ADVP (RB however)) (, ,) (VP (VBP suggest) (SBAR (IN that) (S (ADVP (RB indeed)) (, ,) (NP (NN ITK)) (VP (VP (VBZ lies) (ADVP (RB downstream) (PP (IN of) (NP (DT the) (NN TcR))))) (CC and) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (NN IL-2) (NN secretion)) (CC and) (NP (NN c-jun) (NN phosphorylation)))) (ADVP (FW in) (FW vivo))))))))) (. .)))
( (S (S (S (VP (VBG Corroborating) (NP (NP (DT a) (NN role)) (PP (IN for) (NP (NN c-jun) (NN activation))) (PP (IN in) (NP (NN IL-2) (NN production)))))) (, ,) (NP (NP (NNS mice)) (VP (VBG carrying) (NP (DT a) (JJ dominant) (JJ negative) (NN c-jun)))) (VP (VBP have) (NP (NP (ADJP (RB much) (VBN reduced)) (NN IL-2) (NN secretion)) (ADVP (FW in) (FW vitro)) (NP (NP (CD -LSB-28) (-RRB- -RSB-)) (PRN (-LRB- -LRB-) (S (NP (NP (NNS mice)) (VP (VBG lacking) (NP (NN c-jun)))) (VP (VBP die) (PP (IN during) (NP (NN embryogenesis) (CD -LSB-40))))) (-RRB- -RSB-) (-RRB- -RRB-)))))) (. .)))
( (S (S (ADVP (RB Similarly)) (, ,) (NP (NN JNK)) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (NN IL-2) (NN secretion)) (PP (IN by) (NP (NN T) (NNS cells))) (PP (IN in) (NP (FW vitro) (NN -LSB-25-27) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (PRP$ Our) (NNS data)) (VP (VBP lend) (NP (NN support)) (PP (TO to) (NP (DT this) (NN idea) (SBAR (IN that) (S (NP (DT the) (NN JNK-c-jun) (NN pathway)) (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NN IL-2))) (PP (IN by) (NP (NN T) (NNS cells))))) (ADVP (FW in) (FW vivo)))))))))) (. .)))
( (S (S (ADVP (RB Curiously)) (, ,) (NP (DT the) (JJ immunosuppresant) (NN CsA)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB inhibit) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN SEB) (NN exposure))) (PP (IN in) (NP (NNS mice)))) (SBAR (IN if) (S (VP (VBN delivered) (PP (JJ prior) (TO to) (NP (NN SEB) (NN exposure) (CD -LSB-36) (-RRB- -RSB-))))))))))))) (, ,) (S (ADVP (RB however)) (NP (PRP it)) (VP (VBZ does) (RB not) (VP (VB inhibit) (NP (ADJP (NN SEB) (JJ induced)) (NNS effects)) (PP (IN in) (NP (NNS monkeys))) (SBAR (IN if) (S (VP (VBN delivered) (PP (IN at) (NP (DT the) (JJ same) (NN time))) (PP (IN as) (NP (NN SEB) (CD -LSB-38))) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NN CsA))) (PP (IN on) (NP (ADJP (NN SEB) (JJ induced)) (NNS symptoms)))) (VP (VBZ has) (VP (VBN been) (VP (VBN suggested) (S (VP (TO to) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (PRP$ its) (NNS effects)) (PP (IN on) (S (VP (VBG inhibiting) (NP (NP (NN IL-2) (CC and) (JJ other) (NN cytokine) (NN production)) (ADJP (JJ due) (PP (TO to) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (NN activation)) (PP (IN of) (NP (NP (DT the) (NN transcription) (NN factor) (NN NFAT) (CD -LSB-36,41) (-RRB- -RSB-)) (PRN (, ,) (S (ADVP (RB however)) (, ,) (NP (NN CsA)) (ADVP (RB also)) (VP (VBZ inhibits) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NN JNK) (NN pathway)))) (PP (VBG following) (NP (NP (NP (NN TcR/CD3)) (CC and) (NP (NN CD28))) (NN stimulation) (CD -LSB-29,30))))) (-RRB- -RSB-))))))))))))))))))))))) (, ,) (CC and) (RB so) (S (NP (NN CsA) (NN pretreatment)) (VP (MD may) (VP (VB act) (S (VP (TO to) (VP (VB prevent) (NP (NP (JJ early) (NN T) (NN cell) (NN activation)) (PP (IN of) (NP (DT these) (NNS pathways)))))))) (, ,) (S (ADVP (RB thus)) (VP (VP (VBG blocking) (NP (NN cytokine) (NN production))) (CC and) (VP (VBG protecting) (NP (NNS mice)) (PP (IN from) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ subsequent) (NN SEB) (NN exposure)))))))))) (. .)))
( (S (S (NP (NP (NNS Mice)) (VP (VBG lacking) (NP (NN ITK)))) (VP (VP (VBP exhibit) (NP (VBN reduced) (NN T) (NN cell) (NNS responses)) (ADVP (FW in) (FW vitro))) (, ,) (CC but) (ADVP (RB also)) (VP (VBP have) (NP (NP (VBN reduced) (NNS percentages)) (PP (IN of) (NP (JJ CD4+) (NN T) (NNS cells)))) (PRN (-LRB- -LRB-) (NP (NP (QP (RB approximately) (CD 60–70)) (NN %)) (PP (IN of) (NP (NN WT)))) (, ,) (NP (CD -LSB-16) (-RRB- -RSB-)) (-RRB- -RRB-))))) (. .)))
( (S (SBAR (IN While) (S (NP (DT this)) (VP (MD would) (VP (VB be) (VP (VBN expected) (S (VP (TO to) (VP (VBD reduced) (NP (DT the) (JJ overall) (NN T) (NN cell) (NN response)) (ADVP (FW in) (FW vivo)) (PP (TO to) (NP (NN SEB) (NN exposure))))))))))) (, ,) (SBAR (IN if) (S (NP (DT these) (NNS cells)) (VP (VBD were) (ADJP (JJ able) (S (VP (TO to) (VP (VB respond) (PP (TO to) (NP (NN SEB)))))))))) (, ,) (NP (PRP we)) (VP (MD would) (VP (VB expect) (NP (NP (DT an) (JJ equivalent) (NN reduction)) (PP (IN in) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NP (NN IL-2)) (VP (VBN secreted) (ADVP (FW in) (FW vivo)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN SEB))))))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (MD would) (ADVP (RB also)) (VP (VB expect) (S (VP (TO to) (VP (VB see) (NP (NP (DT an) (JJ equivalent) (NN reduction)) (PP (IN in) (NP (NN proliferation)))) (ADVP (FW in) (FW vitro)))))))) (. .)))
( (S (ADVP (RB However)) (, ,) (PP (IN in) (NP (FW vivo))) (, ,) (NP (PRP we)) (VP (VP (VP (VBD observed) (NP (ADJP (RB much) (VBN reduced)) (NN IL-2) (NN secretion))) (, ,) (CC and) (VP (VBD reduced) (NP (NP (NN expansion)) (PP (IN of) (NP (NN Vβ8+CD4+) (NN T) (NNS cells)))))) (, ,) (SBAR (IN although) (S (NP (DT this)) (VP (VBD was) (RB not) (ADJP (RB as) (JJ dramatic) (PP (IN as) (NP (NP (DT the) (NN reduction)) (PP (IN in) (NP (NN IL-2) (NN secretion)))))))))) (. .)))
( (S (S (ADVP (RB Indeed)) (, ,) (NP (PRP it)) (VP (VBZ has) (VP (VBN been) (VP (VBN observed) (SBAR (IN that) (S (NP (NN SEB)) (VP (VBD induced) (NP (NN T) (NN cell) (NN expansion)) (PP (IN in) (NP (NN IL-2) (JJ null) (NNS mice))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NN IL-2)) (VP (VBZ is) (RB not) (ADJP (JJ necessary) (PP (IN for) (NP (NP (NN expansion)) (PP (IN of) (NP (NN T) (NNS cells))))) (ADVP (FW in) (FW vivo))) (PP (VBG following) (NP (NN SEB) (NN exposure))))))))))))))) (. .)))
( (S (ADVP (RB However)) (, ,) (PP (ADVP (RB even)) (IN with) (NP (NP (DT the) (VBN reduced) (NN T) (NN cell) (NNS responses)) (VP (VBN observed) (PP (IN in) (NP (NN ITK) (JJ null) (NNS mice)))))) (, ,) (NP (PRP they)) (ADVP (RB still)) (VP (VBP suffer) (PP (IN from) (NP (NP (JJ SEB/LPS) (JJ induced) (NN toxicity)) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (VP (VBN seen) (PP (IN in) (NP (DT the) (JJ WT) (NNS mice)))))))))) (. .)))
( (S (S (NP (PRP It)) (VP (MD should) (VP (VB be) (VP (VBN noted) (ADVP (RB however)) (, ,) (SBAR (IN that) (S (NP (NN C57BL/6) (NNS mice)) (VP (VBP are) (ADJP (ADVP (RB much) (RBR less)) (JJ sensitive) (PP (TO to) (NP (NP (NN SEB)) (PRN (S (VP (VB induce) (NP (JJ lethal) (NN shock)) (PP (IN than) (NP (NN Balb/c) (NNS mice) (CD -LSB-34))))) (-RRB- -RSB-)))))))))))) (. .)))
( (S (S (S (ADVP (RB Thus)) (NP (PRP we)) (VP (VBD observed) (NP (ADJP (RB very) (JJ few)) (NNS deaths)) (PP (IN in) (NP (PRP$ our) (NNS experiments))))) (, ,) (CC and) (S (NP (NN ITK)) (VP (MD may) (VP (VB protect) (NP (NN Balb/c) (NNS mice)) (PP (IN from) (NP (JJ actual) (NN death))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP are) (ADVP (RB currently)) (VP (VBG crossing) (NP (DT these) (NNS mice)) (PP (IN onto) (NP (DT the) (NN Balb/c) (NN background))) (S (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP (DT this)) (VP (VBZ is) (NP (DT the) (NN case))))))))))) (. .)))
( (S (NP (NN Conclusion))))
( (S (S (PP (IN In) (NP (NN conclusion))) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VB show) (SBAR (IN that) (S (NP (NN ITK)) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (NN IL-2) (NN production)) (VP (VBN induced) (PP (IN by) (NP (NN SEB)))))) (ADVP (ADVP (FW in) (FW vivo)) (CC and) (ADVP (FW in) (FW vitro)))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB also)) (VP (VBN shown) (SBAR (IN that) (S (NP (NN ITK)) (VP (MD may) (VP (VB regulate) (NP (NP (NNS signals)) (VP (VBG leading) (NP (NN IL-2) (NN production)))) (PP (IN in) (NP (NN part))) (PP (IN by) (S (VP (VBG regulating) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN c-jun)))))))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NP (NNS mice)) (VP (VBG lacking) (NP (NN ITK)))) (VP (VBP exhibit) (NP (NP (JJ similar) (NNS responses)) (PP (TO to) (NP (NN SEB) (NN toxicity)))))) (. .)))
( (S (S (NP (DT The) (NNS data)) (VP (VBP suggest) (SBAR (SBAR (IN that) (S (NP (NP (DT the) (NN inability)) (PP (IN of) (NP (NN T) (NN cell) (VBG lacking) (NN ITK))) (S (VP (TO to) (VP (VB produce) (NP (NN IL-2)))))) (VP (MD cannot) (VP (VB be) (VP (VBN overcome) (PP (IN by) (NP (NN SAG) (NN stimulation)))))))) (, ,) (CC and) (SBAR (IN that) (S (S (VP (VBG perturbing) (NP (NP (NN T) (NN cell) (NN activation) (NNS pathways)) (VP (VBG leading) (PP (TO to) (NP (NN IL-2) (NN production))))))) (VP (VBZ does) (RB not) (ADVP (RB necessarily)) (VP (VB lead) (PP (TO to) (NP (NP (JJ improved) (NNS responses)) (PP (TO to) (NP (NN SEB) (NN toxicity)))))))))))) (. .)))
( (S (NP (NNS Methods))))
( (S (S (NP (NP (NP (JJ Wild) (NN type) (NNS mice)) (CC and) (NP (NP (JJ ITK-deficient) (NNS mice)) (PRN (-LRB- -LRB-) (NP (NP (NN C57BL/6) (NN background)) (, ,) (NP (CD -LSB-16) (-RRB- -RSB-))) (-RRB- -RRB-)))) (PP (IN between) (NP (CD 8) (CC and) (CD 10) (NNS weeks)))) (VP (VBD were) (VP (VBN used) (PP (IN in) (NP (DT all) (NNS experiments)))))) (. .)))
( (S (S (NP (JJ RAG1-/-) (NNS mice)) (VP (VP (VBD were) (NP (NP (DT a) (NN kind) (NN gift)) (PP (IN of) (NP (NP (NNP Dr.) (NN Eric) (NNP Harvill)) (PRN (-LRB- -LRB-) (NP (NNP Penn) (NN State) (NNP University)) (-RRB- -RRB-)))))) (CC and) (VP (VBD were) (ADVP (RB similarly)) (VP (VBN used) (PP (IN between) (NP (NP (CD 6–10) (NNS weeks)) (PP (IN of) (NP (NN age))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ Institutional) (NN Animal) (NN Care) (CC and) (NN Use) (NN Committee)) (PP (IN of) (NP (DT The) (NNP Pennsylvania) (NN State) (NNP University)))) (VP (JJ approved) (NP (DT all) (NNS experiments)))) (. .)))
( (S (S (NP (NN WT) (CC and) (NN ITK) (JJ deficient) (NNS mice)) (VP (VBD were) (VP (VBN injected) (ADVP (ADVP (RB intraperitoneally)) (PRN (-LRB- -LRB-) (ADVP (RB i.p.)) (-RRB- -RRB-))) (PP (IN with) (NP (ADJP (CD 50) (NN μg)) (NN SEB))) (SBAR (IN in) (S (NN PBS) (-LRB- -LRB-) (NNP Sigma-Aldrich) (, ,) (NN St.) (NN Louis) (, ,) (NN MO) (-RRB- -RRB-) (CC and) (PP (IN after) (NP (CD 2) (NNS days))) (, ,) (VP (VBD were) (VP (VBN sacrificed) (NP (CC and) (NP (NP (NNS splenocytes)) (VP (VBN stained) (PP (IN with) (NP (NP (NNS antibodies)) (ADJP (JJ specific) (PP (IN for) (NP (NN Vβ8)))))) (PRN (-LRB- -LRB-) (NP (NN SEB) (JJ reactive) (NN T) (NNS cells)) (-RRB- -RRB-)))) (CC or) (NP (NP (NP (NP (NN Vβ6)) (PRN (-LRB- -LRB-) (NP (JJ non-reactive) (NN T) (NNS cells)) (-RRB- -RRB-))) (CC and) (NP (NN CD4))) (VP (ADVP (RB directly)) (VBN conjugated) (PP (TO to) (NP (NP (NN FITC)) (CC and) (NP (NN PE))))))) (ADVP (ADVP (RB respectively)) (PRN (-LRB- -LRB-) (NP (NP (NNP BDPharmingen) (, ,) (NNP San) (NNP Diego)) (, ,) (NP (NN CA))) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (ADVP (RB Alternatively)) (, ,) (NP (NNS mice)) (VP (VBD were) (VP (VP (VBN injected) (ADVP (RB i.p.)) (PP (IN with) (NP (ADJP (CD 50) (NN μg)) (NN SEB)))) (CC and) (VP (VBN eye-bled) (NP (DT every) (CD 2) (NNS days)) (PP (IN for) (NP (CD 5) (NNS days))))))) (. .)))
( (S (S (PP (VBG Following) (NP (NP (NN lysis)) (PP (IN of) (NP (JJ red) (NN blood) (NNS cells))))) (, ,) (NP (DT the) (VBG remaining) (NNS cells)) (VP (VBD were) (VP (VBN stained) (SBAR (IN as) (S (VP (VBN described) (ADVP (RB above)) (PP (IN for) (NP (DT the) (NNS splenocytes))))))))) (. .)))
( (S (S (NP (NNS Lymphocytes)) (VP (VBD were) (VP (VBN identified) (PP (IN by) (NP (NN flow) (NN cytometry))) (PP (IN by) (NP (PRP$ their) (ADJP (ADJP (JJ forward)) (CC and) (ADJP (JJ side)) (ADJP (JJ scatter))) (NNS characteristics)))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD used) (NP (NP (DT a) (NN protocol)) (VP (VBN reported) (PP (IN by) (NP (NNP Zell) (FW et) (FW al))))) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN phosphorylation) (NN status)) (PP (IN of) (NP (NN c-jun)))) (, ,) (PP (IN as) (NP (NP (DT a) (NN measure)) (PP (IN of) (NP (NP (NN activation)) (PP (IN of) (NP (NP (DT the) (JJ JNK-c-jun) (NN pathway)) (PP (IN in) (NP (NN SEB) (VBG responding) (NN T) (NNS cells)))))))))))))) (. .)))
( (S (S (NP (NP (NP (NN WT)) (CC and) (NP (NN ITK))) (JJ deficient) (NNS mice)) (VP (VBD were) (VP (VP (VBN injected) (ADVP (ADVP (RB i.p.)) (CC or) (ADVP (ADVP (RB intravenously)) (PRN (-LRB- -LRB-) (NP (NN i.v.)) (-RRB- -RRB-)))) (PP (IN with) (NP (ADJP (CD 50) (NN μg)) (NN SEB)))) (CC and) (VP (VBN allowed) (S (VP (TO to) (VP (VB survive) (PP (IN for) (NP (DT an) (CD 1) (NN hr)))))))))) (. .)))
( (S (S (NP (JJ Similar) (NNS results)) (VP (VBD were) (VP (VBN found) (PP (IN with) (NP (NP (DT both) (NNS routes)) (PP (IN of) (NP (NN administration)))))))) (. .)))
( (S (S (S (NP (NNS Animals)) (VP (VBD were) (VP (VBN sacrificed)))) (CC and) (S (NP (NP (NNS spleens)) (, ,) (NP (NN lymph) (NNS nodes)) (, ,) (CC and) (NP (NN blood))) (ADVP (RB rapidly)) (VP (VP (VBN isolated)) (, ,) (CC and) (VP (VBN dounced) (PP (IN in) (NP (ADJP (CD 2) (NN %)) (NN paraformaldehyde))) (S (VP (TO to) (ADVP (RB rapidly)) (VP (VB fix) (NP (DT the) (NNS cells)) (PP (IN as) (NP (ADJP (RB previously) (VBN described)) (NN -LSB-30))) (-RRB- -RSB-)))))))) (. .)))
( (S (S (NP (NNS Cells)) (VP (VBD were) (VP (VBN stained) (PP (IN with) (NP (NP (NNS antibodies)) (PP (TO to) (NP (NP (NNP Vβ8)) (CC or) (NP (NNP Vβ6)))) (VP (ADVP (RB directly)) (VBN conjugated) (PP (TO to) (NP (NN PE))) (PRN (-LRB- -LRB-) (NP (NP (NNP BDPharmingen) (, ,) (NNP San) (NNP Diego)) (, ,) (NP (NN CA))) (-RRB- -RRB-))))) (, ,) (ADVP (RB then)) (ADJP (JJ permeabilized) (PP (IN with) (NP (NN saponin))))))) (. .)))
( (S (S (NP (NNS Cells)) (VP (VBD were) (ADVP (RB then)) (VP (VBN stained) (PP (IN for) (NP (JJ intracellular) (NN phosphorylated-c-jun))) (PP (IN with) (NP (NP (DT a) (JJ monoclonal) (NN antibody)) (PP (IN against) (NP (NP (NP (VBN phosphorylated) (NN c-jun)) (PRN (-LRB- -LRB-) (NP (NP (NN IgG1)) (, ,) (NP (NN Cell) (NN Signaling)) (, ,) (NP (NNP Beverly) (, ,) (NNP MA))) (-RRB- -RRB-))) (, ,) (VP (VBN followed) (PP (IN by) (NP (NP (NP (VBN biotinylated) (NN rabbit) (JJ anti-mouse) (NN IgG1)) (CC and) (NP (NN streptavidin))) (VP (VBN conjugated) (PP (TO to) (NP (NN FITC)))))))))))))) (. .)))
( (S (S (NP (NNS Controls)) (VP (VBD included) (NP (NP (JJ secondary) (NNS reagents)) (ADVP (RB alone))))) (. .)))
( (S (S (NP (NP (NN Upregulation)) (PP (IN of) (NP (NN CD69))) (PP (IN by) (NP (NN SEB))) (ADVP (FW in) (FW vivo))) (VP (VBD was) (VP (VBN performed) (S (VP (VBG using) (NP (NP (JJ similar) (NNS approaches)) (, ,) (SBAR (WHPP (IN except) (WHNP (WDT that))) (S (NP (NN T) (NNS cells)) (VP (VBD were) (RB not) (ADJP (ADJP (JJ fixed)) (CC or) (ADJP (JJ permeabilized))) (PP (JJ prior) (TO to) (NP (NP (NN staining)) (PP (IN with) (NP (NP (JJ PE-conjugated) (NN anti-CD69) (JJ monoclonal) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NP (NNP BDPharmingen) (, ,) (NNP San) (NNP Diego)) (, ,) (NP (NN CA))) (-RRB- -RRB-))))))))))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBD was) (VP (VBN followed) (PP (IN by) (NP (NN analysis))) (PP (IN by) (NP (NN flow) (NN cytometry))) (, ,) (PP (IN with) (NP (NP (JJ post) (NN analysis)) (VP (VBN performed) (S (VP (VBG using) (NP (NP (DT the) (NN WinMDI) (NN program) (CD 2.8)) (PRN (-LRB- -LRB-) (NP (NP (DT The) (NN Scripps) (NN Research) (NN Institute)) (, ,) (NP (NN La) (NN Jolla)) (, ,) (NP (NN CA))) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (NP (NP (NN Lymph) (NNS nodes)) (CC and) (NP (NNS spleens))) (VP (VBD were) (VP (VP (VBN isolated) (PP (IN from) (NP (NP (NP (NN WT)) (CC and) (NP (NN ITK))) (JJ deficient) (NNS mice)))) (CC and) (VP (JJ pooled))))) (. .)))
( (S (S (S (NP (JJ Red) (NN blood) (NNS cells)) (VP (VBD were) (VP (VBN removed) (S (VP (VBG using) (NP (NN ACK) (NN lysis) (NN buffer))))))) (, ,) (CC and) (S (NP (NNS cells)) (VP (VBN resuspended) (PP (IN in) (NP (JJ complete) (NN RPMI)))))) (. .)))
( (S (S (NP (NNS Cells)) (VP (VBD were) (ADVP (RB then)) (ADJP (JJ left)) (UCP (ADJP (JJ unstimulated)) (CC or) (VP (VBN stimulated) (PP (IN with) (NP (NP (JJ varying) (NNS concentrations)) (PP (IN of) (NP (NP (NN SEB)) (PRN (-LRB- -LRB-) (NP (NP (CD 5) (NN μg/ml)) (, ,) (NP (CD 0.5) (NN μg/ml)) (, ,) (NP (CD 0.05) (NN μg/ml)) (, ,) (NP (CD 0.005) (NN μg/ml)) (, ,) (CC and) (NP (CD 0.0005) (NN μg/ml))) (-RRB- -RRB-)))))) (PP (IN at) (NP (NP (DT a) (NN concentration)) (PP (IN of) (NP (CD 2) (NN ×) (CD 106) (NNS cells/ml))))))))) (. .)))
( (S (S (NP (DT These) (NNS cells)) (VP (VBD were) (VP (VP (VBN incubated) (PP (IN at) (NP (NN 37°C))) (PP (IN for) (NP (CD 5) (NNS days)))) (CC and) (VP (VBN pulsed) (PP (IN once) (NP (NP (DT a) (NN day)) (PP (IN for) (NP (CD 5) (NNS days))))) (PP (IN with) (NP (NP (ADJP (CD 0.5) (NN μCi)) (JJ tritiated) (NN thymidine)) (PP (IN per) (NP (NN well))) (PP (IN for) (NP (CD 12) (NNS hrs))))))))) (. .)))
( (S (PP (IN before) (NP (NN harvest))) (. .)))
( (S (S (NP (NN T) (NNS cells)) (VP (VBD were) (VP (VBN purified) (PP (IN from) (NP (NN WT) (CC and) (NN ITK) (JJ null) (NNS mice))) (S (VP (VBG using) (NP (NP (NP (NN MiniMACS) (NN separation) (NNS columns)) (PRN (-LRB- -LRB-) (NP (NNP Miltenyi) (NNP Biotec) (NNP Inc) (, ,) (NNP Auburn)) (, ,) (NP (NN CA)) (-RRB- -RRB-))) (, ,) (VP (CC and) (VP (VBN plated) (PP (IN at) (NP (CD 2) (NN ×) (CD 106) (NNS cells/ml)))) (CC and) (VP (VBN stimulated) (PP (IN as) (NP (JJ above))))) (, ,)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (NNS splenocytes)) (PP (IN from) (NP (NN RAG) (JJ null) (NNS mice))) (VP (VBN pre-treated) (PP (IN with) (S (NP (NN mitomycin) (NN C.) (NN All) (NNS experiments)) (VP (VBD were) (VP (VBN done) (PP (IN in) (NP (NN triplicate))))))))))))))))) (. .)))
( (S (S (NP (NP (NP (JJ Pooled) (NNS lymphocytes)) (CC and) (NP (NNS splenocytes))) (PP (IN from) (NP (NP (NP (NN WT)) (CC and) (NP (NN ITK))) (JJ deficient) (NNS mice)))) (VP (VBD were) (VP (VBN incubated) (PP (IN with) (NP (NP (JJ varying) (NNS concentrations)) (PP (IN of) (NP (NP (NN SEB)) (PRN (-LRB- -LRB-) (NP (NP (CD 5) (NN μg/ml)) (, ,) (NP (CD 0.5) (NN μg/ml)) (, ,) (NP (CD 0.05) (NN μg/ml)) (, ,) (NP (CD 0.005) (NN μg/ml)) (, ,) (CC and) (NP (CD 0.0005) (NN μg/ml))) (-RRB- -RRB-)))))) (PP (IN for) (NP (CD 5) (NNS days))) (SBAR (IN as) (S (VP (VBN described) (ADVP (RB above)) (PP (IN for) (NP (ADJP (FW in) (FW vitro)) (NN proliferation))))))))) (. .)))
( (S (S (NP (NNS Supernatants)) (VP (VBD were) (VP (VP (VBN sampled) (PP (IN once) (NP (DT a) (NN day))) (PP (IN over) (NP (DT this) (NN period)))) (CC and) (VP (VBN analyzed) (PP (IN for) (NP (NN IL-2))) (S (VP (VBG using) (NP (NP (NNS ELISAs)) (VP (VBG according) (PP (TO to) (NP (NP (NP (DT the) (NN manufacturer) (POS 's)) (NNS recommendations)) (PRN (-LRB- -LRB-) (NP (NP (NNP BDPharmingen) (, ,) (NNP San) (NNP Diego)) (, ,) (NP (NN CA))) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (S (NP (NN WT) (CC and) (NN ITK) (JJ deficient) (NNS mice)) (VP (VBD were) (VP (VBN injected) (PP (IN with) (NP (ADJP (CD 50) (NN μg)) (NN SEB) (NN i.v.)))))) (, ,) (CC and) (S (NP (NN serum)) (VP (VBN isolated) (PP (IN from) (NP (NP (JJ cardiac) (NN blood)) (PP (IN from) (NP (NNS mice) (QP (CD 1) (, ,) (CD 2) (, ,) (CD 4) (, ,) (CD 8) (, ,) (CD 12) (, ,) (CC and) (CD 24)) (NNS hrs)))))))) (. .)))
( (S (S (NP (JJ post) (NN SEB) (NN exposure)) (VP (CC and) (VP (VBN used) (S (VP (TO to) (VP (VB perform) (NP (DT an) (NN ELISA) (S (VP (TO to) (VP (VB determine) (NP (NN IL-2) (NNS levels)))))))))))) (. .)))
( (S (S (S (NP (JJ PBS) (VBN injected) (NNS mice)) (VP (VBD served) (PP (IN as) (NP (NNS controls))))) (, ,) (CC and) (S (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (NN change)) (PP (IN in) (NP (NN IL-2) (NN secretion))) (PP (IN in) (NP (DT these) (NNS animals))))))) (. .)))
( (S (S (NP (NNS Values)) (VP (VP (VBD were) (VP (VBN compared) (S (VP (VBG using) (NP (NP (NN student) (POS 's)) (NN t) (NN test)))))) (CC and) (VP (VBD considered) (ADJP (JJ significant) (PP (IN if) (NP (NN p) (NN <) (CD 0.05))))))) (. .)))
( (S (NP (NP (NN List)) (PP (IN of) (NP (NP (NNS abbreviations)) (VP (VBN used)))))))
( (S (NP (NP (NN ITK)) (NP (NN Interleukin-2) (JJ inducible) (NN T) (NN cell) (NN Kinase)))))
( (S (NP (NN IL-2) (NN Interleukin-2))))
( (S (NP (NN SEB) (JJ Staphylococcal) (NN Enterotoxin) (NN B))))
( (S (NP (NN SAG) (NN Superantigen))))
( (S (NP (NN Th1) (NN T-helper) (CD 1) (NNS cells))))
( (S (NP (NN Th2) (NN T-helper) (CD 2) (NNS cells))))
( (S (NP (NN Syk) (NN Spleen) (NN tyrosine) (NN kinase))))
( (S (NP (NN Zap-70) (NN Zeta) (NN chain) (JJ Associated) (CD protein-70))))
( (S (NP (NP (NN Lck)) (NP (NN Lstra) (NN cell) (NN kinase)))))
( (S (NP (NN MAPK) (NN Mitogen) (JJ Activated) (NN Protein) (NN Kinase))))
( (S (NP (NN ERK) (JJ Extracellular) (NN signal) (JJ Regulated) (NN Kinase))))
( (S (NP (NN JNK) (NN c-jun) (JJ N-terminal) (NN kinase))))
( (S (NP (NN NK) (JJ Natural) (NN Killer) (NNS cells))))
( (S (NP (NN LCM) (JJ Lymphocytic) (NN Choriomeningitis))))
( (S (CC VS) (NP (NN Vesicular) (NN Stomatitis))))
( (S (NP (NN PMA) (NN Phorbol) (JJ Myristic) (NN Acid))))
( (S (NP (JJ PBS) (NN Phosphate) (JJ Buffered) (NN Saline))))
( (S (NP (NP (NN NFAT) (JJ Nuclear) (NN Factor)) (PP (IN of) (NP (JJ Activated) (NN T) (NNS cells))))))
( (S (NP (NN AP-1) (NN Activator) (NN protein) (CD 1))))
( (S (NP (NP (NN CsA)) (NP (NN Cyclosporin) (NN A)))))
( (S (NP (NP (NNS Authors) (POS ')) (NNS contributions))))
( (S (S (NP (NN AA)) (VP (VBN designed) (NP (DT the) (NNS experiments)))) (. .)))
( (S (S (NP (NP (NP (NN MJR)) (CC and) (NP (NN JH))) (VP (VBN performed) (NP (NP (NP (NNS experiments)) (VP (VBG leading) (PP (TO to) (NP (NN figure) (LST (LS 1.)) (NN MJR))))) (VP (VBN performed) (NP (NP (NNS experiments)) (VP (VBG leading) (PP (TO to) (NP (NNS figures) (NP (NP (QP (CD 2) (, ,) (CD 3) (, ,) (CD 4) (, ,) (CD 5) (, ,) (CD 6) (, ,) (CD 7.)) (NN AA)) (CC and) (NP (NN AJH))))))))))) (VP (VBD provided) (NP (NP (JJ financial) (NN support)) (CC and) (NP (NN supervision))))) (. .)))
( (S (S (NP (NP (NN MJR)) (, ,) (NP (NN AJH)) (CC and) (NP (NN AA))) (VP (VBP wrote) (NP (DT the) (NN manuscript)))) (. .)))
( (S (S (NP (DT All) (NNS authors)) (VP (VP (VBN read)) (CC and) (VP (JJ approved) (NP (DT the) (JJ final) (NN manuscript))))) (. .)))
( (S (NP (NP (NN Figure)) (CC and) (NP (NN Table)) (NP (NNS captions)))))
( (S (S (NP (NN Figure) (CD 1) (: :) (NN ITK)) (VP (VBZ regulates) (NP (NN proliferation)) (ADVP (FW in) (FW vitro)) (PP (IN in) (NN response) (TO to) (NP (NN SEB))))) (. .)))
( (S (S (S (NP (NP (NP (NNS Splenocytes)) (CC and) (NP (NP (NN lymph) (NN node)) (NNS cells))) (PP (IN from) (NP (ADJP (ADJP (JJ WT)) (PRN (-LRB- -LRB-) (NP (JJ filled) (NNS circles)) (-RRB- -RRB-)) (CC and) (ADJP (NN ITK) (JJ deficient)) (PRN (-LRB- -LRB-) (NP (JJ open) (NNS circles)) (-RRB- -RRB-))) (NNS mice)))) (VP (VBD were) (VP (VBN stimulated) (ADVP (FW in) (FW vitro)) (PP (IN with) (NP (NP (DT the) (VBN indicated) (NNS concentrations)) (PP (IN of) (NP (NN SEB)))))))) (, ,) (CC and) (S (NP (JJ proliferative) (NN response)) (VP (VBN determined)))) (. .)))
( (S (S (NP (NP (NN Time) (NN course)) (PP (IN of) (NP (NN proliferation))) (PP (IN over) (NP (NP (DT the) (VBN indicated) (NNS doses)) (PP (IN of) (NP (NN SEB)))))) (LST (LS a) (-RRB- -RRB-)) (NP (NP (CD 5) (NN μg/ml) (NN SEB) (, ,) (NN b) (-RRB- -RRB-) (NN dose) (NN curve)) (PP (IN of) (NP (QP (CD 0.0005) (, ,) (CD 0.005) (, ,) (CD 0.05) (, ,) (CD 0.5) (, ,)) (NN &) (CD 5) (NN μg/ml) (NN SEB)))) (VP (VBN analyzed) (PP (IN at) (NP (NP (CD 5) (NNS days)) (PP (IN post) (NP (NN stimulation))))))) (. .)))
( (S (S (VP (VBN Purified) (NP (NP (NP (NP (S (NP (ADJP (ADJP (JJ WT)) (PRN (-LRB- -LRB-) (NP (JJ filled) (NNS circles)) (-RRB- -RRB-)) (CC and) (ADJP (NN ITK) (JJ deficient)) (PRN (-LRB- -LRB-) (NP (JJ open) (NNS circles)) (-RRB- -RRB-))) (NN T) (NNS cells)) (VP (VBD were) (VP (VP (VBN stimulated) (PP (IN in) (NP (FW vitro))) (PP (IN over) (NP (NP (NP (DT the) (VBN indicated) (NN time)) (PP (IN with) (NP (NN c) (-RRB- -RRB-) (CD 10) (NN μg/ml) (NN SEB)))) (, ,) (CC or) (NP (NP (DT a) (NN dose) (NN curve)) (PP (IN of) (NP (QP (CD 0.01) (, ,) (CD 0.1) (, ,) (CD 1) (, ,) (CC and) (CD 10)) (NN μg/ml) (NN SEB))))))) (CC and) (VP (VBN analyzed) (PP (IN at) (NP (NN d))))))) (-RRB- -RRB-) (CD 3) (NNS days)) (PRN (, ,) (NP (NN e)) (-RRB- -RRB-))) (NP (CD 4) (NNS days)) (CC or) (NP (NN f) (-RRB- -RRB-) (CD 5) (NNS days))) (PP (IN post) (NP (NN stimulation)))))) (. .)))
( (S (S (NP (NN *)) (VP (VBZ indicates) (NP (ADJP (RB statistically) (JJ significant)) (NN difference)) (PP (IN with) (NP (DT a) (NN p) (NN <) (CD 0.05))))) (. .)))
( (S (S (NP (NN Figure) (CD 2) (: :) (NN ITK)) (VP (VBZ regulates) (NP (NN IL-2) (NN secretion)) (ADVP (FW in) (FW vitro)) (PP (IN in) (NN response) (TO to) (NP (NN SEB))))) (. .)))
( (S (S (S (NP (NP (NP (NNS Splenocytes)) (CC and) (NP (NP (NN lymph) (NN node)) (NNS cells))) (PP (IN from) (NP (ADJP (ADJP (JJ WT)) (PRN (-LRB- -LRB-) (NP (JJ filled) (NNS circles)) (-RRB- -RRB-)) (CC or) (ADJP (NN ITK) (JJ deficient)) (PRN (-LRB- -LRB-) (NP (JJ open) (NNS circles)) (-RRB- -RRB-))) (NNS mice)))) (VP (VBD were) (VP (VBN stimulated) (ADVP (FW in) (FW vitro)) (PP (IN with) (NP (NP (DT the) (VBN indicated) (NNS concentrations)) (PP (IN of) (NP (NN SEB)))))))) (CC and) (S (NP (NP (NN IL-2) (NNS levels)) (VP (VBN secreted) (PP (IN in) (NP (NNS supernatants))))) (VP (VBN determined)))) (. .)))
( (S (NP (NP (LST (LS a) (-RRB- -RRB-)) (NN Time) (NN course)) (PP (IN of) (NP (NN IL-2) (NN secretion))) (PP (IN at) (NP (ADJP (CD 5) (NN μg/ml)) (NN SEB) (NN dose))) (. .))))
( (S (S (NP (NP (NN b) (-RRB- -RRB-) (NN IL-2) (NN secretion)) (IN over) (DT the)) (VP (VBD indicated) (NP (NP (NNS times)) (CC and) (NP (NNS doses))))) (. .)))
( (S (S (NP (NP (LST (-LRB- -LRB-) (LS i) (-RRB- -RRB-)) (NP (NN Day) (CD 1)) (: ;) (NP (LST (-LRB- -LRB-) (LS ii) (-RRB- -RRB-)) (NP (NN Day) (CD 2))) (: ;) (NP (LST (-LRB- -LRB-) (LS iii) (-RRB- -RRB-)) (NP (NN Day) (CD 3))) (: ;) (NP (LST (-LRB- -LRB-) (LS iv) (-RRB- -RRB-)) (NP (NN Day) (CD 4)) (CC and) (NP (LST (-LRB- -LRB-) (LS v) (-RRB- -RRB-)) (NN Day) (CD 5.)))) (NN *)) (VP (VBZ indicates) (NP (ADJP (RB statistically) (JJ significant)) (NN difference)) (PP (IN with) (NP (DT a) (NN p) (NN <) (CD 0.05))))) (. .)))
( (S (S (NP (NN Figure) (CD 3)) (: :) (S (VP (VBN Reduced) (NP (NN T) (NN cell) (NN expansion)) (PP (IN in) (NN response) (TO to) (NP (NN SEB) (NN exposure))) (ADVP (FW in) (FW vivo))))) (. .)))
( (S (S (S (NP (NP (DT a) (-RRB- -RRB-) (NN WT) (PRN (-LRB- -LRB-) (NP (JJ filled) (NNS circles)) (-RRB- -RRB-)) (CC or) (NN ITK) (JJ deficient) (NNS mice)) (PRN (-LRB- -LRB-) (NP (JJ open) (NNS circles)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN injected) (PP (IN with) (NP (CD 50) (NN μg) (NN SEB))) (ADVP (RB i.p.))))) (CC and) (S (NP (JJ peripheral) (NN blood) (NNS lymphocytes)) (VP (VBN analyzed) (PP (IN after) (NP (NP (QP (CD 2) (, ,) (CD 4) (CC and) (CD 5)) (NNS days)) (PP (IN as) (PP (IN in) (NP (NP (NP (DT the) (NNS materials)) (CC and) (NP (NNS methods))) (PP (IN for) (NP (NP (DT the) (NN percentage)) (PP (IN of) (NP (NN Vβ8+CD4+) (NN T) (NNS cells)))))))))) (SBAR (IN as) (S (VP (VBN indicated) (PRN (-LRB- -LRB-) (S (NP (NN Vβ6+CD4+) (NN T) (NNS cells)) (VP (VBD showed) (NP (DT no) (NN change)) (, ,) (S (NP (NNS data)) (VP (RB not) (VBN shown))))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (LST (LS b) (-RRB- -RRB-)) (NP (NP (DT The) (JJ same) (NNS data)) (VP (VBN plotted) (PP (IN as) (NP (NN fold))))) (VP (VBP increase) (PP (IN in) (NP (NP (NN percentage)) (PP (IN of) (NP (NP (NN Vβ8+CD4+) (NN T) (NNS cells)) (PP (IN in) (NP (JJ peripheral) (NN blood))))))))) (. .)))
( (S (S (NP (NN *)) (VP (VBZ indicates) (NP (NP (DT a) (ADJP (RB statistically) (JJ significant)) (NN difference)) (PP (IN with) (NP (DT a) (NN p) (NN <) (CD 0.05)))))) (. .)))
( (S (S (NP (NP (NP (NN Figure) (CD 4)) (: :) (NP (NN ITK))) (JJ null) (NNS mice)) (VP (VBP secrete) (NP (RBR less) (NN IL-2)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN SEB) (NN exposure))) (ADVP (FW in) (FW vivo)))))) (. .)))
( (S (S (NP (NP (NP (NP (NN WT)) (PRN (-LRB- -LRB-) (NP (JJ filled) (NNS circles)) (-RRB- -RRB-))) (CC and) (NP (NN ITK))) (ADJP (JJ deficient)) (PRN (-LRB- -LRB-) (NP (JJ open) (NNS circles)) (-RRB- -RRB-)) (NNS mice)) (VP (VBD were) (VP (VBN injected) (PRT (RP i.v.)) (PP (IN with) (NP (NP (NP (ADJP (CD 50) (NN μg)) (NN SEB)) (CC and) (NP (NN blood))) (VP (VBN sampled) (PP (IN after) (NP (QP (CD 1) (, ,) (CD 2) (, ,) (CD 4) (, ,) (CD 8) (, ,) (CD 12) (CC and) (CD 24)) (NNS hrs))))))))) (. .)))
( (S (PP (IN post) (NP (NN injection))) (. .)))
( (S (S (NP (NP (NN IL-2)) (PP (IN in) (NP (NN serum)))) (VP (VBD was) (VP (VBN determined) (PP (IN by) (NP (NN ELISA)))))) (. .)))
( (S (NP (NP (NN Figure) (CD 5)) (: :) (S (NP (NN SEB)) (VP (VBZ induces) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NN JNK) (NN pathway)))) (ADVP (RB specifically)) (PP (IN in) (NP (VBG responding) (NN T) (NNS cells))) (ADVP (FW in) (FW vivo)))) (. .))))
( (S (S (NP (NN WT) (NNS mice)) (VP (VBD were) (VP (VP (VBN injected) (PP (IN with) (NP (NP (ADJP (CD 50) (NN μg)) (NN SEB)) (CC or) (NP (JJ PBS) (NN i.v.))))) (CC and) (VP (VBN sacrificed) (PP (IN after) (NP (CD 1) (NN hr))))))) (. .)))
( (S (S (NP (NP (NN Spleen)) (CC and) (NP (NN lymph) (NNS nodes))) (VP (VBD were) (VP (VP (VBN harvested)) (CC and) (VP (VBN analyzed) (PP (IN for) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (VBN phosphorylated) (NN c-jun))) (PP (IN in) (NP (DT the) (ADJP (ADJP (JJ Vβ8+)) (CC and) (ADJP (JJ Vβ6+))) (NN T) (NN cell) (NNS populations))))))))) (. .)))
( (S (S (LST (LS a) (-RRB- -RRB-)) (NP (NN Spleen)) (: :) (NP (NP (LST (-LRB- -LRB-) (LS i) (-RRB- -RRB-)) (NN phosphorylation)) (PP (IN of) (NP (NN c-jun))) (PP (IN in) (NP (NP (JJ Vβ6+) (NN T) (NNS cells)) (PP (IN from) (NP (JJ PBS) (VBN injected) (NNS mice))))))) (. .)))
( (S (S (LST (-LRB- -LRB-) (LS ii) (-RRB- -RRB-)) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN c-jun))) (PP (IN in) (NP (NP (JJ Vβ6+) (NN T) (NNS cells)) (PP (IN from) (NP (NP (NN SEB)) (VBN injected) (NNS mice))))))) (. .)))
( (S (S (LST (-LRB- -LRB-) (LS iii) (-RRB- -RRB-)) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN c-jun))) (PP (IN in) (NP (NP (NN Vβ8+) (NN T) (NNS cells)) (PP (IN from) (NP (DT the) (JJ same) (NNS PBS)))))) (VP (VBN injected) (NP (NNS mice)) (PP (IN in) (NP (-LRB- -LRB-) (NN i) (-RRB- -RRB-))))) (. .)))
( (S (S (LST (-LRB- -LRB-) (LS iv) (-RRB- -RRB-)) (NP (NP (NN phosphorylation) (NN c-jun)) (PP (IN in) (NP (NP (JJ Vβ8+) (NN T) (NNS cells)) (PP (IN from) (NP (DT the) (JJ same) (NN SEB)))))) (VP (VBN injected) (NP (NNS mice)) (PP (IN in) (NP (-LRB- -LRB-) (NN ii) (-RRB- -RRB-))))) (. .)))
( (S (NP (NP (LST (LS b) (-RRB- -RRB-)) (NN Lymph) (NN Node)) (: :) (NP (NP (LST (-LRB- -LRB-) (LS i) (-RRB- -RRB-)) (NN phosphorylation)) (PP (IN of) (NP (NN c-jun))) (PP (IN in) (NP (NP (JJ Vβ6+) (NN T) (NNS cells)) (PP (IN from) (NP (JJ PBS) (VBN injected) (NNS mice)))))) (. .))))
( (S (S (LST (-LRB- -LRB-) (LS ii) (-RRB- -RRB-)) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN c-jun))) (PP (IN in) (NP (NP (JJ Vβ6+) (NN T) (NNS cells)) (PP (IN from) (NP (NP (NN SEB)) (VBN injected) (NNS mice))))))) (. .)))
( (S (S (LST (-LRB- -LRB-) (LS iii) (-RRB- -RRB-)) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN c-jun))) (PP (IN in) (NP (NP (NN Vβ8+) (NN T) (NNS cells)) (PP (IN from) (NP (DT the) (JJ same) (NNS PBS)))))) (VP (VBN injected) (NP (NNS mice)) (PP (IN in) (NP (-LRB- -LRB-) (NN i) (-RRB- -RRB-))))) (. .)))
( (S (S (LST (-LRB- -LRB-) (LS iv) (-RRB- -RRB-)) (NP (NP (NN phosphorylation) (NN c-jun)) (PP (IN in) (NP (NP (JJ Vβ8+) (NN T) (NNS cells)) (PP (IN from) (NP (DT the) (JJ same) (NN SEB)))))) (VP (VBN injected) (NP (NNS mice)) (PP (IN in) (NP (-LRB- -LRB-) (NN ii) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (NN Arrow)) (VP (VBZ points) (PP (TO to) (NP (NP (DT the) (NN population)) (PP (IN of) (NP (NP (NNS cells)) (VP (VBG responding) (PP (TO to) (NP (NP (NN SEB) (NN stimulation)) (PP (IN by) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NN JNK) (NN pathway))) (PP (IN by) (S (VP (VBG inducing) (NP (NN c-jun) (NN phosphorylation)))))))))))))))) (. .)))
( (S (S (NP (NN Figure) (CD 6) (: :) (NN ITK)) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (NN SEB) (VBD mediated) (NN induction)) (PP (IN of) (NP (NN c-jun) (NN phosphorylation))) (PP (IN in) (NP (VBG responding) (NN T) (NNS cells))))) (ADVP (FW in) (FW vivo))))) (. .)))
( (S (S (NP (NP (NP (NP (NN WT)) (PRN (-LRB- -LRB-) (NP (NN top) (NNS panels)) (-RRB- -RRB-))) (CC or) (NP (NN ITK))) (JJ null) (PRN (-LRB- -LRB-) (NP (JJ bottom) (NNS panels)) (-RRB- -RRB-)) (NNS mice)) (VP (VBD were) (VP (VP (VBN injected) (PP (IN with) (NP (NP (ADJP (CD 50) (NN μg)) (NN SEB)) (CC or) (NP (JJ PBS) (NN i.v.))))) (CC and) (VP (VBN sacrificed) (PP (IN after) (NP (CD 1) (NN hr))))))) (. .)))
( (S (S (NP (NNS Splenocytes)) (VP (VBD were) (ADVP (RB then)) (VP (VBN analyzed) (PP (IN for) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (VBN phosphorylated) (NN c-jun))) (PP (IN in) (NP (DT the) (ADJP (ADJP (JJ Vβ8+)) (CC and) (ADJP (JJ Vβ6+))) (NN T) (NN cell) (NNS populations)))))))) (. .)))
( (S (S (LST (LS a) (-RRB- -RRB-)) (NP (NP (JJ Vβ6+) (NN T) (NNS cells)) (PP (IN from) (NP (JJ WT) (NNS mice)))) (: ;) (S (LST (LS b) (-RRB- -RRB-)) (VP (JJ Vβ8+) (NP (NP (NN T) (NNS cells)) (PP (IN from) (NP (JJ WT) (NNS mice)))))) (: ;) (LST (LS c) (-RRB- -RRB-)) (S (VP (JJ Vβ6+) (NP (NP (NN T) (NNS cells)) (PP (IN from) (NP (NN ITK) (JJ null) (NNS mice)))))) (: ;) (LST (LS d) (-RRB- -RRB-)) (NP (NP (NN Vβ8+) (NN T) (NNS cells)) (PP (IN from) (NP (NN ITK) (JJ null) (NNS mice))))) (. .)))
( (S (S (NP (NP (NN Figure) (CD 7)) (: :) (S (NP (NN ITK)) (VP (VBZ is) (RB not) (ADJP (JJ necessary) (PP (IN for) (NP (NN SEB))))))) (VP (VBD induced) (NP (NP (NN upregulation)) (PP (IN of) (NP (NN CD69) (JJ inresponding) (NN T) (NNS cells)))) (ADVP (FW in) (FW vivo)))) (. .)))
( (S (S (NP (NP (NP (NP (NN WT)) (PRN (-LRB- -LRB-) (NP (NN top) (NNS panels)) (-RRB- -RRB-))) (CC or) (NP (NN ITK))) (JJ null) (PRN (-LRB- -LRB-) (NP (JJ bottom) (NNS panels)) (-RRB- -RRB-)) (NNS mice)) (VP (VBD were) (VP (VP (VBN injected) (PP (IN with) (NP (NP (ADJP (CD 50) (NN μg)) (NN SEB)) (CC or) (NP (JJ PBS) (NN i.v.))))) (CC and) (VP (VBN sacrificed) (PP (IN after) (NP (CD 2) (NNS hrs))))))) (. .)))
( (S (S (NP (NNS Splenocytes)) (VP (VBD were) (ADVP (RB then)) (VP (VBN analyzed) (PP (IN for) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN CD69))) (PP (IN on) (NP (DT the) (ADJP (ADJP (JJ Vβ8+)) (CC and) (ADJP (JJ Vβ6+))) (NN T) (NN cell) (NNS populations)))))))) (. .)))
( (S (S (LST (LS a) (-RRB- -RRB-)) (NP (NP (JJ Vβ6+) (NN T) (NNS cells)) (PP (IN from) (NP (JJ WT) (NNS mice)))) (: ;) (S (LST (LS b) (-RRB- -RRB-)) (VP (JJ Vβ8+) (NP (NP (NN T) (NNS cells)) (PP (IN from) (NP (JJ WT) (NNS mice)))))) (: ;) (LST (LS c) (-RRB- -RRB-)) (S (VP (JJ Vβ6+) (NP (NP (NN T) (NNS cells)) (PP (IN from) (NP (NN ITK) (JJ null) (NNS mice)))))) (: ;) (LST (LS d) (-RRB- -RRB-)) (NP (NP (NN Vβ8+) (NN T) (NNS cells)) (PP (IN from) (NP (NN ITK) (JJ null) (NNS mice))))) (. .)))
( (S (NP (NP (NN Table) (CD 1)) (: :) (NP (NP (NN Effect)) (PP (IN of) (NP (NN SEB))) (PP (IN on) (NP (NP (NP (NN health)) (CC and) (NP (NN survival))) (PP (IN of) (NP (NP (NP (NN WT)) (CC and) (NP (NN ITK))) (JJ null) (NNS mice)))))) (. .))))
( (S (S (NP (NP (NNS Mice)) (PRN (-LRB- -LRB-) (NP (NP (NN WT)) (CC or) (NP (NN ITK) (NN null))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN injected) (PP (IN with) (NP (NP (DT the) (VBN indicated) (NN amount)) (PP (IN of) (NP (NN LPS))))) (, ,) (S (VP (VBN followed) (ADVP (NP (CD 4) (NNS hours)) (RB later)) (PP (IN by) (NP (NP (ADJP (CD 50) (NN μg)) (NN SEB)) (, ,) (CC both) (NP (VBN delivered) (NN Ip))))))))) (. .)))
( (S (S (ADVP (RB Alternatively)) (, ,) (NP (NNS mice)) (VP (VBD were) (VP (VBN injected) (PP (IN with) (NP (CD 20) (NN mg)))))) (. .)))
( (S (S (NP (NP (NN D-Gal)) (CC and) (NP (ADJP (CD 50) (NN μg)) (NN SEB))) (PP (IN at) (NP (DT the) (JJ same) (NN time)))) (. .)))
( (S (S (NP (DT All) (NNS injections)) (VP (VBD were) (VP (VBN delivered) (ADVP (RB intraperitoneally))))) (. .)))
( (S (S (NP (NNS Mice)) (VP (VBD were) (ADVP (RB then)) (VP (VBN monitored) (PP (IN for) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (VBN ruffled) (NN fur))))) (, ,) (S (ADJP (JJ mucous) (PP (IN in) (NP (NP (NN feces)) (CC and) (NP (NN lethargy))))))))) (. .)))
( (S (S (NP (NN *) (NNS mice)) (VP (VP (VBD had) (NP (NP (JJ ruffled) (NN fur)) (, ,) (NP (NN mucous))) (PP (IN in) (NP (NNS feces)))) (CC and) (VP (VBD were) (ADJP (JJ lethargic))))) (. .)))
( (S (S (NP (NN **) (NN mouse)) (VP (VBD died) (PP (IN over) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (DT the) (NN experiment))))))) (. .)))
( (S (S (NP (NN ***) (NN mouse)) (VP (VBD had) (S (VP (TO to) (VP (VB be) (VP (VBN euthanized) (PP (JJ due) (TO to) (NP (NP (NN severity)) (PP (IN of) (NP (NN sickness))))))))))) (. .)))
( (S (NP (NP (NN Haploinsufficiency)) (PP (IN for) (NP (NN BRCA1)))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (JJ normal) (NNS levels)) (PP (IN of) (NP (NP (NN DNA) (NN nucleotide) (NN excision) (NN repair)) (PP (IN in) (NP (NP (NN breast) (NN tissue)) (CC and) (NP (NN blood) (NNS lymphocytes))))))))))))
( (S (NP (NN Abstract))))
( (S (NP (NP (NN Background)) (: :) (S (NP (NN Screening) (NN mammography)) (VP (VBZ has) (VP (VP (VBD had) (NP (DT a) (JJ positive) (NN impact)) (PP (IN on) (NP (NN breast) (NN cancer) (NN mortality)))) (CC but) (VP (MD cannot) (VP (VB detect) (NP (DT all) (NN breast) (NNS tumors))))))) (. .))))
( (S (S (PP (IN In) (NP (DT a) (JJ small) (NN study))) (, ,) (NP (PRP we)) (VP (VBD confirmed) (SBAR (IN that) (S (NP (NP (JJ low) (NP (NN power) (JJ magnetic) (NN resonance)) (NN imaging)) (PRN (-LRB- -LRB-) (NP (NN MRI)) (-RRB- -RRB-))) (VP (MD could) (VP (VB identify) (NP (ADJP (RB mammographically) (JJ undetectable)) (NNS tumors)) (PP (IN by) (S (VP (VBG applying) (NP (PRP it)) (PP (TO to) (NP (DT a) (JJ high) (NN risk) (NN population)))))))))))) (. .)))
( (S (S (NP (NP (NNS Tumors)) (VP (VBN detected) (PP (IN by) (NP (DT this) (JJ new) (NN technology))))) (VP (VP (MD could) (VP (VB have) (NP (JJ unique) (NP (NP (NNS etiologies)) (CC and/or) (NP (NNS presentations)))))) (, ,) (CC and) (VP (MD may) (VP (VB represent) (NP (NP (DT an) (VBG increasing) (NN proportion)) (PP (IN of) (NP (JJ clinical) (NN practice)))) (SBAR (IN as) (S (NP (JJ new) (NN screening) (NNS methods)) (VP (VBP are) (VP (VP (VBN validated)) (CC and) (VP (VBN applied)))))))))) (. .)))
( (S (S (NP (NP (DT A) (ADJP (RB very) (JJ important)) (NN aspect)) (PP (IN of) (NP (DT this) (NN etiology)))) (VP (VBZ is) (NP (NP (JJ genomic) (NN instability)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN loss)) (PP (IN of) (NP (NP (NN activity)) (PP (IN of) (NP (DT the) (NN breast) (JJ cancer-predisposing) (NNS genes) (NP (NP (NN BRCA1)) (CC and) (NP (NN BRCA2)))))))))))))))) (. .)))
( (S (S (PP (IN In) (NP (JJ sporadic) (NN breast) (NN cancer))) (, ,) (ADVP (RB however)) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (NN evidence)) (PP (IN for) (NP (NP (NP (DT the) (NN involvement)) (PP (IN of) (NP (NP (DT a) (JJ different) (NN pathway)) (PP (IN of) (NP (NN DNA) (NN repair)))))) (, ,) (NP (NP (NN nucleotide) (NN excision) (NN repair)) (PRN (-LRB- -LRB-) (NP (NN NER)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ remediates) (NP (NP (NNS lesions)) (SBAR (WHNP (WDT that)) (S (VP (VBP cause) (NP (NP (DT a) (NN distortion)) (PP (IN of) (NP (DT the) (NN DNA) (NN helix)))) (, ,) (S (VP (VBG including) (NP (NN DNA) (NNS cross-links)))))))))))))))) (. .)))
( (S (NP (NP (NN Case) (NN presentation)) (: :) (S (NP (PRP We)) (VP (VBP describe) (NP (NP (DT a) (NN breast) (NN cancer) (NN patient)) (PP (IN with) (NP (NP (DT a) (ADJP (RB mammographically) (JJ undetectable)) (NN stage) (NN I) (NN tumor)) (VP (VBN identified) (PP (IN in) (NP (PRP$ our) (NN MRI) (NN screening) (NN study))))))))) (. .))))
( (S (S (NP (PRP She)) (VP (VP (VBD was) (ADVP (RB originally)) (VP (VBN considered) (S (VP (TO to) (VP (VB be) (PP (IN at) (NP (NP (JJ high) (NN risk)) (PP (IN due) (TO to) (NP (NP (DT the) (JJ familial) (NN occurrence)) (PP (IN of) (NP (NP (NN breast)) (CC and) (NP (NP (JJ other) (NNS types)) (PP (IN of) (NP (NN cancer))))))))))))))) (, ,) (CC and) (PP (IN after) (NP (NN diagnosis))) (VP (VBD was) (VP (VBN confirmed) (PP (IN as) (NP (NP (DT a) (NN carrier)) (PP (IN of) (NP (NP (DT a) (NN Q1200X) (NN mutation)) (PP (IN in) (NP (DT the) (NN BRCA1) (NN gene))))))))))) (. .)))
( (S (S (NP (NP (ADJP (FW In) (FW vitro)) (NN analysis)) (PP (IN of) (NP (PRP$ her) (JJ normal) (NN breast) (NN tissue)))) (VP (VBD showed) (NP (NP (DT no) (NNS differences)) (PP (IN in) (NP (NP (NN growth) (NN rate)) (CC or) (NP (NN differentiation) (NN potential)))) (PP (IN from) (NP (JJ disease-free) (NNS controls)))))) (. .)))
( (S (S (NP (NP (NN Analysis)) (PP (IN of) (NP (NP (VBN cultured) (NN blood) (NN lymphocyte) (CC and) (NN breast) (NN epithelial) (NN cell) (NNS samples)) (PP (IN with) (NP (DT the) (JJ unscheduled) (NN DNA) (NN synthesis) (-LRB- -LRB-) (NN UDS) (-RRB- -RRB-) (NN assay)))))) (VP (VBD revealed) (NP (NP (DT no) (NN deficiency)) (PP (IN in) (NP (NN NER)))))) (. .)))
( (S (NP (NP (NN Conclusion)) (: :) (S (SBAR (IN As) (S (NP (JJ new) (NN breast) (NN cancer) (NN screening) (NNS methods)) (VP (VBP become) (ADJP (ADJP (JJ available)) (CC and) (ADJP (NN cost) (JJ effective)))))) (, ,) (NP (NP (NNS patients)) (PP (JJ such) (IN as) (NP (DT this) (NN one)))) (MD will) (VP (VBP constitute) (NP (NP (DT an) (VBG increasing) (NN proportion)) (PP (IN of) (NP (DT the) (JJ incident) (NN population)))) (, ,) (SBAR (IN so) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ important)) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (PRP they)) (VP (VBP differ) (PP (IN from) (NP (JJ current) (NNS patients))) (PP (IN in) (NP (DT any) (ADJP (RB clinically) (JJ important)) (NNS ways)))))))))))))) (. .))))
( (S (PP (IN Despite) (NP (NP (PRP$ her) (NN status)) (PP (IN as) (NP (NP (DT a) (NN BRCA1) (NN mutation) (NN carrier)) (, ,) (CC and) (NP (PRP$ her) (ADJP (RB mammographically) (JJ dense)) (NN breast) (NN tissue)))))) (, ,) (NP (PRP we)) (VP (VBD did) (RB not) (VP (VB find) (NP (NP (NP (VBN increased) (NN cell) (NN proliferation)) (CC or) (NP (JJ deficient) (NN differentiation) (NN potential))) (PP (IN in) (NP (NP (NN breast) (JJ epithelial) (NNS cells)) (PP (IN from) (NP (NP (DT this) (NN patient)) (SBAR (WHNP (WDT which)) (S (VP (MD might) (VP (VB have) (VP (VBN contributed) (PP (TO to) (NP (PRP$ her) (NN cancer) (NN susceptibility))))))))))))))) (. .)))
( (S (SBAR (IN Although) (S (NP (NN NER) (NN deficiency)) (VP (VBZ has) (VP (VBN been) (VP (VBN demonstrated) (ADVP (RB repeatedly)) (PP (IN in) (NP (NP (NN blood) (NNS samples)) (PP (IN from) (NP (JJ sporadic) (NN breast) (NN cancer) (NNS patients)))))))))) (, ,) (NP (NP (NN analysis)) (PP (IN of) (NP (NP (NN blood) (VBN cultured) (NNS lymphocytes)) (CC and) (NP (NN breast) (JJ epithelial) (NNS cells)))) (PP (IN for) (NP (DT this) (NN patient)))) (VP (VBZ proves) (ADVP (RB definitively)) (SBAR (IN that) (S (NP (NP (NN heterozygosity)) (PP (IN for) (NP (NP (NN inactivation)) (PP (IN of) (NP (NN BRCA1)))))) (VP (VBZ does) (RB not) (ADVP (RB intrinsically)) (VP (VB confer) (NP (NP (DT this) (NN type)) (PP (IN of) (NP (JJ genetic) (NN instability))))))))) (. .)))
( (S (S (NP (DT These) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NP (JJ genomic) (NN instability)) (VP (VBG driving) (NP (DT the) (NN carcinogenic) (NN process)))))) (VP (MD may) (VP (VB be) (ADJP (RB fundamentally) (JJ different) (PP (IN in) (NP (JJ hereditary) (CC and) (JJ sporadic) (NN breast) (NN cancer)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (JJ different) (JJ genotoxic) (NNS susceptibilities)) (, ,) (NP (NN oncogene) (NNS mutations)) (, ,) (CC and) (NP (DT a) (JJ different) (JJ molecular) (NN pathogenesis)))))))))))) (. .)))
( (S (NP (NN Background))))
( (S (S (NP (NP (DT A) (NN reduction)) (PP (IN in) (NP (NN breast) (NN cancer) (NN mortality)))) (VP (VBZ has) (VP (VBN been) (VP (VBN observed) (PP (IN in) (NP (NP (JJ recent) (NNS years)) (SBAR (WHNP (WDT that)) (S (VP (VBZ has) (VP (VBN been) (ADVP (RB partially)) (VP (VBN attributed) (PP (TO to) (NP (NP (DT the) (JJ widespread) (NN adoption)) (PP (IN of) (NP (NN screening) (NN mammography) (CD -LSB-1) (-RRB- -RSB-)))))))))))))))) (. .)))
( (S (S (NP (JJ Traditional) (NN screening) (NN mammography)) (, ,) (ADVP (RB however)) (, ,) (VP (VBZ fails) (S (VP (TO to) (VP (VB detect) (NP (NP (CD 15) (NN %)) (PP (IN of) (NP (NP (JJ incident) (NNS cancers)) (PRN (NN -LSB-2) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (NP (JJ New) (, ,) (JJ complementary) (NN imaging) (NNS techniques)) (VP (VBP are) (ADVP (RB therefore)) (PP (IN under) (NP (NP (NN development)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN accuracy)) (PP (IN of) (NP (JJ primary) (NN screening)))))))))))) (. .)))
( (S (NP (PRP We)) (VP (VBD performed) (NP (NP (DT a) (JJ small) (NN study)) (S (VP (VP (TO to) (VP (VB validate) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (JJ low) (NN power) (NP (NP (JJ magnetic) (NN resonance) (VBG imaging)) (PRN (-LRB- -LRB-) (NP (NN MRI)) (-RRB- -RRB-))))) (S (VP (TO to) (ADVP (RB prospectively)) (VP (VB detect) (NP (NP (NN breast) (NNS alterations)) (CC and) (NP (NN malignancy))))))))) (CC and) (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN feasibility)) (PP (IN of) (S (VP (VBG applying) (NP (DT this) (NN technique)) (PP (TO to) (NP (NP (DT a) (JJ high-risk) (NN population)) (PRN (NN -LSB-3) (-RRB- -RSB-)))))))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP present) (ADVP (RB here)) (NP (NP (DT a) (NN subject)) (PP (IN from) (NP (DT that) (NN study))) (SBAR (WHNP (WP$ whose) (JJ early) (NN stage) (NN tumor)) (S (VP (VBD was) (RB not) (ADJP (JJ detectable) (PP (IN by) (NP (NN mammography)))))))))) (. .)))
( (S (S (NP (DT This) (NN patient)) (VP (VBD was) (VP (VBN enrolled) (PP (IN in) (NP (NP (DT the) (JJ screening) (NN study)) (ADJP (JJ due) (PP (TO to) (NP (NP (PRP$ her) (NN family) (NN history)) (PP (IN of) (NP (NP (NN breast)) (CC and) (NP (JJ other) (NNS neoplasias)))))))))))) (. .)))
( (S (S (PP (IN After) (NP (NN tumor) (NN diagnosis))) (, ,) (NP (PRP she)) (VP (VBD was) (VP (VBN determined) (S (VP (TO to) (VP (VB be) (ADJP (JJ heterozygous) (PP (IN for) (NP (NP (DT a) (JJ putative) (VBG inactivating) (NN mutation)) (PP (IN in) (NP (DT the) (NN BRCA1) (NN gene)))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP she)) (VP (VBD had) (NP (NP (JJ dense) (NN breast) (NN tissue)) (, ,) (NP (NP (DT an) (NN impediment)) (PP (TO to) (NP (NN mammography))) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (PP (IN in) (NP (PRP itself))) (NP (NP (DT a) (NN risk) (NN factor)) (PP (IN for) (NP (NN breast) (NN cancer) (CD -LSB-4)))) (-RRB- -RSB-)))))))) (. .)))
( (S (S (NP (NP (NN Breast) (NN development)) (CC and) (NP (JJ lactational) (NN differentiation))) (ADVP (RB also)) (VP (VBP appear) (S (VP (TO to) (ADVP (RB individually)) (VP (VB modify) (NP (NN breast) (NN cancer) (NN risk))))) (, ,) (PP (IN with) (NP (NP (JJ early) (NN term) (NN pregnancy)) (VP (VBG conferring) (NP (DT a) (JJ persistent) (JJ protective) (NN effect) (CD -LSB-5) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (NP (NN Exposure)) (PP (TO to) (NP (VBG ionizing) (NN radiation)))) (, ,) (PP (IN while) (NP (NP (DT a) (JJ lifetime) (NN risk) (NN factor)) (PP (IN for) (NP (NN breast) (NN cancer))))) (, ,) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (ADJP (RBR more) (JJ dangerous))) (SBAR (WHADVP (WRB when)) (S (NP (PRP it)) (VP (VBZ occurs) (PP (IN during) (NP (NP (JJ alveolar) (NN differentiation)) (PP (IN of) (NP (DT the) (NN breast))))) (PP (IN at) (NP (NN adolescence) (CD -LSB-6)))) (-RRB- -RSB-))))))) (. .)))
( (S (S (VP (VBG Using) (NP (DT a) (JJ novel) (NN tissue) (NN engineering) (NN system) (CD -LSB-7))) (-RRB- -RSB-)) (, ,) (NP (PRP we)) (ADVP (RB therefore)) (VP (VBD examined) (NP (NP (DT the) (NP (NP (NN growth)) (CC and) (NP (NN differentiation)))) (PP (IN of) (NP (NP (JJ normal) (NN breast) (JJ epithelial) (NNS samples)) (PP (IN from) (NP (DT this) (NN patient)))))) (PP (IN via) (NP (JJ live-cell) (NN imaging)))) (. .)))
( (S (S (NP (DT The) (NN BRCA1) (NP (JJ hereditary) (NN breast) (NN cancer)) (NN gene)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (VP (VBN involved) (PP (IN in) (NP (NN DNA) (JJ double) (NN strand) (NN break) (NN repair) (CD -LSB-8,9) (-RRB- -RSB-))))))))))) (. .)))
( (S (S (S (NP (NP (NN DNA) (NN repair)) (NNS defects)) (VP (VBP have) (ADVP (RB also)) (VP (VBN been) (VP (VBN identified) (PP (IN in) (NP (NP (DT the) (JJ peripheral) (NN blood) (NNS cells)) (PP (IN of) (NP (JJ sporadic) (NN breast) (NN cancer) (NNS patients) (CD -LSB-10-13) (-RRB- -RSB-))))))))) (, ,) (CC but) (S (, ,) (PP (IN in) (NP (DT this) (NN case))) (, ,) (NP (PRP it)) (VP (VBZ seems) (S (VP (TO to) (VP (VB involve) (NP (NP (DT a) (JJ different) (NN pathway)) (PP (IN of) (NP (NP (NN DNA) (NN repair)) (, ,) (NP (NN nucleotide) (NN excision) (NN repair)) (PRN (-LRB- -LRB-) (NP (NN NER)) (-RRB- -RRB-)) (NP (NN -LSB-14-16)) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN extended) (NP (NP (NP (DT this) (NN observation)) (PP (IN of) (NP (NN NER) (NN deficiency))) (PP (TO to) (NP (DT the) (NN tumor) (PRP itself)))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (DT the) (JJ adjoining) (JJ non-diseased) (JJ normal) (NN breast) (NN tissue) (CD -LSB-17)) (-RRB- -RSB-))))) (. .)))
( (S (S (NP (NN NER)) (VP (VBZ is) (NP (NP (DT a) (JJ complex) (NN pathway)) (PP (IN of) (NP (NN DNA) (NN repair) (CD -LSB-18) (-RRB- -RSB-))) (VP (ADVP (RB normally)) (VBN associated) (PP (IN with) (NP (NP (NN removal)) (PP (IN of) (NP (NP (NP (JJ pyrimidine-pyrimidine) (JJ intrastrand) (NNS crosslinks)) (PRN (-LRB- -LRB-) (NP (NN “dimers) (NN '')) (-RRB- -RRB-))) (VP (VBN caused) (PP (IN by) (NP (NP (NN exposure)) (PP (TO to) (NP (NN UV) (NN light)))))))))))))) (. .)))
( (S (S (NP (NN NER) (NN deficiency)) (VP (VBZ is) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (NP (NP (JJ hereditary) (NN xeroderma) (NN pigmentosum)) (PRN (-LRB- -LRB-) (NP (NN XP) (-RRB- -RRB-) (CD -LSB-19)) (-RRB- -RSB-))) (, ,) (NP (NP (DT a) (NN disease)) (PP (IN with) (NP (NP (DT a) (ADJP (RB 1200-fold)) (NN increase)) (PP (IN in) (NP (NP (NN incidence)) (PP (IN of) (NP (NN skin) (NN cancer) (CD -LSB-20))))))) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (NP (DT The) (NN signal)) (PP (IN for) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NN NER) (NN pathway)))))) (VP (VBZ is) (ADVP (RB actually)) (ADJP (RB very) (JJ general)))) (: ;) (S (NP (DT any) (NN lesion)) (VP (VBG causing) (NP (NP (DT a) (NN distortion)) (PP (IN in) (NP (DT the) (NN DNA) (NN helix))) (, ,) (PP (VBG including) (NP (NP (NNS crosslinks)) (VP (VBN caused) (PP (IN by) (NP (NP (NP (JJ oxidative) (NNS radicals)) (, ,) (NP (NP (JJ certain) (NNS types)) (PP (IN of) (NP (NP (NNS mismatches)) (PRN (-LRB- -LRB-) (NP (NP (NN purine-purine)) (CC or) (NP (NN pyrimidine-pyrimidine))) (-RRB- -RRB-))))) (CC and) (NP (ADJP (RB so) (VBN called)) (NN “bulky) (NN '') (NNS adducts))) (VP (VBN caused) (PP (IN by) (NP (NP (NN phase) (NN I) (NN metabolism)) (PP (IN of) (NP (NN polyaromatic) (NNS hydrocarbons) (CD -LSB-21) (-RRB- -RSB-)))))))))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ has) (ADVP (RB recently)) (VP (VBN been) (VP (VBN shown) (SBAR (IN that) (S (NP (NN BRCA1) (NN expression)) (VP (MD can) (VP (VB enhance) (NP (NN NER) (NN activity)) (, ,) (SBAR (IN although) (S (NP (DT this) (NN analysis)) (VP (VBD was) (RB not) (VP (VBN performed) (PP (IN in) (NP (NN breast) (NNS cells))) (NP (CD -LSB-22,23)) (-RRB- -RSB-))))))))))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB therefore)) (VP (VBN applied) (NP (NP (DT the) (JJ functional) (JJ unscheduled) (NN DNA) (NN synthesis) (-LRB- -LRB-) (NN UDS) (-RRB- -RRB-) (NN assay)) (PP (IN for) (NP (NN NER) (NN capacity)))) (PP (TO to) (NP (NP (JJ multiple) (NNS samples)) (PP (IN of) (NP (NP (JJ normal) (NN tissue)) (PP (IN from) (NP (DT this) (NN patient))))))) (, ,) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (NN haploinsufficiency)) (PP (IN for) (NP (NN BRCA1)))) (VP (VBD was) (NP (NP (DT a) (NN mechanism)) (PP (IN of) (NP (NN NER) (NN deficiency)))))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN developed) (NP (NP (DT a) (NN method)) (S (VP (TO to) (ADVP (RB reliably)) (VP (NN culture) (NP (NP (NP (JJ non-diseased) (NN breast) (NN tissue)) (PRN (-LRB- -LRB-) (PP (IN with) (NP (NP (DT a) (NN success) (NN rate)) (PP (IN of) (NP (CD 100) (NN %))))) (-RRB- -RRB-))) (CC and) (NP (NP (NN breast) (NNS tumors)) (PRN (-LRB- -LRB-) (PP (IN with) (NP (NP (DT a) (NN success) (NN rate)) (PP (IN of) (NP (CD 85) (NN %))))) (-RRB- -RRB-) (NP (CD -LSB-7,17)) (-RRB- -RSB-))))))))))) (. .)))
( (S (NP (NN Case) (NN presentation))))
( (S (S (NP (PRP We)) (VP (VBP describe) (NP (NP (DT a) (NN breast) (NN cancer) (NN patient)) (SBAR (WHNP (WP$ whose) (NN tumor)) (S (VP (VBD was) (VP (VBN detected) (PP (IN by) (NP (NN MRI)))))))))) (. .)))
( (S (S (NP (PRP She)) (VP (VBD was) (VP (VBN enrolled) (PP (IN into) (NP (NP (DT a) (NN pilot) (NN screening) (NN study)) (PP (IN of) (NP (NP (JJ low) (NN power) (NN MRI)) (PP (IN due) (TO to) (NP (PRP$ her) (JJ familial) (NN risk)))))))))) (. .)))
( (S (S (S (NP (PRP She)) (VP (VBD had) (NP (ADJP (RB mammographically) (JJ dense)) (NNS breasts)))) (CC and) (S (NP (PRP$ her) (NN tumor)) (VP (VBD was) (ADJP (JJ undetectable) (ADVP (RB mammographically)))))) (. .)))
( (S (S (NP (DT The) (NN patient)) (VP (VBD was) (NP (NP (DT a) (ADJP (CD 35.7) (NN year) (JJ old)) (NN woman)) (SBAR (WHNP (WP who)) (S (VP (VBD presented) (PP (IN with) (NP (NP (NP (DT a) (ADJP (RB very) (JJ strong)) (NN family) (NN history)) (PP (IN of) (NP (NN breast) (NN cancer))) (SBAR (IN as) (S (VP (VBN depicted) (PP (IN in) (NP (NN Figure) (CD 1)))))) (, ,)) (CC and) (NP (JJ negative) (ADJP (ADJP (JJ physical)) (CC and) (ADJP (JJ mammographic))) (NN examination)))))))))) (. .)))
( (S (S (NP (PRP She)) (VP (VBD had) (NP (NP (NP (ADJP (RB extremely) (JJ dense)) (NN breast) (NN tissue) (NN bilaterally)) (PP (IN by) (NP (NN mammography)))) (CONJP (RB as) (RB well) (IN as)) (NP (JJ fibrocystic) (NN breast) (NN tissue))) (PP (IN by) (NP (JJ physical) (NN examination))))) (. .)))
( (S (S (NP (PRP She)) (VP (VBD had) (NP (NP (DT no) (JJ previous) (JJ personal) (NN history)) (PP (IN of) (NP (NP (NN breast) (NN biopsy)) (CC or) (NP (JJ abnormal) (NNS mammograms))))))) (. .)))
( (S (S (S (NP (NP (DT The) (ADJP (CD 5) (NN year)) (NN breast) (NN cancer) (NN risk)) (PP (IN for) (NP (NP (DT this) (NN patient)) (SBAR (IN as) (S (VP (VBN calculated) (PP (IN by) (NP (DT the) (NN BRCAPRO) (NN model))))))))) (VP (VBD was) (NP (CD 5.7) (NN %)))) (, ,) (CC and) (S (NP (NP (PRP$ her) (NN probability)) (PP (IN of) (S (VP (VBG being) (NP (DT a) (NP (NP (NN BRCA1)) (CC or) (NP (NN BRCA2))) (NN carrier)))))) (VP (VBD was) (NP (CD 0.47))))) (. .)))
( (S (S (NP (DT The) (NN Gail) (NN model) (NN risk) (NN assessment)) (VP (VBD was) (VP (VBN calculated) (S (VP (VBG using) (NP (NP (DT the) (VBG following) (NN information)) (: :) (NP (NN Race-Caucasian)) (: ;) (NP (NN Age-35)) (: ;) (NP (NP (NN Age)) (PP (IN at) (NP (JJ first) (NN menses-12)))) (: ;) (NP (NP (NN Age)) (PP (IN at) (NP (JJ first) (JJ live) (NN birth-nulliparous)))) (: ;) (NP (NP (NN Number)) (PP (IN of) (NP (NP (JJ first-degree) (NNS relatives)) (PP (IN with) (NP (NN breast) (NN cancer-2)))))) (: ;) (NP (NP (NN Number)) (PP (IN of) (NP (JJ previous) (NN breast) (NN biopsies-0)))))))))) (. .)))
( (S (S (S (NP (DT The) (VBN calculated) (ADJP (CD 5) (NN year)) (NN Gail) (NN risk)) (VP (VBD was) (NP (CD 1.0) (NN %)))) (CC and) (S (NP (PRP$ her) (NN lifetime) (NN risk)) (VP (VBD was) (NP (CD 31.3) (NN %))))) (. .)))
( (S (S (PP (VBG Following) (NP (JJ genetic) (NN counseling))) (, ,) (NP (DT the) (NN patient)) (VP (VBD elected) (S (VP (TO to) (VP (VB undergo) (NP (NP (NN DNA) (NN sequencing)) (PP (IN of) (NP (NP (DT the) (NP (NP (NN BRCA1)) (CC and) (NP (NN BRCA2))) (NNS genes)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD revealed) (NP (NP (DT a) (JJ Q1200X) (NN truncation) (NN mutation)) (PP (IN in) (NP (NP (CD one)) (PP (IN of) (NP (PRP$ her) (NN BRCA1) (NNS alleles))))))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN C) (TO to) (NN T) (NN mutation)) (PP (IN at) (NP (NN codon) (CD 1200))) (PP (IN in) (NP (NN exon) (CD 11)))) (VP (VBZ results) (PP (IN in) (NP (NP (DT the) (NN change)) (PP (IN of) (NP (NP (DT the) (NN amino) (NN acid) (NN glutamine)) (PP (TO to) (NP (DT a) (NN stop) (NN codon))) (PP (IN with) (NP (NP (VBG resulting) (NN protein) (NN truncation)) (CC and) (NP (NP (NN loss)) (PP (IN of) (NP (NN function)))))))))))) (. .)))
( (S (S (NP (NN Exon) (CD 11)) (VP (VP (VBZ is) (NP (NP (DT the) (JJS largest) (NN exon)) (PP (IN in) (NP (NN BRCA1))))) (CC and) (VP (VBZ has) (NP (NP (DT the) (JJS highest) (NN frequency)) (PP (IN of) (NP (VBN reported) (NNS mutations))))))) (. .)))
( (S (S (NP (DT The) (NN Q1200X) (NN mutation)) (VP (VBZ has) (VP (VBN been) (ADVP (RB independently)) (VP (VBN observed) (NP (JJ several) (NNS times) (CD -LSB-24) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (DT The) (JJ bilateral) (NN screening) (NN mammogram)) (VP (VBD was) (VP (VBN compared) (PP (TO to) (NP (NP (JJ previous) (NNS films)) (PP (IN from) (NP (DT another) (NN hospital)))))))) (. .)))
( (S (S (NP (DT The) (NN breast) (NN tissue)) (VP (VBD was) (VP (VBN described) (PP (IN as) (ADJP (RB heterogeneously) (JJ dense))) (, ,) (S (ADVP (RB thus)) (VP (VBG lowering) (NP (DT the) (NN sensitivity))))))) (. .)))
( (S (S (S (NP (EX There)) (VP (VBD were) (NP (NP (DT no) (NNS masses)) (, ,) (NP (NP (JJ significant) (NNS calcifications)) (CC or) (NP (JJ other) (NNS findings)))))) (CC and) (S (NP (DT the) (NN mammogram)) (VP (VBD was) (VP (VBN interpreted) (PP (IN as) (NP (JJ negative) (NN bilaterally))))))) (. .)))
( (S (S (NP (DT A) (JJ one-year) (NN follow-up)) (VP (VBD was) (VP (VBN recommended)))) (. .)))
( (S (S (NP (DT The) (NN patient)) (VP (VBD was) (ADVP (RB then)) (VP (NN MRI) (VBN scanned) (PP (IN as) (NP (ADJP (RB previously) (VBN described)) (NN -LSB-3) (-RRB- -RSB-))) (, ,) (PP (IN with) (NP (NP (ADJP (ADJP (JJ pre-)) (CC and) (ADJP (JJ post-gadolinium))) (NN enhancement) (NNS images)) (VP (VBG evaluating) (NP (DT both) (NNS breasts)) (PP (ADVP (RB simultaneously)) (IN in) (NP (DT the) (JJ axial) (NN plane))))))))) (. .)))
( (S (S (PP (IN In) (NP (DT the) (JJ upper-outer) (JJ left) (NN breast))) (NP (EX there)) (VP (VBD was) (NP (DT a) (ADJP (ADJP (JJ small) (PRN (-LRB- -LRB-) (NP (QP (RB approximately) (CD 1)) (NN cm)) (-RRB- -RRB-))) (, ,) (ADJP (JJ round)) (, ,) (ADJP (JJ well-demarcated))) (NN enhancing) (NN lesion)))) (. .)))
( (S (S (NP (DT This) (NN lesion)) (VP (VBD was) (VP (VBN seen) (PP (IN on) (NP (CC both) (NP (NP (DT the) (JJ initial) (NN delay)) (PP (IN after) (NP (NN contrast) (NN injection)))) (CC and) (NP (DT the) (VBN delayed) (ADJP (NP (NN contrast)) (VBN enhanced)) (NN subtraction) (NNS images))))))) (. .)))
( (S (S (NP (DT The) (NN lesion)) (VP (VBD appeared) (S (VP (TO to) (VP (VB accumulate) (NP (NP (NN contrast)) (PP (TO to) (NP (DT a) (JJR greater) (NN extent)))) (PP (IN on) (NP (DT the) (VBN delayed) (NN subtraction) (NNS images))) (PP (IN with) (NP (NP (DT an) (JJ additional) (NN lesion)) (ADJP (JJ adjacent) (PP (TO to) (NP (DT the) (JJ first))))))))))) (. .)))
( (S (PP (IN In) (NP (NP (DT the) (JJ medial) (NN aspect)) (PP (IN of) (NP (DT the) (JJ mid) (JJ right) (NN breast))))) (, ,) (NP (EX there)) (VP (VBD were) (NP (NP (JJ several) (JJ small) (NN punctate) (NNS areas)) (PP (IN of) (NP (NN enhancement))) (PP (IN on) (NP (CC both) (NP (DT the) (JJ immediate)) (CC and) (NP (VBN delayed) (NN subtraction) (NNS views)))))) (. .)))
( (S (S (ADVP (RB Also)) (PP (IN in) (NP (NP (DT the) (JJ right) (NN breast)) (PP (ADVP (RB just)) (IN above) (NP (NP (DT the) (NN nipple) (NN level)) (ADJP (ADJP (JJ medial)) (CC and) (ADJP (JJ close) (PP (TO to) (NP (DT the) (NN chest) (NN wall))))))))) (NP (DT an) (JJ additional) (NN enhancing) (NN lesion)) (VP (VBD was) (VP (VBN seen)))) (. .)))
( (S (S (NP (DT This) (NN lesion)) (VP (VP (VBD was) (ADJP (ADJP (QP (RB approximately) (CD 1.5)) (NN cm)) (, ,) (ADJP (JJ round)) (, ,) (ADJP (JJ well-demarcated)))) (CC and) (VP (VBD continued) (S (VP (TO to) (VP (VB accumulate) (NP (NP (NN contrast)) (PP (IN on) (NP (DT the) (VBN delayed) (NN subtraction) (NNS images)))))))))) (. .)))
( (S (S (NP (DT This) (NN lesion)) (VP (VBD appeared) (S (VP (TO to) (VP (VB have) (NP (DT a) (JJ small) (JJ non-enhancing) (NN septation))))))) (. .)))
( (S (S (PP (IN Under) (NP (NN ultrasound))) (, ,) (NP (NP (DT the) (NN lesion)) (PP (IN of) (NP (NN concern))) (PP (IN in) (NP (DT the) (JJ left) (NN breast)))) (VP (VBD was) (VP (VP (VBN identified)) (CC and) (VP (VBN biopsied)))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (CD one) (NN lesion)) (PP (IN in) (NP (NP (DT the) (JJ right) (NN breast)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 2)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NP (DT The) (NN core) (NN biopsy)) (PP (IN of) (NP (DT the) (JJ left) (NN breast)))) (VP (VBD revealed) (NP (NP (NP (JJ infiltrating) (JJ ductal) (NN carcinoma)) (PP (IN in) (NP (NP (CD 2)) (PP (IN of) (NP (CD 5) (NN core) (NNS fragments)))))) (: ;) (NP (JJ high) (JJ nuclear) (NN grade))) (, ,) (PP (IN with) (NP (NP (DT no) (JJ lymphatic) (NN invasion)) (VP (VBN seen)))))) (. .)))
( (S (S (NP (NP (DT The) (NN core) (NN biopsy)) (PP (IN of) (NP (DT the) (JJ right) (NN breast)))) (VP (VBD demonstrated) (NP (JJ benign) (NN pathology)) (, ,) (ADVP (RB specifically)) (, ,) (NP (NN fibrosis)) (PP (IN with) (NP (JJ focal) (JJ ductal) (NN epithelial) (NN hyperplasia))))) (. .)))
( (S (PP (IN Although) (NP (NP (DT a) (JJ surgical) (NN candidate)) (PP (IN for) (NP (NP (NN lumpectomy)) (CC and) (NP (NN radiation)))))) (, ,) (NP (DT the) (NN patient)) (VP (VBP chose) (S (VP (TO to) (VP (VB undergo) (NP (NP (JJ left) (JJ modified) (NN radical) (NN mastectomy)) (PP (IN with) (NP (NP (JJ left) (NN axillary) (NN lymph) (NN node) (NN dissection)) (CC and) (NP (JJ contralateral) (JJ prophylactic) (JJ total) (NN mastectomy))))) (PP (IN because) (IN of) (NP (PRP$ her) (JJ genetic) (NN risk) (NN status))))))) (. .)))
( (S (S (NP (NP (DT The) (NN pathology)) (PP (IN in) (NP (DT the) (JJ left) (NN breast)))) (VP (VBD was) (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (NP (NN imaging)) (CC and) (NP (NN core) (NN biopsy))) (PP (IN in) (NP (NP (NN size)) (CC and) (NP (NN description))))))))) (. .)))
( (S (S (S (NP (NN Tumor) (NN size)) (VP (VBD was) (ADJP (CD 8) (NN mm)) (PP (IN in) (NP (NP (JJS greatest) (NN dimension)) (, ,) (NP (NP (JJ nuclear) (NN grade) (CD III)) (, ,) (NP (NN ER/PR)) (CC and) (NP (NN Her2/neu) (JJ negative))))))) (, ,) (CC and) (S (NP (NP (DT the) (JJ nodal) (NN status)) (PRN (-LRB- -LRB-) (NP (NN 0/4)) (-RRB- -RRB-))) (VP (VBD was) (ADJP (ADJP (JJ negative)) (PRN (-LRB- -LRB-) (NP (NN stage) (CD TIaN0M0)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (DT The) (NN patient)) (VP (VP (VBD underwent) (NP (NP (CD 4) (NNS cycles)) (PP (IN of) (NP (NN chemotherapy))))) (CC and) (VP (VBZ has) (VP (VBN been) (ADJP (RB reportedly) (JJ healthy)) (ADVP (IN since)))))) (. .)))
( (S (S (PP (IN Because) (PP (IN of) (NP (DT the) (JJ positive) (NN BRCA1) (NN mutation) (NNS results)))) (, ,) (NP (PRP she)) (ADVP (RB subsequently)) (VP (VBD underwent) (NP (JJ prophylactic) (JJ bilateral) (NN salpingo-oophorectomy)))) (. .)))
( (S (S (NP (NP (DT A) (NN number)) (PP (IN of) (NP (NN life) (NN history) (NNS factors)))) (VP (VBP have) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (NN breast) (NN cancer) (NN incidence)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB widely)) (VP (VBN interpreted) (PP (IN as) (S (VP (VBG representing) (NP (NP (JJ lifetime) (NN exposure)) (PP (IN of) (NP (DT the) (NN breast) (NN tissue))) (PP (TO to) (NP (JJ estrogen-induced) (NN mitogenesis) (CD -LSB-25))))) (-RRB- -RSB-))))))))))))) (. .)))
( (S (S (NP (NP (DT An) (JJ alternative) (NN interpretation)) (, ,) (VP (VBN based) (PP (IN on) (NP (JJ epithelial) (NN cell) (NN differentiation)))) (, ,)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (JJ lactational) (NN differentiation)) (, ,) (SBAR (JJ such) (IN as) (S (VP (VBZ occurs) (PP (IN during) (NP (NN term) (NN pregnancy)))))) (, ,)) (VP (VBZ confers) (NP (NP (NN resistance)) (PP (TO to) (NP (NN carcinogenesis) (CD -LSB-26,27))))) (-RRB- -RSB-))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN developed) (NP (NP (DT a) (JJ novel) (JJ human) (JJ mammary) (NN epithelial) (-LRB- -LRB-) (NN HME) (-RRB- -RRB-) (NN tissue) (NN engineering) (NN system) (NN wherein)) (S (NP (NP (JJ many) (NNS aspects)) (PP (IN of) (NP (JJ organotypic) (NN differentiation)))) (VP (VBP are) (VP (VBN reiterated) (NP (ADJP (FW in) (FW vitro)) (NN -LSB-28)))) (-RRB- -RSB-)))))) (. .)))
( (S (PP (IN In) (NP (DT this) (NN system))) (, ,) (NP (NN breast) (NN epithelial) (NNS cells)) (ADVP (RB initially)) (VP (VBP retain) (NP (JJ cell-to-cell) (NN contact)) (SBAR (IN while) (S (NP (PRP they)) (VP (VP (VBP proliferate)) (, ,) (VP (ADVP (RB then)) (VBP undergo) (NP (DT an) (JJ architectural) (NN reorganization))) (, ,) (ADVP (RB first)) (S (VP (TO to) (VP (VB form) (NP (NP (JJ three-dimensional) (NNS mammospheres)) (, ,) (CC and) (NP (NP (JJ later) (JJ vast) (NNS networks)) (PP (IN of) (NP (NN branching) (JJ ductal) (CC and) (JJ lobular) (NNS structures)))))))))))) (. .)))
( (S (S (NP (NP (NN Tumor)) (CC and) (NP (DT some) (JJ pre-neoplastic) (NNS samples))) (VP (VBP fail) (S (VP (TO to) (VP (VB form) (NP (JJ such) (NN architecture))))))) (. .)))
( (S (S (NP (NP (JJ Normal) (NN tissue)) (PP (IN from) (NP (NP (DT this) (NN patient)) (, ,) (SBAR (WHNP (WP who)) (S (VP (VP (VBZ is) (NP (PDT both) (DT a) (NN BRCA1) (NN mutation) (NN carrier))) (CC and) (VP (VBZ has) (NP (JJ dense) (NNS breasts)))))) (, ,)))) (VP (VBD was) (VP (VBN evaluated) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (DT either)) (PP (IN of) (NP (DT these) (NNS factors)))) (VP (VBD affected) (NP (ADJP (FW de) (FW novo)) (NN differentiation)) (PP (IN in) (NP (DT this) (NN system)))))))))))) (. .)))
( (S (S (NP (NP (CD Four) (JJ discrete) (NNS pieces)) (PP (IN of) (NP (JJ fresh) (NN tissue)))) (VP (VBD were) (VP (VBN provided) (PP (IN for) (NP (NP (JJ live-cell) (NN analysis)) (PP (IN from) (NP (NP (DT each)) (PP (IN of) (NP (ADJP (ADJP (NP (DT the) (NN patient) (POS 's)) (JJ ipsilateral)) (CC and) (ADJP (JJ contralateral))) (NNS breasts)))))))))) (. .)))
( (S (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (DT the) (JJ ipsilateral) (NN breast))))) (, ,) (NP (DT this) (NN tissue)) (VP (VBD was) (VP (VBN provided) (PP (IN at) (S (VP (VBG increasing) (NP (NP (NN distance)) (PP (IN from) (NP (DT the) (NN tumor) (NN margin)))) (PP (IN in) (NP (CD 1) (NN cm) (NNS increments))))))))) (. .)))
( (S (S (NP (NP (DT All)) (PP (IN of) (NP (DT these) (JJ normal) (NNS samples))) (VP (VBN attached))) (VP (CC and) (VP (VBD grew) (PP (IN in) (NP (PRP$ our) (NN culture) (NN system)))) (CC and) (VP (VBD were) (VP (VBN examined) (PP (IN for) (NP (NP (JJ cell-to-cell) (NNS interactions)) (CC and) (NP (NN morphology)))) (PP (IN over) (NP (NP (DT a) (NN period)) (PP (IN of) (NP (CD one) (NN month))))))))) (. .)))
( (S (S (PP (IN In) (DT the) (NN context) (IN of) (NP (NP (NN breast) (NN reduction) (NN explant) (NNS cultures)) (PP (IN from) (NP (NP (CD 22) (NNS patients)) (PP (IN with) (NP (DT no) (NN breast) (NN disease))))))) (, ,) (NP (DT these) (NN patient) (NNS samples)) (VP (VBN manifested) (NP (NP (JJ typical) (NNS mixtures)) (PP (IN of) (NP (JJ fibroblastic) (CC and) (JJ epithelial) (NNS cells)))))) (. .)))
( (S (PP (IN After) (NP (NP (JJ several) (NNS days)) (PP (IN in) (NP (NP (NN culture)) (PP (IN without) (NP (NN passaging))))))) (, ,) (NP (DT the) (JJ epithelial) (NNS cells)) (VP (VP (VBD began) (S (VP (TO to) (VP (VB self-organize) (, ,) (S (ADVP (RB initially)) (VP (VBG forming) (NP (NP (JJ three-dimensional) (NNS mammospheres)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3A)) (-RRB- -RRB-))))))))) (, ,) (CC and) (, ,) (PP (IN after) (NP (NP (CD 2) (NNS weeks)) (PP (IN in) (NP (NN culture))))) (, ,) (NP (NP (ADJP (RBR more) (JJ complex)) (JJ pre-ductal) (NN linear) (NNS columns)) (PP (IN of) (NP (NP (JJ epithelial) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3B)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NP (DT The) (NN tissue) (NNS explants)) (PP (IN from) (NP (DT both) (NNS breasts)))) (VP (VBD showed) (NP (NP (JJ similar) (NNS patterns)) (PP (IN of) (NP (NN behavior)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 3)) (-RRB- -RRB-)))) (. .)))
( (S (S (NP (NP (NN Tissue)) (VP (VBN cultured) (PP (IN from) (NP (NP (DT a) (JJ contemporaneous) (JJ disease-free) (NN control)) (CC and) (NP (NP (DT the) (JJ contralateral) (NN breast)) (PP (IN of) (NP (DT a) (JJ sporadic) (NN breast) (NN cancer) (NN patient)))))))) (VP (VBD showed) (NP (NP (JJ similar) (NN morphology)) (CC and) (NP (NN architecture))) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN suggested) (SBAR (IN that) (S (NP (NP (DT the) (NN association)) (PP (IN between) (NP (NP (NN breast) (NN density)) (CC and) (NP (NP (NN risk)) (PP (IN of) (NP (NN breast) (NN cancer))))))) (VP (VBZ is) (ADJP (JJ due) (PP (TO to) (NP (VBN increased) (NN cell) (NN proliferation) (CD -LSB-29) (-RRB- -RSB-))))))))))) (. .)))
( (S (S (NP (NP (CD One) (NN measure)) (PP (IN of) (NP (NP (NN cell) (NN growth)) (CC and) (NP (NN viability))))) (VP (VBZ is) (NP (NP (NP (DT the) (NN S-phase) (NN index)) (PRN (-LRB- -LRB-) (NP (NN SPI)) (-RRB- -RRB-))) (CC or) (NP (NP (DT the) (NN percentage)) (PP (IN of) (NP (NP (NNS cells)) (VP (VBG incorporating) (NP (VBN radiolabeled) (NN thymidine)) (PP (IN over) (NP (NP (DT a) (JJ specific) (NN incubation) (NN period)) (PRN (-LRB- -LRB-) (PP (IN in) (NP (PRP$ our) (NN case))) (, ,) (NP (CD 2) (NNS hours)) (-RRB- -RRB-))))))))))) (. .)))
( (S (PP (IN In) (NP (NP (DT a) (JJ previous) (NN study)) (PP (IN with) (NP (CD 22) (JJ normal) (NP (NN breast) (NN reduction) (NN epithelium) (NN -LSB-BRE)) (-RRB- -RSB-) (NNS cultures))))) (NP (PRP we)) (VP (VBD observed) (NP (NP (DT a) (JJ wide) (NN range)) (PP (IN of) (NP (NN proliferation) (NNS rates)))) (, ,) (PP (IN with) (NP (NP (NN SPI)) (VP (VBG ranging) (PP (IN from) (NP (NP (DT a) (JJ low)) (PP (IN of) (NP (CD 0.2) (NN %))))) (PP (TO to) (NP (NP (DT a) (JJ high) (IN of) (CD 46.0) (NN %)) (PRN (-LRB- -LRB-) (NP (NN mean) (IN of) (CD 18.3) (NN ±) (CD 2.6) (NN %) (-RRB- -RRB-) (CD -LSB-30)) (-RRB- -RSB-)))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ contemporaneous) (NN control) (NN sample)) (PP (IN from) (NP (DT a) (JJ disease-free) (NN breast) (NN reduction) (NN patient)))) (VP (VBD had) (NP (NP (DT an) (NN SPI)) (PP (IN of) (NP (CD 30.9) (NN %)))) (, ,) (PP (IN at) (NP (NP (DT the) (JJR higher) (NN end)) (PP (IN of) (NP (DT this) (JJ normal) (NN range))))))) (. .)))
( (S (S (NP (NP (DT The) (ADJP (ADJP (JJ ipsilateral)) (CC and) (ADJP (JJ contralateral))) (NN tissue) (NNS samples)) (PP (IN from) (NP (DT the) (JJ hereditary) (NN breast) (NN cancer) (NN patient)))) (VP (VBD exhibited) (NP (NP (NN SPI)) (PP (IN of) (NP (NP (CD 26.6) (NN %)) (CC and) (NP (CD 26.2) (NN %)) (, ,) (ADVP (RB respectively))))) (, ,) (S (VP (VBG placing) (NP (PRP them)) (PP (IN at) (NP (NP (RB slightly)) (PP (IN over) (NP (NP (DT the) (JJ 70th) (NN percentile)) (PP (IN for) (NP (NN growth) (NN rate))))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ contralateral) (NN sample)) (PP (IN from) (NP (DT the) (JJ sporadic) (NN breast) (NN cancer) (NN patient)))) (VP (VBD had) (NP (NP (DT an) (NN SPI)) (PP (IN of) (NP (CD 17.0) (NN %)))) (, ,) (S (VP (VBG placing) (NP (PRP it)) (ADVP (RB slightly)) (PP (IN under) (NP (DT the) (CD 50th) (NN percentile))))))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (NP (NP (DT all)) (PP (IN of) (NP (DT these) (NN breast) (NN cancer) (NN patient) (NNS samples)))) (VP (VBD appeared) (S (VP (TO to) (VP (VB grow) (ADVP (RB well)) (PP (IN in) (NP (PRP$ our) (NN system))) (, ,) (PP (IN with) (NP (NP (NN SPI)) (PP (ADVP (RB well)) (IN within) (NP (NP (DT the) (NN range)) (PP (IN of) (NP (PRP$ our) (JJ normal) (NNS samples)))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN similarity)) (PP (IN of) (NP (NP (DT the) (NN SPI) (NNS values)) (PP (IN from) (NP (NP (DT the) (CD two) (NNS samples)) (PP (IN from) (NP (DT the) (NN BRCA1) (NN mutation) (NN carrier)))))))) (VP (VBZ does) (RB not) (VP (VB appear) (S (VP (TO to) (VP (VB be) (ADJP (JJ accidental)))))))) (: ;) (S (NP (NP (DT the) (NNS chances)) (PP (IN of) (S (VP (VBG selecting) (NP (NP (CD two) (NNS samples)) (PP (IN from) (NP (DT the) (JJ normal) (NN population))) (PP (IN with) (NP (NNS values)))) (PP (IN as) (ADJP (ADJP (JJ close)) (CC or) (ADJP (JJR closer)))))))) (VP (VBZ is) (ADJP (RB very) (JJ small) (PRN (-LRB- -LRB-) (NP (NN P) (JJ =) (CD 0.026)) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (NP (NP (JJ Peripheral) (NN blood) (NNS lymphocytes)) (CC and) (NP (JJ normal) (NN breast) (JJ epithelial) (NN tissue))) (PP (IN from) (NP (DT the) (JJ hereditary) (NN cancer) (NN patient)))) (VP (VBD were) (ADVP (RB then)) (VP (VBN cultured) (PP (IN for) (NP (NP (NN performance)) (PP (IN of) (NP (NP (DT the) (JJ functional) (NN UDS) (NN assay)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ requires) (NP (VBG living) (NNS cells)) (PP (IN for) (NP (NP (NN radiolabel) (NN incorporation)) (PP (IN during) (NP (NP (NN DNA) (NN repair) (NN synthesis)) (PP (VBG following) (NP (NN UV) (NN exposure))))))))))))))))) (. .)))
( (S (S (NP (DT This) (NN assay)) (VP (VBZ is) (ADJP (JJ diagnostic) (PP (IN for) (NP (NP (DT the) (VBN inherited) (NN cancer-prone) (NN disease) (NN XP)) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (PRP it)) (VP (VBZ is) (ADVP (RB usually)) (VP (VBN performed) (PP (IN in) (NP (NP (NNS lymphocytes)) (CC or) (NP (NN skin) (NNS fibroblasts))))))))))))) (. .)))
( (S (S (NP (PRP$ Our) (JJ novel) (NN HME) (NN tissue) (NN engineering) (NN system)) (VP (VBZ allows) (S (NP (PRP us)) (VP (TO to) (VP (VB apply) (NP (NP (DT the) (NN assay)) (PP (TO to) (NP (NN breast) (JJ epithelial) (NNS cells))))))))) (, ,) (CC and) (S (NP (PRP we)) (VP (VBP have) (ADVP (RB previously)) (VP (VBN demonstrated) (NP (NP (NN tissue-specificity)) (PP (IN in) (NP (NP (DT the) (NN NER) (NN capacity)) (PP (IN of) (NP (DT these) (NNS cells))))) (PP (IN in) (NP (NP (JJ normal) (NNS samples)) (PP (IN from) (NP (NP (NNS patients)) (VP (VBG undergoing) (NP (NN breast) (NN reduction) (NN mammoplasty) (NN -LSB-30))))))) (-RRB- -RSB-))))) (. .)))
( (S (S (NP (NN Patient) (NNS data)) (VP (VBZ is) (ADVP (RB therefore)) (VP (VBN expressed) (PP (JJ relative) (TO to) (NP (NP (DT the) (NN average)) (PP (IN of) (NP (PRP$ our) (NN breast) (NN reduction) (NNS controls)))))))) (. .)))
( (S (NP (NP (NN Analysis)) (PP (IN of) (NP (NP (VBN cultured) (NN blood) (NNS lymphocytes)) (PP (IN from) (NP (DT the) (NN patient)))))) (VP (VBD established) (SBAR (IN that) (S (NP (PRP they)) (VP (VBD had) (NP (NP (NP (JJ normal) (NN NER) (NN capacity)) (PRN (-LRB- -LRB-) (NP (NP (CD 99.6) (NN %)) (PP (IN of) (NP (NP (DT the) (NN average)) (PP (IN of) (NP (PRP$ our) (NP (CD 33) (JJ normal) (NNS samples))))))) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 4)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBZ is) (ADVP (RB well)) (PP (IN above) (NP (NP (DT the) (JJ cut-off) (ADJP (JJ established) (PP (IN in) (NP (PRP$ our) (JJ sporadic) (NN breast) (NN cancer)))) (NN population)) (PRN (, ,) (NP (NP (QP (RB <) (CD 70)) (NN %)) (NP (NP (JJ average) (JJ normal) (NN activity)) (, ,) (SBAR (WHNP (WDT which)) (S (SBAR (WHADVP (WRB when)) (S (VP (VBN applied) (PP (TO to) (NP (PRP$ our) (NP (NNS cases)) (CC and) (NP (NNS controls))))))) (VP (VBD yielded) (NP (NP (DT a) (NP (JJ significant) (NNS odds)) (NN ratio)) (PP (IN of) (NP (CD 37.4) (NN -LSB-31))))))))) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (NP (DT A) (NN trend)) (PP (IN towards) (NP (NN age) (NN dependence)))) (VP (VBD had) (VP (VBN been) (VP (VBN noted) (PP (IN in) (NP (NP (DT the) (NN analysis)) (PP (IN of) (S (NP (NP (DT the) (NN UDS) (NN data)) (PP (IN of) (NP (NP (DT the) (JJ normal) (NNS controls)) (PRN (-LRB- -LRB-) (NP (NN P) (JJ =) (CD 0.059) (-RRB- -RRB-) (CD -LSB-30)) (-RRB- -RSB-))))) (: ;) (S (NP (NP (NN addition)) (PP (IN of) (NP (DT the) (NN patient) (NN sample)))) (VP (VBZ supports) (NP (DT this) (NN trend)))) (, ,) (CC but) (S (NP (PRP it)) (ADVP (RB still)) (VP (VBZ fails) (S (VP (TO to) (VP (VB reach) (NP (NP (NN significance)) (PRN (-LRB- -LRB-) (NP (NN P) (JJ =) (CD 0.056)) (-RRB- -RRB-)))))))))))))))) (. .)))
( (S (NP (DT The) (JJ functional) (NN NER) (NN assay)) (VP (VBD was) (ADVP (RB then)) (VP (VBN applied) (PP (PP (TO to) (NP (NP (DT the) (JJ contemporaneous) (JJ disease-free) (NN breast) (NN reduction) (NN control) (NN sample)) (, ,) (NP (NP (NP (CD one) (NN sample)) (NP (DT each))) (PP (IN from) (NP (NP (DT the) (ADJP (ADJP (JJ ipsilateral)) (CC and) (ADJP (JJ contralateral))) (NNS breasts)) (PP (IN of) (NP (DT the) (NN patient)))))))) (, ,) (CC and) (PP (TO to) (NP (NP (DT a) (NN sample)) (PP (IN from) (NP (NP (DT the) (JJ contralateral) (NN breast)) (PP (IN of) (NP (DT an) (ADJP (RB apparently) (JJ sporadic)) (NN breast) (NN cancer) (NN patient)))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN NER)) (PP (IN of) (NP (DT the) (NN BRE) (JJ non-diseased) (NN control)))) (VP (VBD was) (NP (CD 1.82) (NNS times)) (NP (NP (DT the) (NN average)) (PP (IN of) (NP (PRP$ our) (JJ normal) (NN data) (NN set))) (PP (PP (IN for) (NP (DT this) (NN tissue))) (CC and) (PP (IN within) (NP (NP (DT the) (NN range)) (PP (IN of) (NP (JJ normal))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN NER) (NN capacity)) (PP (IN of) (NP (DT the) (JJ ipsilateral) (NN breast) (NN epithelial) (NN sample)))) (VP (VBD was) (NP (NP (CD 1.05) (NNS times)) (NP (NP (DT the) (NN average)) (PP (IN of) (NP (NP (PRP$ our) (NN population)) (PP (IN of) (NP (NN BRE) (NNS controls))))))) (, ,) (S (ADVP (RB clearly)) (VP (VBG exhibiting) (NP (NP (DT no) (JJ overt) (NN DNA) (NN repair) (NN deficiency)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 5)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (DT The) (JJ contralateral) (NN sample)) (VP (VBD was) (ADJP (RB very) (JJ similar) (, ,) (PP (IN with) (NP (NP (DT an) (NN NER) (NN capacity)) (PP (IN of) (NP (NP (CD 1.17) (NNS times)) (ADJP (NN BRE) (JJ normal))))))))) (. .)))
( (S (S (SBAR (IN Although) (S (NP (NP (DT the) (NN NER) (NNS values)) (PP (IN of) (NP (NP (DT these) (CD two) (NNS samples)) (PP (IN from) (NP (DT the) (JJ same) (NN patient)))))) (VP (VBP are) (ADJP (JJ similar))))) (, ,) (NP (PRP they)) (VP (VBP are) (RB not) (ADJP (JJ close) (S (ADVP (RB enough)) (VP (TO to) (VP (VB distinguish) (NP (PRP themselves)) (PP (IN as) (S (VP (VBG coming) (PP (IN from) (NP (NP (DT the) (JJ same) (NN individual)) (PRN (-LRB- -LRB-) (NP (NN P) (JJ =) (NN 0.16)) (-RRB- -RRB-))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN NER) (NN capacity)) (PP (IN of) (NP (NP (DT the) (JJ contralateral) (NN sample)) (PP (IN from) (NP (DT the) (JJ sporadic) (NN breast) (NN cancer) (NN patient)))))) (VP (VBD was) (NP (CD 1.62) (NNS times)) (NP (NP (DT the) (NN average)) (PP (IN of) (NP (DT the) (NN BRE) (NNS controls)))) (, ,) (ADVP (RB also)) (PP (IN in) (NP (DT the) (JJ normal) (NN range))))) (. .)))
( (S (S (NP (NP (PRP$ Our) (JJR earlier) (NN analysis)) (PP (IN of) (NP (NP (NN NER)) (PP (IN in) (NP (PRP$ our) (JJ normal) (NN population)))))) (VP (VBD revealed) (NP (NP (DT no) (NNS effects)) (PP (IN of) (NP (NP (NN age)) (CC or) (NP (NN cell) (NN proliferation)))) (PRN (-LRB- -LRB-) (SBAR (IN as) (S (VP (VBN represented) (PP (IN by) (NP (DT the) (NN SPI)))))) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (NP (DT All)) (PP (IN of) (NP (DT these) (JJ additional) (NN patient) (NNS samples)))) (VP (VBP are) (ADJP (JJ consistent) (PP (IN with) (NP (DT those) (NNS results)))))) (. .)))
( (S (NP (NN Discussion))))
( (S (S (NP (NP (QP (IN At) (JJS least) (CD two)) (NNS types)) (PP (IN of) (NP (NN breast) (NNS tumors)))) (VP (VBP are) (RB not) (ADVP (RB accurately)) (VP (VBN detected) (PP (IN by) (NP (JJ traditional) (NN screening) (NN mammography))) (: :) (NP (NP (ADJP (`` ``) (NN interval) (JJ '')) (NNS tumors)) (SBAR (WHNP (WDT that)) (S (VP (VBP arise) (ADVP (RB quickly)) (PP (IN between) (NP (NP (NP (NNS screenings)) (, ,) (CC and) (NP (NNS tumors))) (SBAR (WHNP (WP$ whose) (NN density)) (S (VP (VBZ is) (RB not) (ADJP (JJ sufficient) (S (VP (TO to) (VP (VB distinguish) (NP (PRP them)) (PP (IN from) (NP (DT the) (JJ surrounding) (JJ normal) (NN tissue))))))))))))))))))) (. .)))
( (S (S (NP (DT The) (JJ latter) (NN situation)) (VP (VBZ is) (ADJP (RBR more) (JJ likely)) (S (VP (TO to) (VP (VB occur) (PP (IN in) (NP (NP (NNS women)) (PP (IN with) (NP (NP (JJ dense) (JJ normal) (NN breast) (NN tissue)) (, ,) (SBAR (WHNP (WDT which)) (S (, ,) (PP (IN in) (NP (NN turn))) (, ,) (VP (VBZ is) (ADJP (RBR more) (JJ typical) (PP (IN of) (NP (JJR younger) (NNS women)))))))))))))))) (. .)))
( (S (ADVP (RB Thus)) (, ,) (NP (ADJP (RB mammographically) (JJ undetectable)) (NNS tumors)) (VP (MD may) (VP (VB have) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NP (NNS characteristics)) (, ,) (PP (JJ such) (IN as) (NP (NP (NP (JJ fast) (NN growth)) (, ,) (NP (JJ low) (NN density)) (, ,) (NP (JJ early) (NN onset)) (CC and/or) (NP (NN occurrence))) (PP (IN in) (NP (NP (JJ dense) (NNS breasts)) (SBAR (WHNP (WDT that)) (S (VP (MD might) (VP (VB distinguish) (NP (PRP them)) (PP (IN from) (NP (NP (ADJP (RB mammographically) (JJ detectable)) (NNS tumors)) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NP (NP (JJ molecular) (NN etiology)) (CC and) (NP (JJ clinical) (NNS parameters))) (PP (IN of) (NP (NP (NN prognosis)) (CC and) (NP (NN response))))))))))))))))))))))) (. .)))
( (S (S (NP (DT The) (JJ present) (NN patient)) (VP (VP (VBD had) (NP (DT an) (JJ early) (NN onset) (NN breast) (NN tumor))) (, ,) (CC but) (VP (VBD had) (NP (CC both) (NP (NP (JJ hereditary) (NN susceptibility)) (PP (IN due) (TO to) (NP (PRP$ her) (NN BRCA1) (NN mutation)))) (CC and) (NP (JJ dense) (NNS breasts)))) (, ,) (SBAR (IN so) (S (NP (PRP$ her) (NN presentation)) (VP (VBZ is) (RB not) (ADJP (JJ unusual) (PP (IN in) (NP (DT this) (NN context))))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ possible)) (SBAR (IN that) (S (NP (NP (NN breast) (NNS tumors)) (VP (VBN detected) (PP (IN by) (NP (JJ complementary) (NN screening) (NNS methods))) (PP (IN in) (NP (DT the) (JJ future))))) (VP (MD will) (VP (VB demonstrate) (NP (JJ unique) (ADJP (ADJP (JJ clinical)) (CC and) (ADJP (JJ molecular))) (NNS features))) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (PRP it)) (VP (VBZ becomes) (ADJP (JJ feasible) (S (VP (TO to) (VP (VB perform) (NP (JJ such) (NN screening)) (PP (IN in) (NP (DT the) (JJ general) (NN population))))))))))))))) (. .)))
( (S (SBAR (IN Since) (S (NP (DT the) (NN BRCA1) (NN gene) (NN product)) (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (NP (NN DNA) (JJ double) (NN strand) (NN break) (NN repair) (CD -LSB-8,9)))))))) (-RRB- -RSB-))) (, ,) (NP (PRP it)) (VP (VBZ has) (VP (VBN been) (VP (VBN suggested) (SBAR (IN that) (S (NP (VBN decreased) (NN repair) (NN capacity)) (VP (VBZ is) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (NP (DT the) (NN breast) (NN cancer) (NN predisposition)) (VP (VBN observed) (PP (IN in) (NP (NN mutation) (NNS carriers) (CD -LSB-32-35) (-RRB- -RSB-))))))))))))) (. .)))
( (S (S (NP (PDT Such) (DT a) (JJ cellular) (NN phenotype)) (VP (VBZ has) (VP (VBN been) (ADJP (JJ difficult) (S (VP (TO to) (VP (VB demonstrate) (PRN (, ,) (FRAG (ADVP (RB however)) (NP (NN -LSB-36-39))) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (DT An) (JJ alternate) (NN possibility)) (VP (VBZ is) (SBAR (IN that) (S (NP (DT the) (NN mutation)) (VP (VBZ affects) (NP (NP (DT the) (NP (NN growth)) (CC or) (NP (NN differentiation))) (PP (IN of) (NP (NN breast) (NN epithelial) (NNS cells)))) (PP (IN in) (NP (NP (DT a) (NN manner)) (ADJP (JJ consistent) (PP (IN with) (NP (NN cancer) (NN susceptibility))))))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN suggested) (SBAR (IN that) (S (NP (JJ dense) (NN breast) (NN tissue)) (VP (VBZ is) (ADJP (JJ indicative) (PP (IN of) (NP (NP (VBN generalized) (NN hyperproliferation)) (SBAR (WHNP (WDT that)) (S (VP (MD might) (VP (VB promote) (NP (NN oncogenesis) (CD -LSB-29) (-RRB- -RSB-)))))))))))))))) (. .)))
( (S (S (NP (PRP$ Our) (NNS findings)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT all) (CD 8) (NNS samples)) (, ,) (VP (VBN derived) (PP (IN from) (NP (CC both) (NP (DT the) (VBN involved)) (CC and) (NP (NP (DT the) (JJ uninvolved) (NNS breasts)) (PP (IN of) (NP (DT a) (JJ hereditary) (NN breast) (NN cancer) (NN patient)))))))) (VP (VBP develop) (NP (JJ normal) (JJ epithelial) (NN architecture)) (PP (IN in) (NP (FW vitro))) (, ,) (S (VP (VBG implying) (SBAR (IN that) (S (NP (NP (DT the) (JJ epithelial/stromal) (-LRB- -LRB-) (JJ paracrine) (-RRB- -RRB-) (NNS interactions)) (ADJP (JJ necessary) (PP (IN for) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (DT this) (JJ complex) (NN architecture))))))) (VP (VBP are) (ADJP (ADJP (JJ intact)) (CC and) (ADJP (JJ normal)) (PP (IN in) (NP (NN BRCA1) (NNS heterozygotes)))) (PP (IN despite) (NP (NP (PRP$ their) (JJR greater) (NN risk)) (PP (IN of) (NP (NN breast) (NN cancer))))))))))))))) (. .)))
( (S (NP (DT The) (NN SPI) (NNS results)) (ADVP (RB also)) (VP (VBP indicate) (SBAR (IN that) (S (NP (DT this) (JJ non-diseased) (JJ epithelial) (NN tissue)) (VP (VP (VBZ falls) (PP (IN into) (NP (NP (DT the) (JJ typical) (NN range)) (PP (IN of) (NP (JJ normal))) (PP (IN for) (NP (NN BRE) (NN control) (NNS cultures)))))) (CC and) (VP (VBZ is) (S (VP (VBG demonstrating) (NP (JJ typical) (NN growth)) (PP (IN in) (NP (PRP$ our) (NN HME) (NN tissue) (NN engineering) (NN system)))))))))) (. .)))
( (S (S (NP (NN NER) (NN deficiency)) (VP (VBZ is) (ADVP (RBS most) (RB often)) (VP (VBN associated) (PP (IN with) (NP (NP (NN XP)) (, ,) (NP (NP (NN sensitivity)) (PP (TO to) (NP (JJ UV-induced) (NN DNA) (NN damage)))) (CC and) (NP (NN skin) (NN cancer) (CD -LSB-18-21) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (NP (DT The) (NN NER) (NN deficiency)) (PP (IN of) (NP (NN XP) (NNS patients)))) (VP (VBZ is) (VP (VBN manifested) (PP (IN in) (NP (JJ other) (NNS tissues))) (, ,) (ADVP (RB however)) (, ,) (SBAR (IN as) (S (VP (VBN shown) (PP (IN by) (NP (NP (NP (PRP$ their) (JJ high) (JJ spontaneous) (NN frequency)) (PP (IN of) (NP (NP (NN mutation)) (PP (IN in) (NP (NN blood) (NNS lymphocytes) (CD -LSB-40) (-RRB- -RSB-)))))) (CC and) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (NP (JJ other) (NNS types)) (PP (IN of) (NP (NNS tumors) (CD -LSB-41) (-RRB- -RSB-)))))))))))))) (. .)))
( (S (S (NP (DT The) (NN observation) (SBAR (IN that) (S (NP (JJ sporadic) (NN breast) (NN cancer) (NNS patients)) (VP (VBP have) (NP (NP (JJ low) (NNS levels)) (PP (IN of) (NP (NN NER)))) (PP (IN in) (NP (JJ peripheral) (NNS lymphocytes))))))) (VP (VBZ suggests) (SBAR (IN that) (S (NP (JJ sporadic) (NN breast) (NN cancer)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (ADJP (RB constitutively) (JJ low)) (NNS levels)) (PP (IN of) (NP (NN NER) (NN -LSB-14-16) (-RRB- -RSB-))))))))))) (. .)))
( (S (S (NP (NP (PRP$ Our) (NNS results)) (PP (IN from) (NP (DT a) (JJ single) (NN patient)))) (VP (VBP demonstrate) (, ,) (ADVP (RB however)) (, ,) (SBAR (IN that) (S (SBAR (IN while) (S (NP (NP (NN overexpression)) (PP (IN of) (NP (NN BRCA1)))) (VP (MD may) (VP (VB enhance) (NP (NN NER) (NN -LSB-22)))) (-RRB- -RSB-))) (, ,) (NP (NP (NN haploinsufficiency)) (PP (IN for) (NP (DT this) (NN gene)))) (VP (VBZ does) (RB not) (ADVP (RB necessarily)) (VP (VB result) (PP (IN in) (NP (JJ detectable) (NN NER) (NN deficiency))))))))) (. .)))
( (S (SBAR (IN Since) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ clear)) (SBAR (IN that) (S (NP (JJ genomic) (NN instability)) (VP (VBZ is) (NP (NP (DT a) (JJ necessary) (NN prerequisite)) (PP (IN for) (NP (NP (DT the) (NN completion)) (PP (IN of) (NP (NP (DT the) (JJ complex) (JJ multi-step) (JJ carcinogenic) (NN pathway) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-)) (VP (VBN involved) (PP (IN in) (NP (NN breast) (NN cancer))))))))))))))) (, ,) (NP (NP (DT a) (JJ fundamental) (NN difference)) (PP (IN in) (NP (NP (DT the) (NNS mechanisms)) (PP (IN of) (NP (NP (JJ genomic) (NN instability)) (VP (VBG arising) (PP (IN in) (NP (ADJP (ADJP (JJ hereditary)) (CC and) (ADJP (JJ sporadic))) (NN breast) (NNS tumors))))))))) (VP (MD would) (VP (VB be) (ADJP (JJ likely) (S (VP (TO to) (VP (VB translate) (PP (IN into) (NP (NP (ADJP (RB fundamentally) (JJ different)) (NNS patterns)) (PP (IN of) (NP (NP (JJ molecular) (NN pathogenesis)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (NN impact) (PP (IN on) (NP (JJ clinical) (NN management))))))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ relative) (NN NER) (NNS capacities)) (PP (IN of) (NP (NP (NN tumor)) (CC and) (NP (JJ normal) (NN tissue))))) (VP (MD may) (VP (VB have) (NP (JJ important) (JJ practical) (NNS implications))))) (. .)))
( (S (SBAR (IN If) (S (NP (NP (NN breast) (NNS tumors)) (PP (IN from) (NP (JJ hereditary) (NNS patients)))) (VP (VBP exhibit) (NP (NP (NN NER) (NN deficiency)) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (VP (VBN observed) (PP (IN in) (NP (JJ sporadic) (NNS patients)))))))) (, ,) (SBAR (IN while) (S (NP (PRP$ their) (JJ normal) (NNS tissues)) (VP (VBP exhibit) (NP (NP (JJ normal) (NNS levels)) (PP (IN of) (NP (NP (DT this) (NN type)) (PP (IN of) (NP (NN DNA) (NN repair)))))))))))) (, ,) (ADVP (RB then)) (NP (DT the) (NNS tumors)) (VP (MD would) (VP (VB be) (ADJP (JJ hypersensitive) (PP (TO to) (NP (NP (DT a) (NN range)) (PP (IN of) (NP (NP (JJ chemotherapeutic) (NNS drugs)) (, ,) (PP (VBG including) (NP (NP (NP (JJ alkylating) (NNS agents)) (PRN (-LRB- -LRB-) (NP (NN cyclosphosphamide)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ cross-linking) (NNS agents)) (PRN (-LRB- -LRB-) (NP (NN cis-platinum)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ bulky) (NN DNA) (NN adducting) (NNS agents)) (PRN (-LRB- -LRB-) (NP (NN melphalan)) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (NP (NP (NN Individualization)) (PP (IN of) (NP (NN chemotherapy))) (PP (VBN based) (PP (IN on) (NP (NP (DT some) (NN aspect)) (PP (IN of) (NP (NN NER) (NN expression))))))) (VP (VBZ is) (VP (VBG being) (VP (VBN pursued) (PP (IN in) (NP (NP (NN colon) (CD -LSB-42) (-RRB- -RSB-)) (, ,) (NP (NN testicular) (CD -LSB-43,44) (-RRB- -RSB-)) (CC and) (NP (NP (JJ ovarian) (NN cancer)) (CD -LSB-45) (-RRB- -RSB-)))))))) (. .)))
( (S (NP (NN Conclusion))))
( (S (S (NP (NP (DT This) (NN patient)) (CC and) (NP (PRP$ her) (NN tumor))) (VP (VBP represent) (NP (NP (DT the) (NN vanguard)) (PP (IN of) (NP (NP (DT a) (JJ new) (NN population)) (PP (IN of) (NP (JJ early) (NN stage) (NN breast) (NN cancer) (NNS patients))))) (SBAR (WHNP (WDT that)) (S (VP (MD will) (VP (VB be) (ADVP (RB increasingly)) (VP (VBN diagnosed) (SBAR (IN as) (S (NP (NP (JJ new) (NN screening) (NNS technologies)) (ADJP (JJ complementary) (PP (TO to) (NP (NN mammography))))) (VP (VP (VBP are) (ADJP (JJ validated))) (CC and) (VP (VBP become) (ADJP (JJ practicable)))))))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (JJ low) (NN power) (NN MRI)) (VP (MD can) (VP (VB detect) (NP (DT a) (NN stage) (NN I) (NN tumor)) (PP (IN in) (NP (JJ dense) (NN breast) (NN tissue)))))))))) (: ;) (S (NP (DT the) (JJ same) (NN technology)) (VP (MD can) (ADVP (RB also)) (VP (NN impact) (PP (IN upon) (NP (JJ interval) (NNS tumors))) (PP (IN by) (S (VP (VP (VBG staggering) (NP (NP (DT the) (NN procedure)) (PP (IN with) (NP (NN mammography))))) (CONJP (RB rather) (IN than)) (VP (VBG applying) (NP (PRP them)) (ADVP (RB coincidently))))))))) (. .)))
( (S (SBAR (IN Although) (S (NP (PRP we)) (VP (VBD did) (RB not) (VP (VB observe) (NP (NP (JJ obvious) (NNS differences)) (PP (IN in) (NP (NP (DT the) (NP (NN growth) (NN rate)) (CC or) (NP (NN differentiation) (NN potential))) (PP (IN of) (NP (NP (DT the) (JJ dense) (NN breast) (NN tissue)) (PP (IN from) (NP (DT this) (NN patient)))))))))))) (, ,) (NP (PRP we)) (VP (VBP cannot) (NP (NN rule)) (PP (IN out) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP (NP (NP (DT some)) (CC or) (NP (DT all))) (PP (IN of) (NP (NP (DT the) (NNS tumors)) (ADJP (JJ detectable) (PP (ADVP (RB only)) (IN by) (NP (JJ complementary) (NN screening) (NNS procedures))))))) (VP (MD will) (VP (VB differ) (PP (IN from) (NP (NP (DT the) (JJ present) (JJ clinical) (VBP experience)) (PP (IN in) (NP (JJ important) (NNS ways)))))))))))) (. .)))
( (S (S (S (NP (PRP$ Our) (JJ live-cell) (NN analysis)) (VP (VBZ takes) (NP (NP (DT a) (NN step)) (PP (IN toward) (S (VP (VBG defining) (NP (NP (JJ cellular) (NNS characteristics)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB be) (ADJP (JJ useful) (PP (IN for) (NP (NN cancer) (NN risk) (NN assessment))))))))))))))) (, ,) (CC but) (S (NP (PRP we)) (VP (VBP are) (ADVP (RB only)) (VP (VBG beginning) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NNS possibilities)) (PP (IN of) (NP (DT the) (NN system))))))))))) (. .)))
( (S (S (NP (PRP It)) (VP (MD may) (VP (VB be) (SBAR (IN that) (S (NP (NP (JJ different) (NN growth) (NNS conditions)) (, ,) (CC or) (NP (NP (NN induction)) (PP (IN with) (NP (ADJP (ADJP (JJ genotoxic)) (CC or) (ADJP (JJ estrogenic))) (NNS agents)))) (, ,)) (VP (MD will) (VP (VB allow) (PP (IN for) (NP (NP (DT the) (JJR greater) (NN differentiation)) (PP (IN of) (NP (NP (NN breast) (NN tissue)) (CC and) (NP (NN tumor) (NNS behaviours))))))))))))) (. .)))
( (S (S (NP (DT This) (NN technique)) (ADVP (RB also)) (VP (VBZ allows) (PP (IN for) (NP (NP (DT the) (NN application)) (PP (IN of) (NP (JJ functional) (NNS assays))) (PP (TO to) (NP (NN patient) (NNS samples))))) (, ,) (SBAR (IN as) (S (VP (VBN exemplified) (PP (IN in) (NP (DT this) (NN report))) (PP (IN by) (NP (NP (DT the) (NN UDS) (NN assay)) (PP (IN for) (NP (NN NER) (NN capacity)))))))))) (. .)))
( (S (S (NP (NP (DT Those) (NN UDS) (NNS results)) (, ,) (CONJP (IN although) (IN from)) (NP (DT a) (JJ single) (NN patient)) (, ,)) (VP (VBP demonstrate) (ADVP (RB definitively)) (SBAR (IN that) (S (NP (NP (DT the) (ADJP (RB constitutively) (JJ low)) (NN NER) (NNS capacities)) (VP (VBN reported) (PP (IN in) (NP (JJ several) (JJ sporadic) (NN breast) (NNS populations))))) (VP (VBP do) (RB not) (VP (VB arise) (PP (IN as) (NP (NP (DT a) (JJ pleiomorphic) (NN effect)) (PP (IN of) (NP (NN BRCA1) (NN haploinsufficency))))))))))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (NP (JJ genetic) (NN instability)) (, ,) (NP (NP (DT a) (JJ fundamental) (NN element)) (PP (IN in) (NP (NN breast) (NN carcinogenesis)))) (, ,)))) (VP (MD may) (VP (VB differ) (PP (IN between) (NP (ADJP (ADJP (JJ sporadic)) (CC and) (ADJP (JJ hereditary))) (NN breast) (NNS tumors)))))) (. .)))
( (S (S (NP (DT This)) (VP (VBZ results) (PP (IN in) (NP (NP (NP (NP (JJ different) (NNS susceptibilities)) (PP (TO to) (NP (VBG inducing) (NNS agents)))) (, ,) (NP (NP (NNS mutations)) (PP (IN in) (NP (NP (JJ different) (NNS sets)) (PP (IN of) (NP (NP (NNS oncogenes)) (CC and) (NP (NN tumor) (NN suppressor) (NNS genes))))))) (, ,) (CC and) (, ,) (ADVP (RB ultimately)) (, ,) (NP (NNS tumors))) (PP (IN of) (NP (JJ different) (JJ molecular) (NN etiology))) (SBAR (WHNP (WDT that)) (S (VP (VBP express) (NP (ADJP (ADJP (JJ different)) (ADJP (RB clinically) (JJ relevant))) (NNS phenotypes))))))))) (. .)))
( (S (NP (NNS Methods))))
( (S (S (NP (DT The) (NN patient)) (VP (VBD was) (NP (NP (DT a) (ADJP (CD 35.7) (NN year) (JJ old)) (NN woman)) (PP (IN with) (NP (NP (JJ strong) (NN family) (NN history)) (PP (IN of) (NP (NN breast) (NN cancer)))))) (VP (VBN recruited) (PP (IN into) (NP (NP (DT a) (JJ clinical) (NN trial)) (PP (IN of) (NP (NP (NN MRI) (NN screening)) (PP (IN for) (NP (JJ young) (NN woman))))))) (PP (IN at) (NP (NP (JJ high) (NN risk)) (PP (IN for) (NP (NN breast) (NN cancer))) (PP (IN with) (NP (JJ dense) (NN breast) (NN tissue) (CD -LSB-3) (-RRB- -RSB-)))))))) (. .)))
( (S (S (NP (NN Gadolinium) (NN enhancement) (NNS images)) (VP (VBD revealed) (NP (NP (DT a) (JJ small) (ADJP (CD 1) (NN cm)) (NN lesion)) (PP (IN in) (NP (NP (DT the) (JJ upper-outer) (NN quadrant)) (PP (IN of) (NP (NP (DT the) (JJ left) (NN breast)) (, ,) (VP (VBN identified) (ADVP (RB pathologically)) (PP (IN as) (NP (DT an) (VBG infiltrating) (JJ ductal) (NN carcinoma))))))))))) (. .)))
( (S (S (NP (DT The) (NN patient)) (VP (VP (VBD underwent) (NP (NP (DT a) (VBN modified) (NN radical) (NN mastectomy)) (PP (IN of) (NP (DT the) (JJ left) (NN breast))))) (CC and) (VP (VBP chose) (S (VP (TO to) (ADVP (RB also)) (VP (VBP undergo) (NP (DT a) (JJ contralateral) (JJ prophylactic) (JJ total) (NN mastectomy)))))))) (. .)))
( (S (S (NP (NP (NN Blood)) (CC and) (NP (NN tissue))) (VP (VBD were) (VP (VBN obtained) (PP (IN for) (NP (NP (NN analysis)) (PP (IN with) (NP (NN consent))))) (PP (IN under) (NP (NP (NP (NNP Magee-Womens) (NNP Hospital)) (PRN (-LRB- -LRB-) (PP (IN of) (NP (NP (DT the) (NNP University)) (PP (IN of) (NP (NN Pittsburgh) (JJ Medical) (NN Center))))) (-RRB- -RRB-))) (NP (NNP IRB) (NNP #) (CD MWH-94-108))))))) (. .)))
( (S (S (NP (NP (NNS Data)) (PP (IN from) (NP (DT this) (JJ hereditary) (NN breast) (NN cancer) (NN patient)))) (VP (VBD were) (VP (VBN compared) (PP (TO to) (NP (NP (DT that)) (PP (IN from) (NP (NP (CD two) (JJ additional) (NNS patients)) (CONJP (RB as) (RB well) (IN as)) (NP (ADJP (RB previously) (VBN published)) (NNS controls))))))))) (. .)))
( (S (S (NP (DT The) (JJ first) (JJ new) (NN control) (NN patient)) (VP (VBD was) (NP (NP (DT a) (CD 20) (ADJP (NN year) (JJ old)) (NNS women)) (VP (VBG undergoing) (NP (NN breast) (NN reduction) (NN mammoplasty)))))) (. .)))
( (S (S (NP (DT The) (JJ second) (JJ contemporaneous) (NN control) (NN patient)) (VP (VBD was) (NP (NP (DT a) (ADJP (CD 36) (NN year) (JJ old)) (NN woman)) (VP (VBG undergoing) (NP (NP (JJ cosmetic) (NN surgery)) (PP (IN on) (NP (PRP$ her) (JJ contralateral) (NN breast)))) (PP (NP (CD two) (NNS years)) (IN after) (NP (NP (JJ successful) (NN lumpectomy)) (S (VP (TO to) (VP (VB remove) (NP (NP (DT an) (ADJP (RB apparently) (JJ sporadic)) (NN stage) (NN IIA) (NN breast) (NN tumor)) (PRN (-LRB- -LRB-) (NP (NP (CD 2.5) (NN cm)) (, ,) (ADJP (JJ negative) (PP (IN for) (NP (NP (NP (NP (NN estrogen)) (CC and) (NP (NN progesterone))) (NNS receptors)) (, ,) (NP (CD 13) (NN lymph) (NNS nodes) (JJ negative)))))) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (NP (PRP She)) (VP (VBD had) (VP (VBN undergone) (NP (NP (JJ standard) (NN radiotherapy)) (CC and) (NP (NN chemotherapy))) (PP (IN with) (NP (NP (NN adriamycin)) (CC and) (NP (NN cyclophosphamide))))))) (. .)))
( (S (S (NP (JJ Histopathological) (NN analysis)) (VP (VBD confirmed) (SBAR (IN that) (S (NP (NP (DT the) (NN breast) (NN tissue)) (PP (IN from) (NP (NP (DT both)) (PP (IN of) (NP (DT these) (JJ control) (NNS patients)))))) (VP (VBD was) (UCP (ADJP (JJ free) (PP (IN of) (NP (NN cancer)))) (CC and) (PP (IN within) (NP (NP (DT the) (JJ acceptable) (JJ histological) (NN range)) (PP (IN of) (NP (JJ normal))))))))))) (. .)))
( (S (S (NP (NP (JJ Fresh) (NNS tissues)) (PP (IN from) (NP (DT the) (NN patient)))) (VP (VBD were) (VP (VBN obtained) (PP (IN within) (NP (NP (CD 5) (NNS hours)) (PP (IN of) (NP (NN surgery)))))))) (. .)))
( (S (PP (IN After) (NP (JJ pathological) (NN evaluation))) (, ,) (NP (NP (JJ excess) (NN tissue)) (VP (RB not) (VBN needed) (PP (IN for) (NP (NN diagnosis))))) (VP (VBD was) (VP (VBN placed) (PP (IN into) (NP (NP (NN DMEM)) (VP (VBG containing) (NP (NP (ADJP (CD 10) (NN %)) (JJ fetal) (NN calf) (NN serum)) (CC and) (NP (NP (ADJP (RB 3x) (JJ antibiotic)) (NN antimycotic)) (PRN (-LRB- -LRB-) (NP (NP (NN Sigma)) (, ,) (NP (NN St.) (NN Louis)) (, ,) (NP (NN MO))) (-RRB- -RRB-)))) (PP (IN at) (NP (NN 4°C)))))))) (. .)))
( (S (S (NP (DT This) (NN tissue)) (VP (VBD was) (ADVP (RB then)) (VP (VP (VBN processed) (SBAR (IN as) (S (VP (VBN described) (PP (IN in) (NP (NP (NNP Latimer) (FW et) (FW al.)) (NP (CD -LSB-30) (-RRB- -RSB-)))))))) (CC and) (VP (VBN placed) (PP (IN into) (NP (NN culture))) (PP (IN on) (NP (NP (DT a) (JJ diluted) (NN form)) (PP (IN of) (NP (NP (NN matrigel)) (PRN (-LRB- -LRB-) (NP (NN 1:1)) (PP (IN with) (NP (NN DMEM))) (-RRB- -RRB-)))))) (PP (IN in) (NP (DT the) (JJ novel) (NN MWRIα) (NN medium) (CD -LSB-7) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (NP (CD Eight) (NNS samples)) (PP (IN of) (NP (NP (DT the) (JJ principal) (NN patient) (POS 's)) (NN tissue)))) (VP (VBD were) (VP (VBN obtained) (PP (IN for) (NP (NN culture))) (PP (IN after) (NP (JJ bilateral) (NN mastectomy) (NN surgery)))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD were) (RB not) (ADJP (JJ able) (S (VP (TO to) (VP (VB obtain) (NP (NP (DT a) (NN sample)) (PP (IN of) (NP (PRP$ her) (NN tumor)))))))) (, ,) (SBAR (IN because) (S (NP (PRP it)) (VP (VBD was) (VP (VBN utilized) (ADVP (RB entirely)) (PP (IN for) (NP (JJ clinical) (NN diagnosis))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD were) (ADJP (JJ able) (S (VP (TO to) (VP (VB obtain) (NP (NP (CD 4) (NNS pieces)) (PP (IN of) (NP (ADJP (RB histologically) (JJ normal)) (JJ non-tumor) (JJ adjacent) (NN tissue)))) (PP (IN at) (NP (NP (VBG increasing) (ADJP (CD 1) (NN cm)) (NNS intervals)) (PP (IN from) (NP (NP (DT the) (NN tumor) (NN margin)) (PP (IN from) (NP (PRP$ her) (JJ left) (-LRB- -LRB-) (JJ ipsilateral) (-RRB- -RRB-) (NN breast))))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBD obtained) (NP (NP (CD 4) (JJ similar) (NNS pieces)) (PP (IN of) (NP (JJ fresh) (NN tissue))) (PP (IN from) (NP (PRP$ her) (JJ contralateral) (NN breast)))))) (. .)))
( (S (S (NP (DT All)) (VP (VBD were) (VP (VBN placed) (PP (IN into) (NP (JJ primary) (NN explant) (-LRB- -LRB-) (NN HME) (-RRB- -RRB-) (NN culture)))))) (. .)))
( (S (S (PP (IN For) (NP (NP (NN analysis)) (PP (IN of) (NP (NP (NN cell) (NN growth)) (CC and) (NP (ADJP (FW in) (FW vitro)) (NN differentiation)))))) (, ,) (NP (NNS explants)) (VP (VBD were) (VP (VP (VBN cultured)) (CC and) (VP (VBN imaged) (NP (DT every) (JJ second) (NN day)) (S (VP (VBG using) (NP (NP (DT a) (JJ digital) (NN Hamamatsu) (NN Orca) (NN camera)) (PP (IN for) (NP (CD 30–60) (NNS days)))))))))) (. .)))
( (S (S (NP (NNS Images)) (VP (VBD were) (VP (VBN analyzed) (PP (IN on) (NP (NP (DT a) (JJ Macintosh) (NN G4) (NN computer)) (VP (VBG using) (NP (NP (JJ QED) (JJ imaging) (NN software)) (PRN (-LRB- -LRB-) (FRAG (NP (NNS Media) (NN Cybernetics)) (, ,) (NP (NNP Inc.)) (, ,) (NP (NN Silver) (NN Spring)) (, ,) (NP (NN MD))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (NN Breast) (NN reduction) (NN mammoplasty) (NNS tissues)) (VP (VBD were) (VP (VBN obtained) (PP (IN from) (NP (NP (NNS patients)) (VP (NNS ages) (NP (NN 20–70)) (PP (IN at) (NP (NP (NNP Magee-Womens) (NNP Hospital)) (PP (IN under) (NP (DT the) (JJ above) (NN IRB))))))))))) (. .)))
( (S (S (NP (NP (DT A) (JJ neighboring) (NN piece)) (PP (IN of) (NP (NP (NN mammoplasty) (NN tissue)) (PRN (-LRB- -LRB-) (PP (IN from) (NP (DT the) (JJ same) (CD 0.25) (NN cm2) (NN sample))) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (DT that)) (VP (VBN placed) (PP (IN into) (NP (JJ primary) (NN culture))))))) (VP (VBD was) (UCP (ADJP (JJ fixed)) (CC and) (VP (VBN processed) (PP (IN in) (NP (NN paraffin))))))) (. .)))
( (S (S (NP (DT These) (NNS sections)) (VP (VBD were) (VP (VBN examined) (PP (IN by) (NP (NP (DT a) (NN pathologist)) (S (VP (TO to) (VP (VB verify) (NP (NP (DT the) (JJ histological) (NNS features)) (CC and) (NP (NP (NN normality)) (PP (IN of) (NP (DT the) (NN tissue))))))))))))) (. .)))
( (S (S (NP (NN Breast) (NN tissue)) (VP (VBD was) (VP (VBN processed) (PP (IN as) (NP (ADJP (RB previously) (VBN described)) (NN -LSB-30))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (NN Tissue)) (VP (VBD was) (VP (VP (VBN rinsed) (NP (NP (CD three) (NNS times)) (PP (IN in) (NP (NP (NNS PBS)) (VP (VBG containing) (NP (NNS antibiotics))))))) (, ,) (VP (VBN disaggregated)) (CC and) (VP (VBN placed) (PP (IN into) (NP (NN MWRIα) (NN medium) (CD -LSB-7) (-RRB- -RSB-))) (PP (IN on) (NP (NP (DT a) (JJ thin) (NN coat)) (PP (IN of) (NP (NN matrigel))))))))) (. .)))
( (S (S (NP (NP (JJ Peripheral) (NN blood) (NNS lymphocytes)) (PRN (-LRB- -LRB-) (NP (NNS PBLs)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN obtained) (PP (IN with) (NP (NN consent))) (PP (PP (IN from) (NP (JJ normal) (JJ healthy) (NN control) (NNS subjects))) (NP (NP (NNS ages) (CD 20–50)) (NP (NP (NNP working)) (PP (IN at) (NP (NP (NNP Magee-Womens) (NNP Hospital)) (CC or) (NP (NNS students)))) (PP (IN at) (NP (NP (DT the) (NNP University)) (PP (IN of) (NP (NN Pittsburgh))))))))))) (. .)))
( (S (S (NP (NP (NP (NN Foreskin) (NN fibroblast)) (PRN (-LRB- -LRB-) (NP (NN FF)) (-RRB- -RRB-))) (NN tissue)) (VP (VBD was) (VP (VP (VBN obtained) (PP (IN as) (NP (NP (JJ discarded) (NN tissue)) (PP (IN from) (NP (JJ newborn) (NNS infants))))) (PP (IN after) (NP (NN circumcision)))) (CC and) (VP (VBN utilized) (PP (IN between) (NP (NNS passages) (CD 7) (CC and) (CD 10))))))) (. .)))
( (S (S (NP (DT These) (JJ control) (NNS populations)) (VP (VBP have) (VP (VBN been) (ADVP (RB previously)) (VP (VBN described) (PP (IN in) (NP (JJR greater) (NN detail) (CD -LSB-30,46) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (NP (NN Breast) (NN tissue) (NNS samples)) (PP (IN from) (NP (DT the) (CD two) (JJ new) (NN control) (NNS patients)))) (VP (VBD were) (VP (VBN processed) (PP (IN in) (NP (DT the) (JJ same) (NN manner)))))) (. .)))
( (S (S (NP (NP (JJ Primary) (NNS cultures)) (PP (IN of) (NP (JJ mammary) (NN tissue))) (, ,) (VP (VBN established) (NP (CD 10–14) (NNS days))) (, ,)) (VP (VBD were) (VP (VBN labeled) (PP (IN with) (NP (NN 3H-thymidine))) (PP (IN for) (NP (NP (DT a) (NN period)) (PP (IN of) (NP (CD 2) (NNS hours))) (VP (VP (VBN followed) (PP (IN by) (NP (NP (DT a) (NN chase)) (PP (IN with) (NP (JJ cold) (NN thymidine))))) (PP (IN for) (NP (CD 2) (NNS hours)))) (CC and) (VP (ADVP (RB then)) (VBN processed) (PP (IN for) (NP (NN autoradiography)))))))))) (. .)))
( (S (S (PP (IN After) (NP (DT a) (ADJP (CD 10–12) (NN day)) (NN exposure))) (, ,) (NP (NNS slides)) (VP (VBD were) (VP (VP (VBN processed)) (CC and) (VP (VBN analyzed) (PP (IN by) (NP (NP (CD two) (ADJP (ADJP (JJ independent)) (, ,) (ADJP (JJ blinded))) (NNS scorers)) (SBAR (WHNP (WP who)) (S (VP (VBD evaluated) (NP (NP (DT the) (NN tissue) (NNS samples)) (PP (IN for) (NP (NP (DT the) (NN percentage)) (PP (IN of) (NP (NNS cells)))))) (PP (IN in) (NP (NP (NN S) (NN phase)) (-LRB- -LRB-) (VP (VBN characterized) (PP (IN by) (NP (NP (JJ complete) (NN coverage)) (PP (IN of) (NP (DT the) (NN nucleus))) (PP (IN with) (NP (NN silver) (NNS grains)))))) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (NP (NN NER)) (VP (VBD was) (VP (VBN measured) (PP (IN by) (NP (NP (NN autoradiography)) (PP (IN of) (NP (JJ unscheduled) (NN DNA) (NN synthesis))))) (PP (IN after) (NP (NN UV) (NN damage))) (PRN (-LRB- -LRB-) (NP (NNP UDS) (-RRB- -RRB-) (CD -LSB-47,48)) (-RRB- -RSB-))))) (. .)))
( (S (PP (IN After) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (NP (CD 10–14) (NNS days)) (PP (IN in) (NP (NN culture))))))) (, ,) (PP (IN without) (NP (NN passaging))) (, ,) (NP (NNS cultures)) (VP (VBD were) (ADJP (JJ irradiated) (PP (IN with) (NP (NP (NN UV) (NN light)) (PP (IN at) (NP (CD 254) (NN nm)))))) (PP (IN at) (NP (NP (DT a) (JJ mean) (NN fluence)) (PP (IN of) (NP (CD 1.2) (NN Joules/m2))) (PP (IN for) (NP (CD 12) (NNS seconds))))) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN culture) (NN medium))))) (, ,) (PP (IN for) (NP (NP (DT a) (JJ total) (NN dose)) (PP (IN of) (NP (CD 14) (NN J/m2)))))) (. .)))
( (S (S (NP (DT Each) (NN sample)) (VP (VBD was) (VP (VBN represented) (PP (IN by) (NP (QP (IN at) (JJS least) (CD two)) (NN chamber) (NNS slides)))))) (. .)))
( (S (S (NP (NP (CD One) (NN chamber)) (PP (IN of) (NP (DT each) (JJ 2-chamber) (NN slide)))) (VP (VBD was) (VP (VBN shielded) (PP (IN from) (NP (DT the) (NN UV) (NN dose))) (S (VP (TO to) (VP (VB be) (VP (VBN used) (PP (IN as) (NP (DT an) (JJ unirradiated) (JJ control) (NN sample)))))))))) (. .)))
( (S (S (NP (JJ Primary) (NNS cultures)) (VP (VBD had) (RB not) (VP (VP (VBD reached) (NP (NN confluence))) (CC and) (VP (VBD were) (ADVP (RB still)) (ADJP (RB actively) (VBG growing)) (PP (IN at) (NP (NP (DT the) (NN time)) (S (NP (DT the) (NN UDS) (NN assay)) (VP (VBD was) (VP (VBN performed)))))))))) (. .)))
( (S (S (NP (NN Control) (NNS FF)) (VP (VBD were) (VP (VBN plated) (PP (NP (QP (RB subconfluently) (CD 2)) (NNS days)) (IN before) (NP (DT the) (NN UDS) (NN assay))) (S (VP (TO to) (VP (VB insure) (SBAR (IN that) (S (NP (PRP they)) (ADVP (RB also)) (VP (VBD were) (PP (RB not) (IN in) (NP (NP (DT a) (JJ quiescent) (NN state)) (VP (VBN brought) (PRT (IN on)) (PP (IN by) (NP (NN confluence))))))))))))))) (. .)))
( (S (PP (IN After) (NP (NN UV) (NN exposure))) (, ,) (NP (DT all) (NNS cultures)) (VP (VBD were) (VP (VBN incubated) (PP (IN in) (NP (NP (NN medium)) (VP (VBN supplemented) (PP (IN with) (NP (NP (NP (CD 10) (NN μCi) (NN ml) (NN -LSB-3H) (-RRB- -RSB-) (NN methyl-thymidine)) (PRN (-LRB- -LRB-) (NP (CD ~80) (NN Ci) (NN mmol-1)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP PerkinElmer) (NN Life) (NNP Sciences) (, ,) (NNP Boston) (, ,) (NNP MA)) (-RRB- -RRB-))))))) (PP (IN for) (NP (NP (CD 2) (NNS hours)) (PP (IN at) (NP (NN 37°C))))))) (. .)))
( (S (S (NP (NN Labeling) (NN medium)) (VP (VBD was) (ADVP (RB then)) (VP (VP (VBN replaced) (PP (IN with) (NP (NP (JJ unlabeled) (NN chasing) (NN medium)) (VP (VBG containing) (NP (NP (ADJP (CD 10-3) (NN M)) (JJ non-radioactive) (NN thymidine)) (PRN (-LRB- -LRB-) (NP (NN Sigma)) (-RRB- -RRB-))))))) (CC and) (VP (VBN incubated) (PP (IN for) (NP (NP (DT a) (JJ further) (CD 2) (NNS hours)) (PP (TO to) (NP (NP (JJ clear) (JJ radioactive) (VB label)) (PP (IN from) (NP (DT the) (JJ intracellular) (NN nucleotide) (NNS pools))))))))))) (. .)))
( (S (PP (IN After) (NP (NP (NN incubation)) (PP (IN in) (NP (DT the) (JJ post-labeling) (NN medium))))) (, ,) (NP (NNS cells)) (VP (VBD were) (UCP (ADJP (JJ fixed) (PP (IN in) (NP (NP (JJ 1X) (NN SSC)) (, ,) (NP (NP (ADJP (NP (CD 33) (NN %)) (JJ acetic)) (NN acid)) (PP (IN in) (NP (NP (NN ethanol)) (, ,) (VP (VBN followed) (PP (IN by) (NP (ADJP (CD 70) (NN %)) (NN ethanol)))))))))) (CC and) (ADVP (RB finally)) (VP (VBN rinsed) (PP (IN in) (NP (ADJP (CD 4) (NN %)) (JJ perchloric) (NN acid))) (PP (IN over) (NP (NP (NN night)) (PP (IN at) (NP (NN 4°C)))))))) (. .)))
( (S (S (NP (DT All) (NNS slides)) (VP (VBD were) (VP (VP (VP (VBN dried)) (CC and) (ADVP (RB subsequently)) (VP (VBD dipped) (PP (IN in) (NP (NP (JJ photographic) (NN emulsion)) (PRN (-LRB- -LRB-) (NP (NN Kodak) (NN type) (NN NTB2)) (-RRB- -RRB-)))))) (CC and) (VP (VBN exposed) (PP (IN for) (NP (QP (CD 10) (TO to) (CD 14)) (NNS days))) (PP (IN in) (NP (NP (JJ complete) (NNS darkness)) (PP (IN at) (NP (NN 4°C))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN length)) (PP (IN of) (NP (NP (NN exposure)) (PP (IN of) (NP (NN emulsion)))))) (VP (VBD was) (VP (VBN determined) (PP (IN in) (NP (DT each) (NN experiment))) (PP (IN by) (S (VP (VBG preparing) (NP (JJ FF) (`` ``) (NN tester) (NN '') (NNS slides)))))))) (. .)))
( (S (S (S (PP (IN After) (NP (CD 10–12) (NNS days))) (NP (DT these) (NN tester) (NNS slides)) (VP (VBD were) (VP (VBN developed)))) (CC and) (S (NP (NN grain) (NN counting)) (VP (VBD was) (VP (VBN performed))))) (. .)))
( (S (S (SBAR (IN If) (S (NP (NP (DT the) (NNS nuclei)) (PP (IN over) (NP (DT the) (NN foreskin) (NNS fibroblasts)))) (VP (VBD averaged) (NP (QP (CD 50) (CC or) (JJR more)) (NNS grains)) (PP (IN per) (NP (NN nucleus)))))) (, ,) (NP (NP (RB then) (DT the) (NN rest)) (PP (IN of) (NP (DT the) (JJ experimental) (NNS slides)))) (VP (VBD were) (VP (VBN developed)))) (. .)))
( (S (S (SBAR (IN If) (S (NP (DT the) (NN grain) (NN count)) (VP (VBD was) (PP (IN below) (NP (DT this) (NN level)))))) (, ,) (NP (DT the) (VBG remaining) (NNS slides)) (VP (VBD were) (ADJP (JJ left) (S (VP (TO to) (VP (VBP expose) (ADVP (NP (CD 1–3) (NNS days)) (RBR longer)) (PP (IN before) (S (VP (VBG being) (VP (VBN developed))))))))))) (. .)))
( (S (PP (IN After) (NP (NP (JJ photographic) (NN development)) (PP (IN of) (NP (NN emulsion))))) (, ,) (NP (DT all) (NNS slides)) (VP (VBD were) (VP (VBN stained) (PP (IN with) (NP (NN Giemsa))) (, ,) (ADVP (RB then)) (VP (VBN examined) (PP (IN at) (NP (NP (DT a) (JJ total) (NN magnification)) (PP (IN of) (NP (NN 1000X))))) (PP (IN on) (NP (NP (DT a) (NNP Zeiss) (NNP Axioskop)) (PRN (PP (IN under) (NP (NP (NN oil) (NN emersion)) (PP (IN for) (NP (NP (NNS grains)) (ADJP (JJ located) (ADVP (RB immediately))))) (PP (IN over) (NP (NP (DT the) (NNS nuclei)) (PP (IN of) (NP (NP (NN non-S) (NN phase)) (NNS cells))))))) (NP (CD -LSB-48)) (-RRB- -RSB-))))))) (. .)))
( (S (S (S (NP (JJ Local) (NN background) (NN grain) (NNS counts)) (VP (VBD were) (VP (VBN evaluated) (PP (IN in) (NP (NP (DT each) (JJ microscopic) (NN field)) (PP (IN over) (NP (DT an) (NN area) (NP (DT the) (JJ same) (NN size)))))) (PP (IN as) (NP (DT a) (JJ representative) (NN nucleus)))))) (, ,) (CC and) (S (NP (DT this) (NN total)) (VP (VBD was) (VP (VBN subtracted) (PP (IN from) (NP (NP (DT the) (NN grain) (NN count)) (PP (IN of) (NP (DT each) (NN nucleus))) (PP (IN in) (NP (DT that) (NN field))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ average) (NN number)) (PP (IN of) (NP (NNS grains))) (PP (IN per) (NP (NN nucleus)))) (VP (VBD was) (VP (VBN quantified) (PP (IN for) (NP (NP (DT each) (NN side)) (PP (IN of) (NP (NP (DT the) (NN chamber) (NN slide)) (, ,) (ADJP (CC both) (ADJP (JJ unirradiated)) (CC and) (ADJP (JJ irradiated)))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ final) (NN NER) (NN value)) (PP (IN for) (NP (DT each) (NN slide)))) (VP (VBD was) (VP (VBN calculated) (PP (IN by) (S (VP (VBG subtracting) (NP (NP (DT the) (JJ unirradiated) (JJ mean)) (PRN (-LRB- -LRB-) (NP (NP (NNS grains)) (PP (IN per) (NP (NN nucleus)))) (-RRB- -RRB-))) (PP (IN from) (NP (NP (DT the) (JJ irradiated) (NN mean)) (PRN (-LRB- -LRB-) (NP (NP (NNS grains)) (PP (IN per) (NP (NN nucleus)))) (-RRB- -RRB-))))))) (, ,) (PP (IN after) (NP (NP (DT the) (JJ initial) (NN subtraction)) (PP (IN of) (NP (JJ local) (NN background))) (PP (IN in) (NP (DT each) (NN field)))))))) (. .)))
( (S (S (NP (NN NER)) (VP (VBD was) (ADVP (RB initially)) (VP (VBN expressed) (PP (IN as) (NP (NP (DT a) (NN percentage)) (PP (IN of) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (ADJP (RB concurrently) (VBN analyzed)) (NN FF)))))))))) (. .)))
( (S (S (NP (CD Four) (JJ FF) (NNS slides)) (VP (VBD were) (VP (VBN scored) (PP (IN per) (NP (NN experiment))) (, ,) (PP (IN by) (NP (NP (DT an) (NN average)) (PP (IN of) (NP (NP (CD three)) (VBZ counters)))))))) (. .)))
( (S (S (NP (CD 200) (NNS nuclei)) (VP (VBD were) (VP (VBN counted) (PP (IN per) (NP (NN slide))) (, ,) (PP (IN for) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (CD 800))))) (, ,) (PP (IN with) (NP (NP (DT an) (NN average)) (PP (IN of) (NP (CD 61.6) (NN grains/nucleus)))))))) (. .)))
( (S (S (NP (CD Six) (NNS slides)) (VP (VBD were) (VP (VBN evaluated) (PP (IN for) (NP (NP (NP (DT the) (NN patient) (POS 's)) (NN PBL) (NN sample)) (, ,) (NP (NP (CD two)) (PP (IN by) (NP (NP (DT each)) (PP (IN of) (NP (NP (CD three)) (VBZ counters))))))))))) (. .)))
( (S (S (NP (NP (DT An) (NN average)) (PP (IN of) (NP (NN 195) (NNS nuclei)))) (VP (VBD were) (VP (VBN scored) (PP (IN per) (NP (NP (NN slide)) (PRN (-LRB- -LRB-) (PP (IN for) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (RB almost) (CD 1200))))) (-RRB- -RRB-)))) (, ,) (PP (IN with) (NP (NP (DT an) (NN average)) (PP (IN of) (NP (CD 7.5) (NN grains/nucleus)))))))) (. .)))
( (S (S (NP (CD Four) (NNS slides)) (VP (VBD were) (VP (VBN counted) (PP (IN for) (NP (NP (DT the) (JJ contemporaneous) (NN breast) (NN reduction) (NN control)) (, ,) (NP (CD two) (NP (DT each))))) (PP (IN by) (NP (NP (CD two)) (VBZ counters)))))) (. .)))
( (S (S (NP (EX There)) (VP (VBD were) (NP (NP (DT an) (NN average)) (PP (IN of) (NP (CD 200) (NNS nuclei))) (PP (IN per) (NP (NP (NN slide)) (CC and) (NP (CD 14.1) (NN grains/nucleus))))))) (. .)))
( (S (S (S (NP (CD Six) (NNS slides)) (VP (VBD were) (VP (VBN scored) (PP (IN from) (NP (NP (DT the) (NN patient) (POS 's)) (JJ ipsilateral) (NN breast) (NN tissue) (NN sample))) (, ,) (S (NP (NP (CD two)) (PP (IN by) (NP (NP (DT each)) (PP (IN of) (NP (CD three) (JJ independent) (VBZ counters)))))))))) (, ,) (CC and) (S (NP (CD five) (NNS slides)) (VP (VBD were) (VP (VBN counted) (PP (IN from) (NP (DT the) (JJ contralateral) (NN sample))) (, ,) (ADVP (RB again)) (PP (IN by) (NP (CD three) (JJ independent) (VBZ counters))))))) (. .)))
( (S (S (NP (NP (DT An) (NN average)) (PP (IN of) (NP (QP (RB just) (IN over) (CD 100)) (NNS nuclei)))) (VP (VBD were) (VP (VBN evaluated) (PP (IN per) (NP (NN slide))) (PP (IN for) (NP (DT each) (NN sample))) (, ,) (PP (PP (IN for) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (QP (RB almost) (CD 600)) (NNS nuclei))))) (PP (IN for) (NP (DT the) (JJ ipsilateral) (NN sample))) (CC and) (PP (IN over) (NP (CD 500))) (PP (IN for) (NP (DT the) (JJ contralateral) (NN sample))))))) (. .)))
( (S (S (SBAR (IN As) (S (NP (DT the) (NN NER) (NNS capacities)) (VP (VBP indicate)))) (, ,) (NP (DT these) (NNS samples)) (VP (VBD had) (NP (ADJP (RB very) (JJ similar)) (NNS counts))) (: ;) (NP (NP (NP (QP (RB about) (CD 35)) (NN grains/nucleus)) (PP (IN for) (NP (DT the) (JJ ipsilateral) (NN sample)))) (CC and) (NP (NP (CD 28) (NN grains/nucleus)) (PP (IN for) (NP (DT the) (JJ contralateral) (NN sample)))))) (. .)))
( (S (S (ADVP (RB Finally)) (, ,) (NP (CD four) (NNS slides)) (VP (VBD were) (VP (VBN counted) (PP (IN from) (NP (NP (DT the) (JJ contralateral) (NN sample)) (PP (IN of) (NP (DT a) (JJ sporadic) (NN breast) (NN cancer) (NN patient))))) (, ,) (PP (IN by) (NP (NP (CD three)) (VBZ counters)))))) (. .)))
( (S (S (NP (EX There)) (VP (VBD were) (NP (NP (NP (DT an) (NN average)) (PP (IN of) (NP (CD 200) (NNS nuclei))) (PP (IN per) (NP (NN slide)))) (CC and) (NP (NP (CD 29.4) (NNS grains)) (PP (IN per) (NP (NN nucleus))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VP (VB ensure) (NP (NN accuracy))) (CC and) (VP (VB guard) (PP (IN against) (NP (NN transcription) (NNS errors))))))) (, ,) (NP (NP (NN raw) (NN grain) (NNS counts)) (PP (IN from) (NP (DT the) (NN UDS) (NN assay)))) (VP (VBD were) (VP (VBN processed) (ADVP (RB independently)) (PP (IN in) (NP (NN duplicate))) (, ,) (ADVP (RB once)) (S (VP (VBG using) (NP (NP (NN StatView)) (PRN (-LRB- -LRB-) (NP (NN version) (CD 5.0.1))))))))) (, ,)))
( (S (NP (NP (NN SAS) (NN Institute)) (, ,) (NP (NP (NNP Inc.) (, ,) (NNP Cary)) (PRN (, ,) (NP (CD NC)) (-RRB- -RRB-))) (, ,) (CC and) (ADVP (RB once))) (VP (VBG using) (NP (NP (DT the) (NNS Data) (NN Analysis) (NP (NNP Toolpack))) (PP (IN of) (NP (NP (DT the) (NP (NN Excel) (CD 2001) (NN spreadsheet)) (NN program)) (PRN (-LRB- -LRB-) (NP (NP (NN Microsoft) (NNP Corp.)) (, ,) (NP (NNP Redmond) (, ,) (NNP WA))) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NP (DT The) (JJ final) (NN count)) (PP (IN from) (NP (NP (NP (NNS slides)) (PP (IN of) (NP (DT the) (JJ same) (NN cell) (NN type))) (PP (IN within) (NP (DT the) (JJ same) (NN experiment)))) (CC and) (NP (VBN developed) (NP (DT the) (JJ same) (NN day)))))) (VP (VBD were) (VP (VP (VBN averaged) (ADVP (RB together))) (CC and) (VP (VBN expressed) (PP (IN as) (NP (NP (DT a) (NN percentage)) (PP (IN of) (NP (ADJP (RB concurrently) (VBN analyzed)) (NN FF))))))))) (. .)))
( (S (S (NP (DT These) (NNS results)) (VP (VBD were) (ADVP (RB then)) (VP (VBN normalized) (PP (IN by) (NP (NP (NN comparison)) (PP (TO to) (NP (NP (DT the) (NN average)) (PP (IN for) (NP (DT the) (NN tissue) (NN type) (NN control) (NN population) (CD -LSB-48))))))))) (-RRB- -RSB-)) (. .)))
( (S (NP (VBG Competing) (NNS interests))))
( (S (S (NP (DT The) (NNS authors)) (VP (VB declare) (SBAR (IN that) (S (NP (PRP they)) (VP (VBP have) (NP (DT no) (VBG competing) (NNS interests))))))) (. .)))
( (S (NP (NP (NNS Authors) (POS ')) (NNS contributions))))
( (S (S (NP (NN JJL)) (VP (VBD conceived) (PP (IN of) (NP (DT the) (NN study))) (, ,) (S (VP (VP (VBN executed) (NP (PRP it))) (, ,) (CC and) (VP (VBN drafted) (NP (DT the) (NN manuscript))))))) (. .)))
( (S (S (NP (NP (NNS WSR)) (VP (VP (VBN recruited)) (CC and) (VP (VBN consented) (NP (DT the) (NN patient)))) (, ,)) (VP (VBD provided) (NP (NP (JJ clinical) (NNS samples)) (CC and) (NP (NN information))))) (. .)))
( (S (S (NP (NN JMJ)) (VP (VP (VBD evaluated) (NP (DT the) (NN UDS) (NN assay))) (CC and) (VP (VBD analyzed) (NP (DT the) (NNS data))))) (. .)))
( (S (S (NP (NNS AKS)) (VP (VBD performed) (NP (NP (DT the) (JJ histopathological) (NN analysis)) (PP (IN of) (NP (DT the) (NN tissue)))))) (. .)))
( (S (S (NP (NN VGV)) (VP (VBD participated) (PP (IN in) (NP (DT the) (NP (NN study) (NN design)) (CC and) (NP (NN data) (NN interpretation)))))) (. .)))
( (S (S (NP (NN SGG)) (VP (VP (VBD participated) (PP (IN in) (NP (NP (DT the) (NP (NP (NN design)) (CC and) (NP (NN coordination)))) (PP (IN of) (NP (DT the) (NN study)))))) (CC and) (VP (VBD helped) (PP (TO to) (NP (JJ draft) (DT the) (NN manuscript)))))) (. .)))
( (S (NP (NN Pre-publication) (NN history))))
( (S (S (NP (NP (DT The) (JJ pre-publication) (NN history)) (PP (IN for) (NP (DT this) (NN paper)))) (VP (MD can) (VP (VB be) (VP (VBN accessed) (ADVP (RB here)))))) (: :)))
( (S (NP (NP (NN Figure)) (CC and) (NP (NN Table)) (NP (NNS captions)))))
( (S (S (NP (NN Figure) (CD 1)) (: :) (NP (NP (NN Pedigree)) (PP (IN of) (NP (DT the) (NN patient))) (-LRB- -LRB-) (VP (VBN indicated) (PP (IN by) (NP (NN arrow)))) (-RRB- -RRB-))) (. .)))
( (S (S (S (NP (NP (PRP She)) (, ,) (NP (NP (CD one) (JJ maternal) (NN aunt)) (CC and) (NP (CD one) (JJ maternal) (NN cousin)))) (VP (VBD had) (NP (NP (NN breast) (NN cancer)) (VP (VBN diagnosed) (PP (IN at) (NP (CD 36) (, ,) (CD 44) (CC and) (CD 41) (NNS years) (JJ old))))) (, ,) (ADVP (RB respectively)) (, ,) (SBAR (IN as) (S (VP (VBN indicated) (PP (IN by) (NP (DT the) (JJ half-filled) (NNS symbols)))))))) (, ,) (CC and) (S (NP (PRP$ her) (NN aunt)) (VP (VBD died) (PP (IN of) (NP (DT the) (NN disease)))))) (. .)))
( (S (S (NP (PRP$ Her) (NN cousin)) (VP (VP (VBD underwent) (NP (NP (NN lumpectomy)) (VP (VBN followed) (PP (IN by) (NP (NP (NN chemotherapy)) (, ,) (NP (NN radiotherapy))))))) (CC and) (VP (VBZ is) (ADVP (RB presently)) (PP (IN on) (NP (NN tamoxifen)))))) (. .)))
( (S (S (NP (PRP$ Her) (NN mother)) (VP (VBD had) (NP (NN breast) (NN cancer)) (PP (IN in) (NP (NP (DT both) (NNS breasts)) (, ,) (VP (VBN diagnosed) (PP (IN at) (NP (NNS ages) (CD 41) (CC and) (CD 42)))))) (, ,) (SBAR (IN as) (S (VP (VBN indicated) (PP (IN by) (NP (DT the) (ADJP (RB completely) (VBN filled)) (NN symbol)))))))) (. .)))
( (S (S (NP (PRP She)) (VP (VP (VBD underwent) (NP (NP (JJ bilateral) (NN mastectomy)) (CC and) (NP (NP (NN hysterectomy)) (VP (VBN followed) (PP (IN by) (NP (NP (NN chemotherapy)) (CC and) (NP (NN radiotherapy)))))))) (CC and) (VP (VBD died) (PP (IN of) (NP (DT the) (NN disease))) (PP (IN at) (NP (NN age) (CD 44)))))) (. .)))
( (S (S (NP (DT A) (JJ second) (JJ maternal) (NN aunt)) (VP (VBD was) (VP (VBN diagnosed) (PP (IN with) (NP (NP (NP (NP (NN colon) (NN cancer)) (PP (IN at) (NP (NN age) (CD 52)))) (PRN (-LRB- -LRB-) (NP (NN light) (JJ half-filled) (NN symbol)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (NN breast) (NN cancer)) (PP (IN at) (NP (NN age) (CD 55)))) (PRN (-LRB- -LRB-) (NP (NN dark) (JJ half-filled) (NN symbol)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (PP (VBN Based) (PP (IN on) (NP (NP (DT this) (NN pattern)) (PP (IN of) (NP (JJ familial) (NN cancer)))))) (NP (DT the) (NN patient)) (VP (VP (VBD was) (VP (VBN considered) (S (VP (TO to) (VP (VB be) (PP (IN at) (NP (NP (JJ high) (NN risk)) (PP (IN of) (S (VP (VBG developing) (NP (NN breast) (NN cancer)))))))))))) (CC and) (VP (VBD was) (VP (VBD entered) (PP (IN into) (NP (DT the) (JJ low) (NN power) (NN MRI) (NN screening) (NN validation) (CC and) (NN feasibility) (NN study))))))) (. .)))
( (S (S (PP (VBG Following) (NP (PRP$ her) (NN diagnosis))) (, ,) (NP (PRP she)) (VP (VBD was) (VP (VBN confirmed) (PP (IN as) (S (VP (VBG carrying) (NP (NP (DT a) (NN Q1200X) (NN mutation)) (PP (IN in) (NP (DT the) (NN BRCA1) (NN gene)))))))))) (. .)))
( (S (NP (NP (NN Figure) (CD 2)) (: :) (NP (NP (NN Ultrasound)) (PP (IN of) (NP (DT the) (JJ MRI-detected) (NN lesion)))) (. .))))
( (S (S (PP (VBG Following) (NP (NN MRI))) (, ,) (NP (DT the) (NN patient)) (VP (VBD was) (VP (VBN scheduled) (PP (IN for) (NP (NN ultrasound))) (S (VP (TO to) (VP (VB identify) (NP (NP (DT the) (JJ questionable) (NNS lesions)) (VP (VBN seen) (PP (IN on) (NP (NN MRI))) (PP (IN for) (NP (JJ possible) (NN core) (NN biopsy))))))))))) (. .)))
( (S (S (PP (IN Under) (NP (NN ultrasound))) (NP (NP (DT the) (NN lesion)) (PP (IN of) (NP (NN concern)))) (VP (VBD was) (VP (VP (VBN identified)) (CC and) (VP (VBN biopsied) (PP (IN at) (NP (DT the) (CD 1:00) (NN location))) (PP (IN in) (NP (DT the) (JJ left) (NN breast))))))) (. .)))
( (S (S (ADVP (RB Additionally)) (, ,) (NP (NP (CD one) (NN lesion)) (VP (VBN seen) (PP (IN by) (NP (NN MRI))) (PP (IN in) (NP (NP (DT the) (JJ right) (NN breast)) (PP (IN at) (NP (DT the) (NN 4:00) (NN location))))))) (VP (VBD was) (VP (VP (VBN identified)) (CC and) (VP (VBN biopsied))))) (. .)))
( (S (NP (NP (NN Figure) (CD 3)) (: :) (NP (NP (NNS Micrographs)) (PP (IN of) (NP (NP (DT the) (JJ non-diseased) (JJ primary) (JJ human) (JJ mammary) (NN epithelial) (NNS cultures)) (PRN (-LRB- -LRB-) (NP (NNS HMEC)) (-RRB- -RRB-)))) (PP (IN from) (NP (DT the) (NN BRCA1) (NN mutation) (NN carrier)))) (. .))))
( (S (NP (NP (ADJP (NN A) (-RRB- -RRB-) (JJ Contralateral)) (NN breast)) (: –) (S (NP (NP (DT A) (NN cluster)) (PP (IN of) (NP (NP (JJ epithelial) (NNS cells)) (VP (VBN called) (S (NP (DT a) (NN mammosphere))))))) (VP (VBZ is) (VP (VBN shown) (PP (IN on) (NP (NP (DT the) (JJ left) (NN center)) (PP (IN of) (NP (DT the) (NN image) (NN sitting))) (PP (IN on) (NP (NP (DT a) (NN field)) (PP (IN of) (NP (NNS fibroblasts)))))))))) (. .))))
( (S (NP (NP (ADJP (NN B) (-RRB- -RRB-) (JJ Ipsilateral)) (NN breast)) (: –) (S (NP (NP (DT The) (JJ original) (JJ fresh) (NN tissue) (NN block)) (SBAR (WHPP (IN from) (WHNP (WDT which))) (S (NP (DT this) (NN culture)) (VP (VBD was) (VP (VBN derived)))))) (VP (VBD was) (VP (JJ located) (NP (CD 4) (NN cm)) (PP (IN from) (NP (DT the) (JJ infiltrating) (JJ ductal) (NN carcinoma)))))) (. .))))
( (S (S (NP (NP (DT The) (NN structure)) (VP (VBN shown))) (VP (VBZ is) (NP (NP (DT a) (NN cluster)) (PP (IN of) (NP (NP (JJ rounded) (JJ epithelial) (NNS cells)) (VP (VBG manifesting) (NP (NP (DT a) (NN column) (NN configuration)) (VP (VBN called) (S (`` ``) (NP (JJ pre-ductal) (NN linearization) (NN ''))))))))))) (. .)))
( (S (S (NP (DT Both) (NNS images)) (VP (VBD were) (VP (VBN captured) (PP (IN under) (NP (NP (JJ Differential) (NN Interference) (NN Contrast) (-LRB- -LRB-) (JJ DIC) (-RRB- -RRB-) (NNS optics)) (PP (IN on) (NP (NP (DT a) (NP (NNP Zeiss) (NNP Axiovert) (CD 100)) (NN microscope)) (PP (IN at) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (CD 140x) (NN magnification)))))))))))) (. .)))
( (S (NP (NP (NN Figure) (CD 4)) (: :) (NP (NP (NN Comparison)) (PP (IN of) (NP (NP (DT the) (NN NER) (NN capacity)) (PP (IN of) (NP (NP (DT a) (NN PBL) (NN sample)) (PP (IN from) (NP (NP (PRP$ our) (NN BRCA1) (NN mutation) (NN carrier) (NN patient)) (PP (IN with) (NP (NP (DT those)) (PP (IN of) (NP (NP (DT a) (NN population)) (PP (IN of) (NP (JJ disease-free) (NNS controls)))))))))))))) (. .))))
( (S (NP (DT The) (NN dark) (NN horizontal) (NN line)) (VP (VBZ indicates) (NP (NP (DT the) (NN average)) (PP (IN for) (NP (DT the) (JJ normal) (NN population)))) (, ,) (SBAR (IN while) (S (NP (DT the) (JJ dotted) (NNS lines)) (VP (VBP indicate) (NP (NP (JJ upper) (NNS limits)) (PP (IN for) (NP (NP (JJ residual) (NN NER) (NN activity)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NP (DT the) (JJ hereditary) (NN NER) (NN deficiency)) (NN disease) (NN XP) (-LRB- -LRB-) (CD 0.50) (-RRB- -RRB-)) (CC and) (NP (NP (DT the) (JJ cut-off)) (VP (VBN established) (PP (IN in) (NP (PRP$ our) (NN breast) (NN tissue) (NN study))))))))))) (SBAR (WHNP (WDT that)) (S (VP (VBD identified) (NP (NP (NNS tumors)) (PP (IN with) (NP (NP (JJ high) (NN sensitivity)) (CC and) (NP (NN specificity) (-LRB- -LRB-) (CD 0.70) (-RRB- -RRB-))))))))))))) (. .)))
( (S (NP (NP (NN Figure) (CD 5)) (: :) (NP (NP (NN Comparison)) (PP (IN of) (NP (NP (DT the) (NN NER) (NNS capacities)) (PP (IN of) (NP (NP (CD two) (NNS samples)) (PP (IN of) (NP (JJ normal) (NN breast) (NN epithelium))) (PP (IN from) (NP (NP (PRP$ our) (NN BRCA1) (NN mutation) (NN carrier) (NN patient)) (PP (IN with) (NP (NP (DT those)) (PP (IN of) (NP (NP (DT a) (NN population)) (PP (IN of) (NP (NP (JJ disease-free) (NNS controls)) (SBAR (WHNP (WP who)) (S (VP (VBD underwent) (NP (NN breast) (NN reduction) (CD mammoplasty)))))))))))))))))) (. .))))
( (S (S (NP (DT The) (NN dark) (NN horizontal) (NN line)) (VP (VBZ indicates) (NP (NP (DT the) (NN average)) (PP (IN for) (NP (NP (DT the) (JJ normal) (NN population)) (PP (IN of) (NP (NP (NN breast) (NN reduction) (NN epithelium)) (PRN (-LRB- -LRB-) (NP (NN BRE)) (-RRB- -RRB-))))))))) (, ,) (IN while) (S (NP (DT the) (JJ dotted) (NNS lines)) (VP (VBP indicate) (NP (NP (JJ upper) (NNS limits)) (PP (IN for) (NP (NP (JJ residual) (NN NER) (NN activity)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NP (DT the) (JJ hereditary) (NN NER) (NN deficiency)) (NN disease) (NN XP) (-LRB- -LRB-) (CD 0.50) (-RRB- -RRB-)) (CC and) (NP (NP (DT the) (JJ cut-off)) (VP (VBN established) (PP (IN in) (NP (PRP$ our) (NN breast) (NN tissue) (NN study))))))))))) (SBAR (WHNP (WDT that)) (S (VP (VBD identified) (NP (NNS tumors)) (PP (IN with) (NP (NP (JJ high) (NN sensitivity)) (CC and) (NP (NN specificity) (-LRB- -LRB-) (CD 0.70) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN patient) (NN sample)) (PP (IN on) (NP (DT the) (JJ left)))) (VP (VBD was) (VP (VBN derived) (PP (IN from) (NP (DT the) (JJ ipsilateral) (-LRB- -LRB-) (JJ left) (-RRB- -RRB-) (NN breast)))) (, ,) (SBAR (IN while) (S (NP (NP (DT the) (NN sample)) (PP (IN on) (NP (DT the) (JJ right)))) (VP (VBD was) (PP (IN from) (NP (DT the) (JJ contralateral) (-LRB- -LRB-) (JJ right) (-RRB- -RRB-) (NN breast)))))))) (. .)))
( (S (NP (NP (NN Sex) (NN hormone) (NN modulation)) (PP (IN of) (NP (NN cell) (NP (NP (NN growth)) (CC and) (NP (NN apoptosis))))) (PP (IN of) (NP (DT the) (JJ human) (NN monocytic/macrophage) (NN cell) (NN line))))))
( (S (NP (NN Abstract))))
( (S (S (NP (NN Sex) (NNS hormones)) (VP (VBP seem) (S (VP (TO to) (VP (VB modulate) (NP (DT the) (JJ immune/inflammatory) (NNS responses)) (PP (IN by) (NP (NP (JJ different) (NNS mechanisms)) (PP (IN in) (NP (ADJP (ADJP (JJ female)) (CC and) (ADJP (JJ male))) (NP (JJ rheumatoid) (NN arthritis)) (NNS patients)))))))))) (. .)))
( (S (S (NP (NP (DT The) (NNS effects)) (PP (PP (IN of) (NP (NN 17β-oestradiol))) (CC and) (PP (IN of) (NP (NN testosterone))))) (VP (VBD were) (VP (VBN tested) (PP (IN on) (NP (NP (NP (DT the) (VBN cultured) (JJ human) (NN monocytic/macrophage) (NN cell) (NN line)) (PRN (-LRB- -LRB-) (NP (NN THP-1)) (-RRB- -RRB-))) (VP (VBN activated) (PP (IN with) (NP (NN IFN-γ)))))) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB investigate) (NP (NP (PRP$ their) (NN role)) (PP (IN in) (NP (NN cell) (NP (NP (NN proliferation)) (CC and) (NP (NN apoptosis))))))))))))) (. .)))
( (S (S (NP (VBN Activated) (JJ human) (NN THP-1) (NNS cells)) (VP (VBD were) (VP (VBN cultured) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (NN 17β-oestradiol)) (CC and) (NP (NN testosterone)))))) (PRN (-LRB- -LRB-) (NP (NP (JJ final) (NN concentration)) (, ,) (NP (CD 10) (NN nM))) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (NP (DT The) (NN evaluation)) (PP (IN of) (NP (NP (NNS markers)) (PP (IN of) (NP (NN cell) (NN proliferation)))))) (VP (VBD included) (NP (NP (DT the) (JJ NF-κB) (JJ DNA-binding) (NN assay)) (, ,) (NP (DT the) (JJ NF-κB) (NN inhibition) (NN complex)) (, ,) (NP (NP (DT the) (VBG proliferating) (NN cell) (JJ nuclear) (NN antigen)) (NN expression)) (CC and) (NP (DT the) (JJ methyl-tetrazolium) (NN salt) (NN test))))) (. .)))
( (S (S (NP (NN Apoptosis)) (VP (VBD was) (VP (VBN detected) (PP (PP (IN by) (NP (DT the) (NN annexin) (NN V-propidium) (NN assay))) (CC and) (PP (IN by) (NP (NP (DT the) (VBN cleaved) (NN poly-ADP) (NN ribose) (NN polymerase)) (NN expression))))))) (. .)))
( (S (S (NP (JJ Specific) (NNS methods)) (VP (VBD included) (NP (NP (NN flow) (NN analysis) (NN cytometry) (NN scatter) (NN analysis)) (, ,) (NP (NN immunocytochemistry)) (CC and) (NP (NN western) (NN blot) (NN analysis))))) (. .)))
( (S (S (NP (NP (NN Cell) (NN growth) (NN inhibition)) (CC and) (NP (VBN increased) (NN apoptosis))) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (JJ testosterone-treated) (NN THP-1) (NNS cells)))))) (. .)))
( (S (S (NP (NP (NP (VBN Increased) (NN poly-ADP) (NN ribose) (JJ polymerase-cleaved) (NN expression)) (CC and) (NP (VBN decreased) (NP (JJ proliferating) (NN cell) (JJ nuclear) (NN antigen)) (NN expression))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NP (NP (DT an) (NN increase)) (PP (IN of) (NP (NN IκB-α)))) (CC and) (NP (NP (DT a) (NN decrease)) (PP (IN of) (NP (DT the) (JJ IκB-α) (JJ phosphorylated) (NN form))))) (PRN (-LRB- -LRB-) (NP (NN ser) (CD 32)) (-RRB- -RRB-))) (, ,)) (VP (VBD were) (VP (VBN found) (PP (IN in) (NP (JJ testosterone-treated) (NN THP-1) (NNS cells)))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (DT the) (JJ NF-κB) (NN DNA) (NN binding)) (VP (VBD was) (VP (VBN found) (VP (VBN increased) (PP (IN in) (NP (JJ 17β-oestradiol-treated) (NN THP-1) (NNS cells))))))) (. .)))
( (S (S (NP (NP (DT The) (NN treatment)) (PP (IN with) (NP (NP (NN staurosporine)) (PRN (-LRB- -LRB-) (NP (NP (NN enhancer)) (PP (IN of) (NP (NN apoptosis)))) (-RRB- -RRB-))))) (VP (VBD induced) (NP (VBN decreased) (NN NF-κB) (NN DNA) (NN binding)) (PP (PP (IN in) (NP (DT all) (NNS conditions))) (, ,) (CC but) (ADVP (RB particularly)) (PP (IN in) (NP (JJ testosterone-treated) (NN THP-1) (NNS cells)))))) (. .)))
( (S (S (NP (NP (NN Treatment)) (PP (IN of) (NP (NN THP-1))) (PP (IN by) (NP (NN sex) (NNS hormones)))) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB influence) (NP (NN cell) (NP (NP (NN proliferation)) (CC and) (NP (NN apoptosis)))))))))) (. .)))
( (S (S (S (NP (NNS Androgens)) (VP (VBD were) (VP (VBN found) (S (VP (TO to) (VP (VB increase) (NP (DT the) (NN apoptosis)))))))) (, ,) (CC and) (S (NP (NNS oestrogens)) (VP (VBD showed) (NP (NP (DT a) (JJ protective) (NN trend)) (PP (IN on) (NP (NP (NN cell) (NN death)) (VP (VP (VBN –)) (CC both) (VP (VBG acting) (PP (IN as) (NP (NP (NNS modulators)) (PP (IN of) (NP (DT the) (JJ NF-κB) (NN complex))))))))))))) (. .)))
( (S (NP (NN Introduction))))
( (S (S (NP (ADJP (ADJP (JJ Experimental)) (CC and) (ADJP (JJ clinical))) (NN evidence)) (VP (VP (VBZ indicates) (SBAR (IN that) (S (NP (JJ immune) (NN reactivity)) (VP (VBZ is) (ADJP (ADJP (JJR greater)) (PP (IN in) (NP (NNS females))) (PP (IN than) (PP (IN in) (NP (NNS males))))))))) (CC and) (VP (VBZ suggests) (SBAR (IN that) (S (NP (JJ gonadal) (NNS steroids)) (VP (MD may) (VP (VB play) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (DT the) (JJ immune) (NN response) (CD -LSB-1-4) (-RRB- -RSB-)))))))))))) (. .)))
( (S (S (ADVP (RB Indeed)) (, ,) (NP (NP (JJ many) (NNS cells)) (PP (IN of) (NP (DT the) (JJ immune) (NN system)))) (VP (VBP have) (VP (VBN been) (VP (VBN found) (S (VP (TO to) (VP (VB possess) (NP (NP (JJ functional) (NN sex) (NN hormone) (NNS receptors)) (, ,) (PP (JJ such) (IN as) (NP (NP (JJ CD8-positive) (NN T) (NNS cells)) (, ,) (NP (NN B) (NNS cells)) (CC and) (, ,) (ADVP (RB notably)) (, ,) (NP (NNS monocytes/macrophages) (CD -LSB-5,6) (-RRB- -RSB-)))))))))))) (. .)))
( (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (NN 17β-oestradiol)) (PRN (-LRB- -LRB-) (NP (NN E2)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN found) (S (VP (VP (TO to) (VP (VB inhibit) (NP (JJ cellular) (NN apoptosis)))) (, ,) (VP (TO to) (VP (VB increase) (NP (NP (NN antibody) (NN production)) (PP (IN by) (NP (NN B) (NNS cells)))))) (CC and) (VP (TO to) (VP (VB exert) (NP (JJ dose-related) (NNS effects)) (PP (IN on) (NP (NN T-cell) (NNS functions) (CD -LSB-7) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (NP (NNS Androgens)) (VP (VBP seem) (S (VP (TO to) (VP (VB exert) (NP (NP (NNS effects)) (ADJP (JJ opposite) (PP (TO to) (NP (NP (DT those)) (PP (IN of) (NP (NN E2))))))) (PP (IN on) (NP (JJ immune) (NN response) (CD -LSB-8))))) (-RRB- -RSB-)))) (. .)))
( (S (S (NP (JJ Clinical) (NN epidemiology)) (ADVP (RB clearly)) (VP (VBZ confirms) (NP (NP (DT a) (JJR higher) (NN prevalence)) (PP (IN of) (NP (JJ autoimmune) (NNS diseases))) (PP (IN in) (NP (JJ female) (NNS subjects)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (IN with) (NP (JJ male) (NNS subjects) (CD -LSB-9) (-RRB- -RSB-)))))))) (. .)))
( (S (S (NP (NP (DT The) (NNS studies)) (VP (VBG concerning) (NP (NP (NP (DT the) (JJ functional) (NN interaction)) (PP (IN between) (NP (DT the) (JJ NF-κB) (NN pathway)))) (CC and) (NP (NP (NNS members)) (PP (IN of) (NP (DT the) (NN steroid) (NN hormone) (NN receptor) (NN family)))) (, ,) (CC and) (NP (NP (PRP$ their) (NN role)) (PP (IN in) (NP (JJ synovial) (NN inflammation)))))) (, ,)) (VP (VBP have) (VP (JJ advanced) (ADVP (RB significantly)) (, ,) (SBAR (IN although) (FRAG (PP (IN with) (NP (JJ controversial) (NNS results) (NN -LSB-10,11))) (-RRB- -RSB-)))))) (. .)))
( (S (PP (IN In) (NP (JJ particular))) (, ,) (PP (IN after) (S (VP (VBG binding) (PP (IN with) (NP (NN E2)))))) (, ,) (NP (NN oestrogen) (NNS receptors)) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (JJ NF-κB) (NNS factors))) (, ,) (PP (IN via) (NP (JJ transcriptional) (NNS co-factors)))))))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (ADJP (ADJP (JJ mutual)) (CC or) (ADJP (JJ non-mutual))) (NN antagonism)))))) (. .)))
( (S (NP (JJ Other) (NNS studies)) (VP (VBP hypothesize) (SBAR (IN that) (S (, ,) (SBAR (IN since) (S (NP (NN oestrogen) (NNS receptors)) (VP (MD may) (VP (VB repress) (NP (ADJP (CC both) (ADJP (JJ constitutive)) (CC and) (ADJP (JJ inducible))) (NN NF-κB) (NN activity)))))) (, ,) (NP (NP (DT the) (NN overexpression)) (PP (IN of) (NP (JJ NF-κB-inducible) (NNS genes))) (PP (IN in) (NP (NN oestrogen) (JJ receptor-negative) (NNS cells)))) (VP (MD might) (VP (VB contribute) (PP (TO to) (NP (NP (JJ malignant) (NN cell) (NN growth)) (CC and) (NP (JJ chemotherapeutic) (NN resistance) (NN -LSB-12,13)))))) (-RRB- -RSB-)))) (. .)))
( (S (S (PP (IN On) (NP (DT the) (NN contrary))) (, ,) (NP (JJ further) (NNS studies)) (VP (VBP report) (SBAR (IN that) (S (NP (NN E2)) (VP (VBZ blocks) (NP (NP (DT the) (JJ transcriptional) (NN activity)) (PP (IN of) (NP (NN p65))) (PP (IN in) (NP (NNS macrophages) (CD -LSB-14)))))))) (-RRB- -RSB-)) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (DT these) (JJ opposite) (NNS observations)) (VP (VBP arise) (S (VP (VBG using) (NP (NP (NP (JJ different) (NN cell) (NNS lines)) (PRN (-LRB- -LRB-) (NP (NNS human/animals)) (-RRB- -RRB-))) (CC and) (NP (NP (NN culture) (NNS conditions)) (CONJP (RB as) (RB well) (IN as)) (NP (JJ different) (NN hormone) (NNS concentrations)) (NP (CD -LSB-15) (-RRB- -RSB-)))))))) (. .)))
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (JJ multiple) (NNS mechanisms)) (VP (VBG concerning) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NN oestrogen) (NNS receptors)) (CC and) (NP (NNS NF-κB))))))) (VP (VBP have) (VP (VBN been) (VP (VBN proposed) (, ,) (PP (JJ such) (IN as) (NP (NP (NN repression)) (PP (IN of) (NP (NP (NP (JJ NF-κB) (NN DNA) (NN binding)) (PP (IN by) (NP (NP (JJ physical) (NN association)) (PP (IN with) (NP (NN oestrogen) (NNS receptors)))))) (CC and) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NN IκB-α) (NN expression)))))) (PP (IN by) (NP (NNS oestrogens) (CD -LSB-16,17) (-RRB- -RSB-)))))))) (. .)))
( (S (S (NP (DT The) (NN androgen) (NN receptor)) (VP (VBZ seems) (S (VP (TO to) (VP (VB be) (ADJP (RB closely) (JJ related) (PP (TO to) (NP (NP (DT the) (NN glucocorticoid) (NN receptor)) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (CC both) (NP (NN structure)) (CC and) (NP (NN sequence) (NN homology)))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN androgen) (NN receptor)) (CC and) (NP (DT the) (NN glucocorticoid) (NN receptor))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VP (VB interact)) (CC and) (VP (VB repress) (NP (NN activator) (NN protein) (CD 1)) (PP (IN via) (NP (DT a) (JJ similar) (NN mechanism))))))))))) (: ;) (S (ADVP (RB consequently)) (, ,) (NP (PRP it)) (VP (MD would) (RB not) (VP (VB be) (ADJP (JJ surprising)) (SBAR (IN that) (S (NP (DT the) (NN androgen) (NN receptor)) (VP (MD might) (ADVP (RB also)) (VP (VB interact) (PP (IN with) (NP (NN NF-κB))) (PP (IN in) (NP (NP (DT a) (NN manner)) (ADJP (RB very) (JJ similar) (PP (TO to) (NP (NP (DT that)) (VP (VBN observed) (PP (IN for) (NP (DT the) (NN glucocorticoid) (NN receptor) (NN -LSB-18))))))) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (NP (CC Both) (NP (DT the) (NN androgen) (NN receptor)) (CC and) (NP (NN NF-κB))) (VP (VBP are) (NP (NP (NP (JJ inducible) (NN transcription) (NNS factors)) (PP (IN with) (NP (NP (DT some) (JJ opposing) (NNS functions)) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (ADJP (ADJP (JJ immune)) (CC and) (ADJP (JJ inflammatory))) (NNS responses)))))))) (NP (CD -LSB-19) (-RRB- -RSB-))))) (. .)))
( (S (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ possible)) (SBAR (IN that) (S (NP (NP (JJ inflammatory) (NNS agents)) (SBAR (WHNP (WDT that)) (S (VP (VBP activate) (NP (NN NF-κB)) (ADVP (FW in) (FW vivo)))))) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (JJ normal) (NN androgen) (NN signalling))))))))) (, ,) (CC and) (S (NP (JJ recent) (NNS studies)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (DT the) (NN androgen) (NN receptor)) (CC and) (NP (NP (NN NF-κB)) (PRN (-LRB- -LRB-) (NP (NN subunit) (NN p65)) (-RRB- -RRB-)))) (VP (VBP are) (NP (NP (JJ mutual) (JJ transcriptional) (NNS antagonists)) (CD -LSB-20) (-RRB- -RSB-)))))))) (. .)))
( (S (S (NP (DT The) (JJ present) (NN study)) (VP (VBD was) (ADVP (RB therefore)) (VP (VBN undertaken) (S (VP (TO to) (VP (VB examine) (NP (NP (DT the) (ADJP (ADJP (JJ long-term)) (PRN (-LRB- -LRB-) (NP (NP (NN time) (NN course)) (PP (IN of) (NP (CD 7) (NNS days)))) (-RRB- -RRB-))) (NNS effects)) (PP (IN of) (NP (NN sex) (NNS hormones))) (PP (IN on) (NP (VBN activated) (VBN cultured) (JJ human) (JJ monocytic/macrophage) (NN cell) (NN line) (-LRB- -LRB-) (NN THP-1) (-RRB- -RRB-) (NNS cells)))) (PP (IN by) (S (VP (VBG investigating) (NP (NP (PRP$ their) (NNS effects)) (PP (IN on) (NP (NN cell) (NP (NP (NN proliferation)) (CC and) (NP (NN apoptosis))))))))))))))) (. .)))
( (S (S (NP (DT These) (NNS cells)) (VP (VP (VBP are) (VP (VBN equipped) (PP (IN with) (NP (JJ functional) (NN sex) (NN hormone) (NNS receptors))))) (CC and) (VP (VBP are) (NP (NP (DT an) (JJ important) (NN target)) (PP (IN of) (NP (NN sex) (NN steroid) (NNS hormones)))) (, ,) (ADVP (RB particularly)) (PP (IN in) (NP (NP (JJ inflammatory) (NNS diseases)) (PP (JJ such) (IN as) (NP (NP (JJ rheumatoid) (NN arthritis)) (PRN (-LRB- -LRB-) (NP (NN RA) (-RRB- -RRB-) (CD -LSB-21)) (-RRB- -RSB-))))))))) (. .)))
( (S (PP (IN In) (NP (JJ particular))) (, ,) (PP (IN in) (NP (DT the) (JJ present) (NN study))) (NP (PRP we)) (VP (VBD used) (NP (NP (NP (NP (JJ pharmacological) (NNS concentrations)) (PP (IN of) (NP (NN E2)))) (PRN (-LRB- -LRB-) (NP (JJ final) (NN concentration)) (, ,) (NP (NP (CD 10) (NN nM)) (: ;) (NP (NNP Sigma-Aldrich) (, ,) (NNP Milan) (, ,) (NNP Italy))) (-RRB- -RRB-))) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (VP (VBN been) (ADVP (RB already)) (VP (VBN described) (PP (IN as) (NP (NP (DT the) (RBS most) (JJ efficient)) (PP (IN in) (NP (NP (JJ stimulating) (NNS macrophages)) (PP (IN in) (NP (FW vitro) (NN -LSB-22) (-RRB- -RSB-)))))))))))))) (. .)))
( (S (S (ADVP (RB Accordingly)) (, ,) (NP (DT the) (JJ same) (NN concentration)) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (PP (IN for) (NP (NN testosterone) (NN -LSB-23)))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB therefore)) (VP (VBD investigated) (NP (NP (NN sex) (NN hormone) (NNS effects)) (PP (IN on) (NP (DT the) (JJ NF-κB) (NN pathway)))) (, ,) (PP (IN as) (NP (NP (DT a) (NN complex)) (PP (IN of) (NP (NP (NNS molecules)) (VP (VBG modulating) (NP (JJ cellular) (NNS responses)) (PP (IN in) (NP (VBN activated) (NNS cells)))))))))) (. .)))
( (S (NP (NP (NNS Materials)) (CC and) (NP (NNS methods)))))
( (S (S (NP (NP (NN THP-1) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN Interlab) (NN cell) (NN line)) (NP (NN collection) (CD HTL097014))) (: ;) (NP (JJ IST) (NN c/o) (NN CBA)) (, ,) (NP (NNP Genoa) (, ,) (NNP Italy))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN cultured) (PP (IN in) (NP (NP (NN RPMI-1640) (NN medium)) (VP (VBN supplemented) (PP (IN with) (NP (NP (NP (ADJP (CD 2) (NN %)) (JJ foetal) (JJ bovine) (NN serum)) (PRN (-LRB- -LRB-) (NP (NN Sigma-Aldrich)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD 5) (NN %)) (NN CO2) (JJ humidified) (NN atmosphere)) (PP (IN at) (NP (NN 37°C)))) (-RRB- -RRB-)))))))))) (. .)))
( (S (ADVP (RB Moreover)) (, ,) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (NN binding)) (PP (IN of) (NP (DT the) (NNS hormones))) (PP (IN with) (NP (NP (JJ other) (JJ foetal) (NN bovine) (NN serum) (NNS components)) (ADJP (JJ related) (PP (TO to) (NP (NP (NN growth) (NN rate)) (CC and) (NP (NP (DT the) (NN survival)) (PP (IN of) (NP (VBN cultured) (NN THP-1) (NNS cells))) (PP (IN over) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (CD 7) (NNS days)))))))))))))) (VP (VBD were) (VP (VBN investigated))) (. .)))
( (S (S (NP (DT The) (NNS cells)) (VP (VBD were) (VP (VBN maintained) (PP (IN in) (NP (JJ logarithmic) (NN growth))) (PP (IN by) (NP (NN passage) (NP (DT every) (CD 3–4) (NNS days))))))) (. .)))
( (S (S (NP (NP (DT The) (NN viability)) (PP (IN of) (NP (NP (DT the) (NNS cells)) (PRN (-LRB- -LRB-) (NP (CD 97–98) (NN %)) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN tested) (PP (IN by) (NP (DT the) (NP (NN Trypan) (JJ blue) (NN exclusion)) (NN procedure)))))) (. .)))
( (S (S (ADVP (RB Briefly)) (, ,) (NP (DT the) (NNS cells)) (VP (VP (VBD were) (VP (VBN seeded) (PP (IN into) (NP (NP (JJ six-well) (JJ flat-bottom) (NNS plates)) (PRN (-LRB- -LRB-) (NP (CD 106) (NNS cells/well)) (-RRB- -RRB-)))))) (CC and) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (ADJP (CD 500) (NN U/ml)) (NN IFN-γ)) (PRN (-LRB- -LRB-) (NP (NN Sigma-Aldrich)) (-RRB- -RRB-)))) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB differentiate) (NP (NN THP-1)) (PP (IN into) (NP (NN macrophage) (NNS cells) (CD -LSB-24) (-RRB- -RSB-))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NP (NN activation)) (CC and) (NP (NN transformation))) (PP (IN of) (NP (DT the) (NNS cells)))) (VP (VBD was) (VP (VBN evaluated) (PP (IN by) (NP (NP (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (JJ different) (NN macrophage) (NNS antigens)))) (: :) (NP (NN CD68)) (, ,) (NP (NN CD14)) (, ,) (NP (NN HAM) (CD 56))) (, ,) (NP (NN Mac) (CD 387))))))) (. .)))
( (S (S (NP (DT The) (NN THP-1) (JJ activated) (NNS cells)) (VP (VBD were) (ADVP (RB then)) (VP (VBN incubated) (PP (IN for) (NP (QP (CD 24) (, ,) (CD 48) (, ,) (CD 72) (, ,) (CD 96) (CC and) (CD 168)) (NNS hours))) (PP (IN with) (NP (NP (NP (NN E2)) (CC and) (NP (NN testosterone))) (PRN (-LRB- -LRB-) (NP (CD 10) (NN nM)) (-RRB- -RRB-))))))) (. .)))
( (S (S (PP (IN After) (NP (DT that) (NN time))) (NP (NP (NNS samples)) (PP (IN of) (NP (NN THP-1) (NNS cells)))) (VP (VBD were) (ADVP (RB also)) (VP (VBN treated) (PP (IN with) (NP (NP (DT an) (NN apoptosis) (NN inducer) (CD -LSB-25) (-RRB- -RSB-)) (, ,) (NP (NP (NN staurosporine)) (PRN (-LRB- -LRB-) (NP (NP (CD 17) (NN nM)) (: ;) (NP (NN Sigma) (NN Aldrich))) (-RRB- -RRB-))) (, ,))) (PP (IN for) (NP (CD 24) (NNS hours)))))) (. .)))
( (S (S (PP (IN At) (NP (NP (DT the) (NN end)) (PP (IN of) (NP (DT the) (JJ different) (NN incubation) (NNS times))))) (, ,) (NP (DT the) (NNS cells)) (VP (VBD were) (VP (VP (VBN harvested)) (, ,) (VP (VBN washed) (PP (IN in) (NP (NP (NP (NN Dulbecco) (POS 's)) (JJ phosphate-buffered) (NN saline)) (PRN (-LRB- -LRB-) (NP (NN DPBS)) (-RRB- -RRB-))))) (CC and) (VP (VBN treated) (PP (IN with) (NP (NP (JJ different) (NN lysis) (NNS buffers)) (PP (IN for) (NP (DT the) (ADJP (ADJP (JJ nuclear)) (CC and) (ADJP (JJ total))) (NN protein) (NN extraction))))))))) (. .)))
( (S (S (NP (NP (NN Part)) (PP (IN of) (NP (DT the) (NN cell)))) (VP (VBD was) (ADVP (RB then)) (VP (VBN collected) (PP (PP (IN for) (NP (NP (NP (NP (NN DNA) (NN content)) (PRN (-LRB- -LRB-) (ADJP (ADJP (JJ normal)) (CC and) (ADJP (JJ apoptotic))) (-RRB- -RRB-))) (NN evaluation)) (PP (IN by) (NP (NN flow) (NN analysis) (NN cytometry) (NN scatter) (NN analysis))))) (CC and) (PP (IN for) (NP (NN immunocytochemistry) (NN analysis))))))) (. .)))
( (S (NP (NP (DT The) (NN immunocytochemistry) (NN analysis)) (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NN CD68)) (, ,) (NP (NN CD14)) (, ,) (NP (NN HAM56)) (CC and) (NP (NN Mac387)))) (PP (IN in) (NP (DT the) (JJ treated) (NNS cells))))))) (VP (VBD showed) (NP (NP (JJ positive) (NNS results)) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-))) (, ,) (S (VP (VBG confirming) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NNS monocytes))) (PP (IN by) (NP (NN IFN-γ))))))) (. .)))
( (S (S (NP (DT The) (NN cell) (NN growth)) (VP (VBD was) (VP (VBN evaluated) (PP (IN at) (NP (JJ different) (NNS times))) (PP (IN by) (NP (NP (DT the) (JJ methyl-tetrazolium) (NN salt) (NN test)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ represents) (NP (NP (DT a) (JJ quantitative) (JJ colorimetric) (NN assay)) (S (VP (TO to) (VP (VB detect) (NP (NN cell) (NP (NN survival)) (CC and) (NP (NN proliferation))))))))))))))) (. .)))
( (S (S (NP (DT The) (NN test)) (VP (VBZ is) (VP (VBN based) (PP (IN on) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (VBG living) (NNS cells))) (S (VP (TO to) (VP (VB cleave) (NP (DT the) (NN tetrazolium) (NN ring)) (PP (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (JJ active) (NN mitochondria))))))))))))) (. .)))
( (S (S (ADVP (RB Briefly)) (, ,) (NP (DT the) (NNS cells)) (VP (VP (VBD were) (VP (VBN seeded) (PP (IN into) (NP (JJ 96-well) (NN microtitre) (NNS plates))))) (CC and) (VP (VBD were) (VP (VBN treated) (PP (VBG according) (PP (TO to) (NP (DT the) (JJ experimental) (NN design)))))))) (. .)))
( (S (S (PP (IN At) (NP (DT the) (JJ established) (NN time))) (, ,) (NP (NP (NP (ADJP (CD 50) (NN μl)) (NN methyl-tetrazolium) (NN salt) (NN labelling)) (NN reagent) (NN -LSB-3-) (-LRB- -LRB-) (NN 4,5-dimethylthiazol-2-yl) (-RRB- -RRB-) (NN -2,5-diphenyltetrazolium) (NN bromide)) (PRN (, ,) (NP (NP (CD 5) (NN mg/ml)) (PP (IN in) (NP (NNS PBS)))) (-RRB- -RSB-))) (VP (VBD was) (VP (VP (VBN added) (PP (TO to) (NP (DT each) (NN well)))) (CC and) (VP (VBN incubated) (PP (IN in) (NP (JJ humidified) (NN atmosphere))) (PP (IN at) (NP (NN 37°C))))))) (. .)))
( (S (S (ADVP (NP (CD Four) (NNS hours)) (RB later)) (, ,) (NP (CD 100) (NN μl) (NN dimethylsulfoxide)) (VP (VBD were) (VP (VP (VBN introduced) (PP (IN into) (NP (DT each) (NN well)))) (CC and) (VP (VBN mixed) (ADVP (RB thoroughly)))))) (. .)))
( (S (S (NP (DT The) (NN absorbance)) (VP (VBD was) (VP (VBN calculated) (PP (IN at) (NP (CD 540) (NN nm))) (, ,) (S (VP (VBG using) (NP (DT a) (NN scanning) (NN multiwell) (NN spectrophotometer))))))) (. .)))
( (S (S (NP (JJ Standard) (NNS curves)) (VP (VBD were) (VP (VBN constructed) (PP (IN for) (NP (NP (NN THP-1) (NNS cells)) (VP (VBG using) (NP (JJ known) (NN plating) (NNS densities))))) (, ,) (S (VP (VBG allowing) (S (NP (DT the) (NN cell) (NN number)) (VP (TO to) (VP (VB be) (VP (VBN calculated) (PP (IN from) (NP (DT this) (JJ optical) (NN density) (NN reading)))))))))))) (. .)))
( (S (S (NP (DT Each) (NN experiment)) (VP (VBD was) (VP (VBN performed) (PP (IN in) (NP (NN triplicate)))))) (. .)))
( (S (S (NP (DT The) (JJ apoptotic) (NNS events)) (VP (VBD were) (VP (VBN evaluated) (PP (IN after) (NP (NP (CD 168) (NNS hours)) (PP (IN from) (NP (CC both) (NP (NN sex) (NN hormone) (NN stimulation)) (CC and) (NP (NP (NN staurosporine) (NN treatment)) (PRN (-LRB- -LRB-) (NP (NP (CD 17) (NN nM)) (PP (IN for) (NP (CD 24) (NNS hours)))) (-RRB- -RRB-))))))) (PP (IN by) (NP (NP (NN annexin) (NN V-propidium) (NN iodide) (NN analysis)) (PRN (-LRB- -LRB-) (NP (NP (NN MBL) (NN Co.)) (, ,) (NP (NNP Ltd) (, ,) (NNP Nagoya) (, ,) (NNP Japan))) (-RRB- -RRB-)))) (, ,) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB detect) (NP (NP (NP (DT the) (JJ early-stage) (NN apoptosis)) (PRN (-LRB- -LRB-) (NP (NP (NNS cells)) (ADJP (RB only) (JJ annexin-positive))) (-RRB- -RRB-))) (CC and) (NP (NP (DT the) (JJ late-stage) (NN apoptosis)) (PRN (-LRB- -LRB-) (NP (NP (NNS cells)) (ADJP (ADJP (JJ annexin-positive)) (CC and) (ADJP (JJ propidium-positive)))) (-RRB- -RRB-))))))))))) (. .)))
( (S (PP (IN After) (S (VP (VBG resuspending) (NP (NP (DT the) (NNS cells)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN ×) (CD 105)) (-RRB- -RRB-))) (PP (IN into) (NP (NP (CD 200) (NN μl)) (PP (IN of) (NP (CD 1) (NN x) (NN binding) (NN buffer)))))))) (, ,) (NP (NP (CD 1) (JJ μl) (JJ fluorescein-labelled) (NN annexin) (NN V)) (CC and) (NP (ADJP (CD 1) (NN μl)) (NN propidium) (NN iodide))) (VP (VBD were) (VP (VBN added))) (. .)))
( (S (S (ADVP (RB Then)) (NP (DT the) (NNS cells)) (VP (VBD were) (VP (VBN incubated) (PP (IN for) (NP (CD 5) (NN min))) (PP (IN at) (NP (NP (JJ room) (NN temperature)) (PRN (-LRB- -LRB-) (NP (NN dark) (NN light)) (-RRB- -RRB-))))))) (. .)))
( (S (S (ADVP (RB Finally)) (, ,) (NP (DT the) (NNS cells)) (VP (VBD were) (VP (VP (VBN plated) (PP (IN on) (NP (JJ glass) (NNS slides)))) (CC and) (VP (VBN analysed) (PP (IN by) (NP (NP (NN fluorescence) (NN microscopy)) (PRN (-LRB- -LRB-) (NP (CD 550) (NN nm)) (-RRB- -RRB-)))) (PP (IN for) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (NP (CD 500) (NNS cells)) (PP (IN per) (NP (NP (NN sample)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ allows) (NP (NP (NN detection)) (PP (ADVP (RB even)) (IN of) (NP (DT a) (JJ single) (JJ apoptotic) (NN cell))))))))))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB confirm) (NP (NP (DT the) (VBN reduced) (NN DNA) (NN content)) (PRN (-LRB- -LRB-) (NP (JJ oligonucleosomal-size) (NNS fragments)) (-RRB- -RRB-)))))) (NP (NP (DT the) (NNS cells)) (VP (VBN stimulated) (PP (PP (IN with) (NP (NNS hormones))) (, ,) (PP (IN without) (CC and) (PP (IN with) (NP (NN staurosporine)))) (, ,) (PP (IN after) (NP (NN fixation)))))) (VP (VP (VBD were) (VP (VBN stained) (PP (IN with) (NP (NP (NN intercalating) (NNS dyes)) (PRN (-LRB- -LRB-) (NP (NN propidium) (NN iodide)) (-RRB- -RRB-)))))) (CC and) (VP (VBD were) (VP (VBN analysed) (PP (IN by) (NP (NP (NN flow) (NN analysis) (NN cytometry)) (ADJP (JJ scatter) (PRN (-LRB- -LRB-) (NP (NP (JJ Becton-Dickinson-Immunocytometry) (NNS Systems)) (, ,) (NP (NNP Erembodegem) (, ,) (NNP Belgium))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (NN THP-1) (NNS cells)) (VP (VBD were) (VP (VBN harvested) (PP (IN at) (NP (NP (DT a) (NN concentration)) (PP (IN of) (NP (CD 5) (NN ×) (CD 103))))) (, ,) (S (VP (VBG being) (VP (VBD sedimented) (PP (IN on) (NP (NP (JJ poly-L-lysine-coated) (NN glass) (NNS slides)) (PP (IN for) (NP (NP (CD 40) (NN min)) (PP (IN at) (NP (NN 4°C))))))))))))) (. .)))
( (S (S (NP (DT The) (NNS spots)) (VP (VBD were) (ADVP (RB then)) (ADJP (ADJP (JJ air-dried)) (CC and) (ADJP (JJ fixed))) (PP (IN in) (NP (NP (JJ cold) (NN acetone)) (PP (IN for) (NP (CD 30) (NN s))))))) (, ,) (CC and) (S (VP (VBN stored) (PP (IN at) (NP (NN -20°C))) (PP (IN until) (NP (NP (DT the) (NN immunodetermination)) (PP (IN of) (NP (NP (NN poly-ADP) (NN ribose) (NN polymerase) (-LRB- -LRB-) (NN PARP) (-RRB- -RRB-) (JJ -cleaved) (NN expression)) (, ,) (NP (VBG proliferating) (NN cell) (JJ nuclear) (NN antigen) (-LRB- -LRB-) (NN PCNA) (-RRB- -RRB-) (NN expression)) (, ,) (NP (NN NF-κB)) (, ,) (NP (NN IκB-α)) (CC and) (NP (NP (NN IκB-α-ser) (CD 32)) (PRN (-LRB- -LRB-) (NP (NP (NNP Santa) (NNP Cruz) (NN Biotechnology)) (, ,) (NP (NNP Santa) (NNP Cruz)) (, ,) (NP (NN CA)) (, ,) (NP (NN USA))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (PP (IN After) (NP (NP (NN rehydration)) (PP (IN in) (NP (NNS PBS))))) (, ,) (NP (NNS spots)) (VP (VBD were) (VP (VBN incubated) (PP (IN with) (NP (DT the) (JJ anti-human) (NN antibody))) (PP (IN at) (NP (NP (JJ different) (NNS dilutions)) (PP (IN at) (NP (JJ room) (NN temperature)))))))) (. .)))
( (S (S (NP (DT The) (ADJP (ADJP (JJ second)) (CC and) (ADJP (JJ third))) (NNS steps)) (VP (VBD were) (VP (VBN performed) (S (VP (VBG using) (NP (NP (DT the) (JJ improved) (JJ biotin-streptavidin-amplified) (NN detection) (NN system)) (PRN (-LRB- -LRB-) (NP (NP (NN Vector) (NNS Laboratories)) (NP (NP (NNP Inc.) (, ,) (NNP Burlingame)) (, ,) (NP (NN CA)) (, ,) (NP (NNP USA)))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (S (ADVP (RB Briefly)) (, ,) (PP (VBG according) (PP (TO to) (NP (DT this) (NN method)))) (, ,) (NP (NNS cells)) (VP (VBD were) (VP (VBN incubated) (PP (IN with) (NP (NP (DT the) (JJ secondary) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NP (VBN biotinylated) (NN IgG)) (, ,) (NP (CD 1:20) (NN dilution))) (-RRB- -RRB-)))) (PP (IN for) (NP (NP (CD 20) (NN min)) (PP (IN at) (NP (JJ room) (NN temperature)))))))) (CC and) (S (ADVP (RB then)) (, ,) (PP (IN after) (NP (NP (JJ several) (NNS washes)) (PP (IN in) (NP (NNS PBS))))) (, ,) (NP (NNS cells)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (DT the) (JJ concentrated) (NN enzyme) (VB label)) (PRN (-LRB- -LRB-) (NP (NN biotin-streptavidin-peroxidase)) (-RRB- -RRB-) (PP (IN for) (NP (NP (CD 20) (NN min)) (CC and) (, ,) (ADVP (RB finally)) (, ,) (VP (VBN incubated) (PP (IN at) (NP (JJ room) (NN temperature))) (PP (IN with) (NP (NP (NP (DT the) (JJ peroxidase-substrate) (NN solution)) (PRN (-LRB- -LRB-) (NP (CD 0.04) (NN %) (NN 3,3-diaminobenzidine) (NN -LSB-Sigma-Aldrich)) (-RRB- -RSB-))) (PP (IN in) (NP (NP (ADJP (CD 50) (NN mM)) (NN Tris-HCl) (NN buffer)) (VP (VBG containing) (NP (ADJP (CD 0.3) (NN %)) (NN hydrogen) (NN peroxide)))))))))) (-RRB- -RRB-)))) (PP (IN for) (NP (CD 15) (NN min))))))) (. .)))
( (S (PP (IN After) (NP (NP (JJ rinsing)) (PP (IN with) (NP (NNS PBS))))) (, ,) (NP (NNS slides)) (VP (VP (VBD were) (ADJP (JJ counterstained) (PP (IN with) (NP (NN haematoxylin))))) (, ,) (VP (VBD were) (VP (VP (VBN dried)) (CC and) (VP (VBP cover) (VP (VBN slipped) (PP (IN with) (NP (NN Eukitt))))))) (, ,) (CC and) (VP (VBD were) (VP (VBN examined) (PP (IN by) (NP (NP (JJ light) (NN microscopy)) (CC and) (NP (VBN computerized) (NN image) (NN analysis))))))) (. .)))
( (S (S (NP (NNS Controls)) (VP (VBD were) (VP (VBN treated) (ADVP (RB identically)) (, ,) (PP (IN except) (PP (IN for) (S (VP (VBG omitting) (NP (DT the) (ADJP (ADJP (JJ primary)) (CC or) (ADJP (JJ secondary))) (NNS antibodies))))))))) (. .)))
( (S (S (NP (JJ Image) (NN analysis)) (VP (VBD was) (VP (VBN performed) (PP (IN with) (NP (DT the) (NN Leica) (NN Q500) (NN MC) (NN Image) (NN Analysis) (NN System))) (PRN (-LRB- -LRB-) (NP (NP (NNP Leica)) (, ,) (NP (NN Cambridge)) (, ,) (NP (NNP UK))) (-RRB- -RRB-))))) (. .)))
( (S (S (S (PP (IN For) (NP (DT each) (NN sample))) (, ,) (NP (CD 100) (NNS cells)) (VP (VBD were) (ADVP (RB randomly)) (VP (VBN analysed)))) (CC and) (S (NP (NP (DT the) (NNS pixels)) (PP (IN per) (NP (NP (NN micron) (NN square)) (PRN (-LRB- -LRB-) (NP (JJ positive) (NN area)) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN quantified) (PP (IN by) (NP (DT the) (NN Leica) (NN Q500) (NN software))))))) (. .)))
( (S (S (NP (DT The) (JJ single) (NNS cells)) (VP (VBD were) (VP (VP (ADVP (RB randomly)) (VBN selected) (PP (IN by) (NP (NP (DT the) (NNS operators)) (VP (VBG using) (NP (DT the) (NN cursor)))))) (CC and) (VP (RB then) (ADVP (RB automatically)) (VBN measured) (PP (IN as) (NP (DT the) (JJ positive) (NN area))))))) (. .)))
( (S (S (NP (NP (DT A) (JJ constant) (NN optical) (NN threshold)) (CC and) (NP (NN filter) (NN combination))) (VP (VBD was) (VP (VBN set) (S (VP (TO to) (VP (VB select) (NP (RB only) (DT the) (JJ positive) (NNS cells)))))))) (. .)))
( (S (S (S (NP (DT The) (NNS results)) (VP (VBD were) (VP (VBN analysed) (PP (IN by) (NP (NP (DT the) (NN analysis)) (PP (IN of) (NP (NP (NN variance) (JJ non-parametric) (NN test)) (PRN (-LRB- -LRB-) (NP (NN Bonferroni) (NN test)) (-RRB- -RRB-))))))))) (, ,) (CC and) (S (NP (DT the) (NNS values)) (VP (VBP are) (VP (VBN presented) (PP (IN as) (NP (NP (NNS means)) (VP (VBG ±) (NP (JJ standard) (NNS deviations))))))))) (. .)))
( (S (S (NP (NNS Cells)) (VP (VBD were) (VP (VBN lysed) (PP (IN in) (NP (NP (NN buffer)) (VP (VBG containing) (NP (NP (ADJP (CD 20) (NN mM)) (NN Tris-HCl)) (, ,) (NP (ADJP (CD 150) (NN mM)) (NN NaCl)) (, ,) (NP (ADJP (CD 1) (NN mM)) (NN phenylmethylsulfonylfluoride)) (, ,) (NP (ADJP (CD 5) (NN mg/ml)) (NN aprotinin)) (, ,) (NP (NP (ADJP (CD 0.5) (NN %)) (NN Nonidet) (NN P-40)) (PRN (-LRB- -LRB-) (NP (NN Sigma-Aldrich)) (-RRB- -RRB-))))))) (PP (IN for) (NP (NP (CD 1) (NN hour)) (PP (IN at) (NP (NN 4°C)))))))) (. .)))
( (S (S (NP (DT The) (NNS lysates)) (VP (VBD were) (VP (VBN centrifuged) (PP (IN for) (NP (CD 10) (NN min))) (PP (IN at) (NP (CD 13,000) (NN rpm)))))) (. .)))
( (S (S (NP (DT The) (NNS surnatants)) (VP (VBD were) (VP (VP (VBN collected)) (CC and) (VP (VBN stored) (PP (IN at) (NP (NN -80°C))))))) (. .)))
( (S (S (NP (NP (DT The) (NNS samples)) (PP (IN of) (NP (NNS surnatants)))) (VP (VP (VBD were) (ADVP (RB thereafter)) (VP (VBN diluted) (PP (IN with) (NP (NN reducing) (NN sample) (NN buffer))))) (CC and) (VP (VBD were) (VP (VBN separated) (PP (IN by) (NP (NN electrophoresis))) (PP (IN on) (NP (NP (DT a) (ADJP (CD 10) (NN %)) (NN SDS-PAGE) (NN gel)) (PRN (-LRB- -LRB-) (NP (NP (CD 20) (NN μg) (NN protein)) (PP (IN per) (NP (NNP lane))) (VP (VBN loaded))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (DT The) (NNS proteins)) (VP (VBD were) (VP (VBN transferred) (PP (IN onto) (NP (NP (NN Hybond-C-nitrocellulose) (NN membrane)) (PRN (-LRB- -LRB-) (NP (NP (NNP Amersham) (NNP Italia)) (, ,) (NP (NNP Milan) (, ,) (NNP Italy))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (DT The) (NN reaction)) (VP (VBD was) (VP (VBN blocked) (PP (IN by) (NP (NP (NNS DPBS)) (PP (IN with) (NP (ADJP (CD 5) (NN %)) (NN non-fat) (JJ powdered) (NN milk))))) (PP (IN at) (NP (JJ 4°C) (JJ overnight)))))) (. .)))
( (S (PP (IN For) (NP (NN immunoblot) (NN analysis))) (, ,) (NP (DT the) (NNS membranes)) (VP (VP (VBD were) (VP (VBN incubated) (PP (IN with) (NP (DT the) (JJ different) (NNS antibodies))) (PP (IN for) (NP (NP (NP (NP (CD 1) (NN hour)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP NF-κB)) (, ,) (NP (NNP IκB-α)) (, ,) (NP (NNP IκB-α-ser) (CD 32)) (, ,) (ADVP (RB respectively))) (: ;) (NP (NP (NNP Santa) (NNP Cruz)) (NP (NN Biotechnology)))) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NN dilution) (NN 1:200)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NNS DPBS)) (PP (IN at) (NP (JJ room) (NN temperature))) (PP (IN with) (NP (JJ constant) (NN shaking))))))))) (, ,) (CC and) (VP (VBD were) (VP (VBN washed) (ADVP (RB extensively)) (PP (IN in) (NP (NP (ADJP (CD 0.05) (NN %)) (NP (NNP DPBS/Tween) (CD 20))) (, ,) (NP (NN pH) (CD 7.4))))))) (. .)))
( (S (ADVP (RB Finally)) (, ,) (NP (DT the) (NNS membranes)) (VP (VBD were) (VP (VBN incubated) (PP (IN with) (NP (NP (NP (JJ secondary) (NN horseradish) (JJ peroxidase-labelled) (JJ polyclonal) (NN anti-goat) (NN IgG) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NP (NN SC-2020)) (: ;) (NP (NNP Santa) (NNP Cruz) (NN Biotechnology))) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NN dilution) (NN 1:5000)) (-RRB- -RRB-)))) (PP (IN in) (NP (NN DPBS))) (PP (IN for) (NP (NP (CD 1) (NN hour)) (PP (IN at) (NP (JJ room) (NN temperature))))))) (. .)))
( (S (S (PP (IN After) (S (VP (VBG washing) (NP (CD three) (NNS times)) (PP (IN in) (NP (NN DPBS)))))) (, ,) (NP (DT the) (NNS bands)) (VP (VBD were) (VP (VBN detected) (S (VP (VBG using) (NP (NP (DT the) (VBN enhanced) (NN chemiluminescence) (NN system)) (PRN (-LRB- -LRB-) (NP (NNP Amersham) (NNP Italia)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (JJ Double-stranded) (NNS oligonucleotides)) (VP (VBG corresponding) (PP (TO to) (NP (DT the) (ADJP (ADJP (JJ wild-type)) (CC and) (ADJP (VBN mutated))) (NP (NP (NN NF-κB) (NN consensus) (NN element)) (PRN (-LRB- -LRB-) (NP (NNP Santa) (NNP Cruz) (NN Biotechnology)) (-RRB- -RRB-))))))) (VP (VBD were) (VP (VBN used) (PP (PP (IN as) (NP (JJ 32P-labelled) (NNS probes))) (CC or) (PP (IN as) (NP (NP (JJ unlabelled) (NNS competitors)) (PRN (-LRB- -LRB-) (NP (CD 100) (NNS times)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (DT The) (NNS assays)) (VP (VBD were) (VP (VBN performed) (PP (IN in) (NP (NP (DT a) (JJ final) (NN volume)) (PP (IN of) (NP (NP (CD 20) (NN μl)) (VP (VBG containing) (NP (NP (NP (ADJP (CD 10) (NN mM)) (NN Tris-HCl)) (PRN (-LRB- -LRB-) (NP (NN pH) (CD 7.5)) (-RRB- -RRB-))) (, ,) (NP (ADJP (CD 50) (NN mM)) (NN NaCl)) (, ,) (NP (ADJP (CD 1) (NN mM)) (NN dithiothreitol)) (, ,) (NP (ADJP (CD 1) (NN mM)) (NN ethylenediamine) (JJ tetraacetic) (NN acid)) (CC and) (NP (ADJP (CD 10) (NN %)) (NN glycerol))))))))))) (. .)))
( (S (S (ADVP (RB Briefly)) (, ,) (NP (NP (CD 7) (NN μg) (NN cell) (JJ nuclear) (NNS extracts)) (, ,) (UCP (ADJP (JJ unstimulated)) (CC or) (VP (VBN stimulated) (PP (IN with) (NP (NP (NN testosterone)) (CC and) (NP (NN E2)))) (PP (IN as) (ADJP (RB previously) (VBN described))))) (, ,)) (VP (VBD were) (VP (VBN pre-incubated) (PP (IN with) (NP (NP (NP (ADJP (CD 4) (NN μg)) (NN poly)) (PRN (-LRB- -LRB-) (NP (NN dI-dC)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NP (NNP Pharmacia)) (, ,) (NP (NNP Milan) (, ,) (NNP Italy))) (-RRB- -RRB-)))) (PP (IN as) (NP (DT a) (JJ non-specific) (NN competitor))) (, ,) (PP (IN for) (NP (NP (CD 10) (NN min)) (PP (IN at) (NP (JJ room) (NN temperature)))))))) (. .)))
( (S (S (NP (NP (JJ End-labelled) (NNS oligonucleotides)) (PRN (-LRB- -LRB-) (NP (NP (CD 10) (NN fmol)) (, ,) (NP (QP (RB about) (CD 30,000)) (NN cpm))) (-RRB- -RRB-))) (VP (VP (VBD were) (ADVP (RB then)) (VP (VBN added) (PP (TO to) (NP (DT each) (NN mixture))) (PP (TO to) (NP (NP (DT a) (JJ final) (NN volume)) (PP (IN of) (NP (CD 20) (NN μl))))))) (CC and) (VP (VBD were) (VP (VBN incubated) (PP (IN for) (NP (DT an) (JJ additional) (CD 20) (NN min))))))) (. .)))
( (S (S (NP (DT The) (JJ bound/retarded) (NNS complexes)) (VP (VP (VBD were) (VP (VBN separated) (PP (IN from) (NP (DT the) (JJ free) (NN probe))) (PP (IN by) (NP (NN electrophoresis))) (PP (IN on) (NP (ADJP (CD 5) (NN %)) (NN polyacrylamide) (NNS gels))))) (CC and) (VP (VBD were) (VP (VBN visualized) (PP (IN by) (NP (NP (NN autoradiography)) (PP (IN of) (NP (DT the) (JJ dried) (NNS gels))))))))) (. .)))
( (S (S (NP (NP (DT A) (NNP lane)) (PP (IN without) (NP (JJ nuclear) (NN extract)))) (VP (VBD was) (ADVP (RB also)) (VP (VBN included) (PP (IN as) (NP (DT the) (JJ negative) (NN control)))))) (. .)))
( (S (S (NP (NN Competition) (NNS experiments)) (VP (VBD were) (VP (VBN performed) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (DT a) (ADJP (RB 100-fold) (JJ molar)) (NN excess)) (PP (IN of) (NP (NP (JJ unlabelled) (NN wall-type)) (CC or) (NP (VBN mutated) (JJ NF-κB) (NN oligonucleotide)))) (, ,) (VP (VBN added) (PP (TO to) (NP (DT the) (NN pre-incubation) (NN step))))))))))) (. .)))
( (S (PP (IN For) (NP (DT the) (JJ super) (NN shift) (NN assay))) (, ,) (NP (NP (CD 2) (NN μl) (JJ anti-p65)) (, ,) (NP (NP (NP (NN c-rel)) (CC and) (NP (NN p50)) (NP (NN NF-κB) (NN subunit) (NNS antibodies))) (PRN (-LRB- -LRB-) (NP (NNP Santa) (NNP Cruz) (NN Biotechnology)) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN included) (PP (IN in) (NP (NP (DT the) (NN pre-incubation) (NN mixture)) (ADJP (JJ prior) (PP (TO to) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (DT the) (NN probe)))))))))) (. .)))
( (S (S (NP (NP (DT A) (NNP lane)) (VP (VBG containing) (NP (NN pre-immune) (NN serum)))) (VP (VBD was) (ADVP (RB always)) (VP (VBN included) (PP (IN as) (NP (DT the) (NN control)))))) (. .)))
( (S (NP (NNS Results))))
( (S (S (SBAR (IN As) (S (ADVP (RB already)) (VP (VBN stated)))) (, ,) (NP (JJ hormonal) (NNS signals)) (VP (VBP regulate) (NP (NP (DT the) (NN amount)) (PP (PP (IN of) (NP (DT the) (JJ cell-cycle) (NN control) (NNS proteins))) (CC and) (PP (IN of) (NP (DT the) (NN transcription) (NNS factors) (NP (CD -LSB-26))))))) (-RRB- -RSB-)) (. .)))
( (S (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (PP (IN after) (NP (CD 168) (NNS hours))) (NP (PRP we)) (VP (VBD observed) (NP (NP (DT a) (JJ significant) (NN growth) (NN inhibition)) (PP (IN of) (NP (NP (DT the) (JJ human) (JJ monocytic) (NN cell) (NN line)) (VP (VP (VBN activated) (PP (IN with) (NP (NN IFN-γ)))) (CC and) (VP (VBN treated) (PP (IN with) (NP (NN testosterone))))))) (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (IN with) (NP (NP (DT the) (JJ other) (NNS conditions)) (VP (VBN studied)))))))))) (. .)))
( (S (S (PP (IN At) (NP (CD 168) (NNS hours))) (NP (DT the) (NN cell) (NN growth)) (VP (VBD was) (VP (VBN reduced) (PP (PP (IN by) (NP (NP (CD 14.8) (NN %)) (CC versus) (NP (JJ untreated) (NNS controls)))) (CC and) (PP (IN by) (NP (NP (CD 12.7) (NN %)) (CC versus) (NP (JJ E2-treated) (NNS cells)))))))) (. .)))
( (S (S (NP (DT These) (NNS data)) (VP (VBD were) (VP (VP (VBN obtained) (PP (IN with) (NP (DT the) (NN methyl-tetrazolium) (NN salt) (NN test)))) (CC and) (VP (VBN confirmed) (PP (IN with) (NP (NP (DT the) (NN trypan) (JJ blue) (NN exclusion) (NN assay)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 1)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (DT The) (JJ bromodeoxyuridine/propidium) (NN iodide) (NN incorporation) (NN test)) (VP (VBD showed) (NP (JJ similar) (NNS results)) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))) (. .)))
( (S (S (NP (JJ Further) (JJ interesting) (NNS data)) (VP (VBD were) (ADJP (JJ related) (PP (TO to) (NP (NP (DT the) (NN modulation)) (PP (IN of) (NP (DT the) (NN PCNA) (NN expression)))))) (, ,) (PP (IN as) (NP (NP (DT a) (NN marker)) (PP (IN for) (NP (VBG proliferating) (NNS cells))))))) (. .)))
( (S (S (S (NP (DT This) (NN marker)) (VP (VBD was) (VP (VBN analysed) (PP (IN by) (NP (NN immunocytochemistry)))))) (CC and) (S (NP (DT the) (NNS data)) (VP (VBD were) (VP (VBN confirmed) (PP (IN by) (NP (NN western) (NN blot) (NN analysis))))))) (. .)))
( (S (PP (IN In) (NP (DT the) (JJ testosterone-treated) (NNS cells))) (, ,) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (DT the) (NN PCNA))) (PP (IN at) (NP (DT the) (NN immunocytochemistry) (NN analysis)))) (VP (VP (VBD was) (VP (VBN found) (PP (VBN decreased) (PP (IN by) (NP (CD 24) (NN %))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (IN with) (NP (JJ untreated) (NNS cells))))))) (, ,) (CC and) (VP (VBD was) (VP (VBN decreased) (PP (IN by) (NP (CD 40) (NN %)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (IN with) (NP (NP (JJ E2-treated) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NNP 2a–d)) (-RRB- -RRB-))))))))) (. .)))
( (S (ADVP (RB Interestingly)) (, ,) (NP (DT the) (JJ testosterone-treated) (NNS cells)) (VP (VBD showed) (NP (NN staining) (NN positivity)) (VP (VBD localized) (PP (IN in) (NP (DT the) (NN cell) (NN cytoplasm))) (, ,) (SBAR (IN whereas) (S (PP (IN in) (NP (DT the) (ADJP (ADJP (JJ untreated)) (CC and) (ADJP (JJ E2-treated))) (NNS cells))) (NP (DT the) (NN PCNA) (NN expression)) (VP (VBD was) (VP (VBN found) (ADVP (RB predominantly)) (PP (IN in) (NP (DT the) (NN nucleus))))))))) (. .)))
( (S (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (NP (NP (NP (DT the) (JJ inhibitory) (NN role)) (PP (IN of) (NP (NN E2))) (PP (IN on) (NP (NN apoptosis)))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT the) (JJ pro-apoptotic) (NNS effects)) (VP (VBN exerted) (PP (IN by) (NP (NN testosterone))) (PP (IN in) (NP (NP (JJ long-term) (NN treatment)) (PP (IN of) (NP (NN THP-1) (NNS cells))))))) (, ,)) (VP (VBD were) (VP (VBN investigated)))) (. .)))
( (S (S (NP (DT The) (NN annexin) (NN V-propidium) (NN iodide) (NN analysis)) (VP (VBD showed) (NP (NP (DT a) (JJ significant) (NN increase)) (PP (IN of) (NP (ADJP (ADJP (JJ early)) (CC and) (ADJP (JJ late))) (NN apoptosis))) (PP (IN in) (NP (JJ testosterone-treated) (NNS cells)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (IN with) (NP (JJ other) (NNS conditions)))))))) (. .)))
( (S (S (PP (IN In) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN staurosporine))))) (, ,) (NP (DT the) (NN apoptosis)) (VP (VBD was) (VP (VBN found) (VP (VBN increased) (PP (IN in) (NP (NP (JJ testosterone-treated) (NNS cells)) (PRN (-LRB- -LRB-) (NP (CD 9.9) (NN %)) (-RRB- -RRB-)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (PP (IN with) (NP (NP (JJ control) (JJ untreated) (NNS cells)) (PRN (-LRB- -LRB-) (NP (CD 2.7) (NN %)) (-RRB- -RRB-)))) (CC and) (PP (IN with) (NP (NP (JJ E2-treated) (NNS cells)) (PRN (-LRB- -LRB-) (NP (CD 3.8) (NN %)) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (PP (IN In) (DT the) (NN presence) (IN of) (NP (NN staurosporine))) (, ,) (NP (DT the) (JJ apoptotic) (NNS cells)) (VP (VBD were) (VP (VBN increased) (PP (IN in) (NP (DT all) (NNS conditions)))))) (. .)))
( (S (S (PP (IN In) (NP (NP (JJ testosterone-treated) (NNS cells)) (PRN (-LRB- -LRB-) (NP (CD 24.8) (NN %)) (-RRB- -RRB-)))) (NP (DT the) (NN apoptosis)) (VP (VBD was) (VP (VBN found) (VP (VBN increased) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (IN with) (NP (NP (JJ untreated) (NNS cells)) (PRN (-LRB- -LRB-) (NP (CD 19.4) (NN %)) (-RRB- -RRB-))))))))))) (. .)))
( (S (PP (IN On) (NP (DT the) (NN contrary))) (, ,) (PP (IN in) (NP (DT the) (ADJP (ADJP (JJ E2-treated)) (PRN (-LRB- -LRB-) (NP (CD 15) (NN %)) (-RRB- -RRB-))) (NNS cells))) (NP (DT the) (NN apoptosis)) (VP (VBD was) (NP (NP (VBN decreased)) (CC versus) (NP (NP (NP (NNS controls)) (PRN (-LRB- -LRB-) (NP (CD 19.4) (NN %)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 3a)) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (DT These) (NNS data)) (VP (VBD were) (VP (VBN confirmed) (PP (IN by) (NP (NP (NN flow) (NN analysis) (NN cytometry) (NN scatter) (NN analysis)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP Fig.)) (NP (NN 3b))) (, ,) (NP (NN c))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (DT The) (NN immunocytochemistry) (NN analysis)) (VP (VBD showed) (NP (NP (DT a) (JJ significant) (NN increase)) (PP (IN of) (NP (DT the) (JJ PARP-cleaved) (NN form))) (PP (IN in) (NP (JJ testosterone-treated) (NNS cells)))) (PP (VBN compared) (PP (IN with) (NP (JJ other) (NNS conditions)))) (, ,) (S (VP (VBG suggesting) (NP (NP (DT an) (NN increase)) (PP (IN of) (NP (JJ pro-apoptotic) (NNS events)))))))) (. .)))
( (S (PP (IN On) (NP (DT the) (NN contrary))) (, ,) (NP (DT the) (JJ PARP-cleaved) (NN staining)) (VP (VBD showed) (NP (NP (DT a) (NN decrease)) (PRN (-LRB- -LRB-) (NP (NP (CD 19) (NN %)) (CC versus) (NP (JJ untreated) (NNS controls))) (-RRB- -RRB-))) (PP (IN in) (NP (JJ E2-treated) (NNS cells))) (, ,) (S (VP (VBG suggesting) (NP (NP (DT a) (NN trend)) (PP (IN of) (NP (NNS oestrogens))) (PP (IN in) (S (VP (VBG protecting) (NP (NNS cells)) (PP (IN from) (NP (DT the) (JJ apoptotic) (NNS stimuli)))))))))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 4a–e)) (-RRB- -RRB-)) (. .)))
( (S (S (NP (DT These) (NNS data)) (VP (VBD were) (VP (VBN confirmed) (PP (IN with) (NP (NN western) (NN blot) (NN analysis)))))) (. .)))
( (S (NP (NP (DT The) (VBN defined) (NN mechanism)) (PP (IN of) (NP (NN NF-κB) (NN activation)))) (VP (VBZ includes) (NP (NP (DT the) (NP (JJ site-specific) (NN phosphorylation)) (CC and) (NP (JJ subsequent) (NN degradation))) (PP (IN of) (NP (NP (DT the) (JJ inhibitory) (NN IκB-α) (NN factor)) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB usually)) (VP (VBZ retains) (NP (NP (DT the) (JJ NF-κB) (NNS factors)) (VP (VBN inactivated) (PP (IN in) (NP (NN cytosol) (CD -LSB-27)))))) (-RRB- -RSB-))))))) (. .)))
( (S (NP (PRP We)) (ADVP (RB therefore)) (VP (VBD performed) (NP (NN western) (NN blot) (NN analysis)) (S (VP (TO to) (VP (VB detect) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NP (NN NF-κB)) (PRN (-LRB- -LRB-) (NP (NN p65)) (-RRB- -RRB-))) (, ,) (NP (NN IκB-α)) (CC and) (NP (NP (DT the) (JJ IκB-α) (JJ phosphorylated) (NN form)) (PRN (-LRB- -LRB-) (NP (NN IκB-α-ser) (CD 32)) (-RRB- -RRB-))))) (PP (IN in) (NP (NP (NN THP-1) (NNS cells)) (VP (VBN treated) (PP (IN with) (NP (DT the) (JJ different) (NN hormone) (NNS combinations))))))))))) (. .)))
( (S (S (SBAR (IN As) (S (VP (VBN shown) (PP (IN in) (NP (NP (NP (NN western) (NN blot) (NN analysis)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 5)) (-RRB- -RRB-))) (NP (NP (NP (DT a) (VBN decreased) (NN expression)) (PP (IN of) (NP (NP (NN NF-κB)) (PRN (-LRB- -LRB-) (NP (NN p65)) (-RRB- -RRB-))))) (CC and) (NP (NP (DT an) (VBN increased) (NN content)) (PP (IN of) (NP (NN IκB-α))) (PP (IN with) (NP (NP (DT a) (JJ concomitant) (NN decrease)) (PP (IN of) (NP (DT the) (JJ IκB-α) (JJ phosphorylated) (NN form)))))))))))) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (JJ testosterone-treated) (NNS cells))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (PP (IN with) (NP (JJ untreated) (NNS controls))) (CC and) (PP (IN with) (NP (JJ E2-treated) (NN THP-1) (NNS cells)))))))))) (: ;) (S (NP (NP (DT the) (NNS differences)) (PP (IN between) (NP (NP (NNS conditions)) (VP (VBN observed) (PP (IN with) (NP (NN staurosporine) (NN treatment))))))) (VP (VBD were) (ADJP (JJ similar)))) (CC but) (S (NP (DT the) (NN expression)) (VP (VBD was) (ADJP (JJR lower)))) (. .)))
( (S (S (NP (NP (DT The) (VBN observed) (NNS differences)) (PP (IN between) (NP (ADJP (ADJP (JJ E2-treated)) (CC and) (ADJP (JJ testosterone-treated))) (NN THP-1) (NNS cells)))) (VP (VBD were) (VP (VBN confirmed) (PP (IN by) (NP (NP (NN immunocytochemistry) (NN staining)) (CC and) (NP (NN image) (NN analysis))))))) (: ;) (S (NP (JJ similar) (NNS data)) (VP (VBD were) (VP (VBN observed) (PP (IN with) (NP (NP (NN staurosporine) (NN treatment)) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 1)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (NP (DT The) (JJ concomitant) (JJ electrophoretic) (NN mobility) (NN shift) (NN assay)) (NN analysis)) (PP (IN for) (NP (NP (DT the) (NN evaluation)) (PP (IN of) (NP (DT the) (JJ NF-κB) (NN DNA) (NN binding)))))) (VP (VBD confirmed) (NP (DT an) (VBN increased) (NN binding)) (PP (IN in) (NP (JJ E2-treated) (NNS cells))) (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (IN with) (NP (NP (JJ other) (NNS conditions)) (PP (IN with) (CC or) (PP (IN without) (NP (NN staurosporine)))))) (, ,) (SBAR (IN as) (S (VP (VBN shown) (PP (IN in) (NP (NNP Fig.) (CD 6a))))))))))) (. .)))
( (S (S (ADVP (RB Finally)) (, ,) (NP (NP (DT the) (NN gel) (NN shift) (NN assay)) (PP (IN of) (NP (NP (JJ nuclear) (NN protein) (NNS extracts)) (PP (IN from) (NP (JJ E2-treated) (NNS cells)))))) (ADVP (RB again)) (VP (VBD showed) (NP (NP (DT an) (NN increase)) (PP (IN of) (NP (NP (DT the) (NN p65) (NN subunit) (NN DNA) (NN binding)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 6b)) (-RRB- -RRB-))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (IN with) (NP (JJ other) (NNS conditions)))))))) (. .)))
( (S (S (NP (JJ Similar) (NNS results)) (VP (VBD were) (VP (VBN obtained) (PP (IN during) (NP (NN staurosporine) (NN treatment)))))) (. .)))
( (S (NP (NN Discussion))))
( (S (S (NP (NNS Monocytes/macrophages)) (VP (VBP contribute) (PP (PP (TO to) (NP (DT the) (JJ autoimmune) (NN process))) (, ,) (ADVP (RB mainly)) (PP (VBG acting) (PP (IN as) (NP (NP (JJ antigen-processing/presenting) (NNS cells)) (CC and) (NP (NP (NNS sources)) (PP (IN of) (NP (JJ inflammatory) (NNS cytokines))))))) (, ,) (ADVP (RB particularly)) (PP (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (DT the) (JJ synovial) (NN tissue))) (PP (IN in) (NP (NN RA) (CD -LSB-28) (-RRB- -RSB-)))))))) (. .)))
( (S (S (ADVP (RB Moreover)) (, ,) (NP (NN sex) (NNS hormones)) (VP (MD can) (VP (VB exert) (NP (NP (JJ local) (NNS actions)) (PRN (-LRB- -LRB-) (NP (NN paracrine)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (DT the) (NNS tissues)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (PRP they)) (VP (VBP are) (VP (VBN formed))))) (, ,) (PP (VBG including) (NP (DT the) (JJ synovial) (NN tissue) (NN -LSB-29,30))))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (VBN Activated) (NN THP-1) (NNS cells)) (VP (VBP differentiate) (PP (IN into) (NP (NP (NNS macrophages)) (PP (IN for) (NP (JJ long-term) (NNS cultures))))))) (. .)))
( (S (S (PP (IN On) (NP (DT the) (NN contrary))) (, ,) (NP (JJ synovial) (NNS macrophages)) (VP (VBP are) (VP (VBN characterized) (PP (IN by) (NP (NP (DT a) (JJ short) (NN life)) (PP (IN during) (NP (ADJP (FW in) (FW vitro)) (NN culture)))))))) (. .)))
( (S (NP (DT The) (JJ present) (NN study)) (VP (VBZ shows) (NP (NP (JJ opposite) (NNS effects)) (PP (IN by) (NP (NN sex) (NNS hormones))) (PP (IN on) (NP (NP (NNS cultures)) (PP (IN of) (NP (NP (NP (VBN activated) (NN monocytic/macrophage) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN THP-1) (NNS cells)) (-RRB- -RRB-))) (VP (VBG concerning) (NP (NP (PRP$ their) (JJ modulatory) (NNS effects)) (PP (IN on) (NP (NN cell) (NP (NN proliferation)) (CC and/or) (NP (NN apoptosis)))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN signalling) (NNS pathways)) (PP (VBG modulating) (NP (DT the) (ADJP (ADJP (JJ pro-inflammatory)) (CC and) (ADJP (JJ anti-inflammatory))) (NNS mechanisms)))) (VP (VBP seem) (S (VP (TO to) (VP (VB involve) (NP (JJ steroidal) (NN hormone) (NN receptor) (NN activation))))))) (CC and) (S (NP (DT the) (JJ NF-κB) (NN complex) (NNS factors)) (, ,) (PP (IN In) (NP (NN addition))) (, ,) (NP (NNS oestrogens)) (VP (MD may) (ADVP (RB differently)) (VP (VB regulate) (NP (NN NF-κB) (NN activation)) (PP (VBG depending) (PP (IN on) (NP (NP (DT the) (NN cell) (NN type)) (VP (VBN tested) (S (NP (NN -LSB-14,31))))))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (NN E2)) (ADVP (RB therefore)) (VP (VBD increased) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NNS markers)) (PP (IN of) (NP (NN cell) (NP (NN growth)) (CC and) (NP (NN proliferation))))))) (, ,) (SBAR (IN whereas) (S (NP (NN testosterone)) (VP (VBD induced) (NP (NP (DT an) (NN increase)) (PP (IN of) (NP (DT the) (JJ PARP-cleaved) (NN expression))))))) (, ,) (S (VP (VBG indicating) (NP (NP (NN DNA) (NN damage)) (CC and) (NP (NN apoptosis))))))) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (S (VP (TO to) (VP (VB support) (NP (NP (DT the) (JJ proliferative) (NN role)) (VP (VBN exerted) (PP (IN by) (NP (NN E2)))))))) (, ,) (NP (NP (DT the) (NN THP-1) (NNS cells)) (VP (VBN pre-treated) (PP (IN with) (NP (DT the) (NNS oestrogens))))) (VP (VBD showed) (NP (NP (DT a) (NN decrease)) (PP (IN of) (NP (JJ staurosporine-induced) (NN apoptosis)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (IN with) (NP (ADJP (ADJP (JJ testosterone-treated)) (CC and) (ADJP (JJ untreated))) (NNS cells)))))))) (. .)))
( (S (ADVP (RB Furthermore)) (, ,) (NP (NP (NP (NP (DT the) (VBN increased) (NN NF-κB) (NN p65) (NN expression)) (CC and) (NP (NP (DT the) (JJ evident) (NN NF-κB) (NN binding)) (PP (TO to) (NP (NN DNA))))) (PP (IN in) (NP (NP (JJ E2-treated) (NNS cells)) (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (PP (IN with) (NP (JJ untreated) (NNS cells))) (CC or) (PP (IN with) (NP (JJ testosterone-treated) (NNS cells)))))))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT the) (VBN increased) (NNS levels)) (PP (IN of) (NP (DT the) (JJ IκB-α) (JJ phosphorylated) (NN form)))) (, ,)) (VP (VBZ seems) (S (VP (TO to) (VP (VB support) (NP (NP (DT the) (JJ major) (JJ enhancing) (NN role)) (VP (VBN exerted) (PP (IN by) (NP (NNS oestrogens))) (PP (IN on) (NP (DT the) (JJ immune/inflammatory) (NN response))) (PP (IN by) (S (VP (VBG activating) (NP (DT the) (JJ NF-κB) (NN complex))))))))))) (. .)))
( (S (PP (IN On) (NP (DT the) (NN contrary))) (, ,) (NP (NP (DT the) (VBN observed) (JJ positive) (NN upregulation)) (PP (IN of) (NP (NP (NN IκB-α)) (VP (VBN exerted) (PP (IN by) (NP (NN testosterone) (NN treatment))))))) (ADVP (RB presumably)) (VP (VP (VBZ dampens) (NP (NP (DT the) (JJ pro-inflammatory) (NNS effects)) (VP (VBN mediated) (PP (IN by) (NP (DT the) (JJ NF-κB) (NN activation)))))) (, ,) (CC and) (ADVP (RB therefore)) (VP (MD might) (VP (VB represent) (NP (NP (DT a) (JJ further) (NN mechanism)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (NNS androgens)) (VP (VBP exert) (NP (JJ anti-inflammatory) (NNS effects))))))))) (. .)))
( (S (S (NP (JJ Recent) (NNS studies)) (VP (VBP support) (NP (DT these) (NNS results)) (, ,) (S (VP (VBG showing) (SBAR (IN that) (S (NP (NN E2)) (VP (VBZ inhibits) (NP (NP (NN apoptosis)) (PP (IN in) (NP (NP (JJ different) (NN cell) (NNS types)) (PRN (-LRB- -LRB-) (NP (NP (JJ cardiac) (NNS myocytes)) (CC and) (NP (NNS others))) (-RRB- -RRB-))))) (SBAR (IN whereas) (S (NP (NNS androgens)) (VP (VBP have) (VP (VBN been) (VP (VBN found) (S (VP (TO to) (VP (VB induce) (NP (NN apoptosis) (CD -LSB-32,33) (-RRB- -RSB-))))))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (VBN increased) (NNS concentrations)) (PP (IN of) (NP (NP (NP (NNS oestrogens)) (-LRB- -LRB-) (CC and) (NP (JJ low) (NNS androgens)) (-RRB- -RRB-)) (VP (ADVP (RB recently)) (VBN described) (PP (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NP (DT the) (JJ synovial) (NN fluid)) (PP (IN of) (NP (NN RA) (NNS patients)))))))))) (PP (IN of) (NP (DT both) (NNS sexes) (NP (CD -LSB-29)))) (-RRB- -RSB-)) (VP (VBP seem) (S (VP (TO to) (VP (VB support) (NP (PRP$ their) (JJ possible) (NN modulator) (NNS roles)) (PP (IN on) (NP (NP (JJ synovial) (NN tissue) (NN hyperplasia)) (CC and) (NP (JJ chronic) (JJ synovial) (NN cell) (NN activation)))) (, ,) (PP (IN by) (S (VP (VBG considering) (NP (NP (DT the) (JJ oestrogenic) (NNS effects)) (PP (IN on) (NP (NP (NN cell) (NN proliferation)) (CC and) (NP (NN apoptosis))))))))))))) (. .)))
( (S (S (NP (DT These) (NNS observations)) (VP (VBP have) (VP (VBN been) (ADVP (RB recently)) (VP (VBN obtained) (PP (ADVP (RB also)) (IN in) (NP (JJ human) (NN breast) (NN cancer) (NNS cells))) (NP (CD -LSB-34)) (-RRB- -RSB-))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB explain) (NP (NP (VBN increased) (NN oestrogen) (NNS concentrations)) (PP (IN in) (NP (NN RA) (JJ synovial) (NNS fluids))))))) (, ,) (S (NP (NP (DT the) (JJ pro-inflammatory) (NNS cytokines)) (PRN (-LRB- -LRB-) (NP (NP (NN tumour) (NN necrosis) (NN factor) (NN alpha)) (, ,) (NP (NN IL-1β)) (, ,) (NP (NN IL-6))) (-RRB- -RRB-))) (VP (VBP have) (VP (VBN been) (VP (VBN found) (S (VP (TO to) (VP (VB accelerate) (NP (NP (DT the) (JJ metabolic) (NN conversion)) (PP (IN of) (NP (NNS oestrogens))) (PP (IN from) (NP (NNS androgens)))) (PP (IN by) (S (VP (VBG inducing) (NP (NP (DT the) (JJ synovial) (NN tissue) (NNS aromatases)) (CD -LSB-35-37) (-RRB- -RSB-))))))))))))) (. .)))
( (S (S (PP (IN As) (NP (DT a) (NN consequence))) (, ,) (NP (ADJP (RB locally) (VBN increased)) (NN oestrogen) (NNS levels)) (VP (MD might) (VP (VB exert) (NP (NP (JJ activating) (NNS effects)) (PP (IN on) (NP (JJ synovial) (NN cell) (NN proliferation))) (, ,) (PP (VBG including) (NP (NP (NNS macrophages)) (CC and) (NP (NNS fibroblasts) (CD -LSB-38) (-RRB- -RSB-)))))))) (. .)))
( (S (NP (NN Conclusion))))
( (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (NP (NP (DT the) (NNS concentrations)) (PP (IN for) (NP (NP (NN E2)) (CC and) (NP (NN testosterone))))) (VP (VBD tested) (VP (VB seem) (S (VP (TO to) (VP (VB modulate) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (JJ NF-κB) (NNS molecules))) (PP (IN in) (NP (NP (NP (DT the) (JJ human) (NN monocytic/macrophage) (NN cell) (NN line)) (PRN (-LRB- -LRB-) (NP (NN THP-1)) (-RRB- -RRB-))) (PP (IN with) (NP (JJ opposite) (NNS effects)))))))))) (, ,) (S (VP (VBG interfering) (PP (IN with) (NP (NN cell) (NP (NP (NN growth)) (CC and) (NP (NN apoptosis)))))))) (. .)))
( (S (S (NP (DT These) (NNS observations)) (VP (MD might) (VP (VBP provide) (NP (NP (DT a) (JJ further) (JJ biological) (NN link)) (PP (IN between) (NP (NP (NN gender) (NNS effects)) (CC and) (NP (NP (DT the) (JJ complex) (JJ inflammatory) (NN process)) (VP (VBN involved) (PP (IN in) (NP (JJ rheumatoid) (NN synovitis))))))))))) (. .)))
( (S (S (NP (NP (JJ Further) (NNS studies)) (, ,) (VP (VBG using) (NP (NP (NP (JJ peripheral) (NNS metabolites)) (PP (IN of) (NP (NNS oestrogens)))) (CC and) (NP (NP (JJ synovial) (NNS macrophages)) (PP (IN from) (NP (NN RA) (NNS patients)))))) (, ,)) (VP (MD might) (VP (VB extend) (NP (NP (DT the) (NN value)) (PP (IN of) (NP (DT these) (NNS observations))))))) (. .)))
( (S (NP (NNS Abbreviations))))
( (S (S (NP (NNS DPBS)) (VP (VBG =) (NP (NP (NP (NN Dulbecco) (POS 's) (JJ phosphate-buffered) (NN saline)) (: ;) (NP (NN E2) (JJ =) (NN 17β-oestradiol)) (: ;) (NP (ADJP (NP (NP (NN IFN) (JJ =) (NN interferon)) (: ;) (NP (NN IL) (JJ =) (NN interleukin)) (: ;) (NP (NN NF) (JJ =) (JJ nuclear) (NN factor)) (: ;) (NP (NN PARP) (JJ =) (NN poly-ADP) (NN ribose) (NN polymerase)) (: ;) (NP (NNS PBS))) (JJ =)) (JJ phosphate-buffered) (NN saline)) (: ;) (NP (NN PCNA) (JJ =) (JJ proliferating) (NN cell) (JJ nuclear) (NN antigen)) (: ;) (NP (NN RA) (JJ =) (JJ rheumatoid) (NN arthritis)) (: ;) (NP (NN THP-1))) (JJ =) (NP (VBN cultured) (JJ human) (NN monocytic/macrophage) (NN cell) (NN line))))) (. .)))
( (S (NP (VBG Competing) (NNS interests))))
( (S (S (NP (DT The) (NN author) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-)) (VP (VB declare) (SBAR (IN that) (S (NP (PRP they)) (VP (VBP have) (NP (DT no) (VBG competing) (NNS interests))))))) (. .)))
( (S (NP (NP (NNS Authors) (POS ')) (NNS contributions))))
( (S (S (NP (NN MC)) (VP (VP (VBN conceived) (NP (DT the) (NN study))) (CC and) (VP (VBN drafted) (NP (DT the) (NN manuscript))))) (. .)))
( (S (S (NP (NN SC)) (VP (VBD participated) (PP (IN in) (S (VP (VBG conducting) (NP (NP (NN THP-1) (NN cell) (NN growth)) (CC and) (NP (DT the) (JJ functional) (NN assay)))))))) (. .)))
( (S (S (NP (NN PM)) (VP (VBN conducted) (NP (NP (DT the) (NN immunocytochemistry) (NN assay)) (CC and) (NP (DT the) (NN western) (NN blot) (NN assay))))) (. .)))
( (S (S (NP (NN PG)) (VP (VBN conducted) (NP (NP (DT the) (JJ electrophoretic) (NN mobility) (NN shift) (NN assay)) (CC and) (NP (DT the) (NN super) (NN shift) (NN assay))))) (. .)))
( (S (S (IN AS) (VP (VBD helped) (S (VP (TO to) (VP (VB perform) (NP (JJ statistical) (NN analysis))))))) (. .)))
( (S (S (NP (NN BV)) (VP (VP (VBD participated) (PP (IN in) (NP (NP (DT the) (NN study) (NN design)) (, ,) (NP (NN coordination)) (CC and) (NP (NN data) (NN analysis))))) (, ,) (CC and) (VP (VBN drafted) (NP (DT the) (NN manuscript))))) (. .)))
( (S (S (NP (DT All) (NNS authors)) (VP (VP (VBN read)) (CC and) (VP (JJ approved) (NP (DT the) (JJ final) (NN manuscript))))) (. .)))
( (S (NP (NP (NN Figure)) (CC and) (NP (NN Table)) (NP (NNS captions)))))
( (S (NP (NP (NN Figure) (CD 1)) (: :) (NP (NP (NN Growth) (NN rate)) (PP (IN of) (NP (NP (DT the) (VBN cultured) (JJ human) (NN THP-1) (NN cell) (NN line)) (PP (PP (IN without)) (CC or) (PP (IN with) (NP (NP (NP (NN 17β-oestradiol)) (PRN (-LRB- -LRB-) (NP (NN E2)) (-RRB- -RRB-))) (CC and) (NP (NP (NN testosterone)) (PRN (-LRB- -LRB-) (NP (NN T)) (-RRB- -RRB-))))) (, ,) (CC and) (PP (IN with) (NP (NN staurosporine))) (PP (IN after) (NP (CD 168) (NNS hours))))))) (. .))))
( (S (S (NP (NP (DT The) (NN number)) (PP (IN of) (NP (VBN recovered) (JJ live) (NNS cells))) (PP (IN at) (NP (JJ different) (NNS times)))) (VP (VBD was) (VP (VBN evaluated) (S (VP (VBG using) (NP (DT the) (NP (NN methyl) (NN tetrazolium) (NN salt)) (NN reduction) (NN test))))))) (. .)))
( (S (S (NP (NNS Results)) (VP (VBP are) (VP (VBN expressed) (PP (IN as) (NP (NP (DT the) (NN mean) (NN ±) (JJ standard) (NN deviation)) (PP (IN of) (NP (CD five) (JJ different) (NNS experiments)))))))) (. .)))
( (S (NP (NP (NN Figure) (CD 2)) (: :) (NP (NP (NP (NP (JJ Proliferating) (NN cell) (JJ nuclear) (NN antigen)) (PRN (-LRB- -LRB-) (NP (NN PCNA)) (-RRB- -RRB-))) (NN expression)) (PP (IN in) (NP (VBN cultured) (JJ human) (NN THP-1) (NN cell) (NN line)))) (. .))))
( (S (S (LST (-LRB- -LRB-) (LS a) (-RRB- -RRB-)) (S (VP (VBG Proliferating) (NP (NP (NP (NP (NN cell) (JJ nuclear) (NN antigen)) (PRN (-LRB- -LRB-) (NP (NN PCNA)) (-RRB- -RRB-))) (NN expression)) (PP (IN in) (NP (DT the) (VBN cultured) (JJ human) (NN THP-1) (NN cell) (NN line)))) (PP (IN after) (NP (JJ hormonal) (NN treatment)))))) (. .)))
( (S (S (NP (NNS Results)) (VP (VBP are) (VP (VBN expressed) (PP (IN as) (NP (NP (DT the) (NN mean) (CD ±) (JJ standard) (NN deviation)) (PP (IN of) (NP (NP (DT the) (NN percentage)) (PP (IN of) (NP (NP (NP (NN staining) (NN area)) (PRN (-LRB- -LRB-) (NP (NP (JJ positive) (NN area)) (VP (VBN defined) (PP (IN as) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NNS pixels)) (ADJP (JJ detectable) (PP (IN per) (NP (NN micron) (NN square)))))))))) (-RRB- -RRB-))) (PP (IN for) (NP (NP (CD 100) (NNS cells)) (PP (IN in) (NP (CD five) (JJ different) (NNS experiments)))))))))))))) (. .)))
( (S (S (NP (NN Bottom)) (: :) (NP (NN western) (NN blot) (NN analysis))) (. .)))
( (S (S (LST (-LRB- -LRB-) (LS b) (-RRB- -RRB-)) (NP (NN PCNA)) (VP (NN expression) (PP (IN in) (NP (NP (JJ untreated) (NN THP-1) (NNS cells)) (PRN (-LRB- -LRB-) (NP (JJ control) (JJ -LSB-cnt)) (-RRB- -RSB-) (-RRB- -RRB-)))))) (. .)))
( (S (S (LST (-LRB- -LRB-) (LS c) (-RRB- -RRB-)) (NP (NP (NN PCNA) (NN expression)) (PP (IN in) (NP (NN THP-1) (NNS cells)))) (VP (VBN treated) (PP (IN with) (NP (NP (NN testosterone)) (PRN (-LRB- -LRB-) (NP (NN T)) (-RRB- -RRB-)))) (PP (IN after) (NP (CD 168) (NNS hours))))) (. .)))
( (S (S (LST (-LRB- -LRB-) (LS d) (-RRB- -RRB-)) (NP (NP (NN PCNA) (NN expression)) (PP (IN in) (NP (NN THP-1) (NNS cells)))) (VP (VBN treated) (PP (IN with) (NP (NP (NN 17β-oestradiol)) (PRN (-LRB- -LRB-) (NP (NN E2)) (-RRB- -RRB-)))) (PP (IN after) (NP (NP (CD 168) (NNS hours)) (PRN (-LRB- -LRB-) (NP (NP (NN magnification)) (, ,) (NP (NN ×) (CD 500))) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NN Figure) (CD 3)) (: :) (NP (NP (NN Apoptosis) (NN evaluation)) (PP (IN in) (NP (VBN cultured) (JJ human) (NN THP-1) (NN cell) (NN line))))) (. .)))
( (S (S (LST (-LRB- -LRB-) (LS a) (-RRB- -RRB-)) (NP (NN Apoptosis)) (VP (NN evaluation) (PP (IN in) (NP (DT the) (VBN cultured) (JJ human) (NN THP-1) (NN cell) (NN line))) (PP (IN after) (NP (NP (CD 168) (NNS hours)) (PP (IN of) (NP (NP (JJ hormonal) (NN treatment)) (PP (PP (IN without)) (CC and) (PP (IN with) (NP (NN staurosporine)))))))))) (. .)))
( (S (S (NP (NNS Results)) (VP (VBP are) (VP (VBN expressed) (PP (IN as) (NP (NP (DT the) (NN mean) (NN ±) (JJ standard) (NN deviation)) (PP (IN of) (NP (NP (DT the) (NN percentage) (NN number)) (PP (IN of) (NP (JJ annexin-positive) (NNS cells))))) (PP (IN in) (NP (CD five) (JJ different) (NNS experiments)))))))) (. .)))
( (S (S (LST (-LRB- -LRB-) (LS b) (-RRB- -RRB-)) (NP (NP (JJ Apoptotic) (NN DNA) (NN evaluation)) (PP (IN in) (NP (NN THP-1) (NNS cells))) (PP (IN after) (NP (NP (CD 168) (NNS hours)) (PP (IN of) (NP (NP (JJ hormonal) (NN treatment)) (PP (IN without) (NP (NN staurosporine)))))))) (ADVP (RB as)) (VP (VBN detected) (PP (IN by) (NP (NN flow) (NN analysis) (NN cytometry) (NN scatter) (NN analysis))))) (. .)))
( (S (NP (NP (NP (NP (NN Region) (NN G)) (, ,) (NP (NN control))) (PRN (-LRB- -LRB-) (NP (NN cnt)) (-RRB- -RRB-))) (, ,) (NP (NP (CD 3.96) (NN %)) (: ;) (NP (NP (NN 17β-oestradiol)) (PRN (-LRB- -LRB-) (NP (NN E2)) (-RRB- -RRB-))) (, ,) (NP (CD 5.54) (NN %)) (: ;) (NP (NP (NN testosterone)) (PRN (-LRB- -LRB-) (NP (NN T)) (-RRB- -RRB-))) (, ,) (NP (CD 15.9) (NN %))) (. .))))
( (S (NP (NP (LST (-LRB- -LRB-) (LS c) (-RRB- -RRB-)) (JJ Apoptotic) (NN DNA) (NN evaluation)) (PP (IN in) (NP (NN THP-1) (NNS cells))) (PP (IN after) (NP (NP (CD 168) (NNS hours)) (PP (IN of) (NP (NP (JJ hormonal) (NN treatment)) (CC and) (NP (NP (NP (NN staurosporine)) (PRN (-LRB- -LRB-) (NP (NN stau)) (-RRB- -RRB-))) (PP (IN for) (NP (CD 24) (NNS hours)))))) (, ,) (SBAR (IN as) (S (VP (VBN detected) (PP (IN by) (NP (NN flow) (NN analysis) (NN cytometry) (NN scatter) (NN analysis)))))))) (. .))))
( (S (NP (NP (NN Region) (NN G)) (: :) (NP (NP (NN control/S)) (, ,) (NP (NP (CD 18.9) (NN %)) (: ;) (NP (NN E2/S)) (, ,) (NP (CD 16.5) (NN %)) (: ;) (NP (NN T/S)) (, ,) (NP (CD 24.5) (NN %)))) (. .))))
( (S (NP (NP (NN PI)) (, ,) (NP (NN propidium) (NN iodide)) (. .))))
( (S (S (NP (NP (NN Figure) (CD 4)) (: :) (NP (NP (NN Poly-ADP-ribose) (NN polymerase)) (PRN (-LRB- -LRB-) (NP (NN PARP)) (-RRB- -RRB-)))) (VP (VBD -cleaved) (NP (NP (NN expression)) (PP (IN in) (NP (VBN cultured) (JJ human) (NN THP-1) (NN cell) (NN line)))))) (. .)))
( (S (S (NP (NP (LST (-LRB- -LRB-) (LS a) (-RRB- -RRB-)) (NN Poly-ADP-ribose) (NN polymerase)) (PRN (-LRB- -LRB-) (NP (NN PARP)) (-RRB- -RRB-))) (NP (NP (JJ -cleaved) (NN expression)) (PP (IN in) (NP (DT the) (VBN cultured) (JJ human) (NN THP-1) (NN cell) (NN line))) (PP (PP (IN in) (NP (JJ basal) (NNS conditions))) (CC and) (PP (IN after) (NP (NP (CD 168) (NNS hours)) (PP (IN of) (NP (NP (JJ hormonal) (NN treatment)) (CC and) (NP (NP (NN staurosporine)) (PRN (-LRB- -LRB-) (NP (NN stau)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NNS Results)) (VP (VBP are) (VP (VBN expressed) (PP (IN as) (NP (NP (DT the) (NN mean) (NN ±) (JJ standard) (NN deviation)) (PP (IN of) (NP (NP (DT the) (NN percentage)) (PP (IN of) (NP (DT the) (JJ positive) (NN area))))) (PP (IN for) (NP (NP (CD 100) (NNS cells)) (PP (IN in) (NP (CD five) (JJ different) (NNS experiments)))))))))) (. .)))
( (S (NP (NP (NN Bottom)) (: :) (NP (NP (NN western) (NN blot) (NN analysis)) (ADJP (JJ related) (PP (TO to) (NP (NP (JJ PARP-cleaved) (NN expression)) (PP (IN in) (NP (NP (NP (JJ untreated) (NNS cells)) (PRN (-LRB- -LRB-) (NP (JJ basal) (NN condition)) (-RRB- -RRB-))) (CC and) (NP (NP (NNS cells)) (VP (VBN treated) (PP (IN with) (NP (NP (NNS hormones)) (CC and) (NP (NN staurosporine)))))))))))) (. .))))
( (S (S (LST (-LRB- -LRB-) (LS b) (-RRB- -RRB-)) (VP (VBD PARP-cleaved) (NP (NP (NN expression)) (PP (IN in) (NP (NN THP-1) (NNS cells)))) (PRN (-LRB- -LRB-) (NP (JJ basal) (NN condition)) (-RRB- -RRB-)))) (. .)))
( (S (S (LST (-LRB- -LRB-) (LS c) (-RRB- -RRB-)) (VP (VBD PARP-cleaved) (NP (NP (NN expression)) (PP (IN in) (NP (NN THP-1) (NNS cells)))) (PP (IN after) (NP (JJ normal) (NN medium))))) (. .)))
( (S (S (LST (-LRB- -LRB-) (LS d) (-RRB- -RRB-)) (VP (VBD PARP-cleaved) (NP (NP (NN expression)) (PP (IN in) (NP (NN THP-1) (NNS cells)))) (PP (IN after) (NP (NP (NP (NN testosterone)) (PRN (-LRB- -LRB-) (NP (NN T)) (-RRB- -RRB-))) (NN treatment))))) (. .)))
( (S (S (PRN (-LRB- -LRB-) (NP (NN e)) (-RRB- -RRB-)) (VP (VBD PARP-cleaved) (NP (NP (NN expression)) (PP (IN in) (NP (NN THP-1) (NNS cells)))) (PP (IN after) (NP (NN 17β-oestradiol) (-LRB- -LRB-) (NN E2) (-RRB- -RRB-) (NN treatment))))) (. .)))
( (S (NP (NP (NN cnt)) (, ,) (NP (NN control)) (. .))))
( (S (NP (NP (NN Figure) (CD 5)) (: :) (NP (NP (NP (NP (NP (JJ NF-κB) (NN p65)) (, ,) (NP (NN IκB-α)) (CC and) (NP (JJ phosphorylated) (NN IκB-α))) (PRN (-LRB- -LRB-) (NP (NN ser) (CD 32)) (-RRB- -RRB-))) (NN protein) (NN expression)) (PP (IN in) (NP (DT the) (VBN cultured) (JJ human) (NN THP-1) (NN cell) (NN line))) (PP (IN after) (NP (NP (CD 168) (NNS hours)) (PP (IN of) (NP (NP (JJ hormonal) (NN treatment)) (PP (IN without) (CC or) (PP (IN with) (NP (NN staurosporine))))))))) (. .))))
( (S (S (NP (DT The) (NNS results)) (VP (VBP are) (ADJP (JJ representative) (PP (IN of) (NP (CD four) (JJ separate) (NNS experiments)))))) (. .)))
( (S (S (PRN (NP (NN CNT)) (, ,) (NP (NN control)) (: ;) (NP (NN T)) (, ,) (NP (NN testosterone)) (: ;) (NP (NN E2)) (, ,) (NP (NN 17β-oestradiol)))) (. .)))
( (S (NP (NP (NN Figure) (CD 6)) (: :) (NP (NP (JJ Electrophoretic) (NN mobility) (NN shift) (NN assay)) (PP (IN for) (NP (NP (NN NF-κB)) (PRN (-LRB- -LRB-) (NP (NN arrow)) (-RRB- -RRB-)))) (PP (IN in) (NP (DT the) (VBN cultured) (JJ human) (NN THP-1) (NN cell) (NN line)))) (. .))))
( (S (NP (NP (LST (-LRB- -LRB-) (LS a) (-RRB- -RRB-)) (JJ Electrophoretic) (NN mobility) (NN shift) (NN assay)) (PP (IN for) (NP (NP (NP (NN NF-κB)) (PRN (-LRB- -LRB-) (NP (NN arrow)) (-RRB- -RRB-))) (PP (IN in) (NP (DT the) (VBN cultured) (JJ human) (NN THP-1) (NN cell) (NN line))))) (PP (PP (IN after) (NP (NP (CD 168) (NNS hours)) (PP (IN of) (NP (JJ hormonal) (NN treatment))))) (CC and) (PP (IN without) (CC or) (PP (IN with) (NP (NP (NN staurosporine)) (PRN (-LRB- -LRB-) (NP (CD 17) (NN nM)) (-RRB- -RRB-))))))) (VP (VBZ reveals) (NP (NP (DT an) (VBN increased) (NN DNA) (NN binding)) (PP (IN in) (NP (ADJP (NN 17β-oestradiol) (-LRB- -LRB-) (NN E2) (-RRB- -RRB-) (JJ -treated)) (NNS cells))))) (. .)))
( (S (S (LST (-LRB- -LRB-) (LS b) (-RRB- -RRB-)) (NP (NP (NN Super) (NN shift) (NN assay)) (PP (IN for) (NP (NP (NP (NN p65)) (PRN (-LRB- -LRB-) (NP (NN arrow)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (DT the) (NNS cells)) (PP (IN under) (NP (DT the) (JJ same) (NNS conditions)))))))) (VP (VBZ confirms) (NP (NP (DT the) (VBN increased) (NN binding)) (PP (IN of) (NP (NN p65))) (PP (IN in) (NP (JJ E2-treated) (NNS cells)))))) (. .)))
( (S (S (NP (DT The) (NNS results)) (VP (VBP are) (ADJP (JJ representative) (PP (IN of) (NP (CD four) (JJ separate) (NNS experiments)))))) (. .)))
( (S (S (NP (NP (NN cnt)) (, ,) (NP (NN control) (: ;) (NN T)) (, ,)) (NP (NN testosterone))) (. .)))
( (S (NP (NP (NN Table) (CD 1)) (: :) (NP (NP (NP (NN NF-κB) (NN complex)) (, ,) (NP (NN IκB-α)) (CC and) (NP (NN IκB-α-ser) (CD 32))) (VP (VBN evaluated) (PP (IN by) (NP (NN immunocytochemistry))))))))
( (S (NP (NP (NN Development)) (PP (IN of) (NP (NP (JJ real-time) (NN NASBA) (NNS assays)) (PP (IN with) (NP (JJ molecular) (NN beacon) (NN detection))))) (VP (TO to) (VP (VB quantify) (NP (NP (NN mRNA)) (VP (VBG coding) (PP (IN for) (NP (NN HHV-8))) (NP (ADJP (ADJP (JJ lytic)) (CC and) (ADJP (JJ latent))) (NNS genes)))))))))
( (S (NP (NN Abstract))))
( (S (NP (NP (NN Background)) (: :) (S (S (NP (NP (JJ Human) (NN herpesvirus-8)) (PRN (-LRB- -LRB-) (NP (NN HHV-8)) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN linked) (PP (TO to) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (NP (NP (NN Kaposi) (POS 's)) (NN sarcoma)) (PRN (-LRB- -LRB-) (NP (NN KS)) (-RRB- -RRB-))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN HHV-8) (NN DNA) (NN load)) (PP (IN in) (NP (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN PBMC)) (-RRB- -RRB-))))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (JJ clinical) (NN stage)) (PP (IN of) (NP (NN KS))))))))) (. .))))
( (S (VP (TO To) (VP (VB examine) (NP (DT the) (NN expression) (S (PP (IN of) (NP (NP (NN HHV-8)) (PP (IN in) (NP (NN PBMC))))) (, ,) (NP (CD four) (NN HHV-8) (NN mRNA) (JJ specific) (NN NASBA) (NNS assays)) (VP (VBD were) (S (NP (NNS developedMethodsWe)) (VP (VBP have) (VP (VBN developed) (NP (NP (CD four) (JJ quantitative) (JJ nucleic) (NN acid) (JJ sequence-based) (NN amplification) (NNS assays)) (PRN (-LRB- -LRB-) (NP (NN NASBA-QT)) (-RRB- -RRB-))) (S (ADVP (RB specifically)) (VP (TO to) (VP (VB detect) (NP (NN mRNA) (NN coding)) (PP (IN for) (NP (NP (NP (NN ORF) (CD 73)) (PRN (-LRB- -LRB-) (NP (JJ latency-associated) (JJ nuclear) (NN antigen)) (, ,) (NP (NN LANA)) (-RRB- -RRB-))) (, ,) (NP (NP (NN vGCR)) (PRN (-LRB- -LRB-) (NP (DT a) (NN membrane) (NN receptor)) (-RRB- -RRB-))) (, ,) (NP (NP (NN vBcl-2)) (PRN (-LRB- -LRB-) (NP (NP (DT a) (JJ viral) (NN inhibitor)) (PP (IN of) (NP (NN apoptosis)))) (-RRB- -RRB-))) (CC and) (NP (NP (NN vIL-6)) (PRN (-LRB- -LRB-) (NP (DT a) (JJ viral) (NN growth) (NN factor)) (-RRB- -RRB-)))))))))))) (. .)))))))
( (S (S (NP (NP (DT The) (NN NASBA) (NN technique)) (VP (VBZ amplifies) (NP (JJ nucleic) (NNS acids)) (PP (IN without) (NP (NP (NN thermocycling)) (CC and) (NP (NN mRNA)))))) (VP (MD can) (VP (VB be) (VP (VBN amplified) (PP (IN in) (NP (DT a) (JJ dsDNA) (NN background))))))) (. .)))
( (S (S (NP (DT A) (JJ molecular) (NN beacon)) (VP (VBZ is) (VP (VBN used) (PP (IN during) (NP (NN amplification))) (S (VP (TO to) (VP (VB enable) (NP (NP (JJ real-time) (NN detection)) (PP (IN of) (NP (DT the) (NN product)))))))))) (. .)))
( (S (S (NP (DT The) (NNS assays)) (VP (VBD were) (VP (VBN tested) (PP (IN on) (NP (NP (NN PBMC) (NNS samples)) (PP (IN of) (NP (NP (CD two) (JJ AIDS-KS) (NNS patients)) (PP (IN from) (NP (DT the) (NN Amsterdam) (NN Cohort)))))))))) (. .)))
( (S (NP (NP (NNS Results)) (: :) (S (PP (IN For) (NP (DT all) (CD four) (NNS assays))) (, ,) (NP (NP (NP (DT the) (NN limit)) (PP (IN of) (NP (NP (NP (NN detection)) (PRN (-LRB- -LRB-) (NP (NN LOD)) (-RRB- -RRB-))) (PP (IN of) (NP (CD 50) (NNS molecules)))))) (CC and) (NP (NP (DT the) (NN limit)) (PP (IN of) (NP (NP (NP (NN quantification)) (PRN (-LRB- -LRB-) (NP (NN LOQ)) (-RRB- -RRB-))) (PP (IN of) (NP (CD 100) (NNS molecules))))))) (VP (VBD were) (VP (VBN determined) (S (VP (VBG using) (NP (ADJP (ADVP (FW in) (FW vitro)) (VBN transcribed)) (NN RNA))))))) (. .))))
( (S (S (NP (DT The) (JJ linear) (JJ dynamic) (NN range)) (VP (VBD was) (NP (NP (QP (CD 50) (TO to) (CD 107)) (NNS molecules)) (PP (IN of) (NP (NN HHV-8) (NN mRNA)))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD found) (NP (NN HHV-8) (NN mRNA) (NN expression)) (PP (IN in) (NP (NP (CD 9)) (PP (IN out) (IN of) (NP (DT the) (CD 10) (VBN tested) (NNS samples))))))) (. .)))
( (S (NP (NP (NN Conclusion)) (: :) (S (NP (NP (DT These) (JJ real-time) (NN NASBA) (NNS assays)) (PP (IN with) (NP (NN beacon) (NN detection)))) (VP (VBP provide) (NP (NP (NNS tools)) (PP (IN for) (NP (NP (JJ further) (NN study)) (PP (IN of) (NP (NP (NN HHV-8) (NN expression)) (PP (IN in) (NP (NN patient) (NN material)))))))))) (. .))))
( (S (NP (NN Background))))
( (S (S (NP (NP (JJ Homosexual) (NNS men)) (VP (VBN infected) (PP (IN with) (NP (NN HIV-1))))) (VP (VBP are) (PP (IN at) (NP (NP (VBN increased) (NN risk)) (PP (IN for) (S (VP (VBG developing) (NP (NP (JJ AIDS-related) (NN Kaposi) (POS 's) (NN sarcoma)) (PRN (-LRB- -LRB-) (NP (NN AIDS-KS)) (-RRB- -RRB-))) (PP (IN due) (TO to) (NP (NP (NN co-infection)) (PP (IN with) (NP (NP (NN HHV-8)) (, ,) (NP (DT a) (NN gamma) (NN herpes) (NN virus))))))))))))) (. .)))
( (S (S (S (ADVP (RB Also)) (VP (VBN known) (PP (IN as) (NP (ADJP (NP (NN Kaposi) (POS 's) (NN sarcoma)) (JJ associated)) (NN herpes) (NN virus))))) (, ,) (NP (NN HHV-8)) (VP (VBD was) (ADVP (RB first)) (VP (VBN discovered) (PP (IN in) (NP (CD 1994))) (PP (IN in) (NP (JJ KS-affected) (NN tissue) (NN -LSB-1))))) (-RRB- -RSB-)) (. .)))
( (S (S (PP (IN Since) (NP (RB then))) (NP (PRP it)) (ADVP (RB also)) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ multicentric) (NN Castleman) (POS 's) (NN disease)))) (CC and) (NP (NP (JJ primary) (NN effusion) (NN lymphoma)) (PRN (-LRB- -LRB-) (NP (NN PEL) (-RRB- -RRB-) (CD -LSB-2-5)) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (NN HHV-8) (NN DNA)) (VP (VBZ has) (VP (VBN been) (VP (VBN detected) (PP (IN in) (NP (CC both) (NP (NNS tissues)) (CC and) (NP (NP (JJ bodily) (NNS fluids)) (CD -LSB-6,7) (-RRB- -RSB-)))))))) (. .)))
( (S (S (NP (NNS Studies)) (ADVP (RB initially)) (VP (VBD focused) (PP (IN on) (NP (NP (NN HHV-8)) (CC and) (NP (NP (NP (PRP$ its) (NN association)) (PP (IN with) (NP (NN KS)))) (, ,) (NP (NP (NN transmission)) (PP (IN of) (NP (NN HHV-8)))) (, ,) (CC and) (NP (NP (DT the) (JJ natural) (NN history)) (PP (IN of) (NP (NN HHV-8) (NN infection))))))))) (. .)))
( (S (S (SBAR (IN As) (S (VP (VBN shown) (PP (IN by) (NP (NP (NP (NP (NNP Renwick) (FW et) (FW al.)) (CC and) (NP (NNP Jacobsen) (FW et) (FW al.))) (NN -LSB-8,9) (-RRB- -RSB-) (NN seroconversion)) (PP (IN for) (NP (NN HHV-8))) (PP (IN during) (NP (NN HIV) (NN infection)))))))) (VP (VBZ increases) (NP (NP (DT the) (NN risk)) (PP (IN of) (S (VP (VBG developing) (NP (NN KS)))))) (, ,) (S (VP (VBG implying) (SBAR (IN that) (S (NP (NN HIV-1)) (VP (VBZ has) (NP (NP (DT an) (NN impact)) (PP (IN on) (NP (NN HHV-8))))))))))) (. .)))
( (S (S (NP (NP (NN Laboratory) (NNS assays)) (VP (VBN developed) (PP (IN for) (NP (NP (DT the) (NN detection)) (PP (IN of) (NP (NN HHV-8))))))) (VP (VBP include) (NP (NP (NP (JJ serologic) (NNS assays)) (CONJP (JJ such) (IN as)) (NP (NN immunofluorescence) (NN antibody) (NNS assays)) (NP (CD -LSB-10-13) (-RRB- -RSB-))) (, ,) (NP (NP (NN immunoblot) (NNS assays)) (CD -LSB-10) (-RRB- -RSB-)) (, ,) (CC and) (NP (NP (JJ various) (NN enzyme) (NNS immunoassays)) (CD -LSB-14-16) (-RRB- -RSB-))))) (. .)))
( (S (S (NP (JJ PCR-based) (NNS assays)) (VP (VBP have) (ADVP (RB also)) (VP (VBN been) (VP (VBN used) (S (VP (TO to) (VP (VB detect) (NP (NN HHV-8) (NN DNA) (NN -LSB-1)))) (-RRB- -RSB-)))))) (. .)))
( (S (S (PP (IN With) (NP (DT the) (JJ serologic) (NNS assays))) (, ,) (NP (NP (NN sensitivity)) (CC and) (NP (NN specificity))) (VP (VBP are) (ADVP (RB always)) (ADJP (JJ problematic)))) (. .)))
( (S (S (NP (DT No) (JJ single) (NN assay)) (VP (VBZ is) (ADVP (RB completely)) (ADJP (ADJP (JJ sensitive)) (CC and) (ADJP (JJ specific)) (NP (CD -LSB-17)) (-RRB- -RSB-)))) (. .)))
( (S (S (NP (PRP We)) (VP (MD would) (VP (VBP prefer) (NP (NP (DT a) (NN method)) (VP (VBG using) (NP (NP (JJ viral) (NN RNA)) (CC or) (NP (NN DNA))) (PP (IN as) (NP (NP (DT a) (NN marker)) (PP (IN for) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN HHV-8)))))))))))) (. .)))
( (S (S (SBAR (IN Though) (S (NP (NN DNA)) (VP (VBZ is) (NP (DT an) (JJ obvious) (NN choice)) (SBAR (IN because) (S (NP (NN HHV-8)) (VP (VBZ is) (NP (DT a) (NN DNA) (NN virus)))))))) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN chosen) (NP (NN RNA)) (, ,) (SBAR (IN because) (S (NP (PRP it)) (VP (VP (VBZ indicates) (NP (NP (NN activity)) (PP (IN of) (NP (DT the) (NN virus))))) (CC and) (VP (MD may) (ADVP (RB thus)) (VP (VB be) (NP (DT a) (JJR better) (JJ prognostic) (NN marker)))))))))) (. .)))
( (S (S (NP (JJ Active) (JJ infected) (NNS cells)) (VP (VBP produce) (NP (JJR more) (NN RNA)) (PP (IN than) (NP (NN DNA))))) (. .)))
( (S (S (NP (ADJP (FW In) (FW situ)) (NN hybridisation)) (VP (VBZ has) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (JJ most) (NN HHV-8) (JJ infected) (NNS cells)) (PP (IN in) (NP (NN KS) (NNS lesions)))) (VP (VBP are) (NP (ADJP (RB latently) (JJ infected)) (NN -LSB-18,19))) (-RRB- -RSB-)))))) (. .)))
( (S (S (CC but) (NP (JJ lytic) (NN HHV-8) (NN infection)) (VP (VBZ is) (ADJP (RB clearly) (JJ present) (PP (IN in) (NP (NP (DT a) (JJ small) (NN proportion)) (PP (IN of) (NP (NNS cells) (CD -LSB-20-22))))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (NP (DT A) (NN method)) (PP (IN for) (NP (NP (DT the) (NN detection)) (PP (IN of) (NP (NN RNA)))))) (VP (VBZ is) (NP (NN RT-PCR)))) (. .)))
( (S (S (S (VP (TO To) (VP (VB increase) (NP (NN sensitivity))))) (NP (DT an) (JJ additional) (NN amplification) (NN step)) (VP (MD can) (VP (VBP follow) (NP (DT the) (NN RT-PCR))))) (. .)))
( (S (S (NP (DT This) (NN method)) (VP (VP (VBZ is) (ADJP (NN time) (JJ consuming))) (CC and) (ADVP (RB also)) (VP (VBZ increases) (NP (NP (DT the) (NN likelihood)) (PP (IN of) (NP (JJ false) (JJ positive) (NNS reactions))) (PP (JJ due) (TO to) (NP (JJ cross-contamination.) (JJ Nucleic) (NN acid))))))) (S (NP (NP (JJ sequence-based) (NN amplification)) (PRN (-LRB- -LRB-) (NP (NN NASBA)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (JJ single-step) (JJ isothermal) (JJ RNA-specific) (NN amplification) (NN process) (CD -LSB-23) (-RRB- -RSB-)) (SBAR (WHNP (WDT that)) (S (VP (VBZ amplifies) (NP (NP (NN mRNA)) (PP (IN in) (NP (DT a) (JJ dsDNA) (NN background) (CD -LSB-24) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (NP (NN NASBA)) (VP (VBZ has) (VP (VBD proved) (ADJP (JJ successful) (PP (PP (IN in) (NP (NP (DT the) (NN detection)) (PP (IN of) (NP (JJ various) (NNS mRNAs) (CD -LSB-24-26) (-RRB- -RSB-))))) (CC and) (PP (IN in) (NP (NP (DT the) (NN detection)) (PP (IN of) (NP (ADJP (CC both) (ADJP (JJ viral) (NP (CD -LSB-23) (-RRB- -RSB-))) (CC and) (ADJP (JJ bacterial))) (NN -LSB-27) (-RRB- -RSB-) (NN RNA))) (PP (IN in) (NP (JJ clinical) (NNS samples)))))))))) (. .)))
( (S (S (PP (IN By) (S (VP (VBG combining) (NP (DT the) (JJ standard) (NN NASBA) (NN technology) (CD -LSB-28) (-RRB- -RSB-)) (PP (IN with) (NP (NP (DT a) (JJ molecular) (NN beacon)) (SBAR (WHNP (WDT that)) (S (VP (VBZ anneals) (PP (IN during) (NP (NN amplification))) (PP (TO to) (NP (DT the) (NN target) (NN sequence))))))))))) (, ,) (NP (DT a) (JJ real-time) (NN detection) (NN system)) (VP (VBZ is) (VP (VBN generated) (NP (CD -LSB-29) (-RRB- -RSB-))))) (. .)))
( (S (S (NP (DT This) (NN paper)) (VP (VBZ describes) (NP (NP (PRP$ our) (NN development)) (PP (IN of) (NP (JJ real-time) (NN NASBA) (NNS assays))) (S (VP (TO to) (VP (VB quantify) (NP (NP (NP (CD four) (ADJP (RB functionally) (JJ different)) (NNS genes)) (PP (IN of) (NP (NN HHV-8)))) (: :) (NP (NN ORF) (CD 73)) (, ,) (NP (NP (DT a) (JJ latent) (NN gene)) (, ,) (NP (NN vGCR))) (, ,) (NP (DT a) (ADJP (RB constitutively) (JJ active)) (NN gene)) (, ,) (CC and) (NP (DT the) (JJ lytic) (NNS genes) (NP (NP (NN vBcl-2)) (CC and) (NP (NN vIL-6))))))))))) (. .)))
( (S (S (VP (TO To) (VP (VB normalise) (NP (DT the) (NN input) (NN mRNA))))) (NP (PRP we)) (VP (VBD developed) (NP (NP (DT a) (JJ fifth) (NN NASBA)) (PP (IN for) (NP (NP (DT a) (ADJP (RB constitutively) (VBN expressed)) (NN mRNA)) (, ,) (NP (NN U1A) (NN mRNA)) (, ,) (CC and) (NP (NN standardised)) (NP (DT the) (JJ specific) (NN HHV8) (NNS mRNAs)))) (PP (TO to) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN U1A) (NN mRNA))))))) (. .)))
( (S (NP (NNS Methods))))
( (S (S (NP (PRP$ Our) (JJ first) (NN assay)) (VP (VP (VBD was) (VP (VBN developed) (PP (IN for) (NP (NN ORF) (CD 73))))) (CC and) (VP (VBZ is) (VP (VBN based) (PP (IN on) (NP (NP (DT the) (NN amplification)) (PP (IN of) (NP (NP (DT a) (CD 192) (NN bp) (NN fragment)) (ADJP (JJ situated) (PP (IN within) (NP (DT the) (NN gene)))))))))))) (. .)))
( (S (S (NP (NN ORF) (CD 73)) (VP (VBZ encodes) (NP (NP (NP (DT the) (JJ major) (JJ immunogenic) (JJ latency-associated) (JJ nuclear) (NN antigen)) (PRN (-LRB- -LRB-) (NP (NN LANA)) (-RRB- -RRB-))) (PP (IN of) (NP (NN HHV-8)))))) (. .)))
( (S (S (NP (NN LANA)) (VP (VBZ is) (ADJP (JJ essential) (PP (IN for) (NP (NP (NN maintenance)) (PP (IN of) (NP (DT this) (NN virus)))))) (PRN (PP (IN in) (NP (ADJP (RB latently) (JJ infected)) (NNS cells))) (NP (CD -LSB-30,31)) (-RRB- -RSB-)))) (. .)))
( (S (S (NP (PRP It)) (VP (VP (VBZ is) (VP (VBN expressed) (ADVP (RB only)) (PP (IN in) (NP (JJ such) (NNS cells))))) (CC and) (VP (ADVP (RB thus)) (VBZ gives) (NP (NP (DT a) (JJ good) (NN indication)) (PP (IN of) (NP (JJ latent) (NN HHV-8) (NN infection))))))) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NN LANA)) (VP (VP (VBZ interacts) (PP (IN with) (NP (DT the) (NN tumour) (NN suppressor) (NN protein) (NN p53)))) (CC and) (VP (VBZ represses) (NP (PRP$ its) (JJ transcriptional) (NN activity) (CD -LSB-32)))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (PRP$ Our) (JJ second) (NN assay)) (VP (VP (VBD was) (VP (VBN developed) (PP (IN for) (NP (NP (NN vGCR)) (, ,) (NP (NN G-protein) (JJ coupled) (NN receptor)) (, ,))))) (CC and) (VP (VBZ amplifies) (NP (DT a) (CD 168) (NN bp) (NN fragment))))) (. .)))
( (S (NP (NP (NP (DT A) (NN receptor)) (SBAR (WHNP (WDT that)) (S (VP (VBZ binds) (NP (JJ several) (NN CXC) (CC and) (NN CC) (NNS chemokines)))))) (, ,) (NP (NN vGCR))) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (NP (ADJP (RB constitutively) (JJ active)) (NN -LSB-33) (-RRB- -RSB-))))) (, ,) (SBAR (IN although) (S (NP (DT some) (NNS studies)) (VP (VBP indicate) (SBAR (IN that) (S (NP (PRP it)) (VP (VBZ is) (VP (VBN expressed) (ADVP (RB only)) (PP (IN during) (NP (JJ lytic) (NN replication) (CD -LSB-34))) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (PRP It)) (VP (MD may) (VP (VB contribute) (PP (TO to) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (NN KS))))) (PP (IN by) (S (VP (VBG increasing) (NP (NP (DT the) (NN release)) (PP (IN of) (NP (NP (JJ cellular) (NN growth) (NNS factors)) (PP (JJ such) (IN as) (NP (NN VEGF) (NN -LSB-33))))))) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (PRP It)) (VP (VP (VBZ transforms) (NP (JJ rodent) (NNS fibroblasts))) (CC and) (VP (VBZ induces) (NP (NP (NN expression)) (PP (IN of) (NP (JJ angiogenic) (NNS factors)))))) (LST (CD -LSB-35) (-RRB- -RSB-))) (. .)))
( (S (S (NP (DT The) (JJ final) (CD two) (NNS assays)) (VP (VBD were) (VP (VBN developed) (PP (IN for) (NP (DT the) (NNS genes) (NP (NP (NN vBcl-2)) (CC and) (NP (NN vIL-6)))))))) (. .)))
( (S (S (S (NP (NP (DT The) (NN assay)) (PP (IN for) (NP (NN vBcl-2)))) (VP (VBZ amplifies) (NP (DT a) (JJ 216-bp) (NN fragment)))) (, ,) (CC and) (S (PP (IN for) (NP (NN vIL-6))) (NP (DT the) (NN fragment)) (VP (VBZ is) (NP (CD 186) (NN bp))))) (. .)))
( (S (S (NP (NP (NN vBcl-2)) (CC and) (NP (NN vIL-6))) (VP (VBP are) (NP (DT both) (JJ early) (JJ lytic) (NNS genes)) (, ,) (SBAR (IN as) (S (NP (PRP$ their) (NN expression)) (VP (VBZ increases) (PP (IN within) (NP (CD 10) (NNS hours))) (PP (IN after) (NP (NN induction) (CD -LSB-9) (-RRB- -RSB-)))))))) (. .)))
( (S (S (S (NP (NN vBcl-2)) (VP (VBZ is) (NP (NP (DT a) (NN member)) (PP (IN of) (NP (DT the) (NN Bcl-2) (NN family)))))) (, ,) (CC and) (S (NP (JJ functional) (NNS studies)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN vBcl-2)) (VP (VP (VBZ prevents) (NP (JJ Bax-mediated) (NN apoptosis))) (CC and) (ADVP (RB thus)) (VP (VBZ is) (NP (DT an) (JJ anti-apoptotic) (NN protein) (NN -LSB-36,37)))) (-RRB- -RSB-)))))) (. .)))
( (S (S (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB primarily)) (ADJP (JJ active) (PP (IN during) (NP (JJ lytic) (NN replication)))))) (CC and) (S (NP (PRP$ its) (NN expression) (NN pattern)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (PRP it)) (VP (MD may) (VP (VB function) (S (VP (TO to) (VP (VB prolong) (NP (NP (DT the) (NN survival)) (PP (IN of) (NP (NNS cells))))) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (JJ lytic) (NN infection)) (VP (VBZ is) (ADJP (JJ present)))))))))))))) (. .)))
( (S (S (NP (NN vIL-6)) (VP (VBZ is) (NP (NP (DT a) (VBN secreted) (NN cytokine)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBZ maintains) (NP (NP (NN proliferation)) (PP (IN of) (NP (JJ IL-6-dependent) (NN mouse) (CC and) (JJ human) (NN mycelia) (NN cell) (NNS lines) (NP (CD -LSB-21,38,39)) (-RRB- -RSB-))))) (CC and) (VP (VBZ prevents) (NP (NN apoptosis) (CD -LSB-21,38,40) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (DT A) (NN NASBA) (NN reaction)) (VP (VBZ is) (VP (VBN based) (PP (IN on) (NP (NP (DT the) (JJ simultaneous) (NN activity)) (PP (IN of) (NP (NP (NP (NP (NP (JJ avian) (NN myeloblastosis) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN AMV)) (-RRB- -RRB-))) (NP (NP (JJ reverse) (NN transcriptase)) (PRN (-LRB- -LRB-) (NP (NN RT)) (-RRB- -RRB-)))) (, ,) (NP (NN RNase) (NN H)) (CC and) (NP (NN T7) (NN RNA) (NN polymerase))) (PP (IN with) (NP (CD two) (NN oligonucleotide) (NNS primers))) (S (VP (TO to) (VP (VB produce) (NP (NP (NN amplification)) (PP (IN of) (NP (NP (DT the) (JJ desired) (NN fragment)) (ADJP (QP (JJR more) (IN than) (CD 1012)) (JJ fold) (PP (IN in) (NP (QP (CD 90) (TO to) (CD 120)) (NNS minutes) (CD -LSB-23,41) (-RRB- -RSB-))))))))))))))))) (. .)))
( (S (S (PP (IN In) (NP (DT a) (NN NASBA) (NN reaction))) (, ,) (NP (JJ nucleic) (NNS acids)) (VP (VBP are) (NP (NP (DT a) (NN template)) (PP (IN for) (NP (DT the) (NN amplification) (NN reaction)))) (SBAR (RB only) (IN if) (S (NP (PRP they)) (VP (VBP are) (ADJP (ADJP (JJ single) (JJ stranded)) (CC and) (ADJP (JJ located) (PP (IN in) (NP (DT the) (JJ primer-binding) (NN region)))))))))) (. .)))
( (S (SBAR (IN Because) (S (NP (DT the) (NN NASBA) (NN reaction)) (VP (VBZ is) (ADJP (ADJP (JJ isothermal)) (PRN (-LRB- -LRB-) (NP (NN 41°C)) (-RRB- -RRB-)))))) (, ,) (NP (NP (JJ specific) (NN amplification)) (PP (IN of) (NP (NN ssRNA)))) (VP (VBZ is) (ADJP (JJ possible)) (SBAR (IN if) (S (NP (NP (NN denaturation)) (PP (IN of) (NP (NN dsDNA)))) (VP (VBZ is) (VP (VBN prevented) (PP (IN in) (NP (NP (DT the) (NN sample) (NN preparation)) (NN procedure)))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB thus)) (ADJP (JJ possible) (PP (TO to) (NP (NP (NN pickup) (NN mRNA)) (PP (IN in) (NP (DT a) (JJ dsDNA) (NN background)))))) (PP (IN without) (S (VP (VBG getting) (NP (NP (ADJP (ADJP (JJ false)) (ADJP (JJ positive))) (NNS results)) (VP (VBN caused) (PP (IN by) (NP (JJ genomic) (NNS dsDNA)))))))) (, ,) (PP (IN in) (NP (NP (NN contrast)) (PP (IN with) (NP (NN RT-PCR))))))) (. .)))
( (S (S (PP (IN In) (NP (NN figure) (CD 1))) (NP (NP (DT a) (JJ schematic) (NN presentation)) (PP (IN of) (NP (DT the) (NN NASBA) (NN amplification)))) (VP (VBZ is) (VP (VBN given)))) (. .)))
( (S (S (NP (NN NASBA)) (VP (VBZ is) (VP (VBN achieved) (PP (IN with) (NP (NP (DT the) (NN P1) (-LRB- -LRB-) (JJ antisense) (-RRB- -RRB-) (NN –) (NN P2) (-LRB- -LRB-) (NN sense) (-RRB- -RRB-) (NN oligonucleotide)) (VP (VBN set))))))) (. .)))
( (S (S (NP (NP (DT The) (NN overhang)) (PP (IN on) (NP (NN P1)))) (VP (VBZ encodes) (NP (NP (DT the) (NN promoter) (NN sequence)) (PP (IN for) (NP (DT the) (NN T7) (NN RNA) (NN polymerase)))))) (. .)))
( (S (S (PP (IN By) (S (VP (VBG using) (NP (NP (JJ molecular) (NNS beacons)) (PP (IN with) (NP (DT the) (NN NASBA) (NN amplification))))))) (NP (DT a) (JJ real-time) (NN detection) (NN system)) (VP (MD can) (VP (VB be) (VP (VBN generated))))) (. .)))
( (S (S (NP (JJ Molecular) (NNS beacons)) (VP (VBP are) (NP (NP (JJ stem-and-loop-structured) (NNS oligonucleotides)) (PP (IN with) (NP (NP (DT a) (JJ fluorescent)) (VP (VB label) (PP (IN at) (NP (NP (DT the) (NP (CD 5)) (POS ') (NN end)) (CC and) (NP (DT a) (JJ universal) (NN quencher)))) (PP (IN at) (NP (DT the) (NP (CD 3)) (POS ') (NN end))))))))) (. .)))
( (S (S (NP (PRP They)) (VP (VP (VBP are) (ADJP (RB highly) (JJ specific) (PP (IN for) (NP (PRP$ their) (NN target))))) (CC and) (VP (VBP hybridise) (PP (IN with) (NP (PRP$ their) (VBN amplified) (NN target) (NN RNA))) (SBAR (WHADVP (WRB when)) (S (ADJP (JJ present) (PP (IN in) (NP (DT a) (NN NASBA) (NN amplification) (NN reaction) (S (VP (TO to) (VP (VB form) (NP (DT a) (JJ stable) (NN hybrid) (NN -LSB-42) (-RRB- -RSB-)) (PP (IN at) (NP (NP (DT a) (JJ relative) (JJ low) (NN temperature)) (PRN (-LRB- -LRB-) (NP (NN 41°C)) (-RRB- -RRB-))))))))))))))) (. .)))
( (S (S (NP (DT The) (NN NASBA) (NN quantification) (NN method)) (VP (VBZ is) (VP (VBN based) (PP (IN on) (NP (NP (DT a) (JJ standard) (NN curve)) (PP (IN with) (NP (NP (DT a) (JJ known) (NN input)) (PP (IN of) (NP (NN RNA)))))))))) (. .)))
( (S (S (PP (IN For) (NP (DT this) (NN input))) (NP (PRP we)) (VP (VBD used) (NP (NP (ADJP (FW in) (FW vitro)) (NN RNA)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (VP (VBN transcribed) (PP (IN from) (NP (CD four) (JJ different) (NNS plasmids)))))))))) (. .)))
( (S (S (NP (DT These) (NNS plasmids)) (VP (VBD were) (VP (VBN generated) (PP (IN by) (S (VP (VBG cloning) (NP (NP (DT a) (JJ specific) (NN PCR) (NN product)) (PP (IN for) (NP (NP (DT each)) (PP (IN of) (NP (DT the) (CD four) (NN target) (NNS genes))))))))) (, ,) (S (VP (VBG using) (NP (NP (NN primer) (NNS sets)) (ADJP (JJ located) (PP (IN on) (NP (NP (DT the) (NNS borders)) (PP (IN of) (NP (DT the) (JJ different) (NNS genes)))))))))))) (. .)))
( (S (S (NP (NN Primer) (NNS sequences)) (VP (VBP are) (VP (VBN shown) (PP (IN in) (NP (NN table) (LST (LS 1.)) (NN Input))) (SBAR (IN for) (S (NP (DT the) (NN PCR)) (VP (VBD was) (NP (NP (DT the) (JJ nucleic) (NNS acids)) (PP (IN of) (NP (DT the) (NN BCP-1) (NN cell) (NN line)))) (PRN (-LRB- -LRB-) (NP (NP (DT a) (NN cell) (NN line)) (VP (VBG containing) (NP (NN HHV-8)))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (DT The) (NNS sizes)) (PP (IN of) (NP (DT the) (CD four) (JJ different) (NN PCR) (NNS fragments)))) (VP (VBD were) (NP (NP (CD 595) (NN bp)) (, ,) (NP (CD 926) (NN bp)) (, ,) (NP (CD 473) (NN bp)) (, ,) (CC and) (NP (CD 589) (NN bp))) (PP (IN for) (NP (NP (NN ORF) (CD 73)) (, ,) (NP (NN vGCR)) (, ,) (NP (NN vBcl-2)) (CC and) (NP (NN vIL-6)))) (, ,) (ADVP (ADVP (RB respectively)) (PRN (-LRB- -LRB-) (NP (NN table) (CD 1)) (-RRB- -RRB-))))) (. .)))
( (S (S (S (NP (DT Each) (NN PCR) (NN fragment)) (VP (VBD was) (VP (VBN cloned) (PP (IN into) (NP (DT the) (NN TOPO-TA) (NN plasmid))) (PRN (-LRB- -LRB-) (NP (NP (NNP Invitrogen/) (NNP Lifetechnologies)) (, ,) (NP (NNP Carlsbad) (, ,) (NNP USA))) (-RRB- -RRB-))))) (, ,) (CC and) (S (SBAR (IN after) (S (NP (DT all) (NNS inserts)) (VP (VBD were) (VP (VBN verified) (PP (IN by) (NP (NN sequencing))))))) (, ,) (NP (DT the) (NNS fragments)) (VP (VBD were) (VP (VBN cloned) (PP (IN in) (NP (NP (DT a) (NN plasmide)) (, ,) (NP (NP (NN pBluescript) (NN SK)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP Stratagene)) (, ,) (NP (NN La))) (NP (NNP Jolla) (, ,) (NNP USA))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (ADJP (FW In) (FW vitro)) (NN RNA)) (VP (VP (VBD was) (VP (VBN generated) (PP (IN from) (NP (NP (DT these) (NNS plasmids)) (VP (VBG using) (NP (NP (NN T7)) (CC or) (NP (NN T3)) (NP (NN RNA) (NN polymerase)))))) (, ,) (PP (VBG depending) (PP (IN on) (NP (NP (DT the) (NN orientation)) (PP (IN of) (NP (DT the) (NN fragment)))))))) (, ,) (CC and) (VP (VBD was) (VP (VBN treated) (PP (IN with) (NP (NN DNase))) (S (VP (TO to) (VP (VB remove) (NP (DT the) (NN plasmid))))))))) (. .)))
( (S (S (NP (DT The) (NN Q-RNA)) (VP (VBD was) (VP (VP (VBN purified) (PP (IN by) (NP (NP (NN RNeasy)) (PRN (-LRB- -LRB-) (NP (NP (NN Qiagen)) (, ,) (NP (NNP Hilden) (, ,) (NNP Germany))) (-RRB- -RRB-))))) (, ,) (VP (VBN quantified) (ADVP (RB spectrophotometrically))) (, ,) (CC and) (VP (VBN checked) (PP (IN by) (NP (NN eye))) (PP (IN on) (NP (NN agarose) (NN gel))))))) (. .)))
( (S (S (NP (DT The) (VBG resulting) (ADJP (FW in) (FW vitro)) (NN RNA)) (VP (VBD was) (VP (VBN used) (PP (IN for) (NP (DT the) (CD four) (JJ different) (JJ standard) (NNS curves)))))) (. .)))
( (S (S (S (NP (NN NASBA) (NN amplification)) (VP (VBZ requires) (NP (NP (NP (DT a) (NN sense)) (CC and) (NP (DT an) (NN anti-sense))) (NN primer)))) (, ,) (CC and) (S (PP (IN for) (NP (JJ real-time) (NN detection))) (NP (DT a) (JJ unique) (NN beacon)) (VP (VBZ is) (VP (VBN added) (PP (TO to) (NP (DT the) (NN reaction))))))) (. .)))
( (S (NP (PRP We)) (VP (VBD developed) (NP (NP (JJ molecular) (NNS beacons)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB hybridise) (PP (IN with) (NP (NP (DT the) (JJ known) (NNS sequences)) (PP (IN of) (NP (DT the) (CD four) (NN HHV-8) (NNS genes)))))) (, ,) (SBAR (IN as) (S (VP (VBN shown) (PP (IN in) (NP (NN table))) (S (LST (LS 2.)) (NP (PDT All) (DT the) (NNS beacons)) (VP (VBP have) (NP (NP (NP (NP (NN 6-fluorescine)) (PRN (-LRB- -LRB-) (NP (NN 6-FAM)) (-RRB- -RRB-))) (PP (IN as) (NP (NP (DT the) (JJ fluorescent) (VB label)) (PP (IN at) (NP (DT the) (CD 5) ('' ') (NN end)))))) (CC and) (NP (NP (DT a) (ADJP (-LRB- -LRB-) (NP (CD 4-) (-LRB- -LRB-) (NN dimethylamino) (-RRB- -RRB-) (NN phenyl) (-RRB- -RRB-) (NN azo)) (-RRB- -RRB-) (JJ benzoic)) (NN acid)) (PRN (-LRB- -LRB-) (NP (NN Dabcyl)) (-RRB- -RRB-)))) (PP (IN as) (NP (JJ universal) (NN quencher))) (PP (IN at) (NP (DT the) (CD 3) ('' ') (NN end))))))))))))) (. .)))
( (S (S (NP (NN A) (NN BLAST) (NN analysis)) (VP (VBD revealed) (SBAR (IN that) (S (PP (IN in) (NP (DT each) (NN case))) (, ,) (NP (CC neither) (NP (DT the) (NNS primers)) (CC nor) (NP (DT the) (NN beacon))) (VP (VBD shared) (NP (NP (JJ significant) (NN homology)) (PP (IN with) (NP (NP (DT any) (JJ known) (NN nucleotide) (NNS sequences)) (ADJP (JJ other) (PP (IN than) (NP (DT the) (NN target) (NN gene)))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN quality)) (PP (IN of) (NP (DT the) (JJ different) (NNS beacons)))) (VP (VBD was) (VP (VBN tested) (PP (IN with) (NP (NP (NP (DT a) (JJ melting) (NN curve)) (PRN (-LRB- -LRB-) (PP (IN from) (NP (CD 80°C) (TO to) (CD 20°C))) (-RRB- -RRB-))) (CC and) (NP (NN acryl) (NN amide) (NN gel) (NN electrophoresis))))))) (. .)))
( (S (S (NP (DT Each) (NN reaction)) (VP (VBD consisted) (PP (IN of) (NP (NP (NP (CD 5) (NN μl)) (PP (IN of) (NP (DT the) (NN sample) (NN RNA)))) (CC and) (NP (NP (CD 10) (NN μl)) (PP (IN of) (NP (NN NASBA) (NN reaction) (NN mix)))))))) (. .)))
( (S (NP (DT This) (NN mix)) (VP (VBD consisted) (PP (IN of) (NP (NP (ADJP (CD 80) (NN mM)) (NN Tris-HCl) (NN -LSB-pH) (CD 8.5) (-RRB- -RSB-)) (, ,) (NP (ADJP (CD 24) (NN mM)) (NN MgCl2)) (, ,) (NP (ADJP (CD 140) (NN mM)) (NN KCl)) (, ,) (NP (ADJP (CD 1.0) (NN mM)) (NN DTT)) (, ,) (NP (NP (CD 2.0) (NN mM)) (PP (IN of) (NP (DT each) (NN dNTP)))) (, ,) (NP (NP (NP (CD 4.0) (NN mM)) (NP (DT each))) (PP (IN of) (NP (NP (NN ATP)) (, ,) (NP (NP (NN UTP)) (CC and) (NP (NN CTP))) (, ,) (NP (ADJP (CD 3.0) (NN mM)) (NN GTP)) (, ,) (CC and) (NP (ADJP (CD 1.0) (NN mM)) (NN ITP)))) (PP (IN in) (NP (ADJP (CD 30) (NN %)) (NN DMSO))))))) (. .)))
( (S (S (NP (DT This) (NN solution)) (ADVP (RB also)) (VP (VBD contained) (NP (NP (NP (DT the) (ADJP (ADJP (JJ anti-sense)) (CC and) (ADJP (JJ sense))) (NNS primers)) (PP (IN for) (NP (NN amplification)))) (CC and) (NP (NP (DT the) (JJ molecular) (NNS beacons)) (VP (VBN used) (PP (IN for) (NP (NN detection)))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ final) (NN concentration)) (PP (IN for) (NP (DT the) (VBZ primes)))) (VP (VP (VBD was) (NP (CD 0.1) (NN μM))) (CC and) (VP (PP (IN for) (NP (DT the) (NNS beacons))) (NP (CD 40) (NN nM))))) (. .)))
( (S (S (S (NP (DT The) (NN reaction) (NNS mixtures)) (VP (VBD were) (VP (VBN incubated) (PP (IN at) (NP (NN 65°C))) (PP (IN for) (NP (CD 5) (NN min)))))) (, ,) (CC and) (S (PP (IN after) (NP (NP (NN cooling)) (PP (TO to) (NP (NP (NN 41°C)) (PP (IN for) (NP (CD 5) (NN min))) (S (VP (TO to) (VP (VB allow) (PP (IN for) (NP (NN primer) (NN annealing)))))))))) (, ,) (NP (NP (CD 5) (NN μl)) (PP (IN of) (NP (NN enzyme) (NN mix)))) (VP (VBD was) (VP (VP (VBN added) (PP (IN by) (NP (NN pipetting))) (PP (IN into) (NP (NP (DT the) (NNS lids)) (PP (IN of) (NP (DT the) (NNS microtubes)))))) (CC and) (VP (ADVP (RB subsequently)) (VBG spinning) (NP (NN down))))))) (. .)))
( (S (S (NP (DT This) (NN mix)) (VP (VBD contained) (, ,) (PP (IN per) (NP (NP (NN reaction)) (, ,) (NP (NN 375) (NN mM) (NN sorbitol)) (, ,) (NP (CD 2.1) (NN μg) (NN BSA)) (, ,) (NP (ADJP (CD 0.08) (NN U)) (NN RNase) (NN H)))) (, ,) (NP (NP (CD 32) (NN U)) (NP (NP (NN T7) (NN RNA) (NN polymerase)) (CC and) (NP (CD 6.4) (NN U) (NN AMV) (JJ reverse) (NN transcriptase)))))) (. .)))
( (S (S (NP (NNS Reactions)) (VP (VBD were) (VP (VBN incubated) (PP (IN at) (NP (NN 41°C))) (PP (IN for) (NP (CD 120) (NN min))) (PP (IN in) (NP (NP (DT a) (NN fluorometer)) (PRN (-LRB- -LRB-) (NP (NP (NNP Cytofluor) (CD 4000)) (: ;) (NP (NNP Perkin-Elmer) (, ,) (NNP Wellesley)) (, ,) (NP (NNP Mass.))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (DT The) (NN RNA) (NNS amplicons)) (VP (VBN generated) (PP (IN in) (NP (DT the) (NN NASBA) (NN process))))) (VP (VBP are) (VP (VBN detected) (PP (IN by) (NP (JJ molecular) (NNS beacons) (CD -LSB-29) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (DT These) (NNS beacons)) (VP (VBP generate) (NP (DT a) (JJ fluorescent) (NN signal)) (PP (IN during) (NP (NN amplification))) (SBAR (WHADVP (WRB when)) (S (VP (VBG hybridising) (PP (IN with) (NP (PRP$ their) (NN target)))))))) (. .)))
( (S (S (NP (DT The) (NN fluorescence)) (VP (VBZ is) (VP (VBN measured) (ADVP (RB continuously)) (PP (IN during) (NP (NN amplification))) (PP (IN for) (NP (NP (JJ real-time) (NN monitoring)) (PRN (-LRB- -LRB-) (PP (FW i.e.)) (, ,) (SBAR (IN as) (S (NP (DT the) (NN reaction)) (VP (VBZ proceeds)))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (DT A) (NN threshold)) (VP (VBZ is) (VP (VBN determined) (PP (IN by) (S (VP (VBG setting) (NP (NP (DT the) (NN fluorescence)) (VP (VBN emitted) (PP (IN in) (NP (DT the) (JJ first) (CD 5) (NN measure) (NNS points))) (PP (IN as) (NP (DT a) (NN background))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN time-point)) (SBAR (WHPP (IN at) (WHNP (WDT which))) (S (NP (DT a) (NN reaction)) (VP (VP (VBZ rises) (PP (IN above) (NP (NP (DT this) (NN threshold)) (PP (IN of) (NP (NN detection)))))) (CC and) (VP (VBZ becomes) (ADJP (JJ positive))))))) (VP (VBZ is) (VP (VBN determined)))) (. .)))
( (S (S (NP (DT This) (NN time-to-positivity) (-LRB- -LRB-) (NN TTP) (-RRB- -RRB-) (NN principle)) (VP (VBZ is) (ADJP (JJ similar) (PP (TO to) (NP (JJ real-time) (NN PCR) (CD -LSB-43) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (NP (DT A) (JJ calibration) (NN curve)) (PP (IN with) (NP (QP (CD 50) (, ,) (CD 102) (, ,) (CD 103) (, ,) (CD 104) (, ,) (CD 105) (, ,) (CD 106) (CC and) (CD 107)) (NNS molecules) (NN HHV-8) (NN mRNA)))) (VP (VBD was) (VP (VBN included) (PP (IN in) (NP (DT each) (NN experiment)))))) (. .)))
( (S (S (NP (NP (DT The) (NN number)) (PP (IN of) (NP (NN mRNA) (NNS copies))) (PP (IN per) (NP (NN sample) (NN input)))) (VP (MD can) (VP (VB be) (VP (VBN extrapolated) (PP (IN from) (NP (DT the) (JJ standard) (NN curve))))))) (. .)))
( (S (S (NP (FW De) (NP (NNP Baar) (FW et) (FW al))) (VP (VBD showed) (SBAR (IN that) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ possible) (S (VP (TO to) (VP (VB use) (NP (NP (NN ttp) (NNS values)) (PP (IN for) (NP (NN quantification)))) (PP (IN without) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (DT an) (JJ internal) (NN calibrator) (NN -LSB-44))))))) (-RRB- -RSB-)))))))) (. .)))
( (S (S (PP (IN For) (NP (NP (NN standardisation)) (PP (IN of) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NN RNA) (NN input))))))) (NP (DT the) (NN U1A) (NN assay)) (VP (VBD was) (VP (VBN used) (PP (IN in) (NP (DT each) (NN experiment)))))) (. .)))
( (S (S (NP (NN U1A) (NN mRNA)) (VP (VBZ encodes) (PP (IN for) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (NNS proteins)) (PP (IN of) (NP (DT the) (NN U1) (NN snRNP) (CD -LSB-45,46)))))))) (-RRB- -RSB-)) (. .)))
( (S (S (SBAR (IN Because) (S (NP (NN U1A)) (VP (VBZ is) (ADVP (RB constitutively)) (VP (VBN expressed))))) (, ,) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NN U1A) (NN mRNA))) (VP (VBN measured) (PP (IN in) (NP (DT the) (NNS samples))))) (VP (VBZ is) (NP (NP (DT an) (NN indication)) (PP (IN of) (NP (JJ total) (NN RNA) (NN input)))))) (. .)))
( (S (S (S (NP (NP (DT The) (NN mean)) (PP (IN of) (NP (NP (CD 6) (NNS assays)) (PRN (-LRB- -LRB-) (NP (NN variation) (CD 0.6) (NN log)) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN taken) (PP (IN as) (NP (NP (DT the) (NN input) (NN RNA) (NN amount)) (PP (IN of) (NP (DT the) (NN sample)))))))) (, ,) (CC and) (S (NP (NN sample) (NN input) (NN RNA)) (VP (VBD was) (VP (VBN normalised) (ADVP (RB accordingly)))))) (. .)))
( (S (S (NP (NP (DT The) (NN NASBA) (NN conditions)) (PP (IN for) (NP (DT the) (NN U1A) (NN assay)))) (VP (VBD were) (NP (NP (DT the) (JJ same)) (PP (IN as) (NP (NP (DT those)) (PP (IN for) (NP (DT the) (NN HHV-8) (NN assay)))))) (, ,) (PP (IN with) (NP (NP (DT the) (NN exception)) (PP (IN of) (NP (NP (DT the) (JJ final) (NN concentration)) (PP (IN of) (NP (NP (NP (DT the) (NN primer)) (PRN (-LRB- -LRB-) (NP (CD 0.2) (NN μM)) (-RRB- -RRB-))) (CC and) (NP (NP (DT the) (NN beacon)) (PRN (-LRB- -LRB-) (NP (CD 50) (NN nM)) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN DNA) (NNS fractions)) (PP (IN of) (NP (DT the) (NN PBMC) (NNS samples)))) (VP (VBD were) (VP (VBN tested) (PP (IN for) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN HHV-8) (NN DNA))))) (S (VP (VBG using) (NP (NP (DT a) (JJ nested) (NN PCR)) (PP (IN for) (NP (NN ORF) (CD 73))) (VP (VBN described) (PP (IN by) (NP (NP (NNP Goudsmit) (FW et) (FW al.)) (CD -LSB-47) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (PP (IN As) (NP (NP (DT a) (NN quantification)) (PP (IN of) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NN DNA) (NN input))))))) (, ,) (NP (NP (DT a) (JJ limited) (NN dilution) (NN PCR)) (PP (IN for) (NP (DT the) (JJ cellular) (NN CCR5) (NN gene)))) (VP (VBD was) (VP (VBN used)))) (. .)))
( (S (S (PP (IN With) (NP (JJ limited) (NN dilution))) (, ,) (NP (NP (DT an) (NN estimation)) (PP (IN of) (NP (NP (NNS copies)) (PP (IN of) (NP (NN HHV-8) (NN DNA)))))) (VP (VBD was) (VP (VBN made) (PP (IN in) (NP (NP (NN relation)) (PP (TO to) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NNS cells)))))))))) (. .)))
( (S (S (PP (IN For) (NP (CC both) (DT the) (NP (NN ORF) (CD 73)) (CC and) (NP (DT the) (NN CCR5) (JJ nested) (NN PCR)))) (, ,) (NP (DT the) (NN detection) (NN level)) (VP (VBD was) (NP (CD 5) (NNS molecules) (NN input)) (PP (IN per) (NP (NN reaction))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB test) (NP (PRP$ our) (NNS assays)) (ADVP (FW in) (FW vivo))))) (, ,) (NP (PRP we)) (VP (VBD selected) (NP (NN PBMC) (NNS samples)) (PP (IN from) (NP (NP (CD two) (NNS participants)) (PP (IN of) (NP (DT the) (NN Amsterdam) (NN Cohort) (NNS Studies))))))) (. .)))
( (S (S (S (VP (VBN Described) (ADVP (RB elsewhere)) (PP (IN in) (NP (NN detail) (CD -LSB-48,49)))) (-RRB- -RSB-)) (, ,) (NP (PRP they)) (VP (VP (VBD were) (NP (NP (DT both) (JJ HIV-1-infected) (NNS men)) (PP (IN with) (NP (NP (NN Kaposi) (POS 's)) (NN sarcoma))))) (CC but) (VP (VBD had) (NP (ADJP (RB very) (JJ different)) (NN disease) (NN development))))) (. .)))
( (S (S (NP (NN Patient) (CD 1)) (VP (VBD was) (NP (NP (DT a) (JJ 30-year-old) (NN man)) (SBAR (WHNP (WP who)) (S (VP (VBD was) (VP (VBN demonstrated) (S (VP (TO to) (VP (VB be) (ADJP (JJ HIV-1-seropositive) (PP (IN in) (NP (CD 1995)))))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NNP July) (CD 1996))) (NP (NN he)) (VP (VBD was) (VP (VBN diagnosed) (PP (IN with) (NP (NN KS)))))) (. .)))
( (S (S (NP (NN He)) (VP (VP (VBD did) (RB not) (VP (VB respond) (PP (TO to) (NP (NP (ADJP (JJ anti-retroviral))) (CC or) (NP (NN chemotherapy)))))) (CC and) (VP (VBD died) (PP (IN in) (NP (NP (NNP January)) (PP (IN of) (NP (CD 1997))))) (PP (IN as) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NP (JJ severe) (NN infiltration)) (PP (IN of) (NP (NN KS))) (PP (IN in) (NP (DT both) (NNS lungs)))))))))) (. .)))
( (S (S (NP (NN Patient) (CD 2)) (VP (VBZ is) (NP (NP (DT a) (JJ 36-year-old) (NN man)) (SBAR (WHNP (WP who)) (S (VP (VBD visited) (NP (PRP$ our) (JJ outpatient) (NN clinic)) (PP (IN in) (NP (CD 1992))) (PP (IN with) (NP (NP (DT an) (VBG increasing) (NN number)) (PP (IN of) (NP (JJ KS-related) (NN skin) (NNS lesions))))))))))) (. .)))
( (S (S (S (PP (IN After) (S (VP (VBG he) (NP (VBN started) (JJ anti-retroviral) (NN therapy))))) (NP (JJ several) (NNS lesions)) (VP (VBD disappeared))) (CC and) (S (NP (JJ complete) (NN remission)) (VP (VBD was) (ADVP (RB gradually)) (VP (VBN reached) (PP (IN over) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (CD two) (NNS years))))))))) (. .)))
( (S (S (NP (DT These) (CD two) (NNS patients)) (VP (VBD were) (VP (VBN chosen) (PP (IN in) (NP (JJ large) (NN part))) (PP (IN for) (NP (NP (DT the) (NN diversity)) (PP (IN in) (NP (NP (PRP$ their) (NN course)) (PP (IN of) (NP (NP (NN Kaposi) (POS 's)) (NN sarcoma)))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD tested) (NP (NP (NP (NP (NP (CD three) (NNS samples)) (PP (IN for) (NP (NN patient) (CD 1)))) (CC and) (NP (NP (CD seven) (NNS samples)) (PP (IN for) (NP (NN patient) (CD 2))))) (VP (VBN collected) (PP (IN over) (NP (NN time))))) (, ,) (NP (NP (DT all)) (VP (VBN taken) (PP (IN after) (NP (NP (NN diagnosis)) (PP (IN of) (NP (NN KS)))))))))) (. .)))
( (S (PP (IN After) (S (NP (DT the) (CD frozen) (NN PBMC) (NNS samples)) (VP (VBD were) (VP (VBN thawed))))) (NP (DT the) (NNS cells)) (VP (VBD were) (VP (VP (VBN collected)) (CC and) (VP (VBN resuspended) (PP (IN in) (NP (JJ Trizol™) (NN buffer))) (S (VP (TO to) (VP (VB isolate) (NP (NP (NN RNA)) (CC and) (NP (NN DNA))) (ADVP (RB simultaneously)) (, ,) (PP (VBG according) (PP (TO to) (NP (NP (DT the) (NN manufacturer) (POS 's)) (NNS recommendations)))))))))) (. .)))
( (S (S (NP (JJ Precipitated) (NN RNA)) (VP (VBD was) (ADJP (JJ redissolved)) (PP (IN in) (NP (CD 50) (NNP μl) (NNP H2O))))) (. .)))
( (S (S (PP (IN For) (NP (DT each) (NN time-point))) (, ,) (NP (NP (DT a) (JJ known) (NN amount)) (PP (IN of) (NP (NP (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN 7.6–11.1) (NN *) (CD 106) (NNS cells)) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN isolated)))) (. .)))
( (S (S (S (PP (IN With) (NP (NP (JJ high) (NN input)) (PP (IN of) (NP (JJ total) (NN RNA))))) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP (NN background) (NN RNA)) (VP (MD can) (VP (VBP disturb) (NP (NP (DT the) (NN amplification)) (PP (IN if) (NP (NN present))) (PP (IN in) (NP (JJ large) (NNS amounts)))))))))) (CC and) (S (NP (PRP it)) (VP (VBD was) (ADJP (JJ necessary) (S (VP (TO to) (VP (NN dilute) (NP (DT the) (NNS samples))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB have) (NP (NP (DT a) (JJ broad) (NN range)) (PP (IN in) (NP (NP (DT the) (NN dilution)) (PP (IN for) (NP (DT the) (NN RNA) (NN quantification)))))) (PP (IN in) (NP (DT the) (NN NASBA) (NNS experiments)))))) (, ,) (NP (DT the) (NNS samples)) (VP (VBD were) (VP (VBN diluted) (NP (QP (CD 10,100) (, ,) (CC and) (CD 1000)) (NNS times))))) (. .)))
( (S (S (S (PP (IN Of) (NP (DT these) (JJ diluted) (NNS samples))) (NP (CD 5) (NN μl)) (VP (VBD was) (VP (VBN used) (PP (IN per) (NP (NN reaction)))))) (, ,) (CC and) (S (NP (NP (CD 10) (NN μl)) (PP (IN of) (NP (NN reaction) (NN mix)))) (VP (VBD was) (VP (VBN added))))) (. .)))
( (S (S (NP (NN U1A) (NN mRNA)) (VP (VBD was) (VP (VBN used) (PP (IN as) (NP (DT an) (JJ external) (JJ standard))) (S (VP (TO to) (VP (VB compare) (NP (NN quantification) (NNS signals)) (PP (IN among) (NP (DT the) (JJ different) (NNS samples))))))))) (. .)))
( (S (NP (NNS Results))))
( (S (S (NP (DT These) (ADJP (RB newly) (VBN developed)) (NNS assays)) (VP (MD can) (VP (VB be) (VP (VBN used) (ADVP (RB quantitatively)) (PP (IN by) (S (VP (VBG testing) (NP (NP (DT a) (JJ standard) (NN curve)) (PP (IN of) (NP (NP (NNS samples)) (PP (IN with) (NP (NP (DT a) (JJ known) (NN amount)) (PP (IN of) (NP (NP (NN mRNA) (NNS molecules)) (PP (IN within) (NP (DT the) (JJ same) (NN experiment)))))))))) (PP (IN as) (NP (DT the) (JJ unknown) (NNS samples))) (, ,) (S (ADVP (RB then)) (VP (VBG extrapolating) (NP (DT the) (NNS results)) (PP (TO to) (NP (DT the) (JJ standard) (NN curve)))))))))))) (. .)))
( (S (S (NP (JJ Typical) (NN amplification) (NNS curves)) (VP (MD could) (VP (VB be) (VP (VBN plotted) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (DT an) (NN increase)) (PP (IN of) (NP (NN fluorescence)))) (VP (VBD was) (VP (VBN observed) (SBAR (IN until) (S (S (NP (NP (JJS most)) (PP (IN of) (NP (DT the) (JJ molecular) (NN beacon)))) (VP (VBD had) (VP (VBN hybridised) (PP (IN with) (NP (DT the) (VBN synthesised) (NNS amplicons)))))) (CC and) (S (NP (DT the) (NN fluorescence)) (VP (VBD reached) (NP (DT a) (JJ maximum) (NN level)))))))))))))) (. .)))
( (S (S (NP (NP (PDT Such) (DT an) (NN amplification)) (PP (IN of) (NP (ADJP (ADVP (FW in) (FW vitro)) (VBN synthesised)) (NN ORF) (CD 73) (NN RNA)))) (VP (VBZ is) (VP (VBN shown) (PP (IN in) (NP (NP (DT the) (NN insert)) (PP (IN in) (NP (NN figure) (NN 2a)))))))) (. .)))
( (S (S (NP (NP (NP (DT The) (NN time-point)) (SBAR (WHPP (IN at) (WHNP (WDT which))) (S (NP (DT the) (NN fluorescence) (NN signal)) (VP (VBD became) (ADJP (JJ detectable)) (PP (IN over) (NP (DT the) (NN background))) (PP (FW i.e.)))))) (, ,) (NP (NP (NN time-to-positivity)) (PRN (-LRB- -LRB-) (NP (NN ttp)) (-RRB- -RRB-))) (, ,)) (VP (VBD was) (ADJP (JJ linear)) (PP (IN over) (NP (NP (DT a) (NN range)) (PP (IN of) (NP (NP (QP (IN at) (JJS least) (CD six)) (NNS orders)) (PP (IN of) (NP (NP (NN magnitude)) (PP (IN of) (NP (NN input) (NN RNA) (NNS molecules))))))))) (, ,) (SBAR (IN as) (S (VP (VBN shown) (PP (IN by) (NP (NP (DT the) (NN dilution) (NN series)) (PP (IN of) (NP (ADJP (ADVP (FW in) (FW vitro)) (VBN synthesised)) (NN RNA)))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN figure) (NN 2a))) (NP (NP (DT the) (NN relationship)) (PP (IN between) (NP (NP (NN ttp) (NNS values)) (PP (IN of) (NP (NP (NP (DT the) (JJ standard) (NN curve)) (PP (IN for) (NP (NN ORF) (CD 73)))) (CC and) (NP (NP (DT the) (NN log) (NN input)) (PP (IN of) (NP (ADJP (FW in) (FW vitro)) (NN RNA))))))))) (VP (VBZ is) (VP (VBN shown)))) (. .)))
( (S (S (NP (DT This) (NN relationship)) (VP (VBD extended) (PP (IN from) (NP (QP (CD 107) (TO to) (CD 50)) (NNS molecules) (NN input))))) (. .)))
( (S (S (NP (NP (DT The) (NN dilution) (NN series)) (PP (IN of) (NP (ADJP (FW in) (FW vitro)) (NN RNA)))) (VP (VBD showed) (NP (NP (DT a) (NN detection) (NN level)) (PP (IN of) (NP (CD 50) (NNS molecules) (NN input)))))) (. .)))
( (S (S (PP (IN For) (NP (JJ accurate) (NN quantification))) (NP (DT the) (JJ required) (NN level)) (VP (VBZ is) (NP (CD 102) (NNS molecules) (NN input)) (PP (IN per) (NP (NN assay))))) (. .)))
( (S (S (NP (DT The) (NN line)) (VP (VBZ is) (VP (VBN calculated) (PP (IN with) (NP (JJ linear) (NN regression) (NN analysis)))))) (. .)))
( (S (S (PP (IN Besides) (NP (NP (DT the) (NN limit)) (PP (IN of) (NP (NP (NN detection)) (PRN (-LRB- -LRB-) (NP (NN LOD)) (-RRB- -RRB-)))))) (, ,) (NP (NP (DT the) (NN limit)) (PP (IN of) (NP (NP (NN quantification)) (PRN (-LRB- -LRB-) (NP (NN LOQ)) (-RRB- -RRB-))))) (VP (MD can) (VP (VB be) (VP (VBN determined))))) (. .)))
( (S (S (PP (IN For) (NP (NN ORF) (CD 73))) (, ,) (NP (DT the) (NN LOD)) (VP (VBZ is) (NP (NP (CD 50) (NNS molecules) (NN input)) (PRN (-LRB- -LRB-) (NP (CD 84) (NN %) (CD pos.)) (-RRB- -RRB-))) (SBAR (IN while) (S (NP (DT the) (NN LOQ)) (VP (VBZ is) (NP (NP (CD 102) (NNS molecules)) (PP (IN per) (NP (NN reaction))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ linear) (NN quantification)) (PP (IN of) (NP (NP (DT the) (NN ORF)) (ADJP (CD 73) (NN assay))))) (VP (VBD was) (VP (VBN determined) (S (VP (TO to) (VP (VB be) (PP (IN between) (NP (NP (QP (CD 102) (TO to) (CD 107)) (NNS copies)) (PP (NP (NN RNA)) (IN per) (NP (NP (NN reaction)) (PRN (-LRB- -LRB-) (NP (NP (NN R) (CD 2)) (ADJP (JJ =) (NP (CD 0.96)))) (, ,) (NP (NN p) (NN <) (CD 0.001)) (, ,) (NP (NN fig))))))))))))) (. .)))
( (S (S (NP (NN 2a)) (-RRB- -RRB-)) (. .)))
( (S (S (NP (NP (DT The) (NN sensitivity)) (PP (IN of) (NP (DT all) (CD four) (NNS assays)))) (VP (VBD was) (VP (VBN studied) (S (VP (VBG using) (NP (CD five) (JJ serial) (NNS dilutions))))))) (. .)))
( (S (S (NP (NP (DT The) (NN linear) (NN regression) (NNS analyses)) (PP (IN for) (NP (DT the) (JJ other) (NNS assays)))) (VP (VBP are) (VP (VBN shown) (PP (IN in) (NP (NN figure) (NN 2b,2c,2d,2e)))))) (. .)))
( (S (S (S (NP (NP (DT The) (NN assay)) (PP (IN for) (NP (NN vGCR)))) (VP (VBZ has) (NP (DT a) (ADJP (RB very) (JJ small)) (JJ standard) (NN deviation)))) (, ,) (CC and) (S (NP (DT the) (NN amplification)) (VP (VBZ is) (ADJP (JJ linear)) (PP (IN from) (NP (QP (CD 107) (TO to) (CD 50)) (NNS molecules) (NN input))) (PP (IN per) (NP (NN reaction))) (PRN (-LRB- -LRB-) (NP (NN R) (CD 2) (NNP >) (CD 0.99) (, ,) (NP (NN p) (JJ <) (CD 0.001)) (, ,) (NP (NN fig))))))) (. .)))
( (S (S (NP (NN 2b)) (-RRB- -RRB-)) (. .)))
( (S (S (S (NP (DT The) (NN LOD)) (VP (VBZ is) (NP (NP (CD 50) (NNS molecules)) (PRN (-LRB- -LRB-) (NP (CD 55) (NN %) (CD pos.)) (-RRB- -RRB-))))) (CC and) (S (NP (DT the) (NN LOQ)) (VP (VBZ is) (NP (NP (CD 102) (NNS molecules)) (PP (IN per) (NP (NN reaction))))))) (. .)))
( (S (S (NP (NP (DT The) (NNS assays)) (PP (IN for) (NP (CC both) (NP (NN vBcl-2)) (CC and) (NP (NN vIL-6))))) (VP (VP (VBP are) (ADJP (JJR weaker))) (CC but) (VP (ADVP (RB still)) (PP (IN within) (NP (DT a) (JJ workable) (NN range)))))) (. .)))
( (S (PP (IN As) (NP (JJ above))) (, ,) (NP (DT the) (JJ linear) (NN quantification)) (VP (VBD was) (PP (IN between) (S (S (NP (QP (CD 102) (TO to) (CD 107)) (NNS copies) (NN RNA) (IN per) (NN reaction) (-LRB- -LRB-) (NN R) (CD 2)) (VP (JJ =) (NP (CD 0.94)))) (CC and) (S (NP (NN R) (CD 2)) (VP (JJ =) (NP (CD 0.95) (ADVP (RB respectively)) (, ,) (NP (NN p) (JJ <) (CD 0.001)) (, ,) (NP (NN fig)))))))) (. .)))
( (S (S (NP (NN 2c,2d)) (-RRB- -RRB-)) (. .)))
( (S (PP (IN For) (NP (DT both) (NNS assays))) (, ,) (NP (DT the) (NN LOD)) (VP (VBZ is) (NP (NP (NP (CD 50) (NNS molecules)) (PRN (-LRB- -LRB-) (NP (CD 72) (NN %)))) (CC and) (NP (ADJP (CD 50) (NN %)) (NN pos)))) (. .)))
( (S (S (S (ADVP (RB respectively)) (-RRB- -RRB-)) (CC and) (S (NP (DT the) (NN LOQ)) (VP (VBZ is) (NP (NP (CD 102) (NNS molecules)) (PP (IN per) (NP (NN reaction))))))) (. .)))
( (S (S (NP (NN U1A)) (VP (VBZ has) (NP (NP (DT a) (JJ linear) (NN quantification) (NN range)) (PP (IN of) (NP (NP (QP (CD 103) (TO to) (CD 108)) (NNS molecules)) (PRN (-LRB- -LRB-) (NP (NP (NN R2)) (ADJP (JJ =) (NP (CD 0.99)))) (, ,) (NP (NN p) (NN <) (CD 0.001)) (, ,) (NP (NN fig) (NNS 2e)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (DT The) (NN assay)) (PP (IN for) (NP (NN U1A)))) (VP (VBD had) (NP (NP (DT a) (NN sensitivity)) (PP (IN of) (NP (QP (RB only) (CD 103)) (NNS copies) (NN input/reaction))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (JJ feasible) (PP (JJ due) (TO to) (NP (NP (DT the) (JJ high) (NN expression) (NN level)) (PP (IN of) (NP (NN U1A)))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN specificity)) (PP (IN of) (NP (DT the) (CD five) (NNS assays)))) (VP (VBD was) (VP (VBN tested) (PP (IN by) (S (VP (VBG spiking) (NP (DT each) (NN reaction)) (PP (IN with) (NP (NP (CD 106) (NNS molecules)) (PP (IN of) (NP (ADJP (FW in) (FW vitro)) (NN RNA))))) (SBAR (IN that) (S (NP (NP (DT the) (NNS primers)) (CC and) (NP (NN beacon))) (VP (VBD were) (RB not) (VP (VBN designed) (PP (IN for)))))))))))) (. .)))
( (S (S (PP (IN For) (NP (NN example))) (, ,) (NP (NP (NN ORF) (CD 73)) (NP (ADJP (FW in) (FW vitro)) (NN RNA))) (VP (VBD did) (RB not) (VP (VB give) (NP (NP (DT a) (NN signal)) (PP (IN with) (NP (DT the) (NN vGCR) (NN assay)))) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-))))) (. .)))
( (S (S (PP (IN In) (NP (VB replicate) (NP (JJ independent) (NNS experiments)))) (, ,) (NP (DT the) (NN time-to-positivity) (-LRB- -LRB-) (NN TTP) (-RRB- -RRB-) (NN value)) (VP (VBD had) (NP (NP (DT a) (JJ linear) (NN relationship)) (PP (IN with) (NP (NP (DT the) (NN logarithm)) (PP (IN of) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (ADJP (FW in) (FW vitro)) (NN RNA))) (VP (VBN added) (PP (IN in) (NP (DT the) (NN reaction))))))))))) (. .)))
( (S (S (NP (JJ Subsequent) (NNS experiments)) (VP (VBD used) (NP (NP (JJ serial) (JJ 10-fold) (NNS dilutions)) (PP (IN of) (NP (NP (ADJP (FW in) (FW vitro)) (NN RNA)) (-LRB- -LRB-) (PP (IN from) (NP (NP (QP (CD 107) (TO to) (CD 102) (CC and) (CD 50)) (NNS molecules)) (PP (IN per) (NP (NN reaction))))) (-RRB- -RRB-)))) (PP (IN as) (NP (DT a) (JJ standard) (NN curve))) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NN HHV-8) (NN RNA))) (PP (IN in) (NP (NNS samples))))))))) (. .)))
( (S (S (NP (DT The) (NNS experiments)) (VP (VBD were) (VP (VBN done) (PP (PP (IN on) (NP (JJ different) (NNS days))) (CC and) (PP (IN by) (NP (NP (JJ different) (NN people)) (PP (IN with) (NP (NP (DT no) (JJ significant) (NN variation)) (PP (IN in) (NP (NP (NNS results)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VP (VBD confirmed) (NP (NP (DT the) (NN robustness)) (PP (IN of) (NP (DT the) (NNS assays))))) (CC and) (VP (ADVP (RB also)) (NP (NP (PRP$ their) (NN ease)) (PP (IN of) (NP (NN performance)))))))))))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB address) (NP (NP (DT the) (NP (NN functionality)) (CC and) (NP (NN quality))) (PP (IN of) (NP (DT the) (NN HHV-8) (NNS assays))) (ADVP (FW in) (FW vivo)))))) (, ,) (NP (PRP they)) (VP (VBD were) (VP (VBN tested) (PP (IN on) (NP (NP (NN PBMC) (NNS samples)) (VP (VBN collected) (PP (IN after) (NP (NN KS) (NN diagnosis))) (PP (IN from) (NP (NP (CD two) (NNS participants)) (PP (IN in) (NP (DT the) (NN Amsterdam) (NN Cohort) (NNS Studies))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN total))) (, ,) (NP (CD 10) (JJ frozen) (NNS samples)) (VP (VBD were) (VP (VBN analysed)))) (. .)))
( (S (S (PP (IN As) (NP (DT a) (JJ positive) (NN control))) (, ,) (NP (DT all) (NNS samples)) (VP (VP (VBD were) (VP (VBN tested) (PP (IN for) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN HHV-8) (NN DNA))))) (PP (IN with) (NP (DT a) (JJ nested) (NN PCR))))) (CC and) (VP (VBD were) (VP (VBN found) (S (VP (TO to) (VP (VB be) (ADJP (JJ positive))))) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (NP (NNS Materials)) (CC and) (NP (NNS Methods))))) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NP (DT The) (NNS copies)) (PP (IN of) (NP (NN HHV-8) (NN DNA)))) (VP (VBD varied) (PP (IN between) (NP (CD 2) (CC and) (CD 2) (NN *) (CD 102))) (PP (IN per) (NP (CD 103) (NNS cells))) (PRN (-LRB- -LRB-) (NP (NN table) (CD 3)) (-RRB- -RRB-)))) (. .)))
( (S (S (NP (DT A) (NN relation)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (PP (IN between) (NP (NP (NP (DT the) (NN HHV-8) (NN DNA) (NNS levels)) (PP (IN in) (NP (NN PBMC)))) (CC and) (NP (NP (DT the) (NN extent)) (PP (IN of) (NP (NN Kaposi) (POS 's) (NN sarcoma) (CD -LSB-50) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (NP (NP (DT A) (JJ possible) (NN correlation)) (PP (IN between) (NP (NP (NN DNA) (NNS levels)) (CC and) (NP (NN mRNA) (NN expression))))) (VP (MD should) (VP (VB be) (VP (VBN investigated))))) (. .)))
( (S (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (DT the) (NN HHV-8) (NNS assays)))) (VP (VBP are) (VP (VBN shown) (SBAR (IN in) (NN table) (S (LST (LS 3.)) (PP (IN Of) (NP (DT the) (CD 10) (NNS samples))) (, ,) (NP (CD 9)) (VP (VBD were) (ADJP (JJ positive) (PP (IN for) (NP (NN ORF) (CD 73)))) (, ,) (SBAR (IN whereas) (S (NP (RB only) (NN half)) (VP (VBD were) (ADJP (JJ positive) (PP (IN for) (NP (NN vGCR))))))))))))) (. .)))
( (S (S (SBAR (IN While) (S (NP (NN vBcl-2)) (VP (VBD was) (VP (VBN measured) (PP (IN in) (NP (QP (CD 9) (IN out) (IN of) (CD 10)) (NNS samples))))))) (, ,) (NP (NN vIL-6)) (VP (VBD was) (VP (VBN detected) (PP (IN in) (NP (NP (RB approximately) (NN half)) (PP (IN of) (NP (DT the) (NNS samples)))))))) (. .)))
( (S (S (NP (NP (PDT All) (DT the) (NNS samples)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (ADJP (JJ positive) (PP (IN for) (NP (NN ORF) (CD 73)))))))) (VP (VBD were) (ADVP (RB also)) (ADJP (JJ positive) (PP (IN for) (NP (NN vBcl-2)))))) (. .)))
( (S (S (ADVP (RB Surprisingly)) (NP (DT the) (NNS samples)) (VP (VBD were) (ADJP (JJ positive)) (PP (IN for) (NP (DT a) (ADJP (ADJP (JJ latent)) (CC and) (ADJP (NN a) (JJ lytic))) (NN gene))) (PP (IN at) (NP (DT the) (JJ same) (NN time))))) (. .)))
( (S (S (NP (NP (DT The) (NN variation)) (PP (IN in) (NP (NN expression) (NNS levels)))) (VP (VBZ is) (ADJP (JJ large)) (PP (CC both) (PP (IN among) (NP (DT the) (JJ different) (NNS assays))) (CC and) (PP (IN among) (NP (DT the) (NNS samples)))))) (. .)))
( (S (S (NP (NP (DT No) (JJ clear) (NN trend)) (PP (IN in) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (JJ HHV-8-specific) (NN mRNA)))))) (VP (MD can) (VP (VB be) (VP (VBN distinguished) (, ,) (PP (VBN based) (PP (IN on) (NP (NP (NN HHV-8) (NN DNA) (NNS levels)) (, ,) (NP (NN patient)) (, ,) (CC or) (NP (NN disease) (NN status))))))))) (. .)))
( (S (NP (NN Discussion))))
( (S (S (PP (IN In) (NP (JJ general))) (NP (DT the) (NN NASBA) (NN assay)) (VP (VBZ has) (NP (JJ several) (NNS advantages)) (PP (IN over) (NP (DT the) (NN PCR) (NN technique) (CD -LSB-51) (-RRB- -RSB-))))) (. .)))
( (S (S (NP (NP (DT The) (NN amplification) (NN procedure)) (PP (IN of) (NP (DT the) (NN NASBA) (NN assay)))) (VP (VP (VBZ is) (ADVP (RB entirely)) (ADJP (JJ isothermal))) (CC and) (VP (VBZ is) (VP (VBN conducted) (PP (IN at) (NP (NN 41°C))))))) (: ;) (S (NP (PRP it)) (VP (VBZ does) (RB not) (VP (VB require) (NP (JJ thermal) (NN cycling) (NN instrumentation))))) (. .)))
( (S (S (NP (DT The) (NN NASBA) (NN product)) (VP (VP (VBZ is) (ADJP (JJ single-stranded))) (CC and) (VP (MD can) (ADVP (RB therefore)) (VP (VB be) (ADVP (RB readily)) (VP (VBN detected) (PP (IN by) (NP (NN hybridisation) (NN analysis)))))))) (. .)))
( (S (S (NP (PRP$ Our) (CD four) (JJ real-time) (NN NASBA) (NNS assays)) (VP (VP (VB offer) (NP (DT these) (NNS benefits))) (CC and) (VP (ADVP (RB also)) (NP (NP (NP (DT the) (CD five) (NNS features)) (SBAR (WHNP (WDT that)) (S (VP (VBP define) (NP (NP (NN validation)) (PP (IN of) (NP (DT any) (NN assay)))))))) (: :) (NP (NP (NN accuracy)) (, ,) (NP (NN sensitivity)) (, ,) (NP (NN precision)) (, ,) (NP (NN robustness)) (, ,) (CC and) (NP (NN specificity))))))) (. .)))
( (S (S (PP (IN With) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (JJ standard) (NNS curves))) (PP (IN in) (NP (DT each) (NN experiment))))) (, ,) (NP (NN accuracy)) (VP (VBZ is) (VP (VBN achieved)))) (. .)))
( (S (S (NP (DT The) (NN sensitivity)) (VP (VBZ is) (VP (VBN determined) (PP (IN with) (NP (DT a) (JJ linear) (JJ standard) (NN curve)))))) (. .)))
( (S (S (NP (NP (NP (NP (DT The) (NN limit)) (PP (IN of) (NP (NN detection)))) (PRN (-LRB- -LRB-) (NP (NN LOD)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (DT the) (NN limit)) (PP (IN of) (NP (NN quantification)))) (PRN (-LRB- -LRB-) (NP (NN LOQ)) (-RRB- -RRB-)))) (VP (VBP are) (VP (VBN determined)))) (. .)))
( (S (PP (IN For) (NP (PDT all) (DT the) (NN HHV-8) (NNS assays))) (, ,) (NP (DT the) (NN LOD)) (VP (VBZ is) (NP (NP (CD 50) (NNS molecules)) (SBAR (IN per) (S (NP (NP (NN reaction)) (CC and) (NP (NN LOQ))) (VP (VBD was) (NP (NP (CD 100) (NNS molecules)) (PP (IN per) (NP (NN reaction))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB achieve) (NP (JJ linear) (NN amplification))))) (VP (VBZ requires) (NP (QP (IN at) (JJS least) (CD 5)) (NNS concentrations)) (PP (IN on) (NP (NP (DT the) (JJ linear) (NN portion)) (PP (IN of) (NP (DT the) (NN curve))))))) (. .)))
( (S (S (S (PP (IN For) (NP (DT the) (NN HHV-8) (NNS assays))) (, ,) (NP (DT the) (JJ linear) (NN range)) (VP (VBZ spans) (NP (CD 7) (NNS concentrations)))) (CC and) (S (PP (IN for) (NP (NN U1A))) (NP (PRP it)) (VP (VBZ spans) (NP (CD 6) (NNS concentrations))))) (. .)))
( (S (S (NP (NN Quantification)) (VP (VBD was) (VP (VBN achieved) (PP (IN within) (NP (NP (NP (DT this) (JJ linear) (NN range)) (PP (IN of) (NP (NP (QP (IN at) (JJS least) (CD six)) (NNS orders)) (PP (IN of) (NP (NN magnitude)))))) (PRN (-LRB- -LRB-) (NP (NP (QP (CD 102) (TO to) (CD 107)) (NNS molecules)) (PP (IN per) (NP (NN reaction)))) (-RRB- -RRB-))))))) (. .)))
( (S (S (PP (IN Within) (NP (DT this) (JJ linear) (NN range))) (NP (NP (NN quantification)) (PP (IN of) (NP (NP (NP (QP (IN at) (JJS least) (CD six)) (NNS orders)) (PP (IN of) (NP (NN magnitude)))) (PRN (-LRB- -LRB-) (NP (NP (QP (CD 102) (TO to) (CD 107)) (NNS molecules)) (PP (IN per) (NP (NN reaction)))) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN achieved)))) (. .)))
( (S (S (NP (NP (DT The) (NN precision)) (PP (IN of) (NP (DT the) (NNS assays)))) (VP (VBD was) (VP (VBN measured) (PP (IN as) (NP (NP (DT the) (JJ standard) (NN deviation)) (CC and) (NP (NP (DT the) (NN confidence) (NN interval)) (PRN (-LRB- -LRB-) (NP (NN fig))))))))) (. .)))
( (S (S (NP (CD 2)) (-RRB- -RRB-)) (. .)))
( (S (S (NP (PRP We)) (VP (VBD used) (NP (NP (LS 5) (VBZ replicates)) (PP (IN of) (NP (NP (CD 7) (JJ different) (NNS concentrations)) (PP (IN of) (NP (DT the) (JJ standard) (NN curve)))))))) (. .)))
( (S (S (NP (NN Robustness)) (VP (VBD was) (VP (VBN determined) (PP (IN by) (S (VP (VBG having) (NP (JJ different) (NN people)) (VP (VB perform) (NP (NP (DT the) (NNS experiments)) (PP (IN on) (NP (JJ different) (NNS days))))))))))) (. .)))
( (S (S (NP (NN Specificity)) (VP (VBD was) (VP (VBN shown) (PP (IN with) (NP (JJ spiking) (NNS experiments)))))) (. .)))
( (S (S (NP (NP (DT The) (JJR lower) (NN detection) (NN level)) (PP (IN of) (NP (DT the) (NNS assays)))) (VP (VBD was) (NP (QP (RB approximately) (CD 50)) (NNS copies)) (PP (IN per) (NP (NN reaction))))) (. .)))
( (S (S (NP (DT The) (NNS assays)) (VP (VBP work) (ADVP (RB equally) (RB well)) (ADVP (FW in) (FW vivo)) (PP (IN as) (ADJP (FW in) (FW vitro) (FW e.g.))) (, ,) (PP (IN for) (NP (NP (NN quantification)) (PP (IN of) (NP (NP (NN HHV-8) (NN RNA)) (PP (IN in) (NP (NNS PBMCs))))))))) (. .)))
( (S (S (S (NP (NP (DT The) (NN onset)) (PP (IN of) (NP (NN KS)))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (JJ high) (NN HHV-8) (NN load)) (PP (IN in) (NP (NN PBMC) (CD -LSB-19) (-RRB- -RSB-)))))))) (CC and) (S (NP (DT this)) (VP (VBZ indicates) (SBAR (IN that) (S (NP (NN HHV-8) (JJ infected) (JJ circulating) (NNS cells)) (VP (VBP play) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NN KS) (NN development) (CD -LSB-20,52,53)))) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (NN HHV-8)) (VP (MD can) (VP (VB infect) (NP (NP (VBG circulating) (NN B) (NNS cells)) (, ,) (NP (NNS monocytes/macrophages)) (, ,) (NP (NN T) (NNS cells)) (CC and) (NP (JJ KS-like) (NN spindle) (NN cell) (NNS progenitors) (NP (CD -LSB-54-56) (-RRB- -RSB-))))))) (. .)))
( (S (S (PP (IN In) (NP (NN KS) (NNS lesions))) (S (NP (NN B) (NNS cells)) (VP (VBP are) (ADJP (ADJP (JJ rare)) (CC or) (ADJP (JJ absent))))) (, ,) (CC but) (S (NP (NNS monocytes) (NNS macrophages)) (VP (VBP are) (ADVP (RB abundantly)) (ADJP (JJ present) (NP (NP (CD -LSB-52) (-RRB- -RSB-)) (, ,) (NP (NP (DT this)) (VP (VBP suggest) (SBAR (IN that) (S (NP (VBG circulating) (NNS monocytes)) (VP (MD may) (VP (VP (VB recruit) (NP (DT the) (NN virus)) (PP (IN into) (NP (NNS tissues)))) (CC or) (VP (VB transmit) (NP (DT the) (NN virus)) (PP (TO to) (NP (JJ other) (NNS cells))))))))))))))) (. .)))
( (S (S (SBAR (IN Since) (S (NP (NP (NP (NNS lymphocytes)) (CC and) (NP (NNS monocytes))) (VP (VBG infiltrating) (NP (NN KS) (NNS lesions)))) (VP (MD can) (VP (VB be) (VP (ADVP (RB productively)) (VBN infected) (PP (IN by) (NP (NN HHV-8) (CD -LSB-20,22)))))) (-RRB- -RSB-))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ important) (PP (TO to) (NP (NP (NN look)) (PP (IN at) (NP (NP (JJ active) (NN infection)) (PP (IN in) (NP (DT the) (NN PBMC)))))))))) (. .)))
( (S (S (NP (NP (NNS PBMCs)) (PP (IN of) (NP (CD two) (NN AIDS-KS) (NNS patients)))) (VP (VBD were) (VP (VP (VBN selected)) (CC and) (VP (VBN analysed) (PP (IN for) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN HHV-8) (NN mRNA))))))))) (. .)))
( (S (S (S (PP (IN In) (NP (NP (CD 90) (NN %)) (PP (IN of) (NP (PRP$ our) (NNS samples))))) (, ,) (NP (NP (NN ORF) (CD 73) (NN mRNA)) (CC and) (NP (NN vBcl-2) (NN mRNA))) (VP (VBD were) (VP (VBN detected)))) (, ,) (IN whereas) (S (PP (IN for) (NP (NN vIL-6))) (NP (NP (NN mRNA)) (CC and) (NP (NN vGCR) (NN mRNA))) (VP (VBD were) (ADJP (JJ present) (PP (IN in) (NP (NP (CD 60) (NN %)) (CC and) (NP (CD 50) (NN %)) (, ,) (ADVP (RB respectively)))))))) (. .)))
( (S (S (NP (NP (DT The) (NN expression) (NNS levels)) (PP (IN of) (NP (DT all) (CD four) (NNS genes)))) (VP (VBD varied) (ADVP (RB widely)))) (. .)))
( (S (S (S (VP (VP (VBG Comparing) (NP (NP (DT the) (JJ different) (NN expression) (NNS levels)) (PP (IN of) (NP (DT the) (CD four) (NN HHV-8) (NNS genes)))) (PP (IN within) (NP (CD one) (NN sample)))) (CC or) (VP (VBG comparing) (NP (NP (NN expression) (NNS levels)) (PP (IN of) (NP (CD one) (NN gene)))) (PP (IN in) (NP (CD one) (NN patient)))))) (VP (VBD did) (RB not) (VP (VB show) (NP (DT an) (JJ apparent) (NN tendency))))) (. .)))
( (S (S (NP (DT No) (JJ clear) (NN trend)) (VP (MD can) (VP (VB be) (VP (VBN distinguished) (PP (VBN based) (PP (IN on) (NP (NP (DT the) (NN HHV-8) (NN DNA) (NNS levels)) (, ,) (NP (NP (NN patient)) (CC or) (NP (NN disease) (NN status)))))))))) (. .)))
( (S (S (ADVP (RB Nevertheless)) (NP (NP (DT the) (NN finding)) (PP (IN of) (NP (NP (NN expression)) (PP (IN of) (NP (JJ different) (NN HHV8) (JJ specific) (NNS genes))) (PP (IN in) (NP (NNS PBMCs)))))) (VP (VBZ is) (ADJP (JJ notable) (PP (IN in) (NP (PRP itself)))) (, ,) (SBAR (IN as) (S (NP (PRP it)) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN described) (ADVP (IN before))))))))) (. .)))
( (S (S (NP (NN HHV-8) (NN RNA)) (VP (VBZ has) (VP (VBN been) (VP (VBN found) (PP (IN in) (NP (NP (NNS tissues)) (, ,) (NP (JJ endothelial) (NNS cells)) (CC and) (NP (NP (NN spindle) (NNS cells)) (PRN (NN -LSB-18,57,58) (-RRB- -RSB-))))))))) (. .)))
( (S (S (PP (IN In) (NP (NP (CD 90) (NN %)) (PP (IN of) (NP (JJ fresh) (JJ KS-affected) (NNS tissues))))) (, ,) (NP (NN HHV-8) (NN RNA)) (VP (VBZ has) (VP (VBN been) (VP (VBN detected) (PP (IN with) (NP (NN RT-PCR) (CD -LSB-59)))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (NP (ADJP (FW In) (FW situ)) (NN hybridisation)) (CC and) (NP (NN LANA) (NN immunohistochemistry))) (VP (VBP have) (S (VP (VBD confirmed) (NP (NP (NN HHV-8) (NN gene) (NN expression)) (PP (IN in) (NP (NN KS) (NN spindle) (NNS cells)))) (PP (IN within) (NP (NN KS) (NNS lesions) (CD -LSB-18,58,60-62) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (NP (NN Expression)) (PP (IN of) (NP (JJ lytic) (NN HHV-8) (NNS genes)))) (VP (VBZ has) (ADVP (RB also)) (VP (VBN been) (VP (VBN documented) (PP (IN in) (NP (NP (NNS monocytes)) (CC and) (NP (NNS macrophages)))) (PP (IN in) (NP (NN KS) (NNS lesions) (CD -LSB-20) (-RRB- -RSB-))))))) (. .)))
( (S (NP (NN Conclusion))))
( (S (S (NP (NP (DT The) (NNS assays)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (VP (VBN developed)))))) (VP (VBP work) (ADVP (RB well)) (PP (IN for) (NP (NP (DT the) (NP (NN detection)) (CC and) (NP (NN quantification))) (PP (IN of) (NP (NN HHV-8) (JJ specific) (NN mRNA))))))) (. .)))
( (S (S (SBAR (IN Although) (S (NP (NP (DT no) (JJ clear) (NN trend)) (PP (IN in) (NP (DT the) (NN expression) (NN pattern)))) (VP (MD could) (VP (VB be) (VP (VBN distinguished) (NP (NP (DT the) (NN finding)) (PP (IN of) (NP (NP (NN expression)) (PP (IN of) (NP (JJ different) (NN HHV8) (JJ specific) (NNS genes))) (PP (IN in) (NP (NNS PBMCs))))))))))) (VP (VBZ is) (ADJP (JJ important) (PP (IN in) (NP (PRP itself)))))) (. .)))
( (S (S (IN As) (S (NP (DT this)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NN HHV-8) (NN replication)) (VP (VBZ takes) (NP (NN place)) (PP (IN in) (NP (DT the) (NN PBMC))))))))) (. .)))
( (S (S (NP (NP (NP (DT The) (NNS PBMCs)) (NP (PRP we))) (VP (VBN used))) (VP (VBD were) (VP (VBN obtained) (PP (IN from) (NP (CD two) (NNS patients)))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB draw) (NP (NP (NNS conclusions)) (PP (IN about) (NP (NP (DT the) (ADJP (ADJP (JJ clinical)) (CC and) (ADJP (JJ prognostic))) (NN utility)) (PP (IN of) (NP (DT these) (NNS assays))))))))) (NP (NP (JJR more) (NNS patients)) (CC and) (NP (NN patient) (NNS samples))) (VP (VBP need) (S (VP (TO to) (VP (VB be) (VP (VBN analysed))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (SBAR (IN as) (S (NP (DT the) (NNS assays)) (VP (VBP are) (ADJP (JJ able) (S (VP (TO to) (VP (VB quantify) (NP (NN HHV-8) (NN mRNA)) (PP (IN in) (NP (NN PBMC) (NNS samples)))))))))) (NP (PRP we)) (VP (VBP feel) (SBAR (IN that) (S (NP (NP (DT these) (JJ real-time) (NN NASBA) (NNS assays)) (PP (IN with) (NP (NN beacon) (NN detection)))) (VP (VBP provide) (NP (NP (NNS tools)) (PP (IN for) (NP (NP (JJ further) (NN study)) (PP (IN of) (NP (NP (NN HHV-8) (NN expression)) (PP (IN in) (NP (NN patient) (NN material))))))))))))) (. .)))
( (S (NP (VBG Competing) (NNS interests))))
( (S (S (NP (NN None)) (VP (VBD declared))) (. .)))
( (S (NP (NP (NNS Authors) (POS ')) (NNS contributions))))
( (S (S (NP (NN AP)) (VP (VBD carried) (PRT (RP out)) (NP (NP (DT the) (NP (NN assay) (NN development)) (CC and) (NP (NN validation))) (, ,) (VP (VP (JJ preformed) (NP (DT the) (NN NASBA) (NNS experiments))) (CC and) (VP (VBN drafted) (NP (DT the) (NN manuscript))))))) (. .)))
( (S (S (NP (NN JG)) (VP (VBD participated) (PP (IN in) (NP (DT the) (NN study) (NN design))))) (. .)))
( (S (S (NP (NN MC)) (VP (VP (VBD participated) (PP (IN in) (NP (DT the) (NN study) (NN design)))) (CC and) (VP (VBD carried) (PP (IN out) (NP (PRP$ its) (NN supervision)))))) (. .)))
( (S (NP (NN Pre-publication) (NN history))))
( (S (S (NP (NP (DT The) (JJ pre-publication) (NN history)) (PP (IN for) (NP (DT this) (NN paper)))) (VP (MD can) (VP (VB be) (VP (VBN accessed) (ADVP (RB here)))))) (: :)))
( (S (NP (NP (NN Figure)) (CC and) (NP (NN Table)) (NP (NNS captions)))))
( (S (NP (NP (NN Figure) (CD 1)) (: :) (NP (NP (NN NASBA) (NN amplification) (NN reaction) (NN NASBA) (NN amplification) (NN reaction)) (PP (IN with) (NP (DT the) (NP (NN P1) (-LRB- -LRB-) (NN anti-sense) (-RRB- -RRB-) (NN –) (NN P2) (-LRB- -LRB-) (NN sense) (-RRB- -RRB-) (NN oligonucleotide)) (NN primer) (NN set)))) (. .))))
( (S (S (NP (NP (DT The) (NN overhang)) (PP (IN on) (NP (DT the) (NN P1)))) (VP (VBZ encodes) (NP (NP (DT the) (NN promoter) (NN sequence)) (PP (IN for) (NP (DT the) (NN T7) (NN RNA) (NN polymerase)))))) (. .)))
( (S (S (NP (NP (NP (DT A) (JJ molecular) (NN beacon)) (PP (IN with) (NP (DT a) (NN fluorophore)))) (CC and) (NP (NP (DT a) (NN quencer)) (PP (IN with) (NP (DT the) (NN NASBA) (NN amplification) (NN reaction))))) (VP (VBZ generates) (NP (DT a) (JJ real-time) (NN detection) (NN system)))) (. .)))
( (S (NP (NP (NN Figure) (CD 2)) (: :) (NP (NP (JJ Standard) (NNS curves)) (PP (IN in) (NP (FW vitro) (NN RNA) (NN Figure) (CD 2) (NN a-d)))) (. .))))
( (S (NP (NP (NN Relationship)) (PP (IN of) (NP (NP (NN time-to-positivity)) (PRN (-LRB- -LRB-) (NP (NN TTP)) (-RRB- -RRB-)))) (PP (TO to) (NP (NN HHV-8) (NN mRNA) (NN copy) (NN number))) (. .))))
( (S (S (NP (NP (DT The) (NN number)) (PP (IN of) (NP (NP (NN mRNA) (NNS molecules)) (ADJP (JJ present) (PP (IN in) (NP (DT the) (NN reaction))))))) (VP (VBZ is) (VP (VBN indicated) (PP (IN on) (NP (NP (NP (DT the) (NN x) (NN axis)) (CC and) (NP (DT the) (NN ttp) (NN value))) (PP (IN in) (NP (NP (VBN indicated)) (PP (IN on) (NP (DT the) (NN y) (NN axis)))))))))) (. .)))
( (S (S (PP (IN For) (NP (NP (DT the) (NNS data)) (VP (VBN obtained) (PP (IN with) (NP (QP (CD 50) (, ,) (CD 102) (TO to) (CD 107)) (NNS molecules)))))) (, ,) (NP (NP (DT the) (NNS values)) (PP (IN of) (NP (NN TTP)))) (VP (VBP are) (NP (NP (DT the) (NN mean)) (PP (IN of) (NP (NP (NP (CD five)) (VBZ replicates)) (PP (IN of) (NP (JJ independent) (NNS experiments)))))))) (. .)))
( (S (S (PP (IN For) (NP (DT the) (NN U1A))) (NP (NP (DT the) (NN range)) (PP (IN of) (NP (NN RNA) (NN input)))) (VP (VBD was) (NP (CD 103) (TO to) (CD 108)))) (. .)))
( (S (S (NP (NN Error) (NNS bars)) (VP (VBP indicate) (NP (NP (DT the) (JJ standard) (NN deviation)) (PP (IN for) (NP (NP (DT the) (NNS values)) (PP (IN of) (NP (NN ttp)))))))) (. .)))
( (S (S (S (NP (DT The) (JJ solid) (NN line)) (VP (VBD was) (VP (VBN obtained) (PP (IN by) (NP (NP (JJ linear) (NN regression) (NN analysis)) (PP (IN of) (NP (NP (DT the) (NNS data)) (PP (IN from) (NP (QP (CD 50) (TO to) (CD 107)) (NNS molecules)))))))))) (, ,) (CC and) (S (NP (DT the) (JJ dotted) (NNS lines)) (VP (VBP indicate) (NP (NP (DT the) (ADJP (CD 95) (NN %)) (NN confidence) (NNS intervals)) (PP (IN for) (NP (DT the) (NN regression))))))) (. .)))
( (S (S (VP (VBZ Inserts) (NP (NP (NN a-d) (: :) (NN Amplification) (NN plot)) (PP (IN of) (NP (NP (DT a) (JJ 10-fold) (NN dilution) (JJ serial) (NN dilution)) (PP (IN of) (NP (ADJP (FW in) (FW vitro)) (NN RNA))))) (PP (IN for) (NP (NP (NN ORF) (CD 73)) (, ,) (NP (NN vGCR)) (, ,) (NP (NN vBcl-2)) (CC and) (NP (NN vIL-6))))))) (. .)))
( (S (S (NP (NP (DT The) (NN amount)) (PP (IN of) (NP (NP (NN input) (NN RNA) (CD 1) (NN *) (CD 107)) (, ,) (NP (CD 1) (NN *) (CD 106)) (, ,) (NP (CD 1) (NN *) (CD 105)) (, ,) (NP (CD 1) (NN *) (CD 104)) (, ,) (NP (CD 1) (NN *) (CD 103)) (, ,) (NP (CD 1) (NN *))))) (NP (QP (CD 102) (, ,) (CD 50) (CC and) (CD 0)) (NNS molecules))) (. .)))
( (S (NP (NP (NN Insert) (NN e)) (: :) (NP (NP (NN Amplification) (NN plot)) (PP (IN of) (NP (NP (DT a) (JJ 10-fold) (NN dilution) (JJ serial) (NN dilution)) (PP (IN of) (NP (NN U1A))))) (PP (IN in) (NP (FW vitro) (NN RNA)))) (, ,) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NP (NP (NN input) (NN RNA) (CD 1) (NN *) (CD 108)) (, ,) (NP (CD 1) (NN *) (CD 107)) (, ,) (NP (CD 1) (NN *) (CD 106)) (, ,) (NP (CD 1) (NN *) (CD 105)) (, ,) (NP (CD 1) (NN *) (CD 104)) (, ,) (NP (CD 1) (NN *) (QP (CD 103) (CC and) (CD 0)))) (NNS molecules)))) (. .))))
( (S (NP (NP (NN Table) (CD 1)) (: :) (NP (NP (NNS Primers)) (PP (IN for) (NP (NP (NN PCR) (NN fragment)) (PP (IN in) (NP (NNS plasmids)))))))))
( (S (NP (NP (NN Table) (CD 2)) (: :) (NP (NP (NNS Sequences)) (PP (IN of) (NP (NP (DT the) (NP (NNS primers)) (CC and) (NP (NNS beacons))) (PP (IN for) (NP (NP (DT each)) (PP (IN of) (NP (DT the) (NNS assays)))))))))))
( (S (NP (NP (NN Table) (CD 3)) (: :) (NP (NP (DT The) (NN ratio) (NN mRNA)) (PP (IN of) (NP (PRN (-LRB- -LRB-) (NP (NP (NN HHV-8)) (: /) (NP (NN U1A))) (-RRB- -RRB-)) (NN ×) (CD 107)))))))
( (S (NP (NP (JJ Stage-specific) (NNS changes)) (PP (IN in) (NP (JJ fetal) (NN thymocyte) (NN proliferation))) (PP (IN during) (NP (DT the) (JJ CD4-8-) (TO to) (NN CD4+8+) (NN transition))) (PP (IN in) (NP (NP (NP (JJ wild) (NN type)) (, ,) (NP (ADJP (JJ Rag1-/-))) (, ,) (CC and) (NP (NN Hoxa3)) (, ,) (NP (NN Pax1))) (JJ mutant) (NNS mice))))))
( (S (NP (NN Abstract))))
( (S (NP (NP (NN Background)) (: :) (S (NP (NP (DT The) (NN function)) (PP (IN of) (NP (DT the) (JJ thymic) (NN microenvironment)))) (VP (VBZ is) (S (VP (TO to) (VP (VB promote) (NP (NN thymocyte) (NN maturation)) (, ,) (PP (IN in) (NP (NN part))) (PP (IN via) (NP (NP (NN regulation)) (PP (IN of) (NP (NP (NN thymocyte) (NN proliferation)) (CC and) (NP (NN cell) (NN death))))))))))) (. .))))
( (S (S (NP (NP (NNS Defects)) (PP (PP (IN in) (NP (NP (JJ fetal) (JJ thymic) (NN epithelial) (NN cell) (-LRB- -LRB-) (NN TEC) (-RRB- -RRB-) (NN development)) (CC and) (NP (NN function)))) (, ,) (CC and) (RB therefore) (PP (IN in) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (DT a) (JJ functional) (NN microenvironment))))) (, ,))) (VP (MD can) (VP (VB be) (VP (VBN caused) (ADVP (CC either) (ADVP (RB directly) (PP (IN by) (NP (NN TEC) (NN differentiation) (NNS defects)))) (CC or) (ADVP (RB indirectly))) (PP (IN by) (NP (JJ defective) (NN thymocyte) (NN maturation))))))) (. .)))
( (S (PP (IN In) (NP (DT this) (NN paper))) (NP (PRP we)) (VP (VBD studied) (NP (JJ fetal) (NN thymocyte) (NN proliferation)) (PP (IN during) (NP (NP (DT the) (JJ early) (NN transition)) (PP (IN from) (NP (NP (DT the) (JJ CD3-4-8-)) (PRN (-LRB- -LRB-) (NP (NP (JJ triple) (JJ negative)) (, ,) (NP (NN TN))) (-RRB- -RRB-)))) (PP (TO to) (NP (ADJP (ADJP (JJ CD4+8+)) (PRN (-LRB- -LRB-) (FRAG (NP (JJ double) (JJ positive)) (, ,) (NP (NN DP))) (-RRB- -RRB-))) (NNS stages)))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD compared) (NP (NP (JJ wild) (NN type)) (NNS mice)) (PP (PP (IN with) (NP (JJ Rag1-/-) (NNS mice))) (CC and) (PP (IN with) (NP (NP (JJ Hoxa3+/-Pax1-/-) (NN compound) (JJ mutant) (NNS mice)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (NP (NNS blocks)) (PP (IN at) (NP (NP (JJ different) (NNS stages)) (PP (IN of) (NP (NN thymocyte) (NN development))))))))))))) (. .)))
( (S (NP (NP (NNS Results)) (: :) (S (NP (JJ Wild) (NN type) (ADJP (ADJP (JJ fetal)) (CC and) (ADJP (JJ adult))) (NN thymus)) (VP (VBD showed) (NP (NP (JJ stage-specific) (NNS differences)) (PP (IN in) (NP (NP (DT the) (NN proliferation) (NNS profiles)) (PP (IN of) (NP (VBG developing) (NNS thymocytes)))))) (, ,) (PP (IN with) (NP (NP (JJ fetal) (NNS stages)) (VP (VBG showing) (NP (NP (ADJP (RB generally) (JJR higher)) (NNS levels)) (PP (IN of) (NP (NN proliferation))))))))) (. .))))
( (S (S (NP (NP (DT The) (NN proliferation) (NN profile)) (PP (IN of) (NP (NP (JJ fetal) (NNS thymocytes)) (PP (IN from) (NP (JJ Rag1-/-) (NNS mutants)))))) (ADVP (RB also)) (VP (VBD had) (NP (NP (JJ stage-specific) (NNS increases)) (PP (IN in) (NP (NN proliferation)))) (PP (VBN compared) (PP (TO to) (NP (JJ wild) (NN type) (JJ fetal) (NNS thymocytes)))) (, ,) (PP (IN in) (NN contrast) (TO to) (NP (NP (DT the) (JJR lower) (NN proliferation)) (VP (ADVP (RB previously)) (VBN reported) (PP (IN for) (NP (NP (NNS thymocytes)) (PP (IN from) (NP (JJ adult) (JJ Rag1-/-) (NNS mutants)))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB previously)) (VP (VBN shown) (SBAR (IN that) (S (NP (JJ Hoxa3+/-Pax1-/-) (NNS mice)) (VP (VBP have) (NP (JJ abnormal) (JJ fetal) (NN TEC) (NN development)) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (NP (VBN increased) (NN apoptosis)) (PP (IN at) (NP (DT the) (NN TN) (TO to) (NN DP) (NN transition)))) (CC and) (NP (VBN decreased) (NN DP) (NN cell) (NNS numbers)))))))))))) (. .)))
( (S (S (NP (NP (JJ Fetal) (NNS thymocytes)) (PP (IN from) (NP (JJ Hoxa3+/-Pax1-/-) (NN compound) (NNS mutants)))) (VP (VBD had) (NP (VBN increased) (NN proliferation)) (, ,) (CC but) (NP (JJR fewer) (VBG proliferating) (NNS cells)) (, ,) (PP (IN at) (NP (DT the) (NN DP) (NN stage))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB also)) (VP (VBD observed) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NP (DT the) (NNS cytokines) (NP (NP (NN IL-7)) (CC and) (NP (NN SCF)))) (VP (VBN produced) (PP (IN by) (NP (NN Hoxa3+/-Pax1-/-TECs.) (NN Conclusion))))))))))) (: :) (S (NP (PRP$ Our) (NNS results)) (VP (VBP indicate) (NP (NP (ADJP (ADJP (JJ complex)) (CC and) (ADJP (JJ stage-specific))) (NNS effects)) (PP (IN of) (NP (JJ abnormal) (NN TEC) (NN development))) (PP (IN on) (NP (NN thymocyte) (NN proliferation)))))) (. .)))
( (S (NP (NN Background))))
( (S (S (NP (NN Thymocyte) (NN development)) (VP (VBZ occurs) (PP (IN within) (NP (NP (NP (DT a) (JJ complex) (NN network)) (PP (IN of) (NP (NNS cells)))) (, ,) (NP (JJ extracellular) (NN matrix)) (, ,) (CC and) (NP (NP (JJ secreted) (NNS factors)) (VP (VBN referred) (PP (TO to)) (PP (IN as) (NP (NP (DT the) (JJ thymic) (NN microenvironment)) (NN -LSB-1))))) (-RRB- -RSB-))))) (. .)))
( (S (S (NP (JJ Current) (NN evidence)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (DT this) (NN microenvironment)) (VP (VBZ is) (VP (VBN created) (PP (IN during) (NP (JJ fetal) (NN thymus) (NN organogenesis))) (PP (IN through) (NP (NP (JJ stage-dependent) (NNS interactions)) (PP (IN between) (NP (NP (NP (JJ differentiating) (JJ thymic) (JJ epithelial) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNS TECs)) (-RRB- -RRB-))) (CC and) (NP (VBG developing) (NNS thymocytes) (CD -LSB-2-6) (-RRB- -RSB-)))))))))))) (. .)))
( (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (NNS blocks)) (PP (IN at) (NP (NP (JJ different) (NNS stages)) (PP (IN of) (NP (NN thymocyte) (NN development)))))) (VP (VBP result) (PP (IN in) (NP (NP (JJ differential) (NNS effects)) (PP (IN on) (NP (NNS TEC) (NP (NP (NN differentiation)) (CC and) (NP (NN function))))))))) (. .)))
( (S (S (PP (IN Because) (PP (IN of) (NP (NP (DT the) (JJ complex) (NN interdependence)) (PP (IN of) (NP (NP (NN TEC)) (CC and) (NP (NN thymocyte) (NN differentiation))))))) (, ,) (NP (NP (NNS defects)) (PP (IN in) (NP (JJ fetal) (NN TEC) (NN development)))) (VP (MD can) (VP (VB be) (VP (VBN caused) (PP (CC either) (PP (ADVP (RB directly)) (IN by) (NP (JJ cell-autonomous) (NN TEC) (NN differentiation) (NNS defects))) (, ,) (CC or) (ADVP (RB indirectly)) (PP (IN by) (NP (JJ defective) (NN thymocyte) (NN maturation)))))))) (. .)))
( (S (S (SBAR (IN Once) (S (NP (DT a) (JJ mature) (JJ thymic) (NN environment)) (VP (VBZ is) (VP (VBN formed))))) (, ,) (NP (NP (ADJP (JJ many))) (, ,) (CONJP (IN if) (RB not)) (NP (NP (DT all) (NNS stages)) (PP (IN of) (NP (NN thymocyte) (NN maturation))))) (VP (VBP require) (NP (NP (NNS interactions)) (PP (IN with) (NP (JJ thymic) (JJ epithelial) (NNS cells)))))) (. .)))
( (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (NNS defects)) (PP (IN in) (NP (NNS TECs)))) (VP (MD can) (VP (PP (IN in) (NP (NN turn))) (VB cause) (NP (NP (NNS defects)) (PP (IN in) (NP (NP (NN thymocyte) (NN differentiation)) (, ,) (NP (NN proliferation)) (, ,) (CC or) (NP (NN cell) (NN death)))))))) (. .)))
( (S (S (NP (NN Thymocyte) (NN differentiation)) (VP (VBZ undergoes) (NP (CD two) (JJ main) (NNS transitions)))) (. .)))
( (S (S (NP (DT The) (JJ first)) (VP (VBZ is) (PP (IN from) (NP (NP (NP (DT the) (JJ CD3-4-8-)) (PRN (-LRB- -LRB-) (NP (NP (JJ triple) (JJ negative)) (, ,) (NP (NN TN))) (-RRB- -RRB-))) (PP (TO to) (NP (DT the) (ADJP (ADJP (JJ CD4+8+)) (PRN (-LRB- -LRB-) (NP (ADJP (JJ double) (JJ positive)) (, ,) (NN DP)) (-RRB- -RRB-))) (NNS stages))))))) (. .)))
( (S (PP (IN During) (NP (DT this) (NN transition))) (, ,) (NP (NN T) (NN cell) (NNS precursors)) (ADVP (RB sequentially)) (VP (VP (VB gain)) (CC and) (VP (VB lose) (NP (NP (NN cell) (NN surface) (NN expression)) (PP (IN of) (NP (NP (NP (NN CD44)) (CC and) (NP (NN CD25))) (NNS markers))))) (, ,) (VP (VB express) (NP (NP (DT the) (JJ pre-T) (NN cell) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN pTCR)) (-RRB- -RRB-)))) (, ,) (CC and) (VP (VB undergo) (NP (NN β-selection) (CD -LSB-2,7-9) (-RRB- -RSB-)))) (. .)))
( (S (S (NP (DT The) (JJ other) (NN transition)) (VP (VBZ is) (PP (IN from) (NP (NP (JJ CD4+8+) (NN DP)) (PP (TO to) (NP (ADJP (ADJP (JJ CD4+)) (CC or) (ADJP (ADJP (JJ CD8+) (S (NP (NP (JJ single) (JJ positive) (-LRB- -LRB-) (NN SP) (-RRB- -RRB-) (NNS thymocytes)) (, ,) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NN DP) (NNS cells)) (VP (VP (VBP express) (NP (NN CD3))) (, ,) (VP (VBP rearrange) (NP (PRP$ their) (NN α-TCR))) (, ,) (VP (VBP undergo) (NP (ADJP (ADJP (JJ positive)) (CC and) (ADJP (JJ negative))) (NN selection))) (, ,) (CC and) (ADVP (RB down)) (VP (VBP regulate) (NP (NP (NN CD4)) (CC or) (NP (NN CD8)))))))) (VP (TO to) (VP (VB become) (NP (JJ functional) (JJ CD8+)))))) (CC or) (ADJP (JJ CD4+)))) (NN SP) (NN T) (NNS cells))))) (NP (NN -LSB-10,11)) (-RRB- -RSB-))) (. .)))
( (S (S (PP (IN In) (NP (NP (NN addition)) (PP (TO to) (NP (JJ functional) (CC and) (NN cell) (NN surface) (NN marker) (NNS changes))))) (, ,) (NP (DT each) (NN thymocyte) (NN differentiation) (NN stage)) (VP (VBZ is) (VP (VBN marked) (PP (IN by) (NP (NP (JJ characteristic) (NNS changes)) (PP (IN in) (NP (NP (NN proliferation)) (CC and) (NP (NN apoptosis) (CD -LSB-12-18)))) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (NP (DT The) (ADJP (RBS most) (ADJP (RB well) (VBN defined))) (NN role)) (PP (IN for) (NP (NN TECs))) (PP (IN in) (S (VP (ADVP (RB directly)) (VBG affecting) (NP (NN thymocyte) (NN differentiation)))))) (VP (VBZ is) (S (VP (TO to) (VP (VB mediate) (NP (JJ positive) (NN selection)) (PP (IN via) (NP (NP (NN expression)) (PP (IN of) (NP (NN MHC) (NNS molecules) (CD -LSB-11,19-22) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (PRP it)) (VP (VBZ is) (ADVP (RB still)) (ADJP (JJ unclear)) (SBAR (SBAR (IN whether) (S (NP (NNS TECs)) (ADVP (RB directly)) (VP (VBP promote) (NP (NP (JJ specific) (NNS stages)) (PP (IN of) (NP (NN thymocyte) (NN differentiation)))) (PP (IN during) (NP (NP (NNS stages)) (SBAR (WHNP (WDT that)) (S (VP (VBP do) (RB not) (VP (VB involve) (NP (NN MHC-TCR) (NNS interactions))))))))))) (, ,) (CC or) (SBAR (IN whether) (S (NP (NP (PRP$ their) (NN role)) (PP (IN at) (NP (JJ other) (NNS stages)))) (VP (VBZ is) (ADVP (RB primarily)) (S (VP (TO to) (VP (VB promote) (NP (NP (NN cell) (NN growth)) (CC and) (NP (CC /or) (NP (NN survival))))))))))))) (. .)))
( (S (S (S (NP (NP (NNS Cytokines)) (VP (VBN produced) (PP (IN by) (NP (NNS TECs))))) (VP (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB promote) (NP (NP (NN proliferation)) (PP (IN in) (NP (NP (JJ early) (NNS stages)) (PP (IN of) (NP (NN thymocyte) (NN development)))))))))))) (, ,) (CC and) (VP (VBP have) (VP (VBN been) (VP (VBN proposed) (S (VP (TO to) (VP (VB regulate) (NP (NP (NN apoptosis)) (CC and) (NP (NN differentiation))))))))))) (, ,) (IN although) (S (NP (PRP$ their) (JJ precise) (NNS roles)) (VP (VBP remain) (ADJP (JJ controversial) (NP (CD -LSB-23,24) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (NNS TECs)) (VP (VBP have) (ADVP (RB also)) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB promote) (NP (NN thymocyte) (NN proliferation)) (PP (IN in) (NP (NN SP) (NNS cells)))) (SBAR (IN after) (S (NP (NN selection)) (VP (VBZ has) (VP (VBN occurred) (S (NP (NN -LSB-15)) (-RRB- -RSB-)))))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NP (DT a) (VBN defined) (NN role)) (PP (IN for) (NP (NNS TECs))) (PP (IN at) (NP (DT the) (NN TN-DP) (NN transition)))) (VP (VBZ remains) (ADJP (JJ elusive)))) (. .)))
( (S (S (NP (NP (JJ Much)) (PP (IN of) (NP (NP (DT the) (NN research)) (PP (IN on) (NP (DT this) (NN transition)))))) (VP (VBZ has) (VP (VBN focused) (PP (IN on) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (DT the) (NN pre-TCR)))))))) (. .)))
( (S (S (NP (JJ Mounting) (NN evidence)) (VP (VBZ suggests) (SBAR (IN that) (S (S (NP (DT the) (NN pre-TCR)) (VP (VBZ does) (RB not) (VP (VB require) (NP (NP (NN interaction)) (PP (IN with) (NP (DT a) (NN ligand))) (S (VP (TO to) (VP (VB perform) (NP (PRP$ its) (NN function))))))))) (, ,) (CC and) (S (NP (NP (NP (DT the) (JJ subsequent) (NN CD44-25-)) (PRN (-LRB- -LRB-) (NP (NP (NN TN4)) (CC or) (NP (NN pre-DP))) (-RRB- -RRB-))) (PP (TO to) (NP (NN DP) (NN transition)))) (VP (VBZ has) (VP (VBN been) (VP (VBN termed) (S (`` ``) (NP (NP (VBN programmed) (NN differentiation) (NN '')) (S (VP (TO to) (VP (VB indicate) (SBAR (IN that) (S (NP (DT this) (NN step)) (VP (MD can) (VP (VB occur) (PP (IN in) (NP (VBN isolated) (NNS thymocytes))) (, ,) (PP (ADVP (RB presumably)) (IN without) (NP (NP (NN input)) (PP (IN from) (NP (NP (JJ extrinsic) (NNS signals)) (CD -LSB-25-27) (-RRB- -RSB-)))))))))))))))))))))) (. .)))
( (S (ADVP (RB However)) (, ,) (NP (EX there)) (VP (VBZ is) (ADVP (RB also)) (NP (NN evidence) (SBAR (IN that) (S (NP (DT the) (JJ thymic) (NN microenvironment)) (VP (VBZ does) (VP (VB contribute) (NP (NP (NNS signals)) (VP (VBN required) (PP (IN for) (NP (DT the) (NN TN-DP) (NN transition)))))))))) (, ,) (S (ADVP (RB particularly)) (VP (TO to) (VP (VB promote) (NP (NP (NN thymocyte) (NN proliferation)) (CC and) (NP (NN apoptosis) (CD -LSB-13,28-30) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (NP (DT The) (NP (JJ specific) (NN nature)) (CC and) (NP (NN purpose))) (PP (IN of) (NP (DT the) (NN TEC) (NN contribution))) (PP (IN during) (NP (DT this) (JJ important) (NN transition)))) (ADVP (RB therefore)) (VP (VBZ remains) (S (VP (TO to) (VP (VB be) (VP (VBN determined))))))) (. .)))
( (S (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NN thymocyte) (NN development))) (PP (IN by) (NP (NNS TECs)))))))) (, ,) (NP (PRP we)) (VP (VBP are) (VP (VBG studying) (NP (JJ Hoxa3+/-Pax1-/-) (NN compound) (JJ mutant) (NNS mice))))) (. .)))
( (S (S (NP (NP (NN Hoxa3)) (CC and) (NP (NN Pax1))) (VP (VBP are) (NP (NP (NN transcription) (NNS factors)) (SBAR (WHNP (WDT that)) (S (VP (VBP act) (PP (IN in) (NP (NP (DT a) (JJ common) (NN pathway)) (VP (VBG regulating) (NP (NP (NN thymus) (NN organogenesis)) (CC and) (NP (JJ thymic) (NN epithelial) (NN cell) (NN development) (CD -LSB-29,31-34))))))) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (JJ Hoxa3+/-Pax1-/-) (NN compound) (NNS mutants)) (VP (VBP have) (NP (NP (NP (NNS defects)) (PP (IN in) (NP (NN TEC) (NN development))) (PP (VBG including) (NP (NP (VBN reduced) (NNS numbers)) (PP (IN of) (NP (NNS TECs)))))) (, ,) (NP (JJR fewer) (NN MHC) (NN Class) (JJ II+) (NNS TECs)) (, ,) (CC and) (NP (NP (NNS changes)) (PP (IN in) (NP (NP (NN TEC) (NN proliferation)) (CC and) (NP (NN apoptosis)))))))) (. .)))
( (S (S (NP (DT These) (NN TEC) (NNS defects)) (VP (VBP result) (PP (IN in) (NP (NP (NN thymocyte) (NN maturation) (NNS defects)) (SBAR (WHNP (WDT that)) (S (VP (VBP include) (NP (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (JJ total) (NN thymocyte) (NN number)))) (CC and) (NP (NP (DT a) (JJ 10-fold) (NN reduction)) (PP (IN in) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NN DP) (NNS thymocytes)))))) (, ,) (CC but) (NP (NP (DT an) (ADJP (RB apparently) (JJ normal)) (NN transition)) (PP (IN from) (NP (DT the) (NN TN3))) (PP (TO to) (NP (DT the) (NN pre-DP) (NN stage)))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN decrease)) (PP (IN in) (NP (NN DP) (NNS cells)))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (VBN increased) (NN apoptosis)) (PP (IN in) (NP (CC both) (NP (NN pre-DP)) (CC and) (NP (NN DP) (NNS cells)) (NP (NN -LSB-29)) (-RRB- -RSB-)))))))) (. .)))
( (S (S (SBAR (IN As) (S (NP (NP (DT the) (NNS defects)) (PP (IN at) (NP (DT the) (NN TN) (TO to) (NN DP) (NN transition))) (PP (IN in) (NP (DT these) (NNS mutants)))) (VP (VBP are) (VP (VBN caused) (PP (IN by) (NP (NP (JJ defective) (NN TEC) (NN function)) (CONJP (RB rather) (IN than)) (NP (JJ thymocyte-intrinsic) (NNS defects)))))))) (, ,) (NP (DT these) (NNS mice)) (VP (VBP represent) (NP (NP (DT an) (NN opportunity)) (S (VP (TO to) (VP (VB study) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NNS TECs))) (PP (IN in) (S (VP (VBG promoting) (NP (DT this) (NN transition)))))))))))) (. .)))
( (S (S (S (VP (TO To) (ADVP (RB further)) (VP (VB investigate) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NNS TECs))) (PP (IN in) (S (VP (VBG promoting) (NP (NP (NN thymocyte) (NN death)) (CC and) (NP (NN growth))) (PP (IN during) (NP (DT the) (NN TN) (TO to) (NN DP) (NN transition)))))))))) (, ,) (S (NP (PRP we)) (VP (VBD assayed) (NP (NP (DT the) (NN proliferation)) (PP (IN of) (NP (NP (JJ specific) (NN thymocyte) (NNS subsets)) (VP (VBG using) (NP (NP (NN BrdU) (NN incorporation)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ detects) (NP (NN cycling) (NNS cells)) (PP (IN in) (NP (NN S-phase)))))))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD compared) (NP (NP (ADJP (ADJP (JJ fetal)) (CC and) (ADJP (JJ adult))) (JJ wild) (NN type) (NNS mice)) (PP (IN with) (NP (NN Hoxa3))) (PRN (, ,) (S (NP (NN Pax1) (NN compound) (NNS mutants)) (NP (NN -LSB-29,34))) (-RRB- -RSB-))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB also)) (VP (VBD assayed) (NP (NP (JJ Rag1-/-) (NNS mice)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (NP (NP (NNS defects)) (PP (IN in) (NP (NP (NN TEC) (NN development)) (ADJP (JJ due) (PP (TO to) (NP (VBN arrested) (NN thymocyte) (NN maturation))))))) (PP (IN at) (NP (DT the) (NN TN3) (NN stage) (CD -LSB-35)))))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (PRP We)) (VP (VBD found) (NP (NP (JJ stage-specific) (NNS differences)) (PP (IN in) (NP (NN proliferation) (NNS levels))) (PP (IN between) (NP (ADJP (ADJP (JJ fetal)) (CC and) (ADJP (JJ adult))) (JJ wild) (NN type) (NNS thymocytes)))))) (. .)))
( (S (NP (PRP We)) (ADVP (RB also)) (VP (VBD found) (NP (NP (JJ distinct) (NNS patterns)) (PP (IN of) (NP (NN thymocyte) (NN proliferation))) (PP (IN in) (NP (DT the) (ADJP (ADJP (JJ Rag1-/-)) (CC and) (ADJP (JJ Hoxa3))) (, ,) (NP (NN Pax1) (NNS mutants)))))) (. .)))
( (S (S (NP (NP (DT The) (NP (NP (JJ abnormal) (NN cell) (NN death)) (CC and) (NP (NN proliferation))) (NNS patterns)) (PP (IN in) (NP (NP (NP (DT the) (NN Hoxa3)) (, ,) (NP (NN Pax1) (NN compound))) (JJ mutant) (JJ fetal) (NNS thymocytes)))) (VP (MD might) (VP (VB be) (VP (VBN caused) (PP (IN in) (NP (NN part))) (PP (IN by) (NP (NP (VBN observed) (NNS reductions)) (PP (IN in) (NP (NP (DT the) (NN transcription) (NNS levels)) (PP (IN of) (NP (NP (DT the) (NNS cytokines)) (NP (NP (NN IL-7)) (CC and) (NP (NN SCF))) (VP (VBN produced) (PP (IN by) (NP (NNS TECs)))))))))))))) (. .)))
( (S (S (NP (PRP$ Our) (NNS results)) (VP (VP (VBP support) (NP (NP (DT a) (JJ critical) (NN role)) (PP (IN for) (NP (NP (NN microenvironment)) (VP (VBN created) (PP (IN by) (NP (NNS TECs)))))) (PP (IN in) (S (VP (VBG regulating) (NP (NN thymocyte) (NN proliferation)) (PP (IN during) (NP (DT the) (NN TN) (TO to) (NN DP) (NN transition)))))))) (, ,) (CC and) (VP (VBP show) (SBAR (IN that) (S (NP (DT this) (NN function)) (VP (VBZ is) (VP (VBN disrupted) (PP (IN in) (NP (NP (NN Hoxa3)) (, ,) (NP (NN Pax1) (NN compound) (NNS mutants))))))))))) (. .)))
( (S (NP (NNS Results))))
( (S (PP (IN As) (NP (DT an) (JJ initial) (NN analysis))) (, ,) (NP (PRP we)) (VP (VBD compared) (NP (NN thymocyte) (NN proliferation)) (PP (IN between) (NP (NP (NNS thymocytes)) (PP (IN from) (NP (ADJP (ADJP (JJ late) (JJ fetal)) (PRN (-LRB- -LRB-) (NP (NN E17.5)) (-RRB- -RRB-)) (CC and) (ADJP (JJ adult)) (PRN (-LRB- -LRB-) (NP (CD 6–8) (NN week)) (-RRB- -RRB-))) (JJ wild) (NN type) (JJ C57BL6/J) (NNS mice)))))) (. .)))
( (S (SBAR (IN Although) (S (NP (NP (NNS differences)) (PP (IN in) (NP (NP (DT the) (NN proliferation)) (PP (IN of) (NP (ADJP (ADJP (JJ fetal)) (CC vs.) (ADJP (JJ adult))) (JJ TCR-expressing) (NNS thymocytes)))))) (CC and) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (NP (CD -LSB-36) (-RRB- -RSB-))))))) (, ,) (NP (PRP we)) (VP (VBD were) (ADJP (JJ interested) (PP (IN in) (S (VP (VBG investigating) (NP (DT the) (ADJP (RBR more) (JJ immature)) (NN thymocyte) (NNS subsets))))))) (. .)))
( (S (S (NP (NN BrdU) (VBN labeled) (ADJP (ADJP (JJ fetal)) (CC and) (ADJP (JJ adult))) (NNS thymi)) (VP (VBD were) (VP (VBN analyzed) (PP (IN for) (NP (NP (DT the) (NN percent)) (PP (IN of) (NP (VBG proliferating) (NNS cells))))) (PP (IN in) (NP (NP (JJ different) (JJ CD3-4-8-) (NN TN) (NN thymocyte) (NNS subsets)) (VP (VBN defined) (PP (IN by) (NP (NP (NN CD44)) (CC and) (NP (NN CD25)) (NP (NN expression) (NN -LSB-8)) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (DT The) (JJ CD3+4+8+) (NN population)) (VP (VBD was) (VP (VBN defined) (PP (IN by) (NP (NP (NN co-staining)) (PP (IN of) (NP (NP (DT all) (CD three) (NNS markers)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 1A)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (NP (DT A) (JJ typical) (NN analysis)) (PP (IN of) (NP (NP (NP (DT the) (NN BrdU+) (NNS cells)) (PP (IN in) (NP (NN DP) (NNS cells)))) (CC and) (NP (NP (DT the) (CD four) (NP (NP (NN CD44)) (CC vs.) (NP (NN CD25))) (NNS subsets)) (PP (IN within) (NP (DT the) (NN TN) (NN cell) (NN population))))))) (VP (VBZ is) (VP (VBN shown) (PP (IN in) (NP (NN Figure) (CD 1)))))) (. .)))
( (S (S (NP (NP (JJ Compiled) (NN data)) (PP (IN for) (NP (NP (DT each) (NN subset)) (PP (IN from) (NP (DT all) (NNS experiments)))))) (VP (VBZ is) (VP (VBN shown) (PP (IN in) (NP (NN Table) (CD 1)))))) (. .)))
( (S (S (NP (NP (NP (NP (DT The) (JJ wild) (NN type)) (ADJP (ADJP (JJ adult) (PRN (-LRB- -LRB-) (NP (NP (NNP Fig.) (CD 1C)) (, ,) (NP (NN 1F))) (-RRB- -RRB-))) (CC and) (ADJP (JJ fetal)))) (PRN (-LRB- -LRB-) (NP (NP (NNP Fig.) (CD 1D)) (, ,) (NP (NN 1F))) (-RRB- -RRB-))) (NN thymocyte) (NN proliferation) (NN profile) (NNS patterns)) (VP (VBD differed) (ADVP (RB significantly)) (PP (IN at) (NP (JJ specific) (NNS stages))))) (. .)))
( (S (S (NP (NP (DT The) (JJ overall) (NN proliferation) (NN level)) (PP (IN in) (NP (NN TN) (NNS cells)))) (VP (VBD was) (VP (VBN increased) (PP (IN by) (NP (CD 50) (NN %))) (PP (IN in) (NP (JJ fetal) (NNS thymocytes))) (PRN (-LRB- -LRB-) (NP (NN p) (NN <) (CD 0.01)) (-RRB- -RRB-))))) (. .)))
( (S (S (ADVP (RBS Most) (RB dramatically)) (, ,) (NP (NP (DT the) (NNS percentages)) (PP (IN of) (NP (NN BrdU+) (NNS cells))) (PP (IN in) (NP (JJ fetal) (NNS thymocytes)))) (VP (VBD were) (ADJP (ADJP (RB 10-fold) (JJR higher)) (PP (IN than) (PP (IN in) (NP (DT the) (NN adult)))) (PP (IN at) (NP (NP (DT the) (JJS earliest) (, ,) (NN TN1) (-LRB- -LRB-) (CD CD44+25-) (-RRB- -RRB-) (NN thymocyte) (NN differentiation) (NN stage)) (PRN (-LRB- -LRB-) (NP (NN P) (NN <) (CD 0.001)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (DT A) (ADJP (ADJP (RB much) (JJR lower)) (, ,) (CC but) (ADJP (ADVP (RB still)) (JJ significant))) (NN increase)) (VP (VBD was) (VP (VBN seen) (PP (IN in) (NP (JJ fetal) (NN TN2) (NNS cells))) (PRN (-LRB- -LRB-) (NP (CD 25) (NN %) (NN increase)) (, ,) (NP (NN p) (NN <) (CD 0.01)) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (NN Proliferation)) (VP (VBD was) (ADVP (RB also)) (ADJP (ADJP (RB significantly) (JJR higher)) (PP (IN at) (NP (DT the) (JJ fetal) (NN TN3) (NN stage))) (PP (VBN compared) (PP (TO to) (NP (NN adult))))) (PRN (-LRB- -LRB-) (NP (ADJP (CD 50) (NN %)) (NN increase)) (, ,) (NP (NN p) (JJ <) (CD 0.01)) (-RRB- -RRB-)))) (. .)))
( (S (S (NP (NP (NN Proliferation)) (PP (IN at) (NP (DT the) (NN TN4/pre-DP) (-LRB- -LRB-) (CD CD44-25-) (-RRB- -RRB-) (NN stage)))) (VP (VBD was) (ADJP (JJ similar) (PP (IN between) (NP (ADJP (ADJP (JJ fetal)) (CC and) (ADJP (JJ adult))) (NNS thymocytes)))))) (. .)))
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NN DP) (NNS cells)) (VP (VBD showed) (NP (NP (DT a) (JJ 3-fold) (NN increase)) (PP (IN in) (NP (NN proliferation))) (PP (IN in) (NP (DT the) (JJ fetal) (NN thymus)))) (ADVP (JJ relative) (PP (TO to) (NP (NN adult))) (PRN (-LRB- -LRB-) (NP (NP (NN p)) (QP (RB <) (CD 0.01))) (-RRB- -RRB-)))) (. .)))
( (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (RB nearly) (DT every) (NN stage)) (PP (IN from) (NP (NP (DT the) (JJS earliest) (NN TN)) (PP (TO to) (NP (DT the) (NN DP) (NNS stages)))))) (VP (VBD showed) (NP (NP (ADJP (RB significantly) (VBN increased)) (NN proliferation)) (PP (IN in) (NP (JJ fetal) (NNS thymocytes)))) (ADVP (JJ relative) (PP (TO to) (NP (NNS adults)))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBD was) (ADJP (JJ possible)) (SBAR (IN that) (S (NP (NP (DT the) (JJR lower) (NN percentage)) (PP (IN of) (NP (NP (VBG proliferating) (NNS cells)) (VP (VBN seen) (PP (IN in) (NP (NP (DT the) (NN TN1) (NN population)) (PP (IN in) (NP (NNS adults))))))))) (VP (VBD was) (ADJP (JJ due) (PP (TO to) (NP (NP (DT an) (VBN increased) (NN number)) (PP (IN of) (NP (NP (NN B) (NNS cells)) (CC and) (NP (NN NK) (NNS cells))))))) (PP (IN in) (NP (DT the) (JJ adult) (NN thymus))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD would) (RB not) (VP (VBP have) (VP (VBN been) (VP (VBN excluded) (PP (IN in) (NP (PRP$ our) (JJ initial) (NN analysis)))))))))))))) (. .)))
( (S (SBAR (IN As) (S (NP (DT this)) (VP (VBD was) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (ADJP (RBS most) (JJ striking)) (NNS differences)) (VP (VBN seen) (PP (IN between) (NP (ADJP (ADJP (JJ fetal)) (CC and) (ADJP (JJ adult))) (NNS stages)))))))))) (, ,) (NP (PRP we)) (VP (VBN repeated) (NP (DT this) (NN analysis)) (S (VP (VBG adding) (NP (NP (NNS antibodies)) (PP (IN against) (NP (NP (NP (NN B220)) (CC and) (NP (CD NK1.1) (TO to) (NN CD3))) (, ,) (NP (NP (CD 4)) (CC and) (NP (CD 8)))))) (PP (IN in) (NP (NP (DT the) (VBN excluded) (NN gate)) (PRN (-LRB- -LRB-) (NP (NP (NNP Fig.) (NN 1G)) (, ,) (NP (NN 1H))) (-RRB- -RRB-))))))) (. .)))
( (S (S (VP (ADVP (RB Even)) (VBG excluding) (NP (DT these) (NN cell) (NNS populations)))) (, ,) (NP (EX there)) (VP (VBZ is) (ADVP (RB still)) (NP (NP (DT a) (ADJP (RB significantly) (JJR lower)) (NN percentage)) (PP (IN of) (NP (VBG proliferating) (NNS cells))) (PP (PP (IN in) (NP (NP (DT the) (NN TN1) (NN population)) (PP (IN in) (NP (DT the) (JJ adult) (NN thymus))))) (CONJP (IN than)) (PP (IN in) (NP (DT the) (JJ fetal) (NN thymus)))))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 1I)) (-RRB- -RRB-)) (. .)))
( (S (S (ADVP (RB Therefore)) (, ,) (NP (DT this) (NN difference)) (VP (VBZ is) (RB not) (ADJP (JJ due) (PP (TO to) (NP (NP (JJ different) (NNS numbers)) (PP (IN of) (NP (NP (NP (NP (NN B)) (CC and) (NP (NN NK))) (NNS cells)) (PP (IN in) (NP (DT the) (ADJP (ADJP (JJ adult)) (CC vs.) (ADJP (JJ fetal))) (NN thymus)))))))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB also)) (VP (VBD compared) (NP (NP (NN proliferation)) (PP (IN of) (NP (JJ fetal) (NNS thymocytes)))) (PP (IN from) (NP (JJ Rag1-/-) (NNS mice))) (PP (TO to) (NP (NP (DT the) (NNS results)) (VP (VBN obtained) (PP (IN from) (NP (JJ wild) (NN type) (NNS mice)))))))) (. .)))
( (S (S (NP (NP (NNS Thymocytes)) (PP (IN in) (NP (DT the) (JJ adult) (JJ Rag1-/-) (NN thymus)))) (VP (VBP have) (VP (VBN been) (ADVP (RB previously)) (VP (VBN shown) (S (VP (TO to) (VP (VB have) (NP (NP (ADJP (RB overall) (JJR lower)) (NNS levels)) (PP (IN of) (NP (NN proliferation)))) (PP (IN than) (NP (NP (JJ adult) (JJ wild) (NN type)) (NP (NN TN) (NNS thymocytes) (CD -LSB-13) (-RRB- -RSB-)))) (, ,) (PP (ADVP (RB particularly)) (IN at) (NP (DT the) (NN TN3) (NN stage) (CD -LSB-37-40) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (PP (IN At) (NP (JJ fetal) (NNS stages))) (, ,) (NP (PRP$ our) (NNS results)) (VP (VBD showed) (SBAR (IN that) (S (NP (NN proliferation)) (ADVP (RB also)) (VP (VBD varied) (PP (IN between) (NP (NNS thymocytes))) (PP (IN in) (NP (DT the) (NP (JJ wild) (NN type)) (CC and) (NP (JJ Rag1-/-) (NN thymus)))) (PP (IN at) (NP (NP (JJ discrete) (NNS stages)) (PP (IN of) (NP (NN thymocyte) (NN differentiation)))))))))) (. .)))
( (S (S (PP (IN At) (NP (DT the) (JJS earliest) (NN TN1) (NN stage))) (, ,) (NP (NP (NP (NN thymocyte) (NN proliferation)) (NNS levels)) (PP (IN in) (NP (JJ Rag1-/-) (NNS thymi)))) (VP (VBD were) (ADJP (JJ similar) (PP (TO to) (NP (JJ fetal) (JJ wild) (NN type) (NNS cells)))) (PRN (-LRB- -LRB-) (NP (NP (NNP Fig.)) (NP (NN 1E))) (, ,) (NP (NP (NN 1F)) (: ;) (NP (NN Table) (CD 1))) (-RRB- -RRB-)))) (. .)))
( (S (S (PP (IN At) (NP (DT the) (NN TN2) (NN stage))) (, ,) (NP (NP (JJ fetal) (NNS thymocytes)) (PP (IN from) (NP (JJ Rag1-/-) (NNS mice)))) (VP (VBD had) (NP (NP (DT a) (NN proliferation) (NN level)) (PP (CONJP (RB nearly) (RB twice) (IN that)) (PP (IN of) (NP (JJ wild) (NN type) (NP (NP (JJ fetal) (NNS thymocytes)) (PRN (-LRB- -LRB-) (NP (NN p) (NN <) (CD 0.001)) (-RRB- -RRB-))))))))) (. .)))
( (S (PP (IN By) (NP (DT the) (NN TN3) (NN stage))) (, ,) (NP (NP (DT the) (NN percentage)) (PP (IN of) (NP (VBG proliferating) (JJ Rag1-/-) (NNS thymocytes)))) (VP (VBD had) (VP (VBD dropped) (ADVP (RB slightly)) (PP (IN below) (NP (NP (DT that)) (PP (IN of) (NP (NP (JJ wild) (NN type)) (JJ fetal) (NNS thymocytes))))) (PRN (-LRB- -LRB-) (NP (CD ~30) (NN %) (NN decrease)) (, ,) (NP (NN p) (NN <) (CD 0.01)) (-RRB- -RRB-)) (, ,) (NP (ADJP (JJ equal) (PP (TO to) (NP (JJ wild) (NN type)))) (NP (JJ adult) (NN TN3) (NN proliferation)) (NNS levels)))) (. .)))
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (DT the) (NNS percentages)) (PP (IN of) (NP (NN BrdU+) (NNS cells))) (PP (IN in) (NP (NP (NP (NP (NN TN1)) (CC and) (NP (NN TN2))) (NNS subsets)) (PP (IN in) (NP (DT the) (JJ Rag1-/-) (JJ fetal) (NN thymus)))))) (VP (VBD were) (ADJP (ADJP (RB significantly) (JJR higher)) (PP (IN than) (NP (NP (DT those)) (PP (IN of) (NP (DT the) (JJ wild) (NN type) (NP (NP (NNS adults)) (PRN (-LRB- -LRB-) (NP (NN P) (NN <) (CD 0.001)) (-RRB- -RRB-))))))))) (. .)))
( (S (NP (NP (DT These) (NNS results)) (PP (IN with) (NP (JJ Rag1-/-) (JJ fetal) (NNS thymocytes)))) (VP (NN contrast) (PP (IN with) (NP (NNS thymocytes))) (PP (IN in) (NP (NP (DT the) (JJ Rag-/-) (NN adult)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (NP (NP (ADJP (RB much) (JJR lower)) (NN proliferation)) (PP (IN than) (NP (NP (JJ wild) (NN type)) (JJ adult) (NNS thymocytes)))) (PP (IN at) (NP (NP (DT all) (NNS stages)) (PP (IN of) (NP (NN thymocyte) (NN differentiation) (CD -LSB-13) (-RRB- -RSB-))))))))))) (. .)))
( (S (NP (NP (PRP$ Our) (JJ previous) (NN analysis)) (PP (IN of) (NP (DT the) (JJ Hoxa3+/-Pax1-/-) (NN compound) (JJ mutant) (NN thymocyte) (NN phenotype)))) (VP (VBD showed) (NP (NP (NP (DT a) (JJ specific) (JJ partial) (NN block)) (PP (IN at) (NP (NP (DT the) (NN TN) (TO to) (NN DP) (NN transition)) (, ,) (VP (VBN associated) (PP (IN with) (NP (NP (VBN increased) (NN apoptosis)) (PP (IN at) (NP (CC both) (DT the) (NP (NP (NN TN4/pre-DP)) (CC and) (NP (NN DP))) (NNS subsets)))))) (, ,)))) (CC and) (NP (NP (DT a) (JJ 10-fold) (NN decrease)) (PP (IN in) (NP (NN DP) (NN cell) (NNS numbers)))) (NP (CD -LSB-29) (-RRB- -RSB-)))) (. .)))
( (S (S (S (VP (VBG Using) (NP (NN BrdU) (NN analysis)))) (, ,) (NP (PRP we)) (VP (VBD compared) (NP (NP (DT the) (NN proliferation)) (PP (IN of) (NP (JJ Hoxa3+/-Pax1-/-) (JJ fetal) (NNS thymocytes)))) (PP (IN during) (NP (DT the) (NN TN) (TO to) (NN DP) (NN transition))) (PP (VBN compared) (PP (TO to) (NP (JJ littermate) (NNS controls)))))) (. .)))
( (S (NP (NP (NP (NN Thymocyte) (NN proliferation) (NNS levels)) (PP (IN for) (NP (NP (NP (DT all) (NNS genotypes)) (PRN (-LRB- -LRB-) (ADJP (ADJP (JJ Hoxa3+/-)) (, ,) (ADJP (JJ Pax1+/-)) (, ,) (ADJP (JJ Pax1-/-)) (, ,) (CC and) (ADJP (JJ Hoxa3+/-Pax1-/-))) (-RRB- -RRB-))) (VP (VBD were) (ADJP (JJ similar) (PP (TO to) (NP (JJ wild) (NN type))) (PP (IN in) (NP (NP (DT all)) (PP (IN of) (NP (NP (DT the) (JJ canonical) (NN TN1-TN4) (NNS stages)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 2A,2B,2C)) (: ;) (NP (NN Table) (CD 1)) (-RRB- -RRB-))))))) (, ,) (ADJP (JJ consistent) (PP (IN with) (NP (DT the) (JJ normal) (NNS percentages)))))))) (CC and) (NP (NP (NN cell) (NNS numbers)) (PP (IN for) (NP (DT these) (NNS subpopulations))))) (ADVP (RB previously)) (VP (VBD reported) (NP (CD -LSB-29) (-RRB- -RSB-))) (. .)))
( (S (S (NP (NP (JJ Recent) (NNS papers)) (PP (IN by) (NP (NP (NNP Penit)) (, ,) (ADVP (FW et) (FW al.))))) (VP (VBP have) (VP (VBN provided) (NP (NP (NNS data)) (PP (IN from) (NP (NN cell) (NN cycle) (NN analysis)))) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (DT a) (JJ discrete) (NN CD44-25lo) (NN population)) (PP (IN with) (NP (DT a) (JJ specific) (NN proliferation) (NN profile)))) (VP (MD can) (VP (VB be) (VP (VBN identified) (, ,) (SBAR (JJ such) (IN that) (S (NP (NP (DT the) (NN transition)) (PP (IN from) (NP (NN TN3))) (PP (TO to) (NP (NN DP)))) (VP (MD can) (VP (VB be) (ADVP (RB further)) (VP (VBN subdivided) (PP (IN into) (NP (NP (NP (NNP CD25hi)) (, ,) (NP (NNP CD25lo)) (, ,) (CC and) (NP (JJ CD25-) (NNS subsets))) (NP (CD -LSB-12,13) (-RRB- -RSB-))))))))))))))))))) (. .)))
( (S (S (NP (NP (NN Analysis)) (PP (IN of) (NP (NN proliferation))) (VP (VBG using) (NP (DT these) (ADJP (ADVP (RBR more) (RB narrowly)) (VBN defined)) (NNS subsets)))) (ADVP (RB still)) (VP (VBD showed) (NP (NP (NNS values)) (ADJP (JJ similar) (PP (TO to) (NP (JJ wild) (NN type))))) (PP (IN in) (NP (NP (DT the) (JJ CD44-25lo) (NN subset)) (PRN (-LRB- -LRB-) (NP (NP (NNP Fig.) (NN 2D,2E,2F)) (: ;) (NP (NN Table) (CD 2))) (-RRB- -RRB-)))))) (. .)))
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (DT the) (NN proliferation) (NN level)) (PP (IN of) (NP (NN DP) (NNS cells)))) (VP (VBD increased) (ADVP (RB nearly) (RB 2-fold)) (PP (IN in) (NP (NN compound) (NNS mutants))) (PP (VBN compared) (PP (TO to) (NP (JJ wild) (NN type)))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 2C)) (, ,) (NP (NP (NN 2F)) (: ;) (NP (NN Table) (CD 1))) (-RRB- -RRB-))) (. .)))
( (S (PP (IN In) (NP (NP (NN spite)) (PP (IN of) (NP (NP (DT this) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN percentage)) (PP (IN of) (NP (VBG proliferating) (NNS cells))))))))) (, ,) (NP (NP (DT the) (JJ actual) (NN number)) (PP (IN of) (NP (NN BrdU+) (NN DP) (NNS cells)))) (VP (VBD was) (VP (VBN reduced) (ADVP (RB 4-fold)) (PP (VBN compared) (PP (TO to) (NP (JJ wild) (NN type)))) (PP (IN in) (NP (DT the) (JJ compound) (NNS mutants))))) (PRN (-LRB- -LRB-) (NP (CD 15.03) (NN ±) (NN 8.73) (NN ×) (CD 104) (CC vs.) (CD 61.94)))))
( (S (S (S (NP (NN ±) (CD 32.12)) (VP (JJ ×) (NP (CD 104)) (PP (IN in) (NP (JJ wild) (NN type))))) (: ;) (S (NP (NN p)) (VP (JJ <) (NP (CD 0.01) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (NP (DT The) (NNS numbers)) (PP (IN of) (NP (VBG proliferating) (NNS cells))) (PP (IN at) (NP (DT the) (NN pre-DP) (NN stage)))) (VP (VBD were) (ADJP (ADJP (JJ unchanged)) (PRN (-LRB- -LRB-) (ADVP (RB not)) (VP (VBN shown)) (-RRB- -RRB-))))) (. .)))
( (S (S (VP (VBN Combined) (PP (IN with) (NP (PRP$ our) (JJ previous) (NNS results))))) (, ,) (NP (DT this) (NN result)) (VP (VBZ shows) (SBAR (IN that) (S (NP (CC both) (NP (VBN increased) (NN apoptosis)) (CC and) (NP (VBN reduced) (NN proliferation))) (VP (VBP contribute) (PP (TO to) (NP (NP (DT the) (NN decrease)) (PP (IN in) (NP (NP (NN DP) (NNS cells)) (PP (IN in) (NP (DT the) (NN Hoxa3) (, ,) (NN Pax1) (JJ compound) (NNS mutants))))))))))) (. .)))
( (S (S (ADVP (RB Unfortunately)) (, ,) (NP (JJ Hoxa3+/-Pax1-/-) (NNS mice)) (VP (VBP die) (PP (IN at) (NP (NN birth))) (, ,) (S (VP (VBG preventing) (NP (NP (NN analysis)) (PP (IN of) (NP (NP (NN thymocyte) (NN proliferation)) (PP (IN in) (NP (JJ adult) (NN compound) (NNS mutants)))))))))) (. .)))
( (S (S (NP (NP (NNS Cytokines)) (VP (VBN produced) (PP (IN by) (NP (NNS TECs))))) (VP (VBP are) (NP (NP (JJ good) (NNS candidates)) (PP (IN for) (S (VP (VBG mediating) (NP (NP (NP (ADVP (IN at) (JJS least)) (DT some)) (PP (IN of) (NP (NP (DT these) (NNS changes)) (PP (IN in) (NP (NP (NP (NN thymocyte) (NN proliferation)) (CC and) (NP (NN apoptosis))) (PP (IN in) (NP (DT the) (NN Hoxa3)))))))) (, ,) (NP (NN Pax1) (NN compound) (NNS mutants))))))))) (. .)))
( (S (S (VP (VBG Using) (NP (JJ semi-quantitative) (NN RT-PCR)))) (, ,) (NP (PRP we)) (VP (VBD analyzed) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NP (CD two) (NNS cytokines)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN produced) (PP (IN by) (NP (NNS TECs)))))))) (, ,) (NP (NP (NN IL-7)) (CC and) (NP (NN SCF))) (, ,))) (PP (IN in) (NP (NP (ADJP (ADJP (JJ pooled)) (, ,) (ADJP (JJ genotype-matched))) (NN E14.5) (NNS thymi)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 3)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (JJ Hoxa3+/-Pax1-/-) (NN compound) (NNS mutants)) (VP (VBD had) (NP (NP (VBN decreased) (NN transcription)) (PP (IN of) (NP (NP (DT both) (NNS cytokines)) (ADJP (JJ relative) (PP (TO to) (NP (DT all) (JJ other) (NNS genotypes)))) (, ,) (PP (VBG including) (NP (JJ Pax1-/-) (JJ single) (NNS mutants)))))))) (. .)))
( (S (S (S (ADVP (RB However)) (, ,) (NP (JJ Hoxa3+/-Pax1-/-) (NN compound) (NNS mutants)) (VP (VBD were) (RB not) (ADJP (ADJP (RB completely) (JJ missing)) (CC either) (ADJP (NP (NN cytokine)) (VBN analyzed))))) (, ,) (CC and) (S (NP (NP (DT the) (NN magnitude)) (PP (IN of) (NP (DT the) (NN decrease)))) (VP (VBD was) (ADJP (JJ variable)) (PP (IN between) (NP (NNS pools)))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB test) (SBAR (IN whether) (S (NP (NP (DT the) (NNS changes)) (PP (IN in) (NP (NN cytokine) (NNS levels)))) (VP (VBD were) (ADJP (JJ responsible) (PP (IN for) (NP (DT the) (VBN observed) (NP (NN thymocyte) (NN development)) (NNS phenotypes)))))))))) (, ,) (NP (PRP we)) (VP (VBD attempted) (S (VP (TO to) (VP (VB rescue) (NP (DT these) (NNS phenotypes)) (PP (IN by) (NP (NP (NN supplementation)) (PP (IN in) (NP (NP (JJ fetal) (JJ thymic) (NN organ) (NN culture)) (PRN (-LRB- -LRB-) (NP (NN FTOC)) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (NP (NP (CD E15.5) (JJ embryonic) (JJ thymic) (NNS lobes)) (PP (IN from) (NP (JJ individual) (NNS embryos)))) (VP (VBD were) (VP (VBN cultured) (ADVP (RB separately)) (PP (IN in) (NP (NN FTOC))) (, ,) (PP (PP (IN with)) (CC or) (PP (IN without) (NP (VBN added) (NP (NN IL-7)) (CC or) (NP (NN SCF)))))))) (. .)))
( (S (NP (NP (NNS Cultures)) (PP (IN from) (NP (NP (JJ control) (NNS genotypes)) (PRN (-LRB- -LRB-) (NP (JJ wild) (NN type)) (, ,) (ADJP (ADJP (JJ Pax1+/-)) (, ,) (ADJP (JJ Hoxa3+/-)) (, ,) (ADJP (JJ Pax1-/-))) (-RRB- -RRB-))))) (VP (VBD behaved) (SBAR (IN as) (S (VP (VBN expected) (NP (CD -LSB-41-46) (-RRB- -RSB-)) (, ,) (PP (IN with) (NP (NP (NN addition)) (PP (IN of) (NP (NP (NN IL-7)) (VP (VBG causing) (NP (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN percentage)) (PP (IN of) (NP (JJ DN) (NNS cells)))))) (CC and) (NP (NP (DT a) (JJ corresponding) (NN decrease)) (PP (IN in) (NP (NN DP) (NNS cells))))))))))))) (, ,) (SBAR (IN while) (S (NP (VBG adding) (NN SCF)) (VP (VBD had) (NP (DT no) (JJ significant) (NN effect)) (PP (IN on) (NP (NN thymocyte) (NN development))) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (PP (TO to) (NP (PRP$ our) (NN surprise))) (NP (NP (DT the) (CD two) (JJ separated) (NNS lobes)) (PP (IN from) (NP (JJ Hoxa3+/-Pax1-/-) (NN compound) (NNS mutants)))) (VP (VBD did) (RB not) (ADVP (RB always)) (VP (VB develop) (PP (IN in) (NP (JJ predictable) (NNS ways)))))) (. .)))
( (S (S (PP (IN In) (NP (NN fact))) (, ,) (NP (NP (JJ separated) (NNS lobes)) (VP (VBN cultured) (PP (IN under) (NP (JJ identical) (NNS conditions))) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (DT any) (VBN added) (NNS cytokines))))))) (VP (VBD had) (NP (ADJP (RB widely) (VBG differing)) (NNS results)))) (. .)))
( (S (S (NP (NP (NNS Changes)) (PP (IN in) (NP (NP (NN thymocyte) (NN cell) (NN number)) (CC and) (NP (NN differentiation)))) (PP (IN after) (NP (NN culture)))) (VP (VBD were) (ADJP (RB highly) (JJ variable)))) (: ;) (S (PP (IN for) (NP (NN example))) (, ,) (NP (NN cell) (NNS numbers)) (VP (MD could) (VP (VB differ) (ADVP (RB stochastically)) (PP (IN after) (NP (NN culture))) (PP (IN by) (NP (NP (RB as) (JJ much)) (PP (IN as) (NP (NP (RB 10-fold)) (PP (IN between) (NP (NP (CD two) (NNS lobes)) (PP (IN from) (NP (DT the) (JJ same) (NN compound) (JJ mutant) (NN embryo)))))))))))) (. .)))
( (S (S (NP (DT This) (NN result)) (VP (VBD was) (ADVP (RB never)) (VP (VBN obtained) (PP (IN with) (NP (RB separately) (VBN cultured) (JJ thymic) (NNS lobes))) (PP (IN from) (NP (NP (DT any) (JJ other) (NN genotype)) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB always)) (VP (VBD developed) (ADVP (RB identically)) (SBAR (WHADVP (WRB when)) (S (VP (VBN cultured) (PP (IN without) (NP (NNS cytokines)))))))))))))) (. .)))
( (S (S (NP (NP (DT This) (NN property)) (PP (IN of) (NP (DT the) (JJ compound) (JJ mutant) (JJ thymic) (NNS lobes)))) (ADVP (RB probably)) (VP (VBZ reflects) (NP (NP (JJ phenotypic) (NN variability)) (VP (ADVP (RB previously)) (VBN seen) (PP (IN in) (NP (NP (PRP$ our) (ADJP (ADJP (JJ histological)) (CC and) (ADJP (JJ gross))) (JJ morphological) (NN analysis)) (PP (IN of) (NP (DT these) (NNS mutants) (NP (CD -LSB-29,34) (-RRB- -RSB-)))))))))) (. .)))
( (S (NP (NN Discussion))))
( (S (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN examined) (NP (NN thymocyte) (NN proliferation)) (PP (IN in) (NP (DT the) (JJ fetal) (CC and) (JJ adult) (JJ wild) (NN type) (NN thymus)))))) (. .)))
( (S (NP (PRP$ Our) (NNS results)) (VP (VBD showed) (NP (NP (JJ clear) (JJ stage-specific) (NNS differences)) (PP (IN in) (NP (JJ wild) (NN type) (NN thymocyte) (NN proliferation)))) (PP (VBG depending) (PP (IN on) (NP (NP (DT the) (JJ developmental) (NN age)) (PP (IN of) (NP (DT the) (NN microenvironment)))))) (-LRB- -LRB-) (PP (FW i.e.)))))
( (S (NP (NP (ADJP (JJ fetal))) (CC vs.) (NP (ADJP (JJ adult)))) (-RRB- -RRB-) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB also)) (VP (VBD analyzed) (NP (NP (CD two) (JJ mutant) (NNS strains)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (NP (DT either) (JJ cell-autonomous) (-LRB- -LRB-) (JJ Hoxa3+/-Pax1-/-) (-RRB- -RRB-) (CC or) (JJ non-cell-autonomous) (-LRB- -LRB-) (JJ Rag1-/-) (-RRB- -RRB-) (NN TEC) (NNS defects)) (, ,) (PP (IN with) (NP (NP (NNS blocks)) (PP (IN at) (NP (NP (JJ different) (NNS stages)) (PP (IN of) (NP (NN thymocyte) (NN differentiation))))))))))))) (. .)))
( (S (S (NP (NP (JJ Abnormal) (NN TEC) (NN development)) (PP (IN in) (NP (NP (DT both)) (PP (IN of) (NP (DT these) (JJ mutant) (NNS strains)))))) (VP (VBD resulted) (PP (IN in) (NP (NP (CC both) (NP (NNS increases)) (CC and) (NP (NNS decreases))) (PP (IN in) (NP (NN thymocyte) (NN proliferation))) (PP (PP (IN in) (NP (DT a) (JJ stage-specific) (NN manner))) (, ,) (CONJP (RB rather) (IN than)) (ADVP (RB simply)) (NP (NP (DT an) (ADJP (RB overall) (VBN reduced)) (NN ability)) (S (VP (TO to) (VP (VB promote) (NP (NN proliferation))))))))))) (. .)))
( (S (S (NP (EX There)) (VP (VBZ is) (NP (JJ considerable) (NN evidence) (SBAR (IN that) (S (NP (NN thymopoiesis)) (VP (VBZ differs) (PP (IN in) (NP (NP (DT the) (JJ fetal) (NN thymus)) (PP (IN during) (NP (NP (DT the) (JJ initial) (NN creation)) (PP (IN of) (NP (DT the) (NN microenvironment))))))) (, ,) (SBAR (IN as) (S (VP (VBN opposed) (PP (TO to) (NP (NP (JJ adult) (NN thymus) (NN function)) (PRN (-LRB- -LRB-) (VP (VBN reviewed) (PP (IN in) (NP (NN -LSB-47)))) (-RRB- -RSB-) (-RRB- -RRB-))))))))))))) (. .)))
( (S (S (NP (NNS Differences)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (PP (IN in) (NP (NP (NNS responses)) (PP (TO to) (NP (DT some) (NNS cytokines))))) (, ,) (PP (IN in) (NP (NP (NN signaling)) (PP (IN at) (NP (NP (DT the) (NN TN-DP) (NN transition)) (PP (IN in) (NP (JJ fetal))) (PP (VBN compared) (PP (TO to) (NP (JJ adult) (NN thymus)))))))) (, ,) (CC and) (PP (IN in) (NP (NP (NN proliferation)) (PP (IN of) (NP (JJ CD4+) (NN SP) (NNS thymocytes) (NP (CD -LSB-36,48-50)) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN proliferation) (NNS profiles)) (PP (IN of) (NP (CC both) (NP (JJ wild) (NN type)) (CC and) (NP (JJ Rag-/-) (JJ fetal) (NNS thymocytes))))) (VP (VBP support) (NP (DT the) (NN hypothesis) (SBAR (IN that) (S (NP (JJ fetal) (NN thymocyte) (NN maturation)) (VP (VBZ is) (ADJP (RB fundamentally) (JJ different) (PP (IN from) (NP (NP (NN thymocyte) (NN development)) (PP (IN in) (NP (DT the) (JJ adult) (NN thymus)))))))))))) (. .)))
( (S (S (NP (DT The) (NP (NP (NN TN1)) (CC and) (NP (NN DP))) (NNS stages)) (VP (DT both) (VP (VBP show) (NP (NP (VBN increased) (NN proliferation)) (PP (IN in) (NP (JJ wild-type) (JJ fetal) (NNS thymocytes)))) (PP (VBN compared) (PP (TO to) (NP (NNS adults))))))) (. .)))
( (S (S (NP (NP (DT This) (NN difference)) (PP (IN at) (NP (DT the) (NN TN1) (NN stage)))) (VP (VBZ is) (RB not) (ADJP (JJ due) (PP (TO to) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (RBR more) (NN B) (CC or) (NN NK) (NNS cells))) (PP (IN in) (NP (DT the) (JJ adult) (NN thymus)))))))) (. .)))
( (S (S (SBAR (IN Although) (S (NP (PRP it)) (VP (VBZ is) (ADVP (RB formally)) (ADJP (JJ possible)) (SBAR (IN that) (S (NP (DT some) (JJ other) (NN cell) (NN type)) (VP (MD may) (ADVP (RB still)) (VP (VB be) (VP (VBN included) (PP (IN in) (NP (PRP$ our) (NN TN1) (NN population))))))))))) (, ,) (NP (DT this) (NN analysis)) (ADVP (RB strongly)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NN TN1) (NNS cells)) (VP (VBP have) (NP (JJ different) (NN proliferation) (NNS profiles)) (PP (IN in) (NP (ADJP (ADJP (JJ fetal)) (CC and) (ADJP (JJ adult))) (NN thymus)))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (ADVP (RB well)) (VP (VBN documented) (SBAR (IN that) (S (NP (NP (NNS thymocytes)) (PP (IN in) (NP (JJ adult) (NP (NP (NN Rag1)) (CC or) (NP (NN Rag2))) (NNS mutants)))) (VP (VBP have) (NP (ADJP (RB dramatically) (VBN reduced)) (NN proliferation)) (PP (VBN compared) (PP (TO to) (NP (JJ wild) (NN type)))) (, ,) (PP (ADVP (RB particularly)) (IN at) (NP (DT the) (NN TN3) (NN stage) (CD -LSB-37-40) (-RRB- -RSB-)))))))))) (, ,) (CC and) (S (NP (NNP Penit) (FW et) (FW al.)) (VP (VBD reported) (NP (CD 2–10) (JJ fold) (NNS reductions)) (PP (IN at) (NP (NP (DT every) (NN stage)) (PP (IN of) (NP (NN thymocyte) (NN development))))) (PP (IN in) (NP (JJ Rag-/-) (NNS adults))) (NP (CD -LSB-13)) (-RRB- -RSB-))) (. .)))
( (S (S (NP (NP (JJ Recent) (NN work)) (PP (IN by) (NP (NP (NNP Petrie)) (, ,) (ADVP (FW et) (FW al.))))) (VP (VBZ has) (VP (VBN shown) (SBAR (IN that) (S (NP (DT this) (VBN reduced) (NN proliferation)) (VP (VP (VBZ is) (RB not) (ADJP (JJ intrinsic) (PP (TO to) (NP (NN Rag) (JJ mutant) (NNS thymocytes))))) (, ,) (CONJP (CC but) (RB rather)) (VP (VBZ is) (ADJP (JJ secondary) (PP (TO to) (NP (NP (JJ thymic) (NN microenvironment) (NNS defects)) (PP (IN in) (NP (NN Rag) (NNS mutants) (CD -LSB-37) (-RRB- -RSB-))))))))))))) (. .)))
( (S (NP (PRP$ Our) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (PP (IN at) (NP (JJ fetal) (NNS stages))) (, ,) (NP (NN Rag) (NN mutant) (NNS thymocytes)) (VP (VBP have) (NP (NP (DT a) (NN proliferation) (NN profile)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADJP (ADVP (RB much) (RBR more)) (JJ similar) (PP (TO to) (NP (NP (NP (JJ wild) (NN type)) (NNS thymocytes)) (PP (IN at) (NP (DT the) (JJ same) (NN stage)))))))))) (, ,) (PP (IN with) (NP (ADJP (JJR less) (PP (IN than) (NP (NP (DT a) (JJ 2-fold) (NN difference)) (PP (IN in) (NP (NP (DT the) (NN percentage)) (PP (IN of) (NP (VBG proliferating) (NNS cells))) (PP (IN at) (NP (DT any) (NN stage)))))))))))))) (. .)))
( (S (PP (IN For) (NP (NN example))) (, ,) (NP (NP (NN TN3) (NN stage) (NNS thymocytes)) (PP (IN in) (NP (DT the) (JJ Rag-/-) (JJ adult) (NN thymus)))) (VP (VBP have) (NP (NP (NN proliferation) (NNS levels)) (ADJP (JJ 3-fold) (PP (IN below) (NP (JJ wild) (NN type) (NN thymus) (NN -LSB-13,37)))) (-RRB- -RSB-)) (, ,) (SBAR (IN while) (S (PP (IN in) (NP (DT the) (JJ Rag-/-) (JJ fetal) (NN thymus))) (NP (NN TN3) (NNS cells)) (VP (VBP are) (ADJP (NP (QP (RB only) (CD 25–30)) (NN %)) (JJR lower) (PP (IN than) (PP (IN in) (NP (JJ wild) (NN type) (JJ fetal) (NN thymus))))))))) (. .)))
( (S (S (NP (NN Proliferation)) (VP (VP (VBZ is) (RB not) (VP (VBN changed) (PP (IN at) (NP (DT all) (NNS stages))))) (, ,) (CC and) (VP (VBZ is) (ADVP (RB actually)) (VP (VBN increased) (PP (JJ relative) (TO to) (NP (JJ wild) (NN type))) (PP (IN at) (NP (DT the) (JJ TN2) (NN stage))))))) (. .)))
( (S (S (NP (NP (DT This) (NN increase)) (PP (IN at) (NP (DT the) (NN TN2) (NN stage)))) (VP (MD may) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (DT the) (NN failure)) (PP (IN of) (NP (NN TN2) (NNS cells))) (S (VP (TO to) (VP (VB initiate) (NP (NN TCRβ) (NN gene) (NN rearrangement)) (PP (IN at) (NP (NP (DT this) (NN stage)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADVP (RB normally)) (VP (VBN associated) (PP (IN with) (NP (NP (VBN decreased) (JJ proliferation.Rag-/-) (NNS mutants)) (VP (VBP have) (NP (DT a) (JJ profound) (NN thymocyte) (NN development) (NN block)) (PP (IN at) (NP (DT the) (NN TN3) (TO to) (NN TN4/preDP) (NN transition) (CD -LSB-51) (-RRB- -RSB-))))))))))))))))))))) (. .)))
( (S (S (PP (IN During) (NP (JJ normal) (JJ wild) (NN type) (JJ fetal) (NN thymus) (NN development))) (, ,) (NP (JJ significant) (NN DP) (NN cell) (NN development)) (VP (VBZ does) (RB not) (VP (VB occur) (PP (IN until) (NP (NN E16.5))) (PP (IN in) (NP (JJS most) (JJ genetic) (NNS backgrounds)))))) (. .)))
( (S (PP (IN As) (NP (DT a) (NN result))) (, ,) (PP (IN at) (NP (NN E17.5))) (NP (NP (DT the) (JJ thymic) (NN microenvironment)) (PP (IN in) (NP (NN Rag) (NNS mutants)))) (VP (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN exposed) (PP (TO to) (NP (JJ abnormal) (NN thymocyte) (NN development))) (PP (IN for) (ADJP (RB very) (JJ long)))))) (, ,) (CC and) (VP (VBZ has) (RB not) (ADVP (RB yet)) (VP (VBN developed) (NP (NP (DT the) (JJ full) (NN phenotype)) (VP (VBN seen) (PP (IN in) (NP (DT the) (JJ steady) (NN state) (JJ adult) (NN Rag) (JJ mutant) (NN thymus) (CD -LSB-35)))))))) (-RRB- -RSB-) (. .)))
( (S (PP (IN In) (NP (DT the) (NN Hoxa3))) (, ,) (NP (NN Pax1) (JJ compound) (NNS mutants)) (, ,) (NP (JJ cell-autonomous) (NN TEC) (NNS defects)) (VP (VBP cause) (NP (NP (DT a) (JJ partial) (NN block)) (PP (IN at) (NP (DT the) (NN DN-DP) (NN transition)))) (, ,) (SBAR (IN so) (S (NP (NNS thymocytes)) (VP (VBP do) (VP (VB progress) (PP (TO to) (NP (NP (NN DP)) (CC and) (NP (NN SP) (NNS stages)))))))) (, ,) (PP (IN albeit) (PP (IN at) (NP (VBD reduced) (NNS frequencies) (CD -LSB-29) (-RRB- -RSB-))))) (. .)))
( (S (S (NP (NN TEC) (NNS defects)) (VP (VBP are) (VP (VBN seen) (ADVP (RB as) (RB early)) (PP (IN as) (NP (NP (NN E12.5)) (PP (IN in) (NP (DT these) (NNS mutants))))) (, ,) (PP (IN from) (NP (NP (DT the) (JJS earliest) (NNS stages)) (PP (IN of) (NP (NN organogenesis) (CD -LSB-34))))))) (-RRB- -RSB-)) (. .)))
( (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (DT the) (NN TEC) (NNS defects)) (PP (IN in) (NP (DT these) (NNS mice)))) (VP (MD would) (VP (VB be) (VP (VBN expected) (S (VP (TO to) (VP (VB have) (NP (JJ different) (NNS effects)) (PP (IN on) (NP (NN thymocyte) (NN proliferation))) (PP (IN than) (PP (IN in) (NP (NN Rag) (NNS mutants))))))))))) (. .)))
( (S (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBD found) (NP (NP (JJ stage-specific) (NNS changes)) (PP (IN in) (NP (NN thymocyte) (NN proliferation)))) (PP (IN at) (NP (DT the) (NN DP) (NN stage))))) (. .)))
( (S (S (NP (PRP$ Our) (JJ previous) (NN analysis)) (VP (VBD reported) (NP (NP (VBN decreased) (NN DP) (NN cell) (NN number)) (CC and) (NP (NP (VBN increased) (NN apoptosis)) (PP (IN in) (NP (NP (CC both) (DT the) (NP (NP (NN pre-DP)) (CC and) (NP (NN DP))) (NNS stages)) (PP (IN in) (NP (DT these) (NNS mutants) (NP (CD -LSB-29) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (NP (NP (NN DP) (NN cell) (NNS numbers)) (PP (IN in) (NP (CC both) (DT this) (CC and) (PRP$ our) (JJ previous) (NN study)))) (VP (VBD were) (VP (VBN decreased) (ADVP (RB 10-fold)) (PP (IN in) (NP (DT the) (JJ Hoxa3+/-Pax1-/-) (NN compound) (NNS mutants)))))) (. .)))
( (S (S (PP (IN At) (NP (JJ first) (NN glance))) (, ,) (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN percentage)) (PP (IN of) (NP (VBG proliferating) (NNS cells))))) (PP (IN at) (NP (DT the) (NN DP) (NN stage)))) (VP (VBZ appears) (ADJP (JJ contradictory) (PP (TO to) (NP (DT this) (NN phenotype)))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (DT this) (NN increase)) (ADVP (RB actually)) (VP (VBZ corresponds) (PP (TO to) (NP (NP (VBN decreased) (NNS numbers)) (PP (IN of) (NP (VBG proliferating) (NN DP) (NNS cells))))) (PP (VBN compared) (PP (TO to) (NP (JJ wild) (NN type)))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NN pre-DP) (NNS cells)) (VP (VBD did) (RB not) (VP (VB have) (NP (NP (DT a) (NN change)) (PP (IN in) (NP (NP (DT the) (NP (NN number)) (CC or) (NP (NN percentage))) (PP (IN of) (NP (VBG proliferating) (NNS cells))))))) (, ,) (S (VP (VBG suggesting) (SBAR (SBAR (IN that) (S (NP (NP (DT the) (NNS signals) (VBG promoting) (NN proliferation)) (PP (IN of) (NP (DT these) (NNS cells)))) (VP (VBZ is) (ADVP (RB still)) (ADJP (JJ present))))) (, ,) (CC and) (SBAR (IN that) (S (NP (NP (NN proliferation)) (PP (IN of) (NP (NN DP) (CC and) (NN pre-DP) (NNS cells)))) (VP (MD may) (VP (VB be) (VP (VBN regulated) (ADVP (RB independently)))))))))))) (. .)))
( (S (S (NP (NN Pre-DP) (NNS cells)) (VP (VBP do) (VP (VB have) (NP (NP (DT a) (JJ three-fold) (NN increase)) (PP (IN in) (NP (NN apoptosis) (CD -LSB-29) (-RRB- -RSB-)))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (JJ separate) (NNS signals)) (VP (VBP regulate) (NP (NP (NP (NN proliferation)) (CC and) (NP (NN survival))) (PP (IN of) (NP (DT these) (NNS cells)))))))))))) (. .)))
( (S (S (ADJP (JJ Combined) (PP (IN with) (NP (PRP$ our) (JJ previous) (NNS data))))) (, ,) (NP (DT this) (NN result)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (DT the) (NN decrease)) (PP (IN in) (NP (NN DP) (NN cell) (NNS numbers))) (VP (VBN seen) (PP (IN in) (NP (DT the) (NN Hoxa3-Pax1) (NN compound) (NNS mutants))))) (VP (VBZ is) (PP (CC both) (JJ due) (TO to) (NP (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NN pre-DP) (CC and) (NN DP) (NNS cells)) (VP (VBG undergoing) (NP (NN apoptosis)))))))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (JJ proliferating) (NN DP)))))))))))) (. .)))
( (S (S (NP (NP (NNS Insufficiencies)) (PP (IN of) (NP (JJ multiple) (NNS cytokines)))) (VP (MD might) (VP (VB be) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NNS changes)) (PP (IN in) (NP (NP (NN proliferation)) (CC and) (NP (NP (NN cell) (NN death)) (PP (IN at) (NP (DT the) (NN CD44-25-) (CC and) (NN DP) (NNS stages))) (PP (IN in) (NP (NN Hoxa3-Pax1) (NN compound) (NNS mutants)))))))))))) (. .)))
( (S (S (NP (NP (NN SCF)) (CC and) (NP (NN IL-7))) (VP (VBP are) (ADVP (RB first)) (VP (VBN expressed) (ADVP (RB as) (RB early)) (PP (IN as) (NP (NP (NN E12.5)) (PP (IN in) (NP (DT the) (VBG developing) (NN thymus))))) (, ,) (SBAR (RB well) (IN before) (S (NP (JJ significant) (NN thymocyte) (NN maturation)) (VP (VBZ takes) (NP (NN place) (CD -LSB-52,53) (-RRB- -RSB-)))))))) (. .)))
( (S (S (SBAR (IN Although) (S (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NNS TECs)))) (VP (VBZ is) (VP (VBN reduced) (PP (IN by) (NP (RB about) (RB 2-fold))) (PP (IN in) (NP (JJ Hoxa3+/-Pax1-/-) (NN compound) (NNS mutants))))))) (, ,) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NNS thymocytes)))) (VP (VBZ is) (VP (VBN reduced) (PP (IN by) (NP (NP (DT a) (ADJP (RB slightly) (JJR greater)) (NN amount)) (PRN (, ,) (PP (IN around) (NP (RB 3-fold) (CD -LSB-29))) (-RRB- -RSB-))))))) (. .)))
( (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (DT the) (NNS reductions)) (VP (VBN seen) (PP (IN in) (NP (NP (NN cytokine) (NN message) (NNS levels)) (PP (IN in) (NP (DT the) (JJ Hoxa3+/-Pax1-/-compound) (NNS mutants))))))) (VP (VBP are) (RB not) (ADJP (JJ secondary) (PP (TO to) (NP (VBN decreased) (NN TEC) (NNS numbers)))))) (. .)))
( (S (PP (IN In) (NP (NN fact))) (, ,) (NP (DT these) (NNS mutants)) (VP (MD should) (VP (VB have) (NP (NP (DT a) (JJ relative) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN proportion)) (PP (IN of) (NP (NNS TECs)))))) (, ,) (S (VP (VBG making) (NP (NP (DT the) (NNS reductions)) (VP (VBN seen) (PP (IN in) (NP (NN cytokine) (NNS levels))) (PP (IN in) (NP (NP (DT the) (JJ mutant) (NN thymi)) (ADJP (ADVP (RB even) (RBR more)) (JJ striking)))))))))) (. .)))
( (S (S (NP (NP (DT The) (VBN reduced) (NN expression)) (PP (IN of) (NP (DT these) (NNS cytokines))) (PP (IN in) (NP (JJ Hoxa3+/-Pax1-/-) (NN compound) (NNS mutants)))) (VP (VP (MD could) (VP (VB be) (NP (NP (DT an) (JJ indirect) (NN effect)) (PP (IN of) (NP (JJ defective) (NN TEC) (NN differentiation)))))) (, ,) (CC or) (VP (MD could) (VP (VB be) (NP (JJ direct) (JJ downstream) (NNS targets)) (SBAR (IN since) (S (NP (CC both) (NP (NN Hoxa3)) (CC and) (NP (NN Pax1))) (VP (VBP are) (VP (VBN expressed) (PP (IN in) (NP (JJ fetal) (NN thymus) (CD -LSB-54,55))))) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (NP (NN Comparison)) (PP (IN of) (NP (DT the) (JJ Hoxa3+/-Pax1-/-) (NN phenotype))) (PP (IN with) (NP (NP (DT those)) (PP (IN of) (NP (NN cytokine) (NNS mutants)))))) (VP (VBP do) (RB not) (VP (VB reveal) (NP (JJ many) (NNS similarities) (CD -LSB-30,46,56-61) (-RRB- -RSB-)) (, ,) (PP (RB probably) (IN because) (IN of) (NP (NP (DT the) (JJ simultaneous) (NNS reductions)) (PP (IN in) (NP (NP (JJ multiple) (NNS cytokines)) (PP (IN in) (NP (DT the) (JJ Hoxa3+/-Pax1-/-) (NNS mutants)))))))))) (. .)))
( (S (S (PP (IN For) (NP (NN example))) (, ,) (NP (NP (NN SCF)) (CC and) (NP (NN IL-7))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB have) (NP (JJ synergistic) (NNS functions) (CD -LSB-62,63) (-RRB- -RSB-))))))))) (. .)))
( (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (NNS changes)) (PP (IN in) (NP (JJ multiple) (NNS cytokines))) (PP (IN in) (NP (JJ Hoxa3+/-Pax1-/-) (NNS mutants)))) (VP (MD would) (VP (VB be) (VP (VBN expected) (S (VP (TO to) (VP (VB have) (NP (NP (JJ complex) (NNS effects)) (PP (IN on) (NP (NN thymocyte) (NN development))) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB be) (ADJP (JJ difficult) (S (VP (TO to) (VP (VB predict))))))))))))))))) (. .)))
( (S (S (NP (NP (NN Interpretation)) (PP (IN of) (NP (DT the) (VBN observed) (NN phenotype)))) (VP (VBZ is) (ADVP (RB further)) (VP (VBN complicated) (PP (IN by) (NP (DT the) (NN fact) (SBAR (IN that) (S (NP (NP (NN none)) (PP (IN of) (NP (NP (DT the) (NNS cytokines)) (VP (VBN tested))))) (VP (VBP are) (ADJP (RB completely) (JJ absent)))))))))) (. .)))
( (S (S (NP (DT A) (JJ striking) (NN example)) (VP (VBZ is) (NP (NP (DT the) (JJ complete) (NN absence)) (PP (IN of) (NP (JJ γδTCR+) (NN thymocyte) (NN development))) (PP (IN in) (NP (NN IL-7) (NNS mutants)))) (, ,) (PP (IN in) (NN contrast) (TO to) (NP (NP (JJ normal) (JJ γδTCR+) (NN cell) (NN development)) (PP (IN in) (NP (JJ Hoxa3+/-Pax1-/-) (NNS mutants) (NP (NP (CD -LSB-29) (-RRB- -RSB-)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (NP (ADJP (RB dramatically) (VBN reduced)) (NN IL-7) (NNS levels)))))))))))) (. .)))
( (S (S (NP (DT This) (NN result)) (VP (VBZ suggests) (SBAR (IN that) (S (SBAR (IN although) (S (NP (JJ γδTCR+) (NN cell) (NN development)) (VP (VBZ requires) (NP (NN IL-7))))) (, ,) (NP (JJ low) (NNS levels)) (VP (VBP are) (ADJP (JJ sufficient) (PP (IN for) (NP (DT this) (NN function))))))))) (. .)))
( (S (ADVP (RB Therefore)) (, ,) (NP (NP (NN analysis)) (PP (IN of) (NP (NP (NNS mutants)) (PP (IN with) (NP (NP (JJ low) (NNS levels)) (PP (IN of) (NP (NNS cytokines)))))))) (VP (MD may) (VP (VB provide) (NP (NP (DT a) (NN system)) (PP (IN for) (S (VP (VBG uncovering) (NP (NP (CC both) (NP (JJ dosage-dependent) (NNS requirements)) (CC and) (NP (JJ later) (NNS functions))) (PP (IN for) (NP (DT these) (NNS factors)))) (PP (IN in) (S (VP (VBG promoting) (NP (NN thymocyte) (NN development))))))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB also)) (ADJP (JJ possible)) (SBAR (IN that) (S (NP (NP (DT some)) (PP (IN of) (NP (NP (DT the) (NNS differences)) (VP (VBN seen) (PP (IN between) (NP (ADJP (ADJP (JJ Hoxa3+/-Pax1-/-)) (CC and) (ADJP (NN cytokine) (JJ mutant))) (NNS phenotypes))))))) (VP (VBP reflect) (NP (NP (JJ different) (NNS effects)) (PP (IN of) (NP (NNS cytokines)))) (PP (IN at) (NP (ADJP (ADJP (JJ fetal)) (CC and) (ADJP (JJ adult))) (NNS stages)))))))) (. .)))
( (S (S (NP (NP (NNS Studies)) (PP (IN of) (NP (NN IL-7R) (NNS mutants)))) (VP (VBD showed) (NP (ADJP (RB relatively) (JJ normal)) (NN thymocyte) (NN maturation)) (PP (IN at) (NP (JJ fetal) (NNS stages))) (, ,) (PP (IN albeit) (PP (IN with) (NP (VBN reduced) (NN thymocyte) (NNS numbers)))) (, ,) (PP (IN in) (NN contrast) (TO to) (NP (NP (DT a) (JJ severe) (NN block)) (PP (IN in) (NP (NN thymocyte) (NN differentiation))) (PP (IN in) (NP (JJ adult) (NN thymus) (CD -LSB-49)))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (NP (NN Analysis)) (PP (IN of) (NP (NN cytokine) (NNS mutants))) (PP (IN during) (NP (JJ fetal) (NNS stages)))) (VP (MD could) (ADVP (RB therefore)) (VP (VBP reveal) (NP (NP (DT a) (ADJP (RBR more) (JJ complete)) (NN picture)) (PP (IN of) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (DT these) (NNS cytokines))) (PP (IN during) (NP (JJ fetal) (NN thymus) (NN development))))))))) (. .)))
( (S (NP (NNS Conclusions))))
( (S (NP (PRP$ Our) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (NP (ADJP (ADJP (JJ fetal)) (CC and) (ADJP (JJ adult))) (JJ wild) (NN type) (NNS thymocytes)) (VP (VBP have) (NP (NP (JJ stage-specific) (NNS differences)) (PP (IN in) (NP (NN proliferation)))) (, ,) (PP (IN with) (NP (CC both) (NP (NN TN1)) (CC and) (NP (NP (NN DP) (NNS cells)) (VP (VBG exhibiting) (NP (NP (JJR higher) (NNS levels)) (PP (IN of) (NP (NN proliferation)))) (PP (IN in) (NP (JJ fetal) (NN thymus))))))))))) (. .)))
( (S (S (NP (DT This) (JJ fetal) (JJ wild-type) (NN profile)) (VP (VBD was) (ADJP (RB very) (JJ similar) (PP (TO to) (NP (NP (DT that)) (VP (VBN seen) (PP (IN for) (NP (JJ fetal) (NN Rag) (JJ mutant) (NNS thymocytes))))))) (, ,) (PP (IN in) (NN contrast) (TO to) (NP (JJ adult) (JJ Rag-/-) (NN thymus))))) (. .)))
( (S (ADVP (RB Therefore)) (, ,) (NP (NP (DT the) (NNS changes)) (PP (IN in) (NP (NP (NN proliferation)) (VP (VBN seen) (PP (IN in) (NP (DT the) (JJ fetal) (NN Rag) (JJ mutant) (NNS thymocytes))))))) (VP (VBP reflect) (NP (NP (DT the) (JJS earliest) (NN microenvironment) (NNS changes)) (VP (VBG occurring) (PP (IN as) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NP (JJ defective) (JJ TEC-thymocyte) (NNS interactions)) (PP (IN in) (NP (DT the) (JJ Rag-/-) (NN thymus)))))))))) (. .)))
( (S (NP (DT The) (JJ current) (NN study)) (ADVP (RB further)) (VP (VP (VBZ supports) (NP (NP (DT a) (NN role)) (PP (IN for) (NP (NNS TECs))) (PP (IN in) (S (VP (VBG regulating) (NP (CC both) (NP (NN thymocyte) (NN proliferation)) (CC and) (NP (NN survival))) (PP (IN during) (NP (DT the) (NN DN-DP) (NN transition)))))))) (, ,) (CC and) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (NP (NN proliferation)) (CC and) (NP (NN apoptosis))) (PP (IN of) (NP (NP (NP (NN TN4)) (CC and) (NP (NN DP))) (NNS cells)))) (VP (VBP are) (VP (VBN regulated) (ADVP (RB independently)))))))) (. .)))
( (S (S (NP (PRP$ Our) (NNS results)) (VP (VBP provide) (NP (NP (JJ direct) (JJ genetic) (NN evidence)) (PP (IN for) (NP (NP (DT these) (NNS functions)) (PP (IN of) (NP (NNS TECs)))))) (, ,) (PP (IN by) (S (VP (VBG showing) (SBAR (IN that) (S (NP (DT these) (NNS processes)) (VP (VBP are) (ADJP (JJ defective) (PP (IN in) (NP (NP (NNS mutants)) (PP (IN with) (NP (NP (DT a) (JJ primary) (NN TEC) (NN differentiation) (NN defect)) (PRN (-LRB- -LRB-) (NP (NP (DT the) (NN Hoxa3)) (, ,) (NP (NN Pax1) (NN compound) (NNS mutants))) (-RRB- -RRB-))))))))))))))) (. .)))
( (S (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (NP (PRP$ our) (NNS results)) (ADVP (RB further)) (VP (VBP define) (NP (DT the) (NN role) (S (NP (NNS TECs)) (VP (VBP play) (PP (IN at) (NP (NP (DT this) (JJ complex) (NN stage)) (PP (IN of) (NP (NN thymocyte) (NN development)))))))))) (. .)))
( (S (NP (NNS Methods))))
( (S (S (NP (JJ Hoxa3+/-Pax1+/-) (NNS mice)) (VP (VBD were) (VP (VP (VBN mated) (PP (TO to) (NP (ADJP (ADJP (JJ Pax1+/-)) (CC or) (ADJP (JJ Pax1-/-))) (NNS mice)))) (CC and) (VP (VBN genotyped) (PP (IN for) (NP (CC both) (NP (NN Hoxa3)) (CC and) (NP (NN Pax1)))) (PP (IN by) (NP (NN PCR))) (SBAR (IN as) (S (VP (VBN described) (ADVP (RB previously)) (NP (CD -LSB-29) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (NNS Comparisons)) (VP (VBD were) (VP (VBN made) (PP (IN between) (NP (NP (NNS littermates)) (PP (IN from) (NP (DT the) (JJ same) (NN colony)))))))) (. .)))
( (S (S (NP (NP (JJ Rag1-/-) (NNS mice)) (PRN (-LRB- -LRB-) (NP (NN Jackson) (NNS Labs)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN maintained) (PP (IN as) (NP (DT a) (JJ homozygous) (JJ mutant) (NN colony)))))) (. .)))
( (S (S (NP (DT All) (NNS mice)) (VP (VBD were) (VP (VBN maintained) (PP (IN as) (NP (NN congenic))) (PP (IN on) (NP (DT a) (NN C57BL/6) (JJ genetic) (NN background)))))) (. .)))
( (S (S (NP (NP (NN Noon)) (PP (IN of) (NP (NP (DT the) (NN day)) (PP (IN of) (NP (JJ vaginal) (NN plug)))))) (VP (VBD was) (VP (VBN considered) (NP (NN E0.5))))) (. .)))
( (S (NP (DT All) (NN animal) (NN use) (NNS procedures)) (VP (VBD were) (ADJP (JJ approved) (PP (IN by) (NP (NP (DT the) (JJ Medical) (NN College)) (PP (IN of) (NP (NNP Georgia) (NNP Committee)))))) (PP (IN on) (NP (NP (JJ Animal) (NN Use)) (PP (IN for) (NP (NP (NN Research)) (CC and) (NP (NP (NN Education)) (PRN (-LRB- -LRB-) (NP (NN CAURE)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (JJ Fetal) (NN thymocyte) (ADJP (FW in) (FW vivo)) (NN BrdU) (NN incorporation)) (VP (VBD was) (VP (VBN done) (PP (IN by) (NP (NP (JJ intraperitoneal) (NN injection)) (PP (IN of) (NP (NN BrdU))))) (PRN (-LRB- -LRB-) (NP (NP (NN 5-Bromo-2'-Deoxyuridine)) (: ;) (NP (NN Sigma))) (-RRB- -RRB-)) (PP (IN on) (DT the) (NN morning) (IN of) (NP (NP (NN E17.5)) (, ,) (NP (NP (CD two) (NNS doses)) (PP (IN per) (NP (NN mouse)))) (CC and) (NP (NP (CD 1) (NN mg)) (PP (IN per) (NP (NN dose)))))) (PP (IN with) (NP (NP (DT a) (ADJP (CD 0.5) (NN hour)) (NN pause)) (PRN (, ,) (PP (IN as) (NP (ADJP (RB previously) (VBN described)) (NN -LSB-13))) (-RRB- -RSB-))))))) (. .)))
( (S (S (PP (NP (CD Two) (NNS hours)) (IN after) (NP (DT the) (JJ first) (NN injection))) (, ,) (NP (JJ fetal) (NNS thymi)) (VP (VBD were) (VP (VBN isolated) (PP (IN by) (NP (NP (NN dissection)) (CC and) (NP (NP (NN single-cell) (NNS suspensions)) (VP (VBN prepared) (PP (IN by) (S (VP (VBG passing) (NP (DT the) (NNS thymocytes)) (PP (IN through) (NP (NN cell) (NNS strainers))))))))))))) (. .)))
( (S (S (NP (JJ Adult) (NN thymocyte) (ADJP (FW in) (FW vivo)) (NN BrdU) (NN incorporation)) (VP (VBD was) (VP (VBN done) (PP (IN by) (NP (NP (DT the) (JJ same) (NN injection) (NN protocol)) (VP (VBG using) (NP (ADJP (CD 6–8) (NN week) (JJ old)) (NN C57BL/6) (JJ adult) (NNS mice)))))))) (. .)))
( (S (S (NP (NN Four-color) (NN flow) (NN cytometry)) (VP (VBD was) (VP (VBN performed) (S (VP (VBG using) (NP (NP (DT the) (NP (NP (JJ following) (JJ monoclonal) (NNS antibodies)) (PRN (-LRB- -LRB-) (NP (NNP Pharmingen)) (-RRB- -RRB-)))) (: :) (NP (NP (NP (NN biotin) (JJ anti-mouse) (NN CD25)) (PRN (-LRB- -LRB-) (NP (NN clone) (: :) (NN 7D4)) (-RRB- -RRB-))) (VP (VBN visualized) (PP (IN with) (NP (NP (NN Per-CP)) (VP (VBN conjugated) (NP (NP (NN streptavidin)) (: ;) (NP (NP (NN APC) (JJ anti-mouse) (NN CD44)) (PRN (-LRB- -LRB-) (NP (NN clone)) (: :) (NP (NN IM7)) (-RRB- -RRB-))) (: ;) (CC and) (NP (NP (CD three) (NN phycoerythrin)) (PRN (-LRB- -LRB-) (NP (NN PE)) (-RRB- -RRB-))) (NP (VBN conjugated) (NNS antibodies))))))) (: :) (NP (NP (JJ anti-mouse) (NN CD4)) (PRN (-LRB- -LRB-) (NP (NN clone) (: :) (CD RM4-5)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ anti-mouse) (NN CD8a)) (PRN (-LRB- -LRB-) (NP (NN clone) (: :) (CD 53–6.7)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (JJ anti-mouse) (NN CD3ε)) (PRN (-LRB- -LRB-) (NP (NN clone) (: :) (NN 145-2C11)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (PP (IN In) (NP (DT some) (NNS experiments))) (, ,) (NP (NP (CD PE) (VBN conjugated) (NNS antibodies)) (PP (IN against) (NP (NP (NP (NN B220)) (PRN (-LRB- -LRB-) (NP (NN clone) (: :) (NN RA3-6B2)) (-RRB- -RRB-))) (CC and) (NP (NP (NN NK1.1)) (PRN (-LRB- -LRB-) (NP (NN clone) (: :) (NN PK136)) (-RRB- -RRB-)))))) (VP (VBD were) (ADVP (RB also)) (VP (VBN included)))) (. .)))
( (S (S (PP (IN After) (NP (NN cell) (NN surface) (NN staining))) (, ,) (NP (DT the) (NNS cells)) (VP (VBD were) (NP (ADJP (JJ fixed) (PP (IN with) (NP (ADJP (CD 2) (NN %)) (NN paraformaldehyde)))) (PRN (-LRB- -LRB-) (NP (NN PFA)) (-RRB- -RRB-)) (NNS /PBS)) (PP (IN at) (NP (JJ 4°C) (JJ overnight))))) (. .)))
( (S (S (NP (DT The) (NNS cells)) (VP (VBD were) (ADVP (RB then)) (VP (VBN washed) (, ,) (VP (JJ permeabilized) (PP (IN with) (NP (NP (ADJP (CD 0.1) (NN %)) (NN Triton) (NN X-100/) (CD 0.1) (NN %) (NN Na-Citrate) (-LRB- -LRB-) (CD pH7.2) (-RRB- -RRB-)) (PP (IN on) (NP (NN ice))))) (PP (IN for) (NP (CD 2) (NN min)))) (, ,) (CC and) (ADVP (RB then)) (VP (VBN treated) (PP (IN with) (NP (NP (CD 50) (NNS units)) (PP (IN of) (NP (NN DNaseI) (NN at) (NN 37°C))))) (PP (IN for) (NP (CD 10) (NN min))))))) (. .)))
( (S (S (NP (NNS Cells)) (VP (VBD were) (ADVP (RB then)) (VP (VBN stained) (PP (IN with) (NP (NP (NN FITC) (NN anti-BrdU) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NN Pharmingen)) (-RRB- -RRB-))))))) (. .)))
( (S (S (S (NP (NNS Data)) (VP (VBD were) (VP (VBN collected) (PP (IN by) (S (ADVP (RB selectively)) (VP (VBG gating) (NP (NP (ADJP (CC either) (ADJP (JJ CD3-4-8-)) (CC or) (ADJP (JJ CD3+4+8+))) (NNS populations)) (PRN (-LRB- -LRB-) (NP (NP (NNP Becton) (NNP Dickinson)) (NP (JJ dual) (NN laser) (NN FACSCalibur))) (-RRB- -RRB-))))))))) (, ,) (CC and) (S (NP (NNS analyses)) (VP (VBD were) (VP (VBN performed) (PP (IN with) (NP (NN Cellquest) (NN software))))))) (. .)))
( (S (S (NP (JJ Significant) (NNS differences)) (VP (VBD were) (VP (VBN determined) (PP (IN by) (NP (NP (NP (DT the) (JJ unpaired) (NN Student) (POS 's)) (NN t-test)) (CC or) (NP (NN ANOVA) (NN analysis))))))) (. .)))
( (S (S (NP (NN E14.5) (JJ fetal) (JJ thymic) (NNS lobes)) (VP (VBD were) (VP (VP (VBN collected)) (CC and) (VP (VBN stored) (PP (IN in) (NP (NP (DT the) (NN TRIzol)) (PRN (-LRB- -LRB-) (NP (NN GIBCO) (NN BRL)) (-RRB- -RRB-)))) (PP (IN at) (NP (NN -70°C))) (PP (IN until) (NP (NN RNA) (NN isolation))))))) (. .)))
( (S (S (NP (NP (NNS Pools)) (PP (IN of) (NP (NP (NN 5-to10) (NN thymi)) (PP (IN from) (NP (NP (NNS embryos)) (PP (IN of) (NP (DT the) (JJ same) (NN genotype)))))))) (VP (VBD were) (VP (VBN homogenized) (S (VP (VBG using) (NP (NP (NP (NN Micro) (NN Pellet) (NNS Pestles)) (PRN (-LRB- -LRB-) (NP (NNP Nalge) (NNP Nunc) (NNP International)) (-RRB- -RRB-))) (PP (IN in) (NP (ADJP (CD 1.5) (NN ml-eppendorf)) (NNS tubes))))))))) (. .)))
( (S (S (S (NP (NN RNA)) (VP (VBD was) (VP (VBN isolated)))) (CC and) (S (NP (DT the) (JJ genomic) (NN DNA)) (VP (VBD was) (VP (VBN depleted) (PP (IN by) (S (VP (VBG using) (NP (NP (NN DNaseI)) (PRN (-LRB- -LRB-) (NP (NP (NN Amplification) (NN Grade)) (, ,) (NP (NN GIBCO) (NN BRL))) (-RRB- -RRB-)))))) (PP (VBG following) (NP (NP (DT the) (NN manufacturer) (POS 's)) (NNS protocols))))))) (. .)))
( (S (S (NP (NP (JJ Reverse) (NN transcription)) (PP (IN of) (NP (NP (CD 1) (NN μg)) (PP (IN of) (NP (JJ total) (NN RNA))) (PP (TO to) (NP (NN cDNA)))))) (VP (VBD was) (VP (VBN done) (S (VP (VBG using) (NP (NP (NN SuperScript) (CD II)) (VP (VBG following) (NP (NP (NP (DT the) (NN manufacturer) (POS 's)) (NN protocol)) (PRN (-LRB- -LRB-) (NP (NN GIBCO) (NN BRL)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NP (JJ Equal) (NNS amounts)) (PP (IN of) (NP (NP (NN cDNA)) (PP (IN from) (NP (JJ different) (NNS genotypes)))))) (VP (VBD were) (VP (VBN added) (PP (TO to) (NP (NP (DT a) (JJ final) (CD 20) (NN μl) (NN PCR) (NN reaction) (NN mixture)) (VP (VBG using) (NP (DT the) (NN QIAGEN) (NN Taq) (NN PCR) (NNS kits)))))))) (. .)))
( (S (S (S (NP (NN PCR) (NNS conditions)) (VP (VBD were))) (: :) (FRAG (NP (NN 94°C) (CD 30) (NN sec)) (, ,) (NP (NP (NN 50°C) (CD 1) (NN min)) (, ,) (NP (NP (NN 72°C) (CD 1) (NN min)) (PP (IN for) (NP (NP (NN IL-7)) (, ,) (NP (NN SCF)) (CC and) (NP (PRP$ their) (JJ internal) (NN control) (NN β-actin))))) (: ;) (CC or) (NP (NN 94°C) (CD 30) (NN sec)) (, ,) (NP (NN 60°C) (CD 1) (NN min)) (, ,) (CC 72°C) (NP (NP (CD 1) (NN min)) (PP (IN for) (NP (NP (NN TGFβ1)) (CC and) (NP (PRP$ its) (JJ internal) (NN control) (NN β-actin)))))))) (. .)))
( (S (S (NP (NN PCR) (NNS products)) (VP (VBD were) (VP (VBN visualized) (PP (IN by) (NP (NP (ADJP (CD 5) (NN %)) (NN acrylamide) (NN gel) (NN electrophoresis)) (CC and) (NP (NP (NN ethidium) (NN bromide)) (NN staining))))))) (. .)))
( (S (S (NP (NN Band) (NNS densities)) (VP (VBD were) (VP (VP (VBN measured)) (CC and) (VP (VBN analyzed))) (S (VP (VBG using) (NP (NP (DT the) (JJ Molecular) (NN Analyst) (NN software) (NN package)) (PRN (-LRB- -LRB-) (NP (JJ Bio-Rad) (NNS Laboratories)) (, ,) (NP (NN Version) (CD 1.4.1)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NN Primer) (NNS sequences)) (VP (VBD were) (: :) (NP (NP (NN IL-7) (CD -LSB-65) (-RRB- -RSB-)) (: :) (NP (NP (NN IL-7) (PRN (-LRB- -LRB-) (NP (CD 5) ('' ')) (-RRB- -RRB-)) (CD 5)) (VP (`` ') (VB ACT) (NP (NN ACA) (NN CCC) (NN ACC) (NN TCC) (NN CGC) (NN A3) (POS ')))) (: ;) (NP (NP (NN IL-7) (PRN (-LRB- -LRB-) (NP (CD 3) ('' ')) (-RRB- -RRB-)) (CD 5)) (NP (`` ') (JJ TCT) (NN CAG) (NN TAG) (NN TCT) (NN CTT) (NN TAG) (NN G3) ('' '))) (: ;) (NP (NN SCF) (CD -LSB-65) (-RRB- -RSB-)) (: :) (NP (NP (NP (NN SCF)) (PRN (-LRB- -LRB-) (NP (CD 5) ('' ')) (-RRB- -RRB-))) (S (S (NP (ADJP (CD 5) ('' ') (JJ TCT)) (NN TCA)) (VP (VB ACT) (NP (NN GCT) (NN CCT) (NN ATT) (NN T3) (POS ')))) (: ;) (S (NP (NN SCF) (PRN (-LRB- -LRB-) (NP (CD 3) ('' ')) (-RRB- -RRB-)) (CD 5)) (VP (`` ') (VB ACT) (NP (NP (NP (NN GCT)) (VP (VB ACT) (NP (NN GCT) (NN GTC) (NN ATT) (NN C3) (POS ')))) (: ;) (NP (NP (NP (NNP TGFβ1) (CD -LSB-66) (-RRB- -RSB-) (: :) (CD TGFβ1)) (PRN (-LRB- -LRB-) (NP (CD 5) ('' ')) (-RRB- -RRB-))) (NP (CD 5) (`` ') (NN GCG) (NN GAC) (NN TAC) (NN TAT) (NN GCT) (NN AAA) (NN GAG) (NN G3) ('' ')))))))) (: ;) (NP (NP (NP (CD TGFβ1)) (PRN (-LRB- -LRB-) (NP (CD 3) ('' ')) (-RRB- -RRB-))) (NP (CD 5) (`` ') (NN GTT) (NN GTG) (NN TTG) (NN GTT) (NN GTA) (NN GAG) (NN GGC) (NN A3) ('' '))) (: ;) (NP (NN β-actin) (CD -LSB-67) (-RRB- -RSB-)) (: :) (NP (NP (NN β-actin)) (PRN (-LRB- -LRB-) (NP (CD 5) ('' ')) (-RRB- -RRB-)) (NP (CD 5) (`` ') (NN GGG) (NN TCA) (NN GAA) (NN GGA) (NN CTC) (NN CTA) (NN TG3) ('' '))) (: ;) (NP (NP (NP (NN β-actin)) (PRN (-LRB- -LRB-) (NP (CD 3) ('' ')) (-RRB- -RRB-))) (NP (CD 5) (`` ') (NN GTA) (NN ACA) (NN ATG) (NN CCA) (NN TGT) (NN TCA) (NN AT3) ('' ')))))) (. .)))
( (S (S (NP (JJ Thymic) (NNS lobes)) (VP (VBD were) (VP (VBD dissected) (PP (IN from) (NP (NN E15.5) (NNS embryos)))))) (. .)))
( (S (S (NP (NP (DT The) (CD two) (NNS lobes)) (PP (IN from) (NP (DT each) (NN embryo)))) (VP (VBN cultured) (ADVP (RB separately)) (PP (IN in) (NP (JJ high) (NN oxygen) (NN submersion) (NN culture))) (PP (IN as) (NP (ADJP (RB previously) (VBN described)) (NN -LSB-41)))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (JJ Fetal) (JJ thymic) (NN organ) (NNS cultures)) (VP (VBD were) (VP (VBN supplemented) (PP (IN with) (NP (NP (NP (CD 100) (NN u/ml)) (PP (IN of) (NP (NN IL-7)))) (CC or) (NP (NP (CD 20) (NN ng/ml)) (PP (IN of) (NP (NN SCF)))))) (PRN (-LRB- -LRB-) (NP (NNP Pepro) (NNP Tech) (NNP Inc.)) (-RRB- -RRB-)) (PP (IN as) (NP (ADJP (RB previously) (VBN described)) (NN -LSB-41) (-RRB- -RSB-)))))) (. .)))
( (S (S (PP (IN For) (NP (DT each) (NN embryo))) (, ,) (NP (CD one) (NN lobe)) (VP (VBD was) (VP (VBN treated) (SBAR (IN while) (S (NP (DT the) (JJ other)) (VP (VBD was) (VP (VBN cultured) (PP (IN in) (NP (NN parallel))) (PP (IN without) (NP (JJ supplemental) (NN cytokine))) (PP (IN as) (NP (DT an) (JJ internal) (NN control)))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN control) (NNS experiments))) (, ,) (NP (NNS lobes)) (VP (VBD were) (VP (VBN cultured) (ADVP (RB separately)) (PP (IN under) (NP (NP (JJ identical) (NNS conditions)) (PP (IN without) (NP (NN cytokine)))))))) (. .)))
( (S (S (PP (IN After) (NP (NP (CD five) (NNS days)) (PP (IN in) (NP (NN culture))))) (, ,) (NP (DT the) (NNS cells)) (VP (VBD were) (VP (VP (VBN stained) (PP (IN by) (NP (NP (JJ PE-anti-mouse) (NN CD4)) (CC and) (NP (JJ FITC-anti-mouse) (NN CD8))))) (CC and) (VP (VBN analyzed) (PP (IN by) (NP (NP (NN flow) (NN cytometry)) (ADVP (RB as) (RB above)))))))) (. .)))
( (S (NP (NP (NNS Authors) (POS ')) (NNS contributions))))
( (S (S (NP (NN DMS)) (VP (VP (VBD conceived) (PP (IN of) (NP (DT the) (NN study)))) (CC and) (VP (VBD performed) (NP (NP (DT all)) (PP (IN of) (NP (NP (DT the) (NNS experiments)) (VP (VBN described)))))))) (. .)))
( (S (S (NP (NN NRM)) (VP (VP (VBD contributed) (PP (TO to) (NP (NP (NP (DT the) (NN design)) (PP (IN of) (NP (DT the) (NN study)))) (CC and) (NP (NN data) (NN analysis))))) (, ,) (CC and) (VP (VBN drafted) (NP (DT the) (NN manuscript))))) (. .)))
( (S (S (NP (DT All) (NNS authors)) (VP (VP (VBN read)) (CC and) (VP (JJ approved) (NP (DT the) (JJ final) (NN manuscript))))) (. .)))
( (S (NP (NP (NN Figure)) (CC and) (NP (NN Table)) (NP (NNS captions)))))
( (S (NP (NP (NN Figure) (CD 1)) (: :) (S (NP (NP (NN DNA) (NN synthesis) (NNS patterns)) (PP (IN of) (NP (ADJP (ADJP (JJ fetal)) (CC vs.) (ADJP (JJ adult))) (NN thymocyte) (NNS subsets))) (SBAR (IN as) (S (VP (VBN measured) (PP (IN by) (NP (NP (NN incorporation)) (PP (IN of) (NP (NP (NP (NN BrdU)) (NP (NNP A.))) (NNS Thymocytes))))))))) (VP (VBD were) (VP (VBN gated) (PP (IN as) (NP (CC either) (NP (JJ CD3-4-8-) (NN TN)) (CC or) (NP (JJ CD3+4+8+) (NN DP)))) (PP (IN by) (NP (NP (NN cell) (NN surface) (NN marker) (NN expression)) (CC and) (NP (NP (JJ forward) (NN scatter)) (PRN (-LRB- -LRB-) (S (NP (NN SP) (NNS cells)) (VP (VP (MD should) (VP (VB be) (ADJP (JJ located) (PP (IN between) (NP (DT these) (CD two) (NNS gates)))))) (, ,) (CC and) (ADVP (RB therefore)) (VP (VBN excluded) (PP (IN from) (NP (NN analysis)))))) (-RRB- -RRB-)))))))) (. .))))
( (S (S (NP (NNP B.) (NN Gate)) (VP (VBN used) (PP (IN for) (NP (NP (NN analysis)) (PP (IN of) (NP (NP (NN BrdU) (NN incorporation)) (PP (IN on) (NP (JJ gated) (NNS subpopulations))))))))) (. .)))
( (S (NP (NNS Panels) (NP (CD C-E))) (VP (VBP show) (NP (NP (NP (NP (NN CD44)) (CC vs.) (NP (NN CD25))) (NN dot) (NNS plots)) (PP (IN of) (NP (DT the) (JJ gated) (JJ CD3-4-8-) (NN population))) (PP (IN from) (NP (NP (NP (ADJP (CD 5–6) (NN week) (JJ old)) (JJ adult) (NN C57BL/6)) (PRN (-LRB- -LRB-) (NP (NN C)) (-RRB- -RRB-))) (, ,) (NP (NP (NN E17.5) (JJ fetal) (NN C57BL/6)) (PRN (-LRB- -LRB-) (NP (NN D)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NN E17.5) (JJ fetal) (JJ RAG-/-)) (PRN (-LRB- -LRB-) (NP (NN E)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NNS Percentages)) (VP (VBP are) (VP (VBN shown) (PP (IN in) (NP (DT each) (NN quadrant)))))) (. .)))
( (S (NP (NP (NNP F.) (NNS Percentages)) (PP (IN of) (NP (NP (NN BrdU+) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN Mean) (NN ±) (NN SEM)) (-RRB- -RRB-)))) (PP (PP (IN in) (NP (NP (DT each) (NN subset)) (PP (IN of) (NP (NP (NN TN) (NNS cells)) (VP (VBN defined) (PP (IN by) (NP (NP (NN CD44)) (CC and) (NP (NN CD25))))))))) (, ,) (CC and) (PP (IN in) (NP (NN DP) (NNS cells)))) (. .))))
( (S (S (NP (FW G.) (JJ Adult) (JJ wild-type) (NNS thymocytes)) (VP (VBD were) (VP (VBN gated) (PP (IN as) (NP (NN CD3-4-8-B220-NK1.1-)))))) (. .)))
( (S (NP (NP (NNP H.) (NN CD44) (CC vs.) (NN CD25) (NN dot) (NNS plots)) (PP (IN of) (NP (DT the) (JJ gated) (NN population))) (PP (IN from) (NP (-LRB- -LRB-) (NN G) (-RRB- -RRB-))) (. .))))
( (S (NP (NP (NN I.) (NN Percentage)) (PP (IN of) (NP (NP (NN BrdU+) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN mean) (CD ±) (NN SEM)) (-RRB- -RRB-)))) (PP (IN in) (NP (ADJP (ADJP (JJ adult)) (CC and) (ADJP (JJ fetal))) (NN TN1) (NNS thymocytes)))) (VP (VBG excluding) (NP (NP (NP (NP (NN B)) (CC and) (NP (NN NK))) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NP (NN H)) (, ,) (NP (NN G))) (-RRB- -RRB-)))) (. .)))
( (S (S (NP (NN Figure) (CD 2)) (: :) (S (NP (NP (NN Proliferation)) (PP (IN of) (NP (NN E17.5) (NN Hoxa3-Pax1) (NN compound) (JJ mutant) (NNS thymocytes)))) (VP (VBN compared) (PP (TO to) (NP (JJ wild) (NN type)))))) (. .)))
( (S (S (NP (NP (NNS Panels)) (ADJP (JJ A-B))) (VP (VBP show) (NP (NP (NP (NP (NN CD44)) (CC vs.) (NP (NN CD25))) (NN dot) (NNS plots)) (PP (IN of) (NP (DT the) (JJ gated) (JJ CD3-4-8-) (NN population))) (PP (IN from) (NP (NN E17.5) (JJ wild) (NN type) (-LRB- -LRB-) (NN A) (-RRB- -RRB-) (CC and) (JJ Hoxa3+/-Pax1-/-) (-LRB- -LRB-) (NN B) (-RRB- -RRB-) (NN thymus)))))) (. .)))
( (S (S (NP (NNS Percentages)) (VP (VBP are) (VP (VBN shown) (PP (IN in) (NP (DT each) (NN quadrant)))))) (. .)))
( (S (NP (NP (NN C.) (NNS Percentages)) (PP (IN of) (NP (NP (NN BrdU+) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN Mean) (NN ±) (NN SEM)) (-RRB- -RRB-)))) (PP (IN in) (NP (NP (DT each)) (PP (IN of) (NP (NP (CD 4) (NNS subsets)) (PP (IN of) (NP (NN TN) (NNS cells))) (VP (VBN defined) (PP (PP (IN by) (NP (NP (NN CD44)) (CC and) (NP (NN CD25)))) (, ,) (CC and) (PP (IN in) (NP (NN DP) (NNS cells))))))))) (. .))))
( (S (S (NP (NP (NP (NP (NN D)) (, ,) (NP (FW E.) (NN CD44)) (CC vs.) (NP (NN CD25))) (NN dot) (NNS plots)) (PP (IN of) (NP (DT the) (JJ gated) (JJ CD3-4-8-) (NN population)))) (VP (VBN divided) (PP (IN into) (NP (CD five) (NNS subsets))) (SBAR (IN as) (S (VP (VBN defined) (PP (IN by) (NP (NN -LSB-12))))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (NP (NP (NNP F.)) (NNS Percentages)) (PP (IN of) (NP (NP (NN BrdU+) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN Mean) (NN ±) (NN SEM)) (-RRB- -RRB-)))) (PP (IN in) (NP (NP (DT each)) (PP (IN of) (NP (NP (CD 3) (JJ CD44-) (NN TN) (NNS subsets)) (VP (VBN defined) (PP (IN in) (NP (NP (NNS panels) (NP (NP (NN D)) (CC and) (NP (FW E.) (NN DP) (NNS values)))) (VP (VBN shown) (PP (IN for) (NP (NN comparison)))))))))))) (VP (VBP are) (NP (NP (DT the) (JJ same)) (PP (IN as) (PP (IN in) (NP (NN C))))))) (. .)))
( (S (NP (NP (NN Figure) (CD 3)) (: :) (S (NP (NP (NN Expression)) (PP (IN of) (NP (NNS cytokines))) (PP (IN in) (NP (NP (JJ fetal) (NNS thymi)) (PP (IN of) (NP (NP (JJ Hoxa3+/-Pax1-/-) (NNS mice)) (CC and) (NP (NNS controls)))) (VP (VBN measured) (PP (IN by) (NP (JJ semi-quantitative) (NN RT-PCR) (NP (DT Each) (NNP lane)))))))) (VP (VBZ contains) (NP (NP (JJ pooled) (NN cDNA)) (PP (IN from) (NP (NP (NN 5–10) (NN E14.5) (JJ embryonic) (NN thymi)) (PP (IN of) (NP (DT the) (JJ same) (NN genotype)))))))) (. .))))
( (S (S (NP (NP (JJ Representative) (NNS results)) (PP (IN from) (NP (QP (CD one) (IN of) (CD three)) (NNS experiments))) (PP (IN for) (NP (DT each) (NN cytokine)))) (VP (VBP are) (VP (VBN shown)))) (. .)))
( (S (S (NP (NN β-actin)) (VP (VBD was) (VP (VBN used) (PP (IN as) (NP (DT a) (NN control)))))) (. .)))
( (S (NP (NP (NN Panel) (NN A)) (, ,) (NP (NP (NN expression)) (PP (IN of) (NP (NN IL-7)))) (: ;) (NP (NN Panel) (NN B)) (, ,) (NP (NP (NN expression)) (PP (IN of) (NP (NN SCF)))) (. .))))
( (S (NP (NP (NN Table) (CD 1)) (: :) (NP (NP (NP (NN Percentage)) (PRN (-LRB- -LRB-) (NP (NN Mean) (NN ±) (NN SD)) (-RRB- -RRB-))) (PP (IN of) (NP (NN BrdU+) (NNS cells))) (PP (IN in) (NP (NP (DT each) (NN subset)) (PP (IN of) (NP (JJ fetal) (NNS thymocytes)))))))))
( (S (NP (NP (NN Table) (CD 2)) (: :) (NP (NP (NP (NNS Percentages)) (PRN (-LRB- -LRB-) (NP (NN Mean) (NN ±) (NN SD)) (-RRB- -RRB-))) (PP (IN of) (NP (NN BrdU+) (NNS cells))) (PP (IN in) (NP (NP (VBN selected) (NNS subsets)) (PP (IN of) (NP (ADJP (ADJP (JJ wild-type)) (CC and) (ADJP (JJ compound))) (JJ mutant) (JJ fetal) (NNS thymocytes)))))))))
( (S (NP (NP (NN Down-regulation)) (PP (IN of) (NP (NP (NN interferon) (JJ regulatory) (NN factor) (CD 4)) (NN gene) (NN expression))) (PP (IN in) (NP (JJ leukemic) (NNS cells))) (PP (IN due) (TO to) (NP (NP (NN hypermethylation)) (PP (IN of) (NP (NN CpG) (NNS motifs))) (PP (IN in) (NP (DT the) (NN promoter) (NN region))))))))
( (S (NP (NN Abstract))))
( (S (S (SBAR (IN Although) (S (NP (DT the) (NN bcr-abl) (NN translocation)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (NP (NP (DT the) (JJ causative) (JJ genetic) (NN aberration)) (PP (IN in) (NP (NP (JJ chronic) (JJ myeloid) (NN leukemia)) (PRN (-LRB- -LRB-) (NP (NN CML)) (-RRB- -RRB-))))))))))))) (, ,) (NP (EX there)) (VP (VBZ is) (NP (JJ mounting) (NN evidence) (SBAR (IN that) (S (NP (NP (DT the) (NN deregulation)) (PP (IN of) (NP (NP (JJ other) (NNS genes)) (, ,) (PP (JJ such) (IN as) (NP (NP (DT the) (NN transcription) (NN factor) (NN interferon) (JJ regulatory) (NN factor) (CD 4)) (PRN (-LRB- -LRB-) (NP (NN IRF-4)) (-RRB- -RRB-)))) (, ,)))) (VP (VBZ is) (ADVP (RB also)) (VP (VBN implicated) (PP (IN in) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (NN CML)))))))))))) (. .)))
( (S (S (NP (NP (NP (NN Promoter) (NN methylation)) (PP (IN of) (NP (NN CpG) (NN target) (NNS sites)))) (CC or) (NP (NP (JJ direct) (NNS deletions/insertions)) (PP (IN of) (NP (NNS genes))))) (VP (VBP are) (NP (NP (NNS mechanisms)) (PP (IN of) (NP (NP (DT a) (ADJP (ADJP (JJ reversible)) (CC or) (ADJP (JJ permanent))) (NN silencing)) (PP (IN of) (NP (NN gene) (NN expression)))))) (, ,) (ADVP (RB respectively)))) (. .)))
( (S (S (ADVP (RB Therefore)) (, ,) (NP (PRP we)) (VP (VBD investigated) (SBAR (IN whether) (S (NP (NP (NN IRF-4) (NN promoter) (NN methylation)) (CC or) (NP (NN mutation))) (VP (MD may) (VP (VB be) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (NN IRF-4) (NN expression)) (PP (IN in) (NP (NN leukemia) (NNS cells)))))))))))))) (. .)))
( (S (S (SBAR (IN Whereas) (S (NP (NP (NN promoter) (NNS mutations)) (CC or) (NP (JJ structural) (NNS rearrangements))) (VP (MD could) (VP (VB be) (VP (VBN excluded) (PP (IN as) (NP (NP (DT a) (NN cause)) (PP (IN of) (NP (NP (JJ altered) (NN IRF-4) (NN expression)) (PP (IN in) (NP (JJ hematopoietic) (NNS cells)))))))))))) (, ,) (NP (DT the) (NN IRF-4) (NN promoter) (NN methylation) (NN status)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (ADVP (RB significantly)) (VP (VB influence) (NP (NN IRF-4) (NN transcription)))))))) (. .)))
( (S (S (ADVP (RB First)) (, ,) (NP (NP (NN treatment)) (PP (IN of) (NP (JJ IRF-4-negative) (ADJP (ADJP (JJ lymphoid)) (, ,) (ADJP (JJ myeloid)) (CC and) (ADJP (JJ monocytic))) (NN cell) (NNS lines))) (PP (IN with) (NP (DT the) (JJ methylation-inhibitor) (NN 5-aza-2-deoxycytidine)))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (ADJP (ADJP (NN time-)) (CC and) (ADJP (JJ concentration-dependent))) (NN increase)) (PP (IN of) (NP (NP (NN IRF-4) (NN mRNA)) (CC and) (NP (NN protein) (NNS levels)))))))) (. .)))
( (S (ADVP (RB Second)) (, ,) (S (VP (VBG using) (NP (DT a) (ADJP (ADJP (JJ restriction-PCR-assay)) (CC and) (ADJP (JJ bisulfite-sequencing)))))) (NP (PRP we)) (VP (VBD identified) (NP (ADJP (RB specifically) (VBN methylated)) (NN CpG) (NNS sites)) (PP (PP (IN in) (NP (NN IRF-4-negative))) (CC but) (PP (RB not) (IN in) (NP (JJ IRF-4-positive) (NNS cells))))) (. .)))
( (S (S (ADVP (RB Third)) (, ,) (NP (PRP we)) (ADVP (RB clearly)) (VP (VP (VBD determined) (NP (NN promoter) (NN methylation)) (PP (IN as) (NP (NP (DT a) (NN mechanism)) (PP (IN for) (NP (NP (NN IRF-4) (NN down-regulation)) (PP (IN via) (NP (NN reporter) (NN gene) (NNS assays)))))))) (, ,) (CC but) (VP (VBD did) (RB not) (VP (VB detect) (NP (NP (DT an) (NN association)) (PP (IN of) (NP (NP (NP (JJ methylational) (NN status)) (CC and) (NP (NN mRNA) (NN expression))) (PP (IN of) (NP (NP (NN DNA) (NNS methyltransferases)) (CC or) (NP (JJ methyl-CpG-binding) (NNS proteins))))))))))) (. .)))
( (S (S (ADVP (RB Together)) (, ,) (NP (DT these) (NNS data)) (VP (VBP suggest) (NP (NN CpG) (JJ site-specific) (NN IRF-4) (NN promoter) (NN methylation)) (PP (IN as) (NP (NP (DT a) (JJ putative) (NN mechanism)) (PP (IN of) (NP (NP (VBN down-regulated) (NN IRF-4) (NN expression)) (PP (IN in) (NP (NN leukemia))))))))) (. .)))
( (S (NP (NN INTRODUCTION))))
( (S (S (NP (NP (JJ Chronic) (JJ myeloid) (NN leukemia)) (PRN (-LRB- -LRB-) (NP (NN CML)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (JJ clonal) (JJ myeloproliferative) (NN disorder)) (PP (IN with) (NP (NP (NP (DT a) (JJ typical) (CD three) (JJ phased) (NN course)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (ADJP (JJ chronic)) (, ,) (ADJP (VBN accelerated)))) (CC and) (NP (JJ blastic) (NN phase))) (-RRB- -RRB-))) (VP (VBG reflecting) (NP (NP (DT the) (NN loss)) (PP (IN of) (NP (NP (NN differentiation)) (CC and) (NP (JJ malignant) (NN progress)))))))) (SBAR (WHNP (WDT which)) (S (ADVP (RB inevitably)) (VP (VBZ leads) (PP (TO to) (NP (NP (NN death)) (PP (IN after) (NP (NP (DT the) (JJ blastic) (NN phase)) (PRN (-LRB- -LRB-) (NP (NN 1,2)) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN hallmark) (JJ genetic) (NN aberration)) (PP (IN of) (NP (NN CML)))) (VP (VBZ is) (NP (NP (DT a) (JJ reciprocal) (NN chromosomal) (NN translocation) (NP (NP (NN t)) (PRN (-LRB- -LRB-) (NP (CD 9) (: ;) (CD 22)) (-RRB- -RRB-)))) (VP (VBG leading) (PP (TO to) (NP (NP (NN expression)) (PP (IN of) (NP (NP (DT a) (NN bcr-abl) (NN fusion) (NN gene)) (, ,) (NP (NP (DT an) (JJ aberrant) (JJ activated) (NN tyrosine) (NN kinase)) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (NP (NP (NN Treatment)) (PP (IN with) (NP (NP (NN interferon) (NN α)) (PRN (-LRB- -LRB-) (NP (NN IFN-α)) (-RRB- -RRB-))))) (VP (VP (VBZ prolongs) (NP (NP (NN survival)) (PP (IN of) (NP (NN CML) (NNS patients))))) (CC and) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (JJ complete) (JJ cytogenetic) (NN response)) (PP (IN in) (NP (NP (CD 5–33) (NN %)) (PP (IN of) (NP (NP (NN CML) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NN 1,2)) (-RRB- -RRB-)))))))))))) (. .)))
( (S (ADVP (RB Recently)) (, ,) (NP (PRP we)) (VP (VBD described) (NP (NP (DT an) (JJ impaired) (NN expression)) (PP (IN of) (NP (DT the) (NP (NP (NN interferon) (JJ regulatory) (NN factor) (CD 4)) (PRN (-LRB- -LRB-) (NP (NN IRF-4)) (-RRB- -RRB-))))) (PP (IN in) (NP (NN CML)))) (, ,) (S (VP (VBG correlating) (PP (IN with) (NP (NP (JJ poor) (NN response)) (PP (TO to) (NP (NP (JJ IFN-α) (NN treatment)) (PRN (-LRB- -LRB-) (NP (CD 3)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN cause)) (PP (IN of) (NP (NP (DT the) (NN silencing)) (PP (IN of) (NP (NN IRF-4) (NN level)))))) (VP (VBD remained) (ADJP (JJ unclear)))) (. .)))
( (S (S (NP (NP (NN Interferon) (JJ regulatory) (NNS factors)) (PRN (-LRB- -LRB-) (NP (NNS IRFs)) (-RRB- -RRB-))) (VP (VBP are) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NP (JJ transcriptional) (NNS regulators)) (VP (VBN defined) (PP (IN by) (NP (NP (DT a) (JJ characteristic) (NN homology)) (PP (IN in) (NP (PRP$ their) (JJ DNA-binding) (NN domain))))))))))) (. .)))
( (S (S (NP (PRP They)) (VP (VBP play) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (NP (JJ various) (NNS genes)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NP (NNS IFNs)) (, ,) (NP (NNS interleukins)) (, ,) (NP (NN MHC) (NN class) (NN I/II))))) (-RRB- -RRB-))) (, ,) (NP (NP (NN apoptosis)) (CC and) (NP (NP (NN differentiation/maturation)) (PRN (-LRB- -LRB-) (NP (NN 4–6)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NP (NN IRF-4)) (PRN (-LRB- -LRB-) (NP (NN ICSAT/Pip/MUM1/LSIRF)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (CD one) (NN member)) (PP (IN with) (NP (ADJP (RB very) (JJ restricted)) (NN expression) (NN pattern)))))) (: :) (S (ADVP (RB Predominately)) (NP (NP (NN B-)) (CC and) (NP (VBN activated) (NNS T-lymphocytes))) (VP (VBP are) (ADJP (ADJP (NN IRF-4) (JJ positive)) (PRN (-LRB- -LRB-) (NP (NN 7–11)) (-RRB- -RRB-))))) (. .)))
( (S (PP (IN In) (NN contrast) (TO to) (NP (JJ other) (NNS IRFs))) (, ,) (NP (NP (NN expression)) (PP (IN of) (NP (NN IRF-4)))) (VP (MD cannot) (VP (VB be) (VP (VBN induced) (PP (PP (IN by) (NP (NNS IFNs))) (, ,) (CC but) (PP (IN by) (NP (NN antigen) (NN stimulation))) (, ,) (NP (NP (NN crosslinking)) (PP (IN of) (NP (NP (NP (NP (NN T-)) (CC or) (NP (NN B-cell))) (NNS receptors)) (CC or) (NP (NP (NN phorbol-myristate-acetate)) (PRN (-LRB- -LRB-) (NP (NN 10,11)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (S (ADJP (JJ Consistent) (PP (IN with) (NP (NP (DT the) (NN restriction)) (PP (IN of) (NP (NN expression))) (PP (TO to) (NP (JJ immunocompetent) (NNS cells))))))) (, ,) (NP (NP (NNS mice)) (PP (IN with) (NP (NP (NN deletion)) (PP (IN of) (NP (NN IRF-4)))))) (VP (VBD failed) (S (VP (TO to) (VP (VB develop) (NP (NP (ADJP (ADJP (JJ mature)) (CC and) (ADJP (RB functionally) (JJ active))) (NN B-)) (CC and) (NP (NP (NNS T-lymphocytes)) (PRN (-LRB- -LRB-) (NP (CD 12)) (-RRB- -RRB-))))))))) (, ,) (CC and) (S (NP (NP (DT the) (JJ impaired) (NN expression)) (PP (IN of) (NP (NN IRF-4))) (PP (IN in) (NP (NN CML)))) (VP (VBD was) (ADVP (RB predominately)) (VP (VBN found) (PP (IN in) (NP (NP (NNS T-cells)) (PRN (-LRB- -LRB-) (NP (CD 3)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (DT These) (NNS data)) (VP (VBP suggest) (NP (NP (DT a) (JJ crucial) (NN role)) (PP (IN for) (NP (NN IRF-4))) (PP (IN in) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (JJ immune) (NNS cells)))))))) (. .)))
( (S (NP (NP (NN Methylation)) (PP (IN of) (NP (NP (NN dinucleotide) (NN cytosine-guanosine) (NNS motifs)) (PRN (-LRB- -LRB-) (NP (NN CpG)) (-RRB- -RRB-)))) (, ,) (ADVP (RB especially)) (PP (IN in) (NP (NP (NN CpG) (NNS islands)) (ADJP (JJ located) (PP (IN in) (NP (NN promoter) (NNS regions)))))) (, ,)) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (NNS mechanisms)) (PP (IN of) (NP (NN gene) (NN regulation))) (PP (IN in) (NP (NP (NNS mammals)) (CC and) (NP (NP (DT a) (JJ common) (NN event)) (PP (IN of) (NP (NN gene) (NN silencing))) (PP (IN in) (NP (NP (JJ human) (NNS neoplasias)) (PRN (-LRB- -LRB-) (NP (NN 13,14)) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (SBAR (IN As) (S (VP (VBN opposed) (PP (TO to) (NP (JJ normal) (NNS cells)))))) (, ,) (NP (NP (NN hypermethylation)) (PP (IN of) (NP (NN CpG) (NNS islands)))) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB frequently) (VBN observed)) (NN phenomenon)) (PP (IN in) (NP (DT every) (NN cancer) (NN type)))))) (. .)))
( (S (S (NP (NP (ADJP (FW De) (FW novo)) (NN DNA) (NN methylation)) (PP (IN of) (NP (NP (NNS genes)) (PP (JJ such) (IN as) (NP (NP (NN cell) (NN cycle)) (, ,) (NP (NN DNA) (NN repair)) (, ,) (NP (NN apoptosis)) (CC and) (NP (NN tumor) (NN suppressor) (NNS genes))))))) (VP (VBZ is) (ADVP (RB therefore)) (VP (VBN thought) (S (VP (TO to) (VP (VB be) (VP (VBN involved) (PP (IN in) (NP (NP (NN tumorigenesis)) (PRN (-LRB- -LRB-) (NP (NN 15–17)) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (NP (NP (NNS Examples)) (PP (IN for) (NP (JJ such) (JJ aberrated) (NNS genes)))) (VP (VBP are) (NP (NP (NN MGMT)) (, ,) (NP (NN DAPK)) (, ,) (NP (NN p14ARF)) (, ,) (NP (NN p15INK4b)) (, ,) (NP (NN p16INK4a)) (, ,) (NP (NN BRCA1)) (, ,) (NP (NN CDH13)) (CC and) (NP (NP (NN APAF-1)) (PRN (-LRB- -LRB-) (NP (NN 17–19)) (-RRB- -RRB-)))))) (. .)))
( (S (PP (IN In) (NP (NN CML))) (, ,) (S (S (NP (NN methylation)) (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB regulate) (NP (NP (NN expression)) (PP (IN of) (NP (NP (DT the) (NP (NN c-abl)) (, ,) (NP (DT the) (NN bcr) (NN gene)) (CC and) (NP (NNS others))) (PRN (-LRB- -LRB-) (NP (NN 20–23)) (-RRB- -RRB-))))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN extent)) (PP (IN of) (NP (NN methylation))) (PP (IN in) (NP (DT the) (NN c-abl) (NN promoter)))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NP (JJ advanced) (NN disease)) (PRN (-LRB- -LRB-) (NP (CD 24)) (-RRB- -RRB-))))))))))))) (. .)))
( (S (S (NP (NP (NN Hypermethylation)) (PP (IN due) (TO to) (NP (NP (NN overexpression)) (PP (IN of) (NP (NP (NN DNA) (NNS methyltransferases)) (PRN (-LRB- -LRB-) (NP (NNS DNMTs)) (-RRB- -RRB-))))))) (VP (VBZ remains) (NP (NP (CD one) (JJ possible) (NN explanation)) (PP (IN for) (NP (NP (ADJP (FW de) (FW novo)) (NN methylation)) (PP (IN in) (NP (NN tumorigenesis)))))))) (. .)))
( (S (S (ADVP (RB Recently)) (, ,) (NP (NNS DNMTs)) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (VP (VBN up-regulated) (PP (IN in) (NP (JJ hematopoietic) (NNS malignancies))))))) (PRN (-LRB- -LRB-) (NP (CD 25)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NP (JJ Methyl-CpG-binding) (NNS proteins)) (PRN (-LRB- -LRB-) (NP (NN MBPs)) (-RRB- -RRB-))) (VP (VP (VBP are) (VP (VBN thought) (S (VP (TO to) (VP (VB inhibit) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (JJ transcriptional) (NNS factors))) (PP (TO to) (NP (DT the) (NN promoter))))))))) (CC and) (VP (VBP are) (ADVP (RB therefore)) (VP (VBN discussed) (PP (IN as) (NP (NP (CD one) (NN mechanism)) (PP (IN of) (NP (NP (NN transcription) (NN inhibition)) (PP (IN by) (NP (NN hypermethylation) (-LRB- -LRB-) (CD 26) (-RRB- -RRB-))))))))))) (. .)))
( (S (PP (IN In) (NP (DT this) (NN work))) (, ,) (NP (PRP we)) (VP (VBD studied) (NP (NP (NNS mechanisms)) (PP (IN of) (NP (NN IRF-4) (NN gene) (NN expression) (NN silencing))) (PP (IN in) (NP (JJ leukemic) (NNS cells))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD analyzed) (NP (NP (DT the) (NN IRF-4) (NN promoter) (NN region)) (PP (IN for) (NP (NP (JJ genetic) (NNS aberrations)) (CC and) (NP (JJ methylational) (NN status)))) (PP (IN in) (NP (ADJP (ADJP (JJ IRF-4-positive)) (CC and) (ADJP (JJ -negative))) (JJ hematopoietic) (NNS cells)))))) (. .)))
( (S (NP (NP (NNS MATERIALS)) (CC AND) (NP (NNS METHODS)))))
( (S (S (NP (NP (NN K-562)) (, ,) (NP (NN Jurkat)) (CC and) (NP (NN U-937))) (VP (VBD were) (VP (VBN obtained) (PP (IN from) (NP (NP (NP (DT the) (NN ATCC)) (PRN (-LRB- -LRB-) (NP (NP (NNP American) (NN Type) (NN Culture) (NN Collection)) (, ,) (NP (NNP Rockville) (, ,) (NNP USA))) (-RRB- -RRB-))) (CC and) (NP (NP (NN EM-2)) (, ,) (NP (NP (CD LAMA-84)) (, ,) (NP (NN CML-T1)) (, ,) (NP (CD BV-173)) (, ,) (NP (CD SD-1)) (CC and) (NP (CD RPMI-8226)))))) (PP (IN from) (NP (NP (DT the) (JJ DSMZ)) (PRN (-LRB- -LRB-) (NP (NNP Deutsche) (NNP Sammlung) (NN von) (NNP Mikroorganismen) (NNP und) (NNP Zellkulturen) (NNP GmbH) (, ,) (NNP Braunschweig) (, ,) (NNP Germany)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (DT All) (NN cell) (NNS lines)) (, ,) (PP (IN except) (NP (NP (CD BV-173)) (, ,) (NP (CD SD-1)) (CC and) (NP (CD RPMI-8226)))) (, ,)) (VP (VBD were) (ADJP (JJ IRF-4-negative)))) (. .)))
( (S (S (NP (DT All) (NN cell) (NNS lines)) (VP (VBD were) (VP (VBN maintained) (PP (IN at) (NP (ADJP (CD 5) (NN %)) (NN CO2))) (PP (IN in) (NP (NP (NN RPMI) (CD 1640) (NN medium)) (PP (IN with) (NP (NP (NP (ADJP (CD 1) (NN %)) (NN glutamine)) (PRN (-LRB- -LRB-) (NP (NNP Gibco/BRL) (NNP Eggenstein) (, ,) (NNP Germany)) (-RRB- -RRB-))) (VP (VBN supplemented) (PP (IN with) (NP (NP (NP (ADJP (CD 10) (NN %)) (JJ fetal) (NN calf) (NN serum)) (PRN (-LRB- -LRB-) (NP (NN Gibco/BRL)) (-RRB- -RRB-))) (, ,) (NP (NP (ADJP (CD 1) (NN %)) (NN penicillin/streptomycin)) (PRN (-LRB- -LRB-) (NP (NNP Biochrom) (, ,) (NNP Berlin) (, ,) (NNP Germany)) (-RRB- -RRB-))))))))))))) (. .)))
( (S (S (SBAR (WHADVP (WRB When)) (S (VP (VBN indicated)))) (, ,) (NP (NNS cells)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (NP (NN 5-aza-2-deoxycytidine)) (PRN (-LRB- -LRB-) (NP (NN AzadC)) (-RRB- -RRB-))) (CC or) (NP (NP (NN 5-azacytidine)) (PRN (-LRB- -LRB-) (NP (NN AzaC)) (-RRB- -RRB-))))) (PRN (-LRB- -LRB-) (NP (NN Sigma)) (, ,) (NP (NP (NNP Taufkirchen)) (, ,) (NP (NNP Germany))) (-RRB- -RRB-)) (PP (IN for) (NP (JJ different) (NN time) (NNS periods)))))) (. .)))
( (S (S (S (VP (VBG Owing) (PP (TO to) (NP (PRP$ their) (JJ chemical) (NN instability))))) (NP (JJ fresh) (NNS substances)) (VP (VBD were) (VP (VBN re-added) (NP (DT every) (CD 24) (NN h))))) (. .)))
( (S (PP (IN For) (NP (NP (NN analysis)) (PP (IN of) (NP (NP (DT the) (NN IRF-4) (NN promoter) (NN region)) (PP (IN for) (NP (NP (JJ permanent) (NNS aberrations)) (PP (JJ such) (IN as) (NP (NP (NNS insertions/deletions)) (CC or) (NP (NN mutation)))))))))) (, ,) (NP (PRP we)) (VP (VBN PCR-amplified) (NP (NP (CD two) (NNS fragments)) (PP (IN from) (NP (JJ genomic) (NN DNA))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN extracted) (PP (IN from) (NP (NP (VBN depicted) (NN cell) (NNS lines)) (PP (IN with) (NP (NP (NP (DT a) (JJ commercial) (NN kit)) (PRN (-LRB- -LRB-) (NP (NP (NN Qiagen)) (, ,) (NP (NNP Hilde) (, ,) (NNP Germany))) (-RRB- -RRB-))) (SBAR (IN as) (S (VP (VBN recommended)))))))))))))) (. .)))
( (S (S (NP (DT The) (NNS primers)) (VP (VBD were) (NP (NP (CD 1-forward)) (: :) (NP (NP (CD 5′-TTGAGATGGAGTCTTGCTCTGT-3′)) (, ,) (NP (NN 1-reverse))) (: :) (NP (CD 5′-CCAGGACCTCAGGAGGCCAGTCA-3′)) (: ;) (NP (CD 2-forward)) (: :) (NP (NP (CD 5′-AGCGGTGAAACTGAGAGTGCGAGGT-3′)) (, ,) (NP (NN 2-reverse))) (: :) (NP (CD 5′-GCCACATCGCTGCAGTTTAG-3′))))) (. .)))
( (S (S (NP (DT The) (NNS products)) (VP (VBD were) (VP (VBN cloned) (PP (IN with) (NP (DT the) (NN ‘TOPO) (NN TA) (NN cloning) (CD kit’))) (PRN (-LRB- -LRB-) (NP (NP (NNP Invitrogen)) (, ,) (NP (NNP Groningen) (, ,) (NNP The) (NNP Netherlands))) (-RRB- -RRB-))))) (. .)))
( (S (S (PP (IN After) (NP (NP (JJ bacterial) (NN amplification)) (PP (IN of) (NP (DT the) (VBN cloned) (NN PCR) (NNS fragments))) (PP (IN by) (NP (JJ standard) (NNS procedures))))) (, ,) (NP (NP (QP (IN at) (JJS least) (CD three)) (NNS clones)) (PP (IN from) (NP (DT each) (NN sample)))) (VP (VBD were) (VP (VBN sequenced) (PP (IN with) (NP (NP (DT an) (JJ automated) (NN sequencer)) (PRN (-LRB- -LRB-) (NP (NP (NN ABI) (NN Prism) (NN 377)) (, ,) (NP (VBN Applied) (NN Bio-systems)) (, ,) (NP (NNP Foster) (NNP City) (, ,) (NNP USA))) (-RRB- -RRB-)))) (SBAR (IN as) (S (VP (VBN recommended) (PP (IN by) (NP (DT the) (NN manufacturer))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB analyze) (NP (DT the) (NN IRF-4) (JJ transcriptional) (NN level))))) (, ,) (NP (NN RNA)) (VP (VBD was) (VP (VBN extracted) (PP (IN from) (NP (NP (NNS cells)) (VP (VBG using) (NP (NP (DT the) (JJ commercial) (NN RNAzol-kit)) (PRN (-LRB- -LRB-) (NP (NP (NNP Paesel)) (, ,) (NP (NN Frankfurt)) (, ,) (NP (NNP Germany))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (NP (DT An) (NN aliquot)) (PP (IN of) (NP (CD 1) (NN μg) (JJ total) (NN RNA)))) (VP (VBD was) (VP (VBN used) (PP (IN for) (NP (NN cDNA) (NN synthesis))) (SBAR (IN as) (S (VP (VBN described) (ADVP (RB previously)) (PRN (-LRB- -LRB-) (NP (CD 27)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (NN RNA) (NN expression) (NN analysis)) (PP (IN for) (NP (NP (NN IRF-4)) (CC and) (NP (DT the) (NN reference) (NN gene) (NN β-actin))))) (VP (VBD was) (VP (VBN carried) (PRT (RP out)) (PP (IN by) (NP (JJ semi-quantitative) (NN PCR)))) (SBAR (IN as) (S (VP (VBN described) (ADVP (RB previously)) (PRN (-LRB- -LRB-) (NP (NN 3,27)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NN PCR) (NNS products)) (VP (VBD were) (VP (VBN verified) (PP (IN by) (NP (JJ automated) (NN sequencing)))))) (. .)))
( (S (S (NP (NP (NP (NN PCR) (NNS primers)) (CC and) (NP (NNS conditions))) (PP (IN for) (NP (NP (NN expression) (NN analysis)) (PP (IN of) (NP (NP (NP (NN DNMT)) (CC or) (NP (NN MBP))) (PRN (-LRB- -LRB-) (NP (NP (NN DNMT1) (NN DNMT3A)) (, ,) (NP (NN DNMT3B)) (, ,) (NP (NN MeCP))) (, ,) (NP (NP (NN MBD1)) (, ,) (NP (NN MBD2)) (CC and) (NP (NN MBD4))) (-RRB- -RRB-))))))) (VP (VBD were) (VP (VBN published) (NP (NP (NN elsewhere)) (PRN (-LRB- -LRB-) (NP (CD 28)) (-RRB- -RRB-)))))) (. .)))
( (S (S (PP (IN For) (NP (NP (NN analysis)) (PP (IN of) (NP (NN IRF-4) (NN protein) (NN expression))))) (, ,) (NP (DT a) (JJ standard) (NN immunoblotting) (NN assay)) (VP (VBD was) (VP (VBN performed) (SBAR (IN as) (S (VP (VBN described) (ADVP (RB previously)) (PRN (-LRB- -LRB-) (NP (CD 29)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (ADVP (RB Briefly)) (, ,) (NP (NN protein) (NNS lysates)) (VP (VBD were) (VP (VBN generated) (PP (IN by) (S (VP (VBG incubating) (NP (CD 1) (NN ×) (CD 106) (NNS cells)) (PP (IN in) (NP (NP (ADJP (CD 100) (NN µl)) (NN RIPA) (NN buffer)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD 1) (NN %)) (NN NP-40)) (, ,) (NP (ADJP (CD 0.5) (NN %)) (NN sodiumdesoxycholate)) (, ,) (NP (ADJP (CD 0.1) (NN %)) (NN SDS)) (, ,) (NP (ADJP (CD 100) (NN µg/ml)) (NN phenylmethylsulfonyl) (NN fluoride)) (, ,) (NP (ADJP (CD 10) (NN µl/ml)) (NN protease-inhibitory-mix)) (, ,) (NP (NP (CD 1) (NN µmol/ml) (NN sodiumorthovanadate)) (PP (IN in) (NP (JJ phosphate-buffered) (NN saline))))) (-RRB- -RRB-)))) (PP (IN for) (NP (NP (CD 30) (NN min)) (PP (IN on) (NP (NN ice))))))))))) (. .)))
( (S (S (PP (IN After) (NP (NN centrifugation))) (, ,) (NP (NP (NN protein) (NN concentration)) (PP (IN of) (NP (DT the) (NN supernatant)))) (VP (VBD was) (VP (VBN determined) (PP (IN by) (NP (NN BCA-method))) (PRN (-LRB- -LRB-) (NP (NN Pierce)) (, ,) (NP (NP (NNP Rockford)) (, ,) (NP (NN IL))) (-RRB- -RRB-))) (SBAR (IN as) (S (VP (VBN recommended)))))) (. .)))
( (S (S (NP (NP (NN Protein) (NNS lysates)) (PRN (-LRB- -LRB-) (NP (CD 70–100) (NN µg)) (-RRB- -RRB-))) (VP (VBD were) (VP (VP (VBN electrophoresed) (PP (IN on) (NP (NN polyacrylamide) (NNS gels)))) (CC and) (VP (VBN transferred) (PP (TO to) (NP (NP (DT a) (NN PVDF-membrane)) (PRN (-LRB- -LRB-) (NP (NP (NN Immobilon) (NN P)) (, ,) (NP (NN 0.45) (NN µm)) (: ;) (NP (NNP Millipore) (, ,) (NNP Eschborn) (, ,) (NNP Germany))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NNS Membranes)) (VP (VBD were) (VP (VP (VBN blocked) (PP (IN with) (NP (NP (NP (ADJP (CD 2.5) (NN %)) (NN blocking) (NN reagent)) (PRN (-LRB- -LRB-) (NP (NNP Boehringer) (NNP Mannheim) (, ,) (NNP Germany)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NN TBST) (NN buffer)) (PRN (-LRB- -LRB-) (FRAG (NP (CD 4.44) (NN g/l) (NN Tris–HCL)) (, ,) (NP (CD 2.65) (NN g/l) (NN TrisOH)) (, ,) (NP (NP (NP (ADJP (CD 8.07) (NN g/l)) (NN NaCl)) (, ,) (NP (ADJP (CD 0.2) (NN g/l)) (NN KCl)) (CC and) (NP (ADJP (CD 500) (NN µl/l)) (NN Tween-20))) (PP (IN in) (NP (NNP H2O))))) (-RRB- -RRB-))))))) (CC and) (VP (ADVP (RB subsequently)) (VBN incubated) (PP (IN with) (NP (JJ primary) (NN antibody))))) (SBAR (IN as) (S (VP (VBN indicated) (NP (CC and) (NP (NP (NP (NN horseradish) (JJ peroxidase-conjugated) (JJ secondary) (NN antibody)) (, ,) (NP (JJ anti-mouse) (CC or) (NN anti-goat) (NN IgG))) (PRN (-LRB- -LRB-) (NP (NP (NN DAKO)) (, ,) (NP (NNP Hamburg) (, ,) (NNP Germany))) (-RRB- -RRB-))) (, ,) (ADVP (RB respectively)))))))) (. .)))
( (S (S (NP (DT The) (NNS membranes)) (VP (VBD were) (ADVP (RB then)) (VP (VBN developed) (PP (IN with) (NP (NP (DT an) (NN ECL) (NN detection) (NN kit)) (PRN (-LRB- -LRB-) (NP (NNP Amersham) (NNP Pharmacia) (NNP Biotech) (, ,) (NNP Freiburg) (, ,) (NNP Germany)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (DT The) (JJ primary) (NNS antibodies)) (VP (VBD were) (NP (NP (NP (NP (NN goat) (NN anti-IRF-4/ICSAT)) (PRN (-LRB- -LRB-) (NP (NN M-17)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP Santa) (NNP Cruz)) (NN Biotechnology) (, ,) (NNP Santa) (NNP Cruz)) (, ,) (NP (NN CA))) (-RRB- -RRB-))) (CC and) (NP (NP (NP (NN mouse) (NN anti-β-actin)) (PRN (-LRB- -LRB-) (NP (NN AC-74)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NN Sigma)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NN DNA)) (VP (VBD was) (VP (VBN extracted) (PP (IN with) (NP (NP (NP (DT a) (JJ commercial) (NN kit)) (PRN (-LRB- -LRB-) (NP (NN Qiagen)) (-RRB- -RRB-))) (SBAR (IN as) (S (VP (VBN recommended))))))))) (. .)))
( (S (SBAR (IN Since) (S (NP (NP (DT the) (NN restriction) (NN ability)) (PP (IN of) (NP (JJ several) (NNS endonucleases)))) (VP (VBZ is) (VP (VBN inhibited) (PP (IN by) (NP (NP (NN methylation)) (PP (IN of) (NP (PRP$ their) (NN target) (NN sequence))))))))) (, ,) (NP (PRP we)) (VP (VBD used) (NP (NP (JJ methylation-sensitive) (NNS enzymes) (NN HpaII)) (CC and) (NP (NP (NP (NP (NNP HaeII-isochizomer) (NNP Bsp143II)) (CC and) (NP (NNP Bsh1236I))) (PRN (-LRB- -LRB-) (NP (NP (NNP MBI) (NNP Fermentas)) (, ,) (NP (JJ St) (NN Leon-Rot)) (, ,) (NP (NNP Germany))) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (CD 20,24)) (-RRB- -RRB-))))) (. .)))
( (S (S (PP (IN As) (NP (NN control))) (NP (NP (DT the) (JJ methylation-resistant) (NN enzyme) (NN MspI)) (CC and) (NP (NP (NP (DT an) (NN enzyme)) (PP (IN with) (NP (NP (DT no) (NN recognition) (NN site)) (PP (IN in) (NP (DT the) (NN target) (NN promoter)))))) (, ,) (NP (NN EcoRI)) (, ,))) (VP (VBD were) (VP (VBN used)))) (. .)))
( (S (S (NP (NP (NN DNA)) (PRN (-LRB- -LRB-) (NP (CD 0.8) (NN µg)) (-RRB- -RRB-))) (VP (VBD was) (VP (VP (VBN digested) (PP (IN by) (NP (NP (CD 40) (NN U)) (NP (NP (DT the) (JJ respective) (NN enzyme)) (PP (IN for) (NP (CD 6) (NN h))))))) (CC and) (VP (, ,) (PP (TO to) (S (VP (VB ensure) (NP (JJ complete) (NN cleavage))))) (, ,) (NP (NP (JJ additional) (CD 20) (NN U)) (PP (IN for) (NP (CD 16) (NN h)))))))) (. .)))
( (S (S (NP (NP (QP (RB Thereafter) (CD 100)) (NN ng)) (PP (IN of) (NP (JJ digested) (NN DNA)))) (VP (VBD was) (VP (VBN used) (PP (TO to) (NP (NP (DT a) (NN PCR) (NN amplification)) (PP (IN of) (NP (NP (NP (CD two) (NNS fragments)) (PRN (-LRB- -LRB-) (NP (NP (NNP F1)) (CC and) (NP (NNP F2))) (-RRB- -RRB-))) (VP (VBG spanning) (NP (NP (NN part)) (PP (IN of) (NP (DT the) (NP (NP (NP (NN IRF-4) (NN promoter)) (PRN (-LRB- -LRB-) (NP (CD 30)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP GenBank) (NNP U52683)) (: ;) (S (VP (VB see) (NP (NN Figure) (NN 3A)))) (-RRB- -RRB-)))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NNS sequences)) (PP (IN of) (NP (DT the) (NNS primers)))) (VP (VBD were) (NP (NP (CD F1-forward)) (: :) (NP (NP (CD 5′-TTGAGATGGAGTCTTGCTCTGT-3′)) (, ,) (NP (NN F1-reverse))) (: :) (NP (NP (CD ATCACTTCCAGACTTCAGTTCACCT-3′)) (PRN (-LRB- -LRB-) (NP (CD 341) (NN bp)) (-RRB- -RRB-))) (: ;) (NP (NN F2-forward)) (: :) (NP (NP (CD 5′-AAGGTGAACTGAAGTCTGGAAGTGA-3′)) (, ,) (NP (NN F2-reverse))) (: :) (NP (NP (CD 5′-CCAGGACCTCAGGAGGCCAGTCA-3′)) (PRN (-LRB- -LRB-) (NP (CD 474) (NN bp)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (DT The) (NN PCR) (NNS conditions)) (VP (VBD were) (VP (VBN described) (ADVP (RB elsewhere)) (PRN (-LRB- -LRB-) (NP (CD 3)) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (NN PCR)) (VP (VBD was) (VP (VBN performed) (PP (IN with) (NP (NP (DT an) (NN annealing) (NN temperature)) (PP (IN of) (NP (QP (CD 62°C) (CC and) (CD 35)) (NNS cycles)))))))) (. .)))
( (S (S (SBAR (WHADVP (WRB When)) (S (NP (NN DNA)) (VP (VBD was) (VP (VBN methylated) (PP (IN at) (NP (JJ specific) (NNS sites))))))) (, ,) (NP (DT the) (JJ sensitive) (NNS enzymes)) (VP (VBD were) (RB not) (ADJP (JJ able) (S (VP (TO to) (VP (VB digest) (NP (NP (DT the) (NP (NN DNA)) (CC and) (NP (NN amplification))) (VP (VBD took) (NP (NN place)))))))))) (: ;) (S (PP (IN in) (NP (NP (NN case)) (PP (IN of) (NP (NN no) (NN methylation))))) (, ,) (S (S (NP (NN DNA)) (VP (VBD was) (VP (VBN digested)))) (CC and) (S (NP (DT no) (NN product)) (VP (VBD was) (VP (VBN generated)))))) (. .)))
( (S (S (NP (DT The) (NN PCR) (NNS products)) (VP (VP (VBD were) (VP (VBN electrophoresed) (PP (IN on) (NP (DT a) (ADJP (CD 3) (NN %)) (NN agarose) (NN gel))))) (, ,) (VP (VBD were) (VP (VP (VBN stained) (PP (IN with) (NP (NN ethidium) (NN bromide)))) (CC and) (VP (VBN photographed)))))) (. .)))
( (S (S (NP (NN PCR) (NNS products)) (VP (VBD were) (VP (VBN verified) (PP (IN by) (NP (JJ automated) (NN sequencing)))))) (. .)))
( (S (S (NP (NN DNA)) (VP (VBD was) (VP (VBN extracted) (SBAR (IN as) (S (VP (VBN described) (ADVP (RB above)))))))) (. .)))
( (S (S (NP (NP (NN Bisulfite) (NN treatment)) (PP (IN of) (NP (NN DNA))) (, ,) (VP (VBG leading) (PP (TO to) (NP (NP (NP (NN conversion)) (PP (IN of) (NP (JJ unmethylated) (NN cytosine))) (PP (TO to) (NP (NN uracil) (NNS residues)))) (CC and) (NP (NP (DT no) (NN change)) (PP (IN of) (NP (VBN methylated) (NN cytosine) (NNS residues))))))) (, ,)) (VP (VBD was) (VP (VBN performed) (SBAR (IN as) (S (VP (VBN described) (PP (IN as) (NP (VBZ follows))))))))) (. .)))
( (S (ADVP (RB Briefly)) (, ,) (NP (NP (NP (CD 1) (NN µg)) (PP (IN of) (NP (NN DNA)))) (CC and) (NP (NP (CD 2) (NN µg)) (PP (IN of) (NP (NP (NP (NP (NP (NN poly)) (PRN (-LRB- -LRB-) (NP (NN dA–dT)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NN poly) (-LRB- -LRB-) (CD dA–dT)) (-RRB- -RRB-))) (NNS copolymers)) (PRN (-LRB- -LRB-) (NP (NNP Amersham) (NNP Pharmacia) (NNP Biotech)) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN denaturated) (PP (IN for) (NP (NP (CD 20) (NN min)) (PP (IN at) (NP (NP (NN 42°C)) (PP (IN in) (NP (NP (ADJP (CD 0.3) (NN M)) (NN NaOH)) (PP (IN in) (NP (NP (DT a) (NN volume)) (PP (IN of) (NP (CD 50) (NN µl))))))))))))) (. .)))
( (S (S (NP (NP (JJ Fresh) (NNS solutions)) (PP (IN of) (NP (NP (CD 30) (NN µl)) (PP (IN of) (NP (NP (NP (ADJP (CD 10) (NN mM)) (NN hydrochinon)) (PRN (-LRB- -LRB-) (NP (NN Sigma)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (CD 530) (NN µl)) (PP (IN of) (NP (ADJP (CD 3) (NN M)) (NN sodium) (NN bisulfite)))) (PRN (-LRB- -LRB-) (NP (NP (NN pH) (CD 5.0)) (: ;) (NP (NN Sigma))) (-RRB- -RRB-)))))))) (VP (VBD were) (VP (VBN added)))) (, ,) (S (NP (DT the) (NN solution)) (VP (VBD was) (ADVP (RB gently)) (VP (VBN mixed)) (, ,) (S (VP (VP (VBN overlayed) (PP (IN with) (NP (JJ mineral) (NN oil)))) (CC and) (VP (VBN incubated) (PP (IN in) (NP (DT the) (NN dark))) (PP (IN for) (NP (NP (CD 12–13) (NN h)) (PP (IN at) (NP (NN 50°C)))))))))) (. .)))
( (S (S (NP (DT The) (JJ aqueous) (NN phase)) (VP (VBD was) (VP (VBN recovered) (S (VP (VBG using) (NP (NP (DT the) (JJ ‘Wizard) (NN DNA) (NN clean-up) (NN system’)) (PRN (-LRB- -LRB-) (NP (NP (NNP Promega)) (, ,) (NP (NNP Mannheim) (, ,) (NNP Germany))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (DT The) (VBN purified) (NN DNA)) (VP (VBD was) (VP (VP (ADVP (RB subsequently)) (VBN mixed) (PP (IN with) (NP (NP (ADJP (CD 1) (NN M)) (NN NaOH)) (PP (TO to) (NP (NP (DT a) (JJ final) (NN concentration)) (PP (IN of) (NP (CD 0.3) (NN M)))))))) (CC and) (VP (VBN incubated) (PP (IN for) (NP (CD 20) (NN min))) (PP (IN at) (NP (NP (NN 37°C)) (S (VP (TO to) (VP (VB ensure) (NP (JJ complete) (NN desulfonisation))))))))))) (. .)))
( (S (S (NP (NN DNA)) (VP (VBD was) (ADJP (NN ethanol) (JJ precipitated)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (CD 1/10) (NN vol)) (PP (IN of) (NP (ADJP (CD 3) (NN M)) (NN sodium) (NN acetate))))))) (, ,) (S (VP (VP (VBN washed) (PP (IN with) (NP (ADJP (CD 70) (NN %)) (NN ethanol)))) (CC and) (VP (VBN resuspended) (PP (IN in) (NP (QP (CD 50)) (NN µl) (NN H2O)))))))) (. .)))
( (S (NP (NP (JJ Subsequent) (NN PCR) (NN amplification)) (PP (IN of) (NP (CD 4) (NN µl) (JJ bisulfite-treated) (NN DNA)))) (VP (VBD was) (VP (VBN used) (PP (IN for) (NP (NP (NN cloning)) (PP (IN of) (NP (NP (CD two) (NNS fragments)) (PP (IN of) (NP (DT the) (NP (NP (NN IRF-4) (NN promoter)) (PRN (-LRB- -LRB-) (NP (NP (NN BS-I)) (CC and) (NP (NN BS-II))) (-RRB- -RRB-))))))))) (PP (IN into) (NP (NP (NN pCR2.1) (NN vector)) (PP (IN with) (NP (NP (NP (NP (DT the) (NN ‘TOPO) (NN TA) (NN cloning)) (NN kit’)) (PRN (-LRB- -LRB-) (NP (NN Invitrogen)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (NN Figure) (NN 3A)))) (-RRB- -RRB-)))))))) (. .)))
( (S (NP (NP (DT The) (NNS primers)) (VP (VBN used) (PP (IN for) (NP (NP (NN PCR) (NN amplification)) (PP (IN of) (NP (DT the) (NN BS-I) (CC and) (NN BS-II) (NNS fragments))))))) (VP (VBP contain) (NP (NP (NP (DT the) (JJ putative) (JJ altered) (NN sequence)) (PP (IN of) (NP (NP (DT the) (JJ sense) (NN strand)) (PP (IN due) (TO to) (NP (NP (NN bisulfite) (NN treatment)) (PRN (-LRB- -LRB-) (S (NP (VBN converted) (NN cytosine) (NNS residues)) (VP (VBP are) (VP (VBN written) (PP (IN in) (NP (JJ bold) (NNS letters)))))) (-RRB- -RRB-))))))) (: :) (NP (NP (JJ BS-I-forward) (NN 5′-TATTTGGATTTTTAGGGAGTTTTTTTT-3′)) (, ,) (NP (NP (JJ BS-I-reverse) (NN 5′-ACCCAACTCCCTTAAACTATTAAACT-3′)) (PRN (-LRB- -LRB-) (NP (CD 187) (NN bp)) (-RRB- -RRB-)))) (: ;) (NP (NN BS-II-forward) (NN 5′-AGTTTAATAGTTTAAGGGAGTTGGGT-3′)) (, ,) (NP (NP (JJ BS-II-reverse) (NN 5′-CTCACCCTAAACTCAAAACTAAAAAC-3′)) (PRN (-LRB- -LRB-) (NP (CD 674) (NN bp)) (-RRB- -RRB-))))) (. .)))
( (S (S (PP (IN After) (NP (NP (JJ bacterial) (NN amplification)) (PP (IN of) (NP (DT the) (VBN cloned) (NN PCR) (NNS fragments))) (PP (IN by) (NP (JJ standard) (NNS procedures))))) (, ,) (NP (NP (CD eight) (NNS clones)) (PP (IN from) (NP (DT each) (NN sample)))) (VP (VBD were) (VP (VBN sequenced) (PP (IN with) (NP (NP (DT an) (JJ automated) (NN sequencer)) (PRN (-LRB- -LRB-) (NP (NN ABI) (NN Prism) (NN 377) (, ,) (VBN Applied) (NN Biosystems)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (DT The) (NN IRF-4) (NN promoter-reporter) (NN gene) (NN construct)) (VP (VBD was) (ADVP (RB generously)) (VP (VBN provided) (PP (IN by) (NP (NP (NNP J.) (NNP Hiscott)) (PRN (-LRB- -LRB-) (NP (CD 31)) (-RRB- -RRB-))))))) (. .)))
( (S (S (S (NP (NNS Constructs)) (VP (VBD were) (VP (VBN methylated) (ADVP (FW in) (FW vitro)) (PP (IN with) (NP (NP (NN CpG) (NN Methylase)) (PRN (-LRB- -LRB-) (NP (NN M.Sss) (NN I)) (-RRB- -RRB-)))) (SBAR (IN as) (S (VP (VBN recommended) (PP (IN by) (NP (NP (DT the) (NN manufacturer)) (PRN (-LRB- -LRB-) (NP (NN NE) (NN Biolabs)) (-RRB- -RRB-)))))))))) (CC and) (S (NP (JJ complete) (NN methylation)) (VP (VBD was) (VP (VBN checked) (PP (IN via) (NP (NP (NN restriction) (NN analysis)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 5A)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (NN Reporter) (NN gene) (NNS assays)) (VP (VBG using) (NP (NP (DT the) (JJ dual) (NN luciferase) (NN assay)) (PRN (-LRB- -LRB-) (NP (NN Promega)) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN performed) (ADVP (JJ similar) (PP (TO to) (NP (JJ previous) (NNS reports))) (PRN (-LRB- -LRB-) (NP (CD 29)) (-RRB- -RRB-)))))) (. .)))
( (S (S (ADVP (RB Briefly)) (, ,) (NP (NP (CD 5) (NN nM)) (PP (IN of) (NP (DT the) (NP (NN reporter) (NN construct)) (CC and) (NP (NP (DT the) (NN transfection) (NN control) (NN construct)) (VP (VBG expressing) (NP (DT the) (NN renilla) (NN luciferase) (NN gene))))))) (VP (VBD were) (VP (VBN transientlyco-expressed) (PP (IN via) (NP (NN electroporation)))))) (. .)))
( (S (S (NP (DT The) (NN control) (NN construct)) (VP (VBD served) (PP (IN as) (NP (NP (DT an) (JJ internal) (NN reference)) (PP (IN for) (NP (NN transfection) (NN efficiency))))))) (. .)))
( (S (S (PP (NP (CD Forty-eight) (NNS hours)) (IN after) (NP (NN transfection))) (, ,) (NP (NN luciferase) (NN activity)) (VP (VBD was) (VP (VBN measured) (PP (IN with) (NP (NP (DT a) (NN LB) (CD 96) (NN P) (NN microlumat)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP EG&G) (NNP Berthold)) (, ,) (NP (NN Bad))) (NP (NNP Wildbad) (, ,) (NNP Germany))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NN IRF-4) (NN promoter) (NN activation)) (VP (VBD was) (VP (VBN quantified) (PP (IN as) (NP (NP (DT a) (NN ratio)) (PP (IN of) (NP (NP (VBN measured) (JJ firefly) (JJ light) (NNS units)) (PRN (-LRB- -LRB-) (NP (NN flu)) (-RRB- -RRB-)))) (PP (JJ relative) (TO to) (NP (NP (NN renilla)) (PRN (-LRB- -LRB-) (NP (NN rlu)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (DT Each) (NN experiment)) (VP (VBD was) (VP (VBN carried) (PRT (RP out)) (NP (QP (IN at) (JJS least) (CD three)) (NNS times))))) (. .)))
( (S (NP (NNS RESULTS))))
( (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB previously)) (VP (VBN demonstrated) (NP (NP (DT a) (NN lack)) (PP (IN of) (NP (NP (NN IRF-4) (NN expression)) (PP (PP (IN in) (NP (NN leukemia) (NNS patients))) (CC and) (ADVP (RB specifically)) (PP (IN in) (NP (NP (NN CML) (NNS T-cells)) (PRN (-LRB- -LRB-) (NP (CD 3)) (-RRB- -RRB-))))))))))) (. .)))
( (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN IRF-4) (NN expression))) (PP (PP (IN in) (NP (NP (JJ various) (JJ hematopoietic) (NN cell) (NNS lines)) (, ,) (ADJP (JJ such) (PP (IN as) (NP (NP (NP (NN Jurkat)) (, ,) (NP (DT a) (NN T-cell) (NN leukemia)) (, ,) (NP (NN CML-T1)) (, ,) (NP (DT a) (JJ bcr-abl-positive) (NN T-cell) (NN line)) (, ,) (NP (NN K-562)) (, ,) (NP (DT a) (JJ bcr-abl-positve) (NN erythroleukemia)) (, ,) (NP (NN U-937)) (, ,) (NP (DT a) (JJ monocytic) (NN leukemia)) (, ,) (NP (NN EM-2)) (CC and) (NP (CD LAMA-84))) (, ,) (NP (JJ bcr-abl-positve) (JJ myeloid) (NN leukemia))))) (, ,))) (CC but) (PP (RB not) (IN in) (NP (NP (NN SD-1)) (, ,) (NP (NP (DT a) (JJ bcr-abl-positive) (JJ acute) (JJ lymphoblastic) (NN leukemia)) (PRN (-LRB- -LRB-) (NP (NN pre) (NN B-ALL)) (-RRB- -RRB-))) (, ,) (NP (CD RPMI-8226)) (, ,) (NP (DT a) (JJ multiple) (NN myeloma)) (CC and) (NP (NP (NN BV-173)) (, ,) (NP (DT a) (JJ bcr-abl-positive) (NN B-cell) (NN line)))))) (-LRB- -LRB-) (PP (FW Figures) (NP (NP (NN 1A)) (CC and) (NP (CD 5D) (-RRB- -RRB-)))))) (. .)))
( (S (S (PP (IN After) (NP (NP (NN sequencing)) (PP (IN of) (NP (DT the) (NN IRF-4) (NN promoter))))) (, ,) (NP (PRP it)) (VP (MD could) (VP (VB be) (VP (VBN excluded) (SBAR (IN that) (S (NP (NP (NN absence)) (PP (IN of) (NP (NP (NN IRF-4) (NN expression)) (PP (IN in) (NP (NP (DT any)) (PP (IN of) (NP (DT the) (JJ above) (NN cell) (NNS lines)))))))) (VP (VBD was) (ADJP (JJ due) (PP (TO to) (NP (JJ genetic) (NNS aberrations))))))))))) (. .)))
( (S (ADVP (RB However)) (, ,) (NP (NP (CD 2) (NN bp) (NNS changes)) (PRN (-LRB- -LRB-) (NP (NP (NN nucleotide) (NN −1081) (, ,) (NNP T→C)) (CC and) (NP (NNP −1068) (, ,) (NNP A→C))) (-RRB- -RRB-))) (VP (MD could) (VP (VB be) (VP (VBN detected) (PP (IN in) (NP (CC both) (NP (DT the) (JJ IRF-4-positive) (NN BV-173)) (CC and) (NP (NP (DT the) (JJ IRF-4-negative) (NN LAMA-84)) (, ,) (NP (NP (NP (NN EM-2)) (CC and) (NP (NN K-562))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1B)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (PP (IN At) (NP (NN position) (CD −116))) (NP (DT an) (NN A→C) (NN substitution)) (VP (VBD was) (VP (VBN found) (PP (IN in) (NP (NP (NN EM-2)) (, ,) (NP (NN K-562)) (CC and) (NP (NN CML-T1))))) (, ,) (SBAR (IN whereas) (S (NP (NP (NN Jurkat)) (, ,) (NP (NN BV-173)) (CC and) (NP (NN SD-1))) (VP (VBD exhibited) (NP (NP (DT a) (JJ mixed) (NN A/C) (NN sequence)) (CC and) (NP (NP (NP (NN U-937)) (, ,) (NP (NN LAMA-84)) (CC and) (NP (NP (CD RPMI-8226) (NN no) (NN substitution)) (PP (IN at) (NP (NN all))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1B)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (ADVP (RB Consequently)) (, ,) (NP (DT these) (NNS alterations)) (VP (VBP are) (ADJP (JJ unlikely) (S (VP (TO to) (VP (VB affect) (NP (NN IRF-4) (NN expression)))))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB next)) (VP (VBD analyzed) (SBAR (IN whether) (S (NP (NN promoter) (NN methylation)) (VP (MD could) (VP (VB be) (ADJP (JJ responsible) (PP (IN for) (NP (NP (NN down-regulation)) (PP (IN of) (NP (NN IRF-4) (NN expression)))))))))))) (. .)))
( (S (S (NP (NP (DT A) (NN region)) (VP (VBG including) (NP (NP (NN exon1)) (PP (IN in) (NP (DT the) (NN IRF-4) (NN promoter)))))) (VP (VBD exhibited) (NP (NP (DT a) (JJ large) (NN number)) (PP (IN of) (NP (NP (JJ CpG-rich) (NNS sequences)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3A)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (JJ Several) (JJ chemical) (NNS substances)) (PP (JJ such) (IN as) (NP (NP (NP (NN 5-aza-2-deoxycytidine)) (PRN (-LRB- -LRB-) (NP (NN AzadC)) (-RRB- -RRB-))) (CC or) (NP (NP (NN 5-azacytidine)) (PRN (-LRB- -LRB-) (NP (NN AzaC)) (-RRB- -RRB-)))))) (VP (VBP inhibit) (NP (NP (FW de) (FW novo)) (CC and) (NP (NN maintenance) (NN methylation))))) (, ,) (CC and) (S (ADVP (RB thus)) (VP (MD can) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VB discern) (NP (NP (NN promoter) (NN methylation)) (PRN (-LRB- -LRB-) (NP (NN 32,33)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD used) (NP (NN AzadC)) (S (VP (TO to) (VP (VB generate) (NP (JJ unmethylated) (NN DNA))))))) (. .)))
( (S (S (NP (DT A) (ADJP (CD 72) (NN h)) (NN AzadC-treatment)) (VP (VBD resulted) (PP (PP (IN in) (NP (NP (DT a) (JJ concentration-dependent) (NN activation)) (PP (IN of) (NP (NN IRF-4) (NN transcription))) (PP (IN in) (NP (NN Jurkat) (CC and) (NN CML-T1) (NNS T-cells))))) (CONJP (RB as) (RB well) (IN as)) (PP (IN in) (NP (NP (NP (NP (NN U-937)) (, ,) (NP (NN K-562)) (CC and) (NP (NN EM-2))) (NN cell) (NNS lines)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2A)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NN IRF-4) (NN transcription)) (VP (VP (VBD was) (VP (VBN induced) (PP (IN in) (NP (DT a) (JJ time-dependent) (NN manner))))) (CC and) (VP (VBD was) (VP (VBN observed) (ADVP (RB as) (RB early)) (PP (IN as) (NP (CD 24) (NN h))) (PP (IN after) (NP (NP (NN treatment)) (PP (IN with) (NP (NN AzadC))))))) (CC and) (VP (VBD increased) (PP (IN over) (NP (NN time))) (PP (IN until) (NP (NP (CD 72) (NN h)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2B)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (NP (NN Time)) (CC and) (NP (NN strength))) (PP (IN of) (NP (NP (DT the) (NN appearance)) (PP (IN of) (NP (NN IRF-4) (NNS transcripts)))))) (VP (VBD varied) (PP (IN among) (NP (NN cell) (NNS lines))) (, ,) (PP (FW i.e.)))) (. .)))
( (S (S (NP (NN CML-T1)) (VP (VBD responded) (ADVP (JJS strongest)) (PP (TO to) (NP (NN AzadC-treatment))) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))) (. .)))
( (S (PP (IN In) (NP (NP (NN line)) (PP (IN with) (NP (DT this))))) (, ,) (NP (NP (NN AzadC-treatment)) (PP (IN of) (NP (NP (NN CML-T1)) (CC and) (NP (NN LAMA-84) (NNS cells))))) (ADVP (RB also)) (VP (VBN translated) (PP (IN in) (NP (NP (DT an) (NN induction)) (PP (IN of) (NP (NP (NN IRF-4) (NN protein) (NN expression)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2C)) (-RRB- -RRB-))))))) (. .)))
( (S (ADVP (RB Accordingly)) (, ,) (NP (NP (NN treatment)) (PP (IN of) (NP (NP (DT the) (JJ IRF-4-positive) (NN cell) (NN line) (CD BV-173)) (, ,) (NP (NP (NN SD-1)) (CC and) (NP (NN RPMI-8226))))) (PP (IN with) (NP (NN AzadC)))) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NN IRF-4) (NN expression)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2D)) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (EX There)) (VP (VBD was) (NP (DT no) (NN difference)) (PP (IN in) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NNP AzaC)) (CC versus) (NP (NNP AzadC)))))) (, ,) (SBAR (IN as) (S (NP (DT both)) (VP (VBD increased) (NP (NP (DT the) (NN IRF-4) (NN mRNA) (NN level)) (PP (IN in) (NP (NN CML-T1) (NNS cells)))) (PP (IN as) (NP (NN well))) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBD implied) (SBAR (IN that) (S (S (NP (NN promoter) (NN methylation)) (VP (MD may) (VP (VB control) (NP (NN IRF-4) (NN expression))))) (, ,) (CC but) (S (NP (DT an) (JJ alternative) (NN explanation)) (VP (MD may) (VP (VB be) (NP (NP (NN activation)) (PP (IN of) (NP (NP (JJ positive) (JJ transcriptional) (NNS regulators)) (PP (IN of) (NP (NN IRF-4))))) (PP (IN by) (NP (NP (NNP AzadC)) (-LRB- -LRB-) (CC or) (NP (NNP AzaC)) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (S (VP (TO To) (ADVP (RB further)) (VP (VB investigate) (NP (NN promoter) (NN methylation)) (PP (IN as) (NP (NP (DT a) (JJ regulatory) (NN mechanism)) (PP (IN of) (NP (NN IRF-4) (NN gene) (NN expression)))))))) (, ,) (NP (NNS restriction-PCR-assays)) (VP (VBD were) (VP (VBN performed) (PRN (-LRB- -LRB-) (NP (NN 20,24)) (-RRB- -RRB-))) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (RB only) (VBN methylated) (NN DNA)) (VP (MD would) (RB not) (VP (VB be) (VP (VBN cut) (S (VP (VBG enabling) (NP (NP (JJ subsequent) (NN PCR) (NN amplification)) (CC and) (NP (RB vice) (RB versa)))))))))))) (. .)))
( (S (NP (NP (JJ Genomic) (NN DNA)) (PP (IN from) (NP (NP (JJ leukemic) (NNS cells) (NP (NP (NN Jurkat)) (, ,) (NP (NN CML-T1)))) (, ,) (NP (NP (NN U-937)) (, ,) (NP (NN K-562)) (, ,) (NP (NN EM-2)) (CC and) (NP (NN BV-173)))))) (VP (VBD was) (VP (VBN digested) (PP (IN with) (NP (NP (DT the) (JJ methylation-sensitive) (NNS enzymes)) (NP (NP (NN HpaII)) (, ,) (NP (NN Bsh1236I)) (CC and) (NP (NN HaeII-isochizomer) (NN Bsp143II))))))) (. .)))
( (S (S (NP (NP (NP (NN EcoRI)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (NP (NP (DT no) (NN recognition) (NN site)) (PP (IN within) (NP (DT the) (NN IRF-4) (NN promoter))))))) (, ,)) (CC and) (NP (DT the) (JJ methylation-resistant) (NN enzyme) (NN MspI))) (VP (VBD served) (PP (IN as) (NP (NNS controls))))) (. .)))
( (S (S (NP (CD Two) (JJ separate) (NN amplification) (NNS reactions)) (VP (VBD were) (VP (VBN performed) (, ,) (S (VP (VBG generating) (NP (NP (CD two) (NNS fragments)) (, ,) (NP (NP (NP (NN F1)) (CC and) (NP (NN F2))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3A)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (PP (IN After) (NP (NP (NN digestion)) (PP (IN with) (NP (NP (NN HpaII)) (CC and) (NP (NN Bsp143II)))))) (NP (NP (DT a) (JJ sufficient) (NN PCR) (NN amplification)) (PP (IN of) (NP (NP (NN F1)) (CC and) (NP (NN F2))))) (VP (VBD was) (VP (VBN detected) (PP (IN in) (NP (NP (NN DNA)) (PP (IN from) (NP (JJ IRF-4-negative) (NN Jurkat) (, ,) (NN CML-T1) (, ,) (NN U-937) (, ,) (NN K-562) (CC and) (NN EM-2) (NNS cells))))) (, ,) (S (VP (VBG suggesting) (NP (NP (NP (DT a) (NN promoter) (NN methylation)) (-LRB- -LRB-) (CC and) (NP (NN restriction) (NN protection)) (-RRB- -RRB-)) (PP (IN at) (NP (NP (DT the) (JJ respective) (NN recognition) (NNS sites)) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (NN 3B)) (CC and) (NP (NN C))) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (ADVP (RB Notably)) (, ,) (PP (IN in) (NP (JJ IRF-4-positive) (NN SD-1) (NNS cells))) (NP (NP (NN digestion)) (PP (IN with) (NP (DT the) (JJ methylation-sensitive) (NNS enzymes)))) (ADVP (RB completely)) (VP (VBD inhibited) (NP (NP (NN amplification)) (PP (IN of) (NP (NP (NN F1)) (CC and) (NP (NN F2))))))) (. .)))
( (S (S (PP (IN In) (NP (JJ IRF-4-positive) (NN BV-173) (NNS cells))) (NP (NP (DT a) (NN HpaII)) (, ,) (CONJP (CC but) (RB not)) (NP (DT a) (NN Bsh1236I) (NN digestion)) (, ,)) (ADVP (RB significantly)) (VP (VBD reduced) (NP (NP (DT the) (NN amplifiable) (NN DNA) (NN message)) (PP (IN of) (NP (NP (NN F2)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3C)) (-RRB- -RRB-))))) (, ,) (SBAR (IN whereas) (S (NP (NP (NN amplification)) (PP (IN of) (NP (NN F1)))) (VP (VBD was) (RB not) (VP (VBN affected) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3B)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBD implied) (SBAR (IN that) (S (NP (NP (NN IRF-4) (NN transcription)) (PP (IN in) (NP (QP (CD SD-1) (CC and) (CD BV-173)) (NNS cells)))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (RBR less) (NN promoter) (NN methylation)) (PRN (-LRB- -LRB-) (PP (IN in) (NP (NP (CD BV-173)) (ADVP (RB especially) (PP (IN at) (NP (NN HpaII) (NNS sites)))))) (-RRB- -RRB-)))) (SBAR (IN as) (S (VP (VBN compared) (PP (IN with) (NP (DT the) (VBN tested) (JJ IRF-4-negative) (NNS cells)))))))))))) (. .)))
( (S (PP (IN In) (NP (NP (NN order)) (VP (TO to) (ADVP (RB exactly)) (VP (VB map) (NP (NP (DT the) (NN methylation) (NNS sites)) (PP (IN within) (NP (DT the) (NN IRF-4) (NN promoter)))))))) (, ,) (NP (PRP we)) (VP (VBD treated) (NP (NP (NN DNA)) (PP (PP (IN of) (NP (NN Jurkat) (, ,) (NN CML-T1) (, ,) (NN U-937) (, ,) (NN K-562) (CC and) (NN EM-2) (NNS cells))) (CONJP (RB as) (RB well) (IN as)) (PP (IN of) (NP (QP (CD SD-1) (, ,) (CD RPMI-8226) (CC and) (CD BV-173)) (NN control) (NNS cells))))) (PP (IN with) (NP (NP (NN bisulfite)) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB chemically)) (VP (VBZ converts) (NP (JJ unmethylated) (NN cytosine)) (PP (TO to) (NP (NN uracil)))))))) (, ,) (SBAR (IN whereas) (S (NP (PRP it)) (VP (VBZ has) (NP (DT no) (NN effect)) (PP (PP (IN on) (NP (VBN methylated) (NN cytosine))) (, ,) (FW i.e.) (PP (IN in) (NP (NN CpG) (-LRB- -LRB-) (CD 34) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (DT This) (NN technique)) (VP (VBZ is) (ADJP (RB especially) (JJ useful) (PP (IN for) (NP (NP (NN detection)) (PP (IN of) (NP (JJ unknown) (NN methylation) (NNS patterns)))))))) (. .)))
( (S (S (NP (NP (NP (NN PCR) (NN amplification)) (, ,) (NP (NN cloning)) (CC and) (NP (NN sequencing))) (PP (IN of) (NP (DT the) (JJ bisulfite-treated) (NN DNA)))) (VP (VBD showed) (NP (NP (DT a) (JJ specific) (NN methylation) (NN pattern)) (PP (IN of) (NP (DT the) (VBN analyzed) (CD 62) (NN CpG) (NNS sites)))) (PP (IN in) (NP (NP (DT all) (NN cell) (NNS lines)) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (CD 4)) (CC and) (NP (NN Table) (CD 1))) (-RRB- -RRB-)))))) (. .)))
( (S (PP (IN In) (NP (JJ general))) (, ,) (NP (DT the) (JJ methylational) (NN status)) (VP (VBD ranged) (PP (IN from) (NP (NP (CD one) (NN cell) (NN line)) (PP (IN with) (NP (NP (DT a) (RB nearly) (JJ non-methylated) (NN IRF-4) (NN promoter)) (PRN (-LRB- -LRB-) (NP (NP (NN SD-1)) (, ,) (NP (NN IRF-4-positive))) (-RRB- -RRB-)))))) (PP (TO to) (NP (NP (DT a) (ADJP (RB completely) (VBN methylated)) (NN IRF-4) (NN promoter)) (PP (IN in) (NP (NP (NN CML-T1)) (PRN (-LRB- -LRB-) (NP (NN IRF-4-negative)) (-RRB- -RRB-))))))) (. .)))
( (S (S (ADVP (RB Interestingly)) (, ,) (NP (NP (DT the) (NN percentage)) (PP (IN of) (NP (NN CpG) (NN methylation))) (PP (IN in) (NP (NP (DT the) (NN IRF-4) (NN promoter)) (PP (IN from) (NP (JJ IRF-4-positive) (NNS cells)))))) (VP (VBD was) (ADJP (RB very) (JJ low) (PRN (-LRB- -LRB-) (NP (NN mean) (CD 24) (NN %)) (-RRB- -RRB-))) (SBAR (IN as) (S (VP (VBN compared) (PP (IN with) (NP (NP (NP (JJ IRF-4-negative) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN mean) (CD 94) (NN %)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (NN 4A)) (CC and) (NP (NN Table) (CD 1))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (NP (NP (DT A) (NN 5′-region)) (PRN (-LRB- -LRB-) (NP (NN R1)) (-RRB- -RRB-))) (PP (IN with) (NP (NP (CD 13) (JJ hypermethylated) (NN CpG) (NNS sites)) (PRN (-LRB- -LRB-) (NP (NP (NN mean) (NN number)) (PP (IN of) (NP (NP (VBN methylated) (NNS clones) (NP (CD 5.5))) (PP (IN of) (NP (ADJP (NP (QP (CD 8) (IN with) (CD 77)) (NN %)) (VBN methylated)) (NNS CpGs)))))) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN found) (PP (IN in) (NP (JJS most) (NNS cells))) (PRN (-LRB- -LRB-) (QP (IN except) (CD SD-1) (CC and) (CD RPMI-8226)) (-RRB- -RRB-))))) (CC and) (S (NP (NP (NP (DT a) (NN 3′-region)) (PRN (-LRB- -LRB-) (NP (NN R3)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (CD 6) (VBN hypomethylated) (NN CpG) (NNS sites)) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (NN mean) (NN number)) (PP (IN of) (NP (VBN methylated) (NNS clones)))) (NP (QP (CD 1.7) (IN of) (CD 8)) (PP (IN with) (NP (CD 33) (NN %))))) (VBN methylated) (NNS CpGs)) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN found) (PP (IN in) (NP (NP (NP (JJS most) (NNS cells)) (PRN (-LRB- -LRB-) (PP (IN except) (NP (NP (NN CML-T1)) (CC and) (NP (NN U-937)))) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (NN 4A)) (CC and) (NP (NN Table) (CD 1))) (-RRB- -RRB-))))))) (. .)))
( (S (ADVP (RB Intriguingly)) (, ,) (NP (NP (DT a) (NN stretch)) (PP (IN of) (NP (NP (CD 13) (NN CpG) (NNS sites)) (PRN (-LRB- -LRB-) (NP (NP (NN #) (NN 10–22)) (: ;) (NP (NN R2))) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN detected) (PP (IN in) (PP (IN between) (NP (NP (DT these) (NNS regions)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD were) (UCP (VP (ADVP (RB highly)) (VBN methylated) (PP (IN in) (NP (NP (JJ IRF-4-negative)) (PRN (-LRB- -LRB-) (NP (NP (NN mean) (NN number)) (PP (IN of) (NP (VBN methylated) (NNS clones)))) (QP (CD 7.1) (IN of) (CD 8)) (PP (IN with) (NP (ADJP (NP (CD 89) (NN %)) (VBN methylated)) (NNS CpGs))) (-RRB- -RRB-))))) (CC but) (ADJP (RB totally) (JJ non-methylated) (PP (IN in) (NP (NP (JJ IRF-4-positive) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (NN 4A)) (CC and) (NP (NN B))) (-RRB- -RRB-)))))))))))))) (. .)))
( (S (ADVP (RB Furthermore)) (, ,) (NP (NP (NP (CD three) (NN CpG) (NNS sites)) (PP (IN at) (NP (NP (DT the) (JJ 5′) (NN end)) (PRN (-LRB- -LRB-) (NP (NP (NNP #) (CD 54) (, ,) (CD 56)) (, ,) (NP (CD 58))) (-RRB- -RRB-))))) (CC and) (NP (NP (CD two) (NN CpG) (NNS motifs)) (PP (IN at) (NP (NP (DT the) (JJ 3′) (NN end)) (PRN (-LRB- -LRB-) (NP (NN #) (CD 1) (, ,) (CD 2)) (-RRB- -RRB-)))))) (VP (VBD showed) (NP (NP (DT this) (JJ direct) (NN correlation)) (PP (IN between) (NP (NP (NP (JJ high) (NN methylation) (NN status)) (CC and) (NP (NN absence))) (PP (IN of) (NP (NN IRF-4) (NN expression))))))) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (CD two) (NN CpG) (NNS sites)) (ADJP (JJ located) (PP (IN in) (NP (NP (NP (DT a) (NN NFκB)) (PRN (-LRB- -LRB-) (NP (NN #) (CD 48)) (-RRB- -RRB-))) (CC and) (NP (NP (DT a) (NN SP1) (NN element)) (PRN (-LRB- -LRB-) (NP (NN #) (CD 45)) (-RRB- -RRB-))))))) (VP (VBP are) (ADJP (RBR less) (VBN methylated) (PP (IN in) (NP (NN IRF-4-positive))) (PP (IN than) (PP (IN in) (NP (NP (JJ IRF-4-negative) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NP (NN mean) (NN number)) (PP (IN of) (NP (VBN methylated) (NNS clones)))) (: :) (QP (CD 1/8) (CC versus) (CD 8/8)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (DT These) (NNS results)) (VP (VBP indicate) (NP (NP (DT the) (NN involvement)) (PP (IN of) (NP (NN CpG) (NN methylation))) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (NN IRF-4) (NN expression)) (PP (IN in) (NP (JJ leukemic) (NNS cells)))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB provide) (NP (NP (NN evidence)) (PP (IN for) (NP (NP (DT a) (JJ direct) (NN effect)) (PP (IN of) (NP (JJ methylational) (NN status))) (PP (IN on) (NP (NN IRF-4) (NN promoter) (NN activity))))))))) (NP (PRP we)) (VP (VBD performed) (NP (NN reporter) (NN gene) (NNS assays)) (PP (IN with) (NP (NP (NN IRF-4) (NN promoter) (NNS constructs)) (PP (PP (IN before)) (CC and) (PP (IN after) (NP (PRP$ their) (ADJP (FW in) (FW vitro)) (NN methylation)))))))) (. .)))
( (S (S (NP (NP (DT A) (JJ complete) (NN methylation)) (PP (IN of) (NP (DT these) (NNS constructs)))) (VP (VBD was) (VP (VBN checked) (PP (IN via) (NP (NP (NN restriction) (NNS assays)) (PP (IN with) (NP (NP (JJ methylation-sensitive) (NNS endonucleases)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 5A)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (ADVP (RB Intriguingly)) (, ,) (NP (NP (NN methylation)) (PP (IN of) (NP (DT the) (NN IRF-4) (NN promoter)))) (ADVP (RB significantly)) (VP (VBD decreased) (NP (NN promoter) (NN activity)) (PP (IN in) (NP (JJ IRF-4-positive) (NN SD-1) (NNS cells))) (PP (IN by) (NP (NP (CD 85.0) (NN %)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 5B)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NP (DT The) (JJ silencing) (NN effect)) (PP (IN of) (NP (NN CpG) (NN methylation)))) (VP (VBD was) (RB not) (ADJP (JJ restricted) (PP (TO to) (NP (JJ IRF-4-positive) (NNS cells)))) (, ,) (SBAR (IN since) (S (NP (ADJP (FW in) (FW vitro)) (NN methylation)) (VP (VBD led) (PP (TO to) (NP (NP (DT a) (ADJP (CD 92.9) (NN %)) (NN abrogation)) (PP (IN of) (NP (NN promoter) (NN activity))) (PP (IN in) (NP (NP (JJ IRF-4-negative) (NN Jurkat) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 5C)) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NN control) (NN methylation)) (PP (IN of) (NP (NP (DT a) (NN reporter) (NN construct)) (PP (IN with) (NP (NP (NP (DT a) (JJ different) (NN promoter)) (PRN (-LRB- -LRB-) (NP (NN FasL)) (-RRB- -RRB-))) (CONJP (RB as) (RB well) (IN as)) (NP (DT an) (JJ empty) (NN vector))))))) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN reporter) (NN activity)) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (DT These) (NNS data)) (VP (VBD proved) (NP (NP (DT a) (JJ direct) (NN association)) (PP (IN between) (NP (NP (NP (NN methylation)) (CC and) (NP (NN activity))) (PP (IN of) (NP (DT the) (NN IRF-4) (NN promoter)))))))) (. .)))
( (S (S (SBAR (IN Since) (S (NP (NP (NN abundance)) (PP (IN of) (NP (NP (NN DNMT)) (CC and) (NP (NN MBP))))) (VP (VBP contribute) (PP (TO to) (NP (NP (NN promoter) (NN regulation)) (PP (IN via) (NP (NP (NN methylation)) (PRN (-LRB- -LRB-) (NP (NN 25,26,28)) (-RRB- -RRB-))))))))) (, ,) (NP (PRP we)) (VP (VBD studied) (NP (PRP$ their) (NN mRNA) (NN expression)) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT a) (JJ possible) (NN mechanism)) (PP (IN for) (NP (NP (DT the) (VBN observed) (NN methylation) (NNS differences)) (PP (IN in) (NP (DT the) (NN IRF-4) (NN promoter))))))))))) (. .)))
( (S (S (PP (TO To) (NP (DT this) (NN end))) (, ,) (NP (PRP we)) (VP (VBD did) (RB not) (VP (VB detect) (NP (NP (DT a) (JJ significant) (NN difference)) (PP (IN in) (NP (NP (NN DNMT)) (PRN (-LRB- -LRB-) (NP (NP (NN DNMT1)) (, ,) (NP (NN DNMT3A)) (CC and) (NP (NN DNMT3B))) (-RRB- -RRB-)) (CC or) (NN MBP) (PRN (-LRB- -LRB-) (NP (NP (NN MBD1)) (, ,) (NP (NN MBD2)) (, ,) (NP (NN MBD4)) (CC and) (NP (NN MeCP))) (-RRB- -RRB-)) (NN mRNA) (NN expression))) (PP (IN between) (NP (NP (ADJP (ADJP (JJ IRF-4-positive)) (CC and) (ADJP (JJ -negative))) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 5D)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (PP (IN In) (NP (NN fact))) (, ,) (S (NP (DT all) (VBN analyzed) (NNS cells)) (VP (VBD had) (NP (NP (JJ moderate) (TO to) (JJ high) (NN mRNA) (NNS levels)) (PP (IN of) (NP (DT these) (VBN tested) (NNS DNMT/MBPs)))))) (CC and) (S (NP (NP (NNS differences)) (PP (IN in) (NP (NN expression)))) (VP (VBD were) (RB not) (VP (VBN correlated) (PP (IN with) (NP (NN IRF-4) (NN status))))))) (. .)))
( (S (S (NP (DT These) (NNS results)) (VP (VBP indicate) (NP (NP (DT a) (JJ distinct) (NN cause)) (PP (IN of) (NP (NP (NP (DT the) (NN methylation) (NNS differences)) (PP (IN in) (NP (ADJP (ADJP (JJ IRF-4-positive)) (CC and) (ADJP (JJ -negative))) (NNS cells)))) (CONJP (RB rather) (IN than)) (NP (NP (NNS changes)) (PP (IN in) (NP (DT the) (NN DNMT) (CC and) (NN MBP) (NN mRNA) (NN transcription))))))))) (. .)))
( (S (NP (NN DISCUSSION))))
( (S (S (NP (JJ Many) (JJ genetic) (NNS lesions)) (VP (VBP are) (VP (VBN known) (S (VP (TO to) (VP (VB influence) (NP (NP (NN gene) (NN expression)) (PP (IN of) (NP (NN tumor) (NN suppressor) (NNS genes)))))))))) (. .)))
( (S (S (SBAR (IN Whereas) (S (NP (NP (NNS mutations)) (CC and) (NP (NP (NNS deletions)) (CC or) (NP (NNS insertions)))) (VP (VBP have) (NP (JJ permanent) (NNS effects))))) (, ,) (NP (JJ reversible) (NNS mechanisms)) (VP (VBP are) (NP (NP (NN gene) (NN methylation)) (, ,) (CC or) (NP (NP (NP (NN expression)) (CC and) (NP (NN activation))) (PP (IN of) (NP (NN transcription) (NNS factors))))) (, ,) (ADVP (RB respectively)))) (. .)))
( (S (S (NP (PRP We)) (VP (VP (VBD studied) (NP (NP (DT a) (JJ putative) (NN cause)) (PP (IN for) (NP (NP (JJ absent) (NN IRF-4) (NN expression)) (PP (IN in) (NP (NN leukemia) (NNS cells))))))) (CC and) (VP (ADVP (RB first)) (VBD focused) (PP (IN on) (NP (NP (JJ genetic) (NNS aberrations)) (PP (IN of) (NP (DT the) (NN promoter)))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD observed) (NP (NP (DT no) (JJ genetic) (NNS alterations)) (PP (IN in) (NP (DT the) (NN IRF-4) (NN promoter))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB account) (PP (IN for) (NP (NP (DT the) (NN lack)) (PP (IN of) (NP (NN IRF-4) (NN expression)))))))))))) (: :) (S (NP (NP (DT The) (VBN detected) (NN base) (NN pair) (NNS changes)) (PP (PP (IN at) (NP (NP (NN position) (CD −1081)) (PRN (-LRB- -LRB-) (NP (NN T→C) (NN substitution)) (-RRB- -RRB-)))) (, ,) (PP (IN at) (NP (NP (NN position) (CD −1068)) (PRN (-LRB- -LRB-) (NP (NN A→C) (NN substitution)) (-RRB- -RRB-)))) (CC and) (PP (IN at) (NP (NP (NN position) (CD −116)) (PRN (-LRB- -LRB-) (NP (NN A→C) (NN substitution)) (-RRB- -RRB-)))))) (VP (VBP are) (ADJP (JJ unlikely)) (ADJP (JJ responsible) (PP (IN for) (NP (NP (JJ absent) (NN IRF-4-expression)) (SBAR (IN since) (S (NP (DT the) (JJ first) (CD two) (NNS mutations)) (VP (VBD were) (VP (VBN found) (PP (CC both) (IN in) (NP (ADJP (ADJP (JJ IRF-4-positive)) (CC and) (ADJP (JJ -negative))) (NNS cells))) (PP (IN whereas) (S (NP (DT the) (JJ latter) (NN change)) (VP (VP (VBD was) (RB not) (VP (VBN detected) (ADVP (RB consistently)) (PP (IN in) (NP (DT all) (ADJP (ADJP (JJ IRF-4-negative)) (CC or) (ADJP (JJ -positive))) (NNS cells))))) (CC and) (VP (MD may) (ADVP (RB thus)) (VP (VB be) (NP (DT a) (NN polymorphism)))))))))))))))) (. .)))
( (S (NP (DT All) (CD three) (NNS substitutions)) (VP (VP (VBD did) (RB not) (VP (VB change) (NP (DT any) (JJ known) (JJ putative) (NN transcription) (NN factor) (NN binding) (NNS sites)) (PRN (-LRB- -LRB-) (NP (CD 30,31)) (-RRB- -RRB-)))) (CC and) (ADVP (RB also)) (VP (VBP do) (RB not) (VP (VB affect) (NP (NP (NP (DT any) (NN restriction) (NNS sites)) (CC or) (NP (NN primer) (NN binding) (NNS sites))) (PP (IN of) (NP (DT the) (VBN used) (NNS assays))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NP (JJ permanent) (JJ genetic) (NNS variations)) (PP (IN in) (NP (DT the) (NN IRF-4) (NN coding) (NN sequence))) (, ,) (PP (JJ such) (IN as) (NP (NP (NP (NNS deletions)) (CC or) (NP (NNS mutations))) (VP (VBG resulting) (PP (IN in) (NP (NNS stop-codons))))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN excluded) (PP (IN by) (NP (NN sequence) (NN analysis))))))) (. .)))
( (S (S (SBAR (IN Since) (S (NP (NP (NN IRF-4) (NN expression)) (PP (IN in) (NP (NP (NN cell) (NNS lines)) (CC and) (NP (NN CML))))) (VP (MD can) (VP (VB be) (VP (VBN induced) (PP (IN by) (NP (NP (NN demethylation)) (CC and) (NP (NP (JJ successful) (NN IFN-α) (NN therapy)) (PRN (-LRB- -LRB-) (NP (CD 3)) (-RRB- -RRB-))) (, ,) (ADVP (RB respectively))))))))) (, ,) (NP (NP (DT the) (NN existence)) (PP (IN of) (NP (JJ such) (JJ genetic) (NNS aberrations)))) (VP (VBZ seems) (ADJP (JJ unlikely)))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB then)) (VP (VBD investigated) (SBAR (IN whether) (S (NP (NP (DT the) (ADJP (RB previously) (VBN described)) (NN down-regulation)) (PP (IN of) (NP (NN IRF-4) (NN expression))) (PP (IN in) (NP (JJ human) (JJ myeloid) (NNS leukemias)))) (VP (VBD was) (ADJP (JJ due) (PP (TO to) (NP (NP (DT a) (JJ differential) (NN hypermethylation)) (PP (IN of) (NP (DT the) (NN promoter)))))) (, ,) (SBAR (IN since) (S (NP (NP (DT the) (VBN presented) (NN re-expression)) (PP (IN due) (TO to) (NP (NN AzadC-treatment)))) (VP (MD might) (ADVP (RB also)) (VP (VB be) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NP (NN activation)) (PP (IN of) (NP (NP (JJ positive) (JJ transcriptional) (NNS regulators)) (PP (IN of) (NP (NN IRF-4))))))))))))))))) (. .)))
( (S (S (NP (NP (NN Methylation)) (PP (IN of) (NP (NN CpG) (NNS sites)))) (VP (VP (VBZ is) (NP (NP (DT a) (JJ common) (NN mechanism)) (PP (IN of) (NP (NP (JJ silencing) (NNS genes)) (PP (IN in) (NP (NN leukemia))))))) (CC and) (VP (VBZ has) (ADVP (RB also)) (VP (VBN been) (VP (VBN shown) (PP (PP (IN for) (NP (NP (DT another) (NN IRF)) (, ,) (NP (NN IRF-7) (-LRB- -LRB-) (CD 35) (-RRB- -RRB-)))) (CC and) (PP (IN for) (NP (NP (NN PU.1) (-LRB- -LRB-) (CD 36) (-RRB- -RRB-)) (, ,) (NP (NP (DT an) (VBG interacting) (NN partner)) (PP (IN of) (NP (NN IRF-4)))))))))))) (. .)))
( (S (S (S (S (VP (TO To) (VP (VB elucidate) (NP (NP (DT the) (NN relevance)) (PP (IN of) (NP (DT this) (NN mechanism))) (PP (IN for) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NN IRF-4) (NN expression))))))))) (, ,) (NP (JJ various) (JJ leukemic) (NNS cells)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (JJ demethylating) (NNS agents)))))) (CC and) (S (NP (NNS promoters)) (VP (VBD were) (VP (VBN sequenced) (PP (IN after) (NP (NN bisulfite) (NN treatment))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (NN IRF-4) (NN expression)) (VP (MD could) (ADVP (RB indeed)) (VP (VB be) (VP (VBN connected) (PP (TO to) (NP (NP (DT the) (NN methylation) (NN status)) (PP (IN of) (NP (JJ distinct) (NN CpG) (NNS motifs))) (PP (IN in) (NP (DT the) (NN IRF-4) (NN promoter)))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN Figure) (CD 4A))) (, ,) (NP (DT those) (NN CpG) (NNS sites)) (VP (VBP are) (NP (NP (NP (VBN shown)) (PRN (-LRB- -LRB-) (NP (NN bottom) (NN line)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WP$ whose) (NN hypermethylation)) (S (VP (MD may) (VP (VB account) (PP (IN for) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (NN IRF-4) (NN expression)) (PP (IN in) (NP (DT the) (JJ respective) (NNS cells)))))))))))))) (. .)))
( (S (S (NP (NP (NP (CD One)) (PP (IN of) (NP (PRP them)))) (PRN (-LRB- -LRB-) (NP (NN #) (CD 54)) (-RRB- -RRB-))) (VP (VBZ is) (ADJP (JJ adjacent) (PP (TO to) (NP (DT an) (VBN identified) (NP (NP (JJ regulatory) (NN element)) (PRN (-LRB- -LRB-) (NP (NN NFκB-site)) (-RRB- -RRB-)))))) (, ,) (S (VP (VBG indicating) (NP (NP (DT a) (JJ possible) (NN involvement)) (PP (IN of) (NP (DT this) (NN site)))))))) (. .)))
( (S (S (PP (IN At) (NP (NP (CD two) (JJ further) (NN CpG) (NNS sites)) (PRN (-LRB- -LRB-) (NP (NNP #) (CD 48) (, ,) (CD 45)) (-RRB- -RRB-)))) (NP (NP (DT the) (NN methylation) (NN status)) (PP (IN in) (NP (NN IRF-4-positive)))) (VP (VBD was) (ADJP (ADJP (JJR lower)) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (NP (JJ IRF-4-negative) (NNS cells)))))))) (. .)))
( (S (S (NP (DT These) (NN CpG) (NNS sites)) (VP (VP (VBP are) (ADJP (JJ located) (PP (IN in) (NP (NP (DT an) (NN NFκB)) (CC and) (NP (NP (DT an) (NN SP1) (NN element)) (PRN (-LRB- -LRB-) (NP (CD 31)) (-RRB- -RRB-))))))) (CC and) (VP (ADVP (RB thus)) (VP (MD may) (ADVP (RB also)) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (NP (NP (NN regulation)) (PP (IN of) (NP (NN IRF-4) (NN expression)))))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (SBAR (IN that) (S (NP (NN NFκB) (NNS elements)) (VP (VBP play) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NN IRF-4) (NN induction))) (SBAR (IN as) (S (NP (NN IRF-4) (NN expression)) (VP (VBZ depends) (PP (IN on) (NP (NP (NN binding)) (PP (IN of) (NP (DT the) (NN transactivator) (NN c-Rel))) (PP (TO to) (NP (NP (DT these) (NNS elements)) (PP (IN in) (NP (DT the) (NP (NP (NN IRF-4) (NN promoter)) (PRN (-LRB- -LRB-) (NP (NN 31,37)) (-RRB- -RRB-))))))))))))))))))) (. .)))
( (S (ADVP (RB Furthermore)) (, ,) (NP (NP (NN methylation)) (PP (IN of) (NP (DT the) (JJ central) (NN CpG))) (PP (IN in) (NP (DT the) (NN NFκB) (NN element)))) (VP (VBZ inhibits) (NP (NP (NN binding)) (PP (IN of) (NP (NP (DT the) (NN NFκB) (NN protein) (NNS complexes)) (PRN (-LRB- -LRB-) (NP (CD 38)) (-RRB- -RRB-))))) (, ,) (S (VP (VBG promoting) (NP (NP (DT the) (NN significance)) (PP (IN of) (NP (DT the) (VBN observed) (NN methylation) (NNS differences))) (PP (IN in) (NP (ADJP (ADJP (JJ IRF-4-positive)) (CC and) (ADJP (JJ -negative))) (NNS cells))))))) (. .)))
( (S (S (PP (IN Via) (NP (ADJP (FW in) (FW vitro)) (NN methylation) (CC and) (NN reporter) (NN gene) (NNS assays))) (NP (PRP we)) (VP (MD could) (ADVP (RB clearly)) (VP (NN appoint) (NP (NP (DT the) (NN silencing)) (PP (IN of) (NP (DT the) (NN IRF-4) (NN promoter)))) (PP (TO to) (NP (NP (DT a) (NN methylation) (NN effect)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (ADVP (RB thus)) (VP (VB be) (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NN IRF-4) (NN deregulation)))) (ADVP (FW in) (FW vivo))))))))))) (. .)))
( (S (S (NP (NP (CD One) (JJ possible) (NN cause)) (PP (IN for) (NP (NP (DT the) (JJ aberrant) (NN methylation)) (PP (IN in) (NP (NN tumorigenesis)))))) (VP (VBZ is) (NP (NP (DT an) (VBN increased) (NN level)) (PP (IN of) (NP (NNS DNMTs)))) (PP (IN during) (NP (DT the) (JJ pathogenetic) (NN process))))) (. .)))
( (S (S (PP (IN In) (NP (NP (NN colon)) (, ,) (NP (NN lung)) (CC and) (NP (JJ hematologic) (NNS malignancies)))) (, ,) (NP (NP (NN overexpression)) (PP (IN of) (NP (NP (NN DNMT1)) (, ,) (NP (DT a) (NN maintenance) (NN DNMT)) (, ,)))) (VP (VBZ has) (VP (VBN been) (VP (VBN detected) (PRN (-LRB- -LRB-) (NP (NN 39–41)) (-RRB- -RRB-)))))) (. .)))
( (S (S (ADVP (RB Furthermore)) (, ,) (NP (PRP it)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (NN CML) (NNS cells)) (PP (IN in) (NP (DT the) (JJ acute) (NN phase)))) (VP (VBD exhibited) (NP (NP (JJ elevated) (NNS levels)) (PP (IN of) (NP (DT the) (CD three) (JJ known) (NNS DNMTs)))) (, ,) (SBAR (IN while) (S (NP (NP (NN CML) (NNS cells)) (PP (IN in) (NP (JJ chronic) (NN phase)))) (VP (VBD expressed) (NP (NP (JJ normal) (NNS levels)) (PP (IN of) (NP (NNS DNMTs)))) (SBAR (IN if) (S (VP (VBN compared) (PP (IN with) (NP (NP (JJ normal) (NN bone) (NN marrow) (NNS cells)) (PRN (-LRB- -LRB-) (NP (CD 25)) (-RRB- -RRB-))))))))))))))))) (. .)))
( (S (S (ADVP (RB Interestingly)) (, ,) (NP (NP (DT a) (JJ positive) (NN correlation)) (PP (IN between) (NP (NP (NN DNMT1) (NN expression) (NNS levels)) (CC and) (NP (NP (NN hypermethylation)) (PP (IN of) (NP (NN p15INK4b))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN detected) (PP (IN in) (NP (NN AML) (-LRB- -LRB-) (CD 25) (-RRB- -RRB-))))))) (. .)))
( (S (S (PP (IN In) (NP (DT this) (NN work))) (, ,) (NP (PRP we)) (VP (VBD did) (RB not) (VP (VB detect) (NP (NP (JJ significant) (NN mRNA) (NN expression) (NNS differences)) (PP (IN of) (NP (VBN selected) (NP (NN DNMT)) (CC or) (NP (NN MBP)))))) (, ,) (S (VP (VBG making) (NP (NP (PRP it)) (NP (NP (DT an) (JJ unlikely) (NN cause)) (PP (IN for) (NP (NP (DT the) (VBN observed) (NP (NP (NN methylation)) (CC and) (ADVP (RB thus)) (NP (NN IRF-4) (NN expression))) (NNS differences)) (PP (IN in) (NP (NN leukemia) (NNS cells))))))))))) (. .)))
( (S (S (NP (DT The) (NN finding) (SBAR (IN that) (S (NP (NN IRF-4) (NN expression)) (VP (VBZ is) (VP (VBN silenced) (PP (IN by) (NP (NN promoter) (NN hypermethylation)))))))) (VP (MD might) (VP (VB represent) (NP (NP (DT a) (NN mechanism)) (SBAR (WHNP (WDT that)) (S (VP (VBZ accounts) (PP (IN for) (NP (NP (DT the) (ADJP (RB previously) (VBN observed)) (NN loss)) (PP (IN of) (NP (NP (NN IRF-4) (NN expression)) (PP (IN in) (NP (NN CML)))))))))))))) (. .)))
( (S (ADVP (RB Indeed)) (, ,) (NP (NP (JJ several) (JJ clinical) (NNS trials)) (PP (IN with) (NP (NP (NN leukemia) (NNS patients)) (CC and) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ myelodysplastic) (NNS syndromes))))))) (VP (VBD demonstrated) (NP (NP (DT the) (JJ potential) (JJ clinical) (NN benefit)) (PP (IN of) (NP (NP (DT a) (NN treatment)) (PP (IN with) (NP (NP (JJ demethylating) (NNS agents)) (PRN (-LRB- -LRB-) (NP (NN 42–45)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (NP (DT The) (NN expression)) (PP (IN of) (NP (DT another) (NN IRF)))) (, ,) (NP (NP (NN IFN) (NN consensus) (NN sequence) (NN binding) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN ICSBP/IRF-8)) (-RRB- -RRB-))) (, ,)) (VP (VBZ is) (VP (VBN impaired) (PP (IN in) (NP (NP (JJ myeloid) (NNS leukemias)) (NP (ADVP (RB especially)) (NP (NP (NN CML)) (PRN (-LRB- -LRB-) (NP (NN 27,46,47)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (CC But) (PP (IN in) (NN contrast) (TO to) (NP (NN IRF-4))) (, ,) (S (NP (NP (DT the) (NN loss)) (PP (IN of) (NP (DT this) (NN IRF)))) (VP (MD could) (RB not) (VP (VB be) (VP (VBD reverted) (PP (IN in) (NP (NP (JJ ICSBP-negative) (NN cell) (NNS lines)) (PRN (-LRB- -LRB-) (NP (NN EM-2) (, ,) (NN CML-T1) (, ,) (NN K-562) (CC and) (CD LAMA-84)) (-RRB- -RRB-)))) (PP (IN by) (NP (NP (NN treatment)) (PP (IN with) (NP (NP (NN AzadC)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 6)) (-RRB- -RRB-)))))))))) (CC and) (S (NP (NN AzadC)) (VP (VBZ has) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NN ICSBP) (NNS levels)) (PP (IN in) (NP (NP (JJ ICSBP-positive) (NN U-937) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 6)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (DT These) (NNS data)) (VP (VBP suggest) (NP (NP (DT a) (JJ distinct) (JJ regulatory) (NN mechanism)) (PP (IN for) (NP (DT these) (CD two) (NNS IRFs)))))) (. .)))
( (S (S (NP (NP (NN IRF-4)) (, ,) (ADJP (JJ similar) (PP (TO to) (NP (JJ many) (JJ other) (JJ classical) (NN tumor) (NN suppressor) (NNS genes) (NP (NP (NN p15INK4b)) (, ,) (NP (NN p16INK4a)) (CC or) (NP (NN p53)))))) (, ,)) (VP (MD may) (ADVP (RB thus)) (VP (VB be) (NP (NP (DT a) (NN subject)) (PP (IN of) (NP (NP (NNS alterations)) (PP (IN in) (NP (NP (DT the) (NN promoter) (NN methylation) (NN status)) (VP (VBG leading) (PP (TO to) (NP (NP (NN expression) (NNS changes)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD might) (VP (VB contribute) (PP (TO to) (NP (NP (DT the) (NP (NN initiation)) (CC and/or) (NP (NN progression))) (PP (IN of) (NP (NN cancer)))))))))))))))))))) (. .)))
( (S (S (ADVP (RB Still)) (, ,) (NP (NP (DT the) (JJ obvious) (JJ functional) (NN diversity)) (PP (IN of) (NP (NN IRF-4)))) (VP (VP (VBZ remains) (ADJP (JJ remarkable))) (CC and) (VP (MD cannot) (VP (VB be) (ADVP (RB fully)) (VP (VBN explained) (PP (IN by) (NP (DT the) (NN IRF-4) (NN promoter) (NN methylation) (NN status)))))))) (. .)))
( (S (S (PP (IN For) (NP (NN example))) (, ,) (NP (NN IRF-4)) (VP (VBZ is) (ADVP (RB primarily)) (VP (VBN known) (PP (IN for) (NP (PRP$ its) (JJ oncogenic) (NNS features)))))) (. .)))
( (S (S (PP (IN In) (NP (NP (JJ multiple) (NN myeloma)) (PRN (-LRB- -LRB-) (NP (NN MM)) (-RRB- -RRB-)))) (NP (NP (DT a) (NN translocation)) (PP (IN on) (NP (NN chromosome) (CD 14q)))) (VP (VBD was) (VP (VBN reported) (S (VP (TO to) (VP (VB lead) (PP (TO to) (NP (NP (DT a) (NN fusion) (NN gene)) (PP (IN of) (NP (NP (NP (NP (NN immunoglobulin) (NN heavy-chain)) (PRN (-LRB- -LRB-) (NP (NN IgH)) (-RRB- -RRB-))) (CC and) (NP (NN IRF-4))) (VP (VBG resulting) (PP (IN in) (NP (NP (DT a) (JJ subsequent) (NN overexpression)) (PP (IN of) (NP (NP (NN IRF-4)) (PRN (-LRB- -LRB-) (NP (NN 48,49)) (-RRB- -RRB-))))))))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (JJ abundant) (NN IRF-4) (NN expression)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (NN marker)) (PP (IN for) (NP (NP (JJ various) (NNS subsets)) (PP (IN of) (NP (NP (NNS lymphomas)) (, ,) (CONJP (JJ such) (IN as)) (NP (JJ diffuse) (JJ large) (NN B-cell) (NNS lymphomas)) (, ,) (NP (NP (JJ primary) (NN effusion) (NN lymphoma)) (, ,) (CC and) (NP (JJ marginal) (NN zone) (NN lymphoma))) (, ,) (CC and) (NP (NP (JJ adult) (NN T-cell) (NN leukemia)) (PRN (-LRB- -LRB-) (NP (NN 11,31,50–52)) (-RRB- -RRB-)))))))))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBZ draws) (NP (NP (DT a) (ADJP (RBR more) (JJ complex)) (NN picture)) (PP (IN of) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN IRF-4)))))))) (. .)))
( (S (NP (NP (NN Down-regulation)) (PP (IN of) (NP (NN IRF-4)))) (VP (MD may) (VP (VB promote) (NP (NN leukemogenesis)) (PP (IN in) (NP (NP (NP (JJ myeloid) (NN cell) (NN context)) (PRN (-LRB- -LRB-) (NP (CD 3)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (ADVP (RB recently)) (VP (VBN confirmed) (PP (IN in) (NP (NP (JJ IRF-4−/−) (NN ICSBP−/−) (JJ double) (JJ knock-out) (NNS mice)) (PRN (-LRB- -LRB-) (NP (CD 53)) (-RRB- -RRB-))))) (, ,) (SBAR (IN while) (S (NP (NN IRF-4) (NN up-regulation)) (VP (MD may) (VP (VB induce) (NP (DT a) (NN growth) (NN advantage)) (PP (IN in) (NP (NP (NNS lymphomas)) (CC or) (NP (NN MM) (-LRB- -LRB-) (CD 48) (-RRB- -RRB-))))))))))))))) (. .)))
( (S (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (NP (PRP$ our) (NNS data)) (VP (VBP suggest) (SBAR (SBAR (IN that) (S (NP (NN IRF-4) (NN promoter) (NN methylation)) (VP (VBZ regulates) (NP (NN IRF-4) (NN expression))))) (, ,) (CC and) (SBAR (IN that) (S (NP (NP (JJ aberrant) (NN expression)) (PP (IN of) (NP (NN IRF-4))) (PP (IN in) (NP (NP (JJ certain) (NNS types)) (PP (IN of) (NP (NN leukemia)))))) (VP (MD may) (VP (VB be) (NP (NP (DT a) (NN consequence)) (PP (IN of) (NP (NN IRF-4) (NN promoter) (NN hypermethylation))))))))))) (. .)))
( (S (NP (NP (NN Figure)) (CC and) (NP (NN Table)) (NP (NNS captions)))))
( (S (NP (NP (NN Figure) (CD 1)) (: :) (NP (NP (NP (NN Correlation)) (PP (IN of) (NP (NN IRF-4) (NN mRNA) (NN expression)))) (CC and) (NP (NP (JJ nucleotide) (NNS changes)) (PP (IN in) (NP (DT the) (NN IRF-4) (NN promoter))))) (. .))))
( (S (S (NP (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NN RT–PCR)) (PP (IN of) (NP (JJ different) (JJ hematopoietic) (NN cell) (NNS lines))))) (. .)))
( (S (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (NN nucleotide) (NNS changes)) (PP (IN in) (NP (NP (DT the) (NN promoter)) (PP (IN of) (NP (NP (ADJP (ADJP (JJ IRF-4-positive)) (CC or) (ADJP (JJ -negative))) (NNS cells)) (PP (IN in) (NP (NP (NN comparison)) (PP (TO to) (NP (NP (NP (DT the) (NN germline) (NN sequence)) (PP (IN at) (NP (NNS positions) (QP (CD 98) (, ,) (CD 111) (CC and) (CD 1063))))) (-LRB- -LRB-) (NP (NN GenBank) (NN accession) (NN no)))))))))) (. .))))
( (S (S (LST (CD U52683) (-RRB- -RRB-)) (, ,) (S (VP (VBG representing) (NP (NP (NN nucleotide) (NN −1081)) (, ,) (NP (NP (NP (NP (CD −1068)) (CC and) (NP (CD −116))) (PRN (-LRB- -LRB-) (NP (CD 30)) (-RRB- -RRB-))) (CC or) (NP (NP (NP (CD −1094)) (, ,) (NP (CD −1081)) (CC and) (NP (CD −129))) (PRN (-LRB- -LRB-) (NP (CD 31)) (-RRB- -RRB-))))) (, ,) (ADVP (RB respectively))))) (. .)))
( (S (NP (NP (NN Figure) (CD 2)) (: :) (NP (NP (NN Expression)) (PP (IN of) (NP (NN IRF-4))) (PP (IN in) (NP (NP (JJ hematopoietic) (NNS cells)) (PP (IN after) (NP (NP (NN treatment)) (PP (IN with) (NP (NN AzadC)))))))) (. .))))
( (S (S (NP (NP (JJ Representative) (NNS cells)) (CC and) (NP (NNS experiments))) (VP (VBP are) (VP (VBN shown)))) (. .)))
( (S (NP (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NN RT–PCR)) (PP (IN after) (NP (NP (NN incubation)) (PP (IN of) (NP (NP (NN CML-T1)) (CC and) (NP (NN EM-2)))) (PP (IN with) (NP (NP (NP (NP (CD 0.5) (, ,) (CD 1) (CC and) (CD 3) (NN µM) (NN AzadC)) (PP (IN for) (NP (CD 72) (NN h)))) (: ;) (NP (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NN RT–PCR)) (PP (IN after) (NP (NP (NN treatment)) (PP (IN of) (NP (NP (NN CML-T1)) (CC and) (NP (NN EM-2)))) (PP (IN with) (NP (NP (CD 3) (NN µM) (NN AzadC)) (PP (IN for) (NP (QP (CD 24) (, ,) (CD 48) (CC and) (CD 72)) (NN h)))))))) (: ;)) (-LRB- -LRB-) (NN C) (-RRB- -RRB-) (NN immunoblotting))))) (PP (IN after) (NP (NP (NN treatment)) (PP (IN of) (NP (NP (NN CML-T1)) (CC and) (NP (NP (NP (NP (NP (NP (CD LAMA-84)) (PP (IN with) (NP (QP (CD 1) (CC and) (CD 3)) (NN µM) (NN AzadC)))) (PP (IN for) (NP (CD 72) (NN h)))) (: ;) (NP (NP (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (NN RT–PCR)) (PP (IN after) (NP (NP (NN treatment)) (PP (IN of) (NP (NN BV-173))) (PP (IN for) (NP (QP (CD 24) (, ,) (CD 48) (CC and) (CD 72)) (NN h))))))) (CC and) (NP (CD RPMI-8226))) (PP (IN for) (NP (CD 72) (NN h)))))) (PP (IN with) (NP (CD 3) (NN µM) (NN AzadC))))) (. .))))
( (S (NP (NP (NN Figure) (CD 3)) (: :) (NP (NP (NN Restriction-PCR-assay)) (PP (IN of) (NP (DT the) (NN IRF-4) (NN promoter))) (PP (IN in) (NP (JJ hematopoietic) (NNS cells)))) (. .))))
( (S (S (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (VP (VBN Simplified) (NP (NP (NN structure)) (PP (IN of) (NP (DT the) (NN CpG) (NNS sites)))) (PP (IN in) (NP (NP (DT the) (JJ human) (NN IRF-4) (NN promoter) (NN region)) (VP (VBG including) (NP (NN exon) (CD 1))))))) (. .)))
( (S (S (NP (DT Each) (NN CpG) (NN motif)) (VP (VBZ is) (VP (VBN shown) (PP (IN as) (NP (NP (NN circle)) (CC and) (NP (NP (JJ numbered)) (PRN (-LRB- -LRB-) (NP (NP (JJ above)) (, ,) (NP (NP (NN labeling)) (VP (VBG beginning) (PP (IN from) (NP (NP (DT the) (JJ 3′) (NN end)) (VP (VBG moving) (ADVP (RB upstream)))))))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (NP (NN Restriction) (NNS sites)) (, ,) (NP (NP (NP (NNS fragments)) (PRN (-LRB- -LRB-) (NP (NNP F1) (, ,) (NNP F2)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NN restriction-PCR-assay)))) (CC and) (NP (NNS regions))) (VP (VBN amplified) (PP (IN after) (NP (NN bisulfite) (NN treatment))) (PP (IN for) (NP (NN sequencing))))) (VP (VBP are) (VP (VBN shown) (ADVP (IN below))))) (. .)))
( (S (S (NP (NP (DT The) (NNS numbers)) (PP (IN in) (NP (NNS italics)))) (VP (VBP refer) (PP (TO to) (NP (NP (DT the) (NN sequence) (NN data)) (PP (IN by) (NP (NP (NP (NNP Grossman) (FW et) (FW al)) (. .)) (PRN (-LRB- -LRB-) (NP (CD 30)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (-LRB- -LRB-) (NP (NP (NN B)) (CC and) (NP (NN C))) (-RRB- -RRB-)) (NP (NN Restriction-PCR-assay))) (. .)))
( (S (NP (NP (NN Restriction)) (PP (IN of) (NP (NN DNA))) (PP (IN with) (NP (NP (NP (NN EcoRI)) (PRN (-LRB- -LRB-) (NP (NP (NN E)) (, ,) (NP (DT no) (NN recognition) (NN site))) (-RRB- -RRB-))) (, ,) (NP (NP (NN HpaII)) (PRN (-LRB- -LRB-) (FRAG (NP (NN H)) (, ,) (JJ sensitive)) (-RRB- -RRB-))) (, ,) (NP (NP (NN Bsp143II)) (PRN (-LRB- -LRB-) (FRAG (NP (NN BII)) (, ,) (JJ sensitive)) (-RRB- -RRB-))) (, ,) (NP (NP (NP (NP (NN Bsh1236I)) (PRN (-LRB- -LRB-) (FRAG (NP (NN BI)) (, ,) (JJ sensitive)) (-RRB- -RRB-))) (CC and) (NP (NN MspI))) (PRN (-LRB- -LRB-) (NP (NN M)) (, ,) (NP (JJ resistant)) (-RRB- -RRB-))) (CC and) (NP (JJ subsequent) (NN PCR) (NN amplification)))) (. .))))
( (S (S (NP (NP (CD Three) (JJ representative) (NP (JJ IRF-4-negative) (PRN (-LRB- -LRB-) (NP (NP (NN K-562)) (, ,) (NP (NN CML-T1)) (, ,) (NP (NN EM-2))) (-RRB- -RRB-)) (CC and) (CD two) (JJ IRF-4-positive) (NN cell) (NNS lines))) (PRN (-LRB- -LRB-) (NP (NP (NN SD-1)) (, ,) (NP (NN BV-173))) (-RRB- -RRB-))) (VP (VBP are) (VP (VBN shown)))) (. .)))
( (S (S (NP (NN IRF-4) (NN expression)) (VP (VBZ is) (VP (VBN denoted) (PP (IN on) (NP (DT the) (JJ right)))))) (. .)))
( (S (S (S (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (VP (JJ PCR-fragment) (NP (CD 1) (PRN (-LRB- -LRB-) (NP (NN F1)) (-RRB- -RRB-))))) (: ;) (S (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (VP (JJ PCR-fragment) (NP (NP (CD 2)) (PRN (-LRB- -LRB-) (NP (NN F2)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NN Figure) (CD 4)) (: :) (NP (NP (NN Methylation) (NN pattern)) (PP (IN of) (NP (NN CpG) (NNS sites))) (PP (IN in) (NP (DT the) (NN IRF-4) (NN promoter) (NN region))))) (. .)))
( (S (S (NP (NN Methylation)) (VP (VBZ is) (VP (VBN detected) (PP (IN via) (NP (NP (NN sequencing)) (PP (IN of) (NP (NP (JJ bisulfite-treated) (NN DNA)) (PP (IN from) (NP (JJ hematopoietic) (NNS cells)))))))))) (. .)))
( (S (NP (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (JJ Schematic) (NN figure)) (PP (IN of) (NP (NP (DT the) (NN IRF-4) (NN promoter) (NN region)) (PRN (-LRB- -LRB-) (VP (VB see) (NP (NN Figure) (NN 3A))) (-RRB- -RRB-)))) (PP (IN for) (NP (DT each) (NN cell) (NN line))) (. .))))
( (S (S (NP (DT Each) (NN CpG) (NN motif)) (VP (VBZ is) (VP (VBN shown) (PP (IN as) (NP (NP (ADJP (ADJP (ADJP (ADJP (JJ circle)) (CC and) (ADJP (JJ numbered))) (PRN (-LRB- -LRB-) (FRAG (ADVP (RB above)) (, ,) (NP (NP (NN labeling)) (VP (VBG beginning) (PP (IN from) (NP (NP (DT the) (JJ 3′) (NN end)) (VP (VBG moving) (ADVP (RB upstream)))))))) (-RRB- -RRB-))) (, ,) (ADJP (JJ white))) (NNS circles)) (VP (JJ mean) (NP (NP (NP (DT no) (VBN methylated) (NN clone)) (PRN (-LRB- -LRB-) (QP (IN from) (CD eight)) (-RRB- -RRB-))) (, ,) (NP (NN gray) (NNS circles)) (NP (JJ mean) (NP (QP (CD one) (TO to) (CD four)) (VBN methylated) (NNS clones)) (CC and) (NP (JJ black) (NNS circles)) (NP (NN mean) (QP (CD five) (TO to) (CD eight)) (VBN methylated) (NNS clones)))))))))) (. .)))
( (S (S (NP (NN IRF-4) (NN expression)) (VP (VBZ is) (VP (VBN denoted) (PP (IN on) (NP (DT the) (JJ right)))))) (. .)))
( (S (PP (IN Below)) (, ,) (NP (NN CpG) (NNS sites)) (VP (NN maybe) (NP (ADJP (JJ responsible) (PP (IN for) (NP (NP (NP (JJ methylation-dependent) (NN IRF-4) (NN silencing)) (PRN (-LRB- -LRB-) (NP (NN arrows)) (-RRB- -RRB-))) (: ;) (NP (NP (NN R1)) (, ,) (NP (NP (NN region)) (PP (IN with) (NP (ADJP (RB generally) (JJ high)) (NN methylation)))) (: ;) (NP (NN R2)) (, ,) (NP (NP (NN region)) (PP (IN with) (NP (NP (NN correlation)) (PP (IN between) (NP (NP (NN methylation)) (CC and) (NP (NN IRF-4) (NN expression))))))) (: ;) (NP (NN R3)))))) (, ,) (NN region)) (PP (IN with) (NP (ADJP (RB generally) (JJ low)) (NN methylation)))) (. .)))
( (S (S (NP (NP (JJ Putative) (VBG binding) (NNS sites)) (PP (IN for) (NP (NN transcription) (NNS factors)))) (VP (VBP are) (VP (VBN shown) (ADVP (RB above)) (PRN (-LRB- -LRB-) (FRAG (NP (CD 5×) (NN AP1)) (, ,) (NP (CD 3×) (NN Sp1)) (, ,) (NP (CD 2×) (NN Ets-1)) (, ,) (NP (CD 2×) (NN κB)) (, ,) (NP (CD 1×) (NN NF-3)) (, ,) (NP (CD 1×) (NN CD28RE)) (, ,) (NP (CD 1×) (NN PU.1))) (-RRB- -RRB-))))) (. .)))
( (S (NP (NP (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (JJ Schematic) (NN figure)) (PP (IN of) (NP (JJ specific) (NN region) (CD 2)))) (PRN (-LRB- -LRB-) (NP (NN R2)) (-RRB- -RRB-))) (: :) (S (NP (NP (NN CpG) (NNS sites)) (PP (IN from) (NP (NP (NNP #) (CD 10)) (TO to) (NP (NNP #) (CD 22))))) (VP (VBP are) (VP (VBN shown) (ADVP (RB above))))) (. .))))
( (S (S (NP (NP (NP (NN Number)) (PP (IN of) (NP (VBN methylated) (NNS clones)))) (PRN (-LRB- -LRB-) (PP (IN from) (NP (CD eight))) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN shown) (PP (IN for) (NP (DT each) (NN cell) (NN line)))))) (. .)))
( (S (NP (NP (NN Figure) (CD 5)) (: :) (NP (NP (NN Investigation)) (PP (IN of) (NP (NP (JJ putative) (NNS mechanisms)) (PP (IN for) (NP (NN IRF-4) (NN deregulation)))))) (. .))))
( (S (NP (NP (-LRB- -LRB-) (NN A–C) (-RRB- -RRB-) (NN Influence)) (PP (IN of) (NP (ADJP (FW in) (FW vitro)) (NN methylation))) (PP (IN on) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (DT an) (NN IRF-4) (NN promoter-reporter) (NN gene) (NN construct))))) (. .))))
( (S (NP (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NN Control)) (PP (IN of) (NP (JJ complete) (NN methylation))) (PP (IN via) (NP (NN restriction))) (. .))))
( (S (NP (NP (NN Digestion)) (PP (IN of) (NP (DT the) (NN construct))) (PP (PP (IN before) (S (PRN (-LRB- -LRB-) (NP (NNS lanes) (QP (CD 2) (, ,) (CD 4) (CC and) (CD 6))) (-RRB- -RRB-)))) (CC and) (PP (IN after) (NP (NP (NN methylation)) (PRN (-LRB- -LRB-) (NP (NNS lanes) (QP (CD 1) (, ,) (CD 3) (CC and) (CD 5))) (-RRB- -RRB-))))) (PP (IN with) (NP (NP (JJ respective) (ADJP (ADJP (JJ methylation-sensitive) (PRN (-LRB- -LRB-) (NP (NP (NN HpaII)) (, ,) (NP (NNS lanes) (QP (CD 1) (CC and) (CD 2)))) (-RRB- -RRB-))) (CC and) (ADJP (JJ -resistant))) (NNS endonucleases)) (PRN (-LRB- -LRB-) (NP (NP (NN MspI)) (, ,) (NP (NNS lanes) (QP (CD 3) (CC and) (CD 4)))) (-RRB- -RRB-)))) (. .))))
( (S (NP (NP (-LRB- -LRB-) (NP (NP (NN B)) (CC and) (NP (NN C))) (-RRB- -RRB-) (NN Reporter) (NN gene) (NNS assays)) (PP (IN with) (NP (NP (NP (JJ non-methylated) (NN control)) (PRN (-LRB- -LRB-) (NP (NN co)) (-RRB- -RRB-))) (CC and) (NP (ADJP (ADJP (ADVP (FW in) (FW vitro)) (VBN methylated)) (PRN (-LRB- -LRB-) (NP (NN met)) (-RRB- -RRB-))) (NN IRF-4) (NN promoter) (NNS constructs)) (CC and) (NP (NP (NN SD-1)) (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-))) (CC or) (NP (NP (NN Jurkat) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN C)) (-RRB- -RRB-))))) (. .))))
( (S (S (NP (DT The) (NN promoter) (NN activity)) (VP (VBZ is) (VP (VBN displayed) (PP (IN as) (NP (NP (JJ fold) (NN increase)) (PP (TO to) (NP (NP (JJ non-methylated) (NN construct)) (PRN (-LRB- -LRB-) (PP (IN via) (NP (NP (NN ratio)) (PP (IN of) (NP (NN firefly) (TO to) (NN renilla) (NN luciferase))))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (NP (NP (NN Expression)) (PP (IN of) (NP (NP (NN DNMT)) (CC and) (NP (NN MBP) (NN mRNA)))) (PP (IN in) (NP (JJ various) (JJ hematopoietic) (NNS cells))))) (. .)))
( (S (NP (NP (NP (NN RT–PCR)) (PP (IN of) (NP (JJ various) (JJ hematopoietic) (NNS cells)))) (: :) (NP (NP (NP (CD SD-1)) (PRN (-LRB- -LRB-) (NP (NNP lane) (CD 1)) (-RRB- -RRB-))) (, ,) (NP (NP (CD RPMI-8226)) (PRN (-LRB- -LRB-) (NP (NNP lane) (CD 2)) (-RRB- -RRB-))) (, ,) (NP (NP (NP (CD BV-173)) (PRN (-LRB- -LRB-) (NP (NNP lane) (CD 3)) (-RRB- -RRB-))) (, ,) (NP (NP (NP (NN U-937)) (PRN (-LRB- -LRB-) (NP (NNP lane) (CD 4)) (-RRB- -RRB-))) (, ,) (NP (NP (NN CML-T1)) (PRN (-LRB- -LRB-) (NP (NNP lane) (CD 5)) (-RRB- -RRB-))) (, ,) (NP (NP (NN LAMA-84)) (PRN (-LRB- -LRB-) (NP (NNP lane) (CD 6)) (-RRB- -RRB-))) (, ,) (NP (NP (NN Jurkat)) (PRN (-LRB- -LRB-) (NP (NNP lane) (CD 7)) (-RRB- -RRB-))) (, ,) (NP (NP (NN EM-2)) (PRN (-LRB- -LRB-) (NP (NNP lane) (CD 8)) (-RRB- -RRB-))) (CC and) (NP (NP (NN K-562)) (PRN (-LRB- -LRB-) (NP (NNP lane) (CD 9)) (-RRB- -RRB-)))))) (. .))))
( (S (S (NP (NN β-Actin)) (VP (VBZ is) (VP (VBN used) (PP (IN as) (NP (NN reference)))))) (. .)))
( (S (NP (NP (NN Figure) (CD 6)) (: :) (NP (NP (NN Expression)) (PP (IN of) (NP (NN ICSBP))) (PP (IN in) (NP (NP (JJ hematopoietic) (NNS cells)) (PP (IN after) (NP (NP (NN treatment)) (PP (IN with) (NP (NN AzadC)))))))) (. .))))
( (S (S (NP (JJ Representative) (NNS experiments)) (VP (VBP are) (VP (VBN shown)))) (. .)))
( (S (NP (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP (NN RT–PCR)) (PP (IN after) (NP (NP (NN treatment)) (PP (IN of) (NP (NP (NN CML-T1)) (CC and) (NP (NN EM-2)))) (PP (IN with) (NP (NP (CD 3) (JJ µM) (NN AzadC)) (PP (IN for) (NP (QP (CD 24) (, ,) (CD 48) (CC and) (CD 72)) (NN h)))))))) (: ;) (NP (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NN RT–PCR)) (PP (IN after) (NP (NP (NN treatment)) (PP (IN of) (NP (NP (NN LAMA-84)) (CC and) (NP (NN U-937)))) (PP (IN with) (NP (NP (CD 3) (JJ µM) (NN AzadC)) (PP (IN for) (NP (QP (CD 24) (, ,) (CD 48) (CC and) (CD 72)) (NN h)))))))) (. .))))
( (S (NP (NP (NN Table) (CD 1)) (: :) (NP (NP (NN Sequencing)) (PP (IN of) (NP (JJ bisulfite-treated) (NN DNA))) (PP (IN from) (NP (JJ hematopoietic) (NNS cells)))))))
( (S (NP (NP (NP (NN BRCA1) (NN function)) (PP (IN in) (NP (NN T) (NNS lymphocytes)))) (: :) (NP (NP (DT a) (JJ cellular) (NN specificity)) (PP (IN of) (NP (DT a) (JJ different) (NN kind)))))))
( (S (NP (NN Abstract))))
( (S (S (NP (NP (JJ Recent) (NN work)) (PP (IN by) (NP (NNP Mak) (FW et) (FW al)))) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (NP (NNS mice)) (VP (VBG carrying) (NP (NP (DT a) (JJ T-cell-specific) (NN disruption)) (PP (IN of) (NP (DT the) (NN brca1) (NN gene)))))) (VP (VBP display) (NP (NP (ADJP (RB markedly) (JJ impaired)) (NN T-lymphocyte) (NN development)) (CC and) (NP (NN proliferation))) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (DT any) (VBN increased) (NN tendency)) (PP (IN for) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (NNS tumors)))))))))))))) (. .)))
( (S (S (ADVP (RB Interestingly)) (, ,) (NP (NP (DT the) (NN extent)) (PP (IN of) (NP (DT these) (NNS defects)))) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB be) (ADJP (RB highly) (JJ dependent) (PP (IN on) (NP (JJ cellular) (NN context)))))))))) (. .)))
( (S (S (S (VP (VBG Contrasting) (NP (NP (DT the) (ADJP (RB rather) (JJ broad)) (NN tissue) (NN expression) (NN pattern)) (PP (IN of) (NP (NN brca1)))) (PP (IN against) (NP (NP (PRP$ its) (ADJP (RB exquisitely) (JJ selective)) (JJ etiologic) (NN role)) (PP (IN in) (NP (NP (NNS cancers)) (PP (IN of) (NP (DT the) (NP (NN breast)) (CC and) (NP (NN ovary)))))))))) (, ,) (NP (NP (JJ many)) (PP (IN of) (NP (PRP us)))) (VP (VBP are) (ADJP (JJ left) (PP (TO to) (NP (NP (NN ponder) (: -)) (SBAR (WHADVP (WRB where)) (S (VP (VBZ is) (NP (DT the) (NN specificity)))))))))) (. ?)))
( (S (NP (JJ Full) (NN text))))
( (S (S (NP (NP (NN Mutation)) (PP (IN in) (NP (DT the) (JJ human) (NN BRCA1) (NN gene)))) (VP (VBZ is) (VP (VBN thought) (S (VP (TO to) (VP (VB account) (PP (PP (IN for) (NP (NP (CD 45) (NN %)) (PP (IN of) (NP (JJ familial) (NNS cancers))))) (CC and) (PP (IN for) (NP (NP (QP (JJR more) (IN than) (CD 80)) (NN %)) (PP (IN of) (NP (VBN inherited) (JJ ovarian) (NNS cancers)))))))))))) (. .)))
( (S (NP (NP (NP (PRP$ Its) (NN identification)) (CC and) (NP (NP (NN mapping)) (PP (TO to) (NP (NN chromosome) (NN arm) (NN 17q))))) (, ,) (PP (IN in) (NP (CD 1990))) (, ,)) (VP (VBD was) (VP (VBN followed) (PP (IN by) (NP (NP (JJ intense) (NNS efforts)) (VP (TO to) (VP (VB isolate) (NP (DT the) (NN gene)))))))) (. .)))
( (S (S (NP (PRP It)) (ADVP (RB therefore)) (VP (VBD came) (PP (IN as) (NP (NP (NN something)) (PP (IN of) (NP (NP (DT a) (NN surprise)) (PP (IN in) (NP (CD 1994))))))) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NN gene)) (VP (VBD was) (VP (VP (VBN isolated)) (CC and) (VP (VBN found) (S (VP (TO to) (VP (VB encode) (NP (NP (DT a) (JJ 1863-amino-acid) (NN protein)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (VP (VBN expressed) (PP (IN in) (NP (NP (DT a) (JJ wide) (NN variety)) (PP (IN of) (NP (NP (NNS tissues)) (, ,) (PP (IN with) (NP (NP (JJS highest) (NN expression)) (PP (IN in) (NP (DT the) (NP (NN thymus)) (CC and) (NP (NNS testes))))))))))))))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN flurry)) (PP (IN of) (NP (NP (NNS publications)) (SBAR (WHNP (WDT that)) (S (VP (VBD followed) (NP (NP (DT the) (NN isolation)) (PP (IN of) (NP (DT the) (NN BRCA1) (NN gene)))))))))) (VP (VBZ has) (ADVP (RB slowly)) (VP (VBN begun) (S (VP (TO to) (VP (VBP put) (NP (DT these) (JJ initial) (NNS findings)) (PP (IN into) (NP (NN perspective))))))))) (. .)))
( (S (S (NP (NP (CD One)) (PP (IN of) (NP (NP (DT the) (RBS most) (JJ important)) (PP (IN of) (NP (DT these)))))) (VP (VBZ has) (VP (VBN been) (NP (DT the) (NN observation) (SBAR (IN that) (S (NP (NN BRCA1)) (VP (VBZ plays) (NP (DT a) (JJ major) (NN role)) (PP (IN in) (NP (NN DNA) (NN damage) (NN repair)))))))))) (. .)))
( (S (S (NP (NN DNA) (NN repair) (NNS proteins)) (VP (VBP play) (NP (DT a) (JJ central) (NN role)) (PP (IN in) (NP (NN T-cell) (NN lineage) (NN development))) (SBAR (IN because) (S (NP (PRP they)) (VP (VBP act) (S (VP (TO to) (VP (VB ligate) (NP (NP (NP (CC or) (NN repair) (NN DNA) (JJ double-stranded) (NNS breaks)) (PRN (-LRB- -LRB-) (NP (NNS DSBs)) (-RRB- -RRB-))) (SBAR (WHNP (WDT that)) (S (VP (VBP occur) (PP (IN during) (NP (NP (DT the) (NN initiation)) (PP (IN of) (NP (NP (NN V) (-LRB- -LRB-) (NN D) (-RRB- -RRB-) (NN J) (NN recombination)) (PP (IN of) (NP (DT the) (NP (NP (NN T-cell) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN TCR)) (-RRB- -RRB-))))))))))))))))))))) (. .)))
( (S (S (PP (IN For) (NP (DT this) (NN reason))) (, ,) (NP (NP (NNP Mak) (FW et) (FW al)) (CD -LSB-1) (-RRB- -RSB-)) (VP (VBD sought) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN BRCA1))) (PP (IN in) (NP (NP (NN T-cell) (NN maturation)) (CC and) (NP (NN function)))))))))) (. .)))
( (S (PP (IN By) (S (VP (VBG using) (NP (NP (DT the) (NN Cre/lox/P) (NN system)) (S (VP (TO to) (VP (VB generate) (NP (NNS mice)) (PP (IN with) (NP (NP (DT a) (JJ homozygous) (NN deletion)) (PP (IN of) (NP (NP (NN brca1) (NNS exons) (CD 5) (CC and) (CD 6)) (ADJP (JJ restricted) (PP (TO to) (NP (NP (DT the) (NN T-cell) (NN compartment)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNS mice)) (ADJP (JJ homozygous) (PP (IN for) (NP (NP (DT the) (`` ') (JJ floxed) ('' ') (NN brca1) (NNS exons)) (VP (VBD were) (VP (VBN crossed) (PP (IN with) (NP (JJ transgenic) (NNS mice))))))))) (VP (VBG expressing) (NP (DT the) (NN Cre) (NN recombinase)) (PP (IN under) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (DT the) (NN T-cell) (JJ specific) (NN lck) (NN promoter))))))) (-RRB- -RRB-)))))))))))))))) (, ,) (NP (DT those) (NNS investigators)) (VP (VBD were) (ADJP (JJ able) (S (VP (TO to) (VP (VB study) (NP (NN T-cell) (NN brca1) (NN function)) (SBAR (IN while) (S (ADVP (RB also)) (VP (VBG circumventing) (NP (NP (DT the) (JJ early) (JJ embryonic) (NN lethality)) (VP (VBN associated) (PP (IN with) (NP (DT the) (NN brca1) (NN mutation))))))))))))) (. .)))
( (S (S (PP (TO To) (NP (PRP$ their) (NN surprise))) (, ,) (NP (NNP Mak) (FW et) (FW al)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (NN T) (NNS cells)) (PP (IN from) (NP (NP (NNS mice)) (SBAR (WHNP (WDT that)) (S (VP (VBD lacked) (NP (NN brca1)))))))) (VP (VBD showed) (NP (DT no) (NN abnormality)) (PP (IN in) (NP (NP (NN rearrangement)) (PP (IN of) (NP (DT the) (NN TCR) (NNS loci)))))))))) (. .)))
( (S (SBAR (WHNP (WP What)) (S (NP (PRP they)) (VP (VBD observed) (ADVP (RB instead)) (VP (VBD was) (NP (NP (DT a) (ADJP (ADJP (JJ significant)) (PRN (-LRB- -LRB-) (NP (CD 90) (NN %)) (-RRB- -RRB-))) (NN depletion)) (PP (IN of) (NP (DT the) (NNS thymocytes)))) (, ,) (PP (IN with) (NP (NP (DT a) (JJ developmental) (NN defect)) (VP (VBG occurring) (PP (IN at) (NP (DT some) (NN point))) (PP (IN after) (NP (NP (DT the) (ADJP (RB very) (`` ') (JJ immature) ('' ')) (JJ double-negative) (NN stage)) (PP (IN of) (NP (NN T-lymphocyte) (NN maturation)))))))))))) (. .)))
( (S (S (NP (NP (DT The) (ADJP (RBS most) (JJ interesting)) (NN part)) (PP (IN of) (NP (DT this) (NN work)))) (VP (VBZ is) (SBAR (WHNP (WP what)) (S (NP (PRP they)) (VP (VBN found) (PP (IN on) (NP (NP (NN application)) (PP (IN of) (NP (DT the) (NN brca1) (NN mutant))) (PP (TO to) (NP (JJ different) (JJ genetic) (NNS backgrounds)))))))))) (. .)))
( (S (S (NP (NP (JJ Prior) (JJ transgenic) (NNS studies)) (PP (IN with) (NP (DT the) (NN brca1) (NN gene) (NN -LSB-2,3))) (-RRB- -RSB-)) (VP (VBD revealed) (SBAR (IN that) (S (NP (NP (NN loss)) (PP (IN of) (NP (NN brca1) (NN function)))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (DT the) (NP (NN expression)) (CC and) (NP (NN activity))) (PP (IN of) (NP (DT the) (NN p53) (NN tumor) (NN suppressor) (NN gene))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (VBN increased) (NNS levels)) (PP (IN of) (NP (NN p53)))) (VP (VBZ is) (VP (VBN thought) (S (VP (TO to) (VP (VB occur) (PP (IN in) (NN response) (TO to) (NP (NP (DT the) (JJ marked) (NN accumulation)) (PP (IN of) (NP (JJ chromosomal) (NNS abnormalities))) (PP (IN in) (NP (NP (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP carry) (NP (NP (DT the) (NN brca1) (NN mutation)) (, ,) (NP (NP (DT an) (NN observation)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT a) (NN role)) (PP (IN for) (NP (NN brca1))) (PP (IN in) (NP (NN DNA) (NN repair)))))))))))))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ high) (NNS levels)) (PP (IN of) (NP (NN p53)))) (VP (VP (VBP increase) (NP (NP (DT the) (NN transcription)) (PP (IN of) (NP (NP (NP (NNS genes)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN involved) (PP (IN in) (NP (NP (NN growth) (NN inhibition)) (CC and) (NP (NN apoptosis))))))))) (: -) (NP (VBG including) (NP (NP (NN p21)) (CC and) (NP (NN Bax)))) (: -))))) (CC and) (VP (VBZ is) (NP (NP (DT a) (JJ major) (NN contributor)) (PP (TO to) (NP (NP (DT the) (JJ early) (JJ embryonic) (NN lethality)) (VP (VBN associated) (PP (IN with) (NP (DT the) (NN brca1) (NN mutation)))))))))) (. .)))
( (S (S (NP (NP (NP (NNS Increases)) (PP (IN in) (NP (NP (NN p53)) (, ,) (NP (NN p21)) (CC and) (NP (NN Bax))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (VBN increased) (NN apoptosis)) (CC and) (NP (NP (NN sensitivity)) (PP (TO to) (NP (VBG ionizing) (NN radiation))))) (, ,)) (VP (VBD were) (VP (VBN demonstrated) (PP (IN in) (NP (NP (DT the) (NNS thymocytes)) (VP (VBG carrying) (NP (DT the) (VBN targeted) (NN brca1) (NN mutation)))))))) (. .)))
( (S (ADVP (RB Moreover)) (, ,) (NP (NP (NN application)) (PP (IN of) (NP (DT the) (NN brca1) (NN mutation))) (PP (IN in) (NP (DT a) (JJ p53-null) (JJ genetic) (NN background)))) (VP (VBD led) (PP (TO to) (NP (NP (JJ significant) (NN thymocyte) (NN rescue)) (PP (IN with) (NP (NP (NP (JJ full) (NN recovery)) (PP (IN of) (NP (NP (NNS cells)) (PP (IN in) (NP (DT the) (NN thymus)))))) (CC and) (NP (NP (ADJP (CD 70) (NN %)) (NN recovery)) (PP (IN of) (NP (NP (NNS cells)) (PP (IN in) (NP (DT the) (NN lymph) (NN node))))))))))) (. .)))
( (S (S (ADVP (RB Not) (RB surprisingly)) (, ,) (NP (DT these) (`` ') (VBN rescued) (`` ') (JJ double-mutant) (NNS cells)) (VP (VBD showed) (NP (NP (JJ multiple) (JJ cytogenetic) (NNS changes)) (, ,) (NP (NP (DT an) (NN observation)) (SBAR (WHNP (WDT that)) (S (VP (VBZ affirms) (NP (NP (DT the) (`` ') (JJ caretaker) ('' ') (NN role)) (PP (IN of) (NP (NN brca1))) (PP (IN as) (NP (NP (DT a) (NN guardian)) (PP (IN of) (NP (DT the) (NN genome))))))))))))) (. .)))
( (S (S (ADVP (RB Notably)) (, ,) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ genetic) (NN background)))) (VP (VBD were) (ADJP (JJ dependent) (PP (IN on) (NP (DT the) (NN T-cell) (NN context)))))) (. .)))
( (S (S (NP (NP (NN Expression)) (PP (IN of) (NP (DT the) (NN brca1) (NN mutant))) (PP (IN in) (NP (DT a) (JJ p21-null) (NN background)))) (VP (VP (VBD caused) (NP (NP (JJ little) (NN rescue)) (PP (IN of) (NP (DT the) (NNS cells)))) (PP (IN in) (NP (DT the) (NN thymus)))) (, ,) (CC but) (VP (VBD provided) (NP (DT a) (NN recovery)) (PP (IN in) (NP (NP (DT the) (NN lymph) (NNS nodes)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (ADJP (JJ equivalent) (PP (TO to) (NP (NP (DT that)) (VP (VBN produced) (PP (IN in) (NP (DT the) (JJ p53-null) (NN background))))))))))))))) (. .)))
( (S (S (NP (NP (NN Introduction)) (PP (IN of) (NP (DT the) (NN brca1) (NN gene))) (PP (IN in) (NP (NP (NNS cells)) (VP (VBG carrying) (NP (DT an) (JJ antiapoptotic) (NN Bcl2) (NN transgene)))))) (VP (VP (VBD induced) (NP (NP (JJ significant) (NN rescue)) (PP (IN of) (NP (NNS cells)))) (PP (IN in) (NP (DT the) (NN thymus)))) (, ,) (CC but) (VP (VBD produced) (NP (NP (JJ little) (NN recovery)) (PP (IN of) (NP (NNS cells)))) (PP (IN in) (NP (JJ peripheral) (-LRB- -LRB-) (NP (NN lymph) (NN node)) (-RRB- -RRB-) (NNS compartments)))))) (. .)))
( (S (S (NP (NP (DT A) (JJ possible) (NN explanation)) (PP (IN for) (NP (DT this) (NN observation)))) (VP (VBZ is) (SBAR (IN that) (S (NP (NP (NNS cells)) (PP (IN of) (NP (NP (DT the) (NN thymus)) (PRN (-LRB- -LRB-) (NP (DT a) (ADJP (RB mainly) (JJ nonprofilerating)) (NN compartment)) (-RRB- -RRB-))))) (VP (VBP are) (ADJP (ADVP (RB much) (RBR more)) (JJ sensitive) (PP (TO to) (NP (NN apoptosis)))) (, ,) (SBAR (IN whereas) (S (NP (NP (DT those)) (PP (IN in) (NP (NP (DT the) (JJ peripheral) (NN lymph) (NNS nodes)) (PRN (-LRB- -LRB-) (NP (DT a) (ADJP (RB rapidly) (VBG proliferating)) (NN compartment)) (-RRB- -RRB-))))) (VP (VBP are) (ADVP (RB much) (RBR more)) (VP (VBN influenced) (PP (IN by) (NP (NP (NNS components)) (SBAR (WHNP (WDT that)) (S (VP (VBP induce) (NP (NN cell) (NN cycle) (NN arrest)))))))))))))))) (. .)))
( (S (S (ADVP (RB Indeed)) (, ,) (NP (NP (DT the) (JJ relative) (NN sensitivity)) (PP (TO to) (NP (NP (NN apoptosis)) (CC versus) (NP (NN cell) (NN cycle) (NN arrest))))) (VP (VBZ varies) (PP (IN between) (NP (NP (JJ cellular) (NNS compartments)) (CC and/or) (NP (NN cell) (NNS types)))))) (. .)))
( (S (S (NP (JJ Such) (NNS differences)) (ADVP (RB probably)) (VP (VBP occur) (PP (IN through) (NP (NP (DT a) (NN hierarchy)) (PP (IN of) (NP (NP (ADJP (ADJP (JJ cell-specific)) (CC and) (ADJP (JJ pathway-specific))) (NNS programs)) (PP (IN of) (NP (JJ cellular) (NN behavior))))))))) (. .)))
( (S (SBARQ (WHADVP (RB So) (WRB how)) (SQ (MD might) (NP (NP (DT the) (NN lack)) (PP (IN of) (NP (DT a) (JJ single) (NN gene)))) (VP (VB effect) (NP (NP (NNS cells)) (PP (IN of) (NP (JJ different) (NNS origins)))) (ADVP (RB so) (RB divergently))))) (. ?)))
( (S (S (NP (DT The) (NN answer)) (VP (MD may) (VP (VBP lie) (PP (IN in) (NP (NP (CD two) (ADJP (RB biochemically) (JJ distinct)) (NNS consequences)) (PP (IN of) (NP (NP (DT the) (NN loss)) (PP (IN of) (NP (NN brca1) (NN function)))))))))) (. .)))
( (S (S (NP (DT The) (JJ first)) (VP (VBZ is) (NP (NP (DT the) (JJ resultant) (NN increase)) (PP (IN in) (NP (NP (NN chromosome) (NNS abnormalities)) (, ,) (ADVP (RB namely)) (NP (NN DNA) (NNS DSBs)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN observed) (PP (IN in) (NP (DT the) (NN brca1) (NNS mutants)))))))))))) (. .)))
( (S (S (NP (NP (DT A) (JJ key) (NN feature)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB differentiate) (NP (NP (NP (DT a) (NN cell) (POS 's)) (NN response)) (PP (TO to) (NP (NN brca1) (NN deficiency))))))))) (VP (VBZ is) (SBAR (WHADVP (WRB how)) (S (ADVP (RB robustly)) (NP (PRP it)) (VP (MD may) (VP (VB react) (PP (TO to) (NP (VBN increased) (NN DSB) (NNS levels))))))))) (. .)))
( (S (S (NP (NP (NN Tissue) (NNS types)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB actively)) (VP (VBN engaged) (PP (IN in) (NP (NP (NN DNA) (NN repair/recombination) (NNS activities)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NP (NN thymus)) (, ,) (NP (NN spleen)) (, ,) (CC and) (NP (NNS testes))))) (-RRB- -RRB-))))))))) (VP (MD may) (VP (VB have) (NP (DT a) (JJR greater) (NN surveillance)) (PP (IN for) (NP (NP (NN loss)) (PP (IN of) (NP (NP (NN integrity)) (PP (IN of) (NP (NP (DT the) (NN genome)) (SBAR (WHNP (WDT that)) (S (VP (VBZ results) (PP (IN from) (NP (NN brca1) (NN deficiency))))))))))))))) (. .)))
( (S (S (NP (JJ Affected) (NNS cells)) (VP (MD would) (VP (VB be) (ADVP (RBR more) (RB rapidly)) (VP (VBN removed) (PP (IN from) (NP (DT the) (NN population))) (PP (IN through) (NP (NP (DT the) (NN action)) (PP (IN of) (NP (NP (NP (`` ') (NN gatekeeper) ('' ')) (NNS genes)) (PP (JJ such) (IN as) (NP (NN p53))))))))))) (. .)))
( (S (S (NP (NP (NN Support)) (PP (IN for) (NP (DT this) (NN notion)))) (VP (VBZ comes) (PP (IN from) (SBAR (WHNP (WP what)) (S (NP (PRP we)) (VP (VBP have) (VP (VBN learned) (PP (IN from) (NP (NP (JJ model) (NNS systems)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (JJ other) (NN DNA) (NN repair) (NNS genes)) (VP (VBP have) (VP (VBN been) (VP (VBN deleted))))))))))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBZ includes) (NP (NP (DT the) (NN class)) (PP (IN of) (NP (NP (NP (JJ nonhomologous) (NN end-joining)) (NNS proteins)) (PRN (-LRB- -LRB-) (NP (NN NHEJs)) (-RRB- -RRB-)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (NP (NP (JJ important) (NNS components)) (PP (IN of) (NP (NN DNA) (NN repair) (CD -LSB-4) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (NP (DT These) (NNS proteins)) (VP (VBP include) (NP (NP (NN XRCC4)) (, ,) (NP (NN DNA-PK)) (, ,) (NP (DT the) (NN Ku) (NN 80/86) (NNS proteins)) (CC and) (NP (NN DNA) (NN ligase) (CD IV))))) (, ,) (CC and) (S (NP (PRP they)) (VP (VBP function) (PP (TO to) (NP (NP (NN repair) (JJ random) (NN DNA) (NNS breaks)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN produced) (PP (IN by) (NP (NP (NP (NP (JJ genotoxic) (NNS agents)) (PRN (-LRB- -LRB-) (NP (NP (NN eg)) (VP (VBG ionizing) (NP (NN radiation)))) (-RRB- -RRB-))) (CC and) (NP (JJ specific) (NNS breaks))) (SBAR (WHNP (WDT that)) (S (VP (VBP occur) (PP (IN during) (NP (NP (VBN programmed) (NN gene) (NN rearrangement)) (PRN (-LRB- -LRB-) (NP (NP (JJ eg) (NN V-LSB-D) (-RRB- -RSB-) (NN J)) (VP (VBG joining) (PP (IN of) (NP (DT the) (NN TCR))))) (-RRB- -RRB-))))))))))))))))) (. .)))
( (S (S (NP (NP (NN Loss)) (PP (IN of) (NP (NP (NN function)) (PP (IN of) (NP (DT these) (NNS genes)))))) (VP (VBZ leads) (PP (TO to) (NP (VBN decreased) (CC and/or) (NP (NN error-prone) (NN DSB) (NN repair)))))) (. .)))
( (S (S (PP (IN In) (NP (JJ many) (NNS cases))) (NP (DT the) (NN NHEJ) (NN deficiency)) (VP (VBD led) (PP (TO to) (NP (NP (VBN increased) (NN apoptosis)) (PP (PP (IN in) (NP (DT the) (VBN selected) (NNS tissues))) (, ,) (CC and) (PP (IN in) (NP (ADJP (JJ several) (S (NP (NP (DT the) (NN application)) (PP (IN of) (NP (DT the) (NN deficiency))) (PP (TO to) (NP (DT a) (JJ p53-null) (NN background)))) (VP (VBD increased) (NP (NP (NN survival)) (CC and) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (JJ lymphoid) (NNS tumors)))) (NP (NN -LSB-5,6)))) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (S (VP (VBG Using) (NP (DT a) (JJ similar) (NN approach)))) (, ,) (NP (NP (DT a) (JJ conditional) (NN mutation)) (PP (IN of) (NP (NN brca1))) (PP (IN in) (NP (JJ mammary) (NN epithelia)))) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB lead) (PP (TO to) (NP (JJ rapid) (NN tumor) (NN formation))))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN introduced) (PP (IN into) (NP (DT a) (JJ p53-null) (NN background) (NN -LSB-7))))))) (-RRB- -RSB-)) (. .)))
( (S (S (ADVP (RB Interestingly)) (, ,) (S (NP (NP (JJ mammary) (NN tumor) (NN formation)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN p53)))))) (VP (VBD occurred) (PP (IN after) (NP (DT a) (JJ long) (NN latency))))) (, ,) (CC and) (S (NP (NP (JJ many)) (PP (IN of) (NP (DT the) (NNS tumors)))) (VP (VBD were) (VP (VBN associated) (PP (IN with) (NP (NP (JJ genetic) (NN instability)) (CC and) (NP (NP (NN alteration)) (PP (IN of) (NP (NN p53) (NN transcription)))))))))) (. .)))
( (S (S (PP (IN In) (NP (DT this) (NN example))) (, ,) (NP (NP (DT the) (NN loss)) (PP (IN of) (NP (NN p53) (NN function)))) (VP (MD may) (VP (VBP have) (VP (VBN been) (NP (NP (DT a) (JJ direct) (NN consequence)) (PP (IN of) (NP (JJ genetic) (NN instability)))))))) (. .)))
( (S (S (PP (IN In) (NP (DT this) (NN regard))) (, ,) (NP (PRP it)) (VP (MD would) (VP (VB be) (ADJP (JJ interesting) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (JJ NHEJ-deficient) (NNS mice)) (SBAR (WHNP (WDT that)) (S (VP (VBP survive) (NP (PRP$ their) (JJ lymphoid) (NNS tumors)))))) (VP (VB go) (PP (IN on) (S (VP (TO to) (VP (VB develop) (NP (NP (NNS tumors)) (PP (IN of) (NP (DT any) (JJ other) (NN organ)))))))))))))))))) (. .)))
( (S (S (NP (RB So)) (VP (VBZ is) (NP (PRP it)) (PP (ADVP (RB just)) (IN that) (NP (JJ simple))))) (. ?)))
( (S (SQ (MD Could) (NP (NP (DT the) (NN tissue) (NN specificity)) (PP (IN of) (NP (JJ BRCA1-linked) (NNS tumors)))) (VP (VB reflect) (NP (NP (DT a) (JJ careful) (NN balance)) (PP (IN between) (NP (NP (NP (DT the) (`` ') (NN caretakers) ('' ') (CC and) (NP (`` ') (NP (NNS gatekeepers)) ('' '))) (PP (IN of) (NP (DT the) (NN cell)))) (CC and) (NP (NP (DT the) (VBN programmed) (NNS requirements)) (PP (IN of) (NP (DT the) (NN cell))) (PP (IN for) (NP (NP (NN DNA) (NN damage)) (NN surveillance)))))))) (. ?))))
( (S (SQ (MD Could) (NP (NP (DT the) (NN organ) (NN susceptibility)) (PP (IN of) (NP (DT the) (NN BRCA1) (NN mutation)))) (VP (ADVP (RB simply)) (VB reflect) (NP (DT the) (NN fact) (SBAR (IN that) (S (NP (DT the) (JJ mammary) (NN gland) (NNS gatekeepers)) (VP (VBP have) (NP (NP (DT a) (JJR greater) (NN tendency)) (S (VP (TO to) (VP (`` ') (VB be) (NP (NN asleep)) (PP (IN at) (NP (DT the) (NN wheel) (POS '))) (PP (IN in) (NP (NP (DT the) (NN face)) (PP (IN of) (NP (NN BRCA1) (NN deficiency)))))))))))))) (. ?))))
( (S (S (ADVP (RB Indeed)) (, ,) (NP (NP (NNS aspects)) (PP (IN of) (NP (DT these) (NNS concepts)))) (VP (VBP are) (ADJP (JJ important) (PP (IN in) (NP (NN T-cell) (NN development)))) (SBAR (IN because) (S (NP (JJ immature) (NNS T-cells)) (VP (VBP are) (ADJP (ADVP (RB much) (RBR more)) (JJ resistant) (PP (TO to) (NP (NP (JJ p53-independent) (NN cell) (NN death) (NNS pathways)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN induced) (PP (IN by) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NNS DSBs) (CD -LSB-8) (-RRB- -RSB-))))))))))))))))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (NP (NP (NN surveillance)) (PP (IN of) (NP (NN gatekeeper) (NNS pathways)))) (VP (MD can) (VP (VB be) (VP (VBN influenced) (PP (IN by) (NP (CC both) (NP (NN tissue) (NN type)) (CC and) (NP (NN ontogeny)))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ key)) (PP (TO to) (NP (DT this) (NN solution)))) (VP (MD will) (ADVP (RB ultimately)) (VP (VBN come) (PP (IN from) (S (VP (VBG developing) (NP (NP (DT a) (JJR better) (NN understanding)) (PP (IN of) (NP (NP (DT the) (JJ second) (JJ major) (JJ biochemical) (NN consequence)) (PP (IN of) (NP (NN BRCA1) (NN deficiency)))))))))))) (: :) (NP (NP (DT the) (NN loss)) (PP (IN of) (NP (NP (JJ functional) (NNS complexes)) (PP (IN between) (NP (NP (ADJP (ADJP (JJ BRCA1-)) (CC and) (ADJP (JJ BRCA1-interacting))) (NNS proteins)) (PRN (-LRB- -LRB-) (NP (NNS BIPs)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NN BRCA1)) (VP (VBZ contains) (NP (NP (JJ several) (JJ functional) (NNS domains)) (SBAR (WHNP (WDT that)) (S (VP (VBP interact) (PP (IN with) (NP (NP (DT a) (NN cavalcade)) (PP (IN of) (NP (NP (NNS proteins)) (, ,) (PP (VBG including) (NP (NP (NN ATM)) (, ,) (NP (NN p53)) (, ,) (NP (NN RB)) (, ,) (NP (NN c-Myc)) (, ,) (NP (NN BRCA2)) (, ,) (NP (NN DNA) (NN repair) (NNS factors)) (, ,) (NP (NN E2F)) (, ,) (CC and) (NP (NNS others)))))))))))))) (. .)))
( (S (S (NP (NP (JJ Many)) (PP (IN of) (NP (DT the) (NNS BIPs)))) (VP (VBP are) (NP (NP (NP (NNS proto-oncogenes)) (CC or) (NP (NN tumor) (NNS suppressors))) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB regulate) (NP (NN transcription)) (PP (IN through) (NP (ADJP (CC both) (ADJP (JJ direct)) (CC and) (ADJP (JJ indirect))) (NNS mechanisms)))))))))) (. .)))
( (S (S (SBAR (WHNP (WP What)) (S (VP (VBZ has) (VP (VBN become) (ADJP (JJ clear) (PP (IN from) (NP (NP (DT the) (VBG growing) (NN list)) (PP (IN of) (NP (NNS BIPs)))))))))) (VP (VBZ is) (SBAR (IN that) (S (NP (NN BRCA1)) (VP (VBZ is) (ADVP (RB probably)) (VP (VBN involved) (PP (IN in) (NP (NP (JJ multiple) (JJ biologic) (NNS programs)) (PP (IN of) (NP (JJ cellular) (NN behavior))) (, ,) (PP (VBG including) (NP (NP (NN transcription)) (, ,) (NP (JJ cell-cycle) (NN regulation)) (, ,) (NP (NN DNA) (NN damage) (NN repair)) (, ,) (NP (NN centrosome) (NN duplication)) (, ,) (CC and) (NP (NN cell) (NN growth)) (CC and) (NP (NN apoptosis)))))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NP (DT none)) (PP (IN of) (NP (NP (DT the) (NNS BIPs)) (VP (VBN identified) (ADVP (RB thus) (RB far)))))) (VP (VBP show) (NP (NP (DT a) (NN tissue) (JJ restricted) (NN pattern)) (PP (IN of) (NP (NN expression))) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB explain) (NP (NP (DT the) (NN tissue) (NN tropism)) (PP (IN of) (NP (JJ brca1-related) (NNS cancers))))))))))) (. .)))
( (S (S (ADVP (RB Still)) (NP (DT the) (NN concept) (SBAR (IN that) (S (NP (NP (DT the) (JJ cellular) (NN outcome)) (PP (IN of) (NP (NN BRCA1) (NN expression)))) (VP (MD can) (VP (VB be) (VP (VBN dictated) (PP (IN by) (NP (JJ specific) (NN BIP) (NN expression))))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN verified) (PP (IN by) (NP (DT the) (NN finding) (SBAR (IN that) (S (NP (NP (NP (DT a) (NN cell) (POS 's)) (NN susceptibility)) (PP (TO to) (NP (JJ brca1-induced) (NN cell) (NN cycle) (NN arrest)))) (VP (VBZ is) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN RB) (CD -LSB-9)))))))))))))) (-RRB- -RSB-)) (. .)))
( (S (NP (JJ Future) (NN emphasis)) (VP (MD will) (VP (VB have) (S (VP (TO to) (VP (VB be) (VP (VBN placed) (PP (IN on) (S (VP (VBG identifying) (NP (NP (NP (DT those) (JJ cellular) (NNS genes)) (CC and) (NP (NN gene) (NNS products))) (SBAR (WHNP (WDT that)) (S (VP (VBP become) (UCP (NP (JJ altered) (NN -via) (ADJP (ADJP (JJ transcriptional)) (, ,) (ADJP (JJ post-transcriptional)) (CC or) (ADJP (JJ post-translational))) (NNS mechanisms)) (CC -) (SBAR (WHADVP (WRB when)) (S (NP (EX there)) (VP (VBZ is) (NP (NP (DT a) (NN disruption)) (PP (IN in) (NP (NN brca1) (NN expression))))))))))))))))))))) (. .)))
( (S (S (NP (JJ Combined) (ADJP (ADJP (JJ genomic)) (CC and) (ADJP (JJ proteomic))) (NNS approaches)) (VP (MD will) (VP (VB be) (VP (VBN needed) (S (VP (TO to) (VP (VB unravel) (NP (NP (DT the) (NNS mysteries)) (PP (IN of) (NP (NN BRCA1))) (PP (PP (IN as) (NP (NP (CC both) (DT a) (NN caretaker)) (PP (IN of) (NP (DT the) (NN genome))))) (CC and) (PP (IN as) (NP (NP (DT an) (JJ essential) (NN component)) (PP (IN of) (NP (NP (JJ cellular) (NN homeostasis)) (CC and) (NP (NN development))))))))))))))) (. .)))
( (S (NP (NP (NN Figure)) (CC and) (NP (NN Table)) (NP (NNS captions)))))
( (S (NP (NP (JJ Tumour-stromal) (NNS interactions)) (: :) (NP (NP (NN Role)) (PP (IN of) (NP (DT the) (NN stroma))) (PP (IN in) (NP (JJ mammary) (NN development)))))))
( (S (NP (NN Abstract))))
( (S (NP (JJ Mammary) (NN development)) (VP (VBZ depends) (PP (IN on) (S (VP (VBG branching) (NP (NP (NN morphogenesis)) (, ,) (ADVP (RB namely)) (NP (NP (DT the) (NP (NN bifurcation)) (CC and) (NP (NN extension))) (PP (IN of) (NP (NP (NP (JJ ductal) (NN growth) (NNS points)) (PRN (-LRB- -LRB-) (NP (NN end) (NNS buds)) (-RRB- -RRB-))) (CC and) (NP (JJ secretory) (NNS lobules)))) (PP (IN into) (NP (DT a) (ADJP (ADJP (JJR more)) (CC or) (ADJP (JJR less))) (JJ fatty) (NN stroma))))))))) (. .)))
( (S (S (S (SBAR (IN Because) (S (NP (NN breast) (NNS carcinomas)) (VP (VBP are) (ADJP (RB overwhelmingly) (JJ ductal) (PP (IN in) (NP (NN origin))))))) (, ,) (NP (DT this) (NN review)) (VP (VBZ focuses) (PP (IN on) (NP (NP (JJ stromal) (NNS influences)) (PP (VBG guiding) (NP (JJ postnatal) (JJ ductal) (NN development))))))) (CC and) (S (NP (EX there)) (VP (VBZ is) (NP (NP (RB only) (DT the) (JJ briefest) (NN account)) (PP (IN of) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (JJ embryonic) (NN stroma) (-LRB- -LRB-) (NN mesenchyme) (-RRB- -RRB-))))))))) (. .)))
( (S (S (S (NP (NP (DT The) (NN stroma)) (PP (IN as) (NP (NP (NP (DT the) (JJ necessary) (NN target)) (PP (IN for) (NP (JJ endocrine) (NNS mammogens)))) (CC and) (NP (NP (DT the) (NN source)) (PP (IN of) (NP (JJ stimulatory) (NN growth) (NNS factors))))))) (VP (VBZ is) (VP (VBN described)))) (CC and) (S (NP (NP (DT the) (NN importance)) (PP (IN of) (NP (NP (JJ mammary) (JJ epithelium-induced) (NNS modifications)) (PP (IN of) (NP (DT the) (JJ periductal) (NN stroma)))))) (VP (VBZ is) (VP (VBN emphasized))))) (. .)))
( (S (S (NP (NN Evidence)) (VP (VBZ is) (VP (VBN presented) (SBAR (IN that) (S (SBAR (IN if) (S (NP (PRP they)) (VP (VBP are) (VP (TO to) (VP (VB grow)))))) (, ,) (NP (NN end) (NNS buds)) (VP (MD must) (VP (NN condition) (NP (JJ proximal) (NN fatty) (NN stroma)) (PP (IN by) (S (VP (VP (VBG recruiting) (NP (JJ white) (NN blood) (NNS cells))) (CONJP (RB as) (RB well) (IN as)) (VP (VBG inducing) (NP (NP (JJ stromal) (NN cell) (NN division)) (CC and) (, ,) (ADVP (RB possibly)) (, ,) (NP (NN estrogen) (NNS receptors)))))))))))))) (. .)))
( (S (S (S (NP (NP (DT The) (NN induction)) (PP (IN of) (NP (NP (DT a) (JJ fibrous) (JJ stromal) (NN tunic)) (PP (IN around) (NP (DT the) (NN end) (NN bud)))))) (VP (VBZ is) (VP (VBN described)))) (CC and) (S (NP (NP (PRP$ its) (JJ likely) (NN role)) (PP (IN as) (NP (DT a) (JJ complex) (JJ ductal) (NN morphogen)))) (VP (VBZ is) (VP (VBN discussed))))) (: ;) (S (NP (NP (DT a) (JJ possible) (NN role)) (PP (IN in) (NP (NN growth) (NN inhibition)))) (VP (VBZ is) (ADVP (RB also)) (VP (VBN considered)))) (. .)))
( (S (S (SBAR (IN Although) (S (NP (NP (DT the) (NNS signals)) (VP (VBG governing) (NP (NP (JJ fibrotic) (NN induction)) (, ,) (NP (JJ ductal) (NN morphogenesis)) (, ,) (CC and) (NP (NN growth) (NN inhibition))))) (VP (VBP are) (ADJP (JJ unknown))))) (, ,) (NP (NP (DT a) (NN role)) (PP (IN for) (NP (VBG transforming) (NN growth) (NN factor-β)))) (VP (VP (VBZ is) (ADVP (RB highly)) (ADJP (JJ likely))) (CC and) (VP (VBZ is) (VP (VBN discussed))))) (. .)))
( (S (S (ADVP (RB Finally)) (, ,) (NP (NP (DT a) (NN need)) (PP (IN for) (NP (JJ new) (ADJP (ADJP (JJ conceptual)) (CC and) (ADJP (JJ experimental))) (NNS approaches))) (PP (TO to) (S (VP (VBG understanding) (NP (JJ stromal-epithelial) (NN signaling)))))) (VP (VBZ is) (VP (VBN discussed)))) (. .)))
( (S (NP (NN Introduction))))
( (S (S (NP (JJ Mammary) (NN gland) (NN development)) (VP (VBZ occurs) (PP (IN in) (NP (CD two) (ADJP (RB morphogenetically) (JJ distinct)) (NNS phases))))) (. .)))
( (S (S (NP (DT The) (JJ first)) (VP (VBZ begins) (PP (IN with) (NP (NP (DT the) (NN differentiation)) (PP (IN of) (NP (NP (NP (DT a) (JJ mammary) (JJ ductal) (NN rudiment)) (PP (IN from) (NP (DT the) (JJ embryonic) (NN epidermis)))) (CC and) (NP (NNS ends)))))) (PP (IN after) (NP (NN puberty))) (PP (IN with) (NP (NP (DT an) (JJ elegant) (JJ arborated) (NN system)) (PP (IN of) (NP (NNS ducts))))) (PRN (-LRB- -LRB-) (NP (NP (NNP Fig.)) (NP (NN 1a))) (-RRB- -RRB-)))) (. .)))
( (S (S (PP (IN In) (NP (DT the) (JJ second) (NN phase))) (, ,) (S (VP (VBG beginning) (PP (IN with) (NP (NN pregnancy))))) (, ,) (NP (JJ acinar) (JJ milk-secretory) (NNS lobules)) (VP (VBP develop) (PP (IN on) (NP (DT this) (JJ primary) (NN framework))))) (. .)))
( (S (NP (DT This) (NN review)) (VP (VBZ focuses) (PP (IN on) (NP (JJ organotypic) (NN branching) (NN morphogenesis))) (SBAR (IN as) (S (NP (PRP it)) (VP (VBZ occurs) (PP (IN during) (NP (DT the) (JJ ductal))) (, ,) (SBAR (IN as) (S (VP (VBN opposed) (PP (TO to) (NP (NP (DT the) (JJ lobular)) (, ,) (NP (NN phase)))))))))) (, ,) (SBAR (IN because) (S (NP (PRP it)) (VP (VBZ is) (PP (IN during) (NP (JJ ductal) (NN development))) (SBAR (IN that) (S (NP (JJ stromal) (NNS influences)) (VP (VBP are) (ADJP (RB demonstrably) (DT the) (RBS most) (JJ crucial) (PP (TO to) (NP (NN organogenesis))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (S (NP (NP (QP (JJR more) (IN than) (CD 90)) (NN %)) (PP (IN of) (NP (JJ human) (JJ mammary) (NNS carcinomas)))) (VP (VBP are) (ADJP (JJ ductal) (PP (IN in) (NP (NN origin)))))) (CC and) (S (NP (PRP it)) (VP (VBZ is) (VP (VBG becoming) (ADJP (RB increasingly) (JJ clear)) (SBAR (IN that) (S (NP (NP (DT the) (NN subversion)) (PP (IN of) (NP (JJ reciprocal) (NNS signals))) (PP (IN between) (NP (NP (NN parenchyma)) (CC and) (NP (NN stroma))))) (VP (VBP are) (NP (NP (DT an) (JJ important) (NN aspect)) (PP (IN of) (NP (NN tumor) (NN progression))))))))))) (. .)))
( (S (ADVP (RB Finally)) (, ,) (SBAR (IN although) (S (NP (NN reference)) (VP (MD will) (VP (VB be) (VP (VBN made) (PP (TO to) (NP (NP (DT the) (NN influence)) (PP (IN of) (NP (NP (DT the) (JJ embryonic) (NN stroma)) (, ,) (VP (VBN called) (S (NP (DT the) (NN mesenchyme)))) (, ,))) (PP (IN on) (NP (JJ mammary) (NN development)))))))))) (, ,) (NP (DT the) (NN emphasis)) (VP (MD will) (VP (VB be) (PP (IN on) (NP (JJ postnatal) (NNS events))) (SBAR (IN because) (S (NP (DT these)) (ADVP (RB arguably)) (VP (VBP have) (NP (DT a) (ADJP (RBR more) (JJ direct)) (NN bearing)) (PP (IN on) (NP (NN breast) (NN cancer)))))))) (. .)))
( (S (NP (NP (JJ Mammary) (NNS ducts)) (VP (VB grow) (PP (IN through) (NP (DT a) (JJ complex) (NN stroma)))))))
( (S (S (PP (IN By) (NP (NN parturition))) (, ,) (NP (DT the) (JJ mammary) (NN stroma)) (VP (VBZ comprises) (NP (JJ multiple) (ADJP (ADJP (JJ cellular)) (CC and) (ADJP (JJ acellular))) (NNS elements)))) (. .)))
( (S (S (PP (IN In) (NP (NP (DT the) (NN mouse)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (NP (DT the) (ADJP (ADVP (RBS most) (RB thoroughly)) (VBN studied)) (NN model)) (CC and) (NP (NP (DT the) (NN focus)) (PP (IN of) (NP (DT this) (NN review)))))))))) (, ,) (NP (NNS adipocytes)) (VP (VBP are) (NP (NP (DT the) (ADJP (RBS most) (JJ abundant)) (NN cell) (NN type)) (, ,) (VP (VBN followed) (PP (IN by) (NP (NP (NNS fibroblasts)) (, ,) (NP (JJ various) (JJ migratory) (NN blood) (NNS cells)) (, ,) (NP (NP (JJ endothelial) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN blood) (NNS vessels)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NN nerve) (NNS cells)))))))) (. .)))
( (S (S (NP (JJ Acellular) (NNS elements)) (VP (VBP include) (NP (NP (NP (ADJP (ADJP (JJ fibrous)) (CC and) (ADJP (JJ non-fibrous))) (NNS collagens)) (, ,) (NP (NNS proteoglycans)) (, ,) (CC and) (NP (NNS glycoproteins))) (, ,) (SBAR (WHNP (NP (DT all)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBP provide) (NP (JJ mechanical) (NN support)) (PP (TO to) (NP (DT the) (NN tissue))) (PP (RB as) (RB well) (IN as) (S (VP (VBG forming) (NP (DT a) (ADJP (ADJP (JJ dynamic)) (, ,) (ADJP (RB developmentally) (JJ active))) (JJ extracellular) (NN matrix/basal) (NN lamina) (NN complex)) (PP (IN at) (NP (NP (DT the) (JJ epithelial-stromal) (NN boundary)) (PRN (-LRB- -LRB-) (NP (NP (NNP Fig.)) (NN 1b) (-RRB- -RRB-) (NN -LSB-1)) (-RRB- -RSB-))))))))))))) (. .)))
( (S (S (S (NP (DT This) (JJ complex) (JJ connective) (NN tissue)) (VP (VBZ is) (VP (VBN found) (PP (IN in) (NP (NP (DT the) (JJ mammary) (NNS glands)) (PP (IN of) (NP (NP (JJ different) (NNS species)) (PP (IN with) (NP (NP (JJ various) (NNS ratios)) (PP (IN of) (NP (ADJP (JJ fibrous) (PP (TO to) (NP (JJ fatty) (NNS elements)))) (NN -LSB-2) (-RRB- -RSB-)))))))))))) (, ,) (CC and) (S (NP (PRP it)) (VP (VBZ is) (PP (IN within) (NP (DT this) (NN matrix))) (SBAR (IN that) (S (NP (JJ mammary) (NNS ducts)) (VP (VP (VBP elongate)) (, ,) (VP (VBP arborate)) (, ,) (CC and) (, ,) (ADVP (RB finally)) (, ,) (VP (VB terminate) (NP (NP (NN growth)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 1a)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ mammary) (NN gland)) (VP (VBN pictured) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 1)) (-RRB- -RRB-)))) (VP (VBZ is) (NP (NP (DT a) (NN snapshot)) (PP (IN of) (NP (NP (DT the) (NN situation)) (PP (IN in) (NP (NN adolescence)))))) (, ,) (ADJP (RB roughly) (JJ midway) (PP (IN in) (NP (NP (DT the) (JJ ductal) (NN phase)) (PP (IN of) (NP (NN organogenesis)))))))) (. .)))
( (S (S (NP (NP (NN End) (NNS buds)) (, ,) (NP (DT the) (ADJP (RB highly) (JJ mitotic)) (NP (NP (JJ ductal) (NN growth) (NNS points)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 2a)) (-RRB- -RRB-)))) (, ,)) (VP (VBP are) (PP (IN in) (NP (NP (DT the) (NN process)) (PP (IN of) (NP (NN elongating))))) (PP (IN by) (S (VP (VBG penetrating) (NP (DT the) (JJ fatty) (NN stroma))))))) (: ;) (S (NP (DT some)) (VP (MD can) (VP (VB be) (VP (VBN seen) (ADVP (JJ bifurcating)))))) (. .)))
( (S (S (NP (NP (NNS Others)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBG approaching) (NP (NP (DT the) (NN edge)) (PP (IN of) (NP (NP (DT the) (JJ fat) (NN pad)) (PRN (-LRB- -LRB-) (PP (IN at) (NP (NP (DT the) (JJ right)) (PP (IN of) (NP (DT the) (NN image))))) (-RRB- -RRB-)))))))))) (VP (VP (VBP are) (PP (IN in) (NP (NP (JJ various) (NNS stages)) (PP (IN of) (NP (NP (VBG terminating)) (-LRB- -LRB-) (VP (VBG getting) (ADVP (JJR smaller))) (-RRB- -RRB-)))))) (CC or) (VP (VBP have) (VP (VBN ceased) (S (VP (TO to) (VP (VB grow) (ADVP (RB altogether))))) (PRN (-LRB- -LRB-) (NP (JJ blunt-tipped) (NNS structures)) (-RRB- -RRB-)))))) (. .)))
( (S (S (PP (IN During) (NP (NP (DT this) (NN period)) (PP (IN of) (NP (JJ maximum) (JJ ductal) (NN elongation))))) (, ,) (NP (NP (QP (JJR more) (IN than) (CD 95)) (NN %)) (PP (IN of) (NP (DT the) (NN gland)))) (VP (VBZ is) (NP (NN growth-quiescent)) (, ,) (S (VP (VBG maintaining) (NP (NP (DT the) (JJ open) (NNS spaces)) (PP (IN between) (NP (NP (NNS ducts)) (PRN (-LRB- -LRB-) (NP (NP (NNP Fig.)) (NP (NN 1a))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (NP (DT A) (ADJP (ADJP (JJ prominent)) (, ,) (ADJP (JJ epithelium-induced))) (NN modification)) (PP (IN of) (NP (DT the) (JJ periductal) (NN stroma)))) (VP (VBZ is) (ADVP (RB also)) (VP (VBN noteworthy)))) (. .)))
( (S (S (NP (NP (NN Type) (CD I)) (JJ collagen-rich) (JJ fibrous) (JJ connective) (NN tissue)) (VP (VBZ begins) (PP (TO to) (JJ ensheath) (NP (DT the) (NN end) (NN bud))) (PP (IN on) (NP (PRP$ its) (NN flank))) (, ,) (ADVP (RB roughly)) (PP (IN at) (NP (NP (DT the) (NN point)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (PRP it)) (VP (VBZ begins) (S (VP (TO to) (VP (VB constrict) (PP (TO to) (NP (NP (JJ ductal) (NNS dimensions)) (PRN (-LRB- -LRB-) (NP (NP (NN Figs) (NN 1b)) (CC and) (NP (NN 2a))) (-RRB- -RRB-)))))))))))))) (. .)))
( (S (S (NP (NP (DT This) (NN sheath)) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB also)) (VP (VBZ comprises) (NP (DT the) (JJ basal-lamina/extracellular) (NN matrix) (NN complex))))) (, ,)) (VP (VP (VBZ is) (VP (VBN retained))) (CC and) (VP (VBZ forms) (NP (NP (DT a) (JJ fibrous) (NN sleeve)) (PP (IN around) (NP (DT the) (VBG subtending) (NN duct))))))) (. .)))
( (S (S (PP (IN At) (NP (NP (DT this) (NN point)) (PP (IN in) (NP (PRP$ its) (NN development))))) (, ,) (S (ADVP (RB then)) (, ,) (NP (NP (DT the) (JJ signature) (NNS features)) (PP (IN of) (NP (DT the) (NN gland)))) (VP (VBP are) (NP (DT the) (NN following))) (: :) (LST (-LRB- -LRB-) (LS 1) (-RRB- -RRB-)) (S (NP (ADJP (ADJP (JJ ductal) (PP (IN as) (S (S (VP (VBN opposed) (PP (TO to) (NP (JJ lobular) (NN morphology))) (: ;) (NP (NP (LST (-LRB- -LRB-) (LS 2) (-RRB- -RRB-)) (JJ large) (, ,) (JJ open) (NNS spaces)) (PP (IN between) (NP (NNS ducts)))))) (: ;) (LST (-LRB- -LRB-) (LS 3) (-RRB- -RRB-))))) (ADJP (RBS most) (JJ active))) (NN growth)) (VP (VBD focused) (PP (IN in) (NP (NN end) (NNS buds))))) (: ;) (LST (-LRB- -LRB-) (LS 4) (-RRB- -RRB-))) (VP (VBD regressed) (NP (NN end) (NNS buds)) (PP (IN at) (NP (NP (DT the) (NN edge)) (PP (IN of) (NP (DT the) (JJ fat) (NN pad))))))) (. .)))
( (S (S (NP (NP (DT A) (NN role)) (PP (IN for) (NP (DT the) (NN stroma))) (PP (IN in) (S (VP (VBG defining) (NP (NP (DT each)) (PP (IN of) (NP (DT these) (JJ glandular) (NNS features)))))))) (VP (VBZ is) (VP (VBN supported) (PP (IN by) (NP (NP (JJ experimental) (NN evidence)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN discussed) (ADVP (IN below))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NP (JJ seminal) (NNS experiments)) (PP (IN by) (NP (NP (NNP Kratochwil)) (CC and) (NP (NNP Sakakura)))))) (, ,) (NP (JJ mammary) (NN parenchyma)) (VP (VBD was) (VP (VBN shown) (S (VP (TO to) (VP (VB possess) (NP (NP (DT a) (JJ developmental) (NN plasticity)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VP (VBN constrained)) (CC and) (VP (VBN directed) (PP (IN by) (NP (DT the) (NN stroma) (NN -LSB-3)))))))))))))) (-RRB- -RSB-)) (. .)))
( (S (S (SBAR (WHADVP (WRB When)) (S (NP (NN Kratochwil)) (VP (VBD cultured) (NP (NP (DT a) (NN composite)) (PP (IN of) (NP (NP (JJ embryonic) (JJ mammary) (NN epithelium)) (CC and) (NP (JJ embryonic) (JJ sub-mandibular) (-LRB- -LRB-) (JJ salivary) (-RRB- -RRB-) (NN mesenchyme)))))))) (, ,) (NP (DT the) (JJ mammary) (NN tissue)) (VP (VBD developed) (NP (JJ salivary) (JJ gland-like) (NNS lobules)))) (. .)))
( (S (S (S (VP (VBG Extending) (NP (DT these) (NNS experiments)) (ADVP (FW in) (FW vivo)))) (, ,) (NP (NNP Sakakura)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (ADJP (CONJP (RB not) (RB only)) (ADJP (JJ embryonic)) (CONJP (CC but) (RB also)) (ADJP (JJ adult))) (JJ mammary) (NN tissue)) (VP (MD could) (VP (VB respond) (PP (IN in) (NP (DT this) (NN way))) (PP (TO to) (NP (JJ salivary) (JJ mesenchymal) (NNS signals))))))))) (. .)))
( (S (S (ADVP (RB Importantly)) (, ,) (NP (NP (DT the) (JJ instructive) (NNS properties)) (PP (IN of) (NP (DT the) (NN stroma)))) (VP (VBD did) (RB not) (VP (VB extend) (PP (TO to) (NP (NN cytodifferentiation)))))) (: :) (S (PP (IN in) (NP (DT a) (JJ pregnant) (NN host) (NN animal))) (, ,) (NP (JJ salivary-like) (JJ mammary) (NNS transplants)) (VP (VBD synthesized) (NP (DT the) (NN milk) (NN protein) (NN α-lactal-bumin)))) (. .)))
( (S (S (ADVP (RB Interestingly)) (, ,) (NP (NP (JJ fetal) (JJ mammary) (NN mesenchyme)) (VP (VBN grafted) (PP (IN into) (NP (DT the) (JJ adult) (NN gland))))) (VP (VBD accelerated) (NP (NN tumorigenesis)) (, ,) (S (VP (VBG providing) (NP (NP (DT an) (JJ early) (NN indication)) (SBAR (IN that) (S (NP (NP (NNS modifications)) (PP (IN of) (NP (JJ stromal) (NN signaling)))) (VP (MD could) (VP (VB influence) (NP (NP (DT the) (NN progress)) (PP (IN of) (NP (NN neoplasia))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN absence)) (PP (IN of) (NP (NP (JJ extensive) (JJ ductal) (JJ side) (NN branching)) (CC and) (NP (NP (NN infilling)) (PP (IN of) (NP (JJ interductal) (NNS spaces))))))) (VP (VBZ is) (RB not) (ADJP (JJ due) (PP (TO to) (NP (NP (DT the) (JJ terminal) (NN differentiation)) (PP (IN of) (NP (JJ ductal) (NNS cells)))))))) (. .)))
( (S (S (NP (NP (RB Even) (DT the) (JJ smallest) (NN fragment)) (PP (IN of) (NP (NP (DT a) (NN duct)) (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBN transplanted) (PP (TO to) (NP (NP (NN stroma)) (ADJP (JJ devoid) (PP (IN of) (NP (NN parenchyma))))))))) (, ,)))) (VP (VP (VBZ undergoes) (NP (JJ aggressive) (NN growth))) (CC and) (VP (MD can) (VP (VBP fill) (NP (DT a) (JJ fat) (NN pad)) (PP (IN with) (NP (DT a) (ADJP (ADVP (ADVP (RB morphologically)) (CC and) (ADVP (RB functionally))) (JJ complete)) (JJ ductal) (NN system))))))) (. .)))
( (S (S (NP (DT This) (NN capacity)) (VP (VP (VBZ is) (VP (VBN attributed) (PP (TO to) (NP (NP (QP (RB up) (TO to) (CD three)) (NNS populations)) (PP (IN of) (NP (NP (JJ mammary) (NN stem)) (CC or) (NP (NN progenitor) (NNS cells)) (NP (NN -LSB-4)) (-RRB- -RSB-))))))) (CC and) (VP (VBZ is) (ADJP (JJ subject) (PP (TO to) (NP (JJ stromal) (NN inhibition))))))) (. .)))
( (S (S (SBAR (WHADVP (WRB When)) (S (NP (JJ similar) (NNS fragments)) (VP (VBP are) (VP (VBN transplanted) (PP (IN into) (NP (NP (DT a) (NN space)) (PP (IN between) (NP (JJ existing) (NNS ducts))) (S (NP (DT the) (NN graft)) (VP (VP (VBZ is) (VP (VBN maintained))) (CC but) (VP (VBZ does) (RB not) (VP (VB grow))))))))))) (PRN (-LRB- -LRB-) (FRAG (NP (NNP Daniel)) (, ,) (NP (JJ unpublished) (NNS data))) (-RRB- -RRB-))) (. .)))
( (S (S (NP (NP (JJ Normal) (NN inhibition)) (PP (IN of) (NP (JJ ductal) (NN branching)))) (VP (MD must) (ADVP (RB therefore)) (VP (VB overcome) (NP (NP (DT a) (JJ stromal) (NN background)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADVP (RB strongly)) (ADJP (JJ stimulatory))))))))) (: ;) (S (NP (EX there)) (VP (VBZ is) (ADVP (RB now)) (NP (JJ excellent) (NN evidence) (SBAR (IN that) (S (NP (NP (NP (NN transforming) (NN growth) (NN factor-βs)) (PRN (-LRB- -LRB-) (NP (NN TGF-βs)) (-RRB- -RRB-))) (, ,) (VP (VBG acting) (PP (IN in) (NP (NN part))) (PP (IN on) (NP (JJ stromal) (NNS targets)))) (, ,)) (VP (VBP are) (ADJP (JJ responsible)))))))) (. .)))
( (S (S (NP (NP (DT The) (ADJP (ADJP (JJ rapid)) (CC and) (ADJP (JJ reversible))) (NN inhibition)) (PP (IN of) (NP (NN end) (NN bud) (NN growth))) (PP (IN by) (NP (ADJP (RB experimentally) (VBN implanted)) (NN TGF-β1)))) (VP (VBZ demonstrates) (NP (NP (DT the) (JJ mammotrophic) (NN activity)) (PP (IN of) (NP (DT this) (NN growth) (NN factor)))))) (, ,) (IN whereas) (S (NP (NP (NP (PRP$ its) (ADJP (RB normally) (JJ high)) (NN concentration)) (PP (IN in) (NP (DT the) (JJ periductal) (JJ extracellular) (NN matrix)))) (CC and) (NP (NP (PRP$ its) (JJ localized) (NN loss)) (PP (IN over) (NP (JJ lateral) (NNS buds))))) (ADVP (RB strongly)) (VP (VBZ implies) (NP (NP (DT an) (NN action)) (SBAR (WHNP (WDT that)) (S (VP (VBZ modulates) (NP (JJ secondary) (JJ ductal) (NN growth) (NN -LSB-5))) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (NP (NNS Studies)) (PP (IN with) (NP (NP (JJ transgenic) (NNS mice)) (VP (VBG overexpressing) (NP (NP (DT a) (ADJP (RB constitutively) (VBN activated)) (NN form)) (PP (IN of) (NP (NP (NN TGF-β1) (CD -LSB-6) (-RRB- -RSB-)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (JJ function-ablating) (JJ mutant) (NN TGF-β) (NN signaling) (NNS receptors)) (, ,)))))))) (VP (VBD were) (ADJP (JJ confirmatory)))) (. .)))
( (S (S (S (NP (NP (DT The) (JJ ectopic) (NN expression)) (PP (IN of) (NP (NN TGF-β1)))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (JJ significant) (NN decrease)) (PP (IN in) (NP (JJ lateral) (NN branching))))))) (, ,) (CC and) (S (NP (NP (JJ mutant) (NN TGF-β) (NNS receptors)) (VP (VBN expressed) (PP (IN in) (NP (DT the) (NN stroma))))) (VP (VBD increased) (NP (NP (JJ lateral) (NN branch)) (VP (VBG infilling) (NP (CD -LSB-7) (-RRB- -RSB-))))))) (. .)))
( (S (S (SBAR (IN Because) (S (NP (DT the) (JJ latter)) (VP (VBP are) (NP (NP (DT an) (JJ important) (NN site)) (PP (IN of) (NP (NN TGF-β) (NN action))))))) (, ,) (NP (NP (JJ normal) (JJ chronic) (NN inhibition)) (PP (IN of) (NP (NN branching)))) (VP (MD must) (VP (VB depend) (, ,) (PP (IN in) (NP (NN part))) (, ,) (PP (IN on) (NP (JJ TGF-β-regulated) (JJ secondary) (NNS signals)))))) (. .)))
( (S (S (ADVP (RB Recently)) (, ,) (NP (NP (NP (NN hepatocyte) (NN growth) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN HGF)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VP (MD can) (VP (VB stimulate) (NP (NP (DT the) (NN branching)) (PP (IN of) (NP (JJ mammary) (JJ epithelial) (NNS tubes)))) (ADVP (FW in) (FW vitro)))) (CC and) (VP (VBZ is) (ADVP (RB negatively)) (VP (VBN modulated) (PP (IN by) (NP (NN TGF-β)))))))) (, ,)) (VP (VBZ has) (VP (VBN emerged) (PP (IN as) (NP (DT a) (NN candidate) (JJ secondary) (NN signal) (NN -LSB-8))))) (-RRB- -RSB-)) (. .)))
( (S (S (PP (IN In) (NP (DT this) (NN model))) (, ,) (NP (NN TGF-β)) (VP (VBZ inhibits) (NP (NN branching)) (PP (IN through) (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (NP (NN HGF) (NN expression)) (PP (IN in) (NP (NP (DT the) (JJ periductal) (NN stroma)) (PRN (-LRB- -LRB-) (VP (VBN reviewed) (PP (IN in) (NP (DT this) (NN issue)))) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (JJ protean) (NNS effects)) (PP (IN of) (NP (NN TGF-βs))) (PP (IN on) (NP (NP (NP (NN mitogenesis)) (CC and) (NP (JJ extracellular) (NN matrix)) (NP (NNS dynamics))) (PP (IN in) (NP (JJ mammary) (NN tissue)))))) (VP (VBP make) (NP (NP (DT the) (NN assignment)) (PP (IN of) (NP (DT any) (ADJP (ADJP (JJ single)) (, ,) (ADJP (JJ TGF-β-mediated))) (NN mechanism) (JJ premature) (NN -LSB-5))))) (-RRB- -RSB-)) (. .)))
( (S (NP (NP (NP (JJ Ductal) (NN elongation)) (CC and) (NP (NN branching))) (VP (VB depend) (PP (IN on) (NP (NP (JJ parenchyma-induced) (NNS modifications)) (PP (IN of) (NP (DT the) (JJ periductal) (NN stroma)))))))))
( (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ striking)) (SBAR (IN that) (S (NP (JJ ductal) (NN growth)) (VP (VBZ is) (ADVP (RB so) (RB exquisitely)) (VP (VBN focused) (PP (IN in) (NP (DT the) (NN end) (NNS buds))))))))) (. .)))
( (S (S (NP (DT The) (NN impression) (SBAR (IN that) (S (S (VP (ADVP (RB precisely)) (VBN localized) (, ,) (SBAR (IN as) (S (VP (VBN opposed) (PP (TO to) (NP (JJ general)))))))) (, ,) (NP (NNS signals)) (VP (VBP guide) (NP (DT this) (NN development)))))) (VP (VBZ is) (ADJP (JJ unavoidable)))) (. .)))
( (S (S (PP (IN In) (NP (NN fact))) (, ,) (S (NP (DT this) (NN impression)) (VP (VBZ is) (ADJP (JJ correct)))) (CC and) (S (NP (JJ epithelium-induced) (NNS changes)) (VP (VBP develop) (NP (NP (DT the) (JJ growth-promoting) (NN potential)) (PP (IN of) (NP (DT the) (NN stroma)))) (PP (ADVP (RB immediately)) (IN in) (NP (NP (NN front)) (PP (IN of) (NP (NN end) (NNS buds)))))))) (. .)))
( (S (S (NP (JJ Exciting) (JJ new) (NN evidence)) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (NP (JJ migratory) (JJ white) (NN blood) (NNS cells)) (, ,) (NP (NP (NNS macrophages)) (CC and) (NP (NNS eosinophils))) (, ,)) (VP (VP (VBP are) (VP (VBN drawn) (PP (TO to) (NP (NP (DT the) (NN vicinity)) (PP (IN of) (NP (DT the) (NN end) (NN bud))))) (PP (IN by) (NP (NNS chemoattractants))))) (CC and) (, ,) (ADVP (RB surprisingly)) (, ,) (VP (VB prove) (S (VP (TO to) (VP (VB be) (ADJP (JJ essential) (PP (IN for) (NP (NP (DT the) (JJ normal) (NN development)) (PP (IN of) (NP (NN end) (NNS buds) (CD -LSB-9) (-RRB- -RSB-))))))))))))))) (. .)))
( (S (S (ADVP (RB Interestingly)) (, ,) (NP (NP (JJ extensive) (NN DNA) (NN synthesis)) (PP (IN in) (NP (NP (DT the) (NN stroma)) (PP (IN around) (NP (NN end) (NNS buds)))))) (VP (VBZ accompanies) (NP (DT this) (NN activity)) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (JJ new) (JJ stromal) (NNS cells)) (VP (VP (VBP are) (RB not) (ADVP (RB only)) (VP (VBN recruited) (PP (TO to) (NP (NP (DT the) (NN vicinity)) (PP (IN of) (NP (DT the) (NN end) (NN bud))))))) (CC but) (VP (VBP are) (ADVP (RB also)) (VP (VBN induced) (PP (IN by) (S (NP (PRP it)) (VP (TO to) (VP (VB proliferate) (NP (NN -LSB-10)))) (-RRB- -RSB-)))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN absence)) (PP (IN of) (NP (JJ stromal) (NN DNA) (NN synthesis))) (PP (IN around) (NP (JJ growth-terminated) (NNS ducts)))) (VP (VBZ emphasizes) (SBAR (IN that) (S (NP (DT these) (JJ inductive) (NNS signals)) (VP (VP (VBP are) (ADJP (JJ growth-related))) (CC and) (VP (VBP are) (RB not) (ADJP (JJ due) (PP (ADVP (RB merely)) (TO to) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN epithelium)))))))))))) (. .)))
( (S (S (NP (NN Steroid) (JJ autoradiographic) (NNS experiments)) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NN estrogen) (NNS receptors)) (VP (VBP are) (VP (VBN concentrated) (PP (IN in) (NP (NP (DT the) (NNS nuclei)) (PP (IN of) (NP (JJ stromal) (NNS cells))))) (PP (PP (IN around) (NP (NN end) (NNS buds))) (CC but) (PP (RB not) (IN in) (NP (ADJP (RB rapidly) (JJ dividing)) (NN cap) (NNS cells))))) (PRN (-LRB- -LRB-) (NP (NP (DT a) (NN stem) (NN cell) (NN layer)) (VP (VBG covering) (NP (NP (DT the) (NN tip)) (PP (IN of) (NP (DT the) (NN end) (NN bud)))))) (-RRB- -RRB-)) (, ,) (S (VP (VBG indicating) (NP (NP (DT a) (JJ paracrine) (NN mechanism)) (CD -LSB-11) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBD was) (VP (VBN confirmed) (SBAR (WHADVP (WRB when)) (S (NP (NN estrogen) (NN receptor) (JJ knockout) (-LRB- -LRB-) (NN ERKO) (-RRB- -RRB-) (NNS mice)) (VP (VBD were) (VP (VBN used) (S (VP (TO to) (VP (VB investigate) (SBAR (IN whether) (S (NP (DT the) (NN steroid)) (VP (VBZ acts) (PP (IN on) (NP (ADJP (ADJP (JJ epithelial)) (CC or) (ADJP (JJ stromal))) (NNS targets)))))))))))))))) (. .)))
( (S (NP (NP (NNP Cunha) (FW et) (FW al)) (NP (CD -LSB-12) (-RRB- -RSB-))) (ADVP (RB surgically)) (VP (VP (VBN transplanted) (NP (NP (NN ERKO) (NN epithelium)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (CC either) (NP (NN ERKO)) (CC or) (NP (JJ wild-type) (NN stroma))))))) (PP (IN under) (NP (NP (JJ renal) (NNS capsules)) (PP (IN in) (NP (JJ athymic) (NNS mice)))))) (CC and) (VP (VBD demonstrated) (SBAR (IN that) (S (, ,) (SBAR (IN whereas) (S (NP (JJ wild-type) (NN stroma)) (VP (VBD supported) (NP (NP (JJ organotypic) (NN growth)) (PP (IN of) (NP (DT the) (NN ERKO) (NN epithelium))))))) (, ,) (NP (DT no) (JJ ductal) (NN growth)) (VP (VBD was) (VP (VBN seen) (PP (IN with) (NP (JJ wild-type) (NN epithelium))) (PP (IN in) (NP (NN ERKO) (NN stroma))))))))) (. .)))
( (S (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN suggested) (SBAR (IN that) (S (NP (NN estrogen) (NNS receptors)) (VP (VBP are) (ADVP (RB uniquely)) (VP (VBN concentrated) (PP (IN around) (NP (NN end) (NNS buds))))))))))) (, ,) (CC but) (S (NP (DT this)) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBD proved) (NP (CD -LSB-11) (-RRB- -RSB-)))) (, ,) (S (VP (VBG leaving) (S (VP (VP (VB open) (NP (NP (DT the) (NNS possibilities)) (SBAR (WHNP (WDT that)) (S (NP (JJ elongating) (NNS ducts)) (VP (VBP stimulate) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NN estrogen) (NNS receptors))) (PP (IN in) (NP (JJ nearby) (JJ stromal) (NNS cells))))))))) (, ,) (VP (VB attract) (NP (ADJP (NN estrogen) (JJ receptor-positive)) (JJ stromal) (NNS cells))) (, ,) (CC or) (VP (VB stimulate) (NP (PRP$ their) (NN proliferation)))))))))) (. .)))
( (S (S (PP (IN In) (NP (NP (NN addition)) (PP (TO to) (NP (NN estrogen))))) (, ,) (NP (JJ other) (JJ ductal) (NNS mammogens)) (VP (VBP act) (PP (IN through) (NP (NP (NNS intermediaries)) (VP (VBN generated) (PP (IN in) (NP (NP (DT the) (NN stroma)) (-LRB- -LRB-) (VP (VBN reviewed) (PP (PP (IN in) (NP (DT this) (NN issue))) (CC and) (PP (IN in) (NP (NN -LSB-13))) (-RRB- -RSB-))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (DT These)) (VP (VBP include) (NP (NP (NP (JJ epidermal) (NN growth) (NN factor)) (, ,) (NP (NN activins/inhibins)) (, ,) (CC and) (NP (NN growth) (NN hormone))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ stimulates) (NP (NP (DT the) (NN synthesis)) (PP (IN of) (NP (JJ insulin-like) (NN growth) (NN factor)))))))))) (. .)))
( (S (S (NP (NN Growth) (JJ stimulatory) (JJ stromal-epithelial) (NNS interactions)) (VP (VBP are) (VP (VBN shown) (ADVP (RB diagrammatically)) (PP (IN in) (NP (NNP Fig.) (CD 3)))))) (. .)))
( (S (S (NP (JJ Organotypic) (NN development)) (VP (VBZ depends) (PP (IN on) (NP (NP (NP (CD two) (JJ obvious) (JJ structural) (NNS modifications)) (PP (IN of) (NP (DT the) (NN end) (NN bud)))) (, ,) (NP (NP (NP (PRP$ its) (NN constriction)) (PP (IN into) (NP (DT a) (NN tube)))) (CC and) (NP (PRP$ its) (NN bifurcation))))))) (. .)))
( (S (PP (VBG Preceding) (NP (DT either))) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (JJ focal) (NN induction)) (PP (IN by) (NP (NP (DT the) (NN end) (NN bud)) (PP (IN of) (NP (NN type) (CD I) (NP (JJ collagen-rich) (JJ connective) (NN tissue)) (CC and) (NP (NP (JJ extracellular) (NN matrix)) (PP (PP (IN on) (NP (NP (PRP$ its) (NN flank)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 1b)) (-RRB- -RRB-)))) (CC and) (PP (IN in) (NP (NP (DT the) (NNS clefts)) (SBAR (WHNP (WDT that)) (S (VP (VBP indent) (NP (NP (DT the) (NN tip)) (SBAR (WHADVP (WRB when)) (S (NP (CD two) (JJ new) (NN end) (NNS buds)) (VP (VBP form))))) (PRN (-LRB- -LRB-) (RB not) (VP (VBN shown)) (-RRB- -RRB-))))))))))))))) (. .)))
( (S (S (NP (NP (DT An) (JJ active) (NN role)) (PP (IN for) (NP (NN collagen))) (PP (IN in) (S (VP (NN shaping) (NP (DT the) (NN duct)))))) (VP (VBZ is) (VP (VBN indicated)))) (. .)))
( (S (PP (IN In) (NP (FW vitro))) (, ,) (NP (NP (JJ mammary) (JJ epithelial) (NNS cells)) (ADJP (JJ embedded) (PP (IN in) (NP (NN collagen) (NNS gels))))) (VP (VBP form) (NP (NP (JJ narrow) (NNS tubules)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB also)) (VP (VBN seen) (ADVP (FW in) (FW vivo)) (SBAR (WHADVP (WRB when)) (S (NP (NP (NNS fragments)) (PP (IN of) (NP (NN duct)))) (VP (VBP form) (NP (JJ similar) (NNS tubules)) (PP (IN in) (NP (NP (DT a) (NN bolus)) (PP (IN of) (NP (NP (VBN injected) (NN type) (CD 1) (NN collagen)) (PRN (-LRB- -LRB-) (VP (VBN reviewed) (PP (IN in) (NP (NN -LSB-13)))) (-RRB- -RSB-) (-RRB- -RRB-))))))))))))))) (. .)))
( (S (S (ADVP (RB Mechanistically)) (, ,) (PP (IN by) (S (VP (VBG binding) (PP (TO to) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (NN integrin) (NN family)) (PP (IN of) (NP (JJ extracellular) (NN matrix) (NNS receptors)))))))))) (, ,) (NP (NN collagen)) (VP (MD can) (VP (VB stimulate) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (NP (JJ actin-cytoskeletal) (NNS foci)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG changing) (NP (JJ mammary) (NN cell) (NN shape) (CD -LSB-14) (-RRB- -RSB-))))))))))))))) (. .)))
( (S (S (S (ADVP (RB Indeed)) (, ,) (NP (NN β1-integrin)) (VP (VBD was) (VP (VBN localized) (PP (IN at) (NP (NP (DT the) (JJ basal) (NNS surfaces)) (PP (IN of) (NP (DT the) (NN end) (NN bud) (NN epithelium)))))))) (, ,) (CC and) (S (NP (NP (NP (JJ function-blocking) (NNS antibodies)) (PP (IN against) (NP (NN β-integrin)))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NNS antibodies)) (PP (IN against) (NP (NN laminin)))) (, ,)) (ADVP (RB reversibly)) (VP (VBD inhibited) (NP (NN end) (NN bud) (NN development)) (ADVP (FW in) (FW vivo)) (, ,) (SBAR (IN while) (S (VP (VBG blocking) (NP (NN tubulogenesis) (ADJP (FW in) (FW vitro)) (NN -LSB-15) (-RRB- -RSB-)))))))) (. .)))
( (S (S (S (NP (NP (DT The) (JJ molecular) (NNS signals)) (VP (VBG governing) (NP (NP (DT the) (NNS sites)) (PP (IN of) (NP (JJ fibrous) (NN induction)))))) (VP (VBP are) (ADJP (RB largely) (JJ unknown)))) (: ;) (RB however) (, ,) (S (NP (NN TGF-βs)) (VP (VBP seem) (ADJP (JJ likely) (S (VP (TO to) (VP (VB have) (NP (DT a) (NN role))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ experimental) (NN release)) (PP (IN of) (NP (NP (NN TGF-β1)) (PP (IN in) (NP (NP (DT the) (NN vicinity)) (PP (IN of) (NP (DT an) (NN end) (NN bud))))))) (PP (IN by) (NP (JJ plastic) (NNS implants)))) (VP (VBD caused) (NP (NP (JJ epithelium-dependent) (NN induction)) (PP (IN of) (NP (DT a) (JJ fibrous) (JJ connective) (NN tissue) (NN cap)))) (PP (IN over) (NP (DT the) (NN end) (NN bud) (NN tip))))) (. .)))
( (S (S (NP (NP (DT The) (JJ molecular) (NN composition)) (PP (IN of) (NP (DT this) (NN cap)))) (VP (VBD reflected) (NP (NP (DT that)) (PP (IN of) (NP (DT the) (JJ fibrous) (JJ connective) (NN tissue)))) (PP (PP (IN on) (NP (NP (DT the) (NN flank)) (PP (IN of) (NP (DT the) (NN end) (NN bud))))) (CC and) (PP (IN in) (NP (NP (VBG developing) (NNS clefts)) (PP (IN before) (NP (NN bifurcation)))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NN TGF-β1)) (VP (MD might) (VP (VB be) (NP (DT the) (JJ normal) (NN inducer) (NN -LSB-16)))) (-RRB- -RSB-))))))) (. .)))
( (S (S (ADVP (RBR More) (RB recently)) (, ,) (NP (NP (JJ parathyroid-hormone-related) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN PTHrP)) (-RRB- -RRB-))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (ADJP (JJ crucial) (PP (IN for) (NP (JJ normal) (JJ ductal) (NN development))))))))))) (. .)))
( (S (S (NP (NP (JJ Transgenic) (NNS animals)) (VP (VBG overexpressing) (NP (DT the) (NN peptide)))) (VP (VBP show) (NP (NP (JJ severe) (NN impairment)) (PP (IN of) (NP (NP (JJ ductal) (NN extension)) (CC and) (NP (JJ branching) (NN -LSB-17)))))) (-RRB- -RSB-)) (. .)))
( (S (PP (JJ Pertinent) (TO to) (NP (DT this) (NN discussion))) (, ,) (NP (NN PTHrP) (NN synthesis)) (VP (VBZ is) (VP (VBN concentrated) (PP (IN in) (NP (NP (NP (DT the) (NN cap) (NNS cells)) (PP (IN of) (NP (NN end) (NNS buds)))) (CC and) (NP (NP (PRP$ their) (JJ myoepithelial) (NNS descendents)) (PP (IN on) (NP (DT the) (NN flank)))))) (, ,) (SBAR (IN whereas) (S (NP (JJ cognate) (NNS receptors)) (VP (VBP seem) (S (VP (TO to) (VP (VB be) (VP (VBN concentrated) (PP (IN in) (NP (DT the) (ADJP (RB immediately) (JJ adjacent)) (JJ fibrous) (NN tissue)))))))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBZ indicates) (NP (DT a) (JJ potential) (NN role)) (PP (IN in) (NP (JJ stromal) (NN induction))))) (. .)))
( (S (PP (IN With) (NP (NP (DT this)) (PP (IN in) (NP (NN mind))))) (, ,) (NP (DT the) (NN fact) (SBAR (IN that) (S (NP (NN TGF-β)) (VP (MD can) (ADVP (RB positively)) (VP (VB regulate) (NP (NN PTHrP))))))) (VP (VBZ is) (ADJP (JJ interesting) (NP (CD -LSB-17) (-RRB- -RSB-)) (PP (IN because) (S (NP (NN TGF-β)) (VP (VBZ is) (ADJP (JJ present)) (, ,) (ADVP (RB often)) (PP (IN at) (NP (JJ high) (NNS levels))) (, ,) (PP (IN in) (NP (DT the) (NN end) (NN bud) (CD -LSB-18)))) (-RRB- -RSB-) (PRN (-LRB- -LRB-) (NP (NP (NNP Fig.)) (NP (NN 3b))) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (DT These) (NNS observations)) (VP (VBP suggest) (SBAR (SBAR (IN that) (S (NP (NN TGF-βs)) (VP (MD might) (ADVP (RB indirectly)) (VP (VB cause) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NP (DT the) (JJ fibrous) (NN sheath)) (PP (IN of) (NP (NN end) (NNS buds)))))))))) (CC and) (SBAR (IN that) (S (S (NP (NNS experiments)) (VP (TO to) (VP (VB investigate) (SBAR (SBAR (IN whether) (S (NP (NN PTHrP)) (VP (VBZ induces) (NP (NN fibrosis))))) (CC and) (SBAR (IN whether) (S (NP (NN TGF-β1)) (ADVP (RB normally)) (VP (VBZ regulates) (NP (NN PTHrP)) (PP (IN during) (NP (JJ ductal) (NN development)))))))))) (VP (MD would) (VP (VB be) (ADJP (JJ fruitful))))))))) (. .)))
( (S (S (NP (NP (DT A) (JJ combined) (NN role)) (PP (IN for) (NP (JJ TGF-β-induced) (JJ fibrous) (NN stroma))) (PP (IN in) (S (VP (VBG inhibiting) (NP (NN end) (NN bud) (NN growth)) (PP (IN while) (S (VP (VBG guiding) (NP (NN morphogenesis))))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN suggested) (S (NP (NN -LSB-5)) (-RRB- -RSB-)))))) (. .)))
( (S (SINV (ADJP (JJ Consistent) (PP (IN with) (NP (DT this) (NN hypothesis)))) (VP (VBZ is) (NP (DT the) (NN observation) (SBAR (IN that) (S (NP (NP (JJ fibrous) (JJ connective) (NN tissue)) (PP (IN on) (NP (DT the) (NN flank)))) (ADVP (RB progressively)) (VP (NNS advances) (PP (TO to) (NP (NN envelop))) (NP (NP (DT the) (NNS tips)) (PP (IN of) (NP (NP (NN end) (NNS buds)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (PP (IN in) (NP (NP (DT the) (NN process)) (PP (IN of) (NP (JJ stopping) (NN growth) (NN -LSB-19))))))))))) (-RRB- -RSB-)))))) (. .))))
( (S (S (S (VP (VBG Arguing) (PP (IN against) (NP (DT the) (NN matrix))) (PP (IN as) (NP (DT a) (JJ primary) (NN growth) (NN inhibitor))))) (, ,) (ADVP (RB however)) (, ,) (NP (JJ implanted) (NN TGF-β)) (VP (VBZ inhibits) (NP (NN DNA) (NN synthesis)) (PP (RP up) (TO to) (NP (NP (CD 12) (NN h)) (PP (IN before) (NP (NP (DT the) (NN appearance)) (PP (IN of) (NP (DT the) (JJ fibrous) (NN cap))))))))) (. .)))
( (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (ADJP (RB surprisingly) (JJ high)) (NNS levels)) (PP (IN of) (NP (NN DNA) (NN synthesis)))) (VP (MD can) (VP (VB be) (VP (VBN detected) (PP (IN in) (NP (NP (JJ matrix-ensheathed) (, ,) (NP (NN growth-quiescent) (NNS ducts)) (, ,) (NP (NP (DT some)) (ADJP (RB quite) (JJ distant) (PP (IN from) (NP (DT the) (NN end) (NN bud)))))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 2)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (SBAR (IN Although) (S (NP (DT this) (NN DNA) (NN synthesis)) (VP (MD might) (CC or) (VP (MD might) (RB not) (VP (VB be) (ADJP (JJ related) (PP (TO to) (NP (NN mitosis) (CD -LSB-20))))))) (-RRB- -RSB-))) (, ,) (NP (PRP it)) (ADVP (RB nevertheless)) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (JJ growth-stimulatory) (NNS signals)) (VP (MD can) (VP (VB be) (ADJP (RB quite) (JJ active) (PP (IN in) (NP (NP (NNS ducts)) (PP (IN beneath) (NP (DT an) (JJ intact) (JJ fibrous) (JJ stromal) (NN sheath)))))))))))) (. .)))
( (S (S (SBAR (RB Even) (IN though) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ clear)) (SBAR (IN that) (S (NP (JJ stromal) (NNS signals)) (VP (MD must) (ADVP (RB ultimately)) (VP (VB inhibit) (NP (NP (NN end) (NN bud) (NN growth)) (S (NP (JJ -LSB-how) (NN else)) (VP (MD can) (VP (NP (PRP$ their) (NN regression)) (PP (IN before) (S (VP (VBG reaching) (NP (NP (DT the) (NNS limits)) (PP (IN of) (NP (DT the) (JJ fat) (NN pad)))) (VP (VB be) (VP (VBN explained) (PRN (-LRB- -LRB-) (NP (NP (NNP Fig.)) (NP (NN 1a))) (-RRB- -RRB-)))))))))) (. ?)))) (-RRB- -RSB-)))))) (, ,) (NP (PRP$ their) (NN identity)) (VP (VBZ remains) (ADJP (JJ unknown)))) (PRN (-LRB- -LRB-) (NP (NP (NNP Fig.)) (NP (NN 3b))) (-RRB- -RRB-)) (. .)))
( (S (NP (NP (JJ Resolving) (NN signaling)) (PP (IN between) (NP (NP (NN epithelium)) (CC and) (NP (NN stroma)))))))
( (S (S (PP (IN During) (NP (DT the) (JJ past) (NN decade))) (, ,) (NP (JJ classic) (JJ mammary) (NN tissue) (NN recombination) (NNS experiments)) (VP (VP (VBP have) (VP (VBN been) (VP (VBN recalled) (PP (TO to) (NP (NP (NN duty)) (, ,) (NP (NP (DT this) (NN time)) (VP (VBG using) (NP (NP (NN tissue)) (PP (IN from) (NP (ADJP (RB genetically) (VBN engineered)) (NNS mice))))))))))) (, ,) (CC and) (VP (VBP have) (VP (VBN led) (PP (TO to) (NP (NP (JJ important) (NNS insights)) (PP (IN into) (NP (NP (DT the) (JJ stromal) (NNS origins)) (PP (IN of) (NP (JJ ductal) (JJ mammogenic) (NNS signals))))))))))) (. .)))
( (S (NP (ADJP (RB Much) (JJR less))) (VP (VBZ is) (VP (VBN known) (PP (IN about) (NP (NP (DT the) (JJ epithelial) (NNS signals)) (SBAR (WHNP (WDT that)) (S (VP (VP (VB reorganize) (NP (DT the) (JJ periductal) (NN stroma))) (CC and) (, ,) (SBAR (IN as) (S (NP (PRP I)) (VP (VBP have) (VP (VBN discussed) (ADVP (RB briefly)) (SBAR (IN above) (, ,) (S (NP (DT these) (NN retrograde) (NNS signals)) (VP (VBP are) (ADJP (JJ crucial) (PP (TO to) (NP (NP (DT the) (NN realization)) (PP (IN of) (NP (NP (DT the) (ADJP (ADJP (JJ morphogenetic)) (CC and) (ADJP (JJ growth-promoting))) (NN potential)) (PP (IN of) (NP (DT the) (NN stroma)))))))))))))))))))))) (. .)))
( (S (S (S (VP (VP (VBG Identifying) (NP (DT the) (JJ relevant) (NN epithelial) (NNS signals))) (CC and) (VP (VBG placing) (NP (PRP them)) (PP (IN in) (NP (NP (DT a) (JJ proper) (JJ temporal) (NN order)) (PP (IN with) (NP (NP (NN regard)) (PP (TO to) (NP (NP (DT the) (NN elicitation)) (PP (IN of) (NP (NP (JJ stromal) (NNS signals)) (CC and) (NP (DT the) (JJ ensuing) (JJ morphogenetic) (NNS events))))))))))))) (VP (VBZ is) (ADVP (RB now)) (NP (NP (DT a) (JJ major) (NN challenge)) (SBAR (WHNP (WDT that)) (S (VP (MD will) (VP (VB require) (NP (JJ new) (ADJP (ADJP (JJ conceptual)) (CONJP (RB as) (RB well) (IN as)) (ADJP (JJ experimental))) (NNS tools))))))))) (. .)))
( (S (NP (NP (DT The) (JJ strong) (JJ evolutionary) (NN conservation)) (PP (IN of) (NP (ADJP (ADJP (JJ reciprocal)) (, ,) (ADJP (JJ epithelial-stromal))) (NN signaling))) (PP (IN in) (NP (NP (JJ branching) (NN morphogenesis)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ encompasses) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (JJ branched) (NNS airways)) (PP (IN from) (NP (NP (NNS insects)) (PP (TO to) (NP (NNS mammals)))))))))))))) (, ,) (PP (IN for) (NP (NN example))) (, ,) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (JJ careful) (NN study)) (PP (IN of) (NP (DT these) (NNS systems)))) (VP (MD could) (VP (VB provide) (NP (NP (JJ new) (NNS ideas)) (ADJP (JJ pertinent) (PP (TO to) (NP (JJ mammary) (NP (NN growth)) (CC and) (NP (NN morphogenesis) (CD -LSB-21) (-RRB- -RSB-))))))))))) (. .)))
( (S (NP (NN Conclusion))))
( (S (S (PP (IN In) (NP (DT an) (JJR earlier) (NN review))) (NP (NN -LSB-13) (-RRB- -RSB-) (CD I)) (VP (VBD suggested) (SBAR (IN that) (S (S (VP (VBG bringing) (NP (JJ modern) (JJ molecular) (NNS methods)) (S (VP (TO to) (VP (VB bear) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NNS dynamics)) (PP (IN of) (NP (NN gene) (NN expression))) (PP (IN in) (NP (NP (DT the) (NN stroma)) (CC and) (NP (NN epithelium))))) (PP (IN at) (NP (NP (JJ obvious) (NN growth) (CC and) (NN morphogenetic) (NN inflection) (NNS points)) (PRN (-LRB- -LRB-) (NP (NP (NN eg)) (PP (IN in) (NP (NP (NN front)) (PP (IN of) (NP (NN end) (NNS buds)))))) (-RRB- -RRB-)))))))))))) (VP (MD would) (VP (VB be) (ADJP (JJ useful)))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (DT this) (NN approach)) (VP (VBZ does) (RB not) (VP (VB address) (NP (NP (DT the) (JJ vital) (NN issue)) (PP (IN of) (NP (NP (DT the) (JJ temporal) (NN order)) (PP (IN of) (NP (NP (NN signaling)) (, ,) (SBAR (WHNP (NP (DT the) (NN resolution)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (MD would) (VP (VB benefit) (PP (IN from) (NP (NP (DT a) (`` ') (NN time-zero) (`` ') (JJ experimental) (NN condition)) (, ,) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (JJ growth-static) (JJ mammary) (NNS ducts)) (VP (MD could) (VP (VB be) (VP (VBN induced) (S (VP (TO to) (VP (VB grow) (PP (IN in) (NP (DT a) (JJ controlled) (NN manner))))))))))))))))))))))))) (. .)))
( (S (S (SBAR (IN Although) (S (NP (EX there)) (VP (MD should) (VP (VB be) (NP (NP (JJ several) (NNS ways)) (PP (IN of) (S (VP (VBG accomplishing) (NP (DT this)))))))))) (, ,) (NP (JJ simple) (JJ ductal) (NNS transplants)) (VP (VBN come) (ADVP (RB first)) (PP (TO to) (NP (NN mind))))) (. .)))
( (S (S (PP (IN Through) (NP (NP (DT an) (NN analysis)) (PP (IN of) (NP (NP (DT the) (NP (NN initiation)) (CC and) (NP (JJS earliest) (NNS phases))) (PP (IN of) (NP (NN transplant) (NN outgrowth))) (PP (IN over) (NP (DT a) (ADJP (RB finely) (VBN spaced)) (JJ time-course))))))) (, ,) (NP (PRP it)) (VP (MD might) (VP (VB be) (ADJP (JJ possible) (S (VP (TO to) (VP (VB obtain) (NP (NP (DT an) (JJ orderly) (NN reading)) (PP (IN of) (NP (NP (JJ reciprocal) (ADJP (ADJP (JJ epithelial)) (CC and) (ADJP (JJ stromal))) (NNS signals)) (SBAR (WHNP (WDT that)) (S (VP (VBP underlie) (NP (NP (JJ stromal) (NN reorganization)) (CC and) (NP (JJ ductal) (NN extension)))))))))))))))) (. .)))
( (S (NP (NNS Abbreviations))))
( (S (S (S (NP (NN ERKO)) (VP (VBG =) (ADJP (NP (NN estrogen) (NN receptor)) (JJ knockout)))) (: ;) (S (NP (NN HGF)) (VP (VBG =) (NP (NN hepatocyte) (NN growth) (NN factor)))) (: ;) (S (NP (NN PTHrP)) (VP (VBG =) (NP (JJ parathyroid-hormone-related) (NN protein)))) (: ;) (S (NP (NN TGF-β)) (VP (VBG =) (NP (NN transforming) (NN growth) (NN factor-β))))) (. .)))
( (S (NP (NP (NN Figure)) (CC and) (NP (NN Table)) (NP (NNS captions)))))
( (S (NP (NP (NN Figure) (CD 1)) (: :) (NP (NP (NP (NNS Ducts)) (CC and) (NP (NN end) (NNS buds))) (PP (IN in) (NP (DT the) (JJ juvenile) (NN mouse) (JJ mammary) (NN gland)))) (. .))))
( (S (S (LST (-LRB- -LRB-) (LS a) (-RRB- -RRB-)) (NP (NN Photomicrograph)) (VP (VBG illustrating) (NP (NP (DT the) (JJ mammary) (JJ ductal) (NN system)) (PP (IN in) (NP (DT a) (JJ 5-week-old) (NN nulliparous) (NN mouse)))))) (. .)))
( (S (S (VP (VB Note) (NP (NP (DT the) (`` ') (NN open) (`` ') (JJ ductal) (NN architecture)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ leaves) (NP (NP (NP (CD 80) (NN %)) (CC or) (NP (JJR more))) (PP (IN of) (NP (DT the) (NN gland) (NN parenchyma-free)))))))))) (. .)))
( (S (S (NP (NP (NN End) (NNS buds)) (PRN (-LRB- -LRB-) (NP (JJ large) (NNS arrows)) (-RRB- -RRB-))) (VP (VBP identify) (NP (VBG growing) (NNS ducts)))) (. .)))
( (S (S (NP (NP (DT Those) (NN end) (NNS buds)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN arrayed) (PP (IN along) (NP (NP (DT the) (JJ right-hand) (NN side)) (PP (IN of) (NP (DT the) (NN gland)))))))))) (VP (VBP are) (PP (IN in) (NP (NP (JJ various) (NNS stages)) (PP (IN of) (NP (NN regression))))))) (. .)))
( (S (S (NP (NP (JJ Blunt-tipped) (NNS branches)) (PRN (-LRB- -LRB-) (NP (JJ small) (NNS arrows)) (-RRB- -RRB-))) (VP (VBP mark) (NP (NN growth-quiescent) (NNS ducts)))) (. .)))
( (S (S (NP (NP (DT The) (NN nipple)) (PRN (-LRB- -LRB-) (NP (NN asterisk)) (-RRB- -RRB-))) (VP (VBZ is) (PP (IN at) (NP (NP (NN base)) (PP (IN of) (NP (DT the) (NN gland))))))) (. .)))
( (S (S (NP (NN Magnification)) (VP (ADVP (RB approximately)) (NP (NN ×15)))) (. .)))
( (S (S (LST (-LRB- -LRB-) (LS b) (-RRB- -RRB-)) (NP (NP (NN Photomicrograph)) (PP (IN of) (NP (DT a) (JJ longitudinal) (NN section))) (PP (IN through) (NP (DT an) (NN end) (NN bud)))) (CC and) (VP (VBG subtending) (NP (NN duct)))) (. .)))
( (S (S (NP (NP (DT The) (NN induction)) (PP (IN of) (NP (NP (DT a) (JJ fibrous) (JJ connective) (NN tissue) (NN sheath)) (PRN (-LRB- -LRB-) (NP (JJ large) (NNS arrows)) (-RRB- -RRB-))))) (VP (VBZ coincides) (PP (IN with) (NP (NP (DT the) (NN constriction)) (PP (IN of) (NP (DT the) (NN end) (NN bud))) (PP (TO to) (NP (JJ ductal) (NNS dimensions))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ alcian) (JJ blue) (NN stain)) (VP (VBN used) (PP (IN in) (NP (DT this) (NN preparation))))) (VP (VP (VBZ detects) (NP (NNS glycosaminoglycans))) (CC and) (VP (VBZ highlights) (NP (NP (DT the) (JJ extracellular) (JJ matrix/basal) (NN lamina) (NN complex)) (PP (IN at) (NP (DT the) (JJ epithelial-stromal) (NN interface) (PRN (-LRB- -LRB-) (NP (JJ small) (NNS arrows)) (-RRB- -RRB-)) (CD -LSB-19) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (NN Magnification)) (NP (NN ×250))) (. .)))
( (S (NP (NP (NN Figure) (CD 2)) (: :) (NP (NP (NNP Photomicrographs)) (VP (VBG illustrating) (NP (NP (NNS patterns)) (PP (IN of) (NP (NN DNA) (NN synthesis))) (PP (PP (IN in) (NP (NP (DT an) (NN end) (NN bud)) (, ,) (NP (PRP$ its) (ADJP (RB immediately) (VBG subtending)) (NN duct)) (, ,) (CC and) (NP (NP (DT a) (JJ lateral) (NN branch)) (PRN (-LRB- -LRB-) (NP (NN a)) (-RRB- -RRB-))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (PP (IN in) (NP (NP (DT a) (NN duct)) (ADJP (JJ distant) (PP (IN from) (NP (NP (DT the) (NN growth) (NN front)) (PRN (-LRB- -LRB-) (NP (NN b)) (-RRB- -RRB-))))))))))) (. .))))
( (S (S (NP (ADJP (NN -LSB-3H) (-RRB- -RSB-) (NN Thymidine)) (NNS autoradiographs)) (VP (VBD were) (VP (VBN stained) (PP (IN with) (NP (NN alcian) (JJ blue)))))) (. .)))
( (S (S (NP (NP (JJ Large) (NNS arrows)) (, ,) (NP (NP (NP (JJ fibrous) (NN sheath)) (PP (IN around) (NP (NN end) (NN bud)))) (: ;) (NP (JJ small) (NNS arrows))) (, ,)) (VP (NN DNA) (NP (JJ synthetic) (NNS cells)))) (. .)))
( (S (S (NP (NN Magnification)) (NP (NN ×250))) (. .)))
( (S (NP (NP (NN Figure) (CD 3)) (: :) (NP (NP (NNS Diagrams)) (VP (VBG depicting) (NP (NP (JJ stromal-epithelial) (NN signaling)) (VP (VBG affecting) (NP (NP (JJ mammary) (JJ ductal) (NN growth)) (CC and) (NP (PRP$ its) (NN inhibition))))))) (. .))))
( (S (S (LST (-LRB- -LRB-) (LS a) (-RRB- -RRB-)) (NP (NN Growth) (JJ stimulatory) (NNS signals))) (. .)))
( (S (S (NP (NP (NP (JJ Endocrine) (NNS mammogens)) (ADJP (ADJP (JJ -LSB-estrogen)) (PRN (-LRB- -LRB-) (NP (NN E)) (-RRB- -RRB-)))) (, ,) (NP (NP (NP (NN growth) (NN hormone)) (PRN (-LRB- -LRB-) (NP (NN GH)) (-RRB- -RRB-) (-RRB- -RSB-))) (, ,) (VP (VBG acting) (PP (IN on) (NP (NP (JJ stromal) (NNS targets)) (PP (IN in) (NP (NP (NN front)) (PP (IN of) (NP (DT the) (NN end) (NN bud))))))))) (, ,)) (VP (VBP stimulate) (NP (NP (DT the) (NN synthesis)) (PP (IN of) (NP (NP (DT the) (JJ local) (NNS mammogens) (NP (NP (JJ epidermal) (NN growth) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN EGF)) (-RRB- -RRB-)))) (, ,) (NP (NP (JJ insulin-like) (NN growth) (NN factor-1)) (PRN (-LRB- -LRB-) (NP (NN IGF-1)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NNS members)) (PP (IN of) (NP (DT the) (NN activin/inhibin) (NN family))))))))) (. .)))
( (S (S (PP (IN From) (NP (DT the) (NN end) (NN bud))) (, ,) (NP (NP (JJ unknown) (NN retrograde) (NNS signals)) (PRN (-LRB- -LRB-) (NP (VBN broken) (NNS lines)) (-RRB- -RRB-))) (VP (VP (VB stimulate) (NP (NN vicinal) (NN DNA) (NN synthesis))) (CC and) (VP (VB attract) (NP (NP (NNS macrophages)) (CC and) (NP (NNS eosinophils)))))) (. .)))
( (S (S (NP (NP (DT The) (NN stimulation)) (PP (IN of) (NP (JJ lateral) (NNS branches))) (PP (IN along) (NP (JJ mature) (NNS ducts)))) (VP (VBZ involves) (NP (NP (DT the) (NP (JJ focal) (NN loss)) (CC or) (NP (NN inactivation))) (PP (IN of) (NP (NP (VBG transforming) (NN growth) (NN factor-β1)) (PRN (-LRB- -LRB-) (NP (NN TGF-β1)) (-RRB- -RRB-))))) (, ,) (S (VP (VP (VBG relieving) (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (NP (NP (NN hepatocyte) (NN growth) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN HGF)) (-RRB- -RRB-))) (NN synthesis))))) (CC and) (VP (VBG permitting) (NP (JJ lateral) (NN branch) (NN development))))))) (. .)))
( (S (S (NP (NP (JJ Outer) (JJ shaded) (NN zone)) (, ,) (NP (NP (JJ fibrous) (NN sheath)) (: ;) (NP (NN L))) (, ,)) (NP (NN lumen))) (. .)))
( (S (S (LST (-LRB- -LRB-) (LS b) (-RRB- -RRB-)) (VP (VBZ TGF-β) (PP (IN in) (NP (NP (NN growth) (NN inhibition)) (CC and) (NP (NP (NN induction)) (PP (IN of) (NP (DT the) (JJ periductal) (JJ fibrous) (NN sheath)))))))) (. .)))
( (S (S (SBAR (IN Although) (S (NP (NN end) (NNS buds)) (VP (VBP are) (VP (VBN inhibited) (PP (IN by) (NP (JJ exogenous) (NN TGF-β))))))) (, ,) (NP (PRP it)) (VP (VBZ remains) (VP (VBN unproven) (PP (IN as) (NP (NP (DT the) (JJ natural) (NN mechanism)) (PP (IN for) (NP (NP (NN end) (NN bud) (NN growth)) (NN termination)))))))) (. .)))
( (S (S (PP (IN In) (NP (NP (DT a) (ADJP (RB purely) (JJ speculative)) (NN model)) (PP (IN for) (NP (JJ fibrous) (NN induction))))) (, ,) (NP (NP (NN TGF-β)) (, ,) (VP (VBG acting) (PP (IN in) (NP (DT a) (JJ paracrine) (NN mode))) (PP (IN on) (NP (NP (JJ cap/myoepithelial) (NNS cells)) (PRN (-LRB- -LRB-) (NP (JJ black) (NN layer)) (-RRB- -RRB-))))) (, ,)) (VP (VBZ induces) (NP (NP (JJ parathyroid-hormone-related) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN P)) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (VBN Secreted) (JJ parathyroid-hormone-related) (NN protein)) (ADVP (RB then)) (VP (VBZ acts) (PP (IN on) (NP (JJ stromal) (NNS targets))) (, ,) (S (VP (VBG inducing) (NP (ADJP (RB highly) (JJ localized)) (NN fibrosis)))))) (. .)))
( (S (S (ADVP (RB Finally)) (, ,) (PP (IN along) (NP (DT the) (NN duct))) (, ,) (NP (NN TGF-β1)) (VP (VBZ inhibits) (NP (JJ lateral) (NN branching)) (PP (IN by) (S (VP (VBG blocking) (NP (NN HGF) (NN action))))))) (. .)))
( (S (NP (JJ Cellular) (NN Notch) (NN responsiveness)) (VP (VBZ is) (VP (VBN defined) (PP (IN by) (NP (JJ phosphoinositide) (JJ 3-kinase-dependent) (NNS signals)))))))
( (S (NP (NN Abstract))))
( (S (NP (NP (NN Background)) (: :) (S (NP (NN Notch)) (VP (VBZ plays) (NP (DT a) (JJ wide-ranging) (NN role)) (PP (IN in) (S (VP (VBG controlling) (NP (NP (NN cell) (NN fate)) (, ,) (NP (NN differentiation)) (CC and) (NP (NN development)))))))) (. .))))
( (S (S (NP (DT The) (NN PI3K-Akt) (NN pathway)) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB similarly) (VBN conserved)) (NN signalling) (NN pathway)) (SBAR (WHNP (WDT which)) (S (VP (VBZ regulates) (NP (NP (NNS processes)) (PP (JJ such) (IN as) (NP (NP (NN differentiation)) (, ,) (NP (NN proliferation)) (CC and) (NP (NN survival))))))))))) (. .)))
( (S (S (NP (NP (NNS Mice)) (PP (IN with) (NP (VBN disrupted) (NN Notch) (CC and) (NN PI3K) (NN signalling)))) (VP (VBP show) (NP (JJ phenotypic) (NNS similarities)) (PP (IN during) (NP (JJ haematopoietic) (NN cell) (NN development))) (, ,) (S (VP (VBG suggesting) (NP (NP (JJ functional) (NN interaction)) (PP (IN between) (NP (DT these) (NNS pathways)))))))) (. .)))
( (S (NP (NP (NNS Results)) (: :) (S (NP (PRP We)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (JJ cellular) (NN responsiveness)) (PP (TO to) (NP (NN Notch) (NNS signals)))) (VP (VBZ depends) (PP (IN on) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (DT the) (NN PI3K-Akt) (NN pathway))) (PP (IN in) (NP (NP (NNS cells)) (ADJP (RB as) (JJ diverse) (PP (IN as) (NP (NP (NN CHO) (NNS cells)) (, ,) (NP (JJ primary) (NNS T-cells)) (CC and) (NP (JJ hippocampal) (NNS neurons)))))))))))))) (. .))))
( (S (S (NP (NP (NN Induction)) (PP (IN of) (NP (DT the) (JJ endogenous) (NN PI3K-Akt) (NN pathway))) (PP (PP (IN in) (NP (NP (NN CHO) (NNS cells)) (PRN (-LRB- -LRB-) (PP (IN by) (NP (DT the) (NN insulin) (NN pathway))) (-RRB- -RRB-)))) (, ,) (PP (IN in) (NP (NP (NNS T-cells)) (PRN (-LRB- -LRB-) (PP (IN via) (NP (NN TCR) (NN activation))) (-RRB- -RRB-)))) (CC or) (PP (IN in) (NP (NP (NNS neurons)) (PRN (-LRB- -LRB-) (PP (IN via) (NP (NN TrKB) (NN activation))) (-RRB- -RRB-)))))) (VP (VBZ potentiates) (NP (NN Notch-dependent) (NNS responses)))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP propose) (SBAR (IN that) (S (NP (DT the) (NN PI3K-Akt) (NN pathway)) (VP (VBZ exerts) (NP (NP (PRP$ its) (NN influence)) (PP (IN on) (NP (NN Notch)))) (ADVP (RB primarily)) (PP (IN via) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (NN GSK3-beta)) (, ,) (NP (NP (DT a) (NN kinase)) (VP (VBN known) (S (VP (TO to) (VP (VP (VB phosphorylate)) (CC and) (VP (VB regulate) (NP (NN Notch) (NNS signals))))))))))))))))) (. .)))
( (S (NP (NP (NN Conclusion)) (: :) (S (NP (DT The) (NN PI3K-Akt) (NN pathway)) (VP (VBZ acts) (PP (IN as) (NP (NP (DT a) (`` ``) (NN gain) (NN control) (NN '')) (PP (IN for) (NP (NN Notch) (NN signal) (NNS responses))))))) (. .))))
( (S (S (SBAR (IN Since) (S (NP (NP (JJ physiological) (NNS levels)) (PP (IN of) (NP (JJ intracellular) (NN Notch)))) (VP (VBP are) (ADVP (RB often)) (ADJP (JJ low))))) (, ,) (NP (NP (NN coincidence)) (PP (IN with) (NP (NN PI3K-activation)))) (VP (MD may) (VP (VB be) (ADJP (JJ crucial) (PP (IN for) (NP (NP (NN induction)) (PP (IN of) (NP (NN Notch-dependent) (NNS responses))))))))) (. .)))
( (S (NP (NN Background))))
( (S (S (NP (NP (DT The) (NNS phosphoinositide-3-kinases)) (PRN (-LRB- -LRB-) (NP (NNS PI3Ks)) (-RRB- -RRB-))) (VP (VBP constitute) (NP (NP (DT an) (NN enzyme) (NN family)) (PP (IN of) (NP (NN p85/p110) (NNS heterodimers))) (ADJP (JJ responsible) (PP (IN for) (S (VP (VBG regulating) (NP (JJ numerous) (JJ biological) (NNS processes)) (PP (IN in) (NP (NP (JJ diverse) (NN cell) (NNS types)) (ADJP (NN -LSB-1) (-RRB- -RSB-) (JJ such) (PP (IN as) (NP (NP (JJ cellular) (NN proliferation)) (, ,) (NP (NN differentiation)) (CC and) (NP (NN survival)))))))))))))) (. .)))
( (S (SINV (PP (IN Of) (NP (JJ particular) (NN interest))) (VP (VBZ is) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (DT this) (NN pathway))) (PP (IN in) (NP (NN lymphocyte) (NN activation)))) (PRN (, ,) (SBAR (WHADVP (WRB where)) (S (NP (NP (NN antigen)) (CC and) (NP (NN cytokine) (NN receptor) (NN ligation))) (VP (VBP result) (PP (IN in) (NP (NP (NN activation)) (PP (IN of) (NP (CD PI3K-driven) (NNS signals) (NN -LSB-2)))))))) (-RRB- -RSB-))) (. .))))
( (S (S (NP (NP (DT A) (JJ key) (NN target)) (PP (IN of) (NP (NN PI3K) (NN activity)))) (VP (VBZ is) (NP (NP (NN Akt/PKB)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ mediates) (NP (NP (JJ many)) (PP (IN of) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN PI3K) (NN activation) (CD -LSB-3))))))))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (NN PI3K)) (VP (VBZ is) (VP (VBN activated) (PP (PP (IN in) (NP (NNS T-cells))) (CC both) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (NP (NN T-cell) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN TCR)) (-RRB- -RRB-))) (NN stimulation))))) (, ,) (CC and) (PP (IN by) (NP (NP (NN engagement)) (PP (IN of) (NP (DT the) (JJ co-stimulatory) (NN receptor) (NN CD28))))))))) (. .)))
( (S (S (NP (NN Gene) (NN targeting) (NNS studies)) (VP (VBP have) (VP (VBN emphasised) (NP (DT the) (JJ essential) (NN role) (S (NP (NN PI3K)) (VP (VBZ plays) (PP (IN in) (NP (DT these) (NNS responses))))))))) (: :) (S (SBAR (IN whereas) (S (NP (JJ PI3K-deficient) (NNS mice)) (VP (VBP are) (NP (JJ immunodeficient) (NN -LSB-4,5))) (-RRB- -RSB-))) (, ,) (NP (JJ constitutive) (NN activity)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (JJ hyperproliferative) (NN T-cell) (NNS responses)) (CC and) (NP (NN autoimmunity) (CD -LSB-6) (-RRB- -RSB-))))))) (. .)))
( (S (ADVP (RB Equally)) (, ,) (S (VP (VBG preventing) (NP (NP (DT the) (NN termination)) (PP (IN of) (NP (NN PI3K) (NN activity)))) (PP (IN by) (NP (NP (JJ conditional) (NN gene) (NN targeting)) (PP (IN of) (NP (NP (DT the) (NN lipid) (NN phosphatase) (NN Pten)) (PP (IN in) (NP (NNS T-cells))))))))) (VP (VBZ leads) (PP (TO to) (NP (NP (NP (NN autoimmunity)) (CC and) (NP (NN development))) (PP (IN of) (NP (NN lymphoma) (NN -LSB-7) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (DT These) (NNS studies)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN PI3K) (NN activity)) (VP (VP (VBZ is) (ADVP (RB tightly)) (VP (VBN regulated))) (CC and) (VP (VBZ plays) (NP (DT an) (JJ integral) (NN role)) (PP (IN in) (NP (NP (DT the) (NN maintenance)) (PP (IN of) (NP (NN lymphocyte) (NN homeostasis))))))))))) (. .)))
( (S (S (NP (DT The) (NN Notch) (NN signalling) (NN pathway)) (VP (VBZ plays) (NP (DT a) (JJ critical) (NN role)) (PP (IN in) (NP (NP (DT a) (JJ wide) (NN range)) (PP (IN of) (NP (NP (JJ developmental) (NNS processes)) (PP (IN in) (NP (DT the) (NN embryo))) (, ,) (PP (VBG including) (NP (NP (JJ binary) (NN lineage) (NNS decisions)) (CC and) (NP (NN boundary) (NN formation) (CD -LSB-8))))))))) (-RRB- -RSB-)) (. .)))
( (S (NP (NP (NN Binding)) (PP (IN of) (NP (DT the) (NN Notch) (NNS ligands) (NP (NP (NN Delta)) (CC or) (NP (NN Jagged))))) (PP (TO to) (NP (DT the) (NN Notch) (NN receptor)))) (VP (VBZ instigates) (NP (NP (JJ proteolytic) (NN cleavage)) (SBAR (WHNP (WDT which)) (S (VP (VBZ releases) (NP (NP (NP (DT the) (NN Notch) (JJ intracellular) (NN domain)) (PRN (-LRB- -LRB-) (NP (NNP N-IC) (-RRB- -RRB-) (CD -LSB-8)) (-RRB- -RSB-))) (SBAR (WHNP (WDT which)) (S (VP (VBZ activates) (NP (NP (DT the) (NN transcription) (NN factor) (NN CBF-1)) (SBAR (WHNP (WDT which)) (S (, ,) (PP (IN in) (NP (NN turn))) (, ,) (VP (VBZ controls) (NP (NP (NN target) (NNS genes)) (PP (JJ such) (IN as) (NP (NN Hes-1) (NN -LSB-9))))) (-RRB- -RSB-))))))))))))) (. .)))
( (S (S (NP (NP (JJ Central)) (PP (TO to) (NP (NP (NN Notch) (POS 's)) (NN role)))) (VP (VBZ is) (NP (PRP$ its) (NN ability) (S (VP (TO to) (VP (VB modulate) (NP (NP (DT the) (JJ differentiative) (NN potential)) (PP (IN of) (NP (JJ pluripotent) (NNS cells)))))))) (, ,) (PP (IN for) (NP (NN instance))) (PP (IN in) (NP (DT the) (JJ neural) (NN stem) (NN cell) (NN compartment))))) (. .)))
( (S (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NN Notch)))) (ADVP (RB also)) (VP (VBP extend) (PP (TO to) (NP (NP (DT the) (VBG developing) (JJ immune) (NN system)) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (PRP it)) (VP (VBZ directs) (NP (NP (DT the) (NN differentiation)) (PP (IN of) (NP (JJ lymphoid) (NNS precursors) (NP (CD -LSB-10)))))) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (JJ Recent) (NNS data)) (VP (VBP have) (VP (VBN highlighted) (NP (NP (JJ unexpected) (NNS functions)) (PP (IN for) (NP (DT the) (NN Notch) (NN pathway)))) (PP (IN in) (S (VP (VBG regulating) (NP (NP (NNS cells)) (PP (IN of) (NP (DT the) (JJ peripheral) (JJ immune) (NN system)))))))))) (. .)))
( (S (S (NP (NP (JJ Co-incident) (NN delivery)) (PP (IN of) (NP (NN Notch) (NNS signals))) (PP (TO to) (NP (NNS T-cells)))) (VP (VBZ exerts) (NP (DT a) (JJ profound) (NN effect)) (PP (IN upon) (NP (NP (DT the) (NN outcome)) (PP (IN of) (NP (NP (NN antigen-stimulation) (ADJP (FW in) (FW vitro)) (NN -LSB-11-13) (-RRB- -RSB-)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NP (NN interplay)) (PP (IN between) (NP (DT the) (NN antigen) (NN receptor)))) (CC and) (NP (NN Notch) (NNS pathways))) (VP (VBP regulate) (NP (NP (DT the) (NN outcome)) (PP (IN of) (NP (JJ peripheral) (NN T-cell) (NNS responses)))))))))))))) (. .)))
( (S (S (NP (NP (NNS Mice)) (VP (VBG expressing) (NP (NP (ADJP (RB catalytically) (JJ inactive)) (NN PI3K) (NN subunit) (NN p110δ) (CD -LSB-5) (-RRB- -RSB-)) (CC or) (NP (NP (DT a) (NN deletion)) (PP (IN of) (NP (NN p110δ) (NN -LSB-4)))) (-RRB- -RSB-)))) (VP (VBP exhibit) (NP (JJ defective) (NP (NP (NN B-cell)) (CC and) (NP (NN T-cell))) (NN receptor) (NN signalling)))) (: :) (S (S (NP (NP (JJ antigen-mediated) (NN activation)) (PP (IN of) (NP (NP (NN BCR)) (CC or) (NP (NN TCR))))) (VP (VBZ fails) (S (VP (TO to) (VP (VB activate) (NP (NN Akt))))))) (CC and) (S (NP (NNS cells)) (VP (VBP exhibit) (NP (NP (JJ defective) (NN proliferation)) (CC and) (NP (NN cytokine) (NNS responses)))))) (. .)))
( (S (S (NP (JJ Recent) (NNS publications)) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NN Notch) (NNS signals)) (VP (VBP modulate) (NP (NN cytokine) (NN production)) (PP (IN by) (NP (NNS T-cells) (CD -LSB-12,13) (-RRB- -RSB-))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (DT the) (NN Notch) (NN pathway)) (VP (VBZ integrates) (PP (IN with) (NP (JJ TCR-mediated) (NNS signals))) (S (VP (TO to) (VP (VB modulate) (NP (NN cytokine) (NN production)))))))))))))))) (. .)))
( (S (S (ADVP (RB Furthermore)) (, ,) (NP (JJ marginal) (NN zone) (NN B) (-LRB- -LRB-) (NN MZB) (-RRB- -RRB-) (NN cell) (NN development)) (VP (VBZ is) (ADJP (RB severely) (JJ impaired) (PP (IN in) (NP (UCP (CC both) (NP (NN p110δ-)) (CC and) (ADJP (JJ Notch2-deficient))) (NNS mice) (CD -LSB-4,14) (-RRB- -RSB-)))))) (. .)))
( (S (S (S (VP (VBN Taken) (ADVP (RB together)) (PP (IN with) (NP (NN Notch) (POS 's) (NN ability) (S (VP (TO to) (VP (VB modulate) (NP (NN TCR) (NNS signals))))))))) (, ,) (NP (DT this) (JJ phenotypic) (NN similarity)) (VP (VBD suggested) (PP (TO to) (NP (PRP us))) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (NN Notch/PI3K) (NN signalling) (NN integration)))))) (. .)))
( (S (S (NP (PRP$ Our) (NNS studies)) (VP (VBP reveal) (SBAR (IN that) (S (NP (DT the) (NN PI3K-Akt) (NN pathway)) (VP (VBZ is) (NP (NP (DT a) (JJ potent) (NN inducer)) (PP (IN of) (NP (NN Notch-dependent) (NNS responses)))) (PP (IN in) (NP (NP (NN cell) (NNS types)) (PP (IN as) (NP (NP (JJ diverse) (NNS T-cells)) (CC and) (NP (NNS neurons)))))) (, ,) (S (VP (VBG demonstrating) (SBAR (IN that) (S (NP (DT this)) (VP (VBZ is) (NP (NP (DT a) (NN cell) (NN signalling) (NN paradigm)) (PP (IN with) (NP (JJ broad) (NN applicability)))))))))))))) (. .)))
( (S (NP (NNS Results))))
( (S (S (S (VP (TO To) (VP (VB address) (SBAR (IN whether) (S (NP (DT the) (NN PI3K) (NN pathway)) (VP (VBZ is) (NP (NP (DT a) (NN regulator)) (PP (IN of) (NP (NN Notch-responsiveness)))))))))) (, ,) (NP (PRP we)) (VP (VBD generated) (NP (NP (DT a) (NN Jurkat) (NN E6.1) (NN T-cell) (NN line)) (SBAR (WHNP (WDT which)) (S (ADVP (RB stably)) (VP (VBZ expresses) (NP (NP (JJ full-length) (JJ human) (NN Notch2) (NN cDNA)) (PRN (-LRB- -LRB-) (NP (NN J-N2) (NNS cells)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (S (NP (NN J-N2) (NNS cells)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (JJ plate-bound) (NP (NP (JJ recombinant) (JJ human) (NN Delta1) (NN protein)) (PRN (-LRB- -LRB-) (ADVP (RB hereafter)) (VP (VBN referred) (PP (TO to)) (PP (IN as) (NP (NN Delta1-Fc)))) (-RRB- -RRB-))) (NN fusion) (NN protein)))))) (, ,) (CC and) (S (NP (NN Notch) (NN signalling)) (VP (VBD was) (VP (VBN measured) (S (VP (VBG using) (NP (NP (DT a) (JJ transiently-transfected) (JJ CBF1-driven) (NN luciferase) (NN reporter) (NN construct)) (PRN (-LRB- -LRB-) (NP (NN p10xCBF1-luc)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (JJ Plate-bound) (JJ recombinant) (NN Delta1-Fc)) (ADVP (RB efficiently)) (VP (VBD transactivated) (NP (NP (NN CBF1-luc)) (, ,) (VP (VBG driving) (PP (IN around) (NP (NP (DT a) (JJ 10-fold) (NN increase)) (PP (IN in) (NP (NP (NN activity)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 1A)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (DT A) (JJ similar) (NN result)) (VP (VBD was) (VP (VBN obtained) (S (VP (VBG using) (NP (NP (DT the) (JJ murine) (NN Hes-1) (NN promoter)) (VP (VBN cloned) (ADVP (RB upstream) (PP (IN of) (NP (DT the) (NN luciferase) (NN reporter)))) (PRN (-LRB- -LRB-) (NP (NP (NNS data)) (VP (ADVP (RB not)) (VBN shown))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (ADVP (RB Strikingly)) (, ,) (NP (NP (NN treatment)) (PP (IN of) (NP (DT these) (NNS cells))) (PP (IN with) (NP (DT the) (NN PI3K) (NN inhibitor) (NN LY294002)))) (VP (VBD led) (PP (TO to) (NP (NP (DT a) (JJ dose-dependent) (NN decrease)) (PP (IN in) (NP (NP (JJ Delta1-Fc-induced) (NN Notch) (NN signalling)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 1A)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (DT A) (JJ similar) (NN result)) (VP (VBD was) (VP (VBN observed) (PP (IN with) (NP (NP (DT the) (JJ mechanistically-distinct) (NN PI3K) (NN inhibitor) (NN Wortmannin)) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (DT The) (NN integrity)) (PP (IN of) (NP (DT this) (NN reporter) (NN assay))) (PP (IN as) (NP (NP (DT an) (JJ accurate) (NN reflection)) (PP (IN of) (NP (NN Notch) (NN signalling)))))) (VP (VBD was) (VP (VBN confirmed) (PP (IN by) (S (VP (VBG assessing) (NP (NP (NN mRNA) (NNS levels)) (PP (IN of) (NP (DT the) (NN Notch) (NN target) (NN gene) (NN Hes-1)))) (PP (IN by) (NP (NP (NN Q-PCR)) (PP (IN in) (NP (NP (JJ Delta1-Fc-treated) (NN J-N2) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 1B)) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (PP (IN As) (PP (IN with) (NP (DT the) (JJ CBF1-dependent) (NN reporter)))) (, ,) (NP (NP (NN treatment)) (PP (IN with) (NP (NN LY294002)))) (VP (VBD inhibited) (NP (NP (DT the) (NN up-regulation)) (PP (IN of) (NP (NN Hes-1))) (PP (IN by) (NP (NN Delta1-Fc)))))) (. .)))
( (S (S (NP (DT The) (NN lipid) (NN phosphatase) (NN Pten)) (VP (VP (VBZ dephosphorylates) (NP (NP (DT the) (CD 3) ('' ') (NN phosphoinositide) (NNS products)) (PP (IN of) (NP (NN PI3K) (NN catalysis))))) (CC and) (VP (VBZ prevents) (NP (NP (JJ downstream) (NN PI3K) (NN signaling)) (NN -LSB-1) (-RRB- -RSB-))))) (. .)))
( (S (S (NP (NN Jurkat) (NN E6.1) (NNS cells)) (VP (VP (VBP are) (ADJP (JJ deficient) (PP (IN in) (NP (NP (NN expression)) (PP (IN of) (NP (NN Pten))))))) (, ,) (CC and) (ADVP (RB therefore)) (VP (VBP have) (NP (DT a) (ADJP (RB highly) (JJ active)) (NN PI3K-Akt) (NN pathway) (CD -LSB-15)) (-RRB- -RSB-)))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB therefore)) (VP (VBN hypothesised) (SBAR (IN that) (S (S (VP (VBG reconstituting) (NP (DT this) (NN enzyme)))) (VP (MD would) (VP (VB reduce) (NP (NN Notch) (NN signalling)))))))) (. .)))
( (S (S (NP (NP (JJ Transient) (NN expression)) (PP (IN of) (NP (NN Pten))) (PP (IN in) (NP (NN J-N2) (NNS cells)))) (VP (VBD led) (PP (TO to) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (ADJP (CC both) (ADJP (JJ basal)) (CC and) (ADJP (NN Notch) (JJ ligand-induced))) (NN activation)) (PP (IN of) (NP (NP (JJ CBF1-dependent) (NN gene) (NN expression)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 1C)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NP (ADJP (JJ Pten-transfected))) (CC and) (NP (ADJP (JJ control))) (NP (NNS cells))) (VP (VBD showed) (NP (JJ equivalent) (NN CBF1-reporter) (NN activity)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN LY294002))))) (, ,) (S (VP (VBG demonstrating) (SBAR (IN that) (S (SBAR (IN once) (S (NP (NN PI3K) (NN activity)) (VP (VBZ is) (VP (VBN abolished) (ADVP (RB pharmacologically)))))) (, ,) (NP (NN Pten) (NN over-expression)) (VP (VBZ becomes) (ADJP (JJ redundant))))))))) (. .)))
( (S (S (NP (DT The) (NN PI3K) (NN pathway)) (VP (VBZ activates) (NP (NP (JJ several) (NNS enzymes)) (, ,) (PP (VBG including) (NP (DT the) (JJ central) (NN signalling) (NN molecule) (NN Akt/PKB)))))) (. .)))
( (S (S (S (VP (TO To) (ADVP (RB further)) (VP (VB define) (NP (NP (DT the) (NN mechanism)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (NN PI3K) (NN activity)) (VP (VBZ regulates) (NP (NN Notch) (NNS signals))))))))) (, ,) (NP (PRP we)) (VP (VBD asked) (SBAR (IN whether) (S (NP (NP (DT the) (JJ inhibitory) (NN effect)) (PP (IN of) (NP (NN LY294002)))) (VP (MD could) (VP (VB be) (VP (VBN recapitulated) (PP (IN with) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (NN Akt)))))))))))) (. .)))
( (S (S (S (VP (VBG Blocking) (NP (NP (NN Akt) (NN activity)) (PP (IN in) (NP (NN J-N2) (NNS cells)))) (PP (IN with) (NP (DT the) (JJ selective) (NN inhibitor))))) (NP (NN SH-6) (CD -LSB-16) (-RRB- -RSB-)) (VP (VBD inhibited) (NP (NP (JJ Delta1-Fc-mediated) (NN upregulation)) (PP (IN of) (NP (NP (NN Notch) (NN signalling)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 1D)) (-RRB- -RRB-))))))) (. .)))
( (S (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (NP (DT these) (NNS data)) (VP (VBP identify) (NP (DT the) (NN PI3K-Akt) (NN pathway)) (PP (IN as) (S (VP (VBG being) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (JJ high) (NN level)) (PP (IN of) (NP (NP (JJ ligand-induced) (NN Notch) (NN activation)) (PP (IN in) (NP (NN J-N2) (NNS cells))))))))))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB next)) (VP (VBD investigated) (SBAR (IN whether) (S (NP (NN PI3K) (NN activity)) (ADVP (RB also)) (VP (VBZ regulates) (NP (NP (NN Notch-responsiveness)) (PP (IN in) (NP (JJ primary) (JJ human) (JJ CD4+) (NNS T-cells))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD asked) (SBAR (IN whether) (S (NP (NP (NN PI3K) (NN induction)) (, ,) (VP (VBN triggered) (PP (IN by) (NP (NN TCR) (NN activation)))) (, ,)) (VP (MD could) (VP (VB influence) (NP (NP (NN Hes-1) (NNS levels)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 2A)) (-RRB- -RRB-))))))))) (. .)))
( (S (PP (IN In) (DT the) (NN absence) (IN of) (NP (NP (DT any) (ADJP (RB exogenously) (VBN added)) (NN Delta) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN open) (NN bars-IgG) (NN control)) (-RRB- -RRB-)))) (, ,) (NP (NP (NN TCR) (NN activation)) (PRN (-LRB- -LRB-) (PP (IN with) (NP (JJ anti-CD3/anti-CD28) (NNS antibodies))) (-RRB- -RRB-))) (VP (VBD up-regulated) (NP (NN Hes-1) (NNS levels)) (PP (IN in) (NP (DT a) (JJ LY294002-sensitive) (NN manner)))) (. .)))
( (S (S (ADVP (RB Significantly)) (, ,) (NP (DT this) (NN induction)) (VP (VBD was) (ADVP (RB also)) (VP (VBN blocked) (PP (IN by) (NP (DT the) (NN gamma) (NN secretase) (NN inhibitor) (NN DAPT))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT an) (JJ absolute) (NN requirement)) (PP (IN for) (NP (NN N-IC)))))))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB also)) (VP (VBD studied) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NN Hes-1))) (PP (IN by) (NP (NP (NN Delta) (NN 1-Fc) (NN treatment)) (PRN (-LRB- -LRB-) (NP (JJ closed) (NNS bars)) (-RRB- -RRB-))))))) (. .)))
( (S (S (PP (IN In) (DT the) (NN absence) (IN of) (NP (NN TCR) (NN activation))) (, ,) (NP (NN Delta) (NN 1-Fc)) (VP (VBD induced) (NP (NP (DT a) (ADJP (ADJP (JJ small)) (, ,) (CC but) (ADJP (JJ consistent))) (NN induction)) (PP (IN of) (NP (NN Hes-1)))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NP (NN coincidence)) (PP (IN of) (NP (NN Delta) (NN 1-Fc))) (PP (IN with) (NP (NP (NN TCR) (NN activation)) (PRN (-LRB- -LRB-) (NP (JJ anti-CD3/anti-CD28) (NNS antibodies)) (-RRB- -RRB-))))) (ADVP (RB dramatically)) (VP (VBD up-regulated) (NP (NN Hes-1) (NNS levels)) (PP (IN in) (NP (DT a) (JJ LY294002-sensitive) (NN manner))))) (. .)))
( (S (S (ADVP (RB Again)) (, ,) (NP (DT this) (NN induction)) (VP (VBD was) (ADVP (RB also)) (VP (VBN blocked) (PP (IN by) (NP (DT the) (NN gamma) (NN secretase) (NN inhibitor) (NN DAPT)))))) (. .)))
( (S (NP (NN LY294002)) (ADVP (RB also)) (VP (VBD inhibited) (NP (NP (NN Notch) (NN signalling)) (PP (IN in) (NP (NP (JJ primary) (JJ human) (JJ CD4+) (NNS T-cells)) (VP (VBN transfected) (PP (IN with) (NP (NP (NN p10xCBF1-luc)) (CC and) (NP (NP (DT a) (NN Notch1) (JJ intracellular) (NN domain) (NN expression) (NN plasmid)) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-))))))))) (, ,) (S (VP (VBG demonstrating) (SBAR (IN that) (S (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN PI3K))) (PP (IN on) (NP (NN Notch)))) (VP (VBZ is) (VP (VBN exerted) (ADVP (RB downstream) (PP (IN of) (NP (NN Notch) (NN cleavage))))))))))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (NP (NN TCR) (NN activation)) (ADVP (RB dramatically)) (VP (VBZ increases) (NP (NP (DT the) (JJ cellular) (NN response)) (PP (TO to) (NP (NN Notch) (NNS signals))) (PP (IN in) (NP (JJ primary) (JJ human) (NN T) (NNS cells)))) (PP (IN via) (NP (NP (DT a) (NN mechanism)) (VP (VBG requiring) (NP (DT the) (NN PI3K-Akt) (NN pathway))))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB then)) (VP (VBD tested) (SBAR (IN whether) (S (NP (NN Akt) (NN activation)) (VP (VBZ is) (ADJP (JJ sufficient) (S (VP (TO to) (VP (VB boost) (NP (NP (NN Notch-responsiveness)) (PP (IN in) (NP (JJ human) (NN T) (NNS cells))))))))))))) (. .)))
( (S (S (NP (NP (NN Over-expression)) (PP (IN of) (NP (NP (DT a) (JJ constitutively-active) (NN Akt) (NN construct)) (PRN (-LRB- -LRB-) (NP (NN gagAkt) (CD -LSB-17)) (-RRB- -RSB-) (-RRB- -RRB-))))) (VP (VBD was) (ADJP (JJ sufficient) (S (VP (TO to) (VP (VB potentiate) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN pN1-IC))) (S (VP (TO to) (VP (VB drive) (NP (NP (JJ CBF1-dependent) (NN reporter) (NN activity)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 2B)) (-RRB- -RRB-))))))))))))) (. .)))
( (S (S (NP (JJ Previous) (NNS data)) (VP (VBZ has) (VP (VBN suggested) (SBAR (IN that) (S (NP (NP (NN inactivation)) (PP (IN of) (NP (NN GSK3β))) (PP (IN by) (NP (DT the) (NN Wingless) (NN pathway)))) (VP (VBD enhanced) (NP (NN Notch) (NNS signals)) (PP (IN by) (S (VP (VBG preventing) (NP (NP (JJ inhibitory) (NN phosphorylation)) (PP (IN of) (NP (NN N-IC))) (PP (IN by) (NP (NNP GSK3β) (CD -LSB-18) (-RRB- -RSB-))))))))))))) (. .)))
( (S (ADVP (RB Therefore)) (, ,) (PP (VBN given) (SBAR (IN that) (S (NP (NN Akt)) (VP (VP (VBZ phoshorylates)) (CC and) (VP (VBZ inactivates) (NP (NN GSK3β) (CD -LSB-19) (-RRB- -RSB-))))))) (, ,) (NP (PRP we)) (VP (VBN hypothesised) (SBAR (IN that) (S (NP (NP (JJ Akt-dependent) (NN inactivation)) (PP (IN of) (NP (NN GSK3β)))) (VP (MD might) (VP (VB be) (ADJP (JJ responsible) (PP (IN for) (NP (NN Notch) (NN potentiation))))))))) (. .)))
( (S (S (VP (TO To) (VP (VB address) (NP (DT this) (NN question))))) (, ,) (NP (PRP we)) (VP (VBD looked) (PP (IN at) (NP (NP (DT the) (JJ N1-IC-induced) (NN Notch) (NN response)) (PP (IN in) (NP (NP (JJ primary) (JJ human) (JJ CD4+) (NNS T-cells)) (VP (VBN treated) (PP (IN with) (NP (DT the) (NN GSK3β) (NN inhibitor) (NN lithium) (NN chloride))))))))) (. .)))
( (S (S (NP (NP (VBG Increasing) (NNS concentrations)) (PP (IN of) (NP (NN LiCl)))) (VP (VBD induced) (NP (NP (DT a) (JJ dramatic) (NN increase)) (PP (IN in) (NP (NP (NN Notch) (NN signalling)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 3A)) (-RRB- -RRB-))))))) (. .)))
( (S (S (PP (IN In) (NP (NP (NN contrast)) (PP (TO to) (NP (JJ N1-IC) (NN overexpression))))) (, ,) (NP (NP (VBG triggering) (NN Notch) (NN signalling)) (VP (VBG using) (NP (JJ recombinant) (NN ligand)) (S (VP (TO to) (VP (VB ligate) (NP (JJ endogenous) (JJ full) (NN length) (NN Notch))))))) (VP (VBZ generates) (NP (ADJP (RB far) (JJR weaker)) (NN signalling)))) (. .)))
( (S (S (NP (NP (DT This) (NN fact)) (, ,) (VP (VBN coupled) (PP (IN with) (NP (NP (JJ limited) (NN transfection) (NN efficiency)) (PP (IN of) (NP (JJ primary) (NN T) (NNS cells)))))) (, ,)) (VP (VBZ makes) (S (NP (PRP it)) (ADVP (RB technically)) (ADJP (JJ difficult) (S (VP (TO to) (VP (VB achieve) (NP (NP (JJ robust) (NN induction)) (PP (IN of) (NP (DT a) (VBN transfected) (NN CBF1) (NN reporter) (NN construct))) (PP (IN by) (NP (NN Delta1-Fc))))))))))) (. .)))
( (S (ADVP (RB However)) (, ,) (PP (IN given) (NP (NP (NP (DT the) (JJ large) (NN potentiation)) (PP (IN of) (NP (NN Notch-responsiveness))) (PP (IN by) (NP (NN LiCl)))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 3A)) (-RRB- -RRB-)))) (, ,) (NP (PRP we)) (VP (VBN hypothesised) (SBAR (IN that) (S (, ,) (PP (IN in) (DT the) (NN presence) (IN of) (NP (NN LiCl))) (, ,) (NP (NP (JJ robust) (ADJP (NN Delta1-Fc) (JJ dependent)) (NN induction)) (PP (IN of) (NP (DT a) (NN CBF1) (NN reporter)))) (VP (MD could) (VP (VB be) (VP (VBN observed))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (, ,) (S (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ technical) (NNS issues)) (VP (VBP outline) (ADJP (JJ above))))))) (, ,) (NP (JJ plate-bound) (NN Delta1-Fc)) (VP (VBZ activates) (NP (DT the) (NN CBF1) (NN reporter)) (ADVP (ADVP (RB weakly)) (CC and) (ADVP (RB unreliably))) (PP (IN in) (DT the) (NN absence) (IN of) (NP (NP (NN LiCl)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 3B)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NN LiCl)) (ADVP (RB greatly)) (VP (VBZ potentiates) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NN reporter))) (PP (IN by) (NP (NP (JJ plate-bound) (NN Delta1-Fc)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 3B)) (-RRB- -RRB-))))))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (NP (DT the) (NN GSK3β) (NN inhibitor) (NN LiCl)) (VP (VBZ is) (ADJP (JJ sufficient) (S (VP (TO to) (VP (VB potentiate) (NP (NP (JJ primary) (NN Notch-responsiveness)) (PP (IN in) (NP (JJ primary) (JJ human) (JJ CD4+) (NNS T-cells))) (, ,) (VP (VBN triggered) (PP (CC either) (PP (IN by) (NP (JJ N1-IC) (NN expression))) (, ,) (CC or) (PP (IN by) (NP (NP (NN ligation)) (PP (IN of) (NP (JJ endogenous) (JJ full) (NN length) (NN Notch)))))) (PP (IN by) (NP (JJ plate-bound) (NN ligand))))))))))) (. .)))
( (S (PP (IN In) (NP (NP (NN Jurkat) (NNS T-cells)) (, ,) (ADJP (JJ deficient) (PP (IN in) (NP (NN Pten) (NN expression)))))) (, ,) (NP (JJ basal) (NN Akt) (NN activity)) (VP (VBZ is) (NP (JJ high) (NN -LSB-15) (-RRB- -RSB-)) (, ,) (SBAR (IN so) (S (NP (PRP we)) (VP (VBN expected) (NP (NN GSK3β)) (S (VP (TO to) (VP (VB be) (ADVP (RB maximally)) (VP (VBN inhibited))))))))) (. .)))
( (S (S (S (ADJP (JJ Consistent) (PP (IN with) (NP (DT this))))) (, ,) (NP (NN LiCl) (NN treatment)) (VP (VBD did) (RB not) (VP (VB exert) (NP (DT any) (JJ further) (NN effect)) (PP (IN on) (NP (NP (JJ Delta1-induced) (NN signalling)) (PP (IN in) (NP (NP (JJ Jurkat-N2) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 3C)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB investigate) (SBAR (IN whether) (S (NP (NP (JJ PI3K-dependent) (NN regulation)) (PP (IN of) (NP (NN Notch) (NN responsiveness)))) (VP (MD may) (VP (VB be) (NP (NP (DT a) (JJ general) (NN phenomenon)) (VP (VBG extending) (PP (IN beyond) (NP (NN T-cell) (NN biology)))))))))))) (, ,) (NP (PRP we)) (VP (VBD took) (NP (NP (NN advantage)) (PP (IN of) (NP (NP (DT a) (JJ Notch-dependent) (NN CHO) (NN cell) (NN reporter) (NN assay)) (SBAR (WHNP (WDT which)) (S (NP (PRP we)) (VP (VBP have) (ADVP (RB previously)) (VP (VBN described) (NP (NN -LSB-20)))))))))) (-RRB- -RSB-)) (. .)))
( (S (S (PP (IN In) (NP (DT this) (NN assay))) (, ,) (NP (NP (NN CHO) (NNS cells)) (SBAR (WHNP (WDT which)) (S (ADVP (RB stably)) (VP (VBP express) (NP (NP (DT a) (JJ human) (NN Notch2) (NN receptor) (NN cDNA)) (CC and) (NP (NP (DT a) (JJ CBF1-dependent) (NN luciferase) (NN reporter) (NN construct)) (PRN (-LRB- -LRB-) (NP (VBN termed) (NN CHO-N2)) (-RRB- -RRB-)))))))) (VP (VBP are) (VP (VBN co-cultured) (PP (IN with) (NP (NP (DT a) (JJ second) (NN CHO) (NN cell) (NN line)) (SBAR (WHNP (WDT which)) (S (ADVP (RB stably)) (VP (VBZ expresses) (NP (NP (DT the) (JJ full-length) (JJ human) (NN Delta1) (NN cDNA)) (PRN (-LRB- -LRB-) (NP (VBN termed) (NN CHO-hDelta1)) (-RRB- -RRB-))))))))))) (. .)))
( (S (NP (NN CHO-hDelta1) (NNS cells)) (VP (VBP trigger) (NP (NP (DT a) (JJ dose-dependent) (NN luciferase) (NN response)) (PP (TO to) (NP (DT the) (JJ CHO-N2) (NNS cells)))) (, ,) (SBAR (IN whilst) (S (NP (NN control) (NN CHO) (JJ parental) (NNS cells)) (VP (VBP fail) (S (VP (TO to) (VP (VB activate) (NP (NP (DT the) (NN Notch) (NN pathway)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 4A)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB next)) (VP (VBD asked) (SBAR (IN if) (S (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NN PI3K) (NN pathway)))) (VP (VBD influenced) (NP (NN Notch) (NNS signals)) (PP (IN in) (NP (DT this) (NN assay) (NN system)))))))) (. .)))
( (S (S (S (SBAR (IN As) (S (VP (VBN predicted) (PP (IN from) (NP (NP (PRP$ our) (NN T-cell) (NNS studies)) (, ,) (PP (VBG including) (NP (NP (NN insulin)) (PP (IN in) (NP (DT the) (NN culture) (NN medium)))))))))) (VP (VBD potentiated) (NP (NN Notch) (NN signalling)))) (, ,) (CC and) (S (NP (DT this) (NN effect)) (VP (VBD was) (VP (VBN blocked) (ADVP (RB almost) (RB completely)) (PP (IN by) (NP (NP (NN inclusion)) (PP (IN of) (NP (NN LY294002))))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 4B)) (-RRB- -RRB-)))))) (. .)))
( (S (S (PP (IN From) (NP (NP (PRP$ our) (NNS observations)) (PP (IN with) (NP (NNS T-cells))))) (, ,) (NP (PRP we)) (VP (VBP hypothesisesd) (SBAR (IN that) (S (NP (NP (NN GSK3β) (NN inhibition)) (PP (IN with) (NP (NN LiCl)))) (VP (MD could) (VP (VB substitute) (PP (IN for) (NP (NN insulin))) (PP (IN in) (S (VP (VBG potentiating) (NP (NP (NN Notch) (NN signalling)) (VP (VBN induced) (PP (IN by) (NP (NN CHO-hDelta1) (NNS cells)))))))))))))) (. .)))
( (S (S (NP (NN LiCl)) (VP (VBZ does) (RB indeed) (VP (VB potentiate) (NP (NN Notch) (NN signalling)) (PP (IN in) (NP (DT the) (NN CHO) (NN co-culture) (NN system))) (, ,) (S (VP (VBG leading) (PP (TO to) (NP (NP (DT a) (JJ substantial) (NN enhancement)) (PP (IN of) (NP (NP (JJ ligand-dependent) (NN reporter) (NN activity)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 4C)) (-RRB- -RRB-))))))))))) (. .)))
( (S (NP (PRP We)) (ADVP (RB then)) (VP (VBD extended) (NP (PRP$ our) (NN study)) (ADVP (RB further)) (, ,) (NP (DT this) (NN time)) (PP (IN into) (NP (NP (JJ primary) (NNS neurons)) (, ,) (NP (NN cell) (NNS types)))) (SBAR (WHADVP (WRB where)) (S (NP (NN Notch)) (VP (VBZ plays) (NP (DT an) (VBG emerging) (NN role)) (PP (IN in) (NP (NP (NNS processes)) (PP (JJ such) (IN as) (NP (NP (JJ dendritic) (NN patterning)) (CC and) (NP (JJ synaptic) (NN plasticity) (CD -LSB-21,22))))))) (-RRB- -RSB-)))) (. .)))
( (S (S (SBAR (IN As) (S (VP (VBN observed) (PP (IN with) (NP (NNS T-cells)))))) (, ,) (NP (NP (NN inhibition)) (PP (IN of) (NP (NN GSK3β))) (PP (IN with) (NP (NN lithium) (NN chloride)))) (ADVP (RB strongly)) (VP (VBD enhanced) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN Notch) (NN signalling))) (PP (IN in) (NP (NN rat) (JJ primary) (JJ hippocampal) (NNS neurons)))) (PP (IN in) (NP (DT a) (JJ dose-dependent) (NN manner))) (-LRB- -LRB-) (NP (NNP Fig.) (CD 4D)) (-RRB- -RRB-))) (. .)))
( (S (S (NP (NP (JJ PI3K-activating) (NNS neurotrophins)) (PP (JJ such) (IN as) (NP (NN BDNF)))) (VP (VBP regulate) (NP (NP (NP (NN cell) (NN survival)) (, ,) (NP (NN proliferation)) (CC and) (NP (NN differentiation))) (PP (IN of) (NP (CC both) (NP (ADJP (JJ peripheral))) (CC and) (NP (JJ central) (NNS neurons)) (NP (NN -LSB-23)))))) (-RRB- -RSB-)) (. .)))
( (S (S (ADVP (RB Strikingly)) (, ,) (S (NP (NN BDNF) (NN treatment)) (VP (VBD potentiated) (NP (JJ pN1-IC-driven) (NN reporter) (NN activity)))) (, ,) (CC and) (S (NP (DT this)) (VP (VBD was) (VP (VBN abrogated) (PP (IN by) (NP (NP (NN treatment)) (PP (IN with) (NP (NN LY294002))))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 4D)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (JJ Pten) (NN transfection)) (VP (VBD ablated) (NP (ADJP (CC both) (ADJP (JJ basal)) (CC and) (ADJP (JJ BDNF-stimulated))) (NN reporter) (NN signalling)) (, ,) (S (ADVP (RB further)) (VP (VBG underlining) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (DT the) (NN PI3K) (NN pathway))) (PP (IN in) (S (VP (VBG promoting) (NP (NP (NN Notch-responsiveness)) (PP (IN in) (NP (NNS neurons)))))))))))) (. .)))
( (S (S (ADVP (RB Moreover)) (, ,) (NP (NP (NN over-expression)) (PP (IN of) (NP (ADJP (RB constitutively) (JJ active)) (NN gagAkt)))) (VP (VBD was) (ADJP (JJ sufficient) (S (VP (TO to) (VP (VB potentiate) (NP (JJ pN1-IC-driven) (NN reporter) (NN activity)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 4E)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (S (S (VP (TO To) (ADVP (RB further)) (VP (VB reinforce) (NP (DT this) (NN finding))))) (, ,) (S (NP (NP (NN expression)) (PP (IN of) (NP (NP (DT a) (JJ constitutively-active) (NN GSK3β) (NN construct)) (PRN (-LRB- -LRB-) (NP (NN S9A)) (-RRB- -RRB-)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (JJ resistant) (PP (TO to) (NP (NP (NN inactivation)) (PP (IN by) (NP (NN Akt))))))))) (, ,)) (VP (VBD prevented) (NP (NP (NN BDNF) (NN induction)) (PP (IN of) (NP (NN Notch) (NN responsiveness))))))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 4E)) (-RRB- -RRB-))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NN expression)) (PP (IN of) (NP (JJ wild-type) (NNS GSK3β))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN inhibited) (PP (IN by) (NP (NN Akt) (NN activity))))))) (, ,)) (VP (VBD failed) (S (VP (TO to) (ADVP (RB significantly)) (VP (VB reduce) (NP (NN reporter) (NN activity))))))) (. .)))
( (S (S (SBAR (IN As) (S (VP (VBN observed) (PP (IN with) (NP (NNS T-cells)))))) (, ,) (NP (NP (NN inhibition)) (PP (IN of) (NP (NN GSK3β))) (PP (IN with) (NP (NN lithium) (NN chloride)))) (ADVP (RB strongly)) (VP (VBD enhanced) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN Notch) (NN signalling)))) (PP (IN in) (NP (DT a) (JJ dose-dependent) (NN manner))) (-LRB- -LRB-) (NP (NNP Fig.) (CD 4D)) (-RRB- -RRB-))) (. .)))
( (S (S (ADVP (RB Thus)) (NP (DT the) (NN PI3K-Akt) (NN pathway)) (ADVP (RB positively)) (VP (VBZ regulates) (NP (NN Notch) (NNS signals)) (PP (IN via) (NP (NP (NN GSK3β)) (PP (IN in) (NP (NP (NNS neurons)) (CONJP (RB as) (RB well) (IN as)) (NP (NNS T-cells)))))) (, ,) (SBAR (IN as) (S (VP (VBN summarised) (PP (IN in) (NP (NNP Fig.) (CD 5)))))))) (. .)))
( (S (NP (NN Discussion))))
( (S (S (NP (NP (DT The) (ADJP (ADJP (JJ dynamic)) (CC and) (ADJP (JJ interactive))) (NN nature)) (PP (IN of) (NP (JJ intracellular) (NN communication)))) (VP (VBZ dictates) (SBAR (IN that) (S (NP (NNS cells)) (VP (VBP are) (PP (IN in) (NP (NP (NN receipt)) (PP (IN of) (NP (JJ multiple) (JJ environmental) (NNS signals))))) (PP (IN at) (NP (DT any) (JJ given) (NN time)))))))) (. .)))
( (S (S (S (NP (DT The) (JJ cellular) (NN output)) (VP (MD must) (VP (VB represent) (NP (NP (DT a) (JJ net) (NN response)) (PP (TO to) (NP (NP (DT a) (JJ diverse) (NN set)) (PP (IN of) (NP (NNS cues))))))))) (, ,) (CC and) (ADVP (RB therefore)) (S (NP (NP (DT the) (NNS pathways)) (VP (VBG mediating) (NP (DT these) (NNS responses)))) (VP (VBP are) (ADVP (RB frequently)) (VP (VBN integrated))))) (. .)))
( (S (S (NP (PRP$ Our) (NNS studies)) (VP (VBP demonstrate) (PP (IN for) (NP (DT the) (JJ first) (NN time))) (SBAR (IN that) (S (NP (NN PI3K) (NN activity)) (ADVP (RB strongly)) (VP (VBZ potentiates) (NP (NP (NN Notch) (NN responsiveness)) (PP (IN in) (NP (JJ diverse) (NN cell) (NNS types))))))))) (. .)))
( (S (S (PP (IN Given) (NP (NP (DT the) (JJ vital) (NN nature)) (PP (IN of) (NP (NP (NN PI3K)) (CC and) (NP (NN Notch)))) (PP (IN in) (S (VP (VBG controlling) (NP (NP (JJ cellular) (NN survival)) (CC and) (NP (NN differentiation)))))))) (, ,) (NP (NP (DT the) (NNS implications)) (PP (IN of) (NP (DT this) (NN finding)))) (VP (VBP are) (ADJP (JJ far-reaching)))) (. .)))
( (S (S (NP (NP (NN Ligation)) (PP (IN of) (NP (NN lymphocyte) (NN antigen) (NNS receptors)))) (VP (VBZ leads) (PP (TO to) (NP (NP (NN activation)) (PP (IN of) (NP (NN PI3K))))) (, ,) (S (VP (VBG initiating) (NP (NP (DT a) (ADJP (ADJP (JJ diverse)) (CC and) (ADJP (JJ wide-ranging))) (NN set)) (PP (IN of) (NP (NP (NN signalling) (NNS pathways)) (PRN (NN -LSB-2) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (PRP$ Our) (NNS findings) (SBAR (IN that) (S (NP (NN PI3K) (NN activation)) (VP (VBZ enhances) (NP (NN Notch) (NN signalling)))))) (VP (VBZ leads) (S (NP (PRP us)) (VP (TO to) (VP (VB suggest) (SBAR (IN that) (S (NP (NN Notch) (NN pathway) (NN activation)) (VP (MD might) (VP (VB be) (NP (NP (DT an) (JJ inherent) (NN consequence)) (PP (IN of) (NP (NN lymphocyte) (NN activation))))))))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBZ positions) (NP (DT the) (NN Notch) (NN pathway)) (PP (IN as) (NP (NP (DT a) (JJ central) (NN mediator)) (PP (IN of) (NP (NP (JJ antigen-dependent) (NN stimulation)) (PP (IN of) (NP (JJ immune) (NNS cells))))))))) (. .)))
( (S (S (NP (NNS T-cells)) (VP (VP (VBP are) (ADJP (RB entirely) (JJ quiescent) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN antigen) (NNS signals))))))) (, ,) (CC but) (VP (VBP are) (VP (VBN shifted) (ADVP (RB rapidly)) (PP (IN into) (NP (NP (DT a) (NN state)) (PP (IN of) (NP (NP (NN activation)) (PP (VBG following) (NP (NN TCR) (NN ligation))))))))))) (. .)))
( (S (S (S (NP (NP (JJ Inappropriate) (NN control)) (PP (IN of) (NP (DT this) (NN activation)))) (VP (MD can) (VP (VB lead) (PP (TO to) (NP (JJ autoimmune) (NN disease)))))) (, ,) (CC and) (S (NP (RB therefore) (JJ negative) (NN feedback) (NNS loops)) (VP (VBP are) (NP (NP (DT an) (JJ inherent) (NN feature)) (PP (IN of) (NP (NN T-cell) (NN biology))))))) (. .)))
( (S (S (NP (JJ Recent) (NNS data)) (VP (VBP show) (SBAR (IN that) (S (NP (NN Notch) (NNS signals)) (VP (VBP block) (NP (NN Akt) (NN activation)) (PP (IN in) (NP (JJ peripheral) (JJ CD4+) (NNS T-cells) (NP (CD -LSB-13))))) (-RRB- -RSB-))))) (. .)))
( (S (ADVP (RB Indeed)) (NP (PRP we)) (ADVP (RB also)) (VP (VBP observe) (SBAR (IN that) (S (PP (IN in) (NP (JJ primary) (JJ human) (JJ CD4+) (NNS T-cells))) (NP (NP (JJ recombinant) (NN Delta1-IgG4) (NN fusion) (NN protein)) (, ,) (CC or) (NP (JJ Notch-IC) (NN expression)) (, ,)) (VP (VBZ blocks) (NP (NP (JJ TCR-mediated) (NN phosphorylation)) (PP (IN of) (NP (NP (NP (NN Akt)) (CC and) (NP (NN GSK3β))) (PRN (-LRB- -LRB-) (NP (NP (NN GM)) (, ,) (NP (NN BC)) (, ,) (NP (JJ unpublished) (NNS data))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (S (SBAR (IN Although) (S (NP (NN Akt) (NN activation)) (VP (VBZ is) (ADJP (JJ essential) (PP (IN for) (NP (NP (NN production)) (PP (IN of) (NP (NP (NNS cytokines)) (PP (JJ such) (IN as) (NP (NP (NN IL2)) (CC and) (NP (NN IFNγ)))))) (PP (IN by) (NP (NNS T-cells) (CD -LSB-24) (-RRB- -RSB-))))))))) (, ,) (NP (JJ constitutive) (NN activity)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (JJ cellular) (NN transformation) (CD -LSB-25))))) (-RRB- -RSB-)) (, ,) (CC and) (S (ADVP (RB therefore)) (NP (NP (DT the) (NN existence)) (PP (IN of) (NP (NP (DT a) (JJ negative) (NN feedback) (NN loop)) (S (VP (TO to) (VP (VB limit) (NP (JJ antigen-dependent) (NN Akt) (NN activation)))))))) (VP (MD would) (VP (VB appear) (ADJP (JJ rational)))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (S (NP (JJ co-incident) (NN Notch) (NNS signals)) (VP (VBP are) (VP (VBN enhanced) (PP (IN upon) (NP (NN TCR) (NN activation)))))) (, ,) (CC and) (S (NP (PRP we)) (VP (VBP hypothesise) (SBAR (IN that) (S (PP (IN by) (S (VP (VBG inhibiting) (NP (NN Akt) (NN activity))))) (, ,) (NP (VBN enhanced) (NN Notch) (NN signalling)) (VP (MD may) (VP (VB constitute) (NP (NP (DT a) (JJ negative) (NN feedback) (NN control)) (VP (VBG impacting) (PP (IN upon) (NP (JJ peripheral) (NN T-cell) (NN activation)))))))))))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ interesting) (S (VP (TO to) (VP (VB note) (SBAR (IN that) (S (S (PP (IN whilst) (NP (DT the) (NN model))) (NP (PRP we)) (VP (VBP propose) (S (VP (VBZ is) (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (NNS data)) (VP (VBN generated) (PP (IN in) (NP (JJ peripheral) (NNS T-cells))))))))))) (, ,) (S (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NNS studies)))) (VP (VBP suggest) (SBAR (IN that) (S (NP (DT the) (JJ opposite)) (VP (VBZ is) (ADJP (JJ true) (NP (CD -LSB-26-28) (-RRB- -RSB-)))))))))))))))) (. .)))
( (S (S (NP (NNP Ciofani) (FW et) (FW al)) (VP (VBP demonstrate) (SBAR (IN that) (S (PP (IN during) (NP (NP (DT the) (JJS earliest) (NNS stages)) (PP (IN of) (NP (NN T-cell) (NN development))) (PP (IN in) (NP (DT the) (NN thymus))))) (NP (NN Notch) (NNS signals)) (VP (VBP co-operate) (PP (IN with) (NP (NN pre-TCR) (NN signalling))) (S (VP (TO to) (VP (VB activate) (NP (JJ Akt-dependent) (NN metabolism)) (, ,) (S (ADVP (RB thereby)) (VP (VBG promoting) (NP (NP (NN expansion)) (PP (IN of) (NP (NP (DT those) (NNS T-cells)) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (VP (VBN undergone) (NP (JJ favourable) (NN TCR) (NN rearrangement))))))))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ functional) (NN outcome)) (PP (IN of) (NP (JJ PI3K/Notch) (NN pathway) (NN interaction)))) (ADVP (RB thus)) (VP (VBZ appears) (S (VP (TO to) (VP (VB reverse) (PP (IN from) (S (VP (VBG developing) (PP (TO to) (NP (NP (JJ mature) (NNS T-cells)) (, ,) (NP (NP (DT an) (NN observation)) (SBAR (WHNP (WDT which)) (S (ADVP (RB further)) (VP (VBZ underlines) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (DT the) (NN Notch) (NN pathway))) (S (VP (TO to) (VP (VB perform) (NP (ADJP (ADJP (JJ multiple)) (, ,) (ADJP (JJ context-dependent)) (, ,)) (NNS tasks)) (PP (IN during) (NP (NN development))))))))))))))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT a) (JJ molecular) (NN understanding)) (PP (IN of) (SBAR (WHADVP (WRB how)) (S (NP (NN Notch)) (VP (MD can) (VP (VB function) (PP (IN as) (NP (NP (DT a) (JJ bi-directional) (NN regulator)) (PP (IN of) (NP (NN Akt) (NN activity))))))))))) (VP (VBZ is) (NP (DT a) (NN research) (NN priority))))))) (. .)))
( (S (S (NP (PRP$ Our) (NN data)) (ADVP (RB strongly)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NN PI3K) (NN activity)) (VP (VBZ links) (PP (TO to) (NP (DT the) (NN Notch) (NN signalling) (NN pathway))) (PP (IN through) (NP (NP (JJ Akt-mediated) (NN inactivation)) (PP (IN of) (NP (NP (NN GSK3β)) (, ,) (NP (NP (DT a) (JJ known) (JJ downstream) (NN effector)) (PP (IN of) (NP (NN Akt))))))))))))) (. .)))
( (S (PP (IN In) (NP (NP (NN support)) (PP (IN of) (NP (DT this) (NN data))))) (, ,) (NP (NP (NN PI3K)) (CC and) (NP (NN GSK3β) (CD -LSB-18,28,29) (-RRB- -RSB-))) (VP (VBP have) (DT both) (VP (VBN been) (VP (VBN identified) (PP (IN as) (NP (NP (NN binding) (NNS partners)) (PP (IN for) (NP (NP (NN N-IC)) (PP (IN in) (NP (NN immunoprecipitation) (NNS studies)))))))))) (. .)))
( (S (S (NP (NN GSK3β)) (VP (VBZ has) (ADVP (RB also)) (ADVP (RB previously)) (VP (VBN been) (VP (VBN positioned) (PP (IN as) (NP (NP (DT a) (NN component)) (PP (IN of) (NP (DT the) (JJ downstream) (NN Notch) (NN signalling) (NN pathway))))) (PP (IN in) (NP (NP (JJ lateral) (NN inhibition)) (PP (IN in) (NP (FW Drosophila) (NN -LSB-30) (-RRB- -RSB-))))))))) (. .)))
( (S (ADVP (RB Furthermore)) (, ,) (NP (NN GSK3β) (NN activity)) (VP (VP (VBZ is) (VP (VBN inhibited) (ADVP (RB downstream) (PP (IN of) (NP (CC both) (DT the) (NP (NP (NN wingless)) (CC and) (NP (NN PI3K))) (NNS pathways)))))) (, ,) (CC and) (ADVP (RB thus)) (VP (VBZ represents) (NP (NP (DT a) (JJ convergent) (NN site)) (PP (IN for) (NP (NP (NN integration)) (PP (IN of) (NP (JJ extracellular) (NNS signals))) (PP (IN with) (NP (DT the) (NN Notch) (NN pathway)))))))) (. .)))
( (S (ADVP (RB Indeed)) (, ,) (S (VP (VBG inhibiting) (NP (NN GSK3β) (NN activity)) (PP (IN by) (S (VP (VBG activating) (NP (NP (DT the) (NN wingless) (NN pathway)) (PP (IN with) (NP (NN Wnt-1))))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB enhance) (NP (NN Notch-dependent) (NN reporter) (NN activity)) (PP (IN in) (NP (NN NIH-3T3) (NNS cells) (CD -LSB-18) (-RRB- -RSB-))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VB note) (, ,) (ADVP (RB however)) (, ,) (SBAR (IN that) (S (SBAR (IN although) (S (NP (NP (DT an) (NN interaction)) (PP (IN between) (NP (NP (NN GSK3β)) (CC and) (NP (NN Notch))))) (VP (VBZ seems) (ADVP (RB conclusively)) (VP (VBN proven))))) (, ,) (NP (NP (DT the) (JJ functional) (NNS consequences)) (PP (IN of) (NP (DT this) (NN interaction)))) (VP (VBP are) (RB not) (ADJP (JJ consistent) (PP (IN between) (NP (JJ different) (NNS studies))))))))) (. .)))
( (S (SBAR (IN Whilst) (S (NP (PRP$ our) (NN data)) (VP (VBZ agrees) (PP (IN with) (NP (NP (DT that)) (PP (IN of) (NP (NP (NNP Espinosa) (FW et) (FW al.)) (CD -LSB-18) (-RRB- -RSB-))) (, ,) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (SBAR (IN that) (S (NP (NN GSK3β) (NN activity)) (VP (VBZ inhibits) (NP (NN Notch) (NN signalling))))))))))))) (, ,) (NP (NP (NNS data)) (PP (IN from) (NP (NP (DT the) (NNP Nye) (NN laboratory)) (PP (IN in) (NP (JJ GSK3β-deficient) (JJ murine) (JJ embryonic) (NNS fibroblasts)))))) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (NN GSK3β)) (VP (VP (VBZ phosphorylates)) (CC and) (VP (VBZ stabilises) (ADJP (JJ Notch-IC))) (, ,) (S (VP (VBG leading) (PP (TO to) (NP (VBN enhanced) (NN signalling) (NN -LSB-29)))))) (-RRB- -RSB-)))) (. .)))
( (S (S (SBAR (IN Although) (S (NP (PRP we)) (VP (VBP have) (NP (NP (DT no) (JJ definitive) (NN explanation)) (PP (IN for) (NP (DT these) (JJ experimental) (NNS differences))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ possible)) (SBAR (IN that) (S (, ,) (SBAR (IN as) (S (VP (VBN discussed) (ADVP (RB above)) (PP (IN for) (NP (NP (NNS thymocytes)) (CC and) (NP (NNS T-cells))))))) (, ,) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN GSK3b))) (PP (IN on) (NP (NN Notch)))) (VP (VBZ changes) (PP (IN between) (NP (ADJP (ADJP (JJ embryonic)) (CC and) (ADJP (JJ mature))) (NNS tissues)))))))) (. .)))
( (S (S (NP (NP (NP (NN Notch) (POS 's)) (NN role)) (PP (IN during) (NP (JJ embryonic) (NN development)))) (VP (VBZ is) (RB not) (VP (VP (TO to) (ADVP (RB directly)) (NP (NP (NN program)) (JJ neuronal) (NN differentiation) (NP (PRP itself)))) (, ,) (CC but) (VP (TO to) (VP (VB inhibit) (NP (DT this) (NN cell) (NN fate) (NN choice)) (PP (IN in) (NP (JJ neighbouring) (NNS cells))) (PP (IN during) (NP (DT the) (JJ lateral) (NN inhibition) (NN process) (CD -LSB-8) (-RRB- -RSB-)))))))) (. .)))
( (S (S (PP (IN During) (NP (NN neurogenesis))) (, ,) (NP (DT this)) (VP (VBZ is) (VP (VBN achieved) (PP (IN by) (NP (NP (NN Notch) (NN target) (NNS genes)) (VP (VBG blocking) (NP (NP (NN transcription)) (PP (IN of) (NP (NP (JJ pro-neural) (NN transcription) (NNS factors)) (PP (JJ such) (IN as) (NP (NN MASH-1)))))))))))) (. .)))
( (S (ADVP (RB Interestingly)) (, ,) (NP (NP (JJ conditional) (NN deletion)) (PP (IN of) (NP (NN Pten))) (PP (IN in) (NP (JJ neural) (NNS progenitors)))) (VP (VBZ leads) (PP (TO to) (NP (NP (JJ dramatic) (NNS alterations)) (PP (IN in) (NP (NN brain) (NN architecture))) (, ,) (SBAR (WHNP (NP (DT an) (NN observation)) (WDT which)) (S (NP (DT the) (NNS authors)) (VP (VBP attribute) (PP (TO to) (NP (NP (VBN increased) (NN proliferation)) (CC and) (NP (ADJP (JJ self-renewal) (PP (IN of) (NP (JJ neural) (NN stem) (NN cell) (NNS populations)))) (NN -LSB-31) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (PP (VBN Given) (SBAR (IN that) (S (NP (NP (DT the) (NNS data)) (VP (VBN presented) (ADVP (RB here)))) (VP (VBZ establishes) (NP (NP (DT the) (JJ Notch-suppressing) (NN capability)) (PP (IN of) (NP (NN Pten)))))))) (, ,) (NP (NP (VBN deregulated) (NN renewal)) (PP (IN of) (NP (NP (NNS progenitors)) (PP (IN in) (NP (DT these) (NNS mice)))))) (VP (MD may) (VP (VB be) (PP (IN in) (NP (NP (NN part)) (PP (IN due) (TO to) (NP (VBN enhanced) (NN Notch) (NN signalling)))))))) (. .)))
( (S (S (NP (DT This) (NN hypothesis)) (VP (VBZ awaits) (NP (NN testing)))) (. .)))
( (S (S (NP (NN Notch)) (ADVP (RB also)) (VP (VBZ plays) (NP (NP (DT an) (VBG emerging) (NN role)) (PP (IN in) (NP (JJ differentiating) (NNS neurons)))) (PP (IN by) (S (VP (VBG inhibiting) (NP (JJ dendritic) (NN outgrowth) (NN -LSB-21) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ tempting)) (S (VP (TO to) (VP (VB speculate) (SBAR (IN that) (S (NP (NP (NN Notch-dependent) (JJ dendritic) (NN retraction)) (, ,) (ADJP (JJ reliant) (PP (IN on) (NP (JJ neuron-neuron) (NNS interactions)))) (, ,)) (VP (VBZ is) (VP (VBN augmented) (PP (IN by) (NP (NP (JJ target-derived) (JJ neurotrophic) (NNS factors)) (VP (VBG promoting) (NP (NN PI3K) (NN signalling)))))))))))))) (. .)))
( (S (S (PP (IN In) (NP (VBN differentiated) (NNS neurons))) (, ,) (NP (NN Notch)) (VP (VBZ contributes) (PP (TO to) (NP (NP (JJ synaptic) (NN plasticity)) (, ,) (NP (NN learning)) (CC and) (NP (NN memory) (NN -LSB-22,32))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (NP (DT The) (JJ long-standing) (NN involvement)) (PP (IN of) (NP (NP (NN BDNF)) (CC and) (NP (JJ other) (NNS neurotrophins)))) (PP (IN in) (NP (JJ synaptic) (NN plasticity)))) (VP (VBP raise) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP (JJ PI3K-Notch) (NN interplay)) (VP (VBZ is) (PP (IN at) (NP (NP (NN work)) (PP (IN in) (NP (DT this) (NN scenario))))) (PP (IN as) (NP (NN well))))))))) (. .)))
( (S (NP (NN Conclusion))))
( (S (S (NP (PRP$ Our) (NN data)) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (NP (DT the) (NN potentiation)) (PP (IN of) (NP (NN Notch) (NN signalling))) (PP (IN by) (NP (NN PI3K)))) (VP (VBZ is) (VP (VBN conserved) (PP (IN in) (NP (JJ ontologically-distinct) (NN cell) (NNS types)))) (, ,) (S (VP (VBG leading) (S (NP (PRP us)) (VP (TO to) (VP (VB suggest) (SBAR (IN that) (S (NP (PRP it)) (VP (VBZ represents) (NP (NP (DT a) (JJ general) (NN mechanism)) (PP (IN of) (NP (NN signal) (NN integration)))) (S (VP (VBG linking) (NP (CD two) (JJ evolutionarily-conserved) (NNS pathways)) (ADVP (RB together))))))))))))))))) (. .)))
( (S (S (NP (DT This) (ADJP (RB apparently) (JJ simple)) (NN observation)) (VP (VBZ has) (NP (NP (JJ far-reaching) (NNS implications)) (VP (VBG regarding) (NP (NP (DT the) (NNS mechanisms)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (NN stem) (NN cell) (NP (JJ self-renewal)) (CC and) (NP (NN differentiation))) (VP (VBZ proceeds))))))))) (. .)))
( (S (S (NP (PRP It)) (VP (MD will) (VP (VB be) (ADJP (JJ interesting) (S (VP (TO to) (VP (VB assess) (NP (NP (DT the) (NN relevance)) (PP (IN of) (NP (DT this) (NN finding))) (PP (IN in) (NP (NP (JJ other) (NN signalling) (NNS contexts)) (, ,) (PP (JJ such) (IN as) (NP (NP (NN tumour) (NN formation)) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (NP (NN Notch)) (CC and) (NP (NN PI3K))) (VP (VBP have) (NP (JJ important) (NNS roles))))))))))))))))) (. .)))
( (S (NP (NNS Methods))))
( (S (S (NP (NP (NN SH-6)) (, ,) (NP (NN lithium) (NN chloride)) (, ,) (NP (NN LY294002)) (, ,) (NP (NN Wortmannin)) (CC and) (NP (NN BDNF))) (VP (VBD were) (PP (IN from) (NP (NN Calbiochem))))) (. .)))
( (S (S (NP (JJ Human) (NN IgG4)) (VP (VBD was) (PP (IN from) (NP (NN Sigma))))) (. .)))
( (S (S (NP (NN Dual-Glo) (NN Luciferase) (NN assay) (NN system)) (VP (VBD was) (PP (IN from) (NP (NN Promega))))) (. .)))
( (S (S (NP (NN pN1-IC)) (VP (VBD was) (VP (VBN constructed) (PP (IN by) (S (VP (VBG inserting) (NP (NP (NNS nucleotides)) (VP (VBG coding) (PP (IN for) (NP (NP (DT the) (JJ intracellular) (NN domain)) (PP (IN of) (NP (JJ human) (NN Notch1))) (PRN (-LRB- -LRB-) (NP (NN amino) (NNS acids) (NP (NN 1758) (TO to) (CD 2557))) (-RRB- -RRB-)) (VP (VBN preceded) (PP (IN by) (NP (DT an) (NN initiator) (NN ATG) (NN codon)))))))) (PP (IN into) (NP (NP (DT the) (NN BamHI) (CC and) (NN EcoRI) (NNS sites)) (PP (IN of) (NP (NP (NN pcDNA3.1)) (PRN (-LRB- -LRB-) (NP (NN Invitrogen)) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (NP (NN pAdTATA-luc)) (VP (VBD was) (VP (VBN constructed) (PP (IN by) (S (VP (VBG inserting) (NP (NP (DT the) (JJ Adenoviral) (JJ major) (JJ late) (NN promoter) (NN TATA) (NN sequence) (NP (RB immediately) (CD 5) ('' '))) (PP (IN of) (NP (DT the) (NN luciferase) (NN gene)))) (PP (IN in) (NP (NP (NN plasmid) (NN pGL3Basic)) (PRN (-LRB- -LRB-) (NP (NN Promega)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NN p10xCBF1-luc)) (VP (VBD was) (VP (VBN constructed) (PP (IN by) (S (VP (VBG inserting) (NP (NP (CD 10) (NNS copies)) (PP (IN of) (NP (NP (DT the) (NN CBF1) (NN binding) (NN site) (CD 5) ('' ')) (PP (IN of) (NP (DT the) (NN AdTATA) (NN box))) (PP (IN in) (NP (NN pAdTATA-luc)))))))))))) (. .)))
( (S (S (NP (NN pTK-Renilla)) (VP (VBD was) (PP (IN from) (NP (NN Promega))))) (. .)))
( (S (S (NP (JJ Human) (NN Pten) (NN expression) (NN construct)) (VP (VBD was) (VP (VP (VBN generated) (PP (IN by) (NP (NP (NN PCR) (NN amplification)) (PP (IN of) (NP (JJ full-length) (JJ human) (NN Pten) (IN from) (JJ CD4+) (NN T-cell) (NN cDNA)))))) (, ,) (CC and) (ADVP (RB then)) (VP (VBN cloned) (PP (IN into) (NP (NP (DT the) (NN HindIII) (CC and) (NN EcoRI) (NNS sites)) (PP (IN of) (NP (NN pcDNA3.1))))))))) (. .)))
( (S (S (NP (ADJP (ADJP (JJ Constitutively-active)) (PRN (-LRB- -LRB-) (NP (NN gagAkt)) (-RRB- -RRB-)) (CC and) (ADJP (NN kinase) (JJ dead)) (PRN (-LRB- -LRB-) (ADJP (JJ Akt-KD)) (-RRB- -RRB-))) (NN Akt) (NN expression) (NNS constructs)) (VP (VBD were) (NP (NP (DT a) (NN kind) (NN gift)) (PP (IN from) (NP (NNP Dr.) (NNP Julian) (CD Downward) (CD -LSB-17) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (ADJP (ADJP (JJ Wild-type) (PRN (-LRB- -LRB-) (NP (NN WT)) (-RRB- -RRB-))) (CC and) (ADJP (JJ constitutively-active) (PRN (-LRB- -LRB-) (NP (NN S9A)) (-RRB- -RRB-)))) (NN GSK3β) (NNS constructs)) (VP (VBD were) (NP (NP (DT a) (NN kind) (NN gift)) (PP (IN from) (NP (NNP Dr.) (NNP J.) (NNP Sadoshima) (CD -LSB-33) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (DT All) (NNS plasmids)) (VP (VBD were) (VP (VBN prepared) (S (VP (VBG using) (NP (NP (DT the) (JJ EndoFree) (NN maxiprep) (NN system)) (PRN (-LRB- -LRB-) (NP (NN Qiagen)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (NN Jurkat) (NN E6.1) (NNS cells)) (CC and) (NP (NN Jurkat-N2) (NNS cells))) (VP (VBD were) (VP (VBN grown) (PP (IN in) (NP (NP (NN RPMI1640)) (PRN (-LRB- -LRB-) (NP (NP (NP (ADJP (CD +10) (NN %)) (NN v/v)) (NN FBS)) (, ,) (NP (ADJP (CD 2) (NN mM)) (NN L-glutamine))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (JJ Primary) (JJ CD4+) (NN T) (NNS cells)) (VP (VBD were) (VP (VBN isolated) (PP (IN from) (NP (JJ freshly-collected) (NN donor) (NN blood))) (PP (IN as) (NP (VBZ follows)))))) (. .)))
( (S (S (NP (JJ Peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (VP (VBD were) (VP (VP (VBN prepared) (PP (IN by) (NP (NP (NN centrifugation)) (PP (IN over) (NP (NN Ficoll-Paque)))))) (, ,) (VP (VBN incubated) (PP (IN with) (NP (NP (JJ anti-CD4-coated) (JJ magnetic) (NNS beads)) (PRN (-LRB- -LRB-) (NP (NNP Miltenyi) (NNP Biotec)) (-RRB- -RRB-))))) (CC and) (VP (VBN selected) (PP (IN on) (NP (NP (NN LS) (JJ positive) (NN selection) (NNS columns)) (PRN (-LRB- -LRB-) (NP (NNP Miltenyi) (NNP Biotec)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (PP (IN After) (NP (NN purification))) (, ,) (NP (JJ primary) (JJ CD4+) (NNS T-cells)) (VP (VBD were) (VP (VBN cultured) (PP (IN in) (NP (NP (NN RPMI1640)) (-LRB- -LRB-) (VP (VBN supplemented) (PP (IN with) (NP (NP (NP (ADJP (CD 10) (NN %)) (NN v/v)) (NN FBS)) (, ,) (NP (ADJP (CD 2) (NN mM)) (NN L-glutamine)) (CC and) (NP (ADJP (CD 5) (NN ×)) (NN 10-6M) (NN β-mercaptoethanol))))) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NP (NP (NN CHO-N2)) (CC and) (NP (NN CHO-Delta1))) (NNS cells)) (VP (VP (VBP have) (VP (VBN been) (VP (VBN described) (ADVP (RB previously)) (S (NP (NN -LSB-20)) (-RRB- -RSB-))))) (CC and) (VP (VBD were) (ADVP (RB routinely)) (VP (VBN cultured) (PP (IN in) (NP (NP (NN DMEM)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD +10) (NN %)) (NN v/v/FBS)) (, ,) (NP (ADJP (CD 2) (NN mM)) (NN L-glutamine))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NN Rat) (JJ primary) (JJ hippocampal) (NNS neurons)) (VP (VBD were) (VP (VP (VBN isolated)) (CC and) (VP (VBN cultured) (PP (IN as) (NP (VBN described) (NN -LSB-34) (-RRB- -RSB-))))) (, ,) (SBAR (IN except) (S (NP (NN growth) (NNS media)) (VP (VBD was) (VP (VBN supplemented) (PP (IN with) (NP (NP (NN B27)) (PRN (-LRB- -LRB-) (NP (NN Gibco/BRL)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NP (NN Jurkat) (NN E6.1) (NNS cells)) (CC and) (NP (NN Jurkat-N2) (NNS cells))) (VP (VBD were) (VP (VBN transfected) (S (VP (VBG using) (NP (NP (NN Lipofectamine) (NN 2000)) (PRN (-LRB- -LRB-) (NP (NN Invitrogen)) (-RRB- -RRB-)))))))) (. .)))
( (S (NP (NNS Cells)) (VP (VBD were) (VP (VP (JJ left) (NP (CD 24) (NN h)) (ADVP (RB post-transfection))) (, ,) (VP (VBN washed)) (, ,) (VP (VBN counted)) (CC and) (VP (VBD re-plated) (PP (IN in) (NP (NN triplicate))) (PP (IN at) (NP (QP (CD 2) (CD ×) (CD 105)) (NNS cells/well))) (PP (IN into) (NP (NP (JJ flat-bottomed) (JJ 96-well) (NNS plates)) (SBAR (WHNP (WDT which)) (S (VP (VBD had) (VP (VBN been) (PRN (-LRB- -LRB-) (SBAR (WHADVP (WRB where)) (FRAG (JJ relevant))) (-RRB- -RRB-)) (PP (NP (JJ pre-coated) (NN o/n)) (IN at) (NP (NP (NN 4°C)) (PP (IN with) (NP (NN hDelta1-Fc)))))))))))))) (. .)))
( (S (S (NP (NNS Cells)) (VP (VBD were) (VP (VP (VBN stimulated)) (, ,) (VP (VBN incubated) (NP (NP (NP (NN o/n)) (CC and) (NP (NN luciferase) (NN activity))) (VP (VBN measured) (S (VP (VBG using) (NP (NP (DT the) (JJ Dual-Glo) (NN system)) (PRN (-LRB- -LRB-) (NP (NN Promega)) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (NP (NP (NP (NN Firefly) (NN luciferase)) (NN signal)) (PP (IN from) (NP (DT the) (NN Notch-dependent) (NN p10xCBF1-luc)))) (VP (VBD was) (VP (VBN normalised) (S (VP (VBG using) (NP (NP (DT the) (NN Renilla) (NN luciferase) (NN signal)) (VP (VBN driven) (PP (IN by) (NP (DT the) (NN pTK-Renilla)))))))))) (. .)))
( (S (S (NP (JJ Primary) (JJ CD4+) (NN T) (NNS cells)) (VP (VBD were) (VP (VBN transfected) (S (VP (VBG using) (NP (NP (DT the) (NN Amaxa) (`` ') (NN nucleofection) ('' ') (NN system)) (VP (VBG according) (PP (TO to) (NP (NP (DT the) (NN manufacturer) (POS 's)) (NNS instructions)))))))))) (. .)))
( (S (S (ADVP (RB Briefly)) (, ,) (NP (QP (CD 5) (CD ×) (CD 106)) (VBN purified) (JJ CD4+) (NNS T-cells)) (VP (VBD were) (VP (VP (VBN resuspended) (PP (IN in) (NP (NP (CD 100) (NN μl)) (PP (IN of) (NP (DT the) (JJ appropriate) (NN Amaxa) (NN solution)))))) (CC and) (VP (VBN transfected) (PP (IN with) (NP (NP (ADJP (CD 5) (NN μg)) (NN plasmid) (NN DNA)) (VP (VBG using) (NP (NN Protocol) (NN U-14))))))))) (. .)))
( (S (S (NP (NNS Cells)) (VP (VBD were) (VP (VP (ADVP (RB immediately)) (VBN transferred) (PP (TO to) (NP (NP (CD 1) (NN ml)) (PP (IN of) (NP (JJ pre-warmed) (NNS media)))))) (, ,) (VP (VBN counted)) (CC and) (VP (VBN plated) (PP (IN as) (NP (VBN required))))))) (. .)))
( (S (S (PP (IN After) (NP (NN stimulation))) (NP (NN luciferase) (NN activity)) (VP (VBD was) (VP (VBN detected) (S (VP (VBG using) (NP (NP (DT the) (JJ Dual-glo) (NN assay) (NN system)) (PRN (-LRB- -LRB-) (NP (NN Promega)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (PP (IN For) (NP (JJ neuronal) (NNS experiments))) (, ,) (NP (NN rat) (JJ primary) (JJ hippocampal) (NNS neurons)) (VP (VBD were) (VP (VP (VBN transfected) (PP (IN after) (NP (NP (CD 9) (NNS days)) (PP (IN in) (NP (NP (NN culture)) (VP (VBG using) (NP (NN Lipofectamine) (NN 2000)))))))) (CC and) (VP (VBN stimulated) (ADVP (NP (CD 36-48) (NNS hours)) (RB later)))))) (. .)))
( (S (S (NP (NN Dual-Glo) (NN Luciferase) (NNS assays)) (VP (VBD were) (VP (VBN performed) (PP (VBG following) (NP (NN o/n) (NN stimulation)))))) (. .)))
( (S (S (NP (NP (DT A) (NN fusion) (NN protein)) (VP (VBG comprising) (NP (NP (DT the) (JJ extracellular) (NN domain)) (PP (IN of) (NP (JJ human) (NN Delta1))) (VP (VBN fused) (PP (TO to) (NP (NP (DT the) (NN Fc) (NN domain)) (PP (IN of) (NP (JJ human) (NN IgG4))))))))) (VP (VBD was) (VP (VBN prepared) (PP (IN by) (S (VP (VBG inserting) (NP (NP (DT a) (NN nucleotide) (NN sequence)) (VP (VBG coding) (PP (IN for) (NP (NP (DT the) (JJ extracellular) (NN domain)) (PP (IN of) (NP (NP (JJ human) (NN Delta1)) (PRN (-LRB- -LRB-) (NP (NN amino) (NNS acids) (NP (CD 1) (TO to) (CD 537))) (-RRB- -RRB-)))))))) (PP (IN into) (NP (NP (DT the) (NN expression) (NN vector) (CD pCON©)) (PRN (-LRB- -LRB-) (NP (NNP Lonza) (NNP Biologics)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (DT This) (NN plasmid)) (VP (VBD was) (VP (VBN expressed) (PP (IN in) (NP (NP (NN CHO) (NNS cells)) (, ,) (VP (VBN purified) (PP (IN by) (NP (NP (NN affinity) (NN chromatography)) (PP (IN on) (NP (NP (NP (NN ProteinA-Sepharose)) (PRN (-LRB- -LRB-) (NP (NNP Amersham) (NNP Biosciences)) (-RRB- -RRB-))) (PP (IN before) (NP (NP (NN concentration)) (CC and) (NP (NN buffer) (NN exchange)))) (PP (IN into) (NP (NNS PBS))))))))))))) (. .)))
( (S (S (NP (NP (JJ Batch) (NN activity)) (PP (IN of) (NP (DT this) (NN protein)))) (VP (VBD was) (VP (VBN confirmed) (PP (IN as) (NP (ADJP (RB previously) (VBN described)) (NN -LSB-35))))) (-RRB- -RSB-)) (. .)))
( (S (S (VP (TO To) (VP (VB assess) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (VBN isolated) (NN Delta1-Fc) (NN signalling))) (PP (IN on) (NP (NP (NN Jurkat-N2)) (CC and) (NP (JJ CD4+) (NNS T-cells)))))))) (, ,) (NP (ADJP (ADJP (JJ 96-)) (CC or) (ADJP (JJ 24-well))) (NNS plates)) (VP (VBD were) (VP (VBN coated) (ADVP (JJ overnight)) (PP (IN at) (NP (NN 4°C))) (PP (IN with) (NP (NP (NN anti-hIgG4)) (PRN (-LRB- -LRB-) (NP (NP (CD 1) (NN μg/ml)) (, ,) (NP (NNP BD) (NNP Biosciences))) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NNS Plates)) (VP (VBD were) (VP (VP (VBN washed) (PP (IN with) (NP (NNS PBS)))) (CC and) (VP (VBN incubated) (PP (IN for) (NP (CD 2) (NNS hours))) (PP (IN at) (NP (NN 37°C))) (PP (IN with) (NP (NP (ADJP (CD 20) (NN μg/ml)) (NN Delta1-Fc)) (CC or) (NP (NN hIgG4) (NN control)))) (, ,) (S (VP (VBN washed) (ADVP (RB once) (RB again)) (PP (IN with) (NP (NNS PBS))) (, ,) (SBAR (IN before) (S (NP (NNS cells)) (VP (VBD were) (VP (VBN plated) (PP (IN for) (NP (NN stimulation))))))))))))) (. .)))
( (S (S (VP (TO To) (VP (VB examine) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (JJ coincident) (NN Delta1-Fc)) (CC and) (NP (NN T-cell) (NN receptor) (NN signalling)))) (PP (IN on) (NP (JJ primary) (JJ CD4+) (NNS T-cells))))))) (, ,) (NP (ADJP (ADJP (JJ 96-)) (CC or) (ADJP (JJ 24-well))) (NNS plates)) (VP (VBD were) (ADVP (RB first)) (VP (VBN coated) (ADVP (JJ overnight)) (PP (IN at) (NP (NP (NN 4°C)) (PP (IN with) (NP (NP (NP (DT a) (NN mixture)) (PP (IN of) (NP (NN capture) (NNS antibodies)))) (VP (VBG consisting) (PP (IN of) (NP (NP (NP (JJ anti-mouse) (NN IgG2a)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN μg/ml) (, ,) (NNP BD) (NNP Biosciences)) (-RRB- -RRB-))) (CC and) (NP (NP (NN anti-hIgG4)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN μg/ml) (, ,) (NNP BD) (NNP Biosciences)) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (NP (NNS Plates)) (VP (VBD were) (VP (VP (VBN washed) (PP (IN with) (NP (NNS PBS)))) (CC and) (VP (VBN incubated) (PP (NP (CD 2) (NNS hours)) (IN at) (NP (NN 37°C))) (PP (IN with) (NP (NP (DT a) (NN mixture)) (PP (IN of) (NP (NP (NP (NN anti-CD3)) (PRN (-LRB- -LRB-) (NP (CD 3) (NN μg/ml)) (, ,) (S (NP (NN clone)) (NP (NNP Hit3a) (, ,) (NNP BD) (NNP Biosciences))) (-RRB- -RRB-))) (CC and) (NP (NP (NP (ADJP (CD 20) (NN μg/ml)) (NN Delta1-Fc)) (CC or) (NP (NN hIgG4) (NN control))) (PRN (-LRB- -LRB-) (NP (NN Sigma)) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (S (NP (NNS Plates)) (VP (VBD were) (ADVP (RB again)) (VP (VBN washed) (PP (IN with) (NP (NNS PBS)))))) (CC and) (S (NP (VBN purified) (JJ CD4+) (NN T) (NNS cells)) (VP (VBD were) (VP (VBN seeded) (PP (IN at) (NP (CD 2) (NN ×) (NN 105/well))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (JJ soluble) (NN anti-CD28)) (PRN (-LRB- -LRB-) (NP (CD 2) (NN μg/ml)) (, ,) (NP (NN clone) (CD CD28.2)) (, ,) (NP (NNP BD) (NNP Bioscience)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (DT This) (NN assay)) (VP (VBZ has) (VP (VBN been) (VP (VBN described) (ADVP (RB previously)) (S (NP (NN -LSB-20)) (-RRB- -RSB-)))))) (. .)))
( (S (S (ADVP (RB Briefly)) (, ,) (NP (NP (DT a) (NN CHO) (NN cell) (NN line)) (PRN (-LRB- -LRB-) (NP (NN CHO-N2)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN established) (SBAR (WHNP (WDT which)) (S (VP (VBD expressed) (NP (CC both) (NP (DT a) (JJ full-length) (JJ human) (NN Notch2) (NN cDNA)) (, ,) (CC and) (NP (NN p10xCBF1-luc))))))))) (. .)))
( (S (S (NP (CD 2) (JJ ×) (NN 104) (NN CHO-N2) (NNS cells)) (VP (VBD were) (VP (VBN plated) (PP (IN per) (NP (NN well))) (PP (IN into) (NP (JJ 96-well) (NNS plates))))) (, ,) (CC and) (S (ADJP (JJ left) (S (VP (TO to) (VP (VB adhere) (PP (IN for) (NP (CD 2) (NNS hours))))))))) (. .)))
( (S (S (NP (NN Notch) (NN signalling)) (VP (VBD was) (VP (VBN activated) (PP (IN by) (S (VP (VBG plating) (NP (NP (DT an) (JJ additional) (NN CHO) (NN line)) (SBAR (WHNP (WDT which)) (S (ADVP (RB stably)) (VP (VBZ expresses) (NP (NP (NP (JJ full-length) (JJ human) (NN Delta1)) (PRN (-LRB- -LRB-) (NP (NN CHO-hDelta1)) (-RRB- -RRB-))) (PP (IN onto) (NP (DT the) (JJ CHO-N2) (NNS cells)))))))))))))) (. .)))
( (S (S (S (NP (NNS Cells)) (VP (VBD were) (VP (VBN co-cultured) (PP (IN in) (NP (DT this) (NN manner) (JJ overnight)))))) (, ,) (CC and) (S (NP (NN luciferase) (NN activity)) (VP (VBD determined) (SBAR (IN as) (S (VP (VBN described))))))) (. .)))
( (S (S (NP (NN RNA)) (VP (VBD was) (VP (VBN isolated) (PP (IN from) (NP (NP (NN cell) (NNS samples)) (VP (VBG using) (NP (NP (NN Rneasy) (NNS kits)) (PRN (-LRB- -LRB-) (NP (NN Qiagen)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (JJ First) (NN strand) (NN cDNA)) (VP (VBD was) (VP (VBN synthesised) (PP (IN with) (NP (NP (NP (NN SuperScriptII) (-LRB- -LRB-) (NN Invitrogen) (-RRB- -RRB-) (NN oligo-d)) (PRN (-LRB- -LRB-) (NP (NN T)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ random) (NNS decamers)) (PRN (-LRB- -LRB-) (NP (NNP Invitrogen)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NN Q-PCR)) (VP (VBD was) (VP (VBN performed) (S (VP (VBG using) (NP (NP (NN SYBR) (NN green) (NN detection) (NN chemistry)) (PP (IN on) (NP (DT the) (NN Roche) (NN Lightcycler) (NN system))))))))) (. .)))
( (S (S (NP (JJ Gene-specific) (NN quantification)) (VP (VBD was) (VP (VBN achieved) (PP (IN by) (S (VP (VBG comparing) (NP (DT each) (NN cDNA)) (PP (TO to) (NP (NP (DT a) (JJ serially-diluted) (JJ standard) (NN plasmid)) (VP (VBG containing) (NP (DT the) (JJ relevant) (NN amplicon))))))))))) (. .)))
( (S (S (NP (JJ Relative) (NN Hes-1) (NN expression) (NNS levels)) (VP (VBD were) (VP (VBN normalised) (PP (TO to) (NP (NN 18S) (NN rRNA) (JJ housekeeping) (NN gene)))))) (. .)))
( (S (S (NP (NP (NN Primer) (NNS sequences)) (VP (VBN used))) (VP (VBD were) (PP (IN as) (NP (NP (NP (VBZ follows)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 5) ('' ')) (TO to) (CD 3)) ('' ')) (-RRB- -RRB-)) (: :) (NP (NP (NN 18S) (NN rRNA)) (, ,) (NP (NN GTAACCCGTTGAACCCCATT)) (CC and) (NP (NN CCATCCAATCGGTAGTAGCG)))) (: ;) (NP (NP (NN Hes-1)) (, ,) (NP (NN CTCTCTTCCCTCCGGACTCT)) (CC and) (NP (NN GGCGCAATCCAATATGAAC))))))) (. .)))
( (S (NP (NP (NNS Authors) (POS ')) (NNS contributions))))
( (S (S (NP (NP (NN GM)) (CC and) (NP (NN GH))) (VP (VP (VBD conceived) (NP (DT this) (NN study))) (CC and) (VP (VBP wrote) (NP (DT the) (NN manuscript))))) (. .)))
( (S (S (NP (NN GM)) (VP (VBD was) (ADVP (RB experimentally)) (VP (VBN involved) (PP (IN in) (NP (NP (NP (NN CHO)) (, ,) (NP (NN Jurkat)) (CC and) (NP (JJ primary) (NN T-cell))) (NNS assays)))))) (. .)))
( (S (S (NP (NN GH)) (VP (VBD was) (ADVP (RB experimentally)) (VP (VBN involved) (PP (IN in) (NP (DT the) (JJ neuronal) (NNS studies)))))) (. .)))
( (S (S (NP (NN GW)) (VP (VBD carried) (PRT (RP out)) (NP (NP (PDT all) (DT the) (NN CHO) (CC and) (NN Jurkat) (NNS assays)) (CC and) (NP (NP (DT the) (JJ primary) (NN T-cell) (NNS experiments)) (VP (VBG involving) (NP (JJ N1-IC) (NN transfection))))))) (. .)))
( (S (S (NP (NP (NN YS)) (CC and) (NP (NN EB))) (VP (VBD carried) (PP (IN out) (NP (NP (DT the) (JJ primary) (NN T-cell) (NNS experiments)) (VP (VBG involving) (NP (NN Delta1-Fc) (NN stimulation))))))) (. .)))
( (S (S (NP (NN SP)) (VP (VBD was) (ADVP (RB experimentally)) (VP (VBN involved) (PP (IN in) (NP (DT the) (JJ neuronal) (NNS studies)))))) (. .)))
( (S (S (NP (FW AL) (, ,) (NP (CD BC)) (CC and) (NP (CD MT))) (VP (VBD provided) (NP (NP (JJ susbstantial) (JJ intellectual) (NN input)) (PP (IN into) (NP (NP (DT all) (NNS aspects)) (PP (IN of) (NP (DT this) (NN study)))))))) (. .)))
( (S (S (NP (DT All) (NNS authors)) (VP (VP (VBN read)) (CC and) (VP (JJ approved) (NP (DT the) (JJ final) (NN manuscript))))) (. .)))
( (S (NP (NP (NN Figure)) (CC and) (NP (NN Table)) (NP (NNS captions)))))
( (S (S (NP (NP (NN Figure) (CD 1) (: :) (NN Inhibition)) (PP (IN of) (NP (DT the) (NN PI3K-Akt) (NN pathway)))) (VP (VBZ impairs) (NP (NP (NN Notch) (NN signalling)) (PP (IN in) (NP (NN Jurkat) (NNS T-cells)))))) (. .)))
( (S (S (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NN J-N2) (NNS cells)) (VP (VBD were) (VP (VBN transfected) (PP (IN with) (NP (NP (CD 14) (NN μg)) (PP (IN of) (NP (NN p10xCBF1-luc)))))))) (CC and) (S (NP (NP (CD 1) (NN μg) (NN pTK-RL)) (, ,) (VP (VBN incubated) (S (ADJP (JJ overnight)))) (, ,)) (ADVP (RB then)) (VP (VBN plated) (PP (IN onto) (NP (NP (JJ 96-well) (NNS plates)) (VP (VBN coated) (PP (IN with) (NP (CC either) (NP (ADJP (CD 20) (NN μg/ml)) (NN hIgG4)) (CC or) (NP (ADJP (CD 20) (NN μg/ml)) (NN hDelta1-Fc)))) (PP (IN along) (PP (IN with) (NP (NP (NN LY294002)) (PP (IN for) (NP (CD 6) (NNS hours))))))))))) (. .)))
( (S (S (NP (JJ CBF1-reporter) (NN gene) (NN activity)) (VP (VBZ is) (ADJP (JJ normalised) (PP (TO to) (NP (NN Renilla) (NN control))) (PP (IN in) (NP (NP (DT this)) (CC and) (NP (DT all)) (NP (NN luciferase) (NNS assays))))))) (. .)))
( (S (S (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (NN J-N2) (NNS cells)) (VP (VBD were) (VP (VP (VBN plated) (PP (IN onto) (NP (CC either) (NP (NN hIgG4)) (CC or) (NP (NN Delta1-Fc) (NN ±) (CD 10) (NN μM) (NN LY294002))))) (, ,) (CC and) (VP (VBN incubated) (PP (IN for) (NP (CD 8) (NNS hours))) (PP (IN before) (S (VP (VBG being) (VP (VBN processed) (PP (IN for) (NP (NN Hes1) (NN mRNA) (NNS levels))) (PP (IN by) (NP (NP (NN Q-PCR)) (PRN (-LRB- -LRB-) (NP (NN Hes1/18) (NN rRNA)) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (NP (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NN J-N2) (NNS cells)) (VP (VBD were) (VP (VP (VBN transfected) (PP (IN with) (NP (NP (CD 10) (NN μg)) (PP (IN of) (NP (NP (NN pCBF1x10-luc)) (, ,) (NP (NP (CD 4) (NN μg)) (PP (IN of) (NP (NN Pten) (NN expression) (NN construct)))) (CC or) (NP (NP (JJ empty) (NN pcDNA3.1) (NN vector,1) (NN μg)) (PP (IN of) (NP (NN pTK-RL))))))))) (, ,) (CC and) (VP (VBN treated) (PP (IN with) (NP (CC either) (NP (ADJP (CD 20) (NN μg/ml)) (NN hIgG4)) (CC or) (NP (ADJP (CD 20) (NN μg/ml)) (NN hDelta1-Fc) (NN ±) (CD 10) (NN μM) (NN LY294002)))))))) (. .)))
( (S (S (NP (NN CBF1-reporter) (NN activity)) (VP (VBD was) (VP (VBN measured) (PP (IN after) (NP (CD 6) (NN hr)))))) (. .)))
( (S (S (NP (DT All) (NNS data)) (VP (VP (VBZ is) (VP (VBN presented) (PP (IN as) (NP (NN mean) (NN ±) (NN s.d.))))) (, ,) (CC and) (VP (VBZ is) (ADJP (JJ representative) (PP (IN of) (NP (CD three) (NN repeat) (NNS experiments))))))) (. .)))
( (S (S (NP (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (NN J-N2) (NNS cells)) (VP (VBD were) (VP (VP (VBN transfected) (PP (IN with) (NP (NP (NN p10xCBF1-luc)) (CC and) (NP (NN pTK-RL))))) (CC and) (VP (VBD stimulated) (SBAR (IN as) (S (VP (VBN described) (PP (IN in) (NP (NNP Fig.) (NN 1A)))))))) (, ,) (SBAR (WHPP (IN except) (WHNP (WDT that))) (S (NP (NNS cells)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (NP (NN Akt) (NN inhibitor) (CD SH-6)) (PRN (-LRB- -LRB-) (NP (CD 50) (NN μM)) (-RRB- -RRB-))) (CC or) (NP (NN DMSO) (NN vehicle)))) (PP (IN for) (NP (CD 6) (NNS hours))))))))) (. .)))
( (S (S (NP (NN Figure) (CD 2)) (: :) (NP (DT The) (NN PI3K-Akt) (NN pathway)) (VP (VBZ regulates) (NP (NP (NN Notch-responsiveness)) (PP (IN in) (NP (JJ primary) (JJ human) (JJ CD4+) (NNS T-cells)))))) (. .)))
( (S (S (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (JJ 24-well) (NN tissue) (NN culture) (NNS plates)) (VP (VBD were) (VP (VP (VBN coated) (PP (IN with) (NP (NP (JJ anti-human) (NN IgG4)) (CC and) (NP (JJ anti-mouse) (NN IgG2a) (NN capture) (NNS antibodies)))) (PP (IN at) (NP (NP (CD 1) (NN μg/ml)) (PP (IN in) (NP (NNS PBS)))))) (, ,) (CC and) (VP (VBN incubated) (PP (IN at) (NP (NN 4°C))) (, ,) (S (ADJP (JJ overnight))))))) (. .)))
( (S (NP (JJ Appropriate) (NNS stimuli)) (VP (VP (VBN added) (: :) (NP (NP (NN Delta1-Fc)) (CC or) (NP (NN hIgG4))) (PP (PP (IN as) (NP (NN control))) (, ,) (CC both) (PP (IN at) (NP (NP (CD 20) (NN μg/ml)) (PP (IN in) (NP (NP (NP (NP (NN PBS)) (CC and) (NP (NN anti-CD3))) (PRN (-LRB- -LRB-) (NP (NP (NNP Hit3a)) (, ,) (NP (NN IgG2a))) (-RRB- -RRB-))) (CC or) (NP (NN mIgG)))))) (PP (IN as) (NP (NN control))) (, ,) (CC both) (PP (IN at) (NP (NP (CD 1) (NN μg/ml)) (PP (IN in) (NP (NNS PBS))))))) (, ,) (CC and) (VP (VBN incubated) (PP (IN at) (NP (QP (CD 37°C) (, ,) (CD 3)) (NN h))))) (. .)))
( (S (S (S (NP (NNS Plates)) (VP (VBD were) (VP (VBN washed) (PP (IN with) (NP (NNS PBS)))))) (CC and) (S (NP (ADJP (RB positively) (VBN selected)) (JJ hCD4+) (NNS T-cells)) (VP (VBD were) (VP (VBN seeded) (PP (IN at) (NP (QP (CD 2) (NN ×) (CD 106)) (NN cells/well))) (, ,) (PP (IN in) (NP (NP (CD 1) (NN ml)) (PP (IN of) (NP (NP (NNS media)) (PP (TO to) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (CD 1) (NN ×) (CD 107) (NN cells/stimulation))))))))))))) (. .)))
( (S (NP (NNS Cells)) (VP (VBD were) (VP (VBN stimulated) (S (ADJP (JJ overnight) (PP (VBG ±) (NP (NP (NP (ADJP (CD 10) (NN μM)) (NN DAPT)) (CC or) (NP (ADJP (CD 10) (NN μM)) (NN LY294002))) (CC and) (NP (NP (CD 2) (NN μg/ml) (NN anti-CD28)) (SBAR (WHADVP (WRB where)) (S (VP (VBP applicable))))))))))) (. .)))
( (S (S (NP (NNS Cells)) (VP (VBD were) (ADJP (ADJP (JJ pooled)) (, ,) (ADJP (NP (NN RNA)) (VBN prepared)) (CC and) (ADJP (NP (NN cDNA)) (VBN synthesised))) (SBAR (IN as) (S (VP (VBN described) (PP (IN in) (NP (NNS Methods)))))))) (. .)))
( (S (S (NP (JJ Relative) (NN Hes1) (NN expression)) (VP (VBD was) (VP (VBN determined) (PP (IN by) (NP (NN Q-PCR)))))) (. .)))
( (S (NP (NP (NNS Data)) (VP (VBN shown) (S (VP (VP (VBZ represents) (NP (NP (JJ triplicate) (NNS assays)) (PP (IN of) (NP (NP (NN cDNA)) (VP (VBN prepared) (PP (IN from) (NP (JJ pooled) (NNS cells)))))))) (, ,) (CC and) (VP (VBZ is) (NP (NP (NN representative)) (PP (IN of) (NP (NP (CD two) (JJ individual) (NNS experiments)) (VP (VBN performed) (S (VP (VBG using) (NP (NP (JJ CD4+) (NNS T-cells)) (VP (VBN prepared) (PP (IN from) (NP (NP (JJ different) (NN donors.)) (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-)))))))))))))))))))
( (S (S (NP (JJ Human) (JJ primary) (JJ CD4+) (NNS T-cells)) (VP (VBD were) (VP (VBN nucleofected) (PP (IN with) (NP (NP (ADJP (CD 4) (NN μg)) (NN p10xCBF-luc)) (, ,) (NP (NP (NP (ADJP (CD 0.5) (NN μg)) (NN pTK-RL)) (CC and) (NP (CD 1) (NN μg))) (PP (IN of) (NP (DT either) (ADJP (ADJP (JJ pN1-IC)) (CC or) (ADJP (JJ empty))) (NN pcDNA3.1)))) (, ,) (CC and) (NP (NP (CD 2) (NN μg)) (PP (IN of) (NP (DT either) (NP (NP (NN gagAkt)) (CC or) (NP (NP (NN kinase-dead)) (PRN (-LRB- -LRB-) (NP (NN KD)) (-RRB- -RRB-)))) (NN Akt) (NN construct))))))))) (. .)))
( (S (S (NP (JJ CBF1-reporter) (NN activity)) (VP (VBZ is) (VP (VBN presented) (PP (IN as) (NP (NN mean) (JJ normalised) (NN luminescence) (NN ±) (NN s.d.)))))) (. .)))
( (S (NP (NP (NN Data) (NN representative)) (PP (IN of) (NP (CD two) (NN repeat) (NNS experiments))) (PP (IN from) (NP (JJ different) (NN blood) (NNS donors))) (. .))))
( (S (NP (NP (NN Figure) (CD 3)) (: :) (S (NP (NP (NN Inhibiting) (NN GSK3β)) (PP (IN with) (NP (NN lithium) (NN chloride)))) (VP (VBZ enhances) (NP (NN Notch) (NNS signals)) (PP (IN in) (NP (JJ primary) (JJ human) (UCP (ADJP (JJ CD4+)) (, ,) (CONJP (CC but) (RB not)) (NP (NN Jurkat)) (, ,)) (NNS T-cells))))) (. .))))
( (S (S (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP (JJ Primary) (JJ human) (JJ CD4+) (NNS T-cells)) (VP (VBD were) (VP (VP (VBN nucleofected) (PP (IN with) (NP (NP (NP (ADJP (CD 4) (NN μg)) (NN p10xCBF-luc)) (, ,) (NP (ADJP (CD 0.5) (NN μg)) (NN pTK-RL)) (CC and) (NP (CD 1) (NN μg))) (PP (IN of) (NP (CC either) (NP (NN pN1-IC)) (CC or) (NP (NN pcDNA3.1))))))) (CC and) (VP (VBN plated) (NP (NP (NN o/n)) (PP (IN in) (NP (NN triplicate))) (PP (IN with) (NP (NP (VBG increasing) (NNS concentrations)) (PP (IN of) (NP (NN LiCl)))))))))) (. .)))
( (S (S (NP (NN Data)) (VP (VBZ is) (VP (VBN presented) (PP (IN as) (NP (NP (DT the) (JJ fold) (NN induction)) (PP (IN in) (NP (CD normalised) (NN luminescence))))) (PP (VBN compared) (PP (TO to) (NP (DT the) (JJ untreated) (NN vector) (JJ only) (NN control))))))) (. .)))
( (S (S (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (JJ Primary) (JJ human) (JJ CD4+) (NNS T-cells)) (VP (VBD were) (VP (VP (VBN nucleofected) (PP (IN with) (NP (CD 4) (NN μg) (NN p10xCBF-luc)))) (CC and) (VP (VBN exposed) (PP (TO to) (NP (NP (JJ different) (NNS levels)) (PP (IN of) (NP (JJ plate-bound) (NN Delta1-Fc))) (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC or) (NP (NN absence))) (PP (IN of) (NP (NP (NN LiCl)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN mM)) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (NP (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NN J-N2) (NNS cells)) (VP (VBD were) (VP (VP (VBN transfected) (PP (IN with) (NP (NP (NN p10xCBF1-luc)) (CC and) (NP (NN pTK-RL))))) (CC and) (VP (VBN stimulated) (PP (JJ overnight) (IN in) (NP (NP (VBG increasing) (NNS concentrations)) (PP (IN of) (NP (NN LiCl))))))))) (. .)))
( (S (S (NP (NN Data)) (VP (VBZ is) (VP (VBN presented) (PP (IN as) (NP (NP (DT the) (JJ fold) (NN induction)) (PP (IN in) (NP (CD normalised) (NN luminescence))))) (PP (VBN compared) (PP (TO to) (NP (DT the) (JJ untreated) (NN IgG4) (NN control))))))) (. .)))
( (S (S (NP (NN Figure) (CD 4)) (: :) (NP (DT The) (NN PI3k/GSK3β) (NN pathway)) (ADVP (RB also)) (VP (VBZ regulates) (NP (NP (NN Notch) (NN signalling)) (PP (PP (IN in) (NP (NN CHO) (NNS cells))) (CC and) (PP (IN in) (NP (JJ primary) (NNS neurons))))))) (. .)))
( (S (S (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NN CHO-N2) (NNS cells)) (VP (VBD were) (VP (VBN co-cultured) (PP (IN with) (NP (NP (NP (NP (VBG increasing) (NNS numbers)) (PP (IN of) (NP (CC either) (NP (NN CHO-hDelta1)) (CC or) (NP (NN control) (NN CHO) (NNS cells))))) (CC and) (NP (NN luciferase) (NN reporter) (NN activity))) (VP (VBN assayed) (PP (IN for)) (PP (IN after) (NP (CD 24) (NNS hours))))))))) (. .)))
( (S (S (NP (JJ CBF1-dependent) (NN reporter) (NN activity)) (VP (VBZ is) (VP (VBN presented) (PP (IN as) (NP (NP (DT the) (JJ fold) (NN induction)) (PP (IN in) (NP (NP (NN luminescence)) (CC versus) (NP (NN CHO-N2) (NN cell) (JJ only) (NN value))))))))) (. .)))
( (S (S (NP (NN Mean) (NN ±) (NN sem)) (VP (VBN given))) (. .)))
( (S (S (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NN CHO-N2) (NNS cells)) (VP (VBD were) (VP (VBN co-cultured) (PP (IN with) (NP (NP (NN 104) (NN CHO-hDelta1) (NNS cells)) (PP (IN per) (NP (ADJP (RB well) (VBN ±)) (NN insulin) (NN ±) (NN LY294002))))) (SBAR (IN as) (S (VP (VBN indicated))))))) (. .)))
( (S (S (NP (JJ CBF1-reporter) (NN activity)) (VP (VBZ is) (VP (VBN presented) (PP (IN as) (NP (NP (JJ fold) (NN induction)) (PP (IN of) (NP (JJ non-insulin) (JJ stimulated) (NNS cells)))))))) (. .)))
( (S (S (NP (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NN CHO-N2) (NNS cells)) (VP (VBD were) (VP (VBN co-cultured) (PP (IN with) (S (VP (VBG increasing) (NP (NP (NNS numbers)) (PP (IN of) (NP (NN CHO-hDelta1)))) (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC or) (NP (NN absence))) (PP (IN of) (NP (NP (NN LiCl)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN mM)) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (NP (NN Rat) (JJ primary) (JJ hippocampal) (NNS neurons)) (VP (VBD were) (VP (VBN transfected) (PP (IN with) (NP (NP (CD 0.5) (NN μg)) (PP (IN of) (NP (NP (NN p10xCBF1-luc)) (CC and) (NP (ADJP (CD 0.05) (NN μg)) (NN pTK-RL)))) (, ,) (VP (ADVP (RB then)) (VBN stimulated) (S (ADJP (JJ overnight) (PP (IN with) (NP (CC either) (NP (NN LiCl)) (CC or) (NP (ADJP (CD 25) (NN ng/ml)) (NN BDNF) (NN ±) (CD 10) (NN μM) (NN LY294002)))))))))))) (. .)))
( (S (S (NP (-LRB- -LRB-) (NN E) (-RRB- -RRB-) (NNS Neurons)) (VP (VBD were) (VP (VBN transfected) (PP (IN with) (NP (NP (CD 0.2) (NN μg)) (PP (IN of) (NP (NP (NN p10xCBF1-luc)) (, ,) (NP (ADJP (CD 0.05) (NN μg)) (NN pTK-RL)) (, ,) (NP (NP (CD 0.05) (NN μg)) (PP (IN of) (NP (NN pN1-IC)))) (CC and) (NP (NP (CD 0.4) (NN μg)) (PP (IN of) (NP (DT the) (JJ relevant) (NN expression) (NN plasmid))))))))))) (. .)))
( (S (S (NP (NN CBF1-reporter) (NN activity)) (VP (VBZ is) (VP (VBN presented) (PP (IN as) (NP (NP (JJ normalised) (NN luminescence) (NN ±) (NN s.e.m)) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 3)) (-RRB- -RRB-)))))) (. .)) (PRN (-LRB- -LRB-) (NP (NP (NNP *)) (NP (NN p))))))
( (S (S (PRN (NP (NN <) (CD 0.05)) (, ,) (NP (NNP Mann) (NNP Whitney) (NNP U) (NN test)) (-RRB- -RRB-))) (. .)))
( (S (NP (NP (NN Figure) (CD 5)) (: :) (S (NP (NP (DT A) (NN schematic)) (VP (VBG depicting) (NP (NP (DT a) (JJ proposed) (NN mechanism)) (PP (IN for) (NP (NP (DT the) (NN influence)) (PP (IN of) (NP (DT the) (NN PI3K) (NN pathway))) (PP (IN on) (NP (NN Notch-responsiveness.)))))))) (VP (VB See) (NP (NNS text)) (PP (IN for) (NP (NP (NN discussion)) (PP (IN of) (NP (DT this) (NN model))))))) (. .))))
( (S (NP (NN Btk) (NN expression)) (VP (VBZ is) (VP (VBN controlled) (PP (IN by) (NP (NP (NN Oct)) (CC and) (NP (NN BOB.1/OBF.1))))))))
( (S (NP (NN Abstract))))
( (S (S (NP (NN BOB.1/OBF.1)) (VP (VBZ is) (NP (DT a) (JJ lymphocyte-restricted) (JJ transcriptional) (NN coactivator)))) (. .)))
( (S (S (NP (PRP It)) (VP (VP (VBZ binds) (PP (ADVP (RB together)) (IN with) (NP (DT the) (NP (NN Oct1)) (CC and) (NP (NN Oct2)) (NP (NN transcription) (NNS factors)))) (PP (TO to) (NP (NN DNA)))) (CC and) (VP (VBZ enhances) (NP (PRP$ their) (NN transactivation) (NN potential))))) (. .)))
( (S (S (NP (NP (NNS Mice)) (ADJP (JJ deficient) (PP (IN for) (NP (DT the) (JJ transcriptional) (NN coactivator) (NN BOB.1/OBF.1))))) (VP (VBP show) (NP (NP (JJ several) (NNS defects)) (PP (IN in) (NP (NP (NP (NN differentiation)) (, ,) (NP (NN function)) (CC and) (NP (NN signaling))) (PP (IN of) (NP (NN B) (NNS cells)))))))) (. .)))
( (S (S (PP (IN In) (NP (NP (NN search)) (PP (IN of) (NP (CD BOB.1/OBF.1) (JJ regulated) (NNS genes))))) (NP (PRP we)) (VP (VBD identified) (NP (NP (CD Btk—a) (JJ cytoplasmic) (NN tyrosine) (NNS kinase—as)) (NP (NP (DT a) (JJ direct) (NN target)) (PP (IN of) (NP (NN BOB.1/OBF.1))))))) (. .)))
( (S (S (NP (NP (NNS Analyses)) (PP (IN of) (NP (NP (DT the) (JJ human)) (CONJP (RB as) (RB well) (IN as)) (NP (JJ murine) (NN Btk) (NNS promoters))))) (VP (VBD revealed) (NP (NP (DT a) (JJ non-consensus) (NN octamer) (NN site)) (ADJP (JJ close) (PP (TO to) (NP (NP (DT the) (NN start) (NN site)) (PP (IN of) (NP (NN transcription))))))))) (. .)))
( (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NN Oct) (NNS proteins)) (PP (ADVP (RB together)) (IN with) (NP (NN BOB.1/OBF.1)))) (VP (VBP are) (ADJP (JJ able) (S (VP (TO to) (VP (VB form) (NP (NP (JJ ternary) (NNS complexes)) (PP (IN on) (NP (DT these) (NNS sites)))) (ADVP (ADVP (FW in) (FW vitro)) (CC and) (ADVP (FW in) (FW vivo)))))))))))) (. .)))
( (S (S (NP (NP (DT This)) (PP (IN in) (NP (NN turn)))) (VP (VBZ leads) (PP (TO to) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NN Btk) (NN promoter) (NN activity))) (PP (IN in) (NP (NP (NN synergism)) (PP (IN with) (NP (DT the) (NN transcription) (NN factor) (NN PU.1))))))))) (. .)))
( (S (NP (NP (NN Btk)) (, ,) (PP (IN like) (NP (NN BOB.1/OBF.1))) (, ,))))
( (S (S (VP (VBZ plays) (NP (DT a) (JJ critical) (NN role)) (PP (IN in) (NP (NP (NN B) (NN cell) (NN development)) (CC and) (NP (NN B) (NN cell) (NN receptor) (NN signalling)))))) (. .)))
( (S (NP (NP (RB Therefore) (DT the) (NN down-regulation)) (PP (IN of) (NP (NN Btk) (NN expression))) (PP (IN in) (NP (NN BOB.1/OBF.1-deficient))))))
( (S (NP (NN B) (NNS cells)) (VP (MD could) (VP (VB be) (ADJP (JJ related) (PP (TO to) (NP (NP (DT the) (ADJP (ADJP (JJ functional)) (CC and) (ADJP (JJ developmental))) (NNS defects)) (VP (VBN observed) (PP (IN in) (NP (NN BOB.1/OBF.1-deficient)))))))))))
( (S (NP (NP (NNS mice)) (. .))))
( (S (NP (NN INTRODUCTION))))
( (S (S (NP (DT The) (NN octamer) (NN motif) (NN ATGCAAAT)) (VP (VBZ is) (ADJP (JJ important) (PP (IN for) (NP (ADJP (NN B) (JJ cell-specific)) (NN gene) (NN regulation)))))) (. .)))
( (S (SBAR (IN Although) (S (NP (PRP it)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN found) (PP (IN in) (NP (NP (NNS promoters)) (PP (IN of) (NP (NP (ADJP (RB ubiquitously) (VBN expressed)) (NNS genes)) (PRN (-LRB- -LRB-) (NP (NN 1–3)) (-RRB- -RRB-)))))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (NP (NP (DT a) (JJ critical) (NN element)) (PP (IN in) (NP (NP (DT the) (JJ regulatory) (NNS regions)) (PP (IN of) (NP (JJ several) (ADJP (NN B) (JJ cell-specific)) (VBN expressed) (NNS genes)))))) (, ,) (PP (IN like) (NP (NP (NP (NN immunoglobulin) (NNS genes)) (PRN (-LRB- -LRB-) (NP (NN 4,5)) (-RRB- -RRB-))) (, ,) (NP (NP (NP (NN B29)) (PRN (-LRB- -LRB-) (NP (NN Igβ)) (-RRB- -RRB-))) (, ,) (NP (NN CD20)) (CC and) (NP (NP (NN CD21)) (PRN (-LRB- -LRB-) (NP (NN 6–8)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (JJ Detailed) (NNS analyses)) (PP (IN of) (NP (DT the) (NN octamer) (NN sequence)))) (VP (VBD revealed) (SBAR (IN that) (S (NP (NP (NNS mutations)) (PP (IN in) (NP (NP (JJ most) (NNS positions)) (PP (IN of) (NP (DT the) (VBN conserved) (NN motif)))))) (VP (VBP interfere) (PP (IN with) (NP (NP (PRP$ its) (NN function)) (PRN (-LRB- -LRB-) (NP (CD 9)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN B) (NNS cells))) (, ,) (NP (CD two) (NN octamer) (NN transcription) (NNS factors)) (VP (VBP bind) (PP (TO to) (NP (NP (DT the) (NN octamer) (NN element)) (, ,) (NP (DT the) (ADJP (RB ubiquitously) (VBN expressed)) (NN Oct1)) (CC and) (NP (NP (DT the) (JJ lymphocyte-specific) (VBN expressed) (NN Oct2)) (PRN (-LRB- -LRB-) (NP (CD 10)) (-RRB- -RRB-))))))) (. .)))
( (S (S (PP (IN For) (NP (JJ B-cell-specific) (NN activity))) (NP (DT these) (NN transcription) (NNS factors)) (VP (VBP need) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NP (DT an) (JJ additional) (JJ lymphocyte-restricted) (NN coactivator)) (VP (VBN named) (S (NP (NP (NN BOB.1/OBF.1)) (-LRB- -LRB-) (NP (NP (JJ alternative) (NNS names)) (VP (VBP are) (NP (CD Bob.1)))))))))))))) (, ,)))
( (S (NP (NP (NP (NP (NN OBF-1)) (PRN (, ,) (NP (NN OCA-B)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NN 11,12)) (-RRB- -RRB-))) (. .))))
( (S (S (NP (NN BOB.1/OBF.1)) (VP (VP (VBZ displays) (NP (ADJP (RB only) (JJ weak)) (NN DNA) (NN binding))) (CC and) (VP (VBZ is) (VP (VBN recruited) (PP (TO to) (NP (DT the) (NN octamer) (NN sequence))) (ADVP (RB predominantly)) (PP (IN via) (NP (NP (NN interaction)) (PP (IN of) (NP (PRP$ its) (JJ N-terminal) (NN domain))) (PP (IN with) (NP (NP (DT the) (NNS POU-domains)) (PP (IN of) (NP (NP (NN Oct) (NNS factors)) (PRN (-LRB- -LRB-) (NP (NN 11–19)) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN transactivation) (NNS domains)) (PP (IN of) (NP (CC both) (NP (NP (NN type)) (PP (IN of) (NP (NN proteins—Oct)))) (CC and) (NP (NP (NN BOB.1/OBF.1—act)) (PP (IN in) (NP (NN synergy))))))) (VP (TO to) (VP (VB mediate) (NP (JJ octamer-dependent) (NN transcription))))) (. .)))
( (S (S (NP (NP (DT A) (NN BOB.1/OBF.1) (NN protein) (NN isoform)) (VP (VBG bearing) (NP (DT an) (JJ N-terminal) (VBN myristoylated) (NN extension)))) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB be) (VP (VBN localized) (PP (IN in) (NP (NP (DT the) (NN membrane) (NN fraction)) (PRN (-LRB- -LRB-) (NP (CD 20)) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN function)) (PP (IN of) (NP (DT this) (NN isoform)))) (VP (VBZ is) (RB not) (VP (VBN understood) (ADVP (RB yet))))) (. .)))
( (S (S (NP (NN Gene) (NN targeting) (NNS experiments)) (VP (VBD revealed) (SBAR (IN that) (S (NP (NN BOB.1/OBF.1)) (VP (VBZ is) (ADJP (JJ important)) (PP (IN at) (NP (NP (JJ several) (NNS stages)) (PP (IN of) (NP (NP (NN B) (NN cell) (NN development)) (PP (PP (IN in) (NP (DT the) (NN bone) (NN marrow))) (CONJP (RB as) (RB well) (IN as)) (PP (IN in) (NP (JJ peripheral) (JJ secondary) (JJ lymphoid) (NNS tissues))))))))))))) (. .)))
( (S (S (S (PP (IN In) (NP (DT the) (NN bone) (NN marrow))) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (ADJP (ADJP (JJ immature)) (CONJP (RB as) (RB well)) (ADJP (JJ transitional))) (NN B) (NNS cells)))) (VP (VBZ is) (VP (VBN reduced)))) (CC and) (S (NP (JJR fewer) (NNS cells)) (VP (VBP reach) (NP (DT the) (NN periphery) (-LRB- -LRB-) (CD 21) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (NN BOB.1/OBF.1)) (VP (VBZ is) (VP (VBN expressed) (PP (IN throughout) (NP (NN B) (NN cell) (NN ontogeny))) (, ,) (PP (IN albeit) (PP (IN at) (NP (JJ different) (NNS levels))))))) (. .)))
( (S (S (NP (DT The) (JJS highest) (NN expression)) (VP (VBZ is) (VP (VBN found) (PP (IN in) (NP (NP (JJ germinal) (NN center) (NN B) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN 22,23)) (-RRB- -RRB-))))))) (. .)))
( (S (NP (NP (DT The) (ADJP (RBS most) (JJ striking)) (NN characteristic)) (PP (IN of) (NP (NN BOB.1/OBF.1−/−))))))
( (S (S (NP (NNS mice)) (VP (VBZ is) (NP (DT the) (JJ complete) (NN failure) (S (VP (TO to) (VP (VB form) (NP (NP (JJ germinal) (NNS centers)) (PP (IN in) (NP (NP (NN spleen)) (CC and) (NP (NP (NN lymph) (NNS nodes)) (PRN (-LRB- -LRB-) (NP (NN 24–26)) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (VBN switched) (NN immunoglobulin) (NNS isotypes)))) (VP (VBZ is) (ADVP (RB strongly)) (VP (VBN reduced)))) (. .)))
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (DT the) (JJ marginal) (NN zone) (NN B) (NN cell) (NN compartment))) (PP (IN in) (NP (NN BOB.1/OBF.1−/−))))))
( (S (S (NP (NNS mice)) (VP (VBZ is) (ADVP (RB severely)) (VP (VBN affected) (PRN (-LRB- -LRB-) (NP (CD 27)) (-RRB- -RRB-))))) (. .)))
( (S (NP (NP (DT The) (JJ B-cell-specific) (NN expression)) (PP (IN of) (NP (DT a) (NN bcl2-transgene)))) (VP (MD can) (VP (VB rescue) (NP (NP (JJ several) (NNS aspects)) (PP (IN of) (NP (JJ early) (NN lymphopoiesis))) (PP (IN in) (NP (NNS BOB.1/OBF.1−/−))))))))
( (S (NP (NP (NNS mice)) (. .))))
( (S (S (ADVP (RB However)) (, ,) (NP (NP (JJ terminal) (NN differentiation)) (CC and) (NP (JJ specific) (NN B) (NN cell) (NNS responses))) (VP (VBP are) (ADVP (RB still)) (ADJP (JJ defective)) (PRN (-LRB- -LRB-) (NP (CD 28)) (-RRB- -RRB-)))) (. .)))
( (S (S (NP (NN BOB.1/OBF.1)) (VP (VBZ is) (ADVP (RB also) (JJ inducible)) (VP (VBN expressed) (PP (IN in) (NP (NP (NN T) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN 29,30)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (DT A) (JJ critical) (NN function)) (PP (IN in) (NP (NN T) (NNS cells)))) (VP (VBZ has) (ADVP (RB however)) (RB not) (VP (VBN been) (VP (VBN identified) (ADVP (RB yet)))))) (. .)))
( (S (S (NP (NP (DT Some)) (PP (IN of) (NP (NP (DT the) (NNS defects)) (PP (IN in) (NP (NP (ADJP (ADJP (JJ early)) (CC and) (ADJP (JJ late))) (NN B) (NN cell) (NN development)) (CONJP (RB as) (RB well) (IN as)) (NP (FW in) (NN B) (NN cell) (NN function))))))) (VP (VBD were) (NP (NP (NN reminiscent)) (PP (IN of) (NP (NP (NNS defects)) (PP (IN in) (NP (NP (NNS mice)) (ADJP (JJ deficient) (PP (IN of) (NP (NP (JJ functional) (NN Bruton) (POS 's) (NN tyrosine) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN Btk)) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (NP (NP (NNS Mutations)) (PP (IN in) (NP (NP (DT the) (NN gene)) (VP (VBG coding) (PP (IN for) (NP (NN Btk))))))) (VP (VBP cause) (NP (NP (NP (NP (JJ X-linked) (NN agammaglobulinemia)) (PRN (-LRB- -LRB-) (NP (NN XLA)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NP (NNS humans)) (PRN (-LRB- -LRB-) (NP (CD 31)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ X-linked) (NN immunodeficiency)) (PRN (-LRB- -LRB-) (NP (NN Xid)) (-RRB- -RRB-))))) (PP (IN in) (NP (NP (NNS mice)) (VP (VBN -LSB-reviewed) (PP (IN in) (NP (NN Ref)))))) (. .)) (PRN (-LRB- -LRB-) (NP (CD 32)) (-RRB- -RRB-)))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (DT The) (JJ Xid) (NN phenotype)) (VP (VBZ is) (VP (VBN characterized) (PP (PP (IN by) (NP (NP (DT a) (NN defect)) (PP (IN in) (NP (NP (DT the) (NN transition)) (PP (IN from) (NP (DT the) (NN pre-B))) (PP (TO to) (NP (JJ immature) (NN B) (NNS cells))))) (PP (IN in) (NP (DT the) (NN bone) (NN marrow))))) (CONJP (RB as) (RB well) (IN as)) (PP (IN by) (NP (NP (DT a) (VBN reduced) (NN number)) (PP (IN of) (NP (NP (JJ peripheral) (NN B) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP exhibit) (NP (NP (DT an) (JJ immature) (NN phenotype)) (PRN (-LRB- -LRB-) (NP (NN 33–35)) (-RRB- -RRB-)))))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (DT the) (NN B-1) (NN cell) (NN compartment)) (VP (VBZ is) (ADJP (JJ absent) (PP (IN in) (NP (NN Xid-mice)))))) (. .)))
( (S (S (ADVP (RB Consequently)) (, ,) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NN serum) (NP (NP (NN IgM)) (CC and) (NP (NN IgG3)))))) (VP (VBP are) (ADJP (JJ low)))) (. .)))
( (S (ADJP (JJ Similar) (PP (TO to) (NP (NN BOB.1/OBF.1−/−))))))
( (S (NP (NP (NP (NNS animals)) (PRN (-LRB- -LRB-) (NP (NN 25,27)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS mice)) (ADJP (JJ deficient) (PP (IN for) (NP (NP (NP (DT an) (JJ functional) (NN Btk)) (VP (VBP show) (NP (NP (JJ severe) (NNS defects)) (PP (IN in) (NP (NN B) (NN cell) (NN receptor) (NN signaling)))))) (, ,) (VP (VBN expressed) (PP (IN by) (NP (NP (VBN reduced) (NN tyrosine) (NN phosphorylation)) (ADJP (JJ -LSB-reviewed) (PP (IN in) (NP (-LRB- -LRB-) (CD 32) (-RRB- -RRB-))))))) (-RRB- -RSB-))))) (, ,)) (VP (VP (VBD reduced) (NP (NP (NN elevation)) (PP (IN of) (NP (JJ intracellular) (NN Ca2+) (NNS levels)))) (PRN (-LRB- -LRB-) (NP (CD 36)) (-RRB- -RRB-))) (, ,) (VP (VBD reduced) (NP (NP (NP (NN activation)) (PP (IN of) (NP (NP (NN NF-κB)) (PRN (-LRB- -LRB-) (NP (NN 37,38)) (-RRB- -RRB-))))) (CONJP (RB as) (RB well) (IN as)) (NP (JJ impaired) (NN proliferation))) (PP (IN upon) (NP (NP (NN IgM) (NN crosslinking)) (PRN (-LRB- -LRB-) (NP (NN 33,34)) (-RRB- -RRB-)))))) (. .)))
( (S (S (PP (VBN Based) (PP (IN on) (NP (DT these) (NNS findings)))) (NP (PRP one)) (VP (MD may) (VP (VB suggest) (SBAR (IN that) (S (NP (NP (NN BOB.1/OBF.1)) (CC and) (NP (NN Btk))) (VP (VBP have) (NP (VBG overlapping) (NNS functions)))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NP (NNS mice)) (ADJP (JJ mutant) (PP (IN for) (NP (DT both) (NNS proteins))))) (ADVP (RB almost) (RB completely)) (VP (VP (VBP lack) (NP (JJ peripheral) (NN B) (NNS cells))) (CC and) (VP (VBP show) (NP (NP (NP (DT a) (JJ severe) (NN agammaglobulinemia)) (PRN (-LRB- -LRB-) (NP (CD 39)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NN phenotype)) (VP (VBG resembling) (NP (NP (JJ human) (NNS XLA)) (PRN (-LRB- -LRB-) (NP (CD 31)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (SBAR (IN although) (S (NP (NP (NN BOB.1/OBF.1)) (CC and) (NP (NN Btk))) (VP (VBP share) (NP (DT some) (VBG overlapping) (NNS functions))))) (, ,) (NP (PRP they)) (VP (VBP are) (ADVP (RB also)) (VP (VBN involved) (PP (IN in) (NP (NP (JJ distinct) (NN signaling) (NNS pathways)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (ADJP (JJ important) (PP (IN for) (NP (NP (NN B) (NN cell) (NN development)) (CC and) (NP (NN function))))))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB get) (NP (NP (NNS insights)) (PP (IN into) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NN Btk) (NN expression))))))))) (NP (DT the) (ADJP (ADJP (JJ human)) (PRN (-LRB- -LRB-) (NP (NN 40,41)) (-RRB- -RRB-)) (CC and) (ADJP (JJ murine)) (PRN (-LRB- -LRB-) (NP (NN 42,43)) (-RRB- -RRB-))) (NN promoter) (NNS regions)) (VP (VBD were) (VP (VBN analyzed) (PP (IN for) (NP (NP (JJ conserved) (JJ regulatory) (NNS elements)) (PRN (-LRB- -LRB-) (NP (NN 44–49)) (-RRB- -RRB-))))))) (. .)))
( (S (S (ADVP (RB Recently)) (, ,) (NP (NP (JJ regulatory) (NNS elements)) (ADJP (JJ necessary) (PP (IN for) (NP (NN Btk) (NN gene) (NN activation))))) (VP (VBD were) (ADVP (RB also)) (VP (VBN identified) (PP (IN in) (NP (NN intron1)))))) (. .)))
( (S (S (NP (DT The) (NN btk) (NN promoter)) (VP (VBZ does) (RB not) (VP (VB contain) (NP (DT an) (JJ obvious) (NN TATA) (NN box))))) (. .)))
( (S (S (NP (NN Transcription)) (VP (VBZ is) (VP (VBN initiated) (PP (IN at) (NP (DT a) (JJ putative) (NN initiator) (NN element)))))) (. .)))
( (S (S (NP (NN Deletion) (NNS analyses)) (VP (VBD revealed) (SBAR (IN that) (S (NP (NP (DT a) (NN sequence)) (PP (IN of) (NP (NP (CD 280) (NN bp)) (ADVP (RB upstream) (PP (IN of) (NP (NP (DT the) (NN start) (NN site)) (PP (IN of) (NP (NN transcription))))))))) (VP (VBZ is) (ADJP (JJ sufficient) (PP (IN for) (NP (NP (DT the) (JJ cell-type-specific) (NN regulation)) (PP (IN of) (NP (NN Btk) (NN expression))))))))))) (. .)))
( (S (S (NP (DT The) (NN transcription) (NNS factors) (NP (NP (NN Sp1)) (, ,) (NP (NN Sp3)) (, ,) (NP (NN Spi-B)) (CC and) (NP (NN PU.1)))) (VP (VBP are) (ADJP (JJ able) (S (VP (TO to) (ADVP (RB synergistically)) (VP (VB activate) (NP (DT the) (NN Btk) (NN promoter)))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (PP (IN in) (NP (NP (NP (JJ PU.1-deficient) (JJ fetal) (NN liver) (NNS cells)) (PRN (-LRB- -LRB-) (NP (CD 48)) (-RRB- -RRB-))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ SP1−/−) (JJ embryonic) (NN stem) (NNS cells)) (PRN (-LRB- -LRB-) (NP (CD 49)) (-RRB- -RRB-))))) (, ,) (NP (NN Btk) (NN expression)) (VP (VP (VBD was) (ADJP (CC either) (ADJP (VBN reduced)) (CC or) (ADJP (RB not) (VBN affected)))) (CC but) (RB not) (VP (VBN abolished)))) (. .)))
( (S (S (NP (DT This)) (VP (VBZ indicates) (SBAR (IN that) (S (NP (ADJP (ADJP (JJ additional)) (, ,) (CC yet) (ADJP (RB not) (VBN identified))) (NNS factors)) (ADVP (RB also)) (VP (VBP contribute) (PP (TO to) (NP (NN Btk) (NN promoter) (NN activity)))))))) (. .)))
( (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (DT the) (NN transcription) (NNS factors) (NP (NP (NN Oct1)) (CC and) (NP (NN Oct2)))) (VP (VBP are) (ADJP (JJ able) (S (VP (TO to) (VP (VB bind) (PP (IN in) (NP (NP (NN concert)) (PP (IN with) (NP (DT the) (NN coactivator) (NN BOB.1/OBF.1))))) (PP (TO to) (NP (NP (DT a) (JJ non-perfect) (NN octamer) (NN site)) (PP (IN within) (NP (NP (DT the) (ADJP (ADJP (JJ human)) (CC and) (ADJP (JJ murine))) (NN Btk) (NNS promoters)) (VP (VBG leading) (PP (TO to) (NP (PRP$ their) (NN activation)))))))))))))))) (. .)))
( (S (S (ADVP (RB Moreover)) (, ,) (NP (NP (NP (NN Oct)) (CC and) (NP (NN BOB.1/OBF.1))) (NNS proteins)) (VP (VBP activate) (NP (DT the) (JJ murine) (NN Btk) (NN promoter)) (ADVP (RB synergistically)) (PP (IN with) (NP (NN PU.1))))) (. .)))
( (S (NP (NP (DT The) (NN importance)) (PP (IN of) (NP (DT the) (NN Oct/BOB.1/OBF.1-mediated))))))
( (S (NP (NN btk) (NN gene) (NN activation)) (VP (VBZ is) (VP (VBN underlined) (PP (IN by) (NP (NP (DT the) (NN fact)) (WHNP (WDT that)) (PP (IN in) (NP (NN BOB.1/OBF.1-deficient)))))))))
( (S (S (NP (NP (NP (NN B) (NNS cells)) (NN expression)) (PP (IN of) (NP (NN Btk)))) (VP (VBZ is) (VP (VBN impaired)))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (NP (PRP we)) (VP (VBD identified) (NP (NP (DT the) (JJ non-perfect) (NN octamer) (NN site)) (ADJP (JJ present) (PP (IN in) (NP (NP (ADJP (JJ human))) (CONJP (RB as) (RB well) (IN in)) (NP (DT the) (JJ murine) (NN Btk) (NN promoter)))))) (PP (IN as) (NP (NP (DT a) (VBN conserved) (JJ regulatory) (NN site)) (ADJP (JJ important) (PP (IN for) (NP (ADJP (NN B) (JJ cell-specific)) (NN btk) (NN gene) (NN regulation)))))))) (. .)))
( (S (NP (NP (NNS MATERIALS)) (CC AND) (NP (NNS METHODS)))))
( (S (NP (NP (NN C57BL/6) (JJ wild) (NN type)) (CC and) (NP (NN BOB.1/OBF.1−/−)))))
( (S (NP (NP (NP (NNS mice)) (PP (IN on) (NP (DT the) (JJ same) (JJ genetic) (NN background)))) (CONJP (RB as) (RB well) (IN as)) (NP (DT the) (NNS 1.5/B.1−/−)))))
( (S (S (NP (NNS mice)) (VP (VBD were) (VP (VBN obtained) (PP (IN from) (NP (PRP$ our) (JJ breeding) (NN facility)))))) (. .)))
( (S (S (NP (NNS Mice)) (VP (VBD were) (VP (VBN analyzed) (PP (NP (CD 8–12) (NNS weeks)) (IN after) (NP (NN birth)))))) (. .)))
( (S (S (NP (NP (DT The) (NN generation)) (PP (IN of) (NP (NNS mice)))) (VP (VBZ 1.5/B.1−/−))) (. ,)))
( (S (S (S (ADJP (JJ transgenic) (PP (IN for) (NP (NP (NN µE-tTa)) (CC and) (NP (NN tetO-BOB.1/OBF.1)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN described) (PRN (-LRB- -LRB-) (NP (CD 21)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NNS Cells)) (VP (VBD were) (VP (VP (VP (VBN labeled) (PP (IN with) (NP (DT an) (NN anti-B220-biotin-antibody)))) (CC and) (VP (VBN revealed) (PP (IN by) (NP (NN Streptavidin-Cy-Chrom))))) (CC and) (VP (ADVP (RB subsequently)) (VBN sorted) (PP (IN with) (NP (NP (DT a) (NP (NN FACSORT)) (CC plus) (NP (NN cytometer))) (PRN (-LRB- -LRB-) (NP (NNP Becton) (NNP Dickinson)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NNS Stainings)) (VP (VBD were) (VP (VBN performed) (PP (IN in) (NP (NP (NNS PBS)) (VP (VBG containing) (NP (NP (NP (CD 0.1) (NN %) (NN BSA)) (PRN (-LRB- -LRB-) (NP (NP (NN Roche) (NN Diagnostics)) (, ,) (NP (NNP Mannheim) (, ,) (NNP GER))) (-RRB- -RRB-))) (, ,) (NP (ADJP (CD 0.1) (NN %)) (NN Na-azid)) (CC and) (NP (NP (JJ saturating) (NNS concentrations)) (PP (IN of) (NP (NN anti-CD16/CD32)))))))) (S (VP (TO to) (VP (VB block) (NP (NN FcγIII/II) (NNS receptors)))))))) (. .)))
( (S (S (NP (DT All) (NNS antibodies)) (VP (VBD were) (VP (VBN purchased) (PP (IN from) (NP (NNP Becton) (NNP Dickinson)))))) (. .)))
( (S (S (S (NP (NP (JJ Single) (NN cell) (NNS suspensions)) (PP (IN from) (NP (NN mouse) (NNS splenocytes)))) (VP (VBD were) (VP (VBN incubated) (PP (IN with) (NP (NP (NNS antibodies)) (PP (IN against) (NP (NP (NP (NN CD4)) (, ,) (NP (NN CD8))) (-LRB- -LRB-) (VP (VBN derived) (PP (IN from) (NP (DT an) (JJ antibody-producing) (NN hybridoma) (NN cell) (NN line)))) (-RRB- -RRB-)))))))) (CC and) (S (NP (JJ positive) (NNS cells)) (VP (VBD were) (VP (VBN eliminated) (PP (IN by) (NP (NP (NN complement) (NN lysis)) (VP (VBG using) (NP (NP (NN baby) (NN rabbit) (NN complement)) (PRN (-LRB- -LRB-) (NP (NN Cedarlane)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (DT This) (NN treatment)) (VP (VBD was) (VP (VBN followed) (PP (IN by) (NP (NP (NP (DT a) (JJ lympholyte) (NN M) (NN gradient)) (PRN (-LRB- -LRB-) (NP (NN Cedarlane)) (-RRB- -RRB-))) (S (VP (TO to) (VP (VB eliminate) (NP (JJ red) (NN blood) (CONJP (RB as) (RB well) (IN as)) (JJ dead) (NNS cells)))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN purity)) (PP (IN of) (NP (DT the) (NN B220+) (NN B) (NN cell) (NN population)))) (VP (VBD was) (NP (CD >95) (NN %)))) (. .)))
( (S (S (NP (NN NIH/3T3) (CC and) (NN HeLa) (NNS cells)) (VP (VBD were) (VP (VP (VBN cultured) (PP (IN in) (NP (NP (NP (NN DMEM)) (PRN (-LRB- -LRB-) (NP (NP (NN Life) (NNS Technologies)) (, ,) (NP (NNP Inc.))) (-RRB- -RRB-))) (, ,) (NP (NP (NN BJAB) (CC and) (NN S194) (NNS cells)) (PP (IN in) (NP (NP (NP (NN RPMI)) (PRN (-LRB- -LRB-) (NP (NP (NN Life) (NNS Technologies)) (, ,) (NP (NNP Inc.))) (-RRB- -RRB-))) (VP (VBN supplemented) (PP (CC both) (IN with) (NP (NP (ADJP (CD 10) (NN %)) (NN FCS)) (, ,) (NP (NNS antibiotics)) (CC and) (NP (ADJP (CD 50) (NN µM)) (NN β-ME)))))))) (, ,)))) (CC and) (VP (VBN grown) (PP (IN at) (NP (NP (NN 37°C)) (CC and) (NP (ADJP (CD 5) (NN %)) (NN CO2)))))))) (. .)))
( (S (S (NP (NP (NNS Transfections)) (PP (IN of) (NP (NN NIH/3T3) (NNS cells)))) (VP (VBD were) (VP (VBN performed) (PP (IN by) (NP (NN electroporation))) (PRN (-LRB- -LRB-) (NP (JJ Bio-Rad)) (-RRB- -RRB-)) (PP (IN with) (NP (NP (CD 450) (NN V) (CC and) (CD 250) (NN µF)) (PP (IN in) (NP (NN phosphate) (JJ buffered) (NN saline)))))))) (. .)))
( (S (S (NP (JJ Pre-B) (NN cell) (NNS lines)) (VP (VBD were) (VP (VBN established) (PP (IN by) (S (VP (VBG culturing) (NP (NP (NN bone) (NN marrow) (NNS cells)) (PP (IN from) (NP (NP (NNS mice)) (PP (IN of) (NP (DT the) (VBN indicated) (NN genotype)))))) (PP (IN under) (NP (NP (DT the) (JJ stimulatory) (NN influence)) (PP (IN of) (NP (JJ irradiated) (JJ adherent) (JJ stromal) (NNS cells) (NP (NP (NN ST2)) (CC and) (NP (DT the) (NN cytokine) (NN IL-7))))))))))))) (. .)))
( (S (S (NP (JJ As) (NN culture) (NN medium)) (VP (VBD was) (VP (VBN used) (NP (NP (NP (NN IMDM)) (PRN (-LRB- -LRB-) (NP (NP (NN Life) (NNS Technologies)) (, ,) (NP (NNP Inc.))) (-RRB- -RRB-))) (VP (VBN supplemented) (PP (IN with) (NP (NP (ADJP (CD 5) (NN %)) (NN FCS)) (, ,) (NP (NNS antibiotics)) (, ,) (NP (ADJP (CD 50) (NN µM)) (NN β-ME)) (, ,) (NP (NP (NP (ADJP (CD 2) (NN %)) (NN supernatant)) (PP (IN from) (NP (NN IL-7) (NN producing) (NNS cells)))) (NP (NN J558) (-LRB- -LRB-) (NN A)))))))))) (. .)))
( (S (NP (NP (NP (NP (NNP Rolink)) (PRN (, ,) (NP (NNP Basel)) (-RRB- -RRB-))) (CC and) (NP (NP (ADJP (CD 5) (NN %)) (NP (NNP Primatone))) (PRN (-LRB- -LRB-) (S (NP (NN PAN) (NNS Systems)) (NP (NNP GmbH))) (-RRB- -RRB-)))) (. .))))
( (S (S (NP (NNS Cells)) (VP (VBD were) (VP (VBN grown) (PP (IN at) (NP (NP (NN 37°C)) (CC and) (NP (ADJP (CD 10) (NN %)) (NN CO2))))))) (. .)))
( (S (S (NP (NP (DT The) (JJ murine) (NN Btk) (NN promotor)) (PRN (-LRB- -LRB-) (NP (CD −436) (TO to) (CD +79)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN cloned) (PP (IN into) (NP (NP (DT the) (NN pTKL/2) (NN vector)) (VP (VBG containing) (NP (NP (DT the) (JJ HSV-thymidine) (NN kinase) (NN promoter)) (PRN (-LRB- -LRB-) (NP (CD −105) (TO to) (CD +52)) (-RRB- -RRB-))) (PP (IN from) (NP (NP (DT the) (NN pBLCAT2)) (PP (IN in) (NP (NP (NN front)) (PP (IN of) (NP (NP (DT the) (JJ firefly) (NN luciferase)) (NN coding) (NN region))))))))))))) (. .)))
( (S (S (NP (DT The) (NN HSV-thymidine) (NN kinase) (NN promoter)) (VP (VBD was) (VP (VP (VBN excised) (PP (IN by) (NP (NP (DT a) (NN restriction) (NN endonuclease) (NN digest)) (VP (VBG using) (NP (NP (NN HindIII)) (CC and) (NP (NN BglII))))))) (CC and) (VP (VBN replaced) (PP (IN by) (NP (NP (DT the) (NN Btk) (NN promoter)) (VP (VBN cloned) (PP (IN via) (NP (NP (JJ genomic) (NN PCR)) (VP (VBG using) (NP (DT the) (VBG following) (NNS primers)))))))))))) (: :) (NP (NP (NN mBtkpr-HindIII)) (: :) (NP (NN GAG) (NN TAA) (NN GCT) (NN TTC) (NN TTT) (NN GTC) (NN TGT) (NN CCT) (NN CC)) (: ;) (NP (NN mBtkprom-BglII)) (: :) (NP (NN TGA) (NN GAT) (NN GCC) (NN AGA) (NN TCT) (NN TGG) (NN AAG) (NN GTG))) (. .)))
( (S (S (NP (DT The) (JJ mutant) (NN Btk) (NN promoter)) (VP (VBD was) (VP (VBN created) (PP (IN by) (NP (NP (JJ site-directed) (ADJP (FW in) (FW vitro)) (NN mutagenesis)) (PRN (-LRB- -LRB-) (NP (NN Stratagene)) (-RRB- -RRB-)))) (S (VP (VBG using) (NP (NP (DT the) (VBG following) (NNS primers)) (: :) (NP (NN mBTKprom) (CD 3M) (NP (CD 5) ('' '))) (: :) (NP (NP (NN GTA) (NN AAG) (NN AGG)) (NP (NN TCC) (NN CAG) (NN TAC) (NN AAT) (NN GTC) (NN GGG) (NN GGG) (NN TGG)) (: ;) (NP (NP (NN mBTKprom) (CD 3M)) (CD 3) ('' '))) (: :) (NP (NN CCA) (NN CCC) (NN CCC) (NN GAC) (NN ATT) (NN GTA) (NN CTG) (NN GGA) (NN CCT) (NN CTT) (NN TAC)))))))) (. .)))
( (S (S (NP (DT The) (JJ wild-type) (NN BOB.1/OBF.1) (NN cDNA)) (VP (VBD was) (VP (VBN cloned) (PP (IN into) (NP (DT the) (NN expression) (NN vector) (NN pcDNA3)))))) (. .)))
( (S (S (NP (NP (DT The) (NN cloning)) (PP (IN of) (NP (DT the) (NP (NN Oct2)) (CC and) (NP (NN PU.1)) (NP (NN expression) (NNS vectors))))) (VP (VBZ has) (VP (VBN been) (VP (VBN described) (PRN (-LRB- -LRB-) (NP (NN 50,51)) (-RRB- -RRB-)))))) (. .)))
( (S (S (PP (IN For) (NP (NP (ADJP (FW in) (FW vitro)) (NN translation)) (PP (IN of) (NP (NN BOB.1/OBF.1))))) (NP (DT the) (JJ pMT/PKA-Bob) (NN expression) (NN vector)) (VP (VBD was) (VP (VBN used))) (PRN (-LRB- -LRB-) (NP (CD 15)) (-RRB- -RRB-))) (. .)))
( (S (S (NP (NNS Proteins)) (VP (VBD were) (VP (VBN prepared) (S (VP (VBG using) (NP (NP (NN lysis) (NN buffer)) (VP (VBG containing) (NP (NP (ADJP (CD 20) (NN mM)) (NN Tris)) (NP (NN pH) (CD 7.5)) (, ,) (NP (ADJP (CD 1) (NN mM)) (NN EDTA)) (, ,) (NP (ADJP (CD 100) (NN mM)) (NN NaCl)) (, ,) (NP (ADJP (CD 1) (NN %)) (NN Triton) (NN X-100)) (, ,) (NP (ADJP (CD 0.5) (NN %)) (NN sodiumdeoxycholat)) (CC and) (NP (ADJP (CD 0.1) (NN %)) (NN SDS)))))))))) (. .)))
( (S (S (NP (NNS Proteins)) (VP (VBD were) (VP (VP (VBN resolved) (PP (IN on) (NP (DT a) (ADJP (CD 12.5) (NN %)) (NN SDS–PAGE)))) (CC and) (VP (VBN transferred) (PP (TO to) (NP (NP (NN PVDF) (NN membrane)) (PRN (-LRB- -LRB-) (NP (NN Millipore)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (PP (IN For) (NP (NP (NN immunodetection)) (PP (IN of) (NP (NN Btk))))) (NP (DT a) (JJ polyclonal) (NN anti-Btk) (NN antibody)) (VP (VBD was) (VP (VBN used) (PRN (-LRB- -LRB-) (NP (NN BD)) (-RRB- -RRB-))))) (. .)))
( (S (S (PP (IN For) (NP (NP (NN detection)) (PP (IN of) (NP (NN Rel-A))))) (NP (NP (DT a) (JJ Rel-A-specific) (JJ polyclonal) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NNP Santa) (NNP Cruz) (NN Biotechnology)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN purchased)))) (. .)))
( (S (S (NP (NNS Proteins)) (VP (VBD were) (VP (VBN visualized) (S (VP (VBG using) (NP (NP (NP (NP (NP (ADJP (ADJP (JJ anti-mouse)) (CC or) (ADJP (JJ anti-rabbit))) (NN horseradish) (NN peroxidase)) (VBN conjugated) (NNS antibodies)) (, ,) (ADVP (RB respectively))) (PRN (-LRB- -LRB-) (NP (NN Pierce)) (-RRB- -RRB-))) (CC and) (NP (NP (DT the) (NN ECL) (NN detection) (NN system)) (PRN (-LRB- -LRB-) (NP (NNP Amersham)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (JJ Total) (NN RNA)) (VP (VBD was) (VP (VBN prepared) (S (VP (VBG using) (NP (NP (NP (DT the) (JJ Trizol®-reagent)) (PRN (-LRB- -LRB-) (NP (NP (NN Life) (NNS Technologies)) (, ,) (NP (NNP Inc.))) (-RRB- -RRB-))) (VP (VBG according) (PP (TO to) (NP (NP (DT the) (NN protocol)) (PP (IN of) (NP (DT the) (NN manufacturer)))))))))))) (. .)))
( (S (S (PP (IN After) (NP (NP (NN separation)) (PP (IN of) (NP (NNS RNAs))) (PP (IN on) (NP (DT a) (ADJP (CD 1) (NN %)) (NN formaldehyde) (NN agarose) (NN gel))))) (, ,) (NP (NN northern) (NN blot) (NNS analyses)) (VP (VBD were) (VP (VBN performed) (SBAR (IN as) (S (VP (VBN described) (PP (IN in) (NP (NN Ref)))))))) (. .)) (PRN (-LRB- -LRB-) (NP (CD 52)) (-RRB- -RRB-))))
( (S (S (NP (NP (NP (NN Preparation)) (PP (IN of) (NP (NP (JJ whole) (NN cell) (NNS extracts)) (PP (IN for) (NP (NP (JJ electrophoretic) (NN mobility) (NN shift) (NN assay)) (PRN (-LRB- -LRB-) (NP (NN EMSA)) (-RRB- -RRB-))))))) (CC and) (NP (NP (DT the) (NN protocol)) (PP (IN of) (NP (DT the) (NN EMSA) (NN procedure))))) (VP (VBP have) (VP (VBN been) (VP (VBN described) (ADVP (RBR earlier)) (PRN (-LRB- -LRB-) (NP (NN 53,54)) (-RRB- -RRB-)))))) (. .)))
( (S (IN For) (NN EMSA) (, ,) (DT the) (VBG following) (NNS oligonucleotides) (VBD were) (VBN annealed) (CC and) (RB subsequently) (VBN labeled) (VBG using) (NN P32) (NN αdCTP) (IN in) (DT a) (JJ fill-in) (NN reaction) (: :) (NN mBtkprom) (NN 5′-gcgg) (NN AGA) (NN GGT) (NN CCC) (NN AGG) (NN CAA) (NN ATG) (NN TCG) (NN GGG) (NN GG) (, ,) (NN mBtk) (NN prom) (NN 3′-gcgg) (NN CCC) (NN CCC) (NN GAC) (NN ATT) (NN TGC) (NN CTG) (NN GGA) (NN CCT) (NN CT) (: ;) (NN hBtkprom) (NN 5′) (NN gcgg) (NN AGA) (NN GGT) (NN CCC) (NN AAG) (NN CAA) (NN ATG) (NN AAG) (NN GGC) (NN GG) (, ,) (NN hBtkprom) (NN 3′-ggcg) (NN CCG) (NN CCC) (NN TTC) (NN ATT) (NN TGC) (NN TTG) (NN GGA) (NN CCT) (NN CT) (: ;) (JJ mBtkprom-Mut) (NN 5′-gcgg) (NN AGA) (NN GGT) (NN CCC) (NN AGT) (NN ACA) (NN ATG) (NN TCG) (NN GGG) (NN GG) (, ,) (JJ mBtkprom-Mut) (NN 3′-gcgg) (NN CCC) (NN CCC) (NN GAC) (NN ATT) (NN GTA) (NN CTG) (NN GGA) (NN CCT) (NN CT) (: ;) (JJ hBtkprom-Mut) (NN 5′-gcgg) (NN AGA) (NN GGT) (NN CCC) (NN AGT) (NN ACA) (NN ATG) (NN AAG) (NN GGC) (NN GG) (, ,) (JJ hBtkprom-Mut) (NN 3′-ggcg) (NN CCG) (NN CCC) (NN TTC) (NN ATT) (NN GTA) (NN CTG) (NN GGA) (NN CCT) (NN CT) (: ;) (NN Oct) (NN consensus) (NN 5′-gcgg) (NN ACC) (NN TGG) (NN GTA) (NN ATT) (NN TGC) (NN ATT) (NN TCT) (NN AAA) (IN AT) (, ,) (NN Oct) (NN consensus) (NN 3′-gcgg) (NN ATT) (NN TTA) (NN GAA) (NN ATG) (NN CAA) (NN ATT) (NN ACC) (NN CAG) (NN GT) (. .)))
( (S (S (PP (IN For) (NP (NN competition) (NNS experiments))) (, ,) (NP (DT the) (JJ unlabeled) (JJ annealed) (NNS oligonucleotides)) (VP (VBD were) (VP (VBN used)))) (. .)))
( (S (S (NP (NP (DT The) (VBN indicated) (NN amount)) (PP (IN of) (NP (NNS oligonucleotides)))) (VP (VBD was) (VP (VBN added) (PP (TO to) (NP (DT the) (NN EMSA) (NN reaction) (NN mixture)))))) (. .)))
( (S (S (PP (IN For) (NP (NN supershift) (NNS experiments) (NP (NP (DT an) (NN anti-Oct1-antibody)) (PRN (-LRB- -LRB-) (NP (NN serum)) (-RRB- -RRB-))))) (, ,) (NP (NN anti-Oct2-antibody)) (-LRB- -LRB-) (NP (NN C-20)) (: ;) (NP (NNP Santa) (NNP Cruz) (NN Biotechnology)) (: ;) (NP (NN no))) (. .)))
( (S (NP (NP (NN sc-233)) (-RRB- -RRB-) (CC or) (NP (NN anti-BOB.1/OBF.1-antibody)))))
( (S (S (PRN (-LRB- -LRB-) (NP (NN serum)) (-RRB- -RRB-)) (VP (VBD were) (VP (VBN used)))) (. .)))
( (S (S (NP (NP (JJ Modified) (NN EMSA) (NNS conditions)) (PP (IN for) (NP (NP (DT the) (NN detection)) (PP (IN of) (NP (JJ specific) (NN Oct/BOB.1/OBF.1) (NNS complexes)))))) (VP (VBD were) (ADJP (RB previously) (VBN described) (-LRB- -LRB-) (NP (CD 55)) (-RRB- -RRB-)))) (. .)))
( (S (PP (IN In) (NP (DT these) (NNS experiments))) (NP (NP (CD 2) (JJ µg) (NNS HeLa-extracts)) (CC and) (NP (NP (NP (CD 2.5) (JJ µl) (ADJP (ADVP (FW in) (FW vitro)) (VBN translated)) (NN BOB.1/OBF.1) (NN protein)) (CC or) (NP (NP (DT the) (JJ same) (NN amount)) (PP (IN of) (NP (JJ unprogrammed) (NNS TNT-lysates))))) (PRN (-LRB- -LRB-) (NP (NN Promega)) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN added) (SBAR (WHADVP (WRB where)) (S (VP (VBN indicated)))))) (. .)))
( (S (S (NP (NP (DT The) (NP (NP (NN chromatin) (NN immunoprecipitation)) (PRN (-LRB- -LRB-) (NP (NN ChIP)) (-RRB- -RRB-))) (NN Assay) (NN kit)) (PRN (-LRB- -LRB-) (NP (NP (NNP Biomol) (NNP GmbH) (, ,) (NNP Hamburg) (, ,) (NNP Germany)) (, ,) (NP (NNP #) (CD 17-295))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN used) (PP (VBG according) (PP (TO to) (NP (NP (DT the) (NNS manufacturers) (NNS instructions)) (PP (IN with) (NP (NP (JJ minor) (NNS modifications)) (VP (VBN described) (ADVP (RB elsewhere)) (PRN (-LRB- -LRB-) (NP (CD 56)) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (NP (DT The) (NNS samples)) (VP (VBD were) (VP (VBN amplified) (S (VP (VBG using) (NP (NP (NN Taq) (NN DNA) (NN polymerase)) (PRN (-LRB- -LRB-) (NP (NNP Amersham) (NNP Pharmacia) (NNP Biotech)) (-RRB- -RRB-))) (S (VP (VBG using) (NP (DT the) (VBG following) (NNS primers))))))))) (: :) (FRAG (NP (NN mBtkprom-ChIP) (NN 5′-GGT) (NN TAT) (NN GAC) (NN CTG) (NN TTG) (NN TTT) (NN GTT) (NN CAG) (NN C)) (, ,) (NP (NP (NN mBtkprom-ChIP) (NN 3′-CAC) (NN CCT) (NN TTC) (NN GCA) (NN GCC)) (VP (VB ACT) (NP (NP (NNP C.)) (S (NP (NP (DT The) (NNS primers)) (PP (IN for) (NP (NP (DT the) (NNS analyses)) (PP (IN of) (NP (DT the) (NN H2B) (CC or) (NN Pax5) (NNS promoters)))))) (VP (VBP are) (VP (VBN described) (PP (IN in) (NP (NN Ref)))))) (. .) (-LRB- -LRB-) (CD 56) (-RRB- -RRB-))))) (. .)))
( (S (NP (NNS RESULTS))))
( (S (S (PP (IN In) (NP (NP (NN search)) (PP (IN for) (NP (CD BOB.1/OBF.1) (NN target) (NNS genes))))) (NP (PRP we)) (VP (VBD analyzed) (NP (NP (DT the) (NN promoter) (NNS regions)) (PP (IN of) (NP (NP (NNS genes)) (VP (VBN implicated) (PP (IN in) (NP (NP (NN B) (NN cell) (NN development)) (CC and) (NP (NN function)))))))) (PP (IN for) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (DT the) (NN octamer) (NN motif))))))) (. .)))
( (S (S (NP (NP (NNS Analyses)) (PP (IN of) (NP (DT the) (ADJP (ADJP (JJ human)) (CC and) (ADJP (JJ murine))) (NN Btk) (NNS promoters)))) (VP (VBD revealed) (NP (NP (DT a) (VBN conserved) (JJ non-perfect) (NN octamer) (NN motif)) (PP (IN within) (NP (NP (DT the) (JJ first) (CD 200) (NN bp)) (ADVP (RB upstream) (PP (IN of) (NP (NP (DT the) (NN start) (NN site)) (PP (IN of) (NP (NP (NN transcription)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 1)) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (NP (DT Both) (NN octamer) (NNS motifs)) (VP (VBP differ) (PP (IN from) (NP (NP (DT the) (NN consensus) (NN sequence)) (NN ATGCAAAT))) (PP (IN at) (NP (DT the) (JJ second) (NN position))))) (. .)))
( (S (S (S (NP (DT The) (JJ human) (NN Btk) (NN promoter) (NN motif)) (VP (VBZ bears) (NP (DT a) (JJ T→A) (NN transversion)))) (, ,) (IN whereas) (S (NP (DT the) (JJ murine) (NN variant)) (VP (VBZ shows) (NP (DT a) (JJ T→G) (NN transversion))))) (. .)))
( (S (S (SBAR (IN Since) (S (NP (PRP it)) (VP (VBD was) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT a) (NN mutation)) (PP (IN in) (NP (NP (DT this) (NN position)) (PP (IN of) (NP (DT the) (NN octamer) (NN motif)))))) (VP (VBZ interferes) (PP (IN with) (NP (NP (NN Oct) (NN binding)) (PRN (-LRB- -LRB-) (NP (CD 9)) (-RRB- -RRB-))))))))))) (NP (PRP we)) (VP (VBD wondered) (SBAR (IN whether) (S (NP (DT these) (NNS sites)) (VP (MD might) (ADVP (RB nevertheless)) (VP (VB play) (NP (NP (DT a) (NN role)) (PP (IN for) (NP (NN Btk) (NN promoter) (NN activity)))))))))) (. .)))
( (S (S (ADVP (RB Initially)) (, ,) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN from) (NP (NN BJAB) (NNS cells)))) (VP (VBD were) (VP (VBN incubated) (PP (IN with) (NP (NP (VBN labeled) (NNS probes)) (VP (VBG bearing) (NP (NP (CC either) (NP (DT the) (NN consensus) (NN octamer) (NN motif)) (CC or) (NP (DT the) (JJ putative) (NN octamer) (NN binding) (NNS sites))) (VP (VBN identified) (PP (IN in) (NP (NP (DT the) (ADJP (ADJP (JJ murine)) (CC or) (ADJP (JJ human))) (NN Btk) (NNS promoters)) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (NN 2A)) (CC and) (NP (NN B))) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (SBAR (IN Although) (S (NP (NN complex) (NN formation)) (VP (VBD was) (ADJP (RB much) (JJR weaker)) (PP (IN in) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (DT the) (NN Btk) (NN promoter) (NNS sites))))) (PP (VBN compared) (PP (IN with) (NP (DT the) (NN consensus) (NN octamer) (NN motif))))))) (, ,) (NP (JJ similar) (NNS complexes)) (VP (MD could) (VP (VB be) (VP (VBN detected) (PP (IN upon) (NP (JJ extended) (NN exposure))))))) (. .)))
( (S (S (SBAR (WHADVP (WRB When)) (S (NP (NP (DT the) (NN octamer) (NNS motifs)) (PP (IN in) (NP (DT the) (ADJP (ADJP (JJ murine)) (CC and) (ADJP (JJ human))) (NN Btk) (NNS promoters)))) (VP (VBD were) (ADVP (RB further)) (VP (VP (VBN mutated)) (CC and) (VP (ADVP (RB then)) (VBN used) (PP (IN as) (NP (NNS probes)))))))) (, ,) (NP (DT no) (JJ specific) (NN binding)) (VP (MD could) (VP (VB be) (VP (VBN detected) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2C)) (-RRB- -RRB-)))))) (. .)))
( (S (S (ADVP (RB Furthermore)) (, ,) (NP (NN complex) (NN formation)) (VP (MD could) (VP (VB be) (ADVP (RB efficiently)) (VP (VBN inhibited) (PP (IN by) (NP (NP (NN competition)) (PP (IN with) (NP (NP (JJ unlabeled) (NNS oligonucleotides)) (VP (VBG bearing) (NP (DT the) (JJ wild-type) (ADJP (ADJP (JJ murine)) (CC or) (ADJP (JJ human))) (NN Btk) (NN promoter) (NN octamer) (NNS motifs))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (VBN mutated) (NN octamer) (NNS motifs)) (VP (VBD failed) (S (VP (TO to) (VP (VB compete) (PP (IN for) (NP (NP (NP (NP (NN Oct1)) (CC and) (NP (NN Oct2))) (NN binding)) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (NN 2A)) (CC and) (NP (NN B))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (NN Competition)) (VP (VBD was) (ADJP (RB much) (RBR more) (JJ efficient)) (SBAR (WHADVP (WRB when)) (S (NP (DT a) (NN consensus) (NN octamer) (NN motif)) (VP (VBD was) (VP (VBN used) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (NN 2A)) (CC and) (NP (NN B))) (-RRB- -RRB-)))))))) (. .)))
( (S (S (PP (IN In) (NP (NN supershift) (NNS experiments))) (NP (PRP we)) (VP (MD could) (VP (VB demonstrate) (SBAR (IN that) (S (NP (DT the) (VBN shifted) (NNS complexes)) (VP (VBP contain) (NP (NP (NP (NP (NN Oct1)) (CC and) (NP (NN Oct2))) (NNS proteins)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NNS 2D)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (JJ Oct2-specific) (NNS antibodies)) (VP (VBD revealed) (NP (NP (JJ several) (VBN supershifted) (NNS complexes)) (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (NN existence)) (PP (IN of) (NP (NP (JJ several) (NN Oct2) (NNS isoforms)) (PRN (-LRB- -LRB-) (NP (CD 57)) (-RRB- -RRB-)))))))))) (. .)))
( (S (ADVP (RB Together)) (NP (DT these) (NNS findings)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (DT the) (VBN identified) (NN octamer) (NNS motifs)) (PP (IN within) (NP (DT the) (ADJP (ADJP (JJ murine)) (CC and) (ADJP (JJ human))) (NN Btk) (NNS promoters)))) (VP (VBP serve) (PP (IN as) (NP (NP (VBG binding) (NNS sites)) (PP (IN for) (NP (NP (NN Oct1)) (CC and) (NP (NN Oct2)))))) (, ,) (PP (IN although) (S (VP (VBG showing) (NP (NP (VBN reduced) (NNS affinities)) (PP (IN for) (NP (NP (NN Oct1)) (CC and) (NP (NN Oct2))))) (PP (VBN compared) (PP (IN with) (NP (DT a) (NN consensus) (NN site))))))))))) (. .)))
( (S (ADVP (RB Next)) (NP (PRP we)) (VP (VBD asked) (, ,) (SBAR (IN whether) (S (NP (NN BOB.1/OBF.1)) (VP (VBZ is) (ADJP (JJ able) (S (VP (TO to) (VP (VB form) (NP (NP (JJ ternary) (NNS complexes)) (PP (ADVP (RB together)) (IN with) (NP (NP (NN Oct1)) (CC and) (NP (NN Oct2)))) (PP (IN on) (NP (DT the) (ADJP (ADJP (JJ murine)) (CC and) (ADJP (JJ human))) (NN Btk) (NNS promoters)))))))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (RB extremely) (JJ difficult) (S (VP (TO to) (VP (VB obtain) (NP (JJ ternary) (NNS complexes)) (PP (ADVP (RB even)) (IN on) (NP (NN consensus) (NN octamer) (NNS motives))) (PP (IN by) (NP (NP (NN EMSA)) (PP (IN with) (NP (NP (JJ endogenous) (NNS proteins)) (PP (IN in) (NP (NP (NN B) (NN cell) (NNS extracts)) (PRN (-LRB- -LRB-) (NP (NN 55,58)) (-RRB- -RRB-)))))))))))))) (. .)))
( (S (S (ADVP (RB Therefore)) (, ,) (NP (PRP we)) (VP (VBD used) (NP (DT an) (ADJP (FW in) (FW vitro)) (NN complementation) (NN system)))) (. .)))
( (S (S (NP (NN HeLa) (JJ nuclear) (NNS extracts)) (VP (VBD were) (VP (VP (VBN complemented) (PP (IN with) (NP (ADJP (ADVP (FW in) (FW vitro)) (VBN translated)) (NN BOB.1/OBF.1)))) (CC and) (VP (VBN incubated) (PP (IN with) (NP (CC either) (NP (DT the) (VBN labeled) (NP (DT the) (NN consensus) (NN octamer) (NN motif))) (CC or) (NP (NP (DT the) (NNS motifs)) (VP (VBN found) (PP (IN in) (NP (NP (DT the) (ADJP (ADJP (JJ human)) (CC or) (ADJP (JJ murine))) (NN Btk) (NNS promoters)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 3)) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (ADVP (RB Indeed)) (, ,) (NP (JJ ternary) (NN complex) (NN formation)) (VP (MD could) (VP (VB be) (VP (VBN detected) (PP (IN at) (NP (DT these) (JJ non-conserved) (NN octamer) (NNS sequences))) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (NN 3B)) (CC and) (NP (NN C))) (, ,) (NP (NNP lane) (CD 3)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NN Supershift) (NNS experiments)) (VP (VBD revealed) (SBAR (IN that) (S (NP (DT these) (NNS complexes)) (VP (VBD were) (VP (VBN composed) (PP (IN of) (NP (NP (NP (NN Oct1)) (CC and) (NP (NN BOB.1/OBF.1))) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (CD 3)) (, ,) (NP (NNS lanes) (QP (CD 4) (CC and) (CD 5)))) (-RRB- -RRB-)))))))))) (. .)))
( (S (NP (NN BOB.1/OBF.1-specific))))
( (S (S (NP (NNS antibodies)) (VP (VBD prevented) (NP (JJ ternary) (NN complex) (NN formation)))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NP (DT an) (NN Oct1)) (NN binding)) (VP (VBD was) (ADVP (RB still)) (ADJP (JJ possible)) (PP (IN under) (NP (NP (DT these) (NNS conditions)) (VP (VBG using) (NP (DT the) (NN consensus) (NN octamer) (NN site)) (PP (IN as) (NP (NP (JJ labeled) (NN probe)) (PRN (-LRB- -LRB-) (VP (VB compare) (NP (NNS lanes) (QP (CD 2) (, ,) (CD 4) (CC and) (CD 8))) (PP (IN in) (NP (NN Figure) (NN 3A)))) (-RRB- -RRB-))))))))) (. .)))
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (ADJP (RB only) (RB very) (JJ weak)) (NN Oct1) (NN binding)) (VP (MD could) (VP (VB be) (VP (VBN detected) (PP (IN with) (NP (NP (DT the) (JJ non-consensus) (NN Btk-octamer) (NNS motifs)) (PRN (-LRB- -LRB-) (NP (NNS lanes) (NP (NP (CD 2)) (, ,) (NP (CD 4)) (CC and) (NP (NP (CD 8)) (PP (IN in) (NP (NNS Figures) (NP (NP (NN 3B)) (CC and) (NP (NN C)))))))) (-RRB- -RRB-))))))) (. .)))
( (S (S (ADVP (RB Moreover)) (, ,) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NN anti-Oct1) (NNS antibodies)))) (VP (VBZ leads) (PP (TO to) (NP (DT a) (JJ clear) (NN Oct1) (NN supershift))) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NN consensus) (NN octamer) (NN site)) (VP (VBD was) (VP (VBN used) (PP (IN as) (NP (NN probe))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3A)) (, ,) (NP (NNP lane) (CD 5)) (-RRB- -RRB-)))))))) (. .)))
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (DT no) (JJ clear) (NN Oct1) (NN supershift)) (VP (MD could) (VP (VB be) (VP (VBN detected) (PP (IN with) (NP (NP (DT the) (NN Btk) (NN octamer) (NNS sites)) (PRN (-LRB- -LRB-) (NP (NP (NNS Figures) (NP (NP (NN 3B)) (CC and) (NP (NN C)))) (, ,) (NP (NNP lane) (CD 5))) (-RRB- -RRB-))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (DT the) (JJ ternary) (NN complex) (NN formation)) (VP (VBD was) (VP (VBN prevented) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (DT this) (NN complex)) (VP (VBZ is) (VP (VBN composed) (PP (IN of) (NP (NP (NN BOB.1/OBF.1)) (CC and) (NP (NN Oct1))))))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN addition)) (PP (IN of) (NP (DT an) (JJ anti-Oct2) (NN antibody)))) (VP (VBD did) (RB not) (VP (VB interfere) (PP (IN with) (NP (NN complex) (NN formation))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 3)) (, ,) (NP (NNP lane) (CD 6)) (-RRB- -RRB-))) (, ,) (SBAR (IN since) (S (NP (NN HeLa) (NNS cells)) (VP (VBP do) (RB not) (VP (VB express) (NP (NN Oct2)))))))) (. .)))
( (S (S (NP (DT These) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN case)) (PP (IN of) (NP (NP (DT the) (JJ non-consensus) (NN octamer) (NNS sites)) (CD BOB.1/OBF.1))))) (VP (VBZ supports) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NN Oct1))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB investigate) (SBAR (IN whether) (S (NP (NN BOB.1/OBF.1)) (VP (VBZ binds) (PP (TO to) (NP (DT the) (NN Btk) (NN promoter))) (ADVP (FW in) (FW vivo)))))))) (, ,) (NP (NN ChIP) (NNS experiments)) (VP (VBD were) (VP (VBN performed) (S (VP (VBG using) (NP (NP (JJ primary) (NN B) (NNS cells)) (VP (VBN isolated) (PP (IN from) (NP (NP (NNS spleens)) (PP (IN of) (NP (JJ wild-type) (NNS mice)))))))))))) (. .)))
( (S (S (NP (NP (NN Oct1)) (, ,) (NP (NN Oct2)) (CC and) (NP (NN BOB.1/OBF.1))) (VP (VBP are) (NP (NP (DT all)) (VP (VBD bound) (PP (TO to) (NP (NP (DT the) (JJ murine) (NN Btk) (NN promoter)) (PP (IN in) (NP (NN B) (NNS cells))))) (ADVP (FW in) (FW vivo)) (PP (IN albeit) (PP (IN with) (NP (NP (VBN reduced) (NN affinity)) (PP (IN in) (NP (NP (NN comparison)) (PP (TO to) (NP (DT the) (NP (NP (NN H2B) (NN promoter)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 4)) (-RRB- -RRB-)))))))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB control) (PP (IN for) (NP (NP (DT the) (NN specificity)) (PP (IN of) (NP (DT the) (NN ChIP) (NNS experiments)))))))) (, ,) (NP (NP (NNS antibodies)) (VP (VBG recognizing) (NP (NP (JJ unrelated) (NNS proteins)) (PRN (-LRB- -LRB-) (NP (NP (NN PLCγ1)) (CC and) (NP (NN Lyn))) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN used) (PP (IN for) (NP (NN precipitation)))))) (. .)))
( (S (S (NP (NN No) (NNS signals)) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (NP (DT these) (NNS controls)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 4)) (-RRB- -RRB-))))))) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (DT no) (NN binding)) (PP (IN of) (NP (NP (DT any)) (PP (IN of) (NP (DT these) (NNS proteins))))) (PP (TO to) (NP (NP (DT the) (JJ murine) (NN Pax5) (NN promoter)) (SBAR (WHNP (WDT that)) (S (VP (VBZ does) (RB not) (VP (VB contain) (NP (DT an) (NN octamer) (NN motif))))))))) (VP (MD could) (VP (VB be) (VP (VBN observed))))) (. .)))
( (S (S (SBAR (IN Since) (S (NP (PRP we)) (VP (VBD observed) (NP (NP (NN binding)) (PP (IN of) (NP (NP (NN BOB.1/OBF.1)) (PP (ADVP (RB together)) (IN with) (NP (NNP Oct))))) (PP (TO to) (NP (DT the) (NN Btk) (NN promoter))))))) (, ,) (NP (PRP we)) (VP (VBD asked) (SBAR (IN whether) (S (NP (DT this) (NN binding)) (VP (VBZ results) (PP (IN in) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN Btk) (NN promoter) (NN activity)))))))))) (. .)))
( (S (S (ADVP (RB Therefore)) (, ,) (NP (DT the) (JJ murine) (NN Btk) (NN promoter)) (VP (VBD was) (VP (VP (VBN cloned) (PP (IN in) (NP (NP (NN front)) (PP (IN of) (NP (DT a) (NN luciferase) (NN reporter) (NN gene)))))) (CC and) (VP (VBN transfected) (PP (IN into) (NP (NN NIH/3T3) (NNS cells))) (PP (IN along) (PP (IN with) (NP (NP (NN Oct2)) (, ,) (NP (NN BOB.1/OBF1)))) (CC or) (PP (IN with) (NP (NP (NNS combinations)) (PP (IN of) (NP (DT these) (NN expression) (NNS vectors)))))))))) (. .)))
( (S (S (ADJP (JJ Consistent) (PP (IN with) (NP (PRP$ our) (NN binding) (NNS studies))))) (, ,) (NP (PRP we)) (VP (VBD observed) (SBAR (IN that) (S (NP (NP (NN BOB.1/OBF.1)) (PP (ADVP (RB together)) (IN with) (NP (NN Oct2)))) (VP (VBD was) (ADJP (JJ able) (S (VP (TO to) (VP (VB activate) (NP (DT the) (JJ murine) (NN Btk) (NN promoter)) (ADVP (RB ∼150-fold)) (PP (IN in) (NP (NP (DT a) (JJ dose-dependent) (NN manner)) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (NN 5A)) (, ,) (NP (NN B)) (CC and) (NP (NP (NNS data)) (VP (RB not) (VBN shown)))) (-RRB- -RRB-)))))))))))) (. .)))
( (S (ADVP (RB Notably)) (, ,) (NP (NP (NN Oct2)) (PP (ADVP (RB together)) (IN with) (NP (NN BOB.1/OBF.1)))) (VP (VBD was) (NP (NP (DT a) (JJ potent) (NN inducer)) (PP (IN of) (NP (NN Btk) (NN promoter) (NN activity)))) (, ,) (SBAR (IN whereas) (S (NP (NN Oct1)) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN at) (NP (NN all))) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))))) (. .)))
( (S (S (SBAR (IN Since) (S (NP (DT the) (NP (NP (NP (NN transcription) (NN factor) (NN PU.1)) (VP (VBD was) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (ADJP (JJ important) (PP (IN for) (NP (DT the) (NN Btk) (NN promoter) (NN activity)))))))))) (CC and) (NP (DT the) (NN PU.1))) (NNS sites)) (VP (VBP are) (VP (VBN conserved) (PP (IN between) (NP (NP (DT the) (ADJP (ADJP (JJ human)) (CC and) (ADJP (JJ murine))) (NN Btk) (NNS promoters)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 1)) (-RRB- -RRB-)))))))) (, ,) (NP (PRP we)) (VP (VBD wondered) (SBAR (IN whether) (S (NP (NP (NN Oct2)) (CC and) (NP (NN BOB.1/OBF.1))) (VP (MD can) (VP (VB enhance) (NP (NP (JJ PU.1-mediated) (NN transactivation)) (PP (IN of) (NP (DT the) (NN Btk) (NN promoter)))))))))) (. .)))
( (S (S (NP (NP (NN Transfection) (NNS experiments)) (VP (VBG using) (NP (NN NIH/3T3) (NNS cells)))) (VP (VBD revealed) (SBAR (IN that) (S (NP (NP (NN BOB.1/OBF.1)) (PP (ADVP (RB together)) (IN with) (NP (NN PU.1)))) (ADVP (RB only) (RB marginally)) (VP (VBD enhanced) (NP (JJ PU.1-mediated) (NN Btk) (NN promoter) (NN activity))))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NN co-transfection)) (PP (IN of) (NP (NN Oct2))) (PP (ADVP (RB together)) (IN with) (NP (NN PU.1)))) (VP (VBD stimulated) (NP (JJ PU.1-mediated) (NN Btk) (NN promoter) (NN activity)) (ADVP (RB significantly)) (PRN (-LRB- -LRB-) (PP (IN from) (NP (CD 6-) (TO to) (RB 75-fold))) (-RRB- -RRB-)))) (. .)))
( (S (S (ADVP (RB Moreover)) (, ,) (NP (NP (NN co-transfection)) (PP (IN of) (NP (NN PU.1))) (PP (ADVP (RB together)) (IN with) (NP (NP (NN Oct2)) (CC and) (NP (NN BOB.1/OBF.1))))) (VP (VBD led) (PP (TO to) (NP (NP (NP (DT an) (ADJP (ADJP (RB even) (JJR stronger)) (CC and) (ADJP (JJ synergistic))) (NN activation)) (PRN (-LRB- -LRB-) (NP (NN 325-fold)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NP (NP (JJ murine) (NN Btk) (NN promoter)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 5C)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN conclusion))) (NP (DT these) (NNS findings)) (VP (VBP indicate) (SBAR (IN that) (S (NP (DT the) (JJ transcriptional) (NN coactivator) (NN BOB.1/OBF.1)) (VP (VBZ regulates) (NP (NP (DT the) (NN Btk) (NN promoter) (NN activity)) (PP (IN in) (NP (NN B) (NNS cells)))) (ADVP (FW in) (FW vitro) (CONJP (RB as) (RB well) (IN as)) (ADVP (FW in) (FW vivo))) (, ,) (PP (IN in) (NP (NP (NN concert)) (PP (IN with) (NP (NN Oct) (CC and) (NN PU.1) (NNS proteins)))))))))) (. .)))
( (S (S (S (VP (TO To) (ADVP (RB further)) (VP (VB analyze) (NP (NP (DT the) (ADJP (FW in) (FW vivo)) (NN relevance)) (PP (IN of) (NP (DT the) (NN Btk) (NN promoter) (NN octamer) (NN motif))))))) (NP (PRP we)) (VP (VBD mutated) (NP (NP (DT the) (NN octamer) (NN sequence)) (PP (IN from) (NP (NN AGGCAAAT)))) (PP (TO to) (NP (NN AGtacAAT))))) (. .)))
( (S (S (NP (DT This) (NN mutation)) (VP (VBD prevented) (NP (NP (NN binding)) (PP (IN of) (NP (NP (NN Oct) (NN transcription) (NNS factors)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2C)) (-RRB- -RRB-))))))) (. .)))
( (S (SBAR (WHADVP (WRB When)) (S (NP (DT this) (VBN mutated) (NN construct)) (VP (VBD was) (VP (VBN transfected) (PP (IN into) (NP (NP (DT the) (JJ murine) (NN B) (NN cell) (NN line)) (NP (NN S194)))))))) (NP (DT the) (NN activity)) (VP (VBD was) (VP (VBN reduced) (PP (TO to) (NP (CD 60) (NN %))) (PP (VBN compared) (PP (IN with) (NP (DT the) (JJ wild-type) (NN Btk) (NN promoter) (-LRB- -LRB-) (NN Figure) (NN 6A) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (DT This)) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (DT the) (NN octamer) (NN motif)) (ADVP (RB significantly)) (VP (VBZ contributes) (PP (TO to) (NP (NP (JJ overall) (NN promoter) (NN activity)) (PP (IN in) (NP (NN addition))) (PP (TO to) (NP (DT the) (NP (NP (NN PU.1)) (CC and) (NP (NN Sp1/Sp3))) (NN binding) (NNS sites)))))))))) (. .)))
( (S (S (NP (NP (DT A) (NN prediction)) (VP (VBN based) (PP (IN on) (NP (DT this) (NN result))))) (VP (MD would) (VP (VB be) (SBAR (IN that) (S (NP (NN Btk) (NN expression)) (VP (MD should) (VP (VB be) (VP (VBN attenuated) (PP (IN in) (NP (NP (NN B) (NNS cells)) (VP (VBG lacking) (NP (NN BOB.1/OBF.1) (NN expression))))))))))))) (. .)))
( (S (NP (PRP We)) (ADVP (RB therefore)) (VP (VBD examined) (NP (NP (NP (NP (NN IL-7-dependent)) (CC and) (NP (NN stroma))) (JJ cell-dependent) (JJ pre) (NN B) (NN cell) (NNS lines)) (VP (VBN established) (PP (IN from) (NP (NP (DT the) (NN bone) (NN marrow)) (PP (IN of) (NP (NP (JJ wild) (NN type)) (CC and) (NP (NN BOB.1/OBF.1−/−)))))))))))
( (S (S (NP (NP (NNS mice)) (PP (IN for) (NP (NP (NN expression)) (PP (IN of) (NP (NN Btk)))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 6B)) (-RRB- -RRB-))) (. .)))
( (S (ADVP (RB Indeed)) (, ,) (NP (NN Btk) (NN protein) (NN expression)) (VP (VBZ is) (VP (VBN reduced) (PP (IN in) (NP (NN BOB.1/OBF.1−/−)))))))
( (S (S (NP (JJ pre) (NN B) (NNS cells))) (. .)))
( (S (NP (NP (DT The) (NN requirement)) (PP (IN of) (NP (NN BOB.1/OBF.1))) (PP (IN for) (NP (NP (NN Btk) (NN expression)) (PP (IN in) (NP (NN pre-B) (NN cell) (NNS lines)))))) (VP (VBD was) (ADVP (RB further)) (VP (VBN analysed) (PP (IN in) (NP (NP (JJ IL-7-dependent) (NN cell) (NNS lines)) (VP (VBG expressing) (NP (DT a) (JJ conditional) (NN BOB.1/OBF.1) (NN transgene)) (PP (IN on) (NP (DT a) (NN BOB.1/OBF.1−/−))))))))))
( (S (S (NP (JJ mutant) (NN background))) (. .)))
( (S (S (S (VP (TO To) (VP (VB achieve) (NP (NP (JJ conditional) (NN expression)) (PP (IN of) (NP (NN BOB.1.OBF.1))))))) (NP (DT the) (JJ tet-off) (NN system)) (VP (VBD was) (VP (VBN used) (PRN (-LRB- -LRB-) (NP (NN 27,56,59)) (-RRB- -RRB-))))) (. .)))
( (S (S (S (PP (IN In) (DT the) (NN absence) (IN of) (NP (NP (NN Doxycyclin)) (PRN (-LRB- -LRB-) (NP (NN Dox)) (-RRB- -RRB-)))) (NP (DT the) (JJ co-activator) (NN BOB.1/OBF.1)) (VP (VBZ is) (VP (VBN expressed)))) (, ,) (IN whereas) (S (PP (IN in) (DT the) (NN presence) (IN of) (NP (NN Dox))) (NP (PRP$ its) (NN expression)) (VP (VBZ is) (VP (VBN repressed))))) (. .)))
( (S (S (NP (NN RNA)) (VP (VBD was) (VP (VP (VBN prepared) (PP (IN from) (NP (ADJP (CC either) (ADJP (JJ untreated)) (CC or) (ADJP (NN Dox) (JJ treated))) (NN pre-B) (NNS cells)))) (CC and) (VP (VBN analysed) (PP (IN in) (NP (NN northern) (NN blot) (NNS experiments))))))) (. .)))
( (S (S (SBAR (WHADVP (WRB When)) (S (NP (NN BOB.1/OBF.1) (NN expression)) (VP (VBD was) (NP (NP (NN shut-off)) (PP (IN by) (NP (NN doxycyclin) (NN addition))))))) (, ,) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN Btk)))) (VP (VBD was) (VP (VBN reduced) (S (ADVP (RB further)) (VP (VBG supporting) (NP (NP (DT the) (JJ clear) (NN dependence)) (PP (IN of) (NP (NP (NN Btk) (NN expression)) (PP (IN in) (NP (JJ pre-B) (NNS cells))))) (PP (IN on) (NP (NP (NN BOB.1/OBF.1)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 6C)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (VP (TO To) (VP (VB investigate) (, ,) (SBAR (IN whether) (S (NP (NP (DT the) (NN down-regulation)) (PP (IN of) (NP (NN Btk) (NN expression))) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN BOB.1/OBF.1)))))) (VP (VBZ is) (ADVP (RB also)) (VP (VBN seen) (PP (IN in) (NP (JJ mature) (NN B220+) (NNS cells)))))))))) (, ,) (S (NP (DT these) (NNS cells)) (VP (VBD were) (VP (VBN sorted) (PP (IN by) (NP (NN FACS))) (PP (IN from) (NP (NP (NNS spleens)) (PP (IN of) (NP (NP (JJ wild) (NN type)) (CC and) (NP (NN BOB.1/OBF.1−/−)))))))))))
( (S (S (NP (NNS mice)) (CC and) (VP (VBN analyzed) (PP (IN by) (NP (NN protein) (NN immunoblot))))) (. .)))
( (S (ADVP (RB Again)) (, ,) (NP (NN Btk) (NN expression)) (VP (VBD was) (ADVP (RB strongly)) (VP (VBN reduced) (PP (IN in) (NP (NN B220+) (NN BOB.1/OBF.1−/−)))))))
( (S (S (VP (NNS cells) (PP (IN in) (NP (NP (NN comparison)) (PP (IN with) (NP (NP (JJ wild-type) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NNS 6D)) (-RRB- -RRB-)))))))) (. .)))
( (S (ADVP (RB Furthermore)) (, ,) (PP (IN in) (NP (NP (NN northern) (NN blot) (NNS analyses)) (PP (IN of) (NP (NP (NN RNA)) (VP (VBN prepared) (PP (IN from) (NP (NP (NNS splenocytes)) (PP (IN of) (NP (NP (JJ wild) (NN type)) (CC or) (NP (NN BOB.1/OBF.1−/−)))))))))))))
( (S (NP (NP (NNS mice)) (S (NP (DT a) (VBN reduced) (NN Btk–mRNA) (NN expression)) (VP (VBD was) (VP (VBN detected) (SBAR (WHADVP (WRB when)) (S (NP (NN BOB.1/OBF.1)) (VP (VBZ is) (RB not) (VP (VBN expressed) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 6E)) (-RRB- -RRB-))))))))) (. .))))
( (S (S (ADVP (RB Together)) (, ,) (NP (DT these) (NNS experiments)) (ADVP (RB clearly)) (VP (VBP indicate) (NP (NP (DT the) (JJ physiological) (NN importance)) (PP (IN of) (NP (NN BOB.1/OBF.1))) (PP (IN for) (NP (NP (DT the) (JJ B-cell-specific) (NN expression)) (PP (IN of) (NP (NN Btk)))))))) (. .)))
( (S (NP (NN DISCUSSION))))
( (S (S (NP (NP (DT The) (NN regulation)) (PP (IN of) (NP (ADJP (NN B) (NN cell) (JJ type-specific)) (NN gene) (NN expression)))) (VP (VBZ plays) (NP (NP (DT an) (JJ essential) (NN role)) (PP (IN for) (NP (NP (NN B) (NN cell) (NN generation)) (, ,) (NP (NN maturation)) (, ,) (NP (NN development)) (CC and) (NP (NN function))))))) (. .)))
( (S (S (NP (NP (DT A) (JJ large) (NN number)) (PP (IN of) (NP (NN transcription) (NNS factors)))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NN B) (NN cell) (NN fate))))))))) (PRN (-LRB- -LRB-) (NP (CD 60)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NP (CD One)) (PP (IN of) (NP (DT those) (NNS factors)))) (VP (VBZ is) (NP (NP (DT the) (JJ transcriptional) (NN coactivator) (CD BOB.1/OBF.1)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ enhances) (NP (NP (DT the) (JJ transcriptional) (NN activity)) (PP (IN of) (NP (DT the) (NP (NP (NN Oct1)) (CC and) (NP (NN Oct2))) (NN transcription) (NNS factors)))))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB get) (NP (NP (JJR more) (NNS insights)) (PP (IN into) (NP (NP (DT the) (JJ physiological) (NN role)) (PP (IN of) (NP (NN BOB.1/OBF.1))))))))) (NP (NP (DT the) (JJ transcriptional) (NN network)) (VP (VBN controlled) (PP (IN by) (NP (NN BOB.1/OBF.1))))) (VP (VBZ needs) (S (VP (TO to) (VP (VB be) (VP (VBN elucidated))))))) (. .)))
( (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NN BOB.1/OBF.1)) (VP (VBZ regulates) (NP (NN Btk) (NN gene) (NN expression))))))) (. .)))
( (S (SBAR (IN Although) (S (NP (DT the) (NN Btk) (NN promoter)) (VP (VBD had) (VP (VBN been) (VP (VBN analyzed) (ADVP (RB quite) (RB extensively)) (PP (IN for) (NP (NP (NN binding)) (PP (IN of) (NP (NP (NN transcription) (NNS factors)) (PRN (-LRB- -LRB-) (NP (NN 44–49)) (-RRB- -RRB-))))))))))) (, ,) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (DT a) (JJ functional) (NN octamer) (NN site)) (PP (IN within) (NP (NP (DT the) (JJ first) (CD 200) (NN bp)) (ADVP (RB upstream) (PP (IN of) (NP (NP (DT the) (NN start) (NN site)) (PP (IN of) (NP (NN transcription))))))))))) (VP (VBD had) (RB not) (VP (VBN been) (VP (VBN reported)))) (. .)))
( (S (S (SBAR (IN Although) (S (NP (NN footprint) (NNS experiments)) (VP (VBD identified) (NP (NP (DT a) (JJ protected) (NN region)) (PP (IN in) (NP (DT the) (JJ human) (NN Btk) (NN promoter) (NN region))) (VP (VBG extending) (PP (IN from) (NP (NP (CD −130) (TO to) (CD −152) (NN bp)) (PRN (-LRB- -LRB-) (S (S (NP (DT the) (JJ human) (NN Btk) (NN promoter) (NN octamer) (NN motif)) (VP (VBZ is) (ADJP (JJ located) (PP (IN at) (NP (QP (CD −145) (TO to) (CD −152)) (NN bp)))))) (: ;) (S (VP (VB see) (NP (NN Figure) (CD 1))))) (-RRB- -RRB-))))))))) (, ,) (NP (DT this) (NN area)) (VP (VBD was) (ADVP (RB only)) (VP (VBN analyzed) (PP (IN for) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NN Sp1/3) (NNS factors))) (PP (TO to) (NP (NP (DT the) (NN GC) (JJ rich) (NN box)) (PRN (-LRB- -LRB-) (NP (CD 48)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (DT the) (NN DNA) (NN probe)) (VP (VBN used) (PP (IN in) (NP (NN gel) (NN shift) (NNS experiments))) (S (VP (TO to) (VP (VB detect) (NP (NN Sp1/3) (NN binding))))))) (VP (VBD did) (RB not) (VP (VBP encompass) (NP (DT the) (NN octamer) (NN motif))))) (. .)))
( (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (JJ protein–DNA) (NNS complexes)) (VP (VBG reflecting) (NP (NP (NN Oct) (NN binding)) (PP (TO to) (NP (DT the) (NN Btk) (NN promoter)))))) (VP (MD could) (RB not) (VP (VB be) (VP (VBN observed) (PP (IN in) (NP (DT these) (NNS experiments))))))) (. .)))
( (S (S (ADVP (RB Furthermore)) (, ,) (PP (IN in) (NP (NP (NN search)) (PP (IN for) (NP (NP (NNS factors)) (VP (VBN involved) (PP (IN in) (NP (JJ cell-type-specific) (NN Btk) (NN expression)))))))) (, ,) (NP (NP (DT those) (NN protein) (NNS complexes)) (VP (VBN observed) (PP (IN in) (NP (NN gel) (NN shift) (NNS experiments))))) (VP (VBD were) (VP (VBN excluded) (PP (IN from) (NP (NP (JJ detailed) (NNS analyses)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (VP (VBN found) (S (VP (TO to) (VP (VB bind) (PP (TO to) (NP (DT the) (NN Btk) (NN promoter))) (PP (ADVP (RB also)) (IN in) (NP (NP (NNS cells)) (VP (VBD were) (NP (NP (NN Btk)) (VP (VBZ is) (RB not) (VP (VBN expressed) (PP (JJ such) (IN as) (NP (NP (NN T) (NNS cells)) (CC and) (NP (NP (NNS fibroblasts)) (PRN (-LRB- -LRB-) (NP (CD 46)) (-RRB- -RRB-))))))))))))))))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (S (NP (NN Oct) (NNS proteins)) (VP (VBP are) (RB not) (ADVP (RB exclusively)) (VP (VBN expressed) (PP (IN in) (NP (NN B) (NNS cells)))))) (CC and) (S (NP (NN Oct1)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN found) (PP (IN in) (NP (NP (NN T) (NNS cells)) (CC and) (NP (NNS fibroblasts)))))))) (. .)))
( (S (S (NP (PRP We)) (VP (MD could) (VP (VB show) (SBAR (IN that) (S (NP (NP (NN Oct1)) (CONJP (RB as) (RB well)) (NP (NN Oct2))) (VP (VBP are) (ADJP (JJ able) (S (VP (TO to) (VP (VB bind) (PP (TO to) (NP (DT the) (NN murine))) (ADVP (RB as) (RB well)) (PP (TO to) (NP (DT the) (JJ human) (NN Btk) (NN promoter))) (, ,) (SBAR (IN albeit) (S (NP (DT this) (NN binding) (NN activity)) (VP (VBD was) (ADJP (ADJP (RB much) (JJR weaker)) (PP (IN than) (NP (NP (DT that)) (VP (VBN observed) (S (VP (VBG using) (NP (DT a) (NN consensus) (NN octamer) (NN site))))))))))))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (JJ ternary) (NNS complexes)) (VP (VBN composed) (PP (IN of) (NP (NP (NN Oct1)) (CC and) (NP (NN BOB.1/OBF.1)))))) (VP (MD could) (VP (VB be) (VP (VBN detected) (PP (IN on) (NP (NP (DT the) (ADJP (ADJP (JJ murine)) (CC and) (ADJP (JJ human))) (NN Btk) (NN Oct) (NNS sites)) (PP (IN in) (NP (DT a) (JJ reconstituted) (NN system))))))))) (. .)))
( (S (S (NP (DT This)) (ADVP (RB clearly)) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (NP (NN Oct) (NNS proteins)) (PP (ADVP (RB together)) (IN with) (NP (NN BOB.1/OBF.1)))) (VP (VBP are) (ADJP (JJ able) (S (VP (TO to) (VP (VB bind) (PP (TO to) (NP (NP (DT the) (NN non-perfect) (NN Oct) (NNS motifs)) (VP (VBN found) (PP (IN in) (NP (DT the) (NN Btk) (NN promoter)))))) (ADVP (FW in) (FW vitro))))))))))) (. .)))
( (S (S (ADVP (RB Interestingly)) (, ,) (SBAR (IN whereas) (S (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN BOB.1/OBF.1))))) (NP (NP (RB only) (DT a) (JJ weak) (NN binding)) (PP (IN of) (NP (NN Oct) (NNS factors)))) (VP (VBD was) (VP (VBN observed))))) (, ,) (NP (DT the) (JJ ternary) (NN complex) (NN formation)) (VP (VBD was) (VP (VBN found) (S (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (VP (VBN formed) (PP (IN on) (NP (DT the) (NN consensus) (NN octamer) (NN motif))))))))))) (. .)))
( (S (NP (JJ Similar) (NNS results)) (VP (VBD were) (VP (VBN observed) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NP (NP (NN Oct-dependent)) (CC and) (NP (NN BOB.1/OBF.1-dependent))))))))))
( (S (S (NP (NN osteopontin) (NN promoter)) (VP (VBD had) (VP (VBN been) (VP (VBN analyzed) (PRN (-LRB- -LRB-) (NP (NN 61,62)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (DT This) (NN promoter)) (VP (VBZ contains) (NP (NP (NP (DT a) (NN PORE)) (PRN (-LRB- -LRB-) (NP (NP (JJ Palindromic) (NN Oct) (NN factor) (NN Recognition) (NN Element)) (: ;) (NP (NN ATTTG) (-LRB- -LRB-) (NN N5) (-RRB- -RRB-) (NN CAAAT))) (-RRB- -RRB-))) (SBAR (WHNP (WDT that)) (S (VP (VBZ enables) (S (NP (NN Oct) (NNS factors)) (VP (TO to) (VP (VB assemble) (NP (NP (ADJP (JJ homo-))) (CC or) (NP (NNS hetero-dimers))) (PP (IN at) (NP (DT this) (NN site))) (ADVP (FW in) (FW vitro))))))))))) (. .)))
( (S (S (NP (DT The) (JJ PORE-mediated) (NN Oct) (NN dimerization)) (VP (VBD was) (VP (VBN suggested) (S (VP (TO to) (VP (VB be) (NP (NP (DT an) (JJ essential) (NN prerequisite)) (PP (IN for) (NP (NP (NN binding)) (PP (IN of) (NP (NN BOB.1/OBF.1))) (PP (TO to) (NP (NP (PDT such) (DT an) (NN octamer) (NN site)) (PRN (-LRB- -LRB-) (NP (CD 63)) (-RRB- -RRB-))))))))))))) (. .)))
( (S (S (NP (DT These) (NNS studies)) (ADVP (RB also)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (DT the) (NN transversion) (NN T→G)) (PP (IN at) (NP (NP (DT the) (JJ second) (NN position)) (PP (IN of) (NP (DT the) (NN consensus) (NN octamer) (NN site))))) (-LRB- -LRB-) (VP (VBN identified) (PP (IN in) (NP (DT the) (JJ murine) (NN Btk) (NN promoter)))) (-RRB- -RRB-)) (VP (VBZ impairs) (NP (NN Oct) (NN binding))))))) (. .)))
( (S (ADVP (RB However)) (, ,) (NP (NN luciferase) (NN reporter) (NNS assays)) (VP (VBD revealed) (SBAR (IN that) (S (NP (DT the) (NN T→G) (NN transversion)) (VP (VBZ results) (PP (IN in) (NP (NP (VBN increased) (NN promoter) (NN activity)) (PP (IN in) (NP (NP (NN comparison)) (PP (TO to) (NP (NP (DT the) (JJ wild-type) (NN PORE) (NN promoter)) (PRN (-LRB- -LRB-) (NP (CD 62)) (-RRB- -RRB-)))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NP (NN line)) (PP (IN with) (NP (DT this) (NN observation))))) (NP (PRP it)) (VP (VBD was) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN BOB.1/OBF.1)))) (VP (VBZ enables) (S (NP (NN Oct) (NNS factors)) (VP (TO to) (VP (VB bind) (PP (TO to) (NP (NP (DT this) (JJ unfavorable) (JJ non-consensus) (NN octamer) (NNS motifs)) (PRN (-LRB- -LRB-) (NP (CD 62)) (-RRB- -RRB-))))))))))))) (. .)))
( (S (S (SBAR (IN Although) (S (NP (NP (DT the) (NN octamer) (NNS motifs)) (VP (VBN identified) (PP (IN in) (NP (NN Btk) (NN promoter))))) (VP (VBP do) (RB not) (VP (VB represent) (NP (JJ classical) (NN PORE) (NNS motifs)))))) (, ,) (NP (PRP we)) (VP (VBP show) (ADVP (RB here)) (SBAR (IN that) (S (NP (NP (NN Oct) (NNS proteins)) (CC and) (NP (CD BOB.1/OBF.1))) (VP (VBP bind) (PP (TO to) (NP (DT this) (NN site))) (ADVP (FW in) (FW vitro))))))) (. .)))
( (S (S (ADVP (RB Thus)) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN BOB.1/OBF.1)))) (VP (VBZ facilitates) (NP (NP (NN binding)) (PP (IN of) (NP (NN Oct) (NNS proteins))) (PP (TO to) (NP (NP (ADVP (IN at) (JJS least)) (DT a) (NN subset)) (PP (IN of) (NP (JJ non-consensus) (NN octamer) (NNS motifs)))))))) (. .)))
( (S (S (NP (NN ChiP) (NNS experiments)) (VP (VBD revealed) (SBAR (IN that) (S (NP (JJ ternary) (NN complex) (NN formation)) (ADVP (RB also)) (VP (VBZ occurs) (ADVP (FW in) (FW vivo))))))) (. .)))
( (S (ADVP (RB Furthermore)) (, ,) (NP (NP (NN Oct) (CC and) (NN BOB.1/OBF.1) (NNS proteins)) (VP (VB act) (PP (IN in) (NP (NP (NN synergy)) (PP (IN with) (NP (NP (NP (DT PU.1—a) (ADJP (RB previously) (VBN identified)) (NN factor)) (ADJP (JJ important) (PP (IN for) (NP (NN Btk) (NN promoter) (NN regulation))))) (PRN (-LRB- -LRB-) (NP (NN 46,48,49)) (-RRB- -RRB-)))))))) (ADVP (RB —to)) (VP (VBP induce) (NP (NN Btk) (NN promoter) (NN activity))) (. .)))
( (S (SBAR (IN Since) (S (NP (NP (DT the) (NN PU.1) (NN binding) (NN site)) (VP (VBN identified) (PP (IN in) (NP (DT the) (JJ human) (NN Btk) (NN promoter))))) (VP (VBZ is) (VP (VP (VBN conserved)) (CC and) (ADJP (JJ present) (PP (IN in) (NP (DT the) (NP (NP (JJ murine) (NN Btk) (NN promoter)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 1)) (-RRB- -RRB-)))))))))) (NP (PRP we)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NN Btk) (NN gene) (NN regulation))) (PP (IN by) (NP (NP (NN Oct/BOB.1/OBF.1)) (CC and) (NP (NN PU.1))))) (VP (VBZ is) (VP (VBN conserved) (PP (IN between) (NP (NP (NN mouse)) (CC and) (NP (NNS humans))))))))) (. .)))
( (S (S (NP (NP (DT The) (NN importance)) (PP (IN of) (NP (NN PU.1))) (PP (IN for) (NP (NN Btk) (NN gene) (NN regulation)))) (VP (VBZ is) (VP (VBN underlined) (PP (IN by) (NP (DT the) (NN fact) (SBAR (IN that) (S (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN PU.1)))) (VP (VBZ leads) (PP (TO to) (NP (NP (DT a) (QP (CD two-) (TO to) (JJ 3-fold)) (NN reduction)) (PP (IN of) (NP (NN Btk) (NN expression))) (-LRB- -LRB-) (CD 48) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (DT the) (NN deficiency)) (PP (IN of) (NP (NP (NP (NN Sp1)) (SBAR (WHNP (WDT that)) (S (ADVP (RB also)) (VP (VBZ stimulates) (NP (NN Btk) (NN promoter) (NN activity)))))) (CONJP (RB together) (IN with)) (NP (NN PU.1) (-LRB- -LRB-) (CD 49) (-RRB- -RRB-))))) (VP (VBD had) (NP (NP (DT no) (NN influence)) (PP (IN on) (NP (NN Btk) (NN expression)))) (PRN (-LRB- -LRB-) (NP (CD 49)) (-RRB- -RRB-)))) (. .)))
( (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBD showed) (SBAR (IN that) (S (NP (NN BOB.1/OBF.1-deficiency)))))))
( (S (NP (NP (NNS results)) (PP (PP (IN in) (NP (NP (DT a) (JJ severe) (NN reduction)) (PP (IN of) (NP (NN Btk) (NN expression))) (PP (IN in) (NP (JJ immature) (NN bone) (NN marrow) (VBN derived) (JJ pre-B) (NNS cells))))) (CONJP (RB as) (RB well) (IN as)) (PP (IN in) (NP (JJ peripheral) (NN B220+) (NNS splenocytes)))) (. .))))
( (S (S (NP (DT These) (NNS data)) (VP (VBP indicate) (NP (NP (DT the) (JJ physiological) (NN importance)) (PP (IN of) (NP (NP (NN Oct/BOB.1/OBF.1)) (PP (ADVP (RB together)) (IN with) (NP (NN PU.1))))) (PP (IN in) (NP (ADJP (NN B) (JJ cell-specific)) (NN Btk) (NN gene) (NN regulation)))) (PP (IN at) (NP (NP (ADJP (ADJP (JJ early)) (CC and) (ADJP (JJ late))) (NNS stages)) (PP (IN of) (NP (NN B) (NN cell) (NN development))))))) (. .)))
( (S (S (SBAR (IN If) (S (NP (NN Btk)) (VP (VBZ is) (NP (NP (DT a) (JJ direct) (NN target)) (PP (IN of) (NP (NN BOB.1/OBF.1))))))) (NP (NP (DT the) (NN phenotype)) (PP (IN of) (NP (NP (NNS mice)) (ADJP (JJ deficient) (PP (IN in) (NP (CC either) (NP (NN BOB.1/OBF.1)) (CC or) (NP (NN Btk)))))))) (VP (MD should) (VP (VB be) (ADJP (JJ related))))) (. .)))
( (S (ADVP (RB Indeed)) (, ,) (NP (DT both) (JJ knock-out) (NNS mice)) (VP (VBP share) (NP (JJ similar) (NNS characteristics)) (, ,) (PP (IN like) (NP (NP (NNS defects)) (PP (IN in) (NP (NP (NN B) (NN cell) (NN development)) (PP (IN in) (NP (NP (NN bone) (NN marrow)) (CC and) (NP (NN spleen)))))))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (DT a) (ADJP (CD 2-) (TO to) (JJ 4-fold)) (NN reduction)) (PP (IN of) (NP (NP (JJ peripheral) (NN B) (NN cell) (NN number)) (CC and) (NP (NP (NNS defects)) (PP (IN in) (NP (NN B) (NN cell) (NN receptor) (NN signaling))))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (DT both) (JJ knock-out) (NNS mice)) (VP (VBP have) (ADVP (RB also)) (NP (JJ unique) (NNS features)))) (: :) (SBAR (IN whereas) (S (NP (DT the) (JJ marginal) (NN zone) (NN B) (NN cell) (NN compartment)) (VP (VBZ is) (ADJP (RB almost) (JJ missing) (PP (IN in) (NP (NN BOB.1/OBF.1−/−)))))))))
( (S (S (NP (NNS mice)) (LST (-LRB- -LRB-) (CD 27) (-RRB- -RRB-)) (NP (DT this) (NN B) (NN cell) (NN subset)) (VP (VBD was) (VP (VBN found) (ADVP (JJ normal)) (PP (IN in) (NP (JJ Xid) (NNS mice)))))) (. .)))
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (DT the) (NN B-1) (NN population)) (VP (VBZ is) (UCP (VP (VBN depleted) (PP (IN in) (NP (NP (JJ Xid) (NNS mice)) (PRN (-LRB- -LRB-) (NP (NN 33,34,64)) (-RRB- -RRB-))))) (CC and) (ADJP (JJ normal) (PP (IN in) (NP (NN BOB.1/OBF.1−/−))))))))
( (S (NP (NP (NNS mice)) (. .))))
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NNS mice)) (ADJP (JJ mutant) (PP (IN for) (NP (DT both) (NNS proteins))))) (VP (VBP show) (NP (NP (DT a) (ADJP (RBR more) (JJ severe)) (NN defect)) (PP (IN than) (NP (DT each) (NN mouse) (PRP itself)))))) (. .)))
( (S (S (NP (DT This) (NN phenotype)) (VP (VBZ resembles) (NP (NP (DT that)) (PP (IN of) (NP (NP (JJ severe) (NN agammaglobulinemia)) (PP (IN in) (NP (NP (JJ human) (NNS XLA)) (PRN (-LRB- -LRB-) (NP (NN 31,39)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (NN Btk)) (CC and) (NP (NN BOB.1/OBF.1))) (VP (VBP seem) (S (VP (TO to) (VP (VB be) (VP (VBN involved) (PP (IN in) (NP (ADJP (ADJP (JJ overlapping)) (CONJP (RB as) (RB well) (IN as)) (ADJP (JJ distinct))) (NN signaling) (NNS pathways))))))))) (. .)))
( (S (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (NP (NP (DT the) (NNS analyses)) (PP (IN of) (NP (DT the) (ADJP (ADJP (JJ murine)) (CC and) (ADJP (JJ human))) (NN Btk) (NN promoter)))) (VP (VBD revealed) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (DT a) (JJ functional) (NN octamer) (NN motif)))))) (. .)))
( (S (S (NP (NP (NP (DT The) (NN transcription) (NNS factors)) (NP (NN Oct1/2))) (CONJP (RB as) (RB well) (IN as)) (NP (DT the) (NN coactivator) (NN BOB.1/OBF.1))) (VP (VBP bind) (PP (TO to) (NP (DT these) (NNS sites))) (ADVP (ADVP (FW in) (FW vitro)) (CC and) (ADVP (FW in) (FW vivo))))) (. .)))
( (S (NP (NP (DT The) (JJ physiological) (NN relevance)) (PP (IN of) (NP (DT the) (NN octamer)))) (VP (VBD was) (VP (VBN shown) (PP (IN in) (NP (NN BOB.1/OBF.1−/−)))))))
( (S (S (NP (NN B) (NNS cells)) (VP (VBD were) (S (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN Btk)))) (VP (VBZ is) (ADVP (RB strongly)) (VP (VBN reduced)))))) (. .)))
( (S (S (NP (DT The) (NN finding) (SBAR (IN that) (S (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN BOB.1/OBF.1)))) (VP (VBZ facilitates) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NN Oct) (NNS factors))) (PP (TO to) (NP (NP (DT the) (JJ non-consensus) (NN octamer) (NN sequence)) (VP (VBN identified) (PP (IN in) (NP (DT the) (ADJP (ADJP (JJ human)) (CC and) (ADJP (JJ murine))) (NN Btk) (NNS promoters))))))))))) (VP (MD could) (VP (VB reflect) (NP (NP (DT a) (NN mechanism)) (PP (IN of) (NP (NP (JJ fine-tuned) (NN regulation)) (PP (IN of) (NP (NN promoter) (NN activity)))))) (PP (VBG depending) (PP (IN on) (NP (NP (NN Oct)) (CC and) (NP (NN BOB.1/OBF.1)))))))) (. .)))
( (S (NP (NP (NN Figure)) (CC and) (NP (NN Table)) (NP (NNS captions)))))
( (S (NP (NP (NN Figure) (CD 1)) (: :) (NP (NP (JJ Comparative) (NN analysis)) (PP (IN of) (NP (DT the) (ADJP (ADJP (JJ human)) (CC and) (ADJP (JJ murine))) (NN Btk) (NNS promoters)))) (. .))))
( (S (S (NP (NP (NN Nucleotide) (NNS sequences)) (PP (IN of) (NP (DT the) (ADJP (ADJP (JJ human) (PRN (-LRB- -LRB-) (NP (QP (CD +33) (TO to) (CD −232)) (NN bp)) (-RRB- -RRB-))) (CC and) (ADJP (JJ murine) (PRN (-LRB- -LRB-) (NP (QP (CD +33) (TO to) (CD −243)) (NN bp)) (-RRB- -RRB-)))) (NN Btk) (NNS promoters)))) (VP (VBP are) (VP (VBN presented)))) (. .)))
( (S (S (NP (NP (DT The) (NNS positions)) (PP (IN of) (NP (NP (DT the) (NN octamer) (NN motif)) (, ,) (NP (NP (DT the) (NN GT-)) (, ,) (ADJP (JJ GC-))) (CC and) (NP (NN Pu-boxes)) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NP (DT the) (NN initiator) (NN site)) (CC and) (NP (NP (DT the) (NN start) (NN site)) (PP (IN of) (NP (NN transcription))))) (PRN (-LRB- -LRB-) (NP (NN +1)) (-RRB- -RRB-)))))) (VP (VBP are) (VP (VBN indicated)))) (. .)))
( (S (S (NP (NP (NN Figure) (CD 2)) (: :) (NP (NN Octamer) (NNS factors) (NP (NP (NN Oct1)) (CC and) (NP (NN Oct2))))) (VP (VBP bind) (PP (TO to) (NP (NP (DT the) (JJ non-consensus) (NN octamer) (NN site)) (PP (IN of) (NP (DT the) (ADJP (ADJP (JJ murine)) (CC and) (ADJP (JJ human))) (NN Btk) (NNS promoters))))))) (. .)))
( (S (S (NP (NP (NP (NP (-LRB- -LRB-) (NP (NP (NN A)) (CC and) (NP (NN B))) (-RRB- -RRB-) (NNS EMSA)) (PP (IN with) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN from) (NP (DT the) (NN B) (NN cell) (NN line) (NN BJAB)))))) (CC and) (NP (VBN labeled) (NNS probes))) (VP (VBG presenting) (NP (CC either) (NP (NP (DT a) (NN consensus) (NN octamer) (NN site)) (PRN (-LRB- -LRB-) (NP (NN Oct) (NNS cons)) (-RRB- -RRB-))) (CC or) (NP (DT the) (JJ non-conserved) (NN octamer) (NN site))))) (VP (VBN identified) (PP (IN in) (NP (DT the) (ADJP (ADJP (JJ human)) (CC and) (ADJP (JJ murine))) (NN Btk) (NNS promoters))) (PRN (-LRB- -LRB-) (NP (NNP murBtkprom) (, ,) (NNP humBtkprom)) (-RRB- -RRB-)))) (. .)))
( (S (NP (NP (NN Competitor) (NN binding) (NNS sites)) (PP (PP (IN with) (NP (NP (NP (DT the) (JJ wild-type)) (PRN (-LRB- -LRB-) (NP (NP (NN murBtkprom)) (, ,) (NP (NN humBtkprom))) (-RRB- -RRB-))) (CC or) (NP (NP (VBN mutated) (NN octamer) (NN mortif)) (PP (IN from) (NP (DT the) (NN Btk) (NN promoter)))) (NP (NP (JJ -LSB-mBtkprom) (NN Mut)) (PRN (, ,) (NP (NP (NN humBtkprom) (NN Mut)) (: ;) (S (NP (NP (DT the) (NN octamer) (NNS motifs)) (NP (DT A) (-LRB- -LRB-) (NN A/G) (-RRB- -RRB-) (NN GCAAAT))) (VP (VBD were) (VP (VBN mutated) (PP (TO to) (NP (NN AgtacAAT))))))) (-RRB- -RSB-))))) (CC or) (PP (IN with) (NP (DT the) (NN consensus) (NN octamer) (PRN (-LRB- -LRB-) (NP (NN Oct) (NNS cons)) (-RRB- -RRB-)) (NN site))))) (VP (VBD were) (VP (VBN added) (PP (IN in) (NP (NP (JJ different) (JJ molar) (NN excess)) (PRN (-LRB- -LRB-) (NP (NP (NN 10×)) (, ,) (NP (NN 30×)) (, ,) (NP (NN 100×))) (-RRB- -RRB-)))))) (. .)))
( (S (S (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP (DT The) (VBN mutated) (NNS sites)) (VP (VBD were) (ADVP (RB also)) (ADJP (JJ unable) (S (VP (TO to) (VP (VB bind) (NP (NP (NP (NN Oct1)) (CC or) (NP (NN Oct2))) (NNS proteins)))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN tested) (PP (IN as) (NP (VBN labeled) (NNS probes)))))))) (. .)))
( (S (S (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (NP (NN EMSA)) (VP (NN supershift) (PP (IN with) (NP (NP (DT the) (VBN indicated) (NNS probes)) (CC and) (NP (NP (NNS antibodies)) (ADJP (JJ specific) (PP (IN for) (NP (NP (NN Oct1)) (CC and) (NP (NN Oct2)))))))))) (. .)))
( (S (S (NP (NP (NN EMSA) (NNS experiments)) (VP (VBG using) (NP (NP (DT the) (JJ non-conserved) (NN octamer) (NN site)) (VP (VBN identified) (PP (IN in) (NP (NP (DT the) (ADJP (ADJP (JJ human)) (CC and) (ADJP (JJ murine))) (NN Btk) (NNS promoters)) (PRN (-LRB- -LRB-) (NP (NNP murBtkprom) (, ,) (NNP humBtkprom)) (-RRB- -RRB-)))))))) (VP (VBD were) (NP (NP (VBN exposed) (NNS three-times)) (ADJP (JJR longer) (PP (IN than) (NP (NP (NNS experiments)) (SBAR (WHADVP (WRB where)) (S (NP (DT the) (JJ wild-type) (NN octamer)) (VP (VBD was) (VP (VBN used))))))))))) (. .)))
( (S (NP (NP (NN Figure) (CD 3)) (: :) (NP (NP (JJ Ternary) (NN complex) (NN formation)) (PP (IN on) (NP (NN Btk) (NN promoter) (NN octamer) (NNS motifs)))) (. .))))
( (S (S (NP (NP (NN EMSA) (NNS experiments)) (PP (IN with) (NP (NN HeLa) (JJ nuclear) (NNS extracts)))) (VP (VBD were) (VP (VBN performed) (S (VP (VBG using) (NP (NP (VBN labeled) (NNS probes)) (VP (VBG bearing) (NP (CC either) (NP (NP (DT a) (NN consensus) (NN octamer) (NN motif)) (PRN (-LRB- -LRB-) (NP (NN cons) (NN Oct) (NN site)) (-RRB- -RRB-))) (CC or) (NP (NP (DT the) (NN octamer) (NNS sequences)) (VP (VBN identified) (PP (IN within) (NP (NP (DT the) (ADJP (ADJP (JJ murine)) (CC or) (ADJP (JJ human))) (NN Btk) (NN promoter)) (PRN (-LRB- -LRB-) (NP (NP (NN Oct-hum) (NN Btk) (NN prom)) (, ,) (NP (NN Oct-mur) (NN Btk) (NN prom))) (-RRB- -RRB-)))))))))))))) (. .)))
( (S (S (NP (NP (JJ Unprogrammed) (NN reticulocyte) (NN lysate)) (CC or) (NP (ADJP (ADVP (FW in) (FW vitro)) (VBN translated)) (NN BOB.1/OBF.1) (NN protein))) (VP (VBD were) (VP (VBN included)))) (. .)))
( (S (S (NP (NNS Complexes)) (VP (VBD were) (VP (VBN analyzed) (PP (IN by) (S (VP (VBG adding) (NP (JJ specific) (NNS antibodies)) (PP (IN for) (NP (NP (NP (NN Oct1)) (, ,) (NP (NN Oct2)) (CC or) (NP (NN BOB.1/OBF.1))) (SBAR (IN as) (S (VP (VBN indicated)))))))))))) (. .)))
( (S (S (NP (NN Figure) (CD 4)) (: :) (NP (NN ChIP) (NN assay))) (. .)))
( (S (S (NP (NN BOB.1/OBF.1)) (VP (VBZ binds) (PP (ADVP (RB together)) (IN with) (NP (NP (NN Oct1)) (CC and) (NP (NN Oct2)))) (PP (TO to) (NP (DT the) (JJ murine) (NN Btk) (NN promoter))))) (. .)))
( (S (S (NP (NP (DT The) (NN chromatin)) (PP (IN of) (NP (JJ primary) (JJ wild-type) (NN B) (NNS cells)))) (VP (VBD was) (UCP (ADJP (JJ cross-linked)) (, ,) (ADJP (JJ sheared)) (CC and) (VP (VBN immunoprecipitated) (PP (IN with) (NP (DT the) (VBN indicated) (NNS antibodies))))))) (. .)))
( (S (S (NP (VBN Immunoprecipitated) (NN DNA)) (VP (VBD was) (VP (VP (VBN purified)) (CC and) (VP (VBN used) (PP (IN as) (NP (NN template))) (PP (IN in) (NP (NP (NN PCR)) (PP (IN with) (NP (NP (NNS primers)) (ADJP (JJ specific) (PP (PP (IN for) (NP (NP (DT the) (JJ murine) (NN Btk) (NN promoter)) (PRN (-LRB- -LRB-) (NP (CD −280) (TO to) (CD −10)) (-RRB- -RRB-)))) (, ,) (CC or) (PP (IN for) (NP (NP (DT the) (NN H2B) (CC and) (NN Pax5) (NNS promoters)) (PP (IN as) (NP (JJ internal) (NNS controls))))))))))))))) (. .)))
( (S (S (NP (NP (NN Chromatin)) (VP (VBN immunoprecipitated) (PP (IN with) (NP (NP (NN anti-PLCγ1)) (CC and) (NP (NN anti-Lyn)) (NP (NNS antibodies)))))) (VP (VBD was) (VP (VBN included) (PP (IN as) (NP (JJ negative) (NNS controls)))))) (. .)))
( (S (S (NP (VBN Amplified) (NNS products)) (VP (VBD were) (VP (VBN detected) (PP (IN on) (NP (NP (NN ethidium) (NN bromide)) (VBN stained) (NN agarose) (NNS gels)))))) (. .)))
( (S (NP (NP (NN Figure) (CD 5)) (: :) (NP (NP (NN Analysis)) (PP (IN of) (NP (NP (DT the) (NN dependence)) (PP (IN of) (NP (DT the) (JJ murine) (NN Btk) (NN promoter) (NN activity))) (PP (IN on) (NP (NP (NP (NN Oct)) (CC and) (NP (NN BOB.1/OBF.1) (NNS proteins))) (PP (IN in) (NP (NP (JJ transient) (NN transfection) (NNS experiments)) (VP (VBG using) (NP (NN NIH/3T3) (NNS fibroblasts)))))))))) (. .))))
( (S (S (NP (NP (NN Activity)) (PP (IN of) (NP (DT the) (JJ murine) (NN Btk) (NN promoter))) (PP (IN without) (NP (NN co-transfection)))) (VP (VBD was) (VP (VBN set) (PP (TO to) (NP (NN one)))))) (. .)))
( (S (S (NP (NP (DT The) (JJ fold) (NN induction)) (PP (IN upon) (NP (NP (NP (NN co-transfection)) (PP (IN of) (NP (NP (NN Oct2)) (, ,) (NP (NN BOB.1/OBF.1)) (CC or) (NP (NN PU.1))))) (CC or) (NP (NP (NNS combinations)) (PP (IN of) (NP (DT these) (NN expression) (NNS vectors))))))) (VP (VBD was) (VP (VBN determined)))) (. .)))
( (S (S (S (NP (DT The) (NNS experiments)) (VP (VBD were) (VP (VBN repeated) (NP (CD five) (NNS times))))) (CC and) (S (NP (NP (JJ mean) (NNS values)) (CONJP (RB as) (RB well) (IN as)) (NP (NN SD))) (VP (VBD were) (VP (VBN determined))))) (. .)))
( (S (S (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP (DT The) (JJ murine) (NN Btk) (NN promoter)) (VP (VBZ is) (VP (VBN induced) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN Oct2)) (CC and) (NP (NN BOB.1/OBF.1))) (VP (VBP are) (VP (VBN coexpressed)))))))) (. .)))
( (S (S (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (NP (DT The) (NN activation)) (PP (IN of) (NP (DT the) (JJ murine) (NN Btk) (NN promoter))) (PP (IN by) (NP (NP (NN Oct2)) (CC and) (NP (NN BOB.1/OBF.1))))) (VP (VBZ is) (ADJP (JJ dose-dependent)))) (. .)))
( (S (NP (NP (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (JJ Synergistic) (NN activation)) (PP (IN of) (NP (DT the) (JJ murine) (NN Btk) (NN promoter))) (PP (IN by) (NP (NP (NN Oct2)) (, ,) (NP (NN BOB.1/OBF.1)) (, ,) (CC and) (NP (NN PU.1)))) (. .))))
( (S (S (NP (NP (NN Figure) (CD 6)) (: :) (NP (DT The) (JJ transcriptional) (NN coactivator) (NN BOB.1/OBF.1))) (VP (VBZ is) (ADJP (JJ critical) (PP (IN for) (NP (NN Btk) (NN expression))) (ADVP (FW in) (FW vivo))))) (. .)))
( (S (S (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP (NP (NNS Mutations)) (PP (IN within) (NP (NP (DT the) (NN octamer) (NN motif)) (PP (IN of) (NP (DT the) (JJ murine) (NN btk) (NN promoter)))))) (VP (VBP lead) (PP (TO to) (NP (NP (DT a) (NN reduction)) (PP (IN of) (NP (NN promoter) (NN activity))))))) (. .)))
( (S (S (NP (DT The) (JJ murine) (NN S194) (NN B) (NN cell) (NN line)) (VP (VBD was) (VP (VBN transfected) (PP (IN with) (NP (CC either) (NP (NP (DT the) (JJ wild) (NN type)) (PRN (-LRB- -LRB-) (NP (NN murBtk) (NN pr)) (-RRB- -RRB-))) (CC or) (NP (NP (DT the) (JJ mutant) (NN Btk) (NN promoter)) (PRN (-LRB- -LRB-) (NP (NN mBtk) (NN pr) (NN Mut)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NP (DT The) (NN activity)) (PP (IN of) (NP (DT the) (JJ wild-type) (NN promoter)))) (VP (VBD was) (VP (VBN set) (PP (TO to) (NP (CD 100) (NN %)))))) (. .)))
( (S (S (NP (NP (DT The) (NN activity)) (PP (IN of) (NP (DT the) (JJ mutant) (NN Btk) (NN promoter)))) (VP (VBD was) (VP (VBN determined) (PP (JJ relative) (TO to) (NP (DT the) (JJ wild-type) (NN promoter) (NN activity)))))) (. .)))
( (S (S (S (NP (DT The) (NNS experiments)) (VP (VBD were) (VP (VBN repeated) (NP (CD five) (NNS times))))) (CC and) (S (NP (NP (JJ mean) (NNS values)) (CONJP (RB as) (RB well) (IN as)) (NP (NN SD))) (VP (VBD were) (VP (VBN determined))))) (. .)))
( (S (NP (NP (-LRB- -LRB-) (NN B) (-RRB- -RRB-) (NN Protein) (NNS extracts)) (PP (IN from) (NP (NP (NN pre) (NN B) (NN cell) (NNS lines)) (VP (VBN established) (PP (IN from) (NP (NP (DT the) (NN bone) (NN marrow)) (PP (IN of) (NP (NP (JJ wild) (NN type)) (CC or) (NP (NN BOB.1/OBF.1−/−mice))))))))))))
( (S (S (VP (VBD were) (VP (VBN analyzed) (PP (IN for) (NP (NN Btk) (NN expression))) (PP (IN by) (NP (NN western) (NN blot)))))) (. .)))
( (S (NP (NP (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NN RNA)) (VP (VBN prepared) (PP (IN from) (NP (NP (ADJP (NP (NN bone) (NN marrow)) (VBN derived)) (NN pre) (NN B) (NN cell) (NNS lines)) (, ,) (VP (VBN established) (PP (IN from) (NP (NP (NNS mice)) (VP (VBG expressing) (NP (DT a) (JJ conditional) (NN BOB.1/OBF.1) (NN transgene)) (PP (IN on) (NP (DT a) (NN BOB.1/OBF.1-mutant)))))))))))))
( (S (S (NP (NP (NN background)) (, ,)) (VP (VBD was) (VP (VBN analyzed) (PP (IN for) (NP (NN Btk) (NN mRNA) (NN expression))) (PP (IN by) (NP (NN northern) (NN blot)))))) (. .)))
( (S (S (S (PP (IN In) (DT the) (NN absence) (IN of) (NP (NP (NN Doxycyclin)) (PRN (-LRB- -LRB-) (NP (NN Dox)) (-RRB- -RRB-)))) (NP (DT the) (JJ co-activator) (NN BOB.1/OBF.1)) (VP (VBZ is) (VP (VBN expressed)))) (, ,) (IN whereas) (S (PP (IN in) (DT the) (NN presence) (IN of) (NP (NN Dox))) (NP (PRP$ its) (NN expression)) (VP (VBZ is) (VP (VBN repressed))))) (. .)))
( (S (S (NP (NP (-LRB- -LRB-) (NN D) (-RRB- -RRB-) (NN Protein) (NNS extracts)) (VP (VBD were) (VBN prepared) (PP (IN from) (NP (VBN sorted) (NN B220+mice))))) (VP (VBD were) (VP (VBN analyzed) (PP (IN for) (NP (NN Btk) (NN expression))) (PP (IN by) (NP (NN western) (NN blot)))))) (. .)))
( (S (NP (NP (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NN RNA)) (VP (VBN prepared) (PP (IN from) (NP (NP (ADJP (NP (NN bone) (NN marrow)) (VBN derived)) (NN pre) (NN B) (NN cell) (NNS lines)) (, ,) (VP (VBN established) (PP (IN from) (NP (NP (NNS mice)) (VP (VBG expressing) (NP (DT a) (JJ conditional) (NN BOB.1/OBF.1) (NN transgene)) (PP (IN on) (NP (DT a) (NN BOB.1/OBF.1-mutant)))))))))))))
( (S (S (NP (NP (NN background)) (, ,)) (VP (VBD was) (VP (VBN analyzed) (PP (IN for) (NP (NN Btk) (NN mRNA) (NN expression))) (PP (IN by) (NP (NN northern) (NN blot)))))) (. .)))
( (S (S (S (PP (IN In) (DT the) (NN absence) (IN of) (NP (NP (NN Doxycyclin)) (PRN (-LRB- -LRB-) (NP (NN Dox)) (-RRB- -RRB-)))) (NP (DT the) (JJ co-activator) (NN BOB.1/OBF.1)) (VP (VBZ is) (VP (VBN expressed)))) (, ,) (IN whereas) (S (PP (IN in) (DT the) (NN presence) (IN of) (NP (NN Dox))) (NP (PRP$ its) (NN expression)) (VP (VBZ is) (VP (VBN repressed))))) (. .)))
( (S (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (NP (NN Protein) (NNS extracts)) (VP (VBD were) (VP (VBN prepared) (PP (IN from) (NP (NP (VBN sorted) (NN B220+) (NNS splenocytes)) (PP (IN from) (NP (CC either) (NP (JJ wild) (NN type)) (CC or) (NP (NNS BOB.1/OBF.1−/−))))))))))
( (S (S (NP (NNS mice)) (CC and) (VP (VBN analyzed) (PP (IN for) (NP (NN Btk) (NN expression))))) (. .)))
( (S (NP (NP (PRN (-LRB- -LRB-) (NP (NN E)) (-RRB- -RRB-)) (NN RNA)) (VP (VBD was) (VBN prepared) (PP (IN from) (NP (NNS splenocytes))) (PP (IN from) (NP (NP (JJ wild) (NN type)) (CC or) (NP (NN BOB.1/OBF.1−/−))))))))
( (S (S (NP (NP (NNS mice)) (CC and) (NP (DT the) (NN Btk–mRNA) (NN expression))) (VP (VBD was) (VP (VBN analyzed) (PP (IN by) (NP (NN northern) (NN blot)))))) (. .)))
( (S (S (NP (NP (NP (NN RelA)) (PRN (-LRB- -LRB-) (NP (NN p65)) (-RRB- -RRB-))) (CC or) (NP (NNS GAPDH))) (VP (VBD were) (VP (VBN used) (PP (IN as) (NP (NN loading) (NNS controls)))))) (. .)))
( (S (S (S (NP (NN WB)) (VP (VBG =) (NP (NN western) (NN blot)))) (: ;) (S (NP (NN NB)) (VP (VBG =) (NP (NN northern) (NN blot))))) (. .)))
( (S (NP (NP (NNS Mechanisms)) (VP (VBG Mediating) (NP (NP (DT the) (JJ Biologic) (NN Activity)) (PP (IN of)))))))
( (S (NP (NP (JJ Synthetic) (NN Proline)) (, ,) (NP (NN Glycine)) (, ,) (CC and) (NP (NN Hydroxyproline)))))
( (S (NP (NP (NNS Polypeptides)) (PP (IN in) (NP (JJ Human) (NNS Neutrophils))))))
( (S (NP (NN Abstract))))
( (S (NP (NP (DT The) (NN accumulation)) (PP (IN of) (NP (NNS neutrophils))) (PP (IN at) (NP (NP (NNS sites)) (PP (IN of) (NP (NN tissue) (NN injury)))))) (ADVP (CC or))))
( (S (NP (NN infection)) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (NP (JJ chemotactic) (NNS factors)) (VP (VBN released) (PP (IN as) (NP (NP (NN part)) (PP (IN of)))))))))))
( (S (S (NP (DT the) (JJ inflammatory) (NN process))) (. .)))
( (S (NP (NP (DT Some)) (PP (IN of) (NP (DT these) (NNS factors)))) (VP (VBP are) (VP (VBN generated) (ADVP (IN as))))))
( (S (NP (NP (NP (DT a) (JJ direct) (NN consequence)) (PP (IN of) (NP (NP (NN tissue) (NN injury)) (CC or) (NP (NN infection))))) (, ,) (NP (VBG including)))))
( (S (NP (NP (NN degradation) (NNS fragments)) (PP (IN of) (NP (JJ connective) (NN tissue) (NN collagen))) (CC and))))
( (S (NP (NP (ADJP (ADJP (JJ bacterial-)) (CC or) (ADJP (JJ viral-derived))) (NNS peptides)) (VP (VBG containing) (NP (JJ collagen-related))))))
( (S (NP (NP (JJ structural) (NNS motifs)) (. .))))
( (S (PP (IN In) (NP (DT these) (NNS studies))) (, ,) (NP (PRP we)) (VP (VBD examined) (NP (JJ biochemical)))))
( (S (NP (NP (NNS mechanisms)) (VP (VBG mediating) (NP (NP (DT the) (JJ biologic) (NN activity)) (PP (IN of) (NP (JJ synthetic))))))))
( (S (NP (NP (NNS polypeptides)) (VP (VBG consisting) (PP (IN of) (NP (NP (JJ repeated) (NNS units)) (PP (IN of) (NP (NP (NN proline)) (PRN (-LRB- -LRB-) (NP (NN Pro)) (-RRB- -RRB-))))))) (, ,))))
( (S (NP (NP (NP (NN glycine)) (PRN (-LRB- -LRB-) (NP (NN Gly)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NN hydroxyproline)) (PRN (-LRB- -LRB-) (NP (NN Hyp)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ major) (NN amino) (NNS acids)) (VP (VBN found))))))
( (S (PP (IN within) (NP (ADJP (ADJP (JJ mammalian)) (CC and) (ADJP (JJ bacterial))) (NNS collagens))) (. .)))
( (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (FRAG (DT the))))))
( (S (S (NP (NNS peptides)) (VP (VBD were) (NP (NP (NNS chemoattractants)) (PP (IN for) (NP (NNS neutrophils)))))) (. .)))
( (S (ADVP (RB Moreover)) (, ,) (NP (PRP$ their))))
( (S (NP (JJ chemotactic) (NN potency)) (VP (VBD was) (ADJP (RB directly) (JJ related) (PP (TO to) (NP (PRP$ their) (NN size))))) (CC and)))
( (S (NP (NP (NN composition)) (. .))))
( (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (JJ pentameric) (NNS peptides)) (PRN (-LRB- -LRB-) (NP (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 5)))) (CC and)))
( (S (-LRB- -LRB-) (NP (NN Pro-Hyp-Gly) (-RRB- -RRB-) (CD 5)) (VP (VBD were) (ADJP (RBR more) (JJ active)) (PP (IN in) (S (VP (VBG inducing) (NP (NN chemotaxis) (IN than))))))))
( (S (NP (NP (DT the) (JJ corresponding) (JJ decameric) (NNS peptides)) (PRN (-LRB- -LRB-) (NP (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 10)) (CC and)))))
( (S (NP (NP (PRN (-LRB- -LRB-) (NP (NN Pro-Hyp-Gly)) (-RRB- -RRB-)) (CD 10)) (. .))))
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN Hyp))) (PP (IN in)))))
( (S (S (NP (NNS peptides)) (VP (VBD reduced) (NP (JJ chemotactic) (NN activity)))) (. .)))
( (S (NP (DT The) (JJ synthetic) (NNS peptides))))
( (S (S (VP (VBD were) (ADVP (RB also)) (VP (VBN found) (S (VP (TO to) (VP (VB reduce) (NP (NN neutrophil) (NN apoptosis)))))))) (. .)))
( (S (PP (IN In) (NP (NN contrast))) (PP (TO to))))
( (S (NP (NP (NN chemotaxis)) (, ,) (NP (NP (DT this) (NN activity)) (VP (VBD was) (ADJP (JJ independent) (PP (IN of) (NP (NN peptide) (NN size) (NN or)))))))))
( (S (NP (NP (NN composition)) (. .))))
( (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (DT the) (NNS peptides))) (PP (IN on) (NP (CC both) (NN chemotaxis) (CC and))))))
( (S (NP (NN apoptosis)) (VP (VBD were) (VP (VBN blocked) (PP (IN by) (NP (NP (NNS inhibitors)) (PP (IN of) (NP (NN phosphatidylinositol)))))))))
( (S (S (NP (NP (NP (NN 3-kinase)) (PRN (-LRB- -LRB-) (NP (NN PI3-K)) (-RRB- -RRB-))) (CC and) (NP (NN p38) (JJ mitogen-activated) (NN protein) (-LRB- -LRB-) (NN MAP) (-RRB- -RRB-) (NN kinase)))) (. .)))
( (S (ADVP (RB However)) (, ,) (NP (RB only) (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 5)) (CC and) (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 10))) (VP (VBD induced))))
( (S (NP (NP (NP (NP (NN expression)) (PP (IN of) (NP (NN PI3-K)))) (CC and) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN p38) (NN MAP) (NN kinase))))) (, ,))))
( (S (VP (VBG suggesting) (NP (NP (DT a) (JJ potential) (NN mechanism)) (VP (VBG underlying) (NP (VBN reduced) (NN chemotactic)))))))
( (S (NP (NP (NN activity)) (PP (IN of) (NP (JJ Hyp-containing) (NNS peptides))) (. .))))
( (S (IN Although) (NP (NP (NN none)) (PP (IN of) (NP (DT the))))))
( (S (NP (NP (JJ synthetic) (NNS peptides)) (VP (VBN tested))) (VP (VBD had) (NP (DT any) (NN effect)) (PP (IN on) (NP (JJ intracellular) (NN calcium))))))
( (S (NP (NP (NN mobilization)) (, ,) (NP (NP (DT each) (VBN induced) (JJ nuclear) (NN binding) (NN activity)) (PP (IN of) (NP (DT the)))))))
( (S (S (NP (NN transcription) (NN factor)) (VP (VBZ NF-κB))) (. .)))
( (S (NP (DT These) (NNS findings)) (VP (VBP indicate) (NP (DT that)))))
( (S (NP (NP (JJ polymeric) (NNS polypeptides)) (VP (VBG containing) (NP (NN Gly-X-Y) (JJ collagen-related))))))
( (S (NP (JJ structural) (NNS motifs)) (VP (VBP promote) (NP (NN inflammation)) (PP (IN by) (S (VP (VBG inducing) (NP (NN chemotaxis)))))) (CC and)))
( (S (S (VP (VBG blocking) (NP (NN apoptosis)))) (. .)))
( (S (ADVP (RB However)) (, ,) (NP (JJ distinct) (JJ calcium-independent))))
( (S (S (NP (NN signaling) (NNS pathways)) (VP (VBP appear) (S (VP (TO to) (VP (VB be) (VP (VBN involved) (PP (IN in) (NP (DT these) (NNS activities))))))))) (. .)))
( (S (NP (NN BACKGROUND))))
( (S (S (NP (DT The) (JJ inflammatory) (NN response)) (VP (VBZ is) (VP (VBN characterized) (PP (IN by) (NP (NP (DT an) (NN accumulation)) (PP (IN of) (NP (NNS neutrophils))) (PP (IN at) (NP (NP (NNS sites)) (PP (IN of) (NP (NP (NN tissue) (NN injury)) (CC and) (NP (NN infection))))))))))) (. .)))
( (S (S (NP (NNS Neutrophils)) (VP (VBP respond) (PP (TO to) (NP (NP (JJ chemotactic) (NNS factors)) (PP (VBG including) (NP (NP (JJ connective) (NN tissue) (NN degradation) (NNS products)) (, ,) (NP (NN leukotriene) (NN B4)) (, ,) (CC and) (NP (NP (JJ bacterially-derived) (NN formylmethionine-leucine-phenylalanine)) (PRN (-LRB- -LRB-) (NP (NN fMLP)) (-RRB- -RRB-))))) (, ,) (VP (VBN released) (PP (PP (IN from) (NP (JJ damaged) (NN tissue))) (CC or) (PP (IN by) (NP (JJ invading) (NNS pathogens))))))))) (. .)))
( (S (PP (IN In) (NP (JJ previous) (NNS studies))) (NP (PRP we)) (VP (VBD demonstrated) (SBAR (IN that) (S (S (NP (NP (NP (NP (NN collagenase)) (CC or) (NP (NN cyanogen) (NN bromide))) (NNS digests)) (PP (IN of) (NP (NP (JJ native) (NN collagen)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ synthetic) (JJ collagen-like) (NNS polypeptides)) (VP (VBG containing) (NP (NP (NP (NN glycine)) (PRN (-LRB- -LRB-) (NP (NN Gly)) (-RRB- -RRB-))) (, ,) (NP (NP (NN proline)) (PRN (-LRB- -LRB-) (NP (NN Pro)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NN hydroxyproline)) (PRN (-LRB- -LRB-) (NP (NN Hyp)) (-RRB- -RRB-))))))))) (VP (VBP are) (NP (NP (NP (JJ potent) (NNS chemoattractants)) (PP (IN for) (NP (JJ human) (NNS neutrophils)))) (NP (NN -LSB-1))))) (, ,) (NP (CD 2) (, ,) (CD 3) (-RRB- -RSB-))))) (. .)))
( (S (S (NP (DT These) (NNS polypeptides)) (ADVP (RB also)) (VP (VBD activated) (NP (NNS macrophages)) (PP (TO to) (NP (NN release) (NN neutrophil) (NNS chemokines) (NP (CD -LSB-4))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (DT The) (JJ present) (NNS studies)) (VP (VBD were) (VP (VBN aimed) (PP (IN at) (S (VP (VBG analyzing) (NP (NP (NNS mechanisms)) (VP (VBG mediating) (NP (NP (DT the) (JJ biological) (NN activity)) (PP (IN of) (NP (NP (NN collagen) (NN degradation) (NNS products)) (VP (VBG using) (NP (JJ synthetic) (NNS polypeptides)) (PP (IN as) (NP (DT a) (NN model))))))))))))))) (. .)))
( (S (S (NP (JJ Synthetic) (NNS polypeptides)) (VP (VBP are) (ADJP (JJ similar) (PP (PP (TO to) (NP (NP (NN degradation) (NNS products)) (VP (VBN generated) (PP (IN from) (NP (JJ mammalian) (NN collagen)))))) (CC and/or) (PP (TO to) (NP (NP (JJ collagen-related) (JJ structural) (NNS motifs)) (VP (VBN produced) (PP (IN by) (NP (NP (NNS bacteria)) (CC and) (NP (NNS viruses) (CD -LSB-5))))))) (-RRB- -RSB-))))) (. .)))
( (S (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NP (JJ synthetic) (NN model) (NNS peptides)) (PP (IN of) (S (VP (VBG varying) (NP (NP (NN length)) (CC and) (NP (NN composition))))))))) (VP (VBD allowed) (S (NP (PRP us)) (VP (TO to) (VP (VB perform) (NP (JJ structure-activity) (NNS studies))))))) (. .)))
( (S (S (NP (NP (NNS Chemoattractants)) (PP (JJ such) (IN as) (NP (NP (NN fMLP)) (CC and) (NP (NP (NN interleukin-8)) (PRN (-LRB- -LRB-) (NP (NN IL-8)) (-RRB- -RRB-)))))) (VP (VBP initiate) (NP (PRP$ their) (JJ biological) (NN activity)) (PP (IN by) (S (VP (VBG binding) (PP (TO to) (NP (JJ specific) (NN cell) (NN surface) (NNS receptors)))))))) (. .)))
( (S (S (PP (IN For) (NP (JJS most) (NNS chemoattractants))) (, ,) (NP (DT this)) (VP (VBZ is) (VP (VBN followed) (PP (IN by) (NP (NP (NP (NN mobilization)) (PP (IN of) (NP (JJ intracellular) (NN calcium)))) (, ,) (NP (NP (NN activation)) (PP (IN of) (NP (NN protein) (NNS kinases)))) (, ,) (CC and) (NP (NP (NP (NN translocation)) (CC and) (NP (NN binding))) (PP (IN of) (NP (NN transcription) (NNS factors))) (PP (TO to) (NP (NP (NN consensus) (NNS sequences)) (PP (IN in) (NP (NP (NN promoter) (NNS regions)) (PP (IN of) (NP (NP (NNS genes)) (VP (VBG regulating) (NP (NP (DT the) (JJ inflammatory) (NN response)) (PRN (QP (CD -LSB-6) (, ,) (CD 7) (, ,) (CD 8)) (-RRB- -RSB-)))))))))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD speculated) (SBAR (IN that) (S (NP (NP (NNS variations)) (PP (IN in) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (DT the) (JJ synthetic) (NNS peptides)))))) (VP (MD may) (VP (VB be) (ADJP (JJ related) (PP (TO to) (NP (PRP$ their) (JJ distinct) (NN ability) (S (VP (TO to) (VP (VB activate) (NP (DT these) (VBG signaling) (NNS pathways)))))))))))))) (. .)))
( (S (NP (NNS METHODS))))
( (S (S (NP (NP (NP (NP (DT The) (JJ synthetic) (NNS polypeptides)) (PRN (-LRB- -LRB-) (NP (NN Pro-Pro-Gly)) (-RRB- -RRB-))) (NP (NP (CD 5)) (, ,) (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 10)))) (, ,) (NP (-LRB- -LRB-) (NN Pro-Hyp-Gly) (-RRB- -RRB-) (CD 5)) (, ,) (CC and) (NP (-LRB- -LRB-) (NN Pro-Hyp-Gly) (-RRB- -RRB-) (CD 10))) (VP (VBD were) (VP (VBN purchased) (PP (IN from) (NP (NNS Peptides) (NP (NNP International)))) (PRN (-LRB- -LRB-) (NP (NNP Louisville)) (, ,) (NP (NN Ky)) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (NP (NP (NN Hanks) (POS ') (JJ balanced) (NN salt) (NN solution)) (PRN (-LRB- -LRB-) (NP (NN HBSS)) (-RRB- -RRB-))) (CC and) (NP (NN fMLP))) (VP (VBD were) (VP (VBN obtained) (PP (IN from) (NP (NP (NN Sigma)) (PRN (-LRB- -LRB-) (NP (NP (JJ St) (NN Louis)) (, ,) (NP (NN Mo))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NN LY) (CD 294002)) (VP (VBD was) (PP (IN from) (NP (NP (NP (NN Calbiochem)) (PRN (-LRB- -LRB-) (NP (NP (NN La) (NN Jolla)) (, ,) (NP (NN Calif))) (-RRB- -RRB-))) (CC and) (NP (NP (NN SB) (CD 203580)) (PP (IN from) (NP (NP (NNP Biomol)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP Plymouth)) (VP (VBG Meeting))) (, ,) (NP (NN Pa))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (NP (JJ Indo-1) (NN acetoxymethyl) (NN ester)) (PRN (-LRB- -LRB-) (NP (JJ Indo-1) (NN AM)) (-RRB- -RRB-))) (VP (VBD was) (VP (VP (VBN purchased) (PP (IN from) (NP (NP (JJ Molecular) (NNS Probes)) (PRN (-LRB- -LRB-) (NP (NNP Eugene) (, ,) (NNP Ore)) (-RRB- -RRB-))))) (CC and) (VP (VBN stored) (PP (IN as) (NP (DT a) (JJ 1 mM) (NN stock) (NN solution))) (PP (IN in) (NP (NN dimethylsufoxide))) (PP (IN at) (NP (NN −20°C))))))) (. .)))
( (S (S (NP (NP (NP (JJ Rabbit) (JJ polyclonal) (NNS antibodies)) (PP (IN against) (NP (NP (NN NF-κB-p50)) (, ,) (NP (NN NF-κB-p65)) (, ,) (CC and) (NP (NN p38) (NN MAP) (NN kinase))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NN horseradish) (JJ peroxidase-) (-LRB- -LRB-) (NN HRP-) (-RRB- -RRB-) (VBN linked) (JJ secondary) (NNS antibodies)) (, ,)) (VP (VBD were) (PP (IN from) (NP (NNP Santa) (NNP Cruz) (NN Biotechnology))) (PRN (-LRB- -LRB-) (NP (NNP Santa) (NNP Cruz)) (, ,) (NP (NN Calif)) (-RRB- -RRB-)))) (. .)))
( (S (S (NP (NP (NN Mouse) (JJ monoclonal) (CD anti-phospho-p38) (NN MAP) (NN kinase) (-LRB- -LRB-) (NN Thr180/Tyr182) (-RRB- -RRB-) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NN IgG1)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN purchased) (PP (IN from) (NP (NP (NP (NN Cell) (NN Signaling) (NN Technology)) (PRN (-LRB- -LRB-) (NP (NNP Beverly)) (, ,) (NP (NN Mass)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NN mouse) (JJ monoclonal) (NP (NP (NP (NN anti-phosphatidylinositol) (NN 3-kinase)) (PRN (-LRB- -LRB-) (NP (NN PI3-K)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NN p85-subunit-reactive)) (-RRB- -RRB-))) (NN antibody)))) (PP (IN from) (NP (NP (NNP BD) (NNP Biosciences) (NNP PharMingen)) (PRN (-LRB- -LRB-) (NP (NP (NNP San) (NNP Diego)) (, ,) (NP (NN Calif))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (JJ Double-stranded) (NN DNA) (NNS probes)) (VP (VBN used) (PP (IN for) (NP (NP (JJ electrophoretic) (NN mobility) (NN shift) (NNS assays)) (PRN (-LRB- -LRB-) (NP (NNS EMSAs)) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN obtained) (PP (IN from) (NP (NP (JJ IDT) (NNS Technologies)) (PRN (-LRB- -LRB-) (NP (NNP Coralville) (, ,) (NNP Iowa)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (JJ FITC-linked) (NN Annexin) (NN V)) (VP (VBD was) (PP (IN from) (NP (NP (NP (NN R) (NN &) (NN D) (NNS Systems)) (PRN (-LRB- -LRB-) (NP (NNP Minneapolis) (, ,) (NNP Minn)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NN propidium) (NN iodide)) (PP (IN from) (NP (NP (NNP Calbiochem)) (PRN (-LRB- -LRB-) (NP (NP (NNP San) (NNP Diego)) (, ,) (NP (NN Calif))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (JJ Human) (NNS neutrophils)) (VP (VBD were) (VP (VBN isolated) (PP (IN from) (NP (JJ heparinized) (JJ peripheral) (JJ venous) (NN blood))) (PP (IN by) (NP (NP (NN dextran) (NN sedimentation)) (CC and) (NP (NN Ficoll) (NN density) (NN gradient) (NN centrifugation)))) (PP (IN as) (NP (ADJP (RB previously) (VBN described)) (NN -LSB-9) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (DT These) (NNS studies)) (VP (VBD were) (ADJP (JJ approved) (PP (IN by) (NP (NP (DT the) (JJ Institutional) (NN Review) (NN Board)) (PP (IN of) (NP (NP (NNP UMDNJ) (NNP Robert) (NNP Wood) (NNP Johnson)) (JJ Medical) (NN School)))))))) (. .)))
( (S (S (NP (NP (NN Migration)) (PP (IN of) (NP (NNS neutrophils))) (PP (IN through) (NP (NN nucleopore) (NN polycarbonate) (NNS filters)))) (VP (VBD was) (VP (VBN assayed) (S (VP (VBG using) (NP (DT the) (VBN modified) (NN Boyden) (NN chamber) (NN technique) (CD -LSB-10)))))) (-RRB- -RSB-)) (. .)))
( (S (S (PP (IN For) (NP (PRP$ our) (NNS studies))) (NP (PRP we)) (VP (VBD used) (NP (NP (DT a) (JJ 48-well) (NN microchemotaxis) (NN chamber)) (PRN (-LRB- -LRB-) (NP (NP (NN Neuro) (NN Probe)) (, ,) (NP (NNP Inc) (, ,) (NNP Pleasanton)) (, ,) (NP (NN Calif))) (-RRB- -RRB-))))) (. .)))
( (S (S (NP (NP (CD Thirty) (NNS microliters)) (PP (IN of) (NP (NP (JJ synthetic) (NNS peptides)) (, ,) (NP (NP (NN fMLP)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN ×) (NN 10−8 M)) (-RRB- -RRB-))) (, ,) (CC or) (NP (NN medium) (NN control))))) (VP (VBD were) (VP (VBN placed) (PP (IN in) (NP (NP (DT each) (NN well)) (PP (IN of) (NP (DT the) (JJR lower) (NN chamber)))))))) (. .)))
( (S (S (NP (DT A) (JJ 5-μm) (JJ pore-size) (NN filter)) (VP (VBD was) (ADVP (RB then)) (VP (VBN placed) (PP (IN over) (NP (NP (NP (DT the) (NNS wells)) (CC and) (NP (DT the) (JJ upper) (NN chamber))) (VP (VBN set) (PP (IN into) (NP (NN place))))))))) (. .)))
( (S (S (NP (NP (CD Fifty) (NNS microliters)) (PP (IN of) (NP (NP (DT a) (NN neutrophil) (NN suspension)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN ×) (NN 105cells)) (-RRB- -RRB-)))) (PP (IN in) (NP (NP (NP (NN HBSS)) (VP (VBG containing) (NP (NP (ADJP (CD 0.5) (NN %)) (NP (NP (JJ bovine) (NN serum) (NN albumin)) (PRN (-LRB- -LRB-) (NP (NN BSA)) (-RRB- -RRB-)))) (CC and) (NP (NN 2.4 mg/ml) (NNS HEPES))))) (, ,) (NP (NN pH) (CD 7.2)) (, ,)))) (VP (VBD was) (VP (VBN added) (PP (TO to) (NP (DT each) (NN well)))))) (. .)))
( (S (S (PP (IN After) (NP (NP (NN incubation)) (PP (IN for) (NP (NNS 45 minutes))) (PP (IN at) (NP (NN 37°C))))) (, ,) (NP (NP (DT the) (NN filter)) (VP (VBG containing) (NP (ADJP (ADJP (JJ adhered)) (, ,) (ADJP (VBD migrated))) (NNS neutrophils)))) (VP (VBD was) (VP (VP (VBN removed)) (CC and) (VP (VBN stained) (PP (IN with) (NP (NN Wright-Giemsa))))))) (. .)))
( (S (S (NP (NN Chemotaxis)) (VP (VBD was) (VP (VBN quantified) (PP (IN as) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBD migrated) (PP (IN through) (NP (NP (DT the) (NN filter)) (PP (IN in) (NP (CD 10) (NN oil) (NN immersion) (NNS fields))))))))))))))) (. .)))
( (S (PP (IN In) (NP (DT some) (NNS experiments))) (, ,) (NP (NNS cells)) (VP (VBD were) (VP (VBN incubated) (PP (IN at) (NP (JJ room) (NN temperature))) (PP (IN with) (NP (NP (NP (NN LY) (CD 294002)) (PRN (-LRB- -LRB-) (NP (NP (NN 50 μM)) (, ,) (NP (NN 5 minutes))) (-RRB- -RRB-))) (CC or) (NP (NP (NN SB) (CD 203580)) (PRN (-LRB- -LRB-) (NP (NP (NN 30 μM)) (, ,) (NP (NN 1 hour))) (-RRB- -RRB-))))) (ADVP (ADVP (RB prior)) (PP (TO to) (NP (NP (DT the) (NN analysis)) (PP (IN of) (NP (NN chemotactic) (NN responsiveness)))))))) (. .)))
( (S (S (NP (JJ Indo-1) (NN AM)) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB measure) (NP (JJ intracellular) (NN calcium) (NN mobilization) (CD -LSB-11))))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (NNS Neutrophils)) (VP (VBD were) (VP (VP (VBN inoculated) (PP (IN into) (NP (NP (NN Nunc) (NN coverglass) (NNS chambers)) (PRN (-LRB- -LRB-) (NP (CD 2) (NN ×) (NN 106 cells/chamber)) (-RRB- -RRB-))))) (CC and) (VP (VBN allowed) (S (VP (TO to) (VP (VB adhere) (ADJP (JJ overnight))))))))) (. .)))
( (S (S (NP (NNS Cells)) (VP (VBD were) (VP (VP (ADVP (RB then)) (VBN washed) (PP (IN with) (NP (NP (NN HBSS)) (VP (VBG containing) (NP (ADJP (CD 0.3) (NN %)) (NN BSA)))))) (CC and) (VP (VBN incubated) (PP (IN in) (NP (JJ 1 μM) (JJ Indo-1) (NN AM))) (PP (IN at) (NP (NN 37°C))))))) (. .)))
( (S (S (S (PP (IN After) (NP (NN 30 minutes))) (, ,) (NP (DT the) (NNS cells)) (VP (VBD were) (NP (VBN washed) (NP (CD three) (NNS times))))) (CC and) (S (NP (NP (NN 1 mL)) (PP (IN of) (NP (NP (NN HBSS)) (VP (VBG containing) (NP (ADJP (CD 0.3) (NN %)) (NN BSA)))))) (VP (VBD was) (VP (VBN added) (PP (TO to) (NP (DT each) (NN well))))))) (. .)))
( (S (S (NP (JJ Intracellular) (NN calcium)) (VP (VBD was) (VP (VBN quantified) (PP (IN on) (NP (NP (NP (DT a) (ADJP (NP (NN Meridian) (NN ACAS) (NN 570)) (VBN Anchored)) (NN Cell) (NN Analysis) (NN System)) (PRN (-LRB- -LRB-) (NP (NNP Okemos) (, ,) (NNP Mich)) (-RRB- -RRB-))) (VP (VBN equipped) (PP (IN with) (NP (NP (DT an) (NN Innova) (CD 90) (NN 5-W) (NN laser)) (VP (VBN adjusted) (PP (TO to) (NP (NP (DT an) (NN output)) (PP (IN of) (NP (NN 100 mW)))))))))))))) (. .)))
( (S (S (PP (IN For) (NP (NP (NN measurement)) (PP (IN of) (NP (JJ cellular) (NN fluorescence))))) (, ,) (NP (NN Indo-1)) (VP (VBD was) (VP (VBN excited) (S (VP (VBG using) (NP (NP (NP (DT the) (NN ultraviolet) (NNS lines)) (PRN (-LRB- -LRB-) (NP (NN 351–364 nm)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NN argon) (NN laser))))))))) (. .)))
( (S (S (NP (NN Calcium) (NN mobilization)) (VP (VBD was) (VP (VBN quantified) (PP (IN by) (NP (NP (NN scanning) (JJ single) (CD 130) (NN ×) (NN 130 μm) (NNS fields)) (VP (VP (VBG containing) (NP (NP (NN ≥) (CD 15) (NNS cells)) (NP (NP (DT every) (NNS 8 seconds)) (PP (IN for) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (CD 5) (NNS minutes)))))))) (CC and) (VP (VBG collecting) (NP (NP (DT the) (NNS emissions)) (PP (IN at) (NP (NP (NP (NN 485 nm)) (PRN (-LRB- -LRB-) (NP (JJ calcium-free) (NN Indo-1)) (-RRB- -RRB-))) (CC and) (NP (NP (NN 405 nm)) (PRN (-LRB- -LRB-) (NP (JJ calcium-saturated) (NN Indo-1)) (-RRB- -RRB-))))))))))))) (. .)))
( (S (S (NP (NNS Data)) (VP (VBP are) (VP (VBN presented) (PP (IN as) (NP (NP (DT the) (NN ratio)) (PP (IN of) (NP (NN emission))) (PP (IN at) (NP (NP (NN 405 nm)) (ADJP (JJ relative) (PP (TO to) (NP (NN 485 nm))))))))))) (. .)))
( (S (S (NP (NP (NP (JJ Synthetic) (NNS peptides)) (PRN (-LRB- -LRB-) (NP (NN 10 nM)) (-RRB- -RRB-))) (CC or) (NP (NP (NN fMLP)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN ×) (NN 10−8 M)) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN added) (PP (TO to) (NP (DT the) (NNS cells))) (PP (NP (CD 180) (NNS seconds)) (IN after) (S (NP (JJ stable) (NNS baselines)) (VP (VBD were) (VP (VBN established)))))))) (. .)))
( (S (S (NP (NNS Neutrophils)) (VP (VBD were) (VP (VBN incubated) (PRN (-LRB- -LRB-) (NP (NN 37°C)) (-RRB- -RRB-)) (PP (IN with) (NP (NP (NN medium) (NN control)) (, ,) (NP (NP (NN fMLP)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN ×) (NN 10−8 M)) (-RRB- -RRB-))) (, ,) (CC or) (NP (NP (NN 10 nM) (PRN (-LRB- -LRB-) (NP (NN Pro-Pro-Gly)) (-RRB- -RRB-)) (CD 5)) (, ,) (NP (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 10)) (, ,) (NP (-LRB- -LRB-) (NN Pro-Hyp-Gly) (-RRB- -RRB-) (CD 5)) (, ,) (CC or) (NP (NP (-LRB- -LRB-) (NN Pro-Hyp-Gly) (-RRB- -RRB-) (CD 10)) (PP (IN for) (NP (NP (NP (CD 2) (NNS hours)) (PRN (-LRB- -LRB-) (NP (NN PI3-K)) (-RRB- -RRB-))) (CC or) (NP (NP (NNS 5 minutes)) (PRN (-LRB- -LRB-) (NP (NN p38)) (, ,) (NP (NN phospho-p38)) (-RRB- -RRB-))))))))))))) (. .)))
( (S (S (NP (NNS Cells)) (VP (VBD were) (ADVP (RB then)) (VP (VBN solubilized) (PP (IN in) (NP (NP (NN buffer)) (VP (VBG containing) (NP (NP (CD 50) (NN mM) (NNS HEPES)) (, ,) (NP (NP (NN pH) (CD 7.4)) (, ,) (NP (NN 10 mM) (NN KCl)) (, ,) (NP (NN 1 mM) (NN EDTA)) (, ,) (NP (NN 1 mM) (NN DTT)) (, ,) (NP (NN 1 μg/mL) (NN pepstatin) (NN A)) (, ,) (NP (NN 1 μg/mL) (NN leupeptin)) (, ,) (NP (NP (NN 10 μg/mL) (NN soybean) (NN trypsin) (NN inhibitor)) (, ,) (NP (NN 10 μg/mL) (NN aprotinin))) (, ,) (CC and) (NP (CD 1) (NN %) (NN Triton) (NN X-100)))))))))) (. .)))
( (S (S (S (PP (IN After) (NP (NP (NNS 10 minutes)) (PP (IN in) (NP (NN ice))))) (, ,) (NP (NNS lysates)) (VP (VBD were) (VP (VBN centrifuged) (PRN (-LRB- -LRB-) (NP (CD 4000) (NN xg)) (, ,) (NP (NNS 5 minutes)) (-RRB- -RRB-))))) (CC and) (S (NP (NP (NN protein) (NNS concentrations)) (PP (IN in) (NP (DT the) (NNS supernatants)))) (VP (VBD were) (VP (VBN quantified) (S (VP (VBG using) (NP (NP (DT a) (NN BCA) (NN Protein) (NN Assay) (NN Kit)) (PRN (-LRB- -LRB-) (NP (NP (NN Pierce)) (, ,) (NP (NNP Rockford)) (, ,) (NP (NN Ill))) (-RRB- -RRB-))) (PP (IN with) (NP (NN BSA))) (PP (IN as) (NP (DT the) (JJ standard))))))))) (. .)))
( (S (NP (NP (NNS Aliquots)) (PP (IN of) (NP (NP (NNS supernatants)) (VP (VBG containing) (NP (NP (NN 10 μg)) (PP (IN of) (NP (NN protein)))))))) (VP (VBD were) (VP (VP (VBN fractionated) (PP (IN on) (NP (ADJP (CD 7.5) (NN %)) (NN SDS) (NN polyacrylamide) (NNS gels)))) (CC and) (VP (VBN electroblotted) (PP (IN onto) (NP (NP (JJ 0.45 μm) (NN nitrocellulose) (NN paper)) (PRN (-LRB- -LRB-) (NP (JJ Bio-Rad) (, ,) (NNP Hercules) (, ,) (NNP Calif)) (-RRB- -RRB-)))) (PP (IN at) (NP (NP (NN 250 mA)) (PP (IN for) (NP (NP (NNS 4 hours)) (PP (IN in) (NP (NP (NP (DT a) (JJ Mini) (NN Trans-Blot) (JJ Electrophoretic) (NN Transfer) (NN Cell)) (PRN (-LRB- -LRB-) (NP (JJ Bio-Rad)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NP (NN 25 mM) (NN Tris)) (, ,) (NP (NN pH) (CD 8.3)) (, ,) (NP (NN 192 mM) (NN Gly)) (, ,) (NP (NP (CD 20) (NN %)) (PRN (-LRB- -LRB-) (NP (NN v/v)) (-RRB- -RRB-)))) (NN methanol)))))))))))) (. .)))
( (S (S (NP (NNS Blots)) (VP (VBD were) (ADVP (RB then)) (VP (VBN incubated) (PP (IN in) (NP (NP (DT a) (CD 1) (: :) (CD 250) (NN dilution)) (PP (IN of) (NP (NP (CD anti-phospho-p38) (NN MAP) (NN kinase) (NN antibody)) (, ,) (NP (NN anti-p38) (NN MAP) (NN kinase)) (, ,) (CC or) (NP (NN anti-PI3-K) (NN antibody))))))))) (. .)))
( (S (PP (IN After) (NP (VBG washing))) (, ,) (NP (DT the) (NNS blots)) (VP (VBD were) (VP (VBN incubated) (PP (IN with) (NP (NP (NP (NP (NN goat) (NN antimouse) (NN IgG) (-LRB- -LRB-) (CD 1) (: :) (CD 2000) (-RRB- -RRB-)) (CC or) (NP (NN sheep) (NN antirabbit) (NN IgG) (-LRB- -LRB-) (CD 1) (: :) (CD 1000) (-RRB- -RRB-))) (JJ HRP-conjugated) (NNS antibodies)) (PP (IN for) (NP (NN 1 hour))))) (PP (IN at) (NP (JJ room) (NN temperature))))) (. .)))
( (S (S (NP (NNS Proteins)) (VP (VBD were) (VP (VBN detected) (S (VP (VBG using) (NP (NP (DT a) (NN Renaissance) (NN Western) (NN Blot) (NN Chemiluminescence) (NN Reagent) (NN Plus) (NN kit)) (PRN (-LRB- -LRB-) (NP (NNP NEN) (NN Life) (NNP Sciences) (, ,) (NNP Boston)) (, ,) (NP (NN Mass)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (NNS Neutrophils)) (VP (VBD were) (VP (VP (VBN washed) (PP (IN in) (NP (NNS PBS)))) (, ,) (VP (VBN resuspended) (PP (IN in) (NP (NP (NP (NN Dulbecco) (POS 's) (VBN Modified) (JJ Eagle) (POS 's) (NN Medium)) (PRN (-LRB- -LRB-) (NP (NN DMEM)) (-RRB- -RRB-))) (VP (VBG containing) (NP (ADJP (CD 10) (NN %)) (JJ fetal) (JJ bovine) (NN serum)))))) (, ,) (CC and) (VP (VBN incubated) (PP (IN in) (NP (NP (DT a) (JJ shaking) (NN water) (NN bath)) (PP (IN at) (NP (NN 37°C))) (PP (IN for) (NP (NP (CD 24) (NNS hours)) (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC or) (NP (NN absence))) (PP (IN of) (NP (NP (NNS peptides)) (PRN (-LRB- -LRB-) (NP (NN 10 nM)) (-RRB- -RRB-)))))))))))))) (. .)))
( (S (S (NP (NNS Cells)) (VP (VBD were) (ADVP (RB then)) (VP (VP (VBN centrifuged)) (, ,) (VP (VBN resuspended) (PRN (-LRB- -LRB-) (NP (CD 2) (NN ×) (NN 106 cells/mL)) (-RRB- -RRB-)) (PP (IN in) (NP (NP (NN binding) (NN buffer)) (PRN (-LRB- -LRB-) (NP (CD 10 mM) (NN HEPES/NaOH)) (, ,) (NP (NP (NN pH) (CD 7.4)) (, ,) (NP (JJ 140 mM) (NN NaCl)) (, ,) (NP (NN 2.5 mM) (NN CaCl2))) (-RRB- -RRB-))))) (, ,) (CC and) (VP (VBN incubated) (PRN (-LRB- -LRB-) (NP (NP (NN 15 minutes)) (, ,) (NP (NN room) (NN temperature))) (-RRB- -RRB-)) (PP (IN with) (NP (NP (NN Annexin) (NN V)) (CC and) (NP (NN propidium) (NN iodide)))))))) (. .)))
( (S (S (NP (NNS Samples)) (VP (VBD were) (VP (VBN analyzed) (PP (IN by) (NP (NP (NN flow) (NN cytometry)) (PP (IN on) (NP (NP (DT a) (NN Coulter) (NN EPICS) (NN Profile) (CD II)) (PRN (-LRB- -LRB-) (NP (NNP Hialeah) (, ,) (NNP Fla)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (S (NP (ADJP (ADJP (JJ Viable)) (, ,) (ADJP (JJ apoptotic)) (, ,) (CC and) (ADJP (JJ necrotic))) (NN neutrophil) (NNS populations)) (VP (VBD were) (VP (VBN gated) (ADVP (RB electronically))))) (CC and) (S (NP (NP (NNS data)) (VP (VBN analyzed) (S (VP (VBG using) (NP (NN quadrant) (NNS statistics)))))) (VP (VBN based) (PP (IN on) (NP (NP (JJ relative) (NN Annexin) (NN V)) (CC and) (NP (NN propidium) (NN iodide)) (NP (NN fluorescence) (NN -LSB-12)))) (-RRB- -RSB-)))) (. .)))
( (S (S (VP (TO To) (VP (VB prepare) (NP (JJ nuclear) (NNS extracts))))) (, ,) (NP (NP (NNS neutrophils)) (PRN (-LRB- -LRB-) (NP (CD 2) (NN ×) (CD 106)) (-RRB- -RRB-))) (VP (VBD were) (VP (VP (VBN microcentrifuged) (PP (IN for) (NP (NN 15 seconds)))) (CC and) (VP (ADVP (RB then)) (VBN resuspended) (PP (IN in) (NP (NP (NN 400 μL)) (PP (IN of) (NP (NP (JJ cold) (NN buffer)) (PRN (-LRB- -LRB-) (FRAG (NP (NP (CD 10 mM) (NN HEPES)) (, ,) (NP (NN pH) (CD 7.9))) (, ,) (NP (CD 10 mM) (NN KCl)) (, ,) (NP (CD 0.1 mM) (NN EDTA)) (, ,) (NP (CD 0.1 mM) (NN EGTA)) (, ,) (NP (CD 1 mM) (NN DTT)) (, ,) (NP (CD 0.5 mM) (NN PMSF))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (PP (IN After) (NP (NP (NNS 15 minutes)) (PP (IN in) (NP (NN ice))))) (, ,) (S (NP (NP (NN 25 μL)) (PP (IN of) (NP (NP (DT a) (ADJP (CD 10) (NN %)) (NN solution)) (PP (IN of) (NP (NN NP-40)))))) (VP (VBD was) (VP (VBN added)))) (, ,) (CC and) (S (NP (DT the) (NN sample)) (VP (VBN mixed) (PP (IN on) (NP (NP (DT a) (NN vortex)) (PP (IN for) (NP (NNS 10 seconds)))))))) (. .)))
( (S (S (NP (DT The) (NNS lysates)) (VP (VBD were) (ADVP (RB then)) (VP (VBN centrifuged) (PP (IN for) (NP (NP (NNS 30 seconds)) (PP (IN in) (NP (DT a) (NN microfuge)))))))) (, ,) (NP (NP (DT the) (JJ nuclear) (NNS pellets)) (VP (VP (VBN resuspended) (PP (IN in) (NP (NP (NN 50 μL)) (PP (IN of) (NP (NP (JJ ice-cold) (NN buffer)) (PRN (-LRB- -LRB-) (NP (CD 20) (NN mM) (NNS HEPES)) (, ,) (FRAG (NP (NN pH) (CD 7.9)) (, ,) (NP (CD 0.4 M) (NN NaCl)) (, ,) (NP (CD 1 mM) (NN EDTA)) (, ,) (NP (CD 1 mM) (NN EGTA)) (, ,) (NP (CD 1 mM) (NN DTT)) (, ,) (NP (CD 1 mM) (NN PMSF))) (-RRB- -RRB-))))))) (CC and) (VP (VBN placed) (PP (IN on) (NP (NP (DT a) (JJ rocker) (NN platform)) (PP (IN at) (NP (NN 4°C))) (PP (IN for) (NP (NNS 15 minutes)))))))) (. .)))
( (S (S (S (NP (DT The) (NN sample)) (VP (VBD was) (ADVP (RB then)) (VP (VBN microcentrifuged) (PP (IN for) (NP (NN 5 minutes))) (PP (IN at) (NP (NN 4°C)))))) (CC and) (S (NP (DT the) (VBG resulting) (JJ soluble) (JJ nuclear) (NNS extracts)) (VP (VBD were) (VP (VBN collected))))) (. .)))
( (S (S (NP (NP (JJ Double-stranded) (NNS probes)) (VP (VBG containing) (NP (DT an) (NN NF-κB) (-LRB- -LRB-) (NN AGTTGAGGGGACCGCCCGCGGCCCGT) (-RRB- -RRB-) (NN consensus) (NN sequence)))) (VP (VBD were) (VP (VBN labeled) (PP (IN with) (NP (-LRB- -LRB-) (NN γ-32P) (-RRB- -RRB-) (NN -dCTP)))))) (. .)))
( (S (PP (IN For) (NP (NN binding) (NNS reactions))) (, ,) (NP (NP (JJ nuclear) (NNS extracts)) (PRN (-LRB- -LRB-) (NP (NP (NN 50 μg)) (PP (IN of) (NP (NN protein)))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN incubated) (PP (IN for) (NP (NNS 15 minutes))) (PP (IN at) (NP (JJ room) (NN temperature))) (PP (IN with) (NP (JJ labeled) (NN probe))) (PP (IN in) (NP (NP (NN buffer)) (VP (VBG containing) (NP (NP (NN 10 mM) (NN Tris-HCl)) (, ,) (NP (NN pH) (CD 7.4)) (, ,) (NP (NP (CD 40 mM) (NN NaCl)) (, ,) (NP (CD 10 mM) (NN EDTA))) (, ,) (NP (NN 1 mM) (NN 2-mercaptoethanol)) (, ,) (NP (ADJP (CD 0.1) (NN %)) (NN NP-40)) (, ,) (NP (ADJP (CD 4) (NN %)) (NN glycerol)) (, ,) (CC and) (NP (NN 0.1 μg/μL) (NN poly)))))))) (. .)))
( (S (S (PRN (-LRB- -LRB-) (NP (NN dI-dC)) (-RRB- -RRB-)) (VP (NN poly))) (. .)))
( (S (S (S (PRN (-LRB- -LRB-) (NP (NN dI-dC)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NP (NNP Amersham) (NNP Pharmacia) (NNP Biotech)) (, ,) (NP (NNP Piscataway) (, ,) (NNP NJ))) (-RRB- -RRB-))) (. .)))
( (S (S (PP (IN For) (NP (JJ competitive) (NN binding) (NNS assays))) (, ,) (NP (JJ nuclear) (NNS extracts)) (VP (VBD were) (VP (VBN incubated) (PP (IN with) (NP (DT a) (ADJP (RB 100-fold) (JJ excess)) (JJ unlabeled) (NN probe)))))) (. .)))
( (S (S (NP (NN Supershift) (NNS assays)) (VP (VBD were) (VP (VBN performed) (PP (IN by) (NP (NP (NN incubation)) (PP (IN of) (NP (DT the) (NNS samples))) (PP (IN with) (NP (NP (JJ polyclonal) (NNS antibodies)) (PP (TO to) (NP (NP (NP (NP (NN p50)) (CC or) (NP (NN p65))) (PRN (-LRB- -LRB-) (NP (NN 1 μg/60 μL) (NN reaction) (NN volume)) (-RRB- -RRB-))) (PP (IN for) (NP (NP (NN 1 hour)) (ADJP (JJ prior) (PP (TO to) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (DT the) (JJ labeled) (NN probe))))))))))))))))) (. .)))
( (S (S (NP (NNS Samples)) (VP (VBD were) (VP (VBN electrophoresed) (PP (IN on) (NP (ADJP (CD 4) (NN %)) (JJ nondenaturing) (NN polyacrylamide) (NNS gels))) (PP (IN in) (NP (NP (NP (NN buffer)) (PRN (-LRB- -LRB-) (NP (NP (CD 0.04 M) (NN Tris-acetate)) (, ,) (NP (NN 0.001 M) (NN EDTA))) (, ,) (NP (NN pH) (CD 8.0)) (-RRB- -RRB-))) (PP (IN at) (NP (NN 15 V/cm)))))))) (. .)))
( (S (S (NP (NNS Gels)) (VP (VBD were) (ADVP (RB then)) (ADJP (ADJP (JJ dried)) (CC and) (ADJP (JJ autoradiographed))))) (. .)))
( (S (NP (NNS RESULTS))))
( (S (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB previously)) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NP (JJ synthetic) (JJ pentameric) (NNS peptides)) (VP (VBG consisting) (PP (IN of) (NP (NP (NN Pro)) (CC and) (NP (NP (NP (NNP Gly)) (, ,) (CC or) (NP (NN Pro))) (, ,) (NP (NNP Hyp)) (, ,) (CC and) (NP (NNP Gly))))))) (VP (VBP are) (NP (NP (NP (NNS chemoattractants)) (PP (IN for) (NP (NNS neutrophils)))) (NP (NP (CD -LSB-1)) (, ,) (NP (CD 2)) (, ,) (NP (CD 3) (-RRB- -RSB-))))))))) (. .)) (S (NP (NN Figure) (CD 1)) (VP (VBZ shows) (SBAR (IN that) (S (NP (NP (DT the) (JJ chemotactic) (NN activity)) (PP (IN of) (NP (DT these) (NNS peptides)))) (VP (VBZ is) (ADJP (NN dose) (JJ related)) (, ,) (S (VP (VBG reaching) (NP (DT a) (NN maximum)) (PP (IN at) (NP (NN 10 nM))))))))))) (. .)))
( (S (S (S (VP (VBG Increasing) (NP (NP (DT the) (NN length)) (PP (IN of) (NP (NP (DT the) (NNS peptides)) (PP (IN from) (NP (QP (CD five) (TO to) (CD ten)) (JJ repeated) (NNS units)))))))) (VP (VBD reduced) (NP (PRP$ their) (JJ chemotactic) (NN activity)))) (. .)))
( (S (S (PP (IN At) (NP (NP (NNS concentrations)) (PP (IN of) (NP (NP (CD 1)) (CC and) (NP (CD 10 nM)))))) (, ,) (NP (NP (NNS peptides)) (VP (VBG consisting) (PP (IN of) (NP (NP (NN Pro)) (, ,) (NP (NNP Gly)) (, ,) (CC and) (NP (NN Hyp)))))) (VP (VBD were) (ADJP (RBR less) (JJ chemotactic)) (PP (IN than) (NP (NP (NNS peptides)) (VP (VBG consisting) (PP (IN of) (NP (NP (JJ only) (NN Pro)) (CC and) (NP (NNP Gly))))))))) (. .)))
( (S (S (PP (IN At) (NP (JJ optimal) (NNS concentrations))) (, ,) (NP (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 5)) (, ,) (NP (NP (DT the) (RBS most) (JJ potent)) (PP (IN of) (NP (DT the) (JJ synthetic) (NNS peptides)))) (, ,)) (VP (VBD was) (ADJP (NP (QP (RB approximately) (CD 60)) (NN %)) (RBR less) (JJ active) (PP (IN than) (NP (NN fMLP)))) (PP (IN in) (S (VP (VBG inducing) (NP (NN chemotaxis)) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (VBN Activated) (NNS neutrophils)) (VP (VBP are) (VP (VBN cleared) (PP (IN from) (NP (JJ inflamed) (NNS sites))) (PP (IN by) (NP (NP (DT the) (NN process)) (PP (IN of) (NP (NN apoptosis))))) (, ,) (S (VP (VBN followed) (PP (IN by) (NP (NN macrophage) (NN phagocytosis)))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBZ leads) (PP (TO to) (NP (NP (NN resolution)) (CONJP (RB rather) (IN than)) (NP (NP (NN persistence)) (PP (IN of) (NP (NN tissue) (NN injury)))))))) (. .)))
( (S (S (NP (NP (NNS Chemoattractants)) (PP (JJ such) (IN as) (NP (NN fMLP)))) (VP (VBP promote) (NP (NN inflammation)) (PP (IN by) (S (VP (VP (VBG activating) (NP (NNS neutrophils))) (CC and) (VP (VBG prolonging) (NP (NP (DT the) (NN survival)) (PP (IN of) (NP (DT these) (NNS cells))) (PP (IN in) (NP (NNS tissues)))) (PP (IN by) (S (VP (VBG blocking) (NP (NN apoptosis) (CD -LSB-13) (-RRB- -RSB-))))))))))) (. .)))
( (S (S (PP (IN In) (NP (JJ further) (NNS studies))) (, ,) (NP (PRP we)) (VP (VBD analyzed) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ synthetic) (JJ polymeric) (NNS peptides))) (PP (IN on) (NP (NN neutrophil) (NN apoptosis)))))) (. .)))
( (S (S (NP (NP (CD One)) (PP (IN of) (NP (NP (DT the) (JJS earliest) (NNS signs)) (PP (IN of) (NP (NN apoptosis)))))) (VP (VBZ is) (NP (NP (NN translocation)) (PP (IN of) (NP (NP (NN phosphatidylserine)) (PRN (-LRB- -LRB-) (NP (NN PS)) (-RRB- -RRB-)))) (PP (IN from) (NP (DT the) (JJ inner))) (PP (TO to) (NP (NP (DT the) (JJ outer) (NN surface)) (PP (IN of) (NP (DT the) (NN plasma) (NN membrane))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB be) (VP (VBN detected) (PP (IN by) (NP (NP (NN Annexin) (NN V)) (VP (VBG binding) (NP (CD -LSB-14) (-RRB- -RSB-))))))))))))) (. .)))
( (S (S (NP (NP (QP (RB Approximately) (CD 30)) (NN %)) (PP (IN of) (NP (NNS neutrophils)))) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB undergo) (NP (JJ spontaneous) (NN apoptosis)) (PP (IN after) (NP (NP (NNS 24 hours)) (PP (IN in) (NP (NN culture))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 2)) (-RRB- -RRB-)))))))) (. .)))
( (S (S (NP (DT This) (NN activity)) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN reduced) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (DT the) (NNS polypeptides)))))))) (. .)))
( (S (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (DT the) (JJ synthetic) (NNS peptides)))) (VP (VBD were) (ADJP (JJ similar) (PP (TO to) (NP (NN fMLP)))))) (. .)))
( (S (S (PP (IN In) (NN contrast) (TO to) (NP (NN chemotaxis))) (, ,) (NP (DT no) (NNS differences)) (VP (VBD were) (VP (VBN noted) (PP (IN in) (NP (NP (DT the) (JJ antiapoptotic) (NN activity)) (PP (IN of) (NP (JJ collagen-like) (NNS peptides))) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (PRP$ their) (NP (NN size)) (CC or) (NP (NN composition))))))))))) (. .)))
( (S (S (NP (PRP We)) (ADVP (RB next)) (VP (VBD investigated) (NP (NP (JJ potential) (JJ biochemical) (NN signaling) (NNS pathways)) (VP (VBG mediating) (NP (NP (DT the) (JJ biologic) (NN activity)) (PP (IN of) (NP (DT these) (NNS peptides))) (PP (IN in) (NP (NNS neutrophils)))))))) (. .)))
( (S (S (PP (IN For) (NP (JJ comparative) (NNS purposes))) (, ,) (NP (PRP we)) (ADVP (RB also)) (VP (VBD evaluated) (NP (NP (DT the) (NN response)) (PP (IN of) (NP (DT the) (NNS cells))) (PP (TO to) (NP (NN fMLP)))))) (. .)))
( (S (S (NP (NP (NN Treatment)) (PP (IN of) (NP (NNS neutrophils))) (PP (IN with) (NP (NN fMLP)))) (VP (VBD caused) (NP (NP (DT a) (ADJP (ADJP (JJ rapid)) (CC and) (ADJP (JJ transient))) (NN increase)) (PP (IN in) (NP (JJ intracellular) (NN calcium))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (ADJP (JJ evident) (PP (IN within) (NP (NP (NN 30 seconds)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 3)) (-RRB- -RRB-))))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NN none)) (PP (IN of) (NP (DT the) (JJ synthetic) (NNS polypeptides)))) (VP (VBD induced) (NP (NN calcium) (NN mobilization)) (PP (IN in) (NP (NNS neutrophils))))) (. .)))
( (S (S (NP (NN PI3-K)) (VP (VP (VBZ catalyzes) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (NN phosphatidylinositol) (NN 3,4,5-triphosphate))))) (CC and) (VP (VBZ plays) (NP (DT a) (JJ key) (NN role)) (PP (IN in) (NP (NP (NN neutrophil) (NN activation)) (CC and) (NP (NN chemotaxis) (CD -LSB-15) (, ,) (CD 16) (-RRB- -RSB-))))))) (. .)))
( (S (S (NP (NP (JJ Low) (NNS levels)) (PP (IN of) (NP (NN PI3-K) (NN protein)))) (VP (VBD were) (ADJP (JJ detectable)) (PP (IN in) (NP (JJ unstimulated) (NNS neutrophils))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 4a)) (-RRB- -RRB-)))) (. .)))
( (S (S (NP (NP (NN Treatment)) (PP (IN of) (NP (DT the) (NNS cells))) (PP (IN with) (NP (NP (JJ pentameric) (NNS peptides)) (VP (VBG consisting) (PP (IN of) (NP (NP (NN Pro)) (CC and) (NP (NN Gly)))))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (JJ twofold) (NN increase)) (PP (IN in) (NP (NN PI3-K))))))) (. .)))
( (S (S (NP (DT This)) (VP (VP (VBD was) (ADJP (JJ evident) (PP (IN after) (NP (NN 2 hours))))) (CC and) (VP (VBD was) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT the) (NN response)) (VP (VBN observed) (PP (IN with) (NP (NN fMLP)))))))))) (. .)))
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (DT the) (JJ pentameric) (NN peptide)) (VP (VP (VBG containing) (NP (NP (NN Hyp)) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NN PI3-K)))))) (, ,) (CC and) (VP (VBG increasing) (NP (NP (DT the) (NN length)) (PP (IN of) (NP (NP (DT the) (NNS peptides)) (PP (IN from) (NP (QP (CD 5) (TO to) (CD 10)) (VBN repeated) (NNS units))))))))) (VP (VBD did) (RB not) (VP (VB alter) (NP (NP (DT the) (NN quantity)) (PP (IN of) (NP (NP (NN PI3-K)) (VP (VBN detected))))))) (. .)))
( (S (S (S (VP (TO To) (VP (VB analyze) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN PI3-K))) (PP (IN in) (NP (NP (NN collagen) (JJ peptide-induced) (NN chemotaxis)) (CC and) (NP (NN apoptosis)))))))) (, ,) (NP (NNS cells)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NN LY) (NN 294002) (CD -LSB-17))))) (-RRB- -RSB-)) (. .)))
( (S (S (NP (DT This) (NN PI3-K) (NN inhibitor)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB reduce) (NP (NP (NN chemotaxis)) (VP (VBN induced) (PP (IN by) (NP (NP (NN fMLP)) (, ,) (NP (NP (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 5)) (CC and) (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 10))) (, ,) (ADVP (RB as) (RB well) (PP (IN as) (NP (-LRB- -LRB-) (NN Pro-Hyp-Gly) (-RRB- -RRB-) (CD 5))))) (, ,) (CC and) (-LRB- -LRB-) (NP (NN Pro-Hyp-Gly)) (-RRB- -RRB-) (CD 10))) (PP (IN by) (NP (CD 50) (NN %))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1b)) (, ,) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (DT No) (JJ major) (NNS differences)) (VP (VBD were) (VP (VBN noted) (PP (IN in) (NP (NP (DT the) (NN sensitivity)) (PP (IN of) (NP (DT the) (NNS peptides))) (PP (TO to) (NP (DT the) (NN PI3-K) (NN inhibitor)))))))) (. .)))
( (S (S (ADVP (RB Similarly)) (, ,) (NP (NN LY) (CD 294002)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB block) (NP (NP (DT the) (JJ inhibitory) (NNS effects)) (PP (IN of) (NP (CC both) (NP (NN fMLP)) (CC and) (NP (JJ synthetic) (NNS peptides)))) (PP (IN on) (NP (NN apoptosis)))))))))) (. .)))
( (S (S (SBAR (IN As) (S (VP (VBN observed) (PP (IN with) (NP (NN chemotaxis)))))) (, ,) (NP (DT no) (NNS differences)) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (NP (DT the) (NN sensitivity)) (PP (IN of) (NP (NP (DT the) (JJ antiapoptotic) (NNS effects)) (PP (IN of) (NP (DT the) (NNS peptides))))) (PP (TO to) (NP (NN PI3-K) (NN inhibition))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 2)) (, ,) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-))))) (. .)))
( (S (S (PP (IN In) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (DT these) (NNS peptides))))) (, ,) (NP (NN LY) (CD 294002)) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NN chemotaxis)) (CC or) (NP (NN apoptosis)))))) (. .)))
( (S (S (NP (JJ Recent) (NNS studies)) (VP (VBP have) (VP (VBN implicated) (NP (NN MAP) (NNS kinases)) (PP (PP (IN in) (NP (JJ chemoattractant-induced) (NN signaling))) (CC and) (PP (IN in) (NP (NP (NN PI3-K) (NN activation)) (PP (IN in) (NP (NNS neutrophils) (QP (CD -LSB-18) (, ,) (CD 19) (, ,) (CD 20)))))) (-RRB- -RSB-))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (JJ untreated) (NNS neutrophils)) (VP (VBD expressed) (NP (NP (RB relatively) (JJ large) (NNS quantities)) (PP (IN of) (NP (NP (JJ total) (NP (NN p38) (NN MAP) (NN kinase)) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 4b)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (NP (NN Expression)) (PP (IN of) (NP (DT this) (NN protein)))) (VP (VBD was) (ADJP (JJ unaltered) (PP (PP (IN by) (NP (NN fMLP))) (CC or) (PP (IN by) (NP (JJ synthetic) (NNS polypeptides))))))) (. .)))
( (S (PP (IN In) (NP (NN contrast))) (, ,) (S (S (NP (NP (ADJP (RB only) (JJ low)) (NNS levels)) (PP (IN of) (NP (NN phospho-p38) (NN MAP) (NN kinase)))) (VP (VBD were) (VP (VBN detected) (PP (IN in) (NP (JJ unstimulated) (NNS neutrophils)))))) (, ,) (CC and) (S (NP (DT this)) (VP (VBD was) (ADVP (RB markedly)) (VP (VBN increased) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN fMLP))))) (, ,) (ADVP (RB as) (RB well) (PP (IN as) (NP (NP (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 5)) (CC and) (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 10))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 4c)) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (DT these) (NNS peptides))) (PP (IN on) (NP (NN phospho-p38) (NN expression)))) (VP (VBD were) (ADJP (JJ rapid)) (, ,) (S (VP (VP (VBG peaking) (NP (NP (CD 5) (NNS minutes)) (PP (IN after) (NP (NN treatment))))) (CC and) (VP (VBG persisting) (PP (IN for) (NP (NP (ADJP (IN at) (JJS least)) (NNS 20 minutes)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 4d)) (, ,) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-))))))))) (. .)))
( (S (S (NP (NP (NN Treatment)) (PP (IN of) (NP (NNS neutrophils))) (PP (IN with) (NP (NP (NNS peptides)) (VP (VBG containing) (NP (NN Hyp)))))) (VP (VBD had) (NP (DT no) (JJ significant) (NN effect)) (PP (IN on) (NP (NP (NN phospho-p38) (NN protein) (NN expression)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 4c)) (-RRB- -RRB-)))))) (. .)))
( (S (S (NP (NP (NN Pretreatment)) (PP (IN of) (NP (DT the) (NNS cells))) (PP (IN with) (NP (NP (NN SB) (CD 203580)) (, ,) (NP (DT a) (NN p38) (NN MAP) (NN kinase) (NN inhibitor) (CD -LSB-21) (-RRB- -RSB-)) (, ,)))) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (ADVP (RB significantly)) (VP (VB reduce) (NP (NP (NN chemotaxis)) (VP (VBN induced) (PP (IN by) (NP (NP (PRN (-LRB- -LRB-) (NP (NN Pro-Pro-Gly)) (-RRB- -RRB-)) (NP (CD 5)) (CC and) (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 10))) (, ,) (ADVP (RB as) (RB well) (PP (IN as) (NP (-LRB- -LRB-) (NN Pro-Hyp-Gly) (-RRB- -RRB-) (CD 5)))) (, ,) (CC and) (NP (NP (-LRB- -LRB-) (NN Pro-Hyp-Gly) (-RRB- -RRB-) (CD 10)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1b)) (-RRB- -RRB-))))))))))))) (. .)))
( (S (S (ADVP (RB Similarly)) (, ,) (NP (NN SB) (CD 203580)) (VP (VBD blocked) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NN fMLP)) (CC and) (NP (JJ synthetic) (NNS peptides)))) (PP (IN on) (NP (NN apoptosis)))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (DT this) (NN response)) (VP (VBZ is) (ADVP (RB also)) (ADJP (ADJP (NN p38) (NN MAP) (JJ kinase-dependent)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 2)) (, ,) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (DT The) (NP (NN transcription) (NN factor)) (NP (NN NF-κB))) (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB be) (VP (VBN activated) (PP (IN by) (NP (NNS chemoattractants))) (PP (IN through) (NP (NN MAP) (NNS kinases) (CD -LSB-22) (-RRB- -RSB-)))))))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (DT each)) (PP (IN of) (NP (DT the) (JJ synthetic) (NNS peptides)))) (, ,) (PP (IN like) (NP (NN fMLP))) (, ,) (VP (VBD induced) (NP (NP (JJ nuclear) (NN binding)) (PP (IN of) (NP (NP (NN NF-κB)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 5)) (-RRB- -RRB-)))))))))) (. .)))
( (S (S (NP (DT This) (NN response)) (VP (VBD was) (ADJP (JJ independent) (PP (IN of) (NP (NP (NN peptide) (NN length)) (CC or) (NP (NN composition))))))) (. .)))
( (S (S (NP (NN Supershift) (NNS assays)) (VP (VBD revealed) (SBAR (IN that) (S (NP (DT the) (JJ NF-κB) (NN complex)) (VP (VBD contained) (NP (CC both) (NP (NN p50)) (CC and) (NP (NN p65))) (PRN (-LRB- -LRB-) (ADVP (RB not)) (VP (VBN shown)) (-RRB- -RRB-))))))) (. .)))
( (S (S (NP (NP (NN Preincubation)) (PP (IN of) (NP (JJ nuclear) (NNS extracts))) (PP (IN with) (NP (JJ excess) (JJ unlabeled) (NN probe)))) (ADVP (RB competitively)) (VP (VBD reduced) (NP (NP (NN binding)) (PP (IN of) (NP (DT the) (JJ labeled) (NN probe)))) (, ,) (S (VP (VBG demonstrating) (NP (PRP$ its) (NN specificity)))))) (. .)))
( (S (NP (NN DISCUSSION))))
( (S (S (NP (NP (NN Neutrophil) (NN chemotaxis)) (CC and) (NP (NN survival))) (VP (VBP are) (VP (VBN regulated) (PP (IN by) (NP (NP (JJ inflammatory) (NNS mediators)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (JJ present)) (PP (IN at) (NP (NP (NNS sites)) (PP (IN of) (NP (NP (NN infection)) (CC or) (NP (NN injury)))))))))))))) (. .)))
( (S (S (SBAR (IN Whereas) (S (NP (JJ proinflammatory) (NNS mediators)) (VP (VP (VBP promote) (NP (NN chemotaxis))) (CC and) (VP (VBP block) (NP (NN apoptosis)))))) (, ,) (NP (JJ antiinflammatory) (NNS cytokines)) (VP (VP (VBP are) (ADJP (JJ proapoptotic))) (CC and) (VP (VB abrogate) (NP (DT the) (JJ chemotactic) (NN response))))) (. .)))
( (S (NP (NP (JJ Coordinate) (NN regulation)) (PP (IN of) (NP (NP (NN chemotaxis)) (CC and) (NP (NN survival))))) (VP (VBZ allows) (PP (IN for) (NP (NP (DT the) (NN persistence)) (PP (IN of) (NP (NNS neutrophils))) (PP (IN at) (NP (NP (NP (NNS sites)) (PP (IN of) (NP (NN injury)))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ effective) (NN termination)) (PP (IN of) (NP (DT the) (JJ inflammatory) (NN response) (NN -LSB-23)))))) (-RRB- -RSB-)))) (. .)))
( (S (S (NP (DT The) (JJ present) (NNS studies)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (JJ synthetic) (NNS peptides)) (VP (VBG containing) (NP (JJ collagen-like) (JJ structural) (NNS motifs)))) (VP (VP (VBP induce) (NP (NN chemotaxis))) (CC and) (VP (VBP reduce) (NP (NP (NN apoptosis)) (PP (IN in) (NP (NNS neutrophils)))))))))) (. .)))
( (S (S (NP (DT These) (NNS results)) (VP (VBP are) (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT a) (JJ proinflammatory) (NN role)) (PP (IN of) (NP (DT these) (NNS peptides)))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBZ is) (VP (VBN supported) (PP (IN by) (NP (NNS reports) (SBAR (IN that) (S (NP (JJ synthetic) (JJ collagen-like) (NNS peptides)) (ADVP (RB also)) (VP (VBP stimulate) (NP (NP (NP (JJ oxidative) (NN metabolism)) (CC and) (NP (NN macrophage) (NN release))) (PP (IN of) (NP (NN neutrophil) (NNS chemokines) (NP (NP (CD -LSB-4)) (PRN (, ,) (NP (CD 24)) (-RRB- -RSB-)))))))))))))) (. .)))
( (S (S (NP (NN Tissue) (NN injury)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (NN breakdown)) (PP (IN of) (NP (JJ interstitial) (JJ connective) (NN tissue)))))))) (. .)))
( (S (S (NP (PRP$ Our) (NNS findings) (SBAR (IN that) (S (NP (NP (NNS peptides)) (VP (VBG containing) (NP (JJ collagen-like) (JJ structural) (NNS motifs)))) (VP (VBP exhibit) (NP (JJ proinflammatory) (NN activity)))))) (VP (VBZ suggests) (SBAR (IN that) (S (NP (PRP they)) (VP (MD may) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (S (VP (VBG amplifying) (NP (NP (JJ acute) (JJ immunological) (NNS responses)) (PP (TO to) (NP (NP (NN infection)) (CC or) (NP (NN injury)))))))))))))) (. .)))
( (S (S (ADJP (JJ Consistent) (PP (IN with) (NP (JJ previous) (NNS studies) (NP (NP (NN -LSB-2)) (PRN (, ,) (NP (CD 3)) (-RRB- -RSB-))))))) (, ,) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (DT the) (JJ chemotactic) (NN activity)) (PP (IN of) (NP (DT the) (JJ synthetic) (NNS polypeptides)))) (VP (VBD was) (ADJP (RB directly) (JJ related) (PP (TO to) (NP (PRP$ their) (NP (NN size)) (CC and) (NP (NN composition))))))))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (NP (NP (JJR larger) (NNS peptides)) (VP (VBG containing) (NP (CD ten) (JJ repeated) (NNS subunits)))) (VP (VBD were) (ADJP (RBR less) (JJ active)) (PP (IN than) (NP (NP (DT those)) (VP (VBG containing) (NP (CD five) (NNS subunits))))))) (. .)))
( (S (S (ADVP (RB Moreover)) (, ,) (NP (NP (NNS peptides)) (VP (VBG consisting) (PP (IN of) (NP (NP (NN Pro)) (, ,) (NP (NNP Gly)) (, ,) (CC and) (NP (NN Hyp)))))) (VP (VBD were) (ADJP (RBR less) (JJ chemotactic)) (PP (IN than) (NP (NP (NNS peptides)) (VP (VBG consisting) (PP (IN of) (NP (NP (JJ only) (NN Pro)) (CC and) (NP (NNP Gly))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (SBAR (IN although) (S (NP (NP (DT each)) (PP (IN of) (NP (DT the) (NNS peptides)))) (ADVP (RB markedly)) (VP (VBD reduced) (NP (NN neutrophil) (NN apoptosis))))) (, ,) (NP (DT these) (NNS effects)) (VP (VBD were) (ADJP (JJ independent) (PP (IN of) (NP (NP (NN peptide) (NN size)) (CC or) (NP (NN structure))))))) (. .)))
( (S (S (NP (DT These) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN collagen) (JJ peptide-induced) (NN chemotaxis)) (CC and) (NP (NN apoptosis))) (VP (VBP involve) (NP (NP (JJ distinct) (NNS receptors)) (CC and/or) (NP (NN signaling) (NNS mechanisms)))))))) (. .)))
( (S (S (NP (NP (CD One) (JJ early) (NN step)) (PP (IN in) (NP (NP (DT the) (NN signaling) (NN pathway)) (VP (VBN induced) (PP (IN by) (NP (NNS chemoattractants))))))) (VP (VBZ is) (NP (NP (NN mobilization)) (PP (IN of) (NP (JJ intracellular) (NN Ca++) (NN -LSB-25)))) (PRN (, ,) (NP (CD 26)) (-RRB- -RSB-)))) (. .)))
( (S (S (PP (IN In) (NP (NP (NN contrast)) (PP (TO to) (NP (NN fMLP))))) (, ,) (NP (DT the) (JJ synthetic) (NNS peptides)) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NN calcium) (NN mobilization)) (PP (IN in) (NP (JJ human) (NNS neutrophils))))))) (. .)))
( (S (S (NP (DT These) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (ADJP (ADJP (JJ chemotactic)) (CC and) (ADJP (JJ antiapoptotic))) (NNS actions)) (PP (IN of) (NP (DT these) (NNS peptides)))) (VP (VBP do) (RB not) (VP (VB require) (NP (NP (NNS changes)) (PP (IN in) (NP (JJ intracellular) (NN calcium)))))))))) (. .)))
( (S (S (NP (DT This)) (VP (VBZ is) (ADJP (JJ consistent) (PP (IN with) (NP (NP (NNS reports)) (PP (IN of) (NP (NP (JJ other) (JJ proinflammatory) (NNS mediators)) (SBAR (WHNP (WDT that)) (S (VP (VBP alter) (NP (NP (NN neutrophil) (NN chemotaxis)) (CC and) (NP (NN apoptosis))) (PP (IN by) (NP (NP (NNS mechanisms)) (ADJP (JJ independent) (PP (IN of) (NP (JJ intracellular) (NN calcium) (NNS shifts)))) (, ,) (PP (VBG including) (NP (NP (NN transforming) (NN growth) (NN factor-β1)) (, ,) (NP (JJ soluble) (NN Fas) (NN ligand)) (, ,) (NP (JJ immune) (NNS complexes)) (, ,) (CC and) (NP (NP (DT the) (JJ antineutrophil) (NN antibody)) (, ,) (NP (CD DL1.2) (NN -LSB-27)))))))))) (, ,) (CD 28) (, ,) (CD 29) (, ,) (CD 30) (-RRB- -RSB-)))))))) (. .)))
( (S (S (NP (PRP$ Our) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (NN requirement)) (PP (IN for) (NP (NP (NNS increases)) (PP (IN in) (NP (JJ intracellular) (NN calcium))))) (PP (IN for) (NP (NP (NN induction)) (PP (IN of) (NP (JJ biological) (NN activity)))))) (VP (VBZ depends) (PP (IN on) (NP (DT the) (NN chemoattractant)))))))) (. .)))
( (S (S (NP (NP (NN Activation)) (PP (IN of) (NP (NN protein) (NNS kinases))) (PP (VBG including) (NP (NP (NN PI3-K)) (CC and) (NP (NN p38) (NN MAP) (NN kinase))))) (VP (VBZ is) (VP (VBN thought) (S (VP (TO to) (VP (VB play) (NP (DT a) (JJ critical) (NN role)) (PP (IN in) (NP (NP (JJ chemoattractant-induced) (NN signaling)) (VP (VBG leading) (PP (TO to) (NP (NP (JJ biologic) (NNS responses)) (PRN (QP (CD -LSB-19) (, ,) (CD 20) (, ,) (CD 31) (, ,) (CD 32) (, ,) (CD 33) (, ,) (CD 34) (, ,) (CD 35) (, ,) (CD 36)) (-RRB- -RSB-))))))))))))) (. .)))
( (S (S (S (ADJP (JJ Consistent) (PP (IN with) (NP (DT this) (NN idea))))) (, ,) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (DT the) (JJ synthetic) (NNS peptides))) (PP (IN on) (NP (NP (NN chemotaxis)) (CC and) (NP (NN apoptosis))))) (VP (VBD were) (ADJP (JJ dependent) (PP (IN on) (NP (CC both) (NP (NN PI3-K)) (CC and) (NP (NP (NN p38) (NN MAP) (NN kinase)) (NN activity)))))))))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (NP (NP (NN LY) (CD 294002)) (CC and) (NP (NP (NN SB) (CD 203580)) (, ,) (NP (NP (NNS inhibitors)) (PP (IN of) (NP (NP (NN PI3-K)) (CC and) (NP (NN p38) (NN MAP) (NN kinase)) (, ,) (ADVP (RB respectively))))) (, ,))) (VP (VBD blocked) (NP (NP (CC both) (DT the) (ADJP (ADJP (JJ chemotactic)) (CC and) (ADJP (JJ antiapoptotic))) (NN activity)) (PP (IN of) (NP (NP (DT each)) (PP (IN of) (NP (DT the) (NNS peptides)))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (SBAR (IN whereas) (S (NP (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 5)) (CC and) (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 10))) (VP (VBD induced) (NP (NP (NP (NP (NN PI3-K)) (CC and) (NP (NN phospho-p38))) (NN expression)) (PP (IN in) (NP (NNS neutrophils))))))) (, ,) (NP (NP (-LRB- -LRB-) (NN Pro-Hyp-Gly) (-RRB- -RRB-) (CD 5)) (CC and) (NP (-LRB- -LRB-) (NN Pro-Hyp-Gly) (-RRB- -RRB-) (CD 10))) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (DT these) (NNS proteins))))) (. .)))
( (S (S (NP (NP (NNS Peptides)) (VP (VBG containing) (NP (NN Hyp)))) (VP (VBD were) (ADVP (RB also)) (NP (JJR less) (JJ potent) (NNS chemoattractants)) (PP (IN than) (NP (NP (NNS peptides)) (VP (VBG containing) (NP (RB only) (NP (NN Pro)) (CC and) (NP (NNP Gly)))))))) (. .)))
( (S (S (NP (DT These) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (JJ relative) (JJ chemotactic) (NN potency)) (PP (IN of) (NP (DT these) (NNS peptides)))) (VP (MD may) (VP (VB be) (ADJP (JJ related) (PP (TO to) (NP (NP (PRP$ their) (NN efficacy)) (PP (IN in) (S (VP (VBG upregulating) (NP (NP (NN PI3-K)) (CC and) (NP (NN p38) (NN MAP) (NN kinase))))))))))))))) (. .)))
( (S (ADVP (RB Alternatively)) (, ,) (NP (NP (NN fMLP)) (, ,) (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 5)) (, ,) (CC and) (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 10))) (VP (MD may) (VP (VB induce) (NP (NP (JJ rapid) (NNS alterations)) (PP (IN in) (NP (NP (DT the) (JJ subcellular) (NN localization)) (PP (IN of) (NP (NN PI3-K) (NN protein))) (PP (IN in) (NP (NNS neutrophils))))))) (, ,) (S (VP (VBG leading) (PP (TO to) (NP (NP (VBN increased) (NP (NN accessibility)) (CC and) (NP (NN detection))) (PP (IN by) (NP (NN immunoblotting)))))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (DT this)) (VP (VBZ does) (RB not) (VP (VB appear) (S (VP (TO to) (VP (VB be) (NP (NP (DT the) (NN case)) (PP (IN for) (NP (NN apoptosis)))))))))) (. .)))
( (S (S (ADVP (RB Thus)) (, ,) (NP (NP (DT an) (NN inability)) (VP (TO to) (VP (VB induce) (NP (NP (NN PI3-K)) (CC or) (NP (NN phospho-p38)) (NP (NN MAP) (NN kinase)))))) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (JJ antiapoptotic) (NN activity)) (PP (IN of) (NP (JJ Hyp-containing) (NNS peptides))))))) (. .)))
( (S (S (NP (DT The) (NN observation) (SBAR (IN that) (S (NP (NP (DT the) (JJ antiapoptotic) (NNS effects)) (PP (IN of) (NP (NP (-LRB- -LRB-) (NN Pro-Hyp-Gly) (-RRB- -RRB-) (CD 5)) (CC and) (NP (-LRB- -LRB-) (NN Pro-Hyp-Gly) (-RRB- -RRB-) (CD 10))))) (VP (VBD were) (VP (VBN blocked) (PP (IN by) (NP (NP (NN PI3-K)) (CC and) (NP (NN p38)) (NP (NN MAP) (NN kinase) (NNS inhibitors))))))))) (VP (VBZ indicates) (SBAR (IN that) (S (NP (DT these) (NN signaling) (NNS pathways)) (VP (VBP are) (ADVP (RB nevertheless)) (ADJP (JJ essential) (PP (IN for) (NP (DT this) (NN response))))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (PRP they)) (VP (VBP appear) (S (VP (TO to) (VP (VB be) (VP (VBN activated) (ADVP (RB distinctly)) (PP (IN by) (NP (NP (PRN (-LRB- -LRB-) (NP (NN Pro-Pro-Gly)) (-RRB- -RRB-)) (NN n)) (CC and) (NP (PRN (-LRB- -LRB-) (NP (NN Pro-Hyp-Gly)) (-RRB- -RRB-)) (NN n)) (NP (NNS peptides)))))))))) (. .)))
( (S (S (NP (JJ Previous) (NNS studies)) (VP (VBP have) (VP (VBN suggested) (SBAR (IN that) (S (NP (NP (JJ PI3-K-mediated) (NNS responses)) (VP (VBN induced) (PP (IN by) (NP (NNS chemoattractants))))) (VP (VBP involve) (NP (NP (NN mobilization)) (PP (IN of) (NP (JJ intracellular) (NN calcium)))) (PP (IN through) (NP (NP (NN activation)) (PP (IN of) (NP (NN phospholipase) (NN C) (CD -LSB-37)))))) (-RRB- -RSB-)))))) (. .)))
( (S (S (NP (NP (NNS Alterations)) (PP (IN in) (NP (JJ cytosolic) (NN Ca2+)))) (VP (VBP are) (ADVP (RB also)) (ADJP (JJ important) (PP (IN in) (S (VP (VBG inducing) (NP (NP (NN p38) (NN MAP) (NN kinase)) (NN activity)) (PP (IN in) (NP (NNS neutrophils) (CD -LSB-38) (-RRB- -RSB-))))))))) (. .)))
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (PRP$ our) (NNS findings)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (JJ synthetic) (JJ peptide-induced) (NN activation)) (PP (IN of) (NP (NP (NN PI3-K)) (CC and) (NP (NN p38) (NN MAP) (NN kinase)))) (, ,) (VP (VBG leading) (PP (TO to) (NP (NP (NN chemotaxis)) (CC and) (NP (VBN reduced) (NN apoptosis))))) (, ,)) (VP (VBZ occurs) (PP (IN though) (NP (JJ calcium-independent) (NNS pathways)))))))) (. .)))
( (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ possible)) (SBAR (IN that) (S (NP (NP (NNS phosphoinositides)) (, ,) (CC or) (NP (NP (VBN phosphorylated) (NN protein) (NNS products)) (PP (IN of) (NP (NP (NN PI3-K)) (CC or) (NP (NN p38) (NN MAP) (NN kinase))))) (, ,)) (VP (VBP interact) (ADVP (RB directly)) (PP (IN with) (NP (JJ actin-binding) (NNS proteins))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (JJ directed) (NN migration)) (PP (IN of) (NP (DT the) (NNS cells))))) (NP (CD -LSB-39)) (-RRB- -RSB-)))))))) (. .)))
( (S (S (NP (NN p38) (NN MAP) (NN kinase)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN known) (S (VP (TO to) (VP (VB phosphorylate) (NP (NP (NNS proteins)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB regulate) (NP (NP (NN chemotaxis)) (CC and) (NP (NN apoptosis))) (PP (IN by) (NP (NP (JJ calcium-independent) (NNS mechanisms)) (, ,) (PP (VBG including) (NP (NP (NN MAP) (JJ kinase-activated) (NNS proteins)) (QP (CD 2) (, ,) (CD 3) (, ,) (CC and) (CD 5)))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (DT the) (NN transcription) (NNS factors) (NP (NP (NN ATF-2)) (CC and) (NP (NN CHOP-1) (CD -LSB-40) (-RRB- -RSB-))))))))))))))))) (. .)))
( (S (S (NP (NP (NN Signaling)) (PP (IN via) (NP (NP (NN PI3-K)) (CC and) (NP (NN p38) (NN MAP) (NN kinase))))) (VP (VBZ leads) (PP (TO to) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (DT the) (NN transcription) (NN factor) (NN NF-κB))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB regulate) (NP (NP (NNS genes)) (VP (VBN involved) (PP (IN in) (NP (NP (JJ inflammatory) (NNS responses)) (PP (TO to) (NP (NN tissue) (NN injury) (CD -LSB-41) (-RRB- -RSB-)))))))))))))))))) (. .)))
( (S (S (NP (NN NF-κB)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB be) (VP (VBN involved) (PP (IN in) (NP (NP (JJ chemoattractant-induced) (NN neutrophil) (NN activation)) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT the) (NN suppression)) (PP (IN of) (NP (NN apoptosis) (CD -LSB-22) (, ,) (CD 42)))) (-RRB- -RSB-))))))))))) (. .)))
( (S (ADVP (RB Moreover)) (, ,) (S (S (NP (NP (NNS mice)) (VP (VBG lacking) (NP (DT the) (NN NF-κB) (NN subunit) (NN c-Rel)))) (VP (VBP are) (ADJP (JJ resistant) (PP (TO to) (NP (JJ collagen-induced) (NN arthritis)))))) (, ,) (CC and) (S (NP (NP (NN inhibition)) (PP (IN of) (NP (NN NF-κB)))) (VP (VBZ blocks) (NP (NP (NN neutrophil) (NN migration)) (PP (IN into) (NP (JJ damaged) (NNS lungs)))) (ADVP (FW in) (FW vivo)) (PRN (QP (CD -LSB-43) (, ,) (CD 44) (, ,) (CD 45)) (-RRB- -RSB-))))) (. .)))
( (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (NNS peptides)) (VP (VBG containing) (NP (JJ collagen-related) (JJ structural) (NNS motifs)))) (VP (VBD induced) (NP (JJ NF-κB) (JJ nuclear) (NN binding) (NN activity)) (PP (IN in) (NP (NNS neutrophils)))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (NP (DT no) (JJ significant) (NNS differences)) (PP (IN in) (NP (NN activity)))) (VP (VBD were) (VP (VBN observed) (PP (VBN based) (PP (IN on) (NP (NP (DT the) (NP (NP (NN size)) (CC or) (NP (NN composition)))) (PP (IN of) (NP (DT the) (NNS peptides))))))))) (. .)))
( (S (S (NP (DT These) (NNS findings)) (VP (VP (VBP are) (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ antiapoptotic) (NNS effects)) (PP (IN of) (NP (DT these) (JJ synthetic) (NNS peptides))))))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (ADJP (ADJP (JJ chemotactic)) (CC and) (ADJP (JJ antiapoptotic))) (NNS effects)) (PP (IN of) (NP (DT the) (NNS peptides)))) (VP (VBP involve) (NP (NP (JJ distinct) (NN signaling) (NNS pathways)) (VP (VBG leading) (PP (TO to) (NP (JJ NF-κB) (NN activation))))))))))) (. .)))
( (S (NP (NNS CONCLUSIONS))))
( (S (S (NP (NP (JJ Polymeric) (NNS polypeptides)) (VP (VBG containing) (NP (JJ collagen-related) (JJ structural) (NNS motifs)))) (VP (VBP promote) (NP (NN inflammation)) (PP (IN by) (S (VP (VP (VBG inducing) (NP (NN chemotaxis))) (CC and) (VP (VBG blocking) (NP (NN apoptosis)))))))) (. .)))
( (S (S (ADVP (RB However)) (, ,) (NP (JJ distinct) (JJ calcium-independent) (NN signaling) (NNS pathways)) (VP (VBP appear) (S (VP (TO to) (VP (VB be) (VP (VBN involved) (PP (IN in) (NP (DT these) (NNS activities))))))))) (. .)))
( (S (S (NP (NP (NN Neutrophil) (NN chemotaxis)) (CC and) (NP (NN apoptosis))) (VP (VBP are) (NP (NP (DT a) (JJ key)) (PP (TO to) (S (VP (VP (VBG initiating)) (CC and) (VP (VBG controlling) (NP (NN inflammation))))))))) (. .)))
( (S (S (NP (NP (DT The) (NP (NN accumulation)) (CC and) (NP (NN persistence))) (PP (IN of) (NP (DT these) (NNS cells))) (PP (IN in) (NP (NP (NNS tissues)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (NN protein) (NNS fragments)) (VP (VBN generated) (PP (PP (IN by) (NP (JJ invasive) (NNS pathogens))) (CC or) (PP (IN by) (NP (NP (DT the) (NN degradation)) (PP (IN of) (NP (JJ connective) (NN tissue) (NN collagen)))))))))))))) (VP (MD may) (VP (VB exacerbate) (NP (NN injury))))) (. .)))
( (S (S (NP (NP (DT An) (NN understanding)) (PP (IN of) (NP (NP (DT the) (NNS mechanisms)) (VP (VBG mediating) (NP (DT these) (NNS processes)))))) (VP (VBZ is) (ADJP (JJ essential) (PP (IN in) (S (VP (VBG developing) (NP (NP (NNS strategies)) (PP (IN for) (S (VP (VBG limiting) (NP (JJ maladaptive) (JJ inflammatory) (NNS responses)))))))))))) (. .)))
( (S (NP (NP (NN Figure)) (CC and) (NP (NN Table)) (NP (NNS captions)))))
( (S (NP (NP (NN Figure) (CD 1) (: :) (NN Induction)) (PP (IN of) (NP (NN chemotaxis))) (PP (IN by) (NP (JJ synthetic))))))
( (S (NP (NP (NNS polypeptides)) (. .))))
( (S (NP (NN Neutrophil) (NN chemotaxis)) (VP (VBD was) (VP (VBN assayed) (S (VP (VBG using) (NP (NN microwell))))))))
( (S (NP (NP (NNS chambers)) (. .))))
( (S (NP (DT Each) (NN bar)) (VP (VBZ represents) (NP (NP (DT the) (NN mean) (NN ±) (NN SEM)) (PP (IN of) (NP (NN 3–4)))))))
( (S (NP (NP (NNS experiments)) (. .))))
( (S (NP (NP (NN Background) (NNS levels)) (PP (IN of) (NP (NN migration)))) (VP (VBD were) (VP (VBN subtracted) (PP (IN from))))))
( (S (S (NP (DT each) (NN value))) (. .)))
( (S (NP (LST (-LRB- -LRB-) (LS a) (-RRB- -RRB-)) (NP (JJ Dose-dependent) (NNS effects)) (PP (IN of) (NP (NNS peptides))) (PP (IN on) (NP (NN neutrophil))))))
( (S (NP (NP (NN chemotaxis)) (. .))))
( (S (S (NP (-LRB- -LRB-) (NN b) (-RRB- -RRB-) (NNS Cells)) (VP (VBD were) (VP (VBN incubated) (PP (IN with) (NP (NN medium) (NN control)))))) (, ,) (NP (DT the) (NN p38))))
( (S (NP (NP (NP (NP (NN MAP) (NN kinase) (NN inhibitor)) (NP (NN SB) (CD 203580))) (PRN (-LRB- -LRB-) (NP (NP (NN 30 μM)) (, ,) (NP (NN 1 hour))) (-RRB- -RRB-))) (CC or) (NP (DT the)))))
( (S (NP (NP (NN PI3-K) (NN inhibitor)) (NP (NP (NP (NN LY) (NN 294002)) (PRN (-LRB- -LRB-) (NP (NP (NN 50 μM)) (, ,) (NP (NN 5 minutes))) (-RRB- -RRB-))) (ADJP (JJ prior) (PP (TO to)))))))
( (S (NP (NP (DT the) (NN analysis)) (PP (IN of) (NP (NP (JJ chemotactic) (NN responsiveness)) (PP (TO to) (NP (NNS polypeptides))))))))
( (S (S (PRN (-LRB- -LRB-) (NP (NN 10 nM)) (-RRB- -RRB-))) (. .)))
( (S (NP (NP (PRN (-LRB- -LRB-) (NP (NN Pro-Pro-Gly)) (-RRB- -RRB-)) (NP (NN n))) (, ,) (NP (NP (-LRB- -LRB-) (NN PPG) (-RRB- -RRB-) (NN n)) (: ;)))))
( (S (S (NP (NP (-LRB- -LRB-) (NN Pro-Hyp-Gly) (-RRB- -RRB-) (NN n) (, ,)) (PRN (-LRB- -LRB-) (NP (NN POG)) (-RRB- -RRB-))) (NP (NN n))) (. .)))
( (S (S (NP (NN Figure) (CD 2)) (: :) (NP (NP (NN Measurement)) (PP (IN of) (NP (NN neutrophil) (NN apoptosis))))) (. .)))
( (S (NP (NP (NNS Cells)) (VP (VBD were)))))
( (S (VP (VBN incubated) (PP (IN in) (NP (NP (DT a) (JJ shaking) (NN water) (NN bath)) (PRN (-LRB- -LRB-) (NP (NN 37°C)) (-RRB- -RRB-)))) (PP (IN in) (NP (DT the) (NN presence) (NN or))))))
( (S (NP (NP (NN absence)) (PP (IN of) (NP (NN fMLP))) (PRN (-LRB- -LRB-) (NP (CD 5) (NN ×) (NN 10−8 M)) (-RRB- -RRB-)) (, ,) (NP (JJ synthetic)))))
( (S (NP (NP (NP (NNS polypeptides)) (, ,) (NP (NN SB) (CD 203580)) (, ,) (CC or) (NP (NN LY) (CD 294002))) (UCP (PP (IN for) (NP (NNS 24 hours))) (CC and) (ADVP (RB then))))))
( (S (VP (VP (VBN labeled) (PP (IN with) (NP (NP (NN Annexin) (NN V)) (CC and) (NP (NN propidium) (NN iodide))))) (CC and) (VP (VBN analyzed) (PP (IN by) (NP (NN flow)))))))
( (S (NP (NP (NN cytometry)) (. .))))
( (S (NP (NNS Data)) (VP (VBD were) (VP (VBN analyzed) (S (VP (VBG using) (NP (NN Coulter) (NN quadrant) (NNS statistics))))))))
( (S (VP (VBN based) (PP (IN on) (NP (NP (JJ relative) (NN fluorescence) (NN binding)) (PP (IN of) (NP (NP (NN Annexin) (NN V)) (CC and) (NP (NN propidium)))))))))
( (S (NP (NP (NN iodide)) (. .))))
( (S (NP (DT Each) (NN bar)) (VP (VBZ represents) (NP (NP (DT the) (NN mean) (NN ±) (NN SEM)) (PP (IN of) (NP (NN 3–4)))))))
( (S (NP (NP (NNS experiments)) (. .))))
( (S (NP (NP (ADJP (RB Significantly) (JJ different))) (PRN (-LRB- -LRB-) (NP (NN P) (NN <) (CD .05)) (-RRB- -RRB-)))))
( (S (IN from)))
( (S (NP (NP (NN control)) (. .))))
( (S (NP (NP (NN Figure) (CD 3)) (: :) (NP (NP (NNS Effects)) (PP (IN of) (NP (JJ synthetic) (NNS polypeptides))) (PP (IN on) (NP (NN calcium)))))))
( (S (NP (NP (NN mobilization)) (. .))))
( (S (NP (NNS Neutrophils)) (VP (VBD were) (VP (VBN incubated) (PP (IN with) (NP (NN Indo-1)))))))
( (S (S (PRN (-LRB- -LRB-) (NP (NN 1 μM)) (-RRB- -RRB-))) (. .)))
( (S (PP (IN After) (S (VP (VBG establishing) (NP (DT a) (JJ stable) (NN baseline))))) (, ,) (NP (NN 10 nM))))
( (S (NP (NP (NP (NP (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 5)) (, ,) (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 10)) (, ,)) (PRN (-LRB- -LRB-) (NP (NN Pro-Hyp-Gly)) (-RRB- -RRB-))) (CD 5)) (, ,) (NP (NN or)))))
( (S (S (NP (NN fMLP)) (VP (VBD was) (VP (VBN added) (PRN (-LRB- -LRB-) (NP (NN arrow)) (-RRB- -RRB-)) (PP (TO to) (NP (DT the) (NNS cells)))))) (. .)))
( (S (NP (NP (NN Calcium) (NN mobilization)) (VBZ is))))
( (S (S (VP (VBN indicated) (PP (IN by) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (DT the) (JJ Indo-1) (NN fluorescence) (NN ratio))))))) (. .)))
( (S (NP (DT Each))))
( (S (NP (NN graph)) (VP (VBZ represents) (NP (NP (DT the) (JJ average) (NN change)) (PP (IN in) (NP (NN ratio))) (PP (IN in) (NP (NP (DT a) (NN field)) (VP (VBG containing))))))))
( (S (S (NP (QP (RB not) (JJR less) (IN than) (CD 15)) (NNS cells))) (. .)))
( (S (NP (NP (NN Figure) (CD 4)) (: :) (NP (NP (NNS Effects)) (PP (IN of) (NP (JJ synthetic) (NNS polypeptides))) (PP (IN on) (NP (NP (NN PI3-K)) (CC and) (NP (NN p38)) (NP (NN MAP))))))))
( (S (NP (NP (NN kinase) (NN expression)) (. .))))
( (S (NP (NNS Neutrophils)) (VP (VBD were) (VP (VBN incubated) (PRN (-LRB- -LRB-) (NP (NN 37°C)) (-RRB- -RRB-)) (PP (IN with))))))
( (S (NP (NP (NN medium) (NN control)) (, ,) (NP (NP (NN fMLP)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN ×) (NN 10−8 M)) (-RRB- -RRB-))) (, ,) (CC or) (NP (NN 10 nM)))))
( (S (NP (NP (NP (NP (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 5)) (, ,) (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 10)) (, ,)) (PRN (-LRB- -LRB-) (NP (NN Pro-Hyp-Gly)) (-RRB- -RRB-))) (CD 5)) (, ,) (NP (NN or)))))
( (S (NP (NP (-LRB- -LRB-) (NN Pro-Hyp-Gly) (-RRB- -RRB-) (CD 10)) (PP (IN for) (NP (NP (NP (NNS 2 hours)) (PRN (-LRB- -LRB-) (NP (NN PI3-K)) (-RRB- -RRB-))) (CC or) (NP (NNS 5 minutes)))))))
( (S (S (PRN (-LRB- -LRB-) (NP (NP (NN p38)) (, ,) (NP (NN phospho-p38))) (-RRB- -RRB-))) (. .)))
( (S (NP (NP (-LRB- -LRB-) (DT a) (-RRB- -RRB-) (NP (NP (NN PI3-K)) (, ,) (NP (-LRB- -LRB-) (NN b) (-RRB- -RRB-) (NN p38)) (, ,)) (-LRB- -LRB-) (NN c) (-RRB- -RRB-) (NN phospho-p38) (, ,)) (PRN (-LRB- -LRB-) (NP (NN d)) (-RRB- -RRB-)))))
( (S (NP (NN protein) (NNS expressions)) (VP (VBD were) (VP (VBN measured) (S (VP (VBG using) (NP (NN western) (NN blotting))))))))
( (S (S (CC and) (VP (VBN quantified) (PP (IN by) (NP (NN densitometry))))) (. .)))
( (S (NP (NP (NN Time) (NN course)) (PP (IN of) (NP (NN phospho-p38) (NN protein))))))
( (S (NP (NP (NN expression)) (PP (IN in) (NN response) (TO to) (NP (-LRB- -LRB-) (NN Pro-Pro-Gly) (-RRB- -RRB-) (CD 5))) (. .))))
( (S (NP (NP (NN Western) (NNS blots)) (VP (VBD were)))))
( (S (VP (VBN scanned) (PP (IN by) (NP (NP (NN densitometry)) (CC and) (NP (NP (NNS data)) (VP (VBN presented) (PP (IN as) (NP (JJ relative) (NN intensity))))))))))
( (S (NP (NP (NNS units)) (. .))))
( (S (NP (NP (CD One) (JJ representative) (NN experiment)) (PP (IN of) (NP (CD 3)))) (VP (VBZ is) (VP (VBN shown) (PP (IN for) (NP (DT each)))))))
( (S (NP (NP (NN analysis)) (. .))))
( (S (NP (NP (NN Figure) (CD 5)) (: :) (NP (NP (NNS Effects)) (PP (IN of) (NP (JJ synthetic) (NNS polypeptides))) (PP (IN on) (NP (NN NF-κB)))))))
( (S (S (NP (JJ nuclear) (NN binding) (NN activity))) (. .)))
( (S (NP (NP (NP (NNS Neutrophils)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN ×) (NN 106/mL)) (-RRB- -RRB-))) (VP (VBD were)))))
( (S (S (VP (VBN treated) (PP (IN with) (NP (NN medium) (NN control))) (PRN (-LRB- -LRB-) (NP (NNP Med)) (-RRB- -RRB-)))) (, ,) (NP (JJ synthetic) (NNS peptides))))
( (S (NP (NP (-LRB- -LRB-) (NN 10 nM) (-RRB- -RRB-)) (, ,) (CC or) (NP (NP (NP (NN fMLP)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN ×) (NN 10−8 M)) (-RRB- -RRB-))) (PP (IN for))))))
( (S (NP (NP (NN 30 minutes)) (. .))))
( (S (NP (NP (NP (JJ Nuclear) (NNS extracts)) (PRN (-LRB- -LRB-) (NP (NP (NN 50 μg)) (PP (IN of) (NP (NN protein)))) (-RRB- -RRB-))) (VP (VBD were)))))
( (S (S (VP (VBN analyzed) (PP (IN for) (NP (JJ NF-κB) (NN binding) (NN activity))))) (S (VP (VBG using) (NP (DT a) (NN gel) (NN retardation))))))
( (S (NP (NP (NN assay)) (. .))))
( (S (NP (NP (NNS Extracts)) (, ,) (VP (VBN prepared) (PP (IN from) (NP (JJ fMLP-treated) (NNS cells))))) (VP (VBD were) (VP (VBN incubated)))))
( (S (NP (NP (NN in) (NN ice)) (PP (IN for) (NP (NN 1 hour))) (PP (IN with) (NP (NP (NNS antibodies)) (PP (TO to) (NP (DT the) (NP (NP (NN p50)) (CC or) (NP (NN p65))))))))))
( (S (NP (NP (NP (NNS subunits)) (PP (IN of) (NP (NP (NN NF-κB)) (PRN (-LRB- -LRB-) (NP (NN 1 μg)) (-RRB- -RRB-))))) (, ,) (CC or) (NP (RB 100-fold) (NP (NN excess))))))
( (S (NP (NP (NP (JJ unlabeled) (JJ cold) (NN competitor)) (PRN (-LRB- -LRB-) (NP (NN Comp)) (-RRB- -RRB-))) (ADJP (JJ prior) (PP (TO to) (NP (DT the) (JJ labeled)))))))
( (S (NP (NP (NN probe)) (. .))))
